>SEQF2892_00001 50S ribosomal protein L34
MVKRTYQPNKRKHSKVHGFRKRMSTKNGRKVLARRRRKGRKVLSA
>SEQF2892_00002 Ribonuclease P protein component
MEKAYRIKKNTDFQTIYKRGKSVANRQFVVYTYNSNKNHFRLGISVSKKLGNAVTRNRIK
RAIRENFKIHKEDIIARDIIVIARQPAKDMTTLEIQGSLEHVLKIAKVFNKKIK
>SEQF2892_00003 tRNA modification GTPase MnmE
MDFDTITSISTPMGEGAIGIVRLSGPQAVEIGDKLYKGKKKLEDVDSHTINYGHIVDPET
NEVVEEVMISVLRAPRTFTREDIIEINCHGGILTINRILELTMTHGARMAEPGEYTKRAF
LNGRIDLSQAEAVMDFIRSKTDRASKVAMNQIEGRLSDLIKRQRQSILEILAQVEVNIDY
PEYDDVEDATTEFLLEQSKKIKNEINLLLETGAQGKIMREGLSTVIVGKPNVGKSSMLNN
LIQDNKAIVTEVAGTTRDVLEEYVNVRGVPLRLVDTAGIRDTEDIVEKIGVERSRKALSE
ADLILFVLNNNEPLTQEDRTLYEVIKNEDAIVIVNKTDLEQNLDINEVKEMIGDTPLIQT
SMLKQEGIDQLELQIRDLFFGGDVQNQDMTYVSNSRHISLLKQARNAIQDAIDAAESGIP
MDMVQIDLTRTWELLGEIIGESASDELIDQLFSQFCLGK
>SEQF2892_00004 tRNA uridine 5-carboxymethylaminomethyl modification enzyme MnmG
MVQEYDVIVIGAGHAGIEAGLASARRGAKTLMLTINLDNIAFMPCNPSVGGPAKGIVVRE
IDALGGQMAKAIDKTHIQMRMLNTGKGPAVRALRAQADKVLYQQEMKRVIEDEDNLDIMQ
GMVDELIIEDNEVKGVRTNIGTEYRAQAVVITTGTFLRGEIILGNMKYSSGPNHQLPSIT
LADNLRELGFEVVRFKTGTPPRVNAKTIDYSKTEIQPGDDVGRAFSFETTEYILDQLPCW
LTYTNDRTHKVIDDNLHLSAMYSGMIKGTGPRYCPSIEDKFVRFNDKPRHQLFLEPEGRN
TNEVYVQGLSTSLPEHVQRQMLETIPGLEKADMMRAGYAIEYDAIVPTQLWPTLETKMIK
NLYTAGQINGTSGYEEAAGQGIMAGINAAGKVLGTGEKILSRSDAYIGVLIDDLVTKGTN
EPYRLLTSRAEYRLLLRHDNADLRLTDVGYELGMISEERYARFNEKRQQIQDEIQRLTDI
RIKPNEHTQSVIEANGGSRLKDGILAIDLLRRPEMTYNTILEILEESHQLPEAVEEQVEI
QTKYEGYINKSLQQVEKVKRMEEKKIPEDLDYSKVDSLATEAREKLAEVKPLNIAQASRI
SGVNPADISILLVYLEQGKLQRVKN
>SEQF2892_00005 Ribosomal RNA small subunit methyltransferase G
MNGIEWLAKELSEHGIELSDKQKEQFQTYYRLLVEWNEKMNLTSITDEHEVYLKHFYDSI
TPSFYYDFNQPLTICDVGAGAGFPSIPLKIVYPELKVTIVDSLNKRIQFLNHLAAELGLT
QVSFVHDRAETFGKGVNRETYDVVTARAVARLTVLSELCLPLVKKGGQFIALKSSKGEEE
LEEAQFGISILGGVFSDSYTFDLPEDAGERQMIIIDKRRQTSKKYPRKPGTPNKSPLLEN
>SEQF2892_00006 Nucleoid occlusion protein
MKKPFSKLFGLKNKDDIVGYIEEDRNSSVESIQIERIVPNRYQPRQVFDSSKITELAESI
DEHGLLQPIVVRPIEENMYEIIAGERRFRALQSLHKSQADVIIRHMNDEETAVVALIENI
QRENLSAVEEAEAYKKLLEIGGTTQSELAKSLGKSQSFIANKLRLLKLAPKVINRLREGK
ITERHARAVLSLKEDDQEKLIEQVISQKLNVKQTEARVKQKIGPEKVKAQSFQFSKDLTQ
ARDEVGKSIQAIEQSGIRVEQRDKEHDDYYEIKIKIYKK
>SEQF2892_00007 hypothetical protein
MFGISISSAILHFVIGGLAVAIASIMSEKVGGKMGGIIATMPAVYLAAIIALAIDHRGNQ
LVQMSIHLSSGAIIGIISCIITVFLTSLYISKRDYKRGTGFALICWLVISLGIFVVRHMN
>SEQF2892_00008 hypothetical protein
MKLALIKFLVGGLAVTLSYIISVILPWKELGGVFATLPAVFLVSLFITGMQHGDVIAKHV
SRGAVFGMTGVLISILATWAMLYFTNHWLLSIVTGFIAWFVSAVIIFEAVEFITRLRRGK
HGWKTERSDNQS
>SEQF2892_00009 hypothetical protein
MAGRPKDPTINHKIFDEIDRLLVTTHFRDITIDQISENTGVSKATIYRRWKDKSSIIVDM
FVSRTQIFENENKDLYTGLYQYLVKIMSIYKTNLGRAVIEILISNQQNDARELFMQGYFK
NNRKILKSIIAQHIKEEDQDLFIDLIFSPIYFNILIKPETLDEAYIEKMLKMILKSFND
>SEQF2892_00010 HTH-type transcriptional regulator ImmR
MEIGQQIRKYREKEKYSQEYLAEKLYVSRQTISNWENERSYPDIHNLLMMCTLFNVSLDD
LVKGDVKRMGHEEVKKDMDFWTWMMLIWILLACVLIGPLLYYLSWWGVAITYVIFSVGFY
SSTQVDKIKYRHGMDNYDRIVAFMNGQDPNEVQTSKTRNLITSILSFVFVVGAFVIICWL
SIYLSFKFLP
>SEQF2892_00011 hypothetical protein
MDDANGASVKSRDVAILQPKDSNTVPTPNVVFEKSPDPNQYTFAITDLKDFNAAYQTKYY
YRLSKPYDDSNDVTIELVNGETNTVVETKQINSPGTVSIGQNSLEIAVAAHDPQKAKYGH
INFTFLNTLDSFKNTVSTIRARFEIDDNGSLEDRRGGIQIYDLFNQANEGTTITDPQYYV
PHIVPETTYYRVVTKNNPTYQADKTDINAQTYQPDFTEKELAHYTIKGMDGQIYTASNSR
EFEGYKLYQIAEPNHMIGTMVRPYQVGLRYVDAETNNGGVKRIKEIIGEDGTTRIEIWTL
SVDHMSESAKNTGIDTTNYVKVYEATLRPGERNKNDLGKQIYIPGYNIPFLIQPASAGEG
AVGNIFAPNQSINGVQVGRGSNFRLQNLLAKAHPIIYYYTAIDPVEVTLKANKVVKGEHT
LAQGEFTFNIVAGPNSPAIPETSQSKTNAADGSVTFDKISFTKPGTYTYTITENKANLNS
NFDAEPLTITATVTVTEENVALNANVSYAYDSDTDNNQAFTNYYVAPKQLDFDVHFTKSL
VGRPLNNEEFQFTMKNADGEVIATGTNNATGQINFNFIEGKRPTYTNADAGKTFTYTVEE
VPSNLPNISSDSMKAIVTVNITKDLHVLTATSIAPADTEFNNTFVPPTPPTPVFQPEKFD
LSVEKYDITANKLLDDDSELANKYADTNVNPYADQTTNNEPENINTKTLNRGDKIVYQVW
LDTTHLTPENKINKLGITDDYDETSVAVQSIKVYDGITGQDVTNLFDITDENGVIIATSK
DSLVKDHVLDNAQMPFGRYYKLDIVGVIKDSAKASKDITNVANQSVQFFNPAKGGNEVPP
PKPSEKRVNKVKPVPVNFEFKVTKKLEGGQLKGGDYTFILTDLNTPDHPEQSATNDANGK
VNFLPIKFNKVGTYIYQITEQVGTDSNIAYDTMSIKSTVVVTENPETGNLQATVTYNSSG
GKSVGINDTEFNNTVKPPVPPTPNKPPHNPPKTPGQPPVNPPGNPPEKPGVPPTHHVPPT
PKQLNQPKHLPNTGSDDANINKSLLATMFASLGSVLLFGRRRRDGQNLK
>SEQF2892_00012 hypothetical protein
MLQKTKYRFSIRKFSIGTGSVLLGAFLFVGFQDVAHASELHNSTLTTDTASNP
>SEQF2892_00013 hypothetical protein
MNIKELIRKSYEDLLSLKVNWFNGLMLVLIVFILSGIVTPFIGVPVGLLGGGYILKRYEE
KNSN
>SEQF2892_00014 Bacitracin export permease protein BceB
MTFNQITLKNLKSNFKNYALYLFSLIFSIILYFSFVTLQYTHSINNGGSPKVIQEGAKVG
SVFLFITIIIFLMYANQLFIKRRTREFALFQLIGLTRQNILRMLAIEQLTFFFITGIIGI
LIGIVGSEILLNILVKMMHLKVGVSIGFEFPALIQTIVMLVLAFILIMFQNFLFLKRRTI
LSMMKDSTKSEATKAKITVPELIAGILGIIMIIFGYYISTEMFGKFEVLTMVLVTPFLIL
FLTVVGAYLFFRSSVSIIFKSLKKSKHGRISITDVVFTSSIMHRMKKNAMSLTIIAVISA
VTVTILCFGAISKANTDYMIQVSSPQDVNFSKTESAQKYEKLLKQNHIQYDTKTFEGSNT
KLFKNDALKSKTNEGMQNTGIVVMPDKNNKGNHATITNLQGPLSGIVSVHTNKDMTLQGQ
QKMTLNVNKKDDNEVIPSTVSIGGPVLKVSPDNFNKLKMKDQLMHHYGFNIKDHKDLSKA
ETLAQKVSPNVELKNDTKKMLDESNGILIFVTSFLGLAFLIAAGCIIYIKQMDETEDEIN
NYRILRRIGFTHTDMTKGLALKILFNFGLPLIIALLHALFAAMVFMKLMGEYSPIPIIIV
MIVYSLVYLIFAAISFIHANRIVKHSI
>SEQF2892_00015 Bacitracin export ATP-binding protein BceA
MPILNVNHLSKVYGSKQKYKALHDINFSVDKGEFVAIMGPSGSGKTTLLNVISSIDSISG
GTVEVSGNEINQLKDKQLAQFRKKELGFIFQDYSVLPTLTVKENIMLPLSVQKVSKDEME
QNYKEVTEALGIYELSDKYPSEISGGQQQRTAAARAFVHKPAIIFADEPTGALDSKSAQD
LLNRLEDMNERFNSTIIMVTHDPSAASFAQRVIMLKDGNIHSEIHQEDKSKREFYNEIIQ
LQSALGGVANDV
>SEQF2892_00016 hypothetical protein
MKTLRNIFITIVVIAIIVIGGLFGLNAYSNQHPNNHSINDWNKLNPLAPTYEYYVKTQKP
SKVEVVDKEKDFYIYHYNQTGYTKDGKSKKIEYTASKKLKQNHYLVVREKSHTIQSFEEV
KKSKIPTKAKEKL
>SEQF2892_00017 Signal peptidase IB
MKKEIIEWIVAIGGALLIVGIVLKFIGTSYTVSGSSMYPTFQDRNKVIVSKISKTLNHID
NGDVVVFHEDAQRDFIKRVIGTPGDKVEYEGDQLYVNDKKVSEPYLDYNKKHKQGKYLTG
TFKTSQVNGANGKNKIPKDKYLVLGDNRQNSVDSRLAEVGLVDKDQLVGKVVLRYWPFNK
WEAGFNPGTF
>SEQF2892_00018 hypothetical protein
MQCPNCGNAIEPNDLFCGECGHKIDRQSQTINSAEKDISNAEANGRRQDSNESLGEGNET
TSHQSNHLSRTNESKHDKNSYEEGKVPDHQHVPEQTTSTQQHQMHQPQSNQHQQPHNNAA
HTYHNQQQYNQSYSNHQQPQQTSQFSDHAKEVTEESKGFFRSAFASPDQVLKSQQAFSFK
LLFSLIIVGLLVVALLLAIVIPSSVGMFETPKSQIIFSVMLGVILFLAVIVGATYGISRL
VVRKPITFKKVLSDFVLINSVSVAVLLIALILMFANSFSFGGALFMLSILLIVVSGVYMI
AKYSANHHTRFSSFYGVIIYIIVFFLFVTIFGESLFNQIFGNLISEFNNLFDGSSIY
>SEQF2892_00019 Membrane-associated protein TcaA
MKYCSNCGQPLREGVKVCTNCGKPVQQSKPNHSNTQQDYHNQSRQDKHEQHQYQGYNNHN
QNGYADRHDQQPRKGDNKKTWIIIAVIAVLLIALIVAFSVLKNQFSPEKQASNIAQAIKK
DDEKALAKEVTTQNDQKLSKQEARAYLNYIKTEDDLNNVGSNVEQSAKEIKDNRYNNLSV
DANGNNVLNISKDGKKFLFFDNYSFNVPQKSVSIYPSSSGDITYEYNGKKRTTTVTEDDE
KTLGTFPIGDYNLKATKDIDGKKFKGALMINMSDDATAYESFKQKRFTVSVDGGYMLNNV
KIYANDKEIGSESSSETFGPYDPDEEVTVYAQGTYEGKTFKSDSVNVTSSGEDDDDVTDV
TVTFDDDEIDKYIDDKMDAESDSDSDDSDSSSGEVTRDNVIDKVESYEGHTLDTDTYTYK
EPEKTDDGKWGFSFTDKDGDLAGSYTVDTGDGYVTEYDEDGEEVGSGY
>SEQF2892_00020 Putative ribosomal N-acetyltransferase YdaF
MMFGYEVNEHVTLKILEEREAEQLFKLVDSNRDYLGEFLPFVEYTTEVAHSKKFIQSALE
QFTRCDGFHCGIWYDDELVGVIGLHYLDLVNKRTSIGYYLAEHFQKMGIMTACTKALIRY
VYETFDINRVEIQMSTRNPKSKAIPERLGFTQEGVLRSNERLRGEFSDSYVYSLLREEYE
KLRQTFEL
>SEQF2892_00021 hypothetical protein
MPREKRQSCHLIIITAYLISFSILVPQASHCMYLSIKIKNKALPYHLVHITKLN
>SEQF2892_00022 hypothetical protein
MYEIYNMMSHMLPIHTSILISTDDKSQHMNDIVETISKSFLLFSPFINFVSVIVNPLFSS
FFRIFTIFNF
>SEQF2892_00023 Glycine betaine/carnitine transport binding protein GbuC
MAKENIFAGINQTIMLTLSMVVIASMIGTPGLGEGVLAAVQRSEVGNGFVYGIGIVVLAI
IVDRFTQAMNHSRQEKLPKKTKIILTIIILLVAILGSILGHMFSDDKEANKGTIKLAYAQ
QDDQIVSTNVIAQVLEEQGYKVDTTSLDIPVTWEAVSKGEVDAMTGAWLPITHGAEYKKV
KNDIDNLGPHIDKEAKLGLVVPKYMDVNSIEDLNNQANKKITGIEPGAEIVDATNETLKA
YPNLKGWEQINSSTGAMNAELKRAIKNKDDIIITGWNRYWIFQRYDLKYLDDPKGSMGKA
ESINTIARKGLKEDEPEAYRILDNFKWSVKDMESIMLEIENGKDPEKATKEWIDNNRDKV
DKWTEK
>SEQF2892_00024 Glycine betaine/carnitine transport permease protein GbuB
MKMFKQLPFSNWIDTIVNWLTEHLSGIFSFLQTAENAVMNVTTNILLAIPPFVMILLLVL
LAFFVFKRKIGFPIFILIGLLFIYNQNMWDDLMSTITLVLISSLISIIIGVPLGILMSKS
DTVEKIVKPLLDLMQTMPGFLYLIPAVAFFGIGMVPGVFASVIFALPPTVRMTNLGIRSI
SKELVETSDSFGSTS
>SEQF2892_00025 Glycine betaine transport ATP-binding protein OpuAA
MNDSNFKKFEYHIIKISIHLYILIYLLFLSKVKVRNLTKIFGRKQKEALKLVQEGKSKQE
IFEKTGATVGVYDVNFDVNDGEIFVIMGLSGSGKSTLIRLINRLIEPTSGSIYIGEDDIS
NMSKKELREIRRTKINMVFQNFGLFPKRTVLENTEYGLEIRGIEKAERQKRAEKALDDTG
LLSFKDQYPDQLSGGMQQRVGLARALANDSDILLMDEAFSALDPLIRKDMQNDLLNLQEQ
MQKIIIFITHDLNEALRIGDRIALMRDGKIMQIGTGEEILTNPANAFVSEFTEDVDRSKI
LTAENIMESPLTINIETEGPNVALQRMRQEEVSMLLAIDNKRLLKGSITADNALKAREDG
ISLKHIYQNNVQTINKDMLVTDIFNIIYDSPTPLAVTDENNRLVGVVVRGSVIGAMTTNN
KDRETNHSQENSTEEEVNENV
>SEQF2892_00026 Beta-N-acetylglucosaminidase/beta-glucosidase
MARVDLKAKPYFLNDEQIQWVEETLSHLTDEEKIGQLFFNLFSLEEDGDFNDSEYTNKDI
LNRYHIGGARYQGGNKQQVQALLNDLQQHSKVPLLVAANCDSGGNGACKDGTYIASAAQC
EAAQDSKVAYNAGYVSGRESQALGVNINFDPCVDILKNWRNTIVNTRAYGTTAETVIKYT
NAFINGFNETQDMITCIKHFPGDGTEERDQHLVLGVNEMTTDEWDQSFRKVYENHINNGV
EMIMSGHIALPHYSKKLNPELADKDILPATLSKELITDLLKDDLAFNGLVVTDASHMLGM
TAAMKREDYVPQAIAAGCDMFLFFNDLEEDFHFMLKGYQDGVITDDRLNDAVRRILGLKA
KIHLPKKQAQGTLLKNEDQLSVIGCDEHLTMQQEAADLSITLVKNTLDQLPIRPETHKNI
RLYIIEGEKNGIYKSDDTVEHNLVSILEDRGFNVTVNDGSTRVKGKTLEYRDNVDAALVF
ANIVGYAAENNYRIRWSTAMSNEIPWYVHEVPTVFTSLNFTTHLHDATMVKAYINAYHSN
KTTLETVVDKIMGESDFKGVPNDLVWTDKWQAKL
>SEQF2892_00027 hypothetical protein
MNYTLEHFQPQHDHLICVDSDGCGMDTMTIKHERAFGPALLDIWNLDDIKDDVLNRWNQF
NLYEITRGINRFQGLEKILTELHQQGRTVDGYDDIKAWVDTTTTFSNPQLQQDIEANPDK
KGLRLALDWSNRVNQLIQRLPSIGPFEYVYDALKRAYHNADIVIVSSANLSAVETEWTEH
QLTPFITSIFAQEAGTKKHCINQLKRLYDANQVLVLGDAKGDMQAAQDNDVLFYPILAGN
EATSWLEFKDKYLNLFINNQFDNTIQEHVIQQFYNNFD
>SEQF2892_00028 HTH-type transcriptional activator Btr
MINREVFGILQTHAFELLMVSLERYDLEDLKHISSHLKSPFTNTKSKRYKAELQKLLENM
KSNMIYHYVNQFDAHFLMFKYRKLHQVIILGPFLLQRPSENKCLEMLQEVQIKHSKLTIL
KQYLLQIPVCQYSQALNMTHLAVRYLKNRNIHYSVEDIDFSFHRNPESHAKDKAQYEFTF
NKIKERYDIENRMLTAIQNGNADEALNLFKLMKVSVSGIRRVTDDLLNHKYRGFLVNTLC
RKAIEKANVNLLTINDISGKYAAEIDDATDIEDLDNVMENLIYEYAQTALKVKSLKYSAN
INTVIQHIKINLDRPLCLNELADLVGLAPSYLSRLFNQETGQSVSQYIMQLRVEKGRDLL
IHTPMKVDEISNYIGFKQQSYFTKCFKAKYQLSPLEYRKQYSSVN
>SEQF2892_00029 KHG/KDPG aldolase
MKKIKILNQLHENYLVAVVRGKSKDDAIAAVQQMIEGGIYNIEITFTTPQAEEVIRHLSA
TSDEHIVIGAGTVLDSGTARIAILNGAEYIVSPHLDIEIAKMCNRYAVPYLPGCGSVTEI
VQAMESGVDLVKLFPGDLLGANFIKNVHGPIPHIELMPSGGVSLDNLEDWYNKGAYAVGI
GSALMKNAKDGNDTVIKENTEKFVRKFQTVSG
>SEQF2892_00030 2-dehydro-3-deoxygluconokinase
MRLSTPHHQTFEQAQAFDIHYGGAEMNVAIGLSGLGIDTAMVTALPNNDIGDNIIQHLRR
YNVNADKVKSASGRLGIYFTESGYAQRANRLIYDRQMSVFSQLNPDEYEIESILKAHEWF
HITGITAALNDALFEYLKKAVKIAKTLGLFVSCDLNFRDALWDFQTARRKMSELLYDVDL
IFGYEPLSLPGEDGKDLKDGLDRMANIEDIRPFLTKIHQTYNINYIAFTQRKIFNHKRNR
LQGFLSTPNQLEQTETVEVDILDRLGTGDAFSVGIIYGIMKQWDLKDTVQFGINNMVYKH
NVIGDYSYANLEKINTSIESNKDINR
>SEQF2892_00031 putative symporter YjmB
MGTTVETREKQKVQSLNNIQKSTLGFKEKLSYGFGDLGNGMMFDMGQIYLMMFFTDILGI
SAFYGGLVFLVAKIFDAFVDTGVGTIVDSRTNIGPKGKFRPFILYGTVPLAILTVLSFTA
PNFSDTGKVIWAFATYLMFNAAYSVVNIPYGSLSAAMTVNADDRTQLSVFRNLGSQSALF
IAGIAVVPLVSKFDNHAIGYPVVVGMLAIFGVIFHLICYKGVKERHVIERPKKKGVNKKA
FFNLVKNEAFAVLAIFTLLTIMSMFLVQSTQLYYFKYVLDKPNLVGLVSTLNFIVLLPAL
FATTYISKKLGKKYTALIGIGGFVIFEVLNFLFFGENYVMFLIMNTIAQFFLVIPNTVVW
AFIADVVEYGQWKFRLRSEGITYSSYSFTRKVSQALAGFVPGLALTFIGYQPNVDQSAGT
IFGLKVLFFAVPAVACTIAFIIFFIWYPLTDKRHKQIVKELALREEI
>SEQF2892_00032 Uronate isomerase
MAFINEHFMLNNETGKHLYHDFAKDMPIYDYHCHLDPKQISDNVACDNITDLWLSGDHYK
WRAMRAQGIEEQYITGDAAPLDKFKKWTETLENSVGNPLYHWSQLELKMYFDIEDLLTSD
NAEAIYHRANDYLKQHHTTTQSLITDSNVNLICTTDNPTDDLNYHDAIKAKDGFNTTVLP
AFRPDDVFKVGDPAFTDLLQKLENLTHPITTPSDFIEALYKRIQYFHDKGGRLADHGLEE
MHFEAYTDQAIQDIFKKALNHADISTYERFQFQSYMLNELSKAYYERGWVMQIHFGAIRN
NNTKMFEKVGKDAGFDSIRDQDNLAYHLNATLDMMEQEGHLPKTILYNLNPIYNDIVGST
IANFQTEPGIKSKVQHGAGWWFNDTKRGMLRQMSSLADQGLLMHFVGMLTDSRSFISYSR
HDYFRRILSSFIGDLVEKGEIPNDDQLLKRMIENICYNNAYNYFKLI
>SEQF2892_00033 Mannonate dehydratase
MKMTFRWYGKDDPISLEYIKQIPGMKGIVSAIYDVPVGEVWPLDKIKALKQEIEDAGMEL
SVIESVPVHEDIKLGKPTRDKYIENYCETLRNLGQAGIKIVCYNFMPVFDWTRSQLDYRL
DDGSTCLIYDEQDVEKMNPLSGELSLPGWDSSYTKEDLKQLFDDYKEVDEETLWDNLNYF
IQKVIPVAEEEDVLMAIHPDDPPWNIFGLPRIITNKENLERFINLYDSKYNGLTMCSGSL
GADRRNDFVDMLRYFGEKGRVNFVHARNVKLIGDKSFQESAHLSEKGSIDMYEVVKTLHS
FDYHGPIRPDHGRMIWGETGKPGYGLYDRALGATYLNGLYEAVSKNNK
>SEQF2892_00034 putative oxidoreductase
MKLPFDIDLTDKVVVITGGTGVIGSAMSTALAQSGAKVAMVGLREDASGLVETIKALGGE
SQVFLGDVTNKEDMKRIKQEVNDTFGSVDILINGAGGNAPKGTTDDERFEGDLDQDKQTF
FNLDEESVGFVMDLNFLGTFIPSQVFATDMLDKADATIINISSMNAFTPLTKIPAYSGAK
AAISNFTQWLSVYFSKTNIRVNAIAPGFLLTKQNEALLLNEDGSYTARSEKIINATPMER
FGKPEELVGALLFLVSKEASSFVNGVVLPVDGGFNAYSGV
>SEQF2892_00035 Beta-glucuronidase
MLYPINTETRQLLDVSGIWKFKLVGYKEHVDVSQALDTEDVMAVPGSYNDQGVIQSIRQH
VGDVYYEREIMIPKHLKGERIVLRFGSVTHHATVYLDGKEIVTHSGGFLPFEVNITEIAT
TGSHRLTVKVNNILTHSTLPVGNYSERVDEDGTVTPVNTPNFDFFNYAGIHRPVKIYTTP
QTYIQDIVINPEVKQSGESIVNYKVNVHGNRSDIDRISVTIIDEDGQVVTKHDESEGAMS
IDNPHLWQPLNAYLYHMKVELLNDGEVVDVYTERFGIRSVEVKDGQFLINNKPFYFKGFG
KHEDTFYSGRGLNEAANVMDINLMKWIGANSFRTAHYPYSEEMMRLADEQGIVVIDETTA
VGVHLNFMVALGGQLEHDTWKEIDTHQAHKEVIEGLIERDKNHACVVMWSIANEPASNEK
GAKAYFEPFVELAKRKDPQKRPVTIVTILMAQPDVCEVQDLVDVLCLNRYYGWYTQSADL
ASAKKALDKELAQWSERQPNKPIMFTEYGADTVAGMHAIDDQMFTEEYQLNYYKANHEIM
DKYPQFIGEQTWNFADFETSNGIIRVQGNKKGIFTRDRKPKAIAHYFKERWHNIPDFNYK
S
>SEQF2892_00036 hypothetical protein
MNIIANSIFVDNQEEALQFYTDILGFKKKIDEPVGEGFRWLTLVSPNQPDGAQLVLEPNG
NPIAGDYQQRLFEANIPITMFGVENVHL
>SEQF2892_00037 hypothetical protein
MSTKTVYDVIDTGVNYLLSVYDSWNIEDVLDKENDVFPNTLHWQFGHVLTIFDSALSMGG
QNAVDIETYTKLFGYGSSPANWEGQDIPSIESIKEDLKTIPDRARQLTDEQLSQELEQSI
AGCKTLNELLVLNAIHVPLHAGKIEEMARVLKQAK
>SEQF2892_00038 Energy-dependent translational throttle protein EttA
MNILNATDVTKKFLDETLFDNVKLTLNSGDTIGLVGRNGEGKTTLLRLLCGSESPTTGII
SWKKNIKIGYLDQIPNYADNEKVYTCLKSVFGELNIISEQLKLLEEKMSMDVNDIDELML
RYGNLQSYYEEHGGYEIDAKIRRVASGLNITHLLESQWKDLSGGERTKVGIAQILIKPTD
LLLLDEPTNHLDFKSIEWLTNYIKNYHGATVVVSHDRYFLDETVNQIIEIDQKNLYPYNG
NYSYFVEEREKRLLIEFEAYKTQQKKIKKLKASIKQLRMWASQSNPPNAAMYRRAKSMEK
SLNRIKRLDKPILNSKNMKMELEDATRVSNRVIEMEDVTKTYDKLLFEKVNMLVRRGEHI
AIIGDNGTGKSTLLKIILGVVSIDNGTIKTANNLKIGYLSQHEFENDADNNTVLNKFREE
VNVSEAEARHILADFMFYGKDVFKKVGDLSGGEKIRLRWAQIVHTDYNLLILDEPTNHLD
IEAKEIIEDALLNYEGSIITVSHDIYFLNKLFNTTYLLKNKSLKKFEGNYNYIKEKEYL
>SEQF2892_00039 Inositol-1-monophosphatase
MCAIQEIDCRIEAWIAQIARKVDMMLNDVAVETKKHDLDLVTNIDKEVQADFTKFIEENY
PEHQIMGEEKSNSEVDMYRGYAWAIDPIDGTTNLVKQGKDYCLIVCLFYDGEPLLAYTYE
FYQQKLYKAVQGQGVTINGVPLHVDKYHHLNDALISIDPKRARSELLKALISKSHGFRFI
GAGGIGALRTITGDFGASIDMGANLWDMSAQLLYAKELGLIVTDIQGNAIDLNHVKGAII
AHPDIHEDIINIIKTYQ
>SEQF2892_00040 Kynurenine formamidase
MPNYPLWDQLNQLKEATWVDLTHTFDPEIPRFSEFEKGEVSTLFTVKEHGFYVQRWNIVT
QYGTHIDAPIHFVENKRYLEDLDLKELVLPLIVLDFSKEAAENADFIVTRDHLEAWEAKN
GRIEEGTFVALRTDWSKRWPDIEQFENKDAEGNQHLPGWGLDALKFLIEERGVKSIGHET
FDTDASVDTARNGDIVGERYILGQDTFQLELLTNLDQLPTRGAVIYAISPKPKDAPGFPV
RAFAIKP
>SEQF2892_00041 5-methyltetrahydropteroyltriglutamate--homocysteine methyltransferase
MTTITTSNLGFPRLGRKREWKKAIESYWAKKIDKAELDQKISDLHRENLLLQKHYNLDSV
PVGDFSLYDHILDTSLLFNIIPERFQGREVNDDLLFDIARGNKEHVASALIKWFNTNYHY
IVPEWDNVEPKVNHNVLLDRFNYAKSLNVNAHPVIVGPITFVKLSKGGHQSFEEKVQTLL
PLYKEVLQALVDAGAEYIQVDEPVLVTDESEAYEAITREAYDYFDKAGLADKLVIQTYFE
RANVKFLSSLPVGGLGLDFVHDNGYNLKQIESGDFDSSKTLYAGIIDGRNVWAADIEAKK
KLIETLQGHAKHIVIQPSSSLLHVPVSLDDETLEQSIEEGLSFATEKLDELDALRRLFNQ
NDSAKYDKLKARYERFQSQSFKNLEYDFDSVPTSRKSPFPERKKAQDARLHLPDLPTTTI
GSFPQTQEVRKYRADWKNKRISDEAYNNFLESEIARWIKIQEDIGLDVLVHGEFERNDMV
EFFGEKLQGFLVTKFGWVQSYGSRAVKPPVIYGDVKWTEPLTVKETVYAQSLTDKPVKGM
LTGPVTILNWSFERVDVPRKVVQDQIALAIDEEVLALEEAGIKVIQVDEPALREGLPLRS
EYHEQYLADAVNSFKLATSSVQDETQIHTHMCYSQFGQIIHAIHELDADVISIETSRSHG
DLIKDFEDINYDLGIGLGVYDIHSPRIPTEDEIATAIDRSLQQIDRSLFWVNPDCGLKTR
KEDEVKDALTVLVNTVRKKRASNNQNKPA
>SEQF2892_00042 Bifunctional homocysteine S-methyltransferase/5,10-methylenetetrahydrofolate reductase
MSRLLNQLQNNVLVADGAMGTVLYSEGLDTCPEAYNLTHPEKVESIHRSYIEAGADIIQT
NTYGANFEKLRRFGLEHKVKDIHKAAVAIAKRAAQPDTFILGTVGGFRSLQQEELPLSTI
QYHAENQIDTLVEEGVDGLLFETYYDLEELTNIVTTTRRKYDIPIIAQLTASNTNYLVDG
TEINKALQQLVACGANVVGLNCHHGPHHMQRSFSHIELPETAYLSCYPNASLLDIENSEF
KYSDNAQYFGDVAQELINEGVRLIGGCCGTTPQHIAYIKSSVKDLKPVKNKNVIPINRQT
NRAVTHTYKHNLTTKVKNGPTVIVELDTPKHLDTDLFFENIGKLDEANIDAVTLADNSLA
TVRVSNIAAASIIRQRYNIEPLVHITCRDRNLIGLQSHLLGLSLIGVNEILAITGDPSKV
GHLPGATNVYDVNSKGLTELALRFNQGINTDGDALKKHTNFNIAGAFDPNVRKLDGAVKR
LEKKVAAGMNYFITQPVYSKEKIKEVYEATKHLNVPLFIGIMPIASYNNALFLHNEVPGI
KMSEDVLSQFKAVKDDKEKTKALSLRLSKELIDTVHEYFNGLYIITPFQRIDYSLELAAY
SKAITQNKEAIS
>SEQF2892_00043 Cystathionine beta-lyase MetC
MSLSKETEVIFDEHRGVDYDSANPPLYDSSTFHQKVLGGNAKFDYARSGNPNRQLLEEKL
AKLEGGQYAFAYASGIAAISAVLLTLKANDHVILPDDVYGGTFRLTEQILNRFDIQFTTV
NATQPKEIERAIQPNTKLIYVETPSNPCFKITDIRAVAAIAKRHHLLLAVDNTFMTPLGQ
SPLALGADIVVHSATKFLGGHSDIIAGAAITNRKDVADALYLLQNGTGTALSAHDSWTLA
KHLKTLPVRFKQSTSNAEKLVAFLKEREEIAEVYYPGKSSLHLSQANSGGAVIGFRLKDE
TKAQDFVDALTLPLVSVSLGGVETILSHPATMSHAAVPEDVRNERGITFGLFRLSVGLEQ
PQELIADLNYALKEAFNESIIESITEQRFSS
>SEQF2892_00044 Cystathionine gamma-synthase/O-acetylhomoserine (thiol)-lyase
MKDTQLAQISLTKDITGAIANPIYLSTAYQHPHLGQSTGYDYTRTKNPTRSAFEESFAKL
EGGIASFATSSGMAAVQLICNLFQPGDEILVAFDLYGGTFRLFDFYEKQYGIKFKYVDFL
NYEEVVNAITPNTKALFIEPISNPQMIEIDVDPYYILSQQHNLLTIIDNTFLTPYLSTPL
EDGADIVLHSATKYIGGHNDVLAGVVTVKDGSLAEQLGQLHNMIGATLSPIDSYLLQRGL
KTLHLRIERSEANAKKLAERCKVSSAIDEVLYSGKTGMLSLRLNKDFSVAKFLENLEICI
FAESLGGTETFITFPYTQTHVDMPDEEKDKRGIDEHLIRLSIGIEDYNDIESDILRALEN
SKVGVIS
>SEQF2892_00046 putative chromosome-partitioning protein ParB
MSHNQDERLAISQNEQIQKIDLSKIKANPYQPRKTFDDDRLGDLAMSIQTHGVLQPIVLR
QTVQGYYIVVGERRFRASQLAGLTEIPAIIKELSDSDMMELAIIENLQREDLNAIEEAES
YQRLMNDLGLTQQKVAERLGKSRPYIANMLRLLNLPKDISNQVKEGALSSAHGRTLLGIK
DVTMMKKISQQAIRENWSVRYLEQVVNELQDGGQSKKSKATTQIKPIFIQKQERRLKEKF
GSKVDISTSKNIGKITFEFKTEEEFKRLIQKLNDEV
>SEQF2892_00047 putative MscS family protein YkuT
MNQVKNVLSSLFEPLTKIETYENLAIKIALIIIYIIVALIVIAILNKVIEKAFKIQNRSS
KGNKKRSRTLISLVQNVVSYIVWFIVITTILSKFGISVEGIIASAGVVGLAVGFGAQTIV
KDIITGFFIIFENQFDVGDYVKINSGGTTVAEGTVKSIGLRSTRINTITGELTILPNGSM
GEITNFSITNGFSIVEIPVSVEENLDKVEKRLNKLFTAMRSKYYLFITDPVVEGIDSLDE
TKVTFRISAETIPGEGASGSRILRKEIQRVFVQEGIKLPQPIYIKNNNQQGKS
>SEQF2892_00048 hypothetical protein
MTSNYGINDIVEMKKQHACGTNRFKIIRMGADIRIKCENCQRSIMIPRQTFNKKLKKILV
SNQDTEG
>SEQF2892_00049 Ribosome-binding ATPase YchF
MALTAGIVGLPNVGKSTLFNAITKAGALAANYPFATIDPNVGIVEVPDSRLNKLTEMVKP
KKTIPTTFEFTDIAGIVKGASKGEGLGNKFLSHIREVDAICQVVRAFDDENVTHVSGRVN
PLDDIEVINMELVLADLESVEKRLPRIEKMARQKDKTAEMEMRILSRIKEALENGDPVRS
LDFNEEDQRYVNQAQLLTSKKMLYIANVGEDEIGDEDNDKVKAIREYAAKEDSEVIVISA
KIEEEIATLDDEDREMFLEDLGIEEPGLDVLIRTTYDLLGLSTYFTAGVQEVRAWTFRQG
MTAPQCAGIIHTDFERGFIRAEVTSYDDYVEHGGEQGAKEAGKQRLEGKEYIMQDGDIVH
FRFNV
>SEQF2892_00050 hypothetical protein
MQLDLDWNKDFQEFHEVLNCGINPEWLYCAKANMILEPAYTGEGKQFFSTKDIIEASKVI
PFF
>SEQF2892_00051 hypothetical protein
MFKKTTSSIACLTIMATSIGALNANASEQTEGSQKGTMGYGYQKYLKNHPNEQSNATSNR
STFSTKSKAITTQNGDRVLDISEWQGNLTDSQVKQLKKDYDFIIIRGQYGSEYVDQCLEN
NSALLDKNNMKFGVYSYSLYENADDARNEAQTLYSRAPKASFYVNDFEQNSITSGDADTA
TKAWADEMKQLAGNKKVLFYSYENFMTNNVPNAVSAYDGYWLAAYQEQEPNREKVLWQYT
DSYYAPELNQNVDANYIDANITADWFTS
>SEQF2892_00052 30S ribosomal protein S6
MRTYEIMYVVRPNIEEDAKKAVVERFNGILASEGSEVLEEKDWGKRRLAYEIEDFKEGFY
NIVRIKTDNNRATDEFQRLAKISDDIIRYIVIREDQDK
>SEQF2892_00053 Single-stranded DNA-binding protein A
MINRVVLVGRLTKDPEYRTTPSGVSVATFTLAVNRTFTNAQGEREADFINVVVFRRQAEN
VNNYLFKGSLAGVDGRIQSRSYENQEGRRIFVTEVVADSVQFLEPKNAQGGQRNQSNNND
FQDYGQGFGGQQSGQNTSYNNNNSSNNKQSDNPFANANGPIDISDDDLPF
>SEQF2892_00054 30S ribosomal protein S18
MAGGPRRGGRRRKKVCYFTANGITHIDYKDTELLKRFISERGKILPRRVTGTSAKYQRML
TTAIKRARHMALLPYVKDEN
>SEQF2892_00055 hypothetical protein
MAFNEEPPNNTNSSQEQSQETNIYNQDKNESVSNNESTQNDDSNSSNKGKYWLIGCGAGC
GCLVILIILVLAACVIFMKVSDSISSSDSENATHESKQEGNSRKTGGNDKEEALQRAETY
AKSMYMSKKGIYNQLTSSSGDKFNSSTAKYAVNHLKDVDYKENALKTAEESSDNLHFSKK
ELTDYLKNDENSGQFTSEQVDYAMKHAKIDYKENALETAKHISDQSYSSKSQLEDELTSK
DGRQFTKDEADYAMKHLKTDFKKNALKNAQRYMQDSIESKSELYNKLVEYDDFTEDEAKY
AADNVKVDYKENALERAKSLSKDGDTSKSDIKDMLSSKDGFKFTEEEAQYAVDHLK
>SEQF2892_00056 hypothetical protein
MTQVHFTLKSEEIQSIIEYSVKDDVSKNILTTVFNQLMENQRTEYIQAKEYERTENRQSQ
RNGYYERSFTTRVGTLELKVPRTRDGHFSPTVFERYQRNEKALMASMLEMYVSGVSTRKV
SKIVEELCGKSVSKSFVSSLTEQLEPMVNEWQNRLLSEKNYPYLMTDVLYIKVREENRVL
SKSCHIAIGITKDGDREIIGFMIQSGESEETWTTFFEYLKERGLQGTELVISDAHKGLVS
AIRKSFTNVSWQRCQVHFLRNIFTTIPKKNSKSFREAVKGIFKFTDINLAREAKNRLIHD
YIDQPKYSKACASLDDGFEDAFQYTVQGNSHNRLKSTNLIERLNQEVRRREKIIRIFPNQ
TSANRLIGAVLMDLHDEWIYSSRKYINFDK
>SEQF2892_00057 hypothetical protein
MSSHTLFNLRTKRNLEINELTELINKKYGTHYEPHQLWEWENHQHEPKFKDAMILADFFD
TPYQMLVESKYKEYQQQIDDIDIRL
>SEQF2892_00058 hypothetical protein
MKLFDSHFHIIDYDFPVKENNGYMPPSFKVNDYLNHTQQLNVVGGAILSGSFQGFDQDYL
ISALNQLQG
>SEQF2892_00059 hypothetical protein
MGFIVMLIVGGLIGWVAGMIMGKDIPGGIIGNIIAGLIGSAVGSKLLGTWGPVWGGVPII
PALIGAIIVIFVVSLILKALRK
>SEQF2892_00061 hypothetical protein
MYKNYNMTQLTLPMETSVLIPTNDISRHVNDIVETIPDNEFDEFRHHRGATSYHPKMMLK
VILYAYTQSVFSGRKIEKMLNDSIRMMWLSQNQKPSYKTINRFRVNPKVDALLESLFIQF
YSQCVKQNLIDDKAIFIDGTKIEANANRYTFVWKKSIQNHESKMNEDSKALYHELVTNKI
IPEIKEDHDNELTKEEIDLIGSHLDKEIEDLNQHINNEKCTKTRKQIRLKRTKIKKYKKQ
INDYFERKYRYEFQKSILKDRNSYSKTDHDATFMRMKEDHMKNGQLKPGYNLQIATNSQF
VLSYNVYQNPTDTRTMIPFLNSIQETYGHLPEYIVADAGYGSESNYKAIIDDFNRTSLIT
YGMFIKDKTKKYKSDIFNTQNWNYDKINDEFICPNNKRLGFKRYAYRHDKYGYKRDFKLY
ECDDCSECPLKNQCMNFNSKTNKK
>SEQF2892_00062 hypothetical protein
MKNYNWEYFKSQINNKLSEPETKNIYSQRKIDVEPVFGFMKAILGFTRMSVRGLNKVKRE
LGFVLMALNIRKVVAQRAENNQKIYKKDNFYIISIEIVFFHLSKNFMSRTL
>SEQF2892_00063 putative lipoprotein YehR
MKKVTGLVVSIVFLITLSACGAEKTKTFVGEESNVKMEVTYTYKGDEIIKQKSVNTLKYS
DFSLNDDTSKKIMKEAIEKESKKMQDVKGVKETVKENDEGIVETITIDLKNADIDTLKSK
DIVSMSGNTGNGFSMKKTEKEMKKEGFKEKED
>SEQF2892_00065 Putative cysteine protease YraA
MTKKVAIILADEFEDIELTSPKEALENAGFETEIIGDTANHEVVGKHGKKVTVDVSIADA
KPENYDALLIPGGFSPDHLRGDEEGRYGTFTKYFTQNDAPTFAICHGPLLLVDTDDLNGR
TITGVINVRKDLSNAGAHVVDESVVVDNNIVTSRVPDDLDDFNREIIKQLEA
>SEQF2892_00066 3-hexulose-6-phosphate synthase
MKLQLAIDLLDQKEAAKLAQEVEEFIDIVEIGTPIVINEGLSAVEHMSKSVTNTQVLADL
KIMDAASYEVSQAVKFGADIITILGVSEDASIKSAIEEAHNHGKELLVDMIAVQNLEQRA
AELDKMGADYIAVHTGYDLQAKGVSPLESLRTVKSVISNSKVAVAGGIKPDTIKSVAVEQ
PDLIIVGGGIANADDPKAAAKQCRDIIDGNA
>SEQF2892_00067 HTH-type transcriptional activator HxlR
MLIEYNNKEFYTSKDLALSVIGGRWKIAIVYHLLQNERLRLSELQNKLPDINQRMLIRQL
RELEQDKILERTVYPVVPPKVDYRLTEIGLKLDKVVFSICDWGDDFLDTVKSNNHR
>SEQF2892_00068 putative malate:quinone oxidoreductase 2
MNTKESKTVVIIGAGVLSTTFGSMLKEIEPNWNIKLYERLDRPGIESSNERHNAGTGHAA
LCELNYTVRKPDGSIDIEKAKEINEQFEISKQFWSHLVKNKSISNPKEFIQPLPHISFVR
GKNNVQFLKDRYYAMKDFPMFDNIEYTEDIEEMRKWIPLMMKGHNSSDIMAASKINEGTD
VNFGELTRKMAKNIEQHPNANVQYNHEVIDFNHQKGGKWEVKIRQRNSGDVQTELADYVF
IGAGGGAIPLLQKTGIPESKNLGGFPITGQFLICTNPDIIAKHDAKVYGKEPKGTPPMTV
PHLDTRYIDGERTLLFGPFASVGPKFLKNGSNLDLFKSIKPYNISTLLSAAVKNLPLIKY
SFDQILMTKEGCMNHLRTFYPEARDEDWQLYTAGKRVQVIKDTPDHGKGYIQFGTEVVNS
KDHSVIALLGESPGASTSVSVALEVLEKNFSEYESKWTPKIKKMIPSYGQSLVNDIGLMR
SIRKQTSKDLELNYYENK
>SEQF2892_00069 hypothetical protein
MTNLKKLFVTIAICTIGYSVLKRYQKHVNKIPNIEY
>SEQF2892_00070 hypothetical protein
MYKNYNMTQLTLPMETSVLIPTNDISRHVNDIVETIPDNEFDEFRHHRGATSYHPKMMLK
VILYAYTQSVFSGRKIEKMLNDSIRMMWLSQNQKPSYKTINRFRVNPKVDALLESLFIQF
YSQCVKQNLIDDKAIFIDGTKIEANANRYTFVWKKSIQNHESKMNEDSKALYHELVTNKI
IPEIKEDHDNELTKEEIDLIGSHLDKEIEDLNQHINNEKCTKTRKQIRLKRTKIKKYKKQ
INDYFERKYRYEFQKSILKDRNSYSKTDHDATFMRMKEDHMKNGQLKPGYNLQIATNSQF
VLSYNVYQNPTDTRTMIPFLNSIQETYGHLPEYIVADAGYGSESNYKAIIDDFNRTPLIT
YGMFIKDKTKKYKSDIFNTQNWNYDEINDEFICPNNKRLGFKRYAYRHDKYGYKRDFKLY
ECDDCSECPLKNQCMNFNSKTNKKIMKNYNWEYFKSQINKKLSEPETKNIYSQRKIDVEP
VFGFMKAILGFTRMSVRGLNKVKRELGFVLMALNIRKVVAQRAENNQKIYKKDNFYIISI
EIVFFSLIQELYVPDSF
>SEQF2892_00072 hypothetical protein
MSSDTNSLAHTKWNCKYHIVFAPKYRRQVIYGKIKRDIGVILRQLCERKGVEIIEAEACK
DHIHMLVSISPKLGVSSFVGYLKGKSSLMIFDRHANLKYRYGNRKF
>SEQF2892_00073 hypothetical protein
MHFLKEGDLTVYFYTWNKKEYLASEIFDLTESEKQEINHQMIDEIEEEK
>SEQF2892_00074 hypothetical protein
MNFIIRKEKKEDYKITEEVVKEAFANEEYSDQSEHRLVASLRNSDEFIPDLSLVALHKDK
IIGHILLSKIFIVKGEKSIESLALAPISVLPNYQNKGVGQSLIQRSLEIAEELNFDSVIV
MGHSEYYPKFEFKKASNWCIQAPFEVPDEFLMAIELKKNALDKTSGIIQYSDAFFE
>SEQF2892_00075 hypothetical protein
MKLYVNEIVRTNNFEDDDIMNKILGMWDTFYKNNDDYKGKVYAIYHDYESDYKGDYSLAL
CTEDISADKFFEVDFANSIEYKCSGKDEIVNVWKRIWEDEEENKIQRRYDIDCEEYKEDG
SVVIHLF
>SEQF2892_00076 hypothetical protein
MIFIYIIFSAILLYYALKYGIRNGFVELEANKDGLVYYKKSASLLEEIGNIYSRVSTSKS
KEAKAIYNEAFDILLSEKNRRLYLKN
>SEQF2892_00077 hypothetical protein
MKFGNYKIDSFYLIMIIGFLATSLFFPFMLLSIFVLLIIGLEKDDKEG
>SEQF2892_00079 hypothetical protein
MKLKKISNTDTFEISGTLIISDFKEAGILKSDGSNYQLLFNTDMDYEERINQCQFITAKG
ETLYLRNGILSRHTINFPGSNEYEYLFTQIWVSISHTEIPKTFDSISVKFSGLKENINHI
PFDIKRDQTNNEYTISIDKANLKKEIISLNEVRLSSACKINRKRTRFNEITFQYENSLKF
EYKNNLTSDKCISDALNIAYIFSFITNEKHKIESIILYSKKEAFRIFVDLPFNFKEHHKT
KITYVTKDFLNKYLSNIYSFFYNNHDSFQDIFSNYIKLMYTPKFIEHYLVDLLKINEGLH
RRLVSNQQIILINRYKDLFHSLDNELQNYLKSIVNYDEKLHDYLKDYRHYYSHYFPPSEK
PTYQKDNIFNISNFVLQLHKSFIMFKIGIPSSEIVSLLKITH
>SEQF2892_00080 hypothetical protein
MKFLLRHFYNLSVPIDIIIIIGTIIFWQDINVLQRLALLNLAIINFHFFEEFGYPGGFPK
FANTMFAYKNSPRPDRFPLNQMSAFLTNWGTALVLYVPPIIFPDAIWFGLAPILFGGLAQ
LIVHAIVNNKMLGTYYNAGLATVVFGHLPIAIIYIIYIHTHNLVSFWDYVIGVVIMVLWY
VVGIRILINKGFESMNSSYPFAPEEMAKFKN
>SEQF2892_00081 HTH-type transcriptional repressor Bm3R1
MNNQNIKIDLEPFLENQKITPGKKKVLLSSIELFSKYGFNGVSTANIAKEAEVSEATIFK
HFKNKRELLLAIITPIIEHCIPQYDDIFTQNIENQNNNLRNLVHFIVTDRMQFLKQNKEI
VNIFLSELVINEEVRNLLITTIEQKNKQNSQKILLAFQNTNELSPDINFQSLLRIIIGQL
LIYFVQINLFNVTTINQSQIENQIYKTLKKEGELA
>SEQF2892_00082 hypothetical protein
MLYLRNNWQYLTFFVFVGLTFYMGFWGHEQLSQIQIILMYSMIALSIHQFEEYVFPGGAP
LVINKATYGEMKDYTRYPGNTLSVSIVNISAYIFYILAIIFPQFIWLGLATMIFNLVQLI
GHGISMNKAMGTWYNPGLASSIFLFTPISIYYIVFIHTHDLAGILTWISGIITFIIITIL
TVVLPVQLLKDRNSKYVISEWQVERYNEVLKHCKIK
>SEQF2892_00083 DNA-invertase hin
MKIGYARVSTGLQNLNLQEDRLNQYGCEKIFSDHISGAKSKRPGLDRAIEFARSGDTIVV
WRLDRLGRNMADLITLVNELNNRGVSFHSLEENITMDKSSSTGQLLFHLFAAFAEFERNL
ILERSSAGRIAARARGRYGGRPEKLNKQDLTLLKTLYDNGTPIKTIAEQWKVSRTTIYRY
LNKLERQENKHK
>SEQF2892_00084 Putative aldehyde dehydrogenase AldA
MAKVNVRDFLDEQYDLFINGEFQPSESGETLTVTNPANGEELAKVAKANEKDVDKAVQSA
HEAFDSWSKISKAERADYLLEISRRIEENKEHLATVESLQNGKPYRETSTIDVPQVAEQF
KYFAGVLTTDEGSVNQIDHNTMSLVVNEPVGVVGAVVAWNFPILLASWKLGPALAAGNTV
VIHPSSSTPLSLIELAKILQDVLPKGVVNVITGKGSESGDAIFKHEGVNKLSFTGSTSVG
YGVAKAGAERIVPTTLELGGKSANIIFDDANLDQVIEGVQFGILFNQGEVCSAGSRLLVQ
SSLYDKLLPKLKEAFENIKVGDPFAEDTKMGAQTGPEQIEKIESYIKLAEEDDKANILTG
GHRITDNGLDKGYFFEPTIIELSDNSHKLAQEEIFGPVIVVEKFEDEEEAINIANDSEYG
LAGGVFTTNLLRALNVAKAIRTGRIWVNTYNQIPSGAPFGGYKKSGIGREVYKDAIKNYQ
QVKNIFIDTSNETKGLY
>SEQF2892_00085 putative oxidoreductase
MKKAFEPLFETLKLPNGLELRNRFVLAPLTHESSNDDGTINDDVITYMAQRSSDVSLALT
AASNVTDLGKAFPGQPSVAHDSDLEGLTKLATAMKQNGAKAIIQIHHGGVQSLPRLTPNG
DVAGPSPITMKSYDETQPHDAREMTKTEILDTITAFGEATRRAIQAGFDGVEIHGANHYL
IQQFVSPYYNRRNDEWGTDRFKFPLAVIDEVIRTVKSHDLENFIVGYRFSPEEPEDGGIT
MEITESLIKQLREQPLDYLHVSLMDVHSQTREGKYTGEERIKLLHGWINGRMPLIGIGPI
FTAEEALEAIESPYIEMIALGRELLIDHNFVNKIVNGKDETIISEFDENRQDKHDLPPKL
WKRLNDDFYPVPRKKQ
>SEQF2892_00086 hypothetical protein
MDSNNDFMTYWLKMDDIQSIVKKELEGVLQYEYHLSLKEFYVLYYLSIAPDKKLRLQELQ
KLILLSQSALSRIVTNMESSKCGALEKCICDDDRRGTYTRITDIGEQKLTGSLNIFREIL
AKHFGSVDVEVLMKNFVQSI
>SEQF2892_00087 hypothetical protein
MNENIIDKRVYKTLTKIENDMIRLLEDKPYKDINVKDICRESGISRGTFYQHYTNKDDFL
YQYQKEMMKKLKKWLRKNEHIERIQFFEYVLNFWLYEGELLLLLLKDESAYIIHQAIKKK
FQQNIEVHLVPIINTNSLTNKEKYLLIIFMSNAIFGVLQDWVQRGRQESPKELTYAINNI
FKTVFV
>SEQF2892_00088 putative ABC transporter ATP-binding protein YbhF
MAQTIAKLTDAVKQYDKHKVLDHISLNIQEGELIGLIGPSGSGKTTTIKCLLGIEKLNSG
TTEIFEQRMPNRQVLSHIGYMGQSDALYESLSAKENLIFFGHLAGIKGKQLISSINHNMG
LVNLEEKLNKTVNTFSGGMKRRLSLAITLLSDPSLIILDEPTVGIDPKLRQQIWNQLKYL
TKQGKAVIVTTHVMDEAERCDKIGLIVEGRLFAIGTPNELKQKFNVETIEEVFIKGEEVK
NQ
>SEQF2892_00089 Inner membrane transport permease YbhR
MKLLAMIQRVIIELLKDKRTLALMFLAPLLVLTLMYFIFNSDEDTTLTIGIDNSVSTQIT
DSIESNNVKFKDFTSSQHIKSKIEHHHLDAFIYQNNQTIHVTYTNEDPSKSASIKQLLHQ
SIQKNKMNDIKKVMVSLPQSAKNKDTKDIQLDNTYLYGDEDSNYFDKMFPILMSFFVFLF
VFLISGIALLRERTTGTIERVLATPIKRSEIVFGYLIGYGIFAIIQTLIIVLFSIYLLNI
NLAGSLAYVILINILLAIAALVMGIFISTFANSEFQMIQFIPIVAIPQVFFSGIFPLENM
SPWLSNIGYLFPLRYASHALTNIMIKGQGWSNIWFDVLILFVFIIVFTTMNIIGLKRYRK
V
>SEQF2892_00091 Immunodominant staphylococcal antigen B
MKKFSKIVLASGIVLGFSVTPELFNATEAQAQESIEPYYNYDGYTAYQSGFILDKNFKES
LKYDNFTINGYQISKNPTGDNRINLYDQTLYSVSENKANGVFFSLDGNSINENTLIQNYG
QPNYYSPTSAWGEVYMYKIGNKNVRFYIDNGYVNKCQIMSE
>SEQF2892_00093 hypothetical protein
MYKNYNMTQLTLPMETSVLIPTNDISRHVNDIVETIPDNEFDEFRHHRGATSYHPKMMLK
VILYAYTQSVFSGRKIEKMLNDSIRMMWLSQNQKPSYKTINRFRVNPKVDALLESLFIQF
YSQCVKQNLIDDKAIFIDGTKIEANANRYTFVWKKSIQNHESKMNEDSKALYHELVTNKI
IPEIKEDHDNELTKEEIDLIGSHLDKEIEDLNQHINNEKCTKTRKQIRLKRTKIKKYKKQ
INDYFERKYRYEFQKSILKDRNSYSKTDHDATFMRMKEDHMKNGQLKPGYNLQIATNSQF
VLSYNVYQNPTDTRTMIPFLNSIQETYGHLPEYIVADAGYGSESNYKAIIDDFNRTPLIT
YGMFIKDKTKKYKSDIFNTQNWNYDEINDEFICPNNKRLGFKRYAYRHDKYGYKRDFKLY
ECDDCSECPLKNQCMNFNSKTNKKIMKNYNWEYFKSQINKKLSEPETKNIYSQRKIDVEP
VFGFMKAILGFTRMSVRGLNKVKRELGFVLMALNIRKVVAQRAENNQKIYKKDNFYIISI
EIVFFSLIQELYVPDS
>SEQF2892_00094 hypothetical protein
MELLGYKMVNDELMATVKSDHGHIFRYSFKIETPEYEILEVLEEVNRHVDNGRHPLGCEI
IKNYDFEDIHNNQALIN
>SEQF2892_00095 Threonine efflux protein
MDGIITFITITLLIIIVPGPDFLIVMKNTIHSGKLNGSMAALGITSAHIIYSSLAVLGII
YILTSLYYVFLIIKILGACYLIYLGVQSIRSARQSMNFNTGGIKVNDVSCFTSYRQGFLS
TILNPKALLYYVSVLPQFLSTGGIEVKSQVAILSLAVIMVILIWFLFCVFVFQYIKLLFS
QPKVKAIFDYTVGFILIGLSINLLLSKSS
>SEQF2892_00096 Adenosylcobalamin/alpha-ribazole phosphatase
MKLYLVRHGESQSNYDNKHNRAYFCGQLDVPLTKKGIEGAKNLESYFKDKRIDHVYISDL
TRTQETYRYIFPYDIPSTVTSLLRERSLGVFEGEYKDKLMQDAQYHRYFNDPEYKDFRHS
FTQKAPKGESYRDVYHRVHQFFEQMNMSDDETIVIVAHQVVIRCIFAYFNVIGEEEALDY
NVENCKPYFLEV
>SEQF2892_00097 hypothetical protein
MKKNILIGLFLSLLLTLSACAPEDDNDTTDHHSNGVNAPKHAKNLTESDIFTSNKENQKL
SEDEMNKAIKKYLDVNSDILDNKYVMQSQIDRQSTGQTRVTDKQAKKLSKLSNLAVKNDL
HFKKFVKNNTLPSGYNENTERIINYFHALNSTIADVDKSIEQLNYEPQNTINVVDVPTHY
AGDVNGKQQDKIQKFLDDKNIKSDVLDK
>SEQF2892_00098 Alkyl hydroperoxide reductase subunit F
MLNADLKQQLQQLLGLMEGDVEFRTSIGSDDKSKELKELLDEIAEMSEHITIVEKELKRT
PSFSVSKPDEEAGVTFAGIPLGHEFNSLVLAILQVSGRAPKEKQSIIDQIKGLEGKYNFE
TYVSLTCQKCPDVVQALNLMSVVNPNITHTMIDGSVFREESEDIMAVPAVFLDGEEFGNG
RMTISDILTKLGSTQDASEFEGKDPYDVLIIGGGPASGSAAIYTARKGLRTGIIADRIGG
QVNDTAGIENFITVKETTGSQFSANLAAHIEEYDIDTMTGIRATNIEKTDQAIRVTLENN
AVLETKTAIISTGASWRKLNIPGEDRLINKGVAFCPHCDGPLFENKDVAVIGGGNSGVEA
AIDLAGIVKHVTLFEYSSELKADTVLQDRLRSLSNVDIHTNARTAEVLGEDHVTGISYED
LNSGEMKELSLDGIFVQIGLVPNTSWIGDAVELNNRGEVVIDRNNNTNVPGIFAAGDVTD
QKNKQIIISMGAGANAALNAFDYIIRN
>SEQF2892_00099 Alkyl hydroperoxide reductase subunit C
MSLINKEILPFIAQAYDPKKDEFKEVSQDDLKGSWSVVCFYPADFSFVCPTELEDLQNQY
DKLQDLGVNVFSVSTDTHFVHKAWHDHSDAINKIQYQMIGDPSQTITRNFDVLDEEAGLA
QRGTFIIDPDGVVQAAEINADGIGRDASTLVNKIKAAQYVRKHPGEVCPAKWEEGSESLQ
PGLDLVGKI
>SEQF2892_00100 2-oxo-hept-4-ene-1,7-dioate hydratase
MSQANKEVSNALFQAYISKEPIEFVSKTYNLTEPEAYKTQDDLIHQIQAEKNVPVKGYKV
SMTSAATQAIANTNEPAYGTILSHQVVENGHGVSLTTLFAPLLEPEIIFELTADLPEDAD
TQTILESVKIAPGIEIPDARYKDWFPNFTLGDLISDNTATGLIVVGERITPLDYEAFADI
NLKLFKDDNQIETGHSSEVLGNPIESVKWLNKKLHSHGKSLKRGQFISSGTFISPLNLEE
GTYTADYDRVGSVTVKVID
>SEQF2892_00101 NADPH-dependent oxidoreductase
MSDYVYDLMKKHHSVRQFKDKALSDETVQKLVEAGQSASTSSYLQIYSIIGVDDPEIKKQ
LKEVSGQPYVVDNGYLFVFVLDYYRHNLINENVDFDMQTSFESAEGLLVGAIDVALVSEN
VALAAEDMGYGIVYLGSLRNDVARVKEILDLPEYAFPLFGMAVGEPADDENGAPKPRLPF
EHVFHKNVYNSNAKEQREAIQKYDEEISEYYKERTNGKRQETWSQQVAGFLSGKTRLDML
EELNKSGLMKK
>SEQF2892_00102 L-cystine uptake protein TcyP
MGTFFTVINIVVMILFLIGLFIMAKKHVSFPKRVFTALGLGIVFGIALHLIYGANSKVLE
TTTDWFSIVGDGYVALLQMIVMPLIFISIVSAFSKIQIGDKFAKIGTYIFMFLIGTVAIA
AIVGIFYAIVFGLDASSIDLGSAENSRGSEISSQAKDLTANTLPQQILELLPSNPFLDFT
GQRTTSTIAVVIFAIFVGFAYLRVARKQPESGSLLKRGIDAIYALVMSIVTFVLRLTPYG
IIAIMASTIATSDFQAIWTLGKFMIASYAALITMYIIHLILLAVMGINPVRYVKKTLEVL
IFAFTSRSSAGALPLNIQTQTQRLGVPDGIANFSASFGLSIGQNGCAGIYPAMLAIMVAP
VANVDIDLPFVLTLIGVVIISSFGVAGVGGGATFASILVLSTLNLPVALAGVLISIEPII
DMGRTALNVNDSILAGTGTAKLTGNMDKDKFNSNEYGDLSTN
>SEQF2892_00103 hypothetical protein
MLTKEFAQRVELSEKQVRKIVQHLEERGYQLSKTEYRGREATDFKEEDIELFQDIAEKVK
QTNSYDLAFEELEKEKDFLQVIVKEDNEQLPADQGATQLVEELRTEIQKMREERQMLGQM
ISQVHQQQTELKELQNQITEKLDTHNQSLLAIQNSQEAIQTAQKEQSEYTKNNLVKEIND
NNQQSIDTLKEDIKTQSSLNRPNDEKKGFFARLFNL
>SEQF2892_00104 hypothetical protein
MNFHVIQSIKDEYYDKAITFYNQQSDVNFYEDSYIIERSLKNNKTENDYAFLVGIQDDEI
ISLATAHYEATTNSAFLIHLIANDTPDYEDVLINTLQEIEHQLNQLSNKVHSRDINFVMV
EVPKTDHPLKDINQQVLTQRQQLLLSNGFERQSEIDYIHPNYSKIDSPFKVDLFIKSNIE
LTKDIYPASVKSNYILKYVFANGISRDIIYPLLVKMNLRLPH
>SEQF2892_00105 hypothetical protein
MADFTVLDKQDEIYNVIDKKKAEGYSENELVVVSKSKLHLDNLHDSQVTLIATSGSFSDR
MSKLLTGEDGEEAVLARYELSEEQTEKYKKDILDGKFLVIANKDNSSHDEVEENNSAYEE
IDITHYANESKGPKS
>SEQF2892_00107 Xanthine phosphoribosyltransferase
MYTNLGGFDVESLRQKVKEDGVVIDEKILKVDGFLNHQIDAKLMHEVGKTFYEQFKDKGV
TKILTIEASGIAPAIMASLHFDVPCLFAKKAKPSTLKDGFYSTDIHSFTKNKTSTVIVSE
EFLNENDTVLIIDDFLANGDASLGLYDIAQQAKAKTVGIGIVVEKSFQDGRQRLEEAGLN
VSSLCKVASLKGNQVTLLGENE
>SEQF2892_00108 Uric acid permease PucK
MKTFILSLQHLLAMYAGAILVPIIVGTSLKFTPEQIAYLVTVDVFMCGVATFLQANKVTG
TGLPIVLGCTFTAVAPMILIGQTKGLDVLYGSLFVSGILVVIIAPFFSYLVKFFPPVVTG
SVVTIIGINLMPVAMNYLAGGEGAKDYGNPKNLILGGATLVIILILQRFTKGFLKSIAIL
IGLVAGTILANVLGLVDVKQVGEAHWLGIPQPFRFSGFGFDLGAILVFTIVAIVSLIEST
GVYHALSEITGKKLERKDFRKGYTAEGLAIVLGSIFNSFPYTAYSQNVGLVSLSGAKKNN
VIYGMVILLLICGCIPKLGALANIIPLPVLGGAMIAMFGMVMAYGVSILGHIDFKNQNNL
LIIAVSVGLGTGISAVPQAFKALGEQFAWLTQNGIVLGAISAIILNFFFNGLKYKQSEEN
VK
>SEQF2892_00109 Inosine-5'-monophosphate dehydrogenase
MWENKFAKESLTFDDVLLIPAASDVLPNDADLSVELSERIKLNIPVISAGMDTVTESKMA
IAMARQGGLGVIHKNMGIEEQAEEVQKVKRSENGVITNPFYLTPDESVYEAEALMGKYRI
SGVPIVSDKESRELVGILTNRDLRFIEDFSIKISDVMTKENLITAPVGTTLDEAETILQE
HKIEKLPLVENGRLEGLITIKDIEKVLEFPHAAKDAHGRLLAAAAIGTSKDTEIRAQKLV
EAGVDALIIDTAHGHSSGVIQEVKKMKEKYPEITIVAGNVATAEATRALFEAGADVVKVG
IGPGSICTTRVVAGVGVPQITAIYDCATEARKFGKAIIADGGIKFSGDIIKALAAGGHAV
MLGSLLAGTEESPGATEVFQGRQYKVYRGMGSLGAMEKGSNDRYFQEDKTPRKFVPEGIE
GRTAYKGPLQDTIYQLMGGVRAGMGYTGSPDLKTLRDEAQFTRMGPAGLAESHPHNVQIT
KESPNYSF
>SEQF2892_00110 GMP synthase [glutamine-hydrolyzing]
MEMAQEQELILVLDFGSQYNQLITRRIREMGVYSELHDHEISVDEIKRMNPKGIILSGGP
NSVYEEGSFTIDPEIYNLGIPVLGICYGMQLTTKLLGGKVERANEREYGKAIINAKSDEL
FFGLPAEQTVWMSHSDKVIEIPDGFEVIADSPSTNYAAIEDKKRRIYGVQFHPEVRHTEY
GNDLLRNFVRRVCECTGEWTMENFIDIEVEKIRKRVGDRKVLCAMSGGVDSSVVAVLLHK
AIGDQLTCIFVDHGLLRKGEGDMVMEQFGEGFDMNIIRVNAQERFMDKLKGVSDPEQKRK
IIGNEFVYVFDDEAAKLTDVDFLAQGTLYTDVIESGTKTAQTIKSHHNVGGLPEDMEFEL
IEPINTLFKDEVRALGIELGIPEHLVWRQPFPGPGLGIRVLGEITEDKLEIVRESDAILR
EVVREEGLERDIWQYFTVLPGIQSVGVMGDYRTYDHTVGIRAVTSIDGMTSDFARIDWEV
LQKISSRIVNEVDRVNRVVYDITSKPPSTIEWE
>SEQF2892_00111 Tyrosine recombinase XerD
MFTAYIVEFQVLNGMRIGELLAIQPDNIDFENKKLVIDGTIHWRKDGNKVGFKDTTKTAS
SYRTISLTTRSCDILRRVMLENKKAVQWEIMYVDRGFIFTSHRGNPLPLTSINRNIQIAA
QNIGIEKHVTSHTMRHSHISLLSQLGVSLRAIMERVGHTDHKTTLQIYSHVTEQMDKDMM
NKLEKIRS
>SEQF2892_00112 hypothetical protein
MWHEKFTNKHGETKYRYYEKYKDPLTNKWRRVSVVLNKNGKQSQKEAQKRLNERIEAKLN
DKTPTNLKTLTFHAACDEWFERYKLTSGSKQSTITTKSYKVAHIKRNIDKDILVENMNAD
VIQDLINSSLKDGLSHKLVKDDLSIIKNILRYAQKKYNITDISYIDDVVMPKKATTREEV
KAKRENYLEMAEVLAIVEELNRIANKKAC
>SEQF2892_00113 hypothetical protein
MRILNCKIKLNKITYEVETNNNNYFKHSLPKDINTYQVGKILRNISDELDGV
>SEQF2892_00114 hypothetical protein
MEILNYKINYEYDSDLYTVTAKTNKGRTFTYTFSENHTLKEIRYTLEEIAKQLDT
>SEQF2892_00115 hypothetical protein
MYELGTFLKKERLNRGKSIKEIAEKLEVSSAYISMVENNKTIPNSDYLYNLSSFLYGGDD
IFEMLVAEKYIVFCLVGRIKVQPYPFVKFLLSERGMFEENSMINKPYYSLNWLFNQQKAP
ITFGLKNENTYNIDIEEVYPISQYDYFNGEPKSFIQLDNKDKEFIYKVIETYIKSKYSDK
IMDQLDVDNNNVDLIIEKLYESTGNPDITMPLLAIDDLTEFTNQKEVISIRKNWKIINLT
NLEFFITKNTIEGIRSSNGVLGSFSIVGEIFYKETKNSLTDFEINFPKNYLIDINSKTKE
ITFNYNND
>SEQF2892_00116 hypothetical protein
MEAKGKVLKSEIFSNGYSIKEFSEKVNISRTYMSSVVNNKKGVSPQSAKNIANLLNCNIS
DLFKVTDEKGN
>SEQF2892_00117 hypothetical protein
MSHIKLQELPTKQNTALEEKQIVFPVKYAKPKLLSELFNCSYSTIRRLLISYDEDNLGVE
SMYFDISSTLTLVNVEKFEEFLKRKHKKYL
>SEQF2892_00118 hypothetical protein
MAKFLFRLILISVISFLSGWLLGIHVAFAIYLLGSTIALLNYESVEVK
>SEQF2892_00119 hypothetical protein
MQIKQKYQLSKVVQVLEKVLYEKDKDIFLSAKDSFHFITDYHYNDTAFYEHILKLVHKEL
FNILAEVDFEDEAFSILDEVTMTLSDVMNEDKEIYYYSVEDSTGEQKHTTDREGHVIGIL
EWALDYIVGNIEVE
>SEQF2892_00120 hypothetical protein
MAAKLDVNKQNIMHAINWIIKNEEEIIFESQSQLSFFSCEDLEKIDYCKRTLESLIEAKE
IYNKKIS
>SEQF2892_00121 hypothetical protein
MEWELRNLFDDLEVVQEKINDVVTSFVWFDDEYFTHEPNHMLTKKEIYTHGWNYHEHRIK
NTQVIDLMLMYMKDFDDIMKKIREIEKCASDVSLTTESDNA
>SEQF2892_00122 hypothetical protein
MNKIKLEHDTQVSVVWYNDLDSRSFKNFSQPKWSELINRLSIPQNNTNKYARGVAVYGDI
KDGTDEDGKEYKKYRNNDNVIYRDVLVLDYDDIPKLRPLHDAITDALKGIAWFWHTTFNH
QTESPRIRLYVPLNERLNADDYRKYTKVLVNKIGHPVDEGSFQPSRAMALPVYQQDKYPF
LYQHSDAPILGTKMLEEWFEKYKSQHKGSTKFKYPKRRDNDFWKSIAFGVSTGNRNQTLT
SLIGVLLNRRVPDPLVYAYCYMWNENCNPPMSSREFNATFESIYKREHR
>SEQF2892_00123 hypothetical protein
MATFPDYLENKTIFDEKDFFDGNRFKFYEFALFLYEEYHGCYIDNRPHVFTGKKYEPLNI
DVVRKMTIKYIPSLREQQNKEVYQKLKTLCLGNHQEQCSARYIGLKNGIYDTVEEKLNPF
NPQYYITNIIDVDFDKDAQSDLIEKFIKDISNEDEEVEQLIYEMIGYGLYRDNFLQVAFF
YYSPGGNGKTTLLKLLHHFYNPENTTALSFNDLNDKFKPANLQGKLVNIADDIDPNRIRD
TGNFKIIVTGNYITFEFKGQDAFEFKPYVKLIFASNELPMSNDKSEGFYRRMVIIPMLRK
FGKDGQKRDPMLLNKLITPHNMSALLNLALKGLKRTLENNEIIEPQIARKTKEEYQHDNN
PVLQFIEDAEDKDYRQLPVVEGRPTNKTYEIYNIWAPNNGYMLLNKSNFSKEMGRLGYKT
KMKWSKEKQKSVRFYYKDTTENYYDFDGQSL
>SEQF2892_00124 hypothetical protein
MNNVKIKIIKYITENAGTSFVEIEKIFDENHFEYKGNGAYTSAENNNIIFWYGWNEQAFN
VVSSLVNEGLIDMKICEPVIYMVDGKELNLPVLKSYDIDTYHWLPITFSVNKEVAYE
>SEQF2892_00125 hypothetical protein
MNNLKDKVLDFIRENESTYIYELEPLFDKACVPFEGNRSLTFDGDKNRVFFYHCTTESGL
VIQELYQENKISIVHNPRYVERYLLDGKVPPLPLAITEDVDKPSWIPVVLRIKDKGAN
>SEQF2892_00126 hypothetical protein
MNVEIIANQFETRAATLLRYYTGLLDSSRENHFAFKIYNDPFDMVYVMMNGKLFGHVYIK
DCKVRKSFELASSKHTEGLIRSVEGYYNGFEIHDDMRLSISDMMASQLFENEYFIYELQT
FSESNNTDMFTYIESGLNVEELEGVQSSNADVIGNIEILYQLATGINKPAQELVEGLKLV
TAFVQDENATQDDYKTLERKLSELKESYYSVSK
>SEQF2892_00127 hypothetical protein
MIDTLNKNQSVPTEYLRIFDTIQNSKDKYITKSKILNLMGYESNSTNERWLRNAISKLID
DYGYPIGCSYKKHERGYYIITTDEEKQRAMQNLKKLADGSMRRYEALKRIEL
>SEQF2892_00128 hypothetical protein
MYNTNATKTGSAYDVLFNDRKYKDLLDKVDEFLEETFIMYQRGYRLDAIDEKQKPKVTQI
ENEFKQFASDKIKNIENRLEEIEKESTTENISNPQAELINRQNLKARLSFYDNSEIIEYV
RNADPKEIGVYELSLLQNIYENRFSENEQGQISGTFTQLKRMVLHPYENDEEYNDLAYQY
NILRQIGMENRGSVINKDKDGYVVIKPLADRYNEQLKHAKAKKDGARKQAYAYRQ
>SEQF2892_00129 hypothetical protein
MQESINKPYQQTKISEYELLTKYNPKYINSKIKLAQSHIEEMYHLSTSITTCDDIMGVIS
VSYPVDKLVIWICEKKADLKRFKNDSSVRLSLLKQVLNTYTKEERQQVVRYMQSHGRIKE
HRLIERLQVDLYNVYLNKSITKASEPQQAMVV
>SEQF2892_00130 hypothetical protein
MFVGDKETLKTFILNYHNYVNDVEEEVSADDFFMLNDDVELYSSEITHTDNHIYMNELET
LVDRICTQRELILFLLLRSGRSSKDIAQIFELSVNRINQLTNQLIDKIIENKEWLNGQIN
AQTRAICE
>SEQF2892_00131 hypothetical protein
MDKLTPKQERFANEYIKTLNVTQSAIKAGYSPNSAHVTGSRLLRKEKVDEYIKSKKDEIM
DDTILSAKEILYLLTKSAIGDETETKEVVVKKGTFERNPDTDKMNLVYNEHVEMVEIPIK
PSDRLRARDMLGKYHKLFTDKKELSTDTPIIVNIGDWPEDEEEEKRKTLDELHEQHPNRT
MIIDDVPLEDC
>SEQF2892_00132 hypothetical protein
MNDTADKLNMISIEDMYNRAMAIKKCSVIYYDNLMNDKESAVWHTLSKTQKGLGVILPFN
LMIARNGVDRRIVPSIKLNDDRIFIYPNR
>SEQF2892_00133 hypothetical protein
MYKNYNMTQLTLPMETSVLIPTNDISRHVNDIVETIPDNEFDEFRHHRGATSYHPKMMLK
VILYAYTQSVFSGRKIEKMLNDSIRMMWLSQNQKPSYKTINRFRVNPKVDALLESLFIQF
YSQCVKQNLIDDKAIFIDGTKIEANANRYTFVWKKSIQNHELKMNEDSKALYHELVTNKI
IPEIKEDHDNELTKEEIDLIGSHLDKEIEDLNQHINNEKCTKTRKQIRLKRTKIKKYKKQ
INDYFERKYRYEFQKSILKDRNSYSKTDHDATFMRMKEDHMKNGQLKPGYNLQIATNSQF
VLSYNVYQNPTDTRTMIPFLNSIQETYGHLPEYIVADAGYGSESNYKAIIDDFNRTPLIT
YGMFIKDKTKKYKSDIFNTQNWNYDEINDEFICPNNKRLGFKRYAYRHDKYGYKRDFKLY
ECDDCSECPLKNQCMNFNSKTNKKIMKNYNWEYFKSQINKKLSEPETKNIYSQRKIDVEP
VFGFMKAILGFTRMSVRGLNKVKRELGFVLMALNIRKVVAQRAENNQKIYKKDNFYIISI
EIVFFSLIQELYVPDSFIYIKKQNDFLVILKAWSVTPFSSIIPQISLYHQ
>SEQF2892_00135 Ktr system potassium uptake protein B
MNKANKSLYFYLMLFFSTTLVGAILLYLPYTGKKPITFIDALFIASSAFTVTGLSPVDIG
AQFNLLGEVVILLLIQIGGLGIVTVTMLTFVFLNKKVSLQNRFLIMVTWNIDEAGGVVKL
IKHLAIYSFITELIGAFCLSLSFIPKFGIGQGLFISLFTAVSAFNNAGFALFKNNLIDFS
NDPVVIITVPLLIVLGGLGHFVLVDLINCKKLNKLSFHSKVVLSTTFILIIFGAILFFLL
EQSNTLNNMGLIEKIGNALFQSVTTRTAGFNSIDMGNIKTPTALLLMALMFIGGAPLSAA
GGIKVTTFAIVFIFVLNAICKENTVSLFNREISDKYIKLSIVTITISIIFIFVITFLLTI
INPSIPLVKILFEVISAFGTVGLTMDLTSEYNGLTELIIVIVMLFGKVGLLTMARAFIPP
RSPRKYHYPKGHIHI
>SEQF2892_00136 hypothetical protein
MVGLFYIYTKNLINQWINEESLFYELSSLYPRLN
>SEQF2892_00137 putative N-acetyltransferase YjaB
MRLNKIELQEKDYPKALAIWERSVIATHDFLKEKDRIALKKEIPTYFSHVEAYLWFDGDD
VIGFSGTNEANLEMLFLDPKYFKQGYGTEILQTLIQEHKVQYVDVNKDNPNAVSFYLKNG
FKQYDESAKDGQGRDYPIVHLKLFYFFHAINNSVWFVLSILASIFMKPKSV
>SEQF2892_00138 putative N-acetyltransferase YjaB
MIEHLKKKNHKTIKILGNIWLNANLDTHTFIDSFYWIDNYTTVLDALKDADVYVYKNGKD
IVAFCGLNDTYIAGLFVKEEFRDQGIGHALIKHLQSEYDYLSLKVFEENHRAVHFYTDLG
FIKIDANIDKTNHTELLMAWKK
>SEQF2892_00139 NADH-quinone oxidoreductase subunit L
MLSSGFLLTLFFVTLVIAVLSGLIFLMPSVPVKYIRLHLTLLLLPVIVGVIGLITINGRE
VIGIFALDKLAWLVGAFVLALGFIIQKFSARYLLGDRNYRKYFPLYTFTTVFASIGWLSN
DLRLMVICWGLTLFCLTQLIRLNRSWKVPAEAAKVSARSFIIGWVALLLAVVVFFIGTGD
WVIDPSQDYDVSMSYGLKLIVDLLLVIAVIIPAAQYPFQSWLIESVVAPTPVSAIMHAGI
VNAGGIILTRFSPVFDNNIALTLLLIISSISVLIGSGISLVHVDYKRQLVGSTMSQMGFM
LVQCALGVYSAAIIHLILHGVFKATLFLQSGSIVKRFNIPTPPNVKRSYAWTVLGRTLAV
VIAIIFFLTSSHTPYTLISAFILAWSLSVSWNQMVALNRGMMGRVIGIAMLIIVALVYVV
THEVFVNILNSVYMVTPHPPLISVIICVAILVLGSIFSIWVARRRSSIAFAKVYLWLVKI
GEAKFKSVESHPNYLKNYL
>SEQF2892_00140 hypothetical protein
MTITKHNIEETVKSARRVITPLSPISIFAARNPWEEMEHETFDQVAQWFKHVRDIDLYPS
HASVMTALENGEIDQKLVETEVQQAIKDYNTSVPKSHIDIYCKNAMRIKDLPTNLITKEA
YLKIEVSKLKRVFENEPFKYARSKSANAFNAKGESLMDELNTHIIKWSKLYLDNFQSSWT
IPKREEGFYISWLHLAQHDPMLTKTQRKMIKTLPQDYREALIMALNHLDIAEDERESYLT
GHFLSLPGWAGMMYYRAEQHEHEADLLTQYLAIRLTMECILLDTEKMSRPAVLNVERRIK
ELVSKWLYYGEMSIDDWASMSIEDQLEHLRFAHDFNPLYFKKLWLEAWEETHERELVEAI
YDKSVKPVEQETQVQLAFCIDVRSEPFRRHLESEGPFETIGIAGFFGLPIRKEVLDEQFT
HNSLPVMVPPAYAIKEYADRHDLNTYNQQQHSVTSMFYTFKLMKHNVLPSLLLPELSGPF
LSLNTIASTLMPKKTGHFVRNFTKNWLKKPEAKLTIDREHEIYNDLPIGFTEEEQVAFTR
QALQLMDLTTNFAPLIVLGGHGSVSNNNPYHASLECGACGGASSGFNAKLLAMMCNLPHV
REALKNEGIVIPDSTVFVAAEHKTSIDELEFIYMPELTKEAQNALDMLNEAMPRISYKAN
SERLANLPGLDQDDLKDPVAEAHRFANDWSEIRPEWGLARNAEFIIGQRNITAGTNLEGR
AFLHNYDWKKDTDGQLLNTIISGPALVAQWINLQYYASTVAPHFYGSGNKTTQSVTSGVG
VMQGNSSDLLAGLPWQSVMAADNKIYHSPIRLLVVIQAPDQYIKDLLENNIKFKQKVDNQ
WVRLASIDENGSWKDW
>SEQF2892_00141 hypothetical protein
MAKSKGAYEAEISKAITQWEKDFLGRGSLSVKTDILRDMIIVNLQGVLTPAEYRVCKTQE
GLLNIKRTRSELVESGQDDLMQLILDITGVSVSSFHSDLSTITGERVIVFKLDTNLEKQL
>SEQF2892_00142 hypothetical protein
MRVNEFKQPIGEALDDFVTPSFPDAQTLEGSYGRLTKLSIEHINDLYDVLCDVESRRIWT
YLYEGPFDSKTEFEQYIKQLIDSKDKYFFTILDNVQQKPLGILALMRINPEQGSIEVGNI
IYSKTLKKTRVATETQYLLAKYVFETLGYRRYEWKCDNLNAPSKHAAQRFGFTYEGLFRQ
SNICKGRNRDTAWFSLLDSEWPDVKARFEHWLELSNFDQEGQQIKHLNDF
>SEQF2892_00143 hypothetical protein
MNKQISEISPKMTLPMFMIGLIIFVVVAINVIHDTLLVQNVDIGSLHWLTDYFGEPERKY
GDGIWHNFMTFCAEIGEVKSVIYITLFLAIVLLFKHYKLSIWMVLTITSGTLLNYLIKQL
IERQRPFNHLMRDHGYSFPSGHSNASTLLALILLIILIPLIKLKAIRIIANTITIIIWIG
VLCCRLYFHAHYITDVVGGVTLGIIWVALFLMILPLFYLNLRNKPNNK
>SEQF2892_00144 hypothetical protein
MSKDKERTLVLGGGGITGIAWESGVLAGLIESGVGLELADRIIGTSAGSFVGAVLANGYD
MRTYYYELNERRDDSDHATLSSDIYRLWQNAFIVGRDDATKVGQMMGDIVYTRPSRVDLT
KRKQAIRQRLGDVGWHDNLEITAMNAKTGEVSTFHSHSNVTLEEAVTASGAVPGIWPHIR
LNNCDWIDGGMVSPTNAMLAKGADSIIILAPIADGLGMMPGAFDDAKLLSEHSHVLVISP
DSKSRAEIGDNIYNPNNILKIGNAGYEQGKLLVQRIHLEFCEWVE
>SEQF2892_00145 Carboxylesterase
MKVKSPRPINLKGTRKEAVLLLHSFTGTIRDVKPLAQKLNQEGYTCYAPNYKGHGLPLDQ
FTQYTVHDWWNDVLNGYQYLKDEGYETIYATGVSLGGLFTLKLAETVDVAKIAVMSAPSE
KEEAGIVWRMERYGQRMNELMNLDSDASQEQFNYIEDYRPSVRVFKDFISNITAHLGDIK
TPARILYGEKDEQSYQDSAHYIYEHINSEDKDLTSHPLSKHLMTHGEGSDKVETQIAEFF
MTN
>SEQF2892_00146 hypothetical protein
MKRTFLLTYITTSGKHYNEFKTFKNGPDKDACIQRLIDEFDELAYLFLKDGQQSHYINVD
HIESLSIQEVTEGQDVVYDFND
>SEQF2892_00147 hypothetical protein
MSLLHERIKANYWKGVEAVGGHIVFEDDGFRFTPHSFNIQADSVFVPYQHIQEVSKVNTL
FIVPNGVKIIDKNKNVHKIVVNQREKIFEFLNEMK
>SEQF2892_00148 hypothetical protein
MSKESQWKTSTGFILASAGSAIGLGAMWKFPYMAGIYGGGAFLLLFLIFTIFVGLPLLIM
EFTVGKMGRTYTTHIYSKLTGKKWLNIIGWNGNLAVFILFGFYSVIGGWIIIYIGNVILQ
MLSIEKTTLTNINFEAIISNPWLTVLGQGIFIFLTMIIVMLGVEKGLEKASKVMMPLLFI
FLIIVVVKSLTLDGAIDGVRYILQPRLEDISMEGILFALGQSFFTLSLGTTGMITYASYA
PKEMTIKSSAISIVIMNILVSVLAGLAIFPALKTFGYEPQEGPGLLFKVLPLVFSQMGFG
VMFYFIFLILFLFAALTSSISLLELNVSNFTKNDNSKRKSVAFIASILVLIISIPATLSF
SSLSDIKFGAGTIFDNMDFIVSNILMPLGALGTTLVVGQLLDKEALKESFGRDKFKFFAP
WYFLIKFVMPAVIILVFIVQLF
>SEQF2892_00150 hypothetical protein
MYKNYNMTQLTLPMETSVLIPTNDISRHVNDIVETIPDNEFDEFRHHRGATSYHPKMMLK
VILYAYTQSVFSGRKIEKMLNDSIRMMWLSQNQKPSYKTINRFRVNPKVDALLESLFIQF
YSQCVKQNLIDDKAIFIDGTKIEANANRYTFVWKKSIQNHELKMNEDSKALYHELVTNKI
IPEIKEDHDNELTKEEIDLIGSHLDKEIEDLNQHINNEKCTKTRKQIRLKRTKIKKYKKQ
INDYFERKYRYEFQKSILKDRNSYSKTDHDATFMRMKEDHMKNGQLKPGYNLQIATNSQF
VLSYNVYQNPTDTRTMIPFLNSIQETYGHLPEYIVADAGYGSESNYKAIIDDFNRTPLIT
YGMFIKDKTKKYKSDIFNTQNWNYDEINDEFICPNNKRLGFKRYAYRHDKYGYKRDFKLY
ECDDCSECPLKNQCMNFNSKTNKKIMKNYNWEYFKSQINKKLSEPETKNIYSQRKIDVEP
VFGFMKAILGFTRMSVRGLNKVKRELGFVLMALNIRKVVAQRAENNQKIYKKDNFYIISI
EIVFFSLIQELYVPDSFY
>SEQF2892_00151 hypothetical protein
MSTHENDHYEAFESSQLNREDLMDLSELRQQVDAFKTNNNDSELKEHIASELIKWKEYIR
DQYRPEDPAEQSRLSNIADKVQGDIDSAFEYNDGSKIFAFLEASYQRSKEDLVYGRTLIL
FSEKDTIKRALSFFDSDEENHKLADFIVSKNIEIGKEIMSEDYLELLEIERDYINARFN
>SEQF2892_00152 hypothetical protein
MTSKADLSLSVFTNEHYKSIKYTNSTFRNAMYDDLEINKSYFKNCDFSEGIFKNVHTVSN
TKLINCDFSSSIFVNINFFKTLMSKVNYSVTTFDDSQFNALTIEQTSFKDCSLRNVTFND
VVLKKVVFENVALDLCNLDNVKIKDCVFKNVSINNSAISEKVMKELRKQDVRFENM
>SEQF2892_00153 O-acetylserine dependent cystathionine beta-synthase
MIAFDLIGQTPLVLLESFSDENVQIYAKLEQFNPGGSVKDRLGKYLVETAIKEGRVSSGD
TIVEATAGNTGIGLVIAANRYHLKCVIFAPEGFSEEKISIMRALGADIKHTPKDEGMIGA
QTKARSYAQEYGAVYMNQFETEYNPSAYTHTLGKQLTDTLPNIDYFVAGVGSGGTFTGVA
QHLKQYNVKNVIVEPEGSILNGGEAHSHDIEGIGSEKWPIFLERSLVDQIITVSDKDGFD
NVKRLAQQEGLLVGSSSGAALQGALDIKNQIDKGVIVTIFPDGSDRYMSKKIFEYKGE
>SEQF2892_00154 Cystathionine gamma-lyase
MKKKTQMIHGGHTTDDFTGAVTTPIYQTSTYLQDEIGDLRQGYEYSRTANPTRTAIESVI
ANLENGKHGFAFGSGMAAISAVIMLLDKGDHLILNSDVYGGTYRALTKVFTRYGIDVDFV
DTTHIENVKDYIKPETKMLYVETPSNPLLRVTDIKRTAEIAKENNLISVVDNTFMTPYYQ
NPLDFGIDIVLHSATKYIGGHSDVVAGLVATADDELGERLAFISNSTGGVLGPQDSYLLV
RGIKTLGLRMEQINRNVEAIVETLQNHPSVQQVFHPSIKDHLNHDIHVAQASGHTGVVAF
EVKDTEAAKQLIRETNYFTLAESLGAVESLISVPALMTHASIPADVRAKEGITDGLVRLS
IGIEDTDDLVEDLKQAIDTLN
>SEQF2892_00155 N-acetylmuramoyl-L-alanine amidase sle1
MNKKILATAVLGTGALSTLFAHQAEASTTHTVRSGESLWSISHHYGITVSKLKSLNGLSS
NLIFPNQVLKVSGSSNYSSRSNYGNSSSTYTVRAGDSLSSIASRYGTTYRHIMNLNGLNS
FLIFPGQQLKVSGSVSSNSHSSYNSNSGGSSSTYTVRYGDSLSSIASRYGTTYQHIMRLN
GLNNFFIYPGQKLRVSGSASSNTYSTRSAQSTYYSSPVFNHRNLYDWGQCTWHVFNRRAA
IGKGISTYWWNANNWDNAAARDGYRIDGNPTVGSIAQSDAGYYGHVAFVERVNSNGSILV
SEMNFSASPGILTYRTIPAYQVRNYKFIH
>SEQF2892_00156 hypothetical protein
MAKKSKLTRVSNLVSTAGFIVDGYNGIKFDAKNKNLVYLSLGLSTVGTLLDFVVSMKSPY
KFRKLTSFVSFIINVTRLASSFRKVKEDYNFQ
>SEQF2892_00157 NADH pyrophosphatase
MIKCVCLVEETENQILLVQVRNREKYYFPGGKIDEGETQLEAIQREVKEELQLEFPQEDF
TYIGTVIGDAYPQTNMLTELNGFKLQQEIDWNNVEIDNEITDIRWFDKSDTTLIAPAVIK
WIETFSERK
>SEQF2892_00158 Spermine/spermidine acetyltransferase
MEIRPYSNQDKPLLDVFEILPEDRKFTRTPIQNIDLAKGDDERHPTLVMRDNQCVGFFTL
HEGQGVKPYSDNNKAIFFRSFSVDARYRGQGLGKAVIQQLPSYINSTFPYINEIILTVNT
DNDKAIGLYKRAQYSITGDAILEGRPVYVMNFKI
>SEQF2892_00159 hypothetical protein
MNAVVLLALILLILMLIFGGKKGLISYLTLFLNFIILLISIVFILFGTPIYLVSLVFCIV
IAACNLFILNSYNIKTKAAFIATIITTILLIVGIYLSISIGHLQGFTTEQQDETYIFSMN
IGIDMVQFSVFTVVLAVIAAVIDLTITISSPMYELNETNPTLSRKALFQSGMRVGREILA
TSANTIYLAYFGGQLTLFFWFFQLHYSFGHIINSKIFAQEFISILLGGIAVAISIPITAW
ITALLIKHPKFNQKHSEISSQSTD
>SEQF2892_00160 hypothetical protein
MNAQKRNNSSHRLMNRIIVLIGVLIIGAFIFTFFNASFYNTPIGKVTHVETSNAQKVVDE
QHNTDFKYKQHLTIKILNGKFKGESTTIDNTYVKSQADSEHFSKNNKVLMHIQNSPKDAT
ILEKKRDSLTVAIAGIFIMSLLLVGRNVGLQSILSLIFNTGAILIAIAIHDKHPSTNLFI
LMSVAIIFSTIVTLLLVTGWHMRTWITTVGTLLGTFLCIGITQIIIQFTNGAGIKYETMS
FLTLPPKDIFLASVLIGSLGAVMDVAITISSGMYEILQRTPNISLSRWALAGRNIGQDIM
GTMTNILLFSYLSGSLPMFLIYLKNANTFTYTISMNWSLEIARALTGGIGIVLTIPITIS
LMVMWMKWKGVTR
>SEQF2892_00161 HTH-type transcriptional regulator GltC
MYMEIKQLKYFVEVARREHISEAALELNIAQSAISRQITLLEQELQVTLFNRQGRNIHLT
SHGKALLNQATQILEQLDETIALFQQTNHKNAHVLNIGFEESYISQMITAIIQAFERQYD
SIIVPHIMSSSDISEALYNGKIDIGLVEINAELQKNTNLSLKPLFEETYHIYVPKDDVIA
LSINPPLTQFAKTQLFTLKPLASTIESRLQHTLKLPVNIVGSKSLANYLLKHQRGYVILP
DYLSLDNDQDELCDISLGHTELKRSFCVVFKKDNKKVDILNLSNLIHQLLSKVSTYH
>SEQF2892_00162 Glutamate synthase [NADPH] large chain
MFDERLKRGLYDYREEHDACGIGFYANMNNLRSHDIIEKSLEMLRRLDHRGGVGADGITG
DGAGIMTEIPFQFFKAHVNLDLPNEGDYAVGLFFSNEKIQGTKHETQFNDYFQSEGLKVI
GYRDVPVDVNAVAPHVASTMPHIQQVFIDIRLIETPAKPLYIARKQIEQYAERQDLGLYF
TSLSHKTIVYKGWLRSDQIKKLYLDLNHEDYQSKLGLVHSRFSTNTFPSWKRAHPNRLLM
HNGEINTIKGNVNWMRARQRQLIQTLFGEEHTKIQNIVDEDGSDSAIVDNALEFLSLAME
PEEAAMLLIPEPWLYNKENDDNVRAFYEFYSYLMEPWDGPTMISFCNGDKIGALTDRNGL
RPGRYTITKDNFIVFSSEVGVVDVPEVNVAYKGQLNPGKLLLVDFDSHKVVENNELKARI
ANQYPYKEWLDNHKVDLNLEGQTYHQPLLNSETLFELQRQFGYTKEDIYKYMAELVKGKK
DPIGAMGYDAPLAVLNERPESLFNYFKQLFAQVTNPPIDAYREKIVTSELSYLGGEGNLF
HPDETVLDRIQLAKPVLTLTQLDKIKQSKFNVKHLSTLYQDNLKEALERLGEAAIQATRD
GHTILVLDDSELIDNDDESKLKEQRYAMPILLAISHIHQLLIREGLRMDTSLVALSGETR
EVHHVACLLGYGANAVIPYLAQHTIAHLTETHRLEGTVSDNVETYTRVLSEGVIKVMAKM
GISTVQSYQGAQIFEAVGLSQEVIDDYFTGTQSKLSGLSIQQIDTENKMRQQRHNEYLDS
GSVFQWRQQGQHHVFNPTTIHLLQHACRENDYTQFKTFSNAIHEQRNDHLRDLLEFKAQQ
SIHISEVESVESIVKRFNTGAMSYGSISEEAHQTLAQAMNKIGGKSNSGEGGENPKRYEI
QEDGTVLSSAIKQVASGRFGVTSNYLQHAKELQIKVAQGAKPGEGGQLPGTKVYPWIAET
RGSTPGIGLISPPPHHDIYSIEDLGQLIHDLKNANRSADVAVKLVSKTGIGTIASGVAKA
FADKIVVSGYDGGTGASPKTSIQHAGLPWELGLAETHQTLKLNHLRSRVRLETDGKLMTG
RDVALACALGAEEFGFATAPLVVLGCIMMRVCHNDTCPVGIATQNKDLRALFRGKADHVV
NFMHFIAEELREVLASLGIRTVEELVGRTDLLQRSSRIDEQSKAATLDIEKLLDSDDGPN
SKEINQNHHLDIGFDLNYLYKDAKQSIEDGKLFKGNYVINNEQRDVGVITGSYITQCHGI
KGLPEGTIVAKTHGHAGQSLAAFAPSGLLVQHTGDANDYVGKGLSGGTVVIKAPNKQRER
EIIAGNVCFYGASKGKAFINGSAGERFCIRNSGVDVVVEGIGDHGLEYMTGGHVVNLGDV
GKNFGQGMSGGVCYVFPSNLELFKRKNQLPTLAFERVTHKEEKALLKTMLEEHYRYTQST
KAASILNDFEHVADKVIKVIPKDYELMMQKIELQSRHLPQLDDAKLAAFYDERTTIEQEL
QPAVIY
>SEQF2892_00163 Glutamate synthase [NADPH] small chain
MGEFKGFMKYEKQSLSELSLVERLKNHDAFQQRFSRDEASVQGARCMDCGTPFCQTGLPF
GRETIGCPIGNYVPEWNDLVYRQDFKAAYQRLSETNNFPEFTGRVCPAPCEQSCVMKINR
ESVAIKGIERTIIDEAYDNGWVKPKYPKQRLEQSVAIVGSGPAGLSAAEELNYMGYQVTV
FERAAEAGGLLMYGIPNMKLDKDVVRRRITLMTEAGITFKTNTNIGVDISREELEQTYDA
IILCTGAQKARDLPLEGRMGQGIHFAMDYLTEQTQLLNGEIDEPTITAKGKNVIIIGAGD
TGADCVATALRENCKSIVQFNKYTKAPEEIAFESNTSWPLALPVFKMDYAHKEYEARFGR
EPRAYGVQTMRYDVDHIGNVRGVYTQILEETPEGMVVVDGTERHWPADLVLLSIGFEGTE
PTVPRSFDIATQQNKIIANDKDYRTNKEKIFAAGDARRGQSLVVWAIKEGRAVAQSVDKF
LKQKVFV
>SEQF2892_00165 PTS system trehalose-specific EIIBC component
MAVKRKDVQDIVRAIGGKENIDTATHCVTRLRLVLKDDNKVDKDALDDNTLVKGQFKADN
QYQIVIGPGTVDEVYKQFIQETGVEESSKDDAKAAASKKGNPLQRLIKLLGDIFIPILPA
LVTAGLLMGINNLLTMKDLFGPKPLVEQFPQLGDISNIINVIASTAFIFLPALIGWSSMK
VFGGSPILGLVLGLILMHPQLVSQYDIAKGHIPTWNLFDLEIKQLNYQGQVLPVLIAAYV
LSLIEKALNKVVHDSIKMLVVGPVALLVTGFLAFIIIGPIALAVGTGITGAVQFVFEHAG
WLGGALYGFFYAPLVITGLHHMFLAVDFQLMGSKLGGTYLWPIVAISNICQGSAAFGAWF
IYKRRKMVKEEGLALTSSVSAFLGVTEPAMFGVNLPLKVPFFAAICTSSVLGAIIGANKV
LGSVGVGGVPAFISIHSEFWFIYIPVTLLAMVIPAILTIIFARFTTIKAKKMVATPDETV
AK
>SEQF2892_00166 Trehalose-6-phosphate hydrolase
MAHKDWKKSVVYQIYPKSFNDTTGNGEGDINGIIEKLDYIQYLGVDYIWLTPVYESPMND
NGYDISNYLKINERFGTLEDFETLISEAHKRDLKVMLDIVINHTSTEHQWFKEAISSKDN
PYRDYYYFKPSQDGPPTNWESKFGGNAWQYDEKTDEYYLHLFDVTQADLNWNNEKVRQSL
YEVVNHWIQFGVDGFRFDVINLISKGEFKDSPQIGKEFYTDGPRVHEYLHELNRHTFGDK
DMMTVGEMSSTTIDNCINYTRPDRQELSSVFNFHHLKVDYVDGEKWSNAKLDFLKLKEIL
MDWQIGIFEGGGWNAIFWCNHDQPRVVSRFGDDSTEENRQASAKMLAIALHMLQGTPYIY
QGEEIGMTDPHFDSIQQYRDVESRNAYDNLMQQGIDESEVLTILGQKSRDNSRTPIQWTS
EKQAGFTSGTPWIDIPNNAEHINVEAAIEDTTSVLHTYRELIKLRHEHDIITYGDIEPMY
MEHPQLFIYRRNYDNQTWLVIANFSKETIKLPEDLYSEGTTIIQSGTIENGEISPFGAVV
INVQ
>SEQF2892_00167 HTH-type transcriptional regulator TreR
MATQKFITIYEQLKQRIHEGEYTYGQQLPSEHELLTLYGASRETVRKALDLLANDGMIQK
IRGKGSVVIDQGITEFPFSELISFKEVQEELGLKHETEVLINELVKASSVLHVKKQLNIS
NDDVLIHVVRTRNVNQKVKILDEDYFLTSIVSNISDSVAKDSIYHYLETQLGLDISYSSK
SITFEPFTEREYNVFGKIQPPYTATVRSVVYLKNTMPFQYNVSKHLATEFKFQEFSRRHK
L
>SEQF2892_00171 hypothetical protein
MFEHKMGNAWTNQRGVNMRLFLSTLTEMDYIETLNKIESSYDDKGQGVGQKQRELISRLR
RALNYNYELEVIAKNEAGDIIGHIMLSEINLKADDQRYKALELASLIVDKPYRNEGLGKA
LVQAVEERAKSQHYTTIVVGCCPAYFEELGYEPADKHNIFSKETNPSALRVKFLWDQLDE
YPHGIVQDADMT
>SEQF2892_00172 DNA polymerase III subunit tau
MNYQALYRMFRPQSFQDVVGQEHVTKTLRNAISKGKQSHAYIFSGPRGTGKTSIAKVFAK
AINCLNPQDGEPCNECAICKGITQGTNGDVIEIDAASNNGVDEIRNIRDKVKYAPSESKY
KVYIIDEVHMLTTGAFNALLKTLEEPPAHAIFILATTEPHKIPPTIISRAQRFDFKAIGT
EQITDRLRFVAEEQQLDYDNEALEFIAKASEGGMRDALSIMDQAIAFGDEHLTLQDALDV
TGSVDEAALNELFKDVIDGNVKNAFTRYHQFISEGKEVNRLINDMIYFVRDTIMNKTVNN
HAEFDALMNFDLDMLYHMIDIINDTLVSIRFSVNQNVHFEVLLVKIAEMVKSQPDTVTNV
ATTQVASQPNNEVLLQRMEQLENELKTLKAQGIAQASSKQQSSQSNTRGKRQNKGTFSMT
NIAKVLDEANKEDIQLLKKHWLEVVDYAKKNDKKSLVSLLQNSIPVAASEKRVLIQFDEE
IHCEIVNRDDEKRTSIENVVRNIINKNVEVVGVPSDQWMRVRTEYINSRKQHDKEENQTP
SNEGEEQQDTDVAQKARDLFGEETVHLIDEE
>SEQF2892_00173 Nucleoid-associated protein
MRGGGNMQQMMKQMQKMQKKMAQEQEKLKEERIVGTAGGGMVAVTVTGHKEVVDVEIKEE
AVDPDDIEMLQDLVLAATNEAMNKADELTQERLGKHTQGLNIPGM
>SEQF2892_00174 Recombination protein RecR
MHYPEPISKLIDSFMKLPGIGPKTAQRLAFHTLDMKEDDVVQFAKALVDVKRELTYCSVC
GHITENDPCYICEDKQRDRSVICVVEDDKDVIAMEKMREYKGLYHVLHGSISPMDGIGPE
DINIPTLIDRLKDEEVKELILAMNPNLEGESTAMYISRLVKPIGIKVTRLAQGLSVGGDL
EYADEVTLSKAIAGRTEM
>SEQF2892_00178 Spermidine N(1)-acetyltransferase
MKIRALEETDLQFVHHLNNEYTIMSYWFEEPYESLSELKTLYQKHILDESERRFIIEDDH
TSIGVVELVEINFVHRNCEIQIIIDSQFGNKGYAKKAFKMAIDYAFLVLNLNKVYLYVDV
NNEKAVHIYKKAGFIIEGELKEHFYTQGKYKDCYVMGLLKTKWIEQRNGDDDLSQVR
>SEQF2892_00179 Arginine decarboxylase
MELPIFHKLSQLINENAISLHVPGHKNGTIGNVKNLDFKMDMTEITGLDDLHHPEDIILK
SMQHIHKHPDYDAYFLINGTTSGILSVIQSFSKLKGNYLISRNVHKSVFHGLDIVQQPAD
IIAMTKSNDSSQYLGPDTQSMTFNNQKLAIVTYPNYYGECFDIRAFVDRAHREAIPVLVD
EAHGAHFNLKNFPKSALESGADYVVQSYHKTLPALTMGSMLFIHKDAPLKDEIVRYLGYF
QTSSPSYLVMASLELAHQFYVDYDSTLFFEKRKKLIDTLNMTGLTTICVSDPLKLLIQYQ
GYSGFEIQTWFEQMGIYVELADDKQVLFVLPLWHEDDKYPFETLLNKITKINLPCPLSTK
QSTSIHIPLDEGTYFPQDSGNVTWVDIDQSMGKKLAMHIITYPPGIPVYLKGERITKNMI
KLMREYLQKGDRVEGLKQEKILVKDE
>SEQF2892_00180 Thymidylate kinase
MSAFITFEGPEGSGKTTVLQRVSEKLAQDYQLIATREPGGVPTGEEIRKVVLEGANMDIR
TEAMLFAASRREHLVEKVVPALNDNKIVLCDRYIDSSLAYQGYARGIGIEEVKQLNDFAI
NGLYPDLTIYLDITAEVGRDRILKNQRDQNRLDKEDIAFHEKVIEGYRQIIQETPQRFAV
VDATRNIDDVVNETYEIILNFLK
>SEQF2892_00181 hypothetical protein
MKMIIAIVQDQDSQELSDQLVKNNFRATKLATTGGFLRAGNTTFLCGVDDDRVDDILSVI
DHTCGNRDQLVSPMTPMGGSADSYIPYPVEVEVGGATVFVMPVESFHRF
>SEQF2892_00182 DNA polymerase III subunit gamma/tau
MDEQQKLANAYHSNKLSHAYLFEGDDAQSMKHVAMEFAKLILCNGNQQCEMKVGTFNQPD
FMYVSSEENSIKKEQIEQLVHRMNQLPIEGTHKVYIIEDFEKLTVQGENSILKFLEEPPE
NTIAILLSTKPEQILDTIHSRCQHVYFKPSDKQDFIDRLVDEDINRAVAEMLSTYTTQLE
TAIDLNEEHDLVTLRKVILHWCDLLLTNKPMALIGIIDLLKNAKNRKLQLLTLAAVNAFF
EDIMHAKIGIERDFTYTDLKGNIEKYANQLSLNKVMTMYDQITEAHKKLMQNVNPTLVFE
QIVIKGVS
>SEQF2892_00183 hypothetical protein
MPNIVGVQFQKAGKLEYYAPNDLDVNVDDWVVVESKRGIEIGSVKFPPKDVEDGDVTLPL
KEIIRVATEQDIEKYYQNDKDATNALQLCKDLVKEQQLDMRLVNCEYTLDKSKVIFNFTA
DDRIDFRKLVKHLAQNLKTRIELRQIGVRDEAKLLGGIGPCGRSLCCATFLGDFEPVSIK
MAKDQNLSLNPTKISGACGRLMCCLKYENDFYEEARAQLPDLGDKIVTPEGKGQVIGLNI
LDISMQVKIDGLEQPLEYKMEELEAFN
>SEQF2892_00184 Initiation-control protein YabA
MNRNDLFEKIVKLESNVNQLNQEMSELKALSIQLIEENVALQVENDNLKSLMAKSEQDVE
AIKVTNRIEKDNKPMSKERDNKSSIKHVKKPLPSKDNLAVLYSEGFHICNGELFGKHRYG
EDCLLCMNVLNS
>SEQF2892_00185 tRNA1(Val) (adenine(37)-N6)-methyltransferase
MLKANERIDDLFKENLKIIQNDDVFSFSTDALLLGHFTEVRKNDKILDLCAGNGVIALLL
SAKGSQTIESIEIQEQLADMARRSFEYNDLTNRLLIHHMDLKDVYQNFKPSQYTLVTCNP
PYFKSNQRHQHQKEAHKIARHEIMCTLEDCMLAARHLLKQGGRLMMVHRAERLMDVLTEM
RKASIEPKRVVFIYSKIDKSAVTIVVEGRKNGNQGLTIASPFYIYNNQGDYTDEMKEVYY
G
>SEQF2892_00186 hypothetical protein
MAKHYVYIVKCKDNSLYTGYTTNVEARIATHNAGKGAKYTKTRRPVVLVYQEMFSSKSEA
MRREYEIKTFSRQQKLKMIEER
>SEQF2892_00187 Ribosomal RNA small subunit methyltransferase I
MATLYLVGTPIGNLGDITFRAIETLKDADFIACEDTRVTKKLCNHYDIQTPLKSYHEHNK
SQQTEYLIDLLNEGYNIALVSDAGLPLISDPGYELVVAAHSYDIHVETVPGPNAGLTALM
ASGLPSYTYTFLGFLPRKEKDKVAVLQERMFQDSTLIIYESPFRVVETLKAISKVDDTRR
VAVGRELTKKFEQIVMQEVGHLINAFQNDEIMQKGEFVILIEGAKPLETEQWFQSLTISE
HVEHYISEQNIKPKKAIKLVAEDRHMKTGEVYDIYHDVNQ
>SEQF2892_00188 Methionine--tRNA ligase
MAKETFYITTPIYYPSGNLHIGHAYSTVAGDVISRYKRMQGYDVRYLTGTDEHGQKIQEK
AQKAGKTELEYLDEMISGIKSLWSKLEISNDDFIRTTEDRHKQVVEKVFERLLKQGDIYL
GEYEGWYSVPDETYYTESQLVDPIYENGKIVGGKSPDSGHEVELVKEESYFFNINKYTDR
LLEFYDANPDFIQPPSRKNEMINNFIKPGLEDLAVSRTSFDWGVRVPSNPKHVVYVWIDA
LVNYISALGYLSDDDELFQKYWPADVHLMAKEIVRFHSIIWPILLMALDLPLPKKVFAHG
WILMKDGKMSKSKGNVVDPNVLIDRYGLDATRYYLMRELPFGSDGVFTPEAFVERTNYDL
ANDLGNLVNRTISMINKYFQGELPAYEGPKHELDEDMEALAHETVKHFNESMESFQFSVA
LSTVWKFISRTNKYIDETTPWVLAKDDSQKDMLGNVMAHLVENIRFAAVLLRPFLTHAPK
EIFKQLNINEPELFELESLEQYGALKQPIMVTEKPTPIFPRLDTEAEIAYIKESMQPPKS
EESKDEVEEPSKAQIDIKDFDKVEIKAATITDAENVPKSDKLLKIQIDLGLEQRQIVSGI
AKFYRPEDIIGKKVAVVTNLKPAKLMGQKSEGMILSAEKDGVLTLVSLPSAIPNGAVIK
>SEQF2892_00189 D-aminoacyl-tRNA deacylase
MLIDTHVHLNDEQYAEDLTEVISRAREAGVDRMFVVGFDTPTIERAMELIEQYDFIYGII
GWHPVDAIDFTDERLQWIEELSQHPKVIGIGEMGLDYHWDKSPADVQKDVFRKQIALAKR
VNLPIIIHNREATQDCVDILMEEHAEEVGGIMHSFSGSPEIADVVINKLNFHISLGGPVT
FKNAKQPKEVAKHVPMDRLLVETDAPYLSPHPYRGKRNEPERVTLVAEQIAELRGMSYED
VCRQTTENAERLFKLK
>SEQF2892_00190 Ribonuclease M5
MKINEFIVVEGRDDTERVKSAVECDTIETNGSAINKETLAVIQNAQETRGVIVLTDPDFP
GDKIRHTITEHVSGVKHAYLDREKAKNKRGKIGVEHAHPKDIRDALMHVSSPFEEAEESI
DKSVLIDLGLIIGKDARRKREILGRKLHIGHSNGKQLLKKLNAFGYTESDVREALSMEKE
SE
>SEQF2892_00191 Ribosomal RNA small subunit methyltransferase A
MERKDIATPSRTKALLDQFGFNFKKSLGQNFLVDVNIIHKIIDASEIDDNTGIIEVGPGM
GSLTEQLAKRAKKVMSFEIDQRLIPVLKETLAPYDNVTIINEDILKADIGKAVKTYLNDC
DKIMVVANLPYYITTPILLNLMQQDIPIDGYVVMMQKEVGERLNAQVGTKAYGSLSIVTQ
YYTETSKVLTVPKSVFMPPPNVDSIVVKLMQRETPLVSVDDEETFFKLAKAAFAQRRKTI
NNNYQNFFKDGKKHKESILKWLEQTGIDPKRRGETLSIQDFARLYEEKKNFPELEN
>SEQF2892_00192 hypothetical protein
MPKSILDIKNSIDCHLGNRIVLKANGGRKKTIERCGVLKETYPSVFVVELDQDKHNFERV
SYTYTDVLTENVQVSFEEDNHQEVVAH
>SEQF2892_00193 4-diphosphocytidyl-2-C-methyl-D-erythritol kinase
MIYETAPAKINLTLDTLFKRDDGYHEIAMIMTTVDLNDRLSFQKRKDKKIVVDIEHNYVP
NDHKNLAYRAAQLMMETYDLNEGVTITIDKDIPVSAGLAGGSADAAATMRGINRLFNLDK
SLHELSDLGIQIGTDIPFCIYNRTAVCKGRGEKIRFLKKPPSAWVVLAKPNLGISSADVF
KALDLDDAHHVDTEMCEKAIVEGDYKQLCESLSNRLEPVSMSMHPEIEKIKNNMLQCGAD
GALMSGSGPTVYGLAQKESQAKKIYNAVNGCCNEVYLVRLLG
>SEQF2892_00194 Pur operon repressor
MRYKRSERIVFMTQYLMNHPNQLIPLTFFVKKFKQAKSSISEDVQIIKNTFQKEKLGTVI
TTAGASGGVTYKPMMSKEEASEIVEEVIELLQEKERLLPGGYLFLSDLVGNPSLLNKVGK
LIASIYMEEDLDAVVTIATKGISLANAVANVLNLPVVVIRKDNKVTEGSTVSINYVSGSS
RKIETMVLSKRTLAENSNVLVVDDFMRAGGSINGVMNLMNEFKAQVKGVSVLVESKEVKQ
RLIEDYTSLVKLSDVDEYNQEFKVEPGNSLSKFS
>SEQF2892_00195 2-iminobutanoate/2-iminopropanoate deaminase
MKTINTNKAPEALGPYSHAMVVNNLVFTSGQIPLDTEGNIVSDDVKEQTKQVLDNLSVVL
EEAGSDLNSVVKATIFISDMNEFQQINEVYGSYFSEHQPARSCVEVARLPKDVKVEIEVV
GKVKGI
>SEQF2892_00196 Putative septation protein SpoVG
MKVTDVRLRKIQTDGRMKALVSITLDEAFVIHDLRVIEGNSGLFVAMPSKRTPDGEFRDI
AHPINSDMRQEIQDAVMKVYDETDEVIPDKNASSEDSDEA
>SEQF2892_00197 hypothetical protein
MCKSILKTLRIKDKNINFSDEVIEKKYKGRMSLFYYAELTYQPTYCENCLAKNDNFSIVK
NGKKTSTITLLKIMGMPAYLNLQKQRFYCKTCDSHFTAKSNIVDAHCFISNKTKLAVLNK
AQECRSQKSIAKSCLISSMTVSRVINQAASDVGQSSFDALPEHLMMDEFKSVKNVTGKMS
FIYADAVSHRIVDVVADRKLKSLKDHFYRYSLKLRQKVKTVTIDMYEPYMSLIKQLFPNA
KIIIDRFHIVQSLNRALNMSRVHVMNCYRASNRPLYNKYKSYWKLFLKPFETLEAFNYRK
VHLFKEWKTEKGIVNYLLDVDEELYNTYHYVHELRRFLKENQIEKFNHKLFSIHLSDVCP
KLRPVIRTLRRLATFIENTMTYSNLTNGPLEGINNKIKLIKRVSFGYRNYDNLRNRIIIT
SRLFASTTKKEIKQPKVA
>SEQF2892_00198 Bifunctional protein GlmU
MQRNAVILAAGKGTRMKSNKYKVLHKVAGKSMVEHVLTNVKNAGVNQIVTIVGHGAEDVK
ETLGNQSFYSYQEEQLGTAHAVKMANEHLKEVEGTTLVVCGDTPLITAHTLQKLIEHHES
THAQATVLSATAQIPFGYGRIVRDEQRRLQRIVEEKDASEAQKALTEISSGIFAFDNRVL
FSKLEEVKNDNAQGEYYLPDVISLILAENGVAEVYHTDDFNEIMGVNDRVMLSNAEKALQ
QRINIEHMRNGVTIIDPTTTFIGPDVKIGMDTIIEPGVRINGETVIGEEAVIGQYSEINN
SHIGSQVDIKQSVINDSIVGDKTKVGPFAQLRPGSNLGSDVKVGNFVEVKKADLKDGAKV
SHLSYIGDAEIGERTNIGCGSITVNYDGVNKFKTVVGKDAFIGCNTNLVAPVTVGDGVLI
AAGSTITDNVPNESLALARARQITKEGYLKK
>SEQF2892_00199 Ribose-phosphate pyrophosphokinase
MLNNEYKNSSLKIFSLKGNEPLAQEVADRVGIELGKCSVKRFSDGEIQINIEESIRGCDV
FIIQPTSNPVNLHLMELLIMIDACKRASAANINIVVPYYGYARQDRKARSREPITAKLVA
NLIETAGANRMIALDLHAPQIQGFFDIPIDHLMGVPIIGQHFENDPNIDPEECVVVSPDH
GGVTRARKLADILKTPIAIIDKRRPKPNVAEVMNIVGEIEGRTAIIIDDIIDTAGTITLA
AQALKDKGAKDVYACCTHPVLSGPAKERIENSAIKELIVTNSILLDDTRKPSNTKELSVA
GLLAQAIIRVYERESVSVLFD
>SEQF2892_00200 50S ribosomal protein L25
MASLKSIIRQGKQTRSDLKKLRNTGKVPAVVYGYGTKNTSVKVDEVEFIKVIREVGRNGV
IDLGVGSKSIKVMVSDYQFDPLKNQITHIDFLAINMTEERTVDVPVHLVGEAAGAKEGGV
VEQPLFDLQVTATPENIPETIEVDITELEVNDSYSVSDIKVSGDFTIENDPEESVVTVVP
PTDEPTEEEVEAMEGEAATEEPEVVGEEKEEDSEEENKDEE
>SEQF2892_00201 Peptidyl-tRNA hydrolase
MKCIVGLGNIGKRFELTRHNIGFEVIDYILKKHNFSLDKQKFKGAYTIERLNGDKVLFIE
PMTMMNLSGEAVGPLMDYYNVEVEDLIVLYDDLDLSQGQIRLRQKGSAGGHNGMKSIVKH
LGTDQFKRIRIGVGRPTNGMSVPDYVLQKFSKEEMITMDKVIEHSAHAVEAFIESSRFDH
VMNQYNGEVN
>SEQF2892_00202 Transcription-repair-coupling factor
MRPIISDYIQNDKRFQELDDVFGHQNILVTGLSPSAKATIIAEKYLKDQKQMLLITNNLY
QADKLETDILQYIDHSEVYKYPVQDIMTEEFSTQSPQLMSERVRTLTALAHNKKGLFIVP
LNGLKKWLTPFELWKDHQITLRVGEDIDVDEFLNKLVNMGYRRESVVSHIGEFSLRGGII
DIYPLIGQPVRIELFDTEVDSIRDFDVETQRSNDNIEEVSITTASDYVITDDVIQHLQSE
LKTAYEATRPKIDKSVRNHLKETYESFKLFETTFFDHQLLRRLVAFMYEQPSTLIDYFAK
DAIIVADEYNRIKETEKTLTTEVDDFIQNLIESGNGFIGQSFMQYDGFESLLKDYPVTYF
TLFTSTMPVQLQHIIKFSCKPVQQFYGQYDIMRSEFQRYVHNDYHIVVLVETETKVERIQ
SMLNEMHIPTVTNVHNDIKSGQVVVTEGSLSEGFELPYMQLVVITERELFKTKQKKQRKR
TKTLSNAEKIKSYQDLNVGDYVVHVHHGVGRYLGVETLEVGDVHRDYIKLQYKGTDQLFV
PVDQMDQVQKYVASEDKSPKLNKLGGSEWKKTKAKVQQSVEDIADELIALYKEREMSVGY
QYGEDTAEQSAFEMDFPYELTPDQAKSIDEIKGDMERERPMDRLLCGDVGYGKTEVAVRA
AFKAVMEGKQVAFLVPTTILAQQHYETLIERMQDFPVQIELISRFRSTKEVKETKEGLKS
GYVDIVVGTHKLLGKDIHYKDLGLLIVDEEQRFGVRHKERIKTMKTNVDVLTLTATPIPR
TLHMSMLGVRDLSVIETPPENRFPVQTYVLEQNSNFIKEALERELSRDGQVFYLYNRVQS
IYEKREQLQMLMPDANIAVAHGQMTERDLEETMLSFINGEFDILVTTTIIETGVDVPNAN
TLIIEEADRFGLSQLYQLRGRVGRSSRIGYAYFLHSANKVLTETAEERLQAIKEFTELGS
GFKIAMRDLNIRGAGNLLGKQQHGFIDSVGFDLYSQMLEEAVNEKRGIKEEEPDAPEVEM
ELNLDAYLPAEYIQNEQAKIEIYKKLRKVETEEQLFDIKDELIDRFNDYPVEVERLLEMV
EIKIHALHAGVTLIKDKDKQIEVSLSTKATEQMNGEELFKQTQPLGRAMKLGVKENRMHV
TLTKSKQWLDNLKFLVRCLEGSMVIEDEN
>SEQF2892_00203 Lipid II flippase MurJ
MKMKTKSISESKSTQSLSSKSSNEFKHIEPSNYTAFNGVVILTLALIIVKILSAIYRVPY
QNVLGDTGLYAYQQIYPIVALGMILSMNAIPSAVTQTLGINGQPSSFSKVLIRFQTLGIV
IFLMLLLLAHPVAILMGDSRLAPMIRMASLSYLFIGILGVCRGYYQSQRRMNIPAISQVI
EQIIRVGLIIVAIGLFMIKDWSIYQAGTIAILASALGFLGSSLFLIVMKPFSFKMQNLSA
NIPWKDLLMATLVFALSQLLVILWQFIDSFTIVHTLQSHGLHFKEAIMQKGIYDRGASFI
QMGLIVTTTFSFVLIPLLTEAIEQRNQIKMNRYANASLKITILISSAAGIGLINLLPMMN
AVFFKTNSLGFTLGFYMLTVICVSLIMMDIALLQVLNCIRPILIGVTIGLVVKAILNVLL
IHHYGIAGASISTVLSLICFVIILHKEVLKQYHFSQMKPFILKMFTALVIMTIIIQIIMQ
ILPQVGRIGGLIELVVVAIIGIAVLLILVIYMNILGYKELKHLPFGEKLYHIKKGRH
>SEQF2892_00204 Nucleoside triphosphate pyrophosphohydrolase/pyrophosphatase MazG
MTHTITIVGLGNYGLDELPLGIYRFLIQQPLVYTRTLDHPVINQLQDELKFESFDTIYEK
NEDFDSVYQQIVDVLIEKAQSQDVVYAVPGHPRVAETTTAKLLDYNDHHQDVNVKMLGGK
SFIDDIFAAINQDPNDGFTLLDGTALTEQLLNVRTHTLITQVYSAMVAADIKITLMEHYP
DDFPVKIVTGAHSTGASVLEVPLFELDHHEDAFNNLTSVYVPKVTNDEVLYRNFDYAVEI
IDRLVDDETGCPWDRVQTHASLKRYLLEESFELFEAIDNEDDWHMIEELGDILLQVLLHA
SIGKKEGYMDIQEIIESLSAKMIRRHPHIFGDEKAASIEELNDIWQTAKSKEGKAPRVKF
EKVFADHFMALYDKTKNKDFDEETLRNFLQQGEKDS
>SEQF2892_00205 hypothetical protein
MRLDKYLKVSRLVKRRTLAKEISDQGRITINGNVAKAGTDVKVEDELVIRFGQKLVTVKV
TGLSEHASKENAKGMYDLIKEERINQNQFEEE
>SEQF2892_00206 Cell division protein DivIC
MSKKVEEIGNQYTSDKNRKRQRQQKKMRVVRRRVTVFGGILLAIIIILSIMLVVQKQSND
KAAVERKHKEEQFQKKQDEEIALKEELSNLNNKDYIEKVARDDYYLSNKGEVIFKLPNND
DDSKSKSSNDN
>SEQF2892_00207 General stress protein 13
MSIEVGNKLKGKVTGIKKFGAFVELPEGKSGLVHISEVADNYVENVEDHLSVGDEVEVKV
LSIADDGKISLSIKKAKDRPRRPQHKSNHNRSPQQKGEDFEKKLSNFLKDSEDKLTSIKR
QTESRRGGKGSRR
>SEQF2892_00208 tRNA(Ile)-lysidine synthase
MLKVNTSLWNNTEHIVIAVSTGVDSMSLFHNLLSQSSRTYKQLTCLHVNHGLREASHKEE
AFIEAFCKQYEITCYVKHLNLTDVVAQGKSIQADARQLRYEWFDEMMKRLDADVLLTAHH
LDDQLETIFYRLFTGRSTRSTLGIDVQSIRNHYTICRPLLEVSKEDIRDYQHKYQVPYYE
DSSNSDNKYVRNDIRNRLLPAINQNADLDSTHLLKLKRWHDIQLQESRKKAQSFIENDCL
INKNGTQIQFSRNAFNQLDDIAKMILLDQLFEQLQLNKAFSEKQYHEWFHQISNQIAQFE
ISLTEKWIIQIAYDKFIILAKNEPSLLDNQIVNDADTYRFGHYLVVIHPTIPKQQLPLLI
RTRHNGDKVELNGQKGHKKVSRLFIDHKIPNDVRMQMPLIEDQYHQIIAVGNLYIAKAYN
QHIEIKKIGDE
>SEQF2892_00209 Hypoxanthine-guanine phosphoribosyltransferase
MKDDLKEILLTEEDIQNICKDLGEQLTKDYKDKPLVCVGILKGSVMFMADLIKRIDTHLA
IDFMDVSSYHGGTESTGEVQILKDLGSSIENKDVLIIEDILETGTTLKSITELLQSRKVN
SLEIVTLLDKPNRRKADIEAKYVGKKIPDEFVVGYGLDYAEHYRNLPYIGTLKPEIYNK
>SEQF2892_00210 ATP-dependent zinc metalloprotease FtsH
MQKAFRNVLVIAIIGVIIFGVFSYINGNGNTPKQLSYSQFVEKLDKGDLKTLEIQPEQNV
YLVSGKTKNDEDYSSTILYNNEKDLQKITNEAKSQKGLDFKVKEEEKQSVFVSMLTTLIP
VLIIAFLFIFFLSQAQGGGGGGRMMNFGKSKAKMYDNQKRRVRFSDVAGADEEKQELIEI
VDFLKDNKKFKQMGSRIPKGVLLVGPPGTGKTLLARAVAGEAGAPFFSISGSDFVEMFVG
VGASRVRDLFENAKKNAPCIIFIDEIDAVGRQRGAGVGGGHDEREQTLNQLLVEMDGFGE
NEGIIMIAATNRPDILDPALLRPGRFDRQIQVGRPDVKGREAILHVHSKNKPLDETVDLK
AISQRTPGFSGADLENLLNEASLIAAREGKNKIDMRDIEEATDRVIAGPAKKSRVISDKE
RNIVAHHEAGHTVIGMVLDEAEVVHKVTIVPRGQAGGYAMMLPKQDRFLMTEPELLDKIC
GLLGGRVSEDINFHEVSTGASNDFERATQIARSMVTEYGMSKKLGPLQFSSSGGGQVFLG
KDMQGEPNYSGQIAYEIDKEVQRIIKEQYERCKQILLDHEKELKLIAKTLLTEETLVAEQ
IRSLFYDGVLPEVDYDAARVVKDEDSDYSEGKYGKSYDDIREEQLEEGKEDMREDRKEDN
DMNRERRHRQRDDRDNQTGHDQLRDGSNGDNDQHRGHSNNEEDTGHEQSPNIDKPYNPND
PNNPSNR
>SEQF2892_00211 hypothetical protein
MCKSILNTLRIKDKNLNFSDEVIEKKHKGRMSLFYYAELTYQPTHCENCSTKNENFSIVK
NGKKTSTITLLKIMEMPAYLELQKQRFYCKSCDSHFTAKSNIVDAHCFISNKTKLAVLDK
AQEYRSQKSIAKSCLVSSMTVSRVINQAASDVGQSSFDALPEHLMMDEFKSVKNVIGKMS
FIYADAVSHRIVDVVADRKLKSLKDHFYRYSLKLRQKVKTVTIDMYEPYMSLIKQLFPNA
KIIIDRFHIVQSLNRALNMSRVHVMNCYRTSNRPLYNKYKSYWKLFLKPFETLEAFNYHK
VHLFKEWKTEKGIINYLLGVDVELFNTYHYVHELRRLLKENQIEKFNHKLFSIHLSDVCP
KLRPVIRTLRRLAAFIENTMTYSNLTNGPLEGINNKIKLIKRVSFGYRNYDNLRNRIIIT
SRLFASTTKKEIKQPKVA
>SEQF2892_00212 33 kDa chaperonin
MTHDYIVKSLAFDGEIRAYAALTTESVQEAQTRHYTWPTASAAMGRTMTATLLMGSMLKG
EQKLTVTVDGKGPIGRIIADADAEGNVRAYVDKPQTHFPLNEQGKLDVRRAVGTDGSIQV
VKDVGMKDYFSGASPIVSGELGEDFTYYFATSEQTPSSVGLGVLVNPDNSIKAAGGFIIQ
VMPGAKDETVTKLENAINNMQPVSKLIEQGLTPEGILNEILGEDNVQILETMQAQFECNC
SHEKFLNAIKGLGEAEIQDMIKEDHGAEAICHFCGNKYNYSEAELEDLLASMNA
>SEQF2892_00213 Cysteine synthase
MAQKPVDNITQIIGNTPVVKLRNVVDEDAADVYVKLEYQNPGGSVKDRIALAMIEKAEKE
GKIKPGDTIVEPTSGNTGIGLAFVCAAKGYKAVFTMPETMSSERRNLLKAYGAELVLTPG
SEAMKGAIKKAKELKEEHGYFEPQQFENPANPEIHALTTGPELVEQFEGKQIDAFLAGVG
TGGTLSGVGKVLKEKYPNVEIVAIEPEASPVLSGGEPGPHKLQGLGAGFVPDTLDTNIYD
SIIKVDNDTAMETSRRVAKEEGILAGISSGAAIHAAIQKAKELGKGKTVVTVLPSNGERY
LSTPLYSFDD
>SEQF2892_00214 Dihydropteroate synthase
MTKTKIMGILNVTPDSFSDGGKYNSVDKAVKRAKEMIEEGVDIIDVGGISTRPGFTEIST
EEEIERVVPVVKELAKLNIQLSIDTYRSEVAEACLKLGATMINDQWAGLYDPKILDVVAS
YDAEVVLMHNGDGHREQPVVEEMLLSLITQANKAEMAGIPKHKIWLDPGIGFAKTRDEEN
EVMARLDELVATEYPVLLATSRKRFIKEMIGTETKALERDEATAATTAYGIMKGVKAVRV
HNVQLNARLGQSMDFLKENEDERHNLS
>SEQF2892_00215 Dihydroneopterin aldolase
MNDTIFLNGMRFYAYHGALPAENEIGQIFVVDVTLKVNLEEAGQSDKVIDTVHYGEVFED
VKAIVEGPPCNLIEHLAERIAKRINSHYNRVMETKVRITKENPPIPGHYNGVGIEIVREN
R
>SEQF2892_00216 2-amino-4-hydroxy-6-hydroxymethyldihydropteridine pyrophosphokinase
MVQAYLGLGSNIGDREQQLQEAIKIIDSIEGITVTKISPIYETAPVGYTEQPNFLNLCLE
IDTELEPKELLKYCLETEQRLHRVRDIRWGPRTLDVDILLYGDKVIEEDDLEVPHPRMSE
RAFVLIPLNDIAPTQIEPRSKTRISDLVIPDDTVKKYKG
>SEQF2892_00217 Lysine--tRNA ligase
MSEEMNDQMQVRRQKLQELIDLGIDPFGKRFERSATASELKSQWDEFSKEELHDKEDESH
VSIAGRLMTKRGKGKAGFAHVQDLTGQIQIYVRKDQIGEEDFDNLWKGADLGDIVGIEGV
MFKTNTGELSVKAKTFTLLSKALRPLPDKFHGLQDIEQRYRQRYLDLITNQDSTQTFINR
SKIIQEMRNYLNKQGFLEVETPMMHQIAGGAAARPFVTHHNALDATLYMRIAIELHLKRL
IVGGLEKVYEIGRVFRNEGVSTRHNPEFTMIELYEAYADYHDIMDLTESMVRHIAQEVFG
SAKVQYNEEEIDLESAWTRLHIVDAVKEATGVDFYQIKSDEEAIAAAKEHGIEITNNMKY
GHILNEFFEQKVEETLIQPTFIYGHPIEISPLAKKNPEDPRFTDRFELFIVGREHANAFT
ELNDPIDQRERFEAQLVEKAQGNDEAHEMDEDYIEALEYGMPPTGGLGIGIDRLVMLLTD
SPSIRDVLLFPYMRQK
>SEQF2892_00234 Putative oxidoreductase CatD
MRIGLLLIRLMLGITFTIHGAQKVFGGFKEPMAMISDLGFPAFFGVILGLFEFIGGILMI
IGLFANYIAAGFIIIMLGALFTVHLSQGYMTSELVIILLVMSVAVLISYNWKKALELY
>SEQF2892_00235 HTH-type transcriptional regulatory protein GabR
MKKQKLYISLYEQLKNQIIEGQYQAQDKFPSKRQLSEHLSLSHTTIEHAYQLLLDEGFIY
SKPRSGYYVSDIQSLPVININNQFIEIEPKTPESKQYKYAFNLAEIDAEYFPLNLFRKYA
KEAFEDNELALLEKGDIQGELNLRQQIAHYLFNSRGVSCHPNQIVIGSSTEQLLNMITDL
LKTSSFIIEKPSYPPIKHVLDKNKHNYIQATVEKDGINMIDIINSNNDIVYITPSHQFPT
GYVMNLKKRTQLIKWAHQQNSRYIIEDDYDSEFRYYGKPIPALQSLDKNDKVIYISTFSK
SLYPSCRIAYIVLPQKLLQSYLSMPYKESNTVPVHIQQIIANFMSSGSFERHLNKMRKIY
REKLNYILERLKPHEDQLKIEGALTGMHFTITVDNGLTMSQCLHSAEKLKLKLNVYNYAE
ENELLPKFIIGFGGIPNHKLKEHTDVLIKSLTV
>SEQF2892_00236 Pyridoxal 5'-phosphate synthase subunit PdxS
MSKIVGSDRVKRGMAEMQKGGVIMDVVNAEQAKIAEEAGAVAVMALERVPSDIRAAGGVA
RSANPKIVEEVMNAVSIPVMAKARIGHITEARVLEAMGVDYIDESEVLTPADEEYHLRKD
QFTVPFVCGCRNLGEAARRIGEGAAMLRTKGEPGTGNIVEAVRHMRKVNSEVSRLVVMND
DEIMTYAKELGAPYEVLKQIKDHGRLPVVNFAAGGVATPQDAALMMELGADGVFVGSGIF
KSEDPEKFAKAIVQATTHYQDYELIGKLASELGTAMKGLDINQISLEERMQERGW
>SEQF2892_00237 Pyridoxal 5'-phosphate synthase subunit PdxT
MKIGVLALQGAVREHIRHIELSGHEGIAVKKVEQLDEIDGLILPGGESTTLRRLMDLYGF
KEKLQQSDLPIFGTCAGLIVLAKDVEGEPGYLKKLDITVERNSFGRQVDSFEAELDIKGI
AEDIEGVFIRAPHIANVEEGVEILSTVGDKIVAVKQGKYLGVSFHPELTDDYRVTQYFID
HMVK
>SEQF2892_00238 Nucleoside permease NupC
MHILIGIIGIIFFLALAFLFSSDRKNIRWQYVGILLVIQLVFAFILLKTTAGITVIGGIS
EGFNYLLQKAAEGVNFVFGGFKFVDPKNPPFFFSVLLPIVFISALIGILQYTRILPWIIN
VLGFLISKINGMGRLESYNAVAAAILGQSEVFISLKQQLPYIPKQRLYTLTASAMSTVSA
SIIGAYFTLIEPKYVVTAVVLNLFGGFIIASIINPYKVNEEDDKLLVDESETKKQSFFEM
LGEYILDGFKVAVIVGAMLIGYIAIIALLNGLVSGAFSLLSGGAIKWDFQTLIGFVFAPL
AFLAGVPWEDAVKSGSVMATKLLSNEFVAMQSLGNLKDISEHAKGVTSVFLVSFANFSSI
GIISGAIKSLNSEKGDVVARFGLKLLFGATLVSFISAAIAGFFI
>SEQF2892_00239 Transcriptional regulator CtsR
MHNMSDIIEQYIKKLFEESNEDVVEIQRANIAQRFDCVPSQLNYVIKTRFTNEHGYEIES
KRGGGGYIRITKIENKDATGYINHLLQIIGPSISQQQAYYILDGLLDKGLISEREARMIQ
VIVDRETLKMDVVARDIIRANILKRLLPIINFY
>SEQF2892_00240 Protein-arginine kinase activator protein
MLCENCHLNEAEVKLTVKSKEGTSEKWVCSICAQGENPWQQNETPSPHSQFQDDIEEAFV
VKQILQHLATKHGINFHEVAFQEEKRCPTCKMTLKDIAHVGKFGCANCYATFKDDIVDIV
RRVQGGQFEHVGKTPRSSHKKLAIKKQIEEKTKYLNVLIDEQNFEEAAIVRDEIKALKDE
SGVERNE
>SEQF2892_00241 Protein-arginine kinase
MSDMNAHISEWMKETEESPIVMSSRIRLARNLENHVHPLMFPSEQDGFRVINEVQDVLPD
LDLMRLDTMDQQNKMKLVAKHLISPELIKQPASAVLLNKDESISIMINEEDHIRIQAMGT
DLSLQDLYNIASEIDDTLDQSLDISYDEHLGYLTTCPTNIGTGMRASVMLHLPGLSIMKR
MNRIAQTINRFGFTIRGIYGEGSQVYGHIYQISNQLTLGKTEDEIIDNLTEVVQQIINEE
MQIRERLTQYNELETLDRIYRSLGILQNSRIISMEEASYRLSEVKLGIDLGYLTLSDFKF
NELMVSIQSAFIYNDEDETISVNEKRANILREYTQ
>SEQF2892_00242 ATP-dependent Clp protease ATP-binding subunit ClpC
MLFGRLTERAQRVLAHAQEEAIRLNHSNIGTEHLLLGLMKEPEGIAAKVLESFNITEDKV
IEEVEKLIGHGQDQTGTLHYTPRAKKVIELSMDEARKLHHNFVGTEHILLGLIRENEGVA
ARVFANLDLNITKARAQVVKALGSPEMSNKNATANKSNNTPTLDGLARDLTVIAKDGTLD
PVVGRDKEITRVIEVLSRRTKNNPVLIGEPGVGKTAIAEGLAQAIVNNEVPETLKGKRVM
SLDMGTVVAGTKYRGEFEERLKKVMEEIHQAGNVILFIDELHTLVGAGGAEGAIDASNIL
KPALARGELQCIGATTLDEYRKNIEKDAALERRFQPIQVDEPTVEDTIAILKGLRDRYEA
HHRINISDEALEAAAKLSDRYVSDRFLPDKAIDLIDEASSKVRLKSHTTPNNLKEIEQEI
EKVKNEKDAAVHAQEFENAANLRDKQTKLEKQYEDAKNEWKTTQGDQSTSLSKEDIGEVI
AGWTGIPLTKINETESDRLLNLEQTLHDRVIGQNDAVTSISKAVRRARAGLKDPKRPIGS
FIFLGPTGVGKTELARALAESMFGEEDAMIRVDMSEFMEKHAVSRLVGAPPGYVGHDEGG
QLTEKVRRKPYSVILFDEIEKAHPDVFNILLQVLDDGHLTDTKGRQVDFRNTVIIMTSNV
GAQELQDQRFAGFGGGSEGHDYETIRKTMMKELKNSFRPEFLNRVDDIIVFHKLSKDELK
EIVTMMVNKLTQRLSEQDINIVVTDKAKEKIAEEGYDPEYGARPLIRAIQKTVEDNLSEL
ILDGNQIEGKEVVIDHDGDEFKYNINEKNNGISDEGNEVTETEA
>SEQF2892_00243 DNA repair protein RadA
MAKKKVIFECMACGYQSPKWMGKCPNCGSWNQMEEIVEKASNPKHGVKTSTSSAKVQKLN
DIKNEVTPRVQTESKEFNRVLGGGIVSGSLVLIGGDPGIGKSTLLLQICASLSQKLNVLY
ITGEESLNQTKLRADRLDEDSSNLNVLAETDLEVIHQTVQQAQPDILVVDSIQTIYHPEI
SSAPGSVSQVRESTQSLMNIAKQMNIATFIVGHVTKEGQIAGPRLLEHMVDTVLYFEGDE
HHAYRILRAVKNRFGSTNEMGIFEMKQSGLKGVHNPSEMFLEERSTNVPGSTIVATMEGT
RPLLIEVQALVTPTTFNNPRRMATGIDHNRLSLLMAVLEKKENYLLQQQDAYIKVAGGVR
LTEPAVDLSVIVATASSFKDKAVDGLDCYIGEVGLTGEVRRVSRIEQRVQEAAKLGFERV
IIPQTNIGGWQFPEGIKVVGVSTVHDALKYAFKS
>SEQF2892_00244 putative PIN and TRAM-domain containing protein YacL
MNVLKGIVIIIYIILGAALGILLIPEILKDFNINGYPFLHNYYIDGLIGIVVFFLIFGFF
INKVTKTFKAIEHWIMQRSAVEILFATLGLIIGLFISVMASFILEMIGNTILNHLVPLII
TLLLCYLGFQFGLKKRDEMLMFLPENMARSMSKSNISAVPKLLDTSAIIDGRILDVIRCG
FIDGEILIPQGVINELQVVADANDSVKREKGQRGLDILNELYDLEYPTRVIHPQKSHSDI
DELLVKLAQTYHAHVITTDFNLNKVCHVQGIKALNVNDLSEAIKPNVHQGDRINILLTKM
GKEPGQGVGYLDDGTMVVVDNAKSLVGKHVDLEVISLLQTSSGRIIFAKKIDDSE
>SEQF2892_00245 Glutamate--tRNA ligase
MSERIRVRYAPSPTGYLHIGNARTALFNYLFAKHYDGDFVVRIEDTDSKRNLEDGESSQF
DNLKWLGLDWDESIDKDKGYGPYRQSERGDIYNPLIQQLLDEDKAYKCYMTEEELEKERE
DQIARGEMPRYGGQHAHLTEEERQQFEAEGRRPSIRFRVPQDQTYTFNDMVKGEISFDSN
NIGDWVIVKKDGIPTYNFAVAIDDHYMEISDVIRGDDHVSNTPKQLMIYEAFGWEAPRFG
HMSLIVNEERKKLSKRDGQILQFIEQYRDLGYLPEALFNFITLLGWSPEGEEEIFSKEEF
IKIFDEKRLSKSPAMFDRQKLAWVNNQYMKTKDTDTVFELALPHLIKANLIPESPSEDDK
EWGRKLVALYQKEMSYAGEIVPLSEMFFHEMPELGEEEQEVINGEQVPELMTHLYGKLEA
LEPFEAADIKKTIKEVQKETGIKGKQLFMPIRVAVTGQMHGPELPNTIEVLGKDKVLSRL
KKFV
>SEQF2892_00247 Serine acetyltransferase
MIKRMRDDVKMVFEQDPAARTTFEVITTYAGLHAVWSHLIAHKLYNKKRYVLARIISQVS
RFFTGIEIHPGAKIGKRLFIDHGMGVVIGETCTIGDNVTIYQGVTLGGTGKEKGKRHPDI
GDNVLIAAGSKVLGNIQIDSNVNIGANSVVLQSVPSYTTVVGIPGHIVKQEGKRIGKTFD
HRNLPDPLYEQIKQLEKQLEKAKNGEIKDDYII
>SEQF2892_00248 Cysteine--tRNA ligase
MITLYNTLTRQKETFEPIEPGKVKMYVCGPTVYNYIHIGNARPAINYDVVRRYFEYKGYE
VIYVSNFTDVDDKLINRSKELNESVPDIADRYIKAFYEDVGALNVKKATSNPRVMNHMDE
IIDFIKELVDEGYAYESDGDVYFRTRKFEGYGKLSHQSLDDLKVGARIEAGEQKEDALDF
TLWKKAKPGEISWESPFGEGRPGWHIECSVMAFHELGKTIDIHAGGSDLQFPHHENEIAQ
SEAHNHAPFANYWMHNGFINIDNEKMSKSLGNFILVHDIIKEVDPDVLRFFMISVHYRSP
INYNLELVNAAKSGLERIRNSYQLIEERETIATDIVDQSKYIEQIDAIIEQFETVMDDDF
NTANAVTAWYDLSKLANKYVLENNTSTQVISRFKEVYQIFSDVLGVPLKGNKSDMLLDED
IEKLIEERNEARKNKDFARADEIRDMLKEQNIILEDTPQGVRFKRG
>SEQF2892_00249 Mini-ribonuclease 3
MYALNVDNMDIKLLNPLTLAYMGDAVLDQHVREYIVLKLQSKPNRLHQVSKSYVSAKSQA
QTLETLFEMGWFTDEELDIVKRGRNAKSHTKAKNTDIQTYRKSSGLEAVIGYLYLDHQEE
RLENLLDMIVQTVNER
>SEQF2892_00250 Putative TrmH family tRNA/rRNA methyltransferase
MKTVEDIVIVGRHAVKEAIVSGHTINKIWIQEGIRKQQINDILQNAKEQKLIVQTVPKSK
LDNLANAPHQGVAALIAPYEYADFDQFIQSQKDKEGLSTVVILDGLEDPHNLGSILRTAD
ASGVDGVIIPKRRSVALTQTVAKASTGAIQHVPVMRVTNLAKTIDELKEHGYWVAGAEAD
NATDYRDMAADMPLAIVIGSEGQGMSRLVKDKCDFYIKIPMVGHVNSLNASVAASLMMYE
VYRKRHQVGDNA
>SEQF2892_00251 hypothetical protein
MKDKYLIIDGYNMIGQSPELGKIAKDNLQEAREQLLDAIANYNAVVADEIVCVFDAYEQS
GIEREYIYHGVKTVFTKEKETADSYIERYVYNLYNKHTTHITVVTSDMSEQHAIFGAGAY
RVSSREMWRDLRENEITVSKSLDDFTESKPRTRISLSNDVLAEFEKIRRGNHNKD
>SEQF2892_00252 hypothetical protein
MAHQFIQLEKTFKAFQNSRSSHEQDRLFIDIVNHIQPKLFIKFKSYGIQNEDIEDLVQET
LIRIYLALHTFDFSTDVPFEHYLNCIVRSMRNDFWRRKYIETDKHDSIINDYVIDYKLNQ
SSKYIEDICMIKEKRELLASSLTVLSRFERNVAELLMSDYTPSEIAKQLGIKDKVVYNSI
QRCKMKMRYYLLKRLY
>SEQF2892_00253 Protein translocase subunit SecE
MAKDKGTNKEKDSFFQGVKSEMEKTSWPTKEELFKYTVIVVSTVIFFMVFFWVLDIGIGN
LIELFR
>SEQF2892_00254 Transcription termination/antitermination protein NusG
MSEEVGAKRWYAVHTYSGYENKVKKNLEKRVESMNMTEQIFRVVIPEEEETQVKDGKAKK
QLKKTFPGYVLVELVMTDESWYVVRNTPGVTGFVGSAGAGSKPNPLLPEEMRFILKQMGL
KEKTIDVELDVGEQVRIKSGPFANQVGEVQEIEPDKFKLTVLVDMFGRETPVEVEFDQIE
KL
>SEQF2892_00255 50S ribosomal protein L11
MAKKVEKVVKLQIPAGKANPAPPVGPALGQAGVNIMGFCKEFNARTQEQAGLIIPVEISV
YEDRSFTFITKTPPAPVLLKKAAGVEKGSGEPNKTKVATVTKDQVREIAQTKMQDLNAAD
EEAAMRIIEGTARSMGITVQ
>SEQF2892_00256 50S ribosomal protein L1
MAKKGKKYQEAANKVDRTKHYSVEEAISLAKETSIANFDASVEVAFRLGIDTRKNDQQIR
GAVVLPNGTGKSQRVLVFAKGDKITEAEEAGADYVGESEYVQKIQQGWFDFDVVVATPDM
MGEVGKLGRVLGPKGLMPNPKTGTVTMDVKKAVEEIKAGKVEYRAEKAGIVHASIGKVSF
SDEKLVENFKTLQDVLAKAKPSSAKGTYFKSVAVTTTMGPGVKIDTSSFKL
>SEQF2892_00257 hypothetical protein
MCKSILNTLRIKDKNLNFSDEVIEKKHKGRMSLFYYAELTYQPTHCENCSTKNENFSIVK
DGKKTSTITLLKIMEMPAYLELQKQRFYCKSCDSHFTAKSNIVDAHCFISNKTKLAVLDK
AQEYRSQKSIAKSCLVSSMTVSRVINQAASDVGQSSFDALPEHLMMDEFKSVKNVIGKMS
FIYADAVSHRIVDVVADRKLKSLKDHFYRYSLKLRQKVKTVTIDMYEPYMSLIKQLFPNA
KIIIDRFHIVQSLNRALNMSRVHVMNCYRTFNRPLYNKYKSYWKLFLKPFETLEAFNYHK
VHLFKEWKTEKGIINCLLGVDVELFNTYHYVHELRRLLKENQIEKFNHKLFSIHLSDVCP
KLRPVIRTLRRLATFIENTMTYSNLTNGPLEGINNKTKLIKRVSFGYRNYDNLRNRIMII
YVIELL
>SEQF2892_00259 50S ribosomal protein L10
MSAIIEAKKQQVDVIAEQLKNSVSTVIVDYRGLTVAEVTELRSQLREAGVEYKVYKNTMV
RRAAEQAGIEGLDEFLTGPTAVATSTEDVVAPAKVIAGFAKEHEALEIKTGVMEGSVISA
EEVKTVGSLPSHDGLVSMLLSVLQAPVRNFAYAVKAVGEQKEESAE
>SEQF2892_00260 50S ribosomal protein L7/L12
MANQEQIIEAIKEMSVLELNDLVKAIEEEFGVTAAAPVAAAGAAGGGDAAAEKTEFDVEL
TSAGSSKIKVVKAVKEATGLGLKDAKELVDNAPKVIKEGVAKEEAEKLKEQLEEVGATVE
LK
>SEQF2892_00261 Ribosomal RNA small subunit methyltransferase C
MGHYYDENPDVQSDERVIQYHYHSHQLNLTTDAGVFSKAQVDFGSDTLVQTFLNEHPPGP
SKTIADVGCGYGPIGLMIAKVSPHHQITMVDVNKRALNLAEKNKKANQIDNVIIKESDGL
SQLKDSHFDYVLTNPPIRAGKEVVHRIFEEAYQQLNSQGELYVVIQKKQGMPSAKKKMEE
IFNNVEVVNKNKGYYILKSTKG
>SEQF2892_00262 DNA-directed RNA polymerase subunit beta
MAGQVVQYGRHRKRRNYARISEVLELPNLIEIQTKSYDWFLKEGLLEMFRDISPIEDFTG
NLSLEFVDYRLGEPKYDLEESKNRDATYAAPLRVKVRLIIKETGEVKEQEVFMGDFPLMT
DTGTFVINGAERVIVSQLVRSPSVYFNEKIDKNGRENYDATIIPNRGAWLEYETDAKDVV
YVRIDRTRKLPLTVLLRALGFSNDQEIIDLLGDSEYLRNTLEKDGTENTEQALLEIYERL
RPGEPPTVENAKSLLYSRFFDPKRYDLASVGRYKANKKLHLKHRLFNQRLAEPIVNSETG
EIVAEEGTVLDRRKLDEIMEVLETNANSEVFELEGTVIDEPVEIQSIKVYVPNDEEGRTT
TVIGNALPDSEVKCITPADIIASMSYFFNLLNGIGYTDDIDHLGNRRLRSVGELLQNQFR
IGLSRMERVVRERMSIQDTDSITPQQLINIRPVIASIKEFFGSSQLSQFMDQANPLAELT
HKRRLSALGPGGLTRERAQMEVRDVHYSHYGRMCPIETPEGPNIGLINSLSSYARVNEFG
FIETPYRKVDLDTNSITDQIDYLTADEEDSYVVAQANSRLDENGRFLDDEVVCRFRGNNT
VMAKEKMDYMDVSPKQVVSAATACIPFLENDDSNRALMGANMQRQAVPLMNTEAPFVGTG
MEHVAARDSGAAITAKYRGRVEHVESKEILVRRLVEENGTEHEGELDRYPLAKFKRSNTG
TCYNQRPIVSVGDVVEYNEILADGPSMELGEMALGRNVVVGFMTWDGYNYEDAVIMSERL
VKDDVYTSIHIEEYESEARDTKLGPEEITRDIPNVSENALKNLDDRGIVYVGAEVKDGDI
LVGKVTPKGVTELTAEERLLHAIFGEKAREVRDTSLRVPHGAGGIVLDVKVFNREEGDDT
LSPGVNQLVRVYIVQKRKIHVGDKMCGRHGNKGVISKIVPEEDMPYLPDGRPIDIMLNPL
GVPSRMNIGQVLELHLGMAAKNLGIHVASPVFDGANDDDVWSTIEEAGMARDGKTVLYDG
RTGEPFDNRISVGVMYMLKLAHMVDDKLHARSTGPYSLVTQQPLGGKAQFGGQRFGEMEV
WALEAYGAAYTLQEILTYKSDDTVGRVKTYEAIVKGENISRPSVPESFRVLMKELQSLGI
DVKVMDEQDNEIEMADVDDEDATERKVDLQQKDVPETQKETTD
>SEQF2892_00263 DNA-directed RNA polymerase subunit beta'
MIDVNNFHYMKIGLASPEKIRSWSYGEVKKPETINYRTLKPEKDGLFCERIFGPTKDWEC
SCGKYKRVRYKGMVCDRCGVEVTKSKVRRERMGHIELAAPVSHIWYFKGIPSRMGLLLDM
SPRALEEVIYFASYVVVDPGPTGLEKKSLLSEAEFREYYDKYPGQFVAKMGAEGIKDLLE
EINLDEELKSLRDELESATGQRLTRAIKRLEVVESFRNSGNNPAWMILDVLPIIPPEIRP
MVQLDGGRFATSDLNDLYRRVINRNNRLKRLLDLGAPGIIVQNEKRMLQEAVDALIDNGR
RGRPVTGPGNRPLKSLSHMLKGKQGRFRQNLLGKRVDYSGRSVIAVGPSLKMYQCGLPKE
MALELFKPFVMKELVQREIATNIKNAKSKIERMDDEVWDVLEDVIREHPVLLNRAPTLHR
LGIQAFEPTLVEGRAIRLHPLVTTAYNADFDGDQMAVHVPLSKEAQAEARMLMLAAQNIL
NPKDGKPVVTPSQDMVLGNYYLTLERKDAMNTGTIFNDTNEVLKAYANGYVHLHTRIGVH
AKSFNNPTFTEAQNNKILATSVGKVIFNEIIPDSFAFINEPSQTNLEGKTPDKYFIDSTQ
LGEGGLKAYFEEQELIEPFNKKFLGNIIAEVFNRFSITDTSMMLDRMKDLGFKFSSKAGI
TVGVADIVVLPDKQDILDEHEKLVERVSKQFNRGLITEDERYNAVVEIWTDAKDQIQGEL
MQSLEKTNPIFMMSDSGARGNASNFTQLAGMRGLMAAPSGKIIELPITSSFREGLTVLEY
FISTHGARKGLADTALKTADSGYLTRRLVDVAQDVIVREEDCGTDRGLLVSDIKEGTEMI
EPFIERIEGRYSKETIRHPETDEIIIRPDELITAEIAKKITDAGIEQMYIRSAFTCNTRH
GVCEKCYGKNLATGEKVEVGEAVGTIAAQSIGEPGTQLTMRTFHTGGVAGSDITQGLPRI
QEIFEARNPKGQAVITEIEGVVEDIKLAKDRQQEIVVKGANETRSYLASGTSRLKVEVGQ
SVERGEVLTEGSIEPKNFLAVAGLNATESYLLKEVQKVYRMQGVEIDDKHVEVMVRQMLR
KVRIIEAGDTKLLPGSLVDIHSFTDANREAFKERKRPATAKPVLLGITKASLETESFLSA
ASFQETTRVLTDAAIKGKRDDLLGLKENVIIGKLIPAGTGMRRYSDVKYDKAETPVTETE
EAEIIE
>SEQF2892_00264 Ribosome-associated protein L7Ae-like protein
MSNEKVASFNKQHYVVGLKETLKALNRDQVASLIIAQDVEVHLLARVFSLINHKNIPITY
FQSKHALGSYVGINVNATMVALLNEN
>SEQF2892_00265 30S ribosomal protein S12
MPTINQLVRKPRQSKSKKSDSPALNRGFNSKKKQFTNLNSPQKRGVCTRVGTMTPKKPNS
ALRKYARVRLSNNIEINAYIPGIGHNLQEHSVVLVRGGRVKDLPGVRYHIVRGALDTSGV
DGRRQGRSLYGTKKPKN
>SEQF2892_00266 30S ribosomal protein S7
MPRKGSVPKRDVLPDPIHNSKLVTKLINKIMLDGKRGTAQRILYSAFDLVEQRSGRDALE
VFEEAINNIMPVLEVKARRVGGSNYQVPVEVRPERRTTLGLRWLVNYARLRGEKTMEDRL
ANEILDAANNTGGAVKKREDTHKMAEANKAFAHYRW
>SEQF2892_00267 Elongation factor G
MARDFSLKNTRNIGIMAHIDAGKTTTTERILYYTGRIHKIGETHEGASQMDWMEQEQDRG
ITITSAATTAQWDGHRVNIIDTPGHVDFTVEVERSLRVLDGAVTVLDAQSGVEPQTETVW
RQATTYGVPRIVFVNKMDKLGANFDYSVSTLHDRLDANAAPIQLPIGAEDEFEAIIDLVE
MKCFKYTNDLGTEIDEIEIPEDHKERAEEARSNLIEAVAETNDELMEKYLGDEEISVAEL
KNAIRQATTDVEFYPVLCGTAFKNKGVQLMLNAVIDYLPSPLDVKPIVGHRAENPEEEVI
AKPDDSAEFAALAFKVMTDPYVGKLTFFRVYSGTLTSGSYIKNSTKDKRERVGRLLQMHA
NSRQEIDTVYSGDIAAAVGLKDTGTGDTLCGEKNDIILESMEFPEPVIHLSVEPKSKADQ
DKMTQALVKLQEEDPTFHAHTDEETGQVIIGGMGELHLDILVDRMKKEFNVECNVGAPMV
SYRETFKQSAQVQGKFSRQSGGRGQYGDVHIEFTPNETGAGFEFENAIVGGVVPREYIPS
VEAGLKDAMENGVLAGYPLIDVKAKLFDGSYHDVDSSEMAFKIAASLALKEAAKKCDPVI
LEPMMKVTIEMPEEYMGDIMGDVTARRGRVDGMEPRGNAQVVNAYVPLSEMFGYATSLRS
NTQGRGTYTMYFDHYAEVPKSIADDIIKKNKGE
>SEQF2892_00268 Elongation factor Tu
MAKEKFDRSKEHANIGTIGHVDHGKTTLTAAIATVLAKNGDTVAQSYDMIDNAPEEKERG
ITINTAHIEYQTDKRHYAHVDCPGHADYVKNMITGAAQMDGGILVVSAADGPMPQTREHI
LLSRNVGVPALVVFLNKVDMVDDEELLELVEMEVRDLLSEYDFPGDDVPVIAGSALKALE
GDAQYEEKILELMQAVDDYIPTPERDSDKPFMMPVEDVFSITGRGTVATGRVERGQIKVG
EEVEIIGIHDTSKTTVTGVEMFRKLLDYAEAGDNIGALLRGVAREDVQRGQVLAAPGSIT
PHTKFKADVYVLSKDEGGRHTPFFTNYRPQFYFRTTDVTGVVNLPEGTEMVMPGDNVEMT
VELIAPIAIEDGTRFSIREGGRTVGSGVVTEIIE
>SEQF2892_00269 hypothetical protein
MCKSILNTLRIKDKNLNFSDEVIEKKHKGRMSLFYYAELTYQPTHCENCSTKNENFSIVK
NGKKTSTITLLKIMEMPAYLELQKQRFYCKSCDSHFTAKSNIVDAHCFISNKTKLAVLDK
AQEYRSQKSIAKSCLVSSMTVSRVINQAASDVGQSSFDALPEHLMMDEFKSVKNVIGKMS
FIYADAVSHRIVDVVADRKLKSLKDHFYRYSLKLRQKVKTVTIDMYEPYMSLIKQLFPNA
KIIIDRFHIVQSLNRALNMSRVHVMNCYRTSNRPLYNKYKSYWKLFLKPFETLEAFNYHK
VHLFKEWKTEKGIINYLLGVDVELFNTYHYVHELRRLLKENQIEKFNHKLFSIHLSDVCP
KLRPVIRTLRRLAAFIENTMTYSNLTNGPLEGINNKIKLIKRVSFGYRNYDNLRNRIIIT
SRLFASTTKKEIKQPKVA
>SEQF2892_00270 putative hydrolase YxeP
MVNVLDWFQLASNKENRMIQMRRYMHQYPEPSFEETWTHNYILNQLSHLDCKIESPIGRN
GIKATFKGKENGPTVAFRADFDALPVQELNDVPYKSKNDGFMHACGHDGHTAILLGVAEI
VHEHRHLLKGNVVFIFQYGEEIMPGGSQEMIDDGCLNGVDKIYGTHLWSGYRTGTIYSRP
GAIMASPDEFSVTIKGKGGHGAKPHETIDPIVIMAEFILSAQKIISRTIDPVKEAVLTFG
MIQAGSSDSVIPDSAFCKGTVRTFDTELQTHIHNKMDKLLQGLALANDITYDLEYIRGYL
PVHNHVNAYEVVKQAANDLHLRFNESELMMIGEDFSHYLKVRPGAFFLTGCGNPDKGITA
PHHNPHFDIDESAFKYAASEFLKILEIEQVF
>SEQF2892_00271 Putative pyridoxal phosphate-dependent acyltransferase
MVQSLHNFLEENIQYLKDNGLYNEIDSIEGANGPEITINGKQYINLSSNNYLGLATNEDL
KSAAKHAIDSHGVGAGAVRSINGTLDLHDELEETLAKFKGTEAAIAYQSGFNCNMAAISA
VMNKNDAILSDELNHASIIDGCRLSKAKIIRVNHSDMDDLRAKAKEAVESGQYNKVMYIT
DGVFSMDGDVAKLPEIVEIAEEFGLITYVDDAHGSGVMGKGAGTVKHFGLQDKIDFQIGT
LSKAIGVVGGYVAGTKELIDWLKAQSRPFLFSTSLAPGDTKAITEAVKKLMASTELHDQL
WDNAKYLKDGLEKLGFNTGESETPITPVIIGDEKETQEFSKRLKDEGVYVKSIVFPTVPR
GTGRVRNMPTAAHTKEMLDKAIAAYEKVGKELGTIK
>SEQF2892_00272 hypothetical protein
MIFIVPVFLLLQKAVFEIYALFLSEEQISILVKLIYNE
>SEQF2892_00273 hypothetical protein
MLRLRQLSYADKDALKKYLQEWYANDEPIVPSNTDMSRYESFENMVDHLNSTEVDDDWVP
TTTLFCFEDEMIVGAVDIRHYLNQRLVNIGGHVGYGVCKSRRGQGIASLMLQEAKAFLKE
IGVDKVLMTTNPKNVASQKVIKHSGGYEIESYVKKNGNLVSRFEIPND
>SEQF2892_00274 Nucleoside triphosphatase NudI
MKDLKVVYALIQNEEGNVLLVHNTDGGGWSLPGGKVEYGETLVEALKREVREETGLFVEV
NDIVSVNEGKSTQMNVHTLFFMFKAEVQDYTTDIQMKDEISTLGWFSIPEADEKLIYYHH
SLNAFLNNKATYYDEGFVD
>SEQF2892_00275 Delta(1)-pyrroline-2-carboxylate reductase
MLVLNEQDQQSLLDMKEVIDEVANSLKAFSEGKTDTPLRYVLPFNEGNRYLVMPALSDDL
KVVGIKTVTFAPDNPKKGKKTITGSVLLSDYETGETLAVLDGSYLTKIRTGAISGVATKY
LAREDAKTLCVIGSGDQAQGLIAAVMAVRNIDTIHFSSRTKENAERLAQEVANNYNVSTK
VFEEADDAMEEADVVVTATNSNHPVYSHSLHPGVHLNAVGSFKPDMQELPSESMLVANKI
VVESVEAAMKETGDLKVPQEEGIITKDSLHGELGDIVAGKVSGREDDKEVTLFKSVGLAI
VDIVVANYFYKKSSSK
>SEQF2892_00276 Mannosylglucosyl-3-phosphoglycerate phosphatase
MKRYLIPLLVLCFIVFGITTGTSYAAESQATQSTNITATEEASQTASKEASSANIEFTNK
PLSLESSNVSHNEQATPSSETTTHPSVETSTTQNTTSEKHSNSSQGSAFSQEKATPEPAT
NDDNTSSQEKASSESTSNENNTSQFHGTEVKPSPSTSEQSKSTQVEPTKESTSTKVKQTP
QEPTQQQQKRNVPESQQSTPASKQVSKNSNTTSEQAAPKSQHVTVNKRMAATSDNTNEHT
ILHTNDIHGRFVEDDGRVIGMAKVKGLKDKYNPDLMVDSGDAFQGLPVSNNSKGEEMAKA
MNGVGYDAMTVGNHEFDFGYDQLLKLQKQLNFPIVSSNIYKNGKRVFDPSTTVTKNNVRY
GIVGVTTPETKTKTSPTAVEGVEFKDPLTSVKQAMNEIKNNVDVFVILSHLGVDKSTQKT
WRGDYLIDQLTKDGSFKQPIFVLDGHSHTVIDKGEHYGTNNVLAQTGTALANVGRVDFTF
QNQKASDINASLINVADAKDITPDPQIDAQTKKANDDFLKETSTVVIPNNTVTLNGERAQ
ARTQETNLGNLITDAMEAYASKNFSHQPDFAITNGGGIRASIEKGEVTENDIITVLPFGN
LISQIQVKGSDVEKAFEHSLSADTETQDGKKVLGANGGFLQVSDSLRVYYDINKASGQRI
NAIKVLNKENGEYEDLDPNRTYYVTTNDFTANQGDGYDMFGGQREEGISLDAVVAQYIKN
TDLNQYNTEEPVRIINGLPESNEQPDTSKEDNDNDNNHSTNGHDGQQQTPDSNNDDKDNT
GHINDNDDNIKDDNEADSSNKDNVIEFPNKDHQKDNDNVIEIPANNNQTHNSTNDNIVIP
STTDKMHTNNIKGNAIEHHPTSNLVSISNNNKGTRDQLTGNASHSQHCKDVIKFPVQINP
KDNFYNETLITTNSNASKNSNLMFTQQHGAITSLPNAGLKDGSLEHGIAIILVVAGTGLI
YIRTRKKSA
>SEQF2892_00277 putative epimerase/dehydratase
MERIVITGALGQIGTELVLKCREIYGNDNVLATDIREPEEDSPVNNGPFEVLDVTNREAM
MAIVENFKADTLMHMAALLSATAEKNPLLAWDLNMGGLMNALETARTYELHFFTPSSIGA
FGDSTPKKDTPQNTIQQPTTMYGVNKVAGELLCQYYFTKFGVDTRSVRFPGLISHVKEPG
GGTTDYAVEIYFEAVRKGRYTSYIAKDTYMDMMYMDDAIDAIIKLMEADSDKLVTRNGYN
LSAMSFEPEQIKAEIQKHYPGFALDYEVDPVRQAIADSWPDNIDTSYSRKEWGFNPKYDL
AGMTELMLKAIEEKEQNK
>SEQF2892_00278 putative branched-chain-amino-acid aminotransferase
MSEKVKFEQRDSLKEKPEGNLGFGQYFTDYMLSFDYDVDKGWHDLKIIPYAPFEVSPAAQ
GLHYGQAVFEGLKAYKHEGEVVLFRPDQNFKRINDSLARLEMPKVDEELLLEGLKQLVDV
ERDWVPEGEGQSLYIRPFVFATEGILGVRASHQYKLLIILSPSGAYYGGDTLKTTKIYVE
DEYVRAVRGGVGFAKVAGNYAASLLAQTNANNLGYDQVLWLDGVEQKYVEEVGSMNIFFV
ENGKLVTPALNGSILPGITRKSIIELAKELGYEVEERKVSIEELFEAYDKGELTEVFGSG
TAAVISPVGTLKYEDREIVINNNEPGEITKKLYDIYTGIQSGKLEDTHGWRVVVPEYK
>SEQF2892_00279 hypothetical protein
MAHIIMLIVTIICIVLIIYNLVKDGPIINVFLIAVIQSIILFLIRYLWINQSWKDALKHS
FDLLTLMVVFVYLIYKIYKRNKKKE
>SEQF2892_00280 hypothetical protein
MFLKREKKYKKYQAISKSILGFSVLLLILTWLLNLVFGWSILHLFFNIFSFTFILGLCIG
AIPDILEKDVNTILADILVIILMIVVLFIL
>SEQF2892_00281 hypothetical protein
MKKYLTALTICLVLFNLFSIIFNAFLHIPYGKTIFFTIYLIIIIVFFFIDRKIEKQNKRD
K
>SEQF2892_00282 hypothetical protein
MDYYQMPMFNKLLVSDIQKAAKWYEKTLGFNSVFKFRNDKNEVLMEHLRLEKYQDIMLIS
SDNFEVGNATYLNILVKDINNLEKHISSQFIVEQLEEKPWNAKEMTIKDLDGHLLTLTHS
NITDKDFKKLIKKTSKDF
>SEQF2892_00283 putative N-acetyltransferase YvbK
MFEKLDSIEDAPFDLLLLADPSMKLILEYLQSGECFIYKDGSVILGCYVLKEINIDKVEL
VNIAVSENKQSHGIGKKLLLHLFDYAKQKGYKEIIVGTGNSSIDQIAFYQKAGFRMIGVE
IGFFERNYNDKIYENGILCRDKIWFLKKV
>SEQF2892_00284 hypothetical protein
MEYKSLKKLFHMYGWDNVDTEYNMRLNSYSSYVTDFIIHPIQDEKQQRDVEYPLFFVLNR
SLGINLEKVLKNSDRIKQLSSELPKVANEVYIKHLLIN
>SEQF2892_00285 Adenosine monophosphate-protein transferase SoFic
MIENDDVEINSITDIRNILDLIVPSEILEKDLPDGNLFRKNSIGVYDNAKSKWIHRNEFN
EPEIFEYLTIFLSFIKHYEAPDIYKILASHYMFEYIHPFYDGNGRVGRYILAKLLNDNLD
SFTALTFSYVVNHNKNKYYKAFQEASDYFNKGEITNFIDDMMQLLIEGQNNIIETFENNT
EIIKRLAQALDQQGLNKYDSDVLFILLQDKIFGSKYSRITIKGVKDIAGYSRNKVNEVLK
KYESKLIQLKSNPVVYEVKDSYVQELLSMQNNTN
>SEQF2892_00286 hypothetical protein
MEFKLITYFDESYIDSIYETYQSIGWLKHDKDKIRKIFENSTHVVFAIYDNKVIGFARAL
SDGVFNAAIYDLVVNKDFQNNQIGMYMLKHIIKEIGSLSCIHLISTIDNLEFYQKAGFKK
LKTGMVIYQGKRLLDTYTE
>SEQF2892_00287 Pyrophosphatase PpaX
MKWILFDKDGTLIEFDKSWEKIGIRLVDSLLDEYPVADKEVAHRQLGVLDNAIVPDSVMG
SGSLDEMIKAFNNVVGKDVSTWTRNTSQELVDTRVPENNWIDGVYDMIQSLKKDGYKIGI
VTSDSRKGVLQFLEDTNSKDAFDLVISTESHAAEKPNPAVLNPLFDSYDVEPEDVVIVGD
TNNDMKTKVNAELGLAIGVLTGIAKKEELVDADVIIDTAVSVPEVLKQYIENK
>SEQF2892_00288 Deoxyadenosine/deoxycytidine kinase
MNNYKVPQNAIITIAGTVGVGKSTLTQALADKLNFKTSFENVDHNPYLDKFYDDFERWSF
HLQIYFLAERFKEQKRMFEYGGGFIQDRSIYEDVDIFAKMHEEQGTMNEDDFKTYSELFN
AMVMTPYFPKPDVLIYLECDYNEVIERIKARGRDMEINTDPEYWQKLFKRYEDWINNFNA
CPVVRVNINEYDIHENPDSLDPIIDKIAHVINTYRKVDNR
>SEQF2892_00289 Deoxyguanosine kinase
MNKPFIAIEGPIGVGKSSLTHKLSQTLNYYEEKEIIDENPFLSDFYDDISKWSFQTEMFF
LCNRYKQAKDIAKMTQGVVSDYHIYKNKIFARNTLSNNEFDKFDRIFDILTEDLEMPNMI
IFLDADLEVLKQRIAQRNRSFEHHIEDDYLLNLKEDYLTFYNAMKSEGANVVLINTSEID
FVKNDSDYQSILEKIRPMIGAIEHE
>SEQF2892_00290 tRNA-specific adenosine deaminase
MANDEYYMKLAIEEAKKAQKLGEVPIGAIIVKNNEVIASAHNLRETAQLPTAHAEHIAIE
RASKVVGSWRLEECKLYVTLEPCVMCAGAIVMSRIPKVVYGATDPKGGCSGSLMNLLEES
QFNHRAEIVKGVLEQECGDLLRNFFRELRLKKSKANM
>SEQF2892_00291 Phosphatase YwpJ
MIKLIATDMDGTLLNAAHEISKENVDAIKFAQSQGITVAIATGRAFYEASTPMAETDLKV
PYICLNGAEVRDESFNIMNTSNLNHELVERIKAILDREDVYYQVYTNRGIYTEDPTRDLD
IYLDIARNAGQQGDVEKIKAGIQKRIDNGTLKIVDNYKDIEDIPGELIMKVLAFNPDLEK
IERIGKELSAISSLAVSSSSRGNLEITHSDAQKGIALETIANQLHIDLNEVMAIGDNLND
ASMLERVGYPVAMDNAMPEVKAIAKLVTDTNENSGVGKAIMKVLTEEK
>SEQF2892_00292 FMN-dependent NADPH-azoreductase
MKGLIVVGSAQVGSHTNALAKYLTGQFDNHDVDVDIFDLAERPLNQLDFSGTTHSTEEIK
ANTKAFQDKAMEADFLILGTPNYHGSYSGILKNALDHINMDYVKMKPVGLIGNSGGIVSS
EPLSHLRVIVRSLLGIAVPTQIATHDSDYAKLEDGTLYLNDEEFQLRAKLFVDQIVSFVN
NSPYEHLK
>SEQF2892_00293 Serine-aspartate repeat-containing protein F
MSKRRQGPINKRLDFINNKLNKYSIRKFTVGTASILVGATLIFGADHEAQAAENTADSTN
ETVDSNSANKFDSAETSTTEQPSTQQDSKTDESTTQSTKEQPKEESSSTTEQPSTQQDSK
TDESTTQSTKEQPKEESSSTTEQSSTQQDSKTDESTTQSTKEQPKEESSSTTEQPSTQQD
SKTDESTTQSTKEQPKEESSSTTEQPSTQQDSKTDESTTQSTKEQPKEESSSTTSSKNNT
TQDTTSNKLDSSEASPSDATKQSNNLTDTTGKSSTTDALSITSDSSVANKQAYTNDMVDN
LNAGTSNNKDAIVDAVSNDVNLETATQDQIDNAVVAETIKTDFSNPDYGLASPFMTLVAV
APMSTASTDSTPTTFALNSTDTTSSTGGSLVNDKIHITNASLTLNKKNNQHDNNTVWPTS
NEQLKLSADYELDNSIKEGDTFTIKYGDYIRPGALELPAKNTQLRSKEGSIVANGVYDET
TNTTTYTFTNYVDQYQNITGSFNLLATPKRETVTIDKQTYPMNVTIANQEVSENFVVDYG
NKKNDITNAAVANVDNVNNQHNEVVYLNQSGDRIYDAKYFSIVQNGTFIPNEVKVYEVLD
SNVLVDSFNPDLNGSAVKDVTSKFTPQYSLNNTRVDIDLNRSNLNKGARYIITQAVKPSG
TGNVSTNYELTRYGNEASRYPTGSKSTTVSYINGSSTAQGDNPTYNLGDYVWLDKNKDGI
QNDDEKGIPGVYVILKDSNNKELQRATTDDTGRYQFNNLQNGTYNVEFVIPNNYTPSPSN
TIENDKIDSDGQKDGDYNVVVAKGIIDNADNMTVDTGFYETPKYNLGDYVWEDTNKDGIQ
DSDEKGIAGVTVTLKDDNGNVLKTTTTDESGKYQFTGLENGTYTVDFETPKDYKPTSVNS
GNDNEKDSDGTTTTAIIKDADNETIDSGFYKPTYNLGDYVWEDTNKDGIQDSDEKGIAGV
TVTLKDSDGNTIGTTTTDESGKYQFTDLEDGTYEVSFTTPEDYTPTTVNAGNDEKDSDGL
TTTGVINGADNWTLDSGFYKTPKYNLGDYVWEDTNKDGIQDSDEKGIAGVTVTLKDDNGN
VLKTTTTDESGKYQFTGLENGTYTVDFETPKDYKPTSVNSGNDNEKDSDGTTTTAIIKDA
DNETIDSGFYKPTYNLGDYVWEDTNKDGIQDSDEKGIAGVTVTLKDSDGNTIGTTTTDES
GKYQFTDLEDGTYEVSFTTPEDYTPTTVNAGNDEKDSDGLTTTGVINGADNWTLDSGFYK
TPKYNLGDYVWEDTNKDGIQDSDEKGIAGVTVTLKDDNGNVLKTTTTDESGKYQFTGLDS
GDYIVHFDKPEGLTQTITNSGSDDEKDADGEEVHVTITDHDDFSIDNGYFDEDSDSDSDS
DSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDS
DSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDS
DSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDS
DSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDS
DSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDS
DSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDS
DSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDS
DSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDS
DSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDS
DSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDS
DSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDS
DSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDS
DSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDS
DSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDS
DSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDS
DSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDS
DSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDS
DSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDS
DSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDS
DSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDS
DSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDSDS
DSDSDSDSDSDKKLPDTGENNSNGVLFGSMFAGLGALLLGKRRKRENKEK
>SEQF2892_00294 hypothetical protein
MDIESRVDKLISYIENTTEIKNKIFLSLGNSNIKATVKLLKKPNYLKRNVINEIQKFRKK
TGKYPIWIKLDIVIKSEKILFEKVSNEIIKTRRNYVDFGVAFDDYWDLSFLPEEINANAF
VKPIENNGKKKLILSEKNINNYLRKYTNHKKSFNYDFYENKEVIKFYTKGFMLEEKDVFE
LYSEGYKKGLRKTQDLYKEIDKLIKSGTHFLKNMILDNGRYIYGYFPHFDNEINFYNILR
HSSSTYALVEGLGYIGENLSPVERAIDYIIENNFYEKDNIGYIFDDTEELNEIKLGQNAA
FIFAICEYLKYRKNDYYLNIAQKTARGILSMINKSTYETTHILNYPDLTVKEKFRIIYYD
GEAALALLRLYQQDNDEVWLNVVKKLLDHFIKNDYWQYHDHWLGYCTNELVQIAPKEEYF
EFGIKNVNNYLDYIEQRETTFPTFLEMLMATYKLIQKAKETGFDYVVNNLVDEQRIVDVI
HTRADYQRTGFFYPEVAMYFKKPSRVLGSFFIKHHGYRVRIDDIEHYVSGYVQFRKIFKK
>SEQF2892_00295 hypothetical protein
MTQVHFTLKSEEIQSIIEYSVKDDVSKNILTTVFNQLMENQRTEYIQAKEYERTENRQSQ
RNGYYERSFTTRVGTLELKVPRTRDGHFSPTVFERYQRNEKALMASMLEMYVSGVSTRKV
SKIVEELCGKSVSKSFVSSLTEQLEPMVNEWQNRLLSEKNYPYLMTDVLYIKVREENRVL
SKSCHIAIGITKDGDREIIGFMIQSGESEETWTTFFEYLKERGLQGTELVISDAHKGLVS
AIRKSFTNVSWQRCQVHFLRNIFTTIPKKNSKSFREAVKGIFKFTDINLAREAKNRLIHD
YIDQPKYSKACASLDDGFEDAFQYTVQGNSHNRLKSTNLIERLNQEVRRREKIIRIFPNQ
TSANRLIGAVLMDLHDEWIYSSRKYINFDK
>SEQF2892_00296 hypothetical protein
MMKNYNWEYFKAQINKKLSEPKTKTIYSQRKIDVEPVFGFMKAILGFTRMSVRGINKAKR
ELEFVLMALNIRKVAAQQAENNQKNYKIKKCSSKIYVILLSTIKLNI
>SEQF2892_00297 hypothetical protein
MIENPIIDDFNRTPLITYGMFIKDKTKKYKSDIFNTQNWDYDEINDEYICPNNKRLDFKR
YAYRHDKYGFKRDFKLYECDDCSECPLKHQCMKFNSKTNKK
>SEQF2892_00298 hypothetical protein
MPNEDFKALYHELVTNKIIREIKKDHDNNLTKEEIDLIGSHLDKEIEDLNQHIDNERWTE
IRKQIRLKRTKIKKYKKQINDYSERKYKYEVQKSILKDRNSYSKTDHDATFMRMKEDHMK
NGQLKPGYNLQIATKSQFVLSYNVNQNPTNTRTMIPFLNSIQETYGHLPKYIVSDAGYDR
EPNYR
>SEQF2892_00300 Poly(glycerol-phosphate) alpha-glucosyltransferase
MIYSVGNNLGRKLTGIEKAMINRLNLFKKNSISNKLIFVSWSPRLYLHAQLLKINQNDVF
SLYDVLQDSLNVKEKYFNWINYWENDCNYTLKYVVDTNDIKIYKNGLYKMYVHFVDSNYN
ILDYINYFDIKQRKIRRDLYDTRGFLSCTKVLTTNQKVVMEQYYSPSKNVKFEKYYNPED
KIPKVQSIIYYASDGIKFFEDNNSLLSFAIETLYESGDLFLSDKNIKTSPIFNKCNIKIP
VVAILHSTHVKNINNVYDSEIKNTYKPLFNNLTRYSGIIVSTQQQKIDVSIRINNVIPVY
TIPVGYTENSSFNNENKNLTDSNKIISIARYSPEKQLEHQIELISKLVKDFPSIQLHLYG
FGNEQKKYETLIKNLNLENNVFLRGFIQDLDQEIETAYLSLITSKMEGFNLGLLETIAKG
IPPIGYDSKYGPSDLIINKENGFLISKNDKEKLYHCVKELLYNVNLRNEFSKACKKHANN
FNENKVIDKWQLFLKSILG
>SEQF2892_00301 UDP-N-acetylmuramoyl-tripeptide--D-alanyl-D-alanine ligase
MPLTIKELHDILGGELYDAKNKENNIINNFENWFPFIHNKNTAYISPNKKTWRRFGRSPN
AKEGNEYIRKDKEDLGLIITEHYVSNMSYKIPQLVVKDSAQTLSNLAEKMRIQYKNPVIA
ITGSMGKSSTRMLISAGLKDYMPLQNRYNNNIRSAVYLLLCKLIRQPNFAVLEVSLNALN
AVGNSSYLIKPNIAIVTGIGAAHMSTFKDILNIVEVKASIFDGLDSNGIAIINKDTLHSD
ILINRAKENTKNVITYSTSDSNATIYPKSIEYNKGFTDITVEFEGNEYTYRINSISNGMV
ENSLASFAALTQLNIPLQKALDNLITFKPFEKVLNLKEIKTSKFRVNLIDDTHNASLPAM
INAIKAFDTQTKFFKGNKIIAIGKISDLGKHSRKLHLQLVNVLENSNADYILCMDDDLKG
VVTRVKNKHITWYSNRFLMEQDLLYLCNNDSITLLKSSAGGTEFPKLAKDLSNNLLTYQK
DNSNSSLFDGQSINGRSYIIVNNNDYKIIEQYNSENSSTIEGLGPIFNYLKGIDDNIKNE
TVTIGNWATNNNIYYEGKETSTYNLMKDMLNSPMYSPTYELSKYLFKNGLHRDEYINSII
KKLDLSNSVAINLTGRHTIKERQSFTVNDLYSILKSYKDNLFKFSNKIIIGRKYKSGIIK
GDKQSIIFTSYPSVKTIETLLHSKY
>SEQF2892_00302 GTP cyclohydrolase FolE2
MTEFDLSTREGRWKHFGSVDPIEGTKPTTKNEMTDLQSTHKNFLFEIEEVGIKNLIYPVN
IDRFQTAGRFSFSTSLNKDEKGINMSRILESVEKHYNNGLELNFDTLYQVLRTLQTNMKQ
NSSGVDVSGKWFFDRFSPVTNIKAVGNADVTYGLAIEQDQITRKEITIEATVTTLCPCSK
EISEYSAHNQRGVVTVKVYLDKNNQVVDDYKDKILDAMEANASSILYPILKRPDEKRVTE
RAYENPRFVEDLIRLIAADLVEFDWIDGFDIECRNEESIHQHDAFARLKYRK
>SEQF2892_00303 putative N-acetyl-alpha-D-glucosaminyl L-malate deacetylase 2
MKDERHVLMIFPHPDDETFSSAGTIASYIDNGIPVTYACLTLGQMGRNLGNPPFATRESL
PDIRERELEEAMKIIGITDLRKMGLRDKTVEFEPHEQMDDMVKKLIEETNPSVIISFYPK
FAVHPDHEATAEAVVRTVGRMPEEARPRLQLVAFSNDAPEILGEPDILNDIRAYRGLKLK
AFEAHASQTGPFLKQLASPEVGGETQSFLDVEPYWTYHFES
>SEQF2892_00304 hypothetical protein
MLELINAEEVQQLLTSFENKPVYLHVETTNGAYANHFDQRVFNAGTFLRNIQVTCEHAQL
KGGEKDPYRVGLKLRDGGWVYVQGLTHYEINNNNEFLIAGFNYEGQLAATIEISEKPFTV
>SEQF2892_00305 3-hexulose-6-phosphate synthase
MELQLAIDLLNKEEAAKLAKKVEEYVDIVEIGTPIVINEGLPAVQHLNENINNAKVLADL
KIMDAADYEVSQAIKFGADVVTILGVAEDASIKAAVEEAHKHDKQLLVDMIAVQDLEKRA
KELDEMGADYIAVHTGYDLQAEGQSPLDSLRTVKSVIKNSKVAVAGGIKPDTIKDIVAEQ
PDLVIVGGGIANADDPVEAAKQCRDAIEGK
>SEQF2892_00306 3-hexulose-6-phosphate isomerase
MSQFTNYKLILEELDRTLSHVQDEQYDRFANDVNGAQRIFTAGKGRSGFMANSFAMRLNQ
LGKEAFVVGESTTPSIKEHDLFVILSGSGSTEHLRLLAEKAQSIGAKVVLLTTSPDSPIG
ELAETVIELPAGTKHNVEGSEQPLGSLFEQSSLLFLDSVVLGLMETFDISEEEMQNNHAN
LE
>SEQF2892_00307 putative acyl--CoA ligase YhfT
MLEIIKRLEYYAKVQPQSIALQIDDEIVNYESLYQKICDCTLNSPKFKLGSRVALLNDSP
IVNITNYFVVLMMDGVPCFLDNKWSRDTIDKLIEHFHIEYVMTAIGKFKRTTSFGTYEKY
ISEELKVDDLLHIGFTSGTTGLPKAYYRNEPSWIGSYAENEKLIHNYETALAAPGPLAHS
LSLYTCIYALYSGRTFIGQRQFDAKRFISILNEQHSNIALFLVPTMLHQLLNVDTTITHI
KSIFCSGAKLSESLFKTVSQQFKNANIIEFFGTSEASFITYNFNQTSPTNSVGQVFPNVS
IKLEAQDNRKIGLLKVQSNMIYSGYVDVGVVQPHSWIETGDYAYIQNNQLYLVSRKSDRL
IIGGKNIYPNVIEQQVKSLDGIEEAVVVGEPHRRFGEIAVLIYVGNQELDYTTLRRYLRQ
TLSRYEIPSKLVRVKDLPFTNSGKVARNTVQTLYLEGAFKV
>SEQF2892_00308 3-oxoadipyl-CoA/3-oxo-5,6-dehydrosuberyl-CoA thiolase
MKEAVVIWAKRTPFGKYGGALRHLEPEALLLPLFQNLKQTFPEVMDQVDDVVLGNVVGNG
GNVARKSLLEAGLNHRIPGITLDRQCGSGLESIIYACRMVQCEAGKVFIAGGVESTSRAP
WKIKRPQSVYEMQLPQFFERASFAPEGQDPSMIEAAENVAQHYNISRNDQDLFAARSHRL
VATHFNNGDINREIVPLTIKGALFDRDESLKPNLTEARLHRLRPILPNGTVTVGNSCMKN
DGAGIALIMEKEMAVAMGIKWGMLYRDAVTTGVDPTLLGIGPVPAVSQLLKRQKLNIEDI
SAIELNEAFSSQVLASINELHLGLDKVNQWGGAIATGHPYSASGAALVARLLNLPNWQYG
IATMGIGGGMGNAVLFEKWRQ
>SEQF2892_00309 hypothetical protein
MRYSLKSGANETREFKFHSEDVRIYCSVIGKEYDGTVPPLMCAKLWPKFKMFQIFKGEAI
RLVRTNVELFENLESDIQYCAYLTHKKSEKVKQFDRFIFKLEINKNNKTRMIIEQTFISE
DGIYGF
>SEQF2892_00310 hypothetical protein
MVFNREIVEQYLAIVDDENPIHEYIVPGQLIVEKVFSMMDDQWASYKIKYVQTTDINETI
DFEVVENERIIVSNKANGVKLVIIRN
>SEQF2892_00311 Proline/betaine transporter
MDFKKDRINMVDGQTAKKTVFATGIGNAMEWFDFGVYAYTTAYIGANFFSPVQNPEIQQI
FTFAALAIAFLLRPIGGIVFGIIGDKYGRKVVLTTTIILMALSTLTIGVLPNYDMIGLWA
PALLLLARILQGFSTGGEYAGAMTYIAEISPDKKRNSLGSGLEIGTLSGYIAASIMIALL
SFFLSDAQMEAWGWRIPFILGLFLGLFGLYLRRKLEESPIYENDVETPARDNIGFFTIIR
YYFKDILVCFVAVVFFNVTNYTVTAYLPTYLGQIVKIDETTTSVLITCVMAVMIPLALFF
GKLADKIGEKKVFLIGTGGLTLLSIVAFSLLNTKSLPFIILGVFILGFFLSTYEATMPGS
LPTMFFTHIRYRTLAVTFNISVSLFGGTTPLVNSWLVESTGNIYAPAYYLTAISIIGFIV
IAVLHVSTAGKSLKGSYPNVDNKKDLEFYESNPKKALWWIKVKKNKNA
>SEQF2892_00312 hypothetical protein
MIIYKQNIENGIPMYKIITKTFKTITVKFDETFNKNEIYKLLSLLENDLDNMKLGY
>SEQF2892_00313 Pyridoxine kinase
MALKKVLTIAGSDTSAGAGMQADLKTFQELDTYGMVALTAVVTMDKETWSHDVTPLPMDL
FEKQLETAISIGPDAVKTGMLGTQEIIKRAGEAFEQSGAKYFVVDPVMVCKGEDEVLNPG
NTDAMIEYLLPKATVVTPNLFEAGQLSGLGKLTSIEDMKKAADIIFNQGAQHVIIKGGKA
LDQDKSYDLYYDGNTFYQLTTDMFQQSYNHGAGCTFAAATTAYLANGKSPKEAVISAKAF
VASAIKNGWKMNDFVGPVDHGAYNRVEHIDVDVTEV
>SEQF2892_00314 Uracil-DNA glycosylase
MEWSEIFHDITERHDFKEMHDFLEKEYTTQTIYPDRDNIYQAFDLTPFEDVKVVILGQDP
YHGPNQAHGLAFSVQPNAKFPPSLRNMYQELEDDIGCHRTSPHLQDWAREGVLLLNTVLT
VRQGQAHSHKDIGWETFTDEVIQAISKHRDDVVFILWGKPAQQKIKLIDTSKHYIIKSPH
PSPLSAYRGFFGSKPYSKTNGYLESKGKSPINWCENGEA
>SEQF2892_00315 hypothetical protein
MNRAQVIQLIEHELVQADEATNEQQFEKHMYAIHTLTSIYANNESKPASSKSQGQDFTNT
VTTSFSKVNQSLNTSSSQGKSKVTAAEIEAMGRKVPDSMKSSQNNSLPSNTMVTDDEIGN
GESIFDF
>SEQF2892_00316 hypothetical protein
MYMMKLFIILGALCTMMSVGTGAFGAHGLEGKLSDKYMSIWEKAVNYQMYHGLGLIIIGV
ISGTTSINVNWAGWLLFLGVVFFSGSLYILALTQIRILGAITPIGGVLFIAGWLMLIIST
FKFVG
>SEQF2892_00317 putative amino acid permease YhdG
MSKNNQNQDIDRGDLKQNLSEKFVWAIAYGSCIGWGAFILPGDWIKQSGPIAASIGIVIG
ALLMILIAVSYGALVEKFPVSGGAFAFSYLSFGRYVSFFSSWFLTFGYVCVVALNATAFS
LLVKFLLPDLLNNGKLYTIAGWDVYITEIIIATVLLLVFMLVAIRGASVSGSLQYYFCVA
MVIVVLLMFFGSFFGNNFAFENLQPLANPKSGWFTSIIMIVAVAPWAYVGFDSIPQTAEE
FNFSPNKTFKLIVYSLLAASLTYVVMILYTGWLSTNNASLNGNLWVTGAETQSAFGYIGL
GVLAIAIIMGIFTGLNGFLMSASRLLFSMGRSGIMPTAFSKLHSKYKTPYVAIIFLVAVT
LIAPWLGRTALTWIVDMSSTGVSIAYFITCLSAAKLFSFNKESNTYGPVYKTFAIFGSIV
SFIFLLLLLVPGSPASLSMPSYIALGGWLVIGLIFFVIRYPKLKRMDNDELSRLILNRSE
KEVEDMVDDTYK
>SEQF2892_00318 hypothetical protein
MFWILNLIFSYTASLFFCVIFDAPRKLYLSCGFVGACGWMVYILFYQGLNTHTIYSSFFG
SLALGLISHYMARTKREPAIIFMVPGIIPLVPGGLAFDATKNLVLLDFSKAINTMLEVTL
IAGAIALGLLFADQISKIILSGFARTRKRI
>SEQF2892_00319 Inner membrane protein YjjP
MYHKPKRLLYLRLIDYNYEYILTNGDEMDNTQIHENADEKLIKDVVMMAGRILLESGAEG
TRVEDTMTRIARKLGYPESNSFVTNTVIQFTLHNESYPRIFRINSRDTNLIKISQTNEIS
RLITKGAITLEEAKLKLENIYVAKRDSSLLFKGIAAAIIAISFLYLQDGKLVDVITALLA
GGLGYLVVEILDRRLHAQFIPEFLGSLVIGIISVLGHYLLPTGDLATIIIASVMPIVPGV
LITNAIQDLFGGHMLMFTTKSLEALVTAFGIGAGVGSVLILV
>SEQF2892_00321 Putative heme-dependent peroxidase
MSEAAETLDGWYSLHLFYAVDWTTFRLVPEDEREAMINEFKTFINDKASAREQQAGDYAL
YNITGQKADILLWYLRPEMKELNEIENELNKLRIADFFIQTYSYVSVIELGNYLAGKSDE
DPYQNPHVRVRLYPELPRTEYICFYPMDKRRNETYNWYMLPMEERKKLMYNHGMIGRQYA
GKIKQFITGSVGFDDFEWGVTLFSDDVLQFKKIVYEMRFDETTARYGEFGGFYIGHILKT
DDFEHFFAI
>SEQF2892_00322 Phosphate acetyltransferase
MSSLLDVLQEKLSGKNVKIVLPEGEDERVLTAATQLQATDYVTPVVLGDYDKINLLAKDK
GLDVSDIEIINPSTSELKPELVKSFVERRKGKATEEQADELLNNVNYFGTMLVYAGHADG
LVSGAAHSTGDTVRPALQIIKTKPGVSKTSGIFFMIKDDQQYVFGDCAINPTLESSDLAE
IAVESAKSAKSFGMDPRVAMLSFSTKGSAKSDDVDKVANAVKLAQEKVESEGLTDVVIDG
EFQFDAAIVPSVAEKKAPGAKIQGNANVFVFPSLEAGNIGYKIAQRLGGFDAVGPVLQGL
NSPVNDLSRGCSTEDVYKLSIITAAQTLQ
>SEQF2892_00323 Octanoyl-[GcvH]:protein N-octanoyltransferase
MDLASKYFNDIDWRYVDHSSGLAPMQSFAFDDTFSESVGKDLSCNVVRTWIHQHTVILGI
HDSRLPFLKDGIRYLTDEIGYNAIVRNSGGLGVVLDQGVLNISLIFKGQTETTIDEAFTV
MYLLICKMFENEDVEIDTREIEHSYCPGKFDLSIDGKKFAGISQRRVRGGIAVQIYLCVE
GSGSERAEMMRVFYEHALKGEVTKFKYPDIQPECMASLETLFGREIKVQDVMFQLLHAIK
DLGGNLNMDPITEDEWTRYEGYFDKMIDRNEKMNRSIEAD
>SEQF2892_00324 Homoserine kinase
MVQRGYGESNGKIILIGEHAVTFGEPAIAIPFTSGKVKVLIESLEKGNYSAIQSDVYDGP
LYDAPEHLKSLIGHFVENKKVEEPLLIKIQANLPPSRGLGSSAAVAVAFIRASYDYLGLP
LTDKELLENADWAERIAHGKPSGIDTKTIVTNQPVWYQKGEVEILKTLDLDGYMVVIDTG
VKGSTKQAVEDVHQLCDNDKNYMQVVKHIGSLVYSASEAIEHHSFDQLATIFNQCQDDLR
TLTVSHDKIEMFLRLGEENGSVAGKLTGGGRGGSMLILAKELQTAKNIVAAVEKAGAQHT
WIEKLGG
>SEQF2892_00325 Homoserine kinase
MKKNGKARAHTNIALIKYWGKADEALIIPMNNSLSVTLDRFYTETRVTFDETLTEDQLIL
NGEAVNAKESAKIQRYMEMIRKEAGISEHALIESENFVPTAAGLASSASAYAALAGACNE
ALQLGLSDKDLSRLARRGSGSASRSIYGGFAEWEKGNDDETSFAHRVEADGWENELAMVF
VVINNKSKKVSSRSGMSLTRDTSRFYQYWLDNVEPDLKEIKEAIAQKDFKRMGEVIEANG
LRMHATNLGAQPPFTYLVPESYDAMRIVHECREAGLPCYFTMDAGPNVKVLIEKKNQQAI
VDKFLQEFDQSQIITSDITQSGVEIIK
>SEQF2892_00326 Phosphomevalonate kinase
MIQVKAPGKLYVAGEYAVTEPGYKSVLIAVDRFVTASIEASNAVTSTIHSKTLHYEPVTF
NRNEDKIDISDANAASQLKYVVTAIEVFEQYARSCNVKLKHFHLEIDSNLDDASGNKYGL
GSSAAVLVSVVKALNEFYDMQLSNLYIYKLAVISNMRLQSLSSCGDIAVSVYSGWLAYST
FDHDWVKQQMEETSVNEVLEKNWPGLHIEPLQAPENMEVLIGWTGSPASSPHLVSEVKRL
KSDPSFYGRFLDQSHTCVENLIYAFKTNNIKGVQKMIRQNRMIIQQMDNEATVDIETENL
KMLCDIGERYGAAAKTSGAGGGDCGIAIIDNRIDKNRIYNEWASHGIKPLKFKIYHGQ
>SEQF2892_00327 hypothetical protein
MKNKFLICDECQAVNIKTLKRKLEKLDPEAEIEIGCQSYCGPGRRKTFAFVNNRPLAALT
EDELLEKVTAQLKKPRDPEEEERLRKRNEERKRRKEEQDRKLKEKLAKRKAIK
>SEQF2892_00328 hypothetical protein
MCKSILNTLRIKDKNLNFSDEVIEKKHKGRMSLFYYAELTYQPTHCENCSTKNENFSIVK
NGKKTSTITLLKIMEMPAYLELQKQRFYCKSCDSHFTAKSNIVDAHCFISNKTKLAVLDK
AQEYRSQKSIAKSCLVSSMTVSRVINQAASDVGQSSFDALPEHLMMDEFKSVKNVIGKMS
FIYADAVSHRIVDVVADRKLKSLKDHFYRYSLKLRQKVKTVTIDMYEPYMSLIKQLFPNA
KIIIDRFHIVQSLNRALNMSRVHVMNCYRTSNRPLYNKYKSYWKLFLKPFETLEAFNYHK
VHLFKEWKTEKGIINYLLGVDVELFNTYHYVHELRRLLKENQIEKFNHKLFSIHLSDVCP
KLRPVIRTLRRLAAFIENTMTYSNLTNGPLEGINNKIKLIKRVSFGYRNYDNLRNRIIIT
SRLFASTTKKEIKQPKVA
>SEQF2892_00330 Cold shock-like protein CspLA
MNNGTVKWFNAEKGFGFIEREDGSDVFVHFSGIAGEGYKTLEEGQKVDFDITEGQRGEQA
TNVVVLS
>SEQF2892_00331 putative pyridine nucleotide-disulfide oxidoreductase RclA
MTHFNLLVIGFGKAGKTLAKYAASQGQHVALVEQSSDNYGGTCINHGCIPSKVLVHDGID
GTDFGTAFSRKKDVVSALNKKNYDNLANDTNIEVFNYKAQFKSNTEVNLLDEDGAIVHTL
TADRIVINTGAKSNIPSIPGIESAKHLFDSQGLLNISYQPKHLVIIGGGYIALEFASMFA
NFGSKVTVIEHGEHIMPREDQDVVAHAIKDLEDKGITFVTNADTLEFKNNNNQTTIVTSK
GNFSADAVLIATGRIPNTDLALEETGVELGERGEIKVNEHLQTSVEHIYAVGDVKGGLQF
TYISLDDFRILKSTLYGDQSRTTLNRGTIPYTVFIDPPFSRVGLTAKEAQSQGYNYNENT
LLVAQIPRHKINNDARGIFKVVIDKDTDLILGATLYGKESEEIINLIKLAIDQHIPYQVL
RDTIYTHPTIVESFNDLFNI
>SEQF2892_00332 hypothetical protein
MNLEFNIAVHVLSFLTKHSEEQFNSQDLAELTCLNPVQLRRVTTTLNNQQYIDSIRGKGG
GYRANAHTPTITLDTLYQLFVLDKLPTQRIFTGSEESHCTISRNIATTMNKYKEQETALA
LNFYRNLTINDVIKNTLQEDTSNDTF
>SEQF2892_00333 General stress protein 69
MADLVQLGKSDVHVFPIALGTNAVGGHNLYPNLDEEQGKDVVRKAIDNGITLLDTAYIYG
PERSEELVGQVVQEYPREQVQIATKGSHVIKENDEVVQNNDPDYLKQQVENSLKRLQVDY
IDLYYIHFPDENTPKDKAVAALKELKDEGKIKAIGVSNFSLEQLKEANKDGYVDVVQLEY
NLLHRENEEVMKYAAENNITFIPYFPLASGILAGKYEENQTFDDHRAPRRDFQPEVFNDN
VRRVKQLQGIAEAHNTSIANVVLAFYLTRPALDVVIPGAKRAEQVVQNIEAANIQLTDDE
LNKIDELFPIE
>SEQF2892_00334 Putative NAD(P)H-dependent FMN-containing oxidoreductase YwqN
MITVLFGGSRPEGNTAQLTKSAVEGLDYKWIDLTDYQFNPVRDFRHENRDITSYNDDYKQ
VIDQVLESDTVIFASPVYWYSVSASLKAFIDHWSETLIDDNYKDFKEKMAKKDFRLILVG
GDCPKVKAKPCITQMKYTLDFIGAELNGYIIGTAERPGDISKDTFALERAKEWNGTLV
>SEQF2892_00335 L-amino acid N-acyltransferase MnaT
MFKVREATPNDVVAIRDVATKAWYNTYLNIYAASTINELLAASYNEQHLKKRLEEQLFLV
AEDNDEIIGFANFIYGKELYLSAHYVHPESQHKGYGSSLLKKGLEQFDGKYDAVFLEVDN
KNKDAIQYYQNNGFEIVRSYQPEMYGEQMDLALMKRSL
>SEQF2892_00336 hypothetical protein
MTQTPYVEQKLAEEKVFKDPIHKYIHVKDQLIWDLIKTKEFQRLRRIKQLGTLYLSFHTA
EHSRFGHSLGVYEIVRRMIDESFVGRDAWNNEDRPLALCAALLHDLGHGPFSHSFEKIFN
TNHEAFTQAIITGPTEVNEVLSRVSSTFPKEVAEVINKTHQNKLVISMISSQIDADRMDY
LQRDAYFTGVSYGTFDMERILRLMRPSKDEVLIKESGMHAVENFIMSRYQMYWQIYFHPV
SRGGEVLLNNCLKRVKQLYNEGYHFKMYPEDFVPFFEEKVTIEQYVDLDEVVVLYYLKKW
IQEDDAILSDLARRFINRDLFKYIPFDGSIITISELQELFIEGGIDPNYYFVSEAFSDLP
YDYDRPGSNRQPIHLLRRNGSIREISSQSLVISSITGINREDYKLYYPKEMILNIENPQT
KGSIINLLNELN
>SEQF2892_00337 hypothetical protein
MSENKGFKFNIIKNDPLDGHKGTNIGSISLDNIAPVFIDVANKEAFIDIGGMHARAQVEK
GVKWINDKSEVEGEEAKEYWLCWVTTERSESGPYYAGVTACYLLVNKSIRRGYKSMPEHV
NMMDKSMKHKIIIDHIGEKNKKVLADFLKSHNEEMWNNSSEELFKAFE
>SEQF2892_00339 hypothetical protein
MYKNYNMTQLTLPMETSVLIPTNDISRHVNDIVETIPDNEFDEFRHHRGATSYHPKMMLK
VILYAYTQSVFSGRKIEKMLNDSIRMMWLSQNQKPSYKTINRFRVNPKVDALLESLFIQF
YSQCVKQNLIDDKAIFIDGTKIEANANRYTFV
>SEQF2892_00340 hypothetical protein
MNEDSKALYHELVTNKIIPEIKEDHDNELTKEEIDLIGSHLDKEIEDLNQHINNEKCTKT
RKQIRLKRTKIKKYKKQINDYFERKYRYEFQKSILKDRNSYSKTDHDATFMRMKEDHMKN
GQLKPGYNLQIATNSQFVLSYNVYQNPTDTRTMIPFLNSIQETYGHLPEYIVADAGYGSE
SNYKAIIDDFNRTPLITYGMFIKDKTKKYKSDIFNTQNWNYDEINDEFICPNNKRLGFKR
YTYRHDKYGYKRDFKLYECDDCSECPLKNQCMNFNSKTNKKIMKNYNWEYFKSQINKKLS
EPETKNIYSQRKIDVEPVFGFMKAILGFTRMSVRGLNKVKRELGFVLMALNIRKVVAQRV
ENNQKIYKKDNFYIISIEIVFFHLSKNFMSRTLFTSINLR
>SEQF2892_00341 2-epi-5-epi-valiolone epimerase
MSHIKGINHIGLTVLDIEEATTFLKEAFGAKIAYDALTYEDEPREGAEVERMLGLSKGAR
IVRQRMIVIGNGPNIEMFEVESNNQKAPLKLEDLGFNHISLMVDDIEDVLEDAKRAGAEP
LSETHDNSTYEDSEGSKSVYVKAPFNALIELQAIPNGYYYPEDSEVKVFIPGE
>SEQF2892_00342 Immunodominant staphylococcal antigen B
MNKTAKAIVSATLAMGTVFGVGASVEQPHHNQAHAATTPYYTYSGYVNNDGSFLLNKTFK
NAVKYGNVTLNGTKIVPQSGTSSKLNNFSKYDQSFFSVKSGKKTATSVQIKVNNVTIKQL
KSVYGKDLVEQADVHGHKNPNTDAYKLVGGQNGNYHTPVTFVQKNGKVQSVNIGFEGSGA
>SEQF2892_00343 Carbamoyl-phosphate synthase small chain
MRINVLQHTPNEGVGAIGDWAKENGHDLYIYHPYFYNGVLPKAEETDLLIILGGPMSPND
LDDWILKERELIRVLLKEKKPIFGACFGAQQITKAIGYTVSKSPVKEVGWDKVYLETNTI
PDLPKELMALHWHEEMFQIPKNAELLFSSEYLTNQGFLLNNNVIGLQFHFEPGPFEVKEI
VTNDFSYAVDSVLNQTPQEIIEREVPKENKEVMFKLLDHITGR
>SEQF2892_00344 hypothetical protein
MKGEYYGEKSTKKAIESIQHSHLIGLSLVNFIIFAFYYFIYTGPGIKGHMPLYMKIYLIG
SLLLWLLLYLQEREYIFKNYNRKNYKFRVAIYMTINLLSGYNIPFLISSAYAFYFADSRD
DTYTYWLLICGIITVSAIGLFFFCLGEFQMFGIQKGSFIRMIGILIVLLSFGLLLYVSLI
VPVDSEENRTIWMGMIMLFCSHMLIVRTYFYLGLLDYDIREDGVKLQ
>SEQF2892_00345 hypothetical protein
MLINILAGYNIPFLISSADIFYYSGVDGDAFKYWIIIAGIILISITGLFIFCYSEFEMFG
NKQNVILKILGVFLVLLSFIALIYISFVSPSDSGESKVIWVGCFFLFGVHIIMGRVFFYL
AVLIDDIKEDGMKL
>SEQF2892_00347 putative beta-barrel protein YwiB
MNKNIDVQTKQVLKQNGEKQKFEFTAQGSWQKKNADYIRYQEQIEDAVVNVTIKIEERGV
KLIRKGDINMNLHFVEGHDTTTLYDIPAGRIPLTVKTRSILHFVNENGGKLKIQYELHQN
DEKMGSYQYEINYKEISE
>SEQF2892_00348 Arginine--tRNA ligase
MNIIEKVKSTLIEEIKASIKKANLAEDIPEIKVEIPKDTKNGDYSTNIAMVLTKIAKRNP
REIAQAIVDNLDTSKANVKQVDIAGPGFINFYLDNQYLTTVIPEAINKGDKFGYAEESKN
TNILLEYVSANPTGDLHIGHARNAAVGDSLANILIAAGYNVTREYYINDAGNQITNLARS
IETRFFEALGDTSHEMPADGYNGKDIIEIGKDLADKHPEMKDYSDEERLKTFRKLGVDYE
MDKLKKDLADFNVHFDNWFSETSLYENGAIDNTLAKMNELGYTYEADGATWLRTSDFKDD
KDRVLIKKDGNYTYFTPDTAYHYNKINRGNDILIDLMGADHHGYINRLKASLETFGVDSD
RLEIQIMQMVRLMQDGVEVKMSKRTGNAITLREIMDEVGIDAARYFLTMRSPDSHFDFDL
ELAKEKSQDNPIYYAQYAHARICSILKQAKEQGVEVTADADFSTITNEKAIDLLKKVAEF
EPTIESAAESRAPHRLTNYIQDLASAFHKFYNAEKVLTDDAEKTKAHVALVDAVRITLHN
ALSLVGVSAPETM
>SEQF2892_00349 Ultraviolet N-glycosylase/AP lyase
MPTLTTEALYKILLDNMGPQHWWPAKSPEEMMLGAILVQNTNWKNADMALMRLREETQFD
PQKILSLPLAELQEIIRSSGFYKNKGKAIHALFQWLNQFNFDYENIAQHYGDNLRRELLK
IRGIGSETADVLLVYIFEGIEFIPDSYTRRLYSKLGYAHTESYDKFKKQISLPPHFTNQD
ANEFHALLDNFGKNYFNGKGTQKYTFLEDYFNKND
>SEQF2892_00350 HTH-type transcriptional activator TipA
MLNHGYFTPNEVSKVTSVSTRTLRYYHEIGLLVPSYIDANGYRYYHSQDITKLQTILFLR
QLNLSLENIQDYFQQSITDKNAILEENYAQIIHQRNHLNQIIDYLNHHLINHRNEEINMD
KFNQFDVNEQYDKEAALKYGDTDYYQSYKDNRTQFNDSEKQDNDDHTNEQFNQFFNEMNQ
LLEDSYSADDAYTYQNIETLKKILQRQVPNADNQFLNYMALTYENDERFAKNINKNRNDH
LNQYIARAIRAYIK
>SEQF2892_00351 Inner membrane protein YhaH
MIESYQLFWKNYFNVQGRTRRRHYWFATLANIIVLVLLSLLADLLKWVFGGGDTFFNIVY
ETIDVIIVIGTFTMSVRRFHDVGRTMLIPLIMLISMLLRGLIVLLETISNVYLSDFYSDV
SLMIATVVVLVISIVLLIVSIFALIYCVTDSEKGTNEYGPNPKAQ
>SEQF2892_00352 Vitamin B12-binding protein
MLNKKLWILLSLVMLILVACGQNDQHKQEDKQSNQSDSNSKEHSYKRIVSLMPSNTEILY
ELGLGKDIVGVSTVDDYPKDVKKGKKQFDTMNLNKEALLKVKPDLILAHESQKGTSKKVL
DSLEKNGVKVVYVKDAQSLDQTYETFKQIGKVTGREHEANELVDETKHNVEKVIKSVPRH
HRSQSVFMEVSSKPEIYTAGKHTFFDDMLAQLDAKNSFSNIEGWKPVDKESIIKKNPDIL
ISTEGLSKSDYYKVIKKRDGFRQIKAVKNGRIETVNGDEISRPGPRIDEGLKQLRDAIYK
R
>SEQF2892_00353 Hemin transport system permease protein HmuU
MTRNIYLTFLSWCICLIGAIGLYLLWDMGSLTDSFNQMILLKVRLPRIIEALLTGAILTL
AGQMFQTVLNNPLADSFTLGLASGATFGSGLAIFLGLSFIWVPIFSISASLIALLIVLMI
AAKISRGYPLKILIITGLMIGALFNALLYILVLIKPNKMNQIANYFFGGFAAAETREVIY
IGLIAIPIILILFSMVPAIKLLQLGELKSQSLGLNVQQVMFLILTLASIITAVAIAYTGI
IGFIGMIVPQLIRRYYWRFTLGIQMILNILIGATMMLIADWIGSVLIHPVQIPASIILAL
IGTPTLFYILLKQSKDV
>SEQF2892_00354 (S)-2-haloacid dehalogenase 4A
MDLSHIKAIVFDLEGTLLDRTKSRDKFIEEQYERFHDYFVHVQLADFKQKFIELDDDEDN
DKPDLYKAIIKQFHIDRLTWKDLFNDFEMHFYRYVFPYYDTLYTLEKLSQNNYVLGVIAN
GKSKIKQFRLHSLGLGHVINYLSTSETVGFRKPHPKIFEDMINQLNVQPEEIMYVGDDAL
NDVAPARAMGMVSVWFKHDDAELEPLEEEVDFIITTSEELLSILPIHIKQGGDS
>SEQF2892_00355 Tropinesterase
MDLFTRKGGLSLHYNTMGEGYPVVLVHTAYENASIFQNLAKELAKSFQVVLLDLRGHGYS
DKPRQIDFKEFADDIIQLLDYLYIDESALIGHEMGAAIIADLAERYPNYVSSLIMVTPTS
IEGELPEERLFRKYSHKIRNWDDEKQNKFLEKHRYYKPRKVNKFLKHVEDTNVISTKEET
QAIEDVFKETAISSIFEHVTKPTLIIAGEHGERITTLESKEVADLVKESQFDVYAQSSLY
PFEEEKDKFIKDVTPFIKKYMPEH
>SEQF2892_00356 hypothetical protein
MKKLVAAFIVSGLVMTGVGVNHAEAASGNTIQTVQQLTQGEKSLENITLGESIKNVSNKY
GTPIYSKNPSNNEGYYEYRTNKGLLVVTAVGKKNQGYVTRVSMTYNEANGPTYNQVKKSL
GQNAVARVQYNKVSGNFGYIQKGKTSYQFGSNSPQDKNLKLYRIDLAK
>SEQF2892_00357 hypothetical protein
MRTNDKVLLENINDYFSHKGMAPNLIDDIKENLRNDLKKSESKDEDYLDYRGKSSAQIIL
IIQRNLFGLQTNPVIFFIMNFILISYLYDKQYVPFQAATAISIFYCIIIFPLTIFINIRI
DKKKFLYSNRFEMILGYIVAIIALILIIMRAFNLNWGIIPITIYSHQVVFFIGIILSLIG
VFFKKIEYTAIGLLFCQKTIDAVVTKPEIAQIISLIIWIMIVALIVFYTIKLSSRTRV
>SEQF2892_00358 AB hydrolase superfamily protein YdjP
MKKIETLNQTKLAYQDEGHGSPVILIHGLDGNSAAFDLLNKQLQQNYRVIAYDVRGHGKS
SRPDSYNLEDHVKDLYVLIDKLNLKKVHLLGHDMGGIIAREFTEKHENHVLSLTIISSKA
EDIVHGFTKLMIEHQDEIAGFNKSEALLLLFPYIYKEQESAMKWIQRQRLYSKQNSEDSA
IASRALLDTAYANKGYTHYVKVPTLIINGRYDPIINDKNHYKIEERYQNVEKVLFEESGH
APYVEEEDKFLVLYLSFLENVEQITEVNH
>SEQF2892_00359 Transcriptional regulator SarA
MAISKINDCFELLAMITYADKLKNIIKKEFSISFEEFAVLTYISQSKEDEYYLKDIINHL
NYKQPQVVKAVKNLSQEDYFDKKRNEHDERTVLILVNSTQRKKIDSLLNKVNTRIEEANK
ETEL
>SEQF2892_00360 hypothetical protein
MKTFFTPLRILIATLILLVISFVCYIYAKIPTEPDTSKIETITAKPQYSLSFIGEQQPQE
SFTLYFNPSLGNVSSLLVKNDEIIHSDTPLFEYYNPILEKLIVAKKKALSSLINQSTKQS
ISQQLTLNSQILELQSRLQIRINSPISGKVTILEAHPSKLNTKIMQINSEKHIIRANITE
SQLEHIKANQDVNVTRNHSKLFTGKILSIIQIPYKVEKGESIYQVDISTQDQYPLGRHFD
IDVGTSKIELPISSIYDNYYVLITQNNKIIKRRIEYTKSQKNGYIMVSNGLNIGDKVIVN
PSSSLLQK
>SEQF2892_00361 hypothetical protein
MAFLFILGIVAGMMVPIQTSINSRLGRYTESSFYASTISFFVGTLFLFILNMIFNPKLFD
GSFYSGHTIDYHWWVGGLLGVCFLTGNLLLLPRLGAALTVVMTVAGQIIMGVFIDTFGLL
GASNHSFTFLKVVGIIILFFGILLMNYIPKNKLQEKTNHMFYVWLIIGFIFGFAPPLQTT
INSGLAQQMHNSLFAALVSFTVGTLALFILTLIFNRSLKIKITHPDIGKIKPIHFIGGVL
GVVFVTSNIILMPFLGAALTTIVAMLGQMLMGVIIDHFGLGVRKNPITLRKFSGLIAIAI
GIILLRLF
>SEQF2892_00362 hypothetical protein
MSKTLELAFKTNLNKTAKLQFPQVNVAVSEADAKAAMDNIIKLNILQPTAGTPIKATSAK
LIDVTSTTLFETK
>SEQF2892_00363 hypothetical protein
MNEISQLSVVCTHITHDASGKAKETKRRFTNLNTKATDSEIRSFVNIIAHLINETFDKVE
VVKTQVLA
>SEQF2892_00364 Tyrosine recombinase XerD
MNQVEPIRNKDDIKKMYDVLKKKSDRDYLLFKLAIHTGIRLTDLLNLKVKDVKMIDQDEI
KSSWIESCAPAIKILLPNDLREEVRRFIEYNKLMDDHLLFQSIRTHKELSRQQAYRIIHH
AAEELGLCHIGLTTLRKTFAYHAYQSGISIAIIQKYLGHQTTQETVKFIGLSADDELHTI
IALNL
>SEQF2892_00365 Na(+)/H(+) antiporter subunit A
MSLVYLLGGLIVIMLVVLMTLFIKPLRRFAGYVALLAPILASGYFLAQIPNVLHGKFVEF
KIPWMPAIDVNLDFRLDGLGLMFGLIISIIGVAVFFYATQYLSVNRDNLPHFFLYLLLFM
FSMLGIVVSNNTILMYVFWELTSVSSFLLISYWYSNAESQLGAIQSFIITVLGGLALLTG
FIMLYIITGTNTISELLTQSHSISEHALFIPMMIMLLIGAFTKSAQFPFHIWLPKAMAAP
TPVSAYLHSATMVKAGIFLLFKFTPILGLSDSYIYIVTFVGLTTMIFGSVTALRQYDLKG
ILAYSTISQLGMIMSMVGLGGGIAQHSSGPMAETYTLILFAGLFHLMNHAIFKCALFMGV
GIIDHEAGTRDIRRLSGMRKFFPKMNLVMTLAALSMAGVPLLNGFLSKEMFFDSLVSAIE
LQQFGLTLTIIVVAIGVIASIFTFVYAVYMLKETYWGEFDEKKVPKKHIHEPWLFSLPAI
ILMVMIPIIFFIPNFFTEHLVLPALRNVTNLGSSVDAIAPHVSQWHGVNLPLIFSVIVII
VGLILALKVNWKAITHQVIKYASITNSYRNVYRGFERYSGQMIRGLMNNRLNHYNIITVL
IFSILIAYGIFQVGLPKLHQIEVSEFGPLEVILGIMISVVGIALVFIRQRLTMVILNGII
GYSVALFFLLMRAPDLALTQLVVETITTTLFIVSFSRLPNIARTTANMKKETIKIIVSFI
MAGAVVTLIFIAQQGDGLESISKYYTNAYELTGGKNIVNAILGDFRALDTMFEGIVLIIA
GLGIYTLLHYKDRRGQDERK
>SEQF2892_00366 Na(+)/H(+) antiporter subunit B
MKENDVVLRTVTKIVVFILLTFGFYVFFAGHNNPGGGFIGGLIFSSAFILMFLAFDVHEV
LESLPIDFKKLMIVGAIISALTAIVPVFFGKSFLYQSEAYIHFPLLGELHVTTITLFELG
ILLTVVGVIVTIMLALSGGKS
>SEQF2892_00367 Na(+)/H(+) antiporter subunit C
MNLILLLVIGFLVFIGTYMILSLNLIRIVIGISIYTHAGNLIIMSMGHYSNKMTEPLIHG
SNTNYVDPLLQAIVLTAIVIGFAMTAFLLVLVYRTYRVTKEANIDVLRGEEDENEQ
>SEQF2892_00368 Na(+)/H(+) antiporter subunit D
MNSNLLVLPILLPLLCALVLVFTKEKNRLSKILYIGTMSVNTVISLCLLIYVLQHKPITL
DFGGWAAPYGIQFLGDSLSLVMVTVASFVVTLIMSYGFGRGEDRVNRYYLPTFILFLTTG
VIGSFLTSDLFNLYVMFEIMLLASFVLVTLGQSVEQLRAAIIYVVLNIVGSWLFLLGIGL
LYKTVGTLNFSQVALRLDQIHDNKAIIIISIVFIVAFGSKAALVLFMWLPKAYAVLNTEL
AALFAALMTKVGAYALIRFFTLLFDQHTGVTHPLLVFMSCITMLIGAFGVIAYRDIKKVA
SYQVILSIGFVILGLGSNTFAGVHGAIFYLANDIIVKTMLFFIIGSLVYMSGYREYKYLC
GLAKKEPFFGVAFVVMIFAIGGVPPFSGFPGKVLIFQGAIENGNFIGLALMIITSLLAMY
SLFRILFIMYFGDNDGEQVDFNPLPKHRKTILGILVAVVLAMGIAAPVVMNATENATKLN
MDDNYFHSIVNSHLKEGNK
>SEQF2892_00369 Na(+)/H(+) antiporter subunit E1
MRQVVLNILIAFLWVLFQDEDSFQFSTFVSGFIIGLIVIYILHRFFGQAFYPKKIWIAIK
FLGVYLYQLITSSISIINYILFKTRHMNPGLLTYETNLKNDWAITFLTILIIITPGSTVI
RISKTTNKFFIHSIDVSEKEKESLLKSIKQYENLITEVSQ
>SEQF2892_00370 Na(+)/H(+) antiporter subunit F1
MIETLTNFFITSALVLFGIAFIIGLFRLIKGPTTADRVVAFDASSAVIMCIIGIVSVIYN
TVSFLDSIMLVAIISFVSSVSISRFIGGGRVFNGTNKRNH
>SEQF2892_00371 Na(+)/H(+) antiporter subunit G
MAQINEIIELIAALLIFLGSIIAVISAIGIVKFQDVFLRSHASTKSSTLSVLLTLVGVLI
YFTNEQSFFSVRLLLSIVFINLTSPVGMHLVARAAYRTGAYMYRKDDAPSRSSILLSSKE
YNSTEELKNRARIREERREKIYYDVQKQRQKEKQQEENIESLSEARRETKD
>SEQF2892_00372 hypothetical protein
MNKFKLVLLICSFLLMIATLFFWTLFLPPLSELEGENALAQMVVFVPSIIAYPVLFPIIW
LLEIFYLFTTKHWSYMDLLFLLLSLVTPILLLVVHFIIATSPIPFLLLYIYLSILTMLMT
LVSYINLKK
>SEQF2892_00373 hypothetical protein
MKISWIFWWIISVFEVLSFFGFAFLLWQRSVDAAGVIQTTEVKWINIAVLGLAYLIPFLI
QIVWLIINLIYSKRKQVTI
>SEQF2892_00374 putative succinyl-diaminopimelate desuccinylase
MNTFSEKEKLKLLSDIVEINSVNDNEIEVATYLKDLFEAHHINAEIDVIEGKRANLIATI
GSGSPVVAISGHMDVVSEGDQNDWDYPPFQMTEKDNRLYGRGTSDMKSGLMALAIAMIEL
KENDALPHGTIKFMATAGEEKEQLGSAQLYKKGYMNNVDALIIAEPSETNIVYAHKGSMD
YKITSKGKAAHSSVPVVGFNAIKPLIQFIQDIDTEYDRISKELNSEKLDFSHLIKRIQSQ
LQQENNLDEEEVERVISGLVISNTILHGGNQVNSVPDTATAEFNIRTIPEFDNEKVKSLF
KTYLEEVNKQGGQLEEDLYLDLDPVLTTGDNPLIKIGQRVAKQIFGEDIVASPTVGVTDA
SNLLRDKDEHFSFLMFGPGTAPHQINEYVEKEKYLRFIDYYKELLITYLNEYK
>SEQF2892_00375 Sodium, potassium, lithium and rubidium/H(+) antiporter
MEIFETILIFLAVVIVSSFVHTFLPKVPLAFIQIALGMLLFLTPVPVEFNFDSELFMVAT
IAPLLFVEGVNVSRAHLRRYIKPVMLMALGLVITTVIGVGLFIHWIWPTLPIGAAFAVAA
ILCPTDAVAVQAITKGKVLPKGAMTILEGESLLNDAAGIISFKIAVGVLITGSFSLFEAV
QQFLIASIGGAIIGLLIGIALVRFRLTLTRRGIENINMFTFLQLLTPFVTYLVAEMFHAS
GIIAAVVAGLVHGFERDRIAQTRTRLQMSYNHTWNILGYALNGFVFSILGFLVPEVIGNI
VKTEPHNLLFLVVITALVALAVYLFRFIWVYVLYPLFYLSVSPFQKLMNEEGEDKKKEKP
PKRSMYALIMTLCGVHGTISLAIALTLPYFLADHHAFTYRNDLLFISSGMVIISLVIAQV
VLPFVTSSAPKAKIGSMNFKEARIYILEHVIDYLNHHSSFETSYRYGNVIKEYHDKLTFL
KSVEKDDENSKELERLQSLAFKVETKTLERLADDGEITASVLENYMRYAERTQVYRQASL
IRRMIVGARAVLLKRRIRTRTNAASSLSVTDNLMELSKINKIVHYNVVSRLVDEANEDNK
LEVGMICDGYLMRIDNLSPSNFFNTRAEDSITKIKLNALREQRRVLSSLTDDGEITESTA
LKLREAINYDEMVIVDSLTD
>SEQF2892_00376 Iron-dependent repressor IdeR
MLTEEKEDYLKAILANEGDTSFVSNKKLSQYLNIKPPSVSEMVGRLEKAGYVETKHYKGV
KLSDEGLKHTLDIIKRHRLLELFLIEVLQYNWEEVHQEAEILEHRISDLFVERLDKILDY
PETCPHGGIIPRNQHFEEKFTVSLLEFEPGDKVTIKRVRDKTELLVYLSSKNISIGNDVE
IVTKDETNKVMILKRNDIVTILSYDNAMNIFAEHV
>SEQF2892_00377 hypothetical protein
MVYLENFFTTTINLNIYLICIIAIIYIMIHQNRHRQFNQYLDVYLNYIPVLTHEFGHVLF
NKISGGRAKDLVIVTRPSERLQTMQQGYAITQSKGLIGQFITTLGGYIMPPLILLIGLSA
AYYGHPSLFLSAYIIIFIYFLILTSRKLSPIIVLILFIALLYFLVQHDNQLLFYYLVTFI
YHLILGVLLGEVLQSSWTIFKLTFQRPIPSWDGRTLTELTRIPTFLFSTLWIAINIFTIY
LMLIFTI
>SEQF2892_00378 N-acetylglucosaminyldiphosphoundecaprenol N-acetyl-beta-D-mannosaminyltransferase
MHDQKETTATKVDILGVQFNNVTMLDMIEHVKTFFTQETEDNLFIVTANPEIVDYASEHS
TYKQLINSADFVVPDGTGVIKASNRLGTPLKRRVPGIELMEHCLKIAHTNYQKVYLLGAK
NEVVTLAHKNLQHKYPQAQFDYHHGYIDLNDETVIKRIKRFDPDYIFVGMGFPKQEEWIQ
KHRHTFKRTVMMGVGGSFEIYSGTKKRAPKLFIKLNIEWVYRLLIDWKRIGRMRSIPKFM
FKVFKVQRKMKKKK
>SEQF2892_00379 Teichoic acids export ATP-binding protein TagH
MSVSVNINNVTKEYRIYRNNKERIKDALIPKNKNNTFFALDDVSITAHEGDVIGLVGING
SGKSTLSNMIGGSISPTSGNIERNGEVSVIAINAGLNGRLTGVENIEFKMLCMGFKRKEI
KQLMSQVIEFSELGEFIHQPVKNYSSGMRAKLGFSINVTINPDILVIDEALSVGDQTFTQ
KCLDKIYEFKEANKTIFFVSHNIRQVREFCTKIAWIEGGKLKEYGDLEEVLPKYEQFLKD
FKKKSKADQKAFRKGLDEKRFIVK
>SEQF2892_00380 Teichoic acid translocation permease protein TagG
MKAWLISMSAVGSVFKEHIKNFYLVQRLAQFQIKITNTNNYLGVAWELLNPALQIMVYWF
VFGMGIRSNQPIHGIPFIYWLLVGISMWFFVNQGILEGTKSVSMKFNQVAKMNFPLSIIP
TYTVTSRFYGHIGLLLIIIGICIVNGIFPSIHIVQLLIYVPMTFFFTASVALFTSTLGII
VRDTQMIMQALLRILFYMSPILWVPKDSGIGGTIGEIIKFNPVYFLAESYRAAILFHEWY
FIEHWKLLLYNVIVILIFFVLGSILHRRYRDHFADFL
>SEQF2892_00381 Teichoic acid glycerol-phosphate primase
MRLIIKKVYMLMITLLNFIYKRRQVDKKQITVLMTFPEDVMPIINELDNKGYKITVIAKF
EEHYRLEHLNNINFIPAGNKYIVKHIKALSSSKVILIDTYYLMLGGYTKKKAQTIIQTWH
ASGALKNFGLTDHQVDLNNVTMVRQYQRVYQATDFYIIGGKEMGTCFKESFEATEDQLLP
LGLPRLSQYLKFNLKAEQERLKKHYNIHKKLVVYVPTYREGSENNRQIDVARFEEALPEY
TLINQLHPSISKSQSIATTQELMIMADVIISDYSSLPIEASLLDKPTLFYVYDEHKYDKI
RGLNQFYKAIPQQYKVTTEEELILKIRNDIALFKPLFKNWHKYNREDSVRRVTEFIEKMV
KR
>SEQF2892_00382 Putative glycosyltransferase TagX
MKIAIIIPVYNAEKTIRRAIKSIDTTHEVEIICVNDGSTDHSRHELTQLQKEVKNIMIYN
QDNQGAAASRNFGLAAMSDDVEAFMFLDADDQFLPGRLDKMIDYYERNQEVDIVIGQIGR
GVQGDWKIIPTHEEINRESLVSLAEAPEILQSIGPGGKLFNSKFSALRFDEDVVFCEEHT
FVTRAYLTARDIQLLPLIIYGYNEQEGSITDKRADTFISYIEDARRVRQRVMEMLLLTNE
KAYYSYRMDDLIVSYLIQSYLLKCSKVTPEFIDKVTHYIKDMQHTNYSGDALFRIIQAVE
QGAKNWTRDTYEKWRQTLIDVGIGRPGYFRFQAQVMPKKFAFSSKQLVKRTLKR
>SEQF2892_00383 Glycerol-3-phosphate cytidylyltransferase
MRRVITYGTYDLLHYGHIELLRRAREMGDYLIVALSSDEFNQIKNKKSYYDYEQRKMMLE
SIRYVDLVIPENDWGQKEIDVDRFEVDVFVMGHDWEGEFDFLKDKCEVVYLKRTEGISTT
KIKQELYGKDSK
>SEQF2892_00384 D-alanyl-D-alanine carboxypeptidase DacA
MKRSLIITFALLLTIVIIAPNSYASEYEPTPTEIARQYGYPNVTDAYQPEGSINVSQTGQ
ILYDYQSNQKWYPASMTKLMTMYLTLEAVNKGELSLNDKVHITDKHYRMSTLPELSNTKL
YAGETYTISELLQITVSNSSNAAALILADEVSGNVNDFTDLMNKKAKALGMSNTHFVNPT
GAENKQLKEFAPSKYKNQDNTTSTAKDFAILDHHVIKETPKILHFTKQLAPTQHGVTYYT
FNHSLEGAKMSLLGTDGLKTGSSDVADYNHTITTKRNNFRINQVIMGAGDYVNLGGEKQR
NMMGNAMMNRSFDQYSYKKVLSKGTHKINGKKYYVKDNLYDVVPEGMNKKDYKFIVKDGS
IHLDYNRQFLTKDDGPPKVEVTKPLLHKANTIAQTTWKEHPVVTFVALALLAIAFILIVR
SFIHLLFKRK
>SEQF2892_00385 Multidrug resistance ABC transporter ATP-binding/permease protein BmrA
MKGQNPLFFLFKRLSWPYGLIIAAIIISSLGSISGLLIPLFTGRLVDKFSTSTINWNIVL
LFAGIFIANALLSGIGIYLLSKIGEKMIYDIRSILWEHIIKLKMPFFDKNESGQLMSRLT
DDTKVINEFISQKLPQLLPAVITLIGSIVMLFIMDWQMTLLTFIAIPIFMAIMIPLGRKM
QKISMNTQTEIANFSGLLGRVLTEMRLVKVSNTERQELNNAHSNLREIYNLGLRQAKITA
VIQPISSVIMLLMIAVILGFGAIRIATGAITAGALIAMIFYVMQLSMPLMNLSTLVTDYK
KAVGASSRIFEIMQEPIEPMEDLQPIEDISIYDGELSFENVDFKYDIKTILSNVSFRIPQ
GEVSAFVGPSGSGKSTIFNLIERMYDIESGDIKYGTQSIYDVPITNWRNKIGYVMQSNSM
MSGTIRDNILYGINREVSDEELVKYAKLANCHDFIMQFDDGYDTLVGERGLKLSGGQRQR
IDIARSFVKNPDILLLDEATANLDSESEQKIQEALEILMEGRTTIVIAHRLSTIKKAGKI
IFLDQGKVTGEGTHAELMQNHEKYHQFVTTQNLTE
>SEQF2892_00386 hypothetical protein
MLYTITSTLPPTHGGRTKSLLHRVKFLETQLGEISTILTTNYNANYKNVYRIFRNKELIT
ENTKLDNLYDWLANYNLLE
>SEQF2892_00387 Glycosyltransferase Gtf1
MKFEDTINPNSQKVSKRKAFTLNGRLHKIDYFDDVTAIKTKEEYYDKKGDVYLKKHFTND
EENKLIDIEHLTKRGETRTFNNEKALFTYYYNHVLPNGSVVFNDARLLDRPLIDCENDIK
RILMFHSNHIQGNKVRHSYKLAFDKQEIIDKYIVLIEYQKHDIQSQFGIDDNKIEVIPHF
VSIAQSNRRDEVEDQFCFIGRLAQEKQIDHIIKAFDIYLKKRLFI
>SEQF2892_00388 Poly(glycerol-phosphate) alpha-glucosyltransferase
MLVYGKDKEGNLNTLKQLVKTLQLEDKVIFKGHTNHPKEVFSKVIASLLTSRYEGFGLSI
MESINYGCPVISYNVRYGPSELITNHENGILVKKDDIEGFADTMEMARNIHFKDVKLSEK
FSVEQASNNYQSLIDDVTHAENK
>SEQF2892_00389 Teichoic acid poly(glycerol phosphate) polymerase
MNKLSIIITYFNNEDYISECIHSLKSQRNQDFDIIVVDDGSTDRSTEILQEALKSYDKDV
HFIQLQENTGHAHARNVALEQAHGQYVLFLDADDQLASYAVDYYLQHVNGLDTLIAPIHK
FRSQRPQYVDKDKVRLQYASHQKSPNAILRKESACNILFKNAIIKAHQIQFNESLDIYAD
TSFVLEYLKYAERFVRITNFPFYYRGEVYDPFYGNTLSDQDFTNKFEDHVNSFFDAMQRT
NDKRIKNFLIQRMKNEIKSGFDPALRDIKSRYVSLEDALIKIVKALKWNILKDGKVLYNL
EILFLSMDDVENAKYVNDLRNKTRLVKNIVLNSKMKERSKYQLSDNEDLVDPNTIVFEAF
GGKNYSDSPKYIYEYMQKHYPHLNYIWVFSKPENNNIPGNATKVKKGSQAYYDAYAKAKY
WVTNARLPLYLNKKENQMYIQTWHGTPLKRLANDMKVVRMPGTTTANYKKNFYAEASRWD
RLVSPNRYSSDIFKSAFWMDEDRIWEIGYPRNDVLVNRQNDTEYIEQIKRDLNLPADKKV
IMYAPTWRDDEFVKKGQYLFDLKINLANLQKEIGDEYVILLRMHYLIANALDLHGYDDFA
IDVSNYNDISELYLISDALITDYSSVMFDFGILKRPQFFFAYDIEKYDKGLRGFYMDYMN
DLPGEIITDEFKLAEELKQIDQHKVKYQDKIEAFYNDFCSIENGKASQYIGDYIYNDIEK
NS
>SEQF2892_00390 Purine nucleoside transport protein NupG
MFLLVNIIGLLAFLGIAVLFSRDRKNIQWKSILILVVLNLFLAWFFVYFQIGRTIVEGLA
SAIAWVIQSAHTGTGFAFSSFTSGKQMDMAISALFPILLVVPLFDVLMYFNILPKIIGGI
GWVLAKITRQPKFESFFGIEMMFLGNTEALAVSNEQLKRMNEMRVLTVAMMSMSSISGAI
VGAYVQMIPGDLVLTAIPLNIINAIIVSSILNPVSVEEQEDIIYSIKNNETVKRQPFFSF
LGDSVLNAGKLVLIIIAFVISFVALADLIDRFINLITGLVGGWIGVKGSFGLNQILGLFM
YPFALLLGLPWGEAWIVAQQMAKKIVTNEFVVMGEISKVVDSYSPHRRAVISTFLVSFAN
FSTIGMIVGTLKGIVDQKTSDFVSKYVPMMLLAGILVSLLTAAFVGLFAW
>SEQF2892_00392 hypothetical protein
MYKNYNMTQLTLPMETSVLIPTNDISRHVNDIVETIPDNEFDEFRHHRGATSYHPKMMLK
VILYAYTQSVFSGRKIEKMLNDSIRMMWLSQNQKPSYKTINRFRVNPKVDALLESLFIQF
YSQCVKQNLIDDKAIFIDGTKIEANANRYTFVWKKSIQNHESKMNEDSKALYHELVTNKI
IPEIKEDHDNELTKEEIDLIGSHLDKEIEDLNQHINNEKCTKTRKQIRLKRTKIKKYKKQ
INDYFERKYRYEFQKSILKDRNSYSKTDHDATFMRMKEDHMKNGQLKPGYNLQIATNSQF
VLSYNVYQNPTDTRTMIPFLNSIQETYGHLPEYIVADAGYGSESNYKAIIDDFNRTPLIT
YGMFIKDKTKKYKSDIFNTQNWNYDEINDEFICPNNKRLGFKRYAYRHDKYGYKRDFKLY
ECDDCSECPLKNQCMNFNSKTNKKIMKNYNWEYFKSQINKKLSEPETKNIYSQRKIDVEP
VFGFMKAILGFTRMSVRGLNKVKRELGFVLMALNIRKVVAQRAENNQKIYKKDNFYIISI
EIVFFSLIQELYVPDSWFLWEMNINVLVTVRTRYCHSTSSKICFVTINNTKEITSLIKKL
YTL
>SEQF2892_00394 hypothetical protein
MYVNKNIKDLLLVILGSFIFSAGVNAFIISGNLGEGGVTGIAIVLYYAFHISPAITNFVA
NALLIIVGYKFLSKKSMLLTIVATVLISVFLSLTESWHVETGNVIINAIFGGSCVGLGIG
IIVLAGGTTAGTTILAQIANKYLDVSTAYALLFFDLIVVLISLTVLPLQMALVTVISLYI
GTKVMEYVIEGLNTKKAMTIISSKPDQVAKAIDEQVGRGLTILDGRGYYSREEKDVLYVV
VAKTQVSRAKKIIRKIDNQAFLVVHDVRDVYGNGFLVDE
>SEQF2892_00395 Ferric enterobactin transport ATP-binding protein FepC
MNRLKAQQVEIGYGDHSIINNLDVEIPDGKVTSIIGPNGCGKSTLLKALSRLLTIKNGEI
QLDGQNIHTQSTKEIAKKIAILPQTPEVADGLTVGELVSYGRFPHQKGFGRLSAEDKKEI
DWALNVTGTSEFRHRSINDLSGGQRQRVWIAMALAQKTDIIFLDEPTTYLDISHQLEILE
LVQQLNKEQGCTIIMVLHDINQAIRFSDHLIAMKKGEIIACGATEDVLTKDILEKVFNID
VVLSTDPRTGKPLLVTYDLFERNYS
>SEQF2892_00396 Iron-uptake system permease protein FeuB
MMEKDKKVNIGFIGYIILVFVLLISALLVSILIGEAKISFSTIMDAIFHYNPKNQQHNII
SEIRIPRDLGAVLVGMALSVAGAVIQGVTKNGLADPSLIGLNSGASFALALTFAFYPAAP
FLMLMCAGFLGAMLGGFIVLTIGRSRRDGFNPMRIILAGAAVSALLTALSQGIALTFKLN
QTLTFWTAGGVSGTTWKQLMWSGPVIIIAIIIIIAMSKQLTILNLGETLAKGLGQNITLI
RGVSLFLTMILAGVAVSMVGQIAFVGLMVPHIVRFLVGTDYSKVLPLTALTGGLLMILAD
TVARMLGEAPVGAIISFIGVPYFLYLVKRGGRTI
>SEQF2892_00397 Iron-uptake system permease protein FeuC
MIHPKLRRKQIVTLVIFSILLLAACTWSVSSGEYKIPVDHFFKTLIGQGEYYDQLILMEF
RFPRMLITILAGAALSLSGAIIQSVTKNPIAEPGILGINAGGGFAIALFISIGQINPDNF
VYVLPVISVIGGVATAIVIFLFSVNKKDGITPSSMVLIGVGMQTALYGGSITLMSKFNED
QSEFIATWFAGNIWGDDWTFVIATIPWLIIIIPFLLYKSNVLNLINTHEHIAKGLGVKIE
KERVVLFFIAVVLSSIAVAVAGAIAFIGLMGPHIAKSIIGPRHQLFLPISIIVGAFLLVL
SDTIGKVILEPTGVPAGIVVAIIGAPYFIYLMYKSKSI
>SEQF2892_00398 PTS-dependent dihydroxyacetone kinase, dihydroxyacetone-binding subunit DhaK
MKKLIKQKENFLKDMLDGLKIANNYIEIIAETVVVRRKKKSKGVAIVSGGGSGHEPAHAG
YVAQGMLDAAVCGEVFTSPTPDKVLEAIKAVDTGDGVLLIVKNYAGDVMNFEMAQEMAEM
EDIQVEMVVVKDDISVSEETQRRGVAGTVCVHKYVGYLAEQGLALQEIKEKAEALVSQIK
SIGMALTPPMVPTTGQYGFDINDEDIEIGIGIHGEKGIERIHYEEIDSIVERLLSRLLKE
NQEQSLIVIVNGMGGTPLSELNIVTKYCSLYLEKQNRDVAQWFVGDYMTSLDMQGFSITL
LPNNEELLKALQAPTTSRYF
>SEQF2892_00399 PTS-dependent dihydroxyacetone kinase, ADP-binding subunit DhaL
MDVKDMKQRLLNLEAVFSEKETLLTDLDRAIGDGDHGVNMLRGFKSLKDKIDDSSMSSLF
KSTGMALMSNIGGASGPLYGFSFVKMANVVNDEMDKENLKAVVTEFANAIAQRGKVQRDE
KTMFDVVDRAREALENDETITSEILQQFATDTKEIEATKGRAAYFKKDSIGYIDPGAQSM
VYVLSALIGDDIE
>SEQF2892_00400 PTS-dependent dihydroxyacetone kinase, phosphotransferase subunit DhaM
MTTIIIISHSEDIANGTKALLNQMAQDVNVVAHGGVDGGIGTSFDDIQNIINNLDDDALC
FYDLGSSEMNLDLAIEMYEGSHHIKKIDAPIVEGSFTAAVKLSVGGTTDEAIKEVAQTSF
KENTFD
>SEQF2892_00401 hypothetical protein
MQNSIKEYVLSGEFEQVRQLMAKADFLDFEEAYISCAHENESMMFYTCILDMIKFEETSE
LHDLAFLLLVYPLSEIEGALDSAYYHAQASIQLTNGKEIKSLLQMLLLHAIPEPVITDSE
AFKVAKQILKLDPSNHVARNALKETAKRMDNVVVDINELQQYGNSN
>SEQF2892_00402 hypothetical protein
MGLNKEAVKIGFAYVGIVVGAGFSTGQEVMQFFTPYGLWSYIGVLISGLILGFIGRQVAK
IGTAFEATNHESTLKYLFGEKFSKIFDYILVFFLFGIAVTMIAGSGSTFQESFGIPTWLG
ALIMTIVIYLTLLLDFNKIVRALGIVTPFLIIMVILIAIYYLFAGSVPLNEVNSTVDKTS
VFWGIVRGLMYGGLAFAVGFSTVVAIGGDASKRKISGGGATFGGVIYTILLALINFALQS
EYPKIKDVEIPTLTLANAIHPWIGLVLTVIMLTVMYNTILGLCYSFAARFTEPYSKKYHI
FIIIMMIAAFILSFVGFADLINFLYNIMGVVGLFIVVAVLIKYYVRKSDNKDHIA
>SEQF2892_00403 Acetyl esterase
MNTQKKWTIITGVIIVIVSVVVAWGLYHHQQESEKKKQQREKVQINNPNVKLFQNITYNN
HLPGSQLDIMMPDDVDKDTKLPVIFWMHGGGYVAGDKQYKNPLLSQIVEQGYVVVNVNYA
LAPNYKYPTPLIQFDDAIQFIKHNKDRFPIDLDQVVIGGDSAGAQLTSQYVAMQTNSSLR
SEMGFEQRFTPSQIKGAIFFGGFYDMKTVRETEFPRIQMFMHSYTGATKWESEFKNISQM
STINQVTKDYPSTYLSVGDADPFYSQNIEFYRKLKEEGIPVSTLFYDGSHHLHHQYQFHL
EKPESKENMKRVLAFLSRNTSSSGVEQNQQSPFDGSTSSDKSFSLSPY
>SEQF2892_00404 hypothetical protein
MAHIIREISIKDVEDFIKLLSKIYDESEYTLYNPGEYTPSISSVSDRLERIITSPRNTVY
VAEQDDQLVGYAFITTEDFERKRHEAVITIGVRQLYQKHGIGMALVNATEAWSINHDIRR
IEASVVPENARAVELFKAAGFNIEGELKDKLYINGQYFNKYVMAKLLI
>SEQF2892_00405 hypothetical protein
MKPNVLLAGGSGYIGKYISSVIEKDANIYALSKYPNTKKEDNDRIIWLKRDIYNYTDVVK
AMEGMDIAVFYLDPNKNSAKLTQATARDLNLIAADNFARAAAQQGVSKIVYISGSRFDIE
TVQRLENYGVPVEKTNTQIKRPHINAELQMSKYDDIRTAMRMILPRKWTLSYLVDYFMKW
LNDTRGTFMHTYQDNDRYIVYARKKSKPLLIMEKVEDDSGLITLHLISGSMIKSNQKKQG
KLEFRQIKGTRLVIVHLYDYIPKLLWPIYYFVQAPLQGLIMRGFEIDCRIKHFNGRVQSG
EKMKYTK
>SEQF2892_00406 Response regulator protein GraR
MQVLLVEDDQTLFQELKKELEHWDFFVTGIDDFSAVMDIYEETNPEIVIMDVQLPKYDGF
YWCRKIRQVSNVPILFLSSRDNPMDQVMSMELGADDYMQKPFHTNVLIAKLQAIYRRVYE
FGAEEKRTLNWQDALVDLSKDSIQKGDSVIYLSKTEMIILEMLIQKQNQIVTRDTLITAL
WDDEAFVSDNTLTVNVNRLRKKLSDIGMDTQIETKVGKGYMAHE
>SEQF2892_00407 Sensor histidine kinase GraS
MSNLKWFWLFLKTRSNWIFWIVFLHLILLGMAYIDYDISIESIGFIVTLNLGLTAMFLIF
TFLKEVKLYQHLYNNKEIEEIKHKDLAEDPFQKEVVNYLYRKLTSQKERVVEQQLHIQST
EQSLTEFVHDIKTPVTAMKLLIDQEEEGKRKKSLLYEWARINELLDKQLYLTRLESKNRD
MYFEETSLKRLVIDEVQLTRHISQAKGIGYDLDLETNLDVYTDVKWCRMMIRQILSNSLK
YSQGQDIIIRSYTNDGHVTLEIKDFGRGISHKDLPRIFERGFTSTANRNETTSSGIGLYL
VNSVKDQLGINVRVESTVGQGTTFVLTFPKQNELMARMTQVTTM
>SEQF2892_00408 Bacitracin export ATP-binding protein BceA
MAILQAKQIAKTYGNKQTEQEVLKDIDLSIEAGEFVAIMGPSGSGKTTLLNVLSSIDYLT
HGSIILDGQQLEKLSNKALSEIRKKDIGFIFQEYNLLHTLTVKENIMLPLSVQKLDKKEM
NERYQRITQALNIFEISDKYPSDISGGQRQRTSAARAFITYPKIIFADEPTGALDSKNTR
DLLQRFQKINELYNATIVMVTHDPLAASFSERVIMLKDGQVFTEIYQGEDDKNVFHKEIL
RAQSILGGMMYEF
>SEQF2892_00409 Bacitracin export permease protein BceB
MSFSQIIWKNFQQNIIHYAIYIFSLVLSIVLFFSFITIKYVHHLNVHQSLSMIQQGTQVG
SYFLFIIIVVFIMYTNMLFIKRRSYEFGLLQTIGLGKKSIIYMLMLEQLFIFIITALLGM
IIGILGSKILLMIVLKLLGIHTSVSITFSFQAIAQTLFILVIAYILIIIQASIYLSKSSI
KSLMASQDSKEDSHITLTLGEVILGVLGIVLILTGYYLSTRFVEIVDDVILPFVILILTV
LGTYFFFRSTISLILKTIRYLKGGNVSVNDVIFTSSLMFRIRKNAFSLTVMAIISAITVS
VLCFAAISRGSLTNEILLESPHEVTLKEEKVANELGFELNRHHIPYHYDFKQVVYSQLYK
DHLFDKNQVQPYAITVTSEKYFPNVSIEKGEAHLIMPEGLIHDLSKHTPHGTASIGTKKH
HVNIKLNKVMDKIYFKQSIDLGGPTLVLNDTDYNYLKAHAKNKYIVSQYAFDLKHNRDIP
KLESITKDLDGNVQTRSEVVSEVSSLTGILLFVTSFLGIAFLIATGCIIYIKQIDETEDE
LESYSVLRKLGFIQKDMAKGLKLKVAFNFSIPLIIALLHSYFAAVVFMKVIGFDNKVPIF
VVMGIYTIIYSIFAVIAYNHSKRTINHSI
>SEQF2892_00410 hypothetical protein
MFTKKKDKFMVQLEEMVFNLDRAAVEFGKMDFNTHLDLKAYSDNIKTYESHGDELMHQVI
TDLNQTFITPIEREDILSLCNAIDDVLDAMEETSAMFEMYSIEYTDEYMAEFVENIQKAV
AEMKLAVGLLVEKKLSHMRIHSINIKEFETNCDGILRQSIKHIFNSETDPITLIKIKDIY
ESMEEIADKCQVVANNFETIIMKNS
>SEQF2892_00411 Low-affinity inorganic phosphate transporter 1
MEYVLIITIAIVIFSLIFDFINGFHDTANAIATAVSTRALTPRTAIFLAAIMNFIGALTF
TGVAGTITKDIVDPFKLHNGLVVVLAAILAAIIWNLLTWFYGIPSSSSHALIGSIAGAAI
AAQGFGVLHYQGFTKIIIVLIISPIIAFCVGFIMYTIVKIVFKNANLTRANRNFRFFQVF
TAALQSFSHGTNDAQKSMGIITLALIVANIQDPTNVEPALWVKVACATAMGLGTAIGGWK
IIKTVGGNIMKIRPANGAAADLSSALTIFVASSLHFPLSTTHVVSSSILGVGASNRAKGV
KWNTAQRMIITWVITLPISALLAALIFWVMNIFL
>SEQF2892_00412 N-acetylmuramoyl-L-alanine amidase sle1
MKKLAVAASVATGAVAVLSNHNAEASTQHTVKSGESLWSIASKYNTSVDSIKKSNNLSNN
MIFPGQVISIGGSSNNSNNASSNATTSSSTYTVKAGDSLYAIASKNGVTVNALMEANNLS
GYLITPNQKLKIPNGSTTTPSKTNPSTNNNVGGSGGYSSPTFSHQNLYTAGQCTWYVFDR
RSQAGKPISTYWSDAKYWAGNAAADGYTVDHNATVGSIMQTTTGYYGHVAYVERVNADGS
ILISEMNYANGPYNTNTRTIPASVVSSYNFIH
>SEQF2892_00413 hypothetical protein
MFQSYNNTHHMKTKHRDKDRTRDYAKVWLFFMYYWIIFGIGCYFGQYLPMEWRRPLSIAL
LVLILATLFIQRARKYGLVISHIYAIIVGLLSYATFTTYMQNLGPEVFYKNVLLAIGAFI
VFGILGYFIINDASSIGKYLFVTLIALIIAGLIGMFIDNPIYHTVITVVGLILFLLYTLY
DFNRMKRGNFSPREMGFNLFINLLNIIKDVLRLANRFKN
>SEQF2892_00414 Multiple antibiotic resistance protein MarA
MSNTNIHILTKNEYKMTRCQDGIILLFPIEGQLILQHFTKTVNVENDIYVINNTDIFSIL
KNKKTIMLYIASDWFRDRHFDFFNYKYSTNLVKSINSIKRALLQLALNHLNADSVSEDTT
YITSVVDIIGKEGAIEKSIANHQYNFSFYGELSEILEYINQNITKKLTLTGIASKLFTSK
SNLSAQFNQLLNMGFKTYVDTLKIANSFEWLLTTEYTISLISEKVGFSSASSYSKTFKNY
VDMTPNEYRYCDRYEKSIDMDYENIIEGNIDYINQLIKIKQKYYNQHDEHIIYADSTIGS
TVNPYYLVIQINTIEEIRLLFFQDFARPLYYEHSTLKFYLNVDMRDIKDQMTKYERQRLF
EYIIINELNVVFRLEDLTLTDFLESNFEDVANYFREHQLPTSGNHKLGLVFDLDEVNLKS
IYRIILKIQHKTQQFSFGLEISKLLNDPVLFKTLESQIKRINFEFLYIDNAQLKMPYLIE
QNEHLLVKNILRYQNIRQILKQFDLEDQKIIFLNFENHKFLNSKYNDLNNSAPLLIETFV
RTASYFNGIGFNFKHSGNLFNALHIFDENGFKSILGAILEQLIEISMKPKLFNENYILID
DEDQYTVLIYDWRVLESESLQVNYDQTDIFIDFADDVLKDTYLVQIQLIDDYNGNINHLI
SQSIRKKHKWSKRFLRKLDYLIHPTFQMIEHNFNNAPLQIKLNYNALYIVKVLKNKIYSI
VFCTTIFNIVSKFDKNF
>SEQF2892_00415 HTH-type transcriptional regulator SarX
MNNDKLNKLLEFYKQYKALSEYIDKQYKLTLNDLALLKLAHEHIAKDQMLMQKFLKIAIS
ELELSRTKLLVSIRRLIEKERLSKVRSTEDERKIFIYMDEKNVKKFDALFNDVEEFLDI
>SEQF2892_00416 putative transcriptional regulatory protein
MGRKWNNIKEKKAQKDKNTSRIYAKFGKEIYVAAKSGEPDPESNQALRLVLERAKTYSVP
NHIIDRAIDKAKGAGDENYDHLRYEGFGPSGSMLIVDALTNNVNRTASDVRAAFGKNGGN
MGVSGSVAYMFDHTATFGIEGKSADDILEALMEQDVDVRDVIEDGDLTIVYAEPDQFAHV
QDALRQTGVEEFKVAEFEMLPQTDIELSEDDQATFEKLIDALEDLEDVQNVFHNVDLK
>SEQF2892_00417 hypothetical protein
MKKNADYWIKQLDLTPHPEGGYYKETIRETTNEAQRAPFSSIYFLLNTGDISHFHRIDAD
EVWYYHAGESLTIHMITPQGNYQSVQLGASIENGDVLQYLVPKGTIFASSLTDRKGYSLV
GCMCQPAFDFNHFELFTQDELYSMYPQHEAIIKQYALLNIDQ
>SEQF2892_00418 5-methyltetrahydropteroyltriglutamate--homocysteine methyltransferase
MTYRPFKADHVGSLLRPQRLKDARAKYNQNEISGAELKQIEDEEIDRIIEKQLEIGLHSI
TDGEFRRSWWHFDFLENLDGVEGYTPDHGLEFEGLETRAHNVRVVDKVRYNPNHPHFDHF
KFLYDRVNGRATAKVSIPSPNQLFHPNILNEDIYPNIEDFAHDISEAYRQSLQHFYDLGA
RYIQIDDVYWASLTDGTHKVRGRQRTDEEKVRARELAYKVVNDAVKGLPKDLILTTHICR
GNYQSTWAISGGYEAIAPYLFKEHLHGFFLEYDDERSGDFEPLRYFDKEAYAVLGLITSK
TPALEDKELIKQRIKEAQQYISLDQICLSPQCGFASTEEGNQLTEEEQWTKLKYVVELSN
ELLGSAN
>SEQF2892_00419 hypothetical protein
MKIKYIDKRHWRRLLERDYIEVKVNNNRFKGIIGLVTMKKVREPLEVTVVGQNIIVADDN
YQWLQILPEKKRYSITAMFDDKGNPLEYYFDINIKNITQKGNARTLDLFLDVLVLPSTGE
YELVDENDLKLALKNEQITKKQYHEAYMIAHQLMIEINENFDDVNNRIMYCYNKMVGKLK
KPNYNKTYKKHIQHHKPHVNKGK
>SEQF2892_00420 Hydrogen peroxide-inducible genes activator
MKIEDYRLLITLDETKTLRKAAEILYISQPAVTQRLKAIEHSFGVGIFIRTKKQLITTTE
GAMIIEHARDMLKRERVFFDKMQAHIGEVNGTISIGCSSLIGQTLLPEVLSLYNSQFPNV
EIQVQVGSTEQIKANHRDYHVMITRGNKVMNLTNTHLFDDDHYFIYPKERKSEVSKLPFI
EFQADPIYINQIKEWYNENLGQDYHATITVDQVATCKEMLVSGVGVTILPEIMMKNIDKN
MFEFEKVNIDNQPLIRSTFMSYDSSMLQLPQVESFVTLMLNFIR
>SEQF2892_00421 Sugar efflux transporter A
MFAALLHIKNYKLFVVNMMLLGMGIAITVPYFVLFATKELGMTTNQFGILLALAAVSQFT
VNSIVARFSDTHSINRKVLIISALMMGAISFSIYFYIHNIWLFIIVYAVFQGLFAPAMPQ
LYASARESINVSSSRNNAKFANTVLRSMFSFGFLFGPLIGAYLIQFMGYAGLFGGTVFIL
LFTLILQIFFYKDLNLSAKEQVGGTANIEKTAPNMLKDKTLFIPFIAFILLHIGQWMYTM
NMPLFVTDYLKEQEGYVGTLASLCAGLEVPFMVILGMLSAKLATRTLLIIGAISGGAFYF
SIGVFENIYAMMIGQIFLALFLAILLGLGISYFQDILPDFPGYASTLFANAMVIGQLLGN
LLGGAMSHWVGLENVFFVSATSIFIGMILIFFTKDQKYTEADVKVK
>SEQF2892_00422 hypothetical protein
MEVVLWILILLSFVLAFVGLIKPIIPSVLVLWVGFLIYQFGFSQDGLSWIFYVAMILFTV
FILVSDFLMNKYFVNRFGGSKLGEYAALIGVIVGCFVIPPFGIIIVPFIAVLIVELVQDF
DFGKALKASIGSVVAFLASSVAQALIMFIMVIWFFIDVFLVG
>SEQF2892_00423 hypothetical protein
MKSTAKLARENNVKSLRLNNTDREIFENYMTYIRADLRVNPHDSEVMLSRILKRLLEAEN
EGTLALEFFEHNPKAHAKKEIKSLPNETFQNIFKYIFRNFIFLIGIFCFFKGFIGFFIGG
DNNEVYLYTFPISVIAGLFIIFMFILVIFKTVQLQSFNNSHWVWLFNYTIIALLLVALFY
VFFIPQSFLAFGPYILISNWSFIIISAIITPIAFYIQHHFVNKDSNTIL
>SEQF2892_00424 hypothetical protein
MRKLTVKDMLWIESIAKIQEYYIEKRETHYNATHLSIGLRQDMIIQRLKHSNDIILIELS
EDTQRLISFIWGHFEAVQEKVITEMIYTDPHFRGLGHAKRLKIALENWAIEMGAKSIEGM
VDATNDAMIELNKANGYAISHVKMRKDLR
>SEQF2892_00425 hypothetical protein
MKKWLILLLSATLMLSACGKSDERASLEKDVKKLQKENDDLKNQKKDLEKQKEKLNDQRE
KLQKEVDDSVATESAKDDSESDESDSSDSNQSSDSDTYKQSKSQSTTENSTSSNETNTSE
TNGGSDSQQSNQSSNTQERQSNSGESDTSEQSSSDDTSSSSR
>SEQF2892_00426 hypothetical protein
MHEQDFHILEGREITLPELGREIENITGRTIVDSTGEIKRVVAHLPNFESDTDTFVATFK
LNHRNDFVDATFVAPKDQRDRLKEIPVHIELVSYISRG
>SEQF2892_00427 hypothetical protein
MATYIETERLKLRDWKQEDLLPFQKMNANPQVRRYFPSLLSYRRSELDMKKMDDIIKENG
IGLFAVELKETGEWLGFIGVNYIPQDSQYPFEELPLYEIGWRLIPEVWGNGLATEGATAV
LAFAKKKGIEAIYSFTAENNLPSRKVMEKIGMTLYDHFELPELSKYHMLKRQVRYYKQLS
I
>SEQF2892_00428 LOG family protein YvdD
MKRIAVYCGASKGKDPIYVKEAYELGKYMAEQGYELVFGAGSVGIMGAIQDGVLDHGGHA
IGVMPKMLDEKEITSQKVSELILVDSMHERKQKMAELADAFVMAPGGAGSLEEFFETYSW
AQIGIHEKPIAVYNLNGFFNPLQQLINSMIEEGFIDEKYKHLAPLYNSKEDLINGLLNFK
PLGIRTYD
>SEQF2892_00429 hypothetical protein
MTRVIIDGDACPVVDSVIELTTGTGIFVTILRSFSHYSNKVLPNHVETIYIDDGPDAVDY
KIVKLATPEDIVITQDYGLASLLLSKVKIVMHHKGHLYRSSNIDMLLQQRYNNAQIRKQG
GRHKGPPPFSKEDKKQFERAFKSVIKQL
>SEQF2892_00430 hypothetical protein
MDKKKIIKTAINVLPIIIVPLVVERKRIKSHPEVQKATHATSNAGQAIANKATGAKEYLG
DKKQEFDNKRELKKIAKENDPEYIQKKGEKLAKKNYKEADKMNKKLQKNIEQRHKEEEKE
REKNEKQRIKDMKKTQKYQEKVGLTPGKLDDETEKKGEKLEKDNKKDVNKLDKKLQKNID
KRHKEEEKLQKQEEKARIKEMKKFKDHEAESVVTQNKNEDNNKA
>SEQF2892_00431 Undecaprenyl-diphosphatase
MIIIEFIKGLILGIVEGLTEFAPVSSTGHMILVDDMWLKSTEFLGPHSAFTFKVVIQLGS
VFAAAWVFRERYFEMLHIGKYRNSSINEEFRSKPRRLNLLHVLVGMIPAGILGVLFDDFI
EAHLFSVPTVMIGLFLGAIYMIIADKYSKKVQNPKSVDQINYVQAFVIGISQAVAMWPGF
SRSGSTISTGVLMKLDHKSASDFTFIMAVPIMLAASALSLVKNYQYIELAHIPFYLIGFL
AAFIVGLIAIKTFLHLINKVKLVPFAIYRIVLVIIIAILYFGFGIGQGISG
>SEQF2892_00432 ATP-binding/permease protein CydD
MKKLMNLVFKYKVFPLSMGIVSMFLAITVVVQNISIASFLDRVLYNHLSSVNSLLIIILI
VLILRATLNMINLRLGDMLAGKVKHQLRREVVLKESTIATGTQINILTETIDGLSPFFKN
YLPQVFKSMMIPLMIIIAMCFIHLNTALIMIVTAPFIPLFYIIFGLKTRDESKDQMTYLN
QFSQRFLNVSKGLITLKLFRQTAHTKKQVYEDSTQFRDLTMRILKSAFLSSLMLEFISML
GIGLVALEAALSLVVFHNIDFKTAAIAIILAPEFYNAIKDLGQAFHTGKQSEGASDVVFE
FLDSENTPLTNQEIVKEQQESLIKMRNVNYQYPNSPSYAIRDISLKIDKGENVAIVGPSG
AGKTTLAKLLTQIVRPTSGHVSFNKCVNQIGMLSQNPYIFSASIKDNIAMFKKVDDDQIL
HVLEMVGLKEKVMSLKNGIHSRIGEGGEMLSGGQMRRIELSRVLLMNPDIVVFDEPTTGL
DLETETVIQQVVAQHFEGVTMIMIAHRDSTIRQATRRLFIKDGYLVEDDQTISVRLEKGG
DLV
>SEQF2892_00433 Lipid A export ATP-binding/permease protein MsbA
MKPQIRFRPDKDLILAILTGVIGSVVALAMFFLSGYMVTQSALGAPLYALMVLVVSVKLF
GFIRAIARYGERLLSHKTTFTMLRDVRVQFLEKLIPRVPNLYRQYSSADLLTKMISKVEA
LQNIYLRVFYPPVVIGFTAIIAAVTLVYFSVMHAIVIIISMFCSLWLVPWLSAKRVGKLK
QQVAQQQQTTITQFYDYKEGYAELDRFNNVEAYREDLMNALESYDKMQSKEARFLTLYDY
MLNIIAMIAIFATLALGFIQVKEGQLNVVYLTSIVLMMLTLFEQTVPMSNFAYYKADTDE
ALNSLNDVLSYPVDQSKQSLVTKQSNVYNIRNVSFSYEHQEIPTLSNINLTVGKGEKVAI
VGPSGSGKSTLLQIMSGLYDIDKGQVSLDGQNISQLDEDIRFEKLNVLLQSQQLFDGTLR
YNMFSSKNDDVIQRVLTSLNLGYLDLEKTITLDGNTLSGGEVQRIALGRLFIKGSSIWLL
DEPTTALDEDNTKQVMQLIDEQVETLVIATHDLKLLPYFDKIVVLIDGQIREQGSYDELS
HGNHYLSRLLKMN
>SEQF2892_00434 HTH-type transcriptional regulator MgrA
MSEQHNLKEQLCFSLYNAQRQVNRYYSNKVFKKYNLTYPQFLVLSILWDESPVNVKKVVT
ELALDTGTVSPLLKRMEQVDLIKRERSEVDQREVFIHLTEKSEKFKPELSDASQKVANAS
SLSNDEVHELNRLLGKVIDAFTESK
>SEQF2892_00435 Putative metal chaperone YciC
MINNKNEKVSITIVNGFLGSGKTTFLKHYIEQLLKKDEKITIIMNEFGSFDVDSLLLGND
VSIHSLINGCVCCDLNNDLVNQLKQLIDQTDTSHILIEATGLAHPFEIYSACQDPTIIKN
VHEPTIIGIVDAQRFTKKEVYSPSTTQLLEEQLRYSDTIILNKTDLIGEEALNEVKENLN
KLNPQAPIIITTYSQFNDEQINGKVIQHNEIQHKHIHHHGIQSMQYTFTAAIDRQLFYQF
IMRLPDSVLRLKGFVKFRDLPEVTYEFQYAMGLPDYGIIYKDVPMTIVIIGESLDTDRLR
NQLDMIQFT
>SEQF2892_00436 hypothetical protein
MNNEDKRTKQIRFEFRCITIPYTVFAIIVLLFNIFYTNIKVTMSLFGLFFAYNLGILFIA
FINRFKRTLILSLILTVLSGATFFTLLYVFGLNREIFG
>SEQF2892_00437 Inner membrane protein YbhI
MEKVQATQENNNLLKNKKGKKSKSGYKPIWIIISFAILLIILLLPTPAGLPIMAKGALAI
LAFAVIMWVTEAVTYPVSATMILGLIILICGFSPVQQLSEKLGNPKEGDKILSGADWLGT
GNALTHAFSGFSTSAVALVAAALFLAAAMQETQLHKRLALLVLSIVGNKTRNIVIGAILV
SILLAFFVPSATARAGAVVPILLGMIAAFKVSKESKLASLLIITAVQAVSIWNIGIKTAA
AQNIVATNFINQNLGHDVSWGEWFLYAAPWSILMSIALFFIMMKVMPPEHKEIEGGKELI
KEELDKLGPVSFREWRLIIISVLLLFFWSTEKILHPIDSASITLIALAIMLTPKVGVITW
KGVEKTIPWGTIIVFGVGISLGNVLLKTGAAQWLSDQTFGLMGLQHMPLIATIALITLFN
ILIHLGFASATSLSSALIPVFISLTATLHLGDQSIGFALIQQFVISFGFLLPVSAPQNML
AYGTGTFTVKDFLKTGVPLTIIAYILVIIFSLTYWKWLGLV
>SEQF2892_00438 Deoxyribodipyrimidine photo-lyase
MTIGVILNRVFRINNNPLFEYIHQNKEEIEKCYLIIPQEIFEEDGTNMKANYYYGVMQSF
LNDLRQYDIEPFLLDYSDLGDFCEDKSISEVIVAGDIMSYHQESFDIRHLKKAFNKHNIT
VTTVRANHYFKPSATMNKQGEPYKVFTSFYKAHRSKLRKHDSYAYKLKNLSDLFVKSQQK
LNQDYSKYGLSESKAIKKWNDYIDQDIQNYETNREYLPEVLTSQLSIILAYGIIDIKQIV
TQLIERYEEDEHNIEQFIRELMFREFYYVLMTHYPNTAHEAFNEKYRDIKWEYNKEDYKS
WCEGRTGFPIVDAAMTELNQTGFMHNRMRMVVSQFLTKDLFIDWTWGEDYFRRKLIDFDS
ASNVHGWQWSASTGTDAVPYFRMFNPSRQSERFDKDALYIKTFIPQLNDVTPKLLHEPFK
HEAELEQEGIKLGQDYPKPLVDHKEARDHVMSVFKQI
>SEQF2892_00439 hypothetical protein
MIWHIMILLIIIIALQLIIGHFFHKNGFSMTHSIILMLLPLGIGLYLVQIFYYERRYPKW
EVPLNVKLRLKYMYLVTFLEYVAVYICLFALK
>SEQF2892_00440 hypothetical protein
MTSRYIARIYFIILFTFSLFETRVFNFMSLNLFLAYIPFELCLLLRLFKPRKKYEWPLFI
IFGLIFVLLVPNTFYMLTDLIHLNQFTFDFYVQLNIMEWLYFTYLLLGVFLAMYCMILIF
INLMHFTSKLWINRTLIVVLMFLNGLGIYMGRFLRFHTVHLITEPFTIIRQVIASLNTQS
ITFILLMVLLQTVIIIFVKGVRVAK
>SEQF2892_00441 hypothetical protein
MKYNKDGQTFLLVLDKGEDIVEVLTQFAMEQEMKFGSVSGIGACDNVTLNFYNLDTQKYE
AREVNEALELTSLLGNISHIDDKPFAHLHGTFGTRDFQTLSGHLTKAVVSATAEIVIQMT
NLDVNRTHDEETGLNLLRP
>SEQF2892_00442 Tetracycline resistance protein, class B
MKKQLFTLYFNIFLIFVGIGLVIPVLPVYLKDLGLKGSDLGILVAVFALSQMIISPFGGT
MADKLGKKLIICIGLVLFAISEFLFAIGHHFPVLIASRILGGFSAGMVMPGVTGMIADIS
PAKDKAKNFGYMSAIINSGFILGPGIGGFLAEFSHRAPFYFAGTLGVLAFIMSLLLIHNP
RKETTEGFHSLEPEVFTKINWKVFITPIILTLVLAFGLSAFETLFSLYTAEKANYTPRDI
SIAIVGGGVAGAVFQVFFFDKFMKYMTELTFIIWSLLYSAIVLGLLILSHSYWTIMFISF
IVFIGFDLIRPALTNYYSNIAGNRQGFAGGLNSTFTSMGNFVGPLVAGALFDVNVEFPLY
MAIIVMLFGIVIIFVEKALQATRRRKHTTK
>SEQF2892_00443 hypothetical protein
MGKEMNLKNILLGMVAVILSLCLAFLLFIATNQNALAKVHQTISTFSKMSSVSATEKMLD
ITTSHTAKASEKNADERKMETHYNKIDSTSHDNANSNKHEYSSEECRIIAQNYTNHQYGK
VVNLERSGETNQDITYQLNPNHQSQSSNIAVNKTGKIEALSNNAQ
>SEQF2892_00444 Cys-tRNA(Pro)/Cys-tRNA(Cys) deacylase YbaK
MKHKKTNAMRMLDRAKIDYEVKTFEVEDRHMDGERVAELVGENVHDVFKTLVLENAEHDH
FVFVVPVSESLDMKVAASVVNEKKLQLMPLDNLKQVTGYIRGGCSPVGMKHLFPTTIDQS
ASSREKIIVSGGQRGIQIVLQLKDLVSMTNAQVEDITQK
>SEQF2892_00445 HTH-type transcriptional repressor GlcR
MISEKRHDLILQELRKKDFLTLQELIERTGCSASTVRRDLSKLQQQGRLQRVHGGATLNS
NRNNEQILSDKLSQNLKEKRVIGQFAAKLIEDNDCIFMDAGSSTIEMIPFIKAQNIVVVT
NGLTHVEKLLNQGIKTLMIGGQVKETTFATVGASALDTLSRYCFDKAFLGMNGLDLKYGL
TTPDEKEALIKEKAMEQANQSYVLLDHSKIDEVYFAHVPISQNHVEMVVSKQTIALSHFE
QYKEKYVFIGG
>SEQF2892_00446 Tagatose-6-phosphate kinase
MIYTVTFNPSIDYIMFTNGFEIKGLNRATSTYKFAGGKGINVSRVLKTLGVPSTALGFAG
GFPGEFIAQTLEESQIKTDFIKVDEDTRINVKLKSGDETEINAPGPSITDDQFQALLNQI
KQTTKEDTVIVAGSVPKSIPSDAYAQIAEITQSTGAKLVVDAEKDLVNTVLKYQPLFIKP
NKDELEEMFDMTVESDQDVVKYGREILKEGAQSVIISLGGDGAIYIDKTRSIKAQNPKGQ
VVNTVGSGDSTVAGMVAGLESGLSLEDAFQQAVASGTATAFTEDLATIEDIEKIKSQVTI
TVLDGE
>SEQF2892_00447 PTS system fructose-specific EIIABC component
MRITELLTKDTIAMDLSASDKNGVIDELVNQLDKAGKLSDIAQFKEAIHNRESQSTTGIG
EGIAIPHAKVAAVKSPAIAFGKSKEGVDYQSLDGQPAHLFFMIAAPEGGAQTHLDALAKL
SGILMDDKVRESLLHANSPEEVLQIIDNADDEATKEEEKEAQEQEAAAAGATSGSANTTD
ANEPYVLAVTACPTGIAHTYMARDALKKQADKMGVKMKVETNGSGGIKNHLTQQDIERAT
GVIVAADVHVETDRFDGKNVVEVPVADGIKRPEELINTALDTSRKPFVARGGNSKSTDSE
SNEKQSFGKAFYKHLMNGVSNMLPLVIAGGILMAIVFLFGANSFDPKSSEHNAFAEQLWN
IGNKSAFALIIPILSGFIARSIADKPGFAAGLVGGMLAISGGSGFIGGIIAGFLAGYLTQ
GIKYITRGLPQAVEGLKPTLIYPLLSVTITGLLMIYAFNPPAAWLNNLLLNGLNSLSGSN
IVLLGLVIGAMMAIDMGGPFNKAAYVFATAALTEGNAAPITAAMVGGMIPPLAIATAMIF
FKRKFTKEQRGSIVPNYVMGLSFITEGAIPFAAADPLRVIPSMMVGSGVGGAIALALGSR
INAPHGGIIVIAATDFSHILQTLIALIVGTLVSAIMYGLLKPKVTKNEIEASKAMDE
>SEQF2892_00448 Magnesium and cobalt efflux protein CorC
MDTVTIINLVIFFLLIALTTVFVGSEFALVKVRSTRIEQLAEEGNRSAKIVKKMIANLDY
YLSACQLGITVTSLGLGWLGEPTFEKLLHPLFNLLQLPDALTTTISFVISFIVVTYLHVV
LGELAPKSIAIQHTEKLALTYARPLYYFGNIMKPLIWLMNGSARVIIRMLGVDPDAQTDA
MSEEEIKIIINNSYNGGEINQTELNYMQNIFSFDERHAKDIMVPRTQMVTLNEPFNVDEL
LETIKEHQFTRYPITEDGDKDHIKGFINVKEFLTEYASGKPIKINNYIHELPMISETTRI
SDALVRMQREHVHISLIIDEYGGTAGILTMEDILEEIVGEIRDEFDDDEVNDIVKLGEDT
YQINGRVLLDDLNEKFNIEFEDSEDIDTIGGWLQAHNTNLQVEDHIDTQYDRWIVSEMDN
HQLVWVVLKYEFIDNRPTFGEDQDENEDKKDNNDESRE
>SEQF2892_00449 putative oxidoreductase/MSMEI_2347
MVNDTQILNNGYPMPRLGLGVYKVTDEEMETAIQAALDDGYRAFDTAYFYNNEEALGKAL
KNSGVPREDLFITTKLWNDHQGYDSTLEYFNRSLNNLGLEYIDLYLIHWPCEKNELYIET
YKALEKLYEEGKIKAIGVCNFKVHHLEKLMRETNIVPQVNQIEVHPYFNQQEVQDFCDKH
DIVVTAWMPLMRNRGLLDDPTITKLAKAYDKTPAQIVLRWHVAHNRVVIPKSKTPSRIRE
NHDIFDFNLELTEIAEIDSLNRNARQGKDPDEVSIGDLK
>SEQF2892_00450 hypothetical protein
MCKSILNTLRIKDKNLNFSDEVIEKKHKGRMSLFYYAELTYQPTHCENCSTKNENFSIVK
NGKKTSTITLLKIMEMPAYLELQKQRFYCKSCDSHFTAKSNIVDAHCFISNKTKLAVLDK
AQEYRSQKSIAKSCLVSSMTVSRVINQAASDVGQSSFDALPEHLMMDEFKSVKNVIGKMS
FIYADAVSHRIVDVVADRKLKSLKDHFYRYSLKLRQKVKTVTIDMYEPYMSLIKQLFPNA
KIIIDRFHIVQSLNRALNMSRVHVMNCYRTSNRPLYNKYKSYWKLFLKPFETLEAFNYHK
VHLFKEWKTEKGIINYLLGVDVELFNTYHYVHELRRLLKENQIEKFNHKLFSIHLSDVCP
KLRPVIRTLRRLAAFIENTMTYSNLTNGPLEGINNKIKLIKRVSFGYRNYDNLRNRIIIT
SRLFASTTKKEIKQPKVA
>SEQF2892_00451 Putative glycosyltransferase CsbB
MKIRVIVPCFNEGEVVTKTYDKLTEILMEDSLDKGYDYDLLFVDDGSKDNTIDHVQHLAS
LDQHVKYISFSRNFGKESAMIAGFQHSVKCDAVVMVDGDLQHPPEFIPQMIEGFQEGYDQ
VIAKRDRTGENIARKSMTKLYYKLINSFVEDIEFIDGVGDFRLLSQRAVKAMSSLKEYNR
FSKGLFEWIGYNTKIFTYQNVEREAGHSKWTFTKLLNYGIDGLISFNNKPLRAMIYLGMT
IFSLSIVYILYLLIGIMVNGINNPGYFTTIAAVLLIGGIQLISIGVVGEYIGRIYYEVKQ
RPKYIVQASNLKEPTHDLKVVEQEKEKVH
>SEQF2892_00452 hypothetical protein
MIIYVLINIAVVLGVLGLDLYKHQFKQLKFSSVLIAITINALINAIVIDKFNFITLCSIA
FFICWLGLQFYLNHQHYTLVIYEYKSIALIFSIIISCSLFITYGSSDQSIYMSVPYLAPT
IFLIGASAIFLGTFSRGELGIFKFIKKLKFPITIGYMLIIISIVLLTILTPFWYIFLIIY
ILLGIYLAWQLKNTNLKHHIENK
>SEQF2892_00453 7-carboxy-7-deazaguanine synthase
MAAKIPVLEIFGPTIQGEGRVIGRKTMFVRTAGCDYRCSWCDSAFTWDGSAKEDIKLMTA
EEIYNQLKKIGGDRFDHVTISGGNPALIKGIQDLVDLFEEKQIYTALETQGSKFQPWMRQ
INDLTISPKPPSSNMKPNIDILDSVIEQCIESTLNLKVVIFDDDDYEFAKMIHHRYPNIP
FYLQVGNPYLDDDVDNHTEKLLSRYEALVDRVMASNDMNQVYVLPQLHTLLWSNKKGV
>SEQF2892_00454 6-carboxy-5,6,7,8-tetrahydropterin synthase
MIQQLYPSVAHPYSFELNKDFNFSAAHYIPSEDAGKCMRTHGHTYFVNLTIAGDKLDHNG
FLINFSDLKKLIHDQFDHYLLNDLPQFKDKSPSTEVVAQTIYKMVQTHLQNCDNQPECVQ
VYLRETPTSYVVYRPKEYK
>SEQF2892_00455 7-cyano-7-deazaguanine synthase
MTNQNLNKDKAIVVFSGGQDSTTCLFYAKKHFKDVELVTFNYGQRHDAEIEVATRIAKEQ
NLKHHILDMSLLSQLTPNALTQHDMDIETGEDGIPNTFVPARNLLFLSFAGALAYQRNAK
HIITGVCETDFSGYPDCRDSFIKSMNVTLSLSMDKDFVIHTPLMWLDKAQTWELSDELGV
LDYIRHNTLTCYNGVIGDGCGECPACQLRQRGLQHYLEAKGAN
>SEQF2892_00456 Aminodeoxychorismate synthase component 2
MIIVIDNKDSFTYNLIDYFKTETDKEIVVYEVDDVSVDLLRSSNVEAIVISPGPGKPSDY
PILTEIMNQFEGEIPILGVCLGFQFIYEYYGGTIIHGLKPVHGHTTTLTHRGTGLFKGLP
KSFEVMRYHSLIADKNHIPTVLNMTAYNEEGIIMAFEHNQYPIYGVQYHPESILSEYGHE
QIRLFLEKVRIDYEHRI
>SEQF2892_00457 Aminodeoxychorismate synthase component 1
MNIAFNYRYYTTPDHFETIALNFDTYVSKKVAYTLNDIGAVVRFAQDEQSNGRYVALYLT
YEAAKFFNQEMATHELDNNQVIALAYSFNPNMAKHPSNNLSQSYIPKHQFRFLESDAEMQ
DKIKQVQDAITDGETYQVNYTTRLVSDIHYPISDLYYYLTQTNNGGYTALLDVEEIKVAS
ISPELFFQKGAFNNQENVVVSKPMKGTMPRSINKDEDLMNYEILKNSLKDRAENVMIVDL
LRNDISRISKPGTIHVNKPFFIESYKTVYQMTSMVSGRLEAETSLTDILKALFPCGSITG
APKLNTMSYIKALEANPRYIYCGTIGLLCPDDKMIFNIPIRTLEYRNEKVHYGVGAGITI
DSIPEKEVQEFRDKTKILEML
>SEQF2892_00458 hypothetical protein
MNLFETMRLENGEIPRLQYHINRIQQSCGRLGYAFSKENWLHLVKEIIKNHQQGTFRLKI
EIDKTGDMNYVIKPLSQKSLFTAKFQQVQTHYNERYIINKTTERRHLAHNHETDLILLYD
EKGKILEFDIGNIMIEEEGTYYTPSYDNDFLLGCMRQSLIDEGKLSIKNYTKTELSEKLT
NQQVRIYLLNSLREVADVSIYL
>SEQF2892_00459 hypothetical protein
MAILWVVIIVILNVISKYLADRYLNNNALIKARIVATVTVLIQCVFIYFLIKSIIPYVVD
FLNIFYHH
>SEQF2892_00460 Kinase A inhibitor
MKIYSQGDQAIVIAVEKDVSKNVTTELIAVRNHLLEKDLPFITEIVPTESDMMICYDARD
MIKHHNITSPFQYMKALVTSIQEEIKQLEMNKDESTTYEIPIIYGDEFGPDLQDLLEYYK
LTKDEFIQLHSDNAYFVSMMGYAPGFPYLTGMNEALYVNHTSNKKKLVTAGSVIIEGKKC
GIVTTDTYNDWLVIGYTPMTLFTPEKEDFTLLKLGDNVTFKPEKRKDIELGEFKPCQS
>SEQF2892_00461 KipI antagonist
MSIIIEKAGLFSSFQDFGRHGYEYAGVIPCGALDTLGHEIANRLVANDKNEATLEMTHIM
AKIRFTEPTLIALTGQNFEAYTQNMRVKPYKLYLLGKDDVLSFKETNKTSRVYLAIGGGF
KLDNWLGSNSTDLNVHIGGYHGRKLENGDEVEMKREYTERHHKLFENLKEKRTTDWGIDG
YALSFNYISDVFHVIANKGTEDFDKETQSHFIKGEYKVTNKSNRVGMLLDGEKIKAYYDD
MPAHQSVKRGTIQVKRDGTPIILLNDHYTIGSYPQIGTIASYHLTKLAQKPQGSRLKFQF
IDIETAEKNVVKFSNWMNQLFHGIEFRMQLEMMK
>SEQF2892_00462 Lipoteichoic acid synthase
MSLHKKKISLFAFFLLTVFTVTLKTYFSYYVDFSLGVKGLVQNLILLMNPYSLIALILSV
FLFFKGKKAYWFIFIGGFLLSFLLYANVVYFRFFSDFLTFSTLNQAGNVESMGGAVGASF
KWYDFVYFIDTIVYLFILIFKGSWLDKRVFSKKFVPVVMAASVALFFLNLAFAETDRPEL
LTRTFDHKYLVKYLGPYNFTVYDGVKTIQNNQQKALASEDDLTKVLNYTKQKNTTPNSEY
FGAAKKKNIIKIHLESFQTFLINKKVNGKEVTPFLNKLSTGNEDFRYYPNFFHQTGQGKT
SDAEFTMDNSLYGLPQGSAYSLKGDNTYQSLPAILDQKQGYTSDVMHGDYKTFWNRDQVY
KHFGIDKFYDATYYDMSDDNIVNLGLKDKPFFKESAEYQSKMKGPFYSHLITLTNHYPFT
LSEEDADIDKPNTGDSTVDGYIQTAHYLDQALEEYVTDLKKKGLYDDSVIMIYGDHYGIS
ENHNNAMEKLLGEKITPAKFMDLNRTGFWLKIPGKEGTVDKTYAGQMDVMPTILHLVGID
SKNFLMFGTDMLSKDHNDVIPFRNGDFITKDYKYVNGKAYSNKTNELLETQPKDLDKNKK
QVEKDLEMSDNVLNGDLFRFYKNPDFKKIDPSKYEYKTGPKGNQK
>SEQF2892_00463 Zinc transporter ZupT
MIDFFENLPPYLQALVAGIITWLLTALGAASVFIFKSVNKRILTSMQGFAAGIMIAASFW
SLLQPSIEYGKDGSLPAWLPAAIGFLFGGIFIRVLDSVIPHLHQRIGDKSQYREGVKTSL
SKNTLLVLAITLHNIPEGLSIGVAFGGIATGNSQATFLGALGLAIGIGIQNIPEGAALSM
PIRAAGASRWKAFNYGQASAIVEPIFATIGAALILVITPILPYALAFAAGAMIFVVVEEL
IPDSQSGNNTDLATLSLMIGFTIMMILDVALG
>SEQF2892_00464 Energy-dependent translational throttle protein EttA
MEAYKIEHLNKSYADKIIFDDLNLSISEHERIGLVGINGTGKSTLLKVIGNIDDDYTADI
THPNQYRIRYSSQKQDLDGDMTVFQAVLSSDTSTLQIIKAYEEAVNAYSQQQDDAHFQKM
MKAQEAMDQNSAWDYNAEIKTILSKLGINDTTKKVNELSGGQQKRVVLAKTLIEQPDLLL
LDEPTNHLDFESITWLINYVKQYPHTVLFVTHDRYFLNEIASRIIELDRGKLKSYPGNYE
DYIAMRAENEIIEQKQQEKQKALYKQELAWMRAGAKARTTKQQARINRFNDLESEVQDQH
VQDKGQLNLAYSRLGKQVYELEKLSKQINGRTLFEDITEIIQSGQRIGIVGPNGAGKTTL
LNILSGEDNDYTGTLKIGQTVKVAYFKQTEETLDRDIRMIDYLREESEVAKEKDGTSISV
TQLLERFLFPSSTHGKKIYKLSGGEQKRLYLLRLLVHQPNVLLLDEPTNDLDTETLTILE
DYISSFGGSVITVSHDRYFLNKVAQEYWYIHDGKMERIVGTFEDYETYKKEQDKLAALEK
QAQQPKQKTTARKKSGLSYKEKREYETLMERIEQTETRLEEIDEEMIEASADYGKIKELN
EEKEHLELTYETDITRWSELEELKEQ
>SEQF2892_00465 ATP-dependent DNA helicase RecQ
MEATLSHYFGYDKFRPGQKEIITKIMDHHNVLGVLPTGGGKSICYQVPGLMLGGTTIVIS
PLISLMKDQVDQLKAMGIKAAFLNSSLTKKQQKEIEDDLRKGHIQFLYVAPERFDNQYFL
SLLSRIDIHLIAFDEAHCISKWGHDFRPSYQSVIKKVFTLPQNFTIVALTATATAEVQQD
IMEKLNIDRRDEVKTSTKRRNLIFKVNPTYQRQKFVVDYVQKHKEQAGIIYCSTRKQVEE
LQEALDVINVSSAIYHAGLTNKEREAAQNEFVYDKVKVVIATNAFGMGIDKSNVRYVIHY
NMPGDLESYYQEAGRAGRDGLESECILLFSERDKGLHEYFITVSQADEDYKDKMGEKLTK
MIQYTKTKKCLEATVVHYFEPNEKLEECGQCSSCIQQNKTYDMTQEAKMIISCIARMRQK
ESYSVIIQVLRGETSDYIKYNDYDKLTTHGLMKDYTTSELNHLIDELRFKGFLNENDEIL
ICDESVKKLLNNKEKVFTTPFKQKSKEKVYINTVEGVDRALYSELVEVRRKLSEKLNIAP
VSIFSDYTLEEFAKRKPESKQEMISIDGVGSYKLKHYCPKFLEIIHSYKASI
>SEQF2892_00466 Choline transport ATP-binding protein OpuBA
MIEFKNVTKRYGDNVAVDDVSFKINEGEFFVIIGPSGCGKTTTLKMINRLIPLSEGYIYF
KDKPISDYPVYEMRWDIGYVLQQIALFPHMTIKENIAQVPQMKKWKDKDIDQRVDELLEM
VGLEPEKYRDRKPDELSGGQRQRVGVVRALAVDPPVILMDEPFSALDPISREKLQDDLIE
LQTKIKKTIVFVTHDIQEAMKLGDRICLLNNGHVEQIDTPQAFRNQPKNKFVEEFMGSHL
EQDKESLQLKDLNITSPLTEKETHHDYPEINSDAQLRSVYSTLAQHEAVIVNDVSTSTQS
LLKREDIFKYLSEIDHDKEVKA
>SEQF2892_00467 Choline transport system permease protein OpuBB
MSELFSTLNDRKGEVLTTILEHIQISFIALLIAILIAVPLGIALTKTKRLSEVVMNIAAI
LQTIPSLALLGLMIPIFGIGRVPAIIALVVYALLPILRNTYTGIKEVDPSLIEAAKGIGM
KPMRRLTKVELPIAMPVMMAGIRTAMVLIIGTATLAALIGAGGLGDLILLGIDRNNTSLI
LIGAIPAALLAIMFDLILRYMEKLSYKKLLITVGAMILIILLVIVVPLFGKKGDTITLAG
KLGSEPSIITNMYKILIEDETDDTVDVKDGMGKTSFLFNALKSDDIDGYLEFTGTVLGEL
TKEDLKSKKEDAVYQQAKQSLEKKYDMTMLKPMKYNNTYALAVKRDFAKENNIKTIGDLQ
KVEDKIKPGFTMEFNDRSDGYKAVAKAYGLNLSNVKKMEPKLRYTAVEKGDINLIDAYST
DAELKQYNMVVLKDDKHVFPPYQGAPMFKEKFLKQHPEIKKPLNKLEGKISDEEMQEMNY
KVTVKNEDPYNVAKHYLEKEGLVK
>SEQF2892_00468 Di-/tripeptide transporter
MNTRNYSRREIVESVPQKGFFGHPKGLSTLFFTEFWERFSYYGMKAILAYYLYYSVSKGG
FGLPQGTALQIVSLYGALIYMSGTIGGWIADRIIGTRHALFYGGILIMFGHIMLTIPGSL
TVVMIALLLLIIGTGLLKPNISTTVGELYDHNDRRLDAAFTIFYMGINLGSFLSPFATGY
LQTRLGFHFGFAVAAIGMFIGLVTYFITNKKNLGLAGLSVPNPLRKEEIKRLSIITGIVV
VIFAIILLILQFIGKLSLSSFSVIVTIVGIVLPICIFVYMLSSNKTHKEERSRIYSYIPL
FITSVAFWMIQEQGSTVLANFADQKTELSLAKLTNGALDFHIPAAWFQSVNPVFIIMLAP
VFASLWTKLGRHNPSTVYKFALGAIFAGLSYLVMIIPLNSDAHLIHPIWLVLSFFLITLG
ELCISPVGLSVTSKLAPAKFSAQMMALWMLSNATAQSLNSQIVVLFKIISEKEFFLYSGL
FTLLIGVILVAISPMVKKAMNGVH
>SEQF2892_00469 Histidinol-phosphate aminotransferase
MKQQLNQLAAYQPGLSPQALKEKHGIEGELYKLASNENLYGPSPKAKQAVQAHLDELFYY
PETGSPSLRKAISEHLNVDSSRILFGAGLDEVILMISRAVLTPGDKIVTSEGTFGQYYHN
AIVESAEVVQVPLLNGGFDLENIIKEVDEETALVWLCNPNNPTGTYFNHDELESFLERVP
SHVPVLIDEAYFEFVTAEDYPDTLKLQERFDNAFLLRTFSKAYGLAGLRVGYVVATNEAI
EKWNIIRPPFNVTRISEYAAIAALEDQAYLKDVTAKNAKEREKFFEIPQSKHFLPSQTNF
VFVVTEKAQELYEALLKVGCITRPFPTGVRITIGFPEQNDRMIEVLKHFDY
>SEQF2892_00470 Putative 5'(3')-deoxyribonucleotidase
MSRKSIAIDMDEVLADTLGAIIEAVNVKTELGITVESLNGQKLKNVIPEHDGLVRDILRA
PGFFRNLTVMPHAQEVVKKLTEQYDVYIATAAMDVPTSFHDKYEWLLEFFPFLDPQQFVF
CGRKNVVKTDYLIDDNPRQLQIFEGEPIIFTASHNVSEERFKRVNGWKDVEAFFLGE
>SEQF2892_00471 Putative lipid kinase
MGQKFNHGVLFYHEHSGLKDIYEGLGEVTKSLTTMCKHLSIQLSENEGDIIKYSERIKNQ
EYSSDVDIVFILGGDGTVNELVNGVLANDLNVPIGIIPGGTFNDFTKTLNLNPNFSKASE
QLKTSHLESYDVMKVNGTYVLNFVGLGLIVQNAENVQEGRKDIFGKLSYVGSTVKTLMNP
EDFDYTLTVDDKELNGNTSMLVVANGPNIGGSRIPLMDLSPQDGNLNSFIFDKQSFTILN
DVFKKRDSMDWNEITNGIDHIAGKHITLSTDPVMKVDIDGEISLETPITIEVLPKALQIL
TFPENAEQ
>SEQF2892_00472 Di-/tripeptide transporter
MATNNSHEQAVQTIPQRGFFGHPSGLGVLFFVEFWERFSYYGMRAMLIFYMYDQIKNGGL
GIDQTTAMSIMSVYGALIYMSSIPGAWVADRLFGTRGATLIGAVLIIIGHVCLSLPFAMF
GLFASMFFIIIGSGLMKPNISNIVGRLYPENDTRMDAGFVIFYMSVNLGALISPIILQHF
LDVKNYHGGFLIAAIGMALGLVWYMIFNKKNLGSVGMNPTNPLSSEEKKKYGLIVGIIVA
VIAIVLLVTYFTNTLSFNLISNTVLVLGIALPIIYFTTMIRSKDVTDVERSRVKAFIPLF
ILGMLFWAIQEQGSNVLNIYGLERSDMKMNLFGWTTDFGEAWFQSINPLFILLFAPIVSA
IWLKMGKKQPSLPVKFGLGTLLAGASYILMGLIGMSYGDTHFSVNWVILSYVVCVVGELC
LSPTGNSAAVKLAPKAFNAQMMSVWLLTNASAQALNGTLVKLINPLGQTNYFIFLGSVAI
VITVIILAFTPKISKAMKGIH
>SEQF2892_00473 NADPH-dependent 7-cyano-7-deazaguanine reductase
MTQGRQKEELQDITLLGNQNNKYEFDYTPEVLETFDNKHQGRDYFVKFNCPEFTSLCPIT
GQPDFATIYISYIPNIKMVESKSLKLYLFSFRNHGDFHEDCMNIIMNDLIDLMDPHYIEV
WGKFTPRGGISIDPYTNYGRPNSKYEKMAEHRLMNHDLYPEKIDNR
>SEQF2892_00474 Riboflavin transporter
MNPKVKGIIAILISAVGFSFMSVFFRLAGDLPVFQKSLARNFVAMFIPLFFIFKYKQPMF
GKLSSQPLLISRSTLGLIGVLLNIYAIDHMVLSDADTLMKLNPFWTILLSLIFLNEKVRK
YQIIAMIVAILGMLFIVKPEFSSTMITSLAGLFSGIFAASAYTCVRALSTREAPYTIVFY
FSLFSVVVLIPFSIATYEPMTTIQMVYLLGAGLSAAVGQIGITLAYSFAPAKDISIFTYA
SIIFTAIFGFILFGETPDFYALIGYVIIIGASYYMFEKARRQTDITKQQSNTKE
>SEQF2892_00475 Protein NrdI
MKVVYFSFSGNVRRFIKRSEISDVMEITKDNCTDPFEEPYILVTGTIGFGEVPKEVQSFL
EINHHNLRAVAASGNRNWGQNFAKAGRTISEEYHVPLLMKFEVQGSNKDVIEFKNKVGHF
NENYEREKVQSY
>SEQF2892_00476 Ribonucleoside-diphosphate reductase subunit alpha 1
MKIMNEKKYNHIELNNEVTKRKDNGFFNLEKDQEALAVYLEEIHDKTIYFDSEIERLHYL
VDNNFYFNVFDKYSEEDLVEITEFAKSINFEFASYMSASKFYKDYALKTNDKSQYLEDYN
QHVAIVALYLADGNKQQAKQFILAMVEQRYQPATPTFLNAGRARRGELVSCFLLEVDDSL
NSINFIDSTAKQLSKIGGGVAINLSKLRARGEAIKGIKGVAKGVLPVAKALEGGFSYADQ
LGQRPGAGAVYLNIFHYDVEEFLDTKKVNADEDLRLSTISTGLIVPSKFFDLAKEGKDFY
MFAPHTVKQEYGVTLDDIDLEKYYDDMVANPNIVKKKKDAREMLNMIAQTQLQSGYPYLM
FKDNANKVHANSNIGQIKMSNLCTEIFQLQETSVINDYGIEDEIKRDISCNLGSLNIVNV
METGKIKDSVHTGMDALTVVSDEANIQNAPGVRKANSELHSVGLGVMNLHGYLAKNKIGY
ESEEAKDFANTFFMMMNYYSIERSMEIAKERGEVYQDFEQSDYASGKYFEFYTSQEFEPK
FEKVKRLFDHIDIPTAKDWKALQEQVQQHGLYHAYRLAIAPTQSISYVQNATSSVMPIVD
QIERRTYGNAETFYPMPFLSPETMWYYKSAFNTDQMKLIDLIATIQTHVDQGISTILYVN
SEISTRELSRLYVYAHHKGLKSLYYTRNKLLSVEECTSCAI
>SEQF2892_00477 Ribonucleoside-diphosphate reductase subunit beta
MKAVNWNTQEDMTNMFWRQNISQMWVETEFKVSKDIASWKTLTEDEKNTFKRALAGLTGL
DTHQADDGMPLIMLHTTDLRKKAVYSFMAMMEQIHAKSYSHIFTTLLPSSETNYLLDTWV
IEEPHLKYKSDKIIENYHKLWGKEASIYDQYIARVSSVFLETFLFYSGFYYPLYLAGQGK
MTTSGEIIRKILLDESIHGVFTGLDAQSLRNELSENEKQKADKEMYKLLEDLYANEVSYT
HMLYDDIGLSEDVLNYVQYNGNKALSNLGFEPYFEEKEFNPIIENALDTTTKNHDFFSVK
GDGYTLALNVEALQDEDFIFDN
>SEQF2892_00478 Fe(3+) dicitrate transport system permease protein FecD
MKFLFKGYVLLILLVCLTIVSLFVGVSQLSLSDIFHLSEEQQNILFSSRIPRTVSILLSG
SSLALAGLIMQQMMQNKFVSPTTAGTMEWAKLGILISLIFFPKGHILIKLLFSVGLSLAG
TYLFVKLINLIRVKEVIFVPLLGIMIGGIVSSFTTFIALRTNALQSIGNWMNGNFAIITS
GRYEVLYLVVPLLIIAFIFANHFTIAGMGKDFSHNLGVSYEKIINIALFITAALTALVVV
TVGTLPFLGLIVPNIISMYRGDHLKNALPHTLMLGSIFVLFADIIGRLIVYPYEINIGLT
IGVFGTVIFLILLMKGRKHYAN
>SEQF2892_00479 putative ABC transporter permease protein
MQISSNKKIIILIIATICMAAFYLLVGLDFEIFQYQFQSRLRKLILILIVGGAIGASVVI
FQAITTNRLLTPSIMGLDSVYLFVKVLPVFLVGTQAAVITNVYLNFFVTLIAMVLFSLLL
FEGMFKLGHFSVYFILLVGVILGTFFRSITSFIQLIMDPESFLAVQSAMFASFEASNSRL
VLVSTCLLLVLIIITVIMRPYLDVLLLGRAQAINLGVSYESMTRLLLILVALLVSISTAL
VGPVTFLGLLTVNLAHELMKTYEHKYILPATILISWISLFMAQWVVENLFEATTEFSLII
DLIGGSYFIYLLVKRRSAN
>SEQF2892_00480 putative siderophore transport system ATP-binding protein YusV
MIEIKNLDKAIQNKPILKNINVDIQKGRLTSLIGPNGAGKSTLLSAVSRLFEYEKGTIKI
EGKAVVDYKNDDLAKKLSILKQTNHTEMNITVEQLVNFGRFPYSKGRMKKEDYEQVEYAL
DLLQLQSIRHRNIKTLSGGQRQRAYIAMTIAQDTDYILLDEPLNNLDMKHSVQIMQTLRR
LCKDLNKTIVIVLHDINFASCYSDDIIALKNGEIVKADTKDNVIQAEILKQLYEMDVHIE
EIRGQRICLYYDEDTFDSLL
>SEQF2892_00481 putative ABC transporter solute-binding protein YclQ
MKKTVLFLVLSLVLVLSACSNGSSSNDSGSKSDSKDSKETVKIKNNFEASGKERDGSDAK
KVSNTVEVPKNPKNAVVLDYGALDVLKELGVADKVKGLPKGENNESLPDFLKEFKDDKYV
NTGNLKEVNFDKVAAAKPEVIFISGRTANQKNLDEFKKAAPDAKIVYVGADEKNLVKDMK
KNTENLGKIYDKEDKAKDINEDLDEKISEMKDETKKFNKTVMYLLVNEGELSTFGPKGRF
GGLVFDILGFKPADENVSNSPHGQNVNNEYISKHNPDVILAMDRGEVVGGESTAKKVLSN
NVIKDVKAVKNDKVYQLDPKLWYFASGSTTTTMKQIDELEEVVDK
>SEQF2892_00482 putative ABC transporter solute-binding protein YclQ
MKKIILFLILSLALVLTACGKSSDSNNDTSKKIDNKDIVQIENNYKTRGEKKDKSDAKKI
KETVDVPKNPKRAIVFDYGAVDVLKVFGVQDRIIGLPKGEKNAALPEFLSEFKDDKYINT
GNLIQINFDKIAKAKPEVIYISGRTATVKNIDELKKAAPDAKIVYVGASEKNYINDMKSV
TTKLGKIYGKEDKAKSLIEELDKKIADTKAKVEKLDKKTMYLLVNEGELSTFGPGGRFGD
LIYDTLGFKPTDEHVKASPHGQNINNEYITSKNPDIILAMDRGQVVSGKSSAKQTLSNDV
IKDVNAVKNGNVYELDPKLWYFSAGSTSTTIKQIDELNQILKKLK
>SEQF2892_00483 hypothetical protein
MMPKVYGSLVDNETRCTHYHTFLDVIAIKFKCCNKYYPCYQCHEEHETHPIKRWSEQEFD
EKAIMCGVCKHEMSIQDYMMTELCPKCQAHFNSRCKFHYHLYFEL
>SEQF2892_00484 UDP-N-acetylenolpyruvoylglucosamine reductase
MLKQEDILQDLKSLIPEDIIKVNEPLKRYTYTETGGNADFYLSPTKNEDVQAIVRYAKEK
DIPVTYLGNGSNIIIREGGIRGIVISLLSLNHINVSDDAIIAGSGSAIIDVSRAARDHVL
TGLEFACGIPGSVGGAVYMNAGAYGGEIKDCIDYALCVNEEGDLIQFTNKELELDYRNSI
VQKQHLVVLEAAFTLEPGKLDEIQAKMDDLTERRESKQPLEYPSCGSVFQRPPGHFAGKL
IQDSDLQGYRVGGVEVSKKHAGFMVNVDNGTATDYEDLIHHVQKVVKEKFDVELHREVRI
IGEHPKE
>SEQF2892_00485 hypothetical protein
MYSTVQPFIHGDTQSEYDTLYQTTKTSLFNLLDSPVKFAQHIGGTSHFNYATEPILDVLI
GVNNLHDITALDEKRLNYLGFYRLHHPYKKKVMMAKFNNMIDLRQTIRLHIIQMDTTLFK
QYIEVDKALATQSDIARHFSEKKVSIIQHTNYIRPYENQKQKYFEDIFQKL
>SEQF2892_00486 hypothetical protein
MKKLAILSIMLICGILLSSCGNQSSADLKDFQTQLNKVEDEKEDLKTLMDKIHLKQLDQL
SKTDTTDKNKREFEALKKDINKHLIPQFKKYEKSAKQLPAEHQDVKDLKNKYLENVKQEK
QSIYDIKTFVDLCNKSIKANEDILDYTKLFESNRSQVETQIKKANNQEDANQLTSKIESN
NQNLKEAAQKYLESDDSNSKKAIDEHIKPLIEKQISELNQTNITDPKVNSARKNAIEMYY
NLLNYYDTRETTIEIEKKLSKIDVEKLPKTGKELSKDNNDFYEDLKKLKKQ
>SEQF2892_00487 hypothetical protein
MAIKLSSIDQFEQVLKDNKYVFVLKHSDTCPISADAYDQFNKFLYERDMDGYYLVVQEER
KLSDYIAEKTNVKHESPQAFYFIDGEATWNASHSDINVSSLAQAEE
>SEQF2892_00488 Glycerate 2-kinase
MKILVAMDEFNGIISSYQANRFVEEAVASQIEDADIVQVPLFNGRHELMDSVFLWQSGTK
YRVNVHDADMKEVETVYGQTEQGLTIIEGNLFIKGQKPVEQRSSYGLGEVIIDALNNGAD
NIVISLGGIDSFDGGIGMMQALGAQFYNDEGELLDAREGAQVIKFIRRIDFSAIPQNFKD
AHIQLMSDFSSKLYGKHSEIMKTYETHQLTREKAAEIDNLIWYFSELVKNEMKIAMGPIE
RGGAGGGIAALLNGLYDAEILTSHELVNQITHLDDLVSQADLIIFGEGVKEEDHLLETTT
LTIAELAQKHDKPAIAICATDDKFDVFDQYHVTAMFNTFVEMPERYTDFKMGIQIRHFTV
QALRLLKTTLNNA
>SEQF2892_00489 Peptidase T
MKAQLIDRLSRYVKIDTQSNPESSTTPSTEKQWDLLRLLQQELEGFGLETNLDDNGYLFA
TLESNVSFDVPTVGFLAHVDTSPDFNASNVNPQIVEQYDGKTIKLGDTGRVLSQETFPEL
KKLIGHTLMITDGTSLLGADDKAGVVEIMEAVKYLIEHPEIKHGRIRIAFTPDEEIGRGP
HKFDVERFNADFAYTMDGSEFGELQFESFNAAEAKITTHGVNVHPGSAKNIMVNAISLGH
QFHSLLPAGEVPERTEDYEGFYHLMKFEGNVEKATLQYIIRDHDRESFELRKKKLLEIRD
DINVHYEDFPVKVDIEDQYYNMAEKIEPHPYIIDIPKKVFNDLNIEPNTAPIRGGTDGSQ
LSFKGLPTPNIFTGCGNFHGPFEYASIDVMEKAVQVIIGIAQEVTHHHK
>SEQF2892_00490 hypothetical protein
MLFYLFHFTISFISTVLFSIIFNAPKRLLAACGFVGAVAWTIYQFTVDMDLGKVGASFLG
SLILGLLSHVMSRRYKRPVIIFIVPGIIPLVPGGTAYEATRYLASNDYTQAVNTFLEVTL
ISGSIAFGILVAEILYYIYTRIKQYYDKIKGKTYRKSYNMNNRV
>SEQF2892_00491 Inner membrane protein YjjP
MSDSITIIDENKVIDVVLIAGRILLEAGAETYRVEDTMNRIAHSYGLHDTYSFVTSTAII
FSLNDRTNTRLIRIRERTTDLEKIALTNSLSRKISRNELTIDEAKSEFIHLRRASLQYSF
LLNFFAAAIACGFFLFMFGGVASDCWIAVIAGGAAFLTFSLVQRFIQIKFFSEFVASAVV
ITIAATFTKLGIATNQNIITISSVMPLVPGILICNAIRDLMAGELLAGMSRGVEAALTSF
AIGAGVAIVLLII
>SEQF2892_00492 Diguanylate cyclase DosC
MIESIIYNVAVMVAGIYLFHRLQYSENKIMVFSKGYVTVLMTIVALLLAAYPIPFHQEYL
VHLTFVPLLFLGRFTNMGYTLVSAVIVALVEVFAFGNSLLYGVVLIVIGIIVSMVGPFLK
QNDIVALVILNLISVIILLILSIFSPLYDLTEIAFLVPISFVLTIASAITFVDMWHFFSL
VTRYENEDKYDYLTGLGNVKEFDRHLNHVSQIAEDKNESLALLLIDIDGFKDVNDTYSHK
SGDAVLKQMSQLLKNYVPKQFQIFRNGGEEFSVVIRNYSLDQSVKLAENIRTGVEKSSFH
LPNKEVIKLSVSIGVGYLSQDDHKSQRKVFKDADDMVHVAKNEGRNQVMFNPIIKL
>SEQF2892_00493 putative undecaprenyl-phosphate N-acetylglucosaminyl 1-phosphate transferase
MYTLLLIAVTLVISLILTPMIIKVSIKFDLVDRPNFRKVHTKPVSVLGGTVILLSFLIGI
WLGHPIEREVKPLVMGAIVMYLVGLIDDIYDLKPILKLIGQIVAASIVAFYGITIDFISF
PMGPTIHFGILSIPITIIWIVAITNAINLIDGLDGLASGVSAIGLITIAFIAILQANVFI
IMICSVLIGSLLGFLCFNFHPAKIFLGDSGALLIGFIIGFLSLLGFKNITFISLFFPIVI
LAVPFIDTLFAMIRRMRNGQHIMQADKSHLHHKLLALGYSHRQTVLLIYSIAILFSLSSI
ILYLSQPLGVLLMFILIVITIELIVEFTGLIDDSYRPILNLITKKNEQHHGDNGVDQHDK
K
>SEQF2892_00494 IMPACT family member YigZ
MSNDIITIKQEHSIENVINKSRFIAHIKPVSSEDEAKAFINEIKQQHKEATHNCSAYTVG
DQMNIQKANDDGEPSGTAGVPMLEILKKLDVHNVCVVVTRYFGGIKLGGGGLIRAYSGAV
RDVIYDIGRVELRDAIPTTVTINYDLTGKLEYELASTTYFLRDTTYTDKVSYQIDVVQTE
YDDFIAFLNKNTAGNFELHEADVKKLPFDIPTN
>SEQF2892_00495 DegV domain-containing protein
MKIALMADSTGYLPQDFMDQYEIPIAPLSVAYDDGETFTENDNVPIERFYNKMASSKTFP
TTSQPAIGEWIENYEKLRDKGYTDIIVIALSSGISGSYQSATQAGEMVEGVNVHTFDSKL
AAMIEGSYTIYAKELIDKGFTPEVIIEELKEIREQAGAYLIVDDLKNLQKSGRITGAQAW
VGTLLKMKPVLRFEKDGKIHPFEKVRTKKRAFNTLEENIFEIIKDIDEVTVFVINGDKID
EGKDFYNHLKETYPNINIQYSEFGPVIASHLGSGGLGLGYFPRKIEIN
>SEQF2892_00496 ComF operon protein 1
MTLSDETVTQVTPGIIATDDGYQCLQCGNTDKRYMYEYETPFSEERIIYCRYCIQLGRMD
NITEFKITQSENTISEGHYDLLFQLSEQQQYASEAIVQAIKTLHPLLLYAVTGAGKTEMM
YEGIRVARQLGFNVAIVSPRVDVVVEISLRIKEAFISEDIDVLHQSSQQQYNGHFIVATV
HQLFRFKSHFDVIFIDEVDAFPLSMDPRLMEAIRLSSKQKHSHIFMTATPPKELLNRLSS
EQIITLPARFHKHPLPVPNFTYFKLNVKHIQLKLKRILMNQITEKRYTLVFFNNIELMVE
TYQHYRYHFSDLIYVSSKDALRFSKVQALRNGEHAIVFTTTILERGFTMAQLDVIVINAH
TFEKAALIQIAGRVGRKQGAPTGKVIFMHEGVSIAMIQAKREIKKMNRLGIERGWVIG
>SEQF2892_00497 hypothetical protein
MVKCIQCGLPIYEPLDVFNFYRVPKRMCSSCLEMWDSVKLIKNDQRCPKCLNYRDIKENE
CLDCQFLAKNFKLMEQLYCDYQYSGIMKEMIQQYKLMKDYYLAEVIASQLNLPKTSYDLI
VPIPSPIERDTQRTFNPVATVLEKMGVQYSNLLATELRPKQSKLGKVERAKAMNPFYIKE
DVDLTDKEILLVDDIYTTGLTIHHAGCKLYDKNVRKFKVFTFSR
>SEQF2892_00498 Ribosome hibernation promotion factor
MIRFEIHGDNLTITDAIRNYIEDKIGKLERYFNDVPNAVAHVKVKTYQNSTTKIEVTIPL
KNVTLRAEERHDDLYAGIDLVTSKLERQVRKYKTRVNRKHKTHGEPEAFVAEVQEAPPET
VDDVNAEPTNDSEIEIIRSKQFSLKPMDSEEAVLQMELLGHDFYIFTDRETDGTSIVYKR
KDGKYGLIETTE
>SEQF2892_00499 Protein translocase subunit SecA
MGFLSKIVDGNKKETKRLSKIADEVLSLEEDMAILTDEEIKNKTKQFQQEVQEIEDVKKQ
NDYLDKILPQAYALVREGSKRVFNMTPYKVQVMGGIAIHKGDIAEMRTGEGKTLTATMPT
YLNALAGRGVHVITVNEYLSSVQSEEMAELYEFLGLTVGLNLNSKSTNEKREAYAQDITY
STNNELGFDYLRDNMVNYAEERVMRPLHFAIIDEVDSILIDEARTPLIISGEAEKSTSLY
TQANVFAKMLKAEDDYKYDEKTKAVHLTEQGADKAERMFKIENLYDVQNVEVISHINTAL
KAHVTLQRDVDYMVVDGEVLIVDQFTGRTMPGRRFSEGLHQAIEAKEGVKIQNESKTMAS
ITFQNYFRMYNKLAGMTGTAKTEEEEFRNIYNMTVTQIPTNKPVQRDDKSDLIYISQKGK
FDAVVEDVVEKHKQGQPVLLGTVAVETSEYISNLLKKRGIRHDVLNAKNHEREAEIVANA
GQKGAVTIATNMAGRGTDIKLGEGVEEIGGLAVIGTERHESRRIDDQLRGRSGRQGDRGD
SRFYLSLQDELMVRFGSERLQKMMNRLGMDDSTPIESKMVSRAVESAQKRVEGNNFDARK
RILEYDEVLRKQREIIYNERNNIIDSEDSSQLVNAMLRSTLQRGVTYHISEEDDNPDYAP
FINYVNDVFLQEGDLKEEEINGKDSEDIFEVVWSKIEKVYESQKAKIGDQMAEFERMILL
RSIDTHWTDHIDTMDQLRQGIHLRSYAQQNPLRDYQNEGHELFDMMMQNIEEDTSKFILK
SVIQVDEDIEREKTTDFGTAQHVSAEDGKEKAKKQPIVKGDKVGRNDPCPCGSGKKYKNC
HGKEE
>SEQF2892_00500 Peptide chain release factor 2
MTEPDFWDDQNKAQEVIDKNNALKSVVNGYHELEEEVEDMTATWELLQEELDDDVKSDLE
QNVLDFKEKVDQFELQLLLDGPHDANNAILELHPGAGGTESQDWASMLLRMYQRYGEQQG
FKVETVDYLPGDEAGVKSVTLLIKGHNAYGYLKAEKGVHRLVRISPFDSSGRRHTSFASC
DVIPEFNNDEIEIEINPDDITVDTFRASGAGGQHINKTESAIRITHHPTGIVVNNQNERS
QIKNREAAMKMLKAKLYQLKLEEQEREMAEIRGEQKEIGWGSQIRSYVFHPYSMVKDHRT
NEETGKVDAVMDGEIGPFIESYLRYTMNQSDN
>SEQF2892_00501 Staphylococcal secretory antigen SsaA
MINKTLTVTLTSIAALAGLSGLANAQEHTNSTPSTSQQSNNNNSQVEQETNLGLTNKDIV
KVKAGDTLYQIALSHHLSLEQLYNFNPGVTALIHPGDLIAVSEKGAAKLENKEINYAQTY
AETIAFNQSDVVAQSVSASTTNVTGYNIVPTSAPTTTTHDSYHSPVNTPVSYQHVTTANQ
GNRYSFGNCTYYAFDRRQQLGRSIGSYWGNANNWAYSAKNAGLTVDNRPEVGAIFQTTAG
YYGHVGVVEHVNQDGSVYVSEMNWNGHYNHVTNRTITNTSSYNFIH
>SEQF2892_00502 NADP-dependent 7-alpha-hydroxysteroid dehydrogenase
MLGKVILITGATSGIGYKTAEYLAAQGNIVYGAGRRIESLENIKQVNPLKLDLTNEASIK
TAIDTIIANEGRIDVLVNNAGYGSYGAIEDVTIEEAKQQFEVNIFGLARITQLVLPHMRA
QQSGHIINISSMGGRLTTYFGAWYHATKYALEAFSDALRMEVEEFGIEVSIIEPGGIKTD
WGIIAADKLADSAKGGAYEATAMKVAQSMKKQYHSNLLSNPMVVTKAISKAIDSNKPKPR
YLIGFAAKPLVFLHAILPTKVFDKMMKASNSI
>SEQF2892_00503 5'-deoxynucleotidase YfbR
MGVHQYFKRLSDLEKLIRLPGKFKYFEHNVAAHSFKVTKIAQYLATVEEHHGNTIDWKSL
YEKALNHDFAEVFTGDIKTPVKYAKTELKMLFSQVEQDMVDTFINEEIPEPYKDIYRERL
QEGKDDSLEGQILSVADKIDLLYETFGEIQKRNPEDLFFEIYEHSLETIMQFDHLSSVQD
FIENVIPEMLTENFIPRAELRETTMAILNRRSR
>SEQF2892_00504 hypothetical protein
MIWYALAAFFPCVLVVLFSVITRSKWVGVIVTLILIAASIYKGFFHNEWIIFIDVVSLLA
GYVIIDNLEFHKHQD
>SEQF2892_00505 UvrABC system protein B
MVEHYPFKLNSEFDPQGDQPQAIEKIVKGVKEGKRHQTLLGATGTGKTFTMSNVIKEVGK
PTLIIAHNKTLAGQLYSEFKEFFPENRVEYFVSYYDYYQPEAYVPSTDTFIEKDASINDE
IDQLRHSATSALFERDDVIIIASVSCIYGLGNPEEYKDLVVSVRVGMEMDRSELLRKLVD
VQYSRNDIDFQRGTFRVRGDVVEIFPASREEMCIRVEFFGDEIDRIREVNYLTGEVIRER
EHFAIFPASHFVTREEKMKVAIERIEKELEERLKELKDENKLLEAQRLEQRTNYDLEMMR
EMGFCSGIENYSVHLTLRPLGSTPYTLLDYFGDDWLVMIDESHVTLPQIRGMFNGDRARK
QVLVDHGFRLPSAMDNRPLKFEEFEQKTNQLVYVSATPGPYEIEHTDEMIEQIIRPTGLL
DPKIDVRPTKNQIDDLLSEIQERIDRDERVLVTTLTKKMSEDLTTYMKEAGIKVNYLHSE
IKTLERIEIIRDLRMGTYDVVVGINLLREGIDIPEVSLVVILDADKEGFLRSNRSLIQTI
GRAARNEKGEVIMYADKITDSMQYALDETQRRRDIQMAHNEKYGITPKTINKKIHDVISA
TVDNDETNEKQQTELPKKMTKKERQKTIENIEKEMKKAAKDLDFEKATELRDMLFELKAE
G
>SEQF2892_00506 UvrABC system protein A
MKGPSIIVKGARAHNLKDVDIELPKNKLIVMTGLSGSGKSSLAFDTIYAEGQRRYVESLS
AYARQFLGQMDKPDVDTIEGLSPAISIDQKTTSKNPRSTVATVTEIYDYIRLLYARIGKP
YCPNHNIEIESQTVQQMVDRILELEERTKIQILAPVVSHRKGSHEKLIADIGKKGYVRLR
VEGDIVDVNEVPELDKNKNHTIEVVVDRLVVKDGIETRLADSIETGLELADGNITVDVID
GEDLKFSENHACPICGFSIGELEPRMFSFNSPFGACPTCDGLGQRLTVDLDLVVPDPNKT
LNEGAIEPWEPTSSDFYPTLLKRVCEVYKINMDKPYKKLTDRQKNILMNGSGDKEIDFSF
HSRNGGTRHRRMKFEGVVANIDRRYHESPSEYTREVMSKYMTELPCETCHGKRLSKEALS
VYVGGYNIGEVVEYSIKNALNYYENIELSEQDRAIANQILKEIISRLSFLNNVGLEYLTL
NRASGTLSGGEAQRIRLATQIGSRLTGVLYVLDEPSIGLHQRDNDRLISTLKEMRDLGNT
LIVVEHDDDTMRAADYLVDVGPGAGNHGGEIVSSGTPSKVMKDKKSLTGQYLSGKKRIDV
PEHRREVTDRKISIKGARSNNLKGVNVDIPLSVMTVVTGVSGSGKSSLVNEVLYKSLAQK
INKSKVKPGAFDSIEGIDQLDKIIEIDQSPIGRTPRSNPATYTGVFDDIRDVFAQTNEAK
IRGYQKGRFSFNVKGGRCEACKGDGIIKIEMHFLPDVYVPCEVCDGKRYNRETLEVTYKG
KNIAEVLEMTVEEATYFFENIPKIHRKLQTLVDVGLGYITLGQQATTLSGGEAQRVKLAS
ELHKRSTGRSIYILDEPTTGLHVDDISRLLKVLNRLVENGDTVVIIEHNLDVIKTADHII
DLGPEGGDGGGTLVATGTPEEIANVESSYTGKYLKTVLERDKVE
>SEQF2892_00507 HPr kinase/phosphorylase
MLTTEKLVKLLKLELFTGEKGLHKPIKNTDISRPGLEMAGYFSHYAADRIQLLGTTELSF
YNLLPDEERHGRMRKLCRPETPAIIVTRGLEPPQELIDAAQEMDTPLIVSKDATTSLMSR
LTTFLEHELAKTTSLHGVLVDVYGVGVLITGDSGIGKSETALELVKRGHRLVADDNVEIR
EITKDELIGTPPKLIEHLLEIRGLGIINVMTLFGAGSILTQKQIRLNINLENWDKDKLYD
RVGLNEETLQILDTEITKKTIPVRPGRNVAVIIEVAAMNYRLNIMGINTAEEFNQRLNEE
ILKKGHQSKEN
>SEQF2892_00508 Prolipoprotein diacylglyceryl transferase
MLFNLNYIDPTAFSIGPLSIKWYGIIIAVGILIGYFIAQESLKYVGLHKDTLVDVIFYSA
IFGFITARIYFVIFQWPYYAQNPFEIPMIWHGGIAIHGGLLGGFITGIIVCKIKNLNPFQ
IGDIVAPSIILAQGIGRWGNFMNHEAHGGPVSRTFLENLHIPEFIIRNMYIEGIYYHPTF
LYESIWDILGFIILITIRKHLRVGETFTLYLIWYSIGRFFVEGLRTDSLMLTSHIRVAQL
VSVILIIIGLVILIYRRIKYQPPLYKEAGPLTWNSSKAKVKS
>SEQF2892_00509 Putative acetyltransferase
MRRLTKEDHHKINPLWRIYSLVRFPKVFTNTLLIELCRFIPNLKWKRWIYINLLNMTIGQ
HTAIAYKVMLDIFYPQLITIGNNSVIGYNTTILTHEVLVDEYRYGPVYIGDHTLIGANST
ILPGVHIGNHVVVKAGTVVSKDIPDYAIAYGNPMQIHHK
>SEQF2892_00510 hypothetical protein
MAQNNDKIISMKFDEPFYRKMADQKYRMQDFNKAVEYYKKVLDLSPQDFDIKLKYAYCLN
KLNLGRRAEHLFYDSIIEGNHVADSFYQLSQLNIDLNEPNKAFLFGINYVILTDDTDFRE
ELEKTFEVSYMSEDKIQLEAQLFSTQLLFQYLFSQGRLQDARKYILNQDEKIQEHRVIRN
LLAMCYLYLSEYEIAKDMFEALLAEDNSDVHALCHYTLLLYNTNEKDKYHKYLKILSKVV
PMNDDESFKLGIVLSYLKQYDASQQILLPLYKKGKFASIQMFNALSFNYYYLGNKEQSKV
FWEKLLQISKVDVGYAPWVLEESKQTFDQKILPLLLDDDSHYRLYGVFLLNQLNGKEILM
TQEIWSILETMNDYEKLYLTYLVQGLHLNKLDFIHKGLVSLYEMDDIQKDTELFISWIDK
GEGLIANDVDFSEVDRYVAAHAYLYHRYYHSHMTKKKIMELFNISRYKLDNAIDQLLSI
>SEQF2892_00511 Thioredoxin reductase
MTEINYDVAIIGAGPAGMTAAVYASRANLSTVMIERGMPGGQMANTEEVENFPGFEMITG
PDLSTKMFEHAKKFGAEYQYGDIKSIEDKGDYKEINLGNKEITARAVIISTGAEYKKIGV
PGEQELGGRGVSYCAVCDGAFFKNKNLFVIGGGDSAVEEGAFLTKFADKVTIVHRRDELR
AQKILQDRAFKNDKIDFIWSHTLKSINEKDGKVGSVTLVSTKDASEQTLDADGVFIYIGM
KPLTAPFVNLGITNDMGYIVTEDNMSTKVPGIFAAGDVRDKGLRQIVTATGDGSIAAQSA
IDYIEELKDKQEA
>SEQF2892_00512 Nucleotide-binding protein
MTNHKENEMSKSELLVVTGLSGAGKSVVIQCLEDIGYFCVDNLPPILLPKFVELMEQGNP
SLQKVAIAIDLRGKELFKSLVEEIDAIKSRNDVIVDVMFLEAETEKLISRYKESRRAHPL
NENGQMSLMDSILEEKQLLSNIRTIANYIVDTTQLTTKELKARVKEKFEDENFKSFSINV
SSFGFKHGIQKDADLVFDVRFLPNPYYVEDLRPMTGEDEPVYHYVMKWKETEIFFEKLMD
LLKFMIPGYKKEGKSQLVIAIGCTGGQHRSVALAKRIGEELTEIFDYNVYVHHRDAHIES
GVRK
>SEQF2892_00513 Gluconeogenesis factor
MKQLKIVLIGGGTGLSVLARGLREYPIDITAIVTVADDGGSTGKIRSEMDIPAPGDIRNV
IAALSDAEPVIEELFQYRFKENQIEGHSLGNLLLAALTNIKNDFGHAVKELSKILNIKGK
VIPSTNTNVMLNAVLEDGEIVRGESQIPKKNKCIDRVFLEPENVEPMEEAIDALEDADLI
VLGPGSLYTSVISNLCVKGMSEAILRSKAPKLYISNVMTQPGETSDYDVMDHIQAIHKHA
GSDFIDYVICSNDKYDDKVLERYRERNAKPVVMDEHKITDHNIRMITSSNLVEILDDHLV
RHNTKVLARLIYDLALEMTSTIQFRPKK
>SEQF2892_00514 Putative sporulation transcription regulator WhiA
MSFASDMKNELTRIDVDESNAKAELSALIRMNGALSLSNQQFVINVQTENATTARRIYSL
IKRIFNVEVEILVRKKMKLKKNNIYICRTKVRAKEILDELGILKNGTFVHDIDASMIKDD
EMRRSYLRGAFLAGGSVNNPETSSYHLEIFSQYENHSEGLTKLMNSYGLNAKHLERKKGS
IAYLKEAEKISDFLSLIGGYQALLKFEDVRIVRDMRNSVNRLVNCETANLNKTVSAAMKQ
VESIQLINQEIGLDNLPDRLREIAKLRVEHQEISLKELGEMISTGPISKSGVNHRLRKLN
ELADKIRSGEKIEL
>SEQF2892_00516 ATP-dependent Clp protease proteolytic subunit
MNLIPTVIETTNRGERAYDIYSRLLKDRIIMLGSAIDDNVANSIVSQLLFLQAQDSEKDI
YLYINSPGGSVTAGFAIYDTIQHIKPDVQTICIGMAASMGSFLLAAGAKGKRFALPNAEV
MIHQPLGGAQGQATEIEIAANHILKTREKLNKILAERTGQSIEKIQKDTDRDNFLTADEA
KEYGLIDNVMQPEEK
>SEQF2892_00517 hypothetical protein
MNDEKLTYILLIIASLFLILNGVFAFEHNLIIILMSISFILIGIILFIISIRLFLKHSSN
N
>SEQF2892_00518 Epimerase family protein
MKQFLITGGTGMVGSQLVNELKNRDVHITILTRSDKQSDDPKISYVNWSKDGWMSLVPDI
DVVINLAGATLNKRWTPSYKQLIMTSRIQSTQALVDLFSDREHKPEVLFNASAMGYYPPS
LYHTYTEKYQTHPFDFLSDVVYQWERFAKRFESFGTRVILGRFSMILSDDGGALQTMKLP
YKFFVGGKLGSGFQWYSWIHINDLVRAILFTIDNPKAKGPFNMAAPIAERQNLFGYTLAR
VMHRPHETWVPSFLMRLALGEMSTVVLDTQKVLPNKLDALGFTFNYPNLKIAFEDLIDA
>SEQF2892_00520 hypothetical protein
MKKFVSEDIFEDENVPKHNLKSMMLNNDDYDDSHTSQFDLIFLLVIFIPLIILFLIFIH
>SEQF2892_00521 hypothetical protein
MSKNNRNRDDFGEPEKKKMSGISKLISTIIVLLLLSGLAFAIFAFVDHSNRSSERLNNQS
TEEHKDKNDKKDKEDKDKKDKSDKDKKTSEDSSNVTQENVTQQTAQTQQRQTQQATPSTQ
QRTKQQPSREEKQRTKEAQTKEEKTQEKTTKEEATTEETRTKEQATQESNSNNSSDNNSS
ESNTDKSNSNQTSNQTRTQQSPQTQQRSTTQSSTQQSTSRQTSQRSATSSQSQSSQESSN
SNE
>SEQF2892_00522 hypothetical protein
MARENDNNVEVIDPEDRRYKDDNYFNGNDHNERNNYSIRYHYGCGCPFGCLSSLIISILL
SIIFTFLLNWMF
>SEQF2892_00523 Central glycolytic genes regulator
MKELIKIQQKLIPDLIDKMYRRFSILTTISNNQPVGRRSLSEHMDITERVLRSETDMLKK
QDLIQVKSTGMEITEEGKSVLNQLNEYFNIYTDDNQLADQIKSTFGIKEVHVIPGDADAQ
ENVKSEMGRQAGQLLESILYEDAIVSVTGGSTMANVSRAMHLLPFNVFFVPARGGLGENV
IYQANTISASMAQQTGGYYTTLYVPDNVSESTYNTLLMEPSVVHTLDKIKQANITIHGIG
DALKMAYRRQSSEQVIESLQHHQAVAEAFGYYFDAQGNVVYKVKTIGLQLEDLETKDFIF
AVAGGQSKGEAIKAYLSIAPKNTVLITDEAAAKVILN
>SEQF2892_00524 Glyceraldehyde-3-phosphate dehydrogenase 1
MAVKVAINGFGRIGRLAFRRIQDVEGIEVVAVNDLTDDEMLAHLLKYDTMQGRFTGEVEV
VDGGFRVNGKEVKSYEEPDASKLPWGDLDIDVVLECTGFYTDKEKAEAHINAGAKKVLIS
APAKGDVKTIVFNTNHNDLDGSETVVSGASCTTNSLAPVAKVLSDEFGLVEGLMTTIHAY
TGDQMTQDGPHKKGDKRRARAAAQNIVPNSTGAAKAIGKVIPEIDGKLDGGAQRVPVATG
SLTEVTVVLEKDVTVEDVNKAMKNASNESFGYTEDEIVSSDVVGMTYGSLFDATQTRVMS
VGDRQLVKVAAWYDNEMSYTAQLVRTLEYLAELSK
>SEQF2892_00525 Phosphoglycerate kinase
MAKKIVSDLDLKGKVVLERADFNVPLKDGKITNDNRIVQALPTIKYIIEQGGKLVLFSHL
GKVKQESDKEGLTLKPVADALSEKLGKEVTFVPETRGEKLESAIKNLSEGDVLLVENTRF
EDLDGKKESKNDSKLGKYWASLGDVFVNDAFGTAHREHASNVGISTHLETAAGYLMEKEI
KFIGGVVNDPHKPVVAILGGAKVSDKIGVIKNLVNIADKILIGGGMAYTFLKAQGKEIGL
SLLEEDKIDFAKELLESNGDQIVLPVDAKVAKEFSNDAEITEVSIDNIPSDQEAMDVGPK
TVELFSKELEGAHTVVWNGPMGVFEFSNFAQGTIGVCKAIANLKDATTIIGGGDSAAAAI
SLGFEDDFTHISTGGGASLEYLEGIELPGIKAINDK
>SEQF2892_00526 Triosephosphate isomerase
MRKPIIAGNWKMNKTVKEAKDFVNNLPTLPDEKEVESVICAPTIQLDALISLVNDGKAKG
LKIGAQNTYFEDNGAFTGETSPVALADLGVKYVVIGHSERRELFHETDEDVNKKAHAVFN
HGMTPIICVGETDEERENGKANEIVSNQVEKALEGLSEEQLKEVVIAYEPIWAIGTGKSA
TSDDANEMCAHVRKTVAKVASQDVADATRIQYGGSVKPNNVKEYMAQSDIDGALVGGASL
KVEDFVQLLEGAK
>SEQF2892_00527 2,3-bisphosphoglycerate-independent phosphoglycerate mutase
MAKQPTALIILDGFANRESEHGNAVKQAHKPNFDRYYSKYPTTQIEASGLDVGLPEGQMG
NSEVGHMNIGAGRIVYQSLTRINKSIADGDFFENDVLNNAVQHVNEHDSALHVFGLLSDG
GVHSHYQHLFALLDLAKQKGLDKVYVHAFLDGRDVDQKSALKYIEDTEAKFKSLGVGQFA
SISGRYYAMDRDKRWDREQKAYNAIRNFEGPTYASAKEGVEANYANDLTDEFVEPFIVEG
QNNGINDGDAVIFFNFRPDRAAQLSEVFTNKAFDGFKVEQVNDLFYATFTKYNDNVDAEV
VFEKVDLTNTIGEVAQNNNLKQLRIAETEKYPHVTYFMSGGRNEEFEGERRRLIDSPKVA
TYDLKPEMSAYEVKDALLEELDKGDLDLIILNFANPDMVGHSGMLEPTIKAIEAVDECLG
EVVDKILDMNGYAIITADHGNSDQVLTDDDQPMTTHTTNPVPVIVTKEGVTLRETGRLGD
LAPTLLDLLNVDQPSDMTGESLIKH
>SEQF2892_00528 Enolase
MPIITDVYAREVLDSRGNPTVEVEVLTESGAFGRALVPSGASTGEHEAVELRDGDKSRYS
GKGVTKAVENVNEIIAPEIVEGEFSVLDQVSIDKMMIQLDGTPNKGKLGANAILGVSIAV
ARAAADLLGQPLYKYLGGFNGKQLPVPMMNIVNGGSHSDAPIAFQEFMILPTGAESFKEA
LRWGAEIFHNLKSILSERGLETAVGDEGGFAPKFEGTEDAVETIIKAIEKAGYKPGEDVF
LGFDCASSEFYENGVYDYTKFEGEHGAKRSAAEQVDYLEELIGKYPIITIEDGMDENDWD
GWKQLTNRIGDKVQLVGDDLFVTNTEILSRGIEQGIGNSILIKVNQIGTLTETFEAIEMA
QKAGYTAVVSHRSGETEDTTISDIAVATNAGQIKTGSLSRTDRIAKYNQLLRIEDELFET
AKFDGIKSFYNLDK
>SEQF2892_00529 hypothetical protein
MENQLNQPSQRERNAGKLIGYSSLILCILLIIHNFIALDTLTAKTLLSQAGQKASDSAVA
NILNSFRYTGIMYILAYLAGVIALWNRHKYLWWFMFAVYVSNVLFTLVNVTMVINAIITA
KSVLFIIPIIIVIVGSTVLALYMLVISIIRKSTFNR
>SEQF2892_00530 putative protein-export membrane protein SecG
MHTLFIVLLIIDCIALITVVLLQEGKSNGLSGAISGGAEQLFGKQKQRGVDLFLHRLTII
LAVIFFLIMIGISYFGL
>SEQF2892_00531 Carboxylesterase
MQIKLPQPFFFEEGKRAVLLLHGFTGNSSDVRQLGRFLQKKGYTSYAPQYEGHAAPPEEI
LKSSPHVWFKDVLDGYDYLVDQGYEDIAVAGLSLGGVFALKLSLNRPVKGIVTMCAPAEG
KTQGAIYEGFLEYARNFKKYEGKDQATIDKEMEDFHPTETLKELSETLNNVRNEIDEVLD
PILVVQAENDEMINPQSANYIYENVDSDEKDIKWYANSGHVITIDKEKEQVFEDVYSFLE
SLDWSE
>SEQF2892_00532 Ribonuclease R
MNLKQSIEEIIKQPDYEPMSVSDFQDALGLNSADSFRDLIKVLVELEQAGLVERTKTDRY
QRKQSHKSSNSKLIKGTLSQNKKGFAFLRPEQEDMDDIFIPPTKINRALDGDTVIVEIQK
SKGEHKGKIEGEVKSIEKHSVTQVVGTYSEAKHFGFVIPDDKRIMQDIFIPKGQSLGAVD
GHKVLVQITKYADGTDNPEGHIFAILGHKNDPGVDILSIIYQHGIEIEFPDNVLKEAEAV
PEEIKPDEIKGRTDLRDELTITIDGADAKDLDDAISVKKLKNGHTELTVSIADVSYYVKE
DSALDKEAYDRATSVYLVDRVIPMIPHRLSNGICSLNPEVDRLTLSCRMEINERGEVVKH
DIFDSVIHSNYRMTYDAVNQIITEKDPDVRKQYQEITPMLDLAQDLSNRLIQMRKRRGEI
DFDISEAKVLVNNEGLPTDVVLRERGEGERLIESFMLAANETVAEHFNKLEVPFIYRVHE
QPKSDRLRQFFDFITNFGIMIKGTGEDIHPSTLQSIQEEVEGRTEQMVISTMMLRSMQQA
HYDDTNLGHFGLSAEYYTHFTSPIRRYPDLTVHRLIRKYLIDNSMNNKELHKWEDKLPEL
AEHTSQRERRAIEAERDTDELKKAEYMIQHIGDEFEGIVSSAANFGMFIELPNTIEGMVH
ISNMTDDYYQFDERQMALIGERQAKVFRIGDQVTVKVTHVDVDERIIDFQIVGMPLPKND
RSQRPSRGKTIQAKTRGKSLDKFKDDDHKGKKKKRKQRKGKNQRSRDKQGKTNHKPFYKD
KSVKKKSRRKKK
>SEQF2892_00533 SsrA-binding protein
MAKKKTKSPGTLAENRKARHDYNIEDTIEAGIALKGTEIKSIRRGSANLKDSYAQVKRGE
MFINNMHIAPYEEGNRFNHDPLRSRKLLLHKKEIIKLGERTREIGYSLIPLKLYLKHGQC
KVLLGVARGKKIHDKRQALKDKAMKRDVDRAIKDRY
>SEQF2892_00536 Tyrosine recombinase XerD
MASFTVTKRKNKNSTSWQYDVKHPSFKSGKKRKSGFKTKAEATNAAQRLIRDLEDGSKFE
DNKKFEDYYNEWLIIKNKKKVSPMQYYWYERSLRLFNEYFGKNMLLKNITRSEYQKFLNR
FGEGHADETVRKVNGCLSQCLKDAVYDGHIKKDPTYNIAINGTVKAKDERYKYMSITHYL
AMLDYFKSRDEQSYIFLYLLAITGARYSDLINMTYKDLNKSEGIIHLPGTKTKNSKRDVE
VSTKDVLLINSKLTKLPRRIDGKLFKLSHNAIKKSFNHTKKQVGLENDNITPYSLRHTHT
SYLLSKGLPIEYISKRLGHASISITLETYSHLLEEHKKEQGQRVRELFS
>SEQF2892_00537 hypothetical protein
MAKNVGFKNNYAIGVIKSGLSKEGKKAIDLLSSEEQIKLANLQRNNDPDLSKEVNKAIGM
DNDFTSVQEKNEAYREKSIEKQGIKKPTETTSNAFYFQNKSNTLDDIYNLIGLGTHLSQK
EQAKFVHYKDMKTNTYVQIAQNDEIIKQNNKIQEQNDEIIELLKQIANK
>SEQF2892_00538 hypothetical protein
MHFVYQNSFLKAARAVSALIETNYIDEFPLPIKEIIENDSNVELFTFKEFCDITGYSLNE
LQTYGGSDEAFHIKKGNKFAIIYNENVYNRRLRFTLAHEYGHYIMEHDGMSYKKTPILQD
TQRTNLEEYEANSFASCLLFPLNIRYKYRNVLNVGDAADLFKISYQAAKVALDIFDEHMD
SGLENYISMFEHRHMETYMSFLDEMLGEQMEEYNRIMRTEYGY
>SEQF2892_00539 HTH-type transcriptional regulator Xre
MNLVQRIRNLCNSQSLTFAELERILGFSNGQIRRWEKTKPGIDKIQKVADYFDVSVDYLL
GREKDEYAGEQEDEEIRIMHRGVKNMTKEDREKALKMFETFFDNWDEYTKDK
>SEQF2892_00540 hypothetical protein
MATTEFGMKVRMELLKRNITNKQLADMLGISSAYLSDILRGRRDAFEQKKRIAKILEIKD
EVKN
>SEQF2892_00541 hypothetical protein
MNEIQQLFNLKRNEDGTVAVSGRELHKGLEIGTRYDKWIERMIEYGFEENIDYIIQSEIV
HGQKRARTYEQENHIMTLDMAKEISMIQRSEIGRKIRGYFIKVERQHNELASAYGITSLD
DMNQLIEQLVSDKLDYLISTGQVSNQKLEELNNKFEGEYVTPQDIDAIKFAIKSKAEQIL
GKAGIQVTIDEYLVGDVYEQALANKKAKEEYRYQLGKVKSKLLVKSKKHLGMKGNAPNNH
IKRKDVDLAIQFIKDIRPSSIEI
>SEQF2892_00542 hypothetical protein
MKTFYKHATICLNGHIVSKDEANYFKFCKVCGEPNISECQHCTTPIQGVIYIPNGFPITN
YNRPNYCHACGKPYPWTEKIINNAVELVSLDDQLSDDYKEIIKNALPDLITDTLDTPLAQ
VKYKKYMNSASKHIQDSVRNLLIDVVSDAVKKSIF
>SEQF2892_00543 hypothetical protein
MKQEYKYFLDVKGFVEVSGLSKDDFEKKVAPNQEFKKFIYKFEDSRKRYIKVKPALEFIE
NSLMSKTNEF
>SEQF2892_00544 hypothetical protein
MTNKDKATIIAGMMFNVTFFLAMMLNIFVTNAIAIAMVASTVTYLFFGKLFYAQKKTETH
WRE
>SEQF2892_00545 hypothetical protein
MTETIKTNQHYYTKNFSSYDNTENNFVANQELTVTITLNEYRQLIEMKSKKDKEIEDYRN
RYWEKKSEAEKLKEENLELKNTIFNLQTDKGEEDLTNDQPL
>SEQF2892_00546 hypothetical protein
MTNLYNLSTKHQQLLNMLDEGYSIEDLQDTLDSIEVDMNTKVDNTVGLIRSIEADTDAID
KEIKRLQALKKQKNNFIGRLKQHLQDALEVQQRDNYRTSTNYIYKRNNQPSVNITNEALI
DKSYRIPQPDKYDKKAMKEDILAGAGVEGAELVNSTSLVVK
>SEQF2892_00547 hypothetical protein
MEFKISNAKDITTDKSTYLIYAKPGTGKTHTINFLPGKTLYVNVDKSERPLKGNENIDIL
NFNTHDAWEEWGELMKWFNDNKDIVNQYDTIVIDNISELFRSMLANLGRNGKNERVPEMS
HYQRVDFFTIDSLRFLQSLGKRLVFIAWETNFENYTPAGQQITQAVPDIRKTIRDNVAGL
CQVVARLVFNEKSGKRGFILSPSNNVFAKNQLDNREHCLQEDLFKVGDVDVPTT
>SEQF2892_00548 Putative DNA repair helicase RadD
MMWMFRLRDYQNELIEGIYQSMSKGNTKIMVVSPAGSGKSVTMSEIARRATDKGNRVLFI
VHRRELVNQIKATFVANGVDMNLCNVGMVQTVSNKIKRGKEPTPSIILVDEAHHSMAKTY
LNIFESFNDAYVLAFTATPWRMSGRGFTDIFQDLIVGKTVQWLIDNNRLAPFKYYSVNLM
DDDKLKKNSTGDFSDASITLSMEPQIYGDVIKNYKKFADGQKTIVYTHNVQSSKEVAEKF
ISNGYAAKQVDGKTPKVEREKAMELFRNGDITILVNAELYGEGVDVPDCECVILLRPTMS
LTLFIQQTMRSMRYQPNKLATIIDHVGNYRRHGLPNTEHDWNVHFKGERKKIKDNDAIPI
KECPECYSVIESSYSVCPACGFEFPQEREETELLIDEDAELEEVDDKIITLTLKEPEECE
SVEELYQLAKQKGYKPGWAYIQAKRLGMLGG
>SEQF2892_00549 hypothetical protein
MKERGIYKGGEVINGLTIIGDTGKRTKDNYIIYLVKDKDGNYKEYQSVNISRGNASGYKT
SQEGREKSRQSMNELNKNRDKYLKKRGYVNGTVTWAKNIKKPTHNTSGYKGVSLLKAKPG
KRKKDAWRAYIVVRKKQIHLGTYENKQDAIEARKLAEEKYFNTKGEF
>SEQF2892_00550 hypothetical protein
MTNITLNMEDTFDGGIQDGTYETVITKFEESATQSGTEFVDVRLTIRNDIDQKYKNNIVF
HRIWKAKATGKYDMRFFNTIGAAAQLQRGKQYSSIEELFKDFLGKAVRVTVKNETSEYNG
KTYENLNVKRWDKTKFPELAHKFKTTDDGSNPFAGGLAETENEDYPF
>SEQF2892_00551 hypothetical protein
MYDKIPYELKELDQWCCFKIEEVENGRKTKRPYNPLTNNMAKSNDETTWVSFEDAVNNLN
GYDGIGFFFVEPYIGIDLDKVGNEIKEYLNDPDTDNIISEFINVLETYAEVSPSGTGIHL
ITKGELPKKGRRRGNVEIYDKGRFFTMTGKQIGGYNGISNDEYGQLNFLHSKYIAKQEPD
INAQNLSGGNGNNLTSEQIIDIAKKSKNSLRFTTLYEGDWEQFYSSQSEADLAFANDLAF
WTARDPKKMDDIFRKSNLYRDKWDEKRGEETYGNITINTAIESCQNEFVPETTDDDFQIF
IMDEAIKPAKENRSYSYDDTGNAERLRDKFGENIRYNYTSRLWMYYDGRHWKNDDTGRMK
ILTDKVAESIKKEKLFKSEGIDSDDMEKYRYRHWKDTRNHNKKVNMLKECEHLLPVTNET
FDKDFDLFNTQNGYLNLKTGELKEHDKQQYFTKISNVEYTDKSDCPKWEEFLNDIFLGNQ
ELIKFIQRAVGYSLSGYTTEQVLMVLYGNGRNGKSVFLDILNEIFGNYATNIQPQAIMAS
KTQSDASPEIAKLDGARLVTTTEPNEGERFDEGLIKQLTGGDRVSARKLYENEFEFTPQF
KLWMATNHKPYVRGRDDGIWRRFVIIPFEKQIPLKEIDRDLTNKLKKELPAIMKWCVDGF
LEWQRIGLSEPAIIKEQRDEYRTEMDSTEAFIEECCNIDATKYVKTSELFKAYDMWARQN
HQYKMSNRKFRSEMEKKFSVKKSSSEYYQGIEINNDSYPNKFSLNI
>SEQF2892_00552 hypothetical protein
MKNNDKYIQIITAPNNLYAVFQMEDGTEEYSRIPLFALTEKGDIEMIDVDDSGWFDNPVT
TQNFLRIEYK
>SEQF2892_00553 hypothetical protein
MSEQKIQNEIILAINQRGHRLWRANAGKVQTKDNRIIKLLPKGFPDTFGFRKSDGKFIAI
EVKTENGSLRPEQKKFRDFAETQNILYGVARSVEEAIKIVEED
>SEQF2892_00554 hypothetical protein
MQEETLKLTFDLTVEVEQPIWINKHADRENYIEHYANRYKNDPDNLLDNIKNITDVSVSY
ADWK
>SEQF2892_00555 hypothetical protein
MPKVNLNGKRYRLCDVYKYFDVSDSTVRKRYDEGLRGPELIHGKGVYEYGADVRKK
>SEQF2892_00556 hypothetical protein
MVQMYERNEKQLTAKQLYEIQQAEIRHERALKRKRREERIARAKRAEREVAKHRVNSKWF
RYLSENDIFPKVRR
>SEQF2892_00557 hypothetical protein
MENVRIIDLKVDNIVQFQATFKGVTAMQTAIVNRVYAKEILLKTVWYAEVENAAGYKFTL
TDNDDFVKVNEPFTRKVDMKEGQDMVNEPPHYQFGKFSARVIIELVGKTYKSASVFYHVG
NALKYLMRAPRKNGLQDLQKAKQSVEFAIENWEAK
>SEQF2892_00558 hypothetical protein
MTKYNITVEGTIKVIREYEVDTNEDIDGILDEMETATRYGFETPGSFFNGSPDLEVISST
DETDFSSPEIIEYEVIDVMED
>SEQF2892_00559 hypothetical protein
MIYLGGDMLSIGQQMRREWEKQELQRLGFKVYAPHDDKDINDKANAKQDKLAERIVFNDT
LGMETSSIMIFDYLPHAQGTICEMGYAQRLKRTSEKDIKIYVQCTDIRQGTGHISDEQDR
AEFSINQYVYGVIMDVTDGRGIQTFDEICEELIS
>SEQF2892_00560 hypothetical protein
MIKFRVWDKEEKKMHKVKTIEFSRRGARIIHLAEVNSNGKGDHKRWHSSVELMQSTGLKD
KNGTEIYEGDIVKTNHSKYGRFIGFVDDAASRFDVRGVKQYEHLSVDLRAPCEILGNKHE
NPELLEDE
>SEQF2892_00561 hypothetical protein
MAKLHFGSKEYFEKQSEFWFEENSKHISERDAYKKQRDELINDIEEVKRKAEAFDDILNV
DYIVAPDDYAHEVTKIVNKYKECADHEK
>SEQF2892_00562 hypothetical protein
MKNREYKRAWQKLKDKLTEDYIEQIRYINQYSITDANDTWSSGWNMSTAQQLYTDLHLMD
QLDGTHEFQNLLSDLEEQ
>SEQF2892_00563 Deoxyuridine 5'-triphosphate nucleotidohydrolase
MGILPIKLLSEKAILPTRANPTDSGLDLYVAEDTTILAHSTKVVPTHIAIDLAYGYEAQV
RPRSGNSLKTKLRVALGTIDHTYNKEIGIITDNIGDETIVVKAGTRLAQLVVTPVMLPEP
TEVQEFDEESERGAYGSTGE
>SEQF2892_00564 hypothetical protein
MTGYVIATLFCGSFIGSIVSLSVFTVDLIANKQLSKKGLLFFFLLGIILNILSLLIYPIG
VDYGVLER
>SEQF2892_00565 hypothetical protein
MNIKKKREKKPVEIEFMQFNNIDNAYDISQWAVGKIKYKVSRKFNIGYMYVETLEGTMTA
SLGDYIVKGVNGEFYPVKPDIFERTYDILPDVIKADYIWDKE
>SEQF2892_00566 hypothetical protein
MEDNKNDKKYIIEIKSGLYVSTNAFGNVYSFTKNIEEAIKTSYLDSARDIAERCYGTVKE
YRMKHEILEVVE
>SEQF2892_00567 hypothetical protein
MQFLIREFTDSTGHVHVNVEEPRENEHMTLVDAEDKEEAKKKAKCILSQHDRLQLRKLYR
LQDRLG
>SEQF2892_00568 hypothetical protein
MSDFKIITSELISKGIEFEIEDDTLIVGDCSVINYSDVYFLKLSGVNTQQGIAVKHPIVI
ADFLSSYYYLLEDHNSITVKDINFKSEVRSND
>SEQF2892_00569 hypothetical protein
MIKRVIKIWFIIGMYELSKYLTNELIVKLQSEDDVGTFNQSDHMHLNMEVSK
>SEQF2892_00570 hypothetical protein
MWITISIILAIALLIALGSNSILRNELDALKYTNVYLFSKFVRESDIEDIEREIERAKKQ
FK
>SEQF2892_00571 hypothetical protein
MTLNKRDVVLMEEYWKNLKEMKGQLAYRRYELLYQPTDTNFGGGKSNIVTSPVENEVVKL
HQDDLYKNLSNTITSIEDIYRSATKEQQVIVDYRYWDKDLLIHEWEDIAHELTKQREDDK
VISVYSVLRMRRKLMEETAKRIGFIHFD
>SEQF2892_00572 hypothetical protein
MTESEYKAQRERNRQRNAKQYNAHTRYGKDSKYMEFYHSKEWRNKRKQVLLRDKYLCQSC
LRKGYVNPVKKGQRFYVHHIIELKDDWEKRLDINNLETVCAECHLESHRGQRRKR
>SEQF2892_00573 hypothetical protein
MARPRKLNAVKTGNHNKEDLEYQELKENGLSQFNKIDIKSVPTDLTKEGKKEWKRIIPLL
EQLPIAELDYDRIKRYCQLVSLTDEAYRHIMQHGTVNEEGTKRTPQYFTYMDGIKELKSI
CGQLGMTIDSRMKLVVPTPDEQKESIYGKFGVDDDD
>SEQF2892_00574 hypothetical protein
MTMTNVKIPKAYEEYLNIPDEYKDDAYKYCVMVLSGAFVTCKDTRLACIRHLKDIKRSIE
DNEFPYVYKPKRAKKVIQFIEVLPDTKGKFNKLALFQKFIVSMVRGWFTEEEDYLRFNKA
FISMARKGGKSLLVSGLTLYSFLFDREPAEGRQIFCAANDKKQASIVFNMVAKQLMYFIS
QVPELKKDVKKVRELLQHTKDGSYVMPLSRDTGAVDGFEPFLAVIDEYHAAKTNEMLELI
QSGQGNLMQSLIFIISTAGFNLNAPMYMDEWPYAKEILADTYHDEQYFAIIFEQDSEEEW
QDKTMWAKSNPLINENDDLKEQIEDFLQKRVDEAVKKGTMFRVLVKNFNYWMQASEESYL
DFNDWKKNETEFDIKGTKTYIGLDLSRADDLTAVSFIHLDEVKKQYFVTSHSFVATKGGL
QAKIERDLIDYRQMAQHGYCTITDLQSGIINSNQVLDYIEKYILTNNLDVQAICYDPHAI
HGFIAEIEKRNWRYELIEIRQGAMTLSNPVIDFRLKVIDEQIKHHKNPLLDIAVKNAVAK
NVNDSVMIEKKLNREKIDPLMSTIFAYVIASEHEWDKKRALPVFI
>SEQF2892_00575 hypothetical protein
MEIAKNIIILLLTLIGIVLIGYGAYLAWKPLGFIVAGLLVTGFALTLDQPFKGGGGNS
>SEQF2892_00576 hypothetical protein
MGVFNFNGFRRSNEVSVDRSTLRMITEANGLGDITWNGISSLRNSDVFTAIDIISKDIAS
TSIQFNDKDSYLDDDKKILKLLNRRPNPYLDAWHFKYIIVANMLLNGNSYVEIVRDDKGQ
PIELYHMQNNAVSIEQIDDKIKYNYIDERDGHVRFDTDDVLHFRMFSMDGFNGYSPLFAL
ANEIGISMGSKKFLDEFFKNGGTSTAILKYEDGRYSDEELAIIRQNFENSQLKNNNGLVM
LDDTMTFDRLKVPTEVLNFLNSYKFSTQQVAKAFGLPLSKLGIETVNTSLKDSGIEYYRS
TLYPIFSMMNAEIEEKLFAQAPYEVTLDYDVARLIDSDPEVKLERVTQLFTKKIITLDEA
RAQFGFKPVENGSEPLADLNTIFLKDLSAYQDSKVQKNIDSLNKGGDELGGIQSD
>SEQF2892_00577 hypothetical protein
MAYSQIETTTDEEMVVEGYAIIFDTLSDDLGGFKEIISPTALSQVDVTDVKCLINHDYNQ
IVGRTLANTLELTVDDKGLYFKCFLPNTSYARDIYENIKAGNVNQCSFFYTLPINDDTAR
TWSKINGEYVQTINTIDELLEVSIVTLPAYRDTSVVVGQRAKGLDKFKELEKYKLEFDLE
SLRVDT
>SEQF2892_00578 hypothetical protein
MATLDEQAKSINDLIDQAQKAVADGDVETARKLKEEIEQAKATYNEQKEIADAVQSEEKI
SSNSDKPASTEKTETEVKNDKPDAESKDVEVKEKKEQPEKVEVKEEVENPTDEELEDKKK
LGGKRSMTRQIIENKQSKLSDEAQGFVDYIKSKGTKRDNVKSVDAQPLIPEDIKYVPEEL
PETVVDLKKFVNVQPVTTAAGSHPILNPAQETMIAVEELEKNPELAKPKFTDIDYKIKTY
RGQIPVSQESLDDSEANLAQIIAKNNARQALNTTNQQIADVMKTFEAVNTANLDDIKAII
NVDIDPAYNLSLVVSQSFYQALDTLKDKNGQYLLKQDITSKSGTTLFGRPVFIVKDKILG
AKGDKKAFIGDLNYAIFFADRKQATVKWVENEIYGQVLATYMRFDVVKGVEEAGRFLTYT
GTAGDLGTGSPEA
>SEQF2892_00579 hypothetical protein
MANFKVKQQYNDLELKRVLKKNEEVEMTVKRADAVEKTLSEKGFKGPFLERIDNKDKK
>SEQF2892_00580 hypothetical protein
MLTLELEEVKNRLRVDHDFDDDEILGLIQASEQEIQGAVSGYGKANAFYKGNALYNLAVI
NQVGHHYENRSITSQFAKYNVAPSSLALIQSLRGAYALWKSEGSNIE
>SEQF2892_00581 hypothetical protein
MEIGRLKHRIKIYDQTETVNDEGIYVTDKKLIATPYCEVSKTTIKEFREMGLEARRGTID
FIIRYRQKADIQSDMIVEFKGKGYKIKYIETDLQDLERQMLKCEVVE
>SEQF2892_00582 hypothetical protein
MTKQRYDSDKDISDKIRKLVINSEKQSKQAVTKGAKLYKANIEANTPVHKRQTHSTHAVE
VLKISNFSRDELNPTKTVGFDKGRKRADAGWYIHFPDIGTRPSNRSMGQPPQHFMRRSLE
MSKAPILAIYKEAVRNMVDVD
>SEQF2892_00583 hypothetical protein
MSTRHPIVRIYSWLKGNKELEQLLNSSKQPKIFNFEIPENYQKAEYTPLVRITEILLQNT
IYRDGDSEYYRFLFAIETFGNDINTTYTVSEYVNDIIKQHNGRVISRDLSKDKELGLFNQ
MNEYEIILPVKE
>SEQF2892_00584 hypothetical protein
MADKKVAITCEGFKARRQAGNGFEVGPLTDVPGLQEIELELEQGNEPVYADGVKKLNLFS
GITGATVTANLMELNKEEREQFLGVKVDKGMELYTSDLVPPYLSVSWKYRCNDGSYIYYG
LTRGNFNIPNTSASTMEDSPEQQDQVEMEGSFVQRDNDKLVFARIHSADPDFNEEDFYKA
IHGDDAVTTADNTPAA
>SEQF2892_00585 hypothetical protein
MAKVILKIDGKNKTFVKDKLNLGAVKAQAEFEQKLQTGFSTIGELQNLYRKHRGILNKIE
KVENKLADVETDEEAEKLYQELDELEATDEYKEFLNKSEELNEQIKEEGNDEDFEIYDEF
ANLLVKVFDNQFTIDEVFDGLEVENSLPDTYSKIFASNDAGKPKKKATTTKTKQQTK
>SEQF2892_00586 Murein DD-endopeptidase MepM
MADFNLGAEVSMDVDPIKASTRTLERELKNINKSLRSQRSEFKKNELSAEQLANREKDLG
KAITAQEGLLKKRQDSLEDVRTEISKSNVVTEEQKRKLNSASRAVQQAENQLSTYNRELK
ETELAYKQFNRSSDQVKNSLGELKNRAKLSEIAFKQGTRSVDNYKDHLTEMNYTITKSKA
NINLLKQNLKEVSLAHGSTSRQADKLRNDILKESIAMQIAQGRADELSDELDEVARSQRK
VRLATTLMGAGFAGARDSADRIATTLRSVGEVTQGVVGEIMATQFANLIPIMGSVVSAGA
GIGGMLTSLSGGAIGLGGAFGIGMGAINAFAGQATYALKKLEDGELALTNETRRYQSVLS
SLKSEWEGLIAQNQAKIFNTLSNGINIARTSLSNLNPFLTRTAGQIESMSGKMLNWVKTS
SNAKTAFNILNTQGTQAFGHLLQGAYHFVDGTTAVFNKLSPLFVWASKGFENMALSFRKW
ANSVEGSKAINGFVEYTKTNLPIVGRIFGNVFAGLFNLFSAFSGHSHNVLLGIESVTEGF
RKWSEELKRSDGFKQFVEYLETNGPKVWQLIKNITGVLWGLVKGMAPVASVTLSITNAIT
GWMASMVNTHPMIGKILGSTVALTGAILLLLKPIFLVKGALSGMRGALLAVTGAEKLLGA
QGAFATLGMKRQAIQAKITTAATKAWALVTKAAALATKGLGLALRFMTGPIGIVITIVGA
LTAAIIYLWKNNETFRNFVINAWNAIKNSAVAVFGFIKPYIINIWNAIKNSTIAIWNILK
NAAKVTWNAIKFAVQHPIQALKNIISSIWNFIKTNSLKTWSLIKTGILTIAKSLVSLVRA
SFNGLKSFFSSIWNFIKNISLKTWSAIKNGVLKIIRSLVNGAKTVINSLKKFITTAWNFI
KSTSIKLWNAIKNGVVNAIRGMSNGVKKIVVALKSWMKKTWTAIKNTTIKLAKALWSGVK
NTWNSLKKGTIKIIASVAVWLIKKWLSIKKNVVNTVKKLWSGVKRTWNSLKSGTIKIMAS
IAVWLIKKWTAIKKSVVNKAKGLWSGVKNTWNSLSRGTRNIFNRVKSFMSNIWRGIKNTT
VNMAKGLWNSVRRTFNNMSNGLKNIIEKIKGHITGMVSAVKKSLNALIGAVNWVGGKLGI
DSKIPKLSTGTEGASSQNFVSNGAINQPTLATVNDKGRGNGTGVNGHQELIQRSNGSIYA
PQGRDVVVPLNKGDRVINGKTTQKLQNQGFIPKFSRGTDSGEDVRKRMLREAKKRKKHNH
PTFDAGEMMGQGGFGAGGAGGAAKEAWKYVTDKTKNIGSGAKHTVKSLSDGAKKMINTTK
GALGAAGTWAKEKAGDLLQYLGSPGKLVNKVLKEFGVDFSMVNGEIPKMLWDAMWKQLKE
GVKSLFGGWLDDVSGGDGDGRFIKYLDNITTRYSPNGPPPGYPFNWAHPGIDLPYIYEKV
LTPMGGKVETRHTASGFGKHVIVRAKPYDAYFGHLSKWLVKNGQRVKPGDAIGISGNTGS
SSGPHLHYEMNKHGFGSMTGHSIDPVKWLKSHNGSKSVSKSASAWKPDIRRAAKAIGVRV
SNADVNDVARLIQTESSGNAGVTQGIKDVNSGGNEAQGLLQYTPGSFNSYAIRGHKNIKN
GYDQLLAFFNNTDWRANLSYWKRRMASGLTGWGPTGRRKKYAAGTNNARKGYATVFEKGG
EIMNLRGGEQIIPNDVSIAAIESVINSDIFDRTQSAVYEAISRFADGLREQKENKDNWIE
QLYLKQVEENTELKNQNSILMQVVNKLDQLLNVNNQVAQTNEGILHKEYFDSDKMSKKHN
ENMRKEAITKLMGKGGNV
>SEQF2892_00587 hypothetical protein
MSFTLYNPNMNKLHYPEGVIPLDFIFSSVSKNRLTSERDGKPGVVDFGFDYRERDVTLNF
YLQHSSDLFDHKLLISELYGFLDGYDFFYVVDDNVPTRMLKVAFDEAYTPERYGYWYAKV
EIKATIIGHPFFMTTYTTQQIEQYGYEALQNKFGLADNVSLDYPHYSFSDSTFSVWNGGN
VWIDYRNMDLKITVKGLKTDGNFQIQNLTTQETFIYKEKVTGQDLVLNGPLIYVGPNNML
RNTNRQFIKLGPKKNDFKIINGTYDSIDFDFRYHFK
>SEQF2892_00588 hypothetical protein
MGRRVINSLWNRDNLLNMNYNFEELYNHIRRVSNVTIDIANDNKLTPQQFQDLQITLNGL
LKKGDLSVKDINYNLGKIGLSELSDDVIKAISGNANVNAVTADGSIVTPKLASDAVAIEK
TAFVKTGKNLFRVNEVTRNYSISNTTGELISSQYYVASAFEPIKPSTDYVQNYGEAIAFY
DINKQFVSGLAKATNVKQPRTFTTPSNAYYLRTGCLKESVDTYNYKGYQIELGTTSTPYE
EYYRFINYLKPNLQDNSVTDSKLANSSVTMDKLSFAKTSQNLFDKLKANKGVYVNPTTGA
LSTNASYYASDYINIKGATQLTKTSALNLYAFYDENKQMVVTTTQNTQTIDVPSNAKYIR
ISVSYLNLDKEMLVIGDKLPSAYVPYQIFIPKEYIESSSSGTGYVEDHFGRQFLKTYVAD
FSKAMSSDYTGRAEIAFIGDSWVAGGVNKQGERLTRPLRERYLKNYADGGIGFVSYANSH
IGNGEVAVTLTGTWQHYDEGLGNIAQSKGLDSAMVESSTAGDSIKVQFYEDLDFYEIHTL
NTGTWRYNIDGGSWVTVDATKQEVTPITLSLGKHTINIEIVSGKVTFIGSYAYKGNKGVV
VHKIGNSGLRGGHMTSTDRDNYIKQLKRCRANTFGILLGTNEMAQSVPVATYESDLKEIV
SRIREAKPRASIFLIAPSGNTYDNTKLHTIEEYSNTQLKVAKELNTGHVSLYRNLGDFAM
TNANGLMYTDGVHPNKEGGYAISNIVYDRLLRLAY
>SEQF2892_00589 hypothetical protein
MLFIRDLDGNEYMMEGEVKHEQEINGDERIDVEIEYTDVNAHFMDKHDDLKMWIIGFEAK
EYRILTSSMTGKGNKYTISVTAILYMLDWLNSNRIYKKVDGSYTVTRALNLVFDGSPFTY
HVTETSGSESFEGLGGGETRLEILKKFIERYEYEITIEGNVMYFQKLIGNDTNFQYQYKV
NATDIGVETDSSELYTYIEGYGDYSDDDESKDITEIAKLKPGTMSNNPYVSPIEKILGHR
RQAPPIQDGRVKKPETMLKKLKQVVDDSLKVSFTANLNDLAYQGYKYTHAKLGDRIFLVD
ERIGLDIEIRVIKIDRSYNQEYHLTDIQITFGTKNMAEMYSAKFNTAVSNINDVMAGKKQ
IPFAALGIVTQSMVNKIQQTSSELSFDTNGIHAIDKNNANNIVTLNSSGMYLSTDGGRTG
KTAITAEGITASAITTGEMVANRIRGGTLEALNGWSQWDLNEGSQYYYGNSLIRFYSMYN
QIVQSTKGGTFSGGASFETFTNNSNKEGILAYFGTSEGGFLNPRRNEFAGLTVNSDRRAM
ITGDKIGFSNGRLTNTENLPVWTIDGVHTPDKSEQYFYGFNTPRHNYHLGRIDSPFQSLY
VREIGKQNAAVENLYAVNMVANTLNKFEIKEFGGAPTLMFGATGIQFDGDKGINVINSQG
TRLAQLWKP
>SEQF2892_00590 hypothetical protein
METKYIVTQTNLSNSYVLGVYVDSTGSIYMVDVDKSFRFNNIETANEIKGTLEKVSIAIN
KDYNYKILKETREDV
>SEQF2892_00591 hypothetical protein
MNQQQVSNKEKSLFIQINDLISSSVELRTLVLDYQEENERLKQELEKYKEDNAKLEEQLN
EV
>SEQF2892_00592 hypothetical protein
MKDNETTYKMFSILMLGVGLMMFERGFFWTKEQNDVLDDSDFYMALHQIMPIWMWGIMGM
IFSILIIIAPFFLPKQHINNKFNYLCLIGGTGNGIFYFLMTSASIYNAINWLTPLQFATF
TTINILIGFYGGAAVVRKR
>SEQF2892_00593 hypothetical protein
MSENDSRFVTRTEWLDNNIKVDEKIDKVDRKHTDALNNLSIKVERQSILQEQSLESQKKS
EKHLEKLSETMGSFGTKFTDMEYQVKDHSKQLETVSEVIKKKKDYSATVVGAVITGIFGV
IVASIGFAAAFF
>SEQF2892_00594 hypothetical protein
MESIIAFATVISVITIALTQLVKQAGVPKNIVPLIAIGIGIVLGGITAFIPEIITELSIG
GRLLAGLISGLMATGIWETVRTRTGSTKDKNNKIGGGRA
>SEQF2892_00595 hypothetical protein
MVEKWNGVPVKYDFLPIGTRRSGQPLTSKKPLFAVAHDTGNPHTTAQTNVNYYKNTYMID
WSIVASAHIFVDDKECIVCIPVTEKAWHVLYNTPTDNQWYNADANDVAFGVEGSYFPGNI
ERSRKSLDNMARVLAYLCNYWGIDYKTEVPGHQDIQADKIDPGNLLEACGYSRNVKNLDK
QIAKYINGVKKPAPSKKLSTKTSKKPTPSPQSVVKYKEAIEYMHSLKGQYIDFDKEFAFQ
CADVVVDFIYHVTGGVRFYGNAKQLHTVNAMPKGWKVVENTRDYVPPICAIAIYTAGIYE
KWGHTGLVWDNSGGTKTFTILEQNFDSKADSPAKLREDDYTGLTHFIVPDFADDSVDLTD
IKEVKKSERKSNSSISVNKKPPKKLTWSNQAYFKAIADNAGVTICRPNHNNVMVTTNEEY
KPGDVFYVYEIRDGWARVYSPSNDGYVWYERLIVKDIYKTAGGKKFAKKDDKQAVAQRNI
IQDTTGLKVNSIPPLNMKKSSKAKFRARVDYYGASLVKFKGKEWYVTNNTYRAGYDQFYI
FEIKNGWCRVYSRNNNGYIWHERLRITEVY
>SEQF2892_00596 hypothetical protein
MEIKIVLDESGNFGKDGDYVAVGGLQVYNGKSIQNFMKKQELKFRKMYPEDFEDEEIKHN
NSYPAMRHHYINKIVEKSDKIHYCVSNKRNCAPKMLDDENILYNYMVFRIVKRVIVQNPN
LQKLFLLLDNRTTKITRRDSLVDYLKGKIYFDLARPDVELVVTMLDSENSRLIQAADFIA
GCVRHYYTYSNDLCYNLIKSKLDCKYHYPYNNF
>SEQF2892_00597 hypothetical protein
MRYVNNEKHRHALISQLTDNQREILFKYYKYRKKNILINDMYRYSEEWELIDFKVNENYR
TCCNDTPLYCECGKELKYQYILRSKSKDTIMKLGIEHFKEHSGIPNRIAYQVRKNIFLLD
DWLDDILLNHEKLMNDSEHHFKVINMYKEWTTISELDVKDFNSNSSKPITRKNIELINDF
KKYSMALPTNIEQKVFALIDYFHKKKYLAYLEELERERRIQREKEQEALRKERELKRQQL
LKEAEARNSQKRKIMAKEKADKMLIAECRVKITKLLDVQNVIDITTIYNECKIEIDELLR
SHVNTKIVNDIVNSINRYTMYNVKFQNNKLFKSWTKRF
>SEQF2892_00598 hypothetical protein
MELLTKAISFTMSSLSTWLGSKDLLKDVGKLFDKDHN
>SEQF2892_00599 hypothetical protein
MKKVAFVLLSSFLLLGACGNNDDSVDNVKKSSHKKDNPKAHKDKGESDRTDGKKINDN
>SEQF2892_00600 hypothetical protein
MEKLLFYTGTVLLIIAIILILFAIVAVFKNKNYFKYFSMAITIILLSILALGIHKMIESN
NPSKNQATQSKDKQSKEDKSSKDKKKKDKKNDDKDDNNVTQEEQNRSEETSTNEELNTQE
QQSSQQEQPTTEESNNEAPSTQQDTTQDNTVNNQNNTSSNNNQNANQANDTNQNYNQSNR
NSNNNGDNSGSNGNVSTEDSSSTENQSNENQTQTYSENSSAEQSENGEAITETNTDESNN
SAN
>SEQF2892_00601 hypothetical protein
MTNWKINNQSQRHLMIQEHANEISIVEPYHNGSFKILAEINLNQTSNEAQLNDENLYVSV
SKEHKEINIFDKVK
>SEQF2892_00602 hypothetical protein
MLDSLTQEQKYTIAKFYKLYMERSNEGQSESEANYFGDSIKAQDDYFCDREYDDFLENCK
VLIDHGYLEGQLTADRIDDITVTNKAFTEIEQSFK
>SEQF2892_00603 hypothetical protein
MRKRKNWYSKLYYIFISVIIITIIVIAFILYKTREDKQNRSLDYYSNFEELKENTTEGKD
WRIKTKNRKDNHILVTAIHGGGIEPGTTELARRVANIGEYDFYTFEGLMPKHNERLHITS
TVFDEPTLLKMLDHSDETISIHGYSGEDPIVYVGGKDKKLAKSITKSLKNKGFTVQKSPK
GIEATSSSNIINRSDNDSGVQLELTTGQRALFFKDKQLDQNIRKNPDNYTHTFYKFAKAV
NKGIEDAQ
>SEQF2892_00604 Acetyltransferase YpeA
MTKITIQSAKPHHNEGGQLIYSAIDDMAKIILGKSSDNEIIDDLQQLWKNRANRFSHDMS
FVALEDNQVLGAITCNPLKKIDRAMTPTVLQIISMNKLKPFLSIISHPKSFYSLVTMDEG
NEDEYHISMLATMPNARGKGVGQQLLNFAEQKAKESGFSKLSLTVVQDNDAALKLYQKMG
FEIVGEINKKPYYLYQMRKEVK
>SEQF2892_00605 hypothetical protein
MKKVLFTLLLGLFILTGCSFSNEDKEEDHSKSKSSSQNKKENDDTKKKNDQHSDSKSSKN
DTESDDESTDQSNEDSSSSEQQSTSNSSSQNAKQIDIHNITDRATLEAVINSNNYSEIDK
IAAYNSAVANGVIPQGNVMEGPASEAYASSLRVESGQEKPVYDQSNQSSEEENIDDPNAE
INAATNEDEYVDALRKKYNGGLSSGEIQTKHAIEQGYYDGDDAEEVYQTIQQREQDIANG
KYDKYKNN
>SEQF2892_00606 hypothetical protein
MDKKLLKKYFDNNDFKAIAIVVGSKKMVLENDIHLDYENEIIIYPLKNCTRIIPFSSISY
IDLLEENEHFINYFKETV
>SEQF2892_00607 hypothetical protein
MKYSISPFIKIFFVTLIILITFPTHLLAYTSNSNALSPTEDDFDLQPGDIILTKGPVLFG
FFGHSSIALDHDTVLQIEGPGDKPITESFHSFKQRFGEGKDDWIKIYRCSMPGAGERAAK
WAEEHYKDTDKTYLVTLNLKSERFTYCTKIIYQAYKYGVSKNSINEHGLLIISPYALVDN
FTKDYQLKLVKQY
>SEQF2892_00608 hypothetical protein
MSLHLTILLWLGIIFVIAASIILGLLLKSKKEERKESYLGFTVIFYIFGFALLIYVFIFG
IL
>SEQF2892_00609 hypothetical protein
MNNNKIFWINIFMTLLFLGFNIIVTYNADLDDFFWLIPGLTISGITIVLSLSTALICKNL
VSEVIFLINIVMLLYYIYPMVYTFF
>SEQF2892_00610 hypothetical protein
MTFYDFIIGFINDDTPLGSLAQYIENDCEFPKHERNNKAIRSYVMSNYVDHQLIESTNRA
ISLYKLI
>SEQF2892_00611 hypothetical protein
MSDHNQYNYVNPNKLSLDWECLIISKTDMLLDGVPKELINSWMDRNIIEPFSIKDNEINF
KTKDVWNALNTQNWYYAHSN
>SEQF2892_00612 2,3-bisphosphoglycerate-dependent phosphoglycerate mutase
MSKTLYLMRHGQTMFNLRGKVQGASDSPLTSLGISQAKQAGQYFNEHNISFGNLYSSSSE
RACDTLECVAPNQDYNRLKGLKEWHFGILEGESNDLLNANYDIKDAFGDRLVVFDGESKN
EVEERFIGTLTEIMRTSDSDSNLVVSHGTTIDVFLRKVIGDTEAINYFIGNCHILKFEYR
NNEFRFIEKIDPENEEITKYEN
>SEQF2892_00613 Arginine exporter protein ArgO
MLQAILHGVLLAIGLILPLGAQNIFVFNQGANQTKFRRALPAIITAGLCDSLLIILAVVG
VSLILMSFPILQLIVYIIGLVFLLYMAWTLWHEQSSDIDEQGGISPAKQISFALSVSLLN
PHAIMDTIGVIGTSASAYDGSEKIAFTVATISVSWLWFIFLAIAGRTVGHFDKSGRLLIL
LNKISSIIILIVAFMILQKIYQLIF
>SEQF2892_00614 hypothetical protein
MTNIRILKHDDLDHYTQLLSSNTHTYSWDKVYLENISNNDLKQMLYDDDEFCNIIGAFKD
DKLVACVTLRQLRQVGSSHKAMIENLFLLDKKDESTILNLMQFAIDYAKSRNIEKLMTCV
TSNNISGKIFFSSMGFETLGLESKSSKIGDEYFDVHWLLYDIV
>SEQF2892_00615 Organic hydroperoxide resistance protein-like protein
MAVQYETKATNVGGRKGHVNTDDNAINVDVLPPQQADGNATNPEQLFAAGYASCFNGAFD
LILKQNKVRDAEPEVTLTVRLEDDPDAESPKLSVAIDAKVKNVLSQEDAEKYLQDAHEFC
PYSKATRGNIDVDLNVQVVD
>SEQF2892_00616 3-dehydroquinate dehydratase
MTNVEVAATVAPNQLLDTVTLDNIKEYSDDIDIIELRIDQWEDRHLELLKSNLERLQELN
INVNVLVTYRTVSQGGKGEMKYEAYMTLLKEIIKNHHCQMIDIEWDSDFDVFAHRDLINL
AHRYNKQVVISYHNFQETPDIDILKFTYYKMNQLNPDYVKIAVMPQDKEDVATLLEAVAT
SADTLDAKVIGISMSKVGLVSRTAQGVFGGTVSYGCLGEPQAPGQIHVKTLKQQLLFYSN
H
>SEQF2892_00617 Coenzyme F420:L-glutamate ligase
MELQEAIASRRSIKKFKHDMTIDDDKLYQAIEKAADAPNHGMREPWRIIHIAKDRLGEMS
RDVTHFAFPNHPEKQEDHYNNVTNLGGMLVLVLKTDPRQRQNRENFFAMGAYAQNLMLLL
HEQGIGTCWKTPPYIFEPKVRKVFGVHGDEVIAGFLYLTDLEEVPPKAPRKNKHLISKY
>SEQF2892_00618 Thioredoxin-like protein YdbP
MQSINTTDAFKSTIESDKPVIVKFEAGWCPDCKSMDMWIDPIVEKYNDYDWYTVNRDELE
DVAADNDVMGIPSLLVFENGNKLAHLHSANAKSPEQVESFLSETFNK
>SEQF2892_00619 Regulatory protein MgsR
MIKFYQYSNCTTCKKAAKFLDTHGVSYEPIDIVQHTPTKKEFEEIIDKTGVEVNKLFNTH
GAKYKELGLKDKLKDLSTDEKLNLLASDGMLVKRPLAIAGDNITLGFKEDQYKEIWL
>SEQF2892_00620 Glycine cleavage system H protein
MAVPSELKYSKEHEWVKVEGNTVTIGITEYAQGELGDIVFVELPEVDDEINEGDTFGSVE
SVKTVSELYAPVSGKVVESNEELEDSPEFVNESPYEKAWMVKVELSDESQLDDLLSADQY
KEMIGE
>SEQF2892_00621 Ribonuclease M5
MAILNKVIIVEGKSDKKRVQQVIAEPINIICTHGTMSIDKLDDMIETLYEKQVFVLADSD
DEGEKIRKWFKRHLSECEHIYVDKTFCEVARCPKNYLAHVLSKHGFTVRKEKRLIPNLTT
ERLVIMHE
>SEQF2892_00622 hypothetical protein
MSKSVEIEDICENFNKEKHLIFGYTPMCGTCKMSERMLDIANEILQLPVKKIDLNYHPKY
SERNKIMSVPVLIVMNKDIEIDRIYAFQSVPYLLEKLK
>SEQF2892_00624 Methionine import ATP-binding protein MetN 2
MIELNQVVKRYHTKDKDVLAVDNVNLNIETGSIFGVIGFSGAGKSTLIRMFNNLEEPTSG
DIIIDGDNINKLSKAELRRKRQKVSMVFQHFNLLWSRTVLRNITFPLEIAGYSKTKANER
AKELIDLVGLNGRENAYPSELSGGQKQRVGIARALANEPDVLLCDEATSALDPQTTDEIL
DLLLKIKERENLTIVIITHEMHVIRRVCDEVAVMESGRVIEQGKVTQVFENPQHEVTRRF
VKDDLDDDFEESIKHLEPLDSDAYIVRLNFNGGNTTEPVVSYISKTHNIDINILEANIKN
TRGGSVGFLVVHIPHIAETEFETFKEDLHQQHVNVEVVKHG
>SEQF2892_00625 Methionine import system permease protein MetP
MDKSYGDIFKEMITMPNVQWPEVWQAIYETLYMTVVSTIFAFIFGLILGVLLFLSAKSNS
KGARVFYSIVSFIVNLFRAIPFIILILLLIPFTSVILGTISGPTGALPALVIGAAPFYAR
LVEIAFKEIDKGVIEAAWSMGASTWTVVRKVLLPEAMPALVSGITVTAIALVGSTAIAGV
IGAGGLGNLAYLTGFTRNQNDVILVSTVFILIIVFIIQFIGDWITNKIDKR
>SEQF2892_00626 Methionine-binding lipoprotein MetQ
MKKLLSLFLVLTLTVVLAACGNGSGDKDKKIVVGASPAPHAEILEKAKPLLKKKGYDLEI
KTINDYTTPNKLLDKGELDANYFQHVPYLKTESKEKGYKIEDAGKVHLEPMAVYSKKYKS
LKDLPKGATVYVSNNPAEQGRFLKFFVDEGLIKIKKGVKIEDAKFEDITENKKDIKFNSK
QSAEYLPKIYQNEDVDAAIINSNYAIDQGLSPQKDSIAIEKPNNNPYANLIAVQKGHKDD
EKIKALIEVLQSKEIQDFIKDKYKGAVVPAK
>SEQF2892_00627 hypothetical protein
MKFINFTAMTESGLTKKVNRFLEENPYIEVIKFDYTMGSGGQGVGILYKDRKSF
>SEQF2892_00628 hypothetical protein
MAEDKFEQAKGNLKETVGNVTDNKDLEKEGQNDKASGKAKEAVENVKNKANDLIDKVKGN
NDNK
>SEQF2892_00630 hypothetical protein
MYKNYNMTQLTLPMETSVLIPTNDISRHVNDIVETIPDNEFDEFRHHRGATSYHPKMMLK
VILYAYTQSVFSGRKIEKMLNDSIRMMWLSQNQKPSYKTINRFRVNPKVDALLESLFIQF
YSQCVKQNLIDDKAIFIDGTKIEANANRYTFVWKKSIQNHESKMNEDSKALYHELVTNKI
IPEIKEDHDNELTKEEIDLIGSHLDKEIEDLNQHINNEKCTKTRKQIRLKRTKIKKYKKQ
INDYFERKYRYEFQKSILKDRNSYSKTDHDATFMRMKEDHMKNGQLKPGYNLQIATNSQF
VLSYNVYQNPTDTRTMIPFLNSIQETYGHLPEYIVADAGYGSESNYKAIIDDFNRTPLIT
YGMFIKDKTKKYKSDIFNTQNWNYDEINDEFICPNNKRLGFKRYAYRHDKYGYKRDFKLY
ECDDCSECPLKNQCMNFNSKTNKKIMKNYNWEYFKSQINKKLSEPETKNIYSQRKIDVEP
VFGFMKAILGFTRMSVRGLNKVKRELGFVLMALNIRKVVAQRAENNQKIYKKDNFYIISI
EIVFFSLIQELYVPDSFNLK
>SEQF2892_00631 hypothetical protein
MQNFKWINILKGFGMGTSDLVPGISGGTIALLLGIYDGFISSISGLFSKRFWPSLKFLLP
ILIGMALAIGILSNLINYLLEHHQVITMFFFTGLIIGIIPYLLRTVKFNKTFKAKHYSIM
VVGIIILVVITLMNSGNQSADTSLDLSFGLIIKYFLAGACASSAMLLPGISGSFMLLVFG
AYGTIMLAIADLVKLNFDGLPLLIVVGLGVLAGFLLSSRIIKYFLHHHFYTTFALITGFV
IGSIYAVFPGLPQTGIEWTLSIITLIIGFAASYWIGQITDDNV
>SEQF2892_00632 Vegetative protein 296
MSSTLEIKDLHVSIEDKEILKGVNLTINTGEIHAIMGPNGTGKSTLSSAIMGHPSYEVTQ
GEVLLDGVNILELEVDERAKAGLFLAMQYPSEITGVTNADFMRSAINAKREEGQEINLMQ
FIKKLDKEMDFLDIDKDMAQRYLNEGFSGGEKKRNEILQLMMLEPKFAILDEIDSGLDID
ALKVVSKGINEMRGEEFGALMITHYQRLLNYITPDKVHVMYGGKVVKSGGPELAKRLEEE
GYEWVKEEFGAKE
>SEQF2892_00633 FeS cluster assembly protein SufB
MTTETLNISEEQLVDYSKAHNEPSWMTELRQKALKLTETLEMPKPDKTKLRKWDFDSFKQ
HEVKGQSFSNLSELPEAIKKIIDVENTKNLVVQHNNALAYTQVSDQAQKNGVIIEGLSEA
LINHGELVQKYLMTDAVSVDEHRLTALHTALINGGVFVYVPKNVVVEDPIQYVVLHDDDN
ASFFNHVIIVTEESAEVTYVENYLSTASGEGNQLNIVSEVIAGANSNITYGSVDYLDKGF
TGHIIRRGTTAADASINWALGLMNEGSQIIDNTTNLIGDRSTSELKSVVVGTGDQKINLT
SKIVQYGKETNGYILKHGVMRENASSVFNGIGYIKHGGTKSIANQESRVLMLSENARGDA
NPILLIDEDDVEAGHAASVGRVDPEQLYYLMSRGISQKEAERLVIHGFLDPVVRELPIED
VKRQLREVIELKVNK
>SEQF2892_00634 putative cysteine desulfurase
MAETSLNVEEIIKDFPILDQKVNGKRLAYLDSTATSQTPVQVLNVLDDYYKRYNSNVHRG
VHTLGSLATDGYEGARETVRRFINAKYFEEVIFTRGTTAAINIVARSYGDANVEEGDEIV
VTEMEHHANIVPWQQLAKRKNASLKFIPMTDEGELRLEDVKATINDNTKIVAIAHVSNVL
GTINDIKEIAKVAHEHGAIISVDGAQSAPHMKIDVQDLDADFFSFSGHKMLGPTGIGVLY
GKRDLLKEMEPAEFGGDMIDFVSKYDATWADLPTKFEAGTPIIAQAIGLGEAIRYIEKLG
FDAIHEHEKALTEYAYEQMSSIEGLEIYGPPKERRAGVITFNLADIHPHDVATAVDTEGV
AVRAGHHCAQPLMKWLNVSSTARASFYVYNTKEDVDQLVEALKQTKEFFSYEF
>SEQF2892_00635 Zinc-dependent sulfurtransferase SufU
MNFNNLDQLYRSVIMDHYKNPRNKGVLDNGSMTVDMNNPTCGDRIRLTFDIENGIINDAK
FEGEGCSISMSSASMMTEAVKGHSLGEAMQMSQEFTKMMLGEDYEITEEMGDIEALQGVS
QFPARIKCATLAWKALEKGTVEKEGKAEGTTEE
>SEQF2892_00636 FeS cluster assembly protein SufB
MAKKAPDVGDYKYGFHDEDVSIFRSERGLTENIVREISKMKEEPEWMLDFRLKALKLFYK
MPMPQWGGDLSELNFDDITYYVKPSEHTQRSWDEVPEEIKRTFDKLGIPEAEQKYLAGVS
AQYESEVVYHNMEKELEEKGIIFKDTDSALRENEELFKEYFASVVPAADNKFAALNSAVW
SGGSFIYVPKNVKLDTPLQAYFRINSENMGQFERTLIIADEGASVNYVEGCTAPVYTTSS
LHSAVVEIIVHKDAHVRYTTIQNWANNVYNLVTKRTFVHENGNMEWVDGNLGSKLTMKYP
NCVLLGEGAKGSTLSIAFAGKGQVQDAGAKMIHKAPNTSSTIVSKSISKNGGKVIYRGIV
HFGRKAKGARSNIECDTLILDNESTSDTIPYNEVFNDNISLEHEAKVSKVSEEQLFYLMS
RGISEEEATEMIVMGFIEPFTKELPMEYAVEMNRLIKFEMEGSIG
>SEQF2892_00637 hypothetical protein
MFDFYANWYSLIIIIEYLAIFLGSIGLIFIAMISLRQIQKKKKIWYLGIFLFYSSLLELL
IHFTGEDIHTYNLVFVATLLPFLLMCYLSSHYLVKRPFKTKIEFVKTGHGKTNKVTKQEM
KDMKDELQSANIIAWSGSIGAAFLIVAWSTKVRFIHSKEWMMAQELTKTTDNLLGFGGFM
FLISAFLIVIYFIVDVVLWNKRGKFPGLVFRPMILCLWQFLFLISI
>SEQF2892_00638 Putative monooxygenase
MWYNNQLTQSLNIQYPIIQAGMAGSTTAELVATVSNKGGLGCIGAGYFTTKKLEQEIQKV
QGLTSQPFGVNLFVPSHQSYTNEQVEHMNAWLKPYRKALNLEEPVVNISEEQQFKSAIQT
VIKYRVPVCCFTFGIPSKEIIEQLKGAKITLIGTATTVDEAIANEHAGMDIVVAQGSEAG
GHRGSFLTTNNQREPLIGTMSLIPQIVDHVSIPVVAAGGVMDGRGILASQILGAQGVQMG
TAFLTTEESGANQLVKQAVLHSKETDTIVTDVFSGKSARGINNEFVETMKQYEGNIPPYP
VQNQLTNSIRKTAASTGHREWTHMWSGQSPRLATSQHVNQLMDRLVEQVKTLLTVVR
>SEQF2892_00639 hypothetical protein
MINIGLTGWGDHDSLYEDLERQSDKLQTYASHFPIVELDASYYAIQPERNIMKWIKETPD
RFEFIVKIHQALTLHADYKDYAETRSELFEQFKQMLQPLIDHHKLAMVLVQFPPWFDCTA
QNIKYILYVRQQLDDVPICVEFRHQSWFNDQFKEQTLSFLTEHHIIHSVVDEPQVREGSI
PLVNRITTETAFVRYHGRNRQGWTKKDMTDQEWRDVRYLYNYNKEELTDLANKVRIIEQK
AKKVYVVFNNNSGGHAAQNAKTYQDMLDIEYTGLAPQQLKLF
>SEQF2892_00640 hypothetical protein
MLVTIILLVLIGLFSAILGSLVGIGGGIIIVPTLVYLGVTHDVLHGITPQIAIGTSSVIL
IVTGLSSSLGYLKTKQVDIKNGSIFLFGLLPGSLLGSFLSRYLTLESFNLYFGIFMIIVS
IILMVRHKIKPFKIFDKEKYRKTYVDSEGKTYHYSVPPLFAFVATLFIGILTGLFGIGGG
ALMTPLMLIVFRFPPHVAVGTSMMMIFFSSVMSSIGHILQGHVAWSYSIILIISSYIGAQ
IGVRVNHSIKSETVVTLLRTVMLIMGVYLIIKSFL
>SEQF2892_00641 Mannosylglucosyl-3-phosphoglycerate phosphatase
MKLTIFHTNDIHSHLNEYARITSYMAEHRPKLQHPSLYLDIGDHVDLSAPVTQATIGRKN
IDLLNEAQCDIATIGNNEGMTISHEALNNLYNNATFNVICTNVIDEEGKLPHNIASSCIK
EIEGVRILFVAATAPFTPFYRALDWIVTDPLEAIKDEIANQQGNYDVLIVMSHVGIFFDE
KLCQEIPEIDVIFGSHTHHHFDEGEMNNGVLMAAAGKYGYYLGEVNLTIENKKVVSKEAI
IYPVETLPMVETDYESEGKALMSEPVIDYPINLNSKTDVITKTTYLLAESVFEFTNTDCT
IINAGLIVKGIEADRLTEYDIHKMLPHPINLVRVRLTGSELKKVIEKSQKQEYMHEHAQG
LGFRGDIFGGYILYNCGFIQSENRFFVNGEAVVDDKIYTLGTVDMYTFGRYFPILKGKSI
DYIMPQFLRDIFKDKLLRLQ
>SEQF2892_00642 Lipoyl synthase
MATKNEEILRKPDWLKIKLNTNENYIGLKKMMREKNLHTVCEEAKCPNIHECWGARRTAT
FMILGAVCTRACRFCAVKTGLPNELDLNEPERVAESVELMNLKHVVITAVARDDLRDAGS
NVYAETVRKVRERNPFTTIEILPSDMGGDYEALETLMASKPDILNHNIETVRRLTPRVRA
RATYERTLEFLRRSKELQPDIPTKSSLMVGLGETIEEIYETMDDLRANDVDILTIGQYLQ
PSRKHLKVEKYYTPLEFGKLRKVAMDKGFKHCEAGPMVRSSYHADEQVNEAAKEKHRLGE
EKLQQN
>SEQF2892_00643 hypothetical protein
MIKIGQQYFEIIEEYRSCFDEELFASRYSDILDKYDFIVGDFGYDQLRLKGFYKDTNKKA
EISKRFSSIQDYILEYCNFGCPYFVLRHLSNKEVQQLNHDDEDVILSDSEDKLHDVKIKP
TIQEVKHQDE
>SEQF2892_00644 hypothetical protein
MIDMYLYDDEEQSQVQFVGFVGEHSRYDLMLVQTDRHYGKTLVLNMQTNKFGIIGTDDIE
EEGYIAHILGVSQEESDEIIEYLNQVIQ
>SEQF2892_00645 hypothetical protein
MYFVDKDQLILKLTYLNQLIKDYESNKGNHYAFERIAQMLIESSVDIGNMIIDGFILRDP
GNYKDVIDILELEGVISKSTQRYVNETVDIRKQFAHHYTELDNSKIQPLFDEALPYYEQF
IQEVTQFLEKENVPVTAFGKGDNK
>SEQF2892_00646 Acid sugar phosphatase
MKNYKGYLIDLDGTMYIGTDEIDGAAQFIDYLNNHQIPHLYVTNNSTKTPEEVTQKLKEM
NIDAKPEEVVTSALATANYIADEKSDATVYMLGGSGLRTALTEAGLTVKDDENVDYVAIG
LDENVTYEKLAVATLAVRKGARFISTNPDVSIPKERGFLPGNGAITSVVSVSTGQAPQFI
GKPEPVIMDIALDILKLDKSDVAMVGDLYDTDIMSGINVGVDTIHVQTGVTTYEELKEKD
QQPTYSFKDLNVAISELERNAQK
>SEQF2892_00647 Glyoxylate/hydroxypyruvate reductase B
MVKILVTRQIPDRFIEQLEQFGDVKMWKEAFEPMPREQFLKELEDVDACFITLSEKIDAT
CLEHAKHVKVIANMAVGFDNIDVKLAEDKEIVVTNTPQVLTETTAELGFTLMLTVARRIV
EAEKYVQDGQWKSWGPYLLSGKDVHGSTVGIYGMGDIGKSFARRLQGFNTTILYHNRSRH
EDAESELNASYVSFDTLLEESDFVVCTAPLTPETENKFNKDAFSKMKNDAIFINIGRGAI
VDEDALIDALNNHEIGGCGLDVLREEPIKLDHPLLKMEKAVILPHIGSASVATRDRMIQL
CVDNIVAILKGEKPLTPITNK
>SEQF2892_00648 D-alanine--poly(phosphoribitol) ligase subunit 1
MTDIINLINDFGQSNPERVAVRHKDEELTYQQLMDESSKLAHLLQDNHKPLIVYGHMSPY
MLVGMIGAIKAGCGYVPIDTSVPSERVNMIINKVQPDIIFNTSDTQLNHSNIQELTIQSI
QDSDNPTLFDSQMGLTDVVYTIFTSGSTGEPKGVQIEYASLIEFAEWMVSLNESEGSQEW
LNQAPFSFDLSVMAIYPCLTSGGTLNLVDKEMINKPKLLNEMLVNTPINAWVSTPSFMEM
CLLLPNLNESSYPSLNHFFFCGEILPHRTAKALLDRYPSAVVYNTYGPTEATVAVTGIKL
TPEVIEAYNPLPVGVSRPNTSLFTTDEGELVIKGNSVSLGYLDNKEKTDAVFNFEDGLRI
YHTGDKAIEKDGQWFIQGRIDFQIKLNGYRMELEEIETQLRQSEFVRETVVVPVYKNNKV
IHLIGAVVPTEEVRDDLEMTRQIKSELKSRLPEYMIPRKFVWMKQLPLTSNGKLDRKQVA
EDINA
>SEQF2892_00649 Peptidoglycan O-acetyltransferase
MIPYGTFTFFLVAIIVLLPVIILGFLGKRSYIYNGLSTAIMIVVIFSSDKHNLFGNKYLS
IQLISFVIYLIWQVLLIMGYYKSRQKSNTFSKFVIVMILSILPLAIVKVLQSSWLGGQQI
HFHEHKLIEFVGFLGISYVTFKSVQLIMEIRDGSIKEIKVGKLFQFISFFPTVSSGPIDR
YKRFVKDDKKVPTSEQYREMVAKAIHMIMLGFLYKYIIAYLINVYAILPLLMNLDGFMHK
WLYMYAYSFYLFFDFAGYSLFAVAVSYLYGINTPPNFKQPFKAKNIKDFWNRWHMSLSFW
FRDCIYMRTLFYMSRKKTFKSQFAMSNFAFFLNFFIMGVWHGLELFYIVYGIYHGLMFIG
YGYYERWRKKHPPRWQNGFTKALSIIITFHFVAFGFLIFSGKLI
>SEQF2892_00650 D-alanine--poly(phosphoribitol) ligase subunit 2
MEFKEQVLDLLADVAENDVVKENPDVEIFEEGIIDSFQTVGLLLEIQNRLGIEVSIMDFD
RDEWATPNKIVEALEELR
>SEQF2892_00651 hypothetical protein
MKLKPFLPIIISGILFLAFVLMPASWFTGLVTNKAVANNRISLTDQVLKGTLIQNKLFSS
DKYYPIYGSSELNKLDPFNPALALNHRKNTKPIFLIGTGGNTDLINAIELAGQYDQLKGK
KMTFIISPQWFSTHGVNDRDFAARTTPNQINQLFQQKDMPSELKERYAKRLLHFKSASNK
EFLKDVVNNHGEVDGNYVSRFKENQLLKIEAIKTYFSLDKSPLSHVKPVTEPNVSWQEMQ
DKAVTLGEKRSSSNNYGIRNEYWEKLIHKKPMNHRKYEFKMNSPEFNDLSLLVDTMHNAS
ADVQYVILPVNGKWYDHLGIERSTREPVYKKIHQTVVAHGGKVYDMSDKDYEKYVLSDVV
HVGWKGWAHMNQHIVQHMKDDKNEHNKDHNKQHEHQ
>SEQF2892_00652 Fe/S biogenesis protein NfuA
MPTENATMFDQVAEVIERLRPFLLRDGGDCTLVDVEDGIVKLQLHGACGTCPSSTITLKA
GIERALHEEVPGVIEVEQVF
>SEQF2892_00653 hypothetical protein
MTKVSVVVYGADVVCASCVNAPTSINTFEWIKPLLERKYPDIQFEYTYIDFQNQTDNLSD
HDQQYIEQIEEDELFYPLITMNDEYVADGYIQTKQITNFVDKHFAN
>SEQF2892_00654 NADH dehydrogenase-like protein
MKNLVLLGGGYGNMRIMSRILPDALPENYTLTLIDRMPFHGLKPEFYALAAGTKSDSDVR
MNFPDSERVNTIYGEINDIDLDAQIVSVGNTKVDYDELVIGLGCEDKYHNVPGAEEYTHS
IQTLSKARETFHSISELPSGASVGIVGAGLSGIELASELRESREDLEVILYDRGERILRN
FPEKLSNYIAKWFRENNVKVVPNSLIDKVEPGKIYNSGTPENVDLVVWTAGIQPVEVVRH
LPIDINRSGRVIINQYHQVPTYLNVFIVGDCADLPHAPSAQLAEVQGDQIADVLKKQWNN
EPLPDKMPELKVQGFLGSLGEKKGFAYIMDRTVTGRLAHILKSGVLWLYKYHNG
>SEQF2892_00655 hypothetical protein
MFPLVEFCISNMAKGGDYVYDKLENDPDVDVLEYGCLNNCGVCSCGLYALVDGDTVEGDT
PDELLKNIYKHIEENDFTNLL
>SEQF2892_00656 Iron-sulfur cluster insertion protein ErpA
MSTVTLTEAAAYEVKDMLKSNDMEGGYLKIKVNGGGCTGLTYGMSAEEQPGENDEVLEFY
GLKVLVDKYDVPVLNGTTIDFKQSLMGGGFQIDNPNAIASCGCGSSFRTAKVAGNPEEC
>SEQF2892_00657 NADH dehydrogenase-like protein
MAQDRKKVLVLGAGYAGLQTVTKLQKELSADEADITLINKNKYHYEATWLHEASAGTLNY
EDLIYPIESVIKEDKVKFINAEVTKIDRNAKKVETNHGIYDYDILVVALGFESETFGING
MKDYAFQIENIETARKLSRHIEDKFANYAASKEKDDKDLAILVGGAGFTGIEFLGELTER
IPELCNKYGVNQNKVRVTCVEAAPKMLPMFSDELVNYAVNYLEDRGVEFKIATPIVACNE
KGFVVKINDQEQQLEAGTAIWAAGVRGSKLMEESFEGVKRGRIVTKQDLTIEGHDDIFVI
GDVSAFIPAGEERPLPTTAQIAMQQGEHVAKSIKNILNGQAATDFEYVDRGTVCSLGAHD
GVGIVYGRDITGKKAAFMKKVIDTRAVFKIGGVGLAFKKGKF
>SEQF2892_00658 Cytosol aminopeptidase
MVNFNISNTVLNSEVFIIGLPDHINQLGYINYNNEDITKQIDTYRHHHLISSQLGKISST
LLPLKDSSKRLITVGLGNLKTLDYGTLLRAFGNLFQFLKEERVTEADVLFDTLISKKIEQ
TKVAEVMGLQSEQAVYSFDNYKSDKSAPYQLELNISTNKEDLHRYFINGAIIGQSVNVAR
DYSNMPPNILTPNYFAEQVTQHFDETSVKVDIKDGKQLLDEGFGLIHAVGKGSENPPVVI
TMTYNGGDSEDAPIALVGKGITYDSGGYSIKSKIGMQTMKFDMCGAANVVGMIDAISRLQ
IPINIVGVIASAENMISSNAMKPDDVLTALSGETVEMLNSDAEGRLVLGDAVFYANQFQP
KIILDFATLTGAAVAALGEDKAALFNSNADKEIEEIRVSAKEMDEYAFELPMTQTEQRLI
RQSDVADLVNHTNGHGKALFAATFITHFSGSTPHIHFDIAGPATTNKTSYKGPKGPTGSM
ITTVLNWLR
>SEQF2892_00659 hypothetical protein
MFNAVVIAVLLMIVLCLCRLNVVISLFISALVGGLISGMSVEKVISVFGKNIVDGSEVAL
SYALLGGFAALISYSGITDYLVTKIIRAIHSENSRLSRIKVKIIIIIALLAMSIMSQNLI
PVHIAFIPIVIPPLLSLFNDLKIDRRLISLVIGFGLCWPYVLLPYGFGQIFHQIIQSGFQ
KAHHPIEFNMIWKGMLIPSLGYIVGLILGMFYYRKPREYKTETYVEDENTINEIKPYVLV
VTIVAILATFLVQTFTDSMIFGALAGVLVFFISGVYKWRELDSQFVEGIKIMSFIGVVIL
SANGFAGVMNATGDIEKLVSSLTDISNGHKLLSIVIMYIIGLIVTLGIGSSFATIPIIAT
LFIPLGASLGLSTMALIALVGTASALGDSGSPASDSTLGPTAGLDVDGQHDHIRDTCIPN
FLFYNIPLMVFGTIAAMIL
>SEQF2892_00660 Putative esterase
MTNLLETFEMQIEETSEGKVVISMPVTDKVKQPFGYLHGGATIALGETACSLGAANLIDT
KSFIPLGLEMNANHIHSVKEGRVIATATIIHKGSTTQVWNIEIKSEQGQLISVMRGTIGI
KLLKQ
>SEQF2892_00661 hypothetical protein
MHWTIIGGGLQGTTIAIQLRELGLSRDKLTIIDPYATLCEQFNDFSHRISMPYLRSPIVH
HIHPNPFHLKQFAKVQQYAHGTYGQYQRPQTDMFMHHVHEQVHHYDLNENHIQGYVEALA
KKDGQWQIQLNDNRVIHTDCVILANGCTHKPYIPNIYQDADDVCHIFDKSFNTTMYGHSS
HVIGSGISAAHLTLKLINQSHDKVIHLWMNKDIDIQHFDADPGWLGPKNMNHFLNIESSL
ERQSIIQHERHKGSMPRELYLRLKKHIQSGRLIIHKENILSVDQHQIHTEQAAIPYDFIL
LATGFEPTLLKQPMIQSLIKNEDAPLTRCGLPSISSELEWLPQLFVSGGLADLELGPFAR
NIMGGREAAQRIKQAYKRLSAQPIQKHA
>SEQF2892_00662 Na(+)/H(+) antiporter subunit G1
MITNIIISLAVIFVILGAIISAVTAIGIIRLKDIYSRGHAAGKSATLGAIFLLFGTFLYF
IATDGYINMQLIFGILFILITGPLSSHLIMRAAYNNKTPYTKDTKIDELKNEFKDKMI
>SEQF2892_00663 Na(+)/H(+) antiporter subunit F1
MLKIIMIIALIVVAISMLAMFVRIIKGPTLADRILALDAIGLQLMACIALYSIFIGSEYL
LVAILLIGILAFLGTAVFSKYMDKGKVIERDNEHHH
>SEQF2892_00664 Na(+)/H(+) antiporter subunit E1
MAIQIILNFILAFIWIFLSGSYTLNNLLLGFILGLGFVYLFSRILPGRFYFIKIYKILKL
AVVFFVELLKANIDVLKIVLQPKLKNEPGFFVYHTDLKTDWQIVLLSNLITLTPGTVVLG
ISDDRKKIYIHSIDFSTKEEEVEGIKSSLERVVREVGED
>SEQF2892_00665 Na(+)/H(+) antiporter subunit D1
MIENNLVVLSLVVPIFTAIILVFLGQRYRAKRYVTLTGLVLTLIVAIINLRNVYVDGPLK
VELGSWPAPYGIIFLLDSFSAMLIVTSIIITILITAFSSTTAGIDRERYYYHFSITFMLV
GIIGAFTTGDIFNLFVFFEVFLMSSYALLVLGGTQIQLRETVKYLLVNIVTSTFFVIAVA
ILYSIVGTLNMADISEKLSTLSNTHGGLLSIVFILFIFVFATKAGAFPMYVWLPGSYYAP
PFAIIAFFGALLTKVGVYAILRTLSLFFHNTMSFSHYTILFLALLTIIFGSVGAIAYDDT
KKIIIYNIMIAVGVILVGVAMMNEAGIIGAIYYTIHDMLVKTALFLLIGVMYQITKSTSL
KDFGGLIKHYPVLGWTFFIAALSLAGIPPLSGFYGKYYIVQATFEKGFYVSGIIVLLSSL
VVLYSVIHIFLKGFFGKPKGYEPTQSVNVKHATTISIIAVVITVVFGLSADLLYPLISEA
AQSFYDPSIYIESVLGGRS
>SEQF2892_00666 Na(+)/H(+) antiporter subunit C1
MEIIMIFVCGILASISVYLVLSKSLIRIVMGTTLITHASNLFLITMGGLKHGEMPIYEKN
ISQYVDPIPHALILTAIVIAFATTAFFLVLAFRTYKELGTDNVERMKGVLDDD
>SEQF2892_00667 Na(+)/H(+) antiporter subunit B1
MNRQNNNLMFQYAAVIIAFLIALFGVTLFFAGHYTPGGGFVGGLLLSCALTIIAIAFDIK
TMEKVFPWDFKILIGIGLLFCVGTPLASWFYGENFFTHTEFNIPLPLLQPVHMNTPMFFD
FGVLCAVVGTIMTIIITIGESE
>SEQF2892_00668 Na(+)/H(+) antiporter subunit A1
MSLLHIAVILPLIFALIIPILYRFFKKIHLGWFVLPIPVVLFIYFSSLISTTQSGNTVIK
TLNWMPHIGMNFDLYLDGLSILFSLLITGIGSFVVLYSIGYLSKSEQLGNFYCYLLLFMG
AMLGVVLSDNLIILYLFWELTSFSSFLLISFWREKKASIYGAQKSLIITVFGGLSLLGGF
ILISLAGDSLSLHELIANASEIQHSPLFIFAMVLIMLGAFTKSAQVPFYIWLPDAMEAPT
PVSAYLHSATMVKAGLYLVARVTPLFAISQGWIWTITLVGLITLFWASLNATKQQDLKGI
LAFSTVSQLGMIMSMLGIGAVSYHFEGSQSQLYIAGFTAAVFHLVNHATFKGALFMITGA
VDHVTGTRDVKKLGGLLTIMPISFTITVITALSMAGIPPFNGFLSKEKFLEAMIEISHAN
VFSLDTLGIVFPILAIVGSIFTFVYSIKFIMYIFFGKHQPNALPKKAHEASILMLLSPII
LAVLVVVFGLFPGLLTQSIVEPATTAISGMSNVNAEFHLFHGITPAFISTLIIWILGILL
LLTFSYWIRLLHAQPTRLTLNHWYDSTGKYLPNYSANMTNSYVNGYVRDSLVIIFGMLIV
VTIVTLLSVPFDFNFKDINNIHIYEIAILILLIIAAFMVVIAKSRLFSVIMLGVVGYSVS
VLFVFFKAPDLALTQFVVESISTALFLLCFYHLPNLNRYNETRSFKLTNALISIGVGLVV
IILGLIAYGNRHFTSIGEYYKAHVYDLAHGKNMVNVILVDFRGMDTLFESSVLGIAGLGV
YTMIKLRRKHQSSEVKSDEQTEQ
>SEQF2892_00669 Kinase-associated lipoprotein B
MLYRFSHKTGAYGVTIKEENDDQVLVQVEQVIKHPKQGDLHNPGQTEGVFFHERRALSHF
EKRYATRSQLREFNVEEMTYEASLQQAITKMENDLKQQNTEFAKQALNNLENLKNDYSIQ
YKQKFL
>SEQF2892_00670 Putative peptidyl-prolyl cis-trans isomerase
MTNYPQLNKEIQDNEIKVVMHTNKGDMTFKLFPDIAPKTVENFVTHAKNGYYDGITFHRV
INDFMIQGGDPTATGMGGESIYGGSFEDEFSLEAFNLYGALSMANAGPNTNGSQFFVVQM
KEVPESMVNQLVDGGWPEPIAKAYADNGGTPWLDQKHTVFGQLIEGEATLEDIANTKVGA
QDKPVHDVVIESIDVEDK
>SEQF2892_00671 General stress protein 13
MNNHYKEGQHIKVRVTGIQPYGAFVETPDHTEGLIHISEIMDDYVHNLKKFLSEGQIVKA
KILSIDDEGKLNLSLKDNDYFKNYERKKEKQSVLDEIKETEKYGFQTLEERLPVWIKQSK
RAIRNN
>SEQF2892_00672 putative oxidoreductase
MNKKYEKLFETVTLPNGVELKNRFVLAPLTHISSNDDGTISDVEIPYIEKRSKDVGLAIN
AASNVNDIGKAFPGQPSVAHDSDIEGLKRLAQAMKKNGAKALVQIHHGGAQALANLTPNG
DVVAPSPITLKSFGQQHEHDAREITPKEIEQTIKDFGEATRRVIEAGFDGVEIHGANHYL
IHQFVSPYYNRRNDEWSDHMKFPTAVIDEVLKAKSEYASDDFIVGYRLSPEEAESPGISM
EITEQLINTITEKSIDYVHISLGDIHSTTREGKYAGQERLKLIHQWVDGRIPVIGVGSVF
TADDALDAIESTGVELVALGREILLDYNFISKIQEGKEDEILSEFDPHREDKHELTPNLW
KQFNQGFYPLPRKDK
>SEQF2892_00673 Ornithine aminotransferase 2
MTKSEQIIELTNHYGAQNYVPLPIVVAEAEGIWVTDPEGNKYMDMLSAYSAVNQGHRHPK
IIQALKDQADKVTLVSRAFHSDNLGEWYEKVCKLSGKDKALPMNTGAEAVETALKAARRW
AYDVKGLEPDKAEIIAFNGNFHGRTMAPVSLSSEAEYQRGYGPLLDGFRKVDFGDVDKLK
EAINENTAAILVEPIQGEAGINIPPEGYLKAIRELCDEHNILFIADEIQAGLGRSGKLFA
TDWDNVKPDVYILGKALGGGVLPISVVLADNEVLDVFTPGSHGSTFGGNPLACAVSIAAL
DVILDEDLPGRSHELGEYFKSELQKINHPAIKEVRGRGLFIGVELHESARPFCEALKEKG
LLCKETHDTVIRFAPPLVISKEELDDALDRIRSVFN
>SEQF2892_00674 NAD-specific glutamate dehydrogenase
MTENNNLVTSTQSIIKEALHKLGFDDGMYDLIKEPLRFLQVRIPVRMDDGTVKTFTGYRA
QHNDAVGPTKGGVRFHPEVDEEEVKALSMWMTLKCGIVNLPYGGGKGGIVCDPRQMSIHE
VERLSRGYVRAISQFVGPTKDIPAPDVFTNSQIMAWMMDEYSALDKFNSPGFITGKPIVL
GGSQGRDRSTALGVVIAIEQAAKRRGKEIKGSRVVIQGFGNAGSFLAKFLYDMGAKVVGI
SDAYGALHDPEGLDIDYLLDRRDSFGTVTNLFDNTISNKELFELDCDILVPAAISNQITE
DNANDIKADIVVEAANGPTTPEATRILTERGILLVPDVLASAGGVTVSYFEWVQNNQGYY
WSEEEVNDKLREKLVDAFDTIYELAQNRKIDMRLAAYIVGIKRTAEAARYRGWA
>SEQF2892_00675 hypothetical protein
MCKSILNTLRIKDKNLYFSDEVIEKKHKGRMSLFYYAEPTYQPTLFMQKEIKQLKVD
>SEQF2892_00676 Glycerophosphodiester phosphodiesterase
MKASNKGIISCLTVASLSLAIIHTPVEASGGESSNTTTTNLTNASKTQNNHTNWSRNLTG
ERHTTIAHRGASGYAPEHTFAAYDKSHNELGASYIEIDLQRTKDGHLVAMHDETVDRTTN
GSGRVEDYTLAELKKLDAGSSFNEQNPQLAKDSYKGATVPTLDEILTRYGTDANYYIETK
QPDVYPGMEQQLLDTLNRHNMLTSNSLENGHVLVQSFSEASLLKMHQLNSNVPLIRLLDK
GELAQQSEADLQRIRSYAIGVGPEYSDLNAQNTAHLKDLGFLVHPFTVNETADMQRLNQY
GVDGVFTNYADQFKAISAQK
>SEQF2892_00677 Argininosuccinate lyase
MSSKAWGGRFQQQPEDWVDEFNASIDFDQTLLDEDVQGSIAHATMLANQNIISQDDKDAI
INGLKEIQQDFHNGKLAFKKSLEDIHLNIEHELIQRVGDAGGKLHTGRSRNDQVATDLHL
YVKKEVLEIQDLIRSFQTSILKLAQSHVDTIMPGYTHLQRAQPISFAHHVMTYFWMLERD
YSRFVDSMKRIDISPLGAAALSGTTHPIDRHETQQLLEFSSVYENSLDAVSDRDYIIETL
HNISLTMIHLSRFAEEIIFWSTDEAKFITLSDAFSTGSSIMPQKKNPDMAELIRGKVGRA
TGHLMSMLVTLKGLPLAYNKDLQEDKEGLFDSVRTIKGSLRIFEGMLDTMTVNTDRLNET
VHQDFSNATELADYLVAKDVPFRKAHEIVGKIVFECIQQGIYLLDVPLERYKELNSNIDQ
DVYDYLKPENCLSRRKSYGSTGQDAVRHQLKVAEKLLNND
>SEQF2892_00678 Argininosuccinate synthase
MKEKIVLAYSGGLDTSVAVKWLIDKGYDVVAVCLDVGEGKDLDVVYSKALDMGAVECHII
DATKEFSDDFVSYAIKGNLMYENSYPLVSALSRPLIAKKLVEIAEQTNSVGIAHGCTGKG
NDQVRFEVAIKALNPNLKAFAPVREWGWSREEEIDYAIKHNIPVGINHDSPYSIDQNLWG
RANECGILEDPYAAPPKDAYDLTAELEDTPDTPDEIILSFKNGVPVQLNHQDYDLDQLIL
TLNELAGKHGIGRIDHVENRLVGIKSREIYETPGAEVILKAHKALETLTLTKDVAHFKPV
IEKQLAEQTYNGLWFSPLTDSLKLFIDSTQQYVEGDVRIKLFKGNAIVNGRKSPYTLYDE
KLATYTKEDAFNQSAAVGFIDIYGLPTQVNAYLHGGYSNE
>SEQF2892_00679 Glucose-6-phosphate isomerase
MTHIQLDYGKALEFFGQHEIDQQQDIVKTIHKTIHEGTGAGSDFLGWVNLPEDYDKKEFS
RIVEASKRIKSNSDVLVVIGIGGSYLGARAAIEMLTSSFRNSNEYPEIVFVGNHLSSTYT
KELVDYLSDKDFSVNVISKSGTTTEPAVAFRLFKQLVEDKYGKAEAKKRIFATTDKAKGA
LKQLADNEGYETFVVPDDVGGRYSVLTAVGLLPIATAGINIESIMIGANKARKELSSDKL
DENIAYQYATIRNILYSKGYTTEMLINYEPSMQYFNEWWKQLYGESEGKDFKGIYPSSAN
YTTDLHSLGQYVQEGRRFLFETVVKVNNPKHDITIEEDSDDLDGLNYLAGKTIDEVNTKA
FEGTLLAHTDGGVPNVVVNIPRLDEETFGYVVYFFELACAMSGYQLGVNPFNQPGVEAYK
QNMFALLGKPGFEDKKKELEERL
>SEQF2892_00680 TVP38/TMEM64 family inner membrane protein YdjZ
MFHQIEQWFDLLQGFGYLAGFIILFFRAIVPVLPLTLYVILCVHAYGFIAGTIISWLGVV
AGTYTVFFFCRKFVNANFMKRIKSRRSIERLIHFIDRQGLVPIFILMCFPFTPNTLVNFV
ASFSHIRGKYYFIILLISKLISITFLAIMGKSVTSFFTHPVRAIMVLIVTIALWFVGKKV
EGYFMGSDKE
>SEQF2892_00681 Signal peptidase IB
MRRVTSWIVAFLFACLFVMFIQMFLVKSAVVQTDDMSPTLNKGDRVIINKIKVTFNMLKD
GDIIMYRHNNQLHFGRLVGKPGESIEVRNGKLYRDDRQVNKFYAKNRDINNFAIRDLHDS
DGDIILPNSYFILNDNGDKQSDSRTYGLIDKDDIVGDVSLKYYPFKEFTYQFNK
>SEQF2892_00682 Signal peptidase IB
MKKEIVEWIVAIAVGLLLVWVMVNFVAKSYTIKGDSMDPTLKDGEHVMVNILGYKVGDIK
KGNVIVFHANQQDDYVKRVIGVPGDNVIYKNDKLYVNGKKINEPYLDYNEKRKQGEYITG
SFETKDLLNANPKSNIIPKGKYLVLGDNREVSKDSRAFGLIDRDQIVGKVSFRFWPFSEF
KFNFNPDNEK
>SEQF2892_00683 ATP-dependent helicase/deoxyribonuclease subunit B
MELNAYIGRAGTGKSHHMIDNIKQQMKEDPLGDPIVLIAPTQSTFQLEQAFVNDKELNGS
LRTEVLHFERLSYRVFQEVGGLTEERLTQAATEMMIYDLVQQHKSELKLYQSQVNYYGFS
EKLSEQIQDFKKYSVTPEHLHTFLQDNDLKTRTRHKLEDISLIYQYFEERINGEFITSED
SLNHFIDILSQSEWIKRAEVYIDGFHNFSTLEYQIIKALVQSAKKVTVLLTTDGNEDPFS
LFRKPSEVLTHLKEIAKDLNIELQQQFFKQQYRFNNKDLIQLEQQFDALQINPIAYDGSI
NILESSSIREEVNEVARQIIKDTRDKQYRYQDIAILYRDEAYAYLFDSVLPQYDIPFNID
TKRSMTHHPIMEMVRSLLEVIQTNWNISPMMRLIKTNILTNHFKDSAYLIDLLENFVVER
GVYGKRWLDEKLFSIDNFTKMGRKEHKLTTEEREDFEQVVHLKNDIIDKILTFEKAMNEA
ENVRGFATAFYETMEAFDLPKYLMTHRDQLDVDGRHEEAEEIDQIWNGLIQILDDLVTVF
DNEEMTLKRFLEVFDIGLEQLEFVMIPQTLDQVSIGTMDLAKVDNKKHIYMVGMNDGAMP
QPVSSSSLITDEEKKVFEQQAQVELSPTSDILQMDEAFVCYIAMTRGSEQVTFSYSLMGA
QGEDKEKSPFIDQIQELFNGLEVMNIHYQHNAQPLSLMEHPHQTKVVLFESLKAWLEAEM
VADVWVDAYQVMRDNDKLNNGLEYLLTALTYDNETVKLDEPLAASLYGSTINASVSRFEG
YNDCPFKHYANHGLRLNERTKYKLENFDLGNIFHTALKYISDKVDGDFKNLDNKKIHALT
VEALENVLPQVQFNLMDSNAYYRYVSKRIGVIVESTLKALRYQNKNTKFKPQRFEAGFRK
TPNNSEELIAQPLITKQGIPVNIRGQIDRIDAYTKDDKSYINIIDYKSSNPSAKLDLKKV
YYGKQMQMMTYMDIALQNAQRLGLSNEIKPGGLLYFHVHDERLSFKDWGELEDDALTQDK
LEQAFLKEYKLRGLVNSDMDVVDALDIRLEEIGKSDIVPVSLKKDGSIGSRGSSVADETT
IHKFIKHNKDNFIKTATNIMEGHTEVAPLKFDDQLPCQFCNFQSVCHVDTIIDSKHYRHV
DETIDPIKAIQDVELESGDHNE
>SEQF2892_00684 ATP-dependent helicase/nuclease subunit A
MIIMNNIPIKPKDAQWTDAQWKSIYANGQDILVAAAAGSGKTAVLVERIIQKIIRDEIDV
DKLLVVTFTNLSAREMKHRVDQRIQQAAIENPNNEHLKNQRIKIHQAQISTLHSFCLKII
QQHYDVIDLDPNFRTISDVENVLLLEQSIDEVLEKHYDTPDIEFLTLVEQLSSDRNDDNF
RDLLKRFYNFSIANPSPFEWLDSLVEIYTDDNKHKLYLDELERLSKIYIKAAYHTLLEAE
NNFLNCIEAEKHLDVIKLEKFKCEKMIEGNVINFEEIINYTSEKLPTITKKLKDTNEDEG
ISSQFLTNAKDFYDDYKKLLSEVKNKYLMRSYEDLKVDMKRLAPRIQYLVQIVKDIINGF
AEKKRSRNVLDFSDYEHFALQILTDQEGNASPIAKEYRSQFEEILVDEYQDTNQVQEAII
SKIKRGDESNGNLFMVGDVKQSIYKFRQADPTLFMDKYHRFTKDGDQSGLRIDLSKNFRS
RKEVLATTNYLFDHMMDEEVGEIEYDADARLYFGATKYSDKSMPLELHALIQDKSSDNDL
EKSEQEARYIAEQVKYIIEHKQVYDMKSETYRQATFKDIVILERGLKNARNLQQVFKDYN
IPFHVNSKEGYFEQTEVRLVLSFLRTVDNPLQDIYLVGLMRSVIYQFTEDELANIRVQSM
NDDYFYQSILHYMKDQEANPLLVEKLEHFMDDINMYQEYSQSHPVYQLIDKFYNDHYVIQ
YFSGLIGGKGRRANLYGLFNKAVEFENSSFRGLYQFIRFIDELIERNKDFGEENVIGPND
NVVRMMTVHSSKGLEFPYVIYSELSKNFNKGDLRKPLILNQKYGLGIDYFDLEQNVTYPS
LSSVVIKSITEKELISEEMRLMYVALTRAKEQLILIGTIDKEETLEKLERLPISGNQIAL
HKRLSADRPFDLIYSILAKYQSTSLLPEYQFEKSIDNLDESLRPTVDIKIAQFEELSIED
SESEQESRDVSDLEVEGSHDKTLKQQINDQLSFKYPYLKDTEKPSKQSVSELKRQLETEE
SGTSYERVRQYRIGVSTYERPKFLRENKKRKANEIGTLMHTVMQHLPFKETRMTETELND
YINELIEKHIIEEDAKKDIQFEAVMNFIRSDLYMTITQADKVYRELPFVVNQARVDEMPE
SDEDVSIIQGMIDLIFLKDDQYYFVDYKTDAFNKRRGMTDEEVGIQLRDKYKIQMKYYKN
TLETILNSKVYGYLYFFQFGQMSIEEDV
>SEQF2892_00685 Ureidoglycolate lyase
MKFLSFNYKDAESYGVKVKREDAVWDLKKVFAEFGEGDFHPQTLLEGLQQNQTLDFQEQV
RKAVVAAEDSGKADEFKIAFNDIEFLPPVTPPNNVIAFGRNYQDHASELNHEVQRLYVFT
KAASSLTGDESTIPNHKDITDQLDYEGELGIVIGKSGEKIPKALALDYIYGYTIINDITD
RKAQNEQDQAFLSKSLTGGCPMGPYIVTKDELPTPENVNIVTKVNNDIRQDGNTSQMINK
IDDLIEEISKYVALHPGDIIATGTPAGVGAGLQPPQFLQPGDEVKVTIDNIGTLTTYIAK
D
>SEQF2892_00686 hypothetical protein
MLHMHIASWALTIILYVIAFLHISKSQGPTPMFKPLQMALRVFMLLTLFSGFWLLIQEFM
AASHGGGGNHMLLTLKMLCGIAVVALMEVSIAKRKKHEASHGLFWATIILIIITMSLGII
LPWGPISSLFGIS
>SEQF2892_00687 Coenzyme A disulfide reductase
MMRKIIVVGAVAGGATCASQIRRLDKDSEITIFEKDRDMSFANCGLPYFIGNIVNERKDV
LPITPDVFKEKKDITVKTYHEVIAINDKDQTVTVVNRQTNEKFEASYDKLILSPGAGANS
LGFDSDYIFTLRNMEDTDAIDQFIDQHQAKKALVVGAGYISLEVLENLYARGLDVTLIHR
SEKVNKLMDQDMNQVIFDELDSRHIPYRLNEEIVSVKDHLVTFKSGIQEDFDIIIEGVGT
HPNSKFIESSNVALDDKGFVKVNYKFETNIPNIYALGDVITSTYRHVNLPAQVPLAWGAH
RGASVIAEQLAGNKNIIFKGFLGTNIVKFFDYTLASVGIKVEELTHFDYQMVELNSGTHA
GYYPGNTNVHLRVYFDTNNRHLLRAAAVGKTGVDKRIDVLSMAMMSELTIDELTEFEVAY
APPYSHPKDLVNMIGYKARDL
>SEQF2892_00688 5-amino-6-(5-phospho-D-ribitylamino)uracil phosphatase YitU
MKPYLICLDLDGTLLNDNKEISDYTKQVLTTLKKQGHRIMIATGRPYRASQIYYHELNMD
TPIVNFNGAYVHHPKSDDFKTTHEVLDVDLARNMIETLQKAKVTNIIAEVRDHVFINNHD
PRLFEGFSMGNPKIETGNLLEELDEAPTSLLVEAEEIYIPRIKQMLTRFYAENIEHRRWG
APFPVIEIVKRGISKARGIDQVKDYLGIEPSHIIAFGDEDNDIEMIKYAKYGIAMENGLD
ELKHIANHITYSNNDDGIGRYLNNFFKLNIPYKG
>SEQF2892_00689 Iron-sulfur cluster carrier protein
MEEALKDSILGALEMVIDPELGIDIVNLGLVYKVNVDDDGLCTVEMTLTSMGCPLGPQII
EQIKTVLAEIPEIQDTEVNIVWNPPWNKDMMSRYAKIALGVS
>SEQF2892_00690 O-acetyltransferase OatA
MKQDFEKGKQRKTKMRYMPGLDGLRAIAVLGIIIYHLNRKWLTGGFIGVDTFFVISGYLI
TSLLLKEYEERGIISLKQFWIRRVKRLLPAVVALLIVVGIATLIFEPQQIVRVKHDIIAA
LFYVSNWWYIAKDVNYFEQFSFMPLKHLWSLAIEEQFYLFFPFVLVILLLTIKKYRNVTL
ILWIISLVSLLAMVIISQPNVGYSRVYFGTDTRLQTLLLGVILAFVWPPFKLKANPPKVL
QRSIDGIGILGLIILIYLFFTVKDTSAWIYNGGFYLISGMTLFIIASVVHPSSILAKVLG
HRIFVYIGKRSYSLYLWHFPVISFIHIHFVDGQLPIYVYFVDIILTVLFAELSYRYIETP
FRREGLKAFSFNYLKRPKFIRTIVSIIAVIPIVLLFLGVFDRFGKDEIDNKANSFNTNDQ
DKYLVRMMPGENIKIDGSSSNSKSKKQVYTNISPLLIGDSVMVDIGEEFKSQVPKATIDG
KVGRHLQEALSIAGNYSNYNKPSDKVVLELGTNGDFTEEELNQLINKFGKAQIYLVNTRV
PRDWQDNVNKQLANAAKKHKNVTLVDWYQRSAGHSEYFAPDGVHLENSGVKALSDEIIKT
IKKNSKNK
>SEQF2892_00691 Chaperone protein ClpB
MTYAIQGALQKAVELSKENELQNIEIEAILKGTLEETDSLFKSILERANIDTDELNQAYT
NKLKNYPSVQGDNIQYGQYIGAKANELLNKAESYMKEYEDEYISMEHVLRAAMDIDDTTK
QFVGNKEEVVKEIITKVRGGNHVTSQNPEVNYEALEKYGRDLVEEVRQGKMDPVIGRDEE
IRNTIRILSRKTKNNPVLIGEPGVGKTAIVEGLAQRIVRKDVPESLLDKTIFELDLSALV
AGAKFRGEFEERLKAVLKEVKESDGRIILFIDEIHMLVGAGKTDGAMDAGNMLKPMLARG
ELHCIGATTLNEYREYIEKDSALERRFQKVGVSEPDVEDTISILRGLKERYEVYHGVRIQ
DRALVAAAELSDRYITDRFLPDKAIDLVDQACATIRTEMGSNPTELDQVNRRVMQLEIEE
SALKNESDNASKHRLEELQEELSNEKEKQASLQSRVEQEKEKIANVQEKRAELDRSRQAL
EDAQTEGNLEKAAELQYGTIPQLEKELKEFEEAYQDEQGDSERMIREVVSDEEIGDIVSQ
WTGIPVSKLVETEREKLLNLSDILHERVVGQDKAVDLVSDAVVRARAGIKDPNRPIGSFL
FLGPTGVGKTELAKSLAASLFDSEKHMIRIDMSEYMEKHSVSRLIGAPPGYVGHDEGGQL
TEAVRRNPYSVILLDEVEKAHSDVFNVLLQILDEGRLTDSKGRSVDFKNTIIIMTSNIGS
QVLLENVKDTGDITEETEKAVMDSLHAFFKPEILNRMDDIVLFKPLSINDMSMIVDKILT
QLNIRLMDQRISIEVSDDAKKWLGEEAYEPQFGARPLKRFVQRQIETPLARMMIKEGMPE
GTVVNVDLDDNHELTFDVQKPENE
>SEQF2892_00692 hypothetical protein
MKYLVTFIWAVILLQMVNFVLNSLNGGGTLNFITPIVLAVIFTIVIAILAAMIKPDDFTR
SGNR
>SEQF2892_00693 3-oxoacyl-[acyl-carrier-protein] synthase 3
MNVGIKGFGAYAPEKVVDNAYFESFLETSDEWISKMTGIKERRWASENQDTSDLAFEASK
KAIKDAGITPADIDMIIVATATGDMPFPSVANILQEKLDTRKVPTMDQLAACSGFMYSMI
TAKQYVQSGDYKNILVVGADKLSKITDLTDRSTAVLFGDGAGAVVIGEVSEGRGIISYEM
GSDGNGGKYLYLNKDTGKLVMNGREVFKFAVRIMGEASTRVVDKAGLQSDDIDMFIPHQA
NIRIMESARERLGIEREKMSVSVNRFGNTSAASIPLSISQELENGRIKDDDTLVLVGFGG
GLTWGAMVIKWGK
>SEQF2892_00694 3-oxoacyl-[acyl-carrier-protein] synthase 2
MTENKRVVITGMGALSPIGNDAQTSWENALKGVNGIDTITRIDTEDYNVHLAGELKDFNI
EDHIEKKEARRMDRFTQYAVVAARQAVEDAKLEINDETANRIGVWIGSGIGGMETFETAH
TTLQNKGPRRVSPFFVPMLIPDMATGQVSIDLGAKGPNGSTVTACATGTNSIGEAFKIIQ
RGDADAMITGGTEAPITHMALAGFSASRALSTNDDKETACRPFQEGRDGFVMGEGAGILV
IESLESAQARGAQIYAEIVGYGSTGDAYHITAPAPEGEGGSRAMQAALDDAGIEAKDVQY
LNAHGTSTPVGDMYEIRAIKNTFGDAANQLKVSSTKSMTGHLLGATGGLEAIFSALSIRD
SKVAPTIHANTPDPECDLDIVPNEAQDLEITYAMSNSLGFGGHNAVLVFKKFED
>SEQF2892_00695 hypothetical protein
MKNLKNWMIWLIITPILSMILWIIFTNHTFVSYINTLFYLSLIIFISIFFILLVQEGIFD
ATSYGFRRIRYQLSSRSKKRTMADDEFLNPQQVKKEHYFISTWIAPALICNIAYFVMTII
ISFLL
>SEQF2892_00696 Oligopeptide transport system permease protein OppB
MTRYIFKRLGYMFLSLFIIITITFFLMKLMPGSPFNDAKLSAEQKAILNEKYGLNDPVAI
QYLHYLKNVVTGDFGYSFQYHNQPVWELIKPRLIPSMEMGITAMIIGVILGLILGVAAAT
KQNTWVDYTTTIISVIAVSVPSFVLAVLLQYVFAVRLRWFPVAGWEGFSTAVLPSLALSA
TVLATVARYIRAEMIEVLSSDYILLARAKGNSSLRVLFGHALRNALIPIITIIVPMLASI
LTGTLTIENIFGVPGLGDQFVRSITTNDFPVIMATTILFSTLFIVSIFIVDILYGIIDPR
IRVQGGKK
>SEQF2892_00697 Oligopeptide transport system permease protein OppC
MTNDKFEKPLDDHSNAAMTHTSEGIAASDFVIRDLDINKEPEMKRESKNFWQDAWAQLKR
NKLAVIGMIGLILIIILALVGPLISKHDFAEQNVDYRNLPAKIPVLDKVHFLPFDGTGSD
GKDAYAKVGAKENYWFGTDQLGRDLWTRTWKGTQISLVIGIVAALLDIFIGVVYGAISGF
FGGRVDDVMQRILEIIASIPNLIVVILFVLIFEPSIWTIILAMSITGWLGMSRVVRGEFL
KLKNQEFVMASRTLGASKVNLIFKHILPNTLGAIVVTSMFTVPSAIFFEAFLSFIGIGVP
APQTSLGSLVNDGRAMLLIHPHELFIPATILSLLILFFYLFSDGLRDAFDPKMRK
>SEQF2892_00698 Oligopeptide transport ATP-binding protein OppD
MSERVLEVNDLHVSFDITAGEVQAVRGVDFYLNKGETLAIVGESGSGKSVTTKAITKLFQ
GDAGRIKKGAIDFLGEDLANKSEKELIKLRGKDISMIFQDPMTSLNPTMQIGKQVMEPLI
KHRNYSKSEAKKRALEILNLVGLPNAEKRFKAYPHQFSGGQRQRIVIATALACEPKVLIA
DEPTTALDVTMQAQILDLMKDLQKKIDTSIIFITHDLGVVANIADRVAVMYGGQMIETGD
VDEIFYDPKHPYTWGLLSSMPDLTTSNDTELIAIPGTPPDLLHPPKGDAFAGRSQYALDI
DFKQEPPWFKVSPTHFVKSWLLDERAPKVKPPEMVVKRQRQMPNNYDKPRQVERVSFDG
>SEQF2892_00699 Oligopeptide transport ATP-binding protein OppF
MDKNNEVLLEIKNLKQYFNEGKRNEVRAIEDISFDIYKGETLGLVGESGCGKSTTGKAII
KLNDITSGEILYEGQDIQKISKRKDLLKFNKKIQMIFQDPYASLNPRLKVMDIVAEGIDI
HKLASSKKDRKRRVYDLLETVGLSKEHANRYPHEFSGGQRQRIGIARALAVEPEFIIADE
PISALDVSIQAQVVNLMLKLQKERGITFLFIAHDLSMVKYISDRIAVMHFGKIVELGSAD
EIYYHPLHDYTKSLLSAIPQPDPDSERTRKRVAYQEDESKNSERKLQEIRPDHYVFVTDE
EAAQLKQEHQTQSV
>SEQF2892_00700 Dipeptide-binding protein DppE
MKSLKYIATLLIVVLVLSACSNNKSLYSDDGQVFRKVITQDISTLDTALITDAVSGDIAG
QAFEGLYSIDKGDKVTLGVAKEMPKKSNGGKTLTINLRKNAKWSNGDPVTADDFVYAWRK
VVDPKTASEFAYIMSDIKNADLVNSGKKPVSELGIKALDKYKLQVELEKPVPYINELLAL
NTFDPQNSKIAKKYGEKYGTKADRAVYNGPFKVINWQVEDKIQLVKNDKYWDKKNVKLDK
VNYKVLKDQQAGASLYDTDSVDDTIVTSEQVNKYKNSKALNHRLTAATFYIKMNEKTVPE
FKNKHLRLAIAQAINKKGYVKSVLNDGSLASDNFTGIGTAKTPDGKDFASTVSSPLKYNT
KEAKQNWEIAQKELGKKEFTFTMNTQDTPAAKIAAEYIKSQIETNLPGVTLKIKQMPFKQ
KITLELANNYETSYAGWSPDYPDPTAFLEIMTKGNAQNNTDWGNKEYDNLIKEANGSLLR
EPDKRNEALQKAESILLHDAPVAPIYQKGEAHLTNPQVRGLQYHKVGPDTTLKHVYIDKT
IDRETGKKRKSE
>SEQF2892_00701 hypothetical protein
MYKNYNMTQLTLPMETSVLIPTNDISRHVNDIVETIPDNEFDEFRHHRGATSYHPKMMLK
VILYAYTQSVFSGRKIEKMLNDSIRMMWLSQNQKPSYKTINRFRVNPKIDALLESLFIQF
YSQCVKQNLIDDKAIFIDGTKIEANANRYTFVWKKSIQNHESKMNEDSKALYHELVTNKI
IPEIKEDHDNELTKEEIDLIGSHLDKEIEDLNQHINNEKCTKTRKQIRLKRTKIKKYKKQ
INDYFERKYRYEFQKSILKDRNSYSKTDHDATFMRMKEDHMKNGQLKPGYNLQIATNSQF
VLSYNVYQNPTDTRTMIPFLNSIQETYGHLPEYIVADAGYGSESNYKAIIDDFNRTPLIT
YGMFIKDKTKKYKSDIFNTQNWNYDEINDEFICPNNKRLGFKRYAYRHDKYGYKRDFKLY
ECDDCSECPLKNQCMNFNSKTNKKIMKNYNWEYFKSQINKKLSEPETKNIYSQRKIDVEP
VFGFMKAILGFTRMSVRGLNKVKRELGFVLMALNIRKVVAQGAENNQKIYKKDNFYIISI
EIVFFSLIQELYVPDSLYYSLFLFLPVSRSIVLSIYTCLSVVSGPTL
>SEQF2892_00703 Tryptophan--tRNA ligase
METLFSGIQPSGIPTIGNYIGALKQFADVQNDYDCYFCIVDQHAITVPQDKIKLRKQIRQ
LAAIYLASGINPEKATLFIQSEVPAHVQAGWMLTTISSVGELERMTQYKDKAQKRTDGIP
AGLLTYPPLMAADIVIYNTNIVPVGEDQKQHMELTRNLVERFNSRYNDILVKPEIRMPKV
GGRVMSLQDPTKKMSKSDDNQKNFISLLDEPNVAAKKIKSAVTDSDGIIKFDRDNKPGIS
NLLTIYSSLTNESIKDLEAKYENEGYGKFKTDLSEIVKDFLINFQEKYNEFYNSDKLDDI
LDHGRDKAQKASFKTLKKMERAMGLGRKR
>SEQF2892_00704 Regulatory protein Spx
MVTLFTSPSCTSCRKAKAWLQEHDIPYTERNIFSEHLTIDEIKQILKMTEDGTDEIISTR
SKTYQKLNVDIDSLPLQDLYAIIQDNPGLLRRPIILDEKRLQVGYNEDEIRRFLPRKVRT
FQLQEAQRLVD
>SEQF2892_00705 Adapter protein MecA 1
MRIERVDDTTVKLFITYSDIEARGFSREDLWTNRKRGEEFFWSMMDEINEEEDFVVEGPL
WIQVHAFEKGVEVTISKSKNEEAMNMSDEDANEQFEEQVNELLANTLENEESIEDLFEQR
AQQQKHSHKSEQKQTKQRPNIRTVIVKFDDLEQVISYAYHHNLSTDEFEDLLYMNDNKYY
YAIHFDESVSQEMINDSYSQMLEFAYPTDKTEVYLNDYAKIIMSHNVTAQVRRYFPDTVE
>SEQF2892_00706 Competence protein CoiA
MLIAINQQGEQVYAHRAKKQDSYFCPHCSSQLLLKCGTKNIPHFAHKVDSVCYCAKQESE
QHYFVKCFIAKMLSQLHYHVQIEPYCPTIQQYPDILVNSKYVIEIQFSRIDIEEIIERTK
GFKQLNMEVIWLIQDCRYHRGRLYLNSFQAHFIHPINRCLYVWNQKNKCVVLYSQIQHIG
GKQFIAKQTVIEINELVNLISIMSTPYQHIFKLTKSEIHYYLNQCRRKNSVLEPSLSAIY
QLRLTDEAVYHNFGYIFPYQLYIENHPVQWQLQFKLFNEQEFDVHQCLKAFLKFRQMYLN
TISMDCVVSELINHYIKYS
>SEQF2892_00707 Oligoendopeptidase F, plasmid
MSQQLTREEQERKYPNDTWDLTTIFKNDEAFEEALKEVEGYLGKEEQFKGHLADSADTLC
DALALEDEIGTKLEKVYVYAHLKQDQDTSNDKYTGFESRAHQLIIKISSAWSFLVPEILQ
IDEDKLQSFIETNDNLKRYEFDLKLINEKRPHILDAEQERLLTEAQDALSTPSNVYGMFS
NADLEFEDAVDKDGEKHPLTQGTFIKYLESDDRELRQSAYNNLYKAYGAYNNTLGSTLAG
EVKKNVFNARTHNYKTARERALSNNHIPEEVYDNLVKTVHKYLPLLHRYTKLRKELLAVD
ELKMYDLYTPMVKDVKFEMPYEEAKEWMLKALEPMGEEYLDVVKEGLNNRWVDVYENKGK
RSGGYSSGAHLTNPFILLNWSDTVSDLYTLIHEFGHSAHSYFSRKHQPSNSSDYSIFVAE
VASTCNEALLSDYMDKHLDDERRLLLLNQELERFRATLFRQTMFAEFEHKIHQIEEAGEP
LTATRMNDEYAKLNKQYFGDVVETDDNISKEWSRIPHFYMNYYVYQYATGYSAAQSLSHQ
ILTEGKPAVERYINEFLKKGSSNYPIEILKNAGVDMTSPEPIEQACEVFEQKLDTFEKLM
KA
>SEQF2892_00709 hypothetical protein
MCKSILNTLRIKDKNLNFSDEVIEKKHKGRMSLFYYAELTYQPTHCENCSTKNENFSIVK
NGKKTSTITLLKIMEMPAYLELQKQRFYCKSCDSHFTAKSNIVDAHCFISNKTKLAVLDK
AQEYRSQKSIAKSCLVSSMTVSRVINQAASDVGQSSFDALPEHLMMDEFKSVKNVIGKMS
FIYADAVSHRIVDVVADRKLKSLKDHFYRYSLKLRQKVKTVTIDMYEPYMSLIKQLFPNA
KIIIDRFHIVQSLNRALNMSRVHVMNCYRTSNRPLYNKYKSYWKLFLKPFETLEAFNYHK
VHLFKEWKTEKGIINYLLGVDVELFNTYHYVHELRRLLKENQIEKFNHKLFSIHLSDVCP
KLRPVIRTLRRLAAFIENTMTYSNLTNGPLEGINNKIKLIKRVSFGYRNYDNLRNRIIIT
SRLFASTTKKEIKQPKVA
>SEQF2892_00710 hypothetical protein
MAEELKIVDNRSREDANLSPVNKIEIYSFFDPFNTDCFKLSAIISKLRIEYNQYIRIRHI
LNPSLKVLTKCQAQSTSDFDNIALAYKAAELQGRLRAERFIHLMQNEIIPKKDIITEEMI
CDCIINAGLDYNEFKEDLQKSKLTESLKIDLHIAREMEIEQAPSLVFFSEDVHEEGLKVE
GLYPYHIYTYIINELMGTPIEKNLPPKIEHYIQKKQLVTTEELLTIYEWPEKLMTKELKK
LALQQKVEKLQYPEGDFWQSKMPRI
>SEQF2892_00711 Group 2 truncated hemoglobin YjbI
MSKTPYDIIGETALYNMIDHFYALVEKDDRINHLFPGDFAETSRKQKQFLTQFLGGPNLY
TEEHGHPMLKKRHMEFKITTYERDAWLENMHTAITEAQFPAGVGEYLYERLRLTANHMVN
S
>SEQF2892_00712 Putative triphosphatase YjbK
MATNNEIEFKQLLSKDVYDKFKYTFFEDKEPFIQINYYIDTPNFTLRDHKSALRIRVKND
TYEMTLKVPADVGLMEYNHMVKHIPKTGDVIFNNSLPEDIREIVESYGINDNELTILGAL
RTARLETNYKNELLVLDRSDYFDKVDYELEFEVTDYNNGLKKFHSLLEEFNLEHTVPNNK
VQRFFDYKNQIDK
>SEQF2892_00713 hypothetical protein
MRIYVNEIKIKDDGIYCYSEDPTDGLVEVGQMLVDSDNYGFAYLLDDGQSYDYLIFVQET
WSMLHENRGKKLIVNDDLVLEHFQEELDYILENVEGNNNYGKEFVSAVEETFDLK
>SEQF2892_00714 GTP pyrophosphokinase YjbM
MNQWDQFLTPYKQAVDELKVKLKGLRKQYEVGEDASPIEFVTGRVKPITSIIDKANKRGI
PFDRLREEMYDIAGLRMMCQFVDDIDVVVNMLRQRQDFKVIEERDYINNTKQSGYRSYHV
IIEYPIETLNGQKAILAEIQIRTLAMNFWATIEHTLRYKYDGDYPAEIQHRLERAAEAAY
LLDEEMSEIKDEIQEAQKYYSQKRAKKHD
>SEQF2892_00715 NAD kinase
MRYTILSKGDSKSNALKHKMINHMKDFHMVEDAVNPEIVISVGGDGTLLQAFHQYSHMLS
QVAFVGVHTGHLGFYADWLPHEVEKLIIEINNSEFQVIEYPLLEIIVRYNDNGYETRYLA
LNEATMKTENGSTLVVDVGIRGKQFERFRGDGLCISTPSGSTAYNKALGGALIHPSLEAM
QIAEIASINNRVFRTVGSPLVLPKHHTCLITPVNHDPILTTIDHVSLKHKNVNGIQFRVA
NEKVRFARFRPFPFWKRVHDSFIESEDGR
>SEQF2892_00716 Ribosomal large subunit pseudouridine synthase D
MKFEYVIQHNEMLKSFLQRHQYSKKTISAIKHNGALIINNSHVTVRKMMMAGDKLTIMLP
DETPSSYLIPSRNPIEILYEDDYLIIVSKPNYLNSTPSREHPHDSLIERVLYYLNVGQLI
DTSIVPHIVTRLDRNTKGIVIFAKHGHIHHLMTTSAIDKRYMCVCYGQMQLSGVIEEPIA
RDSQSIITRKVDASGKYAKTSYETVMTKPEASLCEIKLHTGRTHQIRVHFNYVGHPLVGD
DLYEGSHPEIYTQSLQCYKVTFIHPIYNREIEIEIDYKWLQNIFAEL
>SEQF2892_00717 Magnesium transporter MgtE
MSLETENNDYNTDEVYNQNLLDDLLKQDDIDRFREEFLAMHEYEQSEYFEDTTNENRQKI
FEFLSPQEVGEFFEQLEIDDEAYEDLFDTMNAHYASKVLEEMSSDNAVDILNELSKPKVA
SLLTLMNRDDANEIKHLLHYEEDTAGGIMTTEYISLDVNTPVKEALMLVKEQAPDAETIY
VIFAINTDGQLVGVLSLRDLIVAENDAYIEDIMSERVISVNVADDQEDVAQKMRDYDFIA
MPVIDYQQHLLGIITIDDILDVMDEEASEDYSRLAGVSDIDSTNDSVVKTATKRLPWLII
LTFLGMITATILGSFEATLSQVALLAAFIPIISGMSGNSGTQSLAVSVRNISTGEIDEQS
KFKVALREAGSGLLSGLVCATVLFIIIVVIYRQPFLALIVGGSLTIAMTVGTLVGSMIPL
FMNKLNIDPAVASGPFITTINDIVSMLIYFGLATTFMSYLT
>SEQF2892_00718 Na(+)/H(+)-K(+) antiporter GerN
MEFFSLVIVVLAAFFTPIIINRLNINFLPVVVAEIIMGIIIGQSFLNLVHKDSMLNILST
LGFIFLMFLSGLEIDFSTFKKDKRNRQGTNKHEKDVPSHLNLALTVFAFIMIISVILAYA
FKWLGLVDDVLLMIIIISTISLGVVVPTLKEMNIMRTTIGQFILLVAVLADLVTMVLLTI
YGGINGSGNGSVWLSAILLVFTAIFYILGVVFKRMKFLHRLIGGTTQIGIRAIFALIILL
VALAEGVGAEYILGAFLAGVVVSLLKPDEELVHTLDSFGYGFFIPIFFIMVGVDLNIPSL
IKEPSLLLIIPVLILAFIISKLIPVFFIRRWFDNKTTIASAFLLTSTLSLVIASAKIAEQ
LNTISSEMSGILILSAIITCVFVPIIFKKMFPIPDEANRKIDIALIGKNQLTIPIVQNLS
PHLYNVTLYYRKDLGDKRNLSDHITVVEIANYEEQLLERLGLFNQDIVVCSANDDSLNRD
VAKLAKAHDVKRVICRLENSNEDEEMKGEGIEVFSNFISNKIFLQGLIETPNMLNILSNV
ETSLYEIEMLNHQYENIQLRNFPFGGDIIFVRIIRNNESIVPHGDTQLRYKDRLIVTGSK
EYVDELKSDLEFYY
>SEQF2892_00719 Enoyl-[acyl-carrier-protein] reductase [NADPH] FabI
MINLENKTFVIMGIANKRSIGFGVAKVLDQLGAKLVFTYRKDRSRKELEKLLEQLNQEEP
KLYQIDVQKDEDVVNGFAKIGEEVGNIDGVYHSIAFANIEDLRGRFSETSREGFLLAQDI
SSYSLTIVAHEAKKIMPNGGSIVATTYLGGEFAVQNYNVMGVAKASLEANVKYLAYDLGP
DNIRVNAISAGPIRTLSAKGVGGFNTILKEIEERAPLRRNVDQEEVGKTAAYLLSDFSSG
VTGENIHVDSGFHAIK
>SEQF2892_00720 hypothetical protein
MLNKVWFRTGIALVILFVLIKLFMEVQSVFAPIVTIIGSVFLPFMISGFLFYICLPFQSI
LEKWGFPRWASITTIFIGLIAIIAIVVAFIAPIIISNVNSLIKATPSLQKEAEHIVNFSL
TQMDKLPSDVTDRINSAVKSIGDSMTGILANSFTYLTSFISTVFLLIMVPFFLIYMLKDH
EKFIPALAKFFKGERKVFVVDLMKDLNFTLKSYIQGQVTVSVILGVILYIGYTIIGLPYT
PLLVLFAGVANLIPFLGPWLSFAPAAVLGIIDSPTTFIWVCVVTLIAQQLEGNVITPNVM
GKSLSIHPLTIIVVILAAGDLGGFTLILIAVPLYAVLKTIASNVFKYRQRIIDKANSDVK
D
>SEQF2892_00721 hypothetical protein
MSNFKPGKINKHILHSNILERDVTLSVYLPEDYSELFKYQVIICFDGLDFLRFGRLQREY
ERLRREDEIQRAIIIGFHYEDVDKRREEFHPQGTRSHKTVQVVGKELLPFIDKTFPTYKV
GNARILMGDSLAGSIALLTALTYPTIFSQVAMLSPHSDETVIDKFNKCIQYSELSIWHAI
GLEEEDFALPTTGERANFLTPNRDLATVIKDKGLTYHYLEFEGGHNWKSWKPLLSDILKY
YLSDELITQESNEV
>SEQF2892_00722 Putative phosphoesterase
MNIGLALIPSKSFQDEVNGYRKRYDTEYARIMPHITIKSHFEINDDELDSVKEEVKKRLE
GFGPVDVHATKASSFKPTNNVIYFKVAKTDELEQLFNLFNTEDFHGEAEHPFVPHFTIAQ
GLTSQEFEDIFGQVELVGVDLKEKIEELSLLRYDEEEDKWKVIDTFKLA
>SEQF2892_00723 putative glycolipid permease LtaA
MPDSSLSNKGISKNFKIMLVILFLMEFARGMYVLSYVNYLPTVTSIAVAVTSAALSIHFI
SDAATNFVIGFLLKKFGTKLVLTLGFLLAFISLFLVIWFPTNPIVIILSAIMLGIAVSPI
WVIMLSSVEEAQRGKQMGYVYFAWLLGLLVGWAFMNVLVKLHPTRFAFMMSLVVVIAWVL
YYFVDIKLTNYNTKPVSEQLGQIVDVMKRHLVLFPGILLQGASISALLPILPTYATKVVG
VSTIEYTIAIAIGGAGCAFSMLFLSKIIDKNSKGFMYAVIFTGFILFTAFIFGLSLVTNI
LIVWIVAIFIGLMYGILLPAWNTFMAGQIDPAEQEETWGVFNSVQGFGSMIGPLFGGLIA
QFSNGLNNTFYFSAAIFLVLAIFYGVYFVKYRGKANRF
>SEQF2892_00724 Processive diacylglycerol beta-glucosyltransferase
MVTQNKKILIITGSFGNGHLQVTQSVVNQLNEMNLSHLSVIEHDLFMEAHPILTSICKKW
YINSFKYFRNMYKNFYYSRPDELDKCFYKYYGLNKLINLLLKEKPDLILLTFPTPVMSVL
TEQFNINIPIATVMTDYRLQKNWITPNSHRYYVATDDTKRDFVNAGIPASDIKVTGIPIS
DKFESDIDKVAWLKKHNLNPDKPTILMSAGAFGVSKGFDYMIDNILQKSPQSQIIMVCGR
SKGLKRTLEMQFKSYDNVLILGYTKHMNEWMASSQLMITKPGGITISEGLTRSLPMIFLN
PAPGQELENALYFQDKSYGKIANTPEEAIDIVSDLTNHEYRLQAMTNKMTEEKVNHSTYR
LCTDLLNILDSSSQQQEIYGKVPLYARFFVK
>SEQF2892_00725 UDP-N-acetylmuramoyl-L-alanyl-D-glutamate--L-lysine ligase
MNANELFEKIRVKQVIGTLDINVTDITTDSRTASEGSIFVASKGYTVDSHKFCQNVVDQG
AKVIVVNHQQDINGDVTQVIVPDTLRVASLLAHTLYDFPSHQLTTIGVTGTNGKTSIATM
IHLIYRGLGKGSAYLGTNGFQINEHKTRGANTTPETVSLTKKIKQAVDENAEAMTMEVSS
HGLSLGRLRGVEFDVAIFSNLTQDHLDFHGTMEAYGHAKSLLFSQLGEDLSKEKYAVLNN
DDDFSKYLASVTPYEIFTYGIDHDAQFMAKNIQESLQGVHFDFDTPIGTYSVKTPYVGKF
NISNIMAAMIAVWSKGTSMEDIVRVVENLEPVEGRLEVLDPSLPIDLIIDYAHTADGMNK
LIDAVKPFVKQKLIFLIGMAGERDLTKTPEMGAVACRADYVIFTPDNPANDDPKMLTAEL
AKGATHNHYVEFDDRAEGIKHAIDIAEPGDTVVLASKGREPYQIMPGHIKVPHRDDLIGL
EAAYKKFGGGPSEH
>SEQF2892_00726 hypothetical protein
MNIKQLSINDEIVNVYLYISEDKNQIMLAIPDIFWSIELDLNMDSNDVKEELVMQLFAFI
EENEAIKIASNLTNWIVNDFKGDQ
>SEQF2892_00727 Peptide chain release factor 3
MSLKEEVESRKTFAIISHPDAGKTTLTEKLLYFSGAIREAGTVKGKKTGKFATSDWMKVE
QERGISVTSSVMQFDYDDYKINILDTPGHEDFSEDTYRTLMAVDSAVMVIDCAKGIEPQT
LKLFKVCRMRGIPIFTFINKLDRVGKEPFELLDEIEETLNIDTYPMNWPIGMGQNFFGII
DRDSKSIEPFRDEENVLHLNDDYELQEEHAIRNDSAFAQAIEEFMLVEEAGEEFDNDALL
NGELTPVFFGSALANFGVQNFLNAYVDHAPMPNARQTNEEVEVSPFDDEFSGFIFKIQAN
MDPKHRDRIAFMRVVSGAFERGMDVTLQRTSKKQKITRSTSFMADDKETVNHAVAGDIIG
LYDTGNYQIGDTLVGGKQKYSFQDLPQFTPEIFMKVSAKNVMKQKHFHKGIEQLVQEGAI
QYYKTLHTNQIILGAVGQLQFEVFEHRMKNEYNVDVVMEPVGRKIARWIENEDDIQDKMN
TSRSILVKDRYDNFVFLFENEFATRWFEEKFPEIKLYSLL
>SEQF2892_00729 hypothetical protein
MDPSLILPYLWVILVLVFLEGLLAADNAVVMAVMVKHLPPEQRKKALFYGLLGAFVFRFL
ALFLISVIANFWFIQALGAAYLIFMSIRNLWQFFHKEHEDQPEGDDHHFDESGVEKKVGP
MQFWGTVLKVEFADIAFAIDSMLAAMAIAVTLPEVGIHFGGMDLGQFSVMFIGGMIGVIL
MRFAATWFVDLLNKYPGLEGAAFAIVGWVGIKLVVIVLAHEDIGILPEHFPHSTLWQAIF
WTVMILLVVIGWLTSVRSNKKKANK
>SEQF2892_00730 Serine protease HtrA-like protein
MDNDKKHVIPREQYRRKRHEYFHNEEREERLEREREQRERLAKKEQEQAKVNEERVKDNM
RKARIEKLTQEEIHQQQHLAKLRSDNESDQELNDTNTHHLTLPEEQQLKNEHKENNDKVT
KPTDEMEKQEKEDNNSASSKHDEIEPKYSRVEKNKGKQKQDNINKSEVNHLDKSEQTKKH
KETKESSEDVLETNKSQKIEQKEQKASSNETSNKELNSYTKDKNNKVEDNQDLKKASSQN
LAHSNKLEENEHLENEPKNNDTMDKVKDFLKLHWLKIVIVVAIILIVILISAIISTMNQN
SSIEQSSNNDTKYTTTMKNAETAVKSVVTIENDTPKNITTQTIDKTNINSNNEVGSGVVY
KAVDDTFFILTNTHIVGSNKRVNITYDDDKTATATVVGRDMWSDIAVLKATIKNKNMQPI
KIGHSKHLKLGESILVVGNPLGNDFKNTVTKGIISGLNRAVPVDFDKDNKNDEWVNTFQI
DASVNPGNSGGAVVNRVGELVGLVSLKINMPNIEGMGFAIPIDAAREIAEELEKKGEIQY
PNTGIGIKNVSDLMPYERNLLKVPEDVQNGIVVEKLKENGLGKKSGLKIGDVVVELDSKS
IQNNLQYRQIIFNHRQDLKTLSAKIYREGKSQEIRIKLK
>SEQF2892_00731 Ktr system potassium uptake protein B
MSIFSKLLKKSSPQQGIVLYYLIAIVVAFLLLNLPFVHKHGVDVSPIDTLFVAVSGISVT
GLSPVNIVDTYSTFGQIIILIILNIGGIGVMAIGTVLWVVLGKHIGIRERQLIMLDNNKD
TMSGTVKLILEIIKTILTIEFIGALLLAFYFYRDNPDLKNALMQGLFVSVSATTNGGLDI
TGQSLIPYAKDYFVQTIVMFLIVLGSIGFPVLLEIRAYVRNRVSHFRFSLFTKITTCTYL
FLFVFGVLAILALEHHHAFKGLSWHQSLFYSLFQSATTRSAGLQTIDVTNFSDATNVIMS
ILMFIGSSPSSVGGGIRTTTFAILILFVINFNNNAEKTAIKVFNREIHVVDIQRSFAVFT
MASILTFVSMIVILATEKTNLTFLQVFFEVMSAFGTCGLSLGVTDDISGLTKVILMILMF
IGRVGLISFIIMIAGRKEPDKYHYPKERVQIG
>SEQF2892_00732 Trifunctional nucleotide phosphoesterase protein YfkN
MEKNEHINIDILATSDMHSHFMNGDFGSNIYRAGTYVKNIRENNDKVILLDSGGSVAGSL
AAHYYAIVAPYKRHPMIKLMNAMQYDASGISPDDFKFGLSFLTKAVSLSRFQWLSANIEF
ALTKEPYFSTPYIIKEYDNVRIAIVGLTADGLMKNEFAEMEKEVSIEKALLSAKRWIRYI
HESEHPDFLIVIYHGGLYKINQTNTRHRKGSHEAEKIMKEIGVIDLMITAHQHQTIIGND
FETVYVQAGQDAQELVHVKIKFKKRTNSFEKEDIESTVINLSEFPEDQELLETTYYDRKA
LEHWSKDIVSENKVDLQVNGLEDLLSSPHPFIQLLHDSLHLAYVNNITCINVPKNGEKGL
KGIVTNEDVYNAYPHPDKAIDITLRGHQIKKMLEYTYSYIQFEQNQLSMTIIDETLCTLW
QGFDYEVDMSAPRFDRVNIKNIELDEKYRVTMTDYCYRNYRQYLEDESILHSTYDRPMSS
LIAEKLNQPDYYLKLDSNFSVAY
>SEQF2892_00733 hypothetical protein
MKNISKALIWFIASFIVFHLILFVMWGEHQEYWYLYTGIMLIAGISYVFYQRDIESKRLL
TSIGVGIATGIVLVIIQLIFSLLSPQITYAELIKELSRTGVYFKWQMLVTLIFVIPCHEL
YMRTVLQKELTQFKLPTWLIILITALCSSSLFIYLDKWWIVAFIFVAQLVLSLSYQYTRR
IVTTSLGQIVAIILLLIFHG
>SEQF2892_00734 hypothetical protein
MTVAEVGNIVEFYDGLRGRVEKINDNSVIVDLTIMDNFNELDLPEKTVINHKRYTIVE
>SEQF2892_00735 Lipoate--protein ligase 1
MKFVSNNNITDPTINLAMEEYVLKHLPSDDSYFLFYVNGPSIIVGKNQNTIEEVNKQYVG
ENNIHVVRRISGGGAVYHDQGNLNFSFITDDDDNSFHNFKKFTEPIVQALQSMGVDAEMT
GRNDIQVGQAKISGNAMVKVKDRMFSHGTLMLNSDLGEVQNALKVNPKKIQSKGVKSVRK
RVANIDEFLDESISIDDFKQIILKTIFGEHEVEEYKLTDEDWKNIEALSNEKYRTWDWNY
GRNPKYNFERDEKFEKGFVQIKFDVKKGKIEHARIFGDFFGEGDVTELENALIGALHDYT
HIKEAMEDFDFYHYFGDIEKEAILKLMSY
>SEQF2892_00736 hypothetical protein
MKKFLVLLFTSFLILGACSNKDSSSENSNKSSINKSDKKLHDNKKKKDKSKEKKKEYKKN
SSSKENQASQEQAQLQQDITQVPQQNNLQSTSQEQSSQQKQQTNANNQQTQQRYDYDHNG
VYRTPAEQKAHEQWIKDQVEWNKQNETRKQKLQDEYFNLSDKMYEDRVSKAEYNSMEKRQ
NEILDEVRPIN
>SEQF2892_00737 hypothetical protein
MANKTKNLDLIKDVFLHDNETIIYAIFGAYKTKSLGKNTIRHGVLAATDERIIFCAKRLS
GYDSEIFHYGKISTFELSKILMWNTISFYSSGNKVSMKWVNDKDLDKFIEFVNKNVEGSN
NSLGLIDQATHSDNDLQPLEKIKKLKELLDMDAITQE
>SEQF2892_00740 Competence transcription factor
MTNISQSQNTVYIIRKGDMIIKPVIDDYEQTKGSEIWKYDSTIVSSPFKTQKIVERSCKF
YGNSYISKKSETQRIAGITSKPPILLTPLFPTYFFPTHSDRLEENMWINMHYVHEIKPLK
NRKCKIIFANHQTLTLNVSYHSIWHQYSNCIFYYYMVDKQSRMKSNNPEMPIDYEKTTLN
IFEALSHYSLLQDK
>SEQF2892_00741 hypothetical protein
MNHNTNVKNTTLEDFVTTVNDLGVELVIEEALRQGRKKQLMKLIDEALINKNEEEFINYT
TEYKNLEAFLNE
>SEQF2892_00742 hypothetical protein
MNIIKRVLRIVITGYLVKWIRNKIEGKSNGGQK
>SEQF2892_00743 hypothetical protein
MRVNKTLYVLCSLFLGGVGIHKFYADKVWQGVLHLVFFWTTIPTIISIIHGIIIIFTTKA
DQNGYIFIPNNRHPKI
>SEQF2892_00744 hypothetical protein
MIRKARPSDSKQIAELCYIIWHDMELDIVQEITKERVIHAIEESIVNINYRTNYNNIWVY
EQDNHVAGCIIAYKGDKELELEAAWNKLPLEEDIKALGTPLPLKESKDDEWYIEAVATFS
EYRGQGIATKLFNYLISTYPDRKWSLSCDYDNPRAKKLYERLGFKWTEDIELYGHQYLHM
VYSK
>SEQF2892_00745 1,4-dihydroxy-2-naphthoate octaprenyltransferase
MANQYQQYSTVRKYWHLMRPHTLTAAVVPVLVGTATAKLFLLGSQDNIKFMLFIAMLIAC
LLIQAATNMFNEYYDFKKGLDDHTSVGIGGAIVRNGMSPKLVMNLAIAFYIVAALLGIFL
AANSSFWIIPVGIVCMAIGYLYTGGPMPISWTPFGELFSGLFMGMIIILLAFFIQTGNIN
SFVVWISIPIVITIGLINMANNIRDRVKDQASGRKTLPILLGKRASITFMAVMYIIAYVF
VVYTALFVDGGSLFYLLVLLSFPMPVKAIRRFKKNDTPASMMPAMAATGKTNTIFGVLYA
LGIYISALLGGI
>SEQF2892_00746 Salicylate biosynthesis isochorismate synthase
MAANIKEDDIIESIYESNKSWISVEVKIDRELAPDELFNLTESQAGDRFYFRLNDNASSF
FGYHAVQRFKNNFDNKQLIFREWEKFKKDIELVHPDIEKHHLKVIGGFQFSSHKSDDEWR
EFGINHFVIPQVLISNIGQTTYLTYTVERAQFDIEQFKEVVNYFEETQIAKAEHDETLGN
ILRMEDIYVDEWKELVRDAIAQLDETKKIVLARRRMIKFDKPISIPYVLNRALQSERNSY
LFILESNQSVFFSQTPEQLLKVEDGVLSTKAVAGTIKRSNDIDEDEKNIQAFLKDKKNLD
EHDFVVKSILDDIKPYVDNIEYNHSPNILKNDHLYHLYTQIQGQLKNNSFIGLIDEMHPT
PALGGYPKNEALKFIEENEFGTRGLYGAPVGYIDMNDDCEFIVAIRSMLIKQNQTTLFAG
CGIVKDSDPDSELAETAVKFSPMMNALGVVDKNES
>SEQF2892_00747 2-succinyl-5-enolpyruvyl-6-hydroxy-3-cyclohexene-1-carboxylate synthase
MNHNEALTKQVYTFASELYAYGVREVVISPGSRSTPLAIAFEAHPNIKTWIHPDERSAAF
FALGLIKGSERPVAILCTSGTAAANYTPAIAESQISRIPLIVLTSDRPHELRSVGAPQAI
NQVNMFANYVNFQFDMPVADGTDYMLDAIYYQMQIASQYLYGPHRGPIHFNLPFREPLTP
NLERQEWLTSYSKKLPHYQKNINVQDIRHILKEKKGLIIVGDMQHQAIDQILTYATVHDI
PILADPLSQLRKYNHPNVITTYDLYYRAGLDIDVDFVIRVGKPVISKKLNQWLKRTNAYQ
ILVQNNDKIDVFPTPPSISYEISANDFFRNLIEEAAVDRKDWINMWRTLESQARNTIDKH
MTNATDEAAFVKILIDKLTKDDAIFVSNSMPVRDIDNLLYNSEVEVYANRGANGIDGVVS
TAIGMAVHKKITLIIGDLAFYHDMNGLLMAKINNINLNIVLLNNDGGGIFSYLPQKASAE
AYFERLFGTPTGLNFEYTALLYDFTFKRFNTVADFTQEKLSHVNSHIYEMVTNRDDNMSQ
HQILYKKLSGILNVTL
>SEQF2892_00748 2-succinyl-6-hydroxy-2,4-cyclohexadiene-1-carboxylate synthase
MLHYNFYQSQNNSNQLLVLLHGFISDSRTFNDDVQYFSQEANVLTIDLPGHGQDQSPIDV
TWDFPYITTQLDELLDIYKSYDITLLGYSMGGRVALYYAVYGKCSLSKLIIESSSPGIKD
ENNRHERQQIDAARAKVLDIAGLEVFVNDWEKLPLFYTQYELDKDKKSAIREMRLSQDPH
KLAKALRDYGTGQMPNLWEQIGNIQIPCFILTGELDQKFVKTGQAMNKGMKYSQIHIFSN
VGHTIHVEDKAEFDTIVLVFLKEEQND
>SEQF2892_00749 1,4-dihydroxy-2-naphthoyl-CoA synthase
MTRQWETLREYDEIKYEFYEGIAKVTINRPEVRNAFTPKTVAEMIDAFSRARDDQNISVI
ILTGEGDKAFCSGGDQKKRGHGGYVGEDQIPRLNVLDLQRLIRVIPKPVIAMVRGYAIGG
GNVLNVVCDLTIAADNAIFGQTGPKVGSFDAGYGSGYLARIVGHKKAREIWYLCRQYNAQ
EALDMGLVNTVVPLDQIEDETVQWCKEIMKHSPTALRFLKAAMNADTDGLAGLQQMAGDA
TLLYYTTDEAKEGRDAFKEKRDPDFDQFPKFP
>SEQF2892_00750 hypothetical protein
MCKSILKTLRIKDKNINFSDEVIEKKYKGRMSLFYYAELTYQPTYCENCLAKNDNFSIVK
NGKKTSTITLLKIMEMPAYLNLQKQRFYCKTCDSHFTAKSDIVDDYCFISNKTKLAVLNK
AQECRSQKSIAKSCLISSMTVSRVINQAASDVGQSSFDALPEHLMMDEFKSVKNVTGKMS
FIYADAVSHRIVDVVADRKLKSLKDHFYRYSLKLRQKVKTVTIDMYEPYMSLIKQLFPNA
KIIIDRFHIVQSLNRALNMSRVHVMNCYRALNRPLYNKYKSYWKLFLKPFETLEAFNYRK
VHLFKEWKTEKGIVNYLLDVDEELYNTYHYVHELRRFLKENQIEKFNHKLFSIHLSDVCP
KLRPVIRTLRRLATFIENTMTYSNLTNGPLEGINNKIKLIKRVSFGYRNYDNLRNRIIIT
SRLFASTTKKEIKQPKVA
>SEQF2892_00751 Putative N-acetyl-LL-diaminopimelate aminotransferase
MKLSLNTNSKFLRAPSIRQFSNRMKHIDDCVNLTIGQPDFPMPDVVKEVYINAIKEDKTS
YSHNKGLPETRQAISNYFKNKYGFYYSEEEIIITNGASEALDTSLRSIIEPGDEILIPGP
IYAGYIPLVETLGGKPIYIDTTNTEFKITPELIAQHYTDKTKAILLNYPTNPTGVILERD
EVKGIVNYLKEKEIFIISDEIYAENTFKGSHVSFAEFEEIRDQLLLIGGLSKSHSATGIR
IGFLLGPEYLIEKLTFMHAYNCICANVPSQIACIAALNEGLDAPQYMNRAYIERRNYLVS
KLKELGFELDAQPEGAFYIFPSIRNYTSDDFDFCVKVLEEAHVAMVPGSSFTDMGKGYIR
ISYAYDMDVLKEGMRRLERFLKANYNK
>SEQF2892_00752 hypothetical protein
MSMDTKRDYFFDNARAILIFLVVFGHMIQPYTSESKYLSALYLLIYSFHMPSFLFISGYF
AKHLDKPHYLENVAKKLIAPYAIFYAFFSIYYFVTGKSDAIQMDPFNPVFALWFLLTSFC
FHVILVIVRRYKAYYVLPVALIISILAGFSDDIDGYMSISRTIVFFPIFYVGYLTTRAHT
QLLRNKKLRLISIIVLIIFFIVYYIHPINSDWLLGSSPYTSLENNNEDVYSPLKRLLLYF
VIFVAMFSFLNLMSNHKRVYTYIGNRTMYVYLLHGLVIGIVRGLEIYPFKDHISVFTYGY
LILISVLIVYLLSTNFVCKWTNPLINLKKPSSFRG
>SEQF2892_00753 Tryptophan-rich protein TspO
MVGGSIIGRIIAKESRQDYKNFRKPPFSPPTKAFPIVWPILYLLMGVSYLITTKNKTKTT
RIKVTHYTQLTLNYLWSILYFKKKVRGIAFIESIMLFISVVTNAVSMFKIHRVAGLLQIP
YVLWSAFASYLNAGNYYLNKDNPNYK
>SEQF2892_00754 Transcriptional regulator SlyA
MYNQLEILITLTNNDLNLVNRRFGQRTDITNDQLELLRILYSYDRLSQYDLTMKISREQS
IVSRWIKKLVQKGYITSLQSHEDLRCKDLYLTEEARNLIQQINTARCELIEARCQCLSKE
EIQSLNQLLDKLNSRHIYI
>SEQF2892_00755 Bifunctional autolysin
MKKKFNLKFPSMIAITLFGAAFTSQHAHAAEANQNSNNTNNVIDDQQNIENAEQAKKEVT
NSAQNVSGVQTYQNPSDVKASVATVSKTYDAKLDNLATTQQTSQDQQSTQNQSTANTSAT
NSNSELAKVQDNEQEVSTSNKSDQTTNINNTHSNTDANKQTLQASKNALSSSQVQSNDDT
SANSNQNTTQYVNNQIDESSSNSQQENSLTSSNKNQLNSSSVTPSQSNQVAQSNNQIESK
QSSDKKVSTYSNNDNNATQVNVDQAKTSQEANTKNASASKTTQTSTSNSTQSGYSGFRSV
GGKGGPATSVKTVKRYAAKATTSSLPKYKPQVSSSINNYIRSNNLQAPKIEENYSSYFPK
YGYRNGVGKPEGIVVHDTANDNSTIDGEINYMKNNYNSAFVHAFVDGNRIIETAPTDYLS
WGAGPNANGRFINVEIVHTHDYASFAKSMNNYADYAATQLQYYGLTPNSAENDGQGTVWT
HYAISRFLGGTDHSDPHAYLQSHNYTYNELYDLINEKYLIKTGQVAPWGTTSSSSSSSNT
NKGGSSNSGSTTTSPKLTVKSNSGLAQIKTDNSGVYTTVYDDKGKATNQVHNTLSVTKSA
TLGKDKYYLVSDYNSGKVYGWVKQGETVYNTVKSPVKVNQSYNIKSGATLYTVPWGNYNQ
VAGTVSKSNTAPFKATKSQQVGKATYLYGSLNGKNGWVSQAFLSNITKPSSGSKTPTVDN
TLKVSNLKNTLGQVSTKNKGTYTTVYDKNVKANATIGGKTYNITKKATLNNKDYYLISDY
NGNTSRGWVPASEISVKTTTPNKTNATYYDINGNANIYDTPWGTAKQVKATVPSSGKQLK
SIDNLKVGNETYLHGVINNIWGWIKSTDVKQTPKVNAKFAVNTKATKPSTASTQTVSKVA
QVNANNSGARATVYDKTGKNATKYANRTFNVSKEKTIDGNTYVLLQNTTTNTPLGWFNVK
DLKVQNSSSEQKTSGTYKINNKNNGLYSIAWGTNQQRLDNKDLANKSFKVSKSVVIGNTT
YLYGTVNGKTGWIAKNDLTSSNISSDNGEKYQYEFIINTTNGYYYDDPSSAKATSLKAFN
EQIFQVTNRKVVNGKTWYYGKLSNGKYVWIKDTDLKKELVKYSKSYRTLNQVVSLQQNAY
GAPPQVQRNGYGWSNATYSEIKNAMNTEKLAKDDTLKYQFLRLDRPQNLSVASLNQLLKG
KGVLENQGQAFSQAAATSGINEIYLIAHALIETGNGQSQLAKGANIVNNYVTTKSATKYH
NVFGIAAFDANPLYNGINYAKQAGWNSVSKAIIGGAKFIGKDYIKAGQNTLYKMRWNPDH
PATHQYATDINWANANAQYLKQLYNEIKAVGKYFDISSYSK
>SEQF2892_00756 Acetyltransferase
MFEIVKNKDMLSECFYIRREVFVKEQGVPLENELDSFEEESIHIIGYDKKHVPFACARFR
PYNNAAKVERVAILKPYRKDGYGKTMMHATERFAKDKGYNQLVLNAQVQAQGFYEKLGYI
QTGPVFIEENIDHIKMYKNI
>SEQF2892_00757 hypothetical protein
MSRKTYEKAANINGMFNVLEQQIIHSKDMALFRSEFFYVNHEHRENYEALLVYYGENSVN
PIVNGACYILALPEIFNKVDVFESDLPFSWVYDENGITETMQSISVPLQYLIAAALEVTD
VTLFKPSGFTMGMNNWNIAQMRIFWQYSAIVRQEAL
>SEQF2892_00758 Putative transcriptional regulator YwtF
MNRFLKYFMMLLTLVLIVVPVIFIINLYKTSESAMQASYDKSDSKRQSNIREGKVNPSKD
AVSILFLGIDDNEGRRKNGQTTEHSRTDSMILSTFSPEKRQIRLLSIPRDTISYIPKVGY
YDKITHAHAYGGPVAAMDSVEATLNVPVDYYVRVNMDAFVEAVDELGGIYYDVPYDLNEP
NTDDSGRIKIKKGYQKLNGDEALAVARTRHHDSDLKRGERQMDLIKLLFQKAKSLDSYDK
LDDLVQIVGKNAKHNLTSSEIKSLASMYLSDDIEFKKSQLKGKDDYLQNIYYYNPSVSSI
MKYSNILRSDLGLSKITDKDEFLDQRVIKHYGTLIPLTPLDQSLLKNNQKDSSSSDDNND
DSTNSDNNNNIQSSEENSSNSNEGIDQSSQGSTQSDNYNQTNSSNSFNNNQDQMNQIY
>SEQF2892_00759 Putative penicillin-binding protein PbpX
MKNNKLKIIAFILVLIVLILLIILFVIKVTNYSIKDSEYNNVNDNKAYIEHRDKNHKTVD
KLKTVQAKDDNIEQINTYLKNVHFNGSITVLKDGKLMLDKGYGYQNISSKKKSNANTMYL
IGSAQKFTTGLILKHLELSNKININDPVTKYLPWFKTNKTITLKDLMLHRSGLYKFSANP
NTKSLDGAVHDIQRRGINSKYYHKHLYNDANYLVLAQVIEAVTHHSYVENYYKFLAEPYH
LEHSAFFNEKPYKKNMATGYKVKNEKLKTMKPNTLDQYYGAGNLFMSTHDMARLVNDLQQ
NNIFNQAVTTSLLQEIGSTKYPESYRYGFYSTPQVNRINGVFFGQIFTVYFNEDYIIVLA
TNKVDYSKVSNESIISHIYYQLLGQNIYETK
>SEQF2892_00760 Non-specific ribonucleoside hydrolase RihC
MTLPIIIDTDPGIDDAAALSVALLHPFFDVKMISTVNGNVSIEKTTSNALKLKAFFNSDV
PVHRGSAKPLINKAIDASQVHGESGMDGYDFPSISNDQLASTNSISAMREILLHSDTPIT
LIALGPLTNIALLISTFPEVKDHIREIVLMGGSSGRGNVTPLAEFNIYSDPESAHIVFES
DLPITMIGLDLARQSLLTHDYLASFEHLSRTSAMLYQIFQHYRENDFAKGLKLYDVFTVL
YLLDPESYETILASVRIELHGTLTKGATVVDYDSHYPNCKIVTSSINKNYCSIFKDTIK
>SEQF2892_00761 Quinol oxidase subunit 4
MNTIVKHTVGFIASIVLTLLAVFVTLYTNMTFHAKTTIIFGFAFIQAAVQLLMFMHLTEG
KDGQVQSFKVIFAIIITLVTVIGTYWVMQGGHSHHL
>SEQF2892_00762 Quinol oxidase subunit 3
MSHDTNTVDSRTHEGQLNKLGFWIFLTAEFSLFGTLFATLLTLQHGGDYAGKMTTELFEL
PLVLIMTFALLISSYTCGISIYYMRKEKQNLMMFWMILTVLLGLVFVGFEIYEFAHYVSE
GVTPQIGSYWSSFFILLGTHGAHVSLGIGWIICLLIQVATRGLNKYNAPKLFIVSLYWHF
LDVVWIFIFTAVYMIGMVYSG
>SEQF2892_00763 putative quinol oxidase subunit 1
MNFPWDQLLVKGNWMITMAQIGAPFLVIGLIAVITYFKLWKYLYKEWFTSVDHKKIGLMY
LICAVLMFVRGGIDALLLRTQLTIPDNTFLESNHYNEIFSTHGVIMIIFMAMPFVFGLWN
VVVPLQIGARDVAFPVMNNISFWLFFVGMILFNLSFIIGGSPAAGWTNYAPLAGEFSPGP
GVNYYLVAIQISGIGTLMTGINFFVTILRCKTPTMKFMQMPMFTVTTFITTLIVILAFPV
FTVVLALMTFDRVFGTAFFTVADGGMPMLWANFFWVWGHPEVYIVILPAFGIYSEIIPTF
ARKRLFGHQSMVWATAGIAFLSFLVWVHHFFTMGNGALINSFFSISTMLIGVPTGVKLFN
WLLTLYKGRITFESPMLFSLAFIPNFLLGGVTGVMLAMASADYQYHNTYFLVAHFHYTLV
TGVVFACLAGLIFWYPKMMGYKLNEKLNAWCFWLFMIGFNVCFLPQFILGLDGMPRRLYT
YMPSDGWWLLNVISTIGALLMAVGFLFLVVSIVYSHIKAPREATGDNWDGLGRTLEWSTA
SAIPPKYNFAITPDWNDYDTFVDMKEHGRHYLDNHNYKDIHMPNNTHTGVIMGIFMLLGG
FFLIFETVIPAAICLVGILGSLVYQSFVQDHGYHIPASEVAENEARLREARIKEREAVGH
ES
>SEQF2892_00764 putative quinol oxidase subunit 2
MSKFKSLLLMFGTLILLSGCSNVEVFNAKGPVASSQKFLIIYSIIFMLVIVAVVLTMFAI
FIFKYSYNKNSETGKMHHNSLIETIWFVVPIIIVIALSIPTVKTLYDYEKPPESKEDPMV
VYAVSAGYKWFFAYPEQKVETVNTLTIPKNRPVVFKLQAMDTMTSFWIPQLGGQKYAMTG
MTMNWTLQADETGTFRGRNSNFNGEGFSRQTFKVHSVDQSEFDSWVKDAKSKKTLSQDEF
DKQLLPSTPNKELTFSGTHMAFVDPAADPEYIFYAYKRYNYVQKDPNFVAEKDLYKDVTD
KPQKPARKVQITNANYKRHGMKPMILGNNDPYDNEFKKEEDHNSKEMEKISKSAKDENAS
KFGSKADNDHGGGH
>SEQF2892_00765 hypothetical protein
MNKLIQSLSALGVSATLVTPNLSAEATTNHSPELRGVNDIVIEKGQNYNLLNGISAYDKE
DGDLTHKITVDGHVDTSKVGKYKVKYNVIDSDGAEETSTRYIEVK
>SEQF2892_00766 Flavohemoprotein
MLNEKEKGIIKETVPVLQEKGTEITSYFYNRMFNQHPELKNMFNQTNQQKGFQSTALAQS
VLAAAVNIDNLGNIMPVVKEIAYKHCALEVPPAGYDIVGENLIEAIKAVVGLEDDHPIIQ
TWKKAYQEIADVFIQVEKDIYASMLWEGFQPFEIEKIEQLSSDIKAFTVKSTDYDLSQFT
PGEYITVDVSSEKIPYRAKRHYSIVSGEKERLTFAVKRDVTTDHEGEVSTILHDELNEGD
KINLSAPVGPFAVANPENPQLFIGAGIGVTPLVSMFNEVIVKDSNAQFIQVTGDVNDTPF
TSYLENISQKSDKAKYELYDREKNGYLTKEYLEKYISENTEIYVCGGAKFIQSVIEVLKA
LDVDQSHIHYETFVPKLSVAV
>SEQF2892_00768 hypothetical protein
MSSDTNSLAHTKWNCKYHIVFAPKYRRQVIYGKIKRDIGVILRQLCERKGVEIIEAEACK
DHIHMLVSISPKLGVSSFVGYLKGKSSLMIFDRHANLKYRYGNRKF
>SEQF2892_00769 Bifunctional protein FolD protein
MVAKILDGKQISKDYRQGLQDQVEALKEKGYTPKLSVILVGNDGASQSYVNSKKKAAEKI
GMISEIVHLDEDTSEEDVLKELDRLNNDDSVSGILVQVPLPKQVSEQKILEAINPEKDVD
GFHPSNIGKLYIDEQTFVPCTPLGIMEILKHADIDLEGKNAVVIGRSHIVGQPVSKLLLQ
ANATVTILHSRTKDMHSHLKDADVIVSAVGQPGLVTKDDVKEGAVIVDVGNTPDENGKLK
GDVEFEEVKEVAGAITPVPGGVGPLTITMVLNNTLLAEKMRRGIE
>SEQF2892_00770 N5-carboxyaminoimidazole ribonucleotide mutase
MKVAVIMGSSSDWKVMQESCAMLDEFEIPYEKKVVSAHRTPKLMYEFASQARTNGYDVII
AGAGGAAHLPGMVASMTTIPVIGVPIESKSLKGLDSLLSIVQMPGGIPVATTAIGNAGAK
NAGILAARILSISNESVRKHLDEYEQSLVDKVGEMQNELQ
>SEQF2892_00771 N5-carboxyaminoimidazole ribonucleotide synthase
MNFNKLKFGDTIGIIGGGQLGKMMAQSAQKMGFKVICLDPNPDSPCKSVAHEFITAAYDD
EEALHELGEKSDVITYEFENISAEQLIRLTQKFNIPQGYQAIQLLQDRLTEKQTLQKAGS
KIVPFLPIKEEKDLNVVINQLGYPFIVKTRFGGYDGKGQVLVKNEESIQEAKDLISQQEC
VAEQFLDIALEVSLTVTIGNQKQITYFPLQENEHRNQILFKTIVPARSDKEQEARDEVNK
IINEVHFVGTFTVEFFIDKSNNLYVNEIAPRPHNSGHYSIEACDYSQFDTHILAVTGQNL
PKEIEILKPAVMMNLLGRDLDLLEDKFANHPEWHVHIYGKPERKPNRKMGHMTILTNNVD
ETEKAMLKQFEGRE
>SEQF2892_00772 Phosphoribosylaminoimidazole-succinocarboxamide synthase
MALLYEGKAKRIFSTDNEGQLRVEYKDEVTAGNGAKKDKMEGKGRLNNQITSIIFEYLAH
HGIASHFIKQLSETEQLVEEVKIIPLEVVVRNIATGSITKRLGFNKGYEFEAPLVEFFYK
NDDLNDPLITDDHVKLLKIASESEIETLKTMAKDINKVLVQLMDEMDLRLVDFKVEFGKT
SDGKILLADEISPDTCRIWDKYSDTNFDKDVYRNDTGSLIDTYTTFLNKLEELK
>SEQF2892_00773 Phosphoribosylformylglycinamidine synthase subunit PurS
MKTIELHITLQPQVLDTQGQALNRAVHDLGYKQVNDIRVGKVLYMTVDEATDEAVDNIVT
TLSEKLFANTVIEEYNYKIVDEKENA
>SEQF2892_00774 Phosphoribosylformylglycinamidine synthase subunit PurQ
MKFAVLVFPGSNCDRDMYNAAIKSGAQADYVDYRETSLDGYDGVLIPGGFSFGDYLRSGA
MASVAPIINEVKRLANDGKPVLGVCNGFQILTEIGLLPGALLHNDSHLFISRNENLKIAN
NQTPFTNLYGENEIVVYPVAHGEGHYYCTDDIYNELVENNQIILTYEDNPNGSHENIAGI
VNKAGNVCGMMPHPERALEKILGTDSGVKLFEAMVNSWREQNV
>SEQF2892_00775 Phosphoribosylformylglycinamidine synthase subunit PurL
MSKFIEPSIEEIKLEKLYQDMGLSDAEYNKVCEILGREPNFTEVGIFSVMWSEHCSYKHS
KPFLKQFPTTGEHVLMGPGEGAGVVDIGDNQAVVFKVESHNHPSAIEPYQGAATGVGGII
RDIVSIGARPINLLNSLRFGELSVKQNQRLLKGVVRGIGGYGNCIGIPTTAGEIEFDDRY
DGNPLVNAMCVGVIDHDMIQKGTAKGEGNSVIYVGLKTGRDGIHGATFASEELTEESESK
RPSVQIGDPFVGKKLMEATLEAITFDELVGIQDMGAAGLTSSSSEMAAKGGSGLELHLDQ
VPTREPGISPYEMMLSETQERMLLVVEKGTEQKFLDLFEKHELDSAVIGEVTNTDRFVLK
YEDEVFADIPVQSLADEAPVYVLEGEEKEYNTSKNDYSSINVEETFKKLLIHPTIASKHY
LYEQYDQQVGANTIIKPGLQSSVVRVEGTNKAVASTIDGEARYVFNQPYEGGKMVVAEAY
RNLIAVGATPLAMTDCLNYGSPEKKEIYQQLIDSTKGMSEACEVLKTPVVSGNVSLYNET
RGTSIFPTPVVGMVGLIEDIDYLKDFHPEAGHKLYLVGETRDDFGGSQVEKLLYGKVNHE
FEAIDLSDEVNKGEAVKNTIRSGVASHVQTVGKGGLLITLARISAHYGLGLEASIDLSDA
QLFSETQGRYIIVVKEGQTLNIDEAIEIGQLTDVDEFKVTNAQSSIVEKVSEIKESWEGA
IAQCLTTVD
>SEQF2892_00776 Amidophosphoribosyltransferase
MFNYSGLNEECGVFGIWNHSEAAQLTYMGLHSLQHRGQEGAGIVVSDGEILKGERGLGLL
TEAIKGDQMDQLKDGHNAIGHVRYATSGNKGIENIQPFLYHFYDMSVAICHNGNLINAQT
LRQYLEKHGAIFHSSSDTEVIMHLIRRSKAPTFEEALKESLRQIKGGFTFAILTKDALYG
AVDPNAIRPLVVGKMQDDTYILASETCAIDVLGAEYVQDIHAGEYVVINNEGIEVKSYTS
HTNTAISAMEYIYFARPDSTIAGKNVHAVRKASGKKLAQESPANADMVIGVPNSSLSAAS
GYAEESHLPYEMGLVKNQYVARTFIQPTQELREQGVRVKLSAVKDIVEGKRIVLVDDSIV
RGTTSKRIVRMLKDSGAKEVHVRIASPEFMFPSFYGIDVSTTAELISASKSPKEICDYIG
ADSLSYLSVDGLIESIGLDYDAPYSGLCVESFTGDYPAGLFDYEDKYYKNLSQRQQDYIN
NHKHYFDREGNIHV
>SEQF2892_00777 Phosphoribosylformylglycinamidine cyclo-ligase
MSKAYEQSGVDIHAGYEAVERMSSHVKRTMRKEVLGGLGGFGATFDLSQLNMKAPVLVSG
TDGVGTKLKLAIDNDKHDTIGIDAVAMCVNDILTTGAEPLYFLDYIATNKVVPEVIEQIV
KGVSDGCEETNTALIGGETAEMGEMYHEGEYDLAGFAVGAVEKDDYIDGSAIQEGQAIIG
LASNGIHSNGYSLVRKLIKESGIDLNDDFDGRTYLETFLAPTQLYVKPILALKKAVQIKG
MNHITGGGFYENIPRGLPEGLAANIDTQAFPTPNVFNWLQQQANIDTKEMYNVFNMGIGF
TVIIDKKDVAQTLDILKQEGISAFEIGEIIEDKDTPIHLEGVE
>SEQF2892_00778 Phosphoribosylglycinamide formyltransferase
MAKVAIFASGSGSNFENIVLYADKGELNNIEITSLYTDYHDAYCVKRAEQLKVAVNINEP
KDFESKADYEQHLIELLQREEVEWIILAGYMRLIGPDLLDAYEGKILNIHPSLLPKYKGK
DAIGQAFNSGDKVTGSTVHYVDSGMDTGEIIEQRQCDIKQDDTKENLEERVKRLEYELYP
SVIAKVIK
>SEQF2892_00779 Bifunctional purine biosynthesis protein PurH
MKKAILSVSNKSGIVEFAKSLIKLDYELYSTGGTKGALEDASVPVKSVSELTQFPEIMDG
RVKTLHPAVHGGILADRDKPEHLEQLSEQHIDLIDMVVVNLYPFQKTVAKPDVTEAEAIE
NIDIGGPTMLRAAAKNFKHVTTIVHPADYNEVIERIKEDRLDEDFRKELMIKVFAHTNEY
DHAIVSFFKGDSEQLRYGENPQQSARFVRTSNSKHTIAGAKQLHGKALSFNNIKDADSAL
SLVKKFKESAAVAVKHMNPCGVGIGDNIETAFKHAYDADNQSIFGGIIALNRTVTSDLAE
TLHAIFLEVVIAPRFTDEALDILTKKKNIRLLEIDMTIDNREEEFVSVSGGYLVQDKDNF
EVAKEDMKVVTDKAPTDDQWDAMLLGWKVIPSVKSNAVILSNTKQTVGIGAGQMNRVGSA
KIALERAIEINDNIALVSDGFFPMDDTVELAAQHGIKAIIQPGGSIKDQDSIDMANKYGI
AMVTTGMRHFKH
>SEQF2892_00780 Phosphoribosylamine--glycine ligase
MMNVLVIGAGGREHALANKLRQSPLIDQLHAIPGNDAMVNVAEVHTDIAESDHEAILNFV
QENKIEWVVVGPEQPLIDGLPDKLRQTGVKVFGPNKDAAQIEGSKLFAKKIMQKYNIPTA
EYKETNNKTDALAYVNHCDLPIVVKKDGLAAGKGVIIAETREDAIKAVETLYPEEHGEVV
FEQFLEGEEFSLMTFINGDYAVPFDCIAQDHKRAFDNDEGPNTGGMGAYCPVPHITEDVL
TRTNKDIAQPIAKAMKAEGYDYFGLLYIGAILTSEGPKVIEFNARFGDPEAQVLLSRLES
DLMAQIVALDRKEPILFQWQDDFVVGVMLASKGYPGSYAKGTKVAGFELNDTYFVSGLRK
EDDAFVTSGGRVILALGKGATIEDAQKVAYNNVEKIKSDNLFYRHDIGNKALNK
>SEQF2892_00781 Putative HMP/thiamine permease protein YkoC
MFERWKKHYSFVDDVNIITKLLLGVALFIFIIFVHNFDYMIYITIIMFLFLMAFNGTQFK
ITGAFILATVLFALLSSLFMILYGDGTHMLFKWGIIQISTESIVRGLHLSLRTITVSMFG
ILLALTSEIVMIFYSLMQHLKVKPKIAYAFMAAIRMVPLIFTSLIQLRRSLKMRYQMIDA
SNYRGLKRLKHLLIPILSQNIRRAHQLSVAMESKGFKDGPRTYYYKAPFSYKDILFVICV
VAILIIAFYLSQYFPITGITDARVSGYTS
>SEQF2892_00782 Putative HMP/thiamine import ATP-binding protein YkoD
MLKAKNLRLKYPNGERKIFDNLNIEIKDKEKVLLLGPSGSGKSTLLNVLSGIVPNLIELP
IKYDELEIDPHSGVIFQDPDTQFCMPKVYEELAFVLENKQVPHNEMDALIENALASVDLN
VTDNTFVNHLSGGMKQKLAIVETILQEANTLFLDEPTAMLDVDATADLWQRLIQLWSDQT
VLIVEHKVEHIWEHVDRVILLNYEGQIIADGTPDYILNNCEHLLTEFGVWHPHAWDYAPK
PITFPSNEAETLFTFENGQVIRGKKQLFQTSELNVHSGEWITITGKNGTGKTTLLESMMQ
LIKYEGTMAYKNTILKKIKDAAKHMYLVYQNPELQFITNSVYEEIYIHYNHQEPSIAENE
TMKLLKLLHLEAIKNQHPFELSMGQKRRLSVATALSSKADIILLDEPTFGLDSHNTFQLI
ELFQESVSSGQTIIMVTHDPEIIHRYPTRRLIVEDNQLIEEEGESHV
>SEQF2892_00783 Putative HMP/thiamine permease protein YkoE
MSKGLKLSEILVTVLIAVVFAIIYNLWWFAYNVAQVAGVHIEQLTYGVWFMAAIVAYLII
PKPGIALIAEFAAGAGETIVMGKFDIPTIVYAILQGLACEIIFAIFKYKSRSLMVAILAG
LATALISFPVDYYYGYLAEVAGWNLLLFIIFRSISGIVIAGLLSYLIVKALDQTGVTKLF
RPASQKDYDNL
>SEQF2892_00785 hypothetical protein
MTNEDAKKAKEVEEKLKEQKEEKTDDIEQTKKDVQDTLD
>SEQF2892_00786 hypothetical protein
MSFLKKHTEIIFSYIIGIVSLFTGLIILINLPLINQLKDKEKVELKIHNLWDFLNAFFSE
IIRVMSRFIGSFPIISAVIIILFGILVMLIGYALFRTTKYDYDISIFFLIIGILYFLISI
TLMTQVYSFWAIIFIIPFIIHTGYIVYKDELNVANRKSHYLWIIFSYGISYLITQISLYG
KIDANEIAPIDILSVNTFFLVMWLLAQASIWNFLFLRRALPLTKEELGEEEPELSRTSKG
NVSNQSKVHFKQLQDKTSEYARKTRRSVDLEKIRSKRDKFKNKFKNVFNIEEDDIPNWMR
RPKWIKPAYVEIFCGFILFLFTFIEFNNRNALFVSGEWELSQTQYVVEWVTLLLLMFVII
TYIATTFTHFLRGKYSYLQLFMISILFFKLLTEFVNIMIHGLLLSIFITPTLILMLMAVI
IAFTLQLREKP
>SEQF2892_00788 Ribosomal RNA large subunit methyltransferase I
MKIATLNRGKESKYLNQYPLVDEDDIYKNDHLKEGDLFYLMNGQEQYIATAYVGRQHKGL
GWVLSYDQNEAINTSFFEKQFQIALQERDYYYHIEGTNAFRLFNAEGDGVGGLTIDNYDG
HLLIQWYSKGIYKFRYNVIEAIQQVFPFKSIYEKMRFKDSEYTGGHVIGEAPDFPIVIEE
NFTFYNVDLDDGLMTGIFLDQKEVRKKLRDHFAKEKDILNLFSYTGAFSVVAAQNAKSTT
SVDLANRSRSLTEENFGLNGIDPKSQYIYVMDTFDFYNYAARHGKVFDTIVIDPPSFARN
KKKTFSVQKNYDDLINGALSILAPNGSLLLCTNSSTFSLKAFKNVIKTTLNEAGVTYEIE
EVMGLPKDFKTHPHYKPSKYLKAVFINIKH
>SEQF2892_00789 hypothetical protein
MGIMNRFSSGVTNKVGNKVLNIEEIKEKSILPTTKEEIAERRAKAETIVKKKSLLSSGMS
VVPIPGLDFGVDIKLMRDIIEDINKIYGLDHKQVNTLGDDVKERILAAAAIQGSSFIGKK
VSSAVLKVIIRDMAKRAAAKQTKWFPVVGQAVSASISYYFMNKLGREHIEKCEKVLHDII
>SEQF2892_00790 Phosphocarrier protein HPr
MEQKSYVIIDETGIHARPATMLVQTASKFDSDIQLEYNGKKVNLKSIMGVMSLGVGKDAE
ITIYADGSDEADAIQAISDVLSKEGLTE
>SEQF2892_00791 Phosphoenolpyruvate-protein phosphotransferase
MSKLINGIAASDGVAIAKAYLLVEPDLSFTNEKVTDTDAEIQKFRNALEASKIELTKIRN
NAEKQLGPDKAAIFDAHLLVLDDPELIQPIEDKIANEKVSAPEALDEVTSQFITIFESMD
NEYMRERAADIRDVSKRVLAHLLGVELPNPSMIDESVIIVGNDLTPSDTAQLNKEFVQGF
VTNIGGRTSHSAIMSRSLEIAAVVGTKSVTKEVKQGDMVIVDGITGDVIVDPTEDELIAY
QNKRERFFEDKKELQKLRDAETVTIDGEHAELAANIGTPDDLYGVMENGAEGIGLYRTEF
LYMGRDQMPTEDEQFEAYKKVLETMKDKRVVVRTLDIGGDKELPYLNLPKEMNPFLGYRA
IRLCLDQQDIFRTQLRALLRASAYGKLNIMFPMVATINEFRDAKAILLEEKENLKNDGHD
VSDEIELGIMVEIPSTAALADIFAKEVDFFSIGTNDLIQYTMAADRMSERVSYLYQPYNP
AILRLVKQVIEASHKEGKWTGMCGEMAGDETAIPLLLGLGLDEFSMSATSILKARRQING
LSKNEMSELANRAINCATQEEVKDLVNNISK
>SEQF2892_00792 hypothetical protein
MYKNYNMTQLTLPMETSVLIPTNDISRHVNDIVETIPDNEFDEFRHHRGATSYHPKMMLK
VILYAYTQSVFSGRKIEKMLNDSIRMMWLSQNQKPSYKTINRFRVNPKVDALLESLFIQF
YSQCVKQNLIDDKAIFIDGTKIEANANRYTFVWKKSIQNHESKMNEDSKALYHELVTNKI
IPEIKEDHDNELTKEEIDLIGSHLDKEIEDLNQHINNEKCTKTRKQIRLKRTKIKKYKKQ
INDYFERKYRYEFQKSILKDRNSYSKTDHDATFMRMKEDHMKNGQLKPGYNLQIATNSQF
VLSYNVYQNPTDTRTMIPFLNSIQETYGHLPEYIVADAGYGSESNYKAIIDDFNRTPLIT
YGMFIKDKTKKYKSDIFNTQNWNYDEINDEFICPNNKRLGFKRYAYRHDKYGYKRDFKLY
ECDDCSECPLKNQCMNFNSKTNKKIMKNYNWEYFKSQINKKLSEPETKNIYSQRKIDVEP
VFGFMKAILGFTRMSVRGLNKVKRELGFVLMALNIRKVVAQRAENNQKIYKKDNFYIISI
EIVFFSLIQELYVPDSSNTSLFRNVIN
>SEQF2892_00794 hypothetical protein
MSSDTNSLAHTKWNCKYHIVFAPKYRRQVIYGKIKRDIGVILRQLCERKGVEIIEAEACK
DHIHMLVSISPKLGVSSFVGYLKGKSSLMIFDRHANLKYRYCNRKF
>SEQF2892_00795 hypothetical protein
MTELVIYTQNDCPPCTFVKNYLTEHKVDYIEKNISNNEYRSEMIDYDAFATPFILLDGEP
MYQVDLYKINTKCHIKS
>SEQF2892_00796 Putative cytochrome bd menaquinol oxidase subunit I
MDSVEISRFLTGMTLAVHIIFATVGVGMPLMFAIAEFLGIKNKDPKYIALAKRWSKGYTI
TVAVGVVTGTIIGLQLSLIWPTFMKMGGHVIALPLFMETFAFFFEAIFLSIYLYTWDRFK
NKWTHFIISIPVIIGGSFSAFFITSVNSFMNTPAGFEMKDGKMVNVQPLEAMFNSSFLVR
AFHVVATAGMTMAFILASIAAFKLLKNKYNKDAEYHKKALKMTMIVGFISTLLSMLAGDL
SAKFLHQVQPEKLAAYEWHFDTQSKADLVFFGVLNEKTQEVEGAIKIPGMLSFLADNNVN
TKVEGLNDFPKNELPPLIVHYFFDLMVTMGVLCFVISGAFILTLMIKKLRKYVTHKGMLY
AVLLTGPAAMLAIEFGWFLTEVGRQPWIVRGYMRVSEAATQAGGITLVTILFGLLYLVLL
FTSAYVLIRMFKDKPAQDDVDKVIEKGGHA
>SEQF2892_00797 Putative cytochrome bd menaquinol oxidase subunit II
MDYTTIGITVLWTFLFLYIIVASIDFGAGFFTLHTKLTGEEKKINHLVERYLNPVWEVTN
VFFVFFFVGFVGFFPDSALYFGTVLLVPGSIALILISIRGSFYAFEHYGQDTKLPWIIMY
GLTGLLIPASLATVLTISEGGYITERGSHFDLDWFQLLLSPFAWSVVFLAIISVLYISSG
FLTYYASKAKDEVAYKYMRQWFIFWGPPMIIISLFVFLSLRIQNADHFNNAVQNYWWMFA
LSFICFVVAGILNFIKKYHGLAFIMVILQMAFAFYGYGISKLPYLLYPYIKVSDSGVNAS
MGLALVIVFILGLLLLVPSLILLLRLFVFDKEYVEGKK
>SEQF2892_00798 Ktr system potassium uptake protein A
MEKEYVVIGLGRFGGSIVRELNALDMDVMAIDRDEARVNEYSDIATHAVVADTTDEAVMK
SLGIRNFDHVIVAIGENIQSSTLTTLILKELGVKKVTAKAQNDYHAKILNKIGADTVVHP
ERDMGRRIAHNVASASVLDYLELADEHSLVELKASEKMTGQSIIDLDIRAQFGINIIAIK
RGKEIVVSPDPSMNIEFGDILIMIGHDNDLNRFEKKIVR
>SEQF2892_00799 Inner membrane protein YbaN
MRYVLIALGIVFTVIAFTGAVLPLLPTTPFLILAAICFTNSSRKFKIWLESTQIYKNYVE
NLKKYKGYTMKEKIRILISLYIVVGFSIFMISNLYIRIGLMIMVVIQTIVLFTFVKTLPA
NFNQEKDS
>SEQF2892_00801 Ribonuclease J 1
MKQLHANEVGVYALGGLGEVGKNTYAIEYKNEIVIIDAGIKFPDDNLLGIDYVIPDYTYL
EQNQDKIVGLFITHGHEDHIGGVPYLLKQINVPIYGGPLALGLIRNKLDEHNLLRNASLN
EITEDSVIKSKHFEISFYLTTHSIPEAYGVIIDTPEGKIVHTGDFKFDFTPVGEPANIAK
MAELGKEGVLCLLSDSTNALVPDFTLSEREVGQNVDKIFRNCKGRIIFATFASNIYRVQQ
AVEAAIKYNRKIVTFGRSMENNIKIGMELGYIKAPPETFVEPNKINNIPKHELLILCTGS
QGEPMAALSRIANGTHKQIKIIPDDTVVFSSSPIPGNTKSINRTINALYKAGADVIHSKI
SNIHTSGHGSQGDQQLMLRLIQPKYFLPIHGEYRMLKAHGQTGVDCGVKEENVFIFDIGD
VLALTHDSARKAGRIPSGNVLVDGSGIGDIGNVVIRDRKLLSEEGLVIVVVSIDFNTNKL
LSGPDIISRGFVYMRESGQLIYDAQRKIKTDVISKLNANPNIQWHQIKSSIIETLQPYLY
DKTARRPMILPVIMKVNED
>SEQF2892_00802 hypothetical protein
MAVFKVFFQHNKDEVIVRENTNTIYVEGETEEQVRRYLKDRNYNIEFITKLEGAHLEYEK
EHSDHFNVENAQ
>SEQF2892_00803 Peptide deformylase
MLTMKDIIRDGHPTLRAKAEDVSLPLSDEDKNTLKEMRQFLINSQDDDIAKKYGLRSGVG
LAAPQINVSKRMIAVYLPDDGNGKAYDYMLVNPKIMSHSVQRAYLPTGEGCLSVDENIPG
LVHRHFRVTIKALDIDGNEVKLRLKGYPAIIFQHEIDHLNGVMFYDYIDQDNPLTPLPDS
VEV
>SEQF2892_00804 hypothetical protein
MKLRKTVAIVAASTILLAGCTTDKKEVKAYNENIQKAFDKEQSINSISKKLNSLEEKKQG
LYKKANSDNEDTRKKAADDILENIKQRQETFDKEVSTLNDSEKQFKKGKSHIDEIKSDDK
KKEVKQLDDAVKNKYKVHDEYASAYKNVLEKEKDLFELIKQDGVTQSQVDEKNDALNKAQ
KNFQNKFKDYSKAMNTVNKEKQDVDNL
>SEQF2892_00805 Pyruvate dehydrogenase E1 component subunit alpha
MAPKLQAQFDAVKVLNDTQSKFEMVQILDVDGNVVNEDLVPDLTDEQLVELMERMVWTRI
LDQRSISLNRQGRLGFYAPTAGQEASQLASQYALEKEDFILPGYRDVPQIIWHGLPLTEA
FLFSRGHFKGNQFPEGVNAFSPQIIIGAQYIQTAGVAFGIKKRGKKAVAITYTGDGGSSQ
GDFYEGINFASAYKAPAIFVIQNNNYAISTPRSKQTAATSLAQKAIAVGIPGIQVDGMDA
LAVYQATKEARDRAINGEGPTLIETMTYRYGPHTMAGDDPTRYRTSDEDADWEKKDPLVR
FRKFLENKGLWNEEKENEVIERAKDDIKKAIKEADNTPKQTVIDLMDIMYEDMPQNLAEQ
YEIYKEKESK
>SEQF2892_00806 Pyruvate dehydrogenase E1 component subunit beta
MAQMTMVQAINNALKTELQNDENVLVFGEDVGVNGGVFRVTEGLQKEFGEDRVFDTPLAE
SGIGGLALGLTVEGFRPVMEIQFLGFVFEVFDEVAGQIARTRFRSGGSKVAPVTIRAPFG
GGVHTPELHADNLEGILAQSPGIKVVIPSGPYDAKGLLLSSIRSNDPVVYLEHMKLYRSF
REEVPEEEYTIDIGKANVKKEGNDITLIAYGAMVQESEKAAEELEKEGYSVEVIDLRTVQ
PIDIDTLVASVEKTGRAVVVQEAQRQAGVGATVAAELAERAILSLEAPIARVAAADTVYP
FTQAENVWLPNKNDIIEKAKATLEF
>SEQF2892_00807 Dihydrolipoyllysine-residue acetyltransferase component of pyruvate dehydrogenase complex
MAFEFRLPDIGEGIHEGEIVKWFVKAGDTIEEDDVLAEVQNDKSVVEIPSPVSGTVEEVV
VDEGTVAVVGDVIVKIDAPDAEDMQFKGGHDDDASSEEAPAQEEAKTEEAPAASASQDEE
VDENRQIKAMPSVRKYAREKGVNIKAVAGSGKNGRITKEDIDNHLNGGGAQAATASNESA
AASTSEDTSAVQTQSVPEGDFPETTEKIPAMRRAIAKAMVNSKHTAPHVTLMDEIDVQDL
WDHRKKFKEVAAEQGTKLTFLPYVVKALVSALKKYPALNTSFNEEAGEIVHKHYWNIGIA
ADTDRGLLVPVVKNADRKSIFQISDEINELAVKARDGKLTSDEMKGATCTISNIGSAGGQ
WFTPVINHPEVAILGIGRIAQKPIVKDGEIVAAPVLALSLSFDHRQIDGATGQNAMNHIK
RLLNNPELLLMEG
>SEQF2892_00808 Dihydrolipoyl dehydrogenase
MVVGDFPIETDTIVIGAGPGGYVAAIRAAQLGQKVTIVEKGNLGGVCLNVGCIPSKALLH
ASHRFVEAQHSENLGVIAESVSLKFDKVQEFKKSVVNKLTGGVEGLLKGNKVEIVKGEAY
FVDNNSLRVMDEKSAQTYNFKHAIIATGSRPIEIPNFEFGKRVIDSTGALNLQEVPGKLV
VVGGGYIGSELGTAFANFGSDVTILEGAKEILGGFEKQMVQPVKKGMKEKGVEIITEAMA
KNAEETENGVKVTYEAKGEEKTIEADYVLVTVGRRPNTDELGLEELGLKFADRGLLEVDK
QSRTSIDNIYAIGDIVPGLPLAHKASYEAKVAAEAISGQASEVDYIGMPAVCFTEPELAQ
VGYTEAQAKEEGLDYKASKFPYAGNGRALSLDDTTGFVKLITLKEDDTVIGAQIAGNGAS
DIISELGLAIEAGMNAEDIALTVHAHPTLGEMSMEAAEKAIGMPIHTM
>SEQF2892_00809 hypothetical protein
MEYQYPLDLDWSNEEMVDVIAFFNKIENYYENSVNGQDLMNHYKRFKEIVPSKAEEKQLF
KEFEEKSNYNSYKVVQEVKNNPELTSFSAK
>SEQF2892_00810 HTH-type transcriptional regulator PuuR
MQIGNKLRNLRRQKNLTQEELAERTDLSKGYISQIESQHASPSMETFLNILEVLGTSPSD
FFKEKSKEKVLYTKNERTIYDEYDRGYVLNWLVMKSNEFEMEPLILSLKPGASYKHFDPS
ESDTFIYCLKGCVTLTLGNSRYQANEQDVLYFRANEIHQLHNETTDEIEILIVATASYL
>SEQF2892_00811 Spermidine/putrescine import ATP-binding protein PotA
MEPLLSFKGVTKGFDDVTILNKMDLEIESGHFYTLLGPSGCGKTTILKLIAGFEQPDDGD
IIYLNKSIGELPANKRKVNTVFQDYALFPHLNVYDNIAFGLKLKKHSKKDIDKKVIDALK
LVKLSGYEQRNINEMSGGQKQRVAIARAIVNEPEILLLDESLSALDLKLRTEMQYELREL
QKRLGITFIFVTHDQEEALALSDYIFVMKDGKIQQFGTPTDIYDEPVNRFVADFIGESNI
VEGKMVEDFVVNIYGQDFECVDAGIPSGKNVEVVIRPEDISLIEADKGLFKATVDSMLFR
GVHYEICCIDRKGYEWVIQTTKKAEVGSEVGLYFDPEAIHIMVPGETEEEFDKRIESYEE
FDNA
>SEQF2892_00812 Spermidine/putrescine transport system permease protein PotB
MRNINKVLIIPYLLWMVLFIIVPVILLVYFSFTDLNGHFSLTNYEQILSMKYLKMMWDSI
FYAALITIITLLISYPAAYFIRSSKNQNMWLLILIIPTWINLLLKTYAFIGLLSHEGLIN
RFLNFIHLPSANLLFTPGAFLLVASYIYIPFMILPIFNSMKAIPNNLLQASSDLGASPFT
TFRKVIVPLTKEGVMTGIQVTFIPALSLFMITRLIAGNKVINIGTSIEEQFLVIQNYGMG
STIAIFLIVFMAFILIITKSKSTDERR
>SEQF2892_00813 Inner membrane ABC transporter permease protein YdcV
MKWYGKLYIGILLAILYIPIFFLMFYSFNSAGNMIHFEHFTLEHYQSLFQNDRLMSVIFN
TVAVALLAAAISTIIGTFGAISLYYLRNKKFKVTLLTLNNVLMVSSDVVIGASFLIMFTA
IGHLTGLGLGFGTVLASHIAFCIPIVVIVVLPQLNEMNNNILNAARDLGATESQIFGRVL
IPNLMPSIIGGFFMALTYSLDDFTVSFFVTGNGFSVLSVEVYAMARKGISMEINAISTIL
FAAIVLGIVGYYAIQRTVKRRQLTKRGVNQ
>SEQF2892_00814 Spermidine/putrescine-binding periplasmic protein
MKQFLQLILGAIVVGLICLGISHWFKSQDNTGTGEKIYVYNWGEYIDPALIKQFEKETGI
QVIYETFDSNEAMEAKIRNGGTHYDVAFPSEYTVQKLKRENLLEPLDHSKIPNIKNLDSD
YMNMSYDRHNKYSLPYFFGTVGILYNKKVYPNEDFSSWQALYQPKYKNDILLVDGAREIM
GLALNKLGYSLNDTNPSHLKEAEKDLNHLTPQVRGVVGDEVTMMLEQNEGNIAVVWSGVA
APLVQDSNKYNYVIPKEGSNLWFDNMVIPKTAQNKEGAYKFMNFLLDAKNNKQNTEWVGY
ATPNKAARQLLPKEVRDDHRFYPTQKEQSRLEVYKDLGPKTLGEYNESFLNFKMSLK
>SEQF2892_00815 hypothetical protein
MSGERYTQIKRPVSRLTEKLLGWFSWIFLLILTVITMFIALVSFSNDTSIQNLENSMNSN
ELIQQILTNNSLNTTQFVIWLQNGVWAIIVYFIVCLLISFLALISMNMRILSGFLFLIAS
IITLPLVLFFVTLIIPIFFFIIAIMMFARKSKVETVPMYGPSHGYENQYYPRDEYDDRYY
GSNRNINDDYDYDDHNQYNDYDEDYVESPPKTKKSERRTRRKKPYYNDDIDSNYRDNNYD
ETTIRKDEEQDLATDTEEDKYNQYPKRAITGEYQSDADDVEATGVLSRQAKYNKKANKKS
QFDNTSDEESYDFAENVVDTEPKVDKREEKAQRKREKAELKAKKKEKRKAYNQRMKERRK
NQPSAVSQRRMNYEERKQILNKDDIESEKDVNNQEEDNKN
>SEQF2892_00816 hypothetical protein
MSRKVELILGWIACGLSIIYLIMSSLSYFMVRNNNNTEQYQQMLKQFGNQDVKVTPEMVN
FAMAFSMGTLIFSTLLGIIGMLIIKGRPILAGCLLIVAALVGIFNMSLIAGILWIVVAIM
LFVKKDPNQPKQKPKSTKVKMDEWQTEKSYNERKKDDPYIY
>SEQF2892_00817 Divalent metal cation transporter MntH
MGVIDNKEQRSLDEINSTIEFNDSQRTSQKFLAFLGPGLLVAVGYMDPGNWITSMQGGAQ
FGYTLLFVILISSLSAMLLQSMTVRLGIATDKDLAQMTRHYLNKPTAIIFWVIAELAIIA
TDIAEVIGSAIALDLLFNIPLIIGALITVFDVFLLLFIMKFGFRKIEAIVGTLIFTVLMI
FVFEVYISSPNLIEILNGFVPHYQIIANHSILYIALGIIGATIMPHNLYLHSSIVQSRKY
NRHSFTEKAQAIKFATIDSNIQLSIAFIVNCLLLVLGAALFYGVNSNNIGGFYDLYQALR
TQPVLGVVMGSIMSTLFAIALLASGQNSTITGTLAGQIVMEGFLKLSIPNWMRRLVTRSL
AVIPVLLCLVIFRGNESKMEQLLVFSQVFLSIALPFSLIPLQLATSNEKLMGPFKNKKWV
NICAWGLIIILSFLNIYLIIETFKEL
>SEQF2892_00818 hypothetical protein
MTQYTFKPKDFKAFEVEGLDARMEALNEYVRPQLNQLGDYFSEYFTSQTGETFYAHVAKH
ARRSVNPPVDTWVAFAPNKRGYKMLPHFQIGLFKDHLFLMFGVMHEGKDKAERVKVFDKH
FDVLKQLPEDYQVSLDHMKPEKSYIKDLSDDELHKAIDRVKNVKKGEFFVARSLSPKDAE
LKSDKAFLSFVKETFDEFLKFYE
>SEQF2892_00819 Inositol-1-monophosphatase
MSLYEFAQGLILEAGNKVRIMMKEDLSIETKSNPNDLVTNVDKATENYIYDAILRSYPDH
RVIGEEGHGHHMEDINGVVWVVDPIDGTLNFVHQQEGFAISIGIYRDGKPYAGLVYDVMK
DVLYHAKVGEGAFENNHELKTIDNTQLNQSLIGINPNWVTKPKMGPIFSEIVNQARSCRA
FGSAALEIISVARGQLAAYITPRLQPWDFAGGLIILNEVGGIGSNLMGEPLTIESANSIL
VGNKATHNEILENYLNPHNEVLTELHQRFRK
>SEQF2892_00820 hypothetical protein
MEKPKSKGIFWVLSIIAVIFLVLFSFSVGAGSIPMMILTFILFIATFGAGFTLKKKYREN
NWL
>SEQF2892_00821 GTP-binding protein TypA/BipA
MTNRREDVRNIAIIAHVDHGKTTLVDELLKQSGIFRENEHVDERAMDSNDLERERGITIL
AKNTAIDYKGTRINILDTPGHADFGGEVERIMKMVDGVVLVVDAYEGTMPQTRFVLKKAL
EQDLKPVVVVNKIDKPSARPEGVVDEVLDLFIELEANDEQLDFPVVYASAVNGTASLDSE
KQDENMQSLYETIIDYVPAPLDNHDEPLQFQVALLDYNDYVGRIGVGRVFRGKMRVGDNV
SLIKLDGTVKNFRVTKIFGYFGLKREEIEEAQAGDLIAVSGMEDINVGETVTPTDHQEAL
PVLRIDEPTLEMTFKVNNSPFAGREGDYVTARQIQERLDQQLETDVSLKVTPTDSPDTWV
VAGRGELHLSILIENMRREGFELQVSKPQVILREIDGVLSEPFERVQCEVPSENAGSVIE
SLGARKGEMLDMSTTDNGLTRLIFMVPARGMIGYTTEFMSMTRGYGIINHTFEEFRPRVK
AQIGGRRNGALISMDQGQATAYAIINLEDRGVNFMEPGTEVYEGMIVGEHNRENDLTVNI
TKAKHQTNVRSATKDQTQTMNRPRILTLEEALEYINDDELVEVTPQSIRLRKKILNKSLR
EKEAKRVKQMMQDE
>SEQF2892_00822 hypothetical protein
MREVQCIICDTKVLIDENTVEAKRLRNNPIRTFMCDDCKSRLDRPKQRLNKHQPFNFIKS
EEL
>SEQF2892_00823 hypothetical protein
MIQIKGLVKFPITLDSTTWIFDDRKVKIEDIESGVFEGTKPIRFEDNREWNRAILEGQTN
PPTLNSEIKYRKRSVLEDSFAINMTPFFKITEPKDNATAIKLFNDESSIEVPIELLPYLF
FQFAKDGKRMYDDNAVDSFVFNPDKKGYSHEFKYVTHIEVI
>SEQF2892_00824 hypothetical protein
MPKQSKMSNVAYEQLNQDADRILHLIKVQMDNLTLPSCPLYEEVLDTQMFGLQKEVDFAV
KLGLVDKEDGKNLMLRLEKELSKLHEAFTNVK
>SEQF2892_00825 putative peptidoglycan glycosyltransferase FtsW
MSNLKNIFRYIGRTAKFIDYPLLITYVVLCLFGLIMVYSASMVAATKGTLTGGLEVSGTY
FYNRQLIYVIMSFIVVFFIAFMLNIKILQQPNIQKWIMIIIFILLFLTLIIGKNINGSKS
WINLGFMNLQASELLKIAFILYISYVISRKLPQVREKIKVIAAPLFLIGVCLFLVLLQGD
IGQTLLIMIIIVSMFIFAGIGVQKLVRGPVLLIAGSFIAIASLFIVSGMMPHYLKARFST
LMNPFSSEAGTGYHLTNSLMAIGNGGLFGRGLGNGIMKLGYLPEAHTDFIFAVICEELGL
VGGLFVICLLFFIVYRAFVLATKTPSYFYKLICVGVASYIGSQTFVNLGGISATIPLTGV
PLPFISFGGSSMLSLSIAMGLLLLVAKQIKIDEKRSQKARKQKLGITR
>SEQF2892_00826 2-oxoglutarate carboxylase small subunit
MKNIKKLLVANRGEIAIRIFRAATELNIKTVAIYSNEDKNALHRYKADESYLVGKDLGPA
ESYLNIERIIDVAKRAGVDAIHPGYGFLSENKQFAQRCDEEGIKFIGPHIEHLDMFGDKV
KARTTAINAKLPVIPGTDGPIENFEAAKAFAQEAGFPLMIKATSGGGGKGMRIVREEGEL
EDAFHRAKSEAEKSFGNSEVYIERYIDNPKHIEVQIIGDEYGNIVHLYERDCSVQRRHQK
VVEVAPSVGLSKELRERICDAALQLMNNIRYVNAGTVEFLVSGDEFFFIEVNPRVQVEHT
ITEMITGIDIVKTQILVADGANLFDERVSMPQQEEIQTLGYAIQCRITTEDPSNDFMPDS
GTIIAYRSSGGFGVRLDAGDGFQGAEISPYYDSLLVKLSTHAVTFKQAEEKMERSLREMR
IRGVKTNIPFLINVMRNDQFRSGDYTTKFIEETPELFNIAPTLDRGTKTLEYIGNVTING
FPNVEKRLKPDYESTAIPQVPHSKINTLNGTKQLLDSKGPKAVADWVREQNDVLVTDTTF
RDAHQSLLATRVRTKDMMNIASKTAEVFKDSFSLEMWGGATFDVAYNFLKENPWERLERL
RKAIPNILFQMLLRASNAVGYKNYADNVIEKFVKESANAGVDVFRIFDSLNWVDQMKVAN
EAVQNAGKISEGAICYTGDILNPERSNVFTLEYYVKLAKELEREGFHILAIKDMAGLLKP
KAAYELIGELKSAINLPIHLHTHDTSGNGLLIYKEAIDAGVDIIDTAVASMSGLTSQPSA
NSLYYGLNGFNRNLRADIEGLEELSHYWSTVRPYYSDFESDIKSPNTEIYHHEMPGGQYS
NLGQQAKSLGLGERFHEVKDMYRRVNFLFGDIVKVTPSSKVVGDMALYMVQNDLDEQSVI
KEGHKLDFPESVVSYFKGDIGQPVNGFNKELQDVILKGQQPLTERPGEYLDPVNFDEIRQ
ELEAKDYGEVTEQDVISYVLYPKVFDQFMQTKQQYGDLSLLDTPTFFFGMRNGETVEIEI
DTGKRLIIKLETISEPDENGYRTIYYVMNGQARRISIKDENIKTNTNLKPKADKSNPSHI
GAQMPGSVTEVKVTVGEEVKVNQPLLITEAMKMETTIQAPFNGTIKQVTVVNGDAIATGD
LLIEIEKAD
>SEQF2892_00827 Heme A synthase
MMGCITLFNKRNLKWLSVLATIIMAFVQLGGALVTKTGSEDGCGSSWPLCHGALLPQNLP
IDTIIELSHRAVSGLSLIVVLWLAITAWKHIGYIREVKPLAIISIAFLLVQALIGAAAVI
WQQNSYVLALHFGISLISFSSVFVLMLIIFEVDKKYEADELYIRKPLRRLTWIMTGIVYL
TIYTGALVRHAKASLAYGGWPLPFHDIIPHTEQDWVQFAHRGMAFITFFWIMITFIHAVK
NYSENRTIRYGYTTAFILIILQVITGALSVMTNVNLFIALLHALFITILFGMIAYFIMLM
LRTIRSEKIK
>SEQF2892_00828 Protoheme IX farnesyltransferase 2
MSKEQTLSQPSSRVSFKELQQIIKMGLVQGNLIPAFAGAWLAVVMSNHSFLSSIPQILLM
LIGSTLIMGGACALNNYYDQDIDRIMPSKQNRPTVNDRISDKNLLILSFGMMLLGEACLF
LLNVPSGVLGLIGIVGYVSYYSIWSKRHTTWNTVVGSFPGAVPPLIGWVAIDGNISLIAI
ALFLVVFCWQPIHFYALAIKRSDEYSLANIPMLPSVKGFKRTRISMFIWLVFLLPLPFLL
SSLGTTFVVLATLLNLGWLYVGLTSFKKATDQTKWATKMFIYSLNYLVVFFVLVVVISLI
KMI
>SEQF2892_00829 hypothetical protein
MNLPILPTISTSCIVISAIFVAIGWWQIWHRDIDKHKKTMLWAAIFALTFFIIYASRTIF
IGNTDFGGPDSVRTYYKIFLIFHINLATIGGVLGLIQIITAYKDKFKWHRKAGPIASVIW
FFTAITGVAVYLLLYVFYPGGETTSLIKATLGL
>SEQF2892_00830 hypothetical protein
MAKLIIKVLGVIFLVLFLIYLFYSPRLKFDVLENPNKTVSTNHSEQAPKTHNTSENPSPK
EGVGTWIGKDIDDLTDKYGQASRTYPFKGHYMNYVFKKDEQYYIVSTKENKIKSVYATGN
NANVAPLKINESASHIFENTSINPDPSIKVNGQSYNFELSDEDIKTQTLIKYGNVYAQVY
VDQQSNQIMGIRFLDKEALAFLKPYPLANESDDNYNEEDFDKAKKDNLPYEQNPNQLMTL
YEITNEMRKLKNIKPLKVNSDIAHIASVNLYEATGSNDVEFTEDALKSQLSNENISFIST
SQNVGYDFDDVPTLIHSWMNSDMHRSRMLNTKYEEMGGEVMKDYYSLIFLEK
>SEQF2892_00831 hypothetical protein
MYTEETMSILDDIEGLSDMIVQSELYHDFRAAQEMLNNDDEAHLMYQAFLKSKVAYDEVM
RFGKYHPDYQKVMLETRRRKRAYEMLPVVMDYKSKEVALQNLIDEVVSKIAFSVSKNVKI
EAGNPFFKTGHDGCATGGTCNCSLS
>SEQF2892_00832 Glycerophosphodiester phosphodiesterase
MTIKKRWVLNLSLASVSFLGSLFFINKSSKADQTKEIPKLFNGKAPYIFAHRGGMAVRPE
QTQLAFDNAVANNLDGFETDVRLTKDEKLIVFHDATVDRTTNGSGKVSDHRVSELKRLDA
GYHFKDINGQFPYRGHQKAKILTFDELLKMYPNMYINVDLKDAPDSYEGTVAPTKMYEDI
INNQAQDRVLVTSFYKEQNVRFREISKGQVAIGASQKEVAEGFIKFNLGLGNKYQPIADT
FQMPTQFKGIPLTSKRFIQWLNLLNIVPGFYGINSTDLMTDLYHKGVHTLVTDRPDLGKQ
FKSSLNIEK
>SEQF2892_00833 hypothetical protein
MELIPRVSLIVYLKHIKHERQIRKYGHIIYTNKQRKYVVLYVNENDADAIVHKLMKLKYV
VDIDGSPYKYLKKTYEKEKHEIL
>SEQF2892_00834 hypothetical protein
MKQSFIVLGEGLTDLFEFNTLIEYNHLRINKIVYFHTPQSSKQLSSVAMIMNPTSGNHFQ
AMYIMLDALKYPFPNSNKKFELINNQANQYNVPIFGIDVQPPEAFHTLDQYFKYLISVLR
LQNWIPPMQ
>SEQF2892_00835 Ribosomal RNA small subunit methyltransferase D
MRVIAGKHKSKALESLEGRNTRPTMDKVKEGIFNSLQEVHGLGLDLFAGSGALGIEALSR
GMEKVIFVDQNFKAVKVIQANLKQLDLRDQSEVYKNNADRALKALNKREIQFDYIFLDPP
YNKGLIDKALEQIAEFNLLKENGIIICEFSNHEQINTNGFKVIKQYHYGLTDTLLLEKGE
QNG
>SEQF2892_00836 Phosphopantetheine adenylyltransferase
MAKTKAVIPGSFDPITYGHIDIIERSAGRFDELHICVLKNSNKTGTFNIDERMALIEESV
KHLSNVEVHNYNGLLVDFCDKIGAQTIIRGLRAVSDFEYELRLTSMNKKLNSNVETMYMM
TSTNYSFISSSVVKEVAQYKADISDFVPPNVEKALKEKFKK
>SEQF2892_00837 hypothetical protein
MKSVGLITEYNPFHNGHLYHAQQSKLQSDAEISIAIMSGNFVMRGEPAIYNKFLRTKMAL
SGVDLVVELPAIASLSSSDYFATFAIKVAHYLDIDTIAFGSEINDISRLENVASNINSLE
QSSYFQDLIKQGNSYAKIVHDLIDDQQVLRSPNNILGVAYIKAISNIAPTIKRIAIQRQS
TAHHDQEIKHDNFASGSAIRHALLNKENTWKDVVPADIKHLYETPHLLKKQTFNFIKYNI
LSRSSEELSHIYTMSEGFEHRLKSNIQNAQDFDTYMSLIKTKRFTYTHIQRVLMQILLNI
NKSDFDDEIRGVRILGMNQRGQQYLKYLKKQFPNRLYVTNINKESASLLKNEIKATHIYN
LISGQRANDFNTPVIINKKN
>SEQF2892_00838 hypothetical protein
MKWSITQLRKYQGKPFEFNQTANFEHLIEPLGLIDLSEINVEGELTVKANEVIADIHLTG
TYTMPCARTLVPVEVHLDVRTSEIFDLEGYDSYTDEEVEEDEHYHLATDGMINIRDIAEE
LVIIEKPMRAFSENSDQMLTEGNGWEVIDEDQMIELEKEKDNDNSQTQQVDPRLQKLQQL
YDKE
>SEQF2892_00839 50S ribosomal protein L32
MAVPKRRTSKTRKNKRRTHFKISVPGMTECPSCGEYKLSHRVCKNCGSYNGEEVVSK
>SEQF2892_00840 Putative TrmH family tRNA/rRNA methyltransferase
MEQITSAQNSKIKNANKLKKKRDRDKTGQALIEGIHLIEEAYQSGIAIKQLFVIEPNRTD
EALKDYAEETFEINMKVAESLSGTITPQGFFAVIEKPKYDVKQAKQVLLIDRIQDPGNLG
TLIRTSDAAGIDLIVMEKGTADPYQDKVLRASQGSVFHIPVITADLKTFIAGFNGPVYGT
ALENVQPYKEVASQDIFALLLGNEGEGVNKALLNETSQNLTIPIYGKAESLNVAIAGSIL
LYHLKG
>SEQF2892_00842 Phenylalanine--tRNA ligase alpha subunit
MTQNDSMAELKQQALVDINEAQNERELQDVKVKYLGKKGSVSGLMKNMKDLPNEEKPAYG
QKVNELRQTIQKELDEKQELLKNEKLNQQLAEETIDVTLPSRQISIGSKHPLTRTVEEIE
DLFLGLGYEIVDGYEVEQDYYNFEALNLPKSHPARDMQDSFYITDEILMRTHTSPVQART
MEKRNGQGPVKIICPGKVYRRDSDDATHSHQFTQIEGLVVDKNIKMSDLKGTLELVAKKL
FGADREIRLRPSYFPFTEPSVEVDVSCFKCKGKGCNVCKHTGWIEILGAGMVHPNVLEMA
GFDSNEYSGFAFGMGPDRIAMLKYGIEDIRYFYTNDVRFLEQFKAVEDRGEA
>SEQF2892_00843 Phenylalanine--tRNA ligase beta subunit
MLISNEWLKDYVDAGVKVEDLAERITRTGIEVDDMIDYSKDIKNLVVGYIQSKEKHPDAD
KLNICQVDIGEEEPVQIVCGAPNVDAGQHVIVAKVGGRLPGGIKIKRAKLRGERSEGMIC
SLQEIGISSNVVPKAYENGIFVFPTEVEPGTDALTALYLNDQVMEFDLTPNRADALSMVG
TAYEVAALYQTEMTKPETQSNETSESATNELSVTIDNPEKVPYYSARVVKNVSIEPSPIW
VQARLIKAGIRPINNVVDISNYVLLEYGQPLHMFDQDHIGSKEIVVRQAKDEETMTTLDN
NERKLVDTDIVISNGQEPIALAGVMGGDFSEVTEQTTNVVIEGAIFDPVSIRHTSRRLNL
RSEASSRFEKGIATEFVDEAVDRACYLLQELASGEVLQDRVSSGDLGSFVTPIDITAEKV
NKTIGFNLSNDEIQSIFRQLGFETTLKGETLTVNVPSRRKDITIKEDLIEEVARIYGYDE
IPSSLPVFGEVTSGELTDRQHKTRTLKETLEGAGLNQAITYSLVSKDHAKDFALQERPTI
SLLMPMSEAHATLRQSLLPHLIEATAYNVARKNKDVRLYEIGRVFFGNGEGELPDEVEYL
SGILTGEYVVNAWQGKKEEIDFFIAKGVVDRVAEKLNLEFSYKAGKIEGLHPGRTAIVSL
EGQDIGFIGELHPQVAADNDLKRTYVFELNYDAMMQVAVGYINYEQIPKFPGVTRDIALE
VNHDVPSSELKQIIHNNGEDILQSTLVFDVYEGEHLEKGKKSVAIRLNYLDTEDTLTDER
VSKIHDKILEALQAQGATIR
>SEQF2892_00844 Ribonuclease HIII
MANIVYKLSESEIQHLLQQITFETSQLSPGMKARTKYKQSVINIYNSGKVMFQGKNAEAV
AQQLLPDHTTTSKNSSSSNQSSGETLAYNHYNCIGSDEAGSGDYFGPLTVCAAYVSKENV
KILKTLGVDDSKKLNDQKIIELAEQLITFIPHSLLTLDNPKYNDRQAIGWSQVKMKAELH
NEAIKNVTQKINCNELNYIVIDQFAVRGVYQRYALSSLPYPEKTKFETKGESKSLAIAAA
SIISRYAFVKHMDHISHKMKQDIPKGASNKVDLIAAQIIDKHGIETLDLISKKHFKNREK
AQNLVTKKYK
>SEQF2892_00845 Cell division protein ZapA
MGEFRNRINVTINDQNYTIIGEDSPEHIRYVAHLVDEKLKEMGRKSTGLDTTRKSILTAV
NIMHEKVKLEEENRKLLQEIQQLKQREE
>SEQF2892_00846 hypothetical protein
MIIDFTIAIIIVYGLIIGYRRGVWLNSLHLFSTIVSLNIAHQFYQRISSQLIVFIPFPKT
IAYDMKYAFHFNDLQQRFDTIIAFLLIASLCKLILYLIIITFDNIVTYRMINQISRLFGS
LISVVMAVVAIQLSIYVLALYPIEWLQHNLQHAYIGKLILFHTPFFSSYILNL
>SEQF2892_00847 DNA polymerase/3'-5' exonuclease PolX
MTKKDVIQLLEKIAIYMELNGENTFKVSAYRKAAQSLEIDERPLDEIEDVTELKGIGKGV
GEVIDEYRKTGESSYLKELQQLVPEGLIPLMKIQGLGSKKIAKLYKELNITDKESLQLAC
ESGKVSELSGFAKKTEQNILEAVKALGAKKDSYPIDTIRGLNGIIIDYLETIDSIERYSE
AGSFRRYKEMSKDLDYIISTEHPDEVQQQLLNIPNKVKDVVVGQTKVSLELTYDDETIGV
DFRLIEPVAFYHTLQHFTGSKDHNIRIRQMAKAQNEKISEYGIEQQDGSLLQLQSEEEIY
QHFGKEWIAPALREDGSEFDKDLSDIITLDDINGDIHMHTTYSDGAFSIRDMIEANINKG
YQFMVITDHSQSLKVANGLQVERLLRQNEEIKKLNEEYSEIDIYSGTEMDILPDGSLDYD
DDVLSQLDYVIAAIHQSFNQSEEEIMKRLENACRNPYVRHIAHPTGRIIGRREGYKPNID
RLMKLAEETNTIMEINANPKRLDLNAETVKKYPNVTLTINTDAHHIEHLDFMKYGVATAQ
KGFVNKDRVINTMSRQAFKDFVGNNKKLKK
>SEQF2892_00848 Endonuclease MutS2
MRQKTLDVLEFDKIKSFVASETISDLGREKVSKMSPATDFETVEFQMNETDEISQIYNKH
RLPSLSGLAKISPLIHRANIGGVLNVTELNLVKRLIQVQNQFKTFYNQLLEEDEQVVKYP
ILNDKMNQLPILSDLFQEINEKCDTHDLYDSASYELQGIRSKISSTNQRIRQNLDRIVKS
QANQKKLSDAIITVRNDRNVIPVKAEYRQDFKGIVHDQSASGQTLYIEPSSIVEMNNQIS
RLRNDEAVERERILTELTGMVAAEADGCLIAESVMGQIDFLTAKARYARSIKGTKPTFYK
DRTVYLPNAYHPLLNKDTVVANTIEFVDDIETVIITGPNTGGKTVTLKTLGLIIIMAQSG
LLIPTLDGSQLSVFENVYCDIGDEQSIEQSLSTFSSHMKNIVEILQETDKNSLVLFDELG
AGTDPSEGAALAMSILDHVREIGSLVMATTHYPELKAYSYNREGVMNASVEFDVNTLSPT
YKLLMGVPGRSNAFDISRKLGLSLGIINKAKTMIGTDEQEINSMIESLEKNSKRVDEQRI
ELDRLLKEARKTHDDLEHQYEQYKSYEKKLMDEAKEKANQRVKSATKEADSILKELRTLR
DQKGADVKEHELIDKKKQLDDQYEAKSLKQNVQKQKYDEIHAGDEVKVLSYGQKGEVLEL
VSEEEAVVQMGIIKMKLPIEDLEKTKKKKEKPSKMVTRQNRQTIKTELDLRGYRYEEAVS
ELDQYIDQAVLSNYEQVYIIHGKGTGALQKAVQIHLNKHKSVKSYRGGMPSEGGFGVTVA
ELK
>SEQF2892_00849 Thioredoxin
MAIVKVTDSNFDENIQSGVKLVDFWATWCGPCKMIAPVLEELAGDYDGKADILKLDVDEN
PSTAAKFEVMSIPTLIVFKDGEPVDKVVGFQPKENLAEVLDKHL
>SEQF2892_00850 UvrABC system protein C
MLSDYKEKIKNKLSVVPFEPGCYLMKDRNDQVIYVGKAKRLRNRLRSYFTGAHDAKTTRL
VGEIRNFEFIVTSSETESLLLELNLIKQYQPRYNILLKDDKSYPFIKITKEKHPKLIVTR
TVKKGTGKYFGPYPNAYSAQETKKLLDRIYPFRKCDKMPDKLCLYYHIGQCMGPCVYDVD
QQVYAQMTREISDFLNGEDKTILKNLEDRMMDASEKLDFERAKEYRDLIQHIHNLTKKQK
IMSSDNTIRDVFGYNVSKGWMCIQVFFIRQGNLIQRDATMIPLQQQSEEEEFYTFIGQFY
SLNQHILPKEVHVPKNLDKDMIQSVVDTKIVQPARGAKKEMVDLANHNAEVALENKFELI
ARDESRTIKAIEELGERMGIQTPIRIEAFDNSNIQGVDPVSAMVTFVDGKADKKGYRKYK
IKTVDGPDDYKSMREVVRRRYTRVLNEGLPLPDLIIVDGGKGHMSGVLDVLENELGLDIP
VAGLRKNDKHQTSELLYGPNAEVVPLKKNSQAFYLLHRIQDEVHRFAITFHRQTRQKTGL
QSVLDTVDGIGSKRKTSLLRTFGSIKKMKEASVVDLKKAGLPEKVALNLQQALSND
>SEQF2892_00851 Succinate dehydrogenase cytochrome b558 subunit
MAKSKNEFYLRRVHSLLGIIPIGAFLVVHLIVNHQATQGAEAFNKAAGFMESIPFLLAVE
FLLIYIPILYHGLYGIHIAFTAKENIGHYSLFRNWMFALQRFSGIVTFVFIFMHLWQTTI
QKYFFGKAVDFELMHKTLENPIWVIVYIVCVLCVIFHFSNGLWSFFVTWGFLQSKQSQRV
FTWISLIVFLVLGYIGVSAIFAFV
>SEQF2892_00852 Fumarate reductase flavoprotein subunit
MAEKKIIVVGGGLAGLMSTIKAAEQGAHVDLFSIVPVKRSHSVCAQGGINGAVNTKGEGD
SPWIHFDDTVYGGDFLANQPPVKAMAEAAPSIIHLLDRMGVMFSRTKEGLLDFRRFGGTL
YHRTAFAGATTGQQLLYALDEQVRSFEVDGLVTKYEGWEFLGIVKDEDNAARGIVAQNMT
TSEIKSFGSDAVIMATGGPGIIFGKTTNSMINTGSAASIVYQQGAKYANGEFIQIHPTAI
PGDDKLRLMSESARGEGGRIWTYKDGKPWYFLEEKYPDYGNLVPRDIATREIFDVCINQK
LGINGENMVYLDLSHKDPHELDVKLGGIIEIYEKFTGDDPRKVPMKIFPAVHYSMGGLYV
DYDQMTNIKGLFAAGECDFSQHGGNRLGANSLLSAIYGGTVAGPNAIKYVENVETTYTEL
DDSIYQKRVDEEQERFDKLLNMRGTENAYKLHRELGEIMTANVTVVRENDKLLETDKKIV
ELMKRYENIDMEDTQTWSNQAVFFTRQLWNMLVLARVITIGAYNRNESRGAHYKPEFPDR
NDDEWLKTTLAEYQGREEAPKFTYEPVDVSLIPPRKRDYTSKSKGGKK
>SEQF2892_00853 Fumarate reductase iron-sulfur subunit
MADNQSVKDTPEELRQNDSNTNEKEQKEPKQKSIKLIIKRQDNQDSKPYEETFEIPYKEN
MNVIACLMEIRRNPVNNKGEKTTPVTWDMNCLEEVCGACSMVINGRARQSCSAIVDQLEQ
PIRLEPMSTFPVIRDLQVDRTRMFDNLKRMKAWIPIDGTYDLGPGPRMPEKKRQTAYELS
KCMTCGVCLEVCPNVTQNNKFVGAQAISQVRLFDLHPTGAMTKDERLDALMSAGGLQECG
NSQNCVNACPKGIPLTTSIAAMNRETTFHMFKSFFGSDHKVD
>SEQF2892_00854 Glutamate racemase
MNKPIGVIDSGVGGLTVAKEIMRQLPNETIYYLGDIARCPYGPRPGDEVKQFTTQLANKL
MQFDIKMLVIACNTATAVALEHLQQMLPIPVIGVIEPGSRTAIMTTKNQNVLILGTEGTI
KSEAYRHHIKHINPNVHVYGVACPGFVPLVEQMRYDDPTITSIVIHQTLKQWRNTDADTI
ILGCTHYPLLYKPINDYFGGEKKVISSGLETAREVSALLTFSNEHASYTQHPEHRFFATG
DTVHIKNIILQWLKLDVEVERISVDE
>SEQF2892_00855 Non-canonical purine NTP pyrophosphatase
MADIVIATNNKGKINDFKSIFPNDNVIGISELIKDFDVEETGTTFEENARLKSEEAAKVL
NKRVIADDSGLEVFALNGEPGVYSARYAGLDKSDDANIDKLLKNLDGIENRDARFVCVIS
MSAPNETTQTFKGTVSGVITTERQGEHGFGYDPIFYVPEKGKTMAQLTTTEKSEISHRGN
AIKKLNAYLESEK
>SEQF2892_00856 Putative metallophosphoesterase MG207 
MTKWLIVSDNHTESGILYHLYEVHKDADVLLHLGDSEFEYNDTELSLYRRVKGNCDFYPE
FPNEEEVEIKGIKAIYTHGHLYSVNQTRMHLAQKAKSQGCQFAFYGHTHVAKYEYLDGVH
VINPGSISQSRSSIEETFAELVIDEVNGSAILNYRNRDNHIIETIEFEV
>SEQF2892_00858 Antibacterial protein 3
MSKLVQAISDAVQAGQNQDWAKLGTSIVGIVENGVGILGKLFGF
>SEQF2892_00859 Antibacterial protein 2
MEKIANAVKSAIEAGQNQDWTKLGTSILDIVSNGVTELSKIFGF
>SEQF2892_00860 Antibacterial protein 3
MSKLVQAISDAVQAGQNQDWAKLGTSIVGIVENGVGILGKLFGF
>SEQF2892_00861 Antibacterial protein 2
MEKIANAVKSAIEAGQNQDWTKLGTSILDIVSNGVTELSKIFGF
>SEQF2892_00862 Antibacterial protein 1
MQKLAEAIAAAVQAGQDKDWGKMGTSIVGIVENGISVLGKIFGF
>SEQF2892_00863 Putative HAD-hydrolase YfnB
MKYNTILLDFDDTLVDFYDAEDKAFHNMAKHYHHYPTAEDFQFFKQINQAHWEAFQKNKL
TKDEVLSHRFIEYFNHYGIEVDGKQADVTFRDELAKAPIKHFDSTLETIDRLAQNNKLYI
VTNGVTDTQKRRIAQLQFKDIFDGVFISEETGYQKPMIEFFDYVFEKIGKDKRKSTIIVG
DSLTSDVLGGKNAGIATCWFNVRNKKNNSGINPDYEIKSLRELVDLIENE
>SEQF2892_00864 putative N-acetyltransferase
MSEVKHLEINYKTDELFEAFREFGNKDLYMVEELQGQMIDASSESPFYGIFHGENLVARM
ALLKKGDVEEIYFPEFDDYLLLWKLEVLDNYKNKGYGQSLIDYAKSYNMPIKAIARQNSK
EFLMNQDFEDVHAKNPEGHDVLVWAPK
>SEQF2892_00865 Putative cysteine ligase BshC
MDCRVTHFKEKDSFISKLKESDKSLLEFYQYNPVETASFTTKMKRPNNGREKQLAQIIKD
YMADLKLTTSQLEHIEALEQGAKVVIGGQQAGLFGGPLYTFHKILSIVTLSSQLTKEYGE
TVVPVFWIAGEDHDFDEVNHTYVYNAKEAQLKKVKYHTMTPPETNVSRYTPDKEAMLNAL
NLFFEELKETNHSKPLYKLCVDIINEFDTWTDIFKALLHAVFKEHGVLLIDAQNDKLRQL
EKPLLKQIVTNHSKINQVFRQTQEQTIASGLTQMIQTDTNVHLFLHEDGMRQLISKEDNL
FKLSKSDITYSEEELIELIETEPERFSNNVVTRPVMEEWLFNTVAFIGGPSEIKYWAELN
NVFKLLNVEMPIVLPRMKMTYMMERTQKLLKQYSLNVEKVIQNGIDDDKNEFVREKASDT
FIQQVEELKAKHENVYQQLLNEVKENQDNFNLVTKNEEIHNKQFDYLLKRYLLNIEREND
ISMRQFRELDLVLHPHHGLQERIWNPLQIMNDFGIDVFSPSTFPPLEYTFDQIIIKP
>SEQF2892_00866 Transcriptional regulator MraZ
MFMGEYEHQLDAKGRMIIPSKFRYDLNERFIITRGLDKCLFGYTLEEWQQIEEKMKTLPM
TKKDARKFMRMFFSGAIEVELDKQGRINIPQNLRKYASLTKECTVIGVSNRIEIWDRETW
NDFYDESEESFEDIAEDLIDFDF
>SEQF2892_00867 Ribosomal RNA small subunit methyltransferase H
MFHHISVMLNETIDYLDIKEDGIYVDCTLGGAGHALYLLNQLNDDGRLIAIDQDTTALDN
AKEVLKDHLHKVTFVHSNFRELTDILKNLNIEKVDGIYYDLGVSSPQLDVPERGFSYHHD
AKLDMRMDQTQQLSAYEVVNQWPYEALVKIFYRYGEEKFSKQIARRIETHREHQPIETTL
ELVDIIKEGIPAKARRKGGHPAKRVFQAIRIAVNDELSAFEDSIEQAIELVKVGGRISVI
TFHSLEDRLCKQMFQEYEKGPDVPRGLPIIPEAYTPKLKRVNRKPITATDTDLDENNRAR
SAKLRVAEILK
>SEQF2892_00868 Cell division protein FtsL
MAVEEIYEPYEDVQHNSIPKQQPQSEPQTRTVTKKVVVQLTRFEKYLYITLVTAIAVIAI
YMLSLKMDAYDTNGKIADLDSKIEQQSSENSAIQSEIKKSSSYQRIYDKAKAQGMSLNND
NVKVVRTNGEAKN
>SEQF2892_00869 Penicillin-binding protein 2B
MAKRKIKIRKNKLGAVLLVGIFGLLFFILVLRYSYIMITGHSDGQDLVMRANEKYLVQNN
EQAERGKIYDRNGKILAEDVERYKVVAVVDKSVGKSGDKPRYVEDKKKTAKELSKIIDMK
PEEIEKQLNQKKAFQVEFGQKGTNLTYQDKQKLEKMDLPGITLYPETERFYPNGNFASHL
IGMAQKNPDTGELKGALGVEKIFDSYLSGTKGALSYIQDIWGYIAPNTKNEKSPKRGDDV
HLTIDSNIQVFVEEALDDMVKRYQPKDLFAVVMDAKTGEILAFSQRPTFNPETGEDFGKK
WANDLYQNTYEPGSTFKSFGLAAAIQEGKFNPKKKYESGHRDIMGSRISDWNKTGWGEIP
MSLGFTYSSNTLMMHLQDLVGADKMKSWYERFGFSKPTGGLFDGEAEGNIAWSNELQQKT
SAFGQSTTVTPVQMIQAQSAFFNKGNMLKPWFVDSIKNPISKKTFYQGEKEIAGKPITAS
TASKVETELDKVVNSKKSHAMNYRVDGYDIEGKTGTAQVADEKSGGYVKGENPYFVSFIG
DAPKKNPKVIVYAGMSLAQKNDQEAYEMGVSKAFKPIMENTLKYLNVGSKKDETKSAQYS
KVPNVTGQSTDKAKESLKSEDLQATVIGNGDNVKSQSIKANKKLLPNSKVLLLTDGDITM
PNMKGWTKDDVLAFQELTGINVTTKGSGYVTKQSVNNGTTLKDNSKVEIELSPEDPDDTS
TNTNDNETASNDSSNKDKASSSSDDKEKDNKNDTSSSSEQEQQTNNSQDSNE
>SEQF2892_00870 Phospho-N-acetylmuramoyl-pentapeptide-transferase
MLFILAVIALLITFILVPILIPTLKRMKFGQSIREEGPQSHMKKTGTPTMGGLTFLISII
ITSIIAIFFVDNSNPIILLLFVTIGFGLIGFIDDYIIVVKKNNQGLTSKQKFLAQIAIAV
VFFLLSDVFHLVEFSTNLNIPFTNISIPLSFAYVIFIVFWQVGFSNAVNLTDGLDGLATG
LSIIGFTMYAIMSFVLDSPAIGAFCIIMIFALLGFLPYNLNPAKVFMGDTGSLALGGIFA
TISIMLNQELSLLLIGLVFVIETASVMLQVASYKLTKKRIFKMSPIHHHFELSGWGEWKV
VTVFWTAGLISGLIGLWIGVH
>SEQF2892_00871 UDP-N-acetylmuramoylalanine--D-glutamate ligase
MLNYTGLENKDVLVVGLAKSGYEAAKLLIKLGANVTVNDGKDLSQDPHAKDLEALGVKIV
DGGHPLSLLDNEPIIVKNPGIPYTVSIIQEAYQRHLKILTEVELSYLISEAPIIAITGTN
GKTTTSSLIGDMFKKSRLTGRLSGNIGYVASKVAQETSPNEYLITELSSFQLLGVEQYRP
HIAIITNIYSAHLDYHETLENYQNAKKQIYKNQTENDYLICNYHQRHLIESENLKAKTLY
FSTQQEVDGIYIKDGFIVYQGIRIINIDDLVLPGEHNLENILAAVLASILAGVPIKAIID
SLTTFSGIDHRLQYIGTNRTNKYYNDSKATNTLATQFALNSFKQPIVWLCGGLDRGNDFD
ELIPYMKNVRVMVVFGQTQEKFAKLGNSQGKLVVKATDIEDAVKKVQDVVEPNDVVLLSP
ACASWDQYKTFEERGERFIESFRAHLPSY
>SEQF2892_00872 Cell division protein DivIB
MKDKRRKDNKVSSIQSLIEKRNRELNNEEHLSNHDANHKDKNKISTDDAQLYKINKPNET
SKQQDQNQSIDEDNFNNQSNESEQLEQNEAIEQSNETSDENAQNVESTKTNDSHRLSTNS
SENTYKLSIKDRVKEFNDNRKRKKHAKSTQFDHLSPQERKEQLRIQRRKRQKRIQYVIIT
FLVLLIILFLLYMFTPLSRISNIKISGNNNVSNSQVEKALDVKDNSRMYTYSKRKGIQNL
KKNDLIKDVKIKKQLPNTLKVQITENQVVGVVKEKNKYVPIIEGNQELKNFDGNIAGSGP
ILEGFKGEEKSNMIKSLSKMSPEIRDMISEIKYAPKQNSPNRILLYMQDDMQVVGNIKTI
ANKIKYYPQMSQSLSKDDSGNLKTQGYIDLSVGASFIPYNENSSGDSKSDQNVRQKSQQE
TDAKDELQSALNKINEQSDSNN
>SEQF2892_00873 Cell division protein FtsA
MEEHYYVSIDIGSSSVKTIVGEKFHNGINVIGTGQTYTSGIKNGLIDDFDIAKQAVKDTI
KKASIASGVDIKEVFLKLPIIGTEVYDEANEIDFYEDTEINGTHIEEVLEGIRQKNDVAD
TDVIDVFPIRFIVDGDNEVSDPKELIARHSLRVEAGVIAIHKSILINMIKCVESCGVDVL
DVYSDAYNYGSILTATEKELGACVIDIGEDLTQIAFYERGELVDADSIELAGRDITDDIA
EELNTTYETAEKIKHQYGHAYANSASDQDVFSVDQVDSDELVEYTQKDLSAVIERTMQDI
FDEVFDVLVDLGLTRVNGGFIVTGGSSNLLGVKELLNTMVNEKIRVHTPSQMGIRKPEFT
SAISTISSSITFDELLDYVTMSYQDNDEFEEEVIEDNEREHTSKSGGFDWFKRKSNKNEN
TYEEDYNEPHERTDKVDDDDKYDSNESHHDTTEHYDDQEQPQKEEGKFKKLMKSLFE
>SEQF2892_00874 Cell division protein FtsZ
MLEFEQGFNHLATLKVIGVGGGGNNAVNRMIDHGMNNVEFIAINTDGQALNLSKAESKIQ
IGEKLTRGLGAGANPEIGKKAAEESREQIEDAIQGADMVFVTAGMGGGTGTGAAPVVAKI
AKEMGALTVGVVTRPFGFEGRKRSTQAAAGVESMKAAVDTLIVIPNDRLLDIVDKSTPMM
EAFKEADNVLRQGVQGISDLIAVSGEVNLDFADVKTIMSNQGSALMGIGVSSGENRAVEA
AKKAISSPLLETSIVGAQGVLMNITGGESLSLFEAQEAADIVQDAADEDVNMIFGTVINP
ELQDEIVVTVIATGFEDKPTSQGRKASSTGFGTSATSSTSTQTSTPREESFSQSSSSSRS
SESVSERSHTTKDDDIPSFIRNREERRSRRTRR
>SEQF2892_00875 hypothetical protein
MNPQVNSPFYSQLGMIKTINTLNHTTKYRQNLFSINV
>SEQF2892_00876 Laccase domain protein YfiH
MSEKFVKYPHHLKYESQDLKHVKLGFTTREGGYSLYPESSFNMARYVDDNPENITKHQEM
LADAIGFVRAQWVFPIQTHENRVMEISQSHRGTNIDTLTDDMYGIDGIYTYEPDTLLTMC
YADCVPVYFYSEKHHYVGLAHAGWRGTYGQIVSEMLKQIDFDYNDLKIVIGPSTSTTYEI
NDDIKAKFETLPINVKDYIETRGENRHGIDLKRANALLLNHYGVPFDNIYITDYATSEDL
SLFFSYRVEKGQTGRMLAFIGQK
>SEQF2892_00877 hypothetical protein
MDVKQNLRNIESEIQSHFKNSEASTLPNVIAVTKYVTIDRAKEAYDVGLRHFGENRLEGF
LEKKSALPNDVTMHFIGSLQSRKVKEVINEIDYLHALDRLSLAKEINRRADHEIACFIQV
NVSGEESKHGIALNEVNHFIEQIQQYDKIKIVGLMTMAPYTEDTAYIRQLFKQLRVKRDE
IKDLNLDYAPCHYLSMGMSNDYAIAVEEGASFIRIGTKLVGE
>SEQF2892_00878 Cell division protein SepF
MAIKDLFNNFFLMDDEEEVESPEERQRRVVQNEENETNNVQQNQPQQSERSYSNQSKLKT
VPQKKTTRNYNSEERNVRMNQPPSKSNGKNVVTMNQTSQSYSGYESSKMCLFEPRVFSDT
QDIADELKNRRATLVNLQRIDKISAKRIIDFLSGTVYAIGGDIQRVGTDIFLCTPDNVEV
AGSITDHIEQMESQHYE
>SEQF2892_00879 hypothetical protein
MDVGLLATIFNFIIFLVQIYYFGMIIYFFTSWVPNIRESKFGEILGKLYEPFLEPFRKII
PPIGMIDISSLVALFVLVLFQAGLRSIFNMIIVHLM
>SEQF2892_00880 hypothetical protein
MRLFQPLLSFNLESERCKIIDIYQHFRDEEQGLIDQLIDKCDQVEQQYAPILTNFLDPRG
QYILEVISGSYEDMEVTFFGGDNAERKRGLIAPNYFEPGEADFEEVLIQINYPEKFVNIQ
HQHVLGTLMSLGIEREQVGDIIVGDSIQFVLTKQLESYIMLELTKIKGATVKLNSIPFKD
MIQSVENWKIQGSTVSALRLDVVLKEMIHKSRTIAKQLIEKKRVKVNHTIIDSPDFQVQT
NDLLSIQGFGRAQIIDIGGRTKKDKIHINYRTLFK
>SEQF2892_00881 Septum site-determining protein DivIVA
MPFTPSEIKNKEFTKVKNGLEPAEVSDYLNQLSNEIERLKEEKKQLEKVIEERDTNIKSY
QQVHQSVSDALVQAQQAGEETKLAANKEAEAVISKAQAQADLIVNDAIEKARHLSFQTED
MKRQSKIFRSRFRMLVEAQLDLLKNDDWDYLLNYDIDAEKVTQENFQHLNSQDITPEEQL
SAQSQQSESVLASESNNSKTNSLSTSDATSTSENVTSQSSVSQSESTSNK
>SEQF2892_00883 Isoleucine--tRNA ligase
MNYKDTLLMPKTDFPMRGGLPNKEPQIQEQWEANNQYQKALEKNKGNQSYILHDGPPYAN
GNLHMGHALNKIIKDIIVRYKTMQGFYAPYVPGWDTHGLPIEQALTKKGVDRKKMSIAEF
REKCKEFALEQIELQKKDFKRLGVRGDFNDPYITLKPEYEAAQIRLFGEMADKGLIYKGK
KPVYWSPSSESSLAEAEIEYHDKRSASIYVAFDVKDTKGVVDQDAQFIIWTTTPWTIPSN
VAITVHPDLKYGQYNVNGKKYIIAQALSEDVAEALEWDKDAIQLEKEFTGKELEYVEAQH
PFLDRISLVINGNHVTTDAGTGCVHTAPGHGEDDYIVGQKYDLPVISPLDDKGVFTEEGG
QFEGMFYDKANKAVTDLLTEKDALLKLNFITHSYPHDWRTKKPVIFRATPQWFASINKVR
QDILDAIEETDFKVDWGKTRIYNMIRDRGEWVISRQRVWGVPLPVFYAENGDIIMTKETV
NHVADLFEEHGSNIWFEREAKDLLPEGFTHPGSPNGTFTKEMDIMDVWFDSGSSHRGVLE
NRPELSFPADLYFEGSDQYRGWFNSSITTAVATRGQAPYKFLLSHGFVMDGEGKKMSKSL
GNVIVPDQVVKQKGADIARLWVSSTDYLADVRISDEILKQTSDVYRKIRNTLRFMLGNIN
DFNPDTDVIPEAELLEVDRYLLNRLREFTASTIEHYDNFDYLNIYQEVQNFINVELSNFY
LDYGKDILYIEEKNAHKRRSMQTVLYQILVDMTKLLAPILVHTAEEVWTHTPHVKEESVH
LADMPKVVEVDQALLDKWNQFMALRDDVNRALEVARNNKVIGKSLEAKVVIGNNDNFKAA
EFLQQFEDLQQLFIVSQVEVSDSVDNAEAYQHGDIRIDHAVGEKCERCWNYTEELGSVGE
LEHLCPRCQEVVKTLV
>SEQF2892_00884 N-acetyl-alpha-D-glucosaminyl-diphospho-ditrans,octacis-undecaprenol 4-epimerase
MSKILLTGASGYIGGHLKDQLKIHHDIIATSRNTSNKENEENVTWKAADLFDLDEITEVM
EGVDTAIYLVHSMMPNAKLTQANFEDMDALLADNFARAAKKQGVRHIVFMSGLIPNEDKL
SAHLRSRLECEKILGSYGIPVSTLRAGLIIGAKGSSYPILKRLVERLPGMVLPSWAYNMI
APVPINDVINKLALLVERTPQHNESFDITGPEIMNYKELIQRTAVVLNKRLPIVDLPIIP
IWVSRYWVQLISKVPKEMVYPLMNSLVHDMIPQPERTHPDISIGEMTYEESVQQALDEEN
EMNENQNKSKKSSSSNSKEQIKDVRAISRFRIPENYSMEDVSKTYAKFINNITLHLINGT
INENEFNISLPFTNQFILKMERDMQDSSKDMIVYKIVGGNLALSNNGGNARFEFRRILDS
NEAIIALQEYEPTLPWSVYKFTQANIHKSVMELFVNHMNNLADKDKEATTQSDQLFSTIA
MTTGAVIGAYVGSKIYHLIKA
>SEQF2892_00885 Catechol-2,3-dioxygenase
MFHSKHSHFVNGITINVRNLADLRPFYETILGFEVITETNHSVRYEIGQSNHFLTLNEVI
NGREPLLSEAGLFYVGILLPSITDLADLLVQMTDFEIPVNGGEQSVCMSLFFEDPEGNAY
KFYVDHDMDYWVYDNENVKLDIEAINVPRLLTNVSEQTWQGIPKGTKIGNLSLKTIRMSE
VESYYLRYFGLELSAYLDQFSLYMSSNQYHHHLAVNQWLSSTKRVMNNVTYGLALIDYYY
PETTHIDVKGPDGLHFRFNFIEVV
>SEQF2892_00886 Staphylococcal secretory antigen ssaA2
MKKFILIMVLGSALFTGGAIYDGIDNQDMTQPTIHFWEKNPMKLNLYAKGQCTYYVFDRI
RQDGNMISNRWGDAKYWANEASKEGYKVNDNPSVGSILQYPKGQHGHVAYVDKVNHDGSL
TVFDMNYRKPYEVTKRTVYEYQVDEFNYIHPKKNQSENA
>SEQF2892_00887 Lipoprotein signal peptidase
MKKKYYITISLIVAIAILIIDQVTKRIIATTMNIGDSYEVIPNFLNITSHRNNGAAWGIL
SGKMGFFYIITIVILIVLVLFYIKEAKYNLFMQVAISLLFAGALGNFIDRLVNGEVVDFV
DTNIFGYDFPIFNVADSSLTIGVLFIIIALLKDANSKE
>SEQF2892_00888 Ribosomal large subunit pseudouridine synthase D
MKTHEFKIENQELVGQRIDKLLPEFNNEWSRSQIQDLIKEDLVTVNEKVIKSNYKVKLND
LIIVTEKEVVEADIQPENLNLDIYYEDEDVAIVYKPKGMVVHPSPGHYSGTLVNGLMYQI
KDLSGINGEIRPGIVHRIDKDTSGLLMVAKNDIAHRGLVEQLMDKSVKRKYTALVHGNIP
HDYGTIDAPIGRNEKDRQSMDVVDNGKEAVTHFNVLEHFNDYTLIECQLETGRTHQIRVH
MKYIGFPLVGDPKYGPRKTLDIGGQALHAGVIGFEHPVTHEYIERQAELPKEFETLLEDI
RLRDA
>SEQF2892_00889 Bifunctional protein PyrR
MSERIIMDEAAIQRTVTRMAHEILEYNKGTENLVLLGIKTRGEFLAIRIQDKINQIEQKI
VPTGTIDITHFRDDIEIANKQITQDAIEIDADINDKVVIIIDDVLYTGRTVRASLDAILL
HSRPIKIGLAALVDRGHRELPIRADFVGKNIPTSKEESVLVYLNEKDSQNAVIIE
>SEQF2892_00890 Uracil permease
MFERTVKPVLDVQDKPKATQWALLSLQHLFAMFGSTVLVPFLTGLPISAALLASGIGTLL
YILITKAKIPAYLGSSFAFITPIITGLSTHSLGDMLVALFASGVMYAIIGILIKISGTGW
LMHLLPPVVVGPVIMVIGLSLAPTAVNMAMYENSGDMKGYNLSYLVVALITLLVTIIVQG
FFKGFLSLIPVLIGIIVGYIVSIFMGLVNFSNIAKANWIDFPHIYLPFKDYVPSIHLGLI
LVMLPIVFVTVSEHIGHQMVINKIVGRNFFEDPGLHRSIIGDGVSTMFASIIGGPPSTTY
GENIGVLAITKIYSIYVIGGAAVIAIVLSFIGKFSALISSIPTPVMGGVSILLFGIIAAS
GLRMLVESNIDFASNRNLVIASVILVVGIGNLLINLKGLGVNLQIEGMALAALSGIILNL
ILPKEKQDSKN
>SEQF2892_00891 Aspartate carbamoyltransferase
MNNLLSMEHLSNEDIYELIQTACDYKSGKQTLPQFEGKFVSNLFFENSTRTKCSFEVAEQ
KLGLKEVNFETSTSSVQKGESLYDTCKTLESIGVDLLVIRHSQNAYYEELENLNIPIANA
GDGSGQHPTQSLLDIMTIYEEYGSFEGLNILICGDIKNSRVARSNFISLTSLGANVMFSS
PDEWVDDSLDAPYVQIDDVIDQVDIVMLLRVQHERHGITGEANFEANDYHEQYGLTMDRY
NKLKDKAIVMHPAPVNRGVEIDSELVEAPKARIFKQMTNGMYLRMSVINKLLSGKEA
>SEQF2892_00892 Dihydroorotase
MKLIKNAQILDNGELKQASILIDGQHIKEINNNIEVDENVEVIDAQGHFVAPGLIDVHVH
LREPGGEHKETIKTGTKAAARGGFTTVCPMPNTRPVPDSVEHMDRLQQLIQDNAQVRVLP
YASITVRQAGKEHVDFDALAKQGAFAFTDDGVGVQESAMMYEAMQQAAKVNKAVVAHCED
NSLIYGGAMHQGKRSEELGIPGIPNICEAVQIARDVLLAEAANCHYHVCHVSTKESVRAI
RDAKAAGIHVTAEVTPHHLLLTEDDVPGDNAIFKMNPPLRSKEDRDALLEGLLDGTIDCI
ATDHAPHAKEEKAQPMTKAPFGIVGSETAFPLLYTHFVKNGDWSLQQLVDYLTIKPAQTF
DLPYGKLEEGCFADLTIINLDEEREIKGEDFLSKADNTPFIGYKVYGNPILTMVEGEVKF
KEDK
>SEQF2892_00893 Carbamoyl-phosphate synthase small chain
MLERRYLVLEDGTYYEGYKLGSNDLSVGEIVFNTAMTGYQETISDPSYTGQIITFTYPLI
GNYGINRDDFEALTPTLNGVVVKEASTHPSNFRNQKTLHDVLVQYKIPGISGVDTRSITR
KIRQHGVLKAGFTDNRDDIDSLINTLKSTELPRDEVETVSTKTPYVSTGSDLSVVLLDFG
KKQNIVRELNMRGCNVTVVPYNTTAEEILAMSPDGVMLSNGPGDPDVVEVAIEMIKGILG
KIPFFGICLGHQLFALSQGGTSFKMKFGHRGANHPVKDLRSGKVDITSQNHGYAIDKNSL
VNTDLEVTHIALNDGTVEGLRHKTLPAFSVQYHPEARPGPSDSNYLFDEFMTMMKEFKEK
EQTANA
>SEQF2892_00894 Carbamoyl-phosphate synthase large chain
MPKRDDIQTILVIGSGPIIIGQAAEFDYAGTQACLALKEEGYRVILVNSNPATIMTDKEI
ADKVYIEPLTHDFIARIIRKEQPDALLPTLGGQTGLNMAIQLHDSGVLEANNVKLLGTEL
KSIQQAEDRELFRSLMNDLNVPVPESDIVNTVEQAFAFKDEVGYPLIVRPAFTMGGTGGG
ICYNDEELKEVVSNGLHYSPATQCLIEKSIAGYKEIEYEVMRDKNDNAIVVCNMENIDPV
GIHTGDSIVVAPSQTLSDVEYQMLRDVSLKVIRALGIEGGCNVQLALDPHSFNYYIIEVN
PRVSRSSALASKATGYPIAKLAAKIAVGLTLDEMLNPVTGTSYAAFEPTLDYVISKIPRF
PFDKFEKGERELGTQMKATGEVMAIGRTYEESLLKAIRSLEYGVHHLGLPNGESFDLDYI
KERISHQDDERLFFIGEAIRRGTTLEEIHNMTQIDYFFLNKFQNIINIEHELKNHPGDLD
YLKYAKDYGFSDRVIAHRFGMTESEVYQLRQDNNIKPVYKMVDTCAAEFESTTPYYYGTY
ETENESIVTDKEKILVLGSGPIRIGQGVEFDYATVHAVWAIQNAGYEAIIVNNNPETVST
DFSISDKLYFEPLTEEDVMNIINLEQPKGVVVQFGGQTAINLADKLAKHGVKILGTTLEN
LNRAEDRKEFEALLHTIDVPQPKGKTATSPKEALENAREIGYPVVVRPSYVLGGRAMEIV
NSDAELENYMEQAVKASPEHPVLVDRYLTGKEIEVDAISDGETVIIPGIMEHIERAGVHS
GDSIAVYPPQTLSQEDIDTLEDYTIKLAKGLNIVGLINIQFVIAHDGVYVLEVNPRASRT
VPFLSKITDIQMAQLAMQAIMGTRLKDLGYKQGVQPYSEGVFVKAPVFSFNKLKNVDVTL
GPEMKSTGEVMGKDLTLEKALYKGLTGSGVEVKDHGTVLMTVSDKDKDEIVKIAHRLNEV
GYKILATQGTAEKLKEDNIPVEVVGKIGGDDDLLTRIQNGEVQIVINTMTKGKEVERDGF
QIRRTTVENGVPCLTSLDTANALTNVIESMTFSMRTM
>SEQF2892_00895 Orotidine 5'-phosphate decarboxylase
MKDLPIIALDFESATKVNTFLDQFDEPLFVKIGMELFYQAGPDLIKSIKSRGHDIFLDLK
LHDIPNTVEKAMEGLGKLDVDLVNVHAAGGTDMMKAAVRGLHKYSNDTKIIAVTQLTSTT
EEMLRNEQNIQTTIEEAVLNYATLTQQAGLDGVVCSPLEAELLTNKLGSNFLKVTPGIRP
QGAAVDDQKRITTPEDAKQLGATHIVVGRPITQSENPVESYHTIKESWLG
>SEQF2892_00896 Orotate phosphoribosyltransferase
MAKEIAKSLLDIEAVTLSPNDLYTWSSGIKSPIYCDNRVTLGYPEVRRAIRDGLSQMIIE
QFGNVDIVSGTATAGIPHAAYISEKLNLPMNYVRSKSKSHGKQNQIEGAVSKGKKVVVVE
DLISTGGSSITAVEALKDAGADVLGVVAIFTYGLKKADDMFNEIDVPFYTLSNYNELIEV
AREEGKISENDIQTLVEWRDNL
>SEQF2892_00897 hypothetical protein
MTDSEANRFYDNMKHVNEFLYREEDFKSPDNIMSIDNSIREMSGTQSKVSMDSFVHTSDF
FKKAKDTLRQKGKIV
>SEQF2892_00898 hypothetical protein
MEIPKITTFLMFNNQAEEAINLYTSLFENSEILTMVKYGEEGPGVPGTVQHSIFTLNGQV
FMAIDADNGEDLPMNPSISLYITVDNAMEMERLFNGLKKEGAILMPKTAMPPFREFAWVQ
DKFGVSFQLALPEK
>SEQF2892_00899 hypothetical protein
MAYDGLFTKKMVESIQFLVSGRIHKINQPENDTILMVIRQNRKNHQLLLSIHPSFSRMHI
TTKKYDNPFEPPMFARVFRKHLEGGIIKAIRQIGNDRRIEIDIESKDEIGDTIYRTVILE
IMGKHSNLLLVDDNYKIIEGFKHLTPNTNQYRTVMPGFKYEAPPTQNKLNPFNITGEEAL
KYVDFNSGKIAKQLLNTFEGFSPLITNEIVNRYQFMTTETLPKAYDEVINQTLKTPVPIF
HKNHETGKEDFYFMKLKQFHDDMVEYASLHELLDRYYDARGERERVKQRANDLVRFVQQQ
SQKYQHKLSKLIDEYESAKDKDKQQLYGELITANIYRINQGDDAVTVLNYYTNEEITIPL
NPTKSPSVNAQYYYKQYNRMKTRERELDHQIHLTRENIDYFANIEQQLEHITVDEIDDIR
DELAEQGFMKQRKNIKKKKNDKIQLQTYISTDGDTILVGKNNKQNDYLTNRKAQKSHIWF
HTKDIPGSHVVILNDAPSEETIKEAAMLAGYFSKAGNSGQIPVDYTEIRNVHKPSGAKPG
FVTYDNQKTLFATPDYDKIQSMKVK
>SEQF2892_00900 Guanylate kinase
MDNEKGLLIVLSGPSGVGKGTVRKEIFDDPTTSYKYSISMTTRNMREGEVDGVDYFFKTK
EEFEALIQEDQFIEYAEYVGNYYGTPVQYVKDTMAAGHDVFLEIEVEGAKQVRKKFPDAL
FIFLAPPSLDHLKERLVGRGTESDEKIQSRVNEARKEVEMMNLYDYVVVNDEVHLAKERI
QSIVEAEHLKRERVEAIYRKMLLEAKK
>SEQF2892_00901 DNA-directed RNA polymerase subunit omega
MLNPPLNQLQSKINSKYLIATTAAKRARELDERPETALLSGYHSAKPVGEALEEIASGKI
TPVVSDEFTM
>SEQF2892_00902 Coenzyme A biosynthesis bifunctional protein CoaBC
MKHILLAVTGGIAAYKAIDLTSKLTQAGYDVRVMLSEHAQEFVTPLAFQAISRNPVYTNT
FKEENPQEIQHIALGDWADAIVVAPATANVIAKLSVGIADDILTSTLIATETPKFIAPAM
NVHMYENNRTQHNINVLMEDGYHFIEPGDGYLACGYVAKGRMEEPLQIVKVLNDFFNSQK
IKEESSFKGKHALVTAGPTVEVIDPVRFVSNRSSGKMGYALAEALRNRGAHVTLVTGPTQ
LADPIGVDVIHIESAEEMFEAVTTRFDKQDIVIKAAAVSDYTPMEVLDHKMKKQDGDLAV
TFKRTKDILKYLGEHKRQQYLVGFAAETQNIEAYAQDKLKRKNADVIISNNVGDKTIGFK
SDDNELTMHFKNKEMINIKRGKKVQLAEQILDELETRWQ
>SEQF2892_00903 Primosomal protein N'
MIAKVIVDIPSKSVDFKFDYLIPKNLEAFIQVGVRVVVPFGPRTIQGYVMNIETEPSDDI
NLEKLKEIKEVQDIKPELTSELIQLSEWISHYHVSKSISVLEVMLPSAIKAKYTKVFEVV
KHNDMDEQLLKFFDSDGQYKYKDAQKNDHLPILNKLLKAGTVKEVTLLSQNIKKKTQKAV
RIIDGYHPDEVLAKLEKKFKQYDVYAYLLDERHKTVFLKDMEEMGFSKSSIDGLVKKGFI
EKYNAEVERDPFANRVFEQEEKRELTSEQRIAYENIKEKINNSEQRTFLLHGVTGSGKTE
VYLQTIEEVLNKGKEAMMLVPEIALTPQMVLRFKRRFGDDVAVLHSGLSNGERYDEWQKI
RDGRARVSVGARSSIFAPFKNLGIIIIDEEHESTYKQEDYPRYHARDIAEWRSQFHQCPL
VLGSATPSLESYARTEKGVYQLLTLPTRVNQQALPSIDIVDMREELSAGNRSMFSNELRE
AIEDRLRKNEQIVLFLNRRGYASFMLCRDCGYVPQCPHCDISLTYHKSTDQLKCHYCGYH
EVPPNKCPNCESSHIRQVGTGTQRVEEILQQEFEEARIIRMDVDTTSRKGAHEKLLNEFE
EGKGDILLGTQMIAKGLDYPNITLVGVLNADTMLNLPDFRASERTYQLLTQVAGRAGRHD
KPGRVIIQTYNPEHYAIQDVQKNDYLTFYQKEMEYRKIGKYPPYYFLINFTISHKNMKKV
MEASKHIHQILLQHLTDRALVLGPSPAAIARINNEHRFQILVKYKSEPELLKALQYLDDY
YHEAYLKNKLALKIDINPQILM
>SEQF2892_00904 hypothetical protein
MEVNKIIYIVLAFFLGGFGVHKFYAGKTMSGFLHLAFFWTGIPHIIAIISGVLTLLRPAD
ENGNVVM
>SEQF2892_00905 Peptide deformylase 1
MAIQKLVQSTHPVLTKQAQPIKAYDATLKDLLLDLEDTLYAEEASALCAPQIGISKQVAI
IDMEVEGLLQLINPKIKSESNDKIIDLEGSVNLPGIYGEVERSKMITIEANDLEGNTIEL
TAYDDVARMILHIVDQMNGIPFTKRAQHLLTDEEVEAYFEND
>SEQF2892_00906 Methionyl-tRNA formyltransferase
MTKVIFMGTPDFSTKVLEMLIEEHDVIAVVTQPDRPVGRKRVLTPPPVKRVAEEHNLPVF
QPEKLAQSDELAQLLQLEPDLIVTAAFGQLLPDQLLQLPKLGAINVHASLLPKYRGGAPI
HQAIIDGEAQTGITIMYMVKKLDAGNIISQKAINIEDNDDVGTMHDKLSVLGANLLKETL
PSIVNGTNDSISQDDTQATFASNISREDERIDWTMNAKDIHNHIRGLSPWPVGYTTMDDT
NLKLYAAHIVHNKKGQPGEIVETTKKAIIVATGSDDAIALTDIQLAGKKRMLASNYLSGV
QESLVGKILK
>SEQF2892_00907 Ribosomal RNA small subunit methyltransferase B
MTQSVRELAFQTIQEIFNDYAYSNLRINEVLSTGDVSDIDKPLYTELVYGTVKRKMTLDF
YLRPFVKTKIKSWVRQLLWMSLYQYIYLDKVPNHAIINEAVNIAKHRGGPHNGNVVNAIL
RTIFRSELPSLESIKNDKQRMAVEYSIPKWIIEHWITHYGVETTRKMASSFFDQTAGTVR
VNTSKNKVEDVVSSLQSEGYEVEVDELIPYCLHLKGHPIIESSNFKNGNISIQDKSSMFV
GYLMGVEENDVILDACSAPGGKACHIAELLAPSGHVDATDIHKHKIGLIKENIVKLQLNN
IKAFDHDATKPYKDVYDKILVDAPCSGLGVLRHKPEIKYVQTQQDIQDLVELQLEILDNV
KDNLKPGGTLVYSTCTIEQLENENVIYTFLKNNKDFEFELMTHPVTGEQVKTIQILPQDF
NSDGFFITKIKRKES
>SEQF2892_00908 putative dual-specificity RNA methyltransferase RlmN
MITTEKKKKNKFLPDFEKQSIYSLRYDEMQEWLVEHGQQKFRAKQIFEWLYQKRVDSIDD
MTNLSKDLRQVLKDNFAMTTLTTVVKQESKDGTIKFLFELQDGYTIETVLMRHDYGNSVC
VTTQVGCRIGCTFCASTLGGLKRNLEAGEIVSQVLTVQKALDATDERVSQIVIMGIGEPF
ENYDEMMDFLRIVNDDNSLNIGARHITVSTSGIIPRIYDFAEEDIQINFAVSLHAAKDEI
RSKLMPINRAYHVDKLMEAIKYYQEKTNRRVTFEYGLFGGVNDQLEHARDLAHLIKDLNC
HVNLIPVNHVPERNYVKTPKDDIFKFEKELKRLGINATIRREQGSDIDAACGQLRAKERQ
VETR
>SEQF2892_00909 Serine/threonine phosphatase stp
MLNAQFFTDTGQHRNKNEDAGGIFYNQTQQQLLVLCDGMGGHKAGEIASQFVTYELQKRF
EDENFIEYEQAETWLRFNLKEINRELFEYAQTNEEYKGMGTTCVCALVFDKQLVVANIGD
SRAYLINSREIEQITYDHSFVNHLVMTGQITEEEAFTHPQRNIITKVMGTDKRVSPDIFT
KRFNHYDFIMLNSDGLTDYVRGESIHESFNESLSLEEHGEQLIQLALNHDSKDNISVLIA
AIEGDRL
>SEQF2892_00910 Serine/threonine-protein kinase PrkC
MIGKIVSERYKIVDKLGGGGMSTVYLAEDTILNREVAIKAISIPQNEKEETMKRFEREVN
NATQLSHENIVEVYDVQEDEECFFLIMEYIDGPTLSEYIHSHGPLSVDTAIDFTNQILKG
VAQAHEKLIIHRDIKPQNILIDKNKTLKIFDFGIAKALSETSMTQTNHVLGTVQYLSPEQ
AKGETTNEATDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSIPNVTELRSEIPQSL
SNVVLRATEKKASDRYQSVKDMKEDLSSVLVSSRANEKKHSIEEDETNTVSIDRQDIKSK
IKEENEQKQIAQTMQIPIVNEHHFQTSEAQIYEPPKKKRSKKKKFAIALILLLLVASLFG
FIAMGMFGSKYAEVPDLKGKTEKEAEKILRQSHLEIGNISRDYSDDYPENKIIKTKPKQG
ERVNQHEKVDIVLSKGPERAKMPNVIGMKKVDALDKLKQSKLDHVTVNQEYNNQVPKGAI
AKQSVNPDSYVRINDHQITLTESLGVKKVYVKNYENKNYQTAKKELEKNGLKVQMTTESS
NNVKKDNIISQSPKNTEVEEGSTVQFIVSKGKTSSKDEDKDSEKSKSSSEDKSDDTQKVK
NYTETYHIPYTGDDESQKVQVYIRDKDNSGTSASQTFSIKDDKTITIPLKIEQGSDAGYT
IRVDGDVIADKDIEY
>SEQF2892_00911 Small ribosomal subunit biogenesis GTPase RsgA
METGRIIKLISGVYQVDVDGTLYDTKPRGLFRKKKFSPIVGDIVDFEIQNTSEGYIHHVH
ERHNELKRPPVSNIDGLIIVMSAVEPDFSTQLLDRFLVIAHSYDLEPSILVTKKDLASEN
EIEQINAWLKIYEEIGYNTQFVGKHTSQQEVVATWPKGLIVLSGQSGVGKSTFINAFKPE
LNLETNHISKSLNRGKHTTRHVELFERESGFIADTPGFSALDFGHIDKDELKHYFIEMNR
FGEECKFRNCNHIKEPKCHVKQQLENGYLAQFRYDHYIQLYNEISNRKVRY
>SEQF2892_00912 Ribulose-phosphate 3-epimerase
MKKIYPSLLSADFLNLENEIKALEEAQIDGLHFDVMDGQFVPNISIGIPILDSVRAATQL
PIDVHLMIEQPEQYINTFAEHGADMISVHVEATQHIHRALQMIKNAGKKAGVVINPGTPV
ESLLPVLEIVDYVLVMTVNPGFGGQSFIEACAAKVKILRDLRQSLNLNFNIEVDGGINNE
TIKICVDNGADMFVTGSYFFKQEDYGKVTQLLKG
>SEQF2892_00913 Thiamine pyrophosphokinase
MRINLLCSDRHLPSDVLATLKQDHWGGIDRGALILINHSINPVFSVGDFDSVSEEERLQL
KHELNIKPVKAEKDDTDLALGVEEAVNRGFTEIHIYGATGGRLDHFMGVLQILQKPKYIE
QNIIIIVEDLQNEIKLLKQGIHEIHKLQSYPYVSFIPVNEVVALSLNGFKYNLNNQPLEK
GSTLTLSNEVKEKVAQIEVHDGQVLQIRSRDAN
>SEQF2892_00914 50S ribosomal protein L28
MGKQCYVTGRKASTGNNRSHALNANKRRFNANLQKVRILVDGKPKKVWVSARALKSGKVT
RV
>SEQF2892_00915 hypothetical protein
MTIEISNDYGKIDISNEVIASVVGSKAVESYGIVGMASRQQVRDGIAEILGHENYARGIE
VKENNGVIDIDMYIIVSYGVKISEVANNVQSSVKYTLENSLNVKVNSINIFVQGVRLNNK
GK
>SEQF2892_00916 hypothetical protein
MISKINGKLFADMIIQGAQNLSNNADLVDSLNVYPVPDGDTGTNMNLTITSGREEVENNL
SQSIGELGKTFSKGLLMGARGNSGVILSQLFRGFCKNIETENEINAQQLASSFQAGVDTA
YKAVMKPVEGTILTVAKDAAKAAVNKAEETDDCVEVMEYTIAEAEKSLNNTPNLLAVLKE
VGVVDSGGKGLLCVYEGFLKGLTGQTIEAKKEKLNTEELVHEEHDFHGVINTEDIKYGYC
TEMMVRFGKDKRAFDEQTFRTDMSQFGDSLLVINDDEIVKVHVHTETPGEVFNYGQEYGE
LIKLKVENMREQHREVIRKEKLNHHSDEQEESKTVETAIIAISMGDGISELFTSMGATHI
ISGGQTMNPSTEDIVKVIEQSQCKRAIILPNNKNIRMSSDQAATLVEADTVVIPTTSIPK
GIAALFQYDPSSSLEDNHSHMTTALESVKSGSVTFAVRDTKIDGVEIKKGEFMGLSESKI
VTSNDDEFVTVTGLLKSMLNEDSEILTIIAGEDANDDISDKLVEWVESEYPDVEVEEHNG
GQPIYQYLFSVE
>SEQF2892_00917 Thermonuclease
MGNIYLVFICLITISLMLFLFKKKVAIASLSILIAFTSILVVMPQHIVNAQSNVLTKEKV
KFVKGIDGDTVQLLYKGKKLTFRLLLIDTPETKDPRKPVQKYGPEASRFTTNMLANARTI
QVQFDRGQRTDKYGRYLAYVYADGRMVNEAVVRQGLARVTYIYPPNNTFEQMLKVSQSKA
QAEKLNIWSTTTSNSKTKTGQTSTAKSTVKPTIPKTSPSKTTKKQSKEYYKNCTLMRKKY
PNGVKKGHPAYQSKLDRDKDGWACER
>SEQF2892_00918 ATP-dependent DNA helicase RecG
MTKVNLIESPYPLQSIKGLGPKRIALLQELNINTVEDLVLYLPTRYEDNTVVDLNMAEDQ
STVTIVGEVYSMPTVAFFGRNKSKLTVHLMVDNIAVKCIFFNQPYLKKKIELHGTVTVKG
KWNRAKQEINGNRMFFNEQSQDTSEIKLEPVYRIKEGIKQKQMRDMIYQTLDDVTIHEWL
TEELKQKYKLESLEDTLHALHRPKDRQDLLRARRTYAFTELFMFELRMQWLNRLEKSSDE
AIEINYDIQKVKDFIETLPFELTDAQKKSVNEIFRDLKAPIRMHRLLQGDVGSGKTVVAA
ICMYALKTAGYQSALMVPTEILAEQHANSLTELFGEYMNVALLTGSVKGKKRKVLLEQLE
NGTIDCLIGTHALIQDDVTFQNVGLVITDEQHRFGVNQRQLLREKGAMTNVLFMTATPIP
RTLAISVFGEMDVSSIKQLPKGRKPIITNWAKHEQYEQVLSQMTSELKKGRQAYVICPLI
ESSEHLEDVQNVVELYESLKLHYGEKKVGLLHGKMPAEEKDEVMTRFSQHEIDILVSTTV
VEVGVNVPNATFMMIYDADRFGLSTLHQLRGRVGRSEHQSYCVLIASPKTETGIERMTIM
TQTTDGFELSERDLEMRGPGDFFGVKQSGLPDFMVANIVEDYRMLEVARDEAAELIQSGE
FFTETYQHLREFIDQNLLHMSFD
>SEQF2892_00919 Transcription factor FapR
MKLKKAERRQAIQKAIELNPFITDSELCEQFEVSIQTIRLDRTNLSIPELRKRIKLVAEQ
NYEQIRALEANEVVGDLIQVEPNISAQSLIEITEESVFTKTQIARGHVLFAQANSLCVAL
IHKSTVLTQESNVAFIEKVKLNDTVRAEAHVVNKTSHHYVIEVNSYVRDTIVFKGTFKMF
YISEDE
>SEQF2892_00920 Phosphate acyltransferase
MVKIAIDMMGGDDAPGIVLEAVEKAVNDFKDLEIILFGDQNQYTLNHERIEFRHCSEKIE
MEDEPVRAIKRKKDSSMVRMAEAVKNGEADGCVSAGNTGALMSAGLFIVGRIKGVARPAL
VVTLPTIDGKGFVFLDVGANADAKPEHLLQYAQLGNIYAKKIRGIQNPKVSLLNIGTEPA
KGNTLTKKSYQLLKDDQSFNFDGNIEAKTLMEGNTDVVVTDGYTGNMVLKNIEGTAKSIG
KMLKETFLGSLKNKLAALVLKKDLDTFTKKMDYAEYGGSVLLGLDGTVVKAHGGSNARAF
YSAIRQAKIAGDEKIVDIMRETVGGKDE
>SEQF2892_00921 Malonyl CoA-acyl carrier protein transacylase
MSKVAIIFPGQGAQKVGMASDLFNEDKKATNILNSAQEAMDFDLLETMFTDNENKLGETE
HTQPALLTHSIALYSALDNINADYTMGHSLGEYSSLVAAGVLKFEDAVKIVRKRGQLMAQ
AFPNGVGSMAAVLGLSYEEVDRICKELSTNDELVEPANINCPGQIVVSGHKSLIDKFVEE
GKSLGAKRVLPLAVSGPFHSSMMQVIEKDFESFINQFEWHDASFPIVQNVNAQGETDATT
IKSNMIKQLYSPVEFIDSAEWLIAQGVDHFIEIGTGKVLSGLIKKINRDVKLTSIQTLED
VKGWNNHDE
>SEQF2892_00922 3-oxoacyl-[acyl-carrier-protein] reductase FabG
MTNKNALVTGASRGIGRSIALQLAEDGFNVAVNYAGNKEKAEAVVSEIKAKGVESFAIQA
NVAEGDEVKAMIKEVVSQFGSLDVLVNNAGITRDNLLMRMKEHEWDDVINTNLKGTFNCI
QKATPQMLRQRGGAIINLSSIVGAMGNPGQANYVATKAGIEGLTKSSARELASRGITVNA
VAPGFIVSDMTDALSDDLKSQMLEQIPLSRFGEDTDIANTVAFLASDRAKYITGQTIHVN
GGMYM
>SEQF2892_00923 Acyl carrier protein
MENFDKVKDIIVDRLGVDADKVTEDASFKDDLGADSLDIAELVMELEDEFGTEIPDEEAE
KINTVGDAVKYINSLEK
>SEQF2892_00924 Ribonuclease 3
MTNPKKIEMVNDFQQQFAKKMNELGFTYSNIDLYQQAFSHSSFINDFNMDRLAHNERLEF
LGDAVLELTVSRYLFDKHPDLPEGNLTKMRATIVCEPSLVIFANKIELNQLILLGKGEEK
TGGRTRPSLVSDAFEAFVGALYLDQGLDVVWQFAEKVIFPYVEDDELVGVVDFKTQFQEY
VHSQNRGDVTYRLIKEEGPAHHRLFTSEVILENEAVATGQGKTKKESEQKAAESAYSKLK
SNNNL
>SEQF2892_00925 Chromosome partition protein Smc
MVYLKSIDAIGFKSFADHTDVQFDKGVTAIVGPNGSGKSNITDAIKWVLGEQSAKSLRGS
KMEDIIFSGAEHRNAQNYAEVQLKLDNKARKLQVDSDDIVVTRRLYRSGESEYYLNNDKA
RLRDITELFLDSGLGKEAFSIISQGRVDEILNAKPIDRRQILEESAGVLKYKKRKAESLQ
KLDHTEDNLTRVEDILYDLEGRVEPLKAEASIAKEYLKLSEEMKQSDVIVTVNDIDQYSE
DNRQLDQKLNDLKSQQADKEAKQAQINKYIQKQKSQRQQIDNDIEQLNYNLIKATEEYEK
FTGRLNVLEERKRNQSETNARFEEELDNLHQELKNAHNEKADITQQITALKEKQKELNSS
IHQLESQLYVSDEQHDEKLESIKNEYYELMSEQSDVNNDIRFLEHTIKENEAKKSRLDSR
LVEAFNQLKALQSEISNTERNHQATVKQLSDIETQISQLEQQLSKAKQTQTEYEDKLYQA
YRYTDKMRARIESLETQEEDYTYFFNGVKHVLKAKNDNLQGIHGAVAEVINVPSELTQAI
ETALGASLQHIIVDSEKDGRQAIQFLKQKGLGRATFLPLNVIKSRQLSNNIRHIAENTNG
FINVASDAIKVNSQYQAVVENLIGTTIIVDNLKHANELARAIQYKTRIVTLEGDIVNPGG
SMTGGGARKTKSILSQKDELTTMRNQLKDYESQTQDFEKQLQKHKNEVEHLSETYFKMSQ
QYNEVKEQSHNEALELDRLKTQEAHIKDEHEEFEFEKNDGYQSENSRITLTEKQERLTII
QGKLKQLETDIERYTQLSKEGKENTTQVQQQLNQKRSDLAVIKERINAQKASLERTDKQI
ETINKQLTNVDDKIKLFNSDEMMGEQAFEKLQQQIKSKENDRQSITDQLKQLKKERIDVN
EDVESHEATLQECHQDLLSIESFYQDIKAQQSKLDVLINHAIDHLNDEYQLTVERARSEF
SSETPIDALRKKVKLTKMSIEELGSVNINAIEQFEELNERYTFLDEQRTDLREAKQTLEQ
IISEMDQEVKGRFKETFLQVQAHFTTVFQSLFGGGHAKLELTDDDYLSAGVDIIVQPPGK
KLQHLSLLSGGERALSAIALLFAILKVRSAPFVILDEVEAALDEANVIRYAQFLKELSIQ
TQFIVITHRKGTMEYSDRLYGVTMQESGVSKLVSVNLNTIDEVMKEEQA
>SEQF2892_00926 Signal recognition particle receptor FtsY
MSFFKRLKDKFSTKSTEDIEQELSEEEGNQSSTIHDDNDEAQIEPKKKPRKLSEADFDDD
GLISIEDFEEIEAQKMGAKFKAGLEKSRQNFQEQLNNLIARYRTVDEDFFEALEEMLITA
DVGFNTVMQLTEELRTEAQRRNIQETEDLREVIVEKIVEIYHQEDDQSEAMNLEDGRLNV
ILMVGVNGVGKTTTIGKLAHRYKMEGKKVMLVAGDTFRAGAIDQLQVWGDRVGVEVIRQS
EGSDPAAVVYDAINAAKNKGVDILICDTAGRLQNKSNLMQELDKMKRVISRAVPDAPHEA
LLCLDATTGQNALSQARSFKEVTNVSGIVLTKLDGTAKGGIVLAIRNELHIPVKYVGLGE
KLDDLQPFNPESYVYGLFADMIEQNEDIPDEVAELDFNNEDNPNGEK
>SEQF2892_00927 hypothetical protein
MGKNDLVKTLRMNYLFDFYQTLLTEKQRNYLELFYLRDYSLSEIAETFDVSRQAVYDNIR
RTGDLVEDYEAKLNLYEKFEQRRKIYDDMKQTLNDSKKLEQYINQLEELE
>SEQF2892_00928 Signal recognition particle protein
MAFEGLSDRLQATMQRMRGKGKVTEADIKAMMREVRLALLEADVNFKVVKEFVKTVSDRA
LGSDVMQSLTPGQQVIKIVQDELTQLMGGENSTIKMANKPPTVVMMVGLQGAGKTTTAGK
LALLMRKKYNKKPMLVAADIYRPAAINQLQTVGKQLDVPVYSEGDQVKPQQIVENALKHA
KEEHLDFVIIDTAGRLHIDEALMNELQEVKEISKPNEIMLVVDAMTGQDAVNVAQSFDDQ
LDVTGVTLTKLDGDTRGGAALSIRSVTQKPIKFVGMSEKMDGLELFHPERMASRILGMGD
VLSLIEKAQQDVDQEKAKDLEQKMRNSTFTLDDFLEQLDQVKNLGPIDDIMKMIPGMNKM
KGMDKLNMDEKQIDHIKAIIQSMTTSERENPAVLNVSRKKRIAKGSGRSLQEVNRLMKQF
NDMKKMMKQFSGAGRKGKKGKRSQMENMLKGMNLPF
>SEQF2892_00929 30S ribosomal protein S16
MAVKIRLTRLGSKRNPFYRIVVADARSPRDGRIIEQIGTYNPASVNAPEVKIDEELALKW
LKDGAKPTDTVHNILSKQGILKTFDEQKHAK
>SEQF2892_00930 Ribosome maturation factor RimM
MQVEVGQIVNTHGIKGEVKVKSNSDFTDTRFQPGEVLTVNHQNHEEQLTVLSYRVHKGFH
MLKFEGINNINDVEQYKGDYLYQERDHEDIELAENEYYYSDIIGSTVFDDDNQPIGRVIN
IFETGANDVWVVKGEKEYLIPYIADVVKDIDIENKTIHITPMEGLLD
>SEQF2892_00931 tRNA (guanine-N(1)-)-methyltransferase
MKIDYLTLFPEMFDGVLNHSILKRAQDKEIISVNTVNFRDYAINKHNQVDDYPFGGGQGM
VLKPEPVFNAMKDLQRTDQTRVILMCPQGRPFSQEIAQELSEAEHIVFICGHYEGYDERI
RTHLVTDEISMGDYVLTGGELPAMTMTDAIVRLIPGVLGNQQSHQDDSFSDGLLEFPQYT
RPREFEGMTVPDVLLSGNHANIEQWRHEQKLIRTYHKRPDLLDRYPLTEDDEKFLESYKK
QLKNN
>SEQF2892_00933 50S ribosomal protein L19
MSNHKLIEAVTKSQLRTDLPAFRTGDTLRVHVRIVEGSRERIQVFEGVVIKRRGGGISET
FTVRKISSGVGVERTFPLHTPKIEKIELKRRGKVRRAKLYYLRSLRGKAARIQEIR
>SEQF2892_00934 hypothetical protein
MIKKIWSKPLWTFGFIFIIANIVTLTIYYPFIRDYIKDGVVFSGSGDGFRQMMPFQLYLY
EHFTQLKGFYDHSFGLGGDYVKGLAYYYSLSPIMWVNFIIVWIGEHIFHWQPQNIRFWPT
NQLIVAYVRTIITFICAFYYFRYLKLSSTPLLIATILYGASTVVLYYNFTWSFYGDLLII
LPLSLWGMERFFQRRKIGLFIFAVAITLFSNFYFTYYQAIVLGIYFILRVVFQYRHDIVS
RWQKCYLLIIGAMFALLSSILGFYTGVSSFLNNDRQQNSDFNISLFTDLTKNNYYIFSNG
FYVTISLIALVALLTPKLYKHYYYKIFAIITWFLLIGSLSQYFDSAFNGFSLPQRRWVYF
LVLSTSGLIALYIHHLSELTMKQFLFAAVSVFIAGLCRYIIADNFVDWMVIALIIIVVLG
IFIYRKSLLKQPIIMLSLIVLFFGQQIIMTHDSRQRTIDPYSTTINTLSDPSYYNDTIAK
KINSIKEHHDDPFHRIDYMSAYALNSPFLYHYNGISLYSSIFDGGILKYYDKLMQINMPV
DKNSTYRFLGNRANLTALWNVQDRLRHPEDQNMTYGFEKKDTILNGKHTLIHSKNMIDYP
SAHVTNHIYNSDDLKSPLDREQAMLKGIVLNDNSEKANTSFKPNKNLLTESKMSTKDATW
KNQNHLKVHKDNGGVTLKLPESVANQYKDMYVEMDVELLSPDKAHSVSVNEYSQNRNELS
YKYRRLVTPVTMRVKASDKLNIHLSKGNYRLSVKGIYGEDYSTLKKASKELTPVKVKDMR
NGYVVKKPKNATGYVILPTVYAKGMHAQVDGKEVPVHQANGIMTAIPVNKGDKVIKLTYT
PPHFYLLAIMSFIGVIGSILFSLWVKKKH
>SEQF2892_00935 hypothetical protein
MKKILIYICIFLTLSFLGHSYIIYRFIHDGVLFTGPNDGIEQMIPIQMFLFDKWSVGNLF
YATDFGLGGDFFTDLSYYFSTNILFIINVLCIILLKTFIHINTQGLLFWMVNALVISTIK
AALAMYCTYLYSKFISRNTWISIIMAFLFVMSPLYYRFTVYWPFFSDVFIWMPLLLFSIE
RTLQKQKFGLFIVTITLIMINNFYFAYYLCLIGAGYILLRIIFKHSKDIIPRGKALLLFA
ISAILGLGNSLFMFFHGVQSFLNNRRVPFSGTVNTFEKLDINTNIFFDNYLIVLLFLTIQ
ALLCIKLYKHFYYRLFAILTLAFILLSFVPFIDQLFNGFSAPQKRWHFILSFNSAILIGL
FLKYFRTLKIKSYLISNIIAEIIIFASAITYHKFVAWLVLVPIVSLIGLLILILKDRRYR
INLSYIFGISIILLNLMVSFVFIKNQIYFKDHQERANTFYINSSLYSSDLQRSLVNTMKN
SKREDERIDWRVNEQDNTPMYQHFKGLSLYSSIFHHNILDYYYDALKINLAEESLSRYQS
INGRQNIASLFSVRYMMLKDYQGNLPPYFKKVKTSGQYSIYENTLTLPSVKVTKNVYNSK
SLKTAIDREHAMLNGVIMDNAGKSFKQPASNLLSKVDMQQQNIKRIGKNRYKVIGGKGGT
IKLHLPKQIRDKYDDFYLTMKIKRGNPDSNYTVAINNYANHRLFNNSTYRTGVDTQLYRT
QPDKNGDITITLSPDGEFYVDLQQLNGENYDTLKKVHDNANFDTSYHDIKNGIQVQLSHH
ESGVASINIPYRKGMQVYVDGQPAKIQKVNYMTTGVPVDKNAKQIVIKYQPPYWNTMIFI
SLMSMILSAIFVKIFNSKKRKMRK
>SEQF2892_00936 Ribosome biogenesis GTPase A
MAIQWYPGHMAKAKREVTEQLKKVDVVFELVDARIPYSSRNPMIDEVIKQKPRVVILNKK
DMSNLNEMQKWESFFIDKGYYPVSVDAKHGKNLKGVETAAIAATKEKFEREKAKGLKPRA
IRAMIVGIPNVGKSTLINKLARKNIAQTGNKPGVTKQQQWIKVGQSLQLLDTPGILWPKF
EDEIVGKKLSLTGAIKDSIVHLDEVAIYGLQFLINHDLEGFKQHYKIDVSADAEILEWFD
AIGRRRGLLQRGNEVDYEAVIELIINDVRNAKIGTYSFDLYSEMKSELDNDTNN
>SEQF2892_00937 Ribonuclease HII
MTQTINEAKHILSEINSIEVLEQHELNQDVRKGIQQVITRRRKQLLKEQEILDHYNTMNK
FESELLNNNPQALICGIDEVGRGPLAGPVVACAVILNEGHRYLGLDDSKKVTASKRQILN
KKLKDGVLEYAYGLASPEEIDELNIYNATQVAMNRALSQLVNRPDHLLIDAMSLDTTIPQ
TSIIKGDAKSVSIAAASIMAKEYRDDLMKEIADEYPGYEFEKNVGYGTKAHLDGLNKLGI
TPYHRKSFEPIKSMT
>SEQF2892_00938 Succinate--CoA ligase [ADP-forming] subunit beta
MNIHEYQGKEIFRSMGVAVPEGRVAFTAEEAVEKAKELDTEIYVVKAQIHAGGRGKAGGV
KIAKSLSEVETYANELLGKQLVTHQTGPEGKEVKRLYIEQGCDIQKEYYVGFVIDRATDR
ITLMASEEGGTEIEEVAAKTPEKIFKETIDPVVGLSPYQARRIAFNINIPKESINKAAKF
LISLYNVFIEKDCSIVEINPLVTTGEGEVLALDAKINFDDNALFRHKDIQELRDLEEEDP
KEIEASKYDLSYIALDGDIGCMVNGAGLAMATMDTINHFGGNPANFLDVGGGATKEKVTE
AFKIILGDDNVKGIFVNIFGGIMKCDVIAEGIVAAVKEVELTLPLVVRLEGTNVERGKEI
LNESGLAIEPAATMAEGAQKIVKLVKEA
>SEQF2892_00939 Succinate--CoA ligase [ADP-forming] subunit alpha
MSVFIDKNTKVMVQGITGSTALFHTKQMLDYGTQIVAGVTPGKGGQVVEGVPVYNTVAEA
KEETGANVSVVYVPAPFAADSILEAADADLDMVICITEHIPVVDMVKVKRYLEGRKTRLV
GPNCPGVITADECKIGIMPGYIHKKGHVGVVSRSGTLTYEAVHQLTEEGIGQTTAVGIGG
DPVNGTNFIDVLKAFNEDEDTKAVVMIGEIGGTAEEEAAEWIKANMTKPVIGFIGGQTAP
PGKRMGHAGAIISGGKGTADEKIKTLNECGVKTADTPSEIGTTLIEAAKEAGIYEELLTI
K
>SEQF2892_00940 Aminoacyltransferase FemA
MKFTKLNINEYRSFVEQQFSHYTQSMDLYDYRINRAGGVHIVGVKENGNVVAACLLTDAR
IFKVFKYFYTHRGPVMDFTNLALVEFFFKKLTHYVSMRRGVFILVDPYVLENIRSADGEI
IEHFNNKQWFKVMNKLGYQHQGFTTGYSAMSQIRWHSILDLKDKSEQQLLKDMSYQTRRN
IMKTIEMGVQIKTLSIKETNRFYRLYHMAEEKHGFHFQEEPYFKQMLEIYGDKACMKLAY
IDLNKYINLLKQRAIELEEKVTEIKQSLKVNANSKKTKTKYHQLNQQLESLNKKIAKTEQ
LIITDGTLLDLAAALFIYNNHEMYYLSSGSNPKYNEFMGAYCLQWDMIRYAKEKGIERYN
FYGITGDFGEDAEDYGVQQFKKGFNAFVEEYVGNFIKPVNKLLYKLYQK
>SEQF2892_00941 DNA processing protein DprA
MTNNNILLLKLIWLGYTTQHIHHLLKLNPEFFKFSYTDQIDSIKNWDKLFHKGDFIDRYN
HLNDKEILSFLNQHKISFVTPFNANYPRLLKEIYDYPFVLFYQGDPQLLTSPNTLGVVGS
RNATEYSAKAMQYLFPKFKQIPLTIISGLAKGADSIAHHFAIEYQLPTIAVLGFGHMMHY
PRETQKLRNIIEVKGLVISEYPPFTSVRRYHFPQRNRLISGLSQGVLITEASVRSGSQIT
IDCALDQNRNIYVLPGSIFNPLTKGNLKRAQEGAMIVTSADDILCDYK
>SEQF2892_00942 DNA topoisomerase 1
MADNLVIVESPAKAKTIEKYLGKKYKVIASMGHVRDLPRSQMGVDVEDNYEPKYITIRGK
GPVVKDLKKYAKKAKNVFLASDPDREGEAIAWHLSKILELDDSKENRVVFNEITKDAVKE
SFKHPRGIEMDLVDAQQARRILDRLVGYNISPVLWKKVKKGLSAGRVQSVALRLVIDREN
EIRNFKPEEYWSIEGEFRYKKSKFTAKFLHYKNKPFKLKTKKDVEKVTAELDGDKFEITN
VNKKEKTRNPANPFTTSTLQQEAARKLNFKARKTMMLAQQLYEGIDLKRQGTVGLITYMR
TDSTRISQTAKDEAKQYIEDKYGKDYLSNRTAKGKQGDQDAHEAIRPTSTLRTPYEMKAY
LTRDQHRLYKLIWERFVASQMAPAILDTVALDVTQNNIKFRANGQTIKFKGFMTLYVEAK
DDKDNEKENKLPNLSKGDEVTATQIEPAQHFTQPPPRYTEARLVKTLEELKIGRPSTYAP
TIDTIQKRNYVKLESKRFVPTELGEIVYEQVKDYFPEIIDVEFTVNMETLLDKIAEGDIG
WRKVIDNFYGSFKLDVERAEEEMEKVEIKDEPAGEDCEVCGSPMVIKMGRYGKFMACSNF
PDCRNTKAIVKTIGVTCPKCKDGDVVERKSKKNRLFYGCSNYPECDFISWDKPVGRDCPK
CNHYLMEHKKGRSSQVICSNCDYKEEVQK
>SEQF2892_00943 Methylenetetrahydrofolate--tRNA-(uracil-5-)-methyltransferase TrmFO
MSQTVNIVGAGLAGSEAAYQLAQRGIKVNLIEMRPVKQTPAHHTDKFAELVCSNSLRGNA
LTNGVGVLKEEMRRLDSLIISAADKARVPAGGALAVDRHDFSGYITETLRNHPNVTVINE
EINSIPEGYTIIATGPLTTENLAKEIVDITGKDQLYFYDAAAPIIEKESIDMDKVYLKSR
YDKGEAAYLNCPMTEEEFNRFYDAVLEAEVAPTNEFEKEKYFEGCMPFEVMAERGRKTLL
FGPMKPVGLEDPKTGKRPFAVVQLRQDDAAGTLYNIVGFQTHLKWGAQKEVIRLIPGLEN
VDIVRYGVMHRNTFINSPDVLNEKYELIKEDRIQFAGQMTGVEGYVESAASGLVAGINLA
HKLLDKGEVIFPRETMIGSMAYYISHAKNEKNFQPMNANFGLLPSLEKRIKDKKERYEAQ
ANRALEYLENYKKTL
>SEQF2892_00944 Tyrosine recombinase XerC
MEEIQVTFLNMLKVERNFSAHTLKSYHDDLVQFNHFLEQELLNLRTFEYKDARNYLSYLY
SQNLKRTTVSRKISTLRTFYEFWMTQDETIINPFVQLVHPKKENYLPQFFYEEEMEALFE
TVAKDTKKGLRDRVILELLYATGIRVSELVNIQLKDIDMSLPGVKVLGKGNKERFVPFGE
FCRQSIEQYLREFKPIQHTKHSFLLVNMNGAPITERGVRYVLNDVVKRTAGVTEIHPHKL
RHTFATHLLNQGADLRTVQSLLGHVNLSTTGRYTHVSNQQLRKVYLNAHPRAKKESK
>SEQF2892_00945 ATP-dependent protease subunit HslV
MSKTSLHATTIYAVRHNGEAAMAGDGQVTLGEQVIMKQTARKVRRLYEGKVLAGFAGSVA
DAFTLFEKFETKLQQFSGNLERAAVELAQEWRGDKQLRQLEAMLIVMDKDAILVVSGTGE
VIAPDDDLIAIGSGGNYALSAGRALKRHASQLSAKEMAYESLKVASDICVFTNDNIIVET
L
>SEQF2892_00946 ATP-dependent protease ATPase subunit HslU
MDANGIKLTPKDIVSKLDEYIVGQDDAKRKVAIALRNRYRRSLLDEETKQEIAPKNILMI
GPTGVGKTEIARRMAKVVGAPFIKVEATKFTEVGYVGRDVESMVRDLVDVAVRLVKDQKK
GLVKDEAVNKANEKLVKLLVPSMKKKASNNSNPLESLLGGAIPNFGNNDDEEEETPTEEI
KTKRSEIKKQLLDGKLEEEKVRIKVEQDPGALGMLGTNQNQQMQDMMNQLMPKRKVEREV
PVKTARKILADDFADELIDQETANQEALELAEQMGIIFIDEIDKVATNNANSGQDVSRQG
VQRDILPILEGSMIQTKYGTVNTEHMLFIGAGAFHVSKPSDLIPELQGRFPIRVELESLT
VDDFYRILTEPKLSLIKQYEALLQTEEVTVNFTKEAITRLAEMAYQVNQDTDNIGARRLH
TILEKMLEDLSFEAPSMPNAVVDITPQYVDDKLKSISTNKDLSAFIL
>SEQF2892_00947 GTP-sensing transcriptional pleiotropic repressor CodY
MSLLSKTRELNTLLQKHKGIAVDFKDVAQTISSVTVTNVFIVSRRGKILGSSLNELLKSQ
RINEMLESKHIPSEYTELLMDVKQTESNIDIDNELTVFPPEDKEVFSSSRTTVFPILGGG
ERLGTLVLGRVKDDFNENDLVLGEYAATVIGMEILREKHNEVEKEARDKAAITMAINSLS
YSEKEAIEHIFEELGGNEGLLIASKVADRVGITRSVIVNALRKLESAGVIESRSLGMKGT
FIKVKKEKFLDELERNK
>SEQF2892_00948 30S ribosomal protein S2
MAVISMKQLLEAGVHFGHQTRRWNPKMKKYIFTERNGIYIIDLQKTVKKVEEAYNFIKQV
SEDGGRVLFVGTKKQAQESVKAEAERAGQFYVNQRWLGGILTNYKTISKRIKRISEIEKM
EEDGLFDVLPKKEVVELKKEYDRLIKFLGGIRDMKSMPQALFVVDPRKERNAIAEARKLN
IPIVGIVDTNCDPDEIDYVIPANDDAIRAVKLLTGKMADAVLEGQQGVSNDEVAAEQNIN
LDEKEESQEAESTEENTTVESN
>SEQF2892_00949 Elongation factor Ts
MAISAKLVKELRERTGAGMMDCKKALTETDGDIDKAIDYLREKGIAKAAKKADRIAAEGL
VHVEVKGNEAAIVEINSETDFVARNEGFQELVKEIANQVLDSKAETVDALLETKLSSGKT
VDERMKEAISTIGEKLSIRRFEIRTKSDNDAFGAYLHMGGRIGVLTVVEGSTDEEAAKDV
AMHIAAINPKYVSSEQVKEEEINHEREVLKQQALNEGKPENIVEKMVEGRLRKYLQEICA
VDQNFVKDPDQTVEAFLKSKGGKLVDFVRYEVGEGMEKREENFADEVKGQMK
>SEQF2892_00950 Uridylate kinase
MSSLLVYITYFYNREEKTMAQTSKYKRVVLKLSGEALAGDKGFGINPIIIKSVAQQVAEV
AKMDCEIAVIVGGGNIWRGKTGSDLGMDRGTADYMGMLATVMNALALQDSLEQLECDTRV
LTSIEMKQVAEPYIRRRAIRHLEKKRVVIFAAGIGNPYFSTDTTAALRAAEVEADVILMG
KNNVDGVYSADPKVDKNAVKYEHLTHIQMLQEGLQVMDSTASSFCMDNNIPLNVFSIMEE
GNIKRAVMGEKIGTLITK
>SEQF2892_00951 Ribosome-recycling factor
MSDIIQDTKARMSKSIDNLSRELANISAGRANSNLLSGVTVDYYGAPTPVQQLASINVPE
ASLLVISPYDKSSVADIEKAIYAANLGVNPTSDGEVIRITVPALTEERRKELVKNVKKIG
EDAKVSIRNIRRDINDQLKKDEKNGDITEDDLRSQTEDVQKATDNSIKEIDQLVEDKEKD
IMSV
>SEQF2892_00952 Isoprenyl transferase
MFKKLIKRNKTKISHNDDLDLHNLPEHVAIIMDGNGRWAKKRKMPRIKGHYEGMQTIKTV
TREASDLGIKYLTLYAFSTENWSRPENEVNYIMNLPVNFLKTFLPELIEKNVQIETIGFL
DAVPKSTIEAIEHAKEKTKNNTGLKLIFAINYGGRAEIVQSMKSIYDELQRNGQDSKDID
ESMINKHLMTHSYPDPELLIRTSGEQRISNFLIWQSSYSEFIFNEKLWPDFDGEEFKNCL
KIYQSRQRRFGGLSKE
>SEQF2892_00953 Phosphatidate cytidylyltransferase
MKVRTLTAIIALLIFLPILLMGGTTLMLFAYLLALIALKELLNMNMIKLISVPGIFSALA
LIIIMLPQSAGDWVSDIQLKSLIAMSFILLSYTVLSKNRFSFMDAAFCLMSVAYVGIGFM
YFYATRSDGLHYILYAFLVVWLTDTGAYIFGRLMGKHKLWPVISPNKTIEGFIGGLICSL
IVPIVMLFFVDFNLNIWLLLLVTIILSIFGQLGDLVESGFKRHFGVKDSGRILPGHGGIL
DRFDSFMFVLPLLNILLIQM
>SEQF2892_00954 Putative zinc metalloprotease
MSYLITIVSFMIVFGVLVTVHEYGHMFFAKRAGIMCPEFAIGMGPKIFSFRKNETLYTIR
LLPVGGYVRMAGDGLEEPPVEPGMNVKVKLNDKDEITHIILDDQHKFQKIEAIEVKQCDF
KDDLYIEGITSYDNERHHFNIAEKAYFVENGSLIQIAPRHRQFAHKKPLPKFLTLFAGPL
FNFILALILFIALAYFQGTPTTSVGQLADHYPAQQAGLKSGDKIVQVGQYKTKSFDDIQS
AANKIKDNKTTIKFERDNQTKTVDITPKKQVIKQTKLNSETTYILGFQPEKEHTLIKPIA
LGFDQFVSASTLIFKAVGTMIASIFTGQFSFDMLNGPVGIYHNVDSVVKQGIIALTYYTA
LLSVNLGIMNLLPIPALDGGRILFVIYEAIFRRPVNKKAETIIIAAGAIFVLIIMVLVTW
NDIQRYFL
>SEQF2892_00955 Proline--tRNA ligase
MKQSKVFIPTRRDVPAEAEALSHQLLLKAGLIKQSTSGIYSYLPLASRVLNNISKIIREE
MESIDAVEILMPALQQAELWEESGRWGAYGPELMRLKDRNGREFALGPTHEEVVTSIVRD
ELKSYKQLPLTLFQIQSKFRDEKRPRFGLLRGREFIMKDAYSFHADEASLDETYQDMYNA
YDRIFKRVGINARPVVADSGAIGGNHTHEFMALSEIGEDTIVYSEHSDYAANIEKAEVVY
HPNEKHTEVAELEKVETPNVKTAQELADFLNRPVDEIVKSMIFKIDGEFIMFLIRGHHEL
NDVKVKAFFETDNVEMATQEEIVNLLGANPGSLGPVHDKDIRIFADNYVRDLNNLVVGAN
EDGSHYINANLDRDFKVDEFGDFRFILEGETLSDGSGEAKFAEGIEVGQVFKLGTKYSEA
MNATFLDNQGKAKPLIMGCYGIGVSRTLSAIVEQNNDENGIIWPKSVTPFDLHLITINPK
KDEQLELGDQLYKELQQQYDVLYDDRKDRAGVKFNDADLIGLPIRIVVGKNASEGIVEVK
VRQTGESEEVHINDLNTHIATLYSNL
>SEQF2892_00956 DNA polymerase III PolC-type
MAMTNQEKFKVLADQIKVSNQLDQTIIEKGELTRVDVSNKNRTWEFQITLPYFLSHEDYL
IFTNAITEEFKEIAKVDWHFTIQDTSNQDEHAIKYFGHCIEHTALSPKVKGQLKQKRLIM
SGNVLKVMTSNDIERNHFDKVCNGSLVKAFRKCGFDIDKVVFETDDSSSYDDLASLEAHI
QEEDEKSAREATEKIEKIKAEKAKQQDNNESNVDKCQIGKPIQIDNIKPIESIIEEEFKV
AIEGVIFDINLKELKSGRHIVELKVTDYTDSLVLKMFTRKNKDDLDHFKALSVGKWVRAQ
GRIEEDTFVRDLVMMMTDIEEIKKTPKQDKAEEKRVEFHLHTSMSQMDGIPNISAYVNQA
AKWGHKAIAVTDHNVVQAFPDAHGAAEKNGIKMIYGMEGMLVDDGVPIAYKPTDRDLKEA
TYVVFDVETTGLSNQYDQIIELAAVKVKDGEIIDKFERFSNPHEKLSETIINLTHITDDM
LTDAPEIEEVLTEFKEWVGDAIFVAHNASFDMGFIDTGYERLGFGPSTNGVIDTLELSRT
INTEYGKHGLNFLAKKYGVELTQHHRAIYDTEATAYIFIKMVQQMKELGVTNHKDINQKL
SNEDAYKRARPTHVTLIVQTQEGLKNLFKIVSASLVKYYYRTPRIPRSLLNEYREGILVG
TACDEGELFTAVMQRDQSEVEKIAKYYDFIEVQPPKLYQDLIDRELIRDTETLYEIYERI
LKAGESTGIPVIATGNAHYLYEHDAIARKILIASQPGNPLNRSTLPEAHFRTTDEMLDEF
HFLGEEKAHEIVVKNTNELADRIEKVIPIKDQLFTPRMDGANEEIRELSYTNAKKLYGED
LPQIVIDRLEKELASIIGNGFSVIYLISQRLVKKSLDDGYLVGSRGSVGSSFVATMTEIT
EVNPLPPHYICPNCKTSEFFDDGSVGSGFDLPDKQCSTCGAELIKEGQDIPFETFLGFKG
DKVPDIDLNFSGEYQPNAHNYTKVLFGEDKVFRAGTIGTVAEKTAFGYVKGYLNDQGIHK
RGAEIDRLVKGCTGVKRTTGQHPGGIIVVPDYMDIYDFTPIQYPADDQSASWMTTHFDFH
SIHDNVLKLDILGHDDPTMIRMLQDLSGIDPKTIPVDDKETMQIFSSPESLGVTEEEILC
KTGTFGVPEFGTGFVRQMLEDTKPTTFSELVQISGLSHGTDVWLGNAQELIRSGICDLSS
VIGCRDDIMVYLMYAGLEPSMAFKTMESVRKGKGLTEEMIDAMKENNVPDWYLDSCLKIK
YMFPKAHAAAYVLMAVRIAYFKVHHPLYYYASYFTIRASDFDLITMIKDKESIKNTVKDM
YSRYMDLGKKEKDVLTVLEIMNEMAHRGFRMQPISLEKSQAFDFIIEGDTLIPPFISVPG
LGENVAKRIVEAREDGPFLSKEDLNKKAGLSQKIIEYLDDLGSLPNLPDKAQLSIFDM
>SEQF2892_00957 Ribosome maturation factor RimP
MSKITEEVETIITPILDELNFELVEVEYTKEGKDHFLRISIDKEGGVNLNDCTLASEKIS
EAMDENDPIPDMYYLDVASPGAERPIKKEKDYHNAIDKPVFVSLYAPIEGDKEWLGILKA
VDDDTITMEVKEKAKTKQIEIPRNKIAKARHAVMI
>SEQF2892_00958 Transcription termination/antitermination protein NusA
MASNELLLATEYLEKEKKIPREVLIDAIEAALITAYKKNYDSARNVRVELNMDEGTFKVI
ARKEVVEEVFDDRDEVDLSTALVKNPAYEVGDIYEEDVTPKDFGRVGAQAAKQAVMQRLR
DAEREILYTEFIDKEDDILTGVIDRVDHRYVYVNLGRIEAVLSEAERSPNEKYIPNERIK
VYVNKVEQTTKGPQIYVSRSHPGLLKRLFEQEVPEIYDGTVIVKSVAREAGDRSKISVYS
DNPDIDAVGACVGAKGARVEAVVEELGGEKIDIVQWNEDPKVFVRNALSPSQVLEVIVDE
DNQSTVVVVPDYQLSLAIGKRGQNARLAAKLTGWKIDIKSETDARDAGIYPVIESEELAE
DIVLSESDDEDIEIDDVNLEESNLTTAELAADIDETSENNEEADSEEKDV
>SEQF2892_00959 hypothetical protein
MKKKKIPMRKCIITNEMRPKKDMIRVVINKEGDIFADGTGKQQGRGAYVSKDVQSVEAAQ
EKGILERYFNADSEKLDPVYKEIIRLIYREEIPK
>SEQF2892_00960 putative ribosomal protein YlxQ
MSKEQILNFLGLAMRARKVKSGESVLLTEIKKNNIKLVIMASDASENTVKNIKNKCESYH
VPFRIFSTRAELGQSLGKSERVNIGVIDSGFATKLTSMIDEYCKE
>SEQF2892_00961 Translation initiation factor IF-2
MSKKRIYEYAKELNVKSKEIIDELKNMNVEVSNHMQALEDDQIKTLDKKFRQQESNNNTK
QNTQNNHQKQQNNNNNKNNNKQSNKGNANQKGNNNNKNNAKNNKNNKNNKNNKNNKNNKG
NKNNKPAAEPKEMPSKITYEEGITVGELADKLNIESSGIIKKLFLLGIVANINQALDEET
LELIADDYGVELEKEVVVNEEDLSIYFDEEEADPDAIERPAVVTIMGHVDHGKTTLLDSI
RHTKVTAGEAGGITQHIGAYQIENAGKKITFLDTPGHAAFTTMRARGAQVTDITILVVAA
DDGVMPQTIEAINHAKEANVPTIVAVNKIDKPTANPDRVMQELTEYGLIPEDWGGETIFV
PLSALSGEGIDDLLEMIGLVAEVQELKANPDKQAVGTVIEAELDKSRGPAASLLVQNGTL
NVGDSIVVGNTYGRIRAMVNDLGQRIKSAGPSTPVEITGINDVPLAGDRFVIFKDEKQAR
RIGEARHEASVIQQRQESKNVSLDNLFEQMKQGEMKDLNVIIKGDVQGSVEALAASLMKI
DVEGVNVRIIHTAVGAINESDVTLANASNGIIIGFNVRPDAGAKRAAEAENVDMRLHRVI
YNVIEEIESAMKGLLDPEFEEQVIGQAEVRQTFKVSKVGTIAGSYVTEGKITRNAGVRII
RDGIVLFEGELDTLKRFKDDAKEVAQGYECGITIEKFNDIKEGDIIEAFEMVEIER
>SEQF2892_00962 Ribosome-binding factor A
MNNMRAERVGEQMKKEIMDIVNNKVKDPRVGFITITDVDLTNDLSQAKVYLTVLGSEKEV
NDTFKALDKAKGFIKSELGSRMRLRIVPELFFEYDESIEYGNKIEKMIQDLHKQDR
>SEQF2892_00963 tRNA pseudouridine synthase B
MYNGILPVYKERGLTSHDVVFKLRKILKTKKIGHTGTLDPEVSGVLPVCIGTATRVSDYV
MDMGKSYNATITLGESTTTEDQTGEVIDKIDVQANAININEVDAVLKQFEGIIEQVPPMY
SSVKVNGKKLYEYARKGETVERPIRKVNIDSIARTSELQFEDGKCHFNIEVKCGKGTYIR
TLATDIGKQLGYPAHMSLLTRINSGGFDIKDSITLDQISQLHEQDTLQPHLFPLEYGLKS
LPKIYVSDENIKTRILNGQKFNKKQFNQTIEQQLVFIDSETEKVMAIYIQHPEKNHEIKP
KKVFN
>SEQF2892_00964 Riboflavin biosynthesis protein RibF
MKVIEVTHPIQEDQLIKEDVAMAFGFFDGMHRGHHKVFEALDERAAAQNLKKAVTTFDPH
PSVVLNPERKRTDYLTPLSDKLEMIEQHDVDYCIVINFSSRFASVTAEEFVQDYIINNRV
KEVIAGFDFTYGKFGKGNMSVLNEMDEFSTTIVGKQEMETEKISTTAIREALKEGNLKKA
NEQLGYLYRIKGTVVQGEKRGRTIGFPTANVQPSDDYVLPKKGVYAVSMAIGAENKIYRG
VANVGVKPTFHDPSKAEVVIEVNIFDFNDNIYGERVIVYWHHYLRPEVKFDGIDPLVEQM
NNDKEKAKYLLSVDFGDDVSYNI
>SEQF2892_00965 30S ribosomal protein S15
MAITQERKNEIIKEYRVHETDTGSPEVQIAVLTAEIAALNEHLREHKKDHHSRRGLLKMV
GRRRHLLNYLRGKDIQRYRELIKSLGIRR
>SEQF2892_00967 Polyribonucleotide nucleotidyltransferase
MSQEKKVFKTEWAGRSLTIEIGQLAKQANGAVLVRYGDTVVLSTAVASKEPRDGDFFPLT
VNYEEKMYAAGKIPGGFKKREGRPGDEATLTARLIDRPIRPLFPKGYRHDVQIMNTVLSA
DPDCSPEMAAMIGSSMALSVSDIPFQGPIAGVNVGYVDGKYVINPTVEEKEVSRLDLEVA
GHKDAVNMVEAGASEITEKEMLEAIFFGHDEIKRLVAFQEEVVAHIQPVKKEFVPVERDE
ALVSRVKTLTEEKGLKETVLTFDKQQRDENLDTLKAEIATEFVDEADPENELLIDEVYAI
LNDLVKEEVRRLIADEKIRPDGRKPDEIRPLESEVGLLPRAHGSGLFTRGQTQALSVLTL
GALGDYQLIDGLGPEQEKRFMHHYNFPNFSVGETGPVRAPGRREIGHGALGERALKYIIP
DTTEFPYTVRIVSEVLESNGSSSQASICGSTLALMDAGVPIKAPVAGIAMGLVTREDSYT
ILTDIQGMEDALGDMDFKVAGTKEGITAIQMDIKIDGLTREVIEEALEQARQGRLAIMDH
MLQTIDQPRKELSAYAPKVEIMHIKPEKIRDVIGPGGKKINEIIDETGVKLDIEQDGTIF
IGAIDQDMINRAREIIEDITREAEVGQVYNAKVKRIEKYGAFVELFAGKDALLHISQISK
ERINKVEDVLSIGDSIEVKITEIDKQGRVNASHKALDENK
>SEQF2892_00968 Ribonuclease J 2
MDGDFIIGGNILSLVKKKNDDIRIIPLGGVGEIAKNMYIVEVDDEMFMLDAGLMFPEDEM
LGVDIVIPDIQYVIENKEKLKGIFLSHGHEHAIGAVSYILEQIDAPVYGSKLTLALVKEN
MKSRNVKKKVRYYTVNHDSVMRFKNVNITFFNTTHSIPDSLGICIHTSYGSIVYTGEFKF
DQSLQGHYTPDIKRMAEIGEEGVFALISDSTEAEKPGYNTPENVIESHIYDAFAKVKGRL
IVSCYASNFIRIQQVLNTASKLNRKVSFLGRSLESSFNIARKMGYFDIPKDLLIPINEVG
NYPKNEVVIIATGMEGEPIEALSQMAQQKHKIMNIEEGDSVYLAITASANMEVIIADTLN
ELVRAGAYIIPNNKKIHASSHGCMEELKMMINIMKPEYFIPVQGEFKMQIAHAKLANESG
VAPEKIFLVEKGDVIHYDGKDMVLNEKVNSGNILIDGIGVGDVGNIVLRDRHLLAEDGIF
IAVVTLDPKNRRIAAGPEIQSRGFVYVRESEELMKEAEDKVREIVEAGLQEKRIEWSDIK
QNMRDQISKLLFESTKRRPMIIPVISEI
>SEQF2892_00969 DNA translocase FtsK
MPQTKKKTTTRKKGAIARKSTKKKQQKKDSSIRYIVAIIIVILSVLGMFQLGIVGRMIDS
FFNYLFGMSRYLTYILLSLITVYIAMQKKFPKTRRTFGLISLQFVLLITTQIIYHFQKGA
ASEREPVLSYVYKAYEHSHFPNFGGGLIGFYLLKIFIPLISIAGVIILTLILLSSSIILL
LKLRHRDVVKASIDKMRNSSQSASSNFKVKREQNRLKKEERQREKEEERERLRQHQLEQE
QLESEQIKDVSDFPEVSTEPEDIPIYGPSESQESKQTTTNKRKKRRFGLNSEDIDKENSS
NDGTNLEDENLPESNSNDNHQMNGTISEAGEESNVAYHIPPLSLLNQPAKQQSTSKSEVQ
RKGQILESTMKNFGVNAKVKQIKIGPAVTQYEIQPAQGVKVSKIVNLHNDIALALAAKDV
RIEAPIPGRSAVGIEVPNDKISLVTLKEVLESKFPASNKLEVGLGRDISGEPMTIQLNEM
PHLLVAGSTGSGKSVCINGIITSILLNAKPHEVKLMLIDPKMVELNVYNGVPHLLIPVVT
NPHKASQALEKVVAEMERRYDLFQHSSTRNIEGYNKFIRRQNEELDEKQAELPYIVVIVD
ELADLMMVAGKEVENAIQRITQMARAAGIHLIVATQRPSVDVITGIIKNNIPSRIAFAVS
SQTDSRTIIGSGGAEKLLGKGDMLYVGNGESAQTRVQGAFLSDQEVQDVVNYVVEQQKAN
YVKEMEPDAPVDKSEMKSEDALYEDAYIFVIEQQKASTSLLQRQFRIGYNRASRLMDDLE
RNQVIGPQKGSKPRQVLVNLDDEEV
>SEQF2892_00970 putative transcriptional regulator PhnF
MMTELNSAFKVKEYILKQIKEQSLKPGDKLPSNLSIARELNVKTDDVYEAIGELITEQVL
TDNFEEGPSVKTLHPFFYPLNKLFSINDMIKEAGYHSGTEYLSLEQQPASILDAQMLGIN
DKQPITIIERLRTANHQPVIYCLDKIAEDYLTCSDYQVSDGSMLNAIETNTGHKVASAET
EVEAISYEPHISDILNAYPHEGLMLLKVVHYDEMGKPILYSLNYVKSSLVKFKLTRTKI
>SEQF2892_00971 putative zinc protease
MIEQQTNNEHQIHIDVLPTDKFKTTMITFKFMAPLEYETITARSLLSKLLIRATKKWSTD
KAFSKHLSELYGAYIHSFVSKFKDKHVITISLEIVNERYLKDSTPLFEKGLNVLYEVIMN
PLIENNAFNTTFVNQEKSLLSKKIEAVIDNKAQYSFLNLLKYMFKDEPYRHLATGQIEKI
STITPENLYDTYQNMISNDLCSVYVVGNVNKQEVEQLIQFKFTINPFKMAKTNQLNLKDT
SSETQYIVEEDEVDQAKLNMGYRFPTRFGSNDYYALVVLNTMFGGDPSSVLFNEVREKQS
LAYSIHSQLDGKNGYLFVLSGVSADKYELAKDTILEEFDKFKRGEFDVDKLELAKKIIIS
HRHEIADRPKSIIEVMQNQLLLDYEQTDENYIDHIQKVTKDDVISMANKAELDTIYVLTK
GDHS
>SEQF2892_00972 Putative zinc protease AlbF
MRETYYELIDERVFEHELTNGLRLFVIPKNGFQKTFVTYTTQFGSLDNTFKPHNQNDFVT
VPDGVAHFLEHKLFEKDDTEDLFTAFANDNAQVNAFTSFDRTSYLFSATDNVERNILRLL
EMVETPFFSKETVDKEKGIIAEEIKMYQEQPGYKIMFNTLRAMYQKHPIKVDIAGSVESI
YNITKDDLYLCYETFYHPSNMVLFVVGDVNPENIRDIVETHENKRDKTNQPSIERATVDE
PTNVITPFVSEEMKLQSPRLMLGFKNEPTEASPHEYVQHDLEMTLFFELIFGEETEFYQT
LLNEDLIDETFGYQFVLEPTYCFSIITSATQYPDKLKEVLLSELNKYCGNLDDQEAFELL
KKQFIGEFISSLNSPEYIANQYSKLYFEGVSVFDMLDIIDNITLDSINETATKFLNINNM
VDSRLEPKA
>SEQF2892_00973 3-oxoacyl-[acyl-carrier-protein] reductase FabG
MRALVLGGSGTIGTAIVERLLEEGNEVIIQYFQSDLKALQDKYKGEAVEFIQADLTQNID
LETTFAHIKYLDCLIYSSGTALYGLLQDMSDIDIDLSYNIHVKQLIRCCRYFIDLIRQSE
FGRIIVISSIWGETGASMETIYSAMKSAQIGFVKALSQELAMTNVTVNAITPGFVSGNMS
QVFNSDELKAILEELPQQRMINPCEIAHTCAYLWNPLAKSITGTVQKVNGAWYI
>SEQF2892_00974 hypothetical protein
MTVAEKKEWYLEYEITVNRAGLLGDISSLLGMLGISIVTINGVDQGRRGLLIKTDSLEKV
NRFEHIINELSEIEITKLRVPELRDRLAVRHGRYIEQDADDKKTFRFEREDLGLLVDFLA
ELFKEEGHKLIGIRGMPRVGKTESIVAGSVCAHKRWLFISSTLIKQTVRSSLIKGEYDSN
HVYIIDGAVTARESNPKHQELVREVMTLPSIKVVEHPDLFVESGNYSMDDFDYIIELREN
ENQEIEYDQMKQQTVKSKNSLDFGEDMFGGGFGFFE
>SEQF2892_00975 Cytoskeleton protein RodZ
MKTIGETLKGRRERLGMTLAELEERTQIKRDTLKLIEQNQFDKLAKVDYAEGFIRRYASV
VNIDSQQLIQAHQEEIPDSQHQLNELLYRYHNDDAPTYRTKSKEHLQLMIIIGGIIIITF
ILWVLAVLLL
>SEQF2892_00976 CDP-diacylglycerol--glycerol-3-phosphate 3-phosphatidyltransferase
MNIPNQITVFRVILIPLFILFALVNFGFGNVSILGGFEIRIEQLIAAIIFIVASLSDFLD
GYLARKWQLVTNMGKFLDPLADKLLVSSALIVMVQLGLTNSVVAIIIIAREFAVTGLRLL
QIEQGFVSAAGQLGKIKTAVTMVAIIWILLGDLLATWIGIQIGQVLLYIGVLFTILSGIE
YFYKGRDVFKH
>SEQF2892_00977 Putative competence-damage inducible protein
MNISIIAVGSELLLGQIANTNGQYLSRLFNSIGKSVVEHTVIGDNPQRLEYVIKEGLKRF
DTLVFTGGLGPTKDDLTKHTVAKVLGKNLVTDTNALEYIENYFKEQGQEMTPNNKQQALV
IEGAKVLQNNYGMAPGMLVEYEDKKVILLPGPPSEMQPMAKNELLPYLMDEDRVIHSEQL
RFAGIGESKVETELMDLIDSQENPTIAPLAGTHEVYIRLTANANTENECKKLIEPTKEKI
LARIGDYYYGSDDIVIEQALMNIINKSFSIYDGVTNGALYTRLKNQDLNHLLKGQLPDSS
VFVSDFDDILDKLKYVSQYVKDLYKTDWGIALLHNQEQVYLGYYDDSVFKYETFKMPLKR
NILKSRSQNYAMINLINWFK
>SEQF2892_00978 Protein RecA
MDNDRQKALDTVIKNMEKSFGKGAVMKLGDNKGRRVSSVSSGSVTLDNALGVGGYPKGRI
IEIYGPESSGKTTVALHAIAEVQKNGGVAAFIDAEHALDPVYAEALGVDIDNLYLSQPDH
GEQGLEIAEAFVRSGAVDIVVVDSVAALTPKAEIEGEMGDTHVGLQARLMSQALRKLSGA
ISKSNTTAIFINQIREKVGVMFGNPETTPGGRALKFYSSVRLEVRRAEQLKQGQEIVGNR
TKIKVVKNKVAPPFRVAEVDIMYGQGISKEGEVIDLGVENDIVDKSGAWYSYNGDRMGQG
KENVKTYLKENPQVKEEIDRKLREKLGIFDGDVDEKEEDAPQTLFVEE
>SEQF2892_00979 Ribonuclease Y
MNLLNLLLILLGIILGVVVGYFVARNLLHQKQLQARQTADDIIKQGQKEADNIKKEKLLE
AKEENQIIREQTESELRERRGELQRQEARLLQKEENLDRKSDLLDKKDEILEQKESKLEE
RQQQVDAKESSVQTLIMKHEQELERISGLTQEEAVNEQLQRVEEELSQDIAVLVKEKEKE
AKEKVDKKAKELLATTVQRLAADHTTESTVSVVNLPNDEMKGRIIGREGRNIRTLETLTG
IDLIIDDTPEAVILSGFDPIRREIARTALVNLVSDGRIHPGRIEEMVDKARKEVDDIIRD
AGEQATFEINVHNMHPDLVKVLGRLNYRTSYGQNVLKHSIEVAHLSGMLAAELGEDVSLA
KRAGLLHDVGKAIDHEVEGSHVEIGVELAKKYAENETVINAIHSHHGDVEPTSIISILVA
AADALSAARPGARKETLENYIRRLERLETLSEGYDGVEKAFAIQAGREIRVIVSPDEIDD
LKSYRLARDIKTQIEDELQYPGHIKVTVVRETRAVEYAK
>SEQF2892_00980 hypothetical protein
MSINIDPEKFAELVVKSNPSKSKDAEDIAKESLELYINAYRLAERYSNIATNCYDTAEII
SELRKTDLQLK
>SEQF2892_00981 hypothetical protein
MRILFIGDIVGKVGRNAIAEYLPKIKQSYRPTVSIVNAENAAHGKGLTEKLYKQLLRDGV
DFMTMGNHTYGQREIYDFIDDANRMVRPANFPSEAPGVGMRFIQINDIKLAIINLQGRSF
MQDIDDPFKKADQLIEEAKKETNFIFVDFHAETTSEKNAMGWYLDGRVSAVVGTHTHIQT
SDERVLPNGTGYITDVGMTGYYDGILGINRDEVIERFITSLPQRHVVPDDGRSVLSGVII
DLDKDGKTKQIERILINDDHPFNK
>SEQF2892_00982 2-oxoglutarate oxidoreductase subunit KorA
MIYYELIPQEAYDMKSQISWKVGGQQGEGIESTGEIFATAMNRKGYYLYGYRHFSSRIKG
GHTNNKIRVSTAPVHAISDDLDILVAFDQETIELNHHEMREDSIIIADAKAKPTKPEQCR
AQLIELPFTSTAKELGTALMKNMVAVGATCAIMDLDTATFETLITNMFTKKGEKVVEMNI
EALNQGYTLMKEQLNDLQGDFKLQTTEENPHLYMIGNDAIGLGAISAGSRFMAAYPITPA
SEIMEYMIANVTKVGGTVVQTEDEIAAANMAIGANYAGVRAFTASAGPGLSLMMEAIGLS
GMTETPLVIINTQRGGPSTGLPTKQEQSDLMQMIYGTHGDIPKIVVAPTDAEDAFYLTIE
AFNLAEEYQCPVIILSDLQLSLGKQTVERLDYNKIQIRRGELLQSDIEREEDDKQYFRRY
ALTGNGVSPRPIPGVKGGIHHVTGVEHNEEGKPSEAAENRRQQMEKRMRKTSNLLIEKPV
ELDEHHEEADILFIGFISSKGAIQEGAERLNAQGIKVNTMQIRQLHPMPKDVIQAAIDKA
SRVIIVEHNYQGQLSNILKMNTTIQDKLINQTKYDGTPFLPHEIESKGQKVVSESKELV
>SEQF2892_00983 2-oxoglutarate oxidoreductase subunit KorB
MATFKDFRNNVKPNWCPGCGDFSVQAAIQKAAANVGLEPEEVAIITGIGCSGRLSGYINS
YGVHGIHGRALPLAQGVKMANKDLTVIASGGDGDGYAIGMGHTIHALRRNMNMTYIVMDN
QIYGLTKGQTSPSSAVGFVTKSTPKGNIEKNVAPLELALSSGATFVAQGFSSDIKALTKL
IEDAINHDGFSFVNVFSPCVTYNKVNTYDWFKEHLTSLEDIEGYDTSDKQLAMKTVLDYE
SLVKGIVYQDTETPSYESQIEELNESALSKRDIHITEEDFNNLTAQFV
>SEQF2892_00984 hypothetical protein
MDKYHSMKELQNETIENEDWEIITEDRDSNVTILAIHGGGIEPATTELARVIANDGQFNY
FAFNGMRTKGNNELHVTSINYDNDIAMDLVKTSESAITIHGCLGEDEIAYIGGKDNLLKE
RIVEELSQIGIEVKEAPSHMSGTQDNNIVNCTKNGVGVQIELTSSLRKSLFKNNKFNRKS
RMDESNWDDKMYDFGQAINSAIN
>SEQF2892_00985 hypothetical protein
MQDTLMSIQIVPKTPNNEDVIPYVDEAIKIIDDSGLHFRVGPLETTVQGDMSECLILIQK
LHERMVELECPSIISQVKFYHVPAGITIETLTGKYDNE
>SEQF2892_00986 tRNA-2-methylthio-N(6)-dimethylallyladenosine synthase
MNEEQRKAGTINILDERDRKVEKDYSKYFENIYQPPSLKEARKRGKQDINYNRDFHIEDK
FEGMGKGRTFLIKTYGCQMNAHDTEVMAGILQALGYTATEDINEADVILINTCAIRENAE
NKVFSEIGNLKHLKKNRPEALIGVCGCMSQEESVVNKILKSYQNVDMIFGTHNIHKLPEI
LEEAYLSKAMVVEVWSKEGDIIENLPKVREGSTKAWVNIMYGCDKFCTYCIVPFTRGKER
SRRPEDIIEEVRGLARDGYKEITLLGQNVNSYGKDIKDLEYGLGDLLEDISKIDIPRVRF
TTSHPWDFTDRMIEVIAKGGNIVPHIHLPVQSGNNAVLKIMGRKYTRESYLDLVNRIKKS
IPNVALTTDIIVGYPNETEEQFEETLSLYDEVQFEHAYTYLYSQRDGTPAAKMKDNVPED
VKKARLQRLNKKVGHYSEKAMNQYEGKTVTVLCEGSSKKDDTVLAGYTEKNKLVNFKGPR
EAIGKLVNVEIDETKQYSLNGTFKEFNDAPLVTN
>SEQF2892_00987 hypothetical protein
MYSKDDILKQADQLTSKIQDLDLIKSYQNIEKQIHENRNIESKMNRLKKQQKQSVNFQNY
GKQHAYQQSEDEIEALEDEINELPIVEEFRSAQYEANDLLQLMISTMEDRLNEHNEEEHK
D
>SEQF2892_00988 hypothetical protein
MNNRKLTLTALLIATNVVLSSIIIIPLGPVKAAPVQHFINVLCAVFVGPWYGLAQALISS
IIRNLFGTGSFFAFPGSMIGVLLASVFYMYRKHIFMAAVGEVIGTGIIGSLLCIPMAWVL
GMQDFFVKPLMIAFIISSFIGAAISYFLLIMLKKRGLLDRFKK
>SEQF2892_00989 DNA mismatch repair protein MutS
MSNTTPMMQQYLKIKSQYQDCLLFFRLGDFYEMFFEDAKEASRVLEITLTKRDAKKENPI
PMCGVPYHSANSYIETLINNGYKVAICEQMEDPKQTKGMVKREVVRVVTPGTVMEQGGMD
ENQNNYILSFIKQDSNYALSYCDISTGELKATQIEDEDTLINEIVTINPNEIVVNLEIDE
NLKKQIYLTTETITIRESISDASYEVNQLTNNHMYLATQLLLDYVYHTQKRDLSHLETAI
TYAAVDFMKMDYYAKRNLELTESIRLKSKKGTLLWLMDETKTPMGARRLKQWIDRPLINK
ERIEERLSIVESFMNHFIERDTLRGYLNQVYDIERLVGRVSYGNVNARDLIQLKHSISEI
PNIKSLLESMNDVASNQFSSLEPLEDLLQVLEDSLIEEPPISIKDGGLFKQGFSKQLDEY
LEASKNGKDWLAQLQAKERERTGIKSLKISFNKVFGYFIEITRANLQGFEPSKFGYHRKQ
TLSNAERFITDELKEKEDIILGAEDKAVDLEYQLFVRLREHIKTYTERLQKQAKIISELD
CLQSFAEIAQKYNYVKPEFSDNKTLSLENSRHPVVERVMDYNDYVPNDCKLDKDNFIYLI
TGPNMSGKSTYMRQVAIISIMAQMGAYVPCNKAELPIFDQIFTRIGAADDLVSGKSTFMV
EMLEAQKALTYATEDSLIIFDEIGRGTSTYDGLALAQAMIEYVAQTSHAKTLFSTHYHEL
TTLDQELPSLKNVHVAADEYQGELIFLHKVKDGAVDDSYGIQVAKLANLPDEVINRAQVI
LDAFEQSQNTSDNEEHSNITVLKDSASVEGFTDDDAQNANNSDKKSQTTKNAIENEFEQA
SFNLFDSEAMTSEIEEQIKNLNISNMTPIEALLKLSELQNQLR
>SEQF2892_00990 DNA mismatch repair protein MutL
MGKIKELQTSLANKIAAGEVVERPSSVVKELLENAIDAKSTEINIEVEQSGISSIRVVDN
GTGIEQDDLDLVFHRHATSKLDADDDLFHIRTLGFRGEALASISSVAKVTLKTCTDSENG
HEIYAENGEILSRKPAKAKKGTDITVSSLFYNTPARLKYIKSLYTELGKITDIVNRMAMS
HPYIRISLISDGKTLLKTNGSGKTNEVMSEIYGIKVAKDLVHIQGDTSDYHLEGFVAKPE
HSRSNKHYISIFINGRYIKNFVLNKAIIEGYHTLLTIGRYPICYLNIEMDPILVDVNVHP
TKLEVRLSKEEQLYQLIVEKIRYAFKDRILIPQNDLDRTPKKNKVLNQFEQQKLDFERRQ
QNSNQDKTNSHYYGMSESKLQNPNLEKNDLDNNELINESTENFVHNNKRSDDKDYFQIQK
EILNDLDNGDASLLNDESTNDSEEVVTEQSNNDEASSKTYQTLYSKQDNNDIKGKVSNTP
SRRVPYMEVVGQVHGTYIIAQNENGMFMIDQHAAQERIKYEYFREKIGEVTNEVQDLLIP
LTFHFSKDEQMIIDQYQDELDKVGVHLEHFGGHDYIVNSYPVWFPKAEAEEIIQDMVELV
LNDKKVNVKKMREDAAIMMSCKKSIKANHYLKNNEMADLIDQLREAEDPFTCPHGRPIII
NFSNYELEKLFKRVM
>SEQF2892_00991 Glycerol uptake operon antiterminator regulatory protein
MKEYVLPAIRNMKDLEKLIKTDYKICVLLDMHIGHLKSVMALLKANQIETYIHIDLIKGM
AVDEFACEYIIQTYKPKGIVSTKSKVIQKAKSLNKLTIFRVFIIDSQALSRSINLIKKVE
PDFVEVLPGIAHKVVKIIDEETPSKVIAGGLINEESEIVQALDSGASYVTTSNRLLW
>SEQF2892_00992 Glycerol uptake facilitator protein
MNVYLAEFIGTAILILFGGGVCANVNLKRSAGQDSDWIVIAAGWGLAVSMGAYAVGKFSG
AHLNPAVSIALAMDGSFSWAQVPGYIICQMLGGIFGGVLVWLMYLPHWKATEDQGAKLGV
FSTAPAIKNYFANFLSEIIGTAILCLGILFIGVNKIADGMNPLIVGGLIVAIGLSLGGPT
GYAINPARDLGPRIAHAILPIAGKGGSNWGYAIVPVLGPIAGGMLGAVIYKVFYKGQFDL
ICAVGILLVIATLVLGLVLNKSNKSNDIESIY
>SEQF2892_00993 Glycerol kinase
MEKYIMSIDQGTTSSRAILFDKEGDIKGVAQREFKQYFPKSGWVEHDANEIWTSVLAVMT
EVLNENEINADQIEGIGITNQRETTVIWDKNTGRPIYHAIVWQSRQTQSICHELKEQGHE
ETFRNKTGLLLDPYFAGTKVKWILDNVDGAREKVENGDLLFGTIDTWLVWKLSGGEAHIT
DYSNASRTLMYNIYDLQWDDELLDLLNVPKQLLPEVKESSEIYAHTKDYHFFGQEVPISG
IAGDQQAALFGQACFERGDVKNTYGTGGFMLMNTGEEPVKSESGLLTTIAYGLDGKVNYA
LEGSIFVSGSAIQWLRDGLRIINSAPQSENYATRVDSTDNVYFVPAFVGLGTPYWDSEAR
GAIFGLSRGTEKEHFIRATLESLCYQTRDVMEAMSKDSKIEVNNLRVDGGAVKNNFIMQF
QADIVNTAVERPEIQETTALGAAYLAGLAVGFWDSKDEIANRWQLETEFTPQMSEEDRTK
LYKGWKKAVEATQVFKLED
>SEQF2892_00994 Aerobic glycerol-3-phosphate dehydrogenase
MALSTLNREVIKKNLQNEEYDVVIIGGGITGAGIALDASQRGMKVALVEMQDFAQGTSSR
STKLVHGGLRYLKQAQIKVVAETGKERAIVYENGPHVTTPEWMLLPMHKGGTFGKFTTNL
GLTAYDRLAGVKKYERKKMLSKKQTLNKEPLVKKDGLKGGGYYVEYRTDDARLTIEVMKR
AEENGAEILNHTKSTDFIYDSKSKVRGIEVQDLLTGEMYEINAKKVINAAGPWVDEVRKK
DYTRNNKQLRLTKGVHVVIDQSKFPLRQAVYFDTEKDGRMIFAIPREGKAYVGTTDTFYD
NDKTKPLTTQEDRDYLIDAINYMFPDVNVKDEDIESTWAGVRPLILEDGKDPSEISRKDE
IWEGKSGLLTIAGGKLTGYRHMALEIVDLLAKRLKQEYKLTFAECKTKHTPISGGDVGGS
ANFESFVERKVEEGKAIGLQADVAKRLASKYGSNVDKLYNIAQIAQDKDLKLPLELYVEL
VYSVQNEMVFKPTDFLIRRSGKLYFNINEVKQYKDAVVEELAKLLNYTQSQQNEFTKEIN
IAIEEATRGNEQLAVLK
>SEQF2892_00995 Monoacylglycerol lipase
MSQQSFKITVEDGTMIEVKVDKAKIATFGVVHIFHGMAEHMDRYEALVQALTHQGYDVIR
HNHRGHGIDIDENERGHYDDMNIIAQDAYEIAQTLHGSNNNIPYIVLGHSMGSIIARLFV
EKYPDIAQGLILTGTGQYPKYKGIPAIIVLKLITLIFGKRSRLEWVNQFVYKSFNKKIDQ
PETSSDWLSSKRDEINKFVKDDYTGFLVSNQLIYQTVKNMIRTANNNQLKKMNEQLPILL
ISGKDDPFGDYGKGIRKLGKKFKRAGINHITVQLYANRRHEILFEDEKEMIWSHMFEWIQ
KQVLKKK
>SEQF2892_00996 tRNA dimethylallyltransferase
MSDINKPFLVVIVGPTASGKTELSIELAKQINGEIISGDSMQVYKQMDIGTAKVTNEEMD
GIPHYMIDILNPDDSFSVYDFKLRAQALIEDITSRGKIPIIAGGTGLYIQSLIYDYPFDD
ETVSKEVEQKTQLQLQKLEPLTNQEVHDYLATFDPQSAKDIHPNNRKRVLRAIEYYLNTK
KLISSRKKVQQFTENYDTLLIGIEMSRKTLYSRINKRVDIMLGHGLFNEVKNLVEQGYES
TQSMQAIGYKELVPVVNGELSIDQAVETLKQHSRQYAKRQLTWFKNKLTVQWFNRETMSL
QMMLDEITTQINKRSSKHDCKPQHPRSSTREL
>SEQF2892_00997 RNA-binding protein Hfq
MIANHNIQDQALENFKSQQTEVTVFFLNGFQMKGVIEDFDKYVVSLVSQGKQHLIYKHAI
STFTVETEVSDSEESVNSEE
>SEQF2892_00998 Glutathione peroxidase  BsaA
MENIYDFVVQKSNGEDYKLEEYKGKVMLIVNTASECGFTPQFEGLQALYEKYKDQGFVIL
GFPCNQFGGQEPGSGAEANQNCKINYGVTFPIHEKVDVKGENQHPLFRYLTDAAKGMLSE
KIKWNFTKFLVDRDGNVVSRFSPQKKPAQIEKDIEKLL
>SEQF2892_00999 GTPase HflX
MTQQITHETKKKLETAVLVGVHAQNDNEFNFDSTMEELKALSLTCQLDVKGQVTQNREQV
DHKYYVGKGKIDELKAFIEFHDIDVVVTNDELTTAQSKTLNDNLGIKIIDRTQLILEIFA
LRASSREGKLQVELAQLDYLLPRLQGHGKSLSRLGGGIGTRGPGETKLEMDRRHIRTRMN
EIKHQLKTVVEHRERYRSKREQNQVFQIALVGYTNAGKSSWFNVLSGEETFEKDLLFATL
DPKTRQIQINEGFNLIISDTVGFIQKLPTTLIAAFKSTLEEAKGADLLLHVVDASHPEYR
SQYDTVNQLINDLDMNQIPQEVIFNKKDQCGDSDDKPLSASPSIFVSSRDEEDKLKVKAL
LIDQVKSTLSFYEEIVPSTNADRLYFLKQHTLIEEMNFNPENETYIITGYKK
>SEQF2892_01000 hypothetical protein
MKMSDITSMVKDVEKTLAPYFKEIEEIAYSNQEKVLNAFHYVKATESDLVGSTGYGYDDF
GRDHLEEIYAHTFKAEDAIVRPQIISGTHAITLALQSTLKYGDELLYITGSPYDTLLEVI
GVNGNGIESLKEHGVEFKEVPLKDGQIDIQSSIEAISEKTKVVAIQRSKGYDQRPSITID
EIESAIHAIKSQYPNVIVFVDNCYGEFVEQREPIEVGADLIAGSLIKNPGGGLAKIGGYI
AGRKDLIERCGYRLTAPGIGKEAGASLYSLQEMYQGFFLAPHVVSQSLKGALFTSLLLEK
MKMKTVPKYNVKRTDLIQTVQFDAKEQMIAFCQSIQHASPINAHFSPEPSYMPGYEDDVI
MAAGTFVQGSSIELSADGPIRPPYEAYVQGGLTYEHVKLAVTRAVTYLKEQNLI
>SEQF2892_01001 HTH-type transcriptional regulator GlnR
MSNDKIRRNMAVFSMSVVCKLTELTARQIRYYETHELVMPERTEGNKRLFSLNDLERLLE
IKSLIEKGFNLKGIKQIITNNQGHLTSDEQEIRKRMIVDATQKPPGEALPINRGDLSRFI
K
>SEQF2892_01002 Glutamine synthetase
MPKRTFSKDDIRKFAKEENVRYLRLQFTDILGTIKNVEVPVSQLEKVLDNEMMFDGSSIE
GFVRIEESDMYLCPDLDTWVIFPWTAGQGKVARLICDVYTTDGEPFAGDPRNNLKRVLKE
MEDMGYTDFNLGPEPEFFLFKLDEKGEPTLELNDNGGYFDLAPTDLGENCRRDIVLELED
MGFDIEASHHEVAPGQHEIDFKYADAITACDNIQTFKLVVKTIARKHNLHATFMPKPLFG
VNGSGMHFNVSLFKGKENAFFDPNGEMQLTEDAYHFTAGILNNARGFTAVCNPLVNSYKR
LVPGYEAPCYIAWSGKNRSPLVRVPSSRGLSTRIEVRSVDPAANPYMALATILQAGLDGI
KNKTKVPEPVNQNIYEMNREEREAVGIQDLPSTLYTALKAMRENDTVKKALGNHIYNQFI
NSKSIEWDYYRTQVSEWERDQYMKQY
>SEQF2892_01003 hypothetical protein
MKNMQRILGLTIQEVVKKADDFDVYVFRNKAKKYVKRIDFSDEANKALKLYNLTMKVSRE
KLLKQQLDLMVKDSTLDIQDKLENKLVEAVDREVERQAHILGEHVKIDDNEVKAVVNSNF
KGVNWSTRLWQDMALVQKEVETTTSNVLLRGRHPNEYVSEFKKQTNSTTNNASRLLVTES
ARVQAESQKLTYLKELGKDGEYKYVAKIDKKTSKICHSLNGNVFKFKDMIPGVNALPQKY
YSTTCGKLAE
>SEQF2892_01004 hypothetical protein
MLYRRSTTVPHVGNWRNKFFNERKGKYQTENKVIEKEKLQEQAKKEMLDMIHSGKIRIDI
NPEKQNRHCKNHRLFEESKSKAIKNNYMLPSYTTIPNRELNKLLMEKSNTGIMLLVNNKF
NKKEIIDFGVVIGKAFVNGRYINTKLGKVHYSKTGTHVVPYIKKEMKK
>SEQF2892_01005 hypothetical protein
MRIARSYGHKVNVVLNDDNKLFGDVINFENPYESDSANFVMDLETELGIYSIDDSEIKEI
RIIS
>SEQF2892_01006 hypothetical protein
MENNQSNITEEAKSNENLETPNEQIQQNEKTFSQEEVSQMIKDRLARERRKSDEVWDINN
IIMLSSKFTVAD
>SEQF2892_01007 hypothetical protein
MKENEALKAEKALSQMRNETRSMLSESGVENFDDQIVDIIGKP
>SEQF2892_01008 hypothetical protein
MNKLIEYKLENLLKNYKRQYVSVGIKDLATLTGLSKSTLQNKIVCKPEIVEVTRRMGFRV
IYLYPEVLDAYQKVINRIGI
>SEQF2892_01009 Low specificity L-threonine aldolase
MISFENDYLEGAHENVLQRLFDTNLIQASGYGDDQFSKQAAEQIKSVINCPEATVRFLVG
GTQTNQVVINSVLEPYEGVISADTGHVAVHEGGAIEFSGHKVLTVPSHEGKIRPKEVNAY
LDTFYNDFKREHMVFPGMVYISHPTEYGTLYSKKELKNLADVCKEHNVPLFMDGARLGYG
LMSDQSDLTFEDIAKYCDIFYIGGTKIGALCGEAIVFTKNNEPKHFTTRIKQHGALLAKG
RLVGVQFLELFTNNLYLDISRHAINMANKMKKGFLEKGYQLYFDSPTNQQFFVLSEEKIK
ALKQKVKFAIWEKYDDNHRVVRFATSWATTEENVDKLLELI
>SEQF2892_01010 hypothetical protein
MSKIKFKKIQEKTLDELEKEINMYLESDEGSQFEVLNISIDKIEERKFPNNEEVLNAILI
LNAK
>SEQF2892_01011 Cardiolipin synthase
MKFMFGPDLGTVFTILLALGFVINLVLAFIIIFLERNRRSASSTWAWLFVLFVLPLIGFI
LYLFFGRTVSKRKMEKNNGKELDTFKNVIKDQVKQFDAHNYQTDNQQVTKHRDLIRMLLN
KQDAFLTEDNHIDLFTDGNKLYEKVIEDIYNAKNYIHLEYYTFELDGLGHRILDALETKL
KEGLEVKILYDDVGSKKVRMSKFHHFESLGGEVEAFFASKFPLINFRMNNRNHRKIIVID
GQVGYIGGFNIGDDYLGLGKLGYWRDTHIRVEGDVIDALQIRFILDWNSQAHRPQFEYDD
KYFPKKRQHKGKSAIQIASSGPAFDLHQIEYGYTKMIMSAKKSIYMQSPYFIPDQSYINA
LKMAANAGVDVHLMIPCKPDHPFVYWATFSYAAELLNSGVKIYTYQNGFIHSKVMMIDDE
ICSVGSANMDYRSFALNFEVNAFIYDEEIAKEIRVAYEDDIKKSKLLTLEKYNNRSLSIK
VKEDIAKLVSPIL
>SEQF2892_01012 Arginine transport ATP-binding protein ArtM
MIYINQLKKSFGKKTVLNNISLDIEEGKCTALIGKNGAGKSTLIDILIGHKHANSGTVED
KLNLISSHNMGILFQTTNLPKLIKVKELYHLYQQLYTNPMTFNEFQKLTQFSNLQLEQYA
NKLSGGQKRLLDFVLTLIGKPQFLILDEPTTSMDIETREHFWNLIEQLKEDGITILYTSH
YIEEVERMADKVVYLEQGSIKINDTPHNILFSQNNSIIEIMTFTEEQYQILSETYDIEIT
NGNLKIQTENVEAVITNLIKINVDLNQITIYKKSLLELMFSKEERVVQ
>SEQF2892_01013 hypothetical protein
MTNIITLLDIEYKLLFRRKLSSFMAFIFPLAFYLLFTSLIDMPADAKKVFYKEYMYSMTV
FSLMGFCLMQFPLEIIEERNSGWYKRLISTPITVLNYYLAKIIKTMTLFLASILLLFCVA
HFYKGVDLSVSEWILSGVSLWLGASMFLTLGLIITQFTETQKASSVANLCNIVLAIIGGL
WFPVSTFPDWMQTIAKLTPTYHLRHLALEFGKGNGFNVQSFIILGIYSIIFLIIALLINK
SKEVE
>SEQF2892_01014 Sensor histidine kinase DesK
MKRSLGAKMGEISSLIYLIFPYYGLYLTWQDDSFLLNLFIVIIFTFAYASLILFHEALSH
RINLMLFFIHFLAIIYFVYAYNPTLSLFFFFSAFAIPFLFKRGVKSIEFMLLISSMITCI
IITIIQTNHFYVVSIIIYYIVILAILFGNFKIMKERQYRQQIEEKNKYINILIAEQERNR
IGQDLHDTLGHVFASLSVKSELAAKLIDKDPIAAKKEILNINEISKDTLEKVRHIIENLK
VQTFEEEIQSIEQFLKDANIHFNFENIRGASSLNPTKQTILSMILREAVNNVIKHAEASE
INGKIESYDNGIKLIISDNGIGLKQPSEVKLKSINDRVALLSGTVNITSKQGTTIDIMIP
REGVK
>SEQF2892_01015 Transcriptional regulatory protein DesR
MISIVIAEDQNMLRKAMIQLIEFHDDLKVIDDFDNGIDALQSINSQQPDIAILDIEIPGM
TGLEVLSQLRENKINTKVIIVTTFKRPGYFERAVANDVDAYVLKERSVDDLVATIHKVLN
GEKEYSTSLMTSLFKEANPLTHKEQVVLREIGEGLSNKEVADKLYLSNGTVRNYTSNIID
KLEAENRFDAWKKANEKGWI
>SEQF2892_01016 hypothetical protein
MEILDVIIDNHGLIYKVQTQNGHVFEHTLAKDTPPDKVAQVLRLLATHVDNLETQKRDN
>SEQF2892_01017 hypothetical protein
MSEKNENLLTTVAVIIAIIVGVILQIVYKLPIIVSVVVAVLLGVLVGFIAYIIQSIIRKR
KNK
>SEQF2892_01018 Thermonuclease
MNSKKSLSIIVLAVLVVGVLAFQFINHTGPFKNNGSQSSNSTNIKDKEKVHVDRVVDGDT
FVATNSEGKEIKVRLIGIDTPETVKPNTPVQPYGKEASNYSKQHLNGKDVYLEYDKEKED
RYGRTLAYVWLDENIMYNEELVKNGLAREKYFSPNGKYRSLFEKDEQQAKKDKVNLWS
>SEQF2892_01019 hypothetical protein
MTLTIILIVIIVILILAFILNQRYMQDRVDTEVYARNQMVTKNATLSNENLELKNQMLSS
NNDVSSHAKRNAKHVLTSILDKYKDEGKLKYYDIITTSNLATKHPFFEYARTFDYIVVSD
VGLINIDVKNWKQKTFYHFDAPVDDDMQIDTSDVNQIVGHYVSKQYHSQFDSPRSEIYTF
VEKIQNNRVIYEFYDHDPYEQAAINSKVLKDGIENHFNHKVQSIGVVYFSDGSVNIIEGS
EERAQYVDTVSTKSSLEAVIKNAIDLSKHPLSEDQVNKIVNSFNN
>SEQF2892_01020 hypothetical protein
MYESVSFGGSNMEHQQHVEELVKILKNECRTSFKFHGEVAMQLFLSDNFILPSRVDICVE
RKQLVEVLKVISSTYHLNYYDKNNNLMNRDQLSVPEIAHIDITFNGELLMNIFIYDVVNE
EWIFRLDSNIRIPKNSIYFHSLTWGVDYIKPEIVLMYDLLDNQNYHQLPNYKMVLDSLSY
YQFVILKVVVGEQRINEALAHNKL
>SEQF2892_01021 Aspartokinase 3
MKVAKFGGSSVSNATQIKKVLDIVNSDSDRKIIIVSAPGKRHKDDVKTTDLLVRLYEKVM
NNLNYQDKRKEIIQRYADILHDLDMDDSLLKVIDDTLEEIISTLKDKPLRLYDAILSCGE
NFNAQLIASYNDSQGFKTTYLSPKDAGILVTDLPQQAQILEEAYEKISKLKDIEGKIIIP
GFFGVSKNDYVVTFPRGGSDITGAIIARGIRASLYENFTDVSGIYKANPNIINNPDLIEE
ITYREMRELSYAGFSVFHDEALQPLYKHRIPVVIKNTNRPQDKGTFIRHDRDVSDKNVII
GISCDKGFSVINIKKYLMNRQVGFTRKILEILEDYNISFDHMPSGIDSISIILRTYQLKG
KEKDVLNAIRKRCDVDELSIEHDLAILMIVGEGMNKAIGTANTITHALAESNINLKMINQ
GSSEISMMFGISIEDADKAVLSTYEYCYHGICLKNLNKQA
>SEQF2892_01022 Homoserine dehydrogenase
MKELNIALLGLGTVGSGVVKIIEENRQQIIDTLNKDIVIKHILVRDKSKKRPINISRYHL
TEDVNEILNDDSIDIVIEVMGGIEPTVDWLRDALKSGKHVITANKDLLAVHLKLLEDLAE
EKGLALKFEASVAGGIPIVNAINNGLNANNISKFMGILNGTSNFILSKMTREQTTFEDAL
DEAQRLGFAEADPTDDVEGIDAARKVVITSYLSFNQVIKLNDVKVRGISQTTLSDINVAD
KLGYKIKLIGKGTYQNSKVNASVEPTLIHKSHQLATVEDEYNAIYVVGDAVGDTMFYGKG
AGSLATGSAVVSDLLNVALFFESNTHTLPPHFELKTDATREIMDTEDVVAIQEKLNYYIV
LNSDLSKEKFKSLLKETLPFHKSLQVEQRDEQTYGVVIIGLDQSPEDVLSKADFNIEKIY
PVEGV
>SEQF2892_01023 Threonine synthase
MFMKRWQGLVEEFKEYLPVNSDTPKLTLNEGHTPLIHCENLSKMLDIDLYVKYEGANPTG
SFKDRGMVMAVTKAKEQGKKVVICASTGNTSASAAAYAARAGLKAIVVIPEGKIALGKLS
QAVMYGAEIVSIEGNFDEALEIVKEIAENDEEIELVNSVNPYRIEGQKTGAFEIVEQLEQ
APDVLAIPVGNAGNITAYWKGFKEYHEKKGSQLPRLFGFQAEGASPIVQNKVIKNPETIA
TAIRIGNPASWTKATNALDESNGLIDSVTDEEILEAYQLMTSKEGVFSEPASNASIAGLI
KLHRAGQLPKGKKIVAILTGNGLKDPDTAISILDNPIQPLPNDKSSIIDYIKGAL
>SEQF2892_01024 Homoserine kinase
MTEQLHLKIPASTANLGVGFDSIGMAIDKYLHLYVKRIEEEEWEFTYLNSELDSLPKNKD
NYVFKVAQQVASKYNVKLPSLSVEMRSDIPLARGLGSSASALVGALYIANYFGNIQLSKY
ELLQLATEIEGHPDNVAPTIYGGLLAGFYNPDTKETNVTHIDVPDVDIILTIPPYELKTE
DSRNVLPDQFSHKRAVQSSAISNTMLCALIQHNYGLAGKMMSQDGFHEPYRQHLISEFKE
VKAIAQQYDAYATVISGAGPTILTMSSKEKSGQLVRALRKAVTTCHSELATINEIGVVEE
IVYPS
>SEQF2892_01025 Putative phosphatase
MSNYKMIVMDMDDTLINSENKVSKETKNYLIDIQNQGYKVVLASGRPTEGMLPIAKELEL
DVHDSYIISYNGGKTIKVATEEVEVSQSVSKKNFDLIVDFCREHNFLILTYQDGHIIHDG
DHEYRDIESELTGLPMKRVNDIKAYINDSVPKAMGVDYATNIAKVRDDMHGSFNSEIDVT
TSKPFFLEFMAKDVSKGNAIKALCEKLNVSLSEVICFGDSLNDQSMFEVVGCAIAMGNAN
EELKAIADKITLDNDSNGIPAALKTLL
>SEQF2892_01026 hypothetical protein
MVGQTNLFDDVIKSEERFVIVVQSLEEKNGQLLKRTLREYPSLEHDQMENLFTHLKDVFS
TEPFRENQSAFTITVYTNLDYAADQVYAYVKRSKGKHEWTHTAK
>SEQF2892_01027 Lysine-specific permease
MEDNNMKRGLNSRHISMIAIGGAIGTGLFVATGSVVAQAGPGGAILAYLLIGIMLYFLMS
SIGELATFYPVSGSFSSYATRFVDPSLGFTMGWLYYIMWALVSSVDVMVASNVLYYWDIF
KFFSPLTWSLIFITIVFLLNIFTVKAFGETEFWLSLVKVVTIIIFIIVGFLMIFGILGSH
TYGFENYTKGEAPFVGGLSGFLGVLLVAGFSVGGTEVVAVTAGESDNPEKTMPKAVKQVF
WRILLFYVLSIGVIAAIIPYTDPLLLNENESVTQSPFTIVFDRIGVAFAASVINAVILTS
LLSATNSGVYTTSRMLFSLSDEKQAPKFLSKLNEKSKLPLRALVTTYILIVAIIIIANFY
SNAVFSLLNIIGSLVIIVWAASSWAQVRLRKAIKLQGQDINQLLPYKSPLYPLGPILVFA
TLIFLYFGNSIGDLFDGNIGKFFVNILPIIILGLIFLAHKLIRKTKFVKLNDMDITPHHY
HKEN
>SEQF2892_01028 Catalase
MAKDDKRLTGLFGHPVSDRENSMTAGPRGPLLMQDAYFLEQMSHFDREVIPERRMHAKGS
GAFGTFTVTNDITKYTNAKIFSEVGKQTEMFARFSTVAGERGAADLERDIRGFALKFYTE
DGNWDLVGNNTPVFFFRDPKLFVSLNRAVKRDPRTNMRSPQNNWDFWTGVPEALHQVTIL
MSDRGMPKDFRHMHGFGSHTYSMYNDEGERVWVKYHFRTQQGIENYTDDEAAEIVGQDRE
SSQRDLYDAIENGDYPKWKMYIQVMTEEQAKNHPDNPFDLTKVWYKGDYPLIEVGEFELN
RNPENYFMDVEQAAFAPTNIIPGLDFSPDKMLQGRLFSYGDAQRYRLGVNHWQIPVNQPK
GVGIENMCPFSRDGQMRFLDGNQGGGPHYYPNNKGVYQSQPEYKKPAFPVDGDGYEYNQR
QDDDNYFEQPGKLFRLQSDDAKERIFTNTANAMDGVSEDVKHRHIRHCYKADPEYGKGVA
KALEIDINDVDLEGTNDETYENF
>SEQF2892_01029 50S ribosomal protein L33 2
MRVNVTLACTECGDRNYITTKNKRNNPERIEMKKYCPRLNKYTLHRETK
>SEQF2892_01030 Alternate 30S ribosomal protein S14
MAKKSKIAKEMKREKLVNQYYELRKELKAKGDYEALRKLPRDSSPTRLTRRCKVTGRPRG
VLRKFEMSRIAFREHAHKGQIPGVKKSSW
>SEQF2892_01031 GMP reductase
MKIFDYEDIQLIPNKCIVESRSECDTTVQFGPKTFKLPVVPANMQTVMSEELAHWFAKND
YFYIMHRFDEAARIPFIQKMQKDGLFASISVGVKANEFKFIEELADKQLVPEYITIDIAH
GHSDSVIKMIKHIKKYIPKTFVIAGNVGTPEGVRELENAGADATKVGIGPGRVCITKIKT
GFGTGGWQLAALNICSKAARKPIIADGGLRTHGDIAKSIRFGASMVMIGSLFAAHEESPG
ETVELDGKRYKEYFGSASEFQKGEHKNVEGKKMFVEHKGSLKDTLVEMQQDLQSSISYAG
GKDLKSLTTVDYVIVRNSIFNGDKD
>SEQF2892_01032 hypothetical protein
MYVIKKFLLFSLVLLVVALFIPLKENQTLVKLQNDVRSKVQQVMNQDSSLKNNTLKTPTE
QDFAINNIQMNMSKDKVENQLGKPKRVTSNEYGAKWYTYYNNDYDNFIMVSYLGNKVNAL
YSNQNVITSKSKVKYNTPKNVVEDRLGKPLKEIVKGRYRVDISSDEYDVFHEDNIYTTVF
YDKHNDNGVTALLQVSDAMEKRLTQHYGAPSSTLEQSFEYQNYDLVNSERKQHGLNTLSY
SKDVSNTARNHSEDMVKQNYFDHNNLDGESPFDRLKDDDIDFNVAGENLAYGQQNSIFAH
EGLMNSLGHRKNILNTNFSTLGVGVDFNEKRQPYWTENYTG
>SEQF2892_01033 hypothetical protein
MTTKDVNKLDILDKVKEILNKKENEKQKN
>SEQF2892_01034 LexA repressor
MRELTKRQSEIYDYIKHVVQTKGYPPSVREIGEAVGLASSSTVHGHLSRLEEKGYIKRDP
TKPRAIEIVSEQTNDAVNMEETIYVPVIGKVTAGIPITAVENIEEYFPLPEHLTSTHNSD
IFILNVVGESMIEAGILDGDKVIVRSQTIAENGDIIVAMTEDDEATVKRFYKEKTRYRLQ
PENSTMSPIYLDNVTVIGKVIGLYREL
>SEQF2892_01035 hypothetical protein
MFNKYKNKLLTNIAVVSISCVVFIVFFMNLYHNAQMEQTYEITDHTISKKAIIKDDNKNV
NTTNGEQNNYKVFAFVR
>SEQF2892_01036 hypothetical protein
MSNDNLNIDRINELAKKKKEQGLTEAEAKEQSKLRKKYLEAFRKGFKQQIESTKVIDPEG
NDVTPEKLKKIQEQNKD
>SEQF2892_01037 Transketolase
MFNEKDQLAIDTIRALSIDAIEEANSGHPGLPMGAAPMAYTLWTRHLNFNPQSKDYFNRD
RFVLSAGHGSALLYSLLHVSGSLELEELKQFRQWGSKTPGHPEFRHTDGVEVTTGPLGQG
FAMSVGMALAEDHLAGKFNKDDFNIVDHYTYVLASDGDLMEGISHEAASFAGHNQLDKLI
VLYDSNDISLDGELNKAFSEDVKKRFESYGWNHILVKDGNDLDAIDKAITKAKSQNGPTM
IEVKTIIGYGAPNVSGTNGVHGAPLGSDERKLTFEAYGLDPEKRFNVPEEVYEIFQTTML
KRANEHEDAWKALLENYSKQYPELADEFKLAISGKLPKNYRDELPRFDSDHNAATRADSG
EVIQALSKSVPSFFGGSADLAGSNKSNVKEATDYDRNTPEGKNIWFGVREFAMGAAVNGM
AAHGGLHPYGATFFVFSDYLKPALRLSAIMGLNSTFIFTHDSIAVGEDGPTHEPIEQLAG
LRSIPNMNVIRPADGNETRVAWEVALESEQTPTSLVLTRQNLPYLDVDEETVEQGVRKGA
YVVFETETKPEYLLLATGSEVSLAIEAAKDLDKQGKGVRVVSMPNWFAFEQQPEEYKESV
IPKEITKRVAIEMASPLGWHKYVGTEGKVIGIDQFGASAPGDLVVEKYGFTKENVLNQIR
TF
>SEQF2892_01038 hypothetical protein
MGETMATWLAILLIIVALIGGLVGGFFLARKYMMDYLKKNPPINEEMLRMMMMQMGQKPS
QKKINQMMTMMNKNMDQNMKSSKK
>SEQF2892_01039 hypothetical protein
MAYLIFSVVFALFMGIVVIFIRMKAQNFPVNEKKIILPPFFMATGALMYVIPYFRLTGTE
ILESIILGVLFSSVLIWTSHFEVHGTEIYMKRSKAFPIILISLLIIRTVIKIFISSKIDP
GEIGGMFFLLAFSMIVPWRLAMLYKYKKLKRATVK
>SEQF2892_01040 Nuclease SbcCD subunit D
MKVIHTADWHLGKILNGKQFLEDQHYILNKLIDNLKEEKPDVLVISGDIYDTSYPSKETI
RLFEETIKIINVNMKIPTIITNGNHDGRERLNYGSTWFEFSQLYIRTQLELMSTPITINN
INFYTLPFATISEIKAYFDDDDIKTYEQATQKCINHISKIIDPNQINILIGHLTIKGGKT
SESERPLTIGTVESVESANFNIFDKVLLGHLHHPFSITDNIVDYSGSLLQYSFSEVNQAK
GYKKLMINSKGDINTKFVQLKPLRELEEIEGDYSAVIQGDVPVKNKDNYFHFKLKNMSHV
TDPIIHLKQIYPNTLSLSNITFENHNKSTYADFKTTDDPTIIKNFYKTITDEDLTNYQEK
KIHQLLNQVINRED
>SEQF2892_01041 Nuclease SbcCD subunit C
MRPTKLILNNFGPFIHEVIDFEQINKEQLFLISGKTGSGKTMLFDGIVYALFGKASTEGR
NEGELRSHFADGKSPMSVEYEFKINDKKFKISRQAGFIKEGNTSLTPGKLDVFEFDEESQ
LYELRESKISSGNGFIKDLLGINAEQFRQLFILPQGEFKKFLVSNSSDKQSILRTLFNSI
RFEEMQNLLLNQVKDEKKQIESRYSRIQILWEDIETFENDELIQFKSLNSMQTKDIIKAI
PQFELVGQHLNEEYEQLKSEHNDALEAIKRKIEENNKLIESLKELDRNKDKKVQLEKNKD
SIEKLKAELRKIIEIKPLSQLYNQRNTKEQKYENTKVKLNSILEELNELNDKLEKFKKEK
EILNEQLEDINIKSEYIDKTKQFYSNINKYREAFNEIKQNETYLKENNQKQEENKNLIDK
LNNDIAKIDVNNENIDEITQEIFQLTNTFDKKVTLRENKKKYQSLSQKYNETENSIKKTK
EQISDLKLQLENIDKSNIDLNDKQTFIQEIQNALHVGDTCPICGNEIESLNEHIKFDEIA
KNQNLIKEVNNQLNKKINELTKLETTSDYISNQMSELEINDDEISDINEIEQQLRTKNKE
KEKLQIQIKQREKLKSALDKHKDIKHSLQIKHEKLLSLKHQFETLINEFKSYTNYDETNK
FEQCFKQYEQIVTDYVSKSEVLEKEINQTKQQIEIETNNLNNNKLAIKELEQEISGHSDE
INQEMKRIGLNSYKDVEILLSKLENKEQIEMKIQQYEHDHQKLTLEIERLSKLTKDNKSE
SVEKLEATKTEIESNYNKYVEASATIQYQVQKNKDKFNSIMDHINYLEKELKEQQEIFEL
SEVLSGKNSKKLTLENYVLIYYLERIIHQANIRLERMSGERYQLKRRESISHGYSGLEIE
VFDFHSNKSRHISSLSGGETFQASLALALGLSEVVQQESGGITLESMFIDEGFGTLDQET
LETALDTLVKLKTSGRMVGIISHVSELKQRIPLILEVTSNQYQSHTRFKWN
>SEQF2892_01042 Large-conductance mechanosensitive channel
MLKEFKEFALKGNVLDLAIAVVMGAAFNKIVTSLVTYIIMPLIGKIFGSVDFSKDWEFWG
IKYGLFIQSIIDFIIVAIALFIFVKIANTLVKKEEPEEEIEENTVLLTEIRDLLRAK
>SEQF2892_01043 Glycine betaine transporter OpuD
MNSSSEETKQNKKFSSVFIYSAIVVAIVVSIGAFLPEQFGKITGDISSWITEKLGWYYMI
LTTVIVFFCIFLIFSPIGKLKLGKPNDKPEFNTVSWFAMLFSAGMGIGLVFYGAAEPMAD
FASPPNADPKTTEAYTEALRSTFFHWGFHAWAVYGVVALALAYAQFRKNEPGLISRTLRP
ILGDKVEGPIGTIIDVLSVFATVVGVAVSLGMGALQINGGLHYLFGVPNNVWVQSIIIVV
VTILFLASAWSGLSKGIQYLSNLNIGLGTVLMIIALIIGPTVLILNMFTSSTGSLLNSFL
FNSFDTAALNGQKREWMSSWTLYYWGWWLSWSPFVGVFIARVSKGRSIREFISGVLLVPA
IVSFLWFSVFGVLGIETGKKHPELFKMTPETQLFGVFHHVPLGMALSLIALVLIASFFIT
SADSATFVLGMQTTFGSLEPSSAVKVTWGVSQSLIAFILLLAGGGNGADALNAIQSAAII
SAFPFSFVVIMMMISFYKDANQERKFLGLTLQPNKHRLQDYVKYQQQDYESDILEKRESR
RNAEK
>SEQF2892_01044 Aconitate hydratase A
MTSNIKQQAKKTFEANGQSYTYYDLKSLEEQGLTKISKLPYSIRVLLESVLRQEDEFVIT
DEHIKALGNFGNEGNEGEVPFKPSRVILQDFTGVPAVVDLASLRKAMNDVGGDINKINPE
VPVDLVIDHSVQVDSYANPDALERNMKLEFERNYERYQFLNWATKAFDNYNAVPPATGIV
HQVNLEYLANVVHVRDVDGEQTAFPDTLVGTDSHTTMINGIGVLGWGVGGIEAEAGMLGQ
PSYFPIPEVIGVRLTNSLPQGSTATDLALRVTQELRKKGVVGKFVEFFGPGVTDLPLADR
ATIANMAPEYGATCGFFPVDEESLKYMRLTGRKEEHVELVKAYLEQNNMFFTVDKEDPEY
TDVIDLDLSTVEASLSGPKRPQDLIFLSDMKKEFEKSVTAPAGNQGHGLDKSEFDKKANI
NFADGSTATMKTGDIAIAAITSCTNTSNPYVMLGAGLVAKKAVEKGLKVPEFVKTSLAPG
SKVVTGYLRDSGLQEYLDDLGFNLVGYGCTTCIGNSGPLLPEIEKAVAEEDLLVTSVLSG
NRNFEGRIHPLVKANYLASPQLVVAYALAGTVDIDLQNEPIGKGKDGQDVYLNDIWPTIQ
EVADTVDSVVTPELFLEEYKNVYNNNEMWNEIDVTDAPLYDFDPNSTYIQNPSFFQGLSK
EPGTIEPLKELRVMGKFGDSVTTDHISPAGAIGKDTPAGKYLLDHDVPIRNFNSYGSRRG
NHEVMVRGTFANIRIKNQLAPGTEGGFTTYWPTDEVMPIYDAAMKYKEDGTGLAVLAGND
YGMGSSRDWAAKGTNLLGVKTVIAQSYERIHRSNLVMMGVLPLQFKDGESAESLGLDGKE
AISVDIDETVSPRDTVKVHAKKENGEVVDFEAIVRFDSLVELDYYRHGGILQMVLRNKLA
Q
>SEQF2892_01045 Putative esterase
MIYSMTEIEARYQETDKMGVIYHGNYATWFEVARTDYIRKLGFSYADMEKEGIISPVVDL
QIKYRKSIFYPEKVTIKTWVEQYSRLKSVYCYEVYNENGELATTGSTQLICMKSSNFRPI
RLDRYFPEWHKVYSHVDKLNQDGKDFEVTQSSDLEI
>SEQF2892_01046 hypothetical protein
MKIKLTDQAVEWFKDELDLPENNKVLQFYVRYGGEFQLKQGFSPAFRVEPREDVEIGYEE
NYNDLILVVSEEDLWYFEDNEVLVEKVDHDDEIAYSKLK
>SEQF2892_01047 Glycerol-3-phosphate acyltransferase
MMIVVMLILSYLIGAIPNGYVIGKLFFKKDIRQYGSGNTGATNSFRVLGKPAGFIVTFLD
IFKGFITVFFPIWFPVHADGPLSTFFTHGLIVGLFAILGHVYPIYLRFKGGKAVATSAGV
VLGVNPILLLILAIIFFGVLYIFKYVSLSSIIAAICCVIGSLIIQDYILFGMSLLVSIIL
IVRHRTNIVRIFKGEEPKIKWM
>SEQF2892_01048 DNA topoisomerase 4 subunit B
MATKNSNHYSDDSIQVLEGLEAVRKRPGMYIGSTDKRGLHHLVYEVVDNSVDEVLNGYGN
EINVTINQDNSISIEDNGRGMPSGMHASGKPTVEVIFTVLHAGGKFGQGGYKTSGGLHGV
GASVVNALSEWLEVEIHRDGNIYKQSFKNGGVPASGLVKSGKTKKTGTKVTFKPDPEIFK
ATTTFNFETLSERLQESAFLLKNLKITLKDLRNGKEREDVYHYEEGIKEFVSYVNEGKEV
LHDVTMFTGASNGIEVDVAFQYNDQYSESILSFVNNVRTKDGGTHEVGFKTAMTRVFNDY
ARRINELKEKDKNLDGNDIREGLTAVISVRIPEELLQFEGQTKSKLGTSEARSAVDSVVS
DKLPFYLEEKGQLSKSLVKKAIKAQQAREAARKAREDARSGKKNKRKDTLLSGKLTPAQS
KNTEKNELYLVEGDSAGGSAKLGRDRKFQAILPLRGKVINTEKARLEDIFKNEEINTIIH
TIGAGVGNDFKIEDSNYNRIIIMTDADTDGAHIQVLLLTFFFKYMKPLVQAGRVFIALPP
LYKLEKGKGKSKQVEYAWTDDELEKLQKKLGKGFMLQRYKGLGEMNPEQLWETTMNPETR
TLIRVQIEDEMRSSKRVTTLMGDKVAPRREWIESHVEFGMQEDQSILDNTEVQVLETEEY
TEEETN
>SEQF2892_01049 DNA topoisomerase 4 subunit A
MSEIIQDLSLEDVIGDRFGRYSKYIIQERALPDVRDGLKPVQRRILFAMHSSGNTYDKNF
RKSAKTVGDVIGQYHPHGDSPVYDAMVRLSQDWKLRHVLIEMHGNNGSIDNDPPAAMRYT
EAKLSQLSEELVRDINKETVAFVPNYDDTTLEPMVLPARFPNLLVNGSTGISSGYATDIP
PHNLAEVIQATLKYIDNPDITVTQLMKYIKGPDFPTGGIIQGVDGIKKAYETGKGKIVVR
SKVDEETLRNGRQQLIVTEIPYEVNKSSLVKRIDELRADKKVDGIIEVRDETDRTGLRIA
IELKKDVNAEAIKNYLFKNSDLQIAYNFNMVAISDGRPKLMGIRQIIDSYLNHQIEVVAN
RTKYDLDHAEKRMHIVEGLMKALSILDEVITLIRNSKNKKDAKDNLVAEFEFTEAQAEAI
VMLQLYRLTNTDIVALENEHNELANLIKEYRHILDNHDALLQVIKSELTDIRKRFKSERL
SSIEAEIAEIKIDKEVMVPSEDVVLSITRQGYIKRTSTRSFNASGVTEVGLKDGDSLLKY
QTVNTQDTVLVFTNKGRYLFIPVHKLADIRWKELGQHVSQIVPLDDYETVVDVYNEQSFK
DDAFYVLATRNGMIKKSNVSLFKTTRYNKPLVAMKVKDNDELINVIRLNEDQLISVLTHK
GMSLTYSSEELSDTGLRAAGVKSINLKDEDFVVMTDVVDSDSSIIMATQRGAVKRISYKI
LQQAKRAQRGITLLKELKKNPHRVVAGYVVKDESMYTLYSESHSEEGQITDIHLSEQYTN
GSFVVDVKEFGDVLDMTID
>SEQF2892_01050 Amino-acid carrier protein AlsT
MSDFDNLIPGWFKTIVQVGNDLIWSQYLIGLLLTVGFFFTISSKFVQLRMLPEMFRALTE
KPETLNSGEKGISPFQAFAISAGSRVGTGNIAGVATAIVLGGPGAVFWMWVIAFIGAASA
FMEATLAQIYKVHDKEGGFRGGPAYYITKGLNQKWLGILFSILITITFAFVFNTVQSNTI
AESLNTQYNVSPVVTGIILAVITAAIIFGGVRSIATLSSLIVPIMAIIYIGMVLVILLLN
IDQIVPMIGTIIKSAFGFEQVTGGAVGAAILQGIKRGLFSNEAGMGSAPNAAATAAVPHP
VKQGLIQSLGVFFDTMLVCTATAIMILLYSGLKFGENAPQGVQVTQSALNEHLGSAGGIF
LTIAITLFAFSSVVGNYYYGQSNIEFLSKNKVVMFVFRCLVVLLVFVGSVVKTETVWSTA
DLFMGLMAIVNLISIIGLSNIAIAVMKDYQKQRKAGMKPVFKPENLEINLFGIETWGREN
QLPKK
>SEQF2892_01051 GlcA/glcB genes antiterminator
MGEYTISKALNNNVIICTYNNQEVILIGKGIGFNKKAGMTLDESASIEKVYKLEQKQQQE
YYKSLVEIADEDVLQAIIESVNFITSTTHTTDDKNLVVALTDHIIFAYKRLKQNQIISNP
FAIETKHLYSDAYAIASQVIDKLNQRLDVKFPPDEIGFIALHIASNTEDLTIHEMSLINK
LISKSILIIENDLNHEIDNHTVQYQRFIRHIQFLIRRLNKKEYIYAQDVFIDMVKNHYPN
AYNTAFKISKMIQKHLNIPIDDSEIVYLALHIYHFENQISSSHN
>SEQF2892_01052 AI-2 transport protein TqsA
MAIENKQVEEKNAKKFSFTETRFMKFLGGKDLLFALLSLVLIGIVIFIFDKISYVFEPFI
IIFNTIVAPIILSLILFYLINPVINLMERYNIPRLLGIIIVFLAIVGGATLIINLLIPLI
GDQITRLANNFPKYVDKFNNAIDQVTHFSFLSSFYTQIQDWLDSVSNKIPSMVSSYFDGF
GTKIRSFAEAIVNVGVVLVTTPFVLFFMLKDGHKFKEYSTKIMPPKFRKDYHDLMEKMSV
QVGSYIQGQIIVSFCIGILLFIGYSIIGLDYGLVLACIAAVTSVVPYLGPTIAISPAIII
AIITSPFMLLKLIVVWTLVQFIEGHFISPNVMGKTLKIHPLTIIFILLSAGNLLGIVGVI
LGIPGYAILKVLVSHLFLLFKRRYNKYYGDDSGEYEIKKEETKECTQAE
>SEQF2892_01053 Phosphatidylglycerol lysyltransferase
MTEELKNRLLSILKFVFAAVLFIAVVATLYHELAHINFKQTLEAFSKINRWYLVGLFICG
GSAMILLSLYDLILVKGLKLDIPLIRVFKISYIINALNAIVGFGGFIGAGFRAFIYKNYT
TDRKKLVHAISIILISMLMGLSLLSILVVLHIFDASHIINKVSWVRWILYVVALFLPLFI
AYTMINPIDRNNKYLGVYCTLVSSFEWLAAATVLYLSTVIVDINIAFTTVIGIFIIAALS
GLVSFIPGGFGAFDLVVLLGLKSLGVPEEKVLLALLLYRFAYYFVPVIIALILSTFEFGS
SARKYFEESKYFVPARDVTSFLFSYQKDIIAKIPSFALATLVLITSFVFFINNITIVYDG
LYDDHHFAYYIMLSVHTSACLLLLINVRGVFKQSRRAILFVMISLVLIFSATIYTYASLI
LLSWILLIFILLILAYRRSKVMKRPFRLKRLIFTIILSMLVLYVNHFIISETLYALDIYH
IEMDTSLLKYYFWLTILVVVILVGIVAWLLGSRYTRPHQLEDLSRCKSIIETYGGNYLSH
LIYSGDKDVFMHEAQQAFLMYRYKGNALVVLGDPIGDTKAFQSLLIDFYNYGEKLGYDII
FYQVSDRFMPLYHNFGNQFFKLGEEAIIDLTQFTTSGKKRRGFRATLNKFDDLNIQFEIL
EPPFSKDLIFQLKQVSNQWLDGRNEMHFSVGQFTEEYLQQAPIGIMKNEEGKVIAFCTLM
PTYYNEAISVDLIRWLPDLDLPLMDGLYLHMLLWGKDKGYKAFNMGMATLSNVGQLNYSY
PRERVAGRVFEHFNGLYRFQGLRKYKEKYSPNWEPRFLVYRKDSSLWYSMLKVMRVIRHK
>SEQF2892_01054 Peptide methionine sulfoxide reductase MsrA 1
MNINTAYFAGGCFWCMTKPFDQFDGIETVTSGYMGGSTHNPTYEDVKSGTTGHYETVKIE
YDVALFSYNKLLEVFFSVIDPIDDGGQFQDRGSQYRTAIFYTNEDQKRLAEQYVHQLEQT
IHSEKAIATKILPASTFYKAEEYHQDFYKKNPERYAQEQQDRANYKSN
>SEQF2892_01055 Regulatory protein MsrR
MTEEKDKTVYRRQADAQTPSKRRNKKKLRKLPFIILIILILLIAAIIYIVHGYRSGVNYA
EKHAKDIKVHKFNGPVKNDGKISVLVLGADKASGGKSRSDSIMVVQYDYIHKKMKMMSVM
RDIYAEIPGYQNYKINAAYSLGGPELLRKTLNKNLGINPEYYAVIDFTGFEKMIDELEPN
GVPMDVEKDMSENIGVSLKKGHHRLNGKELLGYARFRHDEEGDFGRVRRQQQVMQTLKKE
LVTPSSVIKLPKVAGILRGYINTSMPNSAIFQTGISYGIRGDKNVESLTVPINNSYQNIN
TNNDGSALEIDKEKNKKAVKEFLNN
>SEQF2892_01056 putative tautomerase.1
MPIINVKLLEGRSDEQLKNLVTEVTNAVEKTTGANREAIHVIIEEMQKNHYGVAGVRKSD
AE
>SEQF2892_01057 DNA polymerase IV
MYDYNLLEERDILCIDQKSFFASVSCIQKGLNPLETKLAVVADTKRQGSVVLAATPKLKE
IGIKTGSRLFEIPHRNDIYIINPSMRKYLEVSIAISKIALKYVPGEDLHQYSIDEFFLDV
TDSYHRFNSTVQSFAERLQKEIEDKTGIYCTIGIGSNMLLSKVAMDIEAKHTSNGITEWR
YHDVPQKMWKITPLRDFWGINKKTEAKLNKKGIVTVGDLAQYPYRFLKRDFGVLGIDMHL
HANGIDQSKLREKYNVTNPSICKSQILMRDYRFEESKIVMQELIEDVASRIRARKQLART
IHFSFGYTEGGGVHKQYTLTDATNLERDIYKVVNYYANQLCDKNALYRTLSVSLTQLINE
EDRQLNLFIDEYERRRDEKLAKTIDYLQNKYGKGIVSKAISYTDAGTKHGRLGLMAGHKM
>SEQF2892_01058 Prephenate dehydrogenase
MKNILFIGLGLIGGSLASNLKYYQPNLTISAFDADKDQLEKALSIGIIDKKIEDYSEGVK
NADIIIYATPVQQTELYLKELPNYQTQSHLIVTDTGSTKSNIQSYEKFLLNNDIHLVGGH
PMAGSHKSGVLNSKKHLFENAYYILVYDDARNAESAKKLQILLSTTSAKFITTSAQEHDY
VTGVVSHIPHIIASSLVHLSETNSKNHTLVTQLAAGGFRDVTRIASSNADMWRDITFSNQ
ENILHLLEMLQQQLDSISSHIRLNDTNEVHSFFSGAKKFRDQLPVKQQGALSIAYDLYVD
IPDKSGMISKVTSILSLHNISISNLKILEIREDILGALQISFKTPEDRERGIKALSDFET
YIL
>SEQF2892_01059 Glutamyl aminopeptidase
MTQKVLKTIKELTEINSPSGNATEAINYVKNKVEALGYDTKTTNKGALIIEVQGENDEQQ
RCITAHVDTLGAMVKEIKEDGRLSISLIGGFTYNAIEGEYCEIQTDSGQVYTGTICLHET
SVHVYRNNHEIPRDGEHMEIRIDEKTTSDQETRDLGIEVGDFVSFDPRTEITSSGFIKSR
HLDDKASVAMILELLEKLKQEETQLPHTTQFYISNNEEIGYGANASISDKIVEFIAFDMG
ALGDGQTSDEYTVSICAKDGSGPYHKELKSHLINLCKINDIPYKVDIYPYYSSDASAALK
AGADIRHGLFGAGIESSHALERTHIESIDATQNLLYAYCLSPINL
>SEQF2892_01062 Anthranilate synthase component 1
MEFYYEVLKAHITPEALGQLNEHKIIFESASQQKLKGRYSIVAFDYYGTVKLNDNELIIK
TLKEDKVITTDPYNYLKTFINQFDCVINDEKLKQLPFISGFMGTCSFDLVRHEFPILKRV
AIKSMKTISDVSFYMIEDVFVFDHYKDELYVIASNQFSKASNAELKLRVKHRIQALSQIK
VYQENNKMVPKRSEIKANISDKQFIDIVTQMKQRITEGDMFQVVPSRIYSYQHHFGENKN
QLSYQLYQNLKRKNPSPYMYYMNMENEIVVGSSPESFVAVHNGEVTTNPIAGTIRRGTTP
EIDECNAHQLITDEKEISEHSMLVDLGRNDIHRVSITGTSEISKLMVIEKYEHVMHIVSE
VKGKIKKDISPMTTIASLLPTGTVSGAPKLRAIQRIYESYPYKRGVYSGGVGYINYNQNL
DFALAIRTMLIDDDTVNVEAGCGVVYDSIPEKELEETRLKAKSLLEVTP
>SEQF2892_01063 Anthranilate synthase component 2
MILIIDNYDSFTYNLVDIVSQIDEVIIKYPDDKDVFNYLEKIDGVIISPGPGHPLDDDEL
VKIIDKYHTLPILGICLGAQALTCYYGGKVIQGEKVMHGKVDTLEVKNESELYLTIPHRF
RIMRYHSLVSEMKSFPKNLIITGSTSDSIQSFEDKQHLHFGIQYHPESFATEFGSQIIEN
FIRIVKERVNFNEIIKTIG
>SEQF2892_01064 Anthranilate phosphoribosyltransferase 2
MRLLKQLDNNITLTQSETTQFITYLTNPEINVEDKVDLLTQFTKKEIKQQELTYVVNSLI
QTMYPNQPTYEGSICVCGTGGDKSNSFNISTTVSFIVASAGIPVIKHGNRSITSHSGSTD
LLNELGIKTTKVSEVPLQIEEQGLAFISAMESYPIMKYIQPVRKMISTPTIFNIVGPLIN
PFKLTYQVLGVYDPSRLYMIAQTLKDLGRRRAIVLHGANGMDEATLSGNNEVYELNENGD
ITHYFINAKDYGLKVASNQDLQGGSPKENKMITLDILSGDDKTCRRDVVVLNAALALYVS
EKVDTIASGISLATILIDSGRAMVQFMKMRGDICDDIK
>SEQF2892_01065 Indole-3-glycerol phosphate synthase
MTILSEIVDYKEQLLKDGYYHDKLQNLKGVKHKNKSRLTDALIKNDNLTLIAEIKSKSPS
VKAFQQTNIIKQVSDYERYGANAISVLTDERYFGGSFERLQQISETTQLPVLCKDFIIDP
LQIDVAQKAGASIILLIVNILTDEKLRQLYQYASSKGLEVLVEVHDGIELQRAYQLNPQI
IGVNNRDLKSFNTDVKHTNQILKCKKENYLYISESGIHSQQEVKQIVKSGIDGLLVGGAL
MNCNELEHFIPSLKLKKVKQ
>SEQF2892_01066 N-(5'-phosphoribosyl)anthranilate isomerase
MILKFCGIKTKVEALSIRPLNINMVGFIHYPKSKRHLDIEQINKLSRLLPDEIDRVVVLV
NPTLQLIKKIINATNINAIQLHGDETIDFIKQLRLNFKNIKIIKALPATQNIINDINQFK
EHIDLFIIDTPSEQYGGTGQSFDWTLLKGLDQSIPFLIAGGIDVDKIKQIETLKLNHLGY
DISSSIETDGMKDKNKMLTVIQQVKGEL
>SEQF2892_01067 Tryptophan synthase beta chain
MYNIQTEADELGFFGEYGGQYVPETLMPTIIELKQAYNKAKQDQSFQDELTYYLKEYVGR
ETSLTYAKSYSEALGGAQIYLKREDLNHTGAHKINNAIGQALLAKRMGKNKLVAETGAGQ
HGVASATVAALFDMELIVFMGREDIKRQQLNVFRMELLGAKVEAVDEGQGTLSDAVNKAL
QYWVSHVEDTHYLLGSALGPDPFPTMVRDFQSVIGQEIKEQLLQKTGRLPDAVVACIGGG
SNAIGTFYPFIKDKVKLYGVEAAGQGIDTVKHALAIGKGRPGVLHGSKMYLIQDENGQVE
LAHSISAGLDYPGIGPEHSYYHDIGRVQYKHATDTEAMEALIRFSKMEGIIPAIESAHAL
SYVEKLAPKMNKDEILVVTISGRGDKDMETIRHYMQTRGESHD
>SEQF2892_01068 Tryptophan synthase alpha chain
MTKLFIPYIMGNKSFIKNMKILDENGADIIEIGVPFSDPVADGPIIMEAGNRAIKQGVTI
NYIFNELSNNKDEINCKYVLMTYYNIIVSYGEEAFFKECEKVGVYGVIIPDLPYELTQKL
KHKISKFDVKVISLISMTANDDRIKEIVKHAEGFIYTVTMNATTGKNGTFHPQLKDKLKH
LKAHTDIPVVAGFGIRTKEHIKDLATVADGVVIGSEIVKRFCQDNNEDTIHYLKQVRETL
DTL
>SEQF2892_01069 hypothetical protein
MFNYEQVHLNSKHRLDKTYLDYLHPDFKEIGHSGNIITKNDLYFIELNTFDYEIIDFEYK
SLSDNCRLSVYTLINYTTNRNSRRSSLWLWYDDDWKLYFHQGTPLN
>SEQF2892_01070 Aminoacyltransferase FemA
MKFTNLTATEFGNYTDKMPYSHFTQMTENYEMKVANKTETHLVGIKNKDNEVIAACMLTA
VPVMKFFKYFYSNRGPVIDYDNRELVHFFFNELTKYLKQHNCLYVRVDPYLPYQYLNHDG
EITGNAGNDWFFDKMKHLGFEHEGFTKGFDPIKQIRYHSVLDLKNKTSKDILNGMDSLRK
RNTKKVQKNGVKVKFLSEEELPIFRSFMEDTTETKEFQDRDDSFYYNRYRHFKDRVLVPL
AYIKFDEYIEELQNERETLNKDVNKALKDIEKRPDNKKAFNKKENLEKQLDANQQKLDEA
KKLQAEHGNELPISAGFFFINPFEVVYYAGGTSNKYRHFAGSYAIQWTMINYAIDHGIDR
YNFYGISGNFSEDAEDVGVIKFKKGFNADVIEYVGDFVKPINKPLYSVYKTLKKIKKRFN
>SEQF2892_01071 Aminoacyltransferase FemB
MKFTELTVKEFENFVQNPSLESHYFQMKENIQTRENDGFEVVLLGVKDESNKVLAASLFS
KIPTMGSYVYYSNRGPVMDYSDLGLVDFYLRELEKYLHQHQCLYVKIDPYWIYQIYDKDI
NPLEDREKNDAIINLFKSHGYEHHGFTTEYDTSSQARWMGVSYLKGETPASLRKQFDSQR
KRNINKAINYGVKVRFLGRDEFHIFLDLYRETEARTGFVSKTDEYFYNFFDTYGDKVLVP
LAYIDLDEYIKSLQDALNDKENRRDQMMAKENKNDKQLRKIAELDKQIEHDKKELLQASE
LRQTDGQILNLASGIFFANSYEVNYFSGGSSEKYNNYMGPYMMHWHMMNYCFEHGYDRYN
FYGLSGDFTENSEDYGVYRFKRGFNVYIEELIGDFYKPINKVKYWLFNTLNTIRKKVKK
>SEQF2892_01072 hypothetical protein
MTQVHFTLKSEEIQSIIEYSVKDDVSKNILTTVFNQLMENQRTEYIQAKEYERTENRQSQ
RNGYYERSFTTRVGTLELKVPRTRDGHFSPTVFERYQRNEKALMASMLEMYVSGVSTRKV
SKIVEELCGKSVSKSFVSSLTEQLEPMVNEWQNRLLSEKNYPYLMTDVLYIKVREENRVL
SKSCHIAIGITKDGDREIIGFMIQSGESEETWTTFFEYLKERGLQGTELVISDAHKGLVS
AIRKSFTNVSWQRCQVHFLRNIFTTIPKKNSKSFREAVKGIFKFTDINLAREAKNRLIHD
YIDQPKYSKACASLDDGFEDAFQYTVQGNSHNRLKSTNLIERLNQEVRRREKIIRIFPNQ
TSANRLIGAVLMDLHDEWIYSSRKYINFDK
>SEQF2892_01073 hypothetical protein
MNIILDIDGTICFDGQQINQDIIDRLISLHNIGHRIIFASARPIRDLLPVLPSQFHRFTL
IGGNGSIVSDNNEIQTLATIQPESFNVIKHVINQYDLNYIVDDKWNYAARVDATNTIYQR
LDPHRLAQKLTINDITSPIKTILLNIDEKDFDEVVTYLATNAPSLSLINHSNELNIDITA
KYINKFTAIEHILGKYPTYVAFGNDHNDIEMLQHAKVGYFVNNESMDVSILKNNKNIRCI
NANTEALCLSLDELSKDY
>SEQF2892_01074 putative ABC transporter solute-binding protein YclQ
MKNSFKFIAILFTIIVLLSACGKNSTSESSSSSKDTITVENTYEFKDKNNTHTKGEMKTE
KVKVPVNPDRVAVLDYGALDIMKQMGLEDKIVAIAKGKGAAFLPSSLSEFKKDKYTNLGN
PGQPNYDNLANAKPEVIFTSFRQAHTKTLDEIKKAAPNAKILFVSPNNDHYIDSIKDNTT
LFGKIFKQQNKAKMLNEKLNKKSC
>SEQF2892_01075 putative ABC transporter solute-binding protein YclQ
MRNSIKKVAETKKVINNDTVLFLNVDDKGVKAFGPTGRFGGFLNRDLGIKHADTAMKANS
AGNSITYEYLNKVNPDKLFVIDRTQKGNDKSLPSALNNDVIKNLKAIKNDQVYQFESNAW
YFSEGGIETTIEQLDKIEKAFKK
>SEQF2892_01076 hypothetical protein
MTIFDMPNYLWITIVAMIILTVFCALVLKKWFVSAVITFVALAVLAFFIPNFYDISFQPL
LGYAAFLAIISLIISFLLWYFTRNWRRERKKKQLEKEIRKYEDDDETIRRLRR
>SEQF2892_01077 Oligoendopeptidase F, plasmid
MTSGLPFRKDVPELEKWNLNDLFNSDEQFYDTLDNVLNQSKSFNQQYKGKISDAKMIKKV
LSEFENILIQLDRLGNYAELRLSVDTANTDAQTLSAKLSTNYGKISSQLSFVESEILMLP
EEVIKQAIEESDVPHYLEKLIESKPYQLSPEVEQVMASLSPTFQSAYELYGTTKMLDIAF
ESFEHNNVTYPMDYATFENEYEDNANPEFRQKSFKSFSDALKKYQHTTAATYNQHVQQEK
IEADLRGYDSVIDYLLHDQEVTREMYDRQIDVIMSDLAPVMQKYAKLLQRIHGLDKMRFE
DLKVSVDPSYEPEISIEDSKQYIHGALNVLGEDYIQMVEQAYSDRWIDFAQNKGKDTGAY
CASPYYTHSYVFISWTGKMTETFVLAHELGHAGHFTLAQQHQNLLDSEASMYFVEAPSTM
NEMLMANYLFSNSEDPKFKRWVIGSILSRTYYHNMVTHLLEAAYQREVYRKVDNGESLTG
PVLNNIMRDVYEQFFGDAVELTDGTELTWMRQPHYYMGLYSYTYSAGLTIGTVVSQKIKQ
EGQPAVDAWLETLKAGGSQSPIELAKIAGVDITTDAPLKATIKYISDLVNEAEQLTNEIE
QQD
>SEQF2892_01078 Phosphate-specific transport system accessory protein PhoU
MMTIIRHKYEGQLGELIKDIRHLGLRVYFNLEHALVSLSEDDKNYARQVIENDKDINNLD
YDINEKVIMLITKQQPIATDLRMMMAALKISTDFERMGDNAAHIAHIRLRVKITDHYVLT
RLKTMGKLAMLMLQDLNTATKQEDITLIKEIIERDKDIDDLYANIVNTTYLIDNDPFVAG
QAHLAARNLERVGDHVRNIAESVYYFYTGEHYEK
>SEQF2892_01079 Phosphate import ATP-binding protein PstB 3
MANTNVKEKELAKHTDQSQESISTVVSSNEVKHNKESDSNKKVVYSTQNLDLWYGDTHAL
QNINLDILENNVTAIIGPSGCGKSTYIKTLNRMVELVPSVKTAGKILYRDQNIFDENYSK
EKLRTNVGMVFQQPNPFPKSIYDNITYGPKTHGIKDKKLLDEIVEKSLRGAAIWDELKDR
LHTNAYGLSGGQQQRVCIARCLAIEPDVILMDEPTSALDPISTLRVEELVQELKENYSII
MVTHNMQQAARVSDKTAFFLNGYVNEYDDTDKIFSNPSDKQTEDYISGRFG
>SEQF2892_01080 Phosphate transport system permease protein PstA
MTATTNPKAKTLIDQNKVEKNISSRGKTNKLNKWLFFTCIVIALLVLAALLIQTFVKGVG
YLTPDFFTNFSSSTPSQAGIKGALAGTIWLMISIIPISIVLGVGTAIYLEEYAKDNFFTS
FVKISISNLAGVPSIVFGLLGLTLFVRGGGIQALALGNSVIAAALTMSLLILPIIIVSSQ
EAIRAVPNSVREASYGLGANKWQTIRRVVLPAALPGILTGFILSLSRALGETAPLILIGI
PTILLATPTSIMSMFTALPTQIYTWAKMPQAEFQNVASAAIIILLVILLLMNAVAIFLRN
KFSRKY
>SEQF2892_01081 Phosphate transport system permease protein PstC
MASETNVRDLIAKNNAKKGGFSDKIVPIILGIIAAISILTTIGILFTLITETITFFTRVS
IVEFLFTKDWNPTGSDPKYGIWALVIGTLKITVIATIVAVPIGLGAAIYLSEYASDKARR
IIKPILEILAGIPTIVFGFFALTFVTPVLRTIIPALDSFNSVSPGIVVGIMIVPVITSMS
EDAMASVPNKIREGAYGLGSTKFEVATKVVLPAAASGVVASIVLGISRAIGETMIVSLAA
GSSPTASLNLTNSIQTMTGYIVEVATGDATFGSDMYYSIYAVGFTLFIFTLIMNLISYWI
SKRFREEY
>SEQF2892_01082 Phosphate-binding protein PstS
MKKWQLVGTTVLGASVLLGACGGGDSSGSGSGDGKDLKGEAKGEGSSTVAPIVEKLNEKW
AKDHPNATISSGQAGTGAGFEKFIAGETDFSQASRPIKDEEKQKLEDKDIKYKEFKIAQD
GVTVAVNKDNDFVKELSKDQLKKIYNGEAKTWKDVNSSWPDKKIKAFSPNSSHGTYDFFE
EEVMDKEDIKAEKNGDTNVIVQSVEKNKEGIGYFGYNFYEQNKDKLKEVKIKDDKGKTTE
PTKKTIKDGSYALSRPLFLYVKEKSLKDNDVMREFIKFTLEDKGKSAEDAGYVASPDKTY
KDELKDLKKYDKKSDK
>SEQF2892_01083 Conserved virulence factor B
MALDKDIVGSIEFLEVIGLEGSTYLLKGPNGEQVKLNQSEINDEDELETGEEYSFFIYPN
RSGELFATQNMPDITKDKYDFAKVLKTDRDGARVDVGLPREVLIPWEDLPKVKSLWPQTG
DYVLVTLRIDRENQMFARLASETIVEKMFTPVYDDEKQNELIKARPYRLLRIGSFLLSKE
GYKIFVHESERKEEPRLGEEVEVRIIGHNDKGELNGSFLPLAHERLDDDGQVIFDLLVEY
EGELPFWDKSSPEAIKEVFNMSKGSFKRAIGHLYKHKIINIETGKISLTKKGWSRVEDK
>SEQF2892_01084 putative ABC transporter ATP-binding protein YbiT
MLQVTDVSLRFGDRKLFEDVNIKFTEGNCYGLIGANGAGKSTFLKILSGEIDSQTGHVSM
GKDERLAVLKQDHFAYEEERVLDVVIKGHERLYEVMKEKDEIYMKPDFSDEDGIRAAELE
GEFTEMNGWNAEADAASLLSGLGISADLHDKQMSELENNQKVKVLLAQSLFGEPDVLLLD
EPTNGLDIPAISWLEDFLINFDNTVIVVSHDRHFLNNVCTHIADLDFGKIKLYVGNYDFW
YQSSQLAQKMAQEQNKKKEEKIKELQDFIVRFSANASKSKQATSRKKQLEKIELDDIQPS
SRRYPYVKFTPEREIGNDLLTVQGLSKTIDGEKVLDNISFTMNPNDKAILIGDSEIAKTT
LLKILAGEMEPDEGTFKWGVTTSLSYFPKDNSEFFEGVDMNLVDWLRQYAPEYEQTETFL
RGFLGRMLFSGEEVKKKASVLSGGEKVRCMLSKMMLSSANVLLLDEPTNHLDLESITAVN
DGLASFKGSIIFTSYDFEFINTIANRVIDLNQSGGLSKEVPYEEYLQEIGVLQK
>SEQF2892_01086 Aspartokinase
MKRSVLKFGGSSVADFTKIKNIAEMLKNRVDDGEQLIVVVSAMGKTTDQLMDNVSNLTAT
PKDEELALLLTTGEQQTVSYLSMVLNDIGVNARAMTGYQAGIKTIGHHLKSRIAEINPET
FDKAFTDKDVLVVAGFQGINDAFELTTLGRGGSDTTAVAIAASNQIPCEIYTDVDGVYAT
DPRILSKAKRLDYVSYEEMMEMSALGAGVLETRSVELAKNYDIPLYLGRTLSNEKGTWIM
SRTDLLEKKAVTGVALDKHMMHVTISYPLPDNRLLTQLFTALEEGSVNVDMISQIINIEG
LQLSFSIKDSDVQQISTILSNLSSSFNALDYKINEEYVKISLIGSGMRDMSGVASKAFIT
LINANIPFYQTTTSEISISYVIDADNGEKAVEVLYNAFDI
>SEQF2892_01087 Aspartate-semialdehyde dehydrogenase
MTRLAVVGATGLVGTKMLETIDRKNIKFDELVLFSSARSAGKEVQFQGQTYVVQELTEEA
ASEKFDYVLMSAGGGTSAQFAQIFEKAGAIVIDNSSQWRMTEDIDLIVPEVNQPEFKRGI
IANPNCSTIQSVVPLKVLQDQFGLKRVAYTTYQAVSGSGIKGKRDLAEGANGKEPEAYPH
PIYNNVLPHIDVFLEDGYTKEEQKMIDETRKILHEPELKVTATCARVPVQDSHSVEIDVT
LDKEATVQEIKDLFDKDERVVLVDNPEKNEYPQALNSTGRDEVFVGRIRRDDSLDNTFHV
WCTSDNLLKGAALNAVQVLEQVINLKGAR
>SEQF2892_01088 4-hydroxy-tetrahydrodipicolinate synthase
MPHLFEGVGVALATPFTNNEVDYNALERHVDFLLDNGVKAIIVNGTTAESPTLTEEEKEQ
VLESVIKQVNHRVTIIAGTGTNNTAKSIQASQRAKALGADAIMLITPYYNKTNQRGLVKH
FETIANEVELPVVLYNVPSRTNMTIEPETVETLSHNQYIVAIKDATNDFEYYEDVKSRIN
QEEFALYSGNDDNVVEFYQRGGNGVISVIANAIPKEFQALYDAKQSGQDISNDFEPISKL
LDALSVDVNPIPIKALTSHLGFGNYKLRLPLLPLEDADAKVLINVFEQFKAGEL
>SEQF2892_01089 4-hydroxy-tetrahydrodipicolinate reductase
MKILLIGYGAMNQRVARLAEEKGHEIIGVIEPQKNETTPYTHYDHIADAQNEADVAIDFS
NPNLLFPLLEEEFQLPLVIATTGEKEKLIEKLNELSHNMPVFFSANMSYGVHALTKILEA
AVPLLQDYDIELTEAHHNKKVDAPSGTLVKLYDVIKDLRQNITPVYDRHELTEQRTKDEV
GIHSIRGGTIVGEHDVLFAGTDETITISHKAQSKDIFANGAITAAEKLINQSNGYYTFDN
L
>SEQF2892_01090 2,3,4,5-tetrahydropyridine-2,6-dicarboxylate N-acetyltransferase
MVQHLSAEEIIQYISDAKKSTPLKVYVNGNFDGVTFPDSFKVFGSDNSKVIFCEADDWKP
FYESNQSTITELEIEMDRRNSAIPLKDLTNTNARIEPGAFIREQAIIEDGAVVMMGATIN
IGAVVGEGTMIDMNATLGGRATTGKNVHVGAGAVLAGVIEPPSASPVVIDDNVLIGANAV
ILEGVHVGEGAIVAAGAIVTQDVPAGAVVAGTPAKVIKQTSEVEDSKREIVSALRKLND
>SEQF2892_01091 putative hydrolase YxeP
MMSELEFVTKHRRHLHQHPELSLHEFETTKYITQFLEELGVSYERPLETGAIAYLNGNSD
HTIAFRADIDALPIFEENDVDYRSQTDNVMHACGHDGHTTALMLFVKRCKEMFDKGTLPH
NVVFIFQPAEETGGGANRLIKAGAFNNYPIEAVFGIHVNPFADEGQVVIRDEEITASATE
YRFFLKGLSSHVADKEQGHSCGEALLHVLNQVGQIQQYHLNGLKRNIVHMGHFEAGEAIN
TVASHGYLEGTIRTYDPNDLNVVKTQMHKIAESISLLFNVDCEVKFEEGYPPTMNSPKLR
ASVEQAINAANLEVIDKPLPFLFGEDFSFYGQQLAPAYFAFVGTRNEDKGFVTGLHTSHL
NFDEKVLIYVANYYEQLLMHYGEE
>SEQF2892_01092 Alanine racemase 1
MTAIWSVDKEAFLQNAIKVKNGNSIMAVVKNNAYHYGLEFAVTSFLKAGINTFSTTSLKE
AIKVREIAPDATIFLMNAVYDFEKVRHYQIQMTLPSLAYYYKYKNDLSGIKVHLEFENLL
HRSGFRTLEEIREVLNDHHINSNEDKMIISGLWTHFGYADEFDVPEYSIEREAWLNIVDT
LLDEGYHFDLIHAQNSASYYREGQKLLPHHTHARVGIALYGSRPYSALNEYSIKQSLTVK
GNVIQVREVNAGDNCGYSFAFEATRDHTRLAVVDVGYGDGILKSRAKHEALIKGKRYPIR
ALMMSHMFVEVDEEVDAQDEVILYNNDIRIDEYTFKGVGANSEQLSAMNHDSLIKEYR
>SEQF2892_01093 Diaminopimelate decarboxylase
MAVKYNDYGELTMAGTSLKTLAQSFGTPTIVYDEDEIRNQMRRYHSAFQKSGLKYNISYA
SKAFTCIQMVKLVQEEDLQLDVVSEGELYTALEAKFDPSKIHFHGNNKTKREIQYALESG
VGYFVIDSLEEIDLIDRYASDTVNVVLRVNPGVEAHTHEFIQTGQEDSKFGLSIRHGLAI
EAVNKVRDSKRLHLKGIHFHIGSQIEGTEAMIETAKIVLNWLSENDIKVELLNLGGGFGI
KYVEGDVSFPIEEGIAEITDAIKAETERLNYEVPEIGIEPGRSIVGEAGITLYEVGTIKE
IPEVNKYVSIDGGMSDHIRTALYGAKYQALLVNRHEEADETVTIAGKLCESGDIIIRDAK
LPSSVQRGDYLAILSTGAYHYSMASNYNQMQKPPVFFLKDGKAREVIKRQSLRQLIINDT
K
>SEQF2892_01094 hypothetical protein
MCKSILNTLRIKDKNLNFSDEVIEKKHKGRMSLFYYAELTYQPTHSENCSTKNENFSIVK
DGKKTSTITLLKIMEMPSYLELQKQRFYCKSCDSHFTAKSNIVDAHCFISNKTKLAVLDK
AQEYRSQKSIAKSCLVSSMTVSRVINQAASDVGQSSFDALLEHLMMDEFKSVKNVIGKMS
FIYADAVSHRIVDVVADRKLKSLKDHFYRYSLKLRQKVKTVTIDMYEPYMSLIKQLFPNA
KIIIDRFHIVQSLNRALNMSRVHVMNCYRTSNRPLYNKYKSYWKLFLKPFETLEAFNYHK
VHLFKEWKTEKGIINYLLGVDVELFNTYHYVHELRRLLKENQIEKFNHKLFSIHLSDVCP
KLRPVIRTLRRLATFIENTMTYSNLTNGPLEGINNKIKLIKRVSFGYRNYDNLRNRIIIT
SRLFVLTTKKEIKQLKVAVL
>SEQF2892_01095 hypothetical protein
MCKSILKTLRIKDKNINFSDEVIEKKYKGRMSLFYYAELTYQPTYCENCLAKNDNFSIVK
NGKKTSTITLLKIMEMPAYLNLQKQRFYCKTCDSHFTAKSNIVDAHCFISNKTKLAVLNK
AQECRSQKSIAKSCLISSMTVSRVINQAASDVGQSSFDALPEHLMMDEFKSVKNVTGKMS
FIYADAVSHRIVDVVADRKLKSLKDHFYRYSLKLRQKVKTVTIDMYEPYMSLIKQLFPNA
KIIIDRFHIVQSLNRALNMSRVHVMNCYRASNRPLYNKYKSYWKLFLKPFETLEAFNYRK
VHLFKEWKTEKGIVNYLLDVDEELYNTYHYVHELRRFLKENQIEKFNHKLFSIHLSDVCP
KLRPVIRTLRRLATFIENTMTYSNLTNGPLEGINNKIKLIKRVSFGYRNYDNLRNRIIIT
SRLFASTTKKEIKQPKVA
>SEQF2892_01097 Cold shock protein CspA
MKQGTVKWFNAEKGFGFIEVEGENDVFVHFSAINQDGYKSLEEGQSVEFEVVEGDRGPQA
ANVVKL
>SEQF2892_01098 hypothetical protein
MWTVAKIRADYEGWWLFSDWTDKIIEQYQFTSYDEMLNYYKNIISKSKDYYDNYVVGKYN
IHAFYNNCDLNFCEDCEEDLQIFYSFIVLNNKEVYYNLPKIN
>SEQF2892_01099 Acylphosphatase
MKQKHLQVFGTVQGVGFRYYTQRLANKYNILGTVQNVDDYVEIYAIGNDDDLEQFINAVT
EGASPASHVTHYELEDTNVSEDFSDFKSI
>SEQF2892_01100 hypothetical protein
MRYNISRLLGVIVGIPVAMISWMVSVFGFDLSFIIDALVGIGMFFVSYFPTQRLTSRKYL
TEIGLSRRDYHYVSNHLKQAQDKIRTILKSFVNVRSIQDFRQINDIYRISKSIHFAVKQR
PAMFFKVESFFYSHIDNALNLIESYTRLAKMPKKTIEEKQKLEQTRITLDEVKRTLIADL
KRINEDDYERLDVEMELNKLEQKRHKDN
>SEQF2892_01101 TelA-like protein
MPRNDQFNNSHPLDDYIEQQQLNNLDNNSNVSLANQNTVLDDFQQQFSDKEMQKIESISQ
QIKPLDNDGLLSYGSHLQENMSKFSHKMLDEVQTKDIGPVGDSLNQLMTKLKAVNPDELN
PEKQSKLKRFFKRTKASINEVFSRMQSVSSQIDRITIQLDRHKNNLSKDIKLLDGLYQQN
KDYFDDVNLYIAAAKRRKHEIQTNDIPKLQEHANQTGNQMDIQAVADMEQFVDRLDKRIY
DLQLSRQIAIQTAPQIRMIQNVNQALAEKIQSSILTSIPLWKNQMAIALTLMRQRNAVSA
QRAVTDTTNDLLTQNAAMLKQNAIETATENERGIVDIETLKTTQSDIIETIEQTLQIQQN
GRQKRKEAEKELVGLEDELKQHLLSMKKE
>SEQF2892_01102 Branched-chain amino acid transport system 2 carrier protein
MNKNTWIVGFTLFAMFFGAGNLIFPPNLGQDSGHFFWPAVIAFCLTGIGLPLLGVIVGAL
DKQGYVGSLNKISPKFSVIFLIIIYLTIGPLFAIPRTASTSFEMTVTPIAHTNSNLVLFI
FTLIYFLVVLYLCINPGKIVDRIGSLLTPLLLITILAMIIKGFVDYSGNAPSHGNQVDYN
SAIGSFSKGFTEGYLTMDAIAAIAFSMIVVNAIKATGVKHANQIFKQTVMSGLIAAIALV
FIYVSLGFIGNHMNVDNATLKNLTAKDQNVGAYLLTTMAANSFGVFGKYLLGIIVALACL
TTACGLIVSVSQYFNRIFPKVSYKAYTIFFTLISFILANLGLNAVISMSVPVLSVIYPIA
ITVVLLILLARFIPTKPIAQQIPIAVISIVSILSVISTNGWVKMSFIEALPLKQYSLEWF
PIAVVATIIGYVVAKFVNQDHIVYQKE
>SEQF2892_01103 Aerobic cobaltochelatase subunit CobT
MSDRFIKFNDEQLDAKQVMMLQDLARLLLKNEQTQVKIQKFPYYDPINNTLITSWFWSHR
PEHIEKAGLKTDVMLAAYGYQMMDESIVNEVLHDDEFEHPKFYQQIFRLLEDMRVFNHIR
NERPSTSKLIDLRLQTRLSYTESQIKFYKTKTVYTDLLFLYLEKAFLSQNFFDIPMMHSQ
LDDILNSMFQYLPNFFQNETSEDNMYLAQRIMFQIDDMLTKDMLNEYYHLPRRVYEAIHE
MTFDELKRTDASNVDGKDNTSEDTDSETAEAETNAQDSKSEGGAYLEMELHEGENSEVIS
DNDTAREGDSTDDMTDMMTKKGRGSDNTLNNDEGGSIGENTSFALKGINENVEIKWNVPD
IEPDYLLEYQNVKNDVQFETKDLIQIIKKTIDREHVDERHNLTKGRLQRDLTNWFIDDQY
KLFYKKQDLSKTFDATFTLLIDASASMFDKMEETIKGVVLFHETLKALNVKHEILAFNED
AFDSDDRKQPNIIDEIVHYDYSTMEKSGPRIMSLHPQDDNRDGVAIRIASERLLRRSHNQ
RFLIVFSDGEPSAYNYAQDGILDTYEGVEMARKYGIEVFNVFLSQDVITEDIEQTIHNIY
GQYALFVEGVENLPSHLSPLLKKLLLKSF
>SEQF2892_01104 Denitrification regulatory protein NirQ
MIKNQYINSDESVFNDAKALFNLNKNILLKGPTGSGKTKLAETLSAAVNTPMHQVNCSVD
LDAESLLGFKTIKTNEQGQQEIVFIDGPVIKAMREGHILYIDEINMAKPETLPILNGVLD
YRRQLTNPFTGEVIKAAPGFNVIAAINEGYVGTLPMNEALKNRFVVIQVDYIDGDILKDV
IKQQSQLQDDAIIEQIIKFNEDLRTMSKQGQISEEAASIRALIDLSDLITVMPIERAIKR
TIIDKLEDEREQQAIKNAIELNF
>SEQF2892_01105 hypothetical protein
MAMLHETWKTRTPIKKVEVTNTDAKKFTVSDMLTVGKQYDVINETEEYYQIIDNSGLVGG
YYKTYFKDV
>SEQF2892_01106 Putative ring-cleaving dioxygenase MhqA
MSGLRSVTLGTSDLSKTNKLFKDILGLNVASKNQALRFGDADLSPGTRIHFVEVPNPEYE
NQHIASVGLRTPTDSGLDEYQTILKENQIQASDVTELNGNKHFNFEDSNHQIFDIYSNEH
NTGVGLGTPTFDSTVNPLHQIQGLGPIIIKVNELPVTASILKNVFNLTHYAEYESTEFPE
QVIQVFQIGEGGLGGELHLYQPNEPIELKEEGIVEQIEFNANSVEAFNNAQKELDDIGIP
YQTLNQGDAQSLRITENSGISFIYTLEK
>SEQF2892_01107 hypothetical protein
MDLTFEEQIKLRDIARKMTRARTIEEKWKREQEMDKLLGIYKSNTKNADLPKFVPEVSDE
ELEDILLGRK
>SEQF2892_01108 hypothetical protein
MLDRWEDDKKMFEEQAPKESKEIIKKREDDFIKRLREMQKKS
>SEQF2892_01109 Dihydrolipoyllysine-residue succinyltransferase component of 2-oxoglutarate dehydrogenase complex
MPEVKVPELAESITEGTIAEWLKNVGDSVEKGEAILELETDKVNVEVVSEEEGVLQEQLA
SEGDTVEVGQVIATVGEGSGNASSSKEESSDQSQSANNDEATKELAQPTESQSNNEETQS
NPNNQRVNATPSARRHARENGVDLSTVSGKGNDVVRKDDVENSQKAAQSQSSQETSKKEE
PKKSSGAPNKPVIREKMSRRKKTAAKKLLEVSNNTAMLTTFNEVDMTNVMELRKRKKEQF
IKDHDGTKLGFMSFFTKAAVAALKKYPEVNAEIDGDDMITKQYYDIGVAVSTDDGLLVPF
VRDCDKKNFAELERAIADLAVKARDKKLGLDDMVNGSFTITNGGVFGSMMSTPIINGNQA
AILGMHSIITRPIAIDKDTIENRPMMYIALSYDHRIIDGKEAVGFLKTIKELIESPEDLL
LES
>SEQF2892_01110 2-oxoglutarate dehydrogenase E1 component
MAKDNKDVTEAPVNFGANLGLMLDLYDDYLQDPSSVPDDLQVLFSTIKNGEAHVAAKSTT
EGSGSSAGDGTIKRIMRLIDNIRQYGHLKADIYPVNAPKRTNLPKLEIEEFNLDKETLEN
VSAEIVSDHFKDIYDNAYEAIERMEKRYKGPIAFEYNHINNNKERTWLKRRIETPYRANI
NNDERKKLFDTLAHVEGFEKYLHKNFVGAKRFSIEGVDTLVPMLQHTLKRAAEIEINNIQ
IGMAHRGRLNVLTHVLEKPYEMMISEFMHTDPMKFLPEDGSLELTAGWTGDVKYHLGGVK
TTSSYGIEQRISLANNPSHLEIVAPVVIGKTRASQDDTKHAGKPTTDFHKGMPIIIHGDA
AYPGQGINFETMNLSNLDGYSTGGALHIITNNRIGFTTEPVDGRSTTYSTDIAKGYDVPI
LHVNADDVEATIEAIDIAMEFRKEFHKDFVIDLVGYRRYGHNEMDEPSITNPLPYHNIRK
HDSVEIIYGNKLVEDGVISKEQMEDVMDKVQKEMRAAQDKIDKSDKMDNPDMERPESLQE
PLQSDDKDFSVDHLKEINDAMLTYPEDFHVLKKLNKVLEKRREPFESENGLVDWAQAEQL
AFATIVQDGISVRLTGQDSERGTFSHRHAVLHDEENGDTFTPLHHVPNQKATFEVHNSPL
SEAAVVGFEYGYNVENKNSMNIWEAQYGDFSNMAQMMFDNFMSSARAKWGERSGLTLFLP
HAFEGQGPEHSSARLERFLQLAAENNSTVVNLSSSSNYFHLLRAQAKSLGTEAMRPLIVM
SPKSLLRNKTVAKPIDQFTSGGFKPIIVEDGNKEKVTKLVLASGKMFIDLKEHLAKNPDD
SILLVAVDRLYPFPEGEIKEVLNELPNLETVSWVQEEPKNQGAWLFVYPYLKSLVGNQFN
LSYHGRIQRAAPAEGDGEIHKLVQNQIIESSIEK
>SEQF2892_01111 Signal transduction histidine-protein kinase ArlS
MIKKGTLKYKWMMITTLIMFSTIILFCLVIIFFLKDTLRDGEIDEAEHSSSEIVNLVESR
SMNNITTLDLTAMLENFEKAIIYDRNGKQLMQSSNENMINFKPDIDFVDPETIQISKHNG
IPYLIITEPIHSERFEGYSVLIHSLEGYNNVVRSLYFVAIAFGLLATFIMAGISYIFSTQ
LTKPLVTMSNKMIQIRRDGFQNKLELKTNYEETDNLIDTFNDMMYQIEESFNQQRQFVED
ASHELRTPLQIIQGHLNLIQRWGKKDPAVLEESLNISLEEMNRITKLVEELLLLTKDKVN
IQALEFEEVNINEEIRSRIKSLKQLHPDYQFKTHLSKKPLTLQINRHQFEQLLLIFIDNA
MKYDKDNKQIEIATQLRNKQISIEITDHGLGIPKEDQEFIFDRFYRVDKSRARSQGGNGL
GLSIAEKIVQQYGGYITVDSEVNQYTTFKIIFK
>SEQF2892_01112 Response regulator ArlR
MTNILIVEDEQNLARFLELELTHDNYSVDIEYEGQAGLDKALSNNYDLIILDLMLPNING
LEICRRVRQEQSTPIIIITAKSDTYDKVTGLDYGADDYIVKPFEIEELFARIRAVLRRQP
QKDIIDINGIKIDVDAFNVTINGEQLDFTKTEYDLLYLLATNRNRVLQREQILDHVWGYD
SEVETNVVDVYIRYLRNKLKPYGKDKTIETVRGVGYVIR
>SEQF2892_01114 hypothetical protein
MNRTKRITLLIVFTLIFGIIASFHESRLGKWIDTEVYEFIYSSESFITTSILLGATKLGE
VWAMVCLSLMLVAYLMLKRFKIEALFFVIVMSLSSILNPLLKNIFDRERPTLLRLIDISG
FSFPSGHAMGSTSFFGSAMFIANRKASGHNKGIIIGLCALFILLISISRVYLGVHYPTDV
IAGIIGGAFCIVLSTLILKNHLYPTAT
>SEQF2892_01115 UDP-N-acetylglucosamine--N-acetylmuramyl-(pentapeptide) pyrophosphoryl-undecaprenol N-acetylglucosamine transferase
MSKIAFTGGGTVGHVSVNLSLIPTATDKGHDAFYIGSKTGIEREMIESQLPNIEYYPISS
GKLRRYLSVDNAKDVFKVLKGVIDARKVLKREKPDLLFSKGGFVSVPVVIAARSLNIPTI
IHESDLTPGLANKISLKFAKKIYTTFEDTLKYLPKDKADFVGATIRQDLKEGNQSRGYQL
TGFDASKKVLLVMGGSLGSKKLNQAIRENLEALLQDYQIIHLTGHGLVDSSIDAKGYVQY
EFVKEELTDLLAITDTVVSRAGSNAIYEFLTLRIPMLLIPLGLDQSRGDQIDNAENFESK
GYGRTIPEDQLTQVKLLEQLKEIENDRESIIKQMETYRESYTKEDLFNKILKDAL
>SEQF2892_01116 hypothetical protein
MIRLGNMQDISQIETLVEEAKKLMKEFNNNQWDDKYPVTEHFEEDINTETLYVLEENDTI
YGFIVVDQQQSEWYDELEWPIDREGAYVIHRLAGSQQYKGAATELFDFAVKLAEEHNIHV
LLTDTFALNKPAQGLFEKFGFIKVGEAEIDYHPFDRGAPFYAYYKNI
>SEQF2892_01117 putative CtpA-like serine protease
MSHNPEEKQSNLDSNHKNESSSNKRIKFKTWQFILLLLGVVIITAGITVAATIGISHKIS
GLTKDERQEIKKIEYAYKTLNNDYYKKQNAGKLSEAAIDGMVKELKDPYSEYMTKDETKS
FNEDVSGDFVGIGAEMQKKDKQIMITSPMKDSPAEKAGIQPKDVVTKVDGKSVVGKPLDQ
VVKLVRGKEGTTVKLTIKRGSQEKEIKIKRGKIHVKSVEYKKKDNIGVFTINKFQDNTAG
ELKSAIIKAHKDGVRSIVLDLRNNPGGLLDEAVKMANIFIDKDQTVVKLEKGDDTESIKT
SNDASNEAKDMKVSILVNEGSASASEVFTGAMRDHKKAKVYGSKTFGKGIVQTTREFKDG
SLLKYTQMKWLTPDGHNIHGKGIQPDTKIASPQYQSISVIPTDKSYSVGDNTKYVKSIKI
GLDALGYNVNNDSKQFDTQLESAIKKFQSEHELSVNGKFDKKTNEKFTQLLVEKANKEDK
VLDELINKLK
>SEQF2892_01118 hypothetical protein
MKEHSFYQFALTVRGRKDSKGDLAEEIFNDLSFPKHEKDFNQLSDYIEMQSDISVPMSEF
DDLYEEYIEWLKF
>SEQF2892_01119 PTS system glucose-specific EIIA component
MFKKLFGKGKEVNKEIEIYAPLTGEYINIENIPDPVFAQKMMGEGFGINPTEGEVVSPIE
GKVDNVFPTKHAIGLKADNGLEILVHIGLDTVQLDGQGFEILVSSGDTVQVGDPLLKFDL
EYIRNNAKDVISPIIITNSDQTESIHVNDVKAVIKGETKVVDVTMS
>SEQF2892_01120 Peptide methionine sulfoxide reductase MsrB
MIKKDKNELNEMEYLVTQENGTEPPFQNEYWNHFDKGIYVDKISGKPLFTSEEKFESNCG
WPSFSKSIDDDEIIELVDKTFGMIRTEVRSEDANSHLGHVFNDGPKESGGLRYCINSAAI
QFIPYDKLEELGYGDLIPHFEK
>SEQF2892_01121 Peptide methionine sulfoxide reductase MsrA 2
MAYATLAGGCFWCMVKPFTSYPGIEEVVSGYSGGHVENPTYEQVCTNQTGHREAVQIQFN
SDITSFENILDVYFKTFDPTDGGGQFFDRGESYEPAIFYHDEEQKKAAELKIQQLNEEGI
FKKPVITPILPYKNFYPAEDYHQDYYKKNPAHYEQYQRGSGRKSFIETHWGSQND
>SEQF2892_01122 DegV domain-containing protein
MTKQIIVTDSTSDLSHEYLKQHNIHVVPLSLTIDGKSFVDQIDITSEAFIQRIEEDADVK
TSQPPIGKFIELYEELGKEDVEIFSIHMSSGLSGTYQTALQASDMVDTKVTVIDSKSISF
GLGYQIQRLVELINTNLSSNQIVNKLKELQKNIKLFVVIGQLNQLIKGGRISKTKGFIGN
IMKIKPVGTLEDGYLEIVHNARTQNSSIQYLKKEISEFIDKHKIKSIGVAHANVLDFVDK
LKLQFDEAFGQQKYDVNVTTPVISTHTGQGAIGLVVVRESN
>SEQF2892_01123 Dihydrofolate reductase
MTLSILVAHDEQRVIGYNNDLPWHLPNDLKHVKKLSTGNTLVMGRRTFESIGKPLPNRRN
VVLTSDTTFNVDGVDVIHSIDDIYKLEGHIFIFGGQSLFEEMIDKVDDMYITVVNGKHQG
DTFFPPYTFEEWEVESSVDGELDEKNTIPHTFLHLVRKH
>SEQF2892_01124 Thymidylate synthase
MLNSFDSAYHALCEEILEIGNQRDDRTHTGTISKFGHQLRFDLSKGFPLLTTKKVSFKLI
ATELLWFIKGDTNIQYLLKYNNNIWNEWAFEKYVQSNDYHGPDMTNFGHRALQDDEFNEL
YKEEMSKFKQHILNDDSFAKKYGDLGNVYGKQWRDWVDKEGNHFDQLKTVIEQIKNSPNS
RRHIVSAWNPTEIDSMALPPCHTMFQFYVQDGRLSCQLYQRSADIFLGVPFNIASYALLT
HLIAKECNLEVGEFVHTFGDAHIYSNHIEAIKTQLSRNSFDPPTLKINSNASIFDINYED
LELIGYNSHPAIKAPIAV
>SEQF2892_01125 hypothetical protein
MNPYEQYMQELAQQMRAELTENGFESLETSEDVSNYMKNVNEEDTTFVVINSTCGCAAGL
ARPAAVAVAEQNDKKPTNKITVFAGQDKEATQTMREYIQQVPSSPSYALFKGTELKHFIP
REHIEGRDIQDICMDIKDAFDENC
>SEQF2892_01126 hypothetical protein
MEILRVEPTPSPNTMKIVLSNKREDNKSNTFTYIEEQQPQFINDLLAIDGVKSIFYVMDF
LAIDKEPKSDWEVVLPQITSTLNNESFIDSSHKPDEHYGEIKAEALMFKGIPYQIKLTTT
SDESRKQLPDYFVESMLKAQKDGDNVVFLRKWQDLGVRYGDLEEVMNEVYEEIIALYPSE
KLASLVQTALETDIVIPQQQYHHVTLNEYKEATDWKDKLRMLKEFPTPTLQDIDLLDEAL
QEDKAPLRRQAIVLIGMIEEKEILPYLYKGLRDKNPAVRRTAGDCLSDLGFKEALPEMEN
ALNDPQKIVRWRAAMFLFDEGGPEQLPSLKSHANDPAYEVKLQIEMAISRIENGDEALGS
VWKQIANRNK
>SEQF2892_01127 hypothetical protein
MQIVSIEETPNHKTMKINLSEKREDNKSNTFTSAQEGQPDFINKLFDIDGVKSIFYVMDF
ISVDKEDNADWNNILPQIQSTFE
>SEQF2892_01128 Inner membrane protein YhhQ
MYNEIFGVATFLVTFILMVIMFRCFGKQGLIAWVAIGTIIANIQVIKTVHIFGISATLGN
VMFASIYLATDILNDIYGRKVAKRAVWLGFSSTLVMIIVMQMSLHFIPAPEDMAQKSLST
IFDLVPRIAVGSIIAYIIGQHVDVFIFSTIKKVFSSDKTFIIRAYGSTMLSSIIDTALFV
TIAFAGTLPNMVVFEIFITTYLLKLISTIFNVPFGYIAKSMYRKGQIHKLDKGY
>SEQF2892_01129 14.7 kDa ribonuclease H-like protein
MAKIYFDAATRGNPGRSACGIVIKENDEKYVYTHDLGELDNHSAEWAALIHALEHARELN
VVNALLYTDSKLIEDSVNQGFVKSARFKPYYENLEILEKSFELVFVKWVPREQNKEANQM
AQQALFKLIKKKI
>SEQF2892_01130 Serine-aspartate repeat-containing protein C
MNQHKKLQKFSIRKYAIGTVSTLVATFVFLGVNHDAQASEHLNPTQQHTNNNPENSINES
SNTSIKPSDNKNTTGQVQSNQTSDTIREAKLIQQTNNKPQFNKDSSVSKQPSNTHVRKKR
ASNSDEIEFNRVVTGTVDNPSNAATTNSSLTPNDQQAPLIKPTFITSVGDAANTKRPIEI
LTSPNTDVALLDKDGATMGTGRTNETGHVTIIPQQWIPKGDVSAKATRGSESVTSDPVEA
LNTDPQHRPFVIEVTTDPFTRIELRDKYNKPLGASRTNDKGHAYIVPTRPIPEGNVTAVA
TDDSGNSSTSDPKKATDTTPPDKPIIHTNLVDKVGTLTPIEITTDPDTKVELFDKDNHLI
GSGMTDHTGHITITPSKPLVEGTITAKATDDAETLNSSYSDPVNVTDLTPPILPNLETDL
TSKAGTQTPITVTTDPNTTVELFDKDGNSLGKGTTDTDGHVTIIPNRPIPEGDVTAKATD
NAEHPNSSTSQPKKATDTTPPIVPTFNTDIAGKAGTQTPITVTTDPNTTVELFDKDGNSL
GSGETDGTGQVTIIPTKPIPEGNVTAKATDHAEHPNSSTSDPVKATDTTPPTKPSVVGSL
DGKAGTTDPVEVTTDPNTKVELLDKDGNVIGSGITDGTGHAFITPTKPIPEGNVYVKATD
NAARPNSSVSKPVKTTDTTPPPKPVVKGSMNGKAGTKDPIEIITEPYIKVEILDKDGHVI
GSGKTDKNGHVIIKPNKPYPEGTIIIKATDNAQPPNSSFSDPIKVTDTTAPTEPKIHTTL
IHKANTKTPVKVTTDPYTLVELLDKHGHVIGKATTDGNGNATIKPTTPIPEGEVTVRATD
NAQHPNSSLSKPVKVTLADNDRAHKNGRRTNNTNQKDSKHNSGNTGDQGDNLSGYNQNDS
NQNTVRSLPNTGYSNSESSTAFLMTSLLSGIALLSRKFKKEEK
>SEQF2892_01131 Extracellular matrix-binding protein ebh
MNYRDKLQKFSIRKYAVGTFSTLIATLVFLGTHTDQAHASENTNAAVEKAQQNTESQTSR
DKNSNPNDAITIQNDQTSDQTVEINKQSKFVDKTSTEKKALETQTSEKEITNSTSTSIKE
KIEESSPVTKEEKTNELKEKSSPIVGKQSSNQSKQKVKFSSSKSVKQIDDKIDTPRESKS
DNRQKIDSKNISKLTNLTQEIQSKLLEVETIEPSNPHIEEAKKLTVESSSFTQSSNVSQQ
SLLDLVTRLEQTRNSLANVITRSQSGKRDPRNGQQIEKGTNFRFTTLNGRWNAGRNVIVY
QRNYASLPDGRALGTGQQKNGVEGITSRKTVMRAYYKHEGNSKYLVYDVFFNNDGVNFIS
PGSQQRLGMALLLPYKVMKLNSDGSFASDSVRNLSYAAYEKRSGRNSLLSESPSDFIIDP
DNSTQMIDMLRSNQHDFGHTTFYLSFGVRPGRSFNSDANEYFHSNRNNPDLRKAVEDQRG
IFSGWNYGIGIQVDPNHPEGANRAYHMHLEVKLRDNVTTAELENAWSYANTAAMGGVSKS
AYTVLSGRILPEDGALPSIENQPPVKPTINSDLVGKATTTTVIDVSTDPNTKVEIFDKNG
NKIGTGTTDSSGHAYITPTRPIPEGNVTAKAYNHSDESKVSTSDPKFATDTIPPTTPVIN
TRLVYKAGTLTPIDVSTDPNTQVALIDKNGRIFGAGTTDSSGHVIITPDRVIPEGNVTAK
ATDNALHPNSSVSIPVQATTLIPVMKPVINTDVAGKAFSSPVIDITSTPNTRVELLDKNN
NVIGRGITGSNGHVNITPDHYLFEGNITAKAYDQTDETNNATSDPRHVTDTTPPRKPVIN
TNLVNKVGTRTPIDVSTDVLTRVEIFDENGKSYGVVLTEMDGHGIITPREPLPLGKIYAR
ATDGAETPNSIDSDHVPVTDTIPPTVPTVDTDLTGKATTLTPITVTTDPNTRVDLIDKNG
HIIGTGTTDGNGHVIITPTTPIVEGNVIAKAYDPANNVSTSAPRKATDTTPPTKPRVTSP
LGGKAGTTDPVTVTTDPNTNVQLLDKNGQIIGTGTTDSSGRVNITPTRPIPEGNVTAKAI
DNAEHPNSSTSDPVKATDTTPPTKPRVTTPLGGKATTLTPVEVTTDPNTSVQLLDKDGRV
IGSGTTGANGRVTITPTRPIPEGNVTAKATDNAEHPNSSTSDPVKATDTTPPTKPRVTTP
LGGKATTLTPIEVTTDPNTSVQLLDKDGRVIGSGTTGANGRVTITPTRPIPEGNVTAKAT
DNAERPNSSTSDPVKATDTTPPTEPVVTNDLTGKATTKTPITVTTDPNTHVDLLDKDNHV
IGSGTTDSNGRVTITPTVPIPEGNVRAKATDNAEHPNSSLSQPKKATDTTPPGSPIVNTD
LTGKATTKTPVDVSSDPNTRIELLDKDNHVIGSGTTGANGHVIITPTQPIPEGNVTAKAY
DNAEHPNVSTSEPKKATDTTPPGSPIVNTDLTGKATTRTPVDVSSDPNTRIELLDKDNHV
IGSGTTGANGHVIITPTQPIPEGNVTAKAYDNAEHPNVSTSEPKKATDTTPPTEPVVTND
LTGKATTKTPITVTTDPNTHVDLLDKDNHVIGSGTTDSNGRVTITPTVPIPEGNVRAKAT
DNAEHPNSSLSQPKKATDTTPPGSPIVNTDLTGKATTRTPVDVSSDPNTRIELLDKDNHV
IGSGTTDSNGRVTITPTVPIPEGNVRAKATDNAEHPNSSLSQPKKATDTTPPGSPIVNTD
LTGKATTKTPVDVSSDPNTRIELLDKDNHVIGTGTTGANGHVIITPTQPIPEGNVTAKAY
DNAEHPNSSTSQPKKATDTTPPTEPVVTNDLTGKATTKTPITVTTDPNTHVDLLDKDNNV
IGSGTTDSNGRVTITPTVPIPEGNVRAKATDNAEHPNSSLSQPKKATDTTPPGSPIVNTD
LTGKATTKTPVDVSSDPNTRIELLDKDNHVIGSGTTGANGHVIITPTQPIPEGNVTAKAY
DNAEHPNVSTSEPKKATDTTPPTAPVVTSDLTGKATTTDPVEVTTDPNTKVELLDKDGNV
IGSGTTDNTGHVMITPTKPIPEGNVTAKAYDNAEHPNSSTSQPKKATDTTPPTAPVVTSD
LTGKATTTDPVEVTTDPNTKVELLDKDGNVIGSGTTDNTGHVTITPTKPIPEGNVSAKAT
DNAEHPNSSTSQPKKATDTTPPTAPLVTSDLTGEATTTDPVEVTTDPNTKVELLDKDGNV
IGSGTTDNTGHVTITPTKPIPEGNVTAKAYDNAEHPNSSTSQPKKATDTTPPTAPVVTSD
LTGKATTTDPVEVTTDPNTKVELLDKDGNVIGSGTTDNTGHVTITPTKPIPEGNVSAKAY
DNAEVPNVATSQPKKATDTTPPTTPTLDTDLDGKAGTQTPITVTTDPNTHVDLLDKDGNI
IGSGTTDDTGHVTITPTKPIPEGNVTAKATDDAEHPNSSTSQPKKATDTTPPTAPVVTSD
LTGKATTTDPVEVTTDPNTKVELLDKDGNVIGSGTTDDTGHVTITPTRPIPEGNVSAKAY
DNAEVPNVAASQPKKATDTTPPTTPTLDTDLGGKAGTQTPITVTTDPNTHVDLLDKDGNI
IGSGTTDDTGHVTITPTKPIPEGNVTAKATDNAEHPNSSTSQTKKATDLTPPVKPSVVGT
LDGKAGTKDPVEVVTDPNTKVELLDKDGNVIGSGTTDSTGHATITSTVPIPEGNVTVKAT
DNAEHPNSSTSDPVKATDTTPPTVPTLDTDLGGKAGTQTPITVTTDPNTKVELLDKDSNI
IGSSTTDDTGHVTITPTKPIPEGNVTAKATDNAEHPNSSTSQPKKATDLTPPVKPSVVGT
LDGKAGTKDPVEVVTDPNTKVELLDKDGNVIGSGTTDSTGHATITPTVPIPEGNVTVKAT
DNAEHPNSSTSDPVKATDTTPPTVPTLDTDLGGKAGTQTPITVTTDPNTHVDLLDKDGNI
IGSGTTDDTGHVTITPTKPIPEGNVTAKATDNAEHPNSSTSQPKKATDTTPPTAPVVTSD
LTGKATTTDPVEVTTDPNTKVELLDKDGNVIGSGTTDSTGHATITPTVPIPEGNVTVKAT
DNAEHPNSSTSDPVKATDTTPPTVPTLDTDLGGKAGTQTPITVTTDPNTHVDLLDKDGNI
IGSGTTDDTGHVTITPTKPIPEGNVTAKATDHAEHPNSSTSQPKKATDTTPPTAPVVTSD
LTGKATTTDPVEVTTDPNTHVDLLDKDGNIIGSGTTDDTGHVTITPTKPIPEGNVTAKAT
DDAEHPNSSTSQPKKATDTTPPTAPVVTSDLTGKATTTDPVEVTTDPNTKVELLDKDGNV
IGSGTTDDTGHVTITPTRPIPVGNVSAKAYDNAEVPNVATSQPKKATDTTPPTTPTLDTD
LGGKAGTQTPITVTTDPNTHVDLLDKDGNIIGSGTTGDTGHVTITPTKPIPEGNVTAKAT
DNAEHPNSSTSQPKKATDLTPPVKPSVVGTLDGKAGTKDPVEVVTDPNTKVELLDKDGNI
IGSGTTDSNGHVTITPTRPIPVGDVSAKAYDNAEVPNVATSQPKKATDTTPPTTPTLDTD
LGGKAGTQTPITVTTDPNTHVDLLDKDGNIIGSGTTDSNGHVTITPTKPIPEGNVSAKAT
DNAEHPNSSTSQPKKATDLTPPVKPSVVGTLDGKAGTKDPVEVVTDPNTKVELLDKDGNV
IGSGTTDSTGHATITPTVPIPEGNVTVKATDNAEHPNSSTSDPVKATDTTPPTAPVVTSD
LTGKATTTDPVEVTTDPNTHVDLLDKDGNIIGSGTTDSNGHVTITPTRPIPEGDVYAKAI
DNAEHPNISISKPVKATKLIVKSHKKEAKNGHSKENENHNSRKSKNTIRDEKGNKINTST
KKKVKDLPSTGKKELTNNSLPYIVTLLGSFALLISRKRERKDNNRNK
>SEQF2892_01132 5'-3' exonuclease
MENRVLLVDGMALLFRHFYATSLHNQFMYNSKGIPTNGIQGFVRHIFTAINEINPSHVAV
CWDMGQSTFRNDMYTDYKQNRPAPPEELIPQFDYVKEISDQFGFINVGMTNYEADDVIGT
LAKTFSDNNEVHIITGDKDLLQCINNNVEVWLIKKGFNIYNRYTLARFNEEYQLNPQQLI
DIKAFMGDSADGYPGVKGIGEKTALKLIQTYGSVENVLSNIDQLTPAQRKKIEADKDNLT
LSKRLAEIYTEVPLNSVEIYRDMAYAHSLNQILSICNEHELYVSGKYISTKL
>SEQF2892_01133 GTPase Der
MTNNEQLDILYKLKKEVEKSKNSTLIHTINQVIKKVYLNQYTASFVGHFSAGKSTLINLL
LEQDILPSSPVPTTSNTAIVSVADKQEIIANLENQQYTKLKTYDEVKKMNRLNVDVESVE
INFPSSKFKNGFTLQDTPGVDSNVATHQSTTEQFMYTSNILFYTVDYNHVQSALNFQFIK
RMNDVGIPVIFIINQIDKHNEDEITFETFKQRVNKSIEDWDIKLTDIFYVTKFDHPENEL
SRLSQYLVEKDNYREPIENYVNRTVKFITEAQLGYIQNELQYILEQLNINEDEFEQAYAK
FQQNQAVSEEARLLNNPDQLLSFLKQKRKDILDNAYIMTHDMREDIRHYLESMSDDFKVG
GLLNKKKKKQEEQEARLQNVVSKLQDKVNQQIRQPLREDMSFLTRFINSSEVNHDVLNQH
YEIDSSLFSNLYQPQTSISNTYVLTFSDEVLKAITNFVEKQSNPLFNQAIDHTQAQGLTE
ETNDDLQIYEHYIELQNLKESLTTKNYQHYYIHMDDSLDKLIGRTEANYIVESNDQVLEK
EEKASDENSNERNTKKVNIQEALNIIEPVPLFDRTKNDIKDTLERLENKLVKIGVFGTFS
AGKSSLINALLGGQYLVSSPNPTTAATTELSYGEDSQITLKTEEQLLNELNQLIEYHNVS
FESLEAFVQSDVQQLKNKLEKNQLAFVSAAHKHFSMYKDMLDEGVKHTISQEEIKKWSAE
DEFATFVKTVHINLPLEWLKGKIIVDSLGLHSNNQRHTNETEQILTSSDLILYVSYFNHS
FTDNDKNFIEHMKEMNQLNENQAFKMVINAVDLAENSDDLAAVKHYVKDALTQVNLKSDI
FGVSSRQALRGNDEGINQLRHSIDQFVEVDSNIILEQQMVKQLEQINISFEEMIHDYKTN
QSHIEQRQQQLKKYQNEQRLPNQLLFTTEQHTNNEVEDQIYHLNGRLKLQLLDDVKSIYN
SQMTQNSDFNDEKKISSKAFLDQIHQRLYLEQSLLVERIKKYYNRQLSEQVAPTIQKLNQ
LHVFINTDFSIMPNFTEKAFLRVDLNDMINALPKQLTKRRILNPNTQRELQELISSNTLE
LLQNQISEFRQALIQYVASMNKEAEEKLAQIEDEIQDQIDELLSFNLDNTLIEQLRIANQ
KLNALLK
>SEQF2892_01134 hypothetical protein
MQTVLIIGANGKVSIEATKLFLEDSNFNVDLFLRNAHRIPDYASNRVTVYEGDAKNSKDL
EQALDKVDVVFASLSGSLDIEAQAIVDAMSKKDVKRLIFVAAPGIYDELPAKFNEFNKSQ
FGDKLTKYRKAADIIEASTLDYTIIRPAWLTFKNETDYEVTSKDTQFRGTEVSRRSIASL
AVRIAKNPELYSKENIGVNKPNTDGDKPAWFK
>SEQF2892_01135 Ribosomal RNA large subunit methyltransferase L
MFQLLAVCPMGLEAVVAKEIQELGYETQVENGRIFFEGDAKAIVQCNLWLRTADRIKIVV
GRFNASTFDELFEKTKSLPWENIIDKEGQFPVQGRSVKSTLYSVPDCQAITKKAIVERLK
KAYDEKGWLNESGAKYPVEVAILKDNVLLTIDTSGSGLNRRGYRIAQGEAPIKETLAASL
VRLANWKGDTPFIDPFCGSGTIAIEACLIAQNIAPGFNRDFVSEEWNIMPPNIYDDMRDE
ADQQANYDKDIRVFASDIDPEMVEIAKRNAEEVGLADIIQFSVKDVNTLTIDTDEPVALV
GNPPYGERIGDREEVEEMYRYIGKLMNQHSHLSTYILTSNKEFEFLVNRKATKRRKLFNG
YIECTYYQYWGKKPTTI
>SEQF2892_01138 Cell cycle protein GpsB
MADVSLKLSAKDIYEKDFEKTMARGYRREEVDAFLDDIITDYQKMADMNNEVVKLSEENN
KLKKEVEELRLRVATSRPSDNKSFSSNNSSSSNNNVDILKRISNLEKAVFGK
>SEQF2892_01139 hypothetical protein
MYVTGYKSFELNIFKDDAPEVYYLKAFIKHKLLQYIDEGLEWVLIQGQLGIELWTAEVVI
DLRVEYPDLKLGIITPFYGHTSKWNEQNQMKYNKIAQEADFMESVHHTEYEGPFQFKQTD
QFMLDHTDMTILIYDEEQEGSPKFFKRMLVDFINKTNYTCDIVAFDELTDFINDMQWEQD
QSFE
>SEQF2892_01140 hypothetical protein
MDTMLINDLINELHTIEDRYNIVKNSETNYDFYEVVYPYSQAIDTKLENLIKLKPQIIQL
SYMNANKFDLLIKSYKELSVDCHFYRTSKKLFNEKLKAVNYDLNYIYQTIEG
>SEQF2892_01141 Holliday junction resolvase RecU
MVGRNGKSNSSNIEYGGRGMTLEKDIELSNDYYLKHGKAVIHKKPTPVQIVNVHYPKRSK
AVINEAYFRTPSTTDYNGVYNGYYIDFEAKETKNKTSFPLNNIHDHQVEHMKNAFLQKGI
VFLIIRFKLLDEVYLLPFSKFQKYWDRYKNEIKKSITVEEIRKNSYYIPYQYQPRLNYLN
AVDKLILDESEDRV
>SEQF2892_01142 Penicillin-binding protein 1A/1B
MTENKGSSQPKNGKNGKSKAKKNKNVKRTIIKIIGFLLIAFIVLVLLGILLFAYYAWKAP
AFTESKLQDPKPAEIYDRNGDLVKKLDNGARREHVELKDVPKNMRNAVLATEDNRFYDHG
AIDYKRLFGAIGKNLTGGFGSQGASTLTQQVVKRAFLSEEKSIGRKAQEAYLSYRLEQEY
SKDEIFQMYLNKIYYSDGVYGVKAAAKYYFNKDLKDLNLAEEAYLAGLPQVPNLYNIYDN
PKQAENRKNTVLYLMHYHNRISDKEYNAAKKINLKANLVDRTAKERQIGTDNSDSEYDSY
VNFVKSELMNNKEFKNKNLSDVLQSGIKIYTNMDKDVQKTLQDRIDNGNYYKNEDQRVGS
TILDSKTGGLVAISGGRNFKDVVDNNAATDAHLTGSSLKPFLAYGPAIENMQWATNHAIQ
DESSYSIDGGTFRNYDGNGHGTVTAYDALRQSFNIPALKTWQQVNSQAGDNAVKKFASKV
GLDYQSDIGPSDVLGGGASEFSPTQLASAFAAIANGGTYNNAHSIQKVVTADDDTIEFDH
TSHKAMKDYTSYMLAEMLTGTFKAYGSAYGHGVSGVTMGAKTGTSTYGTEINQQYNLPDN
AAKDVWINGFTPKYTMSIWMGFSEIKEGGVNSFLGHSEQEYPQYLYEDVMSDITSSDDGD
FKKPDSVNGSSADNLSVSGHPDNNTTNREVNGSSGSSSSNSSNNSNNSSNSNTSNTNNSG
NTNSGTTNNNSTTQGTNTVGSTLSNIFNLNSIFDFKKSS
>SEQF2892_01143 hypothetical protein
MINKQEFEEIEELLDEYTKQRALNSPNAKPVIDKYFDLIIRFFKEINEVETINFKLLDQY
PVVPMNFEERYQYMLVRKYHFMGYSQMKTLKSELIKMNASYQIRRKRQS
>SEQF2892_01144 Endonuclease III
MISKKKALEMIDVIADMFPNAECELKHDNAFELTIAVLLSAQCTDNLVNKVTRTLFQKYK
TPQDYLNVDIEELQNDIRSIGLYRNKAKNIQKLCQSLLEQFNGQIPSTHKELESLAGVGR
KTANVVMSVAFDEPSLAVDTHVERVSKRLGINRWKDNVTQVEDRLCSIIPKERWSRSHHQ
LIFFGRYHCLARKPKCDICPLLDDCREGQKRMKGQLKEA
>SEQF2892_01145 DNA replication protein DnaD
MNKIQLKTRPVVVRRELFDHYSELGLTEKDLIVLIKLIYASETSNKQPSIDELKLGSDME
PREITSIIQHLIQRDLLQLHVKKDEEGKFTEYMNLDGFYEKLSNILSQDHSKQLTNQAQQ
NFKDLFQYIESLFARPISPYEIETLNQWIDVDKHDFTLIRAALDEAYSHDKLSFKYVDRI
LLNWKKNNVTTTEESKKIREQFNKPSMTHTVNHIPKFDWLNGEKLDDK
>SEQF2892_01146 Asparagine--tRNA ligase
MKTTIKQAKQHLNQEVTIGAWLTNKRSSGKIAFLQLRDGSGFMQGVVVKSEVSDETFQLA
KEITQESSLYVTGVITEDNRSDLGYEMQVKSIEVIHEAHDYPITPKNHGTEFLMDHRHLW
LRSKKQHAVMKIRNEIIRATYEFFNENGFTKIDPPILTASAPEGTSELFHTKYFDEDAFL
SQSGQLYMEAAAMAHGRVFSFGPTFRAEKSKTRRHLIEFWMIEPEMAFTNHVESLEVQEQ
YVSHVVKSVLKNCQLELKALDRDTSKLEKVSAPFPRISYDDAIKFLKEEGFNDIEWGEDF
GAPHETAIANHYDLPVFITNYPTKIKPFYMQPNPENEETVLCADLIAPEGYGEIIGGSER
INDLELLEQRIDEHQLDAESYNYYLDLRRYGSVPHSGFGLGLERTVAWISGVEHVRETAP
FPRLLNRLYP
>SEQF2892_01147 putative ATP-dependent helicase DinG 
MGHTSYAVVDLETTGNQLDYDEIIQIGITFVSNNKISGTYHSMIRTDLDIPPFIQALTSI
EDTMLEQAPYFHEIAQEIYKQLKDRVFVAHNVDFDLNFIKKAFQNCNIDFKPKKVLDTLE
LFKIAYPTDKSYQLSELAEAHDIPLDNAHRADEDATTTALLMIKAFQKFEQLPIDTLKQL
YYLSKNLKYDLFNVLFEMVRQHENSPLDNQYGQFEQIIYKKQIDLKAPKTSFNGSLKDLY
SEVVKSLNLTYRPQQLYLSEIILEQLMHNDKAMIEAPLGSGKSLAYLLAALMYNIETGRH
VMISTNTKLLQNQLLLKDIPSINQALNFKINATLIKSKSEYISLGLISQILKDETTNYEV
NILKMQLLTWIIETETGDIQDLNLKGGQKMYFDQKIETYVPVRHDMHYYNYIKRNAHHIQ
IGITNHAHLIHSDQENSIYQLFDDCIIDEAHRLPDYALNQVTNDLDYSDLKYQLGLIGKN
ENEKLLKAIDKLEQQRILERLDIAPIDVFGLKMNISEIHDLNERLFNHIFEIIQNSDVYD
DDIHRHHYVFEFDSTQILKDLHLIVDKINKTLEIFNGMTHKTIKTLRKQLLYINDTYRNI
EQSLKDKHTAYLSIRNLTQKSTIKLIVKDYAVRDILTTRVLDKFNSLTFISGTLTFNHKF
DAFKNWFKEDVHFNTYQVPSTLSNHANTNVYIPSDVSSYNFKNIDDYVASIVDYIQEYVT
ITDSKCLVLFTSYRMMHMVQELLNELPTFEDYVVLTQQQNQNYKIVQQFNNFDKTILLGT
STFFEGFDYQAKGIKCVMIAKLPFMNKYNTKHWLMDSEFDSTFKDYVLPDAVTRFRQGLG
RLIRNEDDQGLIVSFDDRLVSSNYKNFFAQTLENYKQKKGDIKQFSKLVNKIQHNIDANK
>SEQF2892_01148 Bifunctional ligase/repressor BirA
MSKYSQDVIRMLYMHQSEYISGQYIANQLNISRAAVKKVIDQLKKDGCKIESINHKGHQL
NELPDSWYNGIVSYILKNSQLASEIKVFKSVESTQIIAKQELVDNNKSMIILSDEQTKGR
GRFNRNWASSKGKGLWMSLVLRPNVPFSMIPKFNLFVALGIRDAIQSFTNDKVEIKWPND
IYIADKKVCGFLTEMIANYDSIDAIICGIGINLNHSDSDFSDDIKQRATSIRLHSNNKIN
RYSFLKKLISSIEKRYSQFLTKPFTEIRNEYIEASNIWQRQLRFTENDKQFIGEAIDIDN
DGFLIVRDENNDVRRLISADIDI
>SEQF2892_01149 CCA-adding enzyme
MGTELFNQAKPILEKIEQHGFEAYFVGGSVRDYLMNRHIHDIDITTSATPDEIESIFEKT
IPIGREHGTINVVYQGTNYEVTTFRAEAEYVDHRRPSEVYFVRDLKEDLQRRDFTINAIA
MDKNFNIYDYFEGDVALNQHIIKTVGDAKERFKEDALRILRGLRFQSQLNFTIEGDTFEA
MKHQIADVEHLSIERIVVELKKLIKGQNVSQSYLNLIDLNFFNYVPFFRSLDMKQTKVNS
PISFELWIAILLTVEQTNTSLSDLKISNNEKTKINQYHKIMIEMPQVSSKEQLKLFVYDY
GINNIIDIIAINSILEDNNIKIASPLIFNLQSIKEIDQHLPIRSRRELNINGGDILRITS
KKSGPWLKEVLRQIEIDVLTNKVPNLKDELLKWVKENVKI
>SEQF2892_01150 N-acetyl-alpha-D-glucosaminyl L-malate synthase
MKIGITCYPSMGGSGIIATELGIKMAERGHEVHFITSNIPFRIRKPLPNITFHQVEVNQY
AVFQYPPYDITLSTKISEVIKEYDLDVLHMHYAVPHAVCGILARQMSGKDIKIMTTLHGT
DITVLGYDHSLKGAIKFGIEQSDIVTSVSHSLAHQTKSIIETEKEIVPIYNFVRENEFPT
RHDETLKEVYGIKPDEKVLIHVSNFRKVKRIDTILETFAKVRKNIPSKLILLGDGPELLD
MRKLARHLGIDSDVLFLGKQDQVSEFYQMSDLVLLLSEKESFGLTLLEAMKTGVVPIGSN
AGGIKEVIKHDETGFIVDIGDSTSASEYALQLLSNKELYNKMQTAMLKDIDERFGSELIT
DQYEHYYRKMLNQKED
>SEQF2892_01151 hypothetical protein
MKSMKEMQNEVDAYIGQFKAGYFSPLANLARLTEEVGELAREINHYHGEKKKKETEEDNT
IKAELGDNLFVLLCIANSLDIDMTESFNETMEKFNTRDKNRFERK
>SEQF2892_01152 hypothetical protein
MSIMSYIIYIVIIMLIPMWAQHKVKSNYEKYAQVRSTSGKTGREVAEEILHANGIYDVDV
VKGEGFLTDHYDPKKKVVCLSPANFDRPSVAGTAIAAHEVGHAIQHQQGYAFLRFRSALV
PLANLGSSLSYMIIMLGIILTAMGSAFGSTALWIGAGLMSLAVLFSIVTLPVEFDASSRA
MKQITALNIVNEKEYKHAKKVLSAAAMTYVAATATAVAELVRIILIARASDN
>SEQF2892_01153 hypothetical protein
MLTLKQMWELTLYRHSCLIFLLICNILGTLYGFIWYGDQLAKTPWYFLPFIPDSPIASLF
LCIVIICLIFNKHIPFVEALAFVTLLKYGLWAVIMNILMINLDHNITIMNVFLIMSHGIM
AIEAIYFYPRLKIRISGLLVAMIWVFNNDYMDYVLNKYPYYDFIEQHKEIVGYIAFWLSV
FALSLYYNLQKILSVKLFD
>SEQF2892_01154 hypothetical protein
MTQTLTQMKQSYIEYALFHYHFKSRISVWILNYIKSHTELLEHVHFVNQRIFNHKTLELA
LTNTDAPAIRLVKNNHLLINTNEIFEYVTTHQNDFDILIHFSDQHTIDFRFNDLIIHQLM
YSPQYMAYLNTIYNLSLDSTRVHSLVEHLRHNIDLSLQLNDREQFYQLTQILEVLENR
>SEQF2892_01155 Lipopolysaccharide assembly protein B
MEDIYKLIDDINLQKLDNLDSRVNDALTSNNDDALFILGETLYNFGLTPQGLEVFRTLYH
KYPDESELLIYFIEGLMSENQTDEALEYLSQVAISTEKLMLEADLYQQINMTEVAIDKLI
EARELEPNDPIIHFALAEMLYFDGQYLRATREYEVVLGTGEYEVNGINLFARMADCALQS
GNYSDAINLYDEINEDEMTSEDFFKKAIAYEKNDITHEAIKITKNLLSKDPDFIQGYFYL
QSLYENEKNYPDAIETGKEGLRLNQFYKELMVSTGSLEIEHGDANEGVELLKQALEVDNA
YHEPLLILSDLFRNEEDYEAIIALLSYVDEDDLDPVFMWHLAHAFGQEERDKEAQHFFEL
AYPTMKTQSAFLSDYYYYLIEIGYKEKAKTILQQLIEMDPSNETWQEEANRLDY
>SEQF2892_01156 3-phosphoshikimate 1-carboxyvinyltransferase
MSNEQMIDIKGPLIGEIEVPGDKSMTHRAIMLASLATGQSTIYKPLLGEDCLRTIEIFKL
LGVNIELAEEKIIVDSPGYNKFKTPHQTLYTGNSGTTTRLLAGLLSGLNLNCVLSGDASI
GKRPMDRVMKPLRLMGANITGIDDNFTPLIIKPASINGITYKMEVASAQVKSALLFASLF
SNDSSKITELDVSRNHTETMFEQFNIPISISGKEITTQPNAIEHIKAKDFYVPGDISSAA
FFIVAALITPGSDITIHNVGINPTRSGIIDIVKQMEGNIECLNITDTSEPTASIRVKYTP
NLKPVLIEGDIVPKAIDELPIIALLCTQASGTSIIKDAEELKVKETNRIDTTADMLGLLG
FELQPTDDGLIIHPSEFKKSATVDSLTDHRIGMMLAIASLLSDKPLNIRQFDAVNVSFPG
FLPKLMLLENEG
>SEQF2892_01157 3-dehydroquinate synthase
MQLQTTYPNNNYPIIVEHNAFEELSEYIQDYDKVFLIIDEYVDFNFKTKFMPFLESTHIY
KIIVPAGEKMKSFEHYQQTLEHLLEYNLTRNTCLVAIGGGATGDFTGFLASSLLRGVDFI
QVPTTILAHDSSVGGKVGINSIHGKNLIGAFYRPKAVIYDLNFLATLPYDEILSGYAEVY
KHALLTGQVAVDDIEKHFSTKEKLQSLNDIDQFIFKGIKAKLNVIIKDEKEHNMRKYLNL
GHTFGHAVEYKTKIPHGHAVMIGIIYQFIVANILLDTQFDISYYANYLKKLHYPVQIVQQ
LNFDDMYHYMLTDKKNNGEGIQMVLLEELGKPRVCHVEKTILIKAFNDLQLVLK
>SEQF2892_01158 Chorismate synthase
MRYLTSGESHGPQLTVIIEGVPANLEIKAEDINKEMFKRQGGYGRGRRMQIEKDAVEIVS
GVRNGYTLGSPITIVVTNDDFTHWRNIMGIEPISDEERDNMKRTITKPRPGHADLIGGMK
YNHRDLRNVLERSSARETAARVAVGAVSKILLEQLDIHMYSRVVEIGGIKDESLYDTETF
KQNIDKNDVRVIDETIAQKMRDKIDAAKKDGDSIGGVVQVMVENMPVAVGSYVQYDRKLD
GRIAQGVVSINAFKGVSYGEGFKAAEKPGSEIQDEILYDNEIGFYRGSNHLGGFEGGMTN
GMPIIVNGVMKPIPTLYKPLNSVDINTKEDFKATIERSDSCAVPAASVVCEHVVAFEVAK
AITEEFQSNHIDQLKAQIDERRRLNIEF
>SEQF2892_01159 Nucleoside diphosphate kinase
MERTFLMIKPDAVQRNLVGEIISRIERKGLKLVGAKLMTVPQALAEEHYSEHTDKPFYGK
LISFITSAPVFAMVVEGEDAVDVSRHIIGKTNPSEATPGSIRGDLGLTVGRNVIHGSDSV
ESAQREINLWFKEEELSSYEAPRDTWLYE
>SEQF2892_01160 Heptaprenyl diphosphate synthase component 2
MAKLNMNSEIKNVEKRLQKAIESNDPILREASSHLLSSGGKRVRPAFVILSSQFGPQKKT
EDTYRVAVALELIHMATLVHDDVIDKSDKRRGRLTIVKKWDVTTAILTGNFLLALGLEHL
SEIRDNRIHHIISNSIVNVGLGELFQFQDQFNSEQSITNYLRRINRKTALLIQLATEVGA
ITSEANDETIRKLKMIGHYIGMSFQIVDDILDFTSTEKKLGKPVGSDLMNGHITLPVLLE
MKKDTSFKKKIAALNHQSESQEFKPLIEQIRNSYSIKESKAISDKYLAKALKLIDELDEP
NAQSLFIKLIKKMGSRSV
>SEQF2892_01161 Demethylmenaquinone methyltransferase
MTENNAKKEQVHTVFQNISSKYDRLNNIISFEQHKVWRKHVMKDMHVKVGSKALDVCCGT
ADWTIALSKAVGAHGEVTGLDFSENMLEVGKEKTKHMNNIHLVHGDAMNLPFEDNSFDYV
TIGFGLRNVPDYLVALKEMNRVLKPGGMIVCLETSQPTMPVFKQVYKLYFKFVMPVFGKL
FAKSKEEYEWLQQSTFDFPDKDKLKQLFEQAGFNKIKIRSFTGGVAAMHLGYKQKSSTK
>SEQF2892_01162 Hexaprenyl-diphosphate synthase small subunit ((2E,6E)-farnesyl-diphosphate specific)
MERTISKLNRQINHKLTGIHDYEAININSRLGGLLDCYDIPENAKLACLTIDTSMKHLDE
ITQNQKSKKSILIGDLLSAHFYMLLAEINDSTFQLAMSKAIVKSNELKSSLHHQVIETED
IYDAIIEIETIFPYITLSHFSKEQVTPLNLYQKLIPEVDDYYPPYLKMYQAADVHQFLKD
INQSYIEKSRGNIND
>SEQF2892_01163 DNA-binding protein HU
MNKTDLINAVAEQADLTKKEAGSAVDAVFESIQQSLSKGEKVQLIGFGNFEVRERAARKG
RNPQTGKEIEIPASKVPAFKAGKALKDAVK
>SEQF2892_01165 Glycerol-3-phosphate dehydrogenase [NAD(P)+]
MTKITVFGMGSFGTALANVLAENGHTVLMWGKNEDSVKELNDHHQNKRYLKDVVLDSRIK
ATSDIKEAANFTDIYLMALPTKAMREVTSEIDSLIDSKKTFIHVAKGIENDTFKRVSEMI
EDSISEDHNGGIGVLSGPSHAEEVVIKQPTTVAASSKDEKVSKLIQDLFMNDYLRVYTNN
DLVGVELGGALKNIIAVASGIVAGMGYGDNAKAALMTRGLAEISRLGEKLGADPMTFLGL
GGIGDLIVTCTSTHSRNYTLGFKLGQGQTMDEALNEMNMVVEGIYTTNSVYHLAKQQNVD
MPITNALYKVLFEDNPVKDSVKDLMGRDKKSE
>SEQF2892_01166 GTPase Der
MTKPIVAIVGRPNVGKSTIFNRVVGERVSIVEDTPGVTRDRIYSSGEWLTHEFNIIDTGG
IEIGDAPFQTQIRAQAEIAIDEADVIIFMVNVREGLTQSDEMVAQMLYKSKKPVVLAVNK
VDNPEMRNDIFDFYSLGFGDPYPISGSHGLGLGDLLDEVVKHFDEETEDSYDEDTIRLSI
IGRPNVGKSSLVNAILGEDRVIVSNVAGTTRDAVDTEYSYDGQDYVLIDTAGMRKKGKVY
ESTEKYSVLRALKAIERSNVVLIVIDAEEGIIEQDKRVAGYAHEEGKAVVIVVNKWDTVD
KDSNTMKKFADDVRNQFQFLDYAQIAFVSAKEGTRLRTLFPYINEASENHKKRVQSSTLN
EVVTDAISMNPTPTDKGRRLNVFYTTQVANEPPTFVVFVNDVELMHFSYKRYLENQIRHA
FGFEGTPIHIIPRRRN
>SEQF2892_01167 30S ribosomal protein S1
MTEEFNESMINDIKEGDKVTGEVQQVEDKQVVVHINGGKFNGIIPISQLSTHHIENPSEV
VKQGDEIEAYVTKIEVDEENDSGVYILSKRQLETEKSYEYLQEKLDNDEIIEAKVTEVVK
GGLVVDVGQRGFVPASLISTDFIEDFSVFDGQTIRIKVEELDPENNRVILSRKAVEQAEN
DVKKASLLESLNAGDVIKGKVARLTNFGAFVDIGGVDGLVHVSELSHEHVDSPEDVVSVG
QEVDVKVKSVEKDAERISLSIKDTLPTPFESIKGQFHEDDVIEGKVVRLANFGAFVEIAP
GVQGLVHISEIAHEHIGTPGEKLEPGQQVNVKILGIDEENERISLSIKATLPKEDVVESD
DATTQSYLSNDSIEDNPTLGDVFGDKFKDLKF
>SEQF2892_01168 Cytidylate kinase
MDLINIALDGPAAAGKSTIARQVASKLSMIYVDTGAMYRAITYKYLQNDKPEDFKTLVNQ
TTLELTYDKSKGQRILLDNQDVTDFLRENDVTQNVSYVASKEPVRTFAVEKQKDLAAKKG
IVMDGRDIGTVVLPDAELKVFMIASVEERAERRQKENEQRGIPSTLSQLKKEIEERDHYD
MNRDISPLKKADDAVTVDTTGKTIEEVTEEIMTLVNNI
>SEQF2892_01169 putative L-asparaginase
MKRLLVIHTGGTISMSQNQFSQVVTNDVNPISLHRDIIGQYANVDEIHPFNIPSPHITIQ
NVEKLRNIIIEANKTGKYDGFVVTHGTDTLEETAYLLDLLLDIRCPVVITGAMRSSNEIG
SDGLYNFISSIRVASSSDANDKGVMVVFNDEIHTARNVTKTHTSNINTFQSPNQGPLGIL
TKDNVQFYNQPYKQQSFKIINYQLKVPLIKAYMGMESDIFNFYAQQNVDGIVIEALGQGN
LPPSCLKGVQTCLDNNIPIVLVSRSFNGIVSPVYAYEGGGFQLANKGLIFSNGLNGPKAR
LKLLIGLSNQLNIVELKNYFEKQN
>SEQF2892_01170 Glucosaminate ammonia-lyase
MQSIESIIIGGGPCGLSAAIEQKRKGIDTLVIEKGNVVDAIYKYPTHQTFFSSSDKLSIG
DIPFIVEESKPRRNQALVYYREVVKHHQLNVRAFEEVLTVKKIDNKFTITTTKDVYECKF
LTVATGYYGQHNKLEVKGAELPKVQHYFKEAHPFFNLDVTVIGGKNSAVDAALELEKAGA
NVTVLYRGDRYSAAIKPWILPNFESLVNHEKITMEFNANVTEITENSVIYEKNGKVTEIP
NDHVFAMIGYHPDYDFLESIGIEINTNEYGTAPVHNKETFETNVENCYIAGVIAAGNDNN
AIFIENGKYHGGIITQSILSKKQTPLES
>SEQF2892_01171 Elastin-binding protein EbpS
MSKNNFRDDFEKNRQSINSDDQFEDNTNEFDENSNESNDFDNQSDQQFPPRNAQRRQRRR
NQATNKNRKFDNQNSDSNANGSLDDRHDEDSFNELQHNQQENHLDNEPIHKDDKRSSEKD
FNNDASRRNNRHEASNRKHDKDYDNGSLNDDDRHRRNHEEGIDERQDNRNHKDQQNKKSR
HGKDAAIAGGAGVAGAAGAKAAKDKRKKDEHHDSKYNEHKDDRDLNNDNQFDQNRKHDKD
LHDDHRDAKDNHSKEEPKKGNKGKKAAVGAGAAGAAGAAGVAGVAAAKHKKDHKNNNHKD
NHSHNRDHQDDHRNHKHEDGNDGFQAHNGKKKRGLAGILLPLIALLLILAALAIFIGMYL
NNDKKDSNQADNKTEQTANKDNNKDSKDKASNDSDKDKASSDKDKDKATNDDDSNDKATT
DNDSSSNSNDDNSSSSDNSTSSNSSDNSSSSDNNGNNSNSDNNNGNSQATSNNSSQSNSN
NNQSNSSNSGQQTHVVSGNENLYRIAIQYYGEGTVENVNKLKQANGLSSNNISNGQKLII
PQ
>SEQF2892_01172 ATP-dependent DNA helicase RecQ
MLEEKLKEWFGFSSFNPGQKEIIESVVNKKDTLGILPTGSGKSLCYQMPTYMKGKPTLII
SPLISLMDDQVMQLKAQGEKFVTSIHSGMDENEKQQNINSLHKSRFVFLSPEFILQTQNF
KLIRNIDFGLIVLDEAHCLSEWGYDFRPHYALIGEITSHYKNASILALTATAPPHLENDL
NLILSRKLNVIKTSMNRENISFSHLNFENDAEKIKWLLNFLDQSGPTIIYVSSKKVCLEL
ANMIYHHGYLTGIYHGDLSYQERHTVQNQFMENFIPVIVATSAFGMGVNKKDIRTVIHFH
LSTSPSNYLQEIGRAGRDNLQSQAISLYQPDDSYILETLLFSDAITTEDIDAFDIGAFLP
PQKQEILTILSQRYSSNVLKTIFDNSLIRKKLGYQRMIGYTSLDQCRRRYLLEFFGDNPT
QPQQCCDIDSNLMTIKVTNRKKVKRKLSYTEKLKYLFKV
>SEQF2892_01173 hypothetical protein
MHSIITYASNHSFDYKTNKSIYNILNGKKSHQTFFDACSQQLLSLYHSLPKLKYPSFERF
LDTYDNQNTDISIHPRYTYDSMIQTFSCIQLLIQTITHFKNNHLNFIPITQQITVQSRVK
QIYSKILEQNLVDDFEKEIEQIFHFIDEKCSNNCLIHYYLQGYEEPMYTRQQVSLIEGIP
VTKLFVLELNNLVQMMFALENDKQFPILTQTIILPTLLNKTTITYHQLLKGLSMDEVAVT
QNVKINTIEDHVLELFIKGYFSEYQTFVNGPQTSEFIAFYDQNRGQRLKLYKEEFDRLTY
FQIKLLIVGIERGELIA
>SEQF2892_01174 Ferredoxin
MAKYTIVDMDTCIACGACGAAAPDIYDYDDEGIAFVILDDNQGTAEVPEELYEDMEDALE
GCPTDSIKIEEEPFDGDALKFE
>SEQF2892_01175 Riboflavin transporter RibU
MQQNKRLITISMLSAIAFILTFIKFPLPFLPPYLTLDFSDVPTLLATFLLGPVAGILVAL
IKNILNFLFNMGDPVGPVANFLAGVSFLLSAYYVTKRQGDTPRSLVVGLAIGTIVMTIVL
SILNYFVLLPLYGMIFNLGDVFNNLKIIILSGVIPFNIIKGIVISIIFALLYRRLKRVLS
>SEQF2892_01177 Sensor protein SrrB
MTNRLNSVVIKLWLTILFIVTTVLILLSAALITFIQYYYTQQTENAIREDASRISHLVEQ
ADNKTLAIEHSQQLIDGSGGVIIMANKSSSIKSSNSNTKDKMLEEIHKNSQFQRVFSQGK
STTQNITISNNGNSHSYILLGYPMKAQENANSKYSAVFIYQDLKSIEDTNNAITIIILIT
AIIFIAVSTVFAFFLSNRITKPLRQLRTQAINISKGDYSKQTSVSTKDEIGELSHTFNNM
SSEIQENIEALSTQKNIRDSLINSMIEGVLGLNDKREVILSNKMADDIIKSIDKTVYKEI
EKQIEATFVSKDTEFQEYEINNKYYVIIMSYVERIQQDGRSGIVVIIRDMTNEHNLDQMK
KDFIANVSHELRTPISLLQGYTESIVDGIVTEPEEIRDSLSIVLDETKRLNRLVNELLNV
ARMDAEGLTVNKEKQPIKPLLSKMQMKYRQQAEDLELNMSLEPNIDDELWEYDADRIDQV
LTNLIDNATRYTQPGDSISITTTTDDSYQTLYIKDTGSGISPEHLELVFDRFYKVEASRT
RGKQGTGLGLFICKMIIEEHGGTIKVESKVNKGTTFIIKLPKPKN
>SEQF2892_01178 Transcriptional regulatory protein SrrA
MTNEILIVDDEDRIRRLLKLYLKRESFTIHEASNGKEAYNLAIENDYACILLDLMLPEMD
GIEVASKLREHKDTPIIMLTAKGEETNRVEGFESGADDYIVKPFSPREVVLRVKALLRRT
QSSKPEQSEPHARDVIEFNHLIIDNDAHRVLADNQQVNLTPKEYELLIYLAKTPNKVFDR
EQLLKEVWHYEFYGDLRTVDTHVKRLREKLNRVSEDAAHMIQTVWGVGYKFEVKSNDEPT
K
>SEQF2892_01179 Ribosomal large subunit pseudouridine synthase B
MSKELERLQKRIANSGYTSRRKAETLITEGKVKVNGQTVTELGTKVKSSDTVEVEGIKIE
QEDKMYILFYKPTQVITSVSDDRGRTVVTDYFKDLETRIYPVGRLDYDTSGLLLLTNDGE
FTNLMTHPRYHIQKKYVAKLKGYLMREEVKALENGIELEDGFTQPAQVKVKKQDKDKNIT
LVEITISEGRNRQVRRMFEHFGHQVDKLTRIEFGNLNLKGLNAGEGRVLTPHEVKVLRHM
AENGK
>SEQF2892_01180 Segregation and condensation protein B
MDKHGIIESLLYTAGDEGLDEKQLLEILEINQAKLSELISSYTSSGLIIQKFGSTYILTS
KKEASPYIEQLIEQKSNMKLSQAAMETLSIIAYNQPLSRSDIELIRGINSDGAVRTLIAR
GLIEAKDVENSRSHALQTTDLFLNVFGIEKIEDLPTTEEDEEEMDDFFSNLVNQKGDTK
>SEQF2892_01181 Segregation and condensation protein A
MYEVKLDAFNGPLDLLLHLIQKYEIDIYDIPMKSLTEQYMQYVHAMKQLEINVASEYLVM
ASELLMIKSKLLLPQHDVDDNLEEDPREDLVGRLIEYQNYKEYTQLLTEKKEEREHYFTK
HPTDLSHLEKNVTWDECQTLDLTDLIVAYQRVKSRLALNKPKTVEIIKESFTIQQATEKV
TTQLRHHTSFNFFSLFTFSEPIEQVVTHFLAILEMSKSGVINIEQVRSFDDIRIIRGVNF
NIG
>SEQF2892_01182 hypothetical protein
MDRALIDFYYYFHKQQHYFLCHDILEEAWKSNINFSKKDGIVSLILFSTAMYHYRRGNTK
GALVTLKKSLSTFEKAKDKALLQLNEQDYKILILSQIKSIEDSKSFKPVYIPVNNVFEKQ
IINTYPDYKFTTLSTQDEYIVNHHKNRDRSDVISARHQAMIKKQNIRSGKDLK
>SEQF2892_01183 Tyrosine recombinase XerD
METIIEEYLKFIQIEKGLSENTIGAYRRDLKKYQLYMQEQKIAHIDFIDRQTIQECLGSL
IDQGASAKSIARFISTIRSFHQFALREKYAAKDPTVLIETPKYEKKLPDVLDVEEVIQLL
ETPDLTKNNGYRDRTILELLYATGMRVTELIQIEIDDVNLIMGFVKVFGKGNKERIIPLG
DTVIEYLDTYINNVRSQLLKKTVTNVLFLNLHGRPLTRQGIWKLIKQYGLRANINKSLTP
HTLRHSFATHLLENGADLRAVQEMLGHSDISTTQLYTHVSKTQIRQMYNQFHPRA
>SEQF2892_01184 Ferric uptake regulation protein
MEERLNRVKQQLQQSSYKLTPQREATVRVLIENEKDHLSAEDVYLKVKDKAPEIGLATVY
RTLELLAEIKVVDKINFGDGVARFDLRKEGAKHFHHHLVCMECGKVDEIHEDLLPQVEER
VETEYNFKILDHRLTFHGVCAECQAKGK
>SEQF2892_01185 ADP-ribose pyrophosphatase
MEFNEKTFDRTVIYNGKIIDLEIHDVELPDGNTSRRELVYHNGAVAVCAITSNDEVLLVK
QFRKPVEKALLEIPAGKLEQYEVREEAAKRELEEETGYVANNLKFITDMYGCPGFTNEKL
TIYFSNNLSEGQLNLDEDEFVELHKVPISDIKALLDNHEIEDAKTIIGLQYILLNYNHSN
>SEQF2892_01186 General stress protein 69
MQKNILKSGIEISELGLGCMSLGTEYANAEPIIEKAIESGITYFDTADIYDKGTNEEIVG
KALKKYQNRDDIVIGTKVGNRPTEDGGTTWDPSKKYIKESVKGSLKRLGLNHIDLYQLHG
GTIDDPLDETISAFNELKQEGIIKAYGISSIRPNVIDYYLKHSEIETIMSQFNLIDNRPE
QLLNDIHAKGVKVLARGPVFKGLLTSNSIDALDHKFSEGIFEYTHHDLGETIASVKEIES
NLSALSFEYLKSHDALGAIIVGASSPQQLEENVNNYNKKVSLDQVKAGRERVKNLEYTQH
LK
>SEQF2892_01187 hypothetical protein
MLCCVNRDVKQCIENVNALSPQSIFTITDLLGQDYYDSLDSAEQSFIDFKFHELILRGEI
MNVVIKEESEHDKHRYLKQY
>SEQF2892_01188 Fatty acyl-CoA reductase
MLGKHYIVTGGTSGLGLEITKRLIKKGAHVTILARNKEKYKQINFKPFEKRVQMLTCDLQ
DKNAISMLPQYIDTQIDGIIYSAGLGYFKSISQHSTNEMLETYEVNIIGFNLLLHALLPY
LSKHASIVGISSQAAFITQANAAHYGASKAAFNAVLNALRLEHPSYHVMSVNPGPVRTPF
HEKADPSLAYAHKYDAMMLDPTLLAKDIIDGIIKRKCEINQPKWMHSTLKFYQIFPRFIE
SLFPFLFKNKQ
>SEQF2892_01189 Pyrroline-5-carboxylate reductase
MKLVFYGAGNMAQAIFKGIINSKKLKSHDIYLTNKSNEEALKNFAEELGVEYSYDDEKLL
QDADYVFLGSKPYDFEKVAQRIQPYINENNRFISIMAGLPINYIQEQLQVENPIARIMPN
TNAQVGHSVTGISFSGNFGPKSKEEVNDLVNAFGSVIEVDEDHLHQVTAITGSGPAFLYH
VFEQYVKAGTDLGLEKDQVEESIKNLIIGTSKMIERSDLSMEQLRKNITSKGGTTQAGLN
ALAQHDIEAIFKDCLNAAVHRSVELSKNEDN
>SEQF2892_01190 Ribonuclease Z
MEVTFFGTSAGLPTKERNTQAIALNLEPFSNSIWLFDVGEGTQHQILHHSIKLGKVDHIF
ITHMHGDHIFGLPGLLTSRSFQGGEDKPLTVIGPRGLQQFIETTLRLSESHLNYPITYIE
IDNHFTYHHKGFSISAHLLNHGIPSYGYRIESPTTPGTIDVEALKSIGLYPGPKYQEVKS
YDNFEHEGQVYNSDDFKGPAKPGPIISIFGDTKPCQSELSIAKDSDVMIHEATYIEGEKT
LANNYHHSHIEDVFELIKQANVKRCLITHLSNRYNHENIQLIKQQLKTHEDVPNFEFVKD
FDTFII
>SEQF2892_01191 Glucose-6-phosphate 1-dehydrogenase
MSKHSKHIPCLITIFGATGDLSHRKLFPSLFHLFQQDNLDEHIAIIGIGRRDYTNEVFRE
QVKSSIQKHVKDTDQIDAFMEHVYYFKHDVSDEQSYDSLLSFSNELDSQYQLKGNRLFYL
AMAPQFFGIISDYLKSSGLTDTTGFKRLVIEKPFGSDLKSAEQLNNQLRRSFKEEEIYRI
DHYLGKDMVQNIEVLRFSNAMFEPLWNNKYISNIQVTSSEVLGVEDRGGYYESSGALKDM
VQNHMLQMVALLAMEAPISLNSEDIRAEKVKVLKSLRQLDPQEVKQNFVRGQYDEGFVEG
EKVIAYRDEDRVAEDSNTPTFVSGRLTIDNFRWAGVPFYIRTGKRMKSKSIQVVVEFKEV
PMNLYYQTDKLLDSNLLVINIQPNEGISLHLNAKKNIQGIDTEPVQLSYAMSAQDKMNTV
DAYENLLFDCLKGDATNFTHWEELKSTWKFVDVIQDEWTMNEPNFPNYESGTNGPLESDL
LLSRDGNHWWDDIQ
>SEQF2892_01192 Multiple antibiotic resistance protein MarA
MDVIKQIQQAIVFIEDRLLEPFNLQDLSDYVGLSPYHLDQSFKMIVGQSPEQYAHARKMT
AAAKEMVQSSSRLVDVAKKYNYHSSNDFANDFSDFHGISPIQASTKKDELKLQERLYIKL
TTTERAPYPYRLDTTEDIALVGYVRYIESNNLSNPYKVPDFLEDLILDGKIKDLKRYNNI
SPYELFVITCPLDNGLELFIGVPSDRYPSHLESRILPGRHYAKFNLQGEIDYAVNEAWYY
IESSLQLTLPYERDSLYVEIYPFDISFEDPFTKIQLWLPIEQENYDL
>SEQF2892_01194 Oligo-1,6-glucosidase
MNKNWWKEVVAYQVYPRSFNDSNNDGIGDLPGVIEKLDYFKDLGIDVIWLSPMYKSPNDD
NGYDISDYQDIMDEFGTMEDFDCLLKGVHDRGMKLILDLVVNHTSDEHPWFIESKSSKDN
PKRDWYIWADPKDDGSEPNNWESIFNGSTWQFDETTNQYYFHLFSKKQPDLNWDNPEVRE
SVFNMMNWWFEKGIDGFRVDAITHIKKTFEAGDLPAPEGKKYAPAFDVDMNQPGIQNWLQ
EMKDESLSQYDIMTVGEANGVNPDNAEEWVGEDKGKFNMIFQFEHLGLWSTGDSQFDVKS
YKEVLNRWQKRLEGIGWNALFIENHDQPRRVSTWGNDKDYWFESATSHAVVYFLQQGTPF
IYQGQEIGMTNYPFESIETFNDVAVRNEYQIVKEQGGDVDQLLDKYRMENRDNSRTPMQW
NNSTNGGFTEGKPWFPVNPNYKDINVAHQLEDEHSVLNFYKKLIQLKKSHDIYMYGQFDL
IDAENENVFAYTRQLEGKTVVVAGNLTDKQSSLTLPFDIEEDAIKLHNYNSQLDATSLKP
FEAFVAEI
>SEQF2892_01195 HTH-type transcriptional regulator MalR
MSKLGYIPNQAARTLITNKTLTIGLIQKSSAPEIRQNPFNSDVLNGINQACNVRGYSTRM
TVSENSGDLYHEVKTMIQSKSVDGFILLYSLKDDPIEHLLNEFKVPYLIVGKSLNYENII
HIDNDNIDAAYQLTQYLYHLGHRHILFLQESGHYAVTEDRSVGFKQYCDDVKISNDCVVI
KSMNDLRDFIKQYCIDASHMPSVIITSDVMLNMQLLNVLYEYQLRIPEDIQTATFNTSFL
TENATPSQTSVNINPDVLGFTAGNTIIDVLRNETISFREKLISTQIVERVSTTKI
>SEQF2892_01196 hypothetical protein
MCKSILKTLRIKDKNINFSDEVIEKKYKGRMSLFYYAELTYQPTYCENCLAKNDNFSIVK
NGKKTSTITLLKIMEMPAYLNLQKQRFYCKTCDSHFTAKSNIVDAHCFISNKTKLAVLNK
AQECRSQKSIAKSCLISSMTVSRVINQAASDVGQSSFDALPEHLMMDEFKSVKNVTGKMS
FIYADAVSHRIVDVVADRKLKSLKDHFYRYSLKLRQKVKTVTIDMYEPYMSLIKQLFPNA
KIIIDRFHIVQSLNRALNMSRVHVMNCYRASNRPLYNKYKSYWKLFLKPFETLEAFNYRK
VHLFKEWKTEKGIVNYLLDVDEELYNTYHYVHELRRFLKENQIEKFNHKLFSIHLSDVCP
KLRPVIRTLRRLATFIENTMTYSNLTNGPLEGINNKIKLIKRVSFGYRNYDNLRNRIIIT
SRLFASTTKKEIKQPKVA
>SEQF2892_01197 6-phosphogluconate dehydrogenase, decarboxylating
MTQQIGVVGLAVMGKNLAWNIESRGYSVSVYNRSSEKTDEMVNESKGKQIHPTYSLEEFV
NSLEKPRKILLMVKAGPATDATIDSLLPLLDDDDILIDGGNTNYQDTIRRNKALAESGIN
FIGMGVSGGEVGALTGPSLMPGGQEAAYNKVSDILDAIAAKAKDGASCVEYIGPNGAGHY
VKMVHNGIEYADMQLIAESYAMMKDLLGMSHEDISKTFKEWNAGELESYLIEITGDIFTK
LDDDNEALVEKILDTAGQKGTGKWTSINALELGIPLTIITESVFARFISSIKQERVNASK
ELNGPKAEFTGNKEEFLEKIRKALYMSKICSYAQGFAQMRKASEENEWNLKLGDLAMIWR
EGCIIRAQFLQKIKDAYDNNSELQNLLLDPYFKGIVTEYQDALRDVVATGVRNGVPTPGF
SASVNYYDSYRSENLPANLIQAQRDYFGAHTYERKDKEGIFHTQWVEE
>SEQF2892_01198 Peptidase T
MINSQRLLETFLELVQINSETGHEEVIQPILKKKFEELGLNVTEDHASEKSWLGANNLIC
TLPATSAKEDVSKIYFTSHMDTVVPGINIKPQIKEDGYIYSDGSTILGADDKAGLAAIIE
TIQYLNENEIPHGQIQFIITVGEESGLKGVKELDSTYIDAEFGYAVDASQPVGTTVVGAP
TQMVINTTILGKTAHASTPSEGISAINIAAKAISRMKLGQIDDYTTANIGKFHGGSATNI
VADEVVLEAEARSHDNQSIEQQVIHMKETFETTAQELGGEAKVIIEKSYPGFKLENDDKV
TQFAINSARELGLAGDTVIAGGGSDGSIINTFGIPTVILGVGYEHIHTTSERISVNSLNQ
LAKQIVKIIDLVAKS
>SEQF2892_01199 hypothetical protein
MYKDYNMTQLTLPMETSVLISTNDISRNVNDIVETIPETEFDEFNCPNNKRIGFKRYAYR
HDKNVFKRDFKLYECDDCSECPLKQQCMNFNLKTNKKIMKDYNWEYFKAQINKKLSEPIT
KTNYSQRKIDVEPFFRFMKAIWGFPRISVRGINKTKRKLGFALMALTIRKVAAQRAEINQ
KHYKKDNFYIIPIEIVFIYLSWKFMS
>SEQF2892_01201 hypothetical protein
MLKLNPYKIGFRTLKTAVGITLGVILAKWIGLDNYASSAILIVLCIKHTKVHSVQAIVSR
FVSCILILLFGSLVFSLLGQNALVLGLIVLLFIPITVMLKVQEGVVTSCVILLHVFNATT
INLHLIINELLLLTIGLGIAFIMNLIMPSLDKTLVSFKKDIEKGFKEIFMTYSEACSNYN
NDFTLSFEKLQLDIRKAKSIAFRDVKNHFIRNENSYYHYFDMRQEQLELLRRIKPLLNQV
TVDDPLLTDVSHLMSEIGNNVNSNDYTALRLHSLYEIRLSLDELPLPKSHQSLKSRSSMM
QILNELEEYLNIKSQFGSLRLHNEI
>SEQF2892_01202 hypothetical protein
MDLNFDLYMNGVVEQARNEIENAGYEQLTTADEVDKVLQQNGTSLVMVNSVCGCAGGIAR
PAASHALHYDKLPDRLVTVFAGQDKEATQQARDYFEGYAPSSPSFALIKDGKITEMIERH
QIEGHDVMDVINQLQGLFDKYCDER
>SEQF2892_01203 Dihydrolipoyllysine-residue acetyltransferase component of pyruvate dehydrogenase complex
MDIKMPKLGESVHEGTIEQWLISVGDYVDEYEPLCEVITDKVTAEVPSTVSGTITEILVS
EGETVQIDHVICKIETSETDNSTNTKNTDIETVKDSTDLNINGNDTLTVETSASASKNTS
DKEVSHSVKSNAHTQASLLNNGRYSPVVFKIASENDIDLSSVPGTGFEGRVTKKDIENYI
NSSHQKPKINNNSQSNFEHTKSNVYSTQSQIGQSIPVKGVRKAIAQNMVTSVTEIPHGWM
MLEVDATNLVKTRNHHKNSFKENEGYNLTFFAFFVKAVAEALKSNPLLNSSWDGEEIILH
KDINISIAVADEDKLYVPVIKHADEKSIKGIAREINELALKARNKQLSQEDMSGGTFTVN
NTGTFGSVSSMGIINHPQAAILQVESIVKKPVVIDDMIAIRSMVNLCISIDHRILDGVQT
GRFMSQVKERIEQFTIENTSIY
>SEQF2892_01204 2-oxoisovalerate dehydrogenase subunit beta
MSKMSYIEAIQQAQDLAMEHDNNVFILGEDVGRKGGVFGATRGLQDKYGVERVIDTPLAE
SNIVGTAIGAAMIGKRPIAEIQFADFILPAVNQIISEAAKMRYRSNNDWQCPITIRAPFG
GGVHGGLYHSQSIESIFASTPGLTIVIPSSPYDAKGLLLSSIESNDPVLFFEHKKAYRFL
KEEVPEDYYTVPLGKADVKREGKDITVFTYGLCVNYCMQAADILAADGISVEIVDLRTVY
PLDKETIIERAKMNGKILLITEDNLEGSVMSEVSAIIAENCLFELDAPIMRLAGPDVPSM
PFSPNLENEVMMNPDKILEKMRELAQF
>SEQF2892_01205 2-oxoisovalerate dehydrogenase subunit alpha
MIDYKSVGLSEEDLKEIYKWMDLGRKVDERLWLLNRAGKIPFVVSGQGQEATQIGMAYAM
KEGDISSPYYRDLAFVTFMGISPYDTMLASFGKKDDINSGGKQMPSHFSHREKGILSQSS
PVATQIPHSVGAALALKMDKKPNIATATVGEGSSNQGDFHEGLNFAGVHKLPFVCVIINN
KYAISVPNTLQYAAEKLSDRALGYGIYGETVDGDDPIAMYKAMKEARERALNGEGATLIE
AITHRMTPHSSDDDDTYRTKEEREALKTYDCNLKFKDYLLEKEIINQEWLDNIEQEHKEI
INKATKDAEKAPYPSVEETYQFVYDPEGGMGNE
>SEQF2892_01206 Dihydrolipoyl dehydrogenase
MSENQYDLVILGGGTAGYVAAIRASQLGNKVAIVEKSLLGGTCLHKGCIPTKALLKSAEV
LRTVKDSVHFGVNVGQYSFDLKSMMKRKDKIVNQMHQGIESLMQKNHIDIFNGTGRIMGT
SIFSPQSGTISVEYDNVESELLPNQNVLIATGSLPTQLPFLPFNHNTVLSSNDILQLTDL
PASIAIIGGGVIGLEFASLLIDLGVNVSVIEAGERILPNESAQIANFLKTSLIARGVTFY
ENCALNESAVKVNSNSVTIQVNKDKTIEVEKVLVSIGRKPNTDDIGLNNTKIKTDDNGNI
LVNDFLQTEDKHIYAAGDCIGKLQLAHVSSKEAILAVEHMFNGNGLPLNYDKMPKCIYTH
PEVASIGYNKESAEAKNIKTKSFKVSFNAIGKAVIEETTNDRGFCEMIINDETNEIIGIN
MIGPQVTELINEASLLQFMNGSAIELGLTTHAHPSISEVLMELGLKVENRAIHV
>SEQF2892_01207 DNA repair protein RecN
MLQTLSIKQFAIIDELEIHFSDGLTVLSGETGSGKSIIIDAIGQLIGMRASSDYVRHGEK
KAIIEGIFDIDESKDVIHILHNLDIEIDEDFLLVKREIFSTGKSICRLNNQIVTLQDLRK
VMQELLDIHGQHETQTLLKQKYHLKLLDDYAEDKYLSTKEKYKNVFNQYKSKTKELEELE
SADQALLQRLDLMKFQYEELEEASLKEGEIEQLEVDIRRIQNSEKLSMALNNAHVTLTDE
HAITDRLYELSNHLQSIDDILPDKFSKLKEDIDQFYYTLEDAKHELYDEMSNTEFDEQML
NELESRMNLLNNLKRKYGKDINELITYKDKLQNEIDKIENYEESTSQLREEISQLYDEVM
SKGKLLSKERRTVARTLRDHIVSEIQNLQMKDANLEISFQLLDKPTIDGIEFVEFLISPN
KGEPLKSLNKIASGGELSRIMLALKSIFVQSRGQTAILFDEVDSGVSGQAAQKMAEKMRD
IAEYIQVICISHLPQVASMSDHHLLISKASNDDRTTTQVKELENDDKIDEIARMISGASV
TELTRENAKEMISQNQRKSSK
>SEQF2892_01208 Arginine repressor
MAKKSVRHIKIREIISSEQIETQDELVKRLNEYDLNVTQATVSRDIKELQLIKVPAPSGQ
YVYSLPNDRKYHPLEKLGRYLMDSFVNIEGTGNLLVLKTLPGNAQSIGAILDQIDWDEVL
GTICGDDTCLLICKDEDASNTIKTRIFNLL
>SEQF2892_01209 Farnesyl diphosphate synthase
MAKKSMNELINQINSALDGVIETSPLNTNLEESMQYSLNAGGKRIRPLLVFLTLDVLNQD
YKKGKKTALALEMIHTYSLIHDDLPAMDNDDYRRGKLTNHKVYGEWKAILAGDALLTKAF
EIIADDELLESDVKVKILSRLAHNSGHLGMVGGQTLDMQSEDKPVDLDTLEQIHKAKTGA
LLQFAVLSAADIAKVDKSTSQALEDFSNHMGLMFQIKDDLLDVYGDESKLGKKVGSDIEN
HKSTYVSLLGKDGAEDKLNFHKDAAIKSIEQLSSHYDIKPLLDIVELFYTRDH
>SEQF2892_01210 Exodeoxyribonuclease 7 small subunit
MSKDQQSFEEMMQELENIVQKLDNETVSLEESLELYQRGMKLSATCDATLKDAEKKVNQL
IKDEAEDEENGKEVNE
>SEQF2892_01211 Exodeoxyribonuclease 7 large subunit
MSEYLSVTTLTKYIKYKFDQDPHLQSILLKGELSNFKKHSSGHLYFNVKDKDSVISAMMF
KGNANQLTFEPKEGDEVLLEARVSVYERRGNYQIYVNKMELDGIGNLYQKLEQLKQKLKK
EGFFNNEHKKPIPRFPKKIAILTASTGAAIRDIQSTINSRYPLAEKIQISTLVQGTQAKE
DIIKNIKYADSLGVDTIIVGRGGGSIEDLWNFNEEDVVKAIFECQTPIISAVGHETDFTL
SDFVADVRAATPTQAAVMATPDQYELMQQIKQYQFSLSRYIKQYLEKQYKQLDHLASYYK
FKQPSLLYDQQIQRKDDLERQLTQLLLSKIENKKYQLKVLHQNFNVKTLNQTILQNKRQL
MNVKNRLSNLTMKNIHNNKLELKNKVELLNNLSPTNTMLRGYSIINKDDKVITSTQDLSK
DDEITLAMKDGNVDAIVKKVRCEHE
>SEQF2892_01212 N utilization substance protein B 
MSRKESRMQAFQTLFQLEMKDTELTINEAINFIKDDEPELDFDFIHWLVTGVKDHEPVLD
DTIKPHLKDWSLQRLLKTDRIILRMATFELLHSDTPPKVIINEAVELAKQFSDDEHYKFI
NGVLSNIK
>SEQF2892_01213 hypothetical protein
MVKVADYSNSNLGKIEIAPEVISVVASIAVSEVEGVTGHFSELKNSNIEKISRKNLNRNL
KIDVKEDGIQIDVYCSIKHGINISKFASKIQTSIFNSIKTMTAIEPKEINVHIMHITVE
>SEQF2892_01214 2-oxoglutarate carboxylase small subunit
MKKILIANRGEIAVRIIRACHDLGIQTVAIYSEGDKDALHTQIADEAYCVGPTQSKDSYL
NIPNILSIATSTGCDGIHPGYGFLAENGDFAELCEACQLKFIGPSYESIQKMGIKDIAKA
EMIAANVPVVPGSDGLVTTISDAKQIAKEIGYPVIIKATAGGGGKGIRVARTEKELENGY
RMTQQEAETAFGNGGLYLEKFIENFRHIEIQIIGDQHGNVIHLGERDCTIQRRMQKLVEE
SPSPILSDEQREEMGNAAIRAAKAVNYENAGTIEFIYDLNDNQFYFMEMNTRIQVEHPVT
EMVTGIDLVKLQLKVAMGEALPYTQEDITINGHAIEYRINAENPYKNFMPSPGKITQYLA
PGGYGVRIESACYTNYTIPPYYDSMVAKLIVHEPTRDEAIMTGLRALSEYLILGIDTTIP
FHLKLMNNDIFRSGSFNTNFLEQYNIMDDEE
>SEQF2892_01215 Biotin carboxyl carrier protein of acetyl-CoA carboxylase
MNFKEIKELIEILDQSSLTEINIEDNKGSVVNLKKQKETEIITPQYTQQAPLAPATSTMA
TPNQSATESPVPQNNDQIDKDDSSYQTINAPMVGTFYKSPSPEEDAYVQVGDKVTNESTV
CILEAMKLFNEIQAEVSGEIVEILVEDGQMVEYGQPLFKVK
>SEQF2892_01216 Elongation factor P
MISVNDFKTGLTISVDNGIWKVIDFQHVKPGKGSAFVRSKLRNLRTGAIQEKTFRAGEKV
EQAMIENRRMQYLYADGDNHVFMDNETFDQTELSADYLKDELKYLKANMEVQIQSYEGET
IGVELPKTVELEVTETEPGIKGDTATGATKSATVETGYTLNVPLFVNEGDVLVINTSDGS
YISRA
>SEQF2892_01217 Aminopeptidase YpdF
MNKLAKVQDLLDVQQLDALVILSDYNRRYLSDFTGTSGALIISKNNYQLITDFRYIEQAT
NQATKFNIIKRSGGLIEAIVEIINHEQFNHVGFEGHLVSYDTYQTLDQSKAKLISIGNEI
EKIREIKTPEEIEKIKYAAKIVDDTYNYVLDIAKVGMTERELKSKLEAKMLELGADGPSF
DTIVASGYRGALPHGVASDKVIEQGDMITLDFGAYYRGYCSDITRTFAIGEPDSKMKDIY
NIVLNSQIKAINEIKAGMTVAEADALSRDYIESHGYREAFGHSLGHGIGLDIHEGPLLSK
NAKGIIQVNNCVTIEPGIYVDGLGGVRIEDDILITENGCEVFTKCTKDLIIL
>SEQF2892_01218 hypothetical protein
MKKLIVIIGASCLLVGCGSQNLGPLEDKTTKLRDQNHNLKLDIQQLNQDISNQKAQVEAL
NKDKKNVSKTVDNNKEAKFLDASSKYYQDITKVISNYNQLDLSKNKKEDKKQNLEKLNTI
ANGIDDAYGKYKGAVTKKDLSSANKNEDKNIRQINKELQSAFKDIKSGYENNNTNKLNKG
KTKLSQVNMSNNS
>SEQF2892_01219 hypothetical protein
MKNILFYLVILIAAIGLILNLNVFMMSFAKTIFTFLIIALIIYLIYYFFFLTEDQRKYRR
AARKYKKRNRK
>SEQF2892_01220 Octanoyltransferase LipM
MTETWNFINTGSHDPYYNMAMDEALLNFVSRGEIDPVVRFYTWNPATLSVGYFQRLKKEI
DIDKVNEKGFGLVRRQTGGRGVLHDKELTYSVIVSEEHPNMPSTVTEAYRVISEGLLEGF
KLLGFEAYFAIPRSKEEREKLKQPRSAVCFDAPSWYELVVEGRKIAGSAQTRQKGVILQH
GSLLQDVNVDELFDMFIFKNDRLKDKMKKAFVDKAVAINDISDRHISIEEMEKAFEEGFK
KGLNIEFKPLTLSDEQIKEVKELEEKYRSDEWLYKK
>SEQF2892_01221 putative adenylyltransferase/sulfurtransferase MoeZ
MNVSLIIALAIIVIIILYMLGNWFMNKRAVTELEQNEFHKGLRKAQVIDVREKVDYDYGH
INGARNIPISMFSQRYQGLRKDQPIYLCDANGVAGYRAARILKKNGYKDIYMLKGGYKKW
TGKIKTKK
>SEQF2892_01222 putative glycine dehydrogenase (decarboxylating) subunit 2
MVVSKSSPLIFERSREGRYAYSLPQSDIKTDSVESILDDKFIRKNKAEFPEVAELDLVRH
YTELSNKNFGVDSGFYPLGSCTMKYNPKINEKVARIPGFAESHPLQEEEQVQGSLEIVYS
LQEELKEITGMDEVTLQPAAGAHGEWTALMIFKAYHLDNGEGHRDEVIVPDSAHGTNPAS
ASFAGFKAVTVKSNERGEVDIEDLKRVVNENTAAIMLTNPNTLGIFEKNIMEIREIVHEA
GGLLYYDGANLNAIMDKVRPGDMGFDAVHLNLHKTFTGPHGGGGPGSGPVGVKKELASYL
PKPMVIKDGDTFKYDNDIKNSIGRVKPFYGNFGIYLRAYTYIRTMGAEGLREVSEAAVLN
ANYIKASLKDHYEIPYEQYCKHEFVLSGSKQKEHGVRTLDMAKRLLDFGVHPPTIYFPLN
VEEGMMIEPTETESKETLDYFIDAMIQIAEEAKNDPDKVLEAPHSTIIDRLDETTAARKP
VLKFDNLHEEKE
>SEQF2892_01223 putative glycine dehydrogenase (decarboxylating) subunit 1
MSHRYIPLTEKDKKEMLDKIGASSINELFGDVPKDILLNRDLNIASGEAETSLLRRLNTV
ANKNVTKETHASFLGAGVYDHYAPAIVDAMISRSEFYTAYTPYQPEISQGELQAIFEFQT
LICELTDMDVANSSMYDGITSFAEACILAFNHTKKNKIVVSKGLHYQALQVLKTYVKVRE
EFEIVEVDLDGTITDLEKLEQAVDDETAAVAVQYPNFYGSVEDLEKIQSFIEGKKALFIV
YANPLALGLLTPPGSFGADIVVGDTQPFGIPTQFGGPHCGYFATTKKLMRKVPGRLVGQT
QDDEGNRGFVLTLQAREQHIRRDKATSNICSNQALNALASSIAMSALGKQGIYDIAVQNL
EHANYAKNQFKDNGFEVLDGTSFNEFVVKFDQPIKDINKKLAEHGFIGGFDLGEASADFE
NHMLIAVTELRTKDEIDTFVKKAGELNGSK
>SEQF2892_01224 Aminomethyltransferase
MTSELKKTPLYQNYVDSGAKIVEFGGWAMPVQFTSIKEEHNAVRYEVGMFDVSHMGEISI
KGNDASKFVQYLLSNDTNNLTDTKAQYTALCNEEGGIIDDLVTYKIGDNDYLLIVNAANT
DKDFAWVQKHAPKFDVEVSNVSNQFGQLAVQGPKARDLVSGLVDIDVSEMKPFDFQQNVT
LFGKNVILSQSGYTGEDGFEIYCEAKDTVDIWNGFIEHNVVPCGLGARDTLRLEAGLPLH
GQDLTESITPYEGGIAFAAKPLIEEDFIGKSVLKDQKENGSERRTVGLELLDKGIARTGY
PVLDLDGNEIGEVTSGTQAPSSGKSIAMAIIKRDEFEMGRELLVQVRKRQLKAKIVKKNQ
IEK
>SEQF2892_01226 Shikimate kinase
MLLNKKNSPIILIGFMGTGKSTIGEYLSLEKQLSFIDLDVYIEIKENKTIPEIFEEVGEI
GFRKIEYNYLTECTKKYDVIATGGGVIEYIESLNYLKQYKYIFWLDCDIDVIVKRVTNDK
HRPNAIDKSKKQLNNLYLSRISRYNEIAFMKVNSDKTIREIYNEIINYLTCG
>SEQF2892_01227 hypothetical protein
MEVGRITMTNHFTYNYKGFISIYTMLIFIIYLSIISFYTTQYSLKLKTIHNINSYYDLKI
NQLFEKG
>SEQF2892_01228 hypothetical protein
MLISLLITIIILTIIPHLFRLTDTYLSAAYEFDQLEYSFFQLDLNKMTNSKAISLKLIDE
HSILLKQQNQNSFIKYQNHKIIFVSNNRGNITLLNNVLNAKFISNHKGIIGVFLRIGSRE
NYYDKSLYL
>SEQF2892_01229 hypothetical protein
MLNYQIRGSLLIDSLLGFMIITIITLIFLPLLQQLNFNLRNQYEILDMKSAIITSQKYYN
IKELKKGITIGKYEIKIYKNAICNNNSLSKNKVCVHLSN
>SEQF2892_01230 hypothetical protein
MRTSKINAFTLLETLLTLLILIIIIMISPSIYTKTKLDLIESELKVKNIITQLEYIKSKA
IAENQSITIVFSKQATEMNIIEQNGNKYKLGLFGTKIISVAKVHTITFNNEGKINRFGSI
ILKAKENIYRVIFNIDKGRIRFVKLSN
>SEQF2892_01231 ComG operon protein 3
MKNHFKNLKKLKAFTLIEMLLVLLIISVLLILIIPNIAKQTAHIQSTGCEAQVKMINSQI
EAYTLKHNRTPSNINDLINDGLIKEGQKQCRSGETITISNGEAIAN
>SEQF2892_01232 Type II secretion system protein F
MKILQVNIFKLSSKNLTSAQMIHLLETLSNLLKSGFTLLESFEFINLYFKYRDKELKNKI
IASIKSGETCYEVLNLIGYPNSITTQIYFSQKYGNLENALEESIKYLKTNLSAKQQVIKA
VQYPLLLCCIFMCMIVVLNYTVIPQFEQLYISMDVNLSFYQKFLTSMITSFPAFLIFFIT
ILILIFVILTIVLLRIETSKKIIILSSIPLFNSYYKIFKTYQISNDLSLFYKNGVSLQDI
VTTYIKQNDNEYLRFLGEFLMDKTNRGETLANSLAMMPCFQKDLIKFIKQGEKSAKLDIE
LKIYSSILINRFKEKSLLHTKIIQPIIFLFLGLFIVSLYLVIMLPMFQLMQNIK
>SEQF2892_01233 ComG operon protein 1
MYQMVLHAYKELNLNVITIENPVEQLLKGITQISINKKAGIDYVSSFKAILRCDPDIILI
GEIRDAEVAKCVIQASLSGHLVLSTMHSTNCRGALLRLLEMGISIQELTQSINIISNQRL
ITTTQNERRLICETIDKKQIQFFFEHEQTMPHNFNNLQQQLNLLSKEGTICEDTASKYF
>SEQF2892_01234 hypothetical protein
MKLVELQKLDFLLKKVNKRRESKSFKIIFSLNNDFFVGDFIPDIQQTSVKLRDVTSTDIE
DHTLFDLDDEKEWKKMFESSHGAYGSYFEMLIDRSNFKNFTDYFRLLENTLEEYSFKFAQ
DLPPIIYNVESVTQNLGLHFFRVDENINFDSISIISEDVLYNDDK
>SEQF2892_01235 hypothetical protein
MAYHFNNRIEILEEQENEGPEAFGSTKVVIATPWADVKTMKGNEFQQWRLTANKENVRFI
IRYRKGINPRQYVRYNGKDYNIVSVTNDNGMNQTLTIFAEVSD
>SEQF2892_01236 hypothetical protein
MANYIEQYYKAIENGEIVTSKRVKKQYQKLIQDMEHHDKYIFDEAKAMRPIQFIENFCRH
SKGELAGKPLVLDLFQKAYISALFGFVDKETGYRRYTESFFFVGRKNGKTTMLAAIALYM
MIADGESGSEVYSVASKRDQANILFDQAHEMIVQSPDLNKNIRKRKSDLYFSHNFSKMQS
LGKNSNSLDGLNAHLVVIDELHSIQDRNLYEVMKQSQSARTQPLLIMITTAGTHRGTIFD
DLYEYACNVVDGNFTDDNFLPIMYELDHKAEYKLPDCWQKANPALGVSKKVEDIERKVAR
AQNNMNDLTGILTKDFNIREVTHSAWLTFDAINNEDTFDINDFAGWYAIGGADLSITTDL
SCATLLFIDPETEMRFAHQMYWLPEDNLYKRVHEDKIPYDKWHEQGLLRLCSGNTIDYSD
ITDWFNEMMNDYDITPLWIYYDNYSARYWVDEMEAYGFHMVRTPQGAKTLSLPMQNMGAD
LEKHKINYNNNPILKWCLTNTGVETDRNGNIVPIKNQSPKRRIDGVASLLDAYVGLFDNY
EQFLRAM
>SEQF2892_01237 hypothetical protein
MNKIYKSINLEQLKIQIDKDNNINKPVAYDLIEELNFMKETMNELKNTVRTHGATYIFKQ
GEQEYLKESPAMKSYNTTVSKYNATLKQLLSLLPQEVEESDAFMDFVTNG
>SEQF2892_01238 hypothetical protein
MAKSIPRAFYKSAKWQKCKNSYMASQNYICERCGDVASICHHKVYLNAENYTNPYVSLNH
DLLESLCQTCHNQEHFGSPSTGEGLRFDEKGNLIKI
>SEQF2892_01239 hypothetical protein
MILSIEDARNALRVDGDFNDDIIIPLVEAIPNYLYITTGRDWLDEPVQPLAQTTAKFILQ
LWFDPQTQDSERLKRTIDSLLGALHALGSEYDG
>SEQF2892_01240 hypothetical protein
MFNTVSEAFNYYRNSSLEEIETRAREIKGQIDTDPETNVTKLNIEIEGLNQAKANIKDKE
NQQVEQNNTEQRSYNPITGTQLRGQNEVPTNNIFGSEEYRSAFFKTMLGKNLTDIEQRTF
NRAMEQQDIEHRADEFASSSNSSAVIPEQTLNEVIKKARTQGGLLANVRTFNMPTKIRIP
IGTPQDRAEWHTEGAYVEADKPITASVQFEANEILKVFSISVKAKTMSIQAFESYLVEEL
TNCVVEAIEYALINGTGKGQGEGILTGIKWDATNSVDVTGKYTDFTKALGMLSRGYAQNA
KFAMSNATLYNQVYGVMDNNQRPIFIQDAQRENVGYIFGKQVIIDDNIEDGTIILGDFNY
VGYNLPQGIMLESSRESSFRSGLIDYRAMAVADTRVLMSEAFVKLTTTTAEA
>SEQF2892_01241 hypothetical protein
MKEIRSADIQAETRDDEMVLEGTAIVFDKPALINTPTGSYTEIIKRNALDGVKFNDTRLL
VSHDQNRLPLAKSPKTMDVWQDDAGMHFRARLANTSESRSVYESVKRGDMSGVSFGFTVS
DGSRYDVETRTRTITKIDKVLEFSVVNFPAYSETSVEARSQMQEAEKRQYEINKAKINLN
KLFIKEIN
>SEQF2892_01242 hypothetical protein
MPKWINKMLGLDKIEQTTSRQFEMLSGSFQSFSQFNGDAYSNDIFRSAVDAIARHIAKLS
GKHVNDTKDFNNYKINRLLQNRPNPYMSGYDFLYKIATQYYLFNNAFILIQKDNNGNLSG
LYPLTPTSVEYVVDGAGEMFLKCLFKDGEIVHFRLSEVAILRRHFNSNELLGDDNSAIMN
TLELAHTQNSGMESAIKNSAQIRGILKYNQKLADSKLKEKKDAFMNDYLSMSNNGGVIPL
DAMLEYIPLKTSDIQIDTSQMEVVKKKIYDYLGINEDIVTGKYDENLWQAFYESTIEPFA
IQLSSELTDKIFTEREQAFSNRIIFESSKLQYASNQSKSNMIKELLPLGLLTINEARDLM
NLSAVEDGDERIQSLNYIEKTLAKNYQMGDKEVGQDEGN
>SEQF2892_01243 hypothetical protein
MNEKDKIFNELVYDAPTQIIPAPPNLYFEIEDAGDKWYSPIVCIALTKGHEVFFMDTDDY
GNTDIGYNKRVKKYNEKTGEFEQLSKMFD
>SEQF2892_01244 hypothetical protein
MAIKEKDKIIEVNALEIPEELKELPQWVLWRAEWNEKQQQFSKVPYSFSGYRASSTNKDT
WTIFDVINRLNEDNENYNGIGFMLSDDDNYIVLDIDNAIDEHGQIISDLALDMTEITYCE
KSPSGTGLHCFFKGQLPSERKKKRSDLDIELYDNARFMTVTGESIGKSEICEEQEILNNL
VERFFKEEQNFETTLTYAPNHKSELSDDEVIDLMLKSKQKDKISDLLKGNYEPYFDSPSE
AVQSLLHYLAFYTGKNKAQMERIFLNYNNLTDKWDSKRSNSTWGELELDRAIANQNEVYK
KSTTKNVKELLNELRKEELQHMREVWEKEKEKGEAFGRPPQTIKPIRCAYILNEHLNFIL
FDMEEDTKLAFYMENEGIYTQNYTYIRRVISWLEPKHNKRKADDVIYHLVHNFAPVTPRT
NDPDLIPVNNGVYNRQTKTLEPFTSKYVFTTKISTNYVANASSPVIDGWTFDEWLYEIAC
ADREVYTLLWQVINDSLNGNYTRKKAIFLVGDGNNGKGTFQVMLSNLIGFDNVASLKVNE
FDHDFKLGVLEGKTLVIGDDVPVGVNVEDSSNFNSVVTGDSVLVNIKNKQPFRTVYRCTV
IQSTNGMPRFKNKTGGTNRRLLIVPFNADFNGNKENTDIKEKYLKDKKVLEYILYKAINM
DFKKFIIPQVSAKMLEEYKQDNDPVYDFKVVEFDTWNIDKVAQVVVYYRYKLFCENSGYR
PLSERKFYKTFEQHLSKNWKKDRSRYYSVADLKSKVGYFEPTLLPHGEPKQSYIKVV
>SEQF2892_01245 hypothetical protein
MKLFKKKYDHKKVNKVKDVVLYTAYSFEAKTYEEAIELLKGNNKQKAIELMYERLIEAQR
NEYEMKLQIEKASSAKFGDRTDNA
>SEQF2892_01246 hypothetical protein
MKIKEKYQLSKVVKVLEKVVSEDSQNGELFMPKQMFHSITDYRYNDTDYYEYMLKLIHKE
LFNILAELDFEDEAFSILDEVTMTLSDVMNEDKEIYYYTVTDSTGEHEHTTDREGHVIGI
LEWALDYIVGNIEVEEVE
>SEQF2892_01247 hypothetical protein
MYKFLFYLLLTVVASCLAIYVVPFHIVLAIYLLGSMIALLNYEYLED
>SEQF2892_01248 hypothetical protein
MFNINIDEDEARELLEQAINARVDELARQKYFLNYKELSEYLNMSKPTIEELLINNGMKY
FKLGSTYRFKKSDVDEFMEQLTAHMDIQNNDFKQVNIKKLLEAQNV
>SEQF2892_01249 hypothetical protein
MKNNFRVLIAIKKLSIAKINEETGIAKATLYGLYYEKTQNPTLPIILKLCNYLKVTPNEF
LGIDNEIKEA
>SEQF2892_01250 hypothetical protein
MIQSRLSVLMAERGLKISDLYEETGISKTTLMAIAENNGKGVQFDTVDKLCNFLGVTPCE
FFEYSPYLVSFQMDKIDSDKNLPIDFTITIKNQNYEKLFYFNVFIYLGNSYDIPVRKDEF
KAYINVGLESSDHYNDEEFYNFISNLTISFRTDFINKIIGSITSLLLDFKEVKTIDRKSI
SFKKGDYIALGLFKESEYETLKKITLK
>SEQF2892_01251 Transposase from transposon Tn916
MASYDQIAKNNWRYRISLGKNAETGKYEYISKTGFKRKSDAKHQAEMIERQLRNGEYIPP
SSSTFKQVADEWLSQYAKDVKISSVRTREKAIKHVLEHFGTKPIQSITKRDYQAFIDNIS
AKYSDSYVTGIMTTTNMIFKYALEMRLIKTLPTENIKRPKKQVTVEELEGNEIKQKFLEK
DELLQFLKVAKNHHSPQNSFEVFTTLAYTGLRIGELQALKWSDIDFENNTISITKTYFNP
TNHKKKYQLLPPKTESSIGKISVDHNVIEMLKDYKINKQDTWKNELYVDNNFVFTDVNGY
PLVLTKLQNWIQAIMQKTDITNKQISTHSFRHTNCALLIEAGVHIKEIQERLRHKDITTT
MNIYAKITNSYKKDASEKFSKLMENVSRELF
>SEQF2892_01252 ComG operon protein 1
MKLLFREIVNKAISKNASDIHFIPTVDEVHIKFRINDYLELYEIFNLDVYQKLLVFMKFK
SGLDVSSHQSAQSGRYTYQAKSTFYLRISTLPLSLGIESCVIRIIQ
>SEQF2892_01253 putative metallo-hydrolase
MKISSLTLGLVDTNAYFIENEESVILIDPAGEPDKIFKKLNQINKPLKAILLTHAHFDHI
GALDDVVNKYEVPLYMNKEEFSFLKDPDKNGSAKFKQYGMPLITSDVKPNHLDEGEYNIE
GFEFNVLHTPGHSPGSLTYVFEDFAVVGDTLFNNGIGRTDLYRGDYETLVDSIKDKLFEL
EGDLPLFPGHGPYTTVDDEQLNPFLDGQ
>SEQF2892_01254 hypothetical protein
MAIVDVVIIPVGTEGPSVSKYIAEIQMKLESFKQEGKIDYQLTPMNTLIEGDLKDLFEVV
QAIHELPFNKGIDRVCTNLRIDDRRDKSRKMNDKLKSVQKHIDNQGE
>SEQF2892_01255 Glucokinase
MKNIILAADIGGTTCKLGIFNGELEQLHKWSIKTDTSDHTGKTLLKNIYDSFNETLSTHQ
LKIDDVIGVGIGVPGPVDFETGIVNGAVNLHWPGSVNVRQIFSEFINCPVYVDNDANVAA
LGEKHKGAGQGADDVVAITLGTGLGGGIISNGELVHGHNGSGAEIGHIRTDFDQRFNCNC
GKSGCIETVASATGVVNLVNFYYPKLTFKSSILPLIKDNKVTAKAVFDAAKAGDQFCIFI
TEKVANHIAYLCSIISATSNPKYIVLGGGMSTAGLILIENIKTEYHNLTFTPAQKDTEIV
QAQLGNDAGITGAAGLIKTYILEKAGVK
>SEQF2892_01256 hypothetical protein
MNREIKNFYDVLQLLKRYGFIIYFKNPNDMYEMMLQEIKSLYHYELLSKDEYLKCILLIN
QRRNEDK
>SEQF2892_01257 Rhomboid protease GluP
MDTEKYFWKSIYYFIKYHNYHIVNIDKNDSEIWLIHKKKNKLVIFRKDIASNQEIQFDKA
KMLDNYQQYEDDLNFKLKSVKYYYFTDQIFDNIKSADSSPIKIESMCISNNNDLHKLIHN
NILTKLMFRQDNKLSNYYKRRVLSQNPIDKHMLRFTPMTYGLIIINVLIWLIMILYLNHF
SDVKLLDLGGLVHFNVVHGEWYRLITSMFLHFNFEHILMNMLSLFIFGKIVESIVGPLRM
LGIYVISGLLGNFISLSFNLHTVSVGASGAIFGLIGSIFAMMFVSKTYSKKTIGQMLIAL
LVLIVLSLFMSNINIMAHLGGFIGGVLITLIGYYFTHNRNLFWIFLIILLVLFVALQVRI
FTIKEENIYDKLIEDAILDYNYKEASSIVNHTIDKGYDDDRTYYLKGLITAATSSRAEGM
ADWERGLKNHPNSGLLNYELAIANRALDDNEKALKYVKKALTINSDDNDYKNLKKELDQS
NESRN
>SEQF2892_01258 5-formyltetrahydrofolate cyclo-ligase
MSKKEIRKEILSQMKQLDKEHKLRADAWLKNQLINNTEYKNAKRIGIVLSMTHEVDTYPI
IETMLSDGKKVFVPNTNYKLKEMNFKQLLSLNRLEKDEKGLLYVNDDTEITDQLDLIVVP
GVAFRDDGYRIGYGGGYYDRFLSDSNANTISLIYDLQLTQFEIESHDQPVEKLIIFNT
>SEQF2892_01259 50S ribosomal protein L33 2
MRVNVTLACTECGDRNYISTKNKRTNPERVEMKKYCSRDNKHTLHRETK
>SEQF2892_01260 Penicillin-binding protein H
MLKRLKEKSNDEKIKHTMNKRISFVFGAIVVIFGIIVLRLGYLQIAQGSQYSQLVKNDEN
ITVNESVPRGRILDRNGKVLVDNASKLTITYTRSRKTSQKDMLDTAKKLSSLITMKTDKI
TERDKQDFWIQKHQDEVDKLMKKETSMLNEGSITQDQYDKQLYKKVGDKQINSLSKKDLR
VLAIYREMSAGSTMNPQTIKNEDVSEKEYAAVSQQLDSLPGVNTTMDWDRRYPYGDTLRS
IFGSVSTSSEGIPKELTEQYLAKGYSRNDRVGKSYLEYQYEDILRGKKKEMKYTTDKSGK
VINSEVINPGSRGDDLQLTIDIDLQKKVESLLENQIKTLRSQGAKDMDNALIVVQNPKNG
DILAMAGKQIDKNGKLTDYDLGNFTGQFAVGSSVKGGTLLAGYQNNAIKVGEEMIDEPLH
FKGGLTKRSYFNKNDKVRINDKEALMHSSNVYMFKTALKLAGDPYYSGMGLPTDISEAGQ
KLRKGLNQVGLGVKTGIDLPNETIGQIEPLTNNSGNYLDLSIGQYDTYSPIQLSQYVSTI
ANDGYRIQPHIGLAIHDATNSDDIGPVKQKIKGNVLNKVNNSEDEIKEVQKGFEMAFNEK
DGTGYSSFHKTKVPSAGKTGTAEVFQDGESRVNSTYIGYAPINNPKLSFSIVYTNQPVPP
PWLNGGDLGRDVINYYFDDKK
>SEQF2892_01261 Superoxide dismutase [Mn/Fe]
MAFELPNLPYATDALEPHIDKQTMEIHHDKHHNTYVTKLNSAVEGTDLESKSIEEIVANL
DSVPEDIQTAVRNNGGGHLNHSLFWELLTPNSEEKGTVVDKIKEQWGSLDEFKKEFADIA
AARFGSGWAWLVVNNGQLEIVTTPNQDNPLTEGKTPILGLDVWEHAYYLKYQNKRPDYIS
AFWNVVNWEKVDELYNATK
>SEQF2892_01262 Zinc-specific metallo-regulatory protein
MNTNDAIKILKDNGLKYTKKREDMINIFVKEDKYINAKHIQQQLDKDYPGISFDTIYRNL
HLFKDLKIIESTELDGEMKFRIACMNHHHHHFICENCGDTKVIDFCPIDQIKVYLPNVDI
HTHKLEVYGVCEECQKQNSK
>SEQF2892_01263 High-affinity zinc uptake system membrane protein ZnuB
MIEALLNFDFMRYSLLSGILIGFIAPLIGAFIVVRRLSLIADALSHVTLGGISFGMFILT
LSPALAIINPMWFGILFAIVGALLIEKLRTSYSNYQEIAIPIIMSAGIALSAIFISLADG
FNQEIVGLLFGSISAVSLSDLLTVVVISIVVVLFITLFYKELFILSFDEEYSRVINIPKW
IQFLFIVIVAMVISASMRVVGILLVSALITLPIAIAMRITKGFKQLIILSVIIGEFSVIM
GLVLAFYMNISPGGVIVVLLVLLLGLTMLFQKSIVRLKKGQ
>SEQF2892_01264 High-affinity zinc uptake system ATP-binding protein ZnuC
MNQPVFELKNIDYQFDNKQVLENINIHINKGEFLAIVGPNGAGKSTLLKIILGLLPLQKG
EIYIDGKSYKKQNQSALKISYVSQKATAFNAGFPASVKEVVLSGLTKTKKLFQKFNKKDE
ALVDKVLTRLNINHLINKNIAELSGGQQQRVLIARALISNPSVLVLDEPTNGIDAKHVSE
FYETLEKLKDEGITIILVTHDIGVVADTATKVACLNKHLHFHGSTEDFKKLDEVEISKIY
GHPIKFVDHQHNRECCEV
>SEQF2892_01265 putative endonuclease 4
MLLGSHVSMSGKKMLEGSAEEAHKFGESTFMIYTGAPQNTRRKSIEDLNIEKGHEAMDKY
GLSNLVVHAPYIINIANTTKPEVFQLGVDFLQNEIERTQALGAKDIVLHPGSHVGAGADK
GIQQIIKGLNEVLTHDNDVRIALETMAGKGSEVGRTFEEIAQIIDGVTHNDRLSICFDTC
HTHDAGYNIKEDFDGVLNEFDKIIGLDRIKVVHVNDSKNEQGAHKDRHENIGFGHIGFDA
LNYVVHHDVFKDIPKILETPYVGEDKKNKKPPYKFEIEMLKAQQFDSELKDKILQQ
>SEQF2892_01266 DEAD-box ATP-dependent RNA helicase CshB
MATHPFELFNLDSKLIEAIKDLKFDKPTEIQNRIIPRIKKGVNLIGQSQTGTGKSHAFLL
PLIDKIDVENKEPQSIVVAPTRELAQQLYQAANHLATFKQGIKVSLFIGGTDIEKDRQRT
SNQPQLVIGTPTRINDLAQSGHLHAHLASYLIVDEADLMIDLGLIEDVDLIASRLDENSH
IAVFSATIPKSLQPFLNKYLSNPEYVEVDSKSQNKKNIEFYLIPTKGTEKVDKTLQLIDI
LNPYLCIVFCNSRDNADELANSLNAAGIKVGMIHGGLTPRERKQQMKRIRNLEFQFVIAS
DLASRGIDIEGVSHVINFDVPKDIDFFTHRVGRTGRGNYKGVAITLYSPDEEHLITLIED
KGYHFENVDVKNNELTPIKAHNTRRKRVRKDDHLTNEVKHKVRSKTKNKVKPGYKKKFKQ
EVERMKRQERKQFSKRQNRQQRKNNKKG
>SEQF2892_01267 GTP cyclohydrolase 1 type 2 
MKIKQLMSIIDTHVPLETAENWDNVGLLIGNHESEINGILTTLDCTDVIVNQAIDKGYNT
IIAHHPLIFKGVKSIIDDGYGQLIKKIIRHNINLIALHTNLDNYVYGVNQMLANKLKLQD
IQFLNQENETYYKVQTYIPKDNVENFKDSLDKHGLAKEGNYEYCFYETEGKGQFKPVGNA
NPHLGQLNNIEYVNEVKIEFMIKASQYALAEKAIIDNHPYETPVYDFIKMTKTANYGLGK
IGTLEDAMSLTDFVKFVKHELDIPSVRYTGDANKHIQKVAIIGGAGIGYEALAFNKGADI
FITGDVKHHDALDAQTYGMTILDINHYSEYVMREGLKELLEQWLYDESIDFPIDASNINT
DPFNYM
>SEQF2892_01268 tRNA (adenine(22)-N(1))-methyltransferase
MITLNQRLTTVCNYLVPGNLADIGSDHAYLPIYAIQHGLITHAIAGEVIKGPFEAAKKNV
SDNQLNNVIDVRLGDGLSVLRQNESIQNITICGMGGPLIARILNEGRIHLANGPRLILQS
NIQTEVLRYTLMTLNYQIIEEVILEEKGHIYEIVVAAHMGHQDHLDKKELKFGPKLLQNK
NEIFYKKWRHELEALNHIRNQLNSELHHERLKEIDNDISLITEVLNNEN
>SEQF2892_01269 RNA polymerase sigma factor SigA
MSDNQVKIKKQTIDPTLTLEDVKKQLIDKGKKEGHLSHEEIAEKLQNFDMDSDQMDDFFD
QLNDNDISLVNEKDSSDTDEKLNPNDLSAPPGVKINDPVRMYLKEIGRVNLLSAQEEIEL
AKRIEQGDEIAKSRLAEANLRLVVSIAKRYVGRGMLFLDLIQEGNMGLIKAVEKFDFSKG
FKFSTYATWWIRQAITRAIADQARTIRIPVHMVETINKLIRVQRQLLQDLGRDPAPEEIG
EEMDLPPEKVREILKIAQEPVSLETPIGEEDDSHLGDFIEDQEAQSPSDHAAYELLKEQL
EDVLDTLTDREENVLRLRFGLDDGRTRTLEEVGKVFGVTRERIRQIEAKALRKLRHPSRS
KRLKDFMD
>SEQF2892_01270 DNA primase
MRIEQSVINEIKDKTDILDLVSEYVKLEKRGRNYIGLCPFHDEKTPSFTVSEDKQICHCF
GCKKGGNVFQFTQEIKDLSFVEAVKELGERINISVDIGNSSDYTSQIASNDLTMIEMHEL
MHEYYQYALLKTVEGEEALNYLTKRGFTEELIKSRGIGYAPNHTHFCHDFLQQKGYDIEL
AYEAGLLSRNEENFSYFDRFRDRIMFPLNNAQGRIVGYSGRTYNNQEPKYLNSPETPIFQ
KRRLLYNLDNARKHIRKNDEAILLEGFMDVIKSDSSGLKPVIASMGTAISDEHITVLKKL
TSHITLMFDGDFAGQEATIKTGQHLLQQGFNVFVVQLPKDMDPDEYITKYGNEKFLEYVN
NEKKSFIIYKVNKHKDEIANNDLAYERYLKEVTQDIALMNSQILQNKIIKDVAHLFNVDS
NTLNSNVLNQQQYIPSEPYINDYQSYDIEIQNNSNNLFSHLSKHESAERALLKHFMNDKD
LFLNYHKQLESDDFDNQFFKRIYSVLEDFYAENDSYTISDMILYTDNDNLRDAIIALDNY
DINQEPYDSEIEDYMNVINESKYGDTLEELNHKLREASRIGDVELQKYYLEQIVNKNKAR
M
>SEQF2892_01271 Putative pyruvate, phosphate dikinase regulatory protein
MENIKIIIASDSIGETAELVARACISQFNPKECKHEFLRYPYIETKEDIDEVIQVANDRN
AIIVYTLVKPEMKTYMESKIGTNKLRSIDIMGPLMGYLKDAFEENPYNQPGRVHRLDDAY
FKKIDAIEFAVKYDDGKDPKGLPKADIVLIGVSRTSKTPLSQYLAHKSYKVMNVPIVPEV
TPPDMLFDIDSSKCIALRISEEKLNRIRKQRLKQLGLGDSARYANEIRIKEEIKYFEDIV
DRIGCAVIDVSDKAIEETANDVINIIESQSK
>SEQF2892_01272 Transcriptional repressor CcpN
MSGFLEARPRVGYYYSGKSKNKLMTDKLRQYVVKDYMSPPVIVKEDMTVYDAICTIFLED
AGTLFITNEHNDFIGVCSRKDLLRASMIGEDIHTMPISVNMSRMPNLTYLEEDELIIYAA
DQMIEKEIDSIPIVKNKGNNKYQVTGRISKTTIAKLFVSLFKE
>SEQF2892_01273 Glycine--tRNA ligase
MVKDMETIVSLAKHRGFVFPGSDIYGGLSNTWDYGPLGVELKNNVKKAWWQKFITQSPFN
VGIDAAILMNPKTWEASGHLGNFNDPMIDNKDSKIRYRADKLIEDYMQKEKGDENFIADG
LSFDEMKRIIDDEGIVCPVSGTANWTDIRQFNLMFKTFQGVTEDSTNEIFLRPETAQGIF
VNYKNVQRSMRKKLPFGIGQIGKSFRNEITPGNFIFRTREFEQMELEFFCKPGEEIEWQN
YWKTFASQWLKDLNINEENMRLRDHDEEELSHYSNATTDIEYRFPFGWGELWGIASRTDF
DLKKHSEHSGEDFKYHDPETNEKYVPYCIEPSLGADRVTLAFLCDAYEEEGVEGSKDART
VMHFHPALAPYKAAVLPLSKKLSEEAIKIFEQLSSKFAIDFDESQSIGKRYRRQDEIGTP
YCITFDFDSLEDNQVTVRDRDSMEQVRMPISELETFLAEKVAF
>SEQF2892_01274 DNA repair protein RecO
MLEKQKGIIIKSVDYGESDKIITILNEHGAKIPLMVRRAKKSKTGLQAHTQLFVYGLFIY
NKWKGMGTLSSVDVINQYYDLRLDIFNSSYATLCTEAIERSMDNDDISPFHYKLLHFVLE
KISNGDSAQLMSIIVLLKCMNRFGFTAFFNHSAISNSYDQSKLVAYSFVYDGTILESELY
KDPHAFRISNKTLYLLDVLQKLPIDKMNQFNISQEILDEMSELILLIYKEYAGMYFKGQK
LINQLKRIEY
>SEQF2892_01275 GTPase Era
MTEHKSGFVSIIGRPNVGKSTFMNRVIGHKIAIMSDKAQTTRNKIQGVMTRNDAQIIFLD
TPGIHKPKHKLGDYMMRVAKNTLSEIDAIMFMVNVNEEIGRGDEYIMEMLKNVKTPVFLV
LNKIDLVHPDALMPRIEQYQKYMNFTEIVPISALEGLNVDHFIDVLKTYLPEGPKYYPDD
QISDHPEQFVVSEIIREKILHLTSEEIPHAIGVNVDRMIKENDERVRVEATIYVERDSQK
GIVIGKGGKKLKEVGKRARHDIEMLLGSKVYLELWVKVQKDWRNKVNFIRQMGYIEDQD
>SEQF2892_01276 Cytidine deaminase
MTYQSHYFQEAREAQSRAYVPYSNFKVGAYLKTKDGRTFYGANVENAAYPATICAERSSL
VAAISEGYRPGDFESITVTVDSEKPSSPCGTCRQVLKELCDDDMPVYMTNHKGELLESTV
GDLLPHGFSGKDLE
>SEQF2892_01277 Undecaprenol kinase
MSAIEWLFILLVIFLVLTLEAVNTAIECVVDLVTMDYHELAKQAKDIAAFSVMLVSIFAL
ITGLVVFLPHIF
>SEQF2892_01278 Endoribonuclease YbeY
MFTIDFNDHTDLVNESWYHQIEDLLNFAKEQEQINEDAELSVTFVDKNEIQEINKTYRDK
DKVTDVISFALEEDEPEIVGLDMPRVLGDIIICTNVAEEQADSFGHSFERELGFLALHGF
LHLLGYDHMNEEDEKVMFSRQDTILNAYGLTRD
>SEQF2892_01279 PhoH-like protein
MPGIIQIDDINHSQALIGNNDEHINAIEEAFDVEIHARGQEIAVKGQKIEPVEKSELVLK
NLLKVIEMGNTITLKDVEAAIKMAKNDTIHHLIDLYDEEITKDAYGKTIRAKTMGQRLYV
NAMKNNDLVFGIGPAGTGKTFLAVVYAAKQLRKGSVKRIVLTRPAVEAGESLGFLPGDLK
EKVDPYLRPLYDGLNTVLGREQTARFIERGTIEIAPLAYMRGRTLDDAFVILDEAQNTTH
AQMKMFLTRLGFSSKMVVTGDQTQIDLPKGVKSGLKEAVKKLHGVKGINIMQLDQSDVVR
HPLVSKIIDRYEGDI
>SEQF2892_01280 hypothetical protein
MNIGIIIFIISIIVTGISAMRDKSHEHRKNQRPPHPKKSTSDKKETHEKGFFEQIEEAFS
ELEKEFTNEDKTTNQQKKDKQTNTKRVYQDQKLEKEIEKESVPEELERSARQRGRVEKET
RQSANSRESNRDSNKLQKELEKQLVDDLYNVRTEIDREKEKQLSRIENNARAIINDKNLS
ERTKRYRLKQLLNSKAIEQDMTHQSFQFDNDPVVNGILWQEILNKPKQL
>SEQF2892_01281 hypothetical protein
MFGLGIIVIAFIIVIALLVLFSFVPVGLWISAIAAGVKVGIGTLVGMRLRRVSPRKVIGP
LIKAHKAGLNLTTNQLESHYLAGGNVDRVVDANIAAQRADINLPFERGAAIDLAGRDVLE
AVQMSVNPKVIETPFITGVAMNGIEVKAKARITVRANISRLVGGSGEETIIARVGEGIVS
TIGSSEHHTQVLENPDNISKTVLSKGLDSGTAFEILSIDIADVDIGKNIGADLQTEQALA
DKNIAQAKAEERRAMAVASEQEMKARVQEMRAKVVEAESEVPLAMAEALREGNLGVKDYY
NLKNVEADTGMRNAINKRTEQNEDESPK
>SEQF2892_01282 hypothetical protein
MNYFNAIHTVINSILTTNNLFNNLSQIVTSPLISLILTCIIFLGFLYQLYSKRINFAGII
AMLALLILFLGFLINGDVNLISVLLFFVGAILVIIELFVIGAIIGIIGISLIILSIIMLG
DNILLMLLNVVIASILAIIEWVILVKWFKRKIPFLDKVVLKDSTNSEAGYRSHDDRSHLV
GQTARTVTDLRPAGIITLDNERIDAVSDGAFILRNKEVKILEVEGSRVVVREIENT
>SEQF2892_01283 30S ribosomal protein S21
MSKTVVRKNESLEDALRRFKRSVSKSGTIQEVRKREFYEKPSVKRKKKSEAARKRKFK
>SEQF2892_01284 Threonylcarbamoyladenosine tRNA methylthiotransferase MtaB
MNIMSTVAFHTLGCKVNHYETEAIWQLFKDANYDRVDFETNADVFVINTCTVTNTGDKKS
RQIIRRAIRQNPDAVVCVTGCYAQTSSAEIMEIPGVDVVVGTQDRHKLLDYIQQFREERQ
PINGVGNIMKNRTYEELDVPYFTDRTRASLKIQEGCNNFCTFCIIPWARGLMRSRNPEKV
VEQATQLVNAGYKEIVLTGIHTGGYGQDLKDYNLAQLLRDLEEIDGLERIRISSIEASQL
TDEVIDVLKRSNKVVRHLHVPLQSGSDTVLKRMRRKYTMEHFSERITKLHDALPNLAVTS
DVIVGFPGETEEEFQETYDFIVKHKFSELHVFPYSARIGTPAARMDDQIDETIKNERVHK
LITLSDQLAKEYASKFEDEVLEVIPEEAGEIEGTLVGYADNYMKVQFEGNDSLIGQIVKV
KIAKADYPINKGKVVRIVEHATNKSEEGVLL
>SEQF2892_01285 Ribosomal RNA small subunit methyltransferase E
MNNLQRYFIDQNADESQRFFITNKEDIHHITNVMRNTIGNQIIITFKDKIVFKSEIITIE
NESIEIKLIEQIDINSELPVQVTICSGLIKADKYEWLIQKATELGADSFIVVEMDRSVVK
LTPNKVQKKLERWQKIIKEAAEQSYRLIIPNIIFKSNLNEIYDTINHYDYILLAYEDEAK
RGEVSLFKETLKKFKTNDRILLIFGPEGGFSEKEITLLNETSFNVGLGPRILRAETAPLY
ALSAISYENELMG
>SEQF2892_01286 Ribosomal protein L11 methyltransferase
MNWTELSIVVNHEVEPLVTDILENYGSNGVVIEDSNDLINQPADKFGEIYELKQEDYPEK
GVRLKAYFNELKFDDSLRNKIKTAVTNLENIDSTVLNFSEQTIAEVDWENEWKNYFHPFR
ASEKFTIVPSWEQYTKEDDSEMCIELDPGMAFGTGDHPTTSMCLKAIETYVDSDNSVIDV
GTGSGILSIASHLLGVKRIKALDIDELAVNVAKENFAKNHCEDAIEAVPGNLLKNETEKF
DIVIANILAHIIEDMIEDAYNTLNKDGYFITSGIIEEKHKQILNKMQNVGFDIKSVNHDN
GWVCIVGQKVSE
>SEQF2892_01287 Chaperone protein DnaJ
MAKRDYYEVLGVSKDASKDEIKKAYRKLSKKYHPDINKEEGADEKFKEISEAYEVLSDDN
KKANYDQFGHDGPQGGFGGQGFSGQDFSGFGGGGFEDIFSSFFGGSRQRDPNAPRKGDDL
QYTMTLEFEEAVFGTKKEISIRKDVTCHTCNGDGAKPGTSKKTCSYCNGAGHVSVEQNTI
LGRVRTQQTCPKCDGTGQEFEEPCPTCHGKGTENKTVKLEVTVPEGVDNDQQIRLAGEGT
PGENGGPHGDLYVVFRVKPSDKFERDGDDLYYNLDVSFPQASLGDEIKVPTLNGNVMLTI
PSGTQTGKQFRLKDKGVKNVHGYGHGDLFVNIKVVTPTKLTDRQKEIMREFAELNGESIE
EQPSNFKDRARKFFKGE
>SEQF2892_01288 Chaperone protein DnaK
MSKVIGIDLGTTNSCVAVLEGDEPKVIQNPEGARTTPSVVAFKNGETQVGEVAKRQAITN
PNTVQSIKRHMGTDYKVDIEGKSYKPQEISAMVLQNLKNTAESYLGDKVDKAVITVPAYF
NDAERQATKDAGKIAGLEVERIINEPTAAALAYGLDKTDQDQKVLVFDLGGGTFDVSILE
LGDGVFEVLSTAGDNKLGGDDFDQVIIDYLVSEFKKENGVDLSQDKMALQRLKDAAEKAK
KDLSGVSQTQISLPFISAGESGPLHLEISLTRSKFEELADSLIRRTMEPTRQALKDAGLS
TSEIDEVILVGGSTRIPAVQEAVKKEIGKDPHKGVNPDEVVAMGAAIQGGVITGDVKDVV
LLDVTPLSLGIEIMGGRMNTLIERNTTIPTSKSQVYSTAADNQPAVDIHVLQGERPMASD
NKTLGRFQLTDIPPAPRGVPQIEVTFDIDKNGIVNVTAKDLGTNKEQNITIQSSSALSDE
EIDRMVKDAEENAEADKKRREEVDLRNEADSLVFQVEKTITDLGDNISEEDKSNAESKKD
ALKSALEGQDIEDIKAKKEELEKVIQDLSAKVYQQAQQAQQQAQDGAQQTQNDSNVEDAE
FKEVNDDEDKK
>SEQF2892_01289 Protein GrpE
MTEKDESVKSNSEYTEEQEVKNEDTSTVENVEDTTSDSDNSSNDSSNEESSEETAVDPKD
EEIQQLQLKANENEEKYLRLYAEFENYKRRIQKENETNKTYQSQRVLTDILPTIDNIERA
LQIEGDDESFKSLQKGVQMVHESLLRALKDNGLEEIESEGQAFDPNFHQAVVQDDNPDFK
SGDITQELQKGYKLKDRVLRPSMVKVNQ
>SEQF2892_01290 Heat-inducible transcription repressor HrcA
MITQRQLSILNAIVEDYVDLGQPIGSKALIDRHHLDVSPATIRNEMKQLEDLNFLEKTHS
SSGRSPSEEGFRLYVDQLLKQTSRQNKNKIQRLNQLLIENHYDISSALSYFANELSMKSH
YATLVVRPKHSEEMINNVHLIKANDSIMILVIIYNSGHVEHFHLNSALELSSDRLIAISN
FISNNNIEISAKLSDKIRSFANSNEENQFINDIVKMINSHISKQSNSIFLGGKVKLIDAL
NESNVSSIQPILQYLESERITELLQTISTNDINVKIGKEIDESLSDISIVTSQYHFDNSL
KGQIAVIGPTAMRYQNVIQLLNQIW
>SEQF2892_01291 Oxygen-independent coproporphyrinogen-III oxidase-like protein YqeR
MEVKSAYIHIPFCVRICTYCDFNKYFIDKQPVDEYIAALIKEMSFSKTKQLETMYVGGGT
PTALSEMQLERLLQAINSKFSINGEFSFEANPDELTLNKVKLLKQYGVNRISMGVQTFKP
ELLKILGRTHNTQDIYNAVNNARKAGINSISLDLMYHLPEQTIDDFADSLNQAINMDIDH
ISSYGLILEPKTQFYNMYRKGKLKLPNEDLGAEMYQYLMKTLNQTDFKQYEISNFAKTNH
ESDHNKVYWFNEEYYGFGAGASGYVEGERYTNLNPVRHYIDAINNGKRPVLTSSCPTLNE
KMEEEMFLGLRMNQGVNRERFKLKFGQTLDDIFGETIYDLKSKQLLIETDGNISLTERGK
VIGNEVFEAFLLN
>SEQF2892_01292 Elongation factor 4
MQERYNRRENIRNFSIIAHIDHGKSTLADRILENTKSVETREMQDQLLDSMDLERERGIT
IKLNAVRLKYEANDGQTYTFHLIDTPGHVDFSYEVSRSLAACEGAILVVDAAQGIEAQTL
ANVYLALDNDLELLPVVNKIDLPAAEPERVKQELEDVIGLNQDDVVLASAKSNIGIEDIL
EKIVEVVPPPEGDPSEPLKALIFDSEYDPYRGVISSIRVMEGVVKAGDKIKMMATGKEFE
VSEVGINTPKQLPIEELTVGDVGYIIASIKNVDDSRVGDTITHANRPAEAPLKGYKKMNP
MVYCGLFPIENKDYNDLREALEKLQLNDASLEFEPESSQALGFGFRTGFLGMLHMEIIQE
RIEREFGIELIATAPSVIYQCIMKDGSEVTVDNPAQMPERDKIDSIYEPYVKATMMVPND
YVGAVMELCQRKRGQFINMDYLDDIRVNIVYEIPLSEVVFDFFDQLKSNTKGYASFDYEF
IENKESNLVKMDILLNGDKVDALSFIVHKDFAYERGKALVEKLKTLIPRQQFEVPVQAAI
GQKIVARTNIKSMGKNVLSKCYGGDISRKRKLLEKQKAGKAKMKAVGSVEIPQDAFLAVL
KMDDE
>SEQF2892_01293 30S ribosomal protein S20
MPNIKSAIKRVRTTENAEARNISQKNAMRTAVKNAKTAINNNADNKAELVNFAIKSVDKA
SQSNLIHSNKADRIKSQLMSSSK
>SEQF2892_01294 hypothetical protein
MYKNYNMTQLTLPMETSVLIPTNDISRHVNDIVETIPDNEFDEFRHHRGATSYHPKMMLK
VILYAYTQSVFSGRKIEKMLNDSIRMMWLSQNQKPSYKTINRFRVNPKVDALLESLFIQF
YSQCVKQNLIDDKAIFIDGTKIEANANRYTFVWKKSIQNHESKMNEDSKALYHELVTNKI
IPEIKEDHDNELTKEEIDLIGSHLDKEIEDLNQHINNEKCTKTRKQIRLKRTKIKKYKKQ
INDYFERKYRYEFQKSILKDRNSYSKTDHDATFMRMKEDHMKNGQLKPGYNLQIATNSQF
VLSYNVYQNPTDTRTMIPFLNSIQETYGHLPEYIVADAGYGSESNYKAIIDDFNRTPLIT
YGMFIKDKTKKYKSDIFNTQNWNYDEINDEFICPNNKRLGFKRYAYRHDKYGYKRDFKLY
ECDDCSECPLKNQCMNFNSKTNKKIMKNYNWEYFKSQINKKLSEPETKNIYSQRKIDVEP
VFGFMKAILVFTRMSVRGLNKVKRELGFVLMALNIRKVVAQRAENNQKIYKKDNFYIISI
EIVFFSLIQELYVPDS
>SEQF2892_01296 hypothetical protein
MGNNIMAIYGEVPELVEKKSNELTHSFLNEDKDDFNYVKYNLYETDMSTVIEEALTMPFI
SEKKVIVVKNSFIFTGEKVNKDITPNNEQVIEFLEKYDGENLVIFEIYSNKLDERKKLTK
SLKKSSKLSKVDQMSEEEIKSWIQNQIHENYKDIKQDALNLFIELTGVNFNIVSQELDKI
SLFLGDRTTITKNDVSLIINRSLEQNVFLLTEFIQKNQKDKAIQLVKDLIIMKEEPIKLL
ALITSNYRLYYQCKILAQKGYSGQQIAKTINVHPYRVKLALNQVRHYELGQLLNIINNCA
ETDYKLKSSYMDKHLILELFILSL
>SEQF2892_01297 ComE operon protein 3
MIFYALSFLSGILWIHIKWVAFLINLLLIIISLQKRLELLHIFILIICLFSGLTLEHFHN
EYNLNKDKFLKSNSNISTEVQFVSRIEKQERQLKGIFELRHQPFVYYLYSNNLKEKDLEN
KSCVIKGKVISVLNHTPYVSISNVDLNSCHITKRKNIIEKQRDFIIKKLNNSSLSHPEYV
IALVTGDVNGINTDFIDKVKDIGIYHLLAVSGSHIATISFLIYHPLVRLNIPKVIINGLI
ILFLSIFAYYTGFAPSALRAILATTTVILISNKTKIASIDILGLIFLVMIIFNPDYLYDI
GFQFSFIISFFIILSFPLIKKLTFFKNIFVLTFIAQLSSTIISIYHFNQIQWIGLLSNLI
FVPFYSFIIFPLSIFLFFAYHFVSDMTLINLVFDKIYIVHNKLLDLFLTFKYYQIFISPK
SAVEFSIFVLLIVLIYIFFCYKKLKILFLFVIVFIVLCVFNVRPNVSTITFFDVGQGDSL
IFQTTKQETVMVDTGGKEIKIGNIDNHNIAKYHIMPTLKQKRITKIDHLIITHPHADHIG
ELPYIAQHIRIKKLYINLYSYSEIELIKIKRLCKINNIELIDATTIQFIQLKNSKISFLH
GDIPNSNDKNEHSIILLIEYQRYKMLLMGDATKNNESKLMKIYQLPKIDILKVGHHGSKT
SSSESFINLIKPTISIISSGKNNKYHLPNRETLQTLRSTNSSILNTQDVGEITLDLDHDL
DIKSKN
>SEQF2892_01298 tRNA-specific adenosine deaminase
MERLKWDEYFMAQSHLLALRSTCQRLSVGATIVKDNRIIAGGYNGSVAGEVHCIDEGCLI
EDGHCIRTIHAEMNALLQCAKQGVSTDGATIYVTHFPCLNCTKSIIQAGIKQIYYAEDYH
NHKYALELLDQAGIDYKKIPFSAQNVARYLTN
>SEQF2892_01299 ComE operon protein 1
MFKDKKELLYAIKQWKFQLSIIILVIISIALFLIYSKSDEETNDTKPIVTSHVNSNQKGK
NHDVLKNDDKTNNKIESNTIQNGDEIVFVDIKGAVEHPNVYKMKSSDRIKDVLDKAKLLT
DADLSQVNLSEKLTDQKLIYIPFANENKNPITQNDANNKSGHSKSLNSSSTNKVNINTAS
EAELLKIPGVGPAKVREIIDYRQKNNTFHSIEDLKNIKGIGDKTFERIKEYITT
>SEQF2892_01300 dTDP-3-amino-3,6-dideoxy-alpha-D-glucopyranose N,N-dimethyltransferase
MTQYVGMSQVYDQLTQDQPYDKWFEIVQHYSQNFNHKPNILDLGCGTGSLTAQLNTIGSV
TGMDLSSDMLAIAANKSNQVSWLEGDMTDFSFNNEFDVITIFCDSLNYLPDIEDVNKTFI
NVFNHLSENGVFIFDVHTIYKMSTLFHNQCYIDENESTFLAWEAIQGDEPFSVYHEMSFF
IEDNNGTYQRFNESHYQRTFEKETYINMLNQIGFKNIETFIDFNRNNHDDHGERLFFVAF
K
>SEQF2892_01301 Ribosomal silencing factor RsfS
MNSEELLNIAVDATENKKAEDIVSLNMKGISDMTDYFVVCHGNNERQVQSIARAVKEAAH
EQAIDVKRMEGYQSARWVLIDLADVVIHVFHKDERNYYNIEKLYQDAPIESYGQVAY
>SEQF2892_01302 hypothetical protein
MKIDKAIELVKDKLPEKRFKHSLRVAETAVKLAEIYDGDKDKANLAGVLHDYCKYDDLST
MYQIVRQHDLDSELLSYGGEILHGPVCAAIMQSEFGIEDEEVLLAIKNHTTGRKEMTKTE
KLVFIADYIEPGRKTPGVEEIRDMAYNQGSLDKTIYEISKRTVLFLISKDITVYGTTISC
LNYYNYSDQRIKDD
>SEQF2892_01303 putative nicotinate-nucleotide adenylyltransferase
MMNKKAIVLYGGQFNPIHTAHLLVANEVYHQLKPDKFYFLPSYMSPLKTHDDYLDAKYRI
KMIQLAIEELGFGEICQIELERKGQSYTYETLKDIVNNEKDADIYFIIGTDQYKQLDKWY
KIEKLKQLITFVIVNRDVNYQEVDESMISVNIPRMDISSSLIRNRVKNKQPINILVPRSI
HDYIREEGFYEN
>SEQF2892_01304 RNA-binding protein YhbY
MLTGKQKRYLRSLAHNIDPIFQIGKAGINDNMIAQIDDTLENRELIKIHVLQNNFDDKNE
LASTLSDATNSEVVQVIGSMIVIYRESVDNKEITLP
>SEQF2892_01305 Shikimate dehydrogenase (NADP(+))
MKYAVIGDPVSHSLSPVMHQVNFKSLNMEDTYEALHIPTQDFHDIRHIIEDNHINGFNVT
IPHKERIIPYLDEINDQAKAVGAVNTVKIINNKWIGYNTDGIGYVMGLKQVYPDLENAYV
LILGAGGASKGIANELSKIVQPKLTIANRTMSRFETWDMDINAISLEQSEQYLDEFDIII
NTTSAGLNNNDDIVISLDNLSSSTLVSDIIYIPYKTKFLKEAEFKGNTVYNGLDMFINQG
AESFKIWTGKQPNILEMKYAVLNKLKGV
>SEQF2892_01306 GTPase Der
MDDTLKCIGCGAPLQSEDKSAPGYVPEHNLFREDVICQRCFRLKNYNEIQDVGMDSEDFL
NLLNELSDRKGIIVNVVDIFDFEGSFINALKRIVGNKKIILAANKLDLLPKQINKRRVKD
WLKKTARKYGLDADDVILISAQKGWGIDDLLTSIDQNRNKQDVYIVGTTNVGKSTLINKL
IEQSVGEKDVVTTSRFPGTTLDLIDIPLDEKTFMYDTPGIIQSHQMTHYVSEKELKTIVP
KNEIKQRVFQLNEGQTLFFGGLSRIDYVSGGKRPLVCYFSNDLNIHRTKTEKANDLWRNQ
IGNVLTPPNNPDHFDMSDTKAVRLETGKEKKDIMISGLGFITIEAGAKVIVRVPKNVDVI
LRNSIM
>SEQF2892_01307 hypothetical protein
MGLIKKFFMPNDYVKSVFQIDIEKLAEAGFKGIITDLDNTLVGWDVKSPTIEIQQWFKRA
NELGITITIVSNNNEDRVSSFSKDLDVDFIFKARKPVGKAFKKAIKHMNIKPEETIVIGD
QMLTDVFGGNRNGLYTIMVVPVKRTDGFITKFNRIIERRLLNYFKNKGYITWEEN
>SEQF2892_01308 5'-methylthioadenosine/S-adenosylhomocysteine nucleosidase
MIGIIGAMEEEVAILKDKLTDMNEISVAHVKFYRGKLNSKEVVLTQSGIGKVNAAISTTL
LIEKFNPKLIINTGSAGALDESLSVGDMLISNDVVYHDVDATAFGYKLGQIPQMPLEFKS
DQELLKSVETVINKKNYNAKIGQIVSGDSFIGSVDQRLTIKRQFPEAMAVEMEATAIAQT
CHQFHVPFIVTRAVSDLANGKADISFEEFLGEAAKSSSSIVESLIKVL
>SEQF2892_01309 Divalent metal cation transporter MntH
MGENLNQNPNQEINPNEKEFKFTKNHRRLLYGSVFLMATSAIGPAFLTQTAVFTAEFYAS
FAFAILISIIIDIGAQINIWRVLVVTGLRGQEVSNKVMPGLGTLISILIAFGGLAFNIGN
IAGAGLGLNAMFGLDIKWGAAITAIFSILIFVSKSGQKIMDVVSMILGVVMILVVAYVMV
VSNPPYGDALVHTFAPEHPVKLILPIITLVGGTVGGYITFAGAHRLLDSGMKGKEFLPFV
NRSAIAGILTTGIMRTLLFLAVLGVVVTGVTLSADNPPASVFQHAIGPIGKNIFGVVIFA
AAMSSVIGSAYTSATFLKTLHKSLLTKNNLIVIIFIVVSTLIFLFIGKPISLLIIAGAIN
GWILPIILGAILIASRKKSIVGDYKHPTWMLIFGIVAVIVTIVTGIFSLQDLATLWKG
>SEQF2892_01310 hypothetical protein
MRIDLNCDLGEAFGNYSFGGDNQIIPLITSANIACGFHAGDENVMYDTIKLVKDNGVGIG
AHPGLPDLKGFGRRNMDITPKEIYNLVVYQLGALDGFCKVHQTRINHVKPHGALYNMGAK
DKNIAHAIAQAVYDFDSSLILVGLSNTLLITEAESLGLRTASEVFADRRYEDNGQLVSRK
EADAVITNTEEALDQVLKMVIENKVVSKNGKEIDLKADTICVHGDGAHALEFVSQIREKL
TKEGIDIQSL
>SEQF2892_01311 Biotin carboxylase
MYRCLVANRGEIAVRIIRACREMGIETVAIYAKGDEQSLHVSLADQAVCIGEANPLDSYL
NIERIIGAAEITGANAIHPGYGFLSESTTFAEKVEENNIQFIGPSKKTMELMGDKITARQ
TVDDAGVPVIPGSKGAVNSVDEIKELAEEIGYPVVLKAASGGGGKGIRIVKDPEQLEKSL
KEAKSEGQKYFNDDRVYVEAFIPVAKHVEVQIIGDGKGNYVHLGERDCSVQRKNQKLIEE
CPCAALTEERRQQICADAVAVAKASNYRSAGTIEFLVTKDAHYFIEMNARIQVEHTVTEM
RADRDLLQAQLYLMQHDKLPFSQDDIVFNGHVIEARINAENPEKKFQPTPGKVKKLHLPQ
GFNIRVDSLLYPGYQVSPYYDSLVAKVIVKDTNRKTAINKLKVALDEMVIDGFTTTANFL
YAVLSYPLYADDDASEVDIKFLEKHQIIEGVEL
>SEQF2892_01312 Biotin carboxyl carrier protein of acetyl-CoA carboxylase
MNIKKIEEVINLVKSNGVKRFKFKDNKSELELDFTEGYQSSNVSSNQNLVSTNTVNDESL
QQVQTSASEETSKEISSPMVGTFFLQDSKELTDPQIKVGDKVKSGDIIGYVEAMKVMNEI
TSDVDGEVVEIVADHGTNVEYDQVLVKLK
>SEQF2892_01313 KipI antagonist
MGIKILKPGLFTTVQDKGRFGYQHLGFSGSGAMDQFSYNLGRKLIGNSGPSLEFTIIGPT
LTFTQANTFVITGGQFNAKLNDINISNNNVLLANKGDVLEFGPAIKGARGYIFFGHPLDI
EMVAGSYSTHTRSKIGGFNGRALKKDDHIQVVQNSNFKVNLGKTSDYDAIEQDNIIHIIE
GPQVNAFSHEKRKTLVESVYKISDQSDRMGYRLIGDNIPPDNGADIISEPVGLGSIQVPN
DGNPIILLNDKQTVGGYTKIATVSQLDLKKLAQFKPGDVIQFKWISVDEANAMLKNFNQQ
FEEKLESVTKAPIFNMHSMRATSKKLAKLIEEEK
>SEQF2892_01314 Kinase A inhibitor
MEVKVINEQSLLLYFKEEISEVNYQEVDLTTQHILSKNIPDIRDVIPSYRAIMINFNNDS
IDYKQLIEKLELDKLKVSKDDTYSKKNVIHIPVLYNLEMGPDLEEVASYNNLTIEEVVQI
HTTNEYLVYMLGFMPGFPFLGGLDERIHTPRRSEPRVKINAGSVGIANNQTGLYPSDSPG
GWQIIGRTPLKVFDQYSEPMTLYEAGDYIKFYSIDETTYNQIESEINDGRFNKEKWVTRS
GH
>SEQF2892_01315 Transcription elongation factor GreA
MENQKQYPMTQEGYEQLEKELEELKTVKRPEVVEKIKVARSFGDLSENSEYDAAKDEQGF
IEQDIQRIEHMLRYALIIEDTGDNNVVQIGKTVTFIELPGDEEENYQIVGSAEADAFNGK
ISNESPMAKALIGKSLKDEVRVPLPNGGEINVKIVNIK
>SEQF2892_01316 Uridine kinase
MANTTIIGIAGGSGSGKTTVTNEIMKNLEGHSVALLAQDYYYKDQSHLTFEERLETNYDH
PFAFDNDLLIENLKDLRNGHAVEVPTYDYTNHTRSNETIAFEPKDVIIVEGIFALENKTL
RDMMDVKIYVDTDADLRILRRLVRDTKERGRSMESVINQYLNVVKPMHNQFIEPTKKYAD
IIIPEGGSNKVAIDIMTTKIQTLVSKQ
>SEQF2892_01317 putative protease YdcP
MKTLTEIQTKVKSKIKKPELLAPAGNLEKLKIAVHYGADAVFLGGQEYGLRSNADNFTMA
EIKEGVEFANQYNAKIYVTTNIIAHDENIKGLENYLIELEKTGATGIIVADPLIIETCKQ
VAPKLEIHLSTQQSLSNTKAVQYWKEEGLDRVVLARETGAMEMKEMKENVDIEIEAFIHG
AMCIAYSGRCTLSNHMTARDSNRGGCCQSCRWDYDLLEVDNDGELDLYYQDGDTVPFAMS
PKDLKLIESIPQMMEIGIDSLKIEGRMKSIHYIATVVSVYRKVIDAYAEDPENFKINPEW
LKELDKCANRDTAPAFFEGTPGYEEQMFGVQQNKKSPYDFCGLVIDYDETTQIATIQQRN
HFKPGQEIEFFGPEIQSFRQVIDAIYDEEGNSLDAARHPLQIVQIKVNHPIYPKNMMRKE
IR
>SEQF2892_01318 putative protease YdcP
MTELLVTPKSLSHLETLIDIGADAFVIGEQKFGLRLPGEFNREDIKQAVNLAHEHDRKIY
VAVNGIFHNYHLNALEDYINFLHEVRVDRIIFGDPAVVMNVKNQHNPIPLNWDAETIVTN
YFQCNYWGKRGAKRALLARELNLDEIINIKENANVEIEVQVHGMTCMFQSKRMLLGNYYT
FQDKQMKIKRENDDKELLLYDEERDNKYPVFEDFNGTHIMSPNDICLIEELEPLFEAGID
SFKIDGILQSEEYINTVTAQYREAIDLYNEDPEAYEDEKFMLVDPIEAIQPEHRPFDEGF
LYKQTVY
>SEQF2892_01319 Putative O-methyltransferase/MSMEI_4947
MEANQQYLLDKHRKTDNKIETLREYAEQNAVPIVDRLSLEMIKQLIRIHRAKNILEIGTA
IGYSSMQFASVSNDIHITTIERDEEMITQAKSNFETYGYSSQIRLIEGNALEQYNEVNDK
QYDIIFIDAAKAQSKKFFEYYTPLLRNGGLVITDNVLYHGFVSNIDIVRSRNVKQMVKKV
QKFNDWLISLENYSTNFINMDDGLAISIKGE
>SEQF2892_01320 hypothetical protein
MTEHNHNHDVELDISNEEELLTLFDENGNEVLYRKMLEFYHPEFKKEYVILAEEGAQSDD
DDMIELIPMINEPDESGDGGKLVPIETDEEWDMIEEVVNTNMEE
>SEQF2892_01321 Putative pre-16S rRNA nuclease
MLTHKILGLDVGSKTVGVAISDLMGWTAQGLDTLRINEELEDYGIEQLVTIIKENNVGSV
VIGLPKNMNNSIGFRGEASLRYKELLKESLPDIEIIMWDERLSTMAAERSLLEADVSRQK
RKKVIDKMAAVFILQGYLDSIQ
>SEQF2892_01322 hypothetical protein
MDNIDKTMKFDYEEIPKDNVETVLNNVHRTLEERGYNAVNQIVGYLLSGDPAYIPRQNDA
RNQIRHIDRDVIMEELVSNYLKENKK
>SEQF2892_01323 Alanine--tRNA ligase
MKNLKASEIRQKYIDFFVEKGHMVEPSAPLVPIDDDSLLWINSGVATLKKYFDGRETPRK
PRIVNSQKAIRTNDIENVGFTARHHTFFEMLGNFSIGDYFKKEAIHFAWEFLTSENWMGM
EPEKLYVTIHPEDSEAYRIWNDEIGLEESRIIRIEGNFWDIGEGPSGPNTEIFYDRGDEY
GQDDPSEEMYPGGENERYLEVWNLVFSEFNHNKDNTYTPLPNKNIDTGMGLERMASVSQN
VRTNYETDLFMPIINEVEKIADKKYLVNNEHDIAFKVIADHIRTIAFAIADGALPANEGR
GYVLRRLLRRAVRFSQTLDINEPFMYKLVDIVAEIMEPYYPNVKEKADFIKRVIKSEEER
FHETLQEGLAILNNLLAKAKSSNNEINGSDAFKLYDTYGFPIELTEELASQENISVDMTT
FEKEMDQQRTRAREARQSSQSMQIQSEVLKNITTESKFVGYETTDYQTTLTDLIYNGEKV
ESAEPGETVYFILKETPFYAVSGGQVADKGTVGNENFEIEVTEVTKAPNGQNLHQGVIQF
GQVTINSDVDASVNRDERKDIQKNHSATHLLHAALKEVLGEHVNQAGSLVESERLRFDFS
HFGPMTQDEIDQVERRVNEEIWRGISVNIQEMPINEAKQMGAMALFGEKYGDIVRVVNMA
PFSIELCGGIHVDNTAEIGLFKIISESGTGAGVRRIEAFTGKSAFLHLEDIQNKFNSIKD
QVKVKSDNQVFDKIVQLQEEEKNLHKQLEQRNKEITSLKMGNIEDQIEEINGFKVLATEV
EVSNAKEIRQTMDDFKSKQQDAIIILASDLGEKVSLIATVPKEQTDKIKAGDIIKNMAPL
VGGKGGGRPDMAQGGGTQPENISEALRFIKDYIKKL
>SEQF2892_01325 ATP-dependent RecD-like DNA helicase
MSDPTLFDYSMIKGTVDAILFQNNDNFYTVIKVETIETNESFGNLPTVVGFFPNIVEGDV
YTFKGQVVEHPRYGKQLKADTFEKEVPQTKDAIITYLSSDLFKGIGKKTAQNIVNTLGEN
AINDIMTDASVLEKVSNLPKKKQKQIADQINANQESEKIMIRLHDLGFGPKLSMAIYQFY
QSETLNVLENNPYQLVYDIKGIGFNKADTLARNNGISFNDPERLKAGLLYTLEEECIKQG
HTYLSLDYAIEVTLDMLMDAHSSDSIDSKQLENILELLNEEQKIIVNNERVAIPSLYYSE
LKSVQNLYRIKTYKHKLKEIEQSDLQIHIGDIETSNNVHYAPSQKEALQTAINSKIMLLT
GGPGTGKTTVIKGIVELYAEVHGLSLSYSDYQEDDYPIVLAAPTGRASKRLQESTGLEAM
TIHRLIGWNQETQPEDILDNEIKAKLIIIDEMSMVDTWLFHQFLSAVPLDAQIILVGDED
QLPSVGPGQIFKDLIDSKAIPRVNLTEVYRQQDGSSIIDLAHRMKHGEPIDITKRFHDRS
FISCNVDQIPKVVEKVVSSAVNKGYDMSDIQVLAPMYKGNAGIKRLNQVLQDILNPKAQD
TREIEFGDIKFRKGDKVLQLVNRPNDNIFNGDIGIIVGIFWAKENALNKDVMVVDFEGNE
ITFTRQDLLELTHAYCTSIHKSQGSEFPIVIMPIVKQYFRMLQRPILYTGLTRAKQSLVL
LGDSTAFEIGLNTQGQLRHTQLQELILSYFDIDHKQSDVTISNTVSKDEEAMNTIHDVDT
KDDQVILSESTLYQINPMINMGDVSPYDFVER
>SEQF2892_01326 TPR repeat-containing protein YrrB
MITKQDTIYEWIQNGQLEDALKALFQNIEEEPNTIENYINAGIVLADINEIEKAERFFQR
AITIDDKNGAVYYNLANLYYDQGKYRDAIKLYQLASKYNMDKIDTNYMIGMSFNQLDAPK
ESLPYFMTAAELDKNQDAEVQFQYGLALCHLEMFNQAINQLKIVLDIDSKHVDALYNLGL
ATYMDTDDLDLAMSYFDKAISIDPNHLLSQHAKKTFEAIKNEEE
>SEQF2892_01327 tRNA-specific 2-thiouridylase MnmA
MSNKDIRVVVGMSGGVDSSVTAHVLKDQGYDVIGIFMKNWDDTDENGVCTATEDYNDVIA
VCNQIGIPYYAVNFEQEYWDKVFTYFLDEYKKGRTPNPDVMCNKEIKFKAFLEHALKLGA
DYVATGHYARIRRHDDGHVEMLRGVDNNKDQTYFLNQLSQQQLSKVMFPIGDIDKKEVRK
IAEEQDLATAKKKDSTGICFIGERNFKTFLSQYLPAQSGEMRTLNGDKMGMHSGLMYYTI
GQRHGLGIGGDGDPWFVVGKNLEDNILYVEQGFHHDALYSDYLIASDFSFVNPVDLDNGF
ECTAKFRYRQKDTKVFVQRESQNALRVTFDEPVRAITPGQAVVFYDEEVCLGGATIDDVF
KTTGQLSYVV
>SEQF2892_01328 Cysteine desulfurase IscS
MEVYADYAATTPVKPEVIEEMMTIYKSHFGNPSSIHSIGRDARRYLDESRRTVAKLLNAK
PSEVIFTSGATESNNTAIKGLVYANEHLGNHIITTKIEHHSVLHVFEQLEKEGYDVTYLD
VDDTGAIDLDQLKEALTNDTILVSIMFVNNEVGTVEPMYDIEDIVSESNALFHVDAVQAI
GHLDVNFEDFKMDTLSLTAHKFGGPKGVGVLLVRDKTPIEYSQLGGEQETKRRAGTENLA
QIVGLTKALELAHKNRDDNNLHLMQLKELFLVSLQERAIPFEVNGSMIDTTGHILNLYFP
FIDVETMLTLLDLANIYVSSGSACTAGSTTPSHVLAAMYEDEERAKHSVRFSFNELTTDQ
EIKYIVAEIHKIYHKFKEE
>SEQF2892_01329 Alkanal monooxygenase beta chain
MGNLKVSALNLVPIREGQSDKEAIEDMISLAQKLDSLNYERYWIAEHHNAPNLVSSATSL
LIQHTLEHTKRIKVGSGGIMLPNHAPLIVAEQFGTMETLFPNRVNLGLGRAPGTDMMTAS
ALRRDQHNGVYEFPEEVEQLQTYFGPGNKQAYVRAYPAVGKNVPLYILGSSTDSAHLAAR
KGLPYVFAGHFAPQQMKEAIQIYKELFEPSDVLDKPYMIVCLNVIVAESDEEAEYLASTL
AQVFIGIARGRMQPVQPPTNDLQALLTPREFEMAKQRFNDSLIGSEETVKEKLEAFIEEY
GEIDELMGISYIYDQEKQFESFTRLQNIIEKLNQ
>SEQF2892_01330 hypothetical protein
MGFMDKAKDAADKFKNSDNEQVDKAKDKINEYTEKNNDDKKDDK
>SEQF2892_01331 HTH-type transcriptional regulator CymR
MKISTKGRYGLTLMISLAKREGQGCVSLKSIAEENSLSDLYLEQLVGPLRNAGLIRSVRG
AKGGYQLRVPADEIKAGDIIRLLEGPITIVESIESEPPAQKQLWLRMRDAVREVLDNTTL
KYLADYVETDDKLNGYMFYI
>SEQF2892_01332 putative AAA domain-containing protein
MITEPLASRMRPTNIDEIISQQHLVGPRGIIRRMVETKRLSSMIFYGPPGIGKTSIAKAI
SGSTDYKFRQLNAVTNSKKDMQMVVEEAKMSGQVILLLDEIHRLDKAKQDFLLPHLENGK
IVLIGATTSNPYHAINPAIRSRAQIFELYSLDHDDVRLAINRALNDSQRGLANYHPKVDE
DALEYFATQSQGDVRSALNALELAVLSASVENEIRHITLQDAKDCLQKGAFVSDKDGDMH
YDVMSAFQKSIRGSDVNAALHYLARLIEAGDLPTIVRRLLVISYEDVGLASPNAGQRTLA
AIQSAERLGFPEARIPLSQAVIELSLSPKSNSAITAIDSALSDIRKGNIGQIPDHLRDGH
YAGAKDLGRAIGYKYPHNYENGHVIQQYLPDKLKNKIYYEPKSTSKSEQQFKTIYDNLRN
KK
>SEQF2892_01333 tRNA threonylcarbamoyladenosine dehydratase
MKHQFSRNELAYGQEGLDLLKEKTVAVLGVGGVGSFAAEALARTNIGHIILIDKDDVDIT
NVNRQIHALTTTIGQSKVTLMEERIKLINPDCKVTPLHMFYTEETYEDLFNNYDIDYFID
ASDTIIYKVHLMKECLERGIKMISSMGAANKTDPTRFKIADISKTYMDPMAKIIRNKLKR
QGIKKGVPVVFSDESPIVIREDVKATVGDANAINRKGQMPPSSNAFVPSTVGLICASYVV
NDILKNIPVRRIKDKGNI
>SEQF2892_01335 Aspartate--tRNA ligase
MSKRTTYCGLVTEELLNQKVTLKGWVHNRRDLGGLIFVDLRDREGIVQIVFNPDFSEEAL
SVAETVRSEYVVEVEGTVTKRDPDTVNSKIKTGQVEVQVSNISIINKSETPPFSINEENQ
NVDENIRLKYRYLDLRRPELAQTFKMRHQTTRAIREYLDNNGFFDIETPVLTKSTPEGAR
DYLVPSRVHEGEFYALPQSPQLFKQLLMISGFDKYYQIVKCFRDEDLRADRQPEFTQVDI
EMSFVDQEDVIQMGEEMLRKVVKDVKGIDVSGPFPRMTYEEAMRRYGSDKPDTRFEMELK
DVSQLGREMDFKVFKDTVENNGEVKAIVAKGAADNYTRKDMDALTEFVNIYGAKGLAWVK
VVDDGLSGPIARFFEDSNVATLKDLTQAESGDLVMFVADKPNVVAQSLGALRIKIAKELG
LIDENKLNFLWVTDWPLLEYDEDAKRYVAAHHPFTSPKQEDISKLDSEPQNAQANAYDIV
LNGYELGGGSIRIADGELQEKMFEVLGFTKEQAREQFGFLLDAFKYGAPPHGGIALGLDR
LVMLLTNRTNLRDTIAFPKTASATCLLTDAPGEVSDKQLEELSLRIRH
>SEQF2892_01336 Histidine--tRNA ligase
MIRIPRGTQDILPEDSSKWRYIENQLDKLMKLYNYKEIRTPIFESTDLFARGVGDSTDVV
QKEMYTFKDKGDRSITLRPEGTAAVVRSYIENKMQGIPNQPVKLYYNGPMFRYERKQKGR
YRQFTQFGVEAIGAENPSMDAEVLAMVMHIYESFGLKHLKLVINSIGDADSRKEYNEALI
RHFEPVIDTFCDDCKSRLHTNPMRILDCKIDRDKEAVKNAPRITDYLNDDSKAYFNEVKT
HLDDLGISYVEDPNLVRGLDYYTHTAFELMMDNPNYDGAITTLCGGGRYNGLLELLDGPN
QTGIGFALSIERLLLALEEEGIELDVEDTFDLFIVTMGEEAERYSVKLLNQLRKSGIKAD
KDYLQRKVKGQMKQADRLNAQYTVVIGDQELENEVIDVKDMSTGETETINLNNLVNYFQE
KNN
>SEQF2892_01338 N-acetylmuramoyl-L-alanine amidase AmiA
MNKVDAWLSKHDLKNLTTLIVVGAFILFLILLFMLMNHSDQGSNRITVSENAELRTGPNA
AYPVIYQVEKGDTFTRLSKSGKWIEVESRDGSEKGWIAGWHTSLNIEADSNKKVNPLKNK
VIVLDPGHGGNDQGASSNTSKKSLEKNYTLKTAKELRRALEKAGATVKLTRSDDTYVSLD
DRKLNGDAYISIHNDSLDSPNANGATVYWYKNNQEALAETLNTNIQKKAMLSNRGTRQEN
FQVLRQTNKPAVLLELGYISNPTDEVMIRNQIHRQVVEEAVVDGLKQYFAS
>SEQF2892_01339 D-aminoacyl-tRNA deacylase
MKVVVQRVKRAAVTNKSIHNEIDKGFCLLVGIGKDTTEADIDAVAKKIINARLFEDENGK
LNLNIQQVEGQILSISQFTLYADVRKGNRPGFSNSKNPEEANVLYEKFNTALRAYDVEVK
AGEFGTDMEVEIINDGPVTIIYESQDGKII
>SEQF2892_01340 GTP pyrophosphokinase
MNNEYPYSADEVLNKAKSYLSTDDYQYVLKSYHIAYEAHQGQFRKNGLPYIMHPIQVAGI
LTEMRLDGPTIVAGFLHDVIEDTPYTFDDVKDMFNEEIARIVDGVTKLKKVKYRSKEEQQ
AENHRKLFIAIAKDVRVILVKLADRLHNMRTLKAMAREKQVRISKETLEIYAPLAHRLGI
NTIKWELEDTALRYIDSVQYFRIVNLMKKKRSEREAYIANAIDKIQTEMIKMDITGEISG
RPKHIYSIYRKMMKQKKQFDQIFDLLAIRVIVNSINDCYAILGLVHTLWKPMPGRFKDYI
AMPKQNMYQSLHTTVVGPNGDPLEIQIRTYEMHEIAEHGVAAHWAYKEGKTVNEKNQDFQ
NKLNWLKELAEADHTSSDAQEFMESLKYDLQSDKVYAFTPASDVIELPYGAVPIDFAYAI
HSEVGNKMIGAKVNGKIVPIDYVLQTGDIIEIRTSKHSYGPSRDWLKIVKSSSAKSKIKG
FFKKQDRSSNIEKGKFMVEAEIKEQGFRVDDILTDKNIEVVNEKYNFANDDDLFAAVGFG
GVTALQVVNKLTERQRIQDKQKALNEAQEVIKSLPIKDDIITDSGVYVEGIENVLIKLSK
CCNPIPGDDIVGYITKGHGIKVHRTDCPNVKNETERLIAVEWVKSKDSTQRYQVDLEVSA
YDRNGLLNEVIQAVNSTVGSIIKINGRSDTDKNAIITISVMVRNVNDVFRVVEKLKQLSD
VYTVSRVWN
>SEQF2892_01341 Adenine phosphoribosyltransferase
MDLKQYVSEVQDWPKPGVSFKDITTIMDNGEAYGYATDQIVKYAKDRDVDVVVGPEARGF
IIGCPVAYSMGIGFAPVRKEGKLPREVIRYEYDLEYGTNILTMHNDAIKPGQRVLITDDL
LATGGTIEAAIKLVEKLGGIVVGIAFIIELKYLNGIEKIKDYDVMSLISYDE
>SEQF2892_01342 Single-stranded-DNA-specific exonuclease RecJ
MIKSKYNWLYEPPTEYINETLIKKYQLTPIIKKLLESKSITDDESIKALLDETIINHDPW
LLSDMEKAVTRINEAIDKNERILVYGDYDADGVTSTTILVKTLQTLGAEVGWYIPNRFSE
GYGPNELAFRNAYDEGVSLIITVDNGIQGHKEIEMVQKLGVDVIVTDHHEIGHTLPEAYA
IVHPMHPEYEYPFHFLCGAGVAYKLSQVLLDNPPNYFVSLAAIGTIADLVSMTDENRSIV
KQGLSFLNQSCPIQIKALLNQAGYNDTINEETVGFIIGPRLNAVGRLEDASLAAELLMTE
DEEEAEFLAEQVEHFNVERKEIVAQITDEALAIAEEKVNNGNQFLLLAKENWHEGVLGIV
ASKIVETYALPTLILNIDLEQNHAKGSARSIEQVSMFEILSAHQDLISKFGGHHMAAGMT
MEIDYIEALEQGLNDWMFKLSEHTSLEPTKHVSVKLEENDISINNIRDIQRLSPFGTDFE
KPLLEIDDNEVVDVRAIGKDKNHLKLVTGQLQLQSIFWKNGQLATQIEPGQPINLLGNLQ
INEWNGNQSPQFIIQDIATNNEQILDYRSKRKQLNIDPNDTKVAFLIHPKKEKLNHNYYY
YGDKIDQEHEVVILRDLPNDLDSLKDSLKNLNYSQLYLVLQHQQSIYFDGMPTSNQFKSC
FKALMTKKETNLEQEGMLLCQHLNVKPNILKFMLKVFYELGFVTEENGIIKIVDNANKQN
IETSRVYQLRQSRMEVEKLLLYDDFTQLKTWIKSQKG
>SEQF2892_01343 hypothetical protein
MKKFSRIIAFILIVAVLFVGMGLTYKNVVKNVNLGLDLQGGFEVLYQVKPFDGDKKIDEK
ALQSTARTLENRVNVLGVSEPHIQVEDPDRIRVQLAGVKDPDEARKILSSQANLTIRDAN
DKVKLTGKDIVQGSAKQEFKQGTNEPAVTFKLKDRAKFKKVTEEISKKQENMMVVWLDYK
KGDSYHKELEKPEDKRKYVSAASVDQPINSDSVEISGGFHGQQGVERAKQIAELLNAGSL
PVDLKEIYSNSVGAQFGQDALDKTIFASAIGVAIIYLFMVGFYRLPGLVAIIALTVYIYL
TLVAFNFISGVLTLPGLAALVLGVGMAVDANIIMYERIKDELRIGRTLKQAYSKANKSSF
LTIFDSNLTTVIAAGVLFFFGESSVKGFATMLLLGILMIFVTAVFLSRGLLSLLVSSNYF
KKKFWLFGVSKKNRHDINEGVDVHDLKTSYEKWNFVKLAKPLIGFSILILIVGIVILSIF
KLNLGIDFSAGTRVDIDSDTKLSQPKVERTMKDMGLTPDQVQINGSDNKQATVQFKKDLS
KNEVVELNKKVNNEYGHKPTVNTVSPMIGQELAKNAMKALIYAAIGIIIYVSLRFEWRMG
LSSVLALLHDVFMIVALFSLLRLEVDITFIAAVLTIVGYSINDTIVTFDRVRENLHKIKV
ITKPEQIDYIVNRSIRQTMTRSVNTVLTVIVVVVAILIFGASSLFNFSLALLIGLVSGVF
SSVFIAVPLWGIMKKRQLKKADNGKLTVYKEKKSNDEKILV
>SEQF2892_01344 hypothetical protein
MNVSALILPIILIIVFYFFLIRPQQKRAKEHREMISRIESGQRITTIGGLKGTVKAVDET
TVVITVNGHGTEMTFEKPAIKQVDPS
>SEQF2892_01345 Queuine tRNA-ribosyltransferase
MPAVTYEHIKTCKQSGARLGIVHTPHGSFETPMFMPVGTKATVKTMSPEELRQIEAKIIL
GNTYHLWLQPGNDIIKQVGSLHNFMNWDGPILTDSGGFQVFSLSNLRKITEEGVEFRHHT
NGSKLFLSPEKSMEIQNDLGSDIMMAFDECPPMPSEYKYVKDSIERTTRWAERCLNAHKR
PEDQALFGIIQGGEYKDLREQSAKELVALDFPGYAIGGLSVGEPKPVMYEMVEHTVQYMP
DDKPRYLMGVGSPDALIECSIRGMDMFDCVLPTRIARNGTCMTSNGRLVIKNAKYANDFK
PLDENCDCYTCKNYSRAYIRHLIKAEETFGIRLTTIHNLHFLLKLMEDIRQAIREDRLLD
FKDEFFEQYGLNVENPKNF
>SEQF2892_01346 S-adenosylmethionine:tRNA ribosyltransferase-isomerase
MNVEEFDYDLPESLIAQTPLKDRDQSRLLVLGRNSGNIEHKHFKDVINYLETGDTLVLND
TRVMPARLFGLKEETGAKVEMLMLTRIENNDWEVLLKPAKRIKVGNKLSFGEGKIIAECI
EELDQGGRIMRLHYEGILEERLNELGEMPLPPYIKERLDDPDRYQTVYAKESGSAAAPTA
GLHFTDELLDEIRAKGINIAFITLHVGLGTFRPVSVEDINDHEMHSEYYQMTQETANLLN
QTKKEGHRIISVGTTSTRTLETIRRDYNEFVAVSGWTDIFIYPGFTYKAIDGLITNFHLP
KSTLVMLVSAFSSRENILNAYKEAVKLEYRFFSFGDAMLII
>SEQF2892_01347 Holliday junction ATP-dependent DNA helicase RuvB
MDDRMVDQALHSEETSFELSLRPTMLKQYIGQSSIKNNLEVFIKAAKLREEPLDHVLLFG
PPGLGKTTLSNIIANEMNVNIRTVSGPSLDRPGDLAAILSGLQPGDVLFIDEIHRLSSTV
EEVLYSAMEDFFIDIIIGKGDEARSIRIDLPPFTLVGATTRAGSLTGPLRDRFGVHLRLE
YYNENDLKEIIIRTAEVLNTKIDDESATELAKRSRGTPRVANRLLKRVRDFQQVNEDEQI
YIETTKQALQLLQVDAEGLDYIDHKMMRCIINQYDGGPVGLDTIAVSIGEERITIEDVYE
PFLIQKGFIERTPRGRKATAFAYEHFKNFNK
>SEQF2892_01348 Holliday junction ATP-dependent DNA helicase RuvA
MYAYIRGKLTQLFPTHVVVESINGVGYEIQTPNSYRFQKYLEKELVIYTSLIVREDAQLL
YGFINEEEKDMFLSLIKVTGIGPKSALAILATSTPNEVKMAIENENDAYLTKFPGIGKKT
ARQIVLDLKGKVQITRETTETLLSMNEENSNSENLVKEALLALEALGYSKREISKVEKVL
NKSTFDSVDEAVKLGLKTLVS
>SEQF2892_01349 hypothetical protein
MDNNDYKKFYLIREDVLPESVVKTLKIKDALKNNPELSIYEAVKLFDLSRSAFYKYRETI
FPVDEKMLDHREFTLILYVNDIVGMLAQVLNTVSKLQLSVLTIHQSVPMEEKATITLSLS
AKDTTISIDEIIKALRNIEHVSKVELISMSM
>SEQF2892_01350 GTPase Obg
MFVDQVTISLKAGDGGNGITAYRREKYVPFGGPAGGDGGKGASVVFEVDEGLRTLLDFRY
QRHFKAKKGENGQSSNMHGRGADDLVLKVPPGTIIKSVETDEVLADLVEDGQRAVVARGG
RGGRGNSRFATPRNPAPDFSENGEPGEELDVTLELKLLADVGLVGFPSVGKSTLLSIVSK
AKPKIGAYHFTTIKPNLGVVSTPDNRSFVMADLPGLIEGASDGVGLGHQFLRHVERTKVI
VHMIDMSGSEGRDPFDDYQIINKELVNYKQRLEDRPQIVVANKMDMPDAQDNLTLFKEQV
DDSVTIIPVSTITRDNIEQLLYAIADKLDEVKDIDFSVDNDEEIGVNRVLYKHTPSQDKF
TITRDDDGAYVVSGNAIERMFKMTDFNSDPAVRRFARQMRSMGIDDALRERGCSNGDIVR
ILGGEFEFVE
>SEQF2892_01351 50S ribosomal protein L27
MLKLNLQFFASKKGVSSTKNGRDSESKRLGAKRADGQYVTGGSILYRQRGTKIYPGENVG
RGGDDTLFAKIDGVVRFERKGRDKKQVSVYAVAE
>SEQF2892_01352 hypothetical protein
MITIDITINDSGKVTDVIMDGHANHGEYGHDIVCAGASAVLFGSVNAILGLTSEKPDIDY
EDDGGHFHIRSVDTNNEQAQLILQAMLVSLQTIEDEYNENIRLNYK
>SEQF2892_01353 50S ribosomal protein L21
MFAIIETGGKQIKVEEGQEIFVEKLDVNEGDSFTFDKVLFVGGDSVKVGAPTVEGATVTA
TVNKQGRGKKITVFTYKRRKDSKRKKGHRQPYTKLTIDKIKA
>SEQF2892_01355 Rod shape-determining protein MreD
MRVFLYLIVGVVLFYIDSIIGLLIPMHFGHFEFNFIPHLILLYILLITIYRGFGIGLIFA
ILFGIVTDIYVGSVYGLYMFGYLALVVIFDKFLKVFYRDYTMICILSIISIIVFEIYVAI
IYGVIGFANIDIINFTLLRMIPTIILNVILLIILFPAFIKFMKKTHIQD
>SEQF2892_01356 Cell shape-determining protein MreC
MQKFFKNNKLIVVFCAVIIFIALIGLSLRSHTQSPPEQYVGDSVSLGQRVVSYPVNFVTG
AINNLFSSNKTTDNKKIKQLEAKNEKLEAENKDLKKELDMTDISKYDPISGAVIARNADQ
WMNTVIIDKGNKDGVKSNMAVMTAEGLVGRVTKVNQFSAQVDLLSTNTRTGKLSVNIQHD
SKNVFGLIDHYDKKNQELIIGNINNKNKISKGDKVVTSGLADQLPSDLYIGEVTKVENDE
YGLAKEVRVKTGANLSDISHIYIAKKDPDNASDESRDN
>SEQF2892_01357 hypothetical protein
MSEQSKEKQANEQAKAQNLFAKWRKDEKLYSDDDKKDKDK
>SEQF2892_01358 hypothetical protein
MRFFLSIIKNTIAVIAIICIIYFALKYAPFLRDQDWNPINHSINNEQLNNLPNNLDRPHN
ISTNGKRYVLEDNDILQNIPASQTRNVFKYIDKKEFMAVSGLGRMGYNENYIAGQRNDEF
IIYKFGSDQIKVYRTEIEMEQDLNALGQYIELKPFDAY
>SEQF2892_01359 hypothetical protein
MSIVSIILIALLVILLFRVGFAILRFIISAALILLGLYLGYQGILWIMENFQVLSAYIQ
>SEQF2892_01360 hypothetical protein
MTLFLIIGILIPVVYVLRLTIKEHTIGLKEMFTTIVLSMIGIVIFTVIGVLISGQNINMA
SLIFASLITGVIWGLLLSGVYKLFNYLTHTFKK
>SEQF2892_01361 hypothetical protein
MAKSELPRERLIHNGAKSLSNSELLAILINTGRHGFSSLDIANELLISFNGLKELKHLSI
NDLTTIKGIGLYKAVILKAAFELGERMYARDFNEKIKITSPSDVSNIMMSKMKDLTQEHF
VVLLLNSKNIVIKEETIYKGTLNSSVIHPREVFKAAIRASSNAIIVLHNHPSGDVTPSKE
DIETTIRLKECGELLGIQVLDHIIIGDQKYASLVEEGYFDLRN
>SEQF2892_01362 Type 4 prepilin-like proteins leader peptide-processing enzyme
MFLISYVCSVLFSFLYHLTNTNSLNLNYLVRRSKCDHCGRKLGWFELVPIFSFFILKGKS
HCCNQKLKRHYIFGECFAFLIIPLIINFDTNVHFSLFITTYLFLLTMALYDLQTLTINIV
MIILYTIVCAKITMIYFSTFIFFTLIFHLYYFLFPRQIGYGDILLLSILSCFFPYHFYLI
FLLYTLLIAIIVSSILLIMKQQTYIPFVPFMFIGFIMTNYLYQNTLLYI
>SEQF2892_01363 Folylpolyglutamate synthase
MNYLESLYWIHERTKFGIKPGVKRMEWMLDRLNNPQLNIRGIHVGGTNGKGSTVAYIRAA
LVENGYEVGTFTSPFIETFNERISLNGLPITNDEIVELVEIVKPISEVLEQETELGGATE
FEIITTMMFVYFGQIHPVDFVVVEAGLGIKNDSTNVFNPILSVLTSIGLDHTDILGNTYL
DIAKDKGAIIKPNIPVIYAVKNEEALKYIRDLAESSEAKPIELDREIVVVSQDDEFTYRY
KDYELETIILNMLGEHQKENAALAITALIELYEQEIITLDFNKMIDAIESVSWTGRIEQV
KENPLIIIDGAHNNESIEALIDTIKNYYDNEKMDVLFSAIKGKPVHGMLNKLEEISNHLY
FTEFDFPKALTKDELSEQVNLEHIEFIDDYVSFINNYDGNGLLITGSLYFISEVKSKTEF
>SEQF2892_01364 Valine--tRNA ligase
MNMEPKYNPREVEAGRYEEWVKNDYFKPSEDKSKETYTIVIPPPNVTGKLHLGHAWDTTL
QDIITRMKRMQGYDTLYLPGMDHAGIATQAKVDAKLKEQGISRHDIGREKFLEHAWSWKE
EYASFIRQQWAKLGLGLDYSRERFTLDDGLSKAVRKVFVDLYNKGIIYRGERIINWDPEA
RTALSDIEVIHEDVQGHFYHFKYPYADGDGYIEIATTRPETMLGDTAIVVNPNDDRYKDV
IGKKVILPIVGRELPILADEYVDIDFGSGAMKVTPAHDPNDFEIGQRHSLENIIVMDENG
KMNDKADKYAGLDRFECRKQLVEDLKAQDLVIKIEEHVHSVGHSERSGAVVEPYLSTQWF
VKMKPLAQRSLDNQKTDDRIDFYPPRFENTFNRWMEEIRDWTISRQLWWGHQIPAWYHKE
TGEIYVGEEAPKDIDNWVQDEDVLDTWFSSALWPFSTLGWPNIDADDFKRYYPTNALVTG
YDIIFFWVARMIFQGLEFTDRRPFNDVLLHGLVRAEDGRKMSKSLGNGVDPMDVIEEYGA
DSLRYFLATGSSPGHDLRYSTEKVESVWNFINKIWNGARFSLMNIGDEFKFEDIDLTGNL
SLADKWILTRLNETIETVTNLSEKYEFGEVGRALYNFIWDEFCDWYIEMSKIPMNGEDEA
QKQTTRSVLSYTLDQIMRMLHPFMPFVTEKIWQSLPHEGETIVKASWPTVREELVFEESK
QTMQQLVEIIKSVRQSRVEVNTPLSKAIPIYIQAKDENIKATLIENEDYIHKFCNPSDLT
IDTHIDIPEKAMTAVVIAGKVVLPLEGLIDMDKEIARLEKELDKLQKELDRVDKKLSNEN
FVNKAPEKVINEEKEKQQRYQEKYDGVKNRIEQLKA
>SEQF2892_01366 DNA-3-methyladenine glycosylase 1
MNECAFSTKDPTYLDYHDNVWGQPIYDSKAIFKLMALESQHAGLSWLTILKKKQSYEQAF
YNFEPSKIAQMSTKDIDDLMEFPNIVHNRKKLEAIVSQAQGYFEIEKDFGSFSNFLWSYV
NHQPIDLNYTTASERITVDDRAKQLSKDLKKYGFKFLGPVTVFSFLEAAGLYDAHLKGCP
SKPS
>SEQF2892_01367 hypothetical protein
MKNVWTNNFILLVTAIVISLLLHVAHVLLPFMFGPIIASIIVIKVFKLEVKWPFWLSQIG
LILLGVQIGSTFTSEVLHDIKNDWLIIVVITLLLLVLSLLIAFFFKKIARVNTETAILSV
IPGALSQMLIMAEENKKANILVVSLTQTSRVIFVVILVPLISYFFSSDGGNETTSIKSPP
LTEVLNLSQIIILMCCIAIIYSLMAKINFPTKQLLAPIVVLVIWNLTTHHTFTLDNYILA
TAQVIYMIRIGLQIANLLSDLKGRIAVAIIYQNVFLIIGSFIMVYIVHIFTNNNINELFL
GGAPGGMSQIVLVAMATGADVAMISSFHIFRIFFILFVVAPVIGFFLRGGISKFHQKR
>SEQF2892_01368 Glutamate-1-semialdehyde 2,1-aminomutase 1
MGYEKSIEAMKIAENLMPGGVNSPVRAFKSVDTPAIFMDHAKGSRIYDIDGNEYIDYVLS
WGPLILGHKNEQVIKKLHEAVNRGTSFGASTLEENKLAELVIERVPSIEKVRMVSSGTEA
TLAALRLARGYTGRNKIIKFEGCYHGHSDSLLIKAGSGVATLGLPDSPGVPEGTAKNTIT
VPYNDLEAIKIAFENYGDDIAGIIVEPVAGNMGVVPPKDGFLQGLREITNDYGALLIFDE
VMTGFRVGYNCAQGYFGVTPDLTCLGKVIGGGLPVGAFGGRKEIMDKVAPVGNIYQAGTL
SGNPLAMTSGYETLSQLTPESYEYFQELGDILEEGLKKVFSKHNVPITINRAGSMIGYFL
NEGPVTNFEEANKSNLELFSQMYREMAKEGVFLPPSQFEGTFLSTAHSKEDIEKTIQAFD
TALSRIV
>SEQF2892_01369 Delta-aminolevulinic acid dehydratase
MKFDRHRRLRSSESMRNLVRENHVRKEDLIYPIFVVEKDNVKSEIKSLPGVYQISLNLLD
DEINEAYELGIRAIMFFGVPNAKDDVGSGAYDHNGIIQEATRKAKELHKDLLIVADTCLC
EYTDHGHCGVIDDHTHDVDNDKSLPLLVKTAISQVEAGADIIAPSNMMDGFVAEIRKGLD
NAGYYNIPIMSYGIKYASSFFGPFRDAADSAPSFGDRKTYQMDPANRLEAFRELESDLKE
GADMMIVKPALSYLDIVRDVKNNTNIPVIAYNVSGEYAMTKAAAQNGWIDEERVVMEQMV
SMKRAGADMIITYFAKDICHYLDK
>SEQF2892_01370 hypothetical protein
MKPVVVMTQSSEFNSDLVEIMHKPFIEIQSLEFDTQVLHHKYDWIIFSSKNAVRIFYKYL
NQLDVKYVAVIGQKTAELCEALKINVDFIPNDYSQEGFLNQFKKDQQSILIPSSAEARPK
LQHTLAQNNIVTKIDLYKPIPNDRNIREVIQLIEHHKVHALTFSSSSAVNAYIKHDVPCG
FDKYVAIGAQTANTLRKNGLKPLIADKQTSESLINKIIESWYNNEI
>SEQF2892_01371 Porphobilinogen deaminase
MRKLVVGSRRSKLALTQSQQFIDKLKAVDPTLEIEIKEIVTKGDRIVNKQLSKVGGKGLF
VKEIQQELFDKEIDMAIHSLKDVPSIIPEGLTLGCIPDREVPFDAYISKNHIPLNELPDG
SIIGTSSLRRGAQILSKYPNLEIKWIRGNIDTRLKKLEIEDYDAIILAAAGLRRMGWSDD
IVTTYLDKDILLPAIGQGALGIECRSDDVELLELLSKVHNQAVANCVTAERTFLSAMDGS
CQVPIGGYATNKENGEIEFTGLIMTPDGTKRYEHTEVGKNPVDLGEAVSRVLKEQGAYEI
IKKLNEEQAH
>SEQF2892_01372 Cytochrome c biogenesis protein CcsA
MQETLFIRFHEIILIIYLISILCYFIDFVKKSHKIRELGIYTLGIVWILQTISLSVYITS
HNEIPLSSLFDVFFFLSWIIICIALVLNVVKVLSFSVFFLNVIGFILLMMNTFQPEHYST
NVQRIAVINELLLVHIGLAVLSYALFALAFVNSLLYIIQYRNLREKNFDQKYFRIGSVAT
LETVVFYSSLSGFIILILSVILGAQWGVYAIGHSIFADPKVVLSSIITIFYAIYLLSRIN
RWFKTIYLIYFNIMLFCLCMINLFFTTHFT
>SEQF2892_01373 Glutamyl-tRNA reductase
MHFIAISINHRTADVALREQVAFRDDALRLAHEDLFETKSILENVILSTCNRTEVYAIVD
QIHTGRYYIQRFLARSFGFDVDDIKNMSEVKVGDEAVEHLLRVTSGLDSIVLGETQILGQ
MRDAFFLAQDIQTTGTIFNHLFKQAITFAKKAHNETDIADNAVSVSYAAVELAKKVFGKL
KGKQTIIIGAGEMSELSLLNLLGSGIDDITVVNRTETNAYKLATKHGVNYNTLESLPTLL
TNADIVISSTSSPDFIVTKSMIESVNLKRKASSLLLIDIAVPRDIEPNVNISENIFSYDV
DDLKGLVDANLRERQMAADFIASQIPDEVQAHNDWVNMLGVVPVIRALREKAMTIQSETM
DSIDRKLPDLSDRERTIISKHTKSIINQMLKDPIKQAKELSNDKRSNEKLELFQNIFDID
TADPYEDIKARKAQKEKEVSIRHIFSFE
>SEQF2892_01374 putative GTP-binding protein EngB
MNINPNNIDLIISAVQEAQYPDTGLSEVALSGRSNVGKSSFINSMIGRKNMARTSQQPGK
TQTLNFFNIDDQLIFVDVPGYGYAKVSKSQREKFGKMIEEYLTKRESLKLVIQLVDLRHN
PTEDDVLMYNYLKHFDIPTLVICTKEDKIAKGKIQKHIKNIKEKLDLDPDDTIISYSSIQ
NTKQQQIWDLIANYL
>SEQF2892_01375 ATP-dependent Clp protease ATP-binding subunit ClpX
MFKFNEDEENLKCSFCGKDQDQVKKLVAGSGVYICNECIELCSEIVEEELAQTTSEEFTE
LPTPKEIMDHLNEYVIGQEKAKKSLAVAVYNHYKRIQQLGPNEDEVELQKSNIALIGPTG
SGKTLLAQTLAKTLNVPFAIADATSLTEAGYVGDDVENILLRLIQAADFDIDKAEKGIIY
VDEIDKIARKSENTSITRDVSGEGVQQALLKILEGTTASVPPQGGRKHPNQELIQIDTTN
ILFILGGAFDGIDEVIKRRLGEKVIGFASNEADKYDEEALLEQIRPEDLQSYGLIPEFIG
RVPIVANLETLDVEALKNILTQPKNALVKQYTKMLELDNVELEFTEEALAAVSEKAIERK
TGARGLRSIIEEALIDIMYDVPSSEDVTKVVITDKTINDEVDPELYDSEGNILNDSKTSA
>SEQF2892_01376 Trigger factor
MTATWEKKEGNEGLLKVTVPAEKVDKALDQAFKKVVKQINVPGFRKGKVPRPIFEQRFGV
EALYQDAVDILLPEAYGEAIDETGINPVAQPEVNVTQIEKGKDFEFEATVTVEPEVQLGD
YKGLEIEKQDSELTDEDLQEAIDHSLGHLADMVVKEDGAVENGDTVNIDFDGYVDGEQFE
GGQADGYDLEIGSGSFIPGFEDQLVGVKTGEEKDVVVTFPEEYHAEELAGKEATFKTKVN
EIKYKEVPELDDEIANELDSDANSVDEYKENLRKRLSEQKAEEAENVEKEEAINKATDNA
TIDIPQAMIDTELDRMVQEFGQRIQQQGLDLQTYFQISGQDESQLREQMKDDAEQRIKTN
LTLSAIADKENIEANDEDIDKELEKMSKQFNISVEDIKNTLGNTDIIKNDVRIQKVIDLL
RDNAKYVESTKEDK
>SEQF2892_01377 hypothetical protein
MSDIIPFPKLQQKLYKDIKSSHNSQHYETVYQLIEDYEAQFELDETLALIKCDMLYHLNS
FLELREEAIVLLKRGIQAYDELMLYYIKALNGLGQYYESVNVINQIIDEVQSHKTRMALF
PLKEYAQSQLNEDKHITSQSLAKFNTLNLNEQIQLVLKLIDNGHYEFKETIAFLLSNEVE
ADNLKSLMLEFLRFAGYNTPININKMNYSVNVIPNELNGLEHTELKTQVIPRVIDKLENG
ALNIIDEAIHTMNNHAILLYPLNVFDLYTCDDWITGYDVYFKSMIGIQTNEDSLKILNFI
NSLDGQI
>SEQF2892_01378 hypothetical protein
MSKYDEQIIVVPRDILFEQESNAFNGFLTKNDPQGEAIFNTFSNYEVKRRGDMEEDPSYK
QLISYCLLENEKNEILVYKRLSGGGESRLHGQSSIGVGGHMNDVIGANSVNEVLRVNAQR
ELEEEVGLLEANSQNLEYIGFINDDTNDVGKVHIGVVFKIKVNSNDIEVRETDTLKIQWL
EKERIDNNDEFETWSALILKDL
>SEQF2892_01379 50S ribosomal protein L20
MPRVKGGTVTRARRKKTIKLAKGYFGAKHTLYKVAKQQVMKSGQYAFRDRRQRKRDFRKL
WITRINAAARQHDMSYSRLMNGLKKADININRKMLSEVAISDEKAFAELVSKAKEALK
>SEQF2892_01380 50S ribosomal protein L35
MPKMKTHRGAAKRVKRTGSGQLKRSRAFTSHLFANKNTKQKRKLRKAKLVSKSDMKRVKQ
LLAYKK
>SEQF2892_01381 Translation initiation factor IF-3
MREERAFYARSFCLENFVKFWEVSTIAKDQTQVNEKIRAKELRLIGQNGDQIGVKSKREA
LEMAERVELDLVVVAPNAKPPVARIMDYGKYKFEQQKKEKEMKKKQKVINVKEIRLSPTI
EEHDFQTKLKNGRKFLSKGDKCKVSIRFRGRAITHKEIGQRVLEKFADECKDIATVEQKP
KMEGRQMFIMLAPINEK
>SEQF2892_01383 Lysine-specific permease
MKKVENQDDGIKRGLKDRHISMIAMGGCIGTGLFMTSGGAIHDAGALGALIAYAIIGAMV
FFLMTSLGEMATYLPVSGSFSTYATRFVDPSLGFALGWNYWFNWVITVAADVTIAAQVIQ
YWTPMAGIPAWVWSCIFLVIIFALNSLSVRVYGESEYWFALIKVVTVIIFIIIGLLTILG
IMGGEFVGFETFTKGDGPILGGNLGGSLLSILGVFLVAGFSFQGTELIGITAGESENPER
AVPKAIKQVFWRILLFYILAIFVIGMLIPYDSNALMGGDDNIATSPFTLVFKNAGLAFAA
SFMNAVILTSVLSAGNSGMYASTRMLYSMSKDKLAFHSFGKTNKYGVPYLSLFATAILVV
IIFLVQKLSGDAYEYIVAASGMTGFIAWVGIAISHYRFRRAFEKQHHSKRELKYKAKWFP
FGPIFAGLLCVIVIIGQDVDFIKTGHFDLNRFIITYMGIPVFLVFFIYHKLRYKTKIIPL
DKVDLRQDVSMDEVKHH
>SEQF2892_01385 Threonine--tRNA ligase
MDQINVQFPDGNSKAFDKGITTEEIAQSISPGLRKKAVAGKFKNQMVDLTRPLEEDGSIE
IVTPGSDEALEVLRHSTAHLMAQALKRLYGDVKFGVGPVIDGGFYYDFDMDEKVSSDDFE
KIEKTMKQIVDENHKIERKVVSREEAKSFFKDDPYKLELIDAIPEDESVTLYSQGEFTDL
CRGVHVPSTSKIKEFKLLSTAGAYWRGDSNNKMLQRIYGTAFFDKKDLKAHLEMLEERRE
RDHRRIGKDLELFTNNQLVGAGLPLWLPNGATIRREIERYIVDKEVSMGYDHVYTPVLAN
VELYKTSGHWDHYRDDMFPPMKLDETEEMVLRPMNCPHHMMVYNNRPHSYRELPIRIAEL
GTMHRYEASGAVSGLQRVRGMTLNDSHIFVRPDQIKDEFKRVVNMIQEVYSDFGFEDYTF
RLSYRDPEDKEKYMDDDEMWNKAETMLKEAVDEMGLPYVEAIGEAAFYGPKLDVQVKTAM
GKEETLSTAQIDFLLPERFELTYIGSDGENHRPVVIHRGVVSTMERFVAFLTEETKGAFP
TWLAPKQVEIIPVNVDLHYDYARNLQDELKSQGVRVEIDDRNEKMGYKIREAQMQKIPYQ
IVVGDKEVENNQVNVRKYGSQDQETVEKDEFIWNLVDEIRLKKHR
>SEQF2892_01387 Primosomal protein DnaI
MKSFNSIIKSNGDLEKRIAKIKKQVVNDPDVKSFLNEHQSELTNEIIDNDLNVLQEYKDQ
QKNYDGHDYENCPNFVKGHVPELYIDNNRIKIRYNMCPCKIKHDEERFNSHLITSHHMQR
DTLNAKMKDIYDTDLNRLVIAKNVNDICKQLVNGENVKGMYIHGPFGTGKSFILGAIANQ
LKAKSVASTIVYLPEYIRTLKSGFRDGSYETKLQRIREANILMIDDIGAEEVTPWVRDEV
IGPLLHYRMVQELPTFFSSNLNFEELEHHLSITREGAEETKAARIIERIKSLSTPYYLDG
KNLRNN
>SEQF2892_01388 Replication initiation and membrane attachment protein
MSLQSYEYGLSPHDGFKVYRQFQFNHNHLEILNRLYMPLIGAQAIGTYHFMNQFVNSDDT
LTHYTIMNELKMNLSEFRQYMDLLEAIGLFKTYVKHDERQSFFIYELIQPPTAYQFFNDP
MLSIYLYNQVDKQRFKSLKNYFKKHDFDLSGFQQVTRKFTDVFKIPHSSVTIDASSIKKE
KPYHGIDLSNVSFDFEILKEMLRHHFISDEIITKEARDLIVQLATLYGLTEDAMKRIILN
SITSNQQLSYEEMRKHARSYYLIEHNQQLPELEPKASNHNEVNSNNQSVSSSQPISNDDW
FQLLEETSPVDMLASWSESEPTFQQKKMIEELVEREKLSFGVINILLQFVMLKNEMKLPK
TYILEIASNWKKLGIKTAKEAYNYALKANESKSEYKGNDQRQSRKRYSKSREIVSREKTP
KWLKNRGQEKTDKETTKEEQEQFEKERAAFREQLKRDWEED
>SEQF2892_01389 Transcriptional repressor NrdR
MKCPKCSSTHSRVVDSRHADDANAIRRRRECENCGTRFTTFEHIEVSPLIVVKKDGTREQ
FLREKILNGLVRSCEKRPVRYQQLEDITNKVEWQLRDSGQTEISSRDIGEHVMNLLMHVD
QVSYVRFASVYKEFKDVDQLLASMQGILNDNKRSDL
>SEQF2892_01390 Glyceraldehyde-3-phosphate dehydrogenase 2
MSTNIAINGMGRIGRMVLRIALHKEDLNVVAINASYPPETIAHLINYDTTHGRFDKKVEP
IENGIRVDGQDIKLVSDRNPENLPWKDLDIDIVIEATGKFNHGDKAIGHINAGAKKVLLT
GPSKGGHVQMVVKGVNDNQLDVDTYDIFSNASCTTNCIGPVAKVLNDKFGIVNGLMTTVH
AITNDQNNIDNPHKDLRRARSCNESIIPTSTGAAKALKEVLPELEGKLHGLALRVPTNNV
SLVDLVVDLKEDVTAEQVNDAFRNAGLDGILDVEDEPLVSMDFNTNPNSAVIDAQNTIVM
DDNKVKVIAWYDNEWGYSNRVVEVAQQIAKLIGSENVATAK
>SEQF2892_01391 Dephospho-CoA kinase
MPKVIGLTGGIATGKSTVSELLTAFGFKVVDADIAARKAVAKGTKGLEQVRAAFGDSAIT
EEGEMDRKYVGEIVFNHPEKRLELNDIVHPIVREIMEEEKQSYLNQGYDVIMDIPLLFEN
ELQNTVDEVWLVYTSESIQIERLMERNQLSLEDAKARVYSQISIDKKSRMADHVIDNLGD
KLELKQNLEQLLTDKGFINKER
>SEQF2892_01392 Formamidopyrimidine-DNA glycosylase
MPELPEVEHVKRGIEPYILNATIKSVTFSNKVIEGKQQGKETIIKGINLDGFRLNSESFK
IKSIDRRSKYIVFTIEKNNNQRIILSHLGMAGGFFIVDKLSDISTPNYRKHWHVVFHLDN
GKQLVYSDIRRFGELRNLATYNDYPAFLEIAPEPFDDNALNYFLDRIKLKKYQNKPIKQM
LLDHKMIAGCGNIYACEALFRAGVLPERKVKDVSNQERQMLFYYVQEVLNEGINNGGTSI
SDYRHADGKTGEMQLHLNVYKQKTCKICGHDIEQKVIASRNSHFCPHCQK
>SEQF2892_01393 DNA polymerase I
MYKPYIRYGSGYMLKYNKITLEVYALNKLVLIDGNSLSFRAFYALPLLSNKAGIHTNAVY
GFAMLLEKIMREEQPSHFLVAFDAGKTTFRHSKYSEYKGGRQSTPPELSEQFPYIRQLLD
TYHIKHYELENYEADDIIGTLSKEANDQGFETIIVTGDRDLTQLATDNVTIYYTKKGVTD
VDHYTPEFIAEKYDGLNPNQIIDMKGLMGDASDNIPGVAGVGEKTAIKLLKQFNTVEGVY
DNIDSVSGKKLKEKLENSREDAFMSKDLATINKNSPIEVTLQDTVLKNQDDNKDKIELFK
KLEFKQLLSDIDSNNTEEKHEDKVIEVSNDFNNINFKELKEAVIHIEVDGTNYLQDTILK
FGFYDGVDHVVIASDQLKEYPELIKWLENETTEKIVYDAKKTYVVAHRLDIDIKNIVFDV
MLASYIIDPSRTIDDVNSVVSNYNQNFVQDDISIYGKGKKRHVPEDTILNKHIASITEAI
YACKPEMVAELESHQQIDLLLNLELPLARILSEMEETGIYTDINDLRQMQSEIQGKLDLL
ISNIHEAAGEEFNINSPKQLGVVLFETLELPVIKKTKTGYSTAVDVLEQLQGQHPIIDYI
LEYRQLSKLQSTYVEGLQKVISKDNRIHTRFNQTLAQTGRLSSVDPNLQNIPVRLEEGRK
IRKAFKPTSNDSVILSADYSQIELRVLAHITQDESMKEAFINEKDVHTATAMKVFDVEAN
EVNALMRRQAKAVNFGIVYGISDYGLSQSLNITRKKAKAFIDDYLASFPGVKQYMSDIVK
DAKADGYVETLLHRRRYIPDINSRNFNLRGFAERTAMNTPIQGSAADIIKLAMVEFDRQI
KQTSYHAQLLLQVHDELIFEVPANEVEDFSLFVEEIMEHALQLDVPLKVDSNYGSTWYDA
K
>SEQF2892_01394 Alkaline phosphatase synthesis sensor protein PhoR
MLKFHHRLLLLLSTITIISFIGLGVIIHHTIYQILSTAQVTELKHVSENFLKLNKQNENN
EIKNISANQNLIVRISENGKVIYQTGNQNKINDNIDNEANPSNIIYKRENGQVRYTFKTT
VNDKTIYISGMNTEILELQKSMWKYLSLIGIIVLLAIYLAVRSINRTYIRPINEVTYATS
LIADGYYHVRVPESNVKETKALFVTTNDLARRLQKLNNKQKMQSNRLKTTLENIPSSVLM
IDKHGEIVVANHAYYELFRPNGKVENKNYTSYLDPKIQQLILESFKTEKPLYDQIEILLN
NVHHKYFDLSCVPILSKSKKKLQGMVVVMHDITNLKKLENLRREFVANVSHELKTPITSI
KGFAETLIEGAKNDEESLDMFLNIILKESNRIESLVMDLLDLSHIEQQTEIETAFMNLSE
LAYTTIDNLQNQARYKDIKIVSEIEKDVIIEAHENKIAQVITNLLSNAINYSLENNEVIV
RVYREGHEVNLEIQDFGIGIDKSDQKHIFERFYRVDKARSRDSGGTGLGLSITKHIVEAH
HGTINVESNIGEGSLFKVSFLDEKE
>SEQF2892_01395 Alkaline phosphatase synthesis transcriptional regulatory protein PhoP
MSQKVLVVDDEQSIVTLLKYNLETAGYIVEVAYDGEEALEKVNEIQPELVVLDVMLPKKD
GIEVCKTIRSDKNLVPILMLTAKDDEFDRVLGLELGADDYMTKPFSPREVVARVKAILRR
SKFASEIEKADVDDEDILIENIRIRPEFFEVYKDDELLELTPKEFELLLYLIERQGRVIT
REHMLNSVWNYEFAGDSRIVDVHISHLRDKLEENPKQPKLIKTVRGLGYKLERPKA
>SEQF2892_01396 Isocitrate dehydrogenase [NADP]
MSAEKITRINDGLNVPNEPIIPFIIGDGIGPDIWKAASRVIDAAVEKAYNGEKRIEWKEV
LAGQKAFDETGEWLPQETLDTIKEYLIAIKGPLTTPIGGGIRSLNVALRQELDLFTCLRP
VRWFKGVPSPVKRPQDVDMVIFRENTEDIYAGIEFKEGTDEVKKIIDFLQNEMGATNIRF
PETSGIGVKPVSKEGTERLVRAAIQYAIDNNRKTVTLVHKGNIMKFTEGAFKQWGYDVAH
NEFADKVFTWQQYDEIVEKDGKDAANQAQEKAEQDGKIIIKDSIADIFLQQILTRPAEHD
VVATMNLNGDYISDALAAQVGGIGIAPGANINYESGHAIFEATHGTAPKYAGLNKVNPSS
ELLSSVLMLEHLGWQEAADKITDAIEATIASKVVTYDFARLMDGATEVSTSEFADELIKN
LK
>SEQF2892_01397 Citrate synthase 2
MAELQKGLEGVIAAETKISSIIDSQLTYAGYDIDDLAENALFEEVVFLLWNYRLPTQDEL
DALREKFYHYMTLNPRVYKHFEEYATDNVHPMTALRTSVSYIAHFDPDAENETEENRKER
AIRIQAKIASLVTAFARVREGKEPVKPNPELSYAANFLYMLRGELPTDTEVEAFNKALVL
HADHELNASAFTARCAVSSLSDMYSGIVAAVGSLKGPLHGGANEQVMSMLADVKSVDEVD
AYLDEKFKNKEKIMGFGHRVYKDGDPRAKYLREMSRKITSETGRSELYDISIAIEKRMKE
EKGLIPNVDFFSATVYHSMDIPHDLFTPIFAVSRTSGWTAHILEQYRDNRIMRPRANYVG
ETNRKYLPIEER
>SEQF2892_01398 D-serine/D-alanine/glycine transporter
MAEEKLQRGLSNRHVQLIAIGGAIGTGLFLGAGQTIAMTGPSILLTYIIIGFMLFMFMRG
LGEIIIQNTRFKSFADVTNEYIGPFAGFVTGWTYWLCWIITGMAEVTAVAKYVSFWFPAI
PNWISALFCVLILMLFNLLSAKLFGELEFWFAIIKIITIIALIVVGLVMILMAYKTQFGH
ASFTNLYKHGIFTHGASGFFMSFQMALFSFVGIEMIGVTAGETKDPQKTIPKAINAVPLR
ILVFYVGALAVIMSIIPWDKVDPSESPFVRLFSLIGIPFAAGLINFVVLTAAASSCNSGI
FSNSRMLFGLSEQDQAPPIFRSTNKNGVPHFAIIGSSALLLVTALLNYIFPDATLVFTYV
TTISTVLFIIVWALIIIAYINYHRKNPELHKTVSYKLPGGKYMGYAILVFFFLVFCLLFV
NETTRNAIFLTPIWFILLGLMYLRYRQVAKNK
>SEQF2892_01399 putative tRNA-dihydrouridine synthase
MKENFWSELPRPFFILAPMEDVTDIVFRHVVSEAARPDVFFTEFTNTESYCHPEGIHSVR
GRLTFSEDEQPMVAHIWGDKPEQFREMSFGLAEMGFKGIDLNMGCPVANVAKKGKGSGLI
LRPETAAEIIQATKAGGLPVSVKTRLGYYDIEEWRDWLKHVFKQDIANLSIHLRTRKEMS
KVDAHWELIAAIKQLRDDIAPNTLLTINGDIPDRKTGHELAMKYGVDGVMIGRGIFNNPF
AFEKEPREHTSKELLNLFRLHLSLFEKYSSDESQQFKRLRRFFKIYVKGIKGASQLRHQL
MSTESVDEARDLLDEFESKIEEDVN
>SEQF2892_01400 Pyruvate kinase
MRKTKIVCTIGPASESEEMLEKLMKAGMNVARLNFSHGSHEEHKARIDTIRKVADRLGKT
IGILLDTKGPEIRTHDMKDGLIMLEKGKEVIVSMSQVEGTPEKFSVTYEDLINDVQVGSY
ILLDDGLVELQVKDIDKTKGEVKCDILNTGELKNKKGVNLPGVKVNLPGITDKDADDILF
GIKEDVDYIAASFVRRPSDVLDIREILERENNHNITIFPKIENQEGIDNIEEILEVSDGL
MVARGDMGVEIPPESVPIVQKDLIRKCNKLGKPVITATQMLDSMQRNPRATRAEASDVAN
AIYDGTDAVMLSGETAAGLYPEEAVKTMRNIAVSAEAAQDYKKLLSDRTKLVETSLVNAI
GVSVAHTALNLNVKAIVAATESGSTAVTISKYRPHSDIIAVTPSEHTARQLALVWGAYPV
IKKGRKTTDDLLNNAVATAVETGRVTNGDLIIITAGVPTGEKGTTNMMKLHLVGDEIAKG
QGVGRGSVVGKTVVANSASDLEGVDLSESVIVTNSVDETLVPYIEQAVGLITEENGITSP
SAIIGLEKSIPTIIGVENATKELKDGILVTVDAAQGKIFEGYANVL
>SEQF2892_01401 ATP-dependent 6-phosphofructokinase
MKKIAVLTSGGDSPGMNAAVRAVVRKAIYNNIEVYGIYQGYQGLLDDNIHKLELGSVGDT
IQRGGTFLYSARCPQFKEASVRQKGLENLHKRGIEGLVVVGGDGSYRGAQRISEETKDIK
TIGIPGTIDNDINGTDFTIGFDTALNTIIDSVDKIRDTASSHARTFIVEVMGRDCGDLAL
WAGLSVGAETILVPEANTDIKDIAEKIESGIKRGKKHSIVMVAEGSMSGQECADQLMKYI
NVDARVSVLGHIQRGGSPSGADRVLASRLGGYAVDLLMQGRSGQGVGIMNNKLTATPFDE
IFNGNDHKFNTDIYELAKELSI
>SEQF2892_01402 Acetyl-coenzyme A carboxylase carboxyl transferase subunit alpha
MLDFEKPLFEIKNKIESLKQSQEKNDVDLQDEIDLLEASLERETKKIYTNLKPWDRVQIA
RLQERPTTLDYIPYIFDSFIELHGDRNFRDDPAMIGGIGYLNGTPVTVIGQQRGKDTKDN
IYRNFGMAHPEGYRKALRLMKQAEKFNRPIFTFIDTKGAYPGKAAEERGQSESIARNLVE
MASLKVPVIAIVIGEGGSGGALGIGIANRIMMLENSTYSVISPEGAAALLWKDSSLAKMA
AETMKITAKDLHHLNVIDSVIDEPLGGAHNNIEQQAIDIKQAFVDQLEQLQQQSADELVE
DRFNKFRNIGAFIEK
>SEQF2892_01403 Acetyl-coenzyme A carboxylase carboxyl transferase subunit beta
MFKDFFNRSSKKRKYLTVQDSKQNEVPAGIMTKCPKCKKIMYTKELNENLNVCFNCDHHI
ALPAYKRIEAITDENSFVEFDKGMTSANPLDFPGYQEKIEKDQQKTDLSEAVVTGTAKLD
GVQFGVAVMDARFRMGSMGSVVGEKICRIIDYATEHRLPFILFSASGGARMQEGIISLMQ
MGKTSVSLKRHSDAGLLYISYLTHPTTGGVSASFASVGDINLSEPKALIGFAGRRVIEQT
INEKLPDDFQTAEFLLEHGQLDKVVHRKEMKETLAQLLKLHQEVKKDA
>SEQF2892_01404 NAD-dependent malic enzyme
MSLRDDALQMHKENQGKLEITPNIKVTNKEELSLAYSPGVAEPCKEIHEDPRTVYDYTIK
RNTVAVVTYGTAVLGLGNIGASASIPVMEGKAVLFKSFAGINGVPIALDTKDTEEIIRTV
KLISPNYGGINLEDISAPRCFEIEDRLKKETNIPVFHDDQHGTAIVTMAGLINALRIVDK
DLSDIKVVLNGAGAAGIAIVKLLDSYGVRNMIMCDSRGAIFEGRSYGMNDTKDYVAKFTN
KDKIEGSLQDVIKNADVFIGVSVASLLSQDMVKSMADDAIIFAMANPDPEIKPNDAKEAG
AKVVGTGRSDFPNQINNVLAFPGIFRGALDTESTHINEDMKKAAVEAIANLIDEDELNPD
YCIPGPFDKRVAPSVAREVAKAAMETGVARIEVDPQKVYDKTMQLTDLK
>SEQF2892_01405 DNA polymerase III subunit alpha
MVAHLNLHTTYDLLNSSLRINDVVKKAQNNHYDTLAITDTNVLYGFPKFYDACIKANIKP
IFGMTVNVTDGLYTIETVVLAINNDGLRSLFQLSSAIKMKQKEVISVEWLKKYSTNFAII
FKQANQPHYSIVEQFQNHQNIFINHSSDLAFYNNIRVVWFKNARYLNQEDVETIPALEAI
KNNTKIDLVNDTEDIGEHFPKQNELETLNIDREVWNNTLELASLCNASLEYHQNLLPKFD
APSGNSSKEYLWSQLQSSLKKMELNHDERYTKRLEHEYRVITEMGFEDYFLIVSDLIHYA
KTHDVMVGPGRGSSAGSLVSFLLDITTIDPIRFNLLFERFLNPERVTMPDIDIDFEDTRR
ERVIQYVQDKYGKHRVSGIVTFGHLLTRAVARDVGRIIGFDDKTLNEISKLIPHQLGITL
DEAYEDEQFKQFVHRNHRHEKWFELSKKLEGLPRHTSTHAAGIIINDQPLYNYAPLTLGD
TGLLTQWTMTEAERIGLLKIDFLGLRNLSIIHQIITQVKKDLNISLEIEEIPFNDVDVFK
LLSRGDTTGIFQLESEGVRKVLKRLQPEHFEDIVAVTSLYRPGPMEEIPTYISRRHNESE
IKYLHPDLEPILKNTYGVIIYQEQIMQIASQFASFSYGQADILRRAMSKKNRAVLESERQ
HFVEGAIKNKYDEKISKQIFDLILKFADYGFPRAHAVSYSKIAYIMAYLKVHYPNYFYAN
ILSNVVGNESKTAAIIDEAKNQKLKILPPNINESHWYYRATKSNIYLSLGAIKGVGYQSV
KSIVDERYQNGKYKDFFDFTRRIPNRIKTRKLLESLILVGAFDTFGKTRSTLLSSIDQVL
DEVSNVEQNDLLLDILTPKQSYADKDEFSDQMISSYEMEYLGFYVSNHPVEKQFNKKQYL
GIYTLSNVVNHKPILVQVDQIKQIRTKNGQNMAFLVLNDGRHTMDAVLFPDKFKRYETQL
NEREMYVVWGKFEKRKQQLQLILNQMDSVEHFEVTKINEASQIILRNIQNLDEIKQILND
HKNNHMIKVNIYNEQTGELDYLGSMDKTSNEIKNFVEAFDPKDIRIL
>SEQF2892_01406 Bifunctional oligoribonuclease and PAP phosphatase NrnA
MVEIFNEIMQRVKEAETIIIHRHVRPDPDAYGSQLGLKLYLERKFPEKNIYATGEAEPSL
SFIGDLDEIDDSVYSDALVIVCDTANAPRIDDQRYLNGQSLIKIDHHPATDQYGNVNFVN
TEASSTSEIIFDFISHFNDLSIIDEHVARVLYLGIVGDTGRFLFSNTSPHTMEVASQLLA
YPFNHNAELNKMSEKDPKLMPFQGYVLQNFELSDSHEYCQIKITNDVLKQFDIQPNEASQ
FVNTVADISGLKIWMFGVDEGDQIRCRIRSKGITINDVANQFGGGGHPNASGVSVYSWDE
FEELAQALRQKL
>SEQF2892_01407 Cobalt-dependent inorganic pyrophosphatase
MTKHEQIIAYIESLNVGQKISVRKVAKVMKVSEGTAYRAIKDAGQLGLVTTIDRVGTVRI
DKKNREEIENLTFNEILNIIDGDIIGGKNGLKKSVSKFAIGAMELKDVVKYLSHHTLLIV
GNRPDVQLEALKRGSGVLITGGFKTTQKIIDYANNHDLPILSSNYDTFLVANIINRAMYN
QMIRKEILIVEDIVKPINDMTVIFDEMGIEDYKSRAKVTGHSRFPVVDKDWRLVGIVTSK
EVIQMNSDDTIAKVMTKRPINVELNTTVASCAHIMIWEGIEILPVTQNKRAIGVITRDDV
LKAMQLIGRQPQIGETINDQIAKHITISQSDISVEVSPLLTNQYGTLSKAVFVAIIEETI
KHELRKYKKVDVMIESLNIIYIKTVPIEASIRVQYDMLDVGRNFAKLEVAMVSGNEKVAN
AMIICQMFEDMQSI
>SEQF2892_01408 Stress response protein NhaX
MYKNILLGVDTQLKNEKALKEVSKLAGPDTVVTILNAIGEQDAQASIKAGTHINELTEKR
SQLLEKTRTTLEDYGIDYDQIIVRGNPKDELVKHANSGKYEIVVLSNRKAESQKKFVLGS
VSHKVAKRATIPVLIVK
>SEQF2892_01409 Hydroxyacylglutathione hydrolase
MKLSFHGQSTIYFEGNGKKVIVDPFISGNDKCDLDEQTLDVDYIILTHGHADHFGDVVEL
ANRNHATVIGSAELQGYLSTYHGVEDVHGMNIGGKAKFDFGSVKYVQAFHSSSFTHEDGI
PVYLGMPMGLILEVEGKTIYHMGDTGLFSDMKLIAERHPVDVCFVPIGDNFTMGIDDASY
AINEFVKPKISVPVHYNTFPLIEQDPQQFKDAVHEGEVQILEPGESVSF
>SEQF2892_01410 putative peptidase
MSKIEKITKQLQHEQADAAWITTPLNVFYFTGYRSEPHERLFALLITANGDQTLYCPKME
VEEVKNSPFEGKIIGYLDTENPFEIDPLSFNKLLIESEHLTVKRQRELTQNFGVQHYGDI
DQTIKELRNIKNESEIENIREAAKLADKCIEIGTEFLKVGVTEREVVNHIENEIKKFGVS
EMSFDTMVLFGDHAASPHGTPGERKLVKDEYVLFDLGVIYNHYCSDMTRTVKFGTPSEEA
QTIYNIVLEAETNAIEAIRAGVPLQDIDKIARDIISDAGYGDYFPHRLGHGLGLEEHEYQ
DVSSTNSNLLEAGMVITIEPGIYVPNVAGVRIEDDILVTENGYEILTHYDK
>SEQF2892_01411 Alanine dehydrogenase 2
MKIGIPKEIKNNENRVGLSPSGVHALVEQGHTVLVEKDAGLGSFFEDKDYKDAGADIVSE
QSSVWDVEMVIKVKEPLEEEYKYFKEGLILFTYLHLANEEKLTQALVDNKVVGIAYETVQ
LPDRSLPLLTPMSEVAGRMSAQVGSQFLQKFNGGMGILLGGVPGVPKGKVSIIGGGQAGT
NAAKIALGLGANVTILDVNPKRLAELDDLFDGRVNTIMSNPLNIENAVKESDLVIGAVLI
PGAKAPSLVTEDMIKQMKDGSVIVDIAIDQGGIFETTDKITTHDDPTYVKHGVVHYAVAN
MPGAVPRTSTIALNNATLPYAQLLASKGYREAFKANHALSLGLNTYKGHVTHKGVAEAFG
LEYTSVEDALKED
>SEQF2892_01412 Putative universal stress protein
MLTYKNILIAVDGSHEAEWAFNKAVDVAKRNDAKLTIVNIIDSRTYSSYEVYDAQFTEKS
RSFSEELLKGYQEVATRAGVTNVETRLEFGSPKAIIPKKLASELGVDLIMCGTSGLNAVE
RFIVGSVSEAIVRHAPCDVLVVRTEEIPEDFQPEVATPEFRKQYS
>SEQF2892_01413 Acetate kinase
MSSLVLAINAGSSSLKFQLIRMPEETLVTKGLIERIGIKDSIFTIEVNGEKIKDVKDIKD
HEEAINIMLDSFKQHGIIDDINDIAGTGHRVVHGGELFPTSALVTDKVEEQIESLSELAP
LHNPANLMGIRAFRKLLPNIPHVAVFDTSFHQSMPEQSYLYSLPYQYYKDYGIRKYGFHG
TSHKYVSQRAAEIMNKPIEELRIISCHIGNGASIAAIDGGESIDTSMGFTPLAGVTMGTR
SGNIDPALIPFIMQKTGQNAEEVLNVLNKESGLLGISGTSSDLRDLESDAEEGKERAQLA
LDVFASRIHKYIGSYATRMHGVDVIVFTAGVGENSSTVRAKVLEGLEFMGIYWDPKKNET
IRGEEGFINYPHSPVKVIVIPTNEEVMIARDTVKFGEL
>SEQF2892_01414 hypothetical protein
MSEEQTIMEKLFKTLDEKAKVLNEQNGQSFIENLGLAMEDVYSNKRELLEQATLQDRRKA
FQFAYLSLMQEETIQANHQITPDSIGLILGFLVQKFTENNEELHVVDIASGAGHLSASVN
EVLKDTTIMHHLIEVDPVLSRVSVHLANFLEIPFDVYPQDAIMPLPLEEADIVIGDLPIG
YYPLDERSHEMQLGFKEGNSYSHYLLIEQAITALKQSGFAFLVVPSNIFENDNVKQLENF
IATETEMQAFLNLPKTLFKNENARKSILILQKKKSNETKPVEVLLANIPDFKNPNQFQGF
IGELNTWMKDNHPQK
>SEQF2892_01415 putative thiol peroxidase
MTQITFKNNPIHLAGSEVSEGQHAPDFKVLDNDLNEVSLENYKGQKKLISVVPSIDTGVC
DQQTRKFNEEAAQEDGVVLTISADLPFAQKRWCASNGLDNVITLSDHKDLSFGQQYGVVM
EELRLLARSVFVLDSNDKVVYKELVSEGTDFPNFDAALEAYRNI
>SEQF2892_01416 hypothetical protein
MEITLNIILIIIAFGFLAAFIDAVVGGGGLISTPALLAIGMPPSLALGTNKLASSFGSLT
SAIKFIRSGKVDLNIVLKLFPFVFIFAAGGASLATMLPAQILKPLIIIILSLVLIYTIMK
KDWGNVRTFSKLTIGKAVIFVSLMLIIGFYDGFLGGGTGSFMLFVLLMFGFDFLSAAGNA
KVLNFASNLGALVLFIILGQVDFVYGLIMAVSMIIGSYVGAQFAISKGVGYVKILFIIVT
AVLILKNTYDYILQLLQH
>SEQF2892_01417 putative tRNA sulfurtransferase
MEFDHLLVRYGELTLKGTNRKKFVNALKDNVIKSLQTIEGTHVKGKRDRMYISLTEEADA
QEVINRLTKIFGIKSISPVHKTSQELDEIKKLCVDLAQDFKPGETFKIDVKRVDKSFPMD
TYALQRELGGAILQATEDISVDVKQPDYNVRVEVRMDGMYVFTQIYEGAGGLPVGTGGKT
LLMLSGGIDSPVAGMEIMKRGVYIEAIHFHSPPFTSEKAKDKVIELTRILSERVGPIKLH
IVPFTELQKQINKVVHPRYTMTSTRRMMLRVADIVLEKVGANAIVNGENLGQVASQTLKS
MYAINDVTSTPILRPLVSLDKEDIVKKAREIGTFDVSIQPYEDCCTIFTPKNPVTEPDFD
KVIKYESVFNFDEMVQRAADNIETLTINKDYKSEKDQNTDALIDELF
>SEQF2892_01418 Cysteine desulfurase IscS
MIYFDNAATTKPHKDVLDSFNKVNETVYFNPNSPHKWGLQAEKVLLQAKERISSMLSIGQ
KTDVIFTSGATESNNIALKGIAYRKKQFANEIITSVLEHPSVLEVMRYLEEDGFVLKYVD
VNADGRVDIEHLASLMNDKVGLVSCMYVNNIMGQIQPIDEIVDILKDYPKAHLHVDAVQA
LGKVTMNLEGVNSVSFSGHKFNGLKGQGLLLIDNKDKLEPIVHGGGQEYGVRSGTVNLPM
NVSLVKAITLAIDNLNERHQRLSDYNHELREFLKEFRGVYINSPLDCAPQILNIAFPGVK
GEVLVNAFSKLDIMVSTTSACSSKRGKLNEVLMSMGFPDNKIEGSIRLSLGDMTTQEDID
QFKVKFETIYKEIKELLK
>SEQF2892_01419 Septation ring formation regulator EzrA
MVLYTILAIIIIVLIIVGIMFYLRSNKRKIVEEAEERKLKVQRLPFEENLKQLSELNLKG
ETRKKYDAFKRDTLDYTNNYLAPVEEKIHDAEIQLDKFQFSGAQSDIDDAHELMDKYEAG
YQQQVEDVNEIVSLHKENEQVYEKCKTNYREMKRDVLANRHQFGDAASPLEKRIESFEPE
LEQYEELKEEGNYVQAHNHIMGLNESMNEVQKYMDEIPELIREAQKELPGQFQDLKYGCR
DLKMNGYDLDHVKIDGTLQSLKTELNFVEPMISRLELDNANDKLEQINDKLDEMYDLIEH
EVKAKNEVEETKEQITDELFKAREMNYTLRTEIDYIRENYFINESDVHSIRQHENEIQNL
VAVYDEILKEMAKSAVRYSEVKDNLEYLDDHVKVINENQEKLQNHLIQLREDEAEAEDNL
LRIQSKKEEVYRRLLASNLTSVPERFIIMKNEIDHEVRETNDQFSERPIHVKQLKDKVAK
IVIQMNTFEDEANDVLVNAVYAERLIQYGNRYRKDHNNVDKSLNEAERLFKNNRYKRSIE
ISEQALESVEPGITKYIEDEVAKG
>SEQF2892_01420 Free methionine-R-sulfoxide reductase
MPLIKETNYNLLTKQLQSLIEDEQNLIAILSNTSAILNDNLDQINWVGFYLIENEELILG
PFQGHPACVHIAIGKGVCGTAVAEDKTQLVKDVHAFPGHIACDANSKSEIVIPIHVNDEI
IGVLDIDAPITDRFTNEDKEGLEVIVKVIEKQLTK
>SEQF2892_01421 30S ribosomal protein S4
MARFRGSNWKKSRRLGISLSGTGKELEKRPYAPGQHGPNQRKKLSEYGLQLREKQKLRYL
YGMTERQFRNTFDIAGKQHGVHGENFMILLASRLDAVVYSLGLARTRRQARQLVGHGHVE
VDGRRVDIPSYSLKPGQVITVREKSQNLDIIKESVEINNFVPEYLDFDADSLKGTFVRFP
ERSELPAEINEQLIVEYYSR
>SEQF2892_01422 Glycerophosphodiester phosphodiesterase
MKINKPNQAFQIVAHRGLSNHFPENTLVGFKAALMQHVDMLEIDVHFSKDNHLVVIHDDT
INRTSNGEGKVKDYTLEELLKFDFGVKHDKSFQNTKISTFEEVLSLIKNFSKKLLIEIKV
PHQYPGIEEAVLNALEIYKVPKYKAIIQSFDEDCVKRLNSLDSEYQLGLLISRKKYWYKS
PNFEEISDYANFINPNYKLVNSRFIKNAHSQSLKVIPYTVNKPKDAKKLINLGVDGIISD
LPEDIFRL
>SEQF2892_01423 hypothetical protein
MVKHDFKVQTKWRGGREEVGTVNGDIISEQISIPAPLGGNGVGTNPDELLVSAASSCYII
SLAATLERAKFTDINLINNSVGTALFENGKFKMVTITHYPKISVTAEDKENLEKRLPKLL
EIADNNCMISNSIRNNVEIKIQASIQ
>SEQF2892_01424 Soluble hydrogenase 42 kDa subunit
MNYYEPLLLTPGPTPVPKEINHALGLPMVGHRSPDFESIAKKAFNNLKPIFGTENEVMIL
TSSGTSVLEASMLNIVNPDDHFVVIVSGAFGNRFKQIAETYYKNVHIYNVEWGQSIDVKE
FITYLNNLNHQISAVFTQFCETSTAVLHPVGELGKALKTFNQDIYFVVDGVSCIGAVDVN
LERDYIDVLVSGSQKAIMLPPGLAFVAYNDRALKRFKEVTTPRFYLNLNKYFDSLQQDST
PFTPNVGLFRAVNAYAELIHSEGFENTIKRHYIIRDGLRLALNALDLELLVEDDFASPTV
TSFIPTSKDELTHIKSTLKTRFNITIAGGQGKLKGKILRIGHMGKVSPFDMLSVISTLEI
ILTDYRQTNYIGKGLTKFSEVIHSEA
>SEQF2892_01425 D-3-phosphoglycerate dehydrogenase
MKHNILVSDPISTDGLQSLLNHSDFNVDIKTDLDEQSLLDIIGDYEGLIVRSQTQVTQQV
IEKASNLKVIARAGVGVDNIDIDAATLQGILVINAPDGNTISATEHSVAMILAMARNIPQ
AHASLKNKEWNRKAFKGVELYQKTLGVIGAGRIGIGVAQRLQSFGMKVLAYDPYLTEDKA
QQLGVKLATIDEIARQADFVTVHTPLTPKTRGIVNADFFSKAKPTLQIINVARGGIINED
DLLNALNNNQIARAALDVFEHEPPTDSPLIEHDKIIVTPHLGASTIEAQEKVAVSVSEEI
IDILENGNVTHAVNAPKISFNDIDEITQQWIEIGELSGELAIQLIEGAPREIKVTFNGDV
AKQETDLITRSIVKQILQQDLGDRVNIINAFALLNEQGVTRNVEKRASQGTFSNYIQVHL
VSDTEEVKIGATVIAGFGARIVRINDYSVDFKPNAYQLVSYHGDKPGMVGLTGQLLGRQN
INIASMSLGRNIQGGQAMMVLSIDQPVTEDIINELYDVGGFDKIYGTTLSVK
>SEQF2892_01426 Pyrophosphatase PpaX
MKSILFDVDGVFLSEERCFDTSALTIETLLKSEHFLGLDKSFKLNALSDETINDIRSKVF
NDDIILNRLKSMGLNSNWDMLFVVFCIHFIHLMKEFTVQEIKDIITDNHFSVKSIQEIQS
MINKNFRIDYELPMNFISQSLGGKDNIYAELQQYAREELNVNDASLFKLKGPLWFVARDL
YQELYLGSELFKQVEEKPSILEGINGFIYHETVLRPVEEIKSLLSTLKERGYHLAIATGR
PRTETLVPFESLGLKAFFSDNHIVTASDVMEAENEYPDFIPLGKPNPFCYIATLYGNNKE
NYKQFISQQDQIVNKEDVIIVGDSLADLFCAKQIGATFIGTLTGLKGQEARKELEHHEAD
YIVDHIGLIKNILL
>SEQF2892_01427 PTS system N-acetylglucosamine-specific EIICBA component
MFKFFQNLGRSLMLPVAVLPAGAIIVGIGNLLKALNLLPTVSLFFTTVGTAILGQLGLIF
AIGVAIGMAKKNDGAVALAGALGYALVVKVLSPEFIAPLFNIKESAVNDGFSKMDNSNVF
IGIIIGLIAAYCYNKFSDVELPTALSFFSGKRLVPIMTVFYCTFLIAILLFAWPFIYSAI
VAFGKWLIGFGPFGAFLYGFFNRLLIPTGLHHALNAVFWFDTAGINDIGKFQTGQDAIKG
ITGRYQAGFFPIMMFGMPAAALAMYHTAESAQKKQVYGWFIASSISAFMVGVTEPIEFAF
MFVAPVLFVIHALLTGLSLFIAALFHWTAGFSFSAGLIDYALSLINPVANHPLMILVQGI
VFFALYYFIFRFVIKIFNLNTIGRGDNLLADPTVNTTEKDGAETTSKSKYHHTASQILEG
LGGSENITTLTNCATRLRMELKDNSIIDEQKIRNAGAVGVTKNGQHSAQVIIGTHVQQVA
DEIEKQM
>SEQF2892_01428 1-acyl-sn-glycerol-3-phosphate acyltransferase
MYQFISRLLDLILVKMAKSLYVIGKENIPKDNKYVVTCTHESYNEVIMLGMALVPNEIHY
MAKKELFNNKWFGQFLTSLNAFPVDRENPGPSTLKRPVNLLKENKTVGIFPTGHRTSAEG
APLKRGASTIAMLGKAPILPAAYVGPKKLHGLITGQALIKFGEPIYQSDIPKDLKRNEKI
DYLTHEIERRTAQLQKELHLIQDSLEK
>SEQF2892_01429 Serine protease Do-like HtrA
MSEFNQENQSIYNNYQQPQPGKPKFPWFKTIIVALIAGVIGALLVLGASKIMGLVGIDNG
GAQVQEANNSKGGNVLDGKSDKYKSVNAMIKDVSPAIVGVINMQKANGLEDFLQGKSSSE
SEEAGIGSGVIYQINNNSAYIVTNTHVISGASEIKVQLHSGKQVKVKLIGKDTVSDIAVL
KIDNTKGIKSIKFANSSKVQTGDSVFAMGNPLGLEFANSVTSGIISANERTIESNTTSGG
TKVNVLQTDAAINPGNSGGALVDINGNLVGINSMKIAAEQVEGIGFAIPSNEVKVTIEQL
VKNGKIERPSIGIGLLNLSDIPDSYKKELNTDRDDGIYVAKVSRSSELKTGDIITKIDDK
TVKEDTDLRTYLYQNKKPGETAKLTVIRDGKTLTVNVNLKSQSDISSNQSSDSESDNSRN
SQFIQ
>SEQF2892_01430 Multidrug export protein EmrB
MSKLNDSQVSREIMIAAWAIALGAIAPMLDSTMINIVIKQLNNTFNTTIEITQWGITGYV
LALALVIPIAGWLVNQFNGKYVFIGASILFGITSVLAGISWNAESFIVFRIIQGMSAGII
TTLMFTLLIKTTGQDNIGKVMAVVSTPMIFGPILGPVIGGFIIHIVSWRWMFFINVLVVI
IAILLQIKYLLNFVPFNKSKSIDILGMILLGLISISTIYGLTKASDYHSFYNRTTILLLI
IGCIMILIYYIHNKVKHDNTILPLSLFCKGNYTASFIGLFLSNIGIMGPMVIIPLYFQTF
KHYTPIEAALALIPQGIGMLITRPYLGKLIDQYGAKWVVLISVIISMFGSIPLLFITDHT
SIIALSIILFLRGCSIGGINLGLTTDTYMGIKESVLAEAGVGINMIENIGSSFGTAFIAT
IIRVVINQLGKSLMHNIIAYHARFLVSVITLFLIIVPGLFLTQKSKATI
>SEQF2892_01431 HTH-type transcriptional regulator Hpr
MTNNKEEILMSSFRDLFNKIGWLNKDKMEQALKGFKSSEVHCVEAIKEYQNPNVQYLANK
LFMTRGAISKLTKRLQQKGLIESFKSKDNKKEIYFKLTTQGESVYQIHSELHETFQKRDQ
SVFDSMTEDEFNNMMTFINRYNQHLDQLIEQEHRSL
>SEQF2892_01432 Tyrosine--tRNA ligase
MSNALIEELQWRGLIYQQTDESSIEELLNKEQISLYCGADPTADSLHIGHLLPFMTLRRF
QEHGHRPIVLIGGGTGMIGDPSGKSEERILQTEDQVEANVEGISAQMHKLFEFGTDKGAI
LVNNKDWLSQISLISFLRDYGKHVGVNYMLGKDSIQSRLENGISYTEFTYTILQAIDFGH
LNRELNCKLQVGGSDQWGNITSGIELMRRMYGQTEAYGLTIPLVTKSDGKKFGKSESGAV
WLDADKTSPYEFYQFWINQSDDDVIKFLKYFTFLDKDEINRLEESKNQEPHLREAQKALA
ENVTEFIHGKEALDDAIRISKALFSGDLKSLSGKELKEGFKDVPQVELSTETSNIIDVLI
ETGIATSKRQAREDVNNGAIYINGERQQSVDYELSNEDKIDDEFTIIRRGKKKYFMVNYK
>SEQF2892_01434 Penicillin-binding protein 1A
MLTNINRDTKFNSFEKFYKKTKHAIVGLFSVGLFICLIGFIGTVIYFNHLTHESSKISDR
ELKQKVLHFAGDDLINHENSDVLSEYDKSENSLIVGPKHVNPNVIKALTSSEDTMFYKHK
GILPKALVRAMIQDVFNLDQSTGGSTITQQLVKNQVLSSKKTYSRKANELILAMRLENLL
SKNEIIYTYLNIVPFGRDYEGNNITGIASASYSLFGIPPKDLNIAQSAYLIGLLQSPYMY
TPYEENGELKTYKEVKISVDRQHYVLKRMLVEGVIDKEEYRHAKRYHIYDHLLTKPQLNN
NQSA
>SEQF2892_01435 Formate--tetrahydrofolate ligase
MAHLSDLDIANQSELKPIGEIAEKAGIPADALEQYGHYKAKIDINQIKPKDNKGKVVLVT
AMSPTPAGEGKSTVTVGLSDAFNELKKNVMVALREPALGPTFGIKGGATGGGYAQVLPME
DINLHFNGDFHAITTANNALSAFIDNHIHQGNELGIDVRRVEWKRVLDMNDRALRHVNVG
LGGPTNGVPREDGFNITVASEVMAILCLARNINDLKEKISRITIGYTRDRKPVTVADLKV
EGALAMILKDAIKPNLVQTIEGTPALVHGGPFANIAHGCNSILATETARDLADIVVTEAG
FGSDLGAEKFIDIKAREAGFEPSAVVLVATVRALKMHGGVAKDDLKEENVEAVKAGIVNL
ERHVNNIRKFGVEPVIALNAFIHDTDAETEAVKAWAKENNVRIALTEVWEKGGKGGVELA
NQVLEVIEQPNDFKFLYDLDQSLEEKIETIVKDIYGGSSVTFSKKAKKQLKEFTDNGWGQ
YPICMAKTQYSFSDDATALGAPTDFDITIRELEAKTGAGFIVALTGAIMTMPGLPKKPAA
LNMDVTEDGHAVGLF
>SEQF2892_01436 Acetyl-coenzyme A synthetase
MKVEVFESEQGNYNLQDYEKTYQDFDWDKVKKAFSWNETGKINMAYECIDRHVDNGKGDK
IALNYRDEKRKEQYSFNELKVLSNKAANVLVDKANVQKGDRVFIFMPRTPELYFAFLGIL
KIGAIVGPLFEAFMEKAVTDRLENSEAKVIVTTNSLLGRIPKDKLPHLETIVVVDDEVDE
QYVDFNKELNQASEEFDIEWLKEDDGLILHYTSGSTGQPKGVLHVQKAMLLHYISGKYVL
DLKEDDIYWCTADPGWVTGTSYGVFAPWLNGVTNCIAGGRFSPEQWYSMIETFKVTIWYT
APTALRMLMSAGDDVVEKYDLSSLRSILSVGEPLNPEVIKWSKDVYDKRVLDTWWMTETG
GHMIVNYPAVDVKLGSMGKPLPGIEAAIIDDSGNVLPPNRMGNLAIKKGWPSMMYSIWKN
PEKYNSYFIGNWYVSGDSAYQDEDGYFWFQGRVDDVIMTAGERVGPFEVESKLVEHEAVA
EAGVIGKPDPVRGEIIKAFISLRQGYEPSDELKADIRKFVKEGLSGHAAPREIEFKDKLP
KTRSGKIMRRVLKAWELNLDAGDLSTMED
>SEQF2892_01437 Acetoin utilization protein AcuA
MKHIKTNVTKHLIINNKHFTIEGPVSCNYLKTLSFDESLNAFRPAKDQFDALKEITQLPE
GRIYIARENKHVIGYVTYHYPDEFERWAEGQLPYLIELGAIEVHRDFRQFHLGGELISLS
LSQDEFEYYIVLTTEYYWHWDLKSAKLDVFEYKKMMQKLMSKGGLEVFATDDPEITSHPA
NCLMARIGNRITLDQQQSFDDLRYKNRFLF
>SEQF2892_01438 Acetoin utilization protein AcuC
MQNNLRTGYVYSDELLKYRFNDNHPFNQMRLKLTTELLQMMKLLKDDQIIYPRIATEEEL
ALIHKYDYIQAIKHASHGILSPSEANKYGLNTDDTFQFRHMHRHSARIVGGALNLADEIM
NENILNGCHLGGGLHHSLPGRANGFCIYNDVAITAKYLATKYNQRVMVIDTDGHHGDGTQ
WSLYTDNTIMCYSIHETGKFLFPGSGHYTERGEDLGYGYTVNLPLEPYTEHDNYLKVFEE
SVTSVIEAYKPDILLSVHGVDIHYLDPLTHMSCSLETLYEIPYIINKLAHKFTDGKVLMF
GGGGYNIWQVVPRAWSHIFLALINKPIQEGPLPEQWIKKWRAYSPVNLPKHWTEDYRDYQ
TIPRTYEISQKNNERASRIVHWYTH
>SEQF2892_01439 Catabolite control protein A
MTVTIYDVAREARVSMATVSRVVNGNQNVKPETRKKVNEVIKRLNYRPNAVARGLASKRT
TTVGVIIPDISNIYYSQLARGIEDIATMYKYHSIISNSDNDSEKEKEIFNNLLSKQVDGI
IFLGGTISDEIKDLINQSSVPVVVSGTNGKDDNIASVNIDFKTAAMEITEQLIQSGAKEF
ALVSGDYSKKAQEDVFNGLKEVVDCHQLKLNETVQFSGSESYKDGIKVFEDLKGNLPDAI
LSISDEQAIGIMHSALDAGIRVPEDLQIVSFNNTRLVEMVRPKLSSVIQPLYDIGAVGMR
LLTKYMNEEEIEEPNVILPHRIEYRGTTKD
>SEQF2892_01440 Phospho-2-dehydro-3-deoxyheptonate aldolase
MSTKLEQYREEIVSINNQILELLSKRGELAQKIGEEKIKQGTKVYDPQREKEMINELMDR
NQGPFNDNVIKQLFKEIFKASTDLQKSENEKHLYVSRKLKPEDTIVKFDNGDIIGDGNKS
FVFGPCSVESQEQVDAVAKDLQARGEKFIRGGAFKPRTSPYDFQGLGIEGLKILKNVKDK
FGLNVVSEIVNPADFEVADEYLDVFQIGARNMQNFELLKEAGRTNKPILLKRGLSATIEE
FTFAAEYIASQGNKNIILCERGIRTYEKATRNTLDISAVPILKQGTHLPVMVDVTHSTGR
KDIMLPTAKAALAVGADGVMAEVHPDPSVALSDSGQQMDLNEFDQFYNELKPLAELYNSK
KLK
>SEQF2892_01441 hypothetical protein
MSKKYNRDAFETTNSGNDLHGKGANQQDNTSQSNATKHYDRDSFATSNTGSDLHGQGANQ
QDSAAQSNATKHYNRDEFEKNNFGHDLHDNGPNQKNGKSRQGLNTEHYNRDEFVTNNTGK
DLHGQGENQNSNNYDVSNSQYSHNKFSSHPSRKDFVISFITGALIGSAVGLFYKNKAEEK
IDGAKTKEKELRNRYQNIKQQTESNIENVKQKIDDFKNRDNSEVSNDELVAQQNAIKAET
SNNLADQSPQAQEIQEAKAEAKKDSKSKEISATELAAQQNAIKAETSDDLSDQSPQAQEI
QEAKADEIQNLRNNEDNSAEEIVAQQNAIKAETSDDLSDKSPQAIEIQEAKAETEKEEEN
EPKEVKVSATELTAQQNAVKVESSNNNLSDSSIKDNASHNKHVTAKNLASAAKTKKSKLD
NDLNVANKTKTLLEEPSVAKSIGNKTVPNLVTKNNNTFNNDEDQVKNNQAHATSKFENGV
ITHDTKSNNEKSTGNSKQSQNEPKAKNKTPKQQQRAEKAKSKIDKRTFND
>SEQF2892_01442 hypothetical protein
MDWILPIAGIIAAIAFLVLCIGIVVVLISVKKNLDHVAKTLDGVEGQVQGITRETTDLLH
KANRLTEDIQGKVERLNSVVDGVKGIGDSVQNLNGSVDRVTNSITHNISQNEDKISQVVQ
WSNVAMEIADKWQNRHYRRGSANYRNTSVGNDANHSNENYTTNVEKNF
>SEQF2892_01443 UDP-N-acetylmuramate--L-alanine ligase
MTHYHFVGIKGAGMSSLAQIMHDLGHEVQGSDIEKYVFTEVALKNKGIKILPFNADNIKE
GMVVIQGNAFPDTHEEIVKAHDLKLDVIRYHDFLGHVIDQYTSVAVTGAHGKTSTTGLLS
HVMNGDKKTSFLIGDGTGMGLPASDYFAFEACEYRRHFLSYHPDYAIMTNIDFDHPDYFK
DIDDVASAFQSMAHNVKKAIIAWGDDDHLRQLKADVPIYYYGLNKNDDIYADNIQITDKG
TQFDVYVNGEYYDQFLSPQYGDHNIQNALAVIAISYLEKMDVNNIKEALETFGGVKRRFN
ETNVSNQVLVDDYAHHPREISATIETARKKYPNKDIVAVFQPHTFSRTQAFLDEFATSLS
KADHVYLCEIFGSIRENTGDLTIQDLINRIDGSALIEENNIDVLDQFDNAVILFMGAGDI
QKLQRAYEEHVGMTNEF
>SEQF2892_01444 DNA translocase SftA
MSWFDDLFSNKENSDEELLRRKSKRRNGDLTQNKDDSLLPENNDIYDRPRGKFRFPIDVG
QDENYEEAIYRDSNDDIGSYRPHSSNDHSSYDSFDYEGHTNQSNNYAKYDSSEDSRRRRR
RNHINQDDTGIPSIKSRSPKSSNKYIDTRESQRFNKHQNNYSSTNVSNYSKANSNHQSRV
KLQSERFKSNYHLSSEPTYHRSSFKTSEVPSAIFGTKKRRPIENGVIPPVKDDEDSKESI
TKYSSSTVEHVPHESNHAIADNSNKEDTKRSSQLDSSITIENESTIESSSNTSNNNERTP
NYSKRDNTVNIENIYASQIVEEIRKERERKVQQKRKFKEALQNKRQQTDEEDSIQRAIDE
MYAKQAEQYTGESSLNQGDNVSNKSNESEIDKSKHSYHSKDKSLADEHNRLVQNQTDEQT
NSDNVDNQTEVSNESLEPYNYEEIDLNQVSSVQQVRQDDVQVKDVLEEQSSKINNNKVES
YSNEKFDDYLEDTNSHEEMLHDDDLHEQVMDDDENEGISNKTTDENNDEKIDDANYREIN
ESESLMQDKANDLKFNDEVNNSENQQNSSENNINNAVRNAVSSDIEYATNEDEENDERLA
QDTNKEDQKLSQSEDIQHESLNNEDVSLTSNKTDDSEHLEKDSLNEDKKAEPSFNKTNKA
PQKMSIKPGSKPFNVVMTPSDKKRVMDAKKNSVSRNKVNVPELKPETKKEAQDEKMNAEF
DNHLNESQLNSDESSDFNVASLEYNESSEHSVEKDNIINDENTRENEHQDVDNSQNNDMP
KGNQFSKVQNSNNQNDNKHDINEFVSKEGYSEVTSTKNHKDGDDANHKAPIRRGPNIKLP
SLDLLEDHEEHEIDESWIEEKKQELNDAFYYFNVPAEVQNVTEGPSVTRFELAVEKGVKV
SRITALQDDIKMALAAKDIRIEAPIPGTSLVGIEVPNLNPTKVNLKSILESPKFKNAESK
LTVAMGNRINNEPLLMDIAKTPHALIAGATGSGKSVCINSILMSLLYKNHPEELRLLLID
PKMVELAPYNDLPHLVSPVITDVKAATQSLKWAVDEMEKRYKLFAQFHVRNITAFNKKAP
YEQRMPKIVIVIDELADLMMMAPQEVEQSIARIAQKARACGIHMLVATQRPSVNVITGLI
KANIPTRIAFMVSSSVDSRTILDSGGAERLLGYGDMLYLGSGMNKPIRVQGTFVSDDEID
DVVDFIKDQREPDYLFEEKELLKKNQTQAQDELFDDVCEFMVKEGHISTSLIQRHFQIGY
NRAARIVDQLEQLDYISGANGSKPRDVFITEADLKKE
>SEQF2892_01445 Phenylalanine--tRNA ligase beta subunit
MNLFYNKDGVGDVAFLQIEPTDGPFEYKKQGDIVEISKEGTIVGFNIFEFSRYNKISGNG
HIKLTSELVDAVQKAINKSGLDYQLNADLSPKFVVGYVETKEKHPDADKLSVLKVNVGNE
HLQIVCGAPNVEAGQKVVVAKVGAVMPSGMVIKDAELRGVASSGMICSMKELNLPNAPQE
KGIMVLSNDYEIGQAFFD
>SEQF2892_01446 hypothetical protein
MNVFQIRDKLKQRLAHLNVDFKFDREEETLRIYRQDNYKGVTIKLNAIVAKYEVQKEKII
DEIVYYVEEAIAQMDDESIEKMTNIQIMPVIRATSFDKKTKEGHRFIIEKHTAETNIYYA
LDLGKSYRLIDESMLESLGLTEQQVKEMSLFNIRKLKNEYKTDEVKGNIFYFVNSNDGYD
ASRILNTKFLDDIYQQCEGEMLVAVPHQDVLVIADIRNKTGYDVMAHLTMEFFTKGLVPI
TSLSFGYEKGHFEPIFILGKNNKQKRDPNVIQRLEANRKRFNNKK
>SEQF2892_01447 Thioredoxin-like protein YtpP
MIKLESESQFNSLKKENTVFEFTAGWCPDCRIIEPDLPRLEEKYNHFNFVSVDRDEFIDL
AIENDIMGIPSFLVYKNDELVGSYIGKERKSIEQIDEFLSKYV
>SEQF2892_01448 Glutamyl aminopeptidase
MDKKKTLERIKSLTELHGAPGFEEDVRNYMKKEMAPYVDEFIVNHMGGFYGVKKSKKANA
KRVMIAAHMDEIGFMITNITTNGMLQFTNLGGVANDIWQGQRLQVKNRKGDIIVGIVSNI
PKHFRTGNEAVPEIKDLLLDIGASSDEEVRELGIEIGDTIVPNTELTQLSEYRYSAKAWD
NRYGCVIAIEILELLSDVELDVDLYVGANVQEEVGLRGAKPAAELIQPDVALVVDCSPAN
DIKGVNQLSGELGGGTLIRIKDGTMILQPEFRDYLIKLAEDNHINYQYYISPGGTDGGEI
HKANIGIPTAVIGVCARYIHSTNAVFDIRDYYSARQLLEQVILNLNIEQINKLQFQD
>SEQF2892_01449 hypothetical protein
MTRQTYKYISISVALLTSIATITFIYFLREKNKIQNPSNVLKEAKSYFMNVKGSFILHEP
YVDDNLYPNRLIFQGGITQIKNNQQVEYIFYADAKSGEIINIVEL
>SEQF2892_01450 putative quorum-quenching lactonase YtnP
MKLGAFNINYLNGGITQMDGGAIFGVVPKPLWTKRYAVNEKNQVPNLTYPILIQTGDKNI
LIDAGIGNHKLTDKQLKNYGVTYESQIHDELEKLNLNVEDIDMVLMSHMHFDHATGLTDV
DGNSIFSNATHFVQQDEWHEFTSPNIRSKATYWEINRGTYENKLILFDKEVEVYPGIHMK
HVGGHSYGQSIITIESEGERAVHMSDILPTNAHINPLWVMAYDDYPMQSIREKERLIPYY
IYQDYWFLYYHDNVFFAAQYERDGKTIKQSIKR
>SEQF2892_01451 tRNA (guanine-N(7)-)-methyltransferase
MRVRYKPWAEDYLKEHPNLVDMDGAHAGKMSEWFDKEQPIYIEIGSGMGQFITTLASKFP
EINFVSMEREKSVMYKVLDKVKELNLTNLKMICNDAIELNEYFNDGEVSRIYLNFSDPWP
KKRHAKRRLTYHTFLALYQQILKEDGEIHFKTDNRGLFAFSLESMSQYGMYFTKLNLNLH
DEDDEDNILTEYEKKFSEKGSRIYRMEAKFHKSI
>SEQF2892_01452 hypothetical protein
MEQFYQLGWTLDSAGGASGEAYMAEQDGQKLFLKRNSNPFIAALSAEGIVPKLVWTKRIE
TGEVVTAQHWKNGRELEPDEMYQSRVAALLKKIHGSKPLLNMLKRMEMEPITPNIMLKKI
NASLSREVLTHHIIRKSLTYLEEHIPNLDSRFFTVVHGDVNHNNWLLSDRDELFLVDWEG
AMIADPAIDIGMLLYNYVPEKNWSDWFKTYGVEENIELNKRMKWYTVIQSIGMVQWYEEQ
KRFKDMNNWLKFLNEVMNSNLFI
>SEQF2892_01453 D-alanine aminotransferase
MTKVFINGEFIDQNEAKVSYEDRGYVFGDGIYEYIRAYDGKLFTVTEHFERFIRSASEIQ
LDLGYTVEELIDVVRELLKVNNIQNGGIYIQATRGVAPRNHSFPTPEVKPVIMAFAKSYD
RPYDDLENGINAATVEDIRWLRCDIKSLNLLGNVLAKEYAVKYNAGEAIQHRGETVTEGA
SSNVYAIKDGAIYTHPVNNYILNGITRKVIKWISEDEDIPFKEETFTVEFLKNADEVIVS
STSAEVTPVVKIDGEQVGDGKVGPVTRQLQEGFNKYIESRSS
>SEQF2892_01454 Putative dipeptidase
MWKEKVQEYEGQIIDDLKGLLSIESVRDDSKASDETPVGPGPRQALDYMYEIAQRDGFST
HDVDHIAGRIEAGKGDDVLGVLCHVDVVPAGDGWDSDPFNPVVTDDAIIARGTLDDKGPT
IAAYYAVKILNDMKVDWKKRIHIIIGTDEESDWKCTERYFQTEEMPTLGFAPDAEFPAIH
GEKGITTFDLVQNSTSEDQDEPDYELISFESGQRYNMVPDHAQARVFVKENMTDVVQHFE
HYLDQHKLQGESVVDSGELVLTLEGKAVHGMDPSLGVNAGLYLLDFISTLNLNQTAREFV
DFSNRYLHESHFGEKMGMKFHTDVMGDVTTNVGIISYDNKQGGRFGINLRYPQKFEFEEA
IQRFTKEIKAYGFDLELGKVQQPHFVDKNDPFVQKLVKAYRNQTGDMSEPYTIGGGTYAR
NLDKGVAFGAMFEDSEDLMHQKNEYITKKQLFNATSIYLEAIYSLCVEG
>SEQF2892_01455 hypothetical protein
MAKTTGLFRIIAGVGAAAVAVVLSRKESRDKLKEQYNKYKEDPEGYKENARGLASQLSSK
ANETIQEVRNNPQDYANRLKNDPKSFLEEEKSKFTNLDANKEDSLEEGKFDDEGGATVNN
NLRVVTEEDLKKNNNALEDKD
>SEQF2892_01456 Ribosomal small subunit pseudouridine synthase A
MRLDKFLANMGVGTRTEVKHLLKKGKVTVNTSVEKSPKSHINPTEDIVHVNGKQVEFVNN
VYIMLNKPKGYISATHDESNRTVIDLIPEYQHLNIFPVGRLDKDTEGLLLITNDGQFSHD
LMSPSKHVSKTYEVTSKKPVTKVDIDAFKKGIILSDGPVKPAQLTRINETISHVTIYEGK
YHQVKRMFHAIENEVLELKRLKIANLALDENLKSGEYKLLSDKELKLLQH
>SEQF2892_01457 Lipid II flippase MurJ
MSENKEMVRGTFLITLSILITKILGVLFVIPFYAIMGANAEEKLAPFNYAYVPYNIAIAV
ATAGIPLAASKFVAKYNALGAYKVGQKLYKSSFIVMSISGIIGFLILFFLAPDIAALTLG
RKEGKGGWTIDDITWIIRVISMVVMFIPLLATWRGVFQGYESMGPTAVSEVTEQIARIVF
ILIGSFLVLNVFHGSYLQANGIATFAAAIGAIAGLLTLWYYWRKRKPHIQKMVASDHTGL
DVPYTKMYKEIISYSVPFVIVSLNFPLFNLVDQFTHNNALDAAGFHANKDYFFTILNFTT
NKIVMIPTSLAAGFAVSLIPFITKTFAEGRLNEMHRQIKTSIGVLMYITVPASLGIMALS
SPLYTVFYQYNPDGNKILFYYAPVAILISLLSVTASMLQGINKQKLTVFVILGSVFVKLI
LNIPLIMIFHTSGAVLSTAIALMVANVANLMILKVYAKFHFTDTLVQVAKIFIYSLIMMI
SVEVVYFLLSLFISVDRKSGAFIILIIGVIVGGLIYGTITIKNRLADEFLGDLPGKIRRK
VGFLR
>SEQF2892_01458 Ferredoxin--NADP reductase
MYQTIIIGGGPSGLMAAVAASEQSQNVLLLEKKKGLGRKLKISGGGRCNVTNRLPYAEII
KNIPGNGKFLYSPFSVFDNESIIDFFESRGVKLKEEDHGRMFPVSNKSQDVVDTLVNTIK
QNKVDIKEETIVNEINVEDNGTFEVTTDKGIFSSKSVIIATGGTSVPQTGSTGDGYKFAK
KLGHSITELFPTEVPITSAEHFIKSKELKGLSLKDVELSVLKKNGKKRISHKMDMIFTHF
GISGPAALRCSQFVYKEQKNQKTKEINMQLDVFPEYKNHVLEKKITSILNEEPDKYIKNS
LRGLIEERYLLFMLNQAQIDENTTYHHLSNQQLKQLVDCFKAFTFKVNGTLPIDKAFVTG
GGVSLKEIWPKTMMSKLQPGLFLCGEVLDIHGYTGGYNITSALVTGHVAGYEAGKF
>SEQF2892_01459 Extracellular matrix-binding protein ebh
MNLFKKQKFSIRKFSVGIFSTVIATLTFLSHPGHAATQEEESNSSQATSQNVKSQTDDKS
IHNNDNYIENEKNSNDSIKEIATAIKINNSEINSKVDNANGTYRIDNEEIKENSIETNQD
EKTIEPELSHQNISKNDSNNTFNENKSIHKRTKRSTDNNVDNNQDQMSINETNSGQIING
TFTDTSNGAVIPTNQTVSEMNQAGKITGWHVKDNDQTEIPLVWGPKTLPPYNPYVFDKTN
NKIAAVLSKYPNNLGGVAGDKTVGPIYQDVDVTPGSEVQLYFIGTSMGNTNGINGVKVSI
YDSNNPTDLLYSGRPNTASKSFGVFTGVFNVPNNVSRLRFMFETFEKRSYESANGGRILK
GKNNFGGSGLADVKVNSGAYLKATTTQTKYTVTSPSTSTSLINATLEVSLENKGHSRSNK
TQYKVVLPEGVQFISAQNARANYNSSNRLLTLNVDRIEPGTIKNITYTVSLPTSEPIKKD
FDATLVYVTDGINMNRRNGSRDFGSNADDNYFRYGGYNEYVKTESNQRRGNVTVATQSVT
VEMYKTDLQQKYNQISAQIEHLNPSDYSQEAWSSMQNVLNASRQILNENDNTPINDRKNQ
ATINDLTLRLDKERAKLDVDQAAKSRKEVINNNNDATREEKDTALTLLKATFDEKVRDIE
SATNINEISERKKQAIVDISPIDVIPAIKQQAIQSLNDKADEKLIEIENDTNATFEEREE
AKTSVNEALTNAKNAVRNATTNQLVETVLTSNSNNISQISTHAIARDKARQELDRVIASK
MSEIDNDHSATIEEKNETKAKIDEIAKQARLNIERGVHNDDVKVAKDKALNQLHNVQVDA
IKKNQAKQIITDQANSKKAEIDQTPNATDEEKAAAKAKVDEAVTTAKNAIDQATNNDGVD
TAKTNGVDTINNVQPTVVKKDEAKTAIDKAAEAKKAEIDQTPDATDEEKAAAKAKVDEAV
NNAKASIDQATNNNGVDTAKSEGSDAINHVQPVVVKKDEAKTAIDKAAEAKKAEIDQTPN
ATDEEKVAAKAKVDEAVTTAKNAIDQTTNNVGVDAAKESGVESINQVQPAVVKKDQAKAE
IDNVAQAKKAEIDRNSNATEEEKVAAKSKVDEAATTIKQAIDKAVNNSEVDNAIDVGKTA
INNIEADNSAKSKAIKHLQELVKQQMTKIDSNHLATEEEKAKAKQMIKLLFEKAKIEIEK
AKTSYEVTKIDAEYSKLITKTLPENKAKLNAKKKIEKIARQLKNKLNNMNGVSKEEKDRI
KVIIEQIVKKSFKDIDLASRNNTINKIVNDVKIQFANIKINKQNNKKSLINNENASVIIT
TEQHKTNKAYHKVRNEKGRYQLPNTGINNDTSSPLISFTFVSGLFLILRSMRRRASK
>SEQF2892_01460 Extracellular matrix-binding protein EbhA
MYKDAINNKISEIETELAQANQNDYSVEAWNNLQTALTNAKVVKNETDATPITDRKNQAE
INNLLLNLEKAKAKFDVDKAAKARENVINSNTEATTEEKQVALTKLQNKYNEKKGEIDNL
TSSSDIAPLKESSIAQINSINVRATKKAAAKQAIEAALTDRKVFIDSHYDATQEEKDVAM
AKATEEANKAKALIDQATSNNDVDQAQTNGINIINSIDADVIKKANAKKAIEQAAEAKKA
LINQNSDATQEEKDAAIQRVTDEVRNADRLIDQSTNNDGVDEVQAHSISSINNIQPEIVK
KSDAKQAIDTAVLNQKSLVNNNNEATQEEKDVALAKIDEAAKQAKAATDAATTNNAVDEA
TNNNTTIISGILPDTVKKAAARKAIDDAATAKKEAINNTSDATQEEKDAAKAKVDEEVAK
AKRAIDSSTTNDAVDQAKDSGVTTINNIQPESIEKIKAKQAIDDTVTAKKNAIDQDGTTT
QEEKDAAKAKVDEEATKAKQLIDQASTNDAVHETRDNEITAINKIQPEAIKKAESKQAID
DAATAKKAAIDQVSDATQEEKDAAKAKVDEEVTKAKSAIDKANTNNDVDQAKTNGTTIIS
SIEPEAIKKAEAKQAIDVAVSAKKQEIDNNENAIQEEKDAAKTKVDEEATKAKAAIDQAS
TNNGVDQAKTSGETTISSIQPEVVKKAEAKQAIDDAVTAKKAEIDQNQEATKEEKDAAKA
KVDEEATKAKNNIDQSTTNNDVDQAKTDGASAITKIQPDVVKKSEAKRAIDDEVIAKKAE
IDQNQEATKEEKDAAKAKVDEEATKAKQSIDNATTNEAVDQAKTQGVTTITAIQPDTIKK
AEAKRAIDEVAKAKKQEIDNNTNATKEEKDVAKSKVDEEVTKAKSAIDQATTNDQVDQGN
NNGHTAIAPIQPETIKKPEAKQAIDEVAKAKKDLIDQTPNATKEEKDAAKSKVDEEVTKE
KKEIDQASTNSDVDQVKDKGTNGINSVVVEVVKKDAAKKAIDELVKAKKSEIDNNHNATR
EEKDSAKSKVDEEAKKAKDNIDKGATNNDVDQAKNSSSNIIKKIQPDTTKKTVVKQTLLD
QAKAKKAEIDKDNKATKEEKDAAKAEVDKIIDKANKAIDNANSNDDVDKVQVTFTSKLKE
VKVKIVKKPKAQETILNVARKQKAKIDALVGLTDEQKNKAKNMIDEIVKNALEKLDNDIN
NNDVDSITNKAIEEIEKVNPEVSKGKKALASGNNNDGYRNNNSSDNYNTSSSNNKDSIKL
PSTGKEGQNQSPLAGLALISGLFLFLKNRKRNKENS
>SEQF2892_01461 Extracellular matrix-binding protein ebh
MNLFKKQKFSIRKFTVGTFSTVIATLSFITHTGHAAELDEQSQSAQQKVTETSGTDDTNQ
KSTAPDNASSQVESKEDTSYPSSKVETKADNNPAPKQNSVDDTSAKSSKSETLSNNKNSN
KDLAETKSEANNVDTNQPSTEEKTLSNEKSIKAKHKRVKRDANDTSSNPQTQPDPMAINE
TNSGQIVNGNFTDTSNGAEIPTAATESAMDAASTIPGWQVVNSQQTQIPLVWGPKVLPSY
TYVTFDKTNNKIGAVLSKYSDNLSYGRPDNNVGPIYQDIDVTPGSELQFHFIGTSMGNIS
GFNSARLFVYDANNPSTLLYKGTPKTSSQPFGIFKGVFNVPDNISRIRVQFESLVNVSHD
TYSGHRLLKGPNNFGGGVVADVSVNTGAYLKVSPAQTEYQANSTSATSPNVNAKLNFSIE
NKGHSSSNKTQYKVVLPEGATFVTAENATGSFNEDTRELTLSINPIDAGTTRDVSYTVSL
PTSVPIKKDFNANLIYQTEGINMNRKNGSRDLATQTPGDNNYLRYGGNNEFIIAESDQR
>SEQF2892_01462 Thiosulfate sulfurtransferase GlpE
MESITVDQLKEKVLESNPVNIVDVRTDEETAMGVIPGAKTIPMDQIPDNLNQFNKNETYY
IICAAGMRSAKVVKYLEDHDIHAINVEGGMNEWGTAGTEINSI
>SEQF2892_01463 Leucine--tRNA ligase
MGYNHKEIEKKWQNYWADNKTFKTSDNLGQKKFYALDMFPYPSGAGLHVGHPEGYTATDI
VSRYKRMQGYNVLHPMGWDAFGLPAEQYALDTGNDPREFTKQNIQTFKRQIQELGFSYDW
DREVNTTDPEYYKWTQWIFIQLYNKGLAYVDEVAVNWCPALGTVLSNEEVVDGVSERGGH
PVYRRPMKQWVLKITEYADRLLEDLDELDWPESIKDMQRNWIGRSEGARVSFEIENKDAS
IDVFTTRPDTIYGTTFLVLSPEHSLVNEITSEDKLEAVKKYQEDSSKKSDLERTDLAKDK
SGVFTGAYAINPLTGKKLPIWIADYVLSSYGTGAVMAVPAHDERDYEFASKFNLPINEVI
AGGDIQKEAYTGVGEHINSGELNGLDNETAISKAIELLVAKGAGEKKVNYKLRDWLFSRQ
RYWGEPIPVIHWEDGTMTTVPEEELPLLLPETDEIKPSGTGESPLANIDEFVNVIDEKTG
MKGRRETNTMPQWAGSCWYYLRYIDPHNSNMLADPEKLKHWLPVDLYIGGVEHAVLHLLY
ARFWHKVLYDLGVVPTKEPFQKLFNQGMILGEGNEKMSKSKGNVVNPDDIVDSHGADTLR
LYEMFMGPLDAAIAWSENGLDGSRRFLDRVWRLFINEDGSLSNKIVENNDNGLDKVYNQT
VKKVTEDFNTLNFNTAISQLMVFINDCYKAETIYQPYAEGFVKMLAPIAPHIGEELWDRL
GNEDTITYQPWPTYDESLLVDSEVEIVVQVNGKVRAKLNIPKDTSKDEMEALALKDENVK
LSIEGKDIKKVIAVPQKLVNIVAK
>SEQF2892_01465 Multidrug resistance protein MdtH
MNIPRSVWWLVIGMALNITGSSFLWPLNTIYMKEELGKSLTIAAIVLMVNSFGMVVGNLL
GGSLFDKLGGYRTIMIGTVTCLISTTLLNFFHGWPWYAIWLVLLGFGGGMIVPAIYAIAG
AVWPNGGRTTFNAIYLAQNIGVATGAAMGGFVAELSFNYIFLANLIMYVLFGIVAITQFN
LEYHAKIRTPDSLDIHSKENKKRFIALLLLCVMFAICWIAYIQWETTIASFTQELNISMS
QYSILWTVNGIMILVAQPLIRPAIILLKGNLKYQMLVGILIFMLSFFVTSFAEQFTVFLI
GMIILTFGEMFVWPAVPTIANYLAPEGKQGQYQGVVNSASTVGKAFGPLIGGVLVDTFNM
SAMFIGIMFLLIVGIIFLSIFDKGLPKGKQSRQSR
>SEQF2892_01466 Biotin synthase
MGNYFPYAFENKRYHTWNYHLKNKFGQKIFKVALDGGFDCPNRDGTVAHGGCTFCSAAGS
GDFAGNRADPIEVQFQQIKDRMHEKWSEGKYIAYFQAFTNTHAPVEVLKEKYEPVLKEEG
VVGLSIATRPDCLPDDVVEYLAELNERTYLWVELGLQTVHQETTDLINRAHDMQTYYDGV
AKLRKHNINVCTHIINGLPGEDYEMMMETAREVAQMDVQGIKIHLLHLLKGTPMVKQYEK
GMLEFMSQENYTKLVCDQLEILPPEMIIHRITGDGPIDLMVGPMWSVNKWEVLNEIDDEL
ARRNSYQGKHYSSEVKVKS
>SEQF2892_01467 Ribosomal RNA small subunit methyltransferase H
MKLERILPFSKTLIKEHIKQDSIVIDATCGNGNDTLFLAQQVSNGHVFGFDIQDTAIQST
FEKVKAFNNVTLIQDGHENIKKHIDIQFKGQIDAAIFNLGYLPKGDKSIVTRPETTIKAI
NAIFDYLSVEGIIVLVIYHGHAEGQVERDALLDFLEHFDQEKAHILKYQFMNQVNHAPFI
CAIEKR
>SEQF2892_01468 HTH-type transcriptional regulator rot
MNNQAGENVSMILQLEEVCKEINSIFKVIYETYDLTKEEVLILLTLWDKGSMTLKEMDSY
VNIKSYKRTRTYNKLVQSEWIFKERPLDDERSVIIHFNKEKQELKNELLDFITATIKKRY
EILENSLNSLMRV
>SEQF2892_01469 Phospholipase YtpA
MWKWETEHDAKGVVVIVHNILEHTGRYAYVITMLRRNGYHVIMGDLPGQGQTSRANKGQL
EHFDIYHETLIEWVRIANEYKIPTFVMGVGLGGLILLNVLEKTELPIEGMLLLSPLLEFK
RNNKTRKNMLISNVGKGSKDARFKLGIETKDLTRNDEVIEETKQDGLMLRKVTYKWYNIL
LETMKDTVQHFKDIQSMPTLLMYGTEDKLLELRSFNELKNNLNTNEFYFKVWEGFYHEIH
NEPERDQVMRYVLTFLNNSVNTMGFIVNEEEIEEV
>SEQF2892_01470 Proline dehydrogenase 1
MSLFKNFFIALSNSTYLNETAKKVGPKMGANKVVAGNTIEQLIDTIERLNDKNIAVTVDN
LGEFVGTVEEATQAKNEILEVMQAIKDYNVDAHMSVKLSSLGGEFDTELAYNNLREILLK
ANEFDNMHINIDTEKYDSLQQIVEVLDRLKGEFRNVGTVIQAYLYDAVDLIDKYPNLRLR
LVKGAYKEDEQIAYQTKEEIDANYIKIIEKRLLTAKNYTSIATHDDQIINHVKQFVKSHN
IDRDQFEFQMLYGFRSELAEDISRQGYHFTIYVPYGNDWFGYFMRRLAERPQNLALAYQE
FVSTKTLKKIGVFTSLGLGAAFIISGLTRLLKR
>SEQF2892_01471 6,7-dimethyl-8-ribityllumazine synthase
MNFEGKLVGTDLKVAIVVSRFNDFITNRLLDGAKDTLVRHGVEDSNIDVAYVPGAFEIPL
VSKKLAQKGEYDAVITLGCVIRGATSHYDYVCNEVAKGVSKANDVSDIPVIFGVLTTESI
EQAVERAGTKAGNKGAEAAVSAIEMANLLKQF
>SEQF2892_01472 Riboflavin biosynthesis protein RibBA
MEFDEIKDALNALKRGESIIVVDDEDRENEGDLVAITQWMNDNTINFMAKEGRGLICAPI
SKDLALKFNLMPMVEHNTDGFGTNFTVSIDHATTSTGISAFDRMATARALINPESTPEDF
HKPGHLFPLIAKENGVLERTGHTEAAVDLAKLTKAAPAGVICEIMNEDGTMAKGEQLEAF
KHQHGLKMITIESLVNYQKDKDTSVELKAKVNMPTDHGAFEMYGFESSLTKEEIVVLAKG
EPRVTENVRIHSACLTGDIFHSQRCDCGAQLESAMKYINEHGGMIIYLPQEGRGIGLINK
LRAYELIEQGHDTVTANLALGFDEDLRDYHIAAQILNYFNVQQVNLLSNNPKKFEGLSEY
GIKVADRTPIIVAENEHNHDYMNTKKIKMGHLI
>SEQF2892_01473 Riboflavin synthase
MFTGIVEEIGTVKNIRTHQSVRTLDIACQTITEDMHIGDSISVNGACLTVIDFTSNYFSV
QLIKGTEDKTYLSQINKNDEVNLERAMSGNGRFGGHFVLGHVDDKGVITQVKETPNSRIV
SIRASSTIINQMVKQGSITVDGVSLTIFDLRHDSFDIHLIPETRRSTILSSKQNGDQVHL
ETDVLFKYVERMVSRNESELTLDKLKAFGF
>SEQF2892_01474 Riboflavin biosynthesis protein RibD
MSNFMEYAIQLAQMVKGQTGINPPVGAVVVNNGRIVGLGAHLKQGEKHAEVQALDMAGKE
AKGGIIYISLEPCTHFGSTPPCVNKIIEFGLSKVIYAVKDTTLPSEGDAILEQAGIDVEY
QYSEEAAALYKDFFKAKSGQIPEITMKVSVSLDGKQATDLGQSKWITNSEVKQDVYHLRH
THDAVLTGNGTINADNPLYTTRIPNGKNPIRIVLAKSGNVDFTKQLFQDSSSEVWIYTEN
QTLESPNRNIKVICIDKCYLKDILKDIYKRGIGSLLIEAGPRITSKFLQTDFINQLIIYY
APKIIGGSGKNQFYQTADIIDLNETTQFEISSTELINQNLKMILRKK
>SEQF2892_01476 hypothetical protein
MRVAIIGVGTAGVSVLRQLVKNEAFKNLEVDVYDHDKNMGQGVPFQNDSSQLLINLPTKQ
MSLNLDDDEEFWKWYQEQSEFKFDNPKYLPRFVFGHYMKSYLSNYDLLFDNLTIIKHPVR
EIFTNSEIDETTLKYYVCTSEDMSEWKEYDYIFLTTGTFAYHDPYNLKGNKGYIQTPYPT
YNTLDEVSQSDDIAIIGTGLASLDVVRYVATHHPKLPITMTSRSAHLPSVRGNMIDVEFK
HLTKQKFNELKSQYYGNVPLELAFELFKLECKDHNIDLEKLVYRRTGNTIQDLQYDLDRP
DEIGVFQSLIENIKENLNWIWNSFSREDQKDFDKRFSKIIQLNSNPMPPRTAELIIDLIN
NQSLIVKSGIEDITYKDNHYLLKFNNDDDYYQYDVIINSTGSKTHLSDLDEEDQLILNLQ
NRQIVQPHPMGGIQIIPETNQVISPRYGTLNNMIAIGQVTNGVNKLRNGVKMIVDQAVNS
VNYLYENQSKFDHFNS
>SEQF2892_01477 hypothetical protein
MCKSILNKLRIKDKNLNFSDEVIEKKHKGRMSLFYYAELTYQPTHCENCSTKNENFSIVK
NGKKTSTITLLKIMEMPAYLELQKQRFYCKSCDSHFTAKSNIVDAHCFISNKTKLAVLDK
AQEYRSQKSIAKSCLVSSMTVSRVINQAASDVGQSSFDALPEHLMMDEFKSVKNVIGKMS
FIYADAVSHRIVDVVADRKLKSLKDHFYRYSLKLRQKVKTVTIDMYEPYMSLIKQLFPNA
KIIIDRFHIVQSLNRALNMSRVHVMNCYRTSNRPLYNKYKSYWKLFLKPFETLEAFNYHK
VHLFKEWKTEKGIINYLLGVDVELFNTYHYVHELRRLLKENQIEKFNHKLFSIHLSDVCP
KLRPVIRTLRRLAAFIENTMTYSNLTNGPLEGINNKIKLIKRVSFGYRNYDNLRNRIIIT
SRLFASTTKKEIKQPKVA
>SEQF2892_01478 Bifunctional autolysin
MTKHKKGSIISLVGLLIVLVAAGFIFFTMISDQIFFKKVNEEEKVEHLNVTLNKAADKQI
DNYTSQQVSNKNNTAWRDASDNEIKAAMDSSKFIDDDKQKYQFLDLSKYQGIDENRIKRM
LFDRPMLLKHTDAFISAAKEKHVNEVYLISHALLETGSVKSELANGVEIDGKKYYNFYGV
GALDSDPIKTGSEYAKKHGWDTPEKAIKGGADFIHQHFLSHDDQNTLYSMRWNPKNPGEH
QYATDIKWAESNAQIIADFYKEMKTEGKYFKLYVYKDDNKHQK
>SEQF2892_01479 hypothetical protein
MDYAHLNLEHFFARNDDLDIIRDRSEFVMINNFTNEMMYRDGEIEGTVDLNQYYYKNRSQ
AASFIMMDYRKDN
>SEQF2892_01480 RNA polymerase sigma factor SigS
MNFDEIYHKYHRFIHYLLKRYYVKYNYDEFYQLLLIKLWQLSKNYNKNSNICLSSYLYQR
LNFYLIDLFRKENLKPELVEVDDLQTPQITSINTETTFFNYNDISKILNTQELAWYNYFI
QGYKQFEIADLMHVSLSSIKKYKSSSIKKLTDYYFKGE
>SEQF2892_01481 hypothetical protein
MIPHNSYHLLYIQTLQHSEHKTKCCFSTYDMVLPFPIKKVLIYYFEQHNQSYLQRLKLAK
RLLAINKLVPLYISDQVVLFPIKHQRAPLQTYINALTIIGLTSTTNGVIITFENNIQLHV
DEPYSLIYKKWQESTLLYHLVQKTMQIY
>SEQF2892_01482 hypothetical protein
MKHTEFEEKVKKQLWFLNKKEKKLLQNNLTHYHNEVEGNEGDIQSKKYRKPIQYANQFLK
NNIFKQKEVASSTLLFLLIGMVLIYAFLLGLFLTGFITSLTAVNYFINPQVSMPVINVIL
ILIGAVLLAIVSLLLIKSVTAFFTKKLLEYKFNKSA
>SEQF2892_01483 Transaldolase
MAKLNVEVFADGADIEQMKAAYKNKEVDGFTTNPSLMAKAGVTDYKSFAEEAVKEIPDAS
ISFEVFADDLETMEKEAEILKQYGDNVFVKIPVVNTKGESTIPLIKKLSADNVRLNVTAV
YTIEQVKEITEAVTEGVPTYISVFAGRIADTGVDPLPLMKESVDVAHSKEGVKLLWASCR
ELFNVIQADEIGADIITCPADVVKKVNTNLGRDINELSVDTVKGFAKDIQSSGLSIL
>SEQF2892_01484 hypothetical protein
MSKPKKYFYISIILLIISFYFNTFNPLLSQQITSVKYLLIACSIINVIILIASIIFSDKA
IKHLGDKQGWIRIASKILPIIILFVILFHIYASIKTFGILS
>SEQF2892_01485 Putative fluoride ion transporter CrcB
MQYLFVFIGGLFGALLRYVLSTLNVDSGLPLGTLIANIVGAFLMGYLSSLSIHFFKNNPL
IKKGVTTGLLGALTTFSTFQFELVTMSQNNSIALLFIYGLTSYIGGILFCWFGVKLGGQP
T
>SEQF2892_01486 Putative fluoride ion transporter CrcB
MIHILFIMVGGGIGAVIRAWLTDVFKSKITSPIPIATLIVNLVGSFLIGFVYGIAQDYQL
FSLFFITGVLGGLTTFSTLSYEIVQFISPSFKPVQFFSYSILQFVIGFISCFIGYSI
>SEQF2892_01487 Glyoxal reductase
METIEFYNGHTMPKVGIGTFRVENNDECKEAVKHAIVSGYRSIDTAKVYGNEEQVGLGIK
EGLEATGLERKDLFITSKLYFEDFGRENVANAYETSINKLGLDYLDLYLVHWPGTNEAIM
IDTWKGMEDLYKDDKVKNIGVSNFNAEHFEALLAQVSIKPVINQVEFHPYFTQNKLRKYL
EVQNIHMESWSPFMNAQILGDETLNQIGKEVNKSAAQVVIRWNMQHGVIVIPKSVTPQRI
EENINVFDFELTDEQMEQIDSLNKDQRIGPDPATFEGH
>SEQF2892_01488 hypothetical protein
MNSFGPIEIGLIVAIVVAIICLILFLVTLKSKNNIKQKTKEEYDLKEKQMKASHDEALEK
ERIQNKKQVTKQKEDFDATVSGKDREIDALKLFSKNKSEYVTDMRLIGIRDRLVKEKRIR
PEDMHIMANIFLPSNEFNDIERISHLVLTRTGLYIIDSQLLKGHVYQGISGKQFNELPMM
EQVFSTLDLDVKSPQTLVLDQNEDKSSLSFVNYSEQLTSIEKLASDLQTQLGAKYTPTAI
LYFNPKHDGDVTISNYAQSSSVKVLVGPDQLDEFFNKFVFHGRIQYNVDELQNVMDKIES
FN
>SEQF2892_01489 S-adenosylmethionine synthase
MTYNKRLFTSESVTEGHPDKIADQVSDAILDEILKDDPNARVACETTVTTGMALISGEIS
TSTYVDIPKVVRETIKGIGYTRAKYGYDYQTMAVLTAIDEQSPDIAQGVDKALEYRNDIS
EEEIEATGAGDQGLMFGYATNETETYMPLPIFLSHQLAKRLSDVRKDGILNYLRPDGKVQ
VTVEYDESDKPKRIDTIVVSSQHADDIELEQIQSDIKEHVIYPTVPEGLIDNETKFFINP
TGRFVIGGPQGDAGLTGRKIIVDTYGGYARHGGGCFSGKDPTKVDRSAAYAARYVAKNIV
AAGLADQCEVQLAYAIGVAEPVSISIDTFKTGKVSEAQLVEAVRANFDLRPAGIIKMLDL
KHPIYKQTAAYGHFGRTDVLLPWEKLDKVNVLKDAVQA
>SEQF2892_01491 Phosphoenolpyruvate carboxykinase (ATP)
MSVDTYGETPKIKKLLEKESSLFQLSTTQLYYKIMDNNEGELTELGAINASTGKYTGRSP
KDKFIVTEPSYKDNIHWGDINQPIDEETFLNLYSKVLDHLDKKDELYVFNGYAGSDKDTQ
LKLTVINELAWHNLFAQNMFIRPDSKEEASNIKPNFTIVSAPHFKADPEVDGTKSETFVI
ISFKHKTILIGGTEYAGEMKKGIFSVMNYLLPMQDIMSMHCSANVGDKGDVALFFGLSGT
GKTTLSAAPDRKLIGDDEHGWNKNGIFNIEGGCYAKAINLSKEKEPQIYNAIQYGTILEN
TVVNERGVVDFDDNSYTENTRAAYPIHHIDNIVLPSKAAHPNTIIFLTADAFGVLPPIAK
LTKSQAMYHFLSGFTSKLAGTERGVTEPEPSFSTCFGAPFLPLNPIKYADLLGELIDKHE
VDVYLVNTGWTGGKYGVGRRISLHYTRYMVDQAIKGKLKNAEFTKDEKFGLSIPTEMEDV
PKTILNPINAWSDSDKYRAQADDLIKRFEENFKKFGPEVEEIANTGGFNK
>SEQF2892_01492 hypothetical protein
MDIIVTKKMPIASRTHQFDEITYKVDGLKVKALQMCPLTKTVKRIVVYLRGGKGQVGRVR
AARLMQFANDNTLVVGPYYRGSNGSEGRDEFANADLKDVTYLIKILKQRFPNAYIHMIGF
SRGGIQGLLTYQDYPVDSYIIWGGVSSMHLMYEERTDLRGMLRRMVGHPSKNKESYDQRD
AIKLIDSNSPPILIVHGGKDKQVGIHHANYLEEQLKLKGVVHDTFYQLDEGHVPRPQAMK
LALDYVHQWMTKCEEI
>SEQF2892_01493 Putative 8-oxo-dGTP diphosphatase YtkD
MEFLDKDNRRVTMCYKTNNDHPDGNHVLAIPLYQSQLLFTHHKLRGIEFPGGKVEKGEES
IQAIKRELFEETGGIPETIDYIAQYQVHTFDNSIFKKDVYIVKVKSFKEKSDYLETRGPL
LFDNINSIPLDKQSYLIQDNAILKCVERMIELGYYRD
>SEQF2892_01494 Putative membrane protein insertion efficiency factor
MLKKLFLGIIHIYQRYISPMTPPTCRFYPTCSEYTREAIEVYGPLKGGYMGIRRILKCHP
LHKGGFDPVPLKKDKHRH
>SEQF2892_01495 o-succinylbenzoate synthase
MRIKAVNFYLYNHEFRDPIVTPKVKLTYRKALIVEILSEEDQSFFGECNAFETNWYNEET
IETVQEILSQWSESIVKKSVHKYEDWKPYLDILDNYPTARSTVVMAIYQMYHDLPKFKVA
YGATISGISAQQLDYLKQTQPKRIKLKWTGQLNDDISLLDDILPYDFELALDANESLDVS
DFQKLESINDQNILYIEEPFKSLSSTLHIDHTQYPAIALDEKATDINSIISIVNQFPVKV
VIVKPFRVGGLDRVQSLIRELKSIDIKVVIGGMYEYGLSRYFTALLAREGDYPGDVTPDG
YYFTDDFTQGVGKLKEGMISFSPPQIDKSKLLKLN
>SEQF2892_01496 2-succinylbenzoate--CoA ligase
MDFWLKEQSIKNRDKVAVTDGNHSITFKELYDKAFSISEQILSLNNNRVGLYIKNDIASI
TLINACWLANVEIAMLNTRLTETEMINQMNSINVSTILTTQPFHLSDFNVIHISEIEQYS
KRINNQTCNYDRIASIMFTSGTTGPQKAVPQTFKNHYASAIGCKESLGYDETTKWLSVLP
IYHISGLSVLLRSIIEGFTVRILEKYNTQTMLSIIKEEGPTHISLVPQTLKWLMDAGLNQ
PFSIEKILLGGAKLSTTLIDEALNYQLPIYNSFGMTETCSQFLTATPEMLAQRYDTVGKP
SENVNVRIKHPNSEGHGELLIKGNNVMNGYLYPAGLSDTFEDGYFKTGDIAEIDEEGFVM
VYDRRKDLIISGGENIYPYEIESIAKTHSDINDAVCVAQEDETWGQIPVLYYVSDDTIPE
IELTKYLKTYLAKYKVPKAFHQVESLPYTSTGKLQRNKMINKGQ
>SEQF2892_01505 Putative hydrolase YdeN
MTNVIIVHSQLGNSHNHWYKWLQHNLELEGYDVQLFHLDESKNDNIDNWVFELNQQIELL
SKDTYFVTHGYGSLATLKYIEGLSIDGPFEGFFSIAGFKEDAKKIDDSINVGEFNVDYDL
IKTKVNHFYGLASKDDSYVSYIETQNLIDELGGKTKIVDEGGHFLEEEGFVSFTELQEKM
QHYMTK
>SEQF2892_01506 Protoporphyrinogen oxidase
MSKKVAIIGAGITGLSSAYYLKHYKPDIDVTIFEATNRPGGKIQTYRKDGYTIELGPESY
LGRKTIMTDIAKDIGLEDDLITNETGQSYIFAKNKLYPIPGGSIMGIPTDIKPFLKTRLI
SPIGKLRAGLDLVIPPIKIEDDISVGAFFRRRLGNEVLENLIEPLMGGIYGTDIDRLSLM
STFPNFKEQEEKYGSLIKGMQHEKAERIKKRQLYPGAPKGQFKQFRHGLSSFIEALAKNV
QDKGVKMKYQTHVEDIIINNDNYEIVTDQYSEQFDGILITTPHQTFMKWFNHDQAFKYFN
EMDSTSVATVVFAFDEKNIENTYNGTGFVIARTSNTNITACTWTSKKWPFTTPQGKVLIR
AYVGKPGDTVVEDHTDDEIATIARRDLNKMMTFHGDPEFTIVNRLTKSMPQYHIGHIGQI
RKIQQHVKNNYSALRITGAPFEAVGLPDCIQQGKNAVEELLDEI
>SEQF2892_01507 Ferrochelatase
MTKTVGLLVMAYGTPYKESDIEPYYTDIRHGKRPTDEELQDLKDRYEFIGGLSPLAGTTD
RQAEALKDALNQVYEDVEFKLYLGLKHISPYIEEAVEKMYKDGIKEAVTVVLAPHYSSFS
VGSYNKRAKEEADKYDIALHHVEHYYHQPKFIEYWTNKINETLEQIPQDEHDETILVVSA
HSLPKGLIEKNNDPYPDELKDTMNRLQTSSNIKHVAQGWQSEGHTGTPWLGPDVQDLTRT
LYIEHQYKHFIYTPVGFVCEHLEVLYDNDYECKVVCDEIGANYYRPTMPNTNPLFINAIV
DEIKTVF
>SEQF2892_01508 Uroporphyrinogen decarboxylase
MHNKNNTILQTIKGEKTSHTPVWFMRQAGRSQPEYRKLKEKYSLFDITHQPELCAYVTQL
PVDNYNTDAAVLYKDIMTPLKPIGVDVDIKSGIGPVISNPIKSVSDVDKLTQIDPKRDVP
YVLETIQLLTQEKLNVPLIGFTGAPFTLASYMIEGGPSKNYNYTKAMMYGDEATWFALMN
HLVQVSIDYVVAQVEAGAELIQIFDSWVGALNVQDYRYYIKPSMDKLINGIKAKYDVPVI
MFGVGASHLINEWNDLAIDVLGLDWRTSISSATKMGVNKTLQGNLDPSLLLAPWDVIEQR
VREILDEGMERGKHIFNLGHGVFPEVQPDTLKRVTQFVHDYTSK
>SEQF2892_01509 Signal transduction protein TRAP
MNIYTTYGTYGYLNQIRTNNTDRNLFLFSTNDSSVIIEESDEKSILKHPTVYTTVNAIND
LDQTHFYSAIFIPSSDDHVHQLEKRIANLELNFDKFAGFKSYRFLKPVQGATYKVYFGFA
NRQTYEDFKETDTFKDYFSKDALRHYFGSSSQHSSYFERYLYPIKE
>SEQF2892_01510 hypothetical protein
MDNSATSLFKSRLNTIQKEKRYYNKFIFNGHFSVFLLILLGAFILGYGQWLQHIPKHIDY
TLCASIILAVTSIFPIRTFLKDADRIFLLPFEKHMKNYMNLSIRYSYFNRIAIQLVILII
LFPLFSKLDGDFITPFIILSILTLIHPWIGLKVRWQWYQLKQSSWSISLILFLINLVTYD
LVLGYQMYWGVIFTFILLGGMLALPKLNRVNLYPWERMINIEERHHTNYYKFVNMFTDVK
HLKESAVRRRYLDFLLPTPKGRKFNSKNMYLYLFTRSFVRGRDAFSIIFRLIVIALVLMI
WLSFPIVSAIIGCLFMYITLLQMSQFYTQQAYGLWPQVWPVSDVEVIKGYEKFLYRLMLI
IGIIFSIAFISIYPQYFFFALIFFIVGWLTIRSTIKKLQYQESLLKD
>SEQF2892_01511 ABC-type transporter ATP-binding protein EcsA
MTVKVEHLTGGYGKRPVIEDINFELKAGEIVGLIGLNGAGKSTTIKHMLGLLTPTEGNLS
ISNTEITDNIEVYRKKLSYIPESPIIYEELTLEEHIAMTAMAYQLSKEEAMKRARPLLKT
FRLENELKVFPSHFSKGMKQKVMIICAFIVNPELYIIDEPFLGLDPLGIQSMLDLMVEKK
NEGRTVLMSTHILATAERYCDRFIILDKGKVVAFGDLEELRKQTGLSGHTLDDIYIHVTQ
GGQENG
>SEQF2892_01512 Purine nucleoside phosphoramidase
MAETVFSKILSGEIPSFKVYEDDFVYAFLDISQVTKGHTLLIPKKASPNIFETDEETMAH
IGAALPKVANAIKKAFNPDGLNIIQNNGEFADQSVFHIHFHFLPRYENDIDGFGYHWETH
ENEINDEQKQAIANQIKAQFD
>SEQF2892_01513 hypothetical protein
MKISRVLFGITAGVASGIAVSWLNRDDQSVKNNTIDAKEPTGSRSELEREIESLKRNFFN
IIDYGKQVKNDGVSYGSEIGDEFKTLIGDFKSDINPNIEKLQSHIENLQNRGEEISNTFS
KDNK
>SEQF2892_01514 hypothetical protein
MFLCKRQIDIHARFGVPRIAFLSFTITVIAFLISYEIMYYFVNTPLSDRHFIILLIIVAL
MYPIHKALHLLFFLPYVNSFRIHKLNKKRWLPYFNTYVSTPVHKIYFCINLILPFILITI
FLIFLTMHFPQYGHYFMFLLALNFGISVMDFLYLKIIIFSNEGHFIEEHQTGINILNKVP
YQSFH
>SEQF2892_01515 Foldase protein PrsA
MKIMNKLIVPVTASALLLGACGSNATDSESNTLISSKAGDVKVKDVMNKIGDEQIASTSF
SIALNKILADKYKDKVDTKDIDDEIKKEQKQYGGKDQFESMLKQQGMSLDDYKEQKKLAA
YQKQLLADKVKVSDKELKENTKKASHILIKVKSSSSDKEGLSDKKAKEKAEKIQKEVEKN
PDKFGEIAKKESMDSSSAKKDGSLGYVVKGQMVSKFEKALFKLKEGQVSDVVKTDYGYHV
IKADKESDFDKQKSKLKAKLIEQKVQKDPKILTNAYKDLLKEYDVDYKDSDIKKAVENTI
LNPEKLKQQQSSSDSSSAASGLSS
>SEQF2892_01516 3'-5' exoribonuclease YhaM
MRNVEKLNPGDSVENFFLIHRATQGVTAQGKDYMTLFLQDKSGDIEAKLWTVSKEDMQIL
KPETIVWVKGDVINYRGRKQMKVNQFRLAKPEDGFKTQDFVAGAPLSPDEIQENISHYIL
DIENANLQRITRHLLKKYQDKFFTYPAASSHHHNFASGLSYHVLTMLEIAKSLCNIYPLL
NRSLLYSSIILHDLGKVRELSGPVATTYTVEGNLLGHISIASDEVAEAAKELGIDGEEVM
LLRHMILAHHGKMEFGSPKLPHLKEAEILFFIDNIDAKMNMFEKAFKKTDKGQFTERIFG
MENRQFYNPEKLD
>SEQF2892_01517 Chromosome partition protein Smc
MIIKSLEIYGYGQFVHRKIEFNREFTEIFGENEAGKSTIQAFIHSILFGFPTKKEKEPRL
EPRMGNQYGGKLTLILDDQSEIVVERVKGNISGDVKVYLENGLIRDETWLKKKLNYISKK
TYQGIFSFNVLGLQDIHRNLDEDQLQSYLLEAGALGSSEFTMMNKMVSQKKTTLYKKAGK
NPILNQQLDELKSLEAQIREEESKLDEYHRLVDDRDKSQRHLEHLKANLNQLSKMHESKQ
KQLAIHEQAQEWKDLEQKLNIEPLSFPEKGIERYETASNYKQSLARDISLREEKLKQLKN
EFNAIPALNEDTANHIYHLTRDENEIQQAEMKSSSLKQEIDDYERQEADLKTSIGWQEVY
HNTDTSESMKNYVSKTIKTRNEQKVLKQQIERAIDENQIEQNTLSQEIENLEKDLVSEDS
LDKKKQYNQQKLELHEKENLYNKLKDTFNSDKERKQKRNWWLRLSFIVLSIVGLGLTLFS
FVTQNLIFGVIFAILTVIFIVGTFLVKTKEIDYSESISEEINDLEQQINDLQSNYDLNFD
LDQQFQLRERWSNASNNKSVLANKLNHQENLLQNTEQQINDLTQKLNAVKENVKVPNEMT
DDLLIDSFKTMNQLKSNDSYRSKLLDQHQQVNQKLTHFYDKALKNTENEITPFNKASLFN
DMKNWISKYESNKEKKEQLKSQIELLSNELKQLKEQLEENEKTINTLFTYINVSSEEAYY
QSYEQYQLYHQQLARFNDLTAYLENQNFSYEDSSNLSEKTTAQLEEEDALLAKQVDAYND
QYLDKQTEVSDLTAQINYMETDKTLSKLRHEYYNLKNRMNDLAKDWASLSYLEALINEHI
KQIKDKRLPQVINEAVNIFTALTQGNYNMITYENDTIMVKHNNGQMYHPLELSQSTKELL
YIALRISLIKILRPYYPFPIIIDDAFVHFDKQRKSMMLNYLRELAKDYQVLYFTCMKDAA
IPSKEMLILNKLEEGGKR
>SEQF2892_01518 putative metallophosphoesterase YhaO
MIKFIHCADLHLDSPFKFKSHLAPSIFEDVQNSAYESFKKIVDKALKEEVDFVLIVGDLF
DSENRTLRAEVFLKEQFMRLEKEQIFVYISHGNHDPLTEKITNDWPDNVSVFSNRVETYQ
AITKDGETIFVHGFSYQHDTSYENKIDEYPSSQGKKGIHIGMLHGTYSKSSTKNRYTEFI
LEDLNQKLYHYWALGHIHERQELSDMPPIYYPGNIQGRHFGEQGPKGCLLVEGDHLRLNA
TFIPTQQIRFEEATIKTDKLTKQGIYEAIQSFKESVRSDGKAFYRLTVNVDSDRPISSQD
ISQIKEMIDDYEENEHHFVIIETLTFNYMQMDEVPLVREFSADLIKDNKVFEEAMTELYL
NPRASKYLEDYTEFDTVELVNRAEKILKADMRGESDDH
>SEQF2892_01519 hypothetical protein
MAVNLYDYANQLEQALRDSDEYKAIKDAFSKVKDNEESKKLFDEFRETQLSFQQKQMQGE
EIPEEDLAKAQEQAQAIEKDENISELMQAEQKMSQVFQEINQIIVKPLDEIYAD
>SEQF2892_01520 hypothetical protein
MQAFLVILFMVVVGAVIGGVTNVIAIRMLFHPFKPYYIFKMRIPFTPGLIPKRREEIATK
IGQVIEEHLITESVILQKLNEPNTREAINDLVIKQLSKLKSDDATIRKFANQFEFDLDDL
INNKLDKTIINKLNNYYYDKQATSINEILPADVITMVDEKLDQAGDLIRERARNYLSSDK
GARDIYDMLDTFFAEKGKIVGLLQMFMTKESIAERVQHELIRLTRHPKAKVIIDKVIRDE
YETLKSQPLSHVVKEEQFTNISESLVHLVITNIQLNEKMDTPISKLTPKLVDQIQVGVAN
TITDLIIKQASNHLSTIMTKINLRQMVENQINTFDLDYIERLIIEIANKELKLIMSLGFI
LGGIIGFFQGIVAIFV
>SEQF2892_01521 hypothetical protein
MDRQSFTDLIQTKFKMVRIEAGYTQDTMAQTIGLSKKTLVQIEKERVLPNWTTCVSICAL
FRDSDVLNNTFGCDPLEIVQTISRNHCAYPNHSTTSDIYWNTIETRNGFMLQSNKVSNIY
RVLNSEKQPIFGTSKLREAETYFNRNAKEELMHV
>SEQF2892_01522 Transcriptional regulatory protein LiaR
MAKVILIDDHHIVRQGLEFLLSTVADLEVLASLSDGQSLINYLNENDIPDIILLDLVMPE
MNGIEVTEYVKSHFPDIKVLVLTSYVDDEHVISAINKGADGYEMKDVEPQKLIQTIHDVL
NNKRIIHPEAQSVIETVSSKPHNTNKLSKREIEVLAEMVKGKTNKEIANTLFVSEKTIKT
HVSHIFNKLSVTDRTQAAIYAIENKLV
>SEQF2892_01523 Sensor histidine kinase LiaS
MEKPTRLALLKEIAEYLNEETELYNMMHGALNYLINGSNFTTGWIFFIDNNGHHEMVADV
DLPGALKKDNCCYMKEGSCWCVTAYHNERLTKASNIINCSRINLANQAYKAETEGVTHHA
TVPLRSGTEQYGLLNVASPYTTRYSEQDLALLESVALQIGSAIKRIYLTDQEKEAARLNE
RNRLARDLHDSVNQLLFSLKLTAHAAHDITTDEIAKKAFKTIEETSQNAVNEMRTLIWQL
KPVGLEHGLVQALNQYAQILNIKLTINVEGIISLSNIVEENVYRILQECINNTKKHAKTN
SVHIILKQDKEKLIIIAKDEGIGFDMNKETNTSSQGLKNISQRIYALNGQVKIDTMPNKG
TTLSLKLPL
>SEQF2892_01524 Ribosomal large subunit pseudouridine synthase D
MKFKIHENYNQNTLREIFQSLKLPKKDLHQLNMSKDITINNHPAKLTDKVVIGDDIYIPT
PVEKSNYLPSYRYAQISYEDDDLAIVMKPKGVKTHPNDLKESNTLMNHVIYTLESDYVEP
IHRLDQETVGLLIVAKNPLMKKILDRMLEENEITRIYKANVKSLLPIKPQTIDSPIGKDK
FHPNKRRISNTGQRAITHILSSKMIKEGVCQLDIKLDTGRTHQIRVHLAEIGHPVIGDPL
YGDSTLRQLELNSHKIEFKHPLTQELISVSLDDE
>SEQF2892_01525 Fumarate hydratase class II
MSVRIEHDTFGEIEVPGDKYWGAQTERSKRNFPVGKERMPIEVVYGFAQLKRGAALANHE
LGKLSDAKKDAIVYACDLILKGELDEHFPLVVWQTGSGTQSNMNVNEVVSFVANKYLKEQ
GIDESIHPNDDVNKSQSSNDTFPTAMHVALYHEVETKLEPALKHLRDTFKEKEDKYQSII
KIGRTHLQDATPIKLGQEISGWRYMLDKCEELLAESKKHILSLAIGGTAVGTGINAHPEF
GNKVAKFISENTGYNFVSSENKFHALTSHDEVVQLHGTLKALAADLMKIANDIRWLASGP
RAGLAEISIPENEPGSSIMPGKVNPTQCEMLTMVAVQVMGNDTTVGIASSQGNFELNVFK
PVILHNTLQSIYLLADGMQTFNDNCAVGIEPIEENINNYLNQSLMLVTALNPHIGYEKAA
QIAKKAHKEGLTLKESAIQSGHVTEEQFEEWIKPEDMVDPH
>SEQF2892_01526 hypothetical protein
MLHKYWLPLTIATIIISLLSIKGFPIAFGALYLPILFKIIKLQLNLSKGLIDNISAQPFI
KSNQTGVFISVLCCILITGILIYSLNDIYTQFTGFIGFLVQISPITITLSIIFYILSALA
VIKAVKVKYQV
>SEQF2892_01527 hypothetical protein
MTKNKDSELNYHEEENAMVQDLDDLKTLGKEMEQISEENDEDKLNQSHE
>SEQF2892_01528 Glucosamine-6-phosphate deaminase
MAMNFKVFNDVEHVAEYTADIIRKQFNNNPTTIAGIHLTKDAAPVLDELKKDVDHNAVDF
SQVNILDYDDNRSYYEALGVPASQIYPINLDDDAESLIDDKIKTKENKGKLILQVTSIDE
SGSLNVNVRQGLLKAREVVLVVTGANKREVVKKLYEENGKSSFEPSDLKAHRMVTVVLDR
AAAEGLPEDVKEYFTARFA
>SEQF2892_01529 tRNA (cytidine(34)-2'-O)-methyltransferase
MTNHIVLFQPEIPANTGNIARTCAGTNTHLHLIKPLGFSTDDKMLKRAGLDYWEHVNITY
HESIEDFFDATQGEYYLLTKFGKQTYSDFDFSKEDTDYYFIFGRETTGLPDWVKDKYADT
ALRIPMSENIRSLNLSNTAALLIYEALRQQNFPGLS
>SEQF2892_01530 Epoxyqueuosine reductase
MDYNWLKQEIIDYAYSIGIDSIGFTTADPFDELKKKLEDYHANGYASGFEESDISLRTEP
KLSLPTARSIIAIAVGYPNKLKGAPKSVRGDRRGMFARASWGQDYHSIMRKRLDKLADFI
QSKVPDVELKSMVDTGVLSDRAVAERAGLGFAGRNGFIINPDLGTWSYLGELLVSIPFEP
DDPLLDSCGDCTICVDRCPTGALVGNGQLNSQKCISFLTQTKGYLQDEYRYKIGNRLYGC
DTCQQVCPRNRGINTTHDDIILEPEILKPRLVPLLQMSNKEFKQTYGHLAGAWRGKKPIQ
RNAIIALAHFNEETAIPELKEVALNDPRPMIRGTAYWAIGQIQGEDAREFIVANYENEIE
EVQNEMIKGLEMRKL
>SEQF2892_01531 Glutamine transport ATP-binding protein GlnQ
MLKDINLEIKKGEVLAIIGPSGSGKSTLLRCMNLLETPTNGRVIFEGNELSNHKNNLNKL
RQKMGMVFQNFNLFPHKTVLNNIILAPKLLNKSDLNQLKQEALTLLEKVGLEDKANVYPS
QLSGGQKQRVAIARALAMHPDIILFDEPTSALDPEVVYDVLKVMKDLAKEGMTMVVVTHE
MGFAKDVSDKVIFMADGYVIEEGSPQQIFQSPTHQRTQNFLSRVL
>SEQF2892_01532 Arginine transport system permease protein ArtQ
MALADEDATWNKIKDRGELRVGLSADYAPLEFEKTKNGKTEYAGVDIELAKKIAKDNHLK
LKIVNMQFDSLLGALKTGKIDVIISGMTTTPERKKEVDFSEPYMETGNVMLIRKNNNDTY
HKLSDFNNKKIGAQKGSEQEKIAQQEIENAQISSLNRLPDAILALKSKKIDGLVIEKPVA
DAYAKQNKDLNIAHVSFNEEKKPTVIALPKDSPILLEHLNHSIKDVKDKHLINKYMDIAS
EQMVNDGSFIQKYGTFFLKGLQNTIIISLIGVVCGAIIGSFIALAKLSKFKIISLPATIY
IEFLRGTPMLVQVFIVFFGTTALLGLDISALICGTIALVINSSAYIAEIIRAGINAVDKG
QTEAAQCLGLNYSKTMIHIILPQAFKNILPALGNEFVTLIKESSIISTIGVGEIMFNAQV
VQGISFDPFTPLIIAACMYFVLTFSLSRLMSLIEGRLKASD
>SEQF2892_01533 hypothetical protein
MSKQRVSLKYFFSNILNAVGAGVVLALLPNALLGEFLKLFMDAHPMLETVFQLVMIIQSF
MAFIIGVLAAHQFKFNGAGSCMVGIAAMLGSGAVQFTAKGIVLKGIGDIINIILVVIIAC
AIYMFLQGKLGSLEMIILPVVIPVLSALIGLLTLPYVQTITKGLGHMVNSFTDLNPLIMS
ILISVTFSLLMVTPISLVAIATAISLTGLGSGAANMGIVAACVTFIFGSIRVNSMGVNIV
LLIGAAKMMIPVYLKHLIIAVPLTLNGIVSGVLAYAIGIKGTPLSAGFGYTGLVGPINAF
NRMSGDATIIIILLVFGYFVIPFVSAFIIHEICKKLIPSYHDGIYKFEIPKQ
>SEQF2892_01567 Peroxide-responsive repressor PerR
MSAELESIDHELEESIAALRRAGVRITSQRQAIIRYLIASHSHPTADEIYQALSPDFPNI
SVATIYNNLRVFKSIGIVKELTYGDASSRFDFNTHNHYHVICEKCGKIVDFHYPQLDEVE
QLAQHITEFDVTHHRMEIYGICKECKDKEE
>SEQF2892_01568 Glyoxylate/hydroxypyruvate reductase B
MKSMKIVSLKRLGEIEASLINSYPDLEFYFFKKAVDIPTELKNELEILIGYDSGVDKNFI
NACPNLKWISWYATGVNNLPLEVIKERNIILTNTRGIQAKQVSEFVLSFILNDYKKMRTS
YVNQVNKVYDSKLTGKRLSDEKVLILGTGSLAQQTVKLLKPFELEIIGISKSGHHKDGFD
NIYTIEDLESHLNKADIIINTLPETQETYHLLSERHFKIMNDKCLFINVGRGTIVEEKIL
IKVLNHNLIRHAYLDVFENEPLDANNELYKLDNVTITAHITGNDKNIKSDATKLFERNLN
DFLNKNDVIENRVDLYKGY
>SEQF2892_01569 Putative peroxiredoxin bcp
MLKKGQKFPEFKLENQNGEWITNETIKGSKTIIYFYPRDNTPTCTTEACDFRDNIEQFND
LNVQIYGVSGDTKKKHQNFIAKHNLNFDLLVDEDFQLSKAIGVYQLKKSFGKESMGIVRT
TFIIDEDGVIIDVIEKVKVKTQIEELNQILG
>SEQF2892_01570 Glutamate-1-semialdehyde 2,1-aminomutase 2
MKFTESERLQQLSNEYILGGVNSPSRSYKAVGGGAPVVMREGHGAYLYDVDGNKFIDYLQ
AYGPIITGHAHPHITKAIQDQAAKGVLYGTPTELEIEFSKKLREAIPSLEKIRFVNSGTE
AVMTTIRVARAYTKRNKIIKFAGSYHGHSDLVLVAAGSGPSQLGSPDSAGVPESVAKEVI
TVPFNDIESYKEAMKHWGDEVAAVLVEPIVGNFGMVEPQPGFLEKVNEITHDYGALVIYD
EVITAFRFHYGAAQDLLNVYPDLTAFGKIIGGGLPIGGYGGRQDIMEHVAPLGPAYQAGT
MAGNPLSMRAGIALLEVLEQNGVYERLDQLGKRLEDGLLELIDKHNITATINRVYGSLTL
YFTDEKITHYEQVENSNGEAFAKFFKLMLNQGINLAPSKFEAWFLTTEHTEEDIDETLKA
VDYAFSQMK
>SEQF2892_01571 hypothetical protein
MRLGARILKTGIAIILALFIASFLPDNVGLKSVAGISAIVAMQPNIYRSIKTISEQATGN
VIGALLAVIMVTIFGKNIVIMGVTVILLIAILYKLNLAHVATLAGVTALIIMGQHTGSFY
VTAAFRFILVMIGVVSASVVNLIFLPPKFETKIYHNSVNIASDIFIWFKLVLNDASDYHQ
IKEDGEQIESRISKLEQIFNYYNEEKALTRKAAFQQNRKKILFKEVVGTTRQAYEVLNRM
ARYQNDLHNLNYNLIFQIKLELDSLTAYHEQILKSLSKKARYNVEHFDNQIMNPQKKDLM
DAFQQQLIQNPYQVEYSYSNIMQIIATIEEYRYYLEHLDRLRLSFFTYHRNDTDIDIADE
DFDL
>SEQF2892_01572 Putative multidrug export ATP-binding/permease protein
MIRRYLEFVKPYKYRIIATIIIGIIKFGIPMLIPLLIKYAIDGVINNSALSTNEKFQHLS
VAIGIALFIFLIVRPPIEYLRQYLAQWTSNKILYDIRKQLYNHLQALSARFYANNQVGQV
ISRVINDVEQTKDFILTGLMNIWLDCITIVIALSIMFFLDVKLTFAAIFIFPFYILTVYF
FFGRLRKLTRKRSQALAEVQGFLHERVQGMSVIKSFAIEDNEAKNFDHKNQHFLNRAFQH
TSWNAYSFAAINTVTDLGPIIVIGFGAYLAINGSITVGTLAAFVGYLEQLFGPLRRLVSS
FTTLTQSFASMDRVFQLMDEDYDIKNGIGAQPIEIKQGHIELKNVSFKYNEDESTILKDI
NLNINKGDTVAFVGMSGGGKSTLINLIPRFYDVSEGEILIDDYNVKDFLTGSLRNQIGLV
QQDNILFSDTVRENILLGRPDATAEEVIEAAKMANAHEFIMNLHDGYDTEVGERGVKLSG
GQKQRLSIARIFLNNPPILILDEATSALDLESEAIIQEALDVLSKDRTTLIVAHRLSTIT
HADKIIVMQNGEIVETGTHKELIEKQGAYEHLYSIQNL
>SEQF2892_01573 hypothetical protein
MVKESIPKEGENIKIQSYKHDGNIHRVWSETTILKGTDHVIIGGNDHTLVTESDGRTWIT
REPAIVYFHSEFWFNVICMFREDGIYYYCNLSSPFVCDEEALKYIDYDLDIKVYPNGKYH
LLDEDEYEQHMNQMNYPHDIDVILRRNVDILQQWIEQKKGPFAPDFIKVWKERYKKIRNY
>SEQF2892_01574 Adenine DNA glycosylase
MLNESTFKKNLIKWFNENQREMPWRETSNPYYIWLSEVMLQQTQVKTVIDYYHKFISRFP
TIEDLSQANEDEVLKYWEGLGYYSRARNFHTAVKEVTSEYKGVVPSTPDQFGKLKGVGPY
TQAAVLSIAFNKPLATVDGNVFRVWSRLNNDQRDIKLQSTRKAYEKELQPYVYHHSGTFN
QAMMELGALVCTPKNPLCLFCPVQDNCSAFKEGTVLDLPVKTKNIKKKTIQQHVFLLRNA
KGEYLIEQRQERLLNGMWQFPMFEAPNTLEQLENKLGMSLSIAEEIVFKLKHQFTHMTWD
ISVFSVIETVSLSKKMMEDYKLEWMNLNRRDEYTLPVSMDKIYKHING
>SEQF2892_01575 hypothetical protein
MDTATHIAIGVGLTALASQDPAMANTMAATATTLIAGSLIPDGDTVLKLKNNATYISHHR
GITHSIPFTILWPILITFIIYVLFPGVDTTHIWLWAQLAVFLHVFVDIFNSYGTQALRPL
TNKWIQLSVINTFDPIIFIILCAGIVVWLFGVHPFVVFFPIISILIIYYIIRFKMQSIIK
KQALSQIKAQHNPVKIFVAPTMKFMEWRVAIQTEEHDYVGRAFGRNVVFSDKVKRQKFSP
DTLLWQIKSNKDIRTFLNFSSIYRWQTRKLDDDTTEVRLIDLRYLNKGHYSFAAIAHVDN
DNNIDHSYIGWVFTEEKLQKKLYSK
>SEQF2892_01576 hypothetical protein
MIDNILLYIKLFPSLIKFTKQRIIDTWKRFAILFIAELVLVLIALITLSFIEIEDISKAR
WLYRIVAMITFATMFATIFKSFKEYSQDYLITKSFQSTPLITTVANALIGSSICCILSII
TLLFKPVNFDASFTAFIVFYIMMILFIIFISVTLGLLDIIYKNMTMIFWLAVVINFFIVP
IIFIPSANENLMIQLLKLNPLFYLIDGLATSTIYGVVNMYNISYHIYFILIIVTIGAINF
MLMRYVAHSKYKYSSNIIATKNK
>SEQF2892_01577 Teichoic acids export ATP-binding protein TagH
MGSSIVLKMLNVTHYYRSKKNRKWYLPFGYAAEDIELNNISLHIYQGEALAIIGEPGASK
TLLGRIIAGDIKPDRGKINKSVSTYYGDIKDKHLIHLTVRQYVKEIQRLFSYETTSHSVD
QIIKFAHLDDKSTFNINMLSHSDFAQLILSIARVCRKELIILNHIIEHLDEDFLEKAKQL
SKDYVNDNNSLVFIDNDLEKVEKVSNYVAWISHGQVRMEGSLNQVLPVFKEHEQDRMSIG
NDEEQQNFDLDWKESRSRLPEMSYNFKRVERYRHAKVPDFVVRFWTILIASLICLAIVGA
LVVNNIGRFDVPIIEAQKKVENKDPFEEKLAYGIVLDDSITLNGDSNTKVPKYAFLTITG
ENSKKYRVNIDNQDYVVEKHKLQYFNPAALYESHSFKKLSPYMKSNYSNFVDYYNSHLHK
KHDRVKKTLVPNKDSRYVVGVTQQPVEMLFNDQDKLTGFVFPIINKDELKDKYHINQDLW
IVKSGDGYLIADMKNSKWIYIEL
>SEQF2892_01578 hypothetical protein
MNDKKLSEMSEQELRHEIQTYKEKMRKAEMNGIMNEYDVYQSKVIIAESYLVDRTKVVLG
RMYKLNDGSDQYFKVERLKGVFAWGYRINSKIPEEGLPLALLKI
>SEQF2892_01579 Regulatory protein RecX
MTKITKIEVQKNNKERFNLFLDEVFEMGIDIDTLVRFNLKKGQILEPSDMENIQKYEHYR
LGINMAIQYLSYKKRTEKEVRQHLQQNEISDIAIQQVIDYCYRESYINHEDYAESLKNTM
INTTDKGPEIFRQKLYQVGIEPNIINTYVPIYEEEQSFEAVIEVAKKIMKTKKGPEIKIR
QKVLQSLIQKGYSMDVVQQAIAELNFEQDENILDDLLQKDLEKVYTKQRRKYDGQQLVMK
TIESLMRKGYKYDKIKSKLEESGILDE
>SEQF2892_01580 Monofunctional glycosyltransferase
MKRSQRMNNSPERHSQYRNEPHYNTYYQPVGKPPKKKKNKRIFLRLFIIFVFIFALFIGL
MYYLSSRANVDDLKTIENKSSYVSADNMPDYVKGAFISMEDERFYKHHGFDVKCTTRALF
STIGDRDVQGGSTITQQTVKNYYYDNERSFTRKLKELFVAHKVEQQYSKNEILSFYLNNI
YYGSDQYTIESAANYYFGTTVNKNSDSMSQITVLQSAILASKVNAPSVYDISNMSDNFKN
RIKTNLEKMKQQEYISDSQYQEALSQLNNY
>SEQF2892_01581 Putative cysteine protease YraA
MTKKVAIILSNEFEDIELTSPKEAIEEAGFETEIIGDTANAEVVGKHGEKVTVDVSIADA
KPEDYDGLLIPGGFSPDHLRGDAEGRYGTFAKYFTKNDVPAFAICHGPQILIDTDDLNGR
TLTAVLNVRKDLSNAGANVVDESVVVDKNIVTSRTPDDLDDFNREIVKQLQA
>SEQF2892_01582 hypothetical protein
MNEQQTMEQIKTRLSKFLEDIDHVNPDEVSVEDIDEWIGLLDQLEEKVKQVSN
>SEQF2892_01583 7-carboxy-7-deazaguanine synthase
MWMTNQKKPISISNDPWETYNDIEDYGQLTLSNIEFTTTTLCNMRCSHCAVGYTLQTKDP
DALPMDIIYRRLDEIPQLRTISITGGEPMFSKKSIKNIVKPLLKYAKDRGIYVQMNSNLT
LPQDRYLDIAEYIDVMHISHNWGTIQEFTDVGFGAMKKQPPLKAKLKLYEQMLDNASTLS
SQGMFVSAETMLNQSTLPYLDKIHKEIVNDMKCSRHEVHPMYPADFASQLNVLSLKEMKQ
AIHHLLDIRDENVWMLFGTLPIYPCINDENDQALLQRLRDAKNVTTRNDPDGRSRLNVNV
FSGDVIVTDFGDENGTISNIKTDKLTDVFNKWLTSDLAKSLNCHCEAFHCLGPNVLVKNM
YYPNTDFKQKEIEMHTENIFS
>SEQF2892_01584 hypothetical protein
MKNYNWEYFKSQINKKLSEPETKNIYSQRKIDVEPVFGFMKAILGFTRMSVRGLNKVKRE
LGFVLMALNIRKVVAQRAENNQKIYKKDNFYIISIEIVFFSLIQELYVPDS
>SEQF2892_01585 hypothetical protein
MYKNYNMTQLTLPMETSVLIPTNDISRHVNDIVETIPDNEFDEFRHHRGATSYHPKMMLK
VILYAYTQSVFSGRKIEKMLNDSIRMMWLSQNQKPSYKTINRFRVNPKVDALLESLFIQF
YSQCVKQNLIDDKAIFIDGTKIEANANRYTFVWKKSIQNHESKMNEDSKALYHELVTNKI
IPEIKEDHDNELTKEEIDLIGSHLDKEIEDLNQHINNEKCTKTRKQIRLKRTKIKKYKKQ
INDYFERKYRYEFQKSILKDRNSYSKTDHDATFMRMKEDHMKNGQLKPGYNLQIATNSQF
VLSYNVYQNPTDTRTMIPFLNSIQETYGHLPEYIVADAGYGSESNYKAIIDDFNRTLLIT
YGMFIKDKTKKYKSDIFNTQNWNYDEINDEFICPNNKRLGFKRYAYRHDKYGYKRDFKLY
ECDDCSECPLKNQCMNFNSKTNKK
>SEQF2892_01587 putative acyl-CoA thioester hydrolase
MSNSQGIRKSMSESKSYKAKQVFPQDTNHHHTMFGGSLMANIDEIAAITAMKHANAQVVT
ASTDSVDFLRPIKTGDITSYEAMVSYAGTSSMEVCVQIIIEDVLNKERHLAALSFLTFVA
LDDNGKPVQVPDVYPESKVEKWFYESAPKRVQRRKDRREESKNTIEFLSNAQHIEEL
>SEQF2892_01588 Aminopeptidase PepS
MTSLSYNEKLQQYAELLVKIGMNVQPKQPVFIRSSVDAIDLTRLIVEESYKAGASDVKVN
YSDSKLNRLKFEYESVDYFENQAVKSYEVDERMDYANRGAANLALLSGDPNLLNGIDPEK
LKANQISYSQAFKGYMEGSQKNRFPWVVAAFPSKDWARRVYPDLDEEIALEKFIDEVFDI
VRIDGNDPIENWKKHIENLSVHAKLMQEKNYKALHYQSEGTDLVVGLPKGHIWEDATSYV
NGNQQAFIANLPTEEVFTAPDRNNVNGYVTNKLPLSYNGTIIDGFTLTFKDGQIVDFKAD
KGEDMLRDLINTDEGSKRLGEVALVPDDSPISNRNTIFYNTLFDENASCHLAIGSAYGFN
VEGGTEMTTEEKIASGLNDSNVHVDFMIGSADLTIYGIKQDDTKELVFKNGNWAQ
>SEQF2892_01589 hypothetical protein
MSQNNNETMIADIRKKLNIVNQGLLNPDKFKNANQQDIEEIHNFVMSKDSFSPSEVTAIA
DELGNLRQD
>SEQF2892_01590 Low molecular weight protein-tyrosine-phosphatase PtpA
MVDVAFVCLGNICRSPMAEAIMRQRLIDRNISGVNVYSKGTGKWNLGEPPHEGTQDILNR
HNIPFDGMISELFESSDDFDYIIAMDQSNVDNIQNINPNIKGKLFKLLEFSNMEESDVPD
PYYTNNFEGVYEMVQSSCDNLIDFIVKDANLKEG
>SEQF2892_01591 hypothetical protein
MENKLIPGILIGAIVGGAATLADKSTRNALVQSVKDVKEGNRSRKPSKFNSIKDEVLYWK
DTIEEIRRNNPELEKSIKDAKDTFVERKNNRIGQ
>SEQF2892_01592 hypothetical protein
MSKENKSNSKYLNSIKDEQEKNQDKINVDRTYVEPQEFQSKEPKKDNQVFFVSRLNKPAK
YTKKSNFLSYLIYRIGKDDASGLAAQMTYHFVLAMFPMLIFLLTLLPLFNLDQSQITGLL
SNAPADTSSLIKGVISDVTKNSSGGLLSIGLILAIWSASNGMTAIMNSFNVAYDVEDNRN
GILLKILSVIFTIVLGVVFLVAMALPTMGSVIAHFLFGPLGLDSQVKWIFSLIRVVLPLI
IILILFTILYSVAPNVKTKLKSVLPGAIFTSVIWLLGSFAFGFYISNFGNYSKTYGSIAG
IIILLIWLYLTSFIIIIGAEINAIIHQRHVINGQTPEEAALDHDDNNQNHYNEDTTYEYK
HTATGKDEDYKVDKDPEDKHEEDASLTEKIKDKFTNNDDDNKK
>SEQF2892_01593 Response regulator protein VraR
MTIKVLFVDDHEMVRIGISSYLSTQSDIEIVGEGESGKDAIAKAHELKPDLILMDLLMDD
MDGVEATTQIKKDLPHIKVVMLTSFIEDKEVYRALDAGVDSYILKTTSASDIADAVRKTF
NGESVFEPEVLVKMRNRMKKRAELYEMLTEREMEILLLIAKGYSNQEIASASHITIKTVK
THVSNILSKLEVQDRTQAVIYAFQHNLIQ
>SEQF2892_01594 Sensor protein VraS
MNHYLRAIGSMLILVYSMLTAFLFIDKVFVNIIYFQGMFYTQIFGIPVFLFLNLVIILLC
IIVGSILAYKINQQNQWIKSQIEHAIEGETVGINDQNIELYNETIDLYQTLVPLNQELHR
LRMKTQNLTNENYNMNDVKVKKIIENERQRLARELHDSVSQQLFAASMMLSAIKETKLEA
PLDQQIPVLEKMVQESQLEMRALLLHLRPLGLKDKSLGEGIKDLVIDLQKKVPMKVIHDI
QDFKVPKGIEDHLFRITQEAISNTLRHSNGTKVTVELFNQQDYLLLRIQDNGKGFNVDEK
LEQSYGLKNMRERALEIGATFHIVSLPDSGTRIEVKAPLNREDDNNDD
>SEQF2892_01595 hypothetical protein
MTRKYISTELLIIFTALMIIANFYYIFFEKIGYLFVLLLGCILVYVGYLYFHKVRGLLAF
WIGALLIAFTLLSNKYTIIILFVFLVIVIIRYLIFKFKPLKVIASEDEVTSPQFIKQKWF
GEQRTPVYVYKWEDVQIQHGVGDIHIDMTKAANIKENNTIVVRHILGKIQLVVPLNYNIN
LHMAALYGNAYLNGQSYKVENNHIQVEEKPKEENYNVNVYVSTFIGDVEVIYR
>SEQF2892_01596 hypothetical protein
MNYMDLYLQHFLKVVIKRNINDYKISLDRKLKSIENYIEYLKEKKTQMNKLIDSLTATLE
NKYIDITNTYNIKHAQEINNYEIEGLKRQLDLFEAYCARIEADIHRCSKEKITTQGQCDI
IEQMSVVA
>SEQF2892_01597 High-affinity nickel-transport protein NixA
MINTHRLNWLPYVLIVISLHILGFGLLYLANTNHLLLGMGLLAYTLGLRHAFDADHIAAI
DNTVRKLIQQQRNPLGVGFYFSIGHSTVVFFMAAFLGISIKWAKDALPHFQEIGEIIGTL
VSGTFLILIGILNLMILISLITLFLKFRKDKINDEKLNDLLDTRGFVSRMVGPYFKFISH
SWHVLPLGFLFGLGFDTASEISLLALSSGASQKAISFVGIISLPILFAAGMSLLDTLDGI
LMTSAYNWAFFNPIRKIYYNITITAISIIAALLIGTVELLQILVDKLQLKGSFWEFIENI
QFDNIGYILVILFIISWLISTLIWKFGKVEQRWS
>SEQF2892_01598 Cyclopentanol dehydrogenase
MNKTIALVTGASSGLGFETSLMLAEKGFQVYATMRNLENQMNLKIEATKRNVDLTILELD
VTKLDSIKSAVEFIIQEEGRIDILINNAGAGFNKTTEQATDEEINWQLNLNLMGVIRMTK
AVLPIMRSQREGRVINISSVGGLVGQPFNEIYCAAKFGVEGYTESLASYIQPEFNIKFTI
IEPGGIQSEFMPNIMNHLTQTGGIQEDEYTHLYNSYVSDIKENYGHDASQSTHEVAQVIL
KTIEMKEPPIRTRTSDWSETFTNIKIKLDPDGKQQQKQVYKLLGK
>SEQF2892_01599 Methionine aminopeptidase
MIVKTEEELQALKEIGYICAKVRDTMQEATKPGITTKELDNIAKDLFEEHGAISAPIHDE
NFPGQTCISVNEEVAHGIPGKRIIREGDLVNIDVSALKNGYYADTGISFVVGEASDPLKQ
KVCDVALMAFENAMAKVKPGTKLSNIGKAVHATARQNDLTVIKNLTGHGVGQSLHEAPNH
VMNYYDPKDKTLLKEGVVIAVEPFISSKATFVTEGKNEWAFETRDKSFVAQIEHTVIVTK
DGPLLTTKID
>SEQF2892_01600 hypothetical protein
MDKWYKKIIGARTIKTGLATFLTSLFCLMLDLTPIFAILTAIVTIEPTAKASLKKGYRRL
PATVIGALFAVLFTFIFGDPSALTYTFSALFTILVCTKLNLQVGTTVAVLTSVAMIPGIH
DAYLFNFFSRLLTALIGLVTAGLVNFIVLPPKYYQQIEDNLTQSEYKMYELFSSRCNELL
LGKFDSDHSNDLLNKLMGVINKTETLTGYQKDELRYHKNKEDEWKRLKNISNRSYIDRLL
ATHLSNIIYLPKHIHLVFTPEEKIAIIKISNSVNNIIKSNHFEPHRSSASTLKSSVKRLE
EFDQNQIKSHVIYEILLIYKLLDSRYNDK
>SEQF2892_01601 Cobyric acid synthase
MNELTVYHFMSDKLNLYSDIGNIIALKQRAKKRGIQLNVVEVNQTEGVTLDNCDIFFIGG
GSDREQSIATKELSKIKTTLKDAIEDGMPGLTICGGYQFLGTKYITPDGTELEGLGILDF
YTESRTERLTGDIVIESDTFGTIVGFENHGGRTHHNFGTLGHVTVGYGNNDDDKQEGIHY
KNLLGTYLHGPILPKNHELTDYLLEKACERKGIPFEPKQLDNTEEEAAKRVIIERSSKK
>SEQF2892_01602 UDP-N-acetylmuramoyl-tripeptide--D-alanyl-D-alanine ligase
MRQWTATHLAKLARKASIAAGKKGTDLPGQVARKVDQNILRKLAAQVDDIVFISGTNGKT
TTSNLIGHTLKANHIDIIHNNEGANMAAGITSAFIMQSTKNTKVAVIEIDEGSIPRVLKE
VTPSMMIFTNFFRDQMDRFGEIDIMVNNIAKSISNKGIKLLLNADDPFVSRLKIASDSIV
YYGMKAHAHEFEQSTMNESKYCPNCGKLLVYDYIHYNQIGHYHCSCGFKRELPKYEVSSF
TVSPFLALNINETTFNMKIAGDFNAYNALAAYTVLRELGLNDESIRIGFESYTSDNGRMQ
YFKLDHKEAMINLAKNPAGMNASLLVGEQLVGKKVYVISLNDNAADGRDTSWIYDADFEK
LSEQNIETIIVTGTRAEELQLRLKLAEVNVPIILVKDIYKATAMTMNYEGFTVAIPNYTS
LSPMLEQLNRSFKGGQ
>SEQF2892_01603 Bacterial non-heme ferritin
MLSKDLLEALNDQMNHEYFAAHAYMAMAAYCDDASYEGFANFYIQQAKEERFHGKKIYDY
INDRGEHAEFKSIPAPKTEFKSILETFKDGLAQEQDVTRRFYNLSEIAQKDKDYATISFL
NWFLDEQVEEESTFETHIDYLNRIGDDCNTLYLYEKELAARSFDEE
>SEQF2892_01604 DNA polymerase III PolC-type
MNSFPLYFILRMQHSGKIFIFLAKIKESILERTVLGMENAFIALDFETANGKRTSICSVG
MVKVVNNEIVESFYTLVNPFDYFSQTNIEVHGITPEDVIDAPSFEYVFPYMMQFIDKLPV
VAHNAAFDMNVLHQSLKQLNIETPSMIYFCSYQLAKRTIDAYRYGLKHLMKHYKLDFHGH
HDALNDAKACAMITFRLLKHYDNLQSMLQIYGKNLKDKG
>SEQF2892_01605 DNA polymerase IV
MAERRIIHIDMDYFFAQVEMRDNPTLKGKPVIVGGKASTRGVVSTASYEARKYGVHSAMP
MSQAHKLCPNGYYVRARFDAYREASAVIMSIFKSYTDIVEPMSLDEAYLDITHLVRPDLS
ASKIATFIRRDIFEQTGLTSSAGVSYNKFLAKLASGMNKPNGMKVIDYNNVNDILMNLDI
GDFPGVGKASKKVMHNHDIYTGKDLYDKTEFELIRWFGKRGRGLYLKARGIDHSEVKATR
VRKSVGTERTFSTDVNDDEEILQKIWELSGKTAERLSKLQKSGSTVTVKLKTYQYETFSK
QRSLREAVSRDIDIYNVAYDLYNDLKDPDVPIRLIGVTVGNLEQSTYENMTIYDFIER
>SEQF2892_01606 hypothetical protein
MQKIDFSPNRINLPKFMATQLVVILFMIVFTYKWAFMFTTIHEQTFLANLLYGILGFIVI
LGLHELIHRISFFIFSRGEQPHFKYKKGFLLVHISKKYFNKWQFCTIMLAPMFILTGLLM
FIFSIYAYSSIIIMLSIHIGYCLIDLYLVGITFTNKFEYVHPSDEGLIMYHQRPIQANNE
FE
>SEQF2892_01607 23S rRNA (uracil-C(5))-methyltransferase RlmCD
MWGEIMETINKNEIKQGNVVDLTHEGHGVIKIDRYPIFVPNALIGEVIKYKIIKVKKNFA
IGKLLQVIKPSEQRVEPPCKYYWKCGGCQLQHMTYDAQLAMKQSQVTNLFHRKAQFSNTI
INKTIGMDHPWHYRNKSQLPIGKDRDGKAIIGYYRQRSHDIIDMDSCLIQDDVHQDIMNH
VKQWIIDYDISVYNESTKKGLLRHLVIRTGYYSDDKMVVFVTNGKNFQQASILVEKLKET
FPNITSIKQNINKSHSNVIMGEQSVTLYGKDKIADQLSDTTFKISDQSFYQINSSQTEKL
YQQAIEYAQLTGEETVLDTYCGIGTIGLYMAPVAKHVYGVEVVPSAIKDAQQNATLNGFE
NTTFVCGKAEEVIIKWKQQGIKPDVVMVDPPRKGCDETFLQTLLKLNPKRIVYISCNPST
QQRDAQILDSQYELQEITPVDMFPQTTHVETVALFERKS
>SEQF2892_01608 Diacylglycerol kinase
MRKCARIIYNPTSGKELFKRTLPDVLIKLERAGYETSAYATEREGDATLEAERALKRDYD
IIIAAGGDGTLNEVVNGIAEQPNRPKLGIIPMGTVNDFGRALHLPSDIMGAVDVIIDDHT
TKVDIGKMNNRYFINLAAGGQLTQVSYETPSRLKSIVGPFAYYIKGFEMLPQMKAVDLRI
EYDNQVFQGEALLFLLGLTNSMAGFEKLVPDAKLDDGHFTLIIVEKANLAELGHIMTLAS
RGEHIKHPKVIYEKAKSINISSFTEMQLNVDGEYGGKLPANFLNLKRHIEVCTPKDIYNE
ELTEDQQVEDGIIEEKPSNEEIIKNNEISE
>SEQF2892_01609 Aspartyl/glutamyl-tRNA(Asn/Gln) amidotransferase subunit B
MHFETVIGLEVHVELKTDSKMFSPSPAHFGAEPNSNTNVIDLAYPGVLPVVNRRAVDWAM
RASMALNMDIATNSKFDRKNYFYPDNPKAYQISQFDQPIGENGYIDIEVDGETKRIGITR
LHMEEDAGKSTHKDGYSLVDLNRQGTPLIEIVSEPDIRSPKEAYAYLEKLRSIIQYTGVS
DCKMEEGSLRCDANISLRPYGQEEFGTKTELKNLNSFNYVRKGLEYEEKRQEEELLNGGT
IGQETRRFDESTGKTILMRVKEGSDDYRYFPEPDIVPLYVDEEWKERVRQTIPELPDERK
AKYVNDLGLPEYDAHVLTLTKEMSDFFEGAIEKGADVKLTSNWLMGGVNEYLNKNQVDLQ
DTKLTPENLAGMIKLIEDGTMSSKIAKKVFPELAENGGDAKQIMEDKGLVQISDEATLTK
FITEALDNNPQSVEDYKNGKGKAMGFLVGQIMKASKGQANPQKVNQILKQELDKR
>SEQF2892_01610 Glutamyl-tRNA(Gln) amidotransferase subunit A
MSIRYESVEKLSEMIKNNEIKPSEIVKDIYDAIEETDPTIKSFLALDKDNAIKKAKELDE
LQAKGQMEGKLFGIPMGIKDNIITKDVETTCASKMLEGFVPIYESTVMNKLHDENAILIG
KLNMDEFAMGGSTETSYFKQTVNPFDHTAVPGGSSGGSAAAVAAGLVPFSLGSDTGGSIR
QPAAYCGVVGMKPTYGRVSRFGLVAFASSLDQIGPITRNVKDNAIVLETISGVDKNDSTS
APVEDVDFTSEIGKDIKGLKVALPKEYLGEGINEDVKEAVKNAVETLKSLGAEVDEVSLP
NTKYGIPSYYVIASSEASANLARFDGIRYGYHSKEAQSLEELYKMSRSEGFGAEVKRRIF
LGTFALSSGYYDAYYKKSQKVRTLIKNDFDKVFENYDVVVGPTAPTTAFNLGDEIDDPLT
MYANDLLTTPVNLAGLPGISVPCGQSNGRPIGLQFIGKPFDEKTLYRVAYQYETQFNLHD
AYEKL
>SEQF2892_01611 Aspartyl/glutamyl-tRNA(Asn/Gln) amidotransferase subunit C
MTKVTREEVEHIAHLARLQISEEETEEMANTLESILDFAKQNDTADTEGIEPTYHVLDLQ
NVLRDDEAIEGIPQELALKNAKETENGQFKVPAIMNEEEA
>SEQF2892_01612 Sodium/proline symporter
MLILGASLPSQVNTNWQTYIMIAIYFIILLIIGYYGYKQATGNLSEYMLGGRSIGPYITA
LSAGASDMSGWMIMGLPGSVYSTGLSAIWITIGLTLGAYVNYLVVAPRLRVYTEVAGDAI
TLPDFFKNRLNDKENIIKIISGLIIVVFFTLYTHSGFVSGGKLFESAFGLNYHFGLILVA
VIVIAYTFFGGYLAVSITDFFQGVIMLIAMVMVPIVAMLQLNGWDTFSRVAEMKPTNMDL
FRGTTFLGIVSLFAWGLGYFGQPHIIVRFMSIKSQKMLPKARRLGISWMTVGLLGAVGVG
LTGIAFIPDNHIKMDDPETLFIIMSQILFHPLVGGFLLAAILAAIMSTISSQLLVTSSSL
TEDFYKLIRGEERVKTHQKEFVLVGRLSVLVVAIVAIAIAWSPNDTILNLVGNAWAGFGA
SFSPLVLFSLYWKKLTRAGAISGMVAGALVVIIWIAWIKPLASINEIFGMYEIIPGFIIS
VIVTYVVSLLTQHPGDFVERDIEKVKSIVREK
>SEQF2892_01613 hypothetical protein
MKRTLFLIITSIVLLTACGNNNDNKNNQSVNKQETKTDSNNVKTIATDKNVQGDNYRTIL
PFKESKARGVLQDNMANSYNGDDFESGLLTLSKDVFPTDDYLYQDGQYLDKDTLNSYLNP
KYTKKEIDKMSEKEKESNKASENLGLNPSHKGEDDPEKIAEQSPAYLSNILEQDFYDSGD
TKGKNIRGMTIGLAMNSVYYYQKEKDGETYSKELDDKEIEKQGKQMASEILTRLRANDDL
KDIPIHFAIYKQSDQNSITPGEFIANTTVDDDQTKINKWKKIDQVLALLPSSTAKKYNEN
LNNNFKQFNDNLQSYFTNFTQAVGKVKFDGKKPTQLTIDLPIDYYSQAETIGITQYVTEQ
ARKYFDNIDSYEIRIKDGNTPRALISKSKEDKEPQVHIYNN
>SEQF2892_01614 DNA ligase
MGNIKSRVNELHDLLNQYGYEYYVQDNPSVPDSEYDKLLRELIDIEEAHPEFKSPDSPTV
RVGGEVQSSFEKVNHDTPMLSLGNAFNEQELRRFDQRIREQVGSVEYMCELKIDGLAVSL
KYVEGRFVQGLTRGDGTTGEDITENLRTIHAIPLKINEPLSFEVRGEAYMPRSSFIRLNE
EKEKNEEQPFANPRNAAAGSLRQLDPKLAAKRKLSVFLYSVNDFTDFDATTQSGALDELD
RLGFKTNHERMRVGDIEGVLEYIEKWTKQREQLSYDIDGIVIKVNDIEQQDEMGYTQKSP
RWAIAYKFPAEEVVTTLQDIELSIGRTGVVTPTAILDPVRVAGTTVSRASLHNEDLIHER
DIRIGDSVVVKKAGDIIPEVVKSITERRPEGTLPYSMPTHCPSCDHELVRIEGEVALRCI
NPKCQAQLVEGLIHFVSRQAMNIDGLGTKIIQQLYHHNVINDVADIFYLTEDDLLPLERM
GSKKVENLLKAIEDAKANSLEHLLFGLGIRHLGVKASQVLAEKYETMDRLLEVTEEELIS
IHDIGDKLAQSVVTYLENEDIKALIEKLKYKNVNMVYNGIKTSDIEGHPDFKNKTIVLTG
KLQQLTRKEASAWLELQGAKVTSSVTKKTDLVIAGEDAGSKLTKAEKFGTEIWTEEQFVA
KQNEISS
>SEQF2892_01615 ATP-dependent DNA helicase PcrA
MNSLVNNMNKEQSEAVRTTEGPLLIMAGAGSGKTRVLTHRIAYLLDEKDVSPYNILAITF
TNKAAKEMKERVEQLVGEEAQVIWMSTFHSMCVRILRRDADRIGIERNFTIIDPTDQKSV
IKDVLKNENIDSKRFEPRMFIGAISNLKNELKTPDDAINEANDFHSQMVATVYSGYQRQL
TRNEALDFDDLIMKTIQLFERIPDALEYYQNKFQYIHVDEYQDTNKAQYTLVKLLASKFK
NLCVVGDSDQSIYGWRGADIQNILSFEEDYPDAKTIFLEQNYRSTKTILTAANEVIKHNS
ERKPKGLWTANTGGEKIKYYEAMTERDEAEYVVREIMKHRKAGKDYSDMAILYRTNAQSR
VLEETFMKSNLPYTMVGGQKFYDRKEIKDLLSYLRVVANSNDEISLQRIINVPKRGIGPS
SVEKIQRYANDNNISMFDALAEVDFIGLSKKVTQECIKFYELIQNLIKEQEFLEVSEIVV
EILDKSGYRDMLEREQTLESRSRLENIDEFMSVPKDYEENTPLEEQSLINFLTDLSLVAD
IDEAQIESGVTLMTMHSAKGLEFPIVFLMGMEESLFPHIRAIKSDDDHEMEEERRICYVA
ITRAEEVLYITHATSRMLYGRSQSNMPSRFLREIPEDLLETPSKQQRQTITPKTSTKQPK
RGFSKRTTSSKKQVSASDWKIGDKVTHKSWGEGMVSNVNEKNGSVELDIIFKSEGPKRLL
AQFAPIEKKED
>SEQF2892_01616 Heptaprenylglyceryl phosphate synthase
MYDIKAWQHVFKLDPAKEISDNDLDALCMSDTDAIMIGGTDNVTEDNVIHLMSRVRRYPL
PLVLEISNIESIIPGFDFYFVPTVLNSQDTTYHNGMMHKALKQFGFMVNFDEVVLEGYLV
LNPDSKVAKLTQSNTNIDIEDVEAYAQMVNEMYKLPLMYIEYSGQYGDVEKVEAASRLLT
NTQLFYGGGITSIEQAREMAQYADTIVVGNIIYDDIKKAIKTVKIKKESNK
>SEQF2892_01617 hypothetical protein
MQIEKLRGQALDELFDAILTLENREECYQFFDDLCTVNELQSLSQRLQVAKMIKQGYTYA
TIEKESGASTATISRVKRSLQWGNDAYTMILERLNIETKK
>SEQF2892_01618 Adenylosuccinate lyase
MIDRYSREEMANIWTDQNRYEAWLEVEILACEAWSELGHIPKEDVKKIRQNAKVDVKRAQ
EIEQETRHDVVAFTRQVSETLGDERKWVHYGLTSTDVVDTALSYVIKQANEIIEKDIERF
IKVLEEKAKNYKYTLMMGRTHGVHAEPTTFGVKMALWYTEMKRNLKRFKEVRKEIEVGKM
SGAVGTFANIPPEIEQYVCDHLGIDTAPVSTQTLQRDRHAYYIATLALVATSLEKFAVEI
RNLQKTETREVEEAFAKGQKGSSAMPHKRNPIGSENITGISRVIRGYITTAYENVPLWHE
RDISHSSAERIMLPDVTIALDYALNRFTNIVDRLTVFEDNMRNNIDKTFGLIFSQRVLLA
LINKGMVREEAYDRVQPKAMESWETKTPFRQLIEKDESITNVLSKEELDECFNPEHHLNQ
VDTIFKRAGLE
>SEQF2892_01619 hypothetical protein
MKFKVNENETISECLTRMREEGYMPVKRIEKPIYTEDEKGNVVVLRQDIQFVGKKL
>SEQF2892_01620 hypothetical protein
MSVITSNPWSMVLAIFVINVFYVTFLTMRTILTLKGYRYMAAAVSFLEVLVYVVGLGMVM
SSLDQIQNIFAYAFGFSIGILVGMKIEEKLALGYTVVNVTSSEYEIDLPNELRNLGYGVT
HYAAHGRDGSRMVMQILTPRRYERKLMETVRNLDEKAFIIAYEPRAIHGGFWTKGVRTRK
VKAYEVEEIESVVEHDDEVQSK
>SEQF2892_01621 NH(3)-dependent NAD(+) synthetase
MTNLQDIVVNEMKVKKHIDSEQESREIIQFIKSYVQSHSFIKSLVLGISGGQDSTLTGKL
AQLAVEELRNEGRDCQFIAVKLPYGVQKDAEEVEDALNFIHPDEIITVNIKPAVDQSVKS
LNEAGIELTDFQCGNEKARERMKVQFSIASNRSGIVIGTDHSAENITGFYTKYGDGAADI
APIFGLNKRQGRQLLKYLNAPKHLYEKVPTADLEDDKPQLPDEEALGVTYDQIDDYLEGK
HISSEARDTIENHYVKNAHKRELAYTRYTWPKN
>SEQF2892_01622 Nicotinate phosphoribosyltransferase pncB2
MVYRYEDDSLMLHNDLYQINMAESYWNDGIHERNAVFDLYFRSMPFESGYAVFNGLKRVI
QFIEHFHFSDSDIEYLQSIGYKNDFLNYLKNLKFTGNIRSMQEGELCFGNEPLLRVEAPL
IQAQLIETVLLNIINFHTLISTKASRIRQVAPDDTLMEFGTRRAQELDAALWGARAAYIG
GFDSTSNVRSGKLFGIPVSGTHAHALVQTYGDEYKAFKIYAERHKNCVFLVDTFHTLKSG
VPTAIKVAKELGDKINFIGIRLDSGDIAYLSKEARRMLDEAGFKDAKIIASNDLDEQTIM
SLKSQGAKVDSWGVGTKLITGYDQPALGAVYKLVAVVDDNGRYVDRIKLSNNAEKVTTPG
KKKVYRIINTKTGKAEGDYITLEHENPNNEKPLKMFHPVHTYKMKHIKHFEAIDLHHSIF
ENGKLVYQLPSEKEAQEYSKKALSKLWDENKRYLNPQEYPVDLSTACWDNKHKRIFEVAE
HVKEMEEDND
>SEQF2892_01623 Nitric oxide synthase oxygenase
MLLEEARSFIETMYRELNYNPSIFDKRIKEIEKEIEHTGTYTHTLEELSYGAKLAWRNSN
RCIGRLFWDSLNVEDARNVDNERDFIDTINHHLEHATNNGKIKPYITIFSPNQAPRIYNN
QLIRYAGYEHAGDPSEREITQLAEHLGWKGKGTDFDVLPLIYQLPNDSIKWFELPHELIK
EVEIEHEHYPKLKDLNLKWYGVPIISNMDLKIGGITYPTAPFNGWYMVTEIAVRNFTDSY
RYNLLESIAEAFEFGTLKNNSFNKDRTLVELNYAVYHSFKSQGVSIVDHLTASKQFQLFE
EKELANNRDVTGKWSWLAPPLSPTLTSNYHHGYNNEIKDPNFHYKKKQSMKCPFH
>SEQF2892_01624 P-protein
MRLYYLGPKGTFSYLAAKTYLSEEEVTYSPKSNLYEVIKAVNSHSDAVGIVPIENSIKGT
INIVADALAQEDIYAHGEIHLDINFGLYANKGTSLDDIKKVYSIAPAISQTSQYIHRHHF
LYDYVDSTIQSLEKIDTHVAAIAPLGSGESYGFEPIDTHIQDYPHNVTRFLVVKSNEHYN
ESASSTLLLITPKHDKAGLLASILNTFALFDINLSWIESRPLKTQLGMYRFFVQTDIGKN
EKLNKVITILQTLDFEVKIIGAFNHH
>SEQF2892_01625 Plasmin and fibronectin-binding protein A
MLINAQDYGLKGCNKRKDTKAIQRALNKARYGEHTVLIPSGTYYISKALIIYDSTTLLLE
DDTTLLRCGKDALLKNGHRFGFYKGYQGNSHIYIKGGTFDMNGSKYPYNNTAMSIGHAED
IQLIGVTVLNVVGGHALDACGINGLYIKNCNFKGFNDFDGDRSFSEAIQLDIQVPGAFPK
FGTTDGTITKNVVIENCYFGNSDDHQMRPWNRAIGSHASRYNKFYENVHIKDNCFEGTED
YALTPLKAKNMIISRNKFKNCKGGIRFLGVKDGKNAADPVTGKVMEPQAGENFSVIGNHF
IGEMKKDAIHIRSYNNVKHQQVFIAGNTFDKASQTIHLEDIEDLTLNQGEDVTIKKINVD
>SEQF2892_01626 Isochorismatase family protein YecD
MTRKALIVVDYSYDFIADDGRLTCGKPGQDIESFILKRLETYQSEGQDIFFMMDLHYEND
MFHPETKLFPPHNIEGTAGRELYGKIKAFYNNISGNSNIHYLNKRRYDSFYGTPLDSLLR
ERNIKDIEIVGVCTDICILHTAVSAYNLGYNITIPKDGVASFNESGHKWALGHFVNSLGA
EVDVAK
>SEQF2892_01627 putative manganese-dependent inorganic pyrophosphatase
MAKTYIFGHQNPDTDAIASAIIMADFEQLTGNSEATPYRLGDINPETKFALDHFEVKAPE
LLSDNLDGQEVILVDHNEFQQSAETISDAEIKHVVDHHRIANFETASPLWYRAEPVGCTA
TILYKMYKERGFEIKPHIAGLMISAIISDSLLFKSPTCTDEDVNAAKDLKDLANVDLDEY
GLEMLKAGASTTDKSAEELLDMDAKSFNMGDYVTRIAQVNTVDIDEVLNRKEDLEKAMLE
TSANEKYDLFVLVVTDIINSDSKILVVGAEKDKVGEAFKVQLDDGMAFLSGVVSRKKQVV
PQITDALIK
>SEQF2892_01628 Aldehyde dehydrogenase
MPSIEQQFEESKAFFKTHKTKDLKFRKHQLKLLSKSIKNHENDLLDALKTDLGKSPVEAY
ATEIGITLKSIKTARKELKNWSKTKQVDTPLFMFPAKSYIKQEPYGTVLIIGPFNYPVQL
LFEPLIGAIAAGNTAIIKPSELTPHVATVIRQIIEDVFTTDYIGVIEGGIEETQTLINLP
FDYIFFTGSDKVGQIVYEAASKNLVPVTLELGGKSPVIVDDTANIKVASDRISFGKFTNA
GQTCVAPDYILVNKKVKNELIEALKQSIQEFYGTNIEESPDFGRIVNDKHFNRLNELLNV
HQNHVIFGGNANATTRYIEPTILDSITSSSKIMQDEIFGPILPIITYDDFNEAVDIIQSK
AKPLSLYLFSEDENTTHRVLNELSFGGGAINDTLMHLANPNLPFGGVGMSGIGQYHGKYT
FQTFSHSKSYIFRSTRLDSSVMYPPYKGKFKYIRTFFKNL
>SEQF2892_01629 6-phosphogluconolactonase
MTTKGYIGSYTKKEGKGIYLFELNEDSGQISSVNTGYEIEASTYLAQTDDYLYAITKEGE
HCGVAAFKKEASGSLTLINKCLESVEGTGCYISVSSDHNFLFEAVYGAGIARIYQLNKDT
GEIIKLIQELNHDYPLGSHERQEHSHVHYINETPDCKYVVATDLGTDRVVTYEFSNEGLK
EYKVSKFKDQDGPRHIAFHNNGEYAYIVHELSNYVSVAKYKDGQFEELERHLTVPEDFND
DTKLAAVRLSHDQQTLYISNRGHDSIAVFTITENGAGLNPVEIVKSGDQFPRDFNITESD
DYLVCAHQEGNYEITVFKRDTNTGKLTPTDNQQIAPEGVHVSFI
>SEQF2892_01630 hypothetical protein
MWDLIKGLFKFLLSLVVITSVVVGVGVVAFAYIFKKDFEDIERKTKEIVSDIESNNA
>SEQF2892_01631 hypothetical protein
MQQVKSDIMTFRGSHYDLGVITALWLKQTPLLQNREREWKKRMPRFDIDVNETYQVFQTY
APEIWEELMGMQEVLNLPTKQMILNFAHYRFTDLKESGCTVFQGKDFMVRNYDYHPATYD
GRYLLFQPNDGGLAQIGPTSRVTGRMDGMNEAGLTMGYNFMHRKHPANGFVCYMIGRLVL
EYCKDVDEAVRFLKELPHRSSFSYILMDRKLNHAIVEVTPRSFDVRYDKVCTNHFEILTH
ENRNYTKESRERLERTVSQTSQSLDKHTAFKLFNDPKFEIYSKLFKSWSGTIHTSMYEPQ
NLTAWMTLGENQSPTSINFQSWLDGNELTIQQFNGLIDTDLTFANY
>SEQF2892_01632 hypothetical protein
MKKAMITGIVIFVGFFLAATLVWFVHDKDEYKKLKYDRAYSNVKMNNLNIDSYNSELTIK
QGEHCGVKYYGDNDVKVYRTKDTLYIKEHKSDKRGYSVNINPFNQSKSKIEVTLPNKNIN
NLDVYSGFGNVNLDGINAKKGSIYQDNKYLKIQNSKFDNLSFKSDAGGVKIKNSDIFNSE
FKTGVGNVEVNNSKLKKSLFVSEFGYLNFTNMNSETDVKGSSKLDYIHLDYKDEPKNTLL
KLHPGTGEAKVENKAFNKGKVGNSNNVIEFYTVKEDITIK
>SEQF2892_01633 hypothetical protein
MDKITFLNELELELDELPRKEKDKLMDDYENHFYEQESKGKSEKDIISDLREPHDIGIEV
KAKEAISYAKVTPNLRNIIRAIMASLSLGVLSFFFIIIPIVIFIALLIVVFIFSVFLISL
PLIIISMSIIKGIVDSFSNFLFSISYAGLGIVLFVVTMKITQNLYRLVLKYLTWYIQTVK
GRIKQ
>SEQF2892_01634 hypothetical protein
MRIQNRWIIFSIFTIIAFIVVTCLTIYKNEKTINLTEVKINDIQLNEPFNENDYEINHHI
KLDRYKFYNDKKHKDLTVKVKNKHQTVKGIVLINDHDVTTNFGVKIGDRVDHAINYLGDN
YRKDKVGKGYDALIYVDKEHHMKLSILYKDNVVKRIEFFSR
>SEQF2892_01635 hypothetical protein
MANLETYFNNSQPLDEYIDSMTVNKDNVLTIYNAFTLPSSDDRINQLKDSSYSKVLVISE
DWCGDAMMNLPILKRISESLQLEVRVFHRDEDTNLIDQYLTNGTARSIPIFIFMNDQFEQ
VSVWGPRAREAQEFVTQLRAEKLPPKDAHNYEDKEKEVHHEITSKYKSDTDLWNQVYDSI
ISKLML
>SEQF2892_01636 hypothetical protein
MRSLQLVKYDILSFCKSYLTYIALILIWLVLGLITFLMARNNDQVNYSSILSMANWMFLF
FGLLVVIKTITRDYSQGTIQLYMNKVKNRIGYIIAKTISIILFSFIFAFITYITLMLVQA
FTEGKNLDGDKFLTNIWFYLIFLLFFGLLLFLVTLIVQKPAVIFTLGIFLVFIVPFIQPF
IGLIPDWGEKIQKSLKYIPFSYLTEKSQTDSIKFSNWQWFISLASIVILFIANIAYAAKR
DI
>SEQF2892_01637 putative ABC transporter ATP-binding protein YxlF
MKLENITKTYGDNNVLDNINFDFGNSKIVGLIGKNGVGKTTLMKVMNGNIINFKGKVQLN
DNENVGYLIEHPKLYDNKTGLNNLKLFAQVLGKGFDKEYTDKIIDAFGMRPYIKKKVKKY
SMGMKQKLAIAVSLMNKPKYLILDEPTNGMDPDGSIDVLETIQSLVNDLEMKILISSHKL
EDIELICDRAVFLRDGNFVQDVNMKDGSAQDHTSIKFEVSEFNTALDYLTEHFNVLQSHK
DSGEIMIKAQKDYKQLLKSLAQKDLYPKYIETRKSSLRDTYFNINQRGDK
>SEQF2892_01638 hypothetical protein
MKQLLIRNFKCRSITIAIYILLLLLNPLYAFVFSKTELYFLFYAPIAITLMAVSILDSGH
LFRLHRRLGGKSSYLFYESLPVSKKDMLNANYITCIVLTLFGGFIIALYNFQSSNIDFGD
LRYSTAIAFIFVNFLSIPIAFSRNTEKKREGISYAPYILIMMLVIPFAITIVFTLINAFV
FHHHISYNIFGIYYNYGLLSLSIVWMILNYLIQLKRIIQRENKGGPI
>SEQF2892_01639 ABC transporter ATP-binding protein NatA
MNVIEVKDVSFQSSAFSINNLSFSIPQGFVTGFIGANGAGKTTIIRMIMDIIEPKQGHIS
IFGEKIANKPKWIKNKIGFVYSEVYFNQQWTAKKLEKMVSPFYTDWDSQAFKNYLEKFNL
PFDEKIKHFSTGMKMKLSLALALSHHAELFILDEPTAGLDPIVRNEVLEILQSELLDEHK
TLFISTHIISDLEKIADYLVHIKDGEVIMQGFRHQLQEQYSIVQGDNQDLDEELNRLFLY
KEVKSTGFVGFTKQAQVFKELFGKKVNIKQPTIEELMIYIEKSKSNDNQIDFQQSRLIK
>SEQF2892_01640 HTH-type transcriptional repressor YtrA
MKIILKNTSEQPIYEQIKQQIKENILKGYVEAGSHLPSMRELAKDLQVSLITTKRAYEDL
EKEGFVTTVRGKGTFVKEQDSSILKEKQFFVIENLARLMIKEAKTIDMPLKELKEILALI
YEEEEE
>SEQF2892_01641 hypothetical protein
MMKHLTKIFVSLAIILFVIGYYLQATGHENQGVKLLLAAIMFIICAFINRNNDRKKNRK
>SEQF2892_01642 hypothetical protein
MSWLLDGMVTLISGGILVIFRVWLESKWKDK
>SEQF2892_01643 Aromatic-amino-acid aminotransferase
MNPLAQNLNNQLVDHCPEILSMLSNLGQSMYYPKGILSQSADAKKTKYNATIGMATNKNG
KMYADTLFDVYNHLSPDEVFPYAPPQGLEALRDLWQDKMLKENPDLSKETITRPIVTNAL
THGLSLIADLFVESGDTVLVPTHNWGNYKLIYETRHSANIETYSIFNQEGHYTTNDLVTT
LENFNQDKVILILNYPNNPTGYTPNNDEVTTIVSAVRSLAEKGTKFIAVVDDAYYGLFYE
DVYRQSIFTALNQIESSNILPIRLDGATKEFFAWGLRVGFLTFGLNNNVAKEVLEAKVKG
LIRSNISSGPMPSQSAIKYVLENHDEFDKEIQQNIDTLQERYEVTKSVVYDDKYKNHWQA
YDFNSGYFMAVKVNGVNPEELRTHLINEYSIGIIALNDSDIRIAFSCIEKDDIPHVFESI
AKAIDDLK
>SEQF2892_01644 hypothetical protein
MQTYSNKDDLIFEISKRAELFINEFSDVSESDKDVYKIGVNRTPAQMIAYQLGWLNLIQS
WENDNKNNIPVVTPSPDYKWNNLGGLYQEFYKTYSNYTLEQLINQFNKEVDSIIDLIKSL
DNETLFESGKRQ
>SEQF2892_01645 hypothetical protein
MFENILASIGINSVKVETLVKNKSIHSNDTLEGIVRIEGGSSAQTINKISLTLVERYENP
DKNSQFPVLENELQTFTLHTNVELKEHQTITEEFKFNIYEYEFKSEPKHLILKTHAYVGY
SVDAYDEDKIVFK
>SEQF2892_01646 hypothetical protein
MKKFLALIFASTLILGACGTKDVEESAKKRKDPKTEVDDKGRVKGEKIEKELK
>SEQF2892_01647 hypothetical protein
MKRVLFLIFSSLLILGACGQVGDNSIKNDNKKSNAPKRNKDSDAKSENQSSKKQSRTYTA
QQYNALVDDYNTMINKPESKSKVSNSVSQSKYNTLLKEYNALVDEAYEENGY
>SEQF2892_01648 hypothetical protein
MIILNCKIKLNEIVYEVKTNKNNCFTYSLPKDITSYKVRKVLKIIESKVDEDED
>SEQF2892_01649 hypothetical protein
MEEKFNNEQEERQFRQFQEYQKQQEEEKKKKRKKSWLFGWGGCLVLLILIIIGVTACTGS
FVNEVDKEINEEGKLDKDKDTKIKSVGETTEIDGVSFTLDSASYTDERNEFAEVQADKVL
KVDMTIKNNSKEEVPVGGDVKVYVDGKQAKSYPITDGLMDSLSPNREISGSEGFAINGNP
EKIELEFQPLTSFSNKRYIYDVKPE
>SEQF2892_01650 hypothetical protein
MFKTLKKMKIKDDIEFKQFSNEVDYCYRKFSEENDKRMKDLNNQRKLDNKNKQQSSLWAN
AIKNGKF
>SEQF2892_01651 hypothetical protein
MKHYLYTDKEFIYSYLSQHGKGLNLSYSQMNKNTSTESESKSTANTKSKDKIDGNSTGEF
GLEISAGIAKGSFSDGTNYKLKINKNSLRETLNFIDSKSEAQSELYKIELHDYLYEIFEN
TAMGKGDKISLYPDKKLTIAELDGNHFKFLEQLMDIYIKSETSSFIGIDKNTREEFTGMK
KDLKPLEKMSAIIDKLVPGDYKIILDHDKQSLIGSLYKENLNVPFKELKYFYAQSKLNVV
GIKASKIEFNKFEYENVFEVIQLDVSLQGPLLNELLPNESIYYFKPILIYSNI
>SEQF2892_01652 hypothetical protein
MYSELTYLKNEEKYRNLFEREYCQKEIITCHNIVVKFYARHFDHAFFSRSNRRSNKKDVF
DSNRAQRILWIKQVLQDNNIPIYQGHNSKTKKSDKSRRVSLLTPDGYVVVIRMTGEDKAE
FLTAFVINDSAVIGKIRSNPLIYDPT
>SEQF2892_01653 hypothetical protein
MVSRNLEVYCDESSLENLFKDNKSGYIVIGGIWLDKKDHKIVKKEIDHLKRKHSIGGEFK
WNKVSYSRKQFYFEILDYFFGNRKIRFRCIVVNTKKVNTEKYHNSDNELGFYKFYFNLLD
KWCMSNDNYYIYLDYKSNKDNNRLPKLKEILNYVSEGEIIDVLPIRSEESVFIQLADLLS
GVVSFHFNNNDVKDNTKYEFKKRLEEHIGESIKSNPSSEKKFNVFQIRLNENV
>SEQF2892_01654 Transposase from transposon Tn916
MASYDQISKNNWRYRISLGKNAETGKYEYISKTGFKRKSDAKHQAEMIGRQLRNGDYIAP
SSSTFKQVADDWLKQYANDVKVSSVRAREKAIQHAIERFNTKPIQTIKKHDYQRFVDDIS
AQYSKNYVDSIVASTNMIFKYAYDTRLIKAMPSEGIKRPKKKVSVEELEDIEIHKKFLEK
DELFQFLKVAKYHHSPQNSFEVFTTLAYTGMRAGELLALKWSDIDFENNTISITKTYYNP
NNNKKHYQILTRKTESSIGKITVDPHVIQLLKDYKVNVQDTWKNELYVDNNFVFTDVNGY
PLVIKKLQLWIKAILKKTDITNKQISTHSFRYTHYALLIEAGVHIKEIQERLRHKDINTT
MNIYAKITNSYKKDASQKFSKLMENVSKGLF
>SEQF2892_01655 60 kDa chaperonin
MAKDLKFSEDARQAMLRGVDKLANAVKVTIGPKGRNVVLDKEYVAPLITNDGVTIAKEIE
LEDPYENMGAKLVQEVANKTNEIAGDGTTTATVLAQAMIQEGLKNVTSGANPVGLREGID
KAVRVAVQALHDISQKVENKNEIAQVGAISAADEEIGKYISEAMDKVGNDGVITIEESNG
LDTELEVVEGMQFDRGYQSPYMVTDSDKMIAELERPYILVTDKKISSFQDILPLLEQVVQ
SSRPILIVADEVEGDALTNIVLNRMRGTFTAVAVKAPGFGDRRKAMLEDLAILTGATVIT
DDLGLELKDASIDMLGSANKVEVTKDNTTVVDGDGDDNSIDARVSQIKAQIEETDSDFDR
EKLQERLAKLAGGVAVIKVGAASETELKERKLRIEDALNSTRAAVEEGIVAGGGTALVNI
YNKVDEIEAEGDVATGVNIVLKALSAPVRQIAENAGLEGSVIVERLKHADAGVGFNAATN
EWVNMLEEGIVDPTKVTRSALQHAASVAAMFLTTEAVVATIPEPDNNDNPGMGGMPGMM
>SEQF2892_01656 10 kDa chaperonin
MLKPLGNRVIIERKEQEQTTKSGIVLTDSAKEKSNEGIVVAVGTGRVLDNGEKVAPEVKE
GDRVVFQEYAGSEVKRGDETYLILNVEDLLAIIED
>SEQF2892_01657 hypothetical protein
MKRIWVAFLTIVIYALAQFLPLLAQQLPFFKDLKGMELAKAGVYTQVILFVIAALLIIWL
NSIIKNPTALERGYKEPKRYILPWALLGFVVVMIYQMVASLITMWLVGQPQQSPNTERIM
AIAKQLPVFILLISIVGPILEEYIFRKVIFGEIYNKIKGNRIVAFLIASIVSSILFAIAH
NDIKFFFIYFGMGMLFSLAYVLTRRIAVPIIIHMLQNGFVVAVQFFFGDTVKHLQEQSNF
IIHFLF
>SEQF2892_01658 hypothetical protein
MKKKIAHTGLILAIGTSMLGHESIVKAAESNQQATNEVDSSNVSSDADTQERQNSSNDIN
ENHQSDTQDSTELGKNNNNQNSGESNSSSNNENDANENSDNTVDQSDSSDNSNSGSNTDL
NNGDDTNNSGDNDTSNPDNGEQPGDNDSSSNPDDGEQPGDNDSGNPDDGEQPGDNDSSSN
PDDGEQPGDNDSGKPDDGEQPGDNDSSSNPDGGEQPGDNDSGKPDNGNNPGNNDSGEQDD
GGNKLGDSGNHQQPPKHDGNSRSNQGDHHSNSGSNGSNNGSQNNSNSNSNNNSNYPGNHS
GHSSTNDTVKPNKPVFNNNNGSTNGNHSTGSNHHNNSVSDSIIHQIYPHKNNGNSTSHSN
RNQNQSIMSGSNTNQWHYGDNLQQNHRQSHIETYSNNDNMQSEVPFYSKSMLLNRLNSLA
TGSYKYNPYIINQVNRLGNNNEYISNQDFYRLFRKQSFNNEYLDYLQKGSNYFRFEYFNP
LNSKKYYKNLDEQVLALITGEIGSMPELKKPSDREKKEDADFQSHDDDKIIDTNEKSKEA
ENKAKYKNINIALITSIIMIFVGVTGRFIYRKIKN
>SEQF2892_01659 hypothetical protein
MGLFSKSKTKPFLQEIEDRRTIYSTETTISISDKELEDMIEHIIKYTPSAFNSQSTRIVL
LLNDQHHKFWDNTKTVLKDVMGPDRDFTPTEQRIDGFKHAYGTILYFEDEDVIKGLQEQM
PNYADNFANWSVQTNAMHQFAIWTALSSKGIGASLQHYNPLVDQITTQEFDIPASWKLVA
QMPFGDIREKAGEKEIQPTNNRLIVKK
>SEQF2892_01660 2-oxoglutaramate amidase
MKIQLFQFYVSYGNVEKNENKIKNWFENKLEEDTEVVVLPEMWNNGYALDELNEKADREL
SRSFPFIQSLAKQYNVDIVAGSVSNIRNSKVYNTAFTVSKNGHRINKYDKVHLVPMLDEP
TYLEDGKAVPEPFPLSSGTQATQIICYDLRFPELLRYPARNGAQIAFFVAQWPTPRLNHW
RVLLQARAIENDMFVIACNGTGNDGNTDYAGHSMIINPNGDILAELGQDEDTIAFNIDLN
EVDVQRENIPVFKNLKPNLYK
>SEQF2892_01662 Accessory gene regulator protein B
MKAIDNKIEQFALYLQRKNNLDHIQFLKVRLGLQVVVSNLVKTIVTYGVALIFHTFLYTL
FTHVSYFLVRRYAHGAHAKSSLLCHVQNLALFVALPWLLVYFQVNLGIMYSVVAIGTVLI
IYYAPSATKKQPIPSHLKMKKKLLSIIITMVLLIISFLAPEPFKQLILLGITLESITLLP
IFFPREDN
>SEQF2892_01663 hypothetical protein
MTVLVDLIIKLFTFLLQSIGTIASFTPCTTYFDEPEVPEELTNAK
>SEQF2892_01664 hypothetical protein
MDFLSNVPLAVFQGILLFIVSNIILNLKYSLRDYLLIAGIIIPSSILYYFFDSFALIILL
VGCAIFLYSKVQFYSILTVLSCAIIMFFSNFVTVITFVLFENYLNTKFLIFIVYITIFSS
FSILFGVFFRFLLNKLKQSYLSINKTYLTIISLVLILSFIILYVYSQTPKLDTSSLKMYG
LIFIGIILFFTVLIIFISNYMIKELRYKRNMEEIETYYEYTLQIESINNEMRKFRHDYVN
ILTTMSEYIREDDMPGLRQYFNENIVPMKDNLQMKSIKINGTENLKVRAIKGLVTTKILQ
AQEKNIPISIEVPELVEHIEMNTIDLSRIIGIITDNAIEASEALEDALIRIAFINTDSSV
MFIVMNKCKEDMPRIHELFQERFSTKGENRGLGLSTLKEITDSTENVLLDTTIENGYFIQ
KVEIINK
>SEQF2892_01665 Accessory gene regulator A
MKIFICEDDVKQRENMVSIINNYIMIEEKPMEIALATDDPYEVIEKSKEMNDVGCYFLDI
QLEADINGIKLGSEIRKYDPIGNIIFVTSHSELTYLTFVYKVSAMDFIFKDDPSQLQSRI
IDCLETAHTRLKLLSKESTVETIELKRGSNSIYVQYDDVMFFESSTKSHRLIAHLDNRQI
EFYGNLKELAQLDERFFRCHNSFVVNRHNIESIDSKERIVNFKNGEHCFASVRNVKKI
>SEQF2892_01666 Fructokinase
MRKLYGIGEALIDFIPNVKNSELKDVEQFSRQVGGAPANVVSVARKMGASTEMVTQLGND
AFGDIIVETLKNIGVGTQFIKRTDEANTALAFVSLKEDGQRDFSFYRKPSADMLYKAEYL
NEITINPNDVLHFCSVDLVESNMKEAHKAMVNKFKSANATIVFDPNVRLPLWQNAEACKE
AIHEFLPKANVIKISDEELEFITGEADEDKAIQSLFEGSVEAVIYTQGAAGASIVLKDGT
KIHHKGFKVKAIDTTGAGDAFIGAAISRMLLSDELNITKLLKEEGQDILRFSNMVAAQVT
TKYGAIESIPTIEDVTTELNK
>SEQF2892_01667 Sucrose-6-phosphate hydrolase
MAEWSREERYRCIEDVDKKYLENLKQQVKASRFRQTFHIQPETGLLNDPNGLIYHNGKYY
ISHQWFPLGAVHGLKYWFNYTSDDLVTFEPQDTLIKPDTYYDSHGVYSGSAFEHNGDLYY
MYTGNHRDEQWNRYASQMIAKVQNNGAITKFDAPVIPSQPEGYTSHFRDPKVFELNNEYY
AIIGAQTNEELGCCLIYKTNDKQLNQWSYCGEIDTKLKNFGYMWECPDYFKLDSKDILLF
SPQGIKPQGDQFRNIYQSGYLIGDLNFDSLSFDHSEFVELDNGFDFYAPQTFLDENGNRV
LIGWMGLPEINYPTDEEGWAHCLTIPRVLSIENDQLRQRPFKGLERLRKNKETALGYANK
FNRKLHPYEGKQYELIIDVIENDASKIYFELRTSKQNNTKIIYNTGDQKITLDRSESGLL
PENVQDLTRSTVLDSPLTRLQIFVDTSSIEIFCNDGERVLTSRIFPNENATGIETSTETG
QVYLKFTKYELKDE
>SEQF2892_01668 HTH-type transcriptional regulator TreR
MKNISDIANLAGVSKSTVSRFLNGGSVSPQTKEKLSRIIEEHDYQPNQFAQSLRAKHTNL
IGAIIPRMNSHAVDETVKGIVSVCHQHQYQLLLNYTGLDIRAEIEALETFSRSKVDGIIL
MATTLTDEHLEVIEKLNVPVILVGQSYPNLHSIIHDDYQAGFIVGEQIGSKKHKNVVFFG
VSEEDVAVGVKRKQGIIDGLKKYDVYPEIYLTSFKYEEAKNDVSEKLKNASGIDALIGAT
DPIALAIHKFYSQQNNATGNYQIFGFGGNPMTQLVTPAITTVKFNYFKAGTYAMNQLNEL
IFSKNAVSKTVIPVEIENF
>SEQF2892_01669 Ammonium transporter NrgA
MSLLYYVTYCVILSYTFLLFQFSIIMIFLKEVVIMKMDDTIFLFLCTLLVWIMTPGLSLF
YGGLVQSKNVLNTVMQSMAAMVIVTFTWVVLGFSLSFGTGNALIGNFDLIGLQHVGFAVN
DQLSPHIPFALFMLFQMMFCTIAVSILSGSIAERMKFFPFIIFIFLWVILIYSPVAHWVW
GGGWIQQLGALDYAGGTVVHITSGLSGLILAIMIGNGKKIEKIQPHNLLITLIGGILVWI
GWYGFNTGSAYTLNDVALTSFVNTIIAASGGAFSWLVVEYCITKKLSLLGLLSGVLAGLV
AITPAAGYVSYFSAFIISFAGGIVCYLVINVIKVKYKYNDTLDAFGIHGAGGIVGAILTG
VFQSQHVNNDVSNGLIYTGDVHSVLIQILAVIVVLCYTIVLTWIIGKILQKIMPIATTEE
EDKAGLDQLVHGEKAYFYGELNKLNKRY
>SEQF2892_01670 hypothetical protein
MLYELGTVGMVCPFPLIEAQKKMQTLDNGDELKIDFDCTQATEAIPNWAAEQGYPVTNYE
QLDDASWTITIQKA
>SEQF2892_01671 hypothetical protein
MIWMIISGLIVGILLGFVMQRTRFCLAGGFRDMYVQKNNKMFYALLVAITVQSIGLLILT
GLNVISIPDSTFPIIGTIIGAFIFGIGIVLAGGCATGTWYRAGEGLIGSWVALVLYAVTA
AITKTGILLPVMSWINKPTNINANMSQTTGIPMWVFTLVLTIITIIFVTKTLRKPKPKFA
VPKLKQKYSGLRHYLFEKRYHPFVAGIAVGLIALIAWPMSISTGRDYGLGITTPSANLIT
FLITGDTKLIDWGVLLILGIFLGSYIAAKGSREFKWRLPDKKTIRNSAIGGICMGFGASV
AGGCSIGNGLVETAIMSWKGWIALGSMILGVWFMSYFIFIRPMKKLEKQTSKSQATTATK
QVQTT
>SEQF2892_01672 Redox-sensing transcriptional repressor Rex
MAHNKSKIPRATLKRLPLYYRFVNTLKSKGIDRVNSKAISEALNIESATIRRDFSYFGEL
GKKGYGYNIDSLLEFFKTALSDSDNIHIALVGVGNLGRALLTYNFSIHDEMTITEAFDID
EQIVGTEIGDVSVHHMNDLKKVLNAQNINVVILTTPEEAAQRVANQLVEADIQGILNFTP
ARIEVPNTVQVHHIDLGIELQSLLFFMKNYSN
>SEQF2892_01673 putative ABC transporter ATP-binding protein YheS
MILLQLNDISKSFDGEDIFTRVNFEVKTGERIGVVGRNGAGKSTLMKIIAGVEDYDSGHI
SKIKNLRMGYLTQQMTLNSSASVFEEMSKPFEHLKKMELLIREETNWLADHASNYYSEEY
QQHMERYESLTNQFEQLDGYQYESKIKTVLHGLNFNEDDFDKPINDFSGGQKTRLSLAQM
LLNEPDLLLLDEPTNHLDLETTKWLEDYLKYFKGAIVIISHDRYFLDKIVTQIYDVALGD
VKRYVGNYEQFIEQRDKYYESRMQEYERQQDEIKRLETFVEKNITRASTSGMAKSRRKTL
EKMERIDKPMLDARSANIQFGFNRNTGNDVMNIRNLKIGYDSPITSPINIEVSKGDHIAI
IGPNGVGKTTLIKTIAQRQNQLEGEITFGANLQIGYYDQKQAEFKSNKTIIDYVWDQYPT
MNEKDIRAILGRFLFVQDDVKKVINDLSGGEKARLQLALLMLQRDNVLILDEPTNHLDID
SKEMLEQALKDFEGTILFVSHDRYFINQLANKVFDLNYDGGQMYLGDYQYYIEKTEEAAA
LEAFKNERNDFSKEDTSNQNEANENVNTYDSQKQQRREQRKLERLIENCEAKIEAFENEI
ARIDEQLTQPDVFNNPEKASSLANQKLETEQMLEQVMSEWENLQENI
>SEQF2892_01674 tRNA N6-adenosine threonylcarbamoyltransferase
MNKETLILAIETSCDETSVSVIKNGNSILSNIVLSQIESHKRFGGVVPEVASRHHVEGIT
TTIEEALTTANISMNDIDAIAVTQGPGLIGALLIGINAAKALAFAYDKPLIPVHHIAGHI
YANHLEEPLTFPLIALIVSGGHTELVYMKSHMHFEVIGETRDDAVGEAYDKVARTIDLPY
PGGPQIDKLAQYGKDTYDFPRVWLEKESYDFSFSGLKSSVINKLHNLRQKNEEVVKEDVA
TSFQNSVVDVLSTKAINACKAYKVNRLIVAGGVASNKGLRYRLQQLCEDNNIHLSIPSPK
LCTDNAAMIGAAAYYYYQSGITAKLDLNGENNMDIEEATIEV
>SEQF2892_01675 Ribosomal-protein-alanine acetyltransferase
MAKPTEAELTIRAMQVDDVPSVFDIERDSFNDSSWTIDAFYHELNENNFAKYFVIVFENE
IIGYLGLWMVIDQAQITTIAIRKDSRGYGLGQLLLKYVMDYASHSCEVMSLEVRIDNVIA
QHVYTNLGFQFGGKRKNYYGEGEDAMVMWVNLNE
>SEQF2892_01676 tRNA threonylcarbamoyladenosine biosynthesis protein TsaB
MNLLMIDTSNQPMSIAIMQDDTVLAETTSEDKRDHSSQLMPGIQHLFEEAKIEKNDIDGI
VVAKGPGSYTGVRIGVTTAKTLAYALNTKLYGVSSLAALAATVKNDKQKLLVPIIDARRE
AVYTGVYQNVDGNITTIIKDQYLPIEELKKQLTEMNQPFLYVGRDADKLSEHLGEEIKNN
LPHAPTMKQLITKSEPIHTFVPNYIKLSEAERNWLNQQKQN
>SEQF2892_01677 tRNA threonylcarbamoyladenosine biosynthesis protein TsaE
MISINNLDELNHFANVLVRHLEPSDLILLNGDLGAGKTTLTQFIGKHLGVKRNINSPTFN
IIKSYKGSNLKLHHMDCYRLEDSDEDLGFDEYFQDEGITIIEWSQFIQDLLPKEHLIINI
ETLSETKRTIKLEAQGTHYLKVKEEVESEFIND
>SEQF2892_01679 Dihydroxy-acid dehydratase
MRSDMIKKGDHQAPARSLLHATGALKNPTDMNKPFVAICNSYIDIVPGHVHLRELADIAK
EAIREAGAIPFEFNTIGVDDGIAMGHIGMRYSLPSREIIADAAETVINAHWFDGVFYIPN
CDKITPGMLLAAVRTNVPAIFCSGGPMKAGLSAQGKALTLSSMFEAVGAFKEGKLSKEAF
LDMEQNACPTCGSCAGMFTANSMNCLMEVLGLALPYNGTALAVSEQRREMIREAAFKLVD
NIKKDIKPLDIVTREAIDDAFALDMAMGGSTNTVLHTLAIANEAGIDYDLERINEIAKKT
PYLSKIAPSSSYSMHDVHEAGGCPAIINELMKKEGTLHPDRLTVTGKTLRENNEGKEIKN
FDVIHSLDDSYDKQGGLSILFGNIAPKGAVIKVGGVDPSIKTFTGKAICFNSHDEAVEAI
DNKIVREGHVVVIRYEGPKGGPGMPEMLAPTSSIVGRGLGKDVALITDGRFSGATRGIAV
GHISPEAASDGPIGLIKDGDEVTIDLINRTLNVNQTKEELNHRKEALQPFKAKVKSGYLA
RYTALVTSANTGGIMQVPENLI
>SEQF2892_01680 Acetolactate synthase large subunit
MTSKKESSVVSPDAMDYSKQTSLKEDSDLDANNNFRSGSELLVEALLHEDVDFIFGYPGG
AVLPLYDTFYDGKIKHILARHEQGATHAAEGYARVSGKTGVVVVTSGPGATNAITGITDA
YCDSLPLVVFTGQVATPGIGKDTFQEADLLSMTTPITKANFQVKNVNDIPRIVHEAFYLA
NSGRKGPVVIDFPKDMGVLKTSAPLVNEVDLPAYDVTVNPKDKDISQLIQYLDNAKQPLI
LAGAGINHSQSNELLTQFVTKHQIPVATTLLGLGAIPYDNPLFLGMGGMHGSYASNMALT
ECDLLINLGSRFDDRLASNPNEFAPHATVVHVDIDESEINKVISTDLGIVADCKKVLEAL
SQRFTNKTSHEHWVNHCIENKHKHPFKYKKTDDTFCKPQEAIEYIGKITNGEAIVTTDVG
QHQMWAAQFYPFKHHGQWVTSGGLGTMGFGIPSAIGAQLAEPDKTVICFVGDGGFQMTNQ
EIALLPEYGLNVKIVLINNGTLGMVKQWQDKFFNHRFSHSVFNDQPDFMKMAEAYGVKGF
LIDHPNKLTKTLDSAFNYSGPALIEVRISPTEPVNPMIPSGKANHEMEGLE
>SEQF2892_01681 Acetolactate synthase isozyme 3 small subunit
MKRILHLKVTDQVSTLNRITSAFVRLQYNINELTVKPSQEKGISDMQITADIEDEAIFKI
LIAKLKKQVSVLEVQDISQN
>SEQF2892_01682 Ketol-acid reductoisomerase (NADP(+))
MTKVYYDQSVEKDALQGKKIAIIGYGSQGHAHAQNLKDNGYDVIVGIRPGHSFDKAKEDG
FDVYPVAEAVKQADIIMVLLPDEIQGNVYKNEIEPNLEAGNALAFAHGFNIHFEVIKPPK
DVDVFLVAPKGPGHLVRRTFVEGTAVPALFGVQQDATGQARDISLSYAKGIGATRAGVIE
TTFKEETETDLFGEQAVLCGGIHKLIQSGFETLVEAGYQKELAYFEVLHEMKLIVDLMYE
GGMENVRYSISNTAEYGDYVSGPRVITPDVKDNMKSVLKDIQNGNFANSFVKDNENGFKE
FYKLREQQHGHEIEAVGRELRKMMPFIKSKSIQK
>SEQF2892_01683 2-isopropylmalate synthase
MESHIQIFDTTLRDGEQTPGVNFSFDERLKIAKQLETWGVDILEAGFPASSAGSFKSVQA
ISNTLTKTAVCGLARCKKSDIDAVYEATKDAVKPVIHVFIATSPIHLTHKLKMTQQQVLE
SIKEHVSYAKQYFDVVQFSPEDATRTDTDFLIKCVQMAVDCGATIINIPDTVGYSYPNEY
GRIFKTLIENINSKQDITYSAHCHDDLGMAVANSLAAIENGAKRIEGTVNGIGERAGNTA
IEELALALYVRKDHYGNETRLKLSETKNTSDIISRYAGIRVPRNKAIVGQNAFSHESGIH
QDGVLKNPETYEIMTPQLVGISKNDLPLGKLSGKHAFAEKLKSLGYDIEPQNQAELFKQF
KAIADKKKSVTDRDIHAIIQGTEHEQNAIYQVDTLQLQFVSNGLQSAVVVIKDKNGNIYQ
DSSIGTGSIVAIYNAVDRIFKHKSELIDYRIESVTEGTDAQAEVHVSLTIEGQPVNGIGI
DHDVLYASCKAYVEAHAKYASEINKKEGNH
>SEQF2892_01684 3-isopropylmalate dehydrogenase
MTYNIVALPGDGIGPEILSGTLELLELISKKYKFDYQLTSYDFGGAAIDSHGVPLPDDTL
NACKNADAILLGAVGGPQWTDPNNRPEQGLLALRKSLGLFANIRPTKVTEGTSHFSPIKE
SRVKGTDFIIVRELTSGLYFGEPRHIDNQSALDSLTYTKKEIERIAMVAFELASQRKKKL
TSVDKENVLATSKLWRKTINEISHEFPDVKVNHLLVDACSMQLISQPTNFDVIVTENLFG
DILSDEASTIPGSLGLSPSASFSLEGPRLYEPIHGSAPDIANQNLANPFGMILSLAMCLR
ESFNFEDAASELEQAVYQLIKDGKTTKDLNGHYTTSDIFNELKKNY
>SEQF2892_01685 3-isopropylmalate dehydratase large subunit
MGQTLFDKVWNKHVLTGNEGEPQLLYIDLHLIHEVTSPQAFEGLRLQNRKLRRPDLTFAT
LDHNVPTIDIFNIKDEIANKQITTLQKNAKEFGVQLFDMVSVEQGIVHMVGPETGLTQPG
KTIVCGDSHTATHGAFGAIAFGIGTSEVEHVFATQTLWQTKPKNLKIDVTGQLPKGVYAK
DIILYLISQYGVDFGTGYAIEFTGETIRSLSMEARMTICNMAIEAGAKYGLMQPDEMTFA
YVKDRKYARNFDRSINDWRQLYTDADAKFDKVIKLDVTNLEPQVTWGTNPEMGVSFNTPF
PKIKNINDERAYQYMGLKPGQKAEDIDLGYVFLGSCTNARLSDLVEASRIVKGKQVHPKI
TAIVVPGSRSVKKEAEALGLDKIFKDAGFQWREPGCSMCLGMNPDQVPEGIHCASTSNRN
FEGRQGKGARTHLVSPAMAAAAAIEGRFVDVRKVVV
>SEQF2892_01686 3-isopropylmalate dehydratase small subunit
MDIQPITTYTGKVVPLFNDNIDTDQIIPKVHLKRITKSGFGPFAFDEWRYLPDGTNNPDF
NPNKPEFSGATILITGDNFGCGSSREHAAWALKDYGFNIIIAGSFSDIFFMNCTKNGMLP
ITLGENERKYLASQKEITIDLPNQTVSANDKSFNFQIDETWKHKLVNGLDDIAITLEYED
LIEQYENKNKG
>SEQF2892_01687 L-threonine dehydratase biosynthetic IlvA
MTVKTTLNAKDVDNAYLRIKDVVKETPLQFDLYLSQKYDCNVYLKREDLQWVRSFKLRGA
YNAISVLTSEAKEKGITCASAGNHAQGVAYTAKALNLKAVIFMPVTTPLQKVNQVKFFGS
KNVKIILTGDTFDDCLKEALIYTEQNHMTFIDPFNNVDTIAGQGTLAKEILNQSSNDSIT
FDYLFAAIGGGGLISGISTYMNQYSPQTKIIGVEPSGASSMYESVVVQNKIVTLDHIDKF
VDGASVARVGDITYDIAKKFVDDYIQVDEGAVCSTILDMYSKQAIVAEPAGALSVSALEQ
YKEKIKGKTVVCVVSGGNNDINRMKEIEERSLLYEEMKHYFILNFPQRPGALKEFVNDVL
GPQDDITKFEYLKKTSQNTGTVIIGIQLKNHDDLNQLKINVHDFDPSNIYINENKMLYSL
LI
>SEQF2892_01688 hypothetical protein
MYKNYNMTQLTLPMETSVLIPTNDISRHVNDIVETIPDNEFDEFRHHRGATSYHPKMMLK
VILYAYTQSVFSGRKIEKMLNDSIRMMWLSQNQKPSYKTINRFRVNPKVDALLESLFIQF
YSQCVKQNLIDDKAIFIDGTKIEANANRYTFVCKKSIQNHESKMNEDSKALYHELVTNKI
IPEIKEDHDNELTKEEIDLIGSHLDKEIEDLNQHINNEKCTKTRKQIRLKRTKIKKYKKQ
INDYFERKYRYEFQKSILKDRNSYSKTDHDATFMRMKEDHMKNGQLKPGYNLQIATNSQF
VLSYNVYQNPTDTRTMIPFLNSIQETYGHLPEYIVADAGYGSESNYKAIIDDFNRTPLIT
YGMFIKDKTKKYKSDIFNTQNWNYDEINDEFICPNNKRLGFKRYAYRHDKYGYKRDFKLY
ECDDCSECPLKNQCMNFNSKTNKKIMKNYNWEYFKSQINKKLSEPETKNIYSQRKIDVEP
VFGFMKAILGFTRMSVRGLNKVKRELGFVLMALNIRKVVAQRAENNQKIYKKDNFYIISI
EIVFFSLIQELYVPDS
>SEQF2892_01695 Protein SprT-like protein
MNNNELQNMVESISNRYFNEPFRHNALFNNKLRTTGGRYMLDSHNIEINPKQYQYYGKNA
LIDIIKHELCHYHLHLGGKGYKHKDSEFKILSKQVGAPRFCAPIQSYEARANYLYKCQSC
GYKYLRIRKVDVRKMRCGICNGKLSLIEHLT
>SEQF2892_01696 30S ribosomal protein S1
MNEIVSKYQFSEKQVKSVLELLEENNTVPFIARYRKEATGGLDEVQIKQISDEYQYVANL
QKRKDEVIHNIEQQGLLTNELKEAILKQTKLQRVEDLYRPFKQKKKTRATEAKRKGLESL
AQWISDGQQGELSKKAEAYINDEVATVDEAIQGALDIIAEHVSDNPKYRSRILKDIYRQG
NIVTAKKKKADDEKETFAMYYDYVEPIKNVANHRVLAMNRGEKEKVLSVKVEFDTQQIAS
AIEKNEVKSNNPHGDYIKLAIEDSLKRLIMPSIEREIRADLTEKAEQHAIEVFSENLKHL
LLQPPMKGKQILGVDPAFRTGCKLAVINPYGTFIDKSVIYPHPPKSKVEASEKEIVRMIK
ENNIELIAIGNGTASRETEQFVADVIKKYNLDIKFIIVNEAGASVYSASEIARSEFPNFQ
VEERSAVSIGRRVQDPLSELVKIDPKSIGVGQYQHDVNQKELESALTFVVETAVNQVGVD
VNTASKSLLQYVSGLSSAIAQNIIDYREENGAIKHNKEISKVKRLGAKTFEQSIGFLRIV
DGSEPLDNTSIHPESYDVTYELLTVLNFDINDLGTDKLKTELSNINTNQIAEQLNVGVPT
LEDIIKSLMAPNRDPRDEFETPILKSDVLSIEDLKEGMKLSGTVRNVVDFGAFVDIGVKQ
DGLVHVSKLSKKFVKNPMDVVSVGDIVEVWILDIDKNKGKVSLTMIDPHE
>SEQF2892_01697 RNA polymerase sigma-B factor
MTKESKSVNDVSPEQINQWIKEHQDNANTEAQDRLVNHYRKLIESLAYKYSKGQSHHEDL
VQVGMVGLIGAINRFDLSFDRKFEAFLVPTVIGEIKRYLRDKTWSVHVPRRIKEIGPRIK
KVSDELTNELERSPSIAEIADRLEVSEEEVLEAMEMGQSYNALSVDHSIEADKDGSTVTL
LDIMGQKDDNYDLTEKRMILERILPILSDREREIIQCTFIEGLSQKETGERIGLSQMHVS
RLQRTAIKKLQQAAKQ
>SEQF2892_01698 Serine-protein kinase RsbW
MPIKNDYIEMKLPASAEYVSLIRLTLSGVFSRAGASYDDIEDSKIAVSEAVTNAVKHAYK
NDETNGMINLCFELFDDKIKIVISDQGESFDYETTKSQLGPYDENENIDFLREGGLGLFL
IESLMDEVKVFKESGVTISMIKYIKKEQVPNNDERVEIS
>SEQF2892_01699 Anti-sigma-B factor antagonist
MNLNIETVTHDEYYEVIVAGELDVYTVPELEEVLMPMRQEGTHDIHVNVTNVSYMDSTGL
GLFVGTLKALNQNDKELYILGVSDRIGRLFDITGLKDLMHVNEGTEVE
>SEQF2892_01700 Phosphoserine phosphatase RsbU
MEEFKQHYKQLIDESLVTQNKQQFLKKCNDFTDEVIKKDILPEDIVNIHKSYVTSLNLDK
EQIFDTLDVLQEVVKGFGYSYRDYQKLVDKMQFHDKEIDLASRLQQTMLKTDIPQFDSIQ
IGVISVAAQKVSGDYFNLIDHRDGTMSFAIADVIGKGIPAALAMSMIKFGMDSYGHSQLP
SDGLKRLNRVVEKNVNQNMFVTMFYGLYEEMNHLLYCSSAGHEPGYIYRAETETFEEIEV
RGRVLGVSQHTRYTQQEIPIHLDDLVIIFTDGVTEARYTDGEFIAKNTLLNLIRKYKHMH
PQDIVQILYEAILKIQNPNKRDDMTIMIIKRVN
>SEQF2892_01701 Endoribonuclease MazF
MIRRGDVYLADLSPVQGSEQGGVRPVVIIQNDTGNKYSPTVIVAAITGRINKAKIPTHVE
IEKKKYRLDKDSVILLEQIRTLDKKRLKEKLTYLSDEKMQEVDEALDISLGLHDEVKTQN
T
>SEQF2892_01702 Antitoxin MazE
MLTFNQNRSHSLEQSLKEGYAQMAELNLSLATEAFHLECEACDCNETYLISNYKSE
>SEQF2892_01703 Alanine racemase 1
MSDKFYRSTYLNVDLSAILNNYNTVRTLHSDKTVIPVVKANSYGLGSVKIAQHLMKNGAD
FFAVATLDEAIELRMHGINAQILILGVIPLEDINKAIQHRVALTVPSLQWLQHAIELISD
DNEKNLWLHVKLDTGMGRLGIKSLEEYKEVIDLIQSHPHLVFEGVYTHFANADEPGDSMD
HQYEQFETLVTQAEKPKFIHSQNSAGSLLRNFELCNAVRLGISLYGYYPSAYVKEKVETE
LQPSAQLLTQVVQTKYLKVGESVSYGSTFTATEDIKIAILPIGYADGYLRSMQGAFVNVK
GHQCEVIGRVCMDQMIIKVPDDVKEGDSVTLLDNAYDSPQSAETLAQKQDTISYEVLCNL
GRRLPRIYQVDDEMHVTNELLK
>SEQF2892_01704 Holo-[acyl-carrier-protein] synthase
MIHGIGIDLIEIDRIKKAFEKQKDKLVKRILTQEEEQQFHSFKSEKRKFEFLSGRFATKE
AFSKALGTGLGKTVAFKDINCYNDIKGKPCIDYNGFIVHVSITHTEHYAMSQVLLEKRD
>SEQF2892_01705 hypothetical protein
MITSIIFTIIVIIASILCDLYIEEMSRALLVSLAIVLIILCCVVFIVITPFLKYKNFRYS
HSNDEIYIRRGIIFINTKIIPFYRIQNIDIKEGFLMRKYELASLHLSTAGGVSQIDLIAK
TDAINLKQMIQNKKKIQQNDISEMNKKIDHSNLPSE
>SEQF2892_01706 hypothetical protein
MFNPQKLHPISYITGIIDVIKQNIFTFIILVGFNIWNFDFTEIRHYIGPSIFLFIFILTF
IHRFLEIKVTRYWIENDQFIVTSGWLNKKRKELNLSRIQSLDTTQGLINQIVGGVSLQIK
TPSDGIELATITKKQSEFIEQTIRMRQKELNNDTQEYSINDEADENELKTEQYNASTSVT
ESNSEHVFNMSLTSLILMAMTSGAIGVAFAAVSPIVGAFQDIIPWDKWTSNLWHWVNSVL
IIVLFVVVSILIISYVLGTIITIIRYYNYKVVQQGNHLKISYGLFNVKNLTVPTDRLQAV
LEKQSFLRKIFGYTSIHFIITSDMDIESKDDASDNGKIMILPFIRQKEAYEIIGKLVPEM
KFNKVENIMPWNGFHRHFFIPSIIVLILASIGTYFWSAWSFFIALMIIIVMMSHAYIYVK
NAGLVIENDEITLKRVSTFGFQTYYFKTDKIIGMETSQHPFLERSHLANLYFLIAKGSIF
EFMELKFIKEDTSQRYVDAYLRGEYDV
>SEQF2892_01707 hypothetical protein
MKVESSFHKSPKNALKYHWLNSGILFLIELIIIVALFSMWRYFNWYHLIVYILIFLVFIS
VIRLLLQPIINYKYRFYRVNDRNVEVKKTFIFKKHQITKIERLQFLEIKSNPILKLLNLN
ILIFVTAGHELKLPIVSEEEMNQLSEDIFIALRGADSDV
>SEQF2892_01708 DEAD-box ATP-dependent RNA helicase CshA
MQNFKELGISDKTVETLEAMGFKEPTPIQKDSIPYTLEGKDILGQAQTGTGKTGAFGIPL
IEKVVGQSGVQALILAPTRELAMQVAEQLREFSRGQNVQVVTVFGGMPIDRQIKALKRGP
QIVVGTPGRVIDHLNRRTLKTNGIHTLILDEADEMMNMGFIDDMRFIMDKIPAEQRQTML
FSATMPKAIQTLVQQFMKSPQIVKTMNNEMSDPQIDEYYTIVKELEKFDTFTNFLDVHQP
ELAIVFGRTKRRVDELTSALLSKGYKAEGLHGDITQAKRLEVLKKFKNDQIDILVATDVA
ARGLDISGVSHVYNFDIPQDTESYTHRIGRTGRAGKEGIAVTFVNPIEMDYIRQIEDSNG
RRMNALRPPHRKEVLKAREDDIKDKVKNWMSRESEARLKRISSELLEEYDSTELVASLLQ
ELVEANDEVEVQLTFEKPLARKNRQGKGNGSRRGGKRNNKFDNKNKRSKGNFNKKKGKKP
DRRERQDKGRSTMKGRTFADLQK
>SEQF2892_01709 UDP-N-acetylmuramoyl-tripeptide--D-alanyl-D-alanine ligase
MIEVTLQQIQEWIPCDIDSQYLRQTIKGVTIDSRAIKTNMLFIPFKGENVDGHCFVSQAL
KDGAGASFYEKGHDIDDNVKGPIIWVDDTLIALQQLAKAYLKHVNPKVIGVTGSNGKTTT
KDMIESVLHTEFKVKKTQGNYNNEIGLPLTILELDLDTEISILEMGMSGFHEIELLSNIA
EPDIAVITNIGESHMQDLGSREGIAKAKSEITIGLKKEGTFIYDGDEPLLEPHVKKIKHA
KCLSVGLKQDNALVCEVEHSENDGIAFSINGNEHYKLPILGIHNMKNAAIAIAIGHELGL
KYETIQHNINHVQLTGMRMERHITDDDITIINDAYNASPTSMKAAIDTLSQMEGRKIIVL
ADSLELGENSRSMHEEVGAYLEGKNIHTLLTYGKDAKYISDIGGQFVDHVEYFIDKQQLT
QYLINNLVANDKVLVKGSRGNKLEEVVNKLI
>SEQF2892_01710 D-alanine--D-alanine ligase
MVKENICIVYGGKSAEHDVSKLTAQNVLNAIDKERYLVDIIYITNDGLWKKKENITEEIK
EIESLNMTDIEAGEITILLKESSNGKPYDAIFPLLHGPNGEDGTIQGLFEVLDLPYVGNG
VLAASSSMDKLVMKQLFEHRGLPQLPYISFLRSEYEKYEGNIIKLVKDKLTYPVFVKPAN
LGSSVGISKCNNEDELKSGIEEAFQFDRKLVIEQGINAREVEVAVLGNDYPETTWPGEVI
KDVAFYDYKSKYKDGKISLQIPAELDEEVQMTLRNMALEAFKATDCSGLVRADFFVTEDN
QIFINETNAMPGFTAFSMYPSLWENMGLSYSDLITKLIDLAKERHEDKKKNKYTID
>SEQF2892_01711 Peptidoglycan glycosyltransferase RodA
MKYSSRQQPSKHWLRKIDWILVALLTILAIISVTTISSAMGGGQYSANFSIRQIIYYILG
AIIALVIMLISPKKIRNNTYILYFIFCVLLIGLLILPETSITPIINGAKSWYSFGPVSIQ
PSEFMKVILILALAKSVSNHNRFTFNKSFQTDLVLFFKIIGISIVPMALILLQNDLGTTL
VICAIIIGIMLVSGITWRILAPLFIVAFVFGGTIILAIIYKPTLIESLLGVKMYQMGRIN
SWLDPYSYSAGDGYHLTESLKAIGSGQLFGKGFNHGEVYIPENHTDFIFSVVGEEMGFIG
AVVLLLIFLALIFHLIRLATKVESPFSKIFIIGYVSLLVFHILQNIGMTIQLLPITGIPL
PFISYGGSSLWSLMVGIGVVLSIHFHQRQTMPNKEESGT
>SEQF2892_01712 hypothetical protein
MYKNYNMTQLTLPMETSVLIPTNDISRHVNDIVETIPDNEFDEFRHHRGATSYHPKMMLK
VILYAYTQSVFSGRKIEKMLNDSIRMMWLSQNQKPSYKTINRFRVNPKVDALLESLFIQF
YSQCVKQNLIDDKAIFIDGTKIEANANRYTFVCKKSIQNHESKMNEDSKALYHELVTNKI
IPEIKEDHDNELTKEEIDLIGSHLDKEIEDLNQHINNEKCTKTRKQIRLKRTKIKKYKKQ
INDYFERKYRYEFQKSILKDRNSYSKTDHDATFMRMKEDHMKNGQLKPGYNLQIATNSQF
VLSYNVYQNPTDTRTMIPFLNSIQETYGHLPEYIVADAGYGSESNYKAIIDDFNRTPLIT
YGMFIKDKTKKYKSDIFNTQNWNYDEINDEFICPNNKRLGFKRYAYRHDKYGYKRDFKLY
ECDDCSECPLKNQCMNFNSKTNKKIMKNYNWEYFKSQINKKLSEPETKNIYSQRKIDVEP
VFGFMKAILGFTRMSVRGLNKVKRELGFVLMALNIRKVVAQRAENIQKIYKKDNFYIISI
EIVFFSLIQELYVPDSSLLGIVCL
>SEQF2892_01714 hypothetical protein
MSNSDKLQNVVKLLSSLGVNIKKTKSRLDIINTLPATTPVRQELK
>SEQF2892_01715 hypothetical protein
MNFSEIRISELNTEEQANSLQHRLEKMIGVDEVIVELNDQLVKISYETPTNLNSIEKEIY
DDGYKVLG
>SEQF2892_01716 Copper-sensing transcriptional repressor CsoR
MIVLLERVTTLNNHENAHHSDQIKMNLKSRLNRIEGQVRAINRMIEEDVYCDDVLTQIRA
TRSALNSVATKLLDHHMKSCIMDKVNNGAQEEAMEELLVTFQKLMKD
>SEQF2892_01717 Cardiolipin synthase
MVEIYSMSFTHSSLIINIILIAAFILNLIFAFVIIFMERRSAGSIWAWLLVLVFLPIIGF
ILYLLLGRQIQRNRIFKLKKEDRKGLAMIVDEQIEALESDDFSKGNHQIVKFKEMVRMLL
FNNAAFLTTDNQTKIYTDGHAKFDALLSDIKNAKDYIHIQYYIFKSDELGHRILSALEDK
LDEGLEVKMLYDDMGSRTLRKKDLKHFRQKGGHVESFFPSKLPLINLRMNNRNHRKIVII
DGKIGYVGGFNVGDEYLGKDKKFGYWRDTHLRLEGDSVNALELRFILDWNSQSNRDSIEY
EDRYFPDVDSGGTIGVQIASSGPDEDWEQIKYGYLKMISSAKQSIYIQSPYFIPDQAFID
AIKIAALGGVEVNIMIPNKPDHPFVYWATLKNAASLLSAGVKIYHYDNGFLHSKTLIIDD
EIASVGTANMDNRSFTLNFEVNAFIYDEAIAAQLKEAFIQDMKVSYRLTEDLYNKRSLWI
KFKEGISQLLSPIL
>SEQF2892_01718 hypothetical protein
MDVTRQIELAHRYMKDFHKSDYSGHDVAHVERVTSLAQTISKCEQQGEYLIITLSALLHD
VIDDKLTNKANALDCLKTFLKNIRVSSDQQQKIIYIIQHLSYRNGQNNHVDLPIEGQIVR
DADRLDAIGAIGIARAFQFSGHFNEPMWTESPHSDIPNIETITNLEPSAIRHFYDKLLKL
KDLMHTETGRKLARERHAFMEQFLNQFYKEWHI
>SEQF2892_01719 hypothetical protein
MCKSILNTLRIKDKNLNFSDEVIEKKHKGRMSLFYYAELTYQPTHCENCSTKNENFSIVK
NGKKTSTITLLKIMEMPAYLELQKQKFYCKSCDSHFTAKSNIVDAHCFISNKTKLAVLDK
AQEYRSQKSIAKSCLVSSMTVSRVINQAASDVGQSSFDALPEHLMMDEFKSVKNVIGKMS
FIYADAVSHRIVDVVADRKLKSLKDHFYRYSLKLRQKVKTVTIDMYEPYMSLIKQLFPNA
KIIIDRFHIVQSLNRALNMSRVHVMNCYRTSNRPLYNKYKSYWKLFLKPFETLEAFNYHK
VHLFKEWKTEKGIINYLLGVDVELFNTYHYVHELRRLLKENQIEKFNHKLFSIHLSDVCP
KLRPVIRTLRRLATFIENTMTYSNLTNGPLEGINNKIKLIKRVSFGYRNYDNLRNRIIIT
SRLFVSTTKKEIKQLKVA
>SEQF2892_01720 Membrane protein insertase YidC
MKKKALLPLLLGVMVFLAGCDYSKSSNRDGFFYNTFVEPMSKVLHWLGHSVFNDDYGIAI
IVLVLVIRIILLPFMLSNYKNSHLMREKMKVAKPEVDGVQEKVKRARTQEEKMAANQEMM
EVYKKYDINPMKSALGCLPVLIQMPVVMGLYFVLRYRIGGGIAEHPHFLWFNLIHPDIWI
TIIAGVLYFIQAWVSSKQMPQEQRQMTYMMMIVSPIMIIWISLSSASALGLYWSVSAAFL
VVQTYFANMYYEKVAQREVAPMIEKFKENNSNSNKKGKNTQVVSKNNKKKK
>SEQF2892_01721 Thiamine-phosphate synthase
MFNSSSLNVYFICGTQDVPEGKDIREILKQALEAGITLFQFREKGPTSLDGVEKEHLAID
LLKLCHDYQVPFIVNDDVDLAEKINADGIHVGQDDENVKSFAERFKDKIIGLSIGNEKEY
YHSDLEHVDYIGVGPMFATISKNDANAPVGPSMIATLKNINPSLPMVAIGGITEDNIEPI
AQNGADGVSVISAIARSHNIDKTVTKMKSYFK
>SEQF2892_01722 Hydroxyethylthiazole kinase
MNNLERLRQENPLVVCYTNDVVKNFTANGLLSIGASPAMSEAPEEAKEFYKVAGALLINI
GTMTKANEQDILEIGKIANQQGTPIVFDPVAVGASSYRKAFCQKFLSEVKVSVIKGNASE
ILTLVDATTTMKGTDGKTDLDVVEIAKRAHEELNTAIVLTGKDDVVVQGGKVVKLSNGSP
LLAKITGAGCLLGGIVASFLFREENPTLQVLEEAVSIYNIAAEIAEKDQQVNGPGTFLPK
LLDQMYNIDFNTYQQQVKRQEVE
>SEQF2892_01723 Hydroxymethylpyrimidine/phosphomethylpyrimidine kinase
MHKPKIALTIAGTDPSGGAGVMADLKSFHACGVYGMAAITSIVAQNTKGVQHIHNLEISW
VQEQLDSVFNDELPHAIKTGMIATHETMELIQHYLKQHSDIPYVIDPVMLAKSGDSLMDD
DTKKHLQNTLLPLADVVTPNIPEAEEITGIKIDTEENIRKAGNIFINEIGSKGVVIKGGH
SADLNNAKDFLFTKDDVYTFEDQRFDTKHTHGTGCTFSAVITAELAKGKSIYEAVKKAKK
FISLSIQYTPEIGQGRGPVNHFAYMKKVGLDDE
>SEQF2892_01724 Aminopyrimidine aminohydrolase
MTFSTEIKEAAQPIIEEIYNDGFIQDLLKGDLDAQAVRQYLRADASYLKEFTNLYALLIP
KAPSMKDVKFLVEQIEFMLDGEVEAHEILADYINEPYEEIVKEKVWPPSGDHYIKHMYYH
AYAHENAAYTIAAMAPCPYVYEVVAKMALDDQNLNRDSVTSKWFDFYSTEMRPLIEVFDN
LLDELTANCTEQEKKDIKESFLQSTIHERNFFNMAYINEQWNFGGDKNA
>SEQF2892_01726 putative transglycosylase SceD
MKKTIIASSLAVGLGVVAGNAGHADASEAQVNKAELAQLAQSNDQSLNDSPIQEGAYNVT
FDYEGFTYHFESDGTNWSWNYAQSGQASQQQDVSAQASTVSNQTSAEQVGSQQQSSQAQP
TQTQQAPQTEQTQQPQTEATTSNSSSSNNNASSGSSVNVNSHLQQIAQRESGGDITAINP
SSGAAGKYQFLQSTWDSVAPDEYKGVSPAQAPEDVQDAAAVKLYNTAGASQWVTA
>SEQF2892_01727 Single-stranded DNA-binding protein B
MLNKIVIVGRLTKKAQIFENEEVKIATFCVATERNYKDENNEIACDYIFCKAFGKTATNI
ESYTDQGTLVGITGQMRSRKYDKDGQTHFVTELYVETIKFMSPKSKNDNILPNTSYDEDA
YSFDHLEVIDVN
>SEQF2892_01728 hypothetical protein
MKTFKAVRFQIVNENGGITESELEDGVIINKENSGTGWLLEVVISNAHYETMKKYYDDQT
LLDIRVVITRPSNDPALFDATIKSISEFETTMSIVFDCHIYTLRQVYAESLLEQLIDEGL
SGEELKITFNRMMQSKPKLKEEKFERE
>SEQF2892_01729 3-hydroxyacyl-[acyl-carrier-protein] dehydratase FabZ
METIFDYNQIKQIIPHRQPFLLIDRVVEYEEGKRCVGLKQVSGNEPFFQGHFPDYAVMPG
VLITEALAQTGAVAMLNSEENKGKIALFAGIDKCRFKKQVTPGDTLMLEVEITKIKGPIG
KGTAKATVDGQLACSCELTFAIQNA
>SEQF2892_01730 UDP-N-acetylglucosamine 1-carboxyvinyltransferase 1
MDKIVIKGGNRLTGEVKVEGAKNAVLPVLTASLLASEGQSKLVNVPDLSDVVTINNVLST
LNANVEYNKEEGAVLVDASTTLKEEAPYEYVSKMRASILVMGPLLARLGHAIVALPGGCA
IGARPIEQHIKGFEALGAEIHLENGNIYASTKDGLKGTDIHLDFPSVGATQNIIMAASLA
KGKTVIENVAKEPEIVDLANYINEMGGKVTGAGTDTITIHGVEKLRGVEHSIIPDRIEAG
TLIIAAAITRGDVFVRDAVKEHMTSLIYKLEEMGVNLDFQEDGVRVTAEDELKPVDVKTL
PHPGFPTDMQSQMMALLLTAEGHKVITETVFENRFMHVAEFRRMNANITVEGRSAKIQGK
SQLQGAQVKATDLRAAAALILAGLVAEGTTQVTELKHLDRGYVNFHEKLKSLGANIERVN
Y
>SEQF2892_01731 hypothetical protein
MDYIGQFAILHLILHVLCICIAYWALNSLKLDQFFKKGYATQVQVCLMFLAVLLGTAVSN
FLIDLLQFSTQVKFLFQ
>SEQF2892_01732 ATP synthase epsilon chain
MSTVNLDIVTPNGSVYEKDDVELVVFQTTAGEMGVMSGHIPTVAALKTGHVKVNFRNGTE
YIAVSGGFVEIRQHKVSVIVQTAETASEIDVERAKLARQRAQSHLEDQDNSDINRAKRAL
ARAENRLRVAELK
>SEQF2892_01733 ATP synthase subunit beta
MSNGRVTQVMGPVIDVRFEHNEVPEINNALIIEVPKEDGTFELTLEVALQLGDDVVRTIA
MDSTDGVQRGMEVQNTGKDISVPVGEVTLGRVFNVLGDTIDLEDKLDGSVRRDPIHRQSP
NFDELSTEVEILETGIKVVDLLAPYIKGGKIGLFGGAGVGKTVLIQELINNIAQEHGGIS
VFAGVGERTREGNDLYYEMRDSGVIKKTAMVFGQMNEPPGARMRVALSALTMAEYFRDEQ
GQDVLLFIDNIFRFTQAGSEVSALLGRMPSAVGYQPTLATEMGQLQERITSTNKGSVTSI
QAVFVPADDYTDPAPATAFAHLDATTNLERKLTEMGIYPAVDPLASTSRALEPAIVGQEH
YEVARDVQSTLQKYRELQDIIAILGMDELSEEDKLTVERARRIQFFLSQNFHVAEQFTGQ
KGSYVPVKTTVADFKDILDGKYDHIPEDAFRLVGSMEDVIAKAKDMGVEV
>SEQF2892_01734 ATP synthase gamma chain
MASLKEIDGRIKSTKKMKQITKAMNMVSSSKLRRAEKNTKQFEPYMEKMQDAITAIAGAS
KNSSHPMLRPRQVQRSGYLVITSDKGLAGAYSSNVLKRLINDIKEKHTSSDEYSIIVLGQ
SGVDFLKNRGYEIENSLVDVPDQPSFKSIQAIAKHAIDLFSEEHIDELKIYYSHYVSVLE
NKPTTKQVLPLSREDSSQGQGQMSSYEFEPDKESILSVILPQYVESLIYGTILDAKASEH
AARMTAMKNASDNATELIDDLSLQYNRARQAEITQQITEIVGGSAALE
>SEQF2892_01735 ATP synthase subunit alpha
MAIKAEEISALLRSQIENYESEMSVTDVGTVLQIGDGIALIHGLNDCMAGELVEFSNGVL
GLAQNLEESNVGVVILGPYTEITEGDEVRRTGRIMEVPVGEELIGRVVNPLGQPIDGQGP
INTTKTRPVEQKATGVMARKSVDEPLQTGIKAIDALVPIGRGQRELIIGDRQTGKTTIGI
DTILNQKGLDTICIYVAIGQKDSTVRANVEKLRQAGALDYTIVVSASASEPSPLLYIAPY
SGVTMGEEFMFNGKHVLIVYDDLTKQAAAYRELSLLLRRPPGREAYPGDVFYLHSRLLER
AAKLNDDLGGGSITALPIIETQAGDISAYVPTNVISITDGQIFLQSDLFFSGVRPAINAG
QSVSRVGGSAQIKAMKKVAGTLRLDLASYRELESFAQFGSDLDEFTARKLERGKRTVEVL
KQDQNKPLPVENQVLIIYALTKGYLDDIPVEDITRFEDELNSWTKSNGSDLLNEIRETGG
LPSDDKFEATINEFKKSFSKSE
>SEQF2892_01736 ATP synthase subunit delta
MANVANKYAKALFDVAIDKDRLDLMYDELSEVSEATKNYGEDLRAIDSNPNQPASERRKF
VGIVFGDANYYLKNMLMILANNRHLVLINSIFKEFKSLYNEYHNEDSAIVESVYQLSDEE
LDRIKDLILKQTNLSQVHITTKINPELIGGFRVKVGTTVLDGSVKKDLEQIERKFRRVN
>SEQF2892_01737 ATP synthase subunit b
MPVNALTNSFVLGAAGGGVEWGTVIVTVITFAILLALLKKFAWGPLKEVMDKRERDINRD
IDEAEEAKLNAQKLEEENKKTLKQTQDEVQRILEDARVQARKQHEEIIHEANIRANGMIE
TAQSEINSEKERALADINNQVSELSVLIASKVLQKEISEQDQKELVDKYLKEAGDK
>SEQF2892_01738 ATP synthase subunit c
MGLIAAAIAIGLSALGAGIGNGLIVSRTVEGVARQPEARGQLMSIMFIGIGLVEALPIIG
VVIAFMTLFQ
>SEQF2892_01739 ATP synthase subunit a
MDHKNPLVSWNVFGFDLVFNLASIMMLVITAIIVFLIAIICTRNLKKRPSGKQNFIEWIF
DFVRSIIESNMAWKKGGQFHFLAVTLILFIFVANMLGLPFAIVTKDHYLWWKSPTADATV
TLTLSTMMILLTHYYGVKMRGTKAYIGNYFKPFWPLAIINVFEEFSSTLTLGLRLYGNIF
AGELLLSLLAGLVVSSAWGWIIGIPGLIVWQGFSIFVGSIQAYIFIMLSMVYMSHKVADT
H
>SEQF2892_01740 hypothetical protein
MRRFSIIFKQFIQYYIYFLILLGVLSIIIPKPFILGLIIGTVGSLINTYIFELYLSRAKQ
PDNIHISTGNTWRYLVAIIACVIWFLLKDYVNIIGVMIGLMFSYVLIILRSLLLKS
>SEQF2892_01741 UDP-N-acetylglucosamine 2-epimerase
MKKIMTVFGTRPEAIKMAPLVKALEYDAELEPMIVVTAQHREMLDSVLHTFNIKPHYDLN
IMEEGQTLSDITSRAMTKLEDVIKKERPDMVLVHGDTTTTFSGALAAFYNKVAIGHVEAG
LRTRHKYAPFPEEVNRQMVSNLADLHFAPTKGAANNLLQENKSPDSIIITGNTAIDTLEL
TIQKEYTSDIIRKHQGKRIILLTVHRRENVGQPMINIYKAMRKIVDEYEDIVIVSPLHLN
PKVRELAYEYLGEHERIELIEPLDVVDFHNFANKAYLILTDSGGIQEEAPSLNKPVLVLR
DVTERPEGVTAGTLKVVGTDFDNVFKSTTEILENQMIYDQMALTQNPYGDGNASLRICES
IKYYFGLTSKMPKSFNS
>SEQF2892_01742 Uracil phosphoribosyltransferase
MSKVHVFDHPLIQHKLSYIRDMNTGTKEFRELVDEVGMLMAYEVTRDLELQDVEIKTPVT
TMTAKRLAGKKLAIVPILRAGLGMTDGVLSLVPAARVGHIGLYRDPNTLKAVEYFAKLPQ
DIDERQIIVVDPMLATGASAIEAINSLKKRGAKNIRFMCLIAAPEGVEKMQEAHDDVDIY
IAALDEKLNDKAYITPGLGDAGDRLFGTK
>SEQF2892_01743 Serine hydroxymethyltransferase
MSYIQNQDKAVYEAIQNEYNRQNNNIELIASENFVSEAVMEAQGSVMTNKYAEGYPGRRY
YGGCDYVDVTETIAIERAKALFGAEHVNVQPHSGSQANMAVYLVALEMGDTVLGMNLSHG
GHLTHGSPVNFSGKFYNFVDYGVDKETEKIDYEVVRQLAHEHKPKLIVAGTSAYSRQLDF
KKFKEIADEVGAKLMVDMAHIAGLVAAGLHPNPVEHADFVTTTTHKTLRGPRGGLILCKE
EYKKDIDKTIFPGIQGGPLEHVIAAKAVAFGEALEQDFKVYQEQVIKNAKVLSQTLQEEG
FRIVSGGTDNHLLSVDVKNSVNVTGKEAEATLDSIGITCNKNTIPFDQEKAFVTSGIRLG
TPAATTRGFDEEAFKEVGRIISLALKNPNNDTKLKEARERVSRLTAKYPLYE
>SEQF2892_01744 hypothetical protein
MQELKTLLDELKSQSFFNENEICVIGCSTSEVIGQKIGSVGSMEVAEAIFNALEEVKQDT
GVSFAFQGCEHINRAVTIEREDFNPLTMEEVTVVPDVHAGGSLATYAYKHMNDPIVVEHI
SVPKGIDIGQTLIGMHIKHICVPVRTSVKQVGEAIVTIATSRPKKIGGERAKYE
>SEQF2892_01745 Low molecular weight protein-tyrosine-phosphatase PtpB
MRITFVCTGNTCRSPIAESIAKKMLVDDTINSRGLFAIDGQSVSPESLEVIMEHNLPEPT
VAKQFSEKDLNSDLILTMTDMHKQQLVSHYGDNGRIYQLSEYVGEIGDIVDPFGGSIDTY
HQTFEQLLYLIGKLRTNS
>SEQF2892_01746 Threonylcarbamoyl-AMP synthase
MKTEIWDMRDYQKSPLDYPELENIKQVYNDGGLIAIPTETVYGLGADARNQYAVSNIYQA
KGRPSDNPLIVHIHDKSQLDQIVSHLPEEAKCLMDEFWPGPISFILPLRQGYLCEKVTGG
LQSIAVRMPSHPIGRAILQYIDIPIAAPSANVSGRPSPTTFQHVFNDLNGKIDGIVNGDQ
SEEGLESTVLDCTQFPFRIARPGSITQAMLNDVFPGSVEEYHYDVNSQPIAPGMKYKHYA
PDTPVTMLMHLSKPIKTIKEWSKTAFILPETLKQYAPSDALFIKLCKDEKDIRQANHNLY
QILHSIDENPSIDQAYIYAFDKTDESEAIMNRIIKATGNHIVRGDNL
>SEQF2892_01747 Release factor glutamine methyltransferase
MVNFKEQLDYAIKQAVDKGYEQSRAEWLMLDLFGWSRTDYLIHMYDDMSKAEEIKFSLAT
ERMLLGEPIQYIVGFQSFYGYQFQVNEHCLIPRPETEEVMLHFLENCKSSATIADIGTGS
GVLAITLKKLNKDFTVYATDIVQETLEVASDNAHYHEVAVTFLKGNALKPFIQNNIKLDG
IVSNPPYIDVDEMEMMENTVVKYEPHKALFAENKGFAIYELILNDLPKVLNKDAYVTFEI
GYNQGERLKNIILEKYPKLDVKVIKDINGNERIVSFKW
>SEQF2892_01748 Peptide chain release factor 1
MFDQLDIVEERYEQLNEMLSDPEIVNDSDKLRKYSKEQADLQKTVDVYRDYKSKKEEIAE
IDEMLNETEDKEEIEMLKEESASLKSAIPELEEQLKFLLIPKDPNDEKDVIVEIRAAAGG
DEAAIFAGDLLRMYSKYAESQNFKTEIVEAAESDHGGYKEISFSVSGSGAYSKLKFENGA
HRVQRVPETESGGRIHTSTATVAVLPEVEDVEIEIRNEDLKIDTYRSSGAGGQHVNTTDS
AVRITHLPTGVIATSSEKSQIQNREKALKVLKARLYDMKLQEEQQKYAAQRKSAVGTGDR
SERVRTYNYPQSRVTDHRIGLTLQKLDQIMEGKLDEIIDALTLSEQTEKLKELNNGEL
>SEQF2892_01749 Thymidine kinase
MYETYHSGWIECITGSMFSGKSEELIRRLRRGIYAKQKVVVFKPAIDDRYHKEKVVSHDG
NELEAINISTSRDILLQDLSHVDVIGIDEIQFFDKEIVNIVEKLAENGHRVVVAGLDMDF
RGEPFEPMPQIMAVSEQVTKLQAVCAVCGSSSSRTQRLIDGQPAKVDDPIILVGANESYE
PRCRAHHIVAPSTSDEEEM
>SEQF2892_01750 50S ribosomal protein L31 type B
MRQGIHPDYHKVIFLDTTTNFKFLSGSTKTSSETMEWEDGNEYPVIRLDVSSDSHPFYTG
RQKFAAADGRVERFNKKFGLKSNNN
>SEQF2892_01751 Transcription termination factor Rho
MPEKVRTSPQYESFHELYKNYTTKELTQKAKTLKLTNYSKLNKSELVLAIMEAQMEKDGN
YYMEGVLDDIQPDGYGFLRTVNYSKGEKDIYISASQIRRFEIKRGDKVTGKVRKPKDNEK
YYGLLQVDFVNDENAEVVKKRPHFQALTPLYPEERIVLETDPQNYSTRIMDLVTPIGLGQ
RGLIVAPPKAGKTSLLKEIANAISKNKPDAKLFILLVGERPEEVTDIERSVESAEVVHST
FDEPPEHHVKVAELLLERAKRLVEIGQDVIILMDSITRLARAYNLVIPPSGRTLSGGLDP
ASLHKPKAFFGAARNIEAGGSLTILATALVETGSRMDDMIYEEFKGTGNMELHLDRKLSE
RRIFPAIDIGRSSTRKEELLISKSELDSLWQLRNMFTDSTDFTERFIRKLKRSKSNKEFF
QQLQKAAEESTKTGKPII
>SEQF2892_01752 Putative aldehyde dehydrogenase
MRNYTQQYINGEWIDSDSNETIEVINPATEEVIGKVAKGNSNDVEKAVEAANNVYLEFRH
SSVKERKELLDKIVEEYKNRKQDIIEAITDELGAPLTLSENVHYQMGLNHFEEASRALDS
FEFEERRGDALVTKEAIGVSGLVTPWNFPTNQTSLKLAAAFAAGSPVVLKPSEETPFAAV
ILAEIFDKVGVPKGVFNLVNGDGEGVGNPLSEHPKVRMMSFTGSGRTGSKIMEKASKDFK
KVSLELGGKSPYIVLDDVDVKEAAKATTGKVVNNTGQVCTAGTRILIPESKKEDFLTALK
EEFSKVKVGDPREEGTQVGPIISKKQFDTVQSYIDKGIEEGAELFYGGPGKPEGLNTGYF
ARPTIFINVDNDMTIAQEEIFGPVASVITYNNLDEAIKIANDTKYGLAGYVIGKDKETLQ
KVARSIEAGRIEINEAGNQPDLPFGGYKQSGIGREWGDYGIEEFLEVKSIAGYFS
>SEQF2892_01753 HTH-type transcriptional regulator YodB
MEICPYLEETFKIVGRSWNGLIINYLSRCTDYTAHFSDMKRDLKTITPRALSIKLTDLGE
WGLVEKKVVSTSPVSIIYELTDKGKALAEALKPIEKWAQEHVTLEEEVKSK
>SEQF2892_01754 UDP-N-acetylglucosamine 1-carboxyvinyltransferase 2
MTQEVIKIRGGQTLKGDVTISGAKNSAVAIIPATLLAQGQVKLDGLPQISDVETLVSLLE
DLNIKAHLNGKTLEVDTSEIENAPLPNNKVESLRASYYMMGAMLGRFKKCVIGLPGGCPL
GPRPIDQHIKGFKALGAEIDESNDTSMKIEAKELHGANIFLDMVSVGATINIMLAAVHAT
GQTVIENAAKEPEVVDVANFLNSLGADIKGAGTSTLKINGVDSLHGSEYQIIPDRIEAGT
YMCIAAAVGEEITINNIVPKHVEALTVKLKELGVDIQVDGDAEKAIIKRKSSYKNVDIKT
LVYPGFATDLQQPITPLLFMADGPSFVTETIYPARFRHVDELKNMGANIEADMETGTATI
KPSSLNGAEVYASDLRAGACLIIAGLLAEGVTTIYNVRHIYRGYTDIVKHLKELGANIWT
EEV
>SEQF2892_01755 hypothetical protein
MYKNYNMTQLTLPMETSVLIPTNDISRHVNDIVETIPDNEFDEFRHHRGATSYHPKMMLK
VILYAYTQSVFSGRKIEKMLNDSIRMMWLSQNQKPSYKTINRFRVNPKVDALLESLFIQF
YSQCVKQNLIDDKAIFIDGTKIEANANRYTFVWKKSIQNHESKMNEDSKALYHELVTNKI
IPEIKEDHDNELTKEEIDLIGSHLDKEIEDLNQHINNEKCTKTRKQIRLKRTKIKKYKKQ
INDYFERKYRYEFQKSILKDRNSYSKTDHDATFMRMKEDHMKNGQLKPGYNLQIATNSQF
VLSYNVYQNPTDTRTMIPFLNSIQETYGHLPEYIVADAGYGSESNYKAIIDDFNRTPLIT
YGMFIKDKTKKYKSDIFNTQNWNYDEINDEFICPNNKRLGFKRYAYRHDKYGYKRDFKLY
ECDDCSECPLKNQCMNFNSKTNKKIMKNYNWEYFKSQINKKLSEPETKNIYSQRKIDVEP
VFGFMKAILGFTRMSVRGLNKVKRELGFVLMALNIRKVVAQRAENNQKIYKKDNFYIISI
EIVFFSLIQELYVPDSFSL
>SEQF2892_01757 Fructose-bisphosphate aldolase
MPLVSMKEMLIDAKENGYAVGQYNLNNLEFTQAILEASQEENAPVILGVSEGAARYMSGF
YTVVKMVEGLIHDLNITVPVAIHLDHGSSFEKCKEAIDAGFTSVMIDASHSPFEENIEIT
SKVVEYAHQHGVSVEAELGTVGGQEDDVVGGIIYADPKECQELVERTGIDTLAPALGSVH
GPYKGEPKLGFKEMEEIGASTGLPLVLHGGTGIPTKDIQKAIPYGTAKINVNTENQIASA
KAVREVLNNDQDVYDPRKYLGPAREAIKETVKGKIREFGTSNRAK
>SEQF2892_01758 hypothetical protein
MSKILQTQLTGIFNRLEDQALDIQMAAQCLIQAIGGEGYVYIKGYGDLKFFEPFVIESEE
HLKSSKLLSTLTTFDDIDSTDRVLLFSPYYTEEVAKDVQTLVDNDIDVVLICNRPKDSEI
PEHFIHFINLATPRPIVYTEDYDKVVQPHTISFNYIYYEIYTQMIEMTRDLEL
>SEQF2892_01759 CTP synthase
MTKFIFVTGGVVSSLGKGITAASLGRLLKDRGLKVTIQKFDPYLNVDPGTMSPYQHGEVF
VTDDGAETDLDLGHYERFIDINLNKYSNVTAGKVYSHVLKKERRGDYLGGTVQVIPHITN
EIKERLLLAGESTNADVVITEIGGTTGDIESLPFIEAIRQIRSDLGRENVMYVHCTLLPY
IKAAGEMKTKPTQHSVKELRGLGIQPDLIVVRTEYEMTQDLKDKIALFCDINKESVIECR
DASSLYEIPLQLSAQDMDDIVIKRLDLDAKYETQLDEWQYLLDTVNSLDGTITIGLVGKY
VSLQDAYLSVVESLKHAGYPLKKDVVVKWIDSGEVNDNNVEDYLKDVDGILVPGGFGFRA
SEGKIAAIKYARENNVPYFGICLGMQLATVEFARNVLGLEGAHSAELNPSTPYPIIDLLP
EQKDIEDLGGTLRLGLYPCKIKENTLAHQIYDAVNIEERHRHRYEFNNEFREQLEANGMV
FSGTSPDGRLVEMVEIPENDFYIACQFHPEFLSRPNRPQPIFKSFVEAAYKHQNK
>SEQF2892_01761 putative DNA-directed RNA polymerase subunit delta
MKIQDYTKEMVDEKSFIDMAYTLLNDKGATMNLYDIIDEFKDLGGYEFEEIENRVVQFYT
DLNTDGRFLNVGENQWGLRDWYSVDDIEEKIAPTIQKFDILDDEDEEDKNLKLLGDDEMD
DDDDIPAQTDDQETLDDPEDEQVEDEISESDLVIEDDEDDELDEEDEDEFED
>SEQF2892_01762 Spermine/spermidine acetyltransferase
MTIKKQFENITIQEFEEKYRQDVVNFELSERQQIYSSLPKSVLDDALTDENRVANIAINE
YGDVVGFFVLHQYYQHEGYDTPENVVYVRSLSINEKFQGNGYGTTMMMYLPQYVQDLFPD
FNHLYLVVDAENKGAWNVYERAGFMHTATKEEGPIGKERLYYLDLDSKHVSSLRLTENEA
SSISSYSVVDLLKDNQKVGFIALEKTDNRINIVAIEVYKEQRKEGIAESALRQIPTYVRK
HFKQAKTIMITLFGENNELKSLCVNSGFVEIDQSDDLIIFEKYVNY
>SEQF2892_01763 Type II pantothenate kinase
MKVGIDAGGTLIKIVQESQQGRSYETKLTTNISEVIAWLNANTFESISLTGGNAGVIAEN
LNVDATIFVEFDASSKGLGMLLKEQGHHIDEYIFANVGTGTSLHYFDGKQQRRVGGVGTG
GGMIQGLGYLLSQITDYEALTNLAQSGDRDTIDLKVKHIYKDTEPPIPGELTAANFGNVL
HNLDVDFSPANKLASVVGVVGEVITTMAITVARENKTENVVYIGSSFNNNPLLREVIEDY
TVLRGFKPYYIENGAFSGALGAIYLN
>SEQF2892_01764 hypothetical protein
MSYKNEAYFKDVLINEVFYVANKNKKLVRLNSNNQDYVGVWTQEGQAEDYLKHASIDYDR
VLKIDIDTFVTYELDDLFDEDDQVIINQTSQETGQIVKVVKMTDELMSELDKIRIKEFVK
DVAKEDQVFGLSKHDENHFILISDDSEEKPQIMPVWSLKNRALKVRDEDFEECELIEIEG
SVFSEWLDKLRDNDQVVAIDLKPGVVGTVISAQKLSNELTF
>SEQF2892_01765 hypothetical protein
MTINEKGLKLTLSDLYNENIVYNSRPSYVSNPWLKPEEHQSNFLTGREMLIADSMPMIVH
EASITEKLDQLFNLVGKKVPTNTYQFKNHETYEALLNRIVKEEGKDIYFQYIHSEDVVSD
KCYAVDKETFVALNNKARIPEWTNHKYLPEREIVSINDFKARIKEWDFPFVIKPGDDLPT
AGGYGVMICYDEEDLAKATQRILEASDATDNLIIEQKIEAVKNYCVQYAYSEEIGVTYLG
TAYQITDKYGFYAGNENVHDVPQQVIDAGREIMENGVKLGFFGVAGFDLLLDKNDDVFAI
DLNFRQNGSTSMLLLQEELNSSYQKFYSYFSNGDNEHFFNTILKFVKKGVLYPLSYYDGD
WFGKNAVNSRFGCIWTGDSKEAIEKIEKSFLAELDKN
>SEQF2892_01766 p-aminobenzoyl-glutamate hydrolase subunit B
MSNKQGILDYIENNKYDYVEISHRIHERPELGNEEIFASRTLIDKLKENDFDIETDIAGH
ATGFIATYDSGQEGPVIGYLAEYDALPGLGHACGHNIIGTASVLAGSALKQVIDRIGGKV
VVLGCPAEEGGENGSAKASYVKAGIIDDIDIALMIHPGNATYPTIDTLAVDVLDIKFYGK
SAHASENADEALNALDAMISYFNGVAQLRQHIKKSQRVHGVILDGGKAANIIPDFTHARF
YTRATTRKELDILTEKVNQIARGAAIQTGCDYEFGPIQNGVNEFIKTPKLDELFEKYALE
VGEDVSHDDFGFGSTDTGNVSHIVPTIHPHVKIGSRNLVGHTHRFREAAASVHGDQALIH
GAKIIALMGLELIENKGMFDEIVQQHSHIKGQSK
>SEQF2892_01767 S-ribosylhomocysteine lyase
MTKMNVESFNLDHTKVVAPFVRLAGTMEGLNGDVIKKYDIRFKQPNKEHMEMPGLHSLEH
LMAENIRNHTDKVVDLSPMGCQTGFYVSFINHDDYEDVLNIIEKTLNDVLEATEIPACNE
VQCGWAASHSLEGAKEIAQAFLDKRNQWSDIFGEGK
>SEQF2892_01768 hypothetical protein
MKVLRYLLGLAFGTAGVLHFTNERSFRNIVPEYLPLRKTAVLVTGVFEIFFGIMLLLKRP
ANWLKTGINLFLLAVLPANIYMARKELPLGDKQVPKWALYSRLPMQFVLIALVKKL
>SEQF2892_01769 Phosphopentomutase
MTTPFKRVHLIVMDSVGIGEAPDAAAFNDEGSHTLKHTLEGFNQTLPNLEKLGLGNIEEL
PVVNKVEQPGAFYTKLSEASVGKDTMTGHWEIMGLNIMQPFKVYPNGFPDELIQEIEEMT
GRKVVANKPASGTAIIDELGEHQMKTGDLIVYTSADPVLQIAAHEDIIPLEELYDICEKV
RELTKDPKYLIGRVIARPYVGEPGNFTRTSNRHDYALKPFGKTVMNTLKDNNYDVIAIGK
INDIYDGEGVTEAIRTKNNMDGMDQLINVVKKDFNGISFLNLVDFDALYGHRRDKEGYAQ
AIKDFDERLPELIDNLQEDDLVIITADHGNDPIADGTDHTREYIPVLMFSPKIDKYHELS
GDSTFSSIGATIADNFNVELPEFGKSYLNEMGVEH
>SEQF2892_01770 Pyrimidine-nucleoside phosphorylase
MRMVDIIEKKRDGKSLSKEEIEFFIKGYTNGDIPDYQASSLAMAIFFQDMNDEERAALTM
AMVNSGDVIDLSKINGIKVDKHSTGGVGDTTTLVLAPLVAAVGVPVAKMSGRGLGHTGGT
IDKLESIKGFHVEISEEDFIKLVNENQVAVIGQSGNLTPADKKLYALRDVTGTVNSIPLI
ASSIMSKKIVAGADAIVLDVKTGNGAFMKTLEDAEALAHAMVSIGNNVGRNTMAIISDMS
QPLGRAIGNALELKEAIDTLNGKGPEDLTELVLTLGSQMVVLANRANTLEEARQLLNEAI
ENGSALEKFKTFLENQGGDASVVDAPELLPTATYQIEYKAQSSGVVSELIANEIGVASMM
LGAGRQTKEDEIDLSVGIVLNKKVGDVVKEGESLLTIHSNRENFDDVIKKLDESIEIQAQ
ATTPTLIHKIITE
>SEQF2892_01771 Deoxyribose-phosphate aldolase 1
MNYAKFIDHTLLKPESTRQQIDQIIDEAKEYNFKSICVNPTHVKYAAERLNDSDVLVCTV
IGFPLGATTTATKIFETEDAIKNGATELDMVINIGALKDGRFEDVQKDIEGVVGAANGKT
VKVIIETVLLSDEEKVKASELAKAAGADFVKTSTGFAGGGATPEDVKLMKDTVGDELEVK
ASGGVRSLEDFNKMIDAGATRIGASAGVQIIQGLESDSDY
>SEQF2892_01772 Purine nucleoside phosphorylase DeoD-type
MTNGTPHIQPNGTKIAKTVLMPGDPLRAKYIADNFLENVEQFNEVRNMFGYTGTYKGKEV
SVMGSGMGIPSIGIYSYELYNFFDVDTIIRVGSCGALQENVNLYDVIIAQAASTNSNYVD
QFNIPGHFAPIADYELITKAKNVADEIGAVSHVGNVLSSDTFYNADKTFNDNWQKMGILG
IEMESAGLYLNAINAGKKALGIFTVSDHILRDEATTAEERQNSFTQMMEIALEIAE
>SEQF2892_01773 General stress protein 20U
MSQQDVVKELNQQVANWTVAYTKLHNFHWYVKGPNFFSLHEKFEELYNEASQYVDDLAER
ILAIGGNPVGTLKESLEISIVDEAGKNYSAEQMVEAFSNDLTHISEQLVKSIEVAGEAGD
DVSEDMFIGMKNSVDKHNWMFKSYLV
>SEQF2892_01774 hypothetical protein
MPIIYYDGNCVYCYNYCIWLIQNGLPKSYEFATLKGEAGQHLFEQHPEALNKNSVILQRG
QHLEFKSNAIASLIMTTTKYKWLGLLIKVIPRQIRDLAYNLFANNRNRMWKTHWHNPNEY
EKSFFIDDKRI
>SEQF2892_01775 hypothetical protein
MEEEVNYFWLNCGYTRWNHNEPLVGQTTLFESGAQFNPTQGFRAFKKAKTGDQVIFYQVQ
TDTGLLGIGEIISVQTGAQNKIRVEFKFNELLKPLTTDYLKRSETLDFRMNNMRETLINQ
LTKEEYDLIVSLGKGEEKLPRYFFLSETESFESGEYYTIYTHTYNGIKRNGYHFYNQLEI
GDNLIFYNKYEDQSVVGIGEVSRHIHEKPPIPGRTNSTAIEIYYDKHITPVTLGALNKHP
KLKNLYFLQENAKQAIASMSQTQYDAIIEMSNNDGVKTPFETIKKTEIDSASHDDSIKPF
ILLVVEQREEGLKAANNLLQKTNANPVITSGHPDFTEDMLYGKYLPNETGALYYREGFIT
QLMPKNDKSYLVIDNFNRIDPDIFQTYINVLEGYEVTLPRYNKEGQMVKWSREKDSFYHF
NPNWHIIGVTYDRLEDIKRKYSNQFLKYTRIVKVNHE
>SEQF2892_01776 hypothetical protein
MKQFLYISLVCGVIAGAGVFFNMPQYPSLVIPRVVAILGIISAIITIKDKDLSGLLKLGG
IMINLMPLLGSLLAPH
>SEQF2892_01777 Mannose-6-phosphate isomerase ManA
MPLFLKPIFFEKIWGGNKLTQFNYDIPSESTGECWGISAHPNGKSMILNGPYAGQTLDQV
WTQHRELFGDFPSKDFPLLCKIVDANEPLSIHVHPDDSYAYEFENGQYGKSECWYIIDAE
EDAEVLIGTTVNSKEELENQINQDNLLESLKRVKVQPGEFYFIPAGTIHSIGSGITVYET
MQSSDITYRLYDYNRQRENSSSLDVDKALDVIQYSQELPSIVPENEIIENHKCSHIVSND
FFTMVKWEVSGTLNYMKPREFCLVSVLNGDGQIIIDGEIFKIQKGSNFVLTSEDLDSVFE
GDFTLIISYI
>SEQF2892_01778 putative sugar epimerase YhfK
MSLLVIGANGGVGSKLVKQLKEDQVDFTAGVRKNEQIETLKQDNIEATLVDVEKDSIEDL
TETFNGYDKVLFTVGSGGSTGADKTIIVDLDGAIKTIEASKQANVKHYIMVSTYDARREA
FDPSGDLKPYTIAKHYADEHLKNSGLNYTIVHPGALEDKEGTSKIETDLYFDGKGSIPRE
DVASVLKEVALSENKFINKEFQVITGNQTISEALSSFE
>SEQF2892_01779 HTH-type transcriptional repressor CzrA
MNVSLSNWNEDATLLQTTEIFKALSDTNRLRILLLLEQEESSVGHITHTLNLSQSNVSHQ
LKILKQARLVKSLRQGQSKIYSIDDQHVSTLLKQAIHHTKHLRGEVSND
>SEQF2892_01780 Cadmium, cobalt and zinc/H(+)-K(+) antiporter
MTNHSHTHSHNHSHVHTNNKKILAISFIIIGLFMVIEIVGGFIANSLALLSDGLHMFSDT
VSLGVALVAFIYAEKNATSSKTFGYKRFEVLAALFNGVTLFVISIVIIVEAIKRFFAPPE
VQSTEMFIISLIGLIVNVVVALIMFKGGDTNHNLNMRGAFIHVLGDLLGSVGAIIASILI
WTFNFTIADPIASIVVSLLILKSAYGITKSSINILMEGTPSDIDLEQVIYTIMGHEEIQN
VHDYHVWTISNDMNALSCHAVVDKSLTIEACEQLLKQIEHELAHLNIQHMTIQLETPKHQ
HDESILCSGFMHQHSH
>SEQF2892_01781 Bis(5'-nucleosyl)-tetraphosphatase, symmetrical
MKFAIITDVHGNFDALQTVLDDIDNREDIDKIYNLGDNIGIGHETNKVLDTIFDRDDMEI
IAGNHDEAVMSLVNNTPYPEDLKDKFYEHHQWIESYMDEDYYDQLNLLPRYIEKTICGKK
LLFIHYEIENQKLETGIEGQPFSPITENSKENIIELFKDKDADLIAFGHNHQMHLYDDNK
TIYFNPGAVGLNNGANAVYGIVTINDNEFSIERIKLPYDNEEYLQGFDEKQVPAKQLIFE
HFL
>SEQF2892_01782 hypothetical protein
MFKYHSLALKNAKPQILKTILFSIVSFIVVFAVFAVARTFFMQYFMQMQLAAQLQQSSGP
YLIIMILALLLGLLFFIFAGYQLLAGAINVIAKAISREDVHFNDLFVAFKKGKYGKSLIL
SLISIGLFIVMYLIIMALNYLFNLALTPLFTSLQSAVSSSDNTIAILLTIQIIILIIIGL
ITSIVSWFFFILMINYTVSLVRESDYSAMSHFKNGFKGIKNGHKTWFKFFIAVLLINLII
IIITQPLGTILSVTTGNMSQKVATVILYVAQVIIVVLRLILYFVLIMGAVQYFLKRGEKL
NKTTKEKKKKHKNKDKSVTNKNETLSNQQKIDNSHQPSKNNVEGHSNNVTNNVKQKSENA
KDEVSHNFNKDK
>SEQF2892_01783 5-amino-6-(5-phospho-D-ribitylamino)uracil phosphatase YwtE
MTLNNIKAIFLDMDGTILHEDNKASIKTKSVIDELREKGYKIFLATGRSYTEIDQLVPPQ
FEVDGIISSNGTSGEVNDDNLFMHSLSSESVKRIVSLAQQQEIYYEVFPFNGSRIALNED
KAWMQEMIKGDTPPNHVSESEWKSRLDAMSGKIDWKEDIPEDDYAKIYLFTPNLEKITTF
RDELIQNQVLLNISVSNSSRFNAETMAYHTDKGTGIKEMIEHFNIKQEDTLVIGDSDNDR
AMFAFGGYSVAMKNARQEIQEITNEVTQFTNEEDGAALFLESKFLK
>SEQF2892_01784 putative ABC transporter ATP-binding protein YlmA
MLISMNKVHRYRRGKHILNGIDWNIKKGDKWVLYGLNGAGKTTLLNILNAYDSITSGNIV
LFGMTPGMVGYSADNVRQHIGFISNKLTNQFQDGEHVIGVVLSGYFKSIGLYKTFNHQQL
IEAQKLLKLVGMAEFENEYLGYLSTGQQQRVMIARALISNPELLILDEPASGLDFLARET
LLEVLETLSHERPEITIIYVTHFIEEIIPIFDKIFILSKGVNFAQGNIDDVLTNKTMSSL
FNRNVEVMNYKNRFSLHLIG
>SEQF2892_01785 Glutamine--fructose-6-phosphate aminotransferase [isomerizing]
MCGIVGYIGYDNAKELLLSGLEKLEYRGYDSAGIAVANDNGTTVFKEKGRIAELRKVADN
NDTDGHVGIGHTRWATHGVPSTVNSHPHQSNNERFTLVHNGVIENYEELKSEYLSDVTFQ
SETDTEVIVQLVEHFSNKGLETEEAFSKVVSLLHGSYALGLLDNQDSDTIYVAKNKSPLL
VGVGEGFNVIASDALAMIKVTNEYKEIHDHEIVIVKKDSVTIKDLDGNVQDRDTYTAQID
ASDAEKGIYDHYMLKEINEQPAVMRRIIQEYEDEKGDLKIDHEIVKDVAAADRIYIIAAG
TSYHAGLVGKEYLEKWAGVPTEVHVASEFVYNMPLLSEKPLFIYISQSGETADSRAVLVE
TNKLGYKSLTVTNVAGSTLSREADHTLLLHAGPEIAVASTKAYTAQTAVLSILSQVVAKA
HGRDNDIDLLRELAKVTTAIETIVDDTPVMEQIAKDFLETTRNAFFIGRTMDYNVSLEGS
LKLKEISYIQAEGFAGGELKHGTIALIEDGTPVIALSTQEKVNLSIRGNVKEVVARGAKP
CIISMEGLEKEGDTYVIPHVHELLTPLVSVVTLQLIAYYAALHRGLDVDKPRNLAKSVTV
E
>SEQF2892_01787 Phosphoglucosamine mutase
MGKYFGTDGLRGIANKELTPELAFKLGRYGGYVLAHNEGADRPKVLVGRDTRVSGEMLES
ALIAGLASIGAEVMRLGVISTPGVAYLTREMGAELGVMISASHNPVADNGIKFFGADGFK
LSDAQEEEIETLLDQDNPDLPRPVGTDIVHFSDYFEGAQKYLSYLKSTIDVNLEGLKITL
DGANGSTSALAPFLFGDLEADTETIGCSPDGYNINDNCGSTHPELLAEKVLETESDFGLA
FDGDGDRLIAVDEKGNIIDGDQIMFVIGQEMHKNQELNNDMIVSTVMSNLGFYKALENEG
IKSNKTKVGDRYVVEEMRKGNYNLGGEQSGHIVMMDYNTTGDGLLTGVQLAAVIKMSGKP
LSELAAQMKKYPQSLINVKVTDKHHVEDNEDVKKVMDEVETEMNGEGRILVRPSGTEPLV
RVMVEASTDEDAQRFAQRIADEVQSKMGLE
>SEQF2892_01788 CdaA regulatory protein CdaR
MLESKWGLRFIALLLAIFFYLSVNNVFGNIFSNDNLSQNSSKTIEDVPVEIIYNSKDLHV
TKAPETVNVTVSGPQSKLLKIENTDDIKVAVDLSNAKAGKYKEDYIVKGLSNDINYNVKP
KQAYVTLENKETKTMHVQADIGKDDIDPNYKVKDSSVEPNSVKVTGGREQLKKIAYLKAT
YKEANKLSQDTSDVADVTAFDKSLNKLDVNIQPNQVKLNVKLQEYSKKVKVKINKKGRLP
DGASLDDITLDENEIEIYGNRDDLQDINEIEANVDLNNITESTDQNVQLKLPDKVKKSDP
DEITAHISLK
>SEQF2892_01789 Cyclic di-AMP synthase CdaA
MTVVIIIGIIITMENIFGGDAMDFSNFFDNLSTLKIVTSVLDLLIVWYVLYLLITVFKGT
KAIQLLKGILFIVIGQQVSKILNLTATSKLFDIVIQWGVLALIVIFQPEIRRALEQLGRG
SLFKRYTNTYSHDEEKLIEAVSKAVQYMAKRRIGALIVFEKETGLQDYIETGIAMNSEIS
QELLINVFIPNTPLHDGAMIVQNSKIASAASYLPLSDSAKISKSLGTRHRAAVGISEVSD
AFTIVVSEETGSISVTFDGKLRRDISTEVFEELLAEHWFGTRFQKKGVK
>SEQF2892_01799 hypothetical protein
MCKSILKTLRIKDKNINFSDEVIEKKYKGRMSLFYYAELTYQPTYCENCLAKNDNFSIVK
NGKKTSTITLLKIMEMPAYLNLQKQRFYCKTCDSHFTAKSDIVDDYCFISNKTKLAVLNK
AQECRSQKSIAKSCLISSMTVSRVINQAASDVGQSSFDALPEHLMMDEFKSVKNVTGKMS
FIYADAVSHRIVDVVADRKLKSLKDHFYRYSLKLRQKVKTVTIDMYEPYMSLIKQLFPNA
KIIIDRFHIVQSLNRALNMSRVHVMNCYRALNRPLYNKYKSYWKLFLKPFETLEAFNYRK
VHLFKEWKTEKGIVNYLLDVDEELYNTYHYVHELRRFLKENQIEKFNHKLFSIHLSDVCP
KLRPVIRTLRRLATFIENTMTYSNLTNGPLEGINNKIKLIKRVSFGYRNYDNLRNRIIIT
SRLFASTTKKEIKQPKVA
>SEQF2892_01800 Iron-sulfur cluster carrier protein
MLTVDQVKEIVGALKDPIIDAPLKETDGIVEVTIKEEIEHVSVKVAMAQLGGQPQLDLQM
AIVKALKDNGANTVGIRFEELPAETVEQYTGKKEEQPKTIEGLLSKDNPVEFIAIASGKG
GVGKSTVAVNLAVALAREGKRVGLVDADIYGFSVPDMMGIDEKPGVQGKEIIPVERHGVK
VISMAFFVEENAPVIWRGPMLGKMLTNFFVEVKWGELDYLLLDLPPGTGDVALDVHSMLP
SSKEIIVTTPHPTAAFVAARAGAMAKHTEHSILGVIENMSYFESKETGNKEYVFGKGGGR
KLADELNTQLLGELPLEQPTWNPKDFSPSIYQADDRLGEIYTSIAQKVIASTIKK
>SEQF2892_01801 putative multidrug resistance protein EmrY
MANIEVSTKKRNLIVAVMLLSAFIAILNQTLLNTALPHIMKELNTSENTAQWLVTGFMLV
NGTMIPLTAYLMDRIKTKPLYLVSMGIFLVGSIVAAIAPSFGVLMFARVIQAIGAGIIMP
LMQFTLFTLFSKEKRGFAMGLAGLVIQFAPAIGPTFSGLIIDNTSWRVPFIIVVGIALVG
YIFGAITLSSYNEIKKTALDKRSVVYSTLGFGLMLYAFSSAGNLGFTNPIVVISAIIGIL
IVITFIRRQLSITNPLLNLKVFKSKIFTFSTITSMIVMMSMVGPALLIPLFVQNGLGLSA
FMSGLVIMPGAILNGIMSVYTGKIYDKYGPRLLILIGFIILIVTTASLSFLKYDSSYTML
VVVYAIRMFAVSLLMMPINTAGINALRNEDISHGTAIMNFGRVMAGSLGTALMVTFMSIG
AKILSTGSSASSNHEILQRQSVAAGVDLSFAIVTGLVIIGFIFSLFIKEERHYNKNSTNT
RDM
>SEQF2892_01802 Multidrug resistance efflux pump SepA
MKFFKNNYKNILSTLLVLTIFIISGAIFLMFLGFGLFGLSRILIFFKLGYFTYNKNLVDN
LVYYGSYIVFGYFILFAIEHLMDYFRKQLPNNPYFNGSLYQLISYVVTTILFYFIIHIHY
VYIEIDFWVISVIIGLLYIFKIIFYPDSENLNNKK
>SEQF2892_01803 Multidrug efflux pump SdrM
MNFKSIGIVVTLVLTMFMAAIESSIISLAMPTIRTDLNAGASISLVFTVYFIALVVANPI
VGELLTRFKILYIAMIGVFLFGIGSLMSGMSDTFIMLIISRIVQGLGAGVMMSLTQIVPK
LAFEIPFRYKIMGIVGSVWGISSIIGPLLGGAILEFATWHWLFFINIPIAVIAIILAFIT
FHFSEESEVKSSSLDVKGLSFFYIFIGLFMFGLLSKSSIVLNIIALMLAFIFIFILFKFE
SKIKNPFIPISEFNRSVSLVFVTDLLIAMSLMGYNLYIPIYLQDHLHLSPLQSGLVIFPL
SVAWLVLNFNLAKVEENLTRKALYISAFTLLLISSIILMFGLKVPLLIAATVILAGVSFG
FVYTKDSVIVQEETDPRHMKKMMSFYALTKNLGSSIGSTVMGYFYAMSVGIMDGHFYNIL
FAVSLVAILLIIMWSTLYRPEV
>SEQF2892_01804 hypothetical protein
MSNSTKNAKGTVVESFKDIIPLSFGEEIGNSVSHGVAALLTLFLLPYAAVHSYIAHGTLS
SVSISIFVISIFMMFISSTIYHAMKNNTAHKYILRIIDHSMIYVAISGTYTPVLLTVVGG
WIGWFVFILLWGTTIWGILYKSISVNVNPKLSLIVYLVMGWVGIIFLPIIIMRTSWLFIL
FIVLGGLSYTIGAWFYAQKNRPYFHMIWHIFIVIASMFHLIAILYFI
>SEQF2892_01805 putative uridylyltransferase
MLDQNQLKKYNQEHLSEYEKLMSSNEKEKLESKVNELDLESIQQLFQDLYVNRQSISDVS
SVSEVKYQRKTELTDQEGAKYEQKGIEAIRNGEFAVLLMAGGQGTRLGYKGPKGSFEIKG
VSLFELQARQLLKLKKETGHLINWYIMTSDINHEETLSYFEQHDYFGYNPDNVHFFKQEN
MVALCETGQLVLNEQGYIMETPNGNGGVFKSLEKNGYLDKMASDGVKFIFLNNIDNVLVK
VLDPLFAGFTVVNDCDVTSKSIQPKDGESVGRLVNQNSKDTVLEYSELDEAVANTFDNAN
IGIHAFKIAFIKQAVNNDLPYHLAVKKLKQLDEDFGVVEKPTLKFELFYFDIFRYATSFV
TLQVNREDEFSPLKNKEGKDSVETATSDLERLNLI
>SEQF2892_01806 Inner membrane protein YdjM
MTGKTHVSAGLLVGALTTEHFQTDLFSTVTVICLSVVSSLLPDICHTGSKIGRKLKLLSL
IIRLLFGHRTFTHSLLFIGIIVFLLNLIQTPTYYLVSIIGGMASHVILDMLTPRGVKLLY
PIPLTIKFPFTFKTGGLVDVSLATALSIGALYILFQTSISHLLKYISQSILG
>SEQF2892_01807 hypothetical protein
MAMTVKKDNNEVRIQWRVADIKIPTSEIKNISQDQEIHAVPDLDSKNISRIGSTFGKTNR
VIIDTDDHEYIIYTHNDQKVYNELTK
>SEQF2892_01808 Heme oxygenase (staphylobilin-producing) 2
MFVVTNRITVKKGFAEKMAPRFTKGGKIEALQGFHKIEVWKVTRDHENEDMYVNTWWETE
KDFEAWTKSDAFKEAHQNRDKTSSESSPVISSEIVKATVLSTLN
>SEQF2892_01809 hypothetical protein
MVEGYSKQQIAKGRAKFITMSIIGIILFLIPVPVTQDGEKQTTLPVAFLANWLKGLLGDA
MPIIIIFIITLSAILTVLYSTIFKSKVKPGGLLDSAFKVGPVWMTLRILAVVFVWMTYFK
LGSKVIYSEDTGGLVFYDLLPTLVAVFLFAALFLPFLMEYGLLEFLGPLFRPIMRPLFTL
PGRSTVDNLASFIGDGTVGVLITSRQYERGIYSRRESIVISTTFSVVSITFAIVIAETVG
LQHKFFAFYLTVIISCFVAAMIMPRIWPLNKIPDEFTKEVSENTRLEKLPEGKTALGYGF
EEATIVGLKAPGFKEFWKSGLKTVIDMWFVILPVVMSIGTLATMIANYTPVFSIIGQPFI
PILELLQIPEAAKASETLLIGFADMFLPSILIADAHSEITRFVIGALSISQLIYLSEVGG
VILGSKIPVSLGKLFMIFLIRTAITLPIIALMAHLLL
>SEQF2892_01810 Fe(3+) dicitrate transport system permease protein FecD
MTKRQLSIRYTVVIICLIVSIFISLCVGSTMYSPLKAIHGILKFDDFILNEYRIPRTLLG
LVVGSSLAISGAVIQGVVRNPLASPDVIGITKGASLAAIIVIMLFPSAPLLVLPIGSFIG
ALFISLILSFLISKYNIKGSTLALIGLAIGAICTAVVQFLLIRNPMDANNALVWLTGSLY
GHTIENFYSVIPWFVITLPLVLCLSYQLDILNLGEHIATALGARVQRLKMILLILSVMLA
GASISVVGGISFLGLIAPHIARSIVGLRYFHVVIMSGCIGSILILFSDGLARGIHPPLDI
PVGVIIAIIGVPYFLFLLRRI
>SEQF2892_01811 putative siderophore transport system permease protein YfiZ
MTIRSTDSQSALDKANKRRTTLTFIVSGCFLFIFAYFNLAIGSSEIHAKHIFEYFFTSIN
NKQTFLIHNVRMPRMIGGLLIGGALALAGLLMQAITRNPLASPQIFGVNSGASFVIVLVT
ILIPSLGNYATYLAFLGAFIGGLTVYVLSGSTKKITPIKLALAGMAIHLFFSSLTQGIII
LNEDSNTTVMFWLVGSLNGLKWTAVLSVMPLLILALIITMLLGRQLTIMELGDDIAKGLG
QKTQLIRIIVGLLVIVLAGASVSIVGPIGFIGLIVPHIVKRYISKDYFLMVPLTFLIGAD
LLLLSDMLSRLITFPYESPVGIVTSFVGAIYFLLITLKGVKRI
>SEQF2892_01812 Fe(3+)-citrate-binding protein YfmC
MKGFKFAGIVALLFALVLVTACGNVSNNGSGDSGNKSSSKDSIKIKHELGTTKVPKDAKR
VVALEFSFVDALAALNVKPVGVADDNKPNRIIKPLKEKIGDYKSVGARKQPNLEEISKLK
PDLIIADSNRHKGIYKELSKIAPTIELKSFDGDYNDNIDAFKTIAKALNKEDEGKKRLDE
HKEKIAKYKDEIQFDKNEKVLPAVASKSGLLAHPSESYVGQFLSQLGFKEALNKDVTKGL
SKYLQGPYLQLNAETLKDVNPERMFIMTDGASPKEPSYQEMKKDPVWDTLDAVKHNRVSI
VSRDTWARARGLISSEEMAKELVEISKKDKEK
>SEQF2892_01813 Ornithine racemase
MAQININLSKIEYNADALRTLLENNDIHLTPVIKCIAGDSRIIETLIQSGFTHFAESRLE
NINEDFKGQCNYLLLRPTSKNRYTQLIKSVKMSMQTEIESIREINDIAKQLNQKHQIMLM
IDWKDRREGVITYDVLNYIEEIIKMTHIQLIGIAFNFMCFKSSAPTEEDILKINQFVDAI
EYNLGFRLKVVSGGNSSMIPQLMYNDLGRINELRIGEALFRGIDTTTNQSIPMLFQNAIT
VEAEILEIKPRLSDNNQCYLQAIVDIGYVDTDVNKIKPIKNDVSIVGASSDHLMINLNNQ
DYYKVGDIIEFAMEYEALSQVMYHNHMTKHYFKDNYIQSLNSMMVDSPLLINKKC
>SEQF2892_01814 N(2)-citryl-N(6)-acetyl-N(6)-hydroxylysine synthase
MTQNAWQNADTNIQYRILNALIKENIWQEQTIITTKDDQLDIQYHGCILSTHFNHNSVMS
RYEFVGPITFRCGTNIMEVSTVEALLDMLSNHFDINIHQQLIDEIIHSRDSFVEIYKQFY
QRQHNVQSSMQFSGMPTTLNFFAWLQHLNDANEINDLLYSESLVLEGHPTHPLTKTKLPL
TMDEVKMYSPEFEKVIPLKIMLIHKDCAQATCIDNDEDFILKKVIPEYQTRIRKYAQSIH
ISLEDYFVILVHPWQYNHTIYDKFANWIANKFLLTTPFDVDSKATLSFRTMALINKPYHI
KLPVNVQATSAVRTVSSVTTVDGPILSSALQNVLNQYPQLNVALEPYGLCAKTNDEDARQ
LACIVRETPYIANNGVTIVTGALVNPNPIDRHITVDSYIEWVNGELNNRGILTFIQNYSR
QLITPLINLIQEYGIALEAHMQNTIVNLGPNYQMNFIVRDLGGSRIDLNTLTHKLKNINV
SNQSLLANSIEEVIAKFQHAVIQNQLAELIHHFSKTEFVTEEELFTLVQDEVKLAINDNK
PHAQALKDVLFGSKITVKALLRMRMSNRVKKYLNIELDNPIRDEVR
>SEQF2892_01815 hypothetical protein
MAKFFFSSSFLLFLGNWIGQIGLNWYVLTSYHNAVYLGLVNFCRLVPILLLSVWAGAIAD
KFDRGKLLKMTISSSFLVTSTLCVCTFLLEQVPIIFILIYATLRGMINATETPIRQAVLP
DLSVHLNTSQAVSYHSFIINICRSIGPAIAGLILSIYHAPFTFLAQSMCYFIAVLLCIPL
TFKTVGEANKANKGFSFTVVWEYFKNNMQASRIFITSLIIMATGFSYTTLVPVLVHDLFP
GRSEIFGVSMTFCAVGGMIATLLLPIILKKFTIVQMYYLSSCLFGLALVGVIIHNIIFML
ICMSLVGLFSQLARTSNRIYFQEDIASEHRGKILSIVMMDRGMIPLGSLILTTLSEIMGP
INTFITMGIFTFVIAFIAYIIQRPIKLEE
>SEQF2892_01816 Aerobactin synthase
MDNLISIDNIDLHLTDEELGALSFLKQEMPHLVNYFKNELLVARDKISQRLITSLYRENL
VNAKSNSTFVSSCDIKNFPINGEHQIMRVHFPESDKYLFAKVSSTHAFGRVDVEGPFYYC
DSDGRQCVRILHPNEVLADILKENPELDNEASSQFKDDMENSVANMALALSYQAYEMQHS
KEPLLEIIINEQDSYLRSEQAVIEGHPLHPGAKLRKGLNANENIKYSSEYNKEIHLKCVL
IHQSIARTQSLSFTYDAELEAQFPELYSQIKTECDNLSNLSEYHLMIVHPWQLDNVLLSQ
YEEEINNNLMIPLKIEIPYYAGLSFRTLMPKFPSTLPHIKLSTNVHITGEIRTLSEQTTH
NGPLVTQILNDILKQDKNFTHYRVGILNEFAGIHFYNSNDEEAIQTDLSEQLGTLFRDNV
YNLTEKDSIPMIPSSLVVTYKYNEEPPIISLIQRYKHHYDKSNLDIAAQEWLSDYISQLL
GIVIPLYAKYGIALEAHLQNSISTFNADGRLNTIYIRDFEGLRIDEQLLNEAGYTTKHFH
EKSRILTDSKTTVFNKVFYSTVQNHIGELILTVSKFIEDEEFESKLWDSVSEIIHNILNS
LTDINTSRISEIKQIMFDRDIDYKCVTTMRLEDEAHHYTYIKVSNPLHG
>SEQF2892_01817 Alkaline shock protein 23
MSVDNNNKAKQAYNNQTGVNEKEREEQQKQAEQYREQNEQQQFENKLTFSDEVVEKIAGI
AAREVKGILDMKGGFADNFTNAFSSGNNVTTGVSVEVGEKQAAIDLKVILEYGESAPKIF
RKVTELVKEQVKYITGLQVVEVNMQVDDVMTKKEWQQKNEKNNNNNNNNNSERSGLQ
>SEQF2892_01818 hypothetical protein
MADNNNQNGQDASQQIIDFIKSYKWRIIGFFAFLIIAILFLTLGFWKTILVIVLCLIGIG
VGYIKDRTQDFMNFLNRWS
>SEQF2892_01819 hypothetical protein
MKRLKNFILGLLIVAIVGFLLFMYIKDSRISKYQDFFLQFNWFQPLLIGLAALLILIGLI
LVFSIFKPTYRKPGLYKDYDDGHIYVSRKAVEKSAYDTLTKYDQVRQPNVVAKLYNKKSK
SYIDIKADFLVPNDVQVKSLTESIRSDIKHNVEYFTELPVRKLEVNVRDQKTAGQRVL
>SEQF2892_01820 hypothetical protein
MTQVHFTLKSEEIQSIIEYSVKDDVSKNILTTVFNQLMENQRTEYIQAKEYERTENRQSQ
RNGYYERSFTTRVGTLELKVPRTRDGHFSPTVFERYQRNEKALMASMLEMYVSGVSTRKV
SKIVEELCGKSVSKSFVSSLTEQLEPMVNEWQNRLLSEKNYPYLMTDVLYIKVREENRVL
SKSCHIAIGITKDGDREIIGFMIQSGESEETWTTFFEYLKERGLQGTELVISDAHKGLVS
AIRKSFTNVSWQRCQVHFLRNIFTTIPKKNSKSFREAVKGIFKFTDINLAREAKNRLIHD
YIDQPKYSKACASLDDGFEDAFQYTVQGNSHNRLKSTNLIERLNQEVRRREKIIRIFPNQ
TSANRLIGAVLMDLHDEWIYSSRKYINFDK
>SEQF2892_01821 Glycine betaine transporter OpuD
MMRKKSISFVFWIALAICTLFVLYGAFMPKQLETGTQNITSFIAKNFSWYYLLLVLLIFF
VCVYLLFSRYASITLGEEGEDPEFSLPSWFAMLFSAGMGIGLVFWTTAEPISHAFTLTPI
HKAGTQSAINDAFQFSFFHWGLHAWAVYGIVALVFAYFSFHKGYPGLVSATLVPIFGEKS
MKGPIGGAIDVLAVIATVTGVAATLGFGALQINEGLNFLFNVPNNFGTQVILIIIATILF
TWSAWSGIDKGIKTLSNVNMFLAFIVLIGLFIVGPTLYILNTFTNGLGNYIFNFFSMSLR
IPMNGGEKFQWLQNWTIFYWAWWVSWAPFVGIFIARVSRGRTIKEFILGVLFVPALVCFF
FFAVFGASAVYLQDKGIANIAKEATETATFATLEHYPLGFILSIITLVVIMIFFVTSADS
ATYVLGMLSSKGDINPASFVKVSWGIILALFAMIMIYTGGTQAIQNLLIIAALPFSIVII
LMIWSLFKSLSIDHPRTSNKFPNILQYKSSKQKELKK
>SEQF2892_01822 Zinc-type alcohol dehydrogenase-like protein
MKAIGFEQPFKLSDGNLFKTFNLDIPEPKVHEILVKIQSISVNPVDTKQRLMDVSKAPRV
LGFDAIGVVESVGNEVTMFNQGDIVYYSGSPDQNGSNAEYQLINERLVAKAPKNISAEQA
VSLPLTGITAYETLFDVFGISRNRNENEGKTLLIINGAGGVGSIATQIAKAYGLRVITTA
SRNETIEWTKKMGADIVLNHKESLLNQFKTQGIELVDYVFCTFNTDMYYDDMIQLVKPRG
HIATIVAFENDQDLNALKPKSLSFSHEFMFARPLNQTDDMIKHHEYLEDITNKVEQNIYQ
PTTTKVIEGLTTENIYQAHQILESNTMIGKLVINLN
>SEQF2892_01823 Alkanal monooxygenase alpha chain
MKLSILDYVPIFEGRNAYDAFNHSITLAQTAEQLGYTRYWVAEHHNVFSVASSAPEIVMM
MLLEQTQTIKIGSGGVMLPHYSAYKVAEQFRIMEARHPNRVDMGLGRSPSFKQVNEALNE
FKSTKPNLDNQIEDLLHYFSNKYEAPHRFMSIKATPEIDTSPQMFILGMSERSAELAAQK
GLPFVIAFMGQSQTKINSLIEYYRKRYKQLNDISKSNEPYVIMSTFVVTANTLNKVDDLL
DALHLWLLRINYLNQPKSYPSINTAQKRNYSTSERNKIEQNKSRVISGLPKDIHLKLTYL
LNTYQVDEIMIMPHVYGEQARLELIQLVANNSL
>SEQF2892_01824 hypothetical protein
MQNAQNIKNVLTKMKSKYNIDNYNFVAHSMGNLSFAYFMKYYGNDKQLPQLQKEVNIAGT
YNGVLNLNEKVNEITVDKDGKPSKMNADYEKLLGLKDVYKNKNIEVLNIYGDLKDGTHSD
GRVSNSSSRSLKYLLGNSPKTYKESEYKGEKAQHSALHHNKEVSDEIINFLWQ
>SEQF2892_01825 hypothetical protein
MRTFKKIIFSLIISLMIFTLVGCQSKSNNSSNYQSNDKKQVATLFMHGYGGTNNSEKYMV
NQAVKKVLQRM
>SEQF2892_01826 6-phospho-beta-galactosidase
MKKLPEDFIFGGATAAYQAEGSTQTDGKGRVAWDTYLEENYWYTAEPASDFYNKYPIDLE
LSEKFGVNGIRISIAWSRIFPKGYGEVNPKGVEYYHNLFKECHRRHVEPFVTLHHFDTPE
TLHSDGDFLNRKTIDYFVEYAKFCFEEFEEVNYWTTFNEIGPIGDGQYLVGKFPPGIKYD
FAKVFQSHHNMMVAHAKAVKLFKDNGYSGEVGVVHALPTKYPYDPTNPEDVRAAELEDII
HNKFILDATYLGKYSRETMEGVQHILSVNGGKLDIPEEDYKVLEAAKDLNDFLGINYYMS
DWMRGYDGESEITHNATGDKGGSKYQLKGVGQREFDVDVPRTDWDWMIYPKGLYDQIMRV
VKDYPNYHKIYITENGLGYKDQFDEERKTVDDDARIDYVKKHLEVISDAIRDGANVKGYF
IWSLMDVFSWSNGYEKRYGLFYVDFETQERYPKKSAYWYKELAESKEIK
>SEQF2892_01827 PTS system lactose-specific EIICB component
MNKLIAWIEKGKPFFEKISRNIYLRAIRDGFIAAIPIILFSSIFILVTYVPNVFGFTWSK
TMEGILMKPYNYTMGIVGFIVAGTTAKSLTDSFNRKLDKTNQINFISTMMAAMCGFLFLA
ADSAKDGGFLSAFMGTKGLLTAFLSAFITVIVYNFFIKRNITIKMPKEVPPNISQVFKDI
FPLSAVIIILYALDLIVRSTAHTNVANGILKLFEPLFTAADGWVGVTIIFGAFAFFWFVG
IHGPSIVEPAIAAIAAITYANLEANLHLIQAGEHANNVITPGTQMFVVTMGGTGATLVVP
FMFMWLTKSKRNKAIGRASVVPTFFGVNEPILFGAPLVLNPVFFIPFIFAPIANVWIFKF
FVDVLGMNSFSIFLPWTTPGPLGIVMGTGFAFWSFVLAIVLIVVDVIIYYPFVKVYDEQI
LEEELGNKEANNELQDKVAANFDTKKADAILASAGASEASHSQTDQGKEVAQQSNITEQT
NVLVLCAGGGTSGLLANALNKAAEEYNVPVKAAAGGYGAHMDIMKDYHLIILAPQVASNY
EDIKQDTDRLGIKLAKTQGVEYINLTRDGKAALDFVQQQFEK
>SEQF2892_01828 PTS system lactose-specific EIIA component
MNREEVQLLGFEIVAYAGDARSKLLEALTAAKNGELDKAEELTEEANECIANAHKAQTSL
LAKEAQGEDIAYSVTMMHGQDHLMTTLLLKDLMKHLLELYRRES
>SEQF2892_01829 Tagatose 1,6-diphosphate aldolase
MTKSQQKLASIEQLSTKDGVISALAFDQRGALKRMMAEHQTEEPTVEQIEQLKVLVSEEL
TKYASSILLDPEYGLPASDARNKDCGLLLAYEKTGYDVNAKGRLPDCLVEWSAKRLKEQG
ANAVKFLLYYDVDDAEEINIQKKAYIERIGSECVAEDIPFFLEVLTYDDNIPDNKSAAFA
KVKPRKVNEAMKLFSEERFNVDVLKVEVPVNMNYVEGFAEGEVVYTKEEAAQYFRDQEAS
TQLPYIYLSAGVSAELFQETLKFAHEAGAKFNGVLCGRATWSGAVKVYIEQGEEAAREWL
RTTDFKNIDDLNKVLETTATSWKSK
>SEQF2892_01830 Tagatose-6-phosphate kinase
MILTLTLNPSIDISYSLDQINLDTVNRVNKTIKTAGGKGLNVTRVLSEYGEDVEASGFLG
GKLGEFIEQQLNNAQIKHNFFKIKEETRNCIAILHEGQQTEILEQGPSITKDEATEFKTH
LTHLLKRAKVIAISGSLPKGLKSDYYADLIQLAEQHQISTVLDSSGQSLLDVLLSEYKPT
VIKPNIDELAQLLQTKVTTEVECLKDAVNQPIFDGIEWIIVSLGSQGAFAKHRNKYYKVN
IPHIEVVNPVGSGDSTVAGIASGLIHHDEDESLLKKANAFGMLNAMESQTGHINVNKFDE
IFQQIEVIEV
>SEQF2892_01831 Galactose-6-phosphate isomerase subunit LacB
MKIAIGCDHIVTDTKMAVSKHLKEQGHEVIDVGTYDFTRTHYPIFGKKVGEAVTSGEADL
GVCICGTGVGISNSANKVPGVRTALVRDMTTALYSKEELNANVVSFGGKIVGELFIFDIV
DAFIKAEYKPTEENKKLIAKIEHLEAHNEKQADPHFFDEFLEKWDKGEYHD
>SEQF2892_01832 Galactose-6-phosphate isomerase subunit LacA
MTVIIGSDVDGKRLKEVVKAFLKENNHEVVDVTEGKDVDFVDSTLAIAQEVQKNDENLGI
AIDAFGAGSFMVATKVKGMIAAEVSDERSAYMTRGHNNARMITMGSEIVGDTLAKHVAKE
FVNGHYDGGRHQIRVDMLNKMC
>SEQF2892_01833 Lactose phosphotransferase system repressor
MNKYDRLDEITKLVNQKGTVRTNEIVEELNVSDMTVRRDLAELEEKGLLTKIHGGARSNS
IFQFKEKSHQEKHTHNIEEKRSVARKAIQIIEENDTIFLGPGTTIECLAEIMELKSLTVI
TNCFPVFKILFEKRSINFKVYLLGGEMRDLTESFVGEMANTLLKTMRFSKMFFSCNGIKD
IDVLTSTIDEAYTQQLALERSVEKYLLVDSSKLGKEDFTQLCKLDDLTAVIIDKGDIDNI
EKLKLHTEVID
>SEQF2892_01834 NAD-dependent protein deacetylase
MSNKIEKLKEIVDKSNNIVFFTGAGVSVASGIPDFRSMGGLFDEISKDGYSPEYLLSVDH
LNDNKESFIDFYHKRLLVADKKPNIVHEWIAELEREGKSLGVITQNIDGLHEDAGSQNID
EIHGTLNRFYCIKCGKEYTKSYVMEHELRYCESCGEVIRPDIVLYGEMLDQPTVFRALDK
IQKADTVIVLGSSLVVQPAAGFISNFTGDNLVIINRDKTPYDRKADLVIHNDMTEVVEEV
FKK
>SEQF2892_01835 30S ribosomal protein S9
MAQVEYRGTGRRKNSVARVRLVPGEGNITVNERDVREYLPFESLILDLNQPFDVTETKGN
YDVLVNVHGGGFTGQAQAIRHGIARALLEADPEYRGSLKRAGLLTRDPRMKERKKPGLKK
ARRSPQFSKR
>SEQF2892_01836 50S ribosomal protein L13
MRQTFMANESNIERKWYVIDAEGQTLGRLSSEVASILRGKNKVTYTPHVDTGDYVIIINA
AKIELTGKKESDKIYYRHSNHPGGIKSVTAGELKRNNPERLLETSIKGMLPSSRLGEKQG
KKLFVYGGAEHPHAAQQPENYELRG
>SEQF2892_01837 tRNA pseudouridine synthase A
MRILVNISYQGSQFLGFQIQQQGRTVQQQFEKILKRMHRRHVRIHPSSRTDRGVHAYEQF
FHFDTDLNIEPKQWKYAMNSALPDDIYVKEVQQVDDHFHCRYDCLGKRYRYKVYQATHRN
PFESGLKTFIKENLDYSKMNEAAKHFIGTHDFTGFCSQKTEVESRVRTVYQSEIIQTNEG
FDYVVTGSGFLYNMVRVLVAFLIEVGKGKRHPSEVPTLLNEKNRDNVPFTAPAEGLYLEK
IYLAENDLITDFGNNIKIHRKKSLQND
>SEQF2892_01838 Energy-coupling factor transporter transmembrane protein EcfT
MKNKLIIGRYLPNNSVIHQLDPRAKVLFVFMFIILIFFAHSFATFGWIILLILMFMFLAK
IKLWFLIKGLTPIFIFTIFTFFMHIFFTHGGTRLVDFGIIKIDSAGILEGIFISLRLITI
VMVATIMTLSTSPIDLTDAFEKLLTPLKWFKLPVHQLSMIMSIALRFIPTLMDELDKIIL
AQKSRGSELSSGGLMTRIKAFLPLMIPLFISAFQRAEELAIAMEVRGYDANVERTSYRKL
QWHIGDTMCLISIIPIAIVLLVLKYIGV
>SEQF2892_01839 Energy-coupling factor transporter ATP-binding protein EcfA2
MKIKFNDVIYTYQQGTPYEYKALDHINLTIEQGKYYAIVGQTGSGKSTLIQHFNGLLKPT
NGNIEHDELTIHSKTKDKFIRPIRQKVGLVFQFPESQLFEDNIEREIEFGPKNFGMNVEE
VKERAFDLLLELGFPRNVMSLSPFQMSGGQMRKIAIVSILAMNPDVIVLDEPTAGLDPKS
RQQVMELFKEIQLKQNKTIILVSHDMNEVAKYAEEIIVMNDGNIIEQDTPKELFRQGSKL
EEWHIDLPDIVQLQRDIEIKHGIKFKTIALTEKEFVSMYQEWQHHEE
>SEQF2892_01840 Energy-coupling factor transporter ATP-binding protein EcfA1
MEANNTNIIELKQVDFQYQGDAAFTLNNVSFKIPKNQWTSIVGHNGSGKSTIAKLIVGIE
IATNGTIIFNQSPISNNDFKDIREHVGIVFQNPENQFVGSIVKYDVAFGLENHAVPTEKM
KEIVAQSISDVGMTDYADSEPHSLSGGQKQRVAIAGVLALSPSVIILDEATSMLDPQAKK
SLMSLIQEVKATKDVTIISITHDLTEALEGDHVIVMNQGTVYKEGNPQTIFKDIKMLQEI
GLDLPFSMKINQLLGFDDHFITYEGLVEKL
>SEQF2892_01841 50S ribosomal protein L17
MGYRKLGRTSDQRKAMLRDLATSLIVSERIETTEARAKEVRSVVEKLITLGKKGDLASRR
NAAKTLRNVEILNEDETTQTALQKLFGEIAERYTERQGGYTRILKVGPRRGDGAESVIIE
LVD
>SEQF2892_01842 DNA-directed RNA polymerase subunit alpha
MIEIEKPRIETIEISEDAKFGKFVVEPLERGYGTTLGNSLRRILLSSLPGAAVKYIEIEG
VLHEFSAIDNVVEDVSTIIMNIKKLALKIYSEEDKTLEIDVRDEGEVTASDITHDSDVEV
LNPELKIATVSKGGHLKIRLVANKGRGYALADQNNTSDLPIGVIPVDSLYSPVERVNYTV
ENTRVGQSSDFDKLTLDVWTNGSITPQESVSLAAKILTEHLNIFVGLTDEAQNAEIMIEK
EEDQKEKVLEMSIEELDLSVRSYNCLKRAGINSVQELADKSEADMMKVRNLGRKSLEEVK
YKLEDLGLGLRKED
>SEQF2892_01843 30S ribosomal protein S11
MARKQVSRKRRVKKNIENGVAHIRSTFNNTIVTITDEFGNALSWSSAGALGFKGSKKSTP
FAAQMASETASKSAMEHGLKTVEVTVKGPGPGRESAIRALQSAGLEVTAIRDVTPVPHNG
CRPPKRRRV
>SEQF2892_01844 30S ribosomal protein S13
MARIAGVDIPREKRIVISLTYVYGIGTSTAKKIVEEANVSADTRVKDLTDDELGRIREVV
DSYKVEGDLRREQNLNIKRLMEISSYRGIRHRRGLPVRGQKTKNNARTRKGPVKTVANKK
K
>SEQF2892_01845 50S ribosomal protein L36
MKVRPSVKPICEKCKVIKRKGKVMVICDNPKHKQRQG
>SEQF2892_01846 Translation initiation factor IF-1
MAKQDVIELEGTVLDTLPNAMFKVELENGHEILAHVSGKIRMNYIRILPGDKVTVEMSPY
DLSRGRITYRYK
>SEQF2892_01847 Adenylate kinase
MNIILMGLPGAGKGTQASEIVKKFPIPHISTGDMFRKAIKDETDLGKEAKSYMDRGELVP
DEVTVGIVKERISEDDAKKGFLLDGFPRTIDQAEALNDIMSELGRNIDAVINIEVPEEEL
MNRLTGRRICEKCGTTYHLVFNPPKVDGICDIDGGKLYQREDDNPETVSNRLNVNVKQSK
PILEYYNEKGVLKNIDGAKDIDDVTKDVIDILDQLK
>SEQF2892_01848 Protein translocase subunit SecY
MFQTLVSFFKTKEVRNKIFFTLAMLVIFKIGTYIPAPGVNPEPFEQQGSDQGVAALLNTF
GGGALKNFSIFAMGIMPYITASIVMQLLQMDIVPKFSEWAKQGEVGKRKLSNVTRYFAII
LAFIQSIGMAFQFNNYLGGKLIIHQSIMSYLLIAVVLTAGTAFLIWLGDQITQFGVGNGI
SIIIFAGILSTLPSSIIQFVQQAFVGNDDTTLAWLKVIGLIVGLVLLTIGAIYVLEAKRK
IPIQYAKKQSAQRLGSQATYLPLKVNSAGVIPVIFAMAFFLLPRTLTLFFPKADWAQTIS
EYANPSNTYGMIVYVVLIIAFTYFYAFVQVNPEKMADNLKKQGSYVPGIRPGEQTKKYIT
KVLYRLTFVGSIFLAVIAILPILATKFMSLPQSIQIGGTSLLIVIGVAIETMKSLEAQVS
QKEYKGFGGR
>SEQF2892_01849 50S ribosomal protein L15
MKLHELKAAEGSRRVRNRVGRGAGSGNGKTSGRGQKGQKARSGGGVRPGFEGGQLPLFRR
LPKRGFTNINRKEYAIVNLDQLNKFEDGTEVTPALLVETGVVKNEKSGIKVLGNGSLDKK
LTVKAHKFSASAVEAIDAKGGAHEVI
>SEQF2892_01850 50S ribosomal protein L30
MAKLQITLTRSVIGRPETQRKTVEALGLKKTNSSVVVEDNPAIRGQINKVRHLLTVEEK
>SEQF2892_01851 30S ribosomal protein S5
MARREEETKEFEERVVTINRVAKVVKGGRRFRFTALVVVGDKNGRVGFGTGKAQEVPEAI
KKAVEAAKKDLVVVPRVEGTTPHTITGRYGSGSVFMKPAAPGTGVIAGGPVRAVLELAGI
TDILSKSLGSNTPINMVRATINGLQNLKNAEDVAKLRGKSVEELYN
>SEQF2892_01852 50S ribosomal protein L18
MISKIDKNKVRLKRHARVRTKLSGTAEKPRLNVYRSNKHIYAQIIDDVKGETLVQASSKD
KDIASDSTSKVDLATKVGEAIAKKASDKGIKEIVFDRGGYLYHGRVKALAEAARESGLEF
>SEQF2892_01853 50S ribosomal protein L6
MSRVGKKIIDIPSDVTVTFDGHTATVKGPKGELTRTFNERMTFKQEENTIEVVRPTESKE
DRTVHGTTRALLNNMVQGVSQGFEKTLELVGVGYRAQMQGSDLVLNVGYSHPVEIKAEDG
ITFAVEKNTTVRVSGVSKEQVGAIASNIRSVRPPEPYKGKGIRYQGEYVRRKEGKTGK
>SEQF2892_01854 30S ribosomal protein S8
MTMTDPIADMLTRVRNANMVRHEKLELPASNIKKQIAEILKSEGFIKNVEYVEDDKQGVI
RLFLKYGQNNERVITGLKRISKPGLRVYAKANEVPKVLNGLGIALVSTSEGVITDKEARK
RNVGGEIIAYVW
>SEQF2892_01855 30S ribosomal protein S14 type Z
MAKTSMVAKQQKKQKYAVREYTRCERCGRPHSVYRKFKLCRICFRELAYKGQIPGVRKAS
W
>SEQF2892_01856 50S ribosomal protein L5
MNRLKERYNTEVTENLVKKFNYSSVMEVPKIEKIVVNMGVGDAVQNSKVLDNAVEELELI
TGQKPLVTKAKKSVATFRLREGMPIGAKVTLRGERMYEFLDKLIAVSLPRVRDFQGVSKT
AFDGRGNYTLGIKEQLIFPEIDYDKVSKVRGMDIVIVTTANTDEEARELLTNFGMPFRK
>SEQF2892_01857 50S ribosomal protein L24
MHIKKGDNVKVIAGKDKGKEGKVIATEPKKDRVVVESVNVIKKHQKPTQLNPEGGILETE
AAIHVSNVQLLDPKTNEPTRVGYKFVDGKKVRIAKKSGEEIKTNN
>SEQF2892_01858 50S ribosomal protein L14
MIQQETRLKVADNSGAREVLTIKVLGGSGRKTANIGDVIVCTVKNATPGGVVKKGDVVKA
VVVRTKSGVRRNDGSYIKFDENACVIIRDDKGPRGTRIFGPVARELREGNFMKIVSLAPE
VL
>SEQF2892_01859 30S ribosomal protein S17
MSERNDRKVYVGKVVSDKMDKTITVLVETYKTHKLYGKRVKYSKKYKTHDENNSAKLGDI
VKIQETRPLSASKRFRLVEIVEESVII
>SEQF2892_01860 50S ribosomal protein L29
MKAKEIRDLTTSEIEEQIKSSKEELFNLRFQLATGQLEETARIRTVRKTIARLKTVARER
EIEESKANQ
>SEQF2892_01861 50S ribosomal protein L16
MLLPKRVKYRRQHRPKTTGRSKGGNYVTFGEYGLQATTTSWITSRQIESARIAMTRYMKR
GGKVWIKIFPHTPYTKKPLEVRMGAGKGAVEGWIAVVKPGRILFEVAGVSEEVAREALRL
ASHKLPVKTKFVKREELGGETNES
>SEQF2892_01862 30S ribosomal protein S3
MGQKINPIGLRVGIIRDWEAKWYAEKDFASLLHEDLRIRKFIDNELKEASVSHVEIERAA
NRINIAIHTGKPGMVIGKGGSEIEKLRNKLNNLTDKKVHINVIEIKKIDIDARLVAENIA
RQLENRASFRRVQKQAISRAMKLGAKGIKTQVSGRLGGADIARAEQYSEGTVPLHTLRAD
IDYAHAEADTTYGKLGVKVWIYRGEVLPTKNTSEGGK
>SEQF2892_01863 50S ribosomal protein L22
MEAKAVARTIRIAPRKVRLVLDLIRGKNAGEAIAILKLTNKASSPVIEKVLMSALANAEH
NYDMNTDELVVKEAYANEGPTLKRFRPRAQGRASAINKRTSHITIVVSDGKEEAKEA
>SEQF2892_01864 30S ribosomal protein S19
MARSIKKGPFVDDHLMKKVEAQDGSEKKQVIKTWSRRSTIFPNFIGHTFAVYDGRKHVPV
YVTEDMVGHKLGEFAPTRTFKGHAADDKKTRR
>SEQF2892_01865 50S ribosomal protein L2
MALKKYKPITNGRRNMTSLDFAEITKSTPEKSLLQPLPKKAGRNNQGKLTVRHHGGGHKR
QYRVIDFKRNKDGITAKVDSIQYDPNRSANIALLVYADGEKRYIIAPKGLQVGQVVESGA
DADIKVGNALPLQNIPVGTVIHNIELKPGKGGQLARSAGASSQVLGKEGKYVLIRLRSGE
VRMILSTCRATIGQVGNLQHELVNVGKAGRSRWKGIRPTVRGSVMNPNDHPHGGGEGRAP
IGRPSPMSPWGKPTLGKKTRRGKKSSDKLIVRGRKKK
>SEQF2892_01866 50S ribosomal protein L23
MEARDVLKRPVITEKSSEAMAEDKYTFDVDTRANKTQVKIAVEEIFDVKVANVNIINYKP
KKKRMGRYQGYTNKRRKAIVTLKEGSIDLFN
>SEQF2892_01867 50S ribosomal protein L4
MANYDVLKVDGSKSGSVELSDSVFAIEPNNSVLFEAINLQRASLRQGTHAVKNRSAVRGG
GRKPWRQKGTGRARQGTIRAPQWRGGGIVFGPTPRSYAYKMPKKMRRLALRSALSFKVKE
NNFTIVDNFGFEAPKTKEFKNVLTTLEQPKKVLVVTDSEDVNVELSARNIPGVQVSTAQG
LNVLDITSADSVIITESAAKKVEEVLG
>SEQF2892_01868 50S ribosomal protein L3
MTKGILGRKIGMTQVFGENGELIPVTVVEASQNVVLQKKTEEVDGYNAIQVGFEDKKAYK
KDAKSNKYANKPAEGHAKKAGAAPKRFIREFRNVNVDEYEVGQEVTVDTFEAGDIIDVTG
TSKGKGFQGAIKRHGQARGPMAHGSHFHRAPGSVGMASDASRVFKGQKMPGRMGGNTVTV
QNLEVVQVDTENNVILVKGNVPGPKKGFVEIQTSIKKGNK
>SEQF2892_01869 30S ribosomal protein S10
MAKQKIRIRLKAYDHRVIDQSAEKIVETAKRSGAEVSGPIPLPTEKSVYTIIRAVHKYKD
SREQFEQRTHKRLIDIVNPTPKTVDALMGLNLPSGVDIEIKL
>SEQF2892_01870 hypothetical protein
MKRNTKVALALISFFLLICEFFYGIPFLGGSFILGFGWQPLLINAFLYLILAIILLVDNQ
NAIKPMSIIPVIGLVGSFIAFIPIVGMFVHWVLFFLLVFFIFIVLSAPTYIRNKDAKVIY
TQYKDDHSNKW
>SEQF2892_01871 Guanine/hypoxanthine permease PbuG
MKKYFQFDEYDTNYKKEIIGGITTFLSMAYILAVNPQVLSLAGVKGVSGDMKMDQGAIFV
ATALAAFVGSLFMGLIAKYPIALAPGMGLNAFFAFTVVLTMGIPWQIGLTGVLCSGIFFA
ILTATGLREIIINAIPYQMKMAVSAGIGLFITFVGLQSAGIIVKNDSTLVTLGHLTKGPV
LLAIFGIAITIILYARKVPGSIFIGMIITAIVGMITGLIHTPSGVVGKIPSITPTFGAAF
EAFKDPSQLFTIQFLIVILTFFFIDFFDTAGTLVAVATQAGIMKDNKLPRAGRALFADSL
ATIVGAIFGTTTTTSYIESTSGVAVGARTGFASIVTGICFLLALFFSPLIEIVTSAVTTP
ALVVVGILMAANFAEINWKKFEVAVPAFITIIMMPLSYSIATGIACGFIFYPITMLITKK
HKEVHPIMYFLMVLFILYFVFVHG
>SEQF2892_01872 DNA topoisomerase 3
MKSLILAEKPSVARDIAEAMNIKGKRNGYIENEKYVVTWALGHLVTNAQPEHYDKAYKEW
KLEDLPIIPKRMQTVVIGKTSKQFKTVKSLILDKKVKEVIIATDAGREGELVARLILDKV
HNKKPIKRLWISSVTKKAIQEGFKKLKDGREFQHLYEAALARSEADWIVGINATRALTTK
YDAQLSLGRVQTPTIQLVNARQQEINHFKAKKYYTLSTEIGGLTFQLSTNKQHMTKEDAT
QIANEIKHVEGNVDSVEKKVKKSHPKPLYNLTDLQQEAYQRYKMGPKETLNTIQNLYERH
KVLTYPRTDSNYLTDDMVDTIKERLYALLATDYKSQVKSLLGQSYSSKMRIFKNHKVSDH
HAIIPTEVRPDMQSLSNRESKIYMMVAERFLESLMAPHEYEAVRVNVTVGQHIFAFNEKV
TRQLGYKALKMNNDNVVKKVAFQKGEKYHLQSLKVNEHETTPPDYFNEGSLLKAMENPQN
YIQLKEKKHANTLRQTGGIGTVATRADIIEKLFNLNAIESRDGKIKVTSKGKQILDLAPQ
ELTSPLLTAEWEEKLLLIEKGRYNSRHFIDEMKAFTQSIVNTIKNSEQKYKHDNLTTTEC
PTCGKFMIKVKTKNGQMLVCQDPTCKTKKNVQRKTNARCPNCKKKMTLFGRGKDAVYRCV
CGHTETQEQMDKRFKNKSSGKVSKKEMKKYMNNEDSLENNPFKDALKNLKL
>SEQF2892_01873 hypothetical protein
MDIVKVSNLNQIISFINTSSDTLASYIYKLHTSKGDVEQLLNESIHTTGVFCLIEDDSIV
ALITGILYEEDKYKVIGPFVSKDFTLTDNHFISLFSTLMESQSDHATFNFSYNDCAQDSK
PLMKLIHANYNFTDYYLNVYKSLNEPESDFNIIEYQPGFQRAFSKLHEQTFRHNALTPKE
IVNTLDEHNRLFLFVSEGLLKGYLYLQIDTLSSLAEIRYFSSHTDYRLKGIAFDLLSYAI
HYAFEHYSIDKVYFKIRSKNATLVERFNELGFEIESEYTKYKIDPSQLNY
>SEQF2892_01874 Glucose uptake protein GlcU
MQFIDILIALLPALFWGSVVLINVFVGGGPYNQIRGTTLGALIVGIVLLLIGKAQFDNLT
VIIVGLISGALWAFGQGNQLRSISLIGVSKTMPISTGMQLVGTTLFSAIFLGEWSTGIQV
TMGIIAMVLLVTGITLTSLRGKNEGKSNDPEFKKAMLILVISTIGYVGYVVIADIFGVSG
TDALFFQSIGMAIGGFLLSMKHETNIKSTALNLIPGVVWAIGNLFMFYSQPKVGVATSFS
LSQLLVIVSTLGGIFLLGEKKDKRQMIGIWSGIILIVIAAFILGNLK
>SEQF2892_01875 Glucose 1-dehydrogenase
MFSDLEGKVVIITGAGSGIGKSFAENFGKSKAKVVLNYRSDRHLDEIEEIKHMISNAGGE
AIAVQADVAVEEDVKRLVQSAVKEFGTLDIMINNAGFEKPIPTHKMSVDEWQKVIDINLT
GAFVGSREAVNQFLKEDKKGIIINTSSVHDTIPWPNYVNYAASKGGLKLMMETMSMEYAQ
YGIRINNISPGAIVTEHTKEKFSDPETRAETLEMIPAKEIGEAQDVANVALFLASDLANY
IHGTTIYVDGGMTNYPAFMGGKG
>SEQF2892_01876 hypothetical protein
MTEQFIMIILLIALGYLLKRINFLKAADSQVLSTLVLNVTLPSLVIVNLNSAELDFSFSI
LPIMMIVYGVLAKFTVLWLFNKHNNHIKGTVGMMTASLNIGLFAYPLVDTIWPKNGMIYF
GMADIGGAIIMFGVTYFVGSYFSQGGDQFDFKFLGKKLITSVPLVTYIVMFTLNMLNIHL
PKVSIDFFTIISKANMPLSMILLGVMLNFKIERHFLPIAVKYLLAHYGLGLLAGLLVHFF
LPVSDNMIKTTLLIAWLLPVGVAIIPYSIQFKYKTLPLVGMVTNISIILSIIILYVYQAI
FI
>SEQF2892_01877 hypothetical protein
MNLESQLDELKYDYVRLQNDLEKRESLNQNIDPLVKQLEDIELQISEIRSKLRQK
>SEQF2892_01878 hypothetical protein
MKLYLLLLPILYLIVSYISIFKMHSIITRILRIIMGVLLLFVLAVTTLQFPAENWWVFIV
LALLVGNVEVTAFKELKHDTKAVSILNILSVILFIIYVILTFIMY
>SEQF2892_01879 Swarming motility protein SwrC
MIKRMLTFSLGNKFAIFLMVVLVILGGVYSSAKLKLELLPDVENPVISVQTTMPGATPQT
TQDEISSKIDNQVRSLAYVKSVETQSIQNASIVTVEYNNGTDMDKAEEVLKKEIDKLDFK
DGVSEPELTRNSMDAFPIVAYSFTNKNDDLKTTTKEINDQLIPKLQTIDGVQNAQLNGQT
TRQVTLKFKQNKLDEAGLTADDVENYIKTATRETPLGLFQFGKNEKSLVVDGQFKSVKAL
KDLEIPLTISGQSQSGSSDDQSGSEMSSTGDNASSSSSQSQMSNQSQASNGEMPSVPLSE
LATITVGDERESISKTNGKDAVNVQIMKAQDANTVQVAKEAQNKIDEFVKNNDDIKATKT
MDTAKPIEDSLYTMVEKAALGTIVAIIVILLFLRNIRTTAISIVSIPLSILIALIALKLS
DVSLNILTLGALTIAISRVIDDSIVVVENIYRRLSDPKEELSGNNLVISATREVVKPILS
STIVTIIVFLPLAFVSGSVGEMFRPFALAIAFSLLASLLVSITVVPALASTFFKKGIKLK
RNSQHQNDRGLGVVSKSYRKILNWSLNHKWIVLIISVVILVGSIALGGAKLGTSYISTGD
DKFLAVTYTPKPGETEKAVLDHAKQAQKYLQSKDKVKTVQYSVGGPSPADPTGSTNSMAI
MVEYDKDTPNFEEEPDKVISHLSKMNQPGEWKNQDMGNGSGNDSVEVTVKGPSTNAIKDT
VAKVEQKMKSVNGITNVKSDLSQTYDQYEIKVDQNKATEKGISAGQLALNLNENLPEKTI
TTVKENDNKVDVKVKQNKQTDWSRNKLNNMELKSPTGETVKLKDIAELERTTTPSKLVQE
DGDYATTVSGKITDSDVGGVSSKVMNKINNIDKPDNVKVNVGGATDDINQAMTQLAFAML
VAIVIVYLVLVITFKGGLAPFTILFSLPFTIIGVVLALLITGETISVPSLIGMLMLIGIV
VTNAIVLIDRVITNEHEGMSMKEALLEAGGTRIRPILMTVIATIGALLPLLFGQDSSILI
SKGMAATVIGGLISSTLLTLIVVPVIYEILFTLKGKLTRK
>SEQF2892_01880 Lipid II:glycine glycyltransferase
MEKMNITNQEHDAFVKAHPNGDLLQLTKWAETKRLTGWYSKRVAVGEDGEIKGVGQLLFK
KIPKLPFTLCYVSRGFVTDYSDKAALEQLLEETKKVAKAEKAYAIKIDPDVEVDKGIDAL
KNLNALGFKHKGFKEGLSKDYIQPRMTMITPIDKLDEEIFQSFERRNRSKVRLSLKRGTK
VERSNREGLKNFAELMKITGERDGFLTRDLSYFQNIYDSLHEDGDAELFLVKLEPKPVLD
DIDNELKELESEKTQLQNKYERKQDKKTKNKLNDVEAKIQKTIERKDDMTDLLAKHPNGI
YLSGALLMFAGSKSYYLYGASSNDYRDFLPNHHMQYEMMKFAREHGAKTYDFGGTDNNPD
KDSEHYGLWAFKRVWGTYLSEKIGEFDYVLNQPLYQLIEQVKPRLTKAKIKISRKLKGK
>SEQF2892_01881 hypothetical protein
MRYLLLILFILFNTIAIGVTMTQPLTVSYFSLRVMFVGLSFVLTIFFLLLRKSKVTTYLS
ILSLILSIVHMTLIAHSTYIYLY
>SEQF2892_01882 hypothetical protein
MELRFDHIIHYVDNLKNFKYPGEILKINSGGKHHKFGTYNRLSYINENYIELIDVEDKEK
LNKESKTEEGRVAFATKIVQDHYKQGFKTIALRTSNIELIKKSLEERNIDTIGPVEMHRE
NKKGDKLNWKLLYIADPDYMVKPPFFIEWEEREEVHNQKLEPLFQKQFKIHKIIIDSEKR
SKTLSKWKKWFDVTILEEGDNYTDVQLTVDHIIYRIQDGKTSGYNTIIFKDTETTVPYSI
ITKGAKYRFEPEG
>SEQF2892_01883 putative HTH-type transcriptional regulator
MLTNEFFNSFIGLYRPYMKRTQSILDQFDLHPGQWLILRDIASTSPTTLVHISKRRFIEK
PTTRKIIKVLSDRELLIVEPSKEDKREKLLSLSDKGQTLYVDVYRKILPVQRELIKNARL
SDVELENVISVMNKLHHAFLEEESE
>SEQF2892_01884 Antiseptic resistance protein
MTQNTDIKQPIFTKSFTVNFSINFFVYLCMYLLLVIIADYSKSTYHASDSLAGLVVGLFI
IGSLIGRFGTGKYVNKFGPKKILITGLLLLVITQLLYFIPGSITFLMFVRLINGIATAIA
TTATGTIAAHVTPVERKSEGISLFSLSLVLGTAIGPFFGILLLKSFSINLLFAICVVLGV
ISLIISLFIKIDFDAVHNNTDAKIAKASGFNIHNFIAKEAVPVSIVMMVIALNYASILTF
LKFFAEQRHLLEASSYFFICYAIASLVTRPIAGRMIDARTENVVVYPAFIALIITFIILV
FSYSGWMLLLAGIFLGIGYGNLSSSMQAIAIKVSPTNKYGIATSTYFIGLDIGIGFGPSL
LGLFTGFISYTEVYIIMAIVAALCTVLYFIVHGRKVKTQLN
>SEQF2892_01885 HTH-type transcriptional regulator SarV
MTTEKVQRFIAAERELSQLKHWLKSSYKISIEEFVVLFKVYEGKKISGKELRDTLHFEML
WDTSKIDVIIRKIYKKELISKLRSETDERQVFYFFNATQQKLLDKMKSEIEAISIAN
>SEQF2892_01886 GTP 3',8-cyclase
MVAQIKDKLGRPIRDLRISVTDRCNFRCDYCMPKEIFGDDYVFLPKDELLTFEEMVRIAK
VYAELGVKKLRITGGEPLLRRNLYQLIAELNQIDGIEDIGMTTNGLLLKKHGQKLYDAGL
RRINVSLDAIDNEVFQAINNRNIKATTILDQIDYAVSIGFHVKVNVVIQKGINDDQIIPM
VDYFKDKNIEIRFIEFMDVGNDNGWDFSKVVTKNEMLDMIESHFDIEPVPPKYFGEVAKY
YKHKDNGAQFGLITSVSASFCSTCTRARLSSDGKFYGCLFSTVEGFNIKSFIRSGVTDDE
LREQLITLWNVRDDRYSDERTEQTVKNRQRKKINMNYIGG
>SEQF2892_01887 putative molybdenum cofactor guanylyltransferase
MKAIILAGGHSERFGKAKAFAEIDGQLFYQRIVQTLQETNMFNDIIISTNDQLANQFKHD
NVIIDDANNKDKGPLAGIHTVMKQYNDEELFFVISVDTPMVTGKAISALYQFLVSRLIED
QIDIAAYSEHNRVIPTIAFYHPNCINVMDEALASNDYSLRHVYNNVTTECLDVTNIQSPE
YWYKNINYQEDLDDLKQQINH
>SEQF2892_01888 Molybdopterin synthase sulfur carrier subunit
MKVLYFAEIKEILQTDSETIDINESINVDAFKQNLFERHPSIKSKKFQVAVNEEFVQDED
IIQPTDTVALIPPVSGG
>SEQF2892_01889 Molybdopterin synthase catalytic subunit
MKQFEIVTEPIQTEQYREFTINEHQGAVVVFTGHVREWTKGIKTEYLEYEAYIPMAEKKL
AQIGDEIEARWPGTITTIVHRIGPLQISDIAVLIAVSSPHRKDAYRANEYAIERIKEVVP
IWKKEIWEDGAEWQGHQRGSHDLATKGED
>SEQF2892_01890 Molybdopterin-guanine dinucleotide biosynthesis adapter protein
MILQIVGFKNSGKTTLMQHTIQFLKSYGYTIATIKHHGHIGEDITLQEDHVDHMKHFNAG
ADQSIVQGEHYQQTVTRAYKQNLTQMIDQSVTIDCNIILVEGFKDEHFDKVVVYQTTEEL
ERLKQLTGVKYCYDVHDKHALSHYDNWLLQWIEQRD
>SEQF2892_01891 Molybdopterin molybdenumtransferase
MSVEKRNPIPVKEAINRVVQQDIYLNTAEVKLEDSLGYVLAEDIVATYDIPRFNKSPYDG
FAIRSKDSAGAYSENRKQFKVIDHIGAGSVSEKILGQNEAVRIMTGAQIPEGADAVVMFE
QTVEDGDTFTIRKSFEANENVSLKGEETTTGDIVLKKGQVINPGAIAVLATYGYSKVPVT
QRPSIAVIATGSELLDVDDELQPGKIRNSNGPMIKALSEKAGLNVEAYKIQQDDLQSSIS
VVKDAMSKHDIVITTGGVSVGDFDYLPEIYKAVNAEVLFNKVAMRPGSVTTVAVANGQYL
FGLSGNPSACFTGFELFVKPAIQHMMGATAYYPQVVKATLMEDFTKANPFTRFIRASATF
SQSGATVVPSGFNKSGAVVAIAHSNSMIMLPGGTRGFKAGHTVNVILTESNVYETEMTL
>SEQF2892_01892 Cyclic pyranopterin monophosphate synthase
MSKFTHINEQGNAKMVDVSNKNITKRTAQAHSSITVNETIYQQIIDNTNKKGNVLNTAQI
AGIMAAKNTSTIIPMCHPLPLTGIDVQFNWQINDNTTYTLNITAIVSTTGKTGVEMEALT
AASATALTVYDMTKAVDKGMIIGETYLESKSGGKSGDYRR
>SEQF2892_01893 Molybdenum cofactor biosynthesis protein B
MHQHDHAKVDRMIQCAVLTVSDTRDKETDKGGQLVQTLIQDINVEVLNSNYAIVKDDKVA
IQSQIEQWLASDIDVIITTGGTGIAQRDVTIEAVKPLLDKEIEGFGELFRYLSYTEDVGT
KALLSRAVAGSVKNKLIYTLPGSTGAVKLAIEKLIKPELNHMLHELNK
>SEQF2892_01894 Sulfur carrier protein ThiS adenylyltransferase
MTSERYSRQTLFKGIGYEGQQKISQKHVLIVGMGALGTHVAEGLVRAGIKTLSIVDRDYI
EFSNLQRQTLFTEEDANTMLPKVVAAERHLKALRHDLKLNTFITHVDYYFLDKYAKHVDL
IIDATDNFETRQLINDFAFKEKVPWIYGGVVQSTYIEAAFIPGETPCFNCLMPQLPAINL
TCDTVGVIQPAVTMTTSFQLRDAFKLLTEQSVPTKLTYGDIWDGQHFTFGFSRMFRKECP
TCGSNPSFPYLNKQHTLYATLCGRDTVQYDNDKISQEMVREFLKQHHLNYRENKYMIMFE
YKGHRIVSFEGGRMLIHGTTKTLDAIHLINQLFG
>SEQF2892_01895 Molybdenum import ATP-binding protein ModC
MLELKLQYQLKKTFIDININDTVPKIYAIRGPSGIGKTTVLNMIAGLRTPDKAYIKINDR
LITDTEHKVNLKIQNRKIGYLFQDYQLFPNMTVYKNITFMSKPSVHIDDLMDRLNIHHLK
EQYPSTLSGGESQRVALARTLSTKPDLILLDEPFSSLDDATRGEGIKLIKRTFKEWKIPI
IFVTHSNFEAEVLADKIIKIG
>SEQF2892_01896 Molybdenum transport system permease protein ModB
MPDITPFWISIQVAVISTIIVSVLGIFVCRLLYKGKGHLTKLLESFILLPIVLPPTVLGF
ILLIIFSPRSVVGQFFENILHLPVVFTMTGAVIASVIVSFPLMYQHTIQGFRSINPKMLN
TARTMGASENKIFYRLILPLSKRSIIAGIMMSFARAIGEFGATLMVAGYIPNKTNTLPLE
IYFLVEQGRENQAWLWVLVLVAFSITVIGVLNFANKDKYREVE
>SEQF2892_01897 Molybdate-binding periplasmic protein
MNIKHFMAVIVTLVIILAGCSNSGSNDSGNKSSDSNKKDNDKKQELQISAAASLGDVSKA
LEKEFKKDHKNVDVSFNYGGSGALRQQIEKGAPADVFMSANTKDVDMLKDKDKAHDTYKY
AHNKLVLVGDKNSDKSSVKDLKDNEKLAIGEVKTVPAGKYAKQYLEDQGLYGEVKDNLVY
AKDVKQVLNYVEKGNAEMGFVYETDLYTDKKKTDKVNEIKEAKLKKPITYEAGATSDKKL
AKEWMDFLKSKKAKDILKEYHFEI
>SEQF2892_01898 Sulfurtransferase FdhD
MNKDVLQGQSIIRYEEGQLIQTTDSYVTEFPLTINVNGTEFATVICSPTHMEELVVGFLA
SEGAIYKKEEIKSLQIDDSKGFAHVELTKDLGDRFEYSTKRMIASCCGKSREFYFHNDAA
IAKTSMSKITLTPKQVLNMMTGLQTASTLFKQTGGLHNAAISDGDEFFEHRQDIGRHNAL
DKLYGFCLERRIPVRNKVLIFSGRISSEILLKAAKIGVGVILSKSAPTTLAITLANDLNI
TAIGFIRDGSFNIYSHPERIKATE
>SEQF2892_01899 hypothetical protein
MSNISIHNIAQDGHLYHEDKQKIIYLTPSEPLKYDTNKWFYKEMPALEQWFKDMTSQYEL
HQKQDSNHLAFTFPENERLSQEWINAIKDRGFQLGILEFYIIEGTELAQLTSRKDIDIKE
VDESNIEDYLNIYYSFALPYGKPFAIESVNNARQTILQKKDSKKRLVAYVDNEPVGTVDV
IITDETIEIDSFGVIEQFQRQGIGSTIQAYIGNLANERPVILVADGEDTAKDMYTKQGYM
YQSFVYHIVKEEVN
>SEQF2892_01900 Biotin transporter BioY
MNTRNLVYTALMTAIICVLGLVPGIPLPIMPVPIVLQNIGIFLAGIILGKKYGALSVIVF
LLLAAAGLPVLSGGRGGIGVFAGPSAGFLFLYPVVAFGIGFVRDQYFNKINFAVLFVTTL
VIGVLFLDIVGTIIMGFIIHIPVSKAFLLSFTFMPGDIIKAIIASLIGVTLLNHSRFKSL
IQ
>SEQF2892_01901 Pyrimidine-specific ribonucleoside hydrolase RihB
MSKVYFNHDGGVDDLISLFLLLQMDDIELVGVSTIGADCYLEPSVSASCKIINRFSNKSL
QVAPSYERGANPFPKEWRMHAFFMDALPILNESTTNEKSTISDVEAYEDIIRVLNQSNEP
VTLLFTGPLTDLAKALKIEPSIQNNIEKLVWMGGTFLEKGNVEEPEHDGTAEWNAFWDPE
AVKTVFDSEVAIDMVALESTNQVPLTLDIRQMWADQRQYPGVDFLGVSYATVPPLTHFIT
NSTYFLWDVLTTAYIGKPDLVQYKSLNVDVKFKGPSQGRTFIKESGRPIKVVTDVKHDDF
FNYITNLAKKVDSPS
>SEQF2892_01902 Iron(3+)-hydroxamate-binding protein FhuD
MKKLILPLLVLIIVLAACGNNGGSGKSDSKEETKSYKLDSGKTIKIPKDPKRIAVVAPTF
AGGLHKLGANIVAVNNQVDQSPILKEKFKDTTKIGEADVEKVAKKKPDLIIVYSTDKNIK
KYQKIAPTIVVDYGKHKYLEQQEMLGKIMGKEDEVKKWEDKWKKQTEKDGKEIKDAIGKD
STVSILDEFDKKVYTYGDNWGRGGEVLYQAFGLNMPKGQQDLVKKEGWAEVSQEKIEDVA
GDYIVSTGEGKSKPSYETTNIWKNLPAVKNNNVIEVKAETYWYNDPYTLDFMRKDLKDKL
LKASK
>SEQF2892_01903 Putative acyl-CoA dehydrogenase YdbM
MIDSVLINTDIQKKWIKKFQSIEETFKARATENDKQSRFPYENIEWLVKEGYSLLTLPVE
YGGEGATIEDMVVLQTYLGANDGATALSIGWHLSVVGQIYEQTMWNQDMLNRFAKDIESG
ALVNRAVSEADTGSPTRGGRPATHAVKQDDGYLLNGVKTFTSMSKALTHYIVAAYVADLQ
EVGFFLVPREFDGVEIAENWNMVGMRATESHDLVLNDVWVPKDFFVESKRKPQPNGWILH
IPSTYLGIAQAARNYAIDFATSYGPNSIEGTISHLPTVQQNIGKMESLLLSARHFLWSTA
KGYNYSENQPHLWNETSASKVLVMNQGLEVVDLAMRIVGAKSLEMDRPLQRYYRDMRAGL
HNPPMEDAAYTNIAKSLCNLF
>SEQF2892_01904 HTH-type transcriptional regulator SarR
MGQIKDINDLVNATFQVKKFFKDTKKKYNLNYEEVYILNYIARSKTNEITSKEIATYSEF
KPYYLTKALQKLKDLQLLSKKRSVQDERIVIVYVTDEQRDKINKLIAELEKYIK
>SEQF2892_01905 hypothetical protein
MILDNVNPNDLFPTESKGPSVLGVIEYNVQGQSEFEGAFIATSERLIMNVDMNGQFYYRN
IPYNEIEEIHFDGTDIVFTFNIGKVPMKQIKTKDVKAFVDYVESKIK
>SEQF2892_01906 hypothetical protein
MMDKNKLETLLFYLVFMKAVGEVLKYSYQLKFEQLKTLNEIIKYFHVHHQGVYIDELITY
QTISKRQLRHHLEHLYHLGWITKLRDDNDQRRLLFLPSNSCQDKLNIMFMEVSEMVKGKN
FDHLIETTAHYNQLGHVITIFDALYKVRNIAKESNLSLDELLLLGKLLSSRQVISLKEIQ
AMSYRYLICMNVVINDLYQKGYLEKYRNSIDERIVNVKFIESRAYETNQLFIRCYNKFQE
EMK
>SEQF2892_01907 Bifunctional transcriptional activator/DNA repair enzyme AdaA
MIDNFSVKLLKNIKISSQKESNIKLIYWLKGSGRVILNLKKFQMKERDLLFVMLNDIYSI
ENEDGAIIASIEIAFKDYLKYADDYIKSNGYKFPSIERKQLEPFILNLLDFESSKSDKLQ
INDKLVKHLCVELGYLQRNQRIHYKLDNALVDKVHEYIINHHSNKISRQDMANALNMSAK
ELSKVIKYHTPYHNITQYINDVRLKLCLIDILKSNHLIQDIAYKHGFNHFPHFIALFNKK
YGITPGQIRTKNQSHQYQSFNQSEIPLDEETQLLIAEAKDNYSLTE
>SEQF2892_01908 Staphylococcal secretory antigen SsaA
MKKIATATIATAGVATIAIAGHGHEAHAAEQGYNPNDPTSYSYSYTIDQQGNYHYTWKGN
WSPNQVNHSSQSNYSYNNYSYNYNNYNNYSNNTQSYSANTQQTGGLGASYSTSDRNIKVT
TTTAPSSQSTGVSISRTSSSGSNLYTAGQCTYYVFDRVGGKIGSTWGNANNWASAAAASG
YTVNNSPSAGAILQTSQGAYGHVAYVESVGSDGSVTVSEMNYGHGAGVVTSRTISASQAA
SYNYIH
>SEQF2892_01909 hypothetical protein
MCKSILNTLRIKDKNLNFSDEVIEKKHKGRMSLFYYAELTYQPTHCENCSTKNENFSIVK
NGKKTSTITLLKIMEMPAYLELQKQRFYCKSCDSHFTAKSNIVDAHCFISNKTKLAVLDK
AQEYRSQKSIAKSCLVSSMTVSRVINQAASDVGQSSFDALPEHLMMDEFKSVKNVIGKMS
FIYADAVSHRIVDVVADRKLKSLKDHFYRYSLKLRQKVKTVTIDMYEPYMSLIKQLFPNA
KIIIDRFHIVQSLNRALNMSRVHVMNCYRTFNRPLYNKYKSYWKLFLKPFETLEAFNYHK
VHLFKEWKTEKGIINYLLGVDVELFNTYRYVHELRRLLKENQIEKFNHKLFSIHLSDVCP
KLRPVIRTLRRLAAFIENTMTYSNLTNGPLEGINNKIKLIKRVSFGYRNYDNLRNRIIIT
SRLFASTTKKEIKQLKVA
>SEQF2892_01910 Malate-2H(+)/Na(+)-lactate antiporter
MKRQPSFLEAISTIIVMVIVVTLGFIKFNIPIQVLLLISSAYAALIAWRVGLKWKDLEEG
ITRRLTTAMPAIFIILAVGIIVGSWMYSGTVPALIYYGLKFLNPHYFLVSAFLISAISSL
ATGTAWGSASTAGIALISIAHQLNIDMGMAAGAIIAGAVFGDKMSPLSDTTNLAALVTKV
NIFSHIRSMMWTTIPASIIGLIVWFFAGLTSKGSVNTKQINKLLNELDGIYNINIWVWVP
LLVIIICLVCNVSTVPSMLASSLSAVIIGTLNNHFNIVDGFKAMFNGFTPAMTGQSNLST
NATSLLEQGGMMSMTEILVTIFCGYAFAGIVEVSGCLDVMLKTVSKGIHSVGTLILITVI
CCLMLVFAAGVASIVIIMVGVLMKDMFVSRNLDKSNLSRTLEDSSTMVLPLIPWGTSGIY
YTQQLGVSVDQFFIWTVPCYLCAVLAIIYGFTGIGIRKLDNKSYVKNS
>SEQF2892_01911 Opine dehydrogenase
MKIAVVGSGNGAVTAAVDMVNQGHDVKLYCRNSSIKKFNNALEKGGFDFNNEGAESFVPF
TEISDDIEYVLKDAEIIQVIIPSSYIEYYAEIMAEHVTSDQLIFFNIAAAMASIRFINVL
EDKHIEVESKFAEANTLTYGTRVDFENARVDLSLNVRKVFFSTYNKKELSDSFEKVSQIY
PYLVKEENLWKTNLENGNPEVHPGPTLLNVGRIDYADSFALYKEGITKHTVRLLHAIELE
RLTLGRKLGFELLTAKEARIQRGYLERKDEDEPLNRLFNTSPVFSQIPGPNSVQNRYLTE
DIAYGLVLWSSLGRAIDVETPNIDAVIMIASTILERDFFDEGLKVEELGLEKLGLE
>SEQF2892_01912 hypothetical protein
MSDYYEQSQDSTVKRDNEDDARLMSMLIFLLGFFTSVIGPIIIWAIKRNESRLVDKAGKN
YFNMLISYLIWNFVVGICMVPVFFIYVVNNEAAIIIATILLFVLSLLLIVLSILYVVFHI
VACVKYFGGKEYVVPLSIRFFK
>SEQF2892_01913 Staphylococcal secretory antigen ssaA2
MKKIITISTLTAGIGVSSLGLNANHADAAEYNHNPAPQHNQFGQQGPHGQNMQFSHQQGQ
GYQQPQFKQQSFNYNQSTTTSTTLDGSSSSSSSSTTTSSSTQTTSSTSGNLYTAGQCTWY
VYDRVGGKIGSTWGNANNWASAASAAGYTVNNTPEKGSILQTSEGSYGHVAYVESVGSNG
SVTVSEMNYSGGPYVKDTRTISASQASSYNYIHLS
>SEQF2892_01914 Multidrug resistance protein YkkC
MQWLKVILAGLIEVIWVIGLNNAHNFVTWLFTLVFIALSFYLMISASKQLPVGTVYAVFV
GIGAAGTVIADMLFFGEPFTIMKVVLLLLLLVGIIGLKLSTNDSPKGGM
>SEQF2892_01915 Multidrug resistance protein YkkD
MSWLYLLIAGLLEVLGVIWLNQYARSKQKFYIVLMAITFIFSFSFLKLAMTTIPMGTAYA
IWTGIGTAGGAIVGMLFYKESTHFSRIIFIFLILFSVIGLKMI
>SEQF2892_01916 Putative 2-hydroxyacid dehydrogenase
MEKVYIAGAIPEVGLNLLKEHFEVEMYEGEGIIDKATLMEGVKDASALISILSTNVDQEV
IDSASNLKIIANYGAGFNNVDVKYAREKDIDVTNTPKASTASTAELTFGLVLAVARRIVE
GDKLSRTQGFDGWAPLFFRGREVSGKTIGIIGLGEIGSAVAKRAKAFDMDILYTGPHQKK
EKEREIGAKYVDLNTLLENADFITINAAYNPDLHHMIDTEQFKLMKSTAYLINAGRGPIV
NEEALVKALEDKQIEGAALDVYEFEPEITEGLKSLDNVVITPHIGNATYEARDMMSKIVS
NDTIKKLNGETPQFIVNK
>SEQF2892_01917 FAD-dependent urate hydroxylase
MKIAIIGAGIGGLTAGALLLEKGHDVSIFERQSNISEVGAGIGIGDNVIKKLGKHDLAKG
IKNAGQNLSAMNVLDDKGNILSAVKLKEATLNVTLARQTLIELIQSYVNPQCIYTDHDVI
RVENVEQHTMVHFSNHASQSFDLCIGSDGLHSVVRQAIHQNAKILYQGYTCFRGLVDDAD
LHNIDIASEYWGKRGRVGIVPLINNQAYWFITINASEKDPKYQTFEKPHLQAYFNNYPEP
VRQILDKQSETGIQKHDLYDMKPLKSFVNQRILLLGDAAHATTPNMGQGAGQAMEDAIVL
VNCLAEYDIEKALKRYDKLRVKHTAKVIKRSRKIGKIAQKDNKLVISLRNGVMKRTPNRL
LSGQTKFLYKAKHK
>SEQF2892_01918 Bifunctional autolysin
MKQLNQMRLPFILLLIIIIVFIVLLIINHSELLDNDRNYSFQEAIQKQTDSSVLNTVDRD
GEFVNANSREIERAMRITRDDNKFKYMDISQQVPMSKQEVKKMLRGNGILENQADAFIEA
QDKYQVNIIYLISHARVETANGNSKLASGIKEGNNRYYNFFGVGAFDESAIHTGKSYAKE
ASWTSPRKAIFGGAKFIRTNYFDNDQITLYQMRWNPKSPGQHQYASDILWADKIAKYMQA
YYDQFGIKKDDVRKNFYAS
>SEQF2892_01919 hypothetical protein
MAERITKIKRLEKSEEQIKIESINEVTDAIAENKDSILKAIRLVKALDEAKILDLMNGGI
RGRQVIINKFMTELNKDLYAGLITNLAPMVFMLGELNVQELSQFLNKLNKGLHVANQANP
NAKTSIRSLMGVLKDDDMNRSLTYMLNLLKGMSREDK
>SEQF2892_01920 Putative formate dehydrogenase
MQEHLIVTLDGTDYLVEPGTSLLEFIKSRDTFVPSICYNESMGPIQTCDTCMVEIDGKIE
RACSTVVDRPMTVNTQNNDVKASQKEALDRILEKHMLYCTVCDYNNGDCEIHNAMDAWGL
EEQSYEYKTKPYEKDYGPFYRYDPDQCILCGRCVEACQDIEVNETISIDWNREHPRVIWD
NDVPINESSCVSCGQCATVCPCNAMMEVNMEGNAGYMTDTEPGSLAAMIDLTKKAEPGDG
LLFAVSDSEAEMRKERIKKTKTVCTYCGVGCSFDVWTKDREVLKVQPSHDSPANKIATCV
KGKFSWGHINSDQRLTKPLVRKDGEFHEVEWDEALDVIETNFKRIKNEYGGDHLAFIASS
KGTNEESYLMQKLSRQVFGSNNVDNCSRYCQAPATKGLFRTVGHGGDSGSIEDLERAAMT
VLIGTNTAEAHPVIASRMKRAQKLFGQKMHVFDIRKHEMAERADAFYQPKPGTDLVWLGA
ATKYIIDNDLHDKAFLNDWVDNYEDYYKSLELFTMDFAEETTGIPKEQIISFAEEAAKAE
SMSICWAMGVTQQDIGSDTSTAISNLLLVTGNYRKPGSGAYPLRGHNNVQGASDMGSMPD
QFPGYQKVADDEVRAKFEKEYGVELNPTPGRDNHQMMEGIHNGDIQSLYLYGEDTGIVDS
NINFVQSALEKVDFLVVQDEFLTFTATYADVVLPASPSLEKDGTFTNTERRIQRINKALQ
PLGDSKPDWEIFQLIAQRMGADWNYKHPSEIMDEIAGLTPSYSGVNYERLQGFNSLQWPV
APDGTDQPTLYMDGFNFENGRAKLFPLTFDNFFKEDEVYDLHVNNGRLLEHFHEGNMTYQ
TEMIKYKVPNAFVEISPELAKDRDIHEGAELRLISETGEATLIATVTDRVKGREIYIPLN
NDAMSNGDLGAINKLTNSDVDKYTDTPSYKRTSCRMEVLTRKGKSPLNPTNFRVDKQRNP
QYSVQVQKKWERPDYVFPGNVVDK
>SEQF2892_01921 Transcriptional regulator LytR
MRRTHRRMSLPVKIITWFIGILVVLAIVASIFVVASIFITSGKIHNPLNRQHSELRSKNV
SLSNGDPFTIALFGVDSNAQRKSENDGERSDTIMLLSINPKKQTTEIVSVPRDTQAEIVG
KETTEKINHAYAYGGPTMAVKSLEKLMNVPIDHYATVDMDGLHDMIDVLGGVNVTSNDTF
TTKGTNFVKGQSTHVDGDTAMAFIRSRKEEGAGGDFGRQERQQLILQAMANKMTSTSALT
HFPSLINQIQKNVKTDLTLNDMNDIRKNYKNANTTVNRHQLEGQGGIQDDGLWYFIPNDD
SKQSATEILNNNLQN
>SEQF2892_01922 Fructose-1,6-bisphosphatase/inositol-1-monophosphatase
MQNKLHNLDAHIMDWLKHLDDVIPNLITDMITDTKINRFDLVTNVDKQLQNKFEAYLAEH
FPSHQLLGEEKDNSMIRPYEGHLWIMDPIDGTANLVKQQEDYCIIIAYFVDGEPKLSYIY
DYPHDKLYKAIAGEGAFVNGQQLMPPNELKLQDAIISFGTQYINDDTSKALYDASFSVRN
IGSCGLDSVRVIKGQFGAHINTNPKPWDIAAQFLFAKELNLKMTQLNGEPLDFAKSGPFI
ISNHGCYKDILTIINRNGGYHI
>SEQF2892_01924 Bifunctional ligase/repressor BirA
MLKKLDRQNQIISLIQQGHTINASELAQHLNVSVRTISRDIVDLENQGVQIYAHKGKNGG
YQIQKSEDKIKLNFTEQQLLSLYLTLIESQSYSTLPYTNEIQSIINQIINIPNTRVRKSL
NQMTNLIKFEDTEQITLPHLFADILIYSSERNVMLIDFIDNQDTIAENVIFIGLLCRNGE
WLSIIYEIGLGRTRELPVLDIYDISYSFEKTIKTYDISIDNYTQFLNPIETTE
>SEQF2892_01925 hypothetical protein
MLPYTIMRQQLIILLTHVEKIRYYYLMDNRFLNREIEAYNTSIKNFTDSLPLTLQNSTNN
SKSKFSMQSDHFFYKLLNDLSLKPLHEFHQGTILVDLQQRQDQLHQTLIYLLNEYK
>SEQF2892_01926 hypothetical protein
MLGFSVYLGQPLNKSYILNMVDLGYDIIFTSLQIPEENDQTKLTYLGELCQLLKDKSVTY
IIDINPSLLNQNVYRFFDQFSNGDFVIRIDDHFNYDLIADLFHHNLQCCLNASTITTEIL
DTLYNQKSLSKVYFCHNYYPRPDTGLALNLFEQRNNLIRKYDEHASIMAFIPGTTLRGPL
YKGLPTIEQHRHMTLLQSAHSLLKYNLDYILIGDTAINYAEAVALQQMIYHRHFKLRLSY
FDKSYEQLIFKQHTSRLDAPENVIRSKYSRLTKVNIPPTNNFNQYRYKGDVTVDNSLNQR
YEGELQVIKADLPNHKAINHVASICDEDKVVIDLIQPGDTFEFITEKEKR
>SEQF2892_01927 N-acetylmuramic acid 6-phosphate etherase
MEHLTTESRNTQTMHLDEMSILEALKTINKEDQLVAKAIEPILPQLNRVIEQTITRFRDG
GRLIYIGAGTSGRLGVLDAAECVPTFNTHPNEVIGLIAGGQQAMTEAIEGAEDNYEMGMT
DLKAIHLNEKDVVIGISASGRTPYVKGALTYANEISALTVALSCNTNSDISTVASHALEV
NVGPEVLAGSTRLKSGTAQKLVLNMISTMTMIGVGKVYDNLMVDLKATNHKLEQRSIHII
EEICGLTFEEAQELYIKADNDIKIAIVMNLCNTTKSDAQSRLINNNDIVKKAIQS
>SEQF2892_01928 PTS system EIIBC component
MNKDQQLAHHILDAVGGIDNVDNIIHCMTRVRLKINNETQVDYPKLKNIEGVLGVIQDER
LQIVVGPGTVNEVSAEMVKLSGVQLGEDIPHRSNTSNIKNQAQQNKREFQQKRKQSKMNT
ILKSIANIFIPLIPAFIGAGLIGGIAAVLNNFITAGTILADWVKQLVAVLNVIKDGMLAY
LAIFTGFNAAKVFGATPGLGGVIGGTTLLTGITEDNPIKNVFTGEPLIAGQGGIIGVILA
VWLLSIIEKKLHKIVPNAIDIIVTPTISLLIIGLLTIFFFMPIAGFISDGLVGVVNWVIG
VGGIFSGFIIGAFFLPLVMLGLHHIFTPIHIELINQSGATYLLPIAAMAGAGQVGAALAL
WVRCKNNTTLRTAIKGALPVGFLGIGEPLIYGVTLPLGRPFITACLGGGIGGAVIGGIGH
IGATAIGPSGISLLPLIAHQKYLGYIIGLLSAYLAGFIFTYFFGTTKEMRNLNKLGD
>SEQF2892_01929 putative HTH-type transcriptional regulator YbbH
MTNILYLIDENYASFSKNEKKLSRFILNSPHKVISMSNQEIAKELEMSVSTLNRYSQKLI
NQSFHEVRSQLAMLFPKQQAPYKIELLNNESVDTLKKKLYHRAEEALLKSSTFADNTTID
NICQHFKRANNIFIFGYGASYVCATDLYQKLSRIGLNVQLVQETHLFTTMLSTHDKEDCV
LFITNNGDQSELRAMVKVVSDYNIPIITISSSEHNHVAQHSDIVLTYGHSDENELRMGAT
TSLFAQMFTIDVLFYRYIALNYESSLDFITQSKMALDNYRKYLSNVEFKH
>SEQF2892_01930 putative transport protein YifK
MDNNELHRGLSARQIRMIALGGTIGVGLFMGATSTIKWTGPSVIFAYLIAGIFLFLIMRA
MGEMIYLNPTTGSFATFASDYIHPAAGYMTAWSNIFQWIVVGMSEVIAVGEYMNYWFPNL
PQWIPGVVAVLLLLAANLTSVKAFGEFEFWFAMIKVVTIVLMIIAGFGLIFFGIGNGGHA
IGISNLWSHGGFMPNGFVGFFFALSIVIGSYQGVELIGITAGETKDPQKNIKSAVNGVIW
RILIFYIGAIFVIVSIYPWNQLGEIGSPFVATFAKIGITFAAGLINFVVLTAALSGCNSG
IFSASRMIFTLAQKGQMPKIFTRVMKNGVPFYPVLAIALGILVGALLNVILPLFIKGADS
IFVYVYSASILPGMIPWFMILISHIRFRKLHPEKVEGHPFKMPGGTVASAITILFLLVVL
VGMLFNKETVVSVVIGIIFLAAVTVYYFVRGHHKNDGFRKVK
>SEQF2892_01931 hypothetical protein
MQSLLKKSVKISIIFGIVFFLLNYFSANHDTVNPLIIRTIIATLTFFLLYLAVFTIFNSD
ERKLKFGITLPISLIVCLIIGGIFFTLEIGIIVGLIIGLAAGFIWEWIDKRNGGTN
>SEQF2892_01932 hypothetical protein
MSVTIGIILIIVLLILSLVPNYKAMQQAKSQGQKSTRFTIMVGIDLILIVLLVVTIILKL
FIN
>SEQF2892_01933 hypothetical protein
MSWQIILFFLAGPIIIGIGNLVLGPIFSKHIPFKVQMRSFLVGTMIYLLLATIGYYLLLQ
GRI
>SEQF2892_01934 Phosphorylated carbohydrates phosphatase
MYKAVVFDFDGTIIDTEKHLYDIINKHLSFHGVKPVSLEFYRSHIGGHAQGLHDYIEQQI
GLEKKQKIYDEHNDTSHELDIIDTVSSLMKYLKQRHIPMAIATSSYREEIMPTINALGID
EYVDVIVGREDVEAVKPDPELYLTAVQRLNYSPAHCLAIEDSANGATGAMNAGLDVIINT
NEMTEAQDFSAITFVGKDLSFEQIKNRFFEPNKE
>SEQF2892_01935 hypothetical protein
MLLDKFETYIINIVGLKSRSTRKHLIKVCKDVKFCDSFQYSIIKHDDIPVLEVSLPKQQL
PYFISFLSFYQFSIYQILSPKRLNTLLDTEQTYQASKRFDLAIDGLQDAFIKDKVIDIMT
YFSNNYEIKYTLNNNCASVCCAPETFSKLLQTIACRNIDILSASYKTRAMHKANIS
>SEQF2892_01936 PTS system maltose-specific EIICB component
MNAIKRFGSAMIVPVLMFAFFGIVLGFATLFKNPTIMSGLANDHTFWFKFWSVIESGGWV
IFNHMEIVFVVGLPLSLAKKAPGHAALAALMGYLMFNTFINAILTQWPHTFGANLEKGVE
NVTGLKAIAGIETLDTNILGGIIISAIVTWIHNRFYSKKLPEMLGVFQGLTFVVTISFFV
MLPIAAITCVVWPTIQNGIESMQHFIIASGYIGVWLYHFLERVLIPTGLHHFIYAPIEVG
PVVAKDGLKAEWFRHLNEFAESSKPLKEQFHYGFMLQGNGKVFGAIGIALAMYSTTPKAN
RKKVAALLVPATLTAVVVGITEPLEFTFLFIAPYLFVIHALLAATMDTIMYGFGVVGNMG
GGLLDFIATNWIPLGQNHWLTYVAQVVIGLIFSGIYFVVFRYLILKFDIPLPGRRAEEEV
KLFSKKDYKEKKGDGSTDNSGFQPSNEYEAKAHYYLEGLGGKENIKDVTNCTTRLRLTVN
DETKVEDSGYFTHEQMSHGLVKSGKNVQVVVGMTVPQVREAFEHLVYDDSDKK
>SEQF2892_01937 HTH-type transcriptional regulator GlvR
MLLDEKVNANFDKLNDNDLQIAHFVNTHVNQCKTLKIHELSQYTHASNATIHRFTRKLGF
DGYSDFKSYLKFESEHLSQLPKDSMDAFKQEIETTLSYLDRIDYNLITDKLNQASTVYLY
GTGRAQKNVADEAQRILLTMHKNIIVLHDVHELKMVLNRSIDEDLFFIISLSGESHQLTD
VTNLLQLRQKYFISVTTMKDNSLAQKASYNVYVSSNTFYLYDGTDYSSFISYHIFFETLL
RKYNERKDNGELS
>SEQF2892_01938 hypothetical protein
MAKYNVENEHVEIHIERLLKYSPELVYQAWTDADLLKQWFMTSQRTNKSIDVDMTESGSY
RIVDSRNGRQNIIQGTYQELVDNEYIKMTIGMPELSDQEDVIEVEFEERENGGTQMFFFY
QSLVERERRLTTLEYKQKKKEYHDSTVHGLELMFDKMHQILEQYVEDNNLLK
>SEQF2892_01939 Malate-2H(+)/Na(+)-lactate antiporter
MEEQRKGNAWALLPLLLFIALFLGVGTITGDFTNMPLNVAITITVIVALIMNRKETFANK
VEVFTKGAGHSNIILMVFIFILAGAFSTTTEKMGGVESTVNLGLSLIPQNLIIVGLFVIC
MFVSISMGTSVSTVAALAPVGFGFAQATDIPAALAMGTVVGGAMFGDNLSMISDTTIAAV
RTQKTRMKDKFKVNFWIVLPGAILTIIVLFFLTNGISIDHSKSYDYNLIKVIPYVLVLVL
ALVGVNVIIVLIGGTLLSGAIGLFDGSFGWKGLLNAVSEGIIGMEDIAIIAVLIGGLVGI
IQHNGGIEWLLNFVRSKVTTKRGAEFGIAGLVSAADIATANNTISIIMSGPLAKNIADEY
DVDPRKSASLLDIFAGCFQGFLPYSPQVIAAAGVASISPFSVMPYCIYSFLLGICGIIAI
ILRYPRVKAKS
>SEQF2892_01940 Flavoredoxin
MKHIDPNQLSDIQNYKLLSGSIIPRPIAFVTSSDIEGNINAAPFSFFNIVNNAPPMIAIS
AQRAGGKRKDTAINIENGQSFVVHVTDEDNVEEINKTAASINPKDNELDLTELNTISSDL
IDIPAIKEAKIRFECQLEQMILLGSEDDGADLIIGKIVKYHIQDDVYFGDSKIDAKQLKP
VARLAGNDYAKLGEQFTIERPSN
>SEQF2892_01941 putative oxidoreductase YghA
MGAQDPRTKFKTSDYEKQEQELPGLQSELTPQPDCGETSYEGHNRLLDYKMLVTGGDSAI
GRAAAIAYAKEGADVAINYLPSEEQDAQEVKAVIEKAGRKAVLIPGDIRDEQFNYDLVEQ
AYKELGGLDNVTLVAGHQQYHDKLEEFDTQSFKETFETNVYPVFWTIQKALDYLQPGASI
TTTSSVQGYNPNPLIHDYAASKAAIISLTKSFSEQLGEQGIRVNCVAPGPFWSPLQITGG
QPQLAIPQFGQDTPLGRAGQPVELSGTYVLLASEESSYTTGQVFGVTGGIQIN
>SEQF2892_01942 putative hydrolase YxeP
MTTYNDYVKWRRTFHQFPEVSQKEYETTKRLKRILKAYEIKIIDYPLETGLIAEIGHGEP
CIAVRTDIDALPITEQVEHEFTSTNEGVMHACGHDIHMASILAIATNLKEQEDKIKGRVK
FIFQPAEETGYGAKAIAETDVLDDVKAILGFHNYPTLNIGEFAIKSGPITSAVDRFEFKI
HGKGAHAAKPEQGNDPVMVLGQLITSLQTIVSRNISAFDSAVVTIGEVSSGNTWNVIADQ
AYVQGTVRSFKPEVQNYIEQRFKEIAKGLEQLFNVDIEVIYTKLPGTVFNDAYLTEQAKE
AAQKVGYQIIELENPYTIGEDFSGLLANHPGVFAFIGSNSKYDLHHPKFDPDERILEKVP
EYFITLIYQLLDDTAFN
>SEQF2892_01943 Bicarbonate transporter BicA
MVMKRLSYKQQWLGEISQNIMAGILMGLALLPVAIAFSFIVHISPTIGLMSCGLMMLFIS
FLGERISMVSGPSSGISIVGAPLVEQYNIHYLIMATLIMGIILIIFGMCHIDKILNHIPD
TVVIGFMNALGILLLTTQIKYIFGITTATYLVAIATFLIIYLSSIFIRFMPAPLIAIIVV
TIASYFLKPNVQLVHDLAEIRLTFPKISVYTELLNLHALSIITLYALTMSIISVVQTNLT
NEMMDVITQSHSNKDREVIGQGLANLIVGLLGGYGSSALVGQSKFNFKMGATTRLATFVT
GLFLLSCVVILGPIVGFIPMAVLASVLITISLNTFDRRTFKHLKEAPIKHSIVMFITIIL
ILMSHNLAIGVVIGTLIYYVIHFIFTKKGRPSL
>SEQF2892_01944 Formimidoylglutamase
MYTQGNPKLWTGRLDSETDPKQFRHFQTVKFANLENMENVSDKTGVGLLGYAVDKGVENN
KGRIGSRKGPDIIKHEFAKLPDLSECEMLIDYGNVEHTSNHLRETQQEMARLSAKVIKQH
KQAFLIGGGHDIAYAQYLATREVYSDASIGIINIDAHFDTRPDEPPTSGTMFREILDNDE
NVDYLVLGLAQGGNTRALYDYAKDNNIIYVYADELLHQVSPTIKDKIERFIHDHDTIMFT
ICMDVIDSAFAPGVSSPSVLGLYPHSVFEISKRVILSDKVSSISIAETNPDYDVDNRTSK
LAANLIHHFLV
>SEQF2892_01945 Lysostaphin resistance protein A
MKSNRISGFQWALTIFVFFVVTMALSLILRDFQASVGIKRFVFDITDLAPFIAAIVCIIA
FKDKRTQLAGLKFSVDIRVIERILLALILPLVIFMIGMFSFNTFADSFILLQATDLSVSV
PTIIIGHILMAFFAEFGFRSYLQNIVENKVNTFFSSIIVGLIYSIWAANTTYGMEYAGYH
FLYTFMFSIIIGELIRATKGRTIYIALVFHASMSFAQVFLFSEETGDLFSMKVIALSTTL
VGIVFIILSLIIRFIVYKTTNRSLDEVEPNNYLDHMNDDDTTTSNETKSEDHEHNDKKDS
FTESQLNEDHVELKSQSENQTDSSNEKLKENTSYKEDRRSSVVDDAKDEIDQMKDTSSHK
TEK
>SEQF2892_01946 Ribose-5-phosphate isomerase A
MKDSKELKIMTVDDAVAQIEDNMVLGIGTGSTIEFLIPKLAERIHKEQLNITGVCTSNKS
AFIAKKLDINVVDINDVGYVDLAIDGADEVDVNINLIKGGGGALFREKVIDEMAHRFVVL
ADESKLVNYLGESFKLPVEVDKFNWFHIAKKIEAYDDIITERRMSDDVPFITDNGNYILD
CQLNKQIDPYQFHEYLIHLTGVLETGYFLNITDQVIVGTQDGVKIINKSN
>SEQF2892_01947 hypothetical protein
MISVCVISVGQIKQLDYGQKREMLSALNKSPISETMWLSRTGFVEDEQAYKDHGGPHKAV
CCFSKSHYQMYKIKYDS
>SEQF2892_01948 hypothetical protein
MFGENLTLKNLDESDVFFGNQYRLGEAILEVSEIREPCWKIQTKYGIKDLVKRMSTSGKT
GFYFRVLQEGYVDQDDDLELIQLADEATRLSVQELNDIYYNDRKNVSRLKYALQNPYLFE
MRLAKLQKLYDNAMN
>SEQF2892_01949 Aldose 1-epimerase
MIVEVEKQRHGIDLIKIDNDETNIVFTNFGARIVSWKYHDNNIVLGNRVEADEFYPSNPY
HFGATIGRYAGRIGNAKFHLNDEEYQLEANNNVHHLHGGSNGLDKRLFNYDIQDNITNIK
VTFTVQLKSMEDGYPGDMTIKVIHTYDVEHRWTVEYEAKTKRDTLFNPTNHVYFNLNRDN
NVIDNHKIKSEQLNMYPIDRNNLIENTSSIDLLAIFKTNSISFSDIFNSDNELLKEQIGS
RNGLDHPFDVGNQQFFIENDEFQLDVTSSMPNVVIYTFNDTKDWDSDFNIYKPNSGISLE
TQFLPNDINLYGNKANSILKANEHFYSKTTYHISEK
>SEQF2892_01950 hypothetical protein
MLYSIFIFLLAGLCEIGGGYLIWLWLREGQSSWLGFIGGVILMMYGVIATFQSFPTFGRV
YAAYGGVFIVMSLIWAYIVDKQAPDKYDLIGACICIIGVCVMILPSRT
>SEQF2892_01951 hypothetical protein
MTKNDEALQVEKITLQAKLGILSLNFLCAIIAFAMFNDLQRQFLSPFFIGSLLLLIVIVC
KLTIHSETVDDIHIYVHDFSDKSKLNRHSKLKRIVYLILWIVYLVLIANIVTPNINHTSN
YEWVFEPSWLILGVGVVVALCMFDDKRIKYTEMDTPTIENRGALPKGVLNLIPNYRYADE
QQKLVILKVHATNFIWITIGLTIVCIVDVIIELILHQMPLAAYITIIFIVVELLILKLKN
KQIRSTLHE
>SEQF2892_01952 hypothetical protein
MNKVKVYRGVKKISQLELARLVGVSRQTINMIENNKYNPSLKLCINIAKTLGVTLNDLFW
EVEND
>SEQF2892_01953 Putative 3-methyladenine DNA glycosylase
MDFVSRPTTETAKALLGVKVIYEDEFQTYSGYIVETEAYLGFTDRAAHGFRGKQTPKVTS
LYKRGGTIYGHVMHTHLLVNFVTQNEGVPEGVLIRAIEPLDGIEMMKHNRNKSGYELTNG
PGKWTKAFNIPRAIDGATLNDCRLSIDTKHRKYPRDIVESARIGIPNKGDWTNKPLRYTV
KGNPFVSHIRKSDCLNPDETWK
>SEQF2892_01954 Sodium/glutamate symporter
MEIDAVTTLCLACLLFLLGEFVVKHVSFLQRICIPPPVIGGLLFAILVAVLDTLNIIQIK
LDASFIQDFFMMVFFTTIGLGASFKLFKIGGKVLILYFVCCAFLAICQNFIGISLAKVLH
IKPLLGLTAGSMSMEGGHGNAAAYGKTLEESFNIDSAITAALAAATLGLVFGGLVGGPLV
KALIKRYNLKPENSDDSFKDYSKVESNEVLHRKYQPTQVFFIQLTIIALCMSVGTWIGDQ
FSNLTGQSLPMYVGSMFVAVTIRNVSEYANIQLIDLKLNDQIGDVALGLFLSLALMSIQL
TQVYSLALPLIAIVLVQVVFISLFAFFILFRVLGKDYDAAVMAGGFIGHGLGATPNAMAN
LDVITKKYGSSPKSYLVVPIVGAFLIDLAGVPIVMGFMNIIGN
>SEQF2892_01955 Isopentenyl-diphosphate delta-isomerase
MSDFQREQRKNEHVEIAMAQSDAPQSDFDRVRFVHHSIPSINVDEVDLTSRTTDFDMTYP
IYINAMTGGSEWTKQINEKLAVVARETGLAMAVGSTHAALRNPKMAESFSIARQTNPEGI
IFSNVGADVPVDKAVEAVSLLDAQALQIHVNAPQELVMPEGNREFSTWLDNVAAIVQRVD
VPVIIKEVGFGMSKELYKDLIDVGVTYVDVSGKGGTNFVTIENERRSNKDMDYLANWGQS
TVESLLESSAYQDSLNVFASGGVRTPLDVVKSLALGAKAVGMSRPFLNQVENGGITTTIE
YVESFIEHTKSIMTMLNARDISELKQSKFVFDHKLMSWIEQRGLDIHRG
>SEQF2892_01956 Cobalt/magnesium transport protein CorA
MTMTIRYQTKNQSLTQVDSVKEIPETATIVWFDFENATQAENDYLISQFEFNYLELEDAI
TGVPRVKYKSYESYQYLVFHSMYKDDFSPISLNVFLSEKVLVTYHHKHFESLNEVAKMNA
QHHEPDLDCADIVIHILDMMVDKYFEFVYTIEDKTYNFEDAHVDDTQSKKIMDNVFQIKS
DLIKIKRVLFPMQELVNTIKTEGNLIVDSKHSMYIQHIDDHLIKQNNIIRTSQEMANEIR
ENFESYSSFRMNSIMQVLTLVSVIFSPLTFIAGVYGMNFEYMPELKWQYSYPICMIVMLI
IAIALIIFFKRKKWF
>SEQF2892_01957 hypothetical protein
MSNPVIINKVVEANQIDHNNHMHDSEYNKVFSEAVNEFNYTHGLSLKEREVLQYTMFTLE
EHTTYLAELSLNSTYRIEVYIYDYDYKRVHFFLMLYTDEDELAATNEVIMMGIDSNKRKS
APFPSDYHQNIANYYNQQGTNDWPKQLGHQIGIPKKEN
>SEQF2892_01958 hypothetical protein
MVSQFRNQLLELLYDLNDELKVNLIELNSAKQLFMNGPSQELLKRAFNISYYQGQKQAIE
ALQNIVASEENEEVLKRLLNDYAGQFANLSSNLVNLLNQQDVSQIDLSQAIDNYYHNLGQ
QTVITKVQNLI
>SEQF2892_01959 Triacylglycerol lipase
MRSHMVNRIINRYLLHNRSIMFDNDSDFDKFMDKRKDINQAKHKQPSSLNVKSNLDKLSH
DDMQVFRFNFRHETKKKILYIHGGYNTLQPSPFHWRFMDKLALSTLYEVVLPIYPKAPEH
HIQDTFKAIDGIYQSLLEEVDAKHIVIMGDGTGGALALSYVQQLVANNQPLPNKVYLLSP
MLDATLTNPEITEDLSNKDRFVNKDGLQRIFNVWTQGEALANPLISPIYGQIHDLPPIVI
FGGGREIYHPDMKRFVYNLEEKGQPVQFFEYPKMFHDFPLFPIHESHKVIKQITKTIDA
>SEQF2892_01960 hypothetical protein
MSERRTTQYDNRPPIDNHNYLRSNRNNRKRRSWVSLIIQIIIFILVAITGYSMYKQPIFN
LAFANQPISYGQIKDFQNTVTQIGTLNINLSQLANLEDVANRLVFVFNTFFILTIVSLVI
TILTIIFNRTLLKILNFIVISILLIMSLYFGYAIQVIGQRIADKLQSFSLNVSANQIISE
ADAIHNALILLVCSLALLIVSFFFRNRKTNHPKIK
>SEQF2892_01961 Multidrug export protein EmrB
MTTTFIVGYIVLAVILVGLVNVLVLKSRKKRKNQAKGQHVNEESKSQSNPSKFKISDLDR
DKVSNRTQDSQRDDDKQRHMNSEDRHIENDKRKNHFENEQDQQDHASEQIHPEQKQASHS
LHYSDDATEDDKQDDDVNNQHLPKDSIYEPINPDSQEGRVNERIKKQKEDFVFGEGITRN
KILAAMLFGMFIAILNQTLLNVALPKINTEFNISASTGQWLMTGFMLVNGILIPISAFLF
NKYSYRKLFIIALLLFTIGSLVCALSNNFPMMMGGRVLQAIGAGVLMPLGSNVIVTIFPP
EKRGVAMGTMGIAMILAPAIGPTLSGYIVQNYHWNVMFYGMFFLGIAAMIFGYFWFRLYQ
RTTNPRADYQGIVYSTIGFGALLYGFSEAGNKGWGSAEIVTMFIIGAIFIAAFVIRELTM
RAPMLNLEVLKSSTFTLTTIINMVVMMSLFGGMILLPIYLQNLRGFSALDSGLLLLPGSL
VMGILGPITGKLLDTIGLKPLALFGIAVMAYGTWELTKLNMDTPYLHIMSIYVIRSFGMA
FVMMPLMTAAINALPPRLISHGNAFLNTMRQLAGSIGTAILVTVMTTQTTNHVGAFTDEL
DKTNPVIQDHVRQMAAQYGGQSEAVQAILKYVNQLAYIEGINDAFWIATGLAVLAFILSL
FLKGKKGADAEHERMMHAESNKFK
>SEQF2892_01962 putative multidrug resistance protein EmrK
MKKMVLINIITIVVLVVVGIVGFYLYHNATSFVTTDNAKVDGEQIQISSPTSGQIKSLDV
KQGDKVKKGDKVAEVSGQSQSGESQTMDIKMPQNGTIVKTSGMEGSVAQAGSPIAYAYNL
DDLYITANIDEKDVSSVEKGDKVDVTIDGEDSDVDGKVEEVGQATAASFSLMPSSNTDGN
YTKVSQVVPVKISLDSAPSKNVVPGMNAEVKIHKD
>SEQF2892_01963 hypothetical protein
MKQNAKYKIIKSLIDLLEIYPFENISIKMICANSNVNRSTFYDHFQDKFDLLSKIQNYHL
NKYEHLLKAFSFNFDNIKKNPEKVYKFFHIILKYIYRKKAFYHAIFISHPNKELVMEYID
ITKQYYTRILGENNTTIQNVPFFITYTMSGQIGVILNWLRLGCQENPDEVASALLANTLK
VQR
>SEQF2892_01964 Bicyclomycin resistance protein
MDIEQKQKKNSPLFIIILGALTAIGALSIDMFLPGLPELKNDFNTTTANAQLTLSLFMIG
LGLGNLFVGPISDSIGRKKPLVISMIIFALASLGIVFVENIWIMVFLRFVQGFTGGAGAV
ISRAIASDMYRGNELTKFLALLMLVNGVAPVIAPALGGLILSFAVWRMVFVILTLFGVLM
VLGSLFKVPKSLSVKNRDSSGVNVIFSNFKSLLTTPRFVLPMLIQGVTFIMLFSYISASP
FLVQKIYGVSPLHFSWMFAGVGITLIIASQIAGKLVDYFHPQVLLRAFTIIQIIGVVIVS
LTLINHWHFALLVIGFIVLVAPVTGVATLGFSIAMEERTTGSGSASSLLGLLQSLLGGLV
TPLVNLKGEYNSMPYIIIISLTAILLIILQLLNIKVFKHDKV
>SEQF2892_01965 Membrane-associated protein TcaA
MSTCPKCGQKIDSNLNKCPNCGNKLDNKDNQINSPQINTSNIRIRKFIPWAIVAFIIVLL
IIVFVLVRNYNSPDAQTKILVNAIDNNDSQKVATLLSSKNSHIDSDEASVYIDYIRSEVG
MKKFARDIKSTVETLNKSDSKEAINLKTRAGNNYLRVSKNGTRLLIFDNMSYTAPTKKAI
VKPKLDTKYEFKDGGKKKTVIADANKTTSLGTYIPGIYSVDAKKETEYGEFSGQLKFDFR
YGKSNTVEVNENFNEALLTVKLKGKSDLDKDSLKVEINDKQMKYSSSREYGPYPQTKDVT
VSALGKAKGKTFHAETKTIKARDLGNINSATLEFDDKEISDYIEEKEAEENSLKTKLSNF
FSNYSFTLNSAISRSDFNLVSTFLKDKSSNYKSIKNNLNQSVAFINPQVISASQKGNTIN
TKVQHLNSNGQYETTNYELREDSDTGNIQIVDSK
>SEQF2892_01966 HTH-type transcriptional regulator TcaR
MSIISRNHIEFMKQFIDDTNTLTAKLLKDQQSKYGISMEQSNVVRLLSHHQVLSITEITE
KQGVNKAAVSRRIKKLIDSGFVALQKPNNNIDQRLKYVALTEKGRKYTEENNKIVSDMVS
DMVADLSSKDIEKALSVLYIIDERVKKFNSKV
>SEQF2892_01967 hypothetical protein
MIAIILALIVLLTVLGVLFNVKWLLNLRLFITTIILCMLITVLNLLTMTLPTTLIIIMII
TMVALLVKHNHLFSLQKGQAFLNKMTKYLILGVLFTSILAYLSTMPVPIVNGGFLWLTMI
AISTCYALLLYMSWSSALGRISTHKQYDLIMVLGAGIFTEKVTPMLAERLNRALSVYQHQ
TDKCKIIVSGGQGPDEPISEALAMQRYLIQHGVPQSSIIMESQSTNTFENFYYSKKVIHN
LYSNSPNILCVTSQFHILRGMKFAHTNRMKVDGIGSHTPYHFFDVALVRDFLALMYQYKL
LLTIYFAVLFFASLFILF
>SEQF2892_01968 Putative hemin import ATP-binding protein HrtA
MALQLKHITKTFGNGDAQTEVLKNINFSVNQGEFIILSGASGSGKSTLLNILGGLLSPSS
GDVLYKGENLFSKEVDKTSLRLNDIGFIFQSSHLVPYLTVREQLMIVAKEAGIKRKEAKD
KAQRLLNEIGLSHRLDVYPHLLSGGEKQRVAIMRAFMNEPKIILADEPTASLDADRATSV
VQMIKAHVQTKNMIGIMITHDKRLFEYADRVIEIQDGKIEL
>SEQF2892_01969 putative ABC transporter permease
MNLAWKEIKFYRFRYTLIMLIIFLLGSMVLFISGLAQGLARENISYLNNMPAEHYIVEDN
KEPKLESSQLNQSQQNKIEKIIHENATQMGTQTLKINQQDQDVITLNTPKHLTPKLVSGN
YPKKQNEIAISEKLTGNDLKVGDTVTFKGHHHNYKISGIMNESMYSHSSMILMNKEAFKS
LNKQVSTFYPVDKINKDNKESLKQIKGIKVVNEKALTDNIASYQAEQMPLNLMIISLFVI
TAIVLSAFFYVMTIQKIPQIGILKAIGIKTKHLLTALLLQIILTTMVGVILAFSVILILN
AFMPVTMPFYLSYSQVLLMIVVFLIVGLIGALLSFIKVLKVDPIEAIGGME
>SEQF2892_01970 Heme response regulator HssR
MVKCLIVDDDYKILHYVSQHLEAAQIQTVTQASGESAIAYLANNKVDIAVVDIMMTGMDG
FELCQLLKNDYDLPVIMLTARDALSDKERAFVSGTDDYVTKPFEVKELLFRIQAVLRRYQ
INSQDIIKLGNVTLIQEYMELSVDSKNVNLPTKEFQLLFLLCGQPKHIFTRDTLIERIWG
FDYEGDERTIDVHIKRLRHRLNQLKATIEIQTVRGQGYRVITHV
>SEQF2892_01971 Heme sensor protein HssS
MFKTLYTRIAIYTITVILFSALVSFLFANVYYHFNLKAHNDAKIMRTLKEARAFHTSSNQ
SDTQSYFKHLGDMNYQIMIVDHSYHKTFFGEPFRKDTISDSAINQVLKGKAYHGIKNKPF
ELFITGFFDNETDNTVGIPFNQNNQKLAVFMRPDIGETFSEFRTFLAVLLICLLGISITL
VIASTYSIIKPIKILKQATERLMHGDFNSPIYQSRHDEIGTLQYRFEAMRQSLKQVDDMR
QHFVQNVSHEIKTPLTHIHRLLSTLQSNVNQGERDQIIHEIHEEVTHLSNLTKELLLLSE
LDNATHLKFEDDVHFKELITDIIRHEQYGIDNKQLMLMSDIDTVHFRGNNRLLHQACSNL
IQNAIKYSNPNSMIDVNLFNNEGTIYFTVTNEGHTIPESVQPHLFDRFYKRNAEDNSNGL
GLAITQSIIHLHRGQISVTSNDRDGTTFTVTLPETN
>SEQF2892_01972 putative HTH-type transcriptional regulator
MKLRLHISPEEDEKYIAIHAPEFDDEVQQVITNIEDLNSLKQLYGKQDDMIHIIEIQTII
SFRTHKNQVIAIRDGEQFKLKERLYELEEKLPTSFIRISKSEIVNINKIKKLQLEPNGLI
RIYLQHIDYTYSSRRYLKSIKERLSL
>SEQF2892_01973 hypothetical protein
MRKLYQFVSISLVIGLTLSIIFSYINAGGEYYPISPVTTLGKLYYSHLSEPIVMLIAICL
WLLIGALFYLANFFFSHTDWSITRSTLMHFMLSYIGLLPIGILSGWFSISVSNIFIFTFY
FIIIYIIIWIIEFLKSRKYVSEINNQLNKK
>SEQF2892_01974 putative malate:quinone oxidoreductase 1
MSSEHSKTDVILIGGGIMSATLGTLLKELSPDKEIKIFEKLEQSGEESSNVWNNAGTGHS
ALCELNYTKEGKEGSVDITKAIKINEQFQVSKQFWAHLVRTGQLENPSNFIQSVPHMSFV
KGIFNVKFLKNRVAALKENILFEKMGITEDREKIKEWVPLMVEGRTSHVPIALSRDESGT
DVNFGALTKKLISNLKERNVEVSYKQEVENIEKLDNGNWKVTVKDLNSGQSHTYESEFVF
IGAGGASLPLLQKTGIKQSKHIGGFPVSGLFLRCTNKDVIEKHHAKVYGKASVGAPPMSV
PHLDTRFVNGERALLFGPFAGFSPKFLKTGSNLDLIRSVKPNNLLTMLSAGVKEIDLTKY
LVSQLMLKHEDRMNDLRVFVPNAKDEDWEVIVAGQRVQVIKDTEDSKGNLQFGTEVITSD
DGSLAALLGASPGASTAVDIMLDLLQRCYGNEFKNWIPKIKEMVPSFGLKLTEHEDVYRA
VNKEIQKYLNVK
>SEQF2892_01975 GalNAc-alpha-(1->4)-GalNAc-alpha-(1->3)-diNAcBac-PP-undecaprenol alpha-1,4-N-acetyl-D-galactosaminyltransferase
MKSFTFFMHNIYALGGTVKAVSELANTLADKGHHIEIISVFRAQDEPYFKINDNIKIKTL
VDYRLKPQNTKAIMMNRLNKYTSLLKPKEINQFEPGLNQFSKYVEHKMIKAIKKVDTDVL
VGTRASFNILISKYHSNDVITVGMEHMNLHAHPENYQQDILTAYRNIDLVTTLTQQDQLN
YEQQIDTPVYTIPNIINPVKHATKKENIIISAGRLEFEKGFDILIESVRRIQNDLKQLNF
KVEIYGDGQERGHLQQLIDQHQLNDLITIYPATQQLNTKLSNSKITVVPSRNEGFGMVLL
EAMAQDNIVISFKDTLGPASIINHNSNGYLANYGDAGSLAKYIDIAMNHVDEASQMINEG
HVTLKQYTPNTVYEKFMTAINNV
>SEQF2892_01976 L-lactate permease
MLVQTFNPFDNLVLSSLIAAVPIILFLLCLTVFKMKGIYAAITTLVVTLLIAIPFFKLPL
GIATGGVVEGFYQGIIPIGYIVMMAVLLYKITQESGQFNTIQDSITSISQDQRIQLLLIG
FSFNAFLEGAAGFGVPIAICALLLAQLGFRPLQAAMLCLVANAASGAFGAIGIPVGVVDT
LHLPGGVHAMGVSQTSTLTLAIINFFIPFLLIFIIDGLKGVKETLPAILVVSVTYTVLQG
LLTVFNGPELADIIPPLVTMGALALFSRKFQPKHIFRVQKDVEPEPAKHHNAKEIIYAWS
PFVILTVVVMIWSAPFFKNLFLPNGKLSSLVLNFNLPGTFSEVAHKPIMLSFNFIGQTGT
AILITIIITVLMAKKVSFGDAGRLFGVTFKELWLPVLTICFILAISKITTYGGLSAAMGQ
GIAKAGNVFPVLSPILGWIGVFMTGSVVNNNSLFAPIQASVAQQIGTSGSLLVASNTVGG
VAAKLISPQSIAIATAAVKEVGKESELLKMTLRYSVGLLIFICIWTFILSLIL
>SEQF2892_01977 Teichoic acid poly(glycerol phosphate) polymerase
MMIKQINISNMRHLALQLNKAKSAGFSHFIPYSNDIKINHDMLEAIDLTHNSIAVDYTLN
GLYLNDCRYFGEDTLTFLSWMKNINHYPNIIFNIDRALLHLSKYDIQSIMDLAVISVLKD
EIDIDNHVVFDFINECRTSHAFWASLDTFDIKKINHFDLNKLAYIHGHSIPYSKFRYPGK
EEEMRFVDSWLVTTKFKLPKWLYNKMQNRALNKHRNLSYVYDKDSSKVKNHVVFLGFDYG
YRGNSKYLFNYFVKRNPTTEAYFITNDRRGPYFLPTDAENNKELIETAKIVVIESYIPDD
FKPNGTVIQLWHGTPIKKLFLDSKEPDQNKNIYNYKARKYNKWLKQDYLLTDSESAEGLF
ETAFPNQHTQMIPYGYPRISYLLHYQNDKNHQKKIKDALNVDRTKPILLYAPTWHATKDS
TELMSISPELIEEYHVIFKGHIEDDMTLPEGAIEAPNHIETQDLLLISDVVITDYSSIIF
DALTIGKKVCLYTPNHSSYQQERGVYDDVMESLSKVWYTDEDLLHNNLIHHTLTDISKHQ
LVNRNNTSLKRLTQLMRDIINNK
>SEQF2892_01978 Spermidine/spermine N(1)-acetyltransferase
MMSEYITMIENMDVSDLRQISETTFYDTFEGEYSDDDFNQFFKESYNEKVLLNELNNPNS
FHYFYKVNDQIAGYLKLNVGNAQTEPKGEDYLEIQRIYFYKTYQGGGRGQKFIQLALDKA
KELNKNKVWLGVWEHNQQALSFYKKHGFEVTGQHEFITGEVVDIDLIMEREI
>SEQF2892_01979 Sec-independent protein translocase protein TatAy
MFVLGITGPTSLVVISIIALIIFGPKKLPQFGRAIGSTLKEFKSAAENIDTDESHDTPSK
ESKQQREHIK
>SEQF2892_01980 Sec-independent protein translocase protein TatCy
MKVMILPVKNQNNNENTLNSNTLLGHFDELRSRLVKVFIAFIVTTIIVYVSSHWWMKPFI
HYIKRAHVTLHAFSFTEMIQIYIMIIFFVALCLIIPIVFYQLWAFIAPGLHVNERGFIIK
YSLWCALLFIIGVAFAFFIGFPLIINFSLTLSEVLSIEPVIGFKAYLHELIRWLLIFGVL
FQLPTLFMGLAKFDLIDVNELKHYRKYIYFGCFVVASIIAPPDITLNLLLTLPLIILFEF
SMFIARISQRS
>SEQF2892_01981 Ferrous iron permease EfeU
MKPYLTKLVVVLVLILTVIRIVPAHQVNAADDSKISDVYVAITDAKSTIEDKNKSNKEKQ
SALADIKEKVKSLNIKDNKEGKDVKSKLEAVDKASSMNAKADKLSQLTKSLIAYEDAVST
KDISGEIKTLKQQVDAKDDSIKKAIKSKNESELQSINNSLNQIWTTHETAIRNYDEGKYG
QIEVNLMQLRVAIQKEPLDTKKVDNAWTTFKSSIDTVDQKQSSSDNGKYKVTQLNDELDK
AIKGIEDNNLDQTDAALSKFVQIWPYVEGKIQTKNGSLYTTIEDKIPYYQSILDQSNKDR
VKDGLNDINNDIKDTVGQDGYTFVDVMIIFLREGLEVLLVIMTLTTMTRKVKDNKGTASV
IGGSILGLILSITLAVVFIQTLGNNGLLREGMEATLGIIAVVLMYIVGIWMHRRSSAKRW
NDMIQNMYQNAISNGNLVLLGTIGLISVLREGVEVIIFYMGMIGSITSMDFVIGIALAIV
ILIIFALLFRFIVKLIPIYYIFRVLSILIFIMAFKMLGVSIQKLQLLGTLPQHGIEGLPT
IGFIGFYPNIESIVAQLIYIVFIVFFILKNRQNKQKNTNLK
>SEQF2892_01982 putative deferrochelatase/peroxidase EfeN
MSKVDNNQNDQVSRRSFLKMLGIGGAGVVIGASGAGSIFSFKSMFDTPENEDKDAFEFYG
RVQAGITTPTQKNCNFVALELKTKDKQAIKDMFKKWTQMSVNMTDGAPAEKDSQNALLPP
VDTGESIGLGASKLTLTYGISKSFLKKIGMSSKIPSGFKDLPHFPNDQLDDEYSDGDIMI
QACSNDPQVTFHAIHNLIRPFRDVVKMKWSQNGFVSGKLEETPRNLMAFKDGTVNPRKND
ELKKYVFIDDGWAKNGTYCIIRRIQIHIETWDRTSLEEQEATFGRKRASGAPLTGKKEFD
NIDLDAKDSSGQYVIDPNAHARLAREVKTSIKRRAYNYNDGTNAKTGALETGLMFICFQK
STQQFIDIQNNLGHSDKLNEYITHRGSASFLVLPGVKKGGYIGETLFN
>SEQF2892_01983 putative iron uptake system component EfeM
MKKLPTILLASSLLLAACGNNSHSDDNSNKDKQSQSSKGENKASLQKATKEYEKYTDGQL
DKFLDGTEKFVAAIKADDMDKAKELYPKVRMYYERSEPVAEAFGDLDPKIDARLADMKEE
KKEDQWTGYHKIEKSLYQDNKIDETTKKDADQLLKDAKELDAKADTLDITPKLMLQGSVD
LLNEVSTSKITGEEEIYSHTDLYDFKANIEGAQKIYELFKPELNKKDKKLSADIQKNFDK
VNQLLDKYKDGDGFKDYSAVTKEDRKALSDAVNSLGEPLSKMAVVTE
>SEQF2892_01984 Putative quinone oxidoreductase YhfP
MSNQFKAFLVDKNNDGSVNSDFTQLTTDDLPKGEVLIKVHYSGINYKDALATTDNNQILK
SYPMVPGIDLAGTVVESEDPTINEGEEVIVTSYDMGVSHYGGFSEYARVNSDWVVKLPDN
MTLEEAMIYGTAGYTAGLAIEKLEKAGFMTLEGGKVLVRGASGGVGALAVLMLSNLGYKV
VASTGNKHAGDKLEALGANEIIDRITDNDEKPLGSRTWQAAIDPIGGNGTPYVTNRIDNN
GGVALIGLTGGVSFDTTVYPFILRGVSLVGIDSVFTPMKLRERVWRRLATDLKSDKLHDI
KKVISFSELPDAISTVLNHDNFGRIIIDFDA
>SEQF2892_01985 hypothetical protein
MIRYSNEPPEVQAYCDLRVKAGMSPKSVAAVRNGLPNGCFNITIYEDQQLIGMGRVIGDG
GTTFQIVDIAVDPDYQGQGYGRVILEKIMEYINSIAEKGTYVSLIADYPADKLYEKFGFK
TTEPKSGGMYIVF
>SEQF2892_01986 Ferredoxin--NADP reductase
MQDVTIIGGGPAGLFASFYAGLRGMSVRIIDVQDKLGGKMQIYPEKIIWDIGGVAPKPCN
EIIKDMINQGLHFNPKVNLNERVTDIRKIAERHFEVETDSGQIYESKAVIFAVGGGIINP
KPLQIKDAERYRLTNLHYVVQSFSKFKGKDILISGGGNTALDWARDLANIANSITLVYRK
SDIKGYEAMISVLKALNVNLLPKTQIKELIGDNKCECIKEVKLENIETGEVTTQAFDDVI
VSHGFDHENPLLKDCTSKLDLYDEYRVKGFGNTTTNIPGIFACGDIVHHDAKVHLIASAF
SDAGNAANLAKTYINPDAYKEGYVSSHNDVFKESNKKVINQYI
>SEQF2892_01987 hypothetical protein
MRRLLYAFLVYMILGLFSGFYYRELTKAHHFTGDTQLSIVHTHTLILGMFMFLILIPLEK
VFKLSSYYLFNWFFIVYNISVIATIGMMVTKGTFQVLGKSFSPEAFAGFAGIGHTGMLAG
LLLLFFLIRQAALKEPRD
>SEQF2892_01988 hypothetical protein
MIKKLLATSFILFFTLGFFKVADAHVTLNPKAVDPESYEKVDVRVPVEQKDHTKKVELEV
PKEVQVVNIQPVEGYKYKLDKDKKGNITKIIWTARGKGIGPDEFMDFPIVVASPKDEGKY
AFKAIQTYDNDDKVKWTGKENSEHPAPTLEVKKNANAADVKDEKSKDTASEQTSSGGSIA
LWIVSIIAIILSLVALFKHSRK
>SEQF2892_01989 Copper transport protein YcnJ
MVNLQRSSKVALALIMMFLLLLIPILHNIASAHATLEKTTPPQNGVISKAPDTLELTFNE
PVNAEYSGITIYNDKGDKVGDINPTTTGHSKTLTFPTDKVQQGTQQLEWHTVSADGHEIS
DRFEFSVGKKTANGVDTSPAFYETPNFWFGLFRYIAEGATIILVGLYWLNGIARRNNLST
FDVFPRHIVVSLIMMMAYLMSLVLYLMTLSSDVLDAILSLEPSSITQFPYILSAIALIVL
SGLFVLRNMEKSWYWIVSIAMIIAMSMSGHAWSQSVPLWSIILRTLHLIGISLWLGALSY
LLISVFTRKKDAVDLLREILFKVNAAAVAIIIISGVLMSIDQTKILSIWTNMQTWTVFLL
IKVFGTLIMMLLGLLQTTRALNKRNRVNKSSLIIEVLIGILLILVGVIMSQISIP
>SEQF2892_01990 Multidrug export protein MepA
MGLIIAVITLPFTDQIASILCASGETLNYTSDYLKIEFLSTPFVILFFVLEQFARAIGKP
IISMIGMLSSVGINIILDPILIFGLHLDVVGAALGTAISNAIAALFFIIYFSRKNETLSF
NVKHAKPTKAMMQEIFKIGIPAFLMVVLMGVTGLVVNLFLATYGNYAIASYGISFRLVQF
PELIIMGLSEGVVPLIAYNFVSNKTRMKDTIKVVIVSIAVIFAVCMTVVLVAGHSIVQLF
STDPQIVVLATFILKVTMTSLLLNGIGFLFTGMLQATGQGRGATIMAIAQGTVIIPVLFV
LNSLFGLTGVIWSLLIAETVCAFLAMFIVYSLRNRLTVDKASLIEVE
>SEQF2892_01991 Multidrug export protein MepA
MKDEQLFYFEESSIFKAMMHFSLPMMIGSLLSVIYGILNIYFIGFLDNSHMISAISLTLP
IFAVLMAFGNLFGVGGGTYISRLLGAKDYIKSHYVSSFSI
>SEQF2892_01992 Transcriptional regulator HosA
MDATYQYLVRMLAHEMKHYADRKLDEYNVTQEQSHTLGYMYRHKDRGITQNELLKTFKRK
GSTVSSTLKGLENKGLIYRMVDPDDSRRKNLKLTQEGMKLVESFVCIFDDIEAILVKDFN
ESEKQQLKDLFERMLNNIKTEK
>SEQF2892_01993 hypothetical protein
MNIFKSKLLWLAPIAVILLLVIFSLAFYPAFNPKPKQLPIAVVNNDKGVDIQGNKVNIGK
KIEDKLMDSDSDTVKWVKVDKESDIKKGLKDEKYYGVAIFNKDFSKNAMSKTQKVVMDSK
KAEMKEKVESGEIPAAAVQQMQKKMGNQKVDVKQATFKTIVNKGASMQAATITGNVLDGM
GDNLNKQITSQSLSTLEKQDVKVSASDIKGITNPVKVDNQEIHKVKDHQGGGNAPFLMFM
PVWMGSLVASVLLFFAFRTSNNFKIQHRIIASFGQMLLAVITAFAGSFAYVYFMHGVLGF
DFNNTNRVALFLAISILGFIGLILGIMVWLGMKAIPIFVILMFFSMQLVTLPKQMLPKGY
QGWVYDFDPFTHYTNTLREIIYMGSHIEMNATIWMMIGFIIFGAISSLTAAIVRKHSNKR
TEIPS
>SEQF2892_01994 hypothetical protein
MKEDRRIRKTKSAIKRAFTDLLKKKDLDKITVQDISNQADINRGTFYLHYKDKYMLLTDM
EDECISQIWSSTQFNQLDTSTPENTADDFINNILTKVLQHISDNMDFYHTILQLERKSRL
EEKIHSLMKENMQKYISIDHEIDGIPEMYFHSYVTGATISIIKYWVQDDSRISVNDLTKH
IFNIIYNGPLRIMIQNHYKRTQPN
>SEQF2892_01995 hypothetical protein
MLTAYKHSTNNDIVETTLDHSASWINVVEPDREEIEQLIETYNLPEDFIRDPLDADESAR
IEYDDDTGYSLIIIDLPIVSSTHRRVLSFVTIPLGIVIGKGLILTICDAENEFLENYARQ
DDVNLNFHSRFALDILLTISNHYNRNLRLLNKSRIRIERELKNNITNKQLYKLMEVEKSL
VYFLAALKGNDTIIKKLFRLPAIKRFEEDEDLLEDLVIENNQAIETTELYTGILESITTS
YSSLLSNEMNNIMKTLTLFTVLLTLPTLVFSFFGMNVPLPLDEKSYSSWLFIVGISLVLV
TIVSIFLWRKQKL
>SEQF2892_01996 PTS system trehalose-specific EIIBC component
MNYKKSAEEILEAIGGEDNLDAMAHCATRLRLVLNDESKVDEETLSKMDVVKGTFSTGGQ
YQIIIGSGTVNKVFNELEKITGKEASTTADVKDKSARNMNPLQRFVKMLSDIFVPIIPAI
VAGGLLMGINNILTAPDLFYDNKSLIDVHSQFAGLADMINIFANAPFTLLPILIGFSAAK
RFGGNPFLGAALGMILVHPSLMSAYDFPKAVEAGKAIPHWDLFGLHINQVGYQGQVLPML
VAAYILATIEKWLRKVIPTVLDNLLTPLLSILVTAFLTFLFVGPLTRQLGYWLSDGLTWL
YEFGGAIGGFIFGLFYAPIVITGMHHSFIAVETTLIADQAKTGGSFIFPIATMSNVAQGG
AALAAFIIIKNNKKLKGVASAAGVSALLGITEPAMFGVNLKLRYPFIGAIIGSAIGSAYI
SFFKVKAIALGTAGLPGFISINPAHAGWLHYFIGMLVAFIVSVAITLILSRRKAYQASAE
>SEQF2892_01997 hypothetical protein
MKERGYIEKLWREEKYNVLYHSQQHYNYIRELLKQSPTLNEVQLTINEALQTTPSNGSII
NAYDHMWGYFKHKANEIEKNKSAQLKADFKQDNVQSKELLIFIKYLADKYEVSYLQKSTL
LNFQ
>SEQF2892_01998 Melibiose operon regulatory protein
MSNSLLLHEHLTTAPSRNINYIIIYFSLTNELTITINGEKNDIHNHIAIVNQGDLFNIDH
AKDLIELKIPIAYFYIEDNDFFNCFFDRHLLQSNHFIKSQILQCISNFSNNEEQDSETVS
KIIRTLYKEAVVRNTTLYAPTMSIDNQLLSNIVMFINNNITSNLSLLDIAKHALISESYC
SNLFARILNVNFKDYYTSLKVNHSVQLLMTTNHSITTISELSGFSSHTNFTNQFKKHLEA
SPKQFRTMLNQLEPLPSILIRSSVSQSFLNLISQFEFTNHLTTETTQINIANYDPKDQTQ
FSTAFIDFQNINELFQFVFNDYFDIDLSYLPRPAILINDVSDMVGRQTNLNLLNSCFEKL
FEKNIRLAVTIKNNQEFKMIYQLIMIFLQNNRDYKWNKKLVKFMLVFDTETMSIHDIHLA
HLKLKNKNRAIKFSLMVDGLLRQLGSLQETYDIMHRMNFDFYFVDIENIDTKNVLIDIQR
GFTHSSTHFENYLRFIEGSNIPSTQFIYSNLSLKCFKYTNNGTQSLQLSDLVCHLYQLMR
HGGGVCYKLIETDPMYISLFNNHGSLLPIMHLYRFVSTFSNESFQISNNYLMCYKDGNYH
VILFNKINDRYLSDSQQHYIFENDFKENTLFIVNTLNNEHGSIQHLIPQDKRDVYIEKDI
IQQLDRCNHPKTELLIQENDYAAFQITLKHDEVKYICIKPS
>SEQF2892_01999 General stress protein 26
MDKQQVIQSIEKVLDTSKVGVLSTAYNNQPNSRYMVFYNDELTLYTKTSNESTKVEEIKN
NPYAYILLGYNETTNNSFVEIEANIEIVEDQKVIDWLWETQDKTFFDSKEDPNLCVLKVV
PKTIKLMNDDDIDTPVTITV
>SEQF2892_02000 hypothetical protein
MKNKKGLGIGIALIAIMLIVCIVLVVMMMTGGQKETYYGYMKNDHTIDKMVNEQTEKIEK
NVELPSDSKANVKKGDFVFLVKEKGSDKFSRVSKVDHDDVPHGLMMKIHEMHDMKGM
>SEQF2892_02001 Proton/sodium-glutamate symport protein
MALFKRKISLPMQVIIALVLGVVVGLLLFGQDNVANYIKPFGDVFLNLIKMIIIPIVFCA
LALSISNLGDSKKIGSYGWKAILYFEIITTIAIGLGLIIGNLFKPGAGLDPDKLPKGDIS
KYQSSASAAEQSTYGNHFIDTIVNIVPTNIFEALTKGELLPIIFFAVFFGLGLAAIGEKA
DPVKGFLNGTLEAVFWMINKILKLAPIGVFAFICTTVMTFGASALIPLLKLVLVVVFAMV
FFIIVVLGIVARICGISIFSIIKILKDELLLAFSTSSSEAVLPVMMKKMEKFGAPRDVTS
FVIPIGYSFNLDGSALYQSIAALFVAQMYGIHLSISEQIILMVTLMVASKGMAGVPGVSI
VVLLTTLGAMGLPAQGLALIIGVDRLLDMVRTCVNVIGNALSAVVISKWEKVYDKEQGKK
YLESI
>SEQF2892_02002 hypothetical protein
MSKKQKWIRICIILAISLVVAIAFFFAMKTYQGHRNIKMVDSYIEQKHLSDDIKSEKTQY
SAKKGVYYKEVVFKDEPHMTYVIQPIGTRKGIFAEGFDTETKKSIKDAKHNYFNQNFKP
>SEQF2892_02003 HTH-type transcriptional regulator SarZ
MYIKDSYLSNQLCFLLYVTSKEVIKKYTYYLKKHDLTYTSFMVIMAIENEEKINIKSLGR
RVFLDSGTLTPLLKKLEKKGYVQRMREKEDERNLQITLTESGINIKPTLKAISDQVFEDF
DISQDEKDNLVNSLKHVISNNFDYTTH
>SEQF2892_02004 Acid shock protein
MNNREFFEQSIFKNNPKDVFRDLGEQVFNQFSSKSFPTNIYNQTNQYVLEAELPGVNKSE
IELKFEHAALTIKVQKHVSEQTGSVQLSERASGELVRHFEFNDIDKSQIKASYEDGILVV
ILPKEVSAQDQSTTITVE
>SEQF2892_02005 putative nitrate transporter NarT
MYKTKGGFQLTLQTLSLVVGFMAWSIISPLMPYISQDVKVNPGQLSIILAIPVILGSILR
VPFGYLTNIIGAKWVFFCSFVILLFPIFFLGQAQTPGMLMLSGFFLGVGGAIFSVGVTSV
PKYFSKDKVGLANGIYGMGNIGTAVSSFLAPPIAGIIGWQTTVRSYLIIIAIFAILMFIF
GDKNEPKVKVPLASQFKKLSSNYKLYYLSLWYFITFGAFVAFGLFLPNYLVNNFGIDKVD
AGIRSGVFIALATFLRPIGGILGDKFNAVKVLMIDFIIMIVGAVILGISSHIALFTIGCL
TISICAGLGNGLIFKLVPSYFAKESGAANGIVSMMGGLGGFFPPLVITYVTGLTGSSHLA
FILLAIFGVLAFITMGHLYKKEYAK
>SEQF2892_02006 Oxygen regulatory protein NreC
MLGEYKVKIVIADDHAVVRTGFSMILNFQEDMEVVATAADGGEAYQKVMEHKPDVLIMDL
SMPPGESGLIATSKISESFPETKILILTMYDDEEYLFHVLRNGAKGYILKNAPDEQLLLA
VRTVYKGETYVDMKLTTSLVNEFVNHKHSDDVSTNDPFKILSKRELEILPLIAKGYGNKD
IAEKLFVSVKTVEAHKTHIMTKLDLKSKPELVEYALKKKLLDF
>SEQF2892_02007 Oxygen sensor histidine kinase NreB
MLDVDNLDLENLLKKYYEKTNEKIVFVNKDGKVIAMNDAAEEIISKDNNYSAMTNAICNR
CEGYSNEFALQSCINCYLDTTKPNDMNFQVFMKTVDNKIQPFTASYQCIDDEAQIYAFTL
QDISPQIERQEKMYQRQMLRKTIAAQENERKRISRELHDSVVQEMLNVDVELRLLKYQQD
MAQLIEKSEHIELLMSNLINDIRDLSVELRPSSLDDLGLEAAFKSYFKQLEYNYGLNVVY
QSNIQTIRFDSEIETVVYRVVQEAIFNALKYAGVYEVEVTIQQTEEGLIAEIIDRGKGFD
PNLKPQGTGLGLYGMNERAELVKGTVNIETHIGKGTIITLEVPV
>SEQF2892_02008 hypothetical protein
MSMRGDSNVITNPVFEKQDFQQQLNNLRVSEGYDFAGVALYEHHMTSAPIKWHYVSGNLN
DRYKMIILRKGRGLAGMVMKTGKRMIIADVVASLSPEDKIKYPILIAENLTAMVAIPLCY
NNQVYGVLLLGQRDGKSLPDYETLDISGKLWTFSEEM
>SEQF2892_02009 Nitrate reductase-like protein NarX
MLNQFLWIIFPYLCVAIFIVGHIARYKYDQFSWTAKSSEFLEKKQLKWGSLLFHLGIIPV
FFGHVVGLAIPAKWIDGLGVSEEMYHFGAVYIGSIFGIMTFIGMLLLTARRITIKNVRKL
SSASDIFVNFLLILIIFMGCYSTLVTNAMVSDFDYRQTISIWFRHLFTFSPDASLMTSVP
LSFKIHILLGFTILACWPFTRLVHVWSVPLSYTNRRYIVYRKHKTRS
>SEQF2892_02010 hypothetical protein
MINLQQFHYYQESFGYIAQQLNFPEKLTFHPKTFEETIEPSHPGYDDLVKYREIMHQFTL
SEIKAIYTDTFDFNKKSPLYMTYNKFDTQKERGQMLAKLKVLYEMFGLKMVDNELSDYLP
LMLQFLHVASWQNDPRAEGNIELVIMIIEDGTYEMANHLAQDNNPYAYVIRALRNTLKAC
LEIPNEVTSHA
>SEQF2892_02011 Respiratory nitrate reductase 1 beta chain
MKIKAQIAMVLNLDKCIGCHTCSVTCKNTWTNRPGAEYMWFNNVETKPGVGYPKRWEDQE
HYKGGWVLNKKGKLELKSGSRWTKMALGKIFYNPDMPLIKDYYEPWTYNYEHLTTAKEGK
HSPVAKAHSLISGEKLNLEWGPNWEDDLAGAHITGPEDPNIQKIEEDIKFQFDETFMMYL
PRLCEHCLNPSCVASCPSGAMYKRDEDGIVLVDQDACRGWRYCMTGCPYKKVYFNWKTNK
AEKCTFCFPRIEAGLPTVCSETCTGRMRYLGVLLYDADRVHEAASAENEKDLYEKQLDIF
LNPFDEEVIEQAEKDGISYEWIEAAQNSPVYKLAIEYKLAFPLHPEFRTMPMVWYCPPLS
PIMSYFEGKNAGQNPDMIFPAIEEMRLPIEYLANLFTAGDVQPVKESLQKMAMMRSYMRS
QVTGKEFDTSKLERLGLSEIQTKDMYRLLGLAKYEDRFVVPTSHKETYLDTYHAQGSQGY
GGEYFGDNCEGCGVPVGSGKTGQEIYNENFYGGIFRD
>SEQF2892_02012 Respiratory nitrate reductase 1 alpha chain
MGKFGLNFFKPTETFNGNWSVLESKSREWEKMYRERWSHDKVVRTTHGVNCTGSCSWKVF
VKNGVITWENQQIDYPSCGPDMPEFEPRGCPRGASFSWYEYSPLRVKYPYIRGKLLDLWN
TALEENNGNRIAAWASIVEDEEKAKAYKQARGKGGHVRANWKDVTDIIAAQILYTIKKDG
PDRIAGFTPIPAMSMISYAAGARFINLLGGEMLSFYDWYADLPPASPQIWGEQTDVPESS
DWYNASYIIMWGSNVPLTRTPDAHFMTEVRYKGTKVVSVAPDYAENVKFADNWLAPNPGT
DAAVAQAMTHVILQEYYQDNPSEMFINYSKQYSDMPFVIMLDEDDNGYKAGRFLRASDLG
MESENSEWKPVIHDMNSHQFVVPNGTMGQRWEEGKKWNLKLENEDGSKIDPAMSMADDTY
ELKTIQFPYFDSQGDGIFERPIAARKVTLADGKEVYVATVYDLMTSQYGIKRFNHELEAT
SYDDAESKYTPAWQQRVTGIKPELVTQVAREFAQNAIDTKGRSMIIMGAGINHWFNSDTI
YRAILNLVLLCGCQGVNGGGWAHYVGQEKCRPIEGWNTVAFAKDWQGPPRLQNGTSWFYF
ATDQWKYEESNVDKLKSPLANNIKHQHPADYNVTAARLGWLPSYPQFNKNSLLFGEEAKD
AGDDSNEAILNRAIESVKNRETQFAIEDPDLRKNHPKTLFVWRSNLISSSAKGQEYFMKH
LLGTRSGLMAEPNEEDKPEEIQWREDTEGKLDLLVSLDFRMTATPLYSDIVLPAATWYEK
HDLSSTDMHPFIHPFNPAIDPLWESRSDWDIYKTLSKAVSEMAKDYLPGTFKDVVTTPLG
HDSKQELGSEYGIVKDWSKGEVEAIPGKTMPNFAVVDRDYTKIYDKYVTLGPLLEKGKVG
AHGVSFSVKDEYEELKSMIGTWNDEDPESVRNNRPRIDTARKVADAILNVSSATNGKLSQ
KSYEDLENQTGMELKDISKERASEKISFLNITSQPREVIPTAVFPGSNKNGRRYSPFTTN
IERLVPFRTLTGRQSYYIDHEVFQQFGESLPVYKPTLPPMVFGTRDKQVKGGQDALVLRY
LTPHGKWNIHSTYQDNERMLTLFRGGPVVWLSNEDADEHGINDNDWLEVYNRNGVVTARA
VTSHRMPRGTMFMYHAQDKHIETPGSEITDTRGGSHNAPTRIHLKPTQLVGGYAQISYHF
NYYGPIGNQRDVYVAVRKMKEVNWLED
>SEQF2892_02013 Uroporphyrinogen-III C-methyltransferase
MSVDEKSKVYLIGAGPGNPNLLTKKAERCIKKAEVILYDRLVNPLILQYAPADAEFIDVG
KKPYAKHIQQDEINLKIVEAAKKYQTVIRLKGGDPAIFGRVTEEVNTLKDYGIEYEIVPG
VTSASAAVATMDLGLTMRSVAPSVTFSTGHFKDSINQETDIRNLINGGTLAIYMGIKRLG
RIIDQITAYTSEDYSIAIVFNATCHNQRVIIGKLSTIEHQLQQHELEGEPGICILGAIVD
YIDKDKVLKQEHERNLDDSLYVIKGSKEDALLKAEELSETGYRCIVHVDESYHPSQQQLY
TQIINNNKIKYINL
>SEQF2892_02014 Assimilatory nitrite reductase [NAD(P)H] small subunit
MKSMEKVKVTTLEELTPLIGKKVIVDGKEIGIFLTESGDIHAINNICPHKQGPLSEGTVS
GDYVYCPLHDQKVDLRSGEVQEPDTGCVETYQVEVIDGDVYVCL
>SEQF2892_02015 Nitrite reductase [NAD(P)H]
MTKQKLVMIGNGMAGLRTIEEILERSDSQFDITIIGKEPYPNYNRIMLSNILQKKMTVEE
TIMNPYEWYEENNIQLIVNDPVETVDRSAQTVTTSKGVEVNYDICIFATGSSAFVLPIPG
SDLPSVIGWRTIEDTERMIEIAKTKKKAVVIGGGLLGLECARGLMDQGMEVTVLHLAEWL
MEMQLDRKAGGMLKADLERQGMNIELQANSKEIIGKDDVEAIKLADGRIIETDLVVMAVG
IRPFTQVARDAGLEVNRGIVVNDYLQTSDPNIYAVGECSEHDGKVYGLVAPLYEQGKVLA
DYLTGKETEGYKGSTTFTSLKVSGCDLYSAGQIVENENVHGIEIFNSVDNIYKKVYLSDG
QVVGAVLYGDTDDGSRFYNMMKKHESLEDYTLVSLLYKGGEEAVTSIADMPDDETICGCN
GVDKGTIVNAITTKGLTSVEEVTKATKAGNSCGKCKGQIGELLQCTLGDDFVAAKPTGIC
ACTDLTRDQIVTQIRAKGLKTSKEVRHVLDFKDKNGCPKCRPAINYYLNMVYPHDHRDEK
ESRFANERYHANIQNDGTFSVIPQMRGGVTDADQLIRLGEVAKKYNVPLVKVTGSQRVGL
YGLKKEELPKVWEDLGMRSASAYGKKTRSVKSCVGKEFCRFGTQYTTRLGIRLEKTFEYI
DTPHKFKMGVSGCPRSCVESGVKDFGVISVENGYQIYIGGNGGTDVTVGKLLTTVETEDE
VIQLCGALMQYYRETGIYAERTAPWLNRLGFENVKEVLLDPERQKELFDRIMDAKKAIDG
HGEPWEAIVEDKEARKIFEVERV
>SEQF2892_02016 Sirohydrochlorin ferrochelatase
MVANILVAHGMRKGDQNKALGEFLDRLLSDESYEYELAFIESEEKSIEKTIGRLIKQGET
QFKVVPLLIFSAMHYIVDVPEILSNIKKDHPEISYEISEPLGTHDCMVDLVEKRIQDVEI
STSSNYAIVLIAHGSFSYTKAHDELKEFSEKMNQPVPIYCRTLYGDITFRNDLDQLSNEY
DELIVVPMFLYDGRLVNKVKRLISEMDIQGTLHITPSINFDNILKRIISERLKQLTFN
>SEQF2892_02017 Nitrite transporter NirC
MLKNNKTVEDTHATRDIVEAAVGQVQTKEIMATKTPGRYALKAIMSGFLLAIVTVFMLAI
KTQFAGTNEGLVNLLGAIAFSLALVLIVLTNSELLTSNFMYLTVGWYYKAITINKMLFIF
LFCFIGNIIGGFILFFLMKGTHIMTPEMIASLSKTVHMKTVESTWLNILVKAIFCNFFIN
IGIYVSMLFKEGLARAFFIAAGVVVFVFMGYEHVVFNAGLYAGMVFYNLDALSWLGVIKN
IVFALIGNYIGGGIFIGLVYAYLNGSRDSMKAK
>SEQF2892_02018 hypothetical protein
MKERYLKVLALFSVSTLIPTVLLNSKAIDNSAIKYVLRTALGYGIFATGLRYLSRLKAHK
>SEQF2892_02019 hypothetical protein
MSIQLKDNKIIFNRTFEAPINEVFEAYTTETLFEQWFHPQGGKTKVYRFNPEAGGDAFFA
IEMPEQTSYTLTEYKKVDKPNHIEYLDFFATSQGEKDTSLPGMQILIDFTSESAQRTLVT
STSIFPTKNAAQQALDMGVEVGMNSTLDQLDSLLKQKKS
>SEQF2892_02020 Protein YceI
MANLNLDPAHSGVNFSIQHLVVSNVKGRFNEFDANISGDFNDLSSLQGTFTVKANSIDTK
VADRDNHLKSADFLDAENYPEIKFEITNVDDKSVTGNLTMKDQTHEETFDLDYKGTSLNP
LNGKNTAGLVITGSLNREKYGITFNQQLETGGFLLGKDLNVEFDLEFPLED
>SEQF2892_02021 Metal-binding protein ZinT
MKRFLSLTILLSIMLCVLVACGKEDSSNKGSKDGDKINVSTTVYPLQSFIKQIGGNHVNV
SSIYPAGSDLHDYEPTQKDMLKVNKSDLFVYTGDDLDPVAKKVAATIKDDKKKVSLQDKL
DRSTLLTDQHEHGDEEHADSHEHHHHHHGGYDPHVWLDPEKNKVFAKEIKDQLVAKDPKH
KNEYEKNFKKLEHALDDIDNQLKEITKDKQGNAVFISHESLGYLADRYGFVQKGIQNMNA
EDPSQKALTQLVKEINEKNVKYILYEDNVANKVTETIRKETNAKPLKFYNMESLNKEQSK
DESMDYQTLMNKNIEALDKALDSNIKVEDEKAEHKHDKAISDGYFKDNQVKDRALSDYEG
KWQSVYPYLKNGDLDDVMKHKSEEDSAMTEKEYKAYYEKGYKTDISSINIKGDNITFEKN
GKKVTGTYKYVGKKILDYKKGNRGVRFIFKLTNDDTQQLPKYVQFSDHNIAPKKAEHFHI
FMGDNNDSLLKEMDHWPTYYPASLDKDDIKEEMLAH
>SEQF2892_02022 Disulfide bond formation protein D
MKKIILIISMLMVLTIIMSACSNNNNEKQPPKTKNGKILIVEYGDFKCPYCKKVEKNVMP
TIKKDYIDTNKVEYQFINAGFLGKDSIVGSRAGNAVQKVAPNEYLTFQRNVLSNQKDEDK
KWLTEQFLDNEIDKLDITTQQKSDIKKQYKTKNSDAWKKAEEQKKMTEDNNIDTVPTVFI
NGKKVKDPYEVEEWKKYL
>SEQF2892_02023 hypothetical protein
MKRILVMLSIGILMLAACGNDKYVDKIDKAVKMQDQKQEQMAKNDTGDMVKHFDKKDANI
YVYENGKYVVLAYKPLSNNEEVHYYTYQFDGKKAKRIDNFDTKQYIESHDADYKEENMN
>SEQF2892_02024 Aminoacyltransferase FemA
MKFVTLSPEEFEKFTSSHFSHYTQSRIHFENRNELKGDVHVVGVKDDSDNVIAATLMTEA
RALKVFKYFYTHRGPVMDYSNIELVHFFFKSLTSYLKKHNCLYVLVDPYILENLRNADGE
ILESYDNRAVIKTLEDLGYKHQGWTVGYSTMSQIRWLSVLDLKDKSEDQLLKEMDYQTRR
NIKKTYEMGVKVRTLPMDETDTFFELFQMAEEKHGFKFRDKPYFYEMQKTYKDHAMLKLA
YIDLKDYLSTLQQKHDSLIEQLAEVDAVLEENPNSKKNKNKRTQIQQQVDSNERKLNETK
NKIAEEGETLNLAAALYLYNEHEVYYLSSGSNPKYNAYMGAYRLQWDMIKFAKEHNVDRY
NFYGITGDFSEDAEDYGVQQFKKGFNANVYEYIGDFIKPIHPLAYKVKQLLERK
>SEQF2892_02025 L-cystine import ATP-binding protein TcyC
MIELSGIHKSFNDKEVIKGIELNVDKGEVVTLIGRSGSGKTTLLRMINALEIPTEGNVSV
NGESYTANNKKSQISVRKQSGMVFQSYNLFPHKSALENVMEGLVTVKKMSKADAKERAMG
LLEKVGLTSVKDQRPHALSGGQQQRVAIARALAMNPQVMLFDEPTSALDPELVNDVLRVI
KELADEGMTMVIVTHEMRFARQVSNKIVFIHEGRIGEQGTPDEVFEHPKTEELRRFLNVI
NED
>SEQF2892_02026 L-cystine transport system permease protein TcyB
MFLSLNSQQQHALDAAGQAFGPMLEGLLKYSIPITIVTFILGLIIALFTALMRISTSKVL
KGIARVYVSIIRGTPMIVQLFIIFYGIPELGRLVTGNADEQWTLSSVISAIIGLSLNVGA
YASEIIRGGIISIPKGQTEAAYSIGMNYRQTIQRIILPQAIRVSIPALGNTFLSLIKDTS
LLGFILVAEMFRKAQEVASTTYEYFTIYILVAVMYWVICFIISVIQSFYESYIERGYNS
>SEQF2892_02027 putative amino-acid ABC transporter-binding protein
MKRLLFVALALIFVLAACGNGGSSDKNSDSKSSSSNSDSKTLKVGTEGTYAPFTFHNKQD
KLTGYDIDVIKAVAKEKGYKLKFNETSWDSMFAGLDAKRFDVIANQVGVNKDREKKYKFS
TPYTYSSAVLVVRENEKNIKSFNDVKGKKMAQTFTSNYGQLAKDKGADITKVDGFNQAMD
LLLSNRVDGTFNDSLSYLDYKKQKPNAKIKAIKGNAEQSKSAFTFNKDVDDKVVSDFNDG
LKTLKENGKLAEIGKKWFGENVSEPK
>SEQF2892_02028 Multidrug export protein EmrB
MSHRQKLAMIFTMLLGGFFGLLNETLLTTALPRIMKDFNIEYSQVQWLTTAFLLTNGVVI
PLSAFIIQRYSTRQVFLTGILIFFIGTMLGGFSPNFTILLIARIIQALGSGIMMPLMMTT
ILDVFQPHERGKYMGMFGLVIGLAPAIGPTLSGYLVEFFDWRSLFHVVAPIAAITFLIAL
KIIKNVGTTVKTPIDIFSIILSILGFGGLLYGVSSISSDGWDDPLVLITIIGGILLVGLF
IWRQERLDTPLLSFKVFKNKEFAVGLAIMAATMISMIGSETVLPMFVQNLLGRTPIDSGL
ILLPGAIVMAIMSVISGWLYETFGAKVLAIIGMSIVLITTSYFVVMDEHTSTVMLATVYA
IRMIGIAMGLMPIMTHTMNQLTPELNAHGSSMTNTIQQIAGSIGTAGLITILSTASKNFQ
PTMSDYQGMDKKEMAGQIQIDAMLHGYHSGFLFAVIITFISLLLTFLIKSKKKVKAEAKL
QND
>SEQF2892_02029 hypothetical protein
MKQDLQTARRNLNSPNIKTRKRALKIIKQHKRNRKSA
>SEQF2892_02030 2,3-bisphosphoglycerate-dependent phosphoglycerate mutase
MPKLILCRHGQSEWNAKNLFTGWEDVQLSEQGRNEAITSGRKLKENGIEIDVAFTSLLTR
ALETTQFLLAESDQEWIPVHKSWRLNERHYGKLQGLNKDEARKEFGEEQVHQWRRSYDVK
PPAQTEEQRESYLKDRRYRHLDHRMMPYSESLKTTLERVVPIWTDKISQHLLDGETVLVA
AHGNSIRALIKYLDNVSDEDIIGYEIKTGAPLIYELDDNLNVIDHYYL
>SEQF2892_02031 putative transglycosylase IsaA
MKKSIFALMTMVSLGAAGLESGQAHASEMTHGQQNQSCQYNQHTQLQHNQPSHQSQHTNV
ASASTTQANTTNVTTNTSSSNTECTADNSSSSNTSSDDSSSNESSSSESTSSVYKQFIAA
GGTEELWEKIVLPESGGDPNASNGQYHGLGQTNQSWGYGSVETQTKGMISYAKERYGSIE
VAISFRESNGWW
>SEQF2892_02033 Ferrous-iron efflux pump FieF
MSQSENLKLAQRGAYLSLVVYIILSVSKYITGFVFDSAAVRADALNNMTDIIVSIAVIVG
LKISIKPADKNHPYGHLKSENISTLLVSFIIMFVGIQVVIENAPRIFTNEHNTPNVVTIF
VGLISGLIMIGVFAINQRLAQKTKSSSLKSAAKDNLSDGLVSMGTAIGLVFTQFGLPIVD
VILATILGFLIIYTGFGIFRESIFALSDGFNEQDLEEYRNVVLEVDDVKDVNNLKGRYHG
SSIFLDVTIVVDAHLSLQQAHDICDRVENHLHSKGISSVYVHPEPDTL
>SEQF2892_02034 hypothetical protein
MKLNQTHFEIIKFIIVGGINTLNYYIVYLLLLKLFHVNYMISHIAGFLVSFVISYYLNCY
FVYKVRPTLKKFLSFPLTQVINMGMQTLLLYVFVKWFQFPSEIAPFAGLIITIPITFIVS
KWILKD
>SEQF2892_02035 hypothetical protein
MYRLKHHEFYIWMIGLILYYGYLGYIIPLHSTDWFWGSDHGMQVVSNAFNNFNGRYISNL
LEFASVHSILLRTLSFAFISIFILVLLLRLLNQFGDTNYLILSTVLLFIIPNPLFAQSYG
NFEFFYTYVFGTCFSLYILSFIIRVLLNKDEFSRIEVFIFWLICILGQWFAEPLAFYNAT
IILVGMIYYAIRNHKLHYSLVLGWLLSLCGAMIMLLNDKYIYIFSSVEALRGHLDMLGLN
HKFEISLLKDIPRYLFFNNIIILSLIVIILMILLLKSSAFLTLPTIKRIILQTGICILPI
YKIFIYEPFNLKQLSETFTFEVINTLLCLIMIVSIAISCKLVIQLPYNRLLVFMSLVSIP
ISVLPVILITEVSVRQFYLAYLLCIIVLISLISELGILTLNHYNLLKSCILIFAIINILI
FTDVHMRSEQRLEDVQSQIDSNKRHITLSHLPYETYLFEITPADEADLTSFKEFHHISEK
YPFKILPFEN
>SEQF2892_02036 Glycerate 2-kinase
MNLRKIVIATDSFKESMSAKEASLAIQDGFKKIFHEDIHYDIIPMADGGEGTTDALKEAH
NAKTYTIPVHDPLHRNIEASYARSQDNQVAIIEMAASSGLDLLTDEERNPLITSTYGVGE
IILDALDHHVTKIILGIGGSATNDGGSGMLCALGAQFLDSKNQPLKLGGGYLSELAKIDI
SNLDQRLKHVTFEVACDVTNPLLGANGATEIYGPQKGADAKMIPKLDSALTTYHDMIERE
LNVSVKDIPGAGAAGGLGAGILAFFNASLSNGIDIVLKETDFSRRVQDADLVVTGEGKMD
AQTVFGKTPIGVAKAAKEHHAPVIAICGSLGEGYQDVYKHGIDSAFSLIEQPESLPSLLN
NAKRNMTHTAENIARLLKLTI
>SEQF2892_02037 hypothetical protein
MKRTDKYKDSYKYDEQYRKRNRQSADGLSRHERRESQEAYNRSNSRYRDDDPRYRNDDRR
YQDDYDYREDYRRRNDEYDEDGNRYYNDRDFRREQQLEEENEKNKKSKKWLIAIIAILLI
IVAVFATRAILNNNSSDNQQTNNASNDNNVSKDYKNEVQNQSDNIKQQVEDAKNDIKDKV
DTDSRIKQIQEDVNNLKNSEQTGEDSKLTKFYQEQVNKLKEANNAQQNNESQSKVNDLLN
DVNTKFDEIKEKLNSILGNSSDTNSQ
>SEQF2892_02038 Bicyclomycin resistance protein
MQPSTHTKLPLLLLIVLGVMTAFGPMIIDMYLPALPEAQHQFRSSTSEIQLTLSFAMIGL
ALGQFLFGPLSDAFGRKRMGLIILCIFFLATLSGVFASNLILFLCIRFIQGFTAGGIIVI
AKAFAGDRYEGDLLAKFLASLMVVNGIVTIIMPLLGGLSLTLGSSRIVFIILTFISLFVL
LGVATMMPKTHKSEHKSLNFKDILLDFGSLMKKPRFIIPMLLQGLTYVMLFSFSSASPFI
TQKIYNMTPQQFSIMVAVNGVGLIIVSQIVALLVAYINRFKLMIYLTLIQVVGVILIVIT
LAVHGPLWILLIAFFLNVCPVTSIGPLGFSMAMEERTGGSGNASSLLGLFQFILGGIISP
IVGLKGQYDATPYIFVIMITAVILITLQVIYFRNHRKPA
>SEQF2892_02039 Iron-sulfur cluster repair protein ScdA
MITNESIVAEIVTDIPLSADIFRKYGIDFCCGGNISINEAVKNKKVDAETLIDEINELPN
HDQGNINVKYLDAPSLIQYIQSRYHETMREEFKNLSPYVTKVAKVHGPNHPFLIQLQDLY
RQYRDGMLEHMAQEDEHDFPALIKLSRGEQVDHSSDIIQSLVDDHTQTGQLLEDMRELTS
QYQPPSEACQTWRLVYHRLMNLERETHEHVHLENHVLFNKFS
>SEQF2892_02040 Demethylrebeccamycin-D-glucose O-methyltransferase
MVTKIAGHTFLAQLGKKRLRPGGVLATNWLINKGHFSSDKRVLEVACNMCTTSIELAQKY
NCHIEGVDLNKTALEKGKQNVSKRNLDKLIHLTQANAMKLPFEDQSFDIILNEAMLTMLP
YQIKEKVLNEYYRVLKPNGIILTHDIAIINRQEAPTVIDELSNAINMKVTPLSPEDWYQL
YQEAGFSNIESKVGPLSLMTPIGMIRDEGLLGTLKIIKNALKPTNRKMFIKMFKTMRKHK
KNMNYIVHAVKK
>SEQF2892_02041 hypothetical protein
MAIQYKLEQLNHVRLIGVLRKYESGDEMQKDIPSFWQKVNNDGVVDDLIELSNQTLSGLL
GVILQKEDNHFEYFIGVPCDNSNNNDSHFNTLELSAHKYVVIDAKGKVPEAIKSITPKIY
QELLPQAKFKTIRAPMFEHYLPGNTQSSDYITEIWIPIED
>SEQF2892_02042 hypothetical protein
MKRTILSIKPISQLFPIPMVMGCEGVSAAMLLQYNDYNIKATEIMKHWPKHPNNPYKGYV
GHHLLVKLGHHQTIFPNAYVPYLQTIDSRIVDGTGTELTSLEAVIDSGQPVIMYHTSLGR
KPFRKHFTFDDRKKELVSNIHVTLLIGYDDKYYYYIDPLWSHLFKFVIFPAIVPNRFQVI
KIAKSKLERSFNAPGRTCIYLKVNTND
>SEQF2892_02043 3',5'-cyclic adenosine monophosphate phosphodiesterase CpdA
MKIGTISDLHIDRHPKLEPQAYLDALVYIVEQRNIELLLIAGDMSNDYLQSYQFIQDLKE
KCRIPILFVPGNHDYWTSEASLSSKQIYEFYASKPDCLIGKPYVVNDHWAIVGHTAWYDY
SYADDKFDLDRIKRGKYYGATWQDKVKIDWDIDDRVLSKEAAKQIQEDLDQVKDKHIILM
THIVTHPKFIVPMPHRIFDFFNAYIGTKDFDEFYSTYSIRYSIMGHVHFRKMINENGITY
ICPCLGYQRQWRTSDINQEINNALVSFDISDE
>SEQF2892_02044 D-serine/D-alanine/glycine transporter
MARQLERELNNRHIQLIAIGGAIGTGLFLGSGQTIALTGPSLLLTYMIIGMVMFAFMRAL
GELLLSNTRFNSFVDIANEYIGPFAGFVIGWTYWLAWIASSMSDLTAMGQYFSFWFPQVP
HWITVLFIVLMLISFNMLGARLFGELEFWFSIIKIVTIIAMIIVGLVMIFFSFKTSYGHA
SFSNLTNHGGIFPNGPFGFLMAFQIAVYSFIGIELIGVTAGETKDPRNVIPKAINNVPIR
ILLFYVGGLLVIMSVIPWNKIDSNSSPFVTMFSLIGLPFAAGLVNFVVLTAAASATNSGI
YSNSRILFGLAKQGLGPKVLSKTNGSSVPYLSMLVSSGTLLAAALLNFIFPDAIKLFIYV
TTLSTVLFLVVWAMIIISYIVFVKKNPEEHHKNKFKLFGGLKTAYVVLAFFAFVFVLLFF
SEDTRAAIFISPIWFIFLFIFYRKYKSNAEDLAERTRSQGRNSINY
>SEQF2892_02045 Sodium, potassium, lithium and rubidium/H(+) antiporter
MELLEAFLLFIFAVIISSIIYNRFPKIPTAFIQIALGVCLFVLPIPMHFEFESEVFMMAV
IAPLLFVEGTHISRTKLLEYRKPIVLMAMALVFATVIGVGFFIHWIWADLPMPAAFAIAA
ILCPTDAVAVSAITKGKILPKGSMSILEGESLLNDAAGIISFKIAVTALVTGSFSAFDAI
GQFIISTILGVLIGIIVGALVVTLRVYLTANKGMKDSNTLTFIQLLTPFAVYFIGEELHA
SGIIAVVVAGLIHGLERDRLIRAQTELQMNYNQIWNTLSYALNGFVFVVLGYIVPEVVME
IIHDEPQNIVFLITTALLIALAIYVFRFVWVYLLFKDFYYPNNVQSYLDDEEDAGPPKRN
HYAFIMTMCGIHGTISLSMALTLPYMMDGNQEFIYRNDLLFIASFMVLTSLILAQVVLPF
ITPSEKISEFKGMSYQSAKIFMVQQVLDAFKKKNSEEKSMDYRPILNQYFNELSFLINME
PDNKNTKELRRLQEIAEEEETRTLERLIEKERITKKDLTDYRNITEFSQSYREMSIIRKI
SRFFKLIGLRFKARKESRKETHRIHKENRGLLKEEHHATPEQNKMDIKAKREEYKAERQK
VKDEKKAQREECANSFNKVQQLMRVVNHNIIMKMRQEQNSSNVLEVSLIINQYHNLSRTI
RHNKNRKQQKNQNKEVYELTTQQQQDVKLEALYIQRTILDELISRNKVTNEVATQLRENI
NYNEIVLAHEVSNAH
>SEQF2892_02046 hypothetical protein
MFTQFKRLLIGKPKRNRDLKNERISNFKALAILSSDALSSVAYGPEQILITLAVVGAIAS
WYTLPIACAVLVLLAALILSYRQVIYAYPKGGGAYMVSKTNLGEKWGLVAGGSLLVDYIL
TVAVSIASGADAFVAAFPSLYHHKVLIACLLVLFILIMNLRGLTESATVLSYPVYLFIIG
LIIMIVVGVWKVATGQAEPHMHATVGTAVPGVTLFLLLKAFSSGASSLTGVEAISNAVTN
FKDPGPKNAVKTLVTMGGILAFLLVGIVGLAYWYGVMPETETTVLSQLAMNILGHNAGYY
FVQATTVMILVLAANTGFTAFPMLAASMAKDKYMPRMFSVRGDRLGYSNSIITLGVGAIL
LIIIFDGKTENLIPLYAVGVFIPFTLAQYGMVLKWIRGREKGWSRKLIANAIGGTITFIV
FMIFLITKFSHVWPILIFLPLIVIVFLRIKGHYKDIAKQLKSTAMVQDMPIVDKNLAIVP
VSTITSAIDKSVYYAQMIADDVIAVHVSFGDEADKCFAEKWQRHYPDVRLVILHSEYRSV
IRPISRFIDKINKKANDKNYVITVVVPQFITKKSWHNFLHNQTSIRLKMHLFYQKNVILA
TVPFKLHK
>SEQF2892_02047 Putative penicillin-binding protein PbpX
MKKTFLFSGVVLVIILFICSIMIKWQPNYSMISPTSQNYLDSIVKNEMNDGHIPGVSVLI
IKDNKMLLNKGYGYANIKNKQKVTSNTRFEIASNSKAMTGYAIMQLVNERKIKLNDPISK
YIPNFHMKYKGKKVEITINQLITQTSGIPGDITDNDKITKKTDSLDGIVNSINGRSLNHR
PGEQFEYANMNYDILGLIVQNISHSPYSSYMSEHIFKPLNMKHISTKESNKKGGDDAQGY
DIQHNKAYSDNPKFNIGDNPAAYLMASTHDLEPWIKFQLHPPKHLKSLVETTHKPKVKTN
DDDDSQYATGWFVTKDNQETLIYHPGTLENYSSYIILNPKKDYGIVVLGNAYSSHTPTLA
KHLNTQLSQGQHIDTVQYYINQYQTMIIVVTIVIWIMVAITLIYLYRHMTSHQSILLSFQ
RKNTKYRILILSIGFILILGLLHLLPSLLLNGSDWQFIMTWLPAPAKVTILGFITLLTSL
FGLVLLKIITNTNK
>SEQF2892_02048 Membrane protein insertase YidC
MRKKWSLFLMSIVILLGGCDYSHKEDQHGFFYTIFVKPMDMLLHFLGRTFHENYGLAIIV
IVLIIRLVLMPLMFIQVKNIHIMRGKTQVVKPEIEKLQDKLKNADTQEERTAANKLLMKK
YNDYGINPFKSLVGTLPILIQIPILLGLYACIKYPTSGGIIEHPHFLWFNLMHTDLIMTF
IAALLYFIQPLVNAMHYPKEERRTYYVMMVLSPLFIIYASLQSASALSLYWAISATFLII
QMHFAHSHYAKVGKAAGEQLKRQIEQQRQNKTNDDKA
>SEQF2892_02049 UDP-glucose 4-epimerase
MTKIFITGATGLIGTRLTKRLVEEGHEVAGFTTSERGKEKLERLNAKAYIGDILKADTID
AAIGDFRPEIIINQITDLKNVDMAANTKVRIEGGKNLTDAALKFDVKKVVAQSIGFMYEP
GEGLATEETPLDNHSDGDRKITVDGVVGLEKETARMDQYVVLRFGWLYGPGTWYGKDGMI
YNQFKDGEVTLSDGVTSFIHLDDAVEVSIQAMNFDTGIYNVADDEPVKGSDFAAWYSKEV
GVDPKVTIQPAQPFERGITNGKFKEQGGTLIYNTWKDGMHPLK
>SEQF2892_02050 Inner membrane protein YagU
MNRSTKRVVITSIVGGLLSGAVKIGWEAIVPPRTPEREKETPPMTLLNQVGLPDSIKKAT
YHYNGNDIPITVMGIHYGFSVANALAYGLLAERFPRITALKGSLFGVAIHIAFHEYLLPK
LKLTPQVKDLPYEERLSELFGHIVWMNTIDMIRDSSK
>SEQF2892_02051 2-dehydropantoate 2-reductase
MKIAIAGSGALGSGFGAMLYRQGYDVTLIDGWEPQAKAVIQEGLHIDINGKNHHLNMTMY
QHNDIPQDAQFDVIFLFTKAMQLQDMLEHIKAHIHDNTIMVCTMNGLKHERLIQHYVDES
RIVRGVTTWTAGLESPGHTHLMGAGPVEIGALVPKGQANVDVVYELLDQSGLNPHKSEQL
QQSIWKKICVNGTANALCTILECRLSNLNESDYAKQLIYKITQEIVQVATVDGVHLNGDE
VYNYLIDLNEKVGPHYPSMYQDLINNNRLTEIDYINGAVAQLGKEHHIDAPVNQFVANMV
HAKEQQRHAK
>SEQF2892_02052 Quinolone resistance protein NorB
MESSKQFRGDNKLLIGIIIGVLTFWLFAQSLVNVVPTLQSSFNTDMGTINIAISLTALFS
GLFIVGAGDIADKLGRVKMTYIGLALNIIGSLCLIIAPVAWLLLVGRALQGLSGALIMPS
TLAIINEYYIGKERQRAVSYWSIGSWGGSGICSLFGGFMASTIGWQWIFIVSIALSILAF
FLIKHTPETKVEPSVDETKTKFDVTGLILLVITLLSVNVMVTQAADRGLFSPMILSLGAV
FLVAGILFIIRELKTENPLVDFHIFKNKGYSGATLSNFMLNGVAGGTLIVVNTYYQSQLG
FSSLQAGLISITYLVAVLIMIRVGEKLLQKLGAKKPLLVGSGFAFLGLLLLSLTFLPNVA
YIISSIIGYLLFGIGLGTYATPSTDTAVAEAPDDKVGVASGLYKMASSLGNAFGVAMSST
IYGFGASFMNLQLGGAAGVLFNAGIALTAFIVILILVPKKLRTN
>SEQF2892_02053 Sensor histidine kinase YpdA
MFNLFILLLERVGLIIIIAYMLMNINHFKTMMGEREKLRSQWQLTILFALFAITSNFTGI
EIENGHIVSSNIYYHLNDDASMANTRVLTIGMSGLIGGPFVAIIVGIVSGLSRLYIGGAN
AYTYLISSIFIALISGFYGYRTMRRYTYPTVLMGAIIGAINEAIQMACILIFANDTASAW
SLVQFIALPMILINSIGTAIFLSIILSTLKQEEQTRAIQTHDVFEIANKTLPYFRSGLTE
QSARSVAEIILKLMNVSAVAITNRTDILTHVGAASDHHVAKKAIITDLSKEVIKTGHLKE
AHSKEEIGCNNPNCSLTSAIVIPLMINQEVAGTLKFYFTNEYENTTSTKQLARGLADIFS
SQLELGQAEMQSKLLKDAEIKSLQAQVNPHFFFNAINTISALVRIDSEKARKLLLQLSQF
FRSNLQGARNNTITLEKELQQVEAYLALEQARFPDRFTIQYHIDSSCKHVLIPPFVIQIL
VENAIKHAFKHRRKDNIIDVVAHHDNEELTLTVRDNGSGIDDDKLPLIGQMSVDSETGTG
SALENLNRRLIGLYGTKAALHFESTEIGTTVSCHIPSHTIKEDI
>SEQF2892_02054 Sensory transduction protein LytR
MKTLIVDDEPLARNELHYLLNEISGFNVIDEAENIEETLEKLLSETYDLVFLDINLMDES
GIDLAQKIKKMKQPPHIIFATAHDTFAVKAFELDAIDYILKPFELERIEQAVNKVKHQIS
NSNEIDHITSEPSTLSMQQDDRQENEDQTVLPIEMNERIYVIRKDDITAVSVNNGITTIN
TTHRTYQTNEPLNYYEKKLSNNTFIKIHRATIINKTHIDSVEHWFNYTYQVTMTSGDKFQ
VSRSFMKAFKHEIGLA
>SEQF2892_02055 Antiholin-like protein LrgA
MANEQSQSNAHKGNHKLAKTYNFFQQALTIAIVLFISKIIESFIPFPMPASVIGLVLLFI
LLCTGVVKLGQVEGVGTALTNNISFLFVPAGISVINSLPILSQHPILILLLIIISTLLLL
ICVGFVSQLFVTKTLFPSKEQNEQTKLGEGN
>SEQF2892_02056 Antiholin-like protein LrgB
MVDHLGITTPYFGILVSLIPFVIAQYFYKKTNGFFLLAPLFVAMVAGIVFLKVTGISYEN
YKIGGDIINFFLEPATISFAIPLYKKRDVLKKYWLQIFGGIAIGTLIALILIYLVAIVFQ
LGDQIGASMLPQAATTAIALPVSQGIGGVKELTSLAVILNAVVISALGTKIVKWFKISNP
IARGLALGTSGHTLGVAAAKELGETEESMGSIAVVIVGVIIVAIVPPLASILF
>SEQF2892_02057 Glycine betaine/carnitine/choline transport system permease protein OpuCD
MKGNLLSSLYEYYTLNFGYLMELFFKHLLMSIYGVLFACIIGIPIGILISRYTKLSWPII
TIANIIQTVPAIAMLAILMLALGVGPNTVVFAVFLYALLPIIKNTYTGITEVDYNIKDAG
KGMGMTKNQVMRMIELPLSLSVIIGGIRIALVVAIGIVAIGSFIGASTLGDIIIRGTNST
DGTVYILAGAIPIALIAIIIDLGLRLLEKKLDPTNNSKKRDNKVQSIN
>SEQF2892_02058 Glycine betaine/carnitine/choline-binding protein OpuCC
MKKLKLTFILLAMSLIVLSGCSLPGLGDGDGKDSVKITATETSETKIMANIEKLMIEHYT
NGKIKPTIVGNLGSSIIQHNALQRGDVNMSAVRYTGTELTSVLDAPPTKDTKKAMSESQR
LFKEKYNQKYYDSFGFENTYAFMVTKEVAEKYHLEKVSDLKKYKDELRLGMDTQWMNRAG
DGYPAFQKEYGFKFASARPMQIGLVYDALKNKKLDVAVGYSTDGRIAAYDLKILKDDRKF
FPPYDGSPLATEKLIKDHPEIDKALKKLQGQISTKEMQKLNYEADGKGKEPAVIAEEYLK
KHNYFEDDSKKGGQK
>SEQF2892_02059 Carnitine transport permease protein OpuCB
MRQFFQEYGSQLVSKTIEHFYISIIALLIAIVVAVPLGILLSKTKRIANVVLTIAGVLQT
IPTLAVLAIMIPIFGVGKTPAIVALFIYVLLPILNNTVLGVQNIDKNIIQAGTSMGMTKM
QLMKDVELPLALPLIISGIRLSSVYVISWATLASYVGAGGLGDLVFNGLNLYQPPMIISA
AILVTCLALLVDFILSLIEKWAVPKGLKVSR
>SEQF2892_02060 Carnitine transport ATP-binding protein OpuCA
MTLSIKNLTKIYSGNKKAVDNISLDIESGEFIAFIGTSGSGKTTALRMINRMIEATDGTI
EMNGKNVRNMNPVELRRSIGYVIQQIGLMPHMTIRENIVLVPKLLKWSKEKKDAKAKELI
KLVDLPEDYLDRYPSELSGGQQQRIGVVRALAAEQDIILMDEPFGALDPITRDTLQDLVK
DLQKKLGKTFIFVTHDMDEAIKLADRICIMSKGKVVQYDTPDNILRNPANDFVREFIGQN
RLIQDRPNMRTVEDAMIKPVTVNANDTLNDAVNVMRQRRVDTIFVVNNHHHLLGFLDIED
INQGLRQRKELIDTMQRDVYKVHIDSKLQDSVRTILKRNVRNVPVVDNDNALIGLITRSN
LVDIVYDSIWGEEDDEMTLSDSHMNDVERENELGNIEKNEHAEDRHNDATSKQKDVTDRL
DTHDVKDSDHSGVDR
>SEQF2892_02061 Sorbitol dehydrogenase
MKAAVWYGQKDVRVEDREPKQLKDNEVKVKVSWAGICGTDLHEYLEGPVFISTDKPDPLL
GQKAPVTLGHEFAGVVEEVGKDVTKYKKGDRVVVNPTVSKHEKDESVDLYDGYSFIGLGS
DGGFAEFTNAPEENVYALPESVSDKEGALVEPTAVAVQAVKEGKLLFGDTVAVFGAGPIG
LLTIVAAKAAGASKIFVFDLSEERLAKAKEVGATHVVNSGNTNPVDFINEHTENGVDVTF
EVAGVGVTLSQSVQVTRPRGTVVIVSIFAHAVDFDPMLLTNSGVQLTSTIAYSPTTFQQT
IDLIANGSLDVKSVVTDEIELENIVESGFEQLVNDKSQAKILVKLNG
>SEQF2892_02062 hypothetical protein
MPEKQSDKQVLAFLEKESQWKESYQYLRNLIFDESELEEAYKWMHPTYTINDKNVITIHG
FKHYVALLFHKGAIIEDKYETLIQQTERVQAARQIRFKTLEEIKERRDEILYYINEAIEV
EKDGKKVEMKKTEDYEIPEELQQAFNDNPNLEEAFYKLTPGRQHQYIYHISQAKRSQTRQ
SRVEKYIDHILDGKGMHDK
>SEQF2892_02063 Aspartate-proton symporter
MGQNNNEGKINLVQLVLLGLGSLIGSGWLFGAWEASSAAGPAAILSWIIGFIVIGTISYN
YIEIGTMFPQSGGMSNYAQYSHGSLLGFIAAWANWVSLVTIIPIEAVSAVQYISSWPWDW
AKPTSALMHNGSISTTGLFAVYVIIIIFSLLNYWSVKLLTSFTSLISFFKLGVPLLTIIM
LMLSGFDTSNYGSSIGEFMPYGSAPIFAATTTSGIIFSFNAFQTIINMGSEIKNPEKNIA
RGIAISLTLSAILYIILQSTFITSMPQSMIHEHGWSGINFNSPFADMAILLGINWLAILL
YIEAVVSPFGTGVSFVAITGRVLNAMERNGHIPKFLGKINTTYNIPRVAIVFNAIISMVM
VTLFRDWGVLAAVISTATLVAYLTGPTTVMSLREMGPKLHRPFRGTMLKVMAPLSFVLAS
LAIYWAMWPTTAEVILIIILGLPIYFFYEYKMNWKNTKKQIGGSMWIIVYLILLACMSFI
GSKEFKGINLIHYPYDFLVIIVLALVFYRIGITSHFKSVYYKRAKKINKQMKEDTLEAEQ
QEPERKEAIQQHND
>SEQF2892_02064 Para-nitrobenzyl esterase
MVIINTKYGSFEGLTHKNLDLFLGIPYAYPPIGHRRFKHASPIYSYDTLVDATQFRAIPP
QPFNKLETFFSTTKQKFQPNEDCLHLNIWRQSTGKAKKPVIIYFYGGGFINGHGSAELYT
PEHIVEQYDVIVITFNYRLGALGFLDWSYFNAHYDKNNGLSDQIAVLKWVAHFIKYFGGD
PDNVTLWGQSAGSMSIQALMQQPQLDHYYHQVMLLSGILQLDSAKTGMMKAQHFDDLMQQ
HFSGKSINDLDDQAILQLMAYDAEARGKSKGLELIYQPIKDSKMCRPLTEFNKPIVLSYT
KDEGDCYIRNESRKLSPQRFVDVMKLNHIHVDFSRVQTGKQQAHVVTELYFKQPTFTLLQ
QMSNNSYRWLLRFDWARPEHVHFASAYHILDLVFWFGKMDILQGHSIKLSNNEFELSKRM
ISDLVHYARTGTMPYEPYSINNLEPHVNK
>SEQF2892_02065 Purine efflux pump PbuE
MMSVMRIATFIISVFIVGMVEMMVAGIMNLMSDDLGVSEAIIGQLVTLYALTFAICGPIL
VKLTNRYPARPVLLWTLVIFVVGNGIIAVAPNFTILVIGRILSSAAASLIIVKVLALTAM
LTIPKNRGKMIGVVYTGFSGANVFGVPIGTMIGDWIGWRFTFVFIIVISLIAGLLMLKYL
PTTTELNQANRMYNNVSDDNQVTSHIVRPVEIIKFLAITLLILIANSVTFVFINPLILEN
GHSMGYVSLALLVNGVAGVVGTSMGGVLADKLTSKRWLIIAFSVFIVVMLAINLILSTTV
LLLVGLFIWNIVQWSTNPAIQSGIIEHVEGDTSQVMSWNMSCLNAGIGLGGIIGGLVVSN
MNVEAVTFVSAFIGLLGLIIVLTLKNVHYAKN
>SEQF2892_02066 hypothetical protein
MKVISQLLGIMITLLALFNILRLLISLIESYFSMNFGIDFLLHNNYVTYGAIALLVVSAF
LQELIEHQYNNNESLF
>SEQF2892_02067 Transcriptional regulatory protein SrrA
MNGEVLIIEDDKDINELMKLSLSTKGIQHIKSVDNIEDAKYELLNFNFQVILLDLNLKSE
DGYQLLKYIDLNDTAVIVVTAKTTHLDVYKGFEQGAVDYIKKPFDPMELYYRVSLHLNDK
GQSMYRYNDLTINFNSMEVCVNEKPINLTNREYNLLTYLVKNKNQVLTKDQLYAKVWGYD
TGVDDNTLMVHIRTLRKKIEAAPNSPKMIKTVRSKGYMFKEDGNDQ
>SEQF2892_02068 Sensor histidine kinase ResE
MINKFTLKFLKYMTIFVLLNFTITCTLIIILFFKVLPNIYWDINEIEPTYLETYGITQEP
NANLKSLAKKSNVDLYFVRKNGDILYPKSKRNSNIKPTLLNNINNANSVVSKEGTYLVYI
YRNKMKQPKITNSDEIKTSQLLDSLSSLDFNHYNYSISNNELQFVKNPGQRTILWNDNFG
EAFNDSKNTYILLFITFIMANVILVALTAMLISKRLTRPLSFYIDWIGNLSLGKLHQPTS
KRKRFKNRRTYPELGASLSKLNEQMLSDKFYHNQMSYYKSKWISQISHDLKSPLTTIYGY
SKLIQADEQSQSYVQLISEKATFMSDLIDSLNQTFDMETNQMKHDKENFPIQSTVNRIAQ
IIGYQSLTCDFHFEDGSTFYGNKLYFERLLINLINNSIDHNEINPSIKITFSKIENNLMI
DYMDDGRGLPHDNIDALFKQSYTSKANKAQHGIGLSIIKDAVNYHHGSITLLPSKQGVHF
HIILVDKA
>SEQF2892_02069 putative iron export permease protein FetB
MSNTALCLTALLLLIPIFISYKEGLHIIKDLVVASVRAVVQLIILGFILHYIFKIDQAWI
LMLAVLIIIINASWNTINRASPVMHHVFWISFIAIFIGTALPLTATVLAGAIDFKANEVI
PIGGMLANNGLIAINLAYQNLDRAFVKDITDIESKLTLAATPKLASKASIRESIRLAIVP
TIDSVKTYGLVSIPGMMTGLIIGGVPPLQAIKFQLLVVFIHTTATIMSALIATYLSYNQF
FNVRHQLVARNSALNAPDEEDEDK
>SEQF2892_02070 putative iron export ATP-binding protein FetA
MLLNIKNLSYKADRRMILKNINFQLNEGEAVAIIGPSGSGKSTFLKQINNLISPTDGELY
FKDKPFNDYPPEELRMKISYLMQQSQLFGETIGDNMSFPALARDAHFDKEKALDLLKKVN
LGQYDLNSKIEHLSGGERQRITIARQLMYRPDILLLDESTSALDTQNKHIIEQMIFDMVK
EGVAVLWITHSDDQSMRHFHRRITISDGEITKEEALNQNE
>SEQF2892_02071 hypothetical protein
MTNEYEHSQETSKHSQLNNEFASKRIVKRDFWLIPGYLIINIVLPLILTIVVMITIVAIT
GQTSQDPFIKQLMGINQIFVLLGQCLLLLLFYLMHRKSLIPLAIQRFKDLKKHIILIIVV
LIAMYLAQFLYGNLIELLPEKYQFNNTENNKQIEELFKTRWIWPILFLDIVIVTPIVEEL
LFRHLIIHELGKKLTYGAMYVVSVLIFAGLHVLSASSPFEVGPYLIMAIGFVVAYHYSGR
NLAITITLHMINNLISYFSIIISIIW
>SEQF2892_02072 hypothetical protein
MEKKGKSLKQEGLRNQWGSPEVVKKDFLLIPIYIVFQNLMPIIIVFGVLGVHAMITQDPP
PLYLYNLMLSVSFVIAQFIVIVSFFALHKLYIADVSFRQFRIAKRNYLPLIVSVSISALL
LYYAFNFVAQKLPKPLSYDVTQAQLRLEGLFNHPIAIVFTFITVVALQPLIQELIYRHLI
IHELGKKLNLMVVIVLSIVIEVSVQVYDLISIMEVIPYLILSIGSIIIYIRSGKSLAASY
LYHSSVHLVIFITTMVEKFF
>SEQF2892_02073 Glutamate synthase [NADPH] large chain
MISILTVMQFIVNIMIFIVILSIIGLVLVLLFKDKGQNQHSVLRNYPVLGRVRYFAEKIG
PELRQYLFANDTEGKPFSRNQYTNIVLAGKYNSRMSSFGTQREYKDGFYIRNTMFPLQRN
ELQIDNQTMISTFIYKVDNERLFQRDEHRDQTDIDPYYLTDDNAINLGNNLRHPYKIKRL
VGQSGMSYGALGGRAITALSQGLARAGTWMNTGEGGLSEYHLKGGGDIIFQIGPGLFGVR
DKDGNFSDEQFLKTANHKEVKAFEIKLAQGAKTRGGHMEGNKVTEEIAKIRNIEPYKTVN
SPNRFDFIDSPEDLLQFVDKLRQLGQKPVGFKIVVSKVEEIEALVQSMVDMNIYPDFITI
DGGEGGTGATFQELQDGVGLPLFTALPIVSGMLEQHQIRDKMKIFASGKLITPDKVAIAL
GLGADLVNIARGMMISVGCIMSQQCHLNTCPVGVATTDPKKEKALIVDEKQYRVTNYITS
LHEGLFNIAAAVGVKSPNEITSDHIVIKRIDGSIENIIDYKLKLIR
>SEQF2892_02074 L-methionine gamma-lyase
MTDNHPNWKFETQTIHAGQVIDEFSKSRAVPIYQTSSYVFDDTQHAQDLFSLAKPGNIYT
RIMNPTQNVFEARITQLEGGVGALATSSGQAAITLALLNIVETGSEIVASSNLYGGSYNL
LNITFAKLGIKVHFVDPSDPNNFKAAINDKTRAIYAETIGNPAIDVLDIEAVAQIAHDNG
LPLVIDNTFASPYLCRPFEHGADIAIHSATKFIGGHGTSIGGIIVDSGKFNWDNGKFPGL
VEPDPSYHGISYTNDVGEAAYITKARVQLLRDLGSAVSPYNVHEFLIGLETLHLRMERHS
ENALKIAQFLDQHPKVTWVNYPGLENNKYHSLAKKYLSKGQGAILTFGVDGSVEDIARFV
DKLQLFSLLANVGDSKSLVIHPASTTHQQLTEAEQRQSGVLPEMVRLSIGTENAEDIIND
LNDALSII
>SEQF2892_02075 hypothetical protein
MSMMKKFFVLTILMVLSVSILGACSKERSKTYEGDMEGKHVLTTLSYKKNKVVKQSTVTT
LKYNDFGMSKKEAKKTFHDHHQLKDLKGVSYSLENNHEKWVETIDINYKKANIKEVEKHF
SLMATSKKGKKVNMEGTVRELKKLGFKQKSNMTDE
>SEQF2892_02076 Putative aminopeptidase YsdC
MKESIELLKSLTDVNGIAGYERNVKAKMKEYLEPVSDEIIEDGLGGIFGKKASDNGTKSL
MVAGHLDEIGFIVTKIDNNGFIKFQPIGGWWNQVMLSQKVTITTDDGTEIRGLIGSKPPH
VLDPEERKKPVQIKDMFIDIGVRSKEDAENHGIEVGNMITPYSEFEELANGKYLTAKAFD
NRYGCALAIDVLKRLKDEQIGVDLYAGATVQEEVGLRGAKVAANKIKPDLAIAVDVAVAY
DTPGMNNLGSETTLGNGPVVILMDASNVAHQGLRQHIKEVARRHYITVQWDTTAGGGTDA
GSIHVANEGIPTISIGVALRYMHSNVSILHTDDYENSVRLVTEIVRSLNDDAYERIKW
>SEQF2892_02077 Dihydroanticapsin 7-dehydrogenase
MKRLENKIAVITGASTGIGQASAKALANEGAHVLALDISDELEKTVEEINHNGGKATAYK
VDISDDKQVQDFADKARDEYGRVDVIFNNAGVDNSAGRIHEYPVEVFDKIMAVDMRGTFL
VTKFLLPLMMEQGGSIINTASFSGQAADLYRSGYNAAKGAVINFTKSIAIEYGRENIRAN
AIAPGTIETPLVDNLAGTSEDEAGKTFRDNQKWVTPLGRLGKPEEVGKLVAFLASDDSSF
ITGETVRIDGGVMAYTWPGEMLSDDRWKNSVE
>SEQF2892_02078 p-aminobenzoyl-glutamate transport protein
MTTNTKERTSLVNKFLNGVEKAGNKLPDPAMLFFLMCVGLAVITWIVSLFDVSVKHPGNG
ETIHIKSILSTEGIAMIMNDAVKNFSEFPALGLVLAVMIGVGAAEKSGYFDKLMISVVNR
ASNQIIVPTIILIGILGSLAGDAATVILPPLAAMIFIKIGYHPIAGLAMAYASSLGGFGA
NFLIGMQDALVYAFTEPATKIVSDSVKINVAMNWYFIAASVILVLPVIYFTTTKVVIPRL
GEYDASQANYDEEEETSSHITPTEKKALFWANMSFLLLIVALIICCIPEGSWLRNAKTGS
LIDDSPLINGVGLVILVIFLIPGMVYGILSKQIKNSKDLGSMISDSLGSMGSFILIVFFA
AQLLAFLQWSNLGIIVSVYGAKLLQHQNGIVLIIGIIILSGLINLIIGSASAKWGILAPI
FVPMMILLGYHPAFTQMIYRVGDSITNPITPMMPYMPLVLSYAQKYDKNMKLGSLLSSLM
PYTFALGVVWTLFVIAWYLLGIPLGPGGPVKIPK
>SEQF2892_02079 Exopolyphosphatase
MEERIGLVDIGSNTIRLVIFNFNKESGINELLNIKTPARLSQYLTKDNKMSKEGIKVLID
ALHSFKSVSDKFNVTELHPIATAAIRQSKNNDEIVNEVKNEVGIDIKIVPEEDEAYYGYY
AITHTTEIENGVSVDIGGGSTEVTLFKDKELFESHSFPFGVVTLKRKFFNDKDHNDKGAI
KDMEKFLSQQFESLEWLKDQEVALVGVGGSARNVARIHQAEHSYPIGGVHNYTMTNKDID
EVFDIIRKSDRDDLTNLDGLSRDRVDIILPAVSVFKTLYKIVDAKQFTFSRNGLREGYVM
KQVRERYPDVFDKNNVRKESIHFLAREYKIEDVSSQARLKLAKSLLSQLIAIADLDISDN
DQRLFEEGAYIYYLGSFIDSDSSSPHTYYIIANSMINGYTHKDRVKLALLASFKNKSLLK
FYCKETDWFSNKEVDTIQALGGIIKFINALNISQTSFVVDVELKKKKKGDEDYQLTVYYT
EGEPIAEEYQANRQKKHIEKILKGNVSIIFTKS
>SEQF2892_02080 Polyphosphate kinase
MQTQLGENDISLPQYYNNRELSWLDFNYRVLQEAYDKNNPLLEKLNFISIFSSNLDEFFM
VRVAGLKDQVKMGYDKPENKAQMTPQEQVDAIQEKAKKYVDTQYERYNELMTELQDYEIV
MCEPHELSEPLLSKLERDFKLTILPTLTPLGIDAYHPFPKLNNKSLNIFVDIDTEDAINS
AIVQIPSLIPRFLTYNEGAKQYVVMVEDVITYFINYLFTGYEVLNTFTFRITRNADLTIH
EDGAEDLLIEIERFLKERKSGSAVRLEVDGRTANPDDLDWLIETLEVDKQDVYFLNGPLD
LTFIFGLVDHLSHKLNYLTYEKYSPQIPRSLGNNNLYELALKRDIFFHHPYESFEPIVDF
IREAADDPNTIAIKQTLYRVSKDSPIIKSLKEAAEKGKQVTVLVELKARFDEENNVHWAR
MLEDAGCHVIYGMTHLKTHSKIALVVKRIGGELTSFVHLGTGNYNDKTAKLYTDMGIITT
NEQIAEDAINFFNYLSGYSVKPEYNKLIVAPFDIRDVFIDRIDKEISSHLQHGNGKIMMK
MNSLTDKAIIEKLFEASQAGVKIQLIIRGICCLKPGIPGISENIEVVSIVGRLLEHSRIY
YFHNNGDERIYLSSADVMTRNMIKRVEILFPVEDKEIGKRLVDFMDLQLSDNQKGRYQDE
HGHYHYVENNLSPLNSQVYLMQEAIKYGQELKKRSAQPSGMPVVSKRRANWMNRIRRSLK
K
>SEQF2892_02081 N-formyl-4-amino-5-aminomethyl-2-methylpyrimidine deformylase
MEKRLYNLLELLVSYNTESPPGRNTDPLQDEIEELLKALGFSIQREQLYMNDSVIVATLK
GSNPSAPKLILNGHVDVASVDDDSNWTYPPFELTQLDDWLYGRGVSDMKGGMASLFYVLE
KLHQEGRQPKGDIIVQSVVGEEVGEAGTKLACEIGPKADLALVLDTSENMALGQGGVITG
WITVKSKNTIHDGARSQTIHAGGGLFGASAIEKMTKIIHALNELEQHWAVMKHSPGMPPG
ANTINPAVIEGGRHPAFIADECRLWITVHYLPNERYEDVVAEIEDYLNRVAEADIWLREN
PLKFEWGGESMIEDKGEIFPSFTIPTEHPGFKQLQSAHQTVHGTDLKHGMSTTVTDGGWT
AHFGIPTILYGPGSLEEAHSVDEKIEASELQTYSDVLYQFLNHWYDHPEK
>SEQF2892_02082 putative oxidoreductase
MTELNGRVAIITGASSGIGAATAKALEKQGVKVVLAGRSHDKLNTVAKDMNEDNIHIVPT
DVTNQVEVDALVAKAIDVFGHVDIFVNCAGVMRSSKITDYQVESWDSMVDTNIKGLLYSL
NAILPKFEAQGSGHVVNLASISANEVSKESALYSATKSAVLMIFNGLEKELAKTGIKTTS
ILPGMVDTPMTERSDFGGRKKLDPENIADAIVYALTQPAHVNVNEVTVRPV
>SEQF2892_02083 hypothetical protein
MTFEERIQALRAEKSRTSFSFHFIDLYSEEEWMEMSVNQRTRQEREFIAQLDQIPRVRMP
FSSQEGYKFKLYNQEYQYNEVKKNFKDL
>SEQF2892_02084 hypothetical protein
MRKVIEEVVFSDEGSYDIYLKTGVNQGMIGDIKDGYLTIDSIPYIDAERLYYYGLERKTL
VTN
>SEQF2892_02085 hypothetical protein
MIKDIKNVLNLIKMKNSEDVRTNKDWDLSDKYSSIIEELLPKQLENLSYNKDLSTTGSVG
KGNYSMVPWVTTFNTNITKSTQKGYYIVYLFHPEGKGVYLSLNQGWSEIKEKTLGVKKAK
EKALALSKYLASYLDDNNFEVGRFYYSNNKDSKYDKSDLPSGYAHGSIIYKYYDFETEVY
TEDMMISDYKEMIKLLNGLVNKININEYNALLLNINEIVTIIETKELNESINENKNIQMS
QIDKPKASTYAKKYKTSTKKQTDDDIEKAHKENKITGQIGEKLAYQYFMNLIEKNISDKN
LQEQFINTIDTSMGELHGYGYDMTAFDPQNLDSPVEKYIEIKATKSKKEDEPFYLSLNEI
YAMYENPQKYLIFRIIGLNSKTPKFYIIDPYENHDEFESVEDLIEKVFNAECIQFKIFNV
KP
>SEQF2892_02086 Putative DNA repair helicase RadD
MPNNIVDSLKQSLNKGFIDKNVVHEGNLNPKILINNKNQNVLTTILNELNKCNTFYISVA
FITESGLASIKSALYDLNKKGISGKLITSNYLGFNTPKMYKELLKLNNVEVRLTDIEDFH
AKGYIFDHDNYSSMIIVSSNLTSTAMKVNYEHNVLLSTHKNGDLIHNVRYQFEELWDNSI
PLDEKWIEDYELSFSPKLYKNLFEINSEQNTLLNKFNKTNEIKPNIMQEEALMSLRQLRE
SGEHKGLVISATGTGKTILCALDVRNYKPTKFLFIVHNESILKKARQEFIKVFPHESPQE
FGLYTGTQKEQKAKYVFATIQSLSRNDNYKNFKKDAFDYIVFDEAHRTDAKTYQIIFNYF
NPDFMLGMTATPERTDDGNIFKLFDNNIAYEIRLPKALESKILCPFHYYGVTDYVHNGIE
SDDFTDLKDLTSEERVSHIVEKANYYGFSGDTLRGLIFVSRKEEAIEIAEMLTARNIPSK
SLIGSDTPNKRMKVTNELINGEIKYIVTVNLFNEGIDIPEVNQILMLRGTQSSIIFIQQL
GRGLRKSSEKEYVTIIDFIGNYKNNYLIPIALSDNQSQNKNAYREFLSNPNKIEGISTIN
FEEIAKKKIYDSIDNAKLNSVKIIIDAYKTVEERIGHIPMLMDYIEQNSIDPQVILSKFS
SYHEFLKKYKYTQMELSDDATKNLCFLSREISPGLKNSDYLVLEYIINKGQIGEEIYDEL
NHLNNEDIKTSLKILTLEYFGQAEHARYGSPIITKNGNKYILSASFKKHLADMQYQLYVD
DLISLAKYYNEKFQNSGNDLILYNQYSRLDFLKLVNWRNDEKNMSNNIYGYRVLDDHIPV
FITYKKSEDIEDNIKYEDHFISQDELAWVSRANASLKSNEIQDIINHKEQNKKVYIFVKK
SDAEGRLHYYLGEAEYIQGTAKEEIRDIGDRVVTMNFTMKTSIRDDIYRYIVEE
>SEQF2892_02087 CTP pyrophosphohydrolase
MKKVINVVGAIIYSEGKILCAQRSENMSLPLMWEFPGGKIEPEESEKEALIREIQEEMKC
DLVVGDKVTTTEHEYEFGIVRLTTFKCTLNNQMPTLTEHKEIKWLHAGELKTLQWAPADI
PAVEMISTGEE
>SEQF2892_02088 UTP--glucose-1-phosphate uridylyltransferase
MKQIKKAIIPAAGLGTRFLPATKAMPKEMLPILDKPTIQYIVEEASRAGIEDIIIVTGKH
KRAIEDHFDNQKELEMVLEEKGKDDLLEKVQYSTDLANIFYVRQKEQKGLGHAIHTARQF
IGNEPFAVLLGDDIVESETPAIKQLMNVYEETGHSVIGVQEVPESVTHRYGIIDPLEKEG
RRYEVKQFVEKPKQGTAPSNLAIMGRYILTPEIFDYLETQKEGAGNEIQLTDAIERMNSD
IPVYAYDFDGDRYDVGEKLGFVKTTIEYALKDPKMKDELIKFIKELGF
>SEQF2892_02089 hypothetical protein
MNRIEYNLTKKEETILTEKFESVMLLRQRQVNEILQKKNKNKYLILYIYIIEYMNRGGIS
TYIFEKCLCILMPKLIEYFDFSIGPFQMKYSFVKLYAPYSSLNEIFNIDYCIAILDNFFE
ENNDLNVYQKLSLYHSGEIDNEYRSTKIYINLYEWYKKTYMF
>SEQF2892_02090 hypothetical protein
MTYFTFLISTIVISILTINILKLYLNDMNIITVFTSNKEGILFEILTIPFISVIDALVTK
KYTDFENEDYNNINRVQFNSNGVHEYENVDENMESDIEDIEEERESSTNFNIYQYKNSEY
RILFISIMNLALALFDVIERKKDKDNFKNE
>SEQF2892_02091 hypothetical protein
MTQVHFTLKSEEIQSIIEYSVKDDVSKNILTTVFNQLMENQRTEYIQAKEYERTENRQSQ
RNGYYERSFTTRVGTLELKVPRTRDGHFSPTVFERYQRNEKALMASMLEMYVSGVSTRKV
SKIVEELCGKSVSKSFVSSLTEQLEPMVNEWQNRLLSEKNYPYLMTDVLYIKVREENRVL
SKSCHIAIGITKDGDREIIGFMIQSGESEETWTTFFEYLKERGLQGTELVISDAHKGLVS
AIRKSFTNVSWQRCQVHFLRNIFTTIPKKNSKSFREAVKGIFKFTDINLAREAKNRLIHD
YIDQPKYSKACASLDDGFEDAFQYTVQGNSHNRLKSTNLIERLNQEVRRREKIIRIFPNQ
TSANRLIGAVLMDLHDEWIYSSRKYINFDK
>SEQF2892_02092 hypothetical protein
MNYIIVILLALCFILFFSVQKLVLPNSYFTYSDPFIRNESISLKKYFYRIVVVIFFNVFF
YLLLNLFYTSGEITTMLLSSNFLGVFLILWPLIFKPSQNLERNLSKKSIALLYSMYFTIK
SV
>SEQF2892_02093 High-affinity gluconate transporter
MFGDIWPLISVVIGILLLLSLIIFLKLNTFISLIITSVVTAILLGMPLNKIMETIEAGMG
STLGHIALIFGLGAMLGKLLADGGGANRIADTLIAKFGPKHVQWAMLVAAFIVGIALFFE
VGLVLLIPLVFTIAKRAKVSPLKLGLPMVTALSVTHGFLPPHPGPVVIAKELKANVGEVL
LFGIIIAIPVTIIAGPVFNKIAQKIIPSAYTREGDISALGSQKEFKESEMPGFGLSLFTA
ILPVILMLISTIVQLMTGHEEAKNLFEQIVYFIGTAGTAMLISVIFAIFSMGLNRGRKMD
DIMKSVTNAIYPIGMMILIIGGGGTFKQVLIDGGVGDTIAKMFEGSTMSPILLAWIVAAV
LRIALGSATVAAISTTGIVLPLLQHSDVNVALVVLAIGAGSVILSHVNDAGFWMFKEYFG
LTVKETFLTWSLLETIISVSGIIFILFISLFV
>SEQF2892_02094 Xylulose kinase
MKYMIGVDIGTTSTKSVLYDENGQFIMKHNIGYPLHTPNVDVSEENPDELFDAVLMTVKY
VVREANIKKEDIKLISFSAQMHSLIALDAEHHRLTESITWADNRASKYAELINKEHQGSD
IYQRTGTPIHPMSPLSKIFWMKHEQSDIYKQTAMFADIKTYIFYQLFEKYVIDYSMASAT
GMFNLEKLDWDKEALELMGITEAQLPQLVPTTHILKGMKKRYATLMGIDENTPIIVGASD
GVLSNLGVNSYKKGEVAVTIGTSGAIRTVINKPRTDYKGRIFCYVLDEDHYVIGGPVNNG
GVVLRWLRDELLASEVETAKRLGVDPYDVLTKIASRVKPGAEGLIFHPYLAGERAPLWNA
DARGSFFGLTLSHQKEHMIRAALEGVLYNLYTVYLALIEVMNETPSTIKATGGFAKSEVW
RQMMADIFDTDLIVPESFESSCLGACVLGLKALGEIDDFSIIEEMVGTTNAHQPDSETVQ
VYQQLVSIFINLSRSLEERYAEIADFQRKHME
>SEQF2892_02095 putative D-xylose utilization operon transcriptional repressor
MKEGYPEQWLGGMSKGEGVAAEIRLQIVSGEIEVDTLLTENQVAKQFDVSRSPVRDAFKL
LQTDQLIQLERMGAKVLQFGDQEKKELYDLRLMLESFAFSKIKHIDRAPITKEMRKHLEM
MKVAVKFEDAEAFTQHDIQFHEAMINASNHQYLQTFWNHLKPVIETLVLLSMRHRMEQDK
ADFERIHSNHEVFIEAVEQYDSTKLREAFHLNFDDVGEDIESFWLR
>SEQF2892_02096 HTH-type transcriptional activator TipA
MSHYKVGELANHLGVTVRTLQYYDCKGLLTAERASESNRRYYNDDHIQQLQLIFLLKQFG
CTLDEIKTLLYEDSDMQTLKAMLQLHKKKLETSIHDQTKALKHLNNVDQYISSHSSAPIN
HLSDIDKAVKQSTTLKSFKSKVWISAGIIGIIQYTGLITSLIRSSSKPFIAIVPILVTYA
VGLTTYYYKNISYLCPNCQHTFKPSLKQFILARHTMQTRKLECPKCHETHYCIEVSDEKK
>SEQF2892_02097 2-succinyl-6-hydroxy-2,4-cyclohexadiene-1-carboxylate synthase
MNRKHFKTQIYQLKNYHNEQVEVAFAGNQTSNRAIVFLHGAIMTYRIMTMFEPYFREYKM
IYINCPSRGKSSSIDRNNHTLDDYSERIEDVLEQIVSSQHLEKVMVIGYSMGGMIGTRLL
KFNTLPISHLVYLSSAAKITPNTSMLARLFSTDSKRDHFKYEITAIKNLPQYILKKTVYA
RKENGLDILSFVAPIKTIITDLIYTIKADYLPDIEEIEQFPKLLFISGKDDEIIPYTDSQ
ATMEQYKRYGGETKEIVYPGIGHMDFPSVLEQLPNGTVGIVDHIKDWIEDK
>SEQF2892_02098 GTP pyrophosphokinase YwaC
MYVERKPSLYIEELRSEFKDNLHHFKDGDEAFDRLIGFVELDHLYSSALKEISTKLDILD
DNFNHVYKHNPIHHMERRVKEMNSLIKKLHRKQLDISAESAREHILDIAGIRVVCNYLED
IYVIEKMLLKQEDVKLLKRKDYIKNPKDNGYRSLHIVVSIPVFLSNKVEKLPVEIQIRTI
GMDMWASLEHKIRYKNNASTDDYSDMLKDCALEIADVESKMQSIHSAISDNN
>SEQF2892_02099 hypothetical protein
MPWTMNDYPNTWKNFDELERKKAIDIGNAMLKDGYKEGDVIPIATQQAKDWYKDATKDEL
DELKHKHITQHQKDQSANPKLNDENVHVYFEDDEWKVKTEGAKQASDTFEKKADATKRAQ
DIADNRGTKVIEHNKNETS
>SEQF2892_02100 Inner membrane protein YccS
MGNVLKSLITFDTSKVDPMKGVRQGLLLIIPALLGYFLGNFALGLLVSTGTLAHIYVFKS
SPRSMIRTVILCSISFAICMILGTLTVTEPILYGVTLLLVTVIPYYIFSALKIAGPSSTF
FLVTFCLPSNLPIAPNEALYRGLAILVGGAIATLVVILTILFQKQKIENRAINSDFNMIK
ELMHNYNDVDKFKESAKTAVTQFKNSDELLITATAGVNQKLSPRFQRLLLLHTSAQGLYS
ELLELHEKGIRPIPNELVEMMDVAIRNAYRTTASREKWIKEVHVDEAFDDLLQYILKIDE
ITNLDSSQIEHEASVRKPLYSQRIIHNLTLDSIVFRNTLIYAVIMAVAIFISLAFNIQKS
YWIPLTAHTVLLGMTTRRMLNRSVARGLGTILGTLVLSTILYFNPHLIIAVIIMGIAAMV
TETFVGSNYAFAVIFITIQVILLNGLASDNLSISIAYTRIFDVLIGIVIAVIGILLINRQ
TASAMLPRTIAEVVRKEAVIFQYLFSENHYQDDLRERDESLALSVKMSNMTQINNSASGE
LFSNQEVIRYYYPSIIALEEINFMLMRAMQNHQRQRISDQQMGEYLVTFENLAKHFELQS
RLEINELSDLPQYNYIKSALMRLQNNCVHTRKDIDDVENGVAIKA
>SEQF2892_02101 Putative monooxygenase YcnE
MIIINAKLKVSEEHREAYLDLMTNLVKHARVEEGNTFYSHYEDVTERNTFVVVENYKDQD
AVGAHNHSDHFKVFSENIGKYITEKPVIDVAEAK
>SEQF2892_02102 putative sulfoacetate transporter SauU
MVQRQKKSSIRWFFALAFFIIGVIAYMDRSNISYIAPQMMEDLHMTKQQFGLLASFFSLG
YALMQVPSGMLAEKFGPRKMITIALVWWSAFTIFTGMIKHHGLLYLVRFLFGIGEAPMYP
SNAVFNANWFSKDEKGRASSMLLAGSYFGPVLAPVITIAIVNAFNWQAVFYIFGAVGILI
AILWGIIAKDLPEQHRMVNDAEKHFIMENRDLVQTSKSLPPWNQFFRRVSFYAIAGQYFV
VQFVISLFLIWLPTYLTEQYHVEFKDMTISSLPWFIMFILILSAGAISDKILRSGQSRFV
SRGLIAIVGFIVFAVSIFFAVHTENLYVTIFWLSLGLGGMGVSMGMSWAAANDIGRNFAG
TVSGWMNLWGNIGALLSPFLAGALVASLGWTMTFQLLIIPAVIAAILWLFVSPDKPLIKD
ESRELK
>SEQF2892_02104 Thiazole tautomerase
MIDIFIAITTYKHLTEADLQHFIEISKGIDGLLFRTPMSSDDLFSFLEKLIAAGFPKDKI
IIHSDVDLLESLTLKRLHCREMDTLAFDYKAQHPDVEVSMSTHTINSVKQAYQHQLDYVF
YGHIFTTASKPNQQPRSMSEIKAVLQVPIPVYAIGGITEDTIQRLPNGFAGICAISYFMS
ASLQQIQHLRKEWLKDA
>SEQF2892_02105 Glycine oxidase
MHDVLIVGSGIIGMSIARHLSHTQLDIAIVDRDIPGKHASYKAGGMLGAQNEFTEDSDLF
RLALESRECFPELCETLQDETGIDIQYQASGLIKIANQIDDVAHLRSQFQFLHALDNDVV
ELSEDELADLTEGNVTASEMAIYIPNDGQINANHYTKALFKSLQQRRISRYFNTNVTDII
RQNGYYQIVSSQGDLYAKKVIVASGAWSSQLLKQYQLPRVVVGVKGEVLLMEHDHLNLKQ
TVFMTNGCYIVPKAPNRYLIGATSEFDNYSVGNTEQGVSWLKHYATERIPELANAHIIKQ
WSGVRPYTDGELPIMDRVDDGLYVITGHYRNGILLSPVIGRDIANWLLTGVKPTRYESFN
VSRRLNHEMHY
>SEQF2892_02106 Sulfur carrier protein ThiS
MKCIINGDAFTFNTEQSIHQVLVSLELDPERVIVEHNKTLIKQEDYHQHTVREDDQLELL
EFVGGG
>SEQF2892_02107 Thiazole synthase
MFKIGNLELHSRLLLGTGKFENEDVQTEAIKASETNVLTFAVRRMNLYDKNLPNPLANIN
LKDFITFPNTAGAKTAEEAIRIAEIAKHAGVCDMIKVEVIGDDETLLPDPFETYEACKVL
LERGYIVCPYISNDVVLAKRLEDLGVHAVMPLASPIGTGRGINNQLNLSYIIKNSNVPVI
VDAGIGSPKDACHAMELGADGILLNTAVSGAKDPVKMAEAMKLGIHAGRLSYEAGRIPVK
YTAQASSPTEGLGFL
>SEQF2892_02108 Molybdopterin-synthase adenylyltransferase
MQRYNRQMRFSPFGEQGQHALSNAKLLILGAGALGSHVAELLARMGAHQITIVDMDIVET
SNLHRQALYTEDDALNMVPKVHAIKEHIARINHHVDVQTYYQEITSNNIEDILDEVKPDI
VIDGMDHFKIRYLINEVCHKYQIPWVYGAAVGNKGTVYGIDFKGPCLKCLLKQMPSSGES
CAINGVLPTIITQVASYEVAEVLRYLSGEGFSKKLITIDTWHIDYKAMNVDILKDHACEV
CTNQNYSLLETKHQQHIESLCGRTYLFRYQSSIFEHAHHLPGEIVKSTSFAKLIKDDDYE
ITLFKDGRMNVYGIEDDEEAFKLYHSYLKALK
>SEQF2892_02109 putative membrane protein
MEQLITDFISKWGYTAIFILILLENVLPVVPSEIILTFAGLMSVKSGLSIPILFLISTIA
SFIGLLILYYLCRLINEESIYRFVDKHGKWFKLKGKDVRRANDWFKRYGAWAVLLCRFIS
VLRVLITIPAGINKMNVVTFAVLSLLGTTIWNFALILLGRMLSGSFDALMAGLHTYSYIM
YVIIILAVLYVLYRIFFKNRNRVK
>SEQF2892_02110 Fructose-1,6-bisphosphatase class 3
MTQTTESELREKYLDLLSQQFDSPEKLATEIVNLESILELPKGTEHFVSDLHGEYESFQH
VLRNGSGNVRSKINDLYAKTLSQKEIDDLAALVYYPEEKLKLVKNNFDSKGKLNVWYITT
IEQLIDLITYCSSKYTRSKLRKALPKEYTYIVEELLYKNNEFNNKKSYYETLVNQIIELE
QSDDLIIGLSYSIQRLVVDHLHVVGDIYDRGPQPDKIMDTLINYHSVDIQWGNHDVLWIG
AYAGSKACLANLLRICARYDNLDIIEDAYGINLRPLLTLAEEHYNGENPAFKPKKRPDKP
VGLSKLEESQITKIHQAIAMIQFKLEMPIIKRRSTFEMEDRLVLEKVNYDTNEITIYGKT
YPLKDTCFSTVDPQDPGKLLPEEEEVMNKLLLSFQQSEKLKRHMSFLMKKGKLYLPYNGN
LLIHGCIPVDENGEMESFEIEGEQHKGRDLLDVFERHVRYAYDYKEITDDLSTDLVWYLW
TGKYSSLFGKRAMTTFERYFIEDKASHKEPKNPYYYLREDVDMIRKMLKDFGLNPDEGRI
INGHTPVKEIDGEDPIKADGKMLVIDGGFSKAYQKTTGIAGYTLLYNSFGMQLVAHQHFD
SRDKVLSDGADELSVRRVVDEELQRKKIRDTNDGKVLQEQIRILKLLMHDRYLN
>SEQF2892_02111 K(+)/H(+) antiporter NhaP2
MSLDLPVMLIIVLFLALGIFSQWLATQIKWPSIVVMSIVGLLIGPILGLVNPQETLGAEV
FSPIVSLAVAVILFEGSSNLDFRELSGISKAVIRIITVGAAISWVLGAIALHKILDFPIS
VAVVMGGLFLITGPTVIQPLLKQAKVRKSVDSILRWESIILDPIGPILALTAFYVYQIFE
QGFGVQIILIFILKMIITAVIGFGASFIFNWLIQRDFIPQNLMPSIQLVFILLVFSICDQ
ILQESGLLAVTIFGLMMARYKRHDLIYKESDHFIENASSILVSTVFILITSSLTSSVLMD
VLSWQLVIFAIAMIVLVRPISVLLSTIGTEITKRERAIVAMMAPRGIVVLTVAQFFGGLF
MDDNVKMASYITPVTFGLVFITVVIYGFSFTPLSKLLGLASTEPPGVIIVGESEFSFHLG
TKLHEHDIPIMVFNLFENTSEKAEELGFEVFKGNLLSSSDRIYADLIRYNKCLLMTKSFI
FNSLAFNELVPEFGLNNVSMMPVSFTDEQARNNLNGPLRNHILFDESHSPRWFDNTIINK
NIVEVLAEEYDTITDHDMIIYHVDDNSVVSFNKSTKPIPQYDQGTYGILRDVY
>SEQF2892_02112 hypothetical protein
MQLFKESIMVAFALVGVVVGAGFATGQEIFQFFTSNGIYSISGIIVTGLIITLAGVFVLN
TGFVIQSHNHSESIRYYLHPIIARIFDIILTLFLFSLAMIMTAGGASTIHESFGLPYWLS
SLILVLVILMTLFLKFERLITVLGMVTPFLVIVVSIIAIYYFITGDLNFSAANRFNKQHQ
SLSLGWWFDGLNYASLQIAAAFSFLSVMGGRMQHRQSGLWGGLLGGIIITLLLLMINLGL
VTEFEHIQSVALPTLLLASHISPLLGTVMSIIMVLVIYNTIVGLMYAFASRFTEPFSKGY
FVLIIIMAIITFICTFIGFISLIGKVFPIMGLFGFILLIPILYQGFKHLVFSK
>SEQF2892_02113 Putative hydrolase MhqD
MEHIYRPGKDNAPTLILLHGTGGDETDLIPLGTALNPNYNLLSIRGEVNENGMNRYFKRL
AEDVYDEEDLEYRGQRLLGFIYEAAEQYQFDLKRTALVGFSNGSNIAINLMLRDKAPFKK
ALLFAPLYPIDASTSKDMSDVDVLLSMGKNDPIVSIDQSEHVINLFKHQGAQVTEVWVNS
HEITQAGLQKGQEILNS
>SEQF2892_02114 Putative ring-cleaving dioxygenase MhqO
MEPITHIHHISAIVGDAQETYDFYTNVLNLSLIKQTVNYDDTKTYHLYFSNDRAQHDMVL
TFFNWPNQYRGRIGSGQVGRLAFRIPKDSMSHWEMKLNANGIQTRQTDSFNQTTLEFEDI
HGLTLAMVESDEERVNNDIIGFHGVTMLSGNPQATEALLQNDLGLEYIQETDDNVHYQTS
GSVHHQIIVKKFVNPQPVRWGGGIFHHIAWSVPNDEVHVQWRDYLHNKGLHVTDVKERFY
FHAVYMKEPGNLIFEFATAGPGFTIDESVDDLGRQLQLPPFYEERRYEIEGHLMPIKLNE
Y
>SEQF2892_02115 Putative ring-cleaving dioxygenase MhqA
MAKHDLLGIHHVTAITDDAERNYKFFTEVLGMRLVKKTVNQDDIQTYHTFFADDEGTAGT
DMTFFDFPGIPQGRKGTNSITKPSFRVPSDEALTYYMKRFEAFGIKHDGIQNVLGKKVLP
FQEEDGQDYQLVSDEGNSGVSPGKPWKNGPVPEDKAIYGLGPIEITVSYFEDFKQLLKNV
YGMRTIMNEEDVALLEVGEGGNGGQVILRKDSEGPVAVQGYGEVHHVSFRVKDHEAIKHW
IQKYQELGIPNSGLVDRFYFEALYARIGHILLEISTDGPGFMGDEPYETLGEKLSLPPFL
EEQREAIEAQVRPFDTTGKSYK
>SEQF2892_02116 HTH-type transcriptional regulator MhqR
MDRTEHSLKAFIGLNRALDTLEKIVQQDVKNYGLNVTEFAVLELLYSKGPQPIQRIRDRV
LIASSSISYVVSQLEDKGWITRDKDPSDKRVYNATLTDKGQQFMADIFPQHASTLEQAFS
VLSEEELITIQQAFKKLSAQSTEV
>SEQF2892_02117 Lactaldehyde dehydrogenase
MTNQLFINNEFVESKSNDTMEVINPATGEAFDTITFATEEEVNEAIEKSKHAQLEWEKVP
APTRAEHVKLLIPLLEQNKDELAKLYVKEQGKTLAQAEGEIDKAVQFIDYMTSLSMRNKG
EVLQNSVSHEMIQLIKKPIGVTAGIVPWNAPIMVLMRKVIPALVTGCSIVIKPSEETTLL
TLRLAELFRASTIPAGLIQIVPGTGEAVGTQLATHKDVQLISLTGSMRAGKAVYKNAADA
VKKVNLELGGNAPVLVTPHANLDKAVDYIVTARINNAGQVCTCPERIFVHEDVHDDFVSK
AKQRMSDLQVGDPLDDNTDYGAIINQTQLDSIDNKVQEAIKNGADLVLGGHKLDRAGFFY
EPTILDNVKKDDSAFKEEIFGPVLAITTYNDFDEAIDAANDTNAGLSSYIFSENLKEVME
ATERLKFGEVYANCEAEEVVNGYHAGWRESGLGGADGIHGFEDYYNTTVSYIRYE
>SEQF2892_02118 High-affinity zinc uptake system binding-protein ZnuA
MKRIGYLIIVLCISIALSACSTGQYSDAKKKDVSTNNKINIYTTVFAFESFTKQIGGKYV
NVDTIYPPGADTHSYEPTQRDMINIAKSDLFIYSSDDLDPVAKTITQSMTNDDMKLAVAA
DLNHHTLLEEDHDHEDHDQHHSHEEESHDPHVWLDPVLDKHFAEKIKNDLVKRDPQHKAY
YEQNFKKLNQDLTDLDNNLKTITKNPKREKVTISHDSLGYLAERYHFQQEGVSGMNNEEP
SQKDILALIKQINQSKQPYILYEQNITSKITDVIRDETNAEPVSFNNLSVLSKEQANDKD
LTFQSIMKKNIKALDKALNK
>SEQF2892_02119 hypothetical protein
MAQEIKKGNQQFYVGEDEQNAQAVITFKQVDNNEIDIDHTGVADELGGQGLGKQLVEAVV
NYARKNNLKIIASCPFAKDVLEKNDDYQDVYLG
>SEQF2892_02120 Catechol-2,3-dioxygenase
MNAFHTTEATQVTNITLNVEDLNKMSNFYKNILGFSIKEQDDNHVIFNVGANGHTLTLQY
LEDGRRPGFREAGLFHVAYLLPTRTDLANFLFHASRLNVPVGGGDHLVSEALYFNDPEGN
GIEVYQDRPYESWQWDGNFVKMDTLAVDADDLIAQRTEEGWNGWPADGKIGHLHLKTHDI
GQARDFYVEQIGLEHISNFPQALFMSTQKYHHHIATNVWQSNQARTDNETTYGLVHFDIY
KPNAKEEHITSPEGFDITVHSDTSVVPG
>SEQF2892_02121 Phosphate-import protein PhnD
MKKLQVLLISFIALVLILSGCSKHDKKHSRDHEPKELKVEFVPSQNSKTLNAKVKPLQQQ
LSKELGIPVKVHVATNYNAMVEALRSKKVDVAFISPVSYTIAHDKGAADVLLKSKGYLVD
DKGNPTNKLVDYYRSQIVVRKDSHLHKLKDLKGTKVGLQDPESTSGYIYPMASLKKVNVN
QNDIKIAQIKGHDQALIALLNGDVDAVATYQDARADLKQDYPKIYKDTKVIYRTDKIPND
TISVRGDMSKQWKTKISNAFLDISKSEKGKKILTDIYGHQGYEKAKDSDFDTVRKYRKLV
EE
>SEQF2892_02122 Putative aldehyde dehydrogenase AldA
MAKVNVRDFIEEQYGLFINGEFQASESGDTLTVTNPANGEDLAKVAKASKSDVDKAVQAA
QDAFDSWSKTSKEERADYLLEISRRIHEKVEHFATIESLQNGKPYRETSTIDVPLTANQF
KYFASVLTTDEGSVNEIDENTMSLVVNEPVGVVGAVVAWNFPILLASWKLAPALAAGNTI
VIQPSSSTPLSLIELAKIFQEVLPKGVVNVLTGKGSESGDAIFNHEGVNKLSFTGSTDVG
YGVAKAGAERIVPTTLELGGKSANIIFDDANLDQVVEGAQLGILFNQGEVCSAGSRLLVQ
SSIYDKVMPKLKEAFENIKVGDPFDEDVKMSAQTGPEQLEKIESYVKIAEEDSNANILTG
GHRLTDNGRDKGYFFEPTIIEIKDNSHQLAQEEIFGPVVVVEKFEDEAEAIKIANDSEYG
LAGGIFTTNINRALNVAKAMRTGRIWINTYNQFPAGAPFGGYKKSGIGREIYKDAIKNYQ
QVKNIFIDTSNQTKGLY
>SEQF2892_02123 Putative NAD(P)H nitroreductase
MSSMQETIINAFNFRHATKEFDPEKKVSESDFHTILETGRLSPSSLGLEPWRFVVIENED
LKEKLKPYSWGAQKQLNTASRFVIILARKNVTADSEYVQHIIRGIKKYEESTIPAVEDKF
NNFQTNFHINDNERTLLDWASKQTYIALANMMTSAALLGIDSCPMEGFDLDKVTEILAEE
NVVDTEHFAPSVMVAFGYRKEEPKDKVRQPAEDVIEWI
>SEQF2892_02124 D-lactate dehydrogenase
MTKIMFYGTRDYEKNDALNWGKANNVEVVTTEEILSEDTVDLAKGFDGVTTMQFGKLADS
VYPKLEEYGIKQIAQRTAGFDMYDLDLAKKHGIIISNVPSYSPETIAEYSVSIALQLVRR
FPAIEKRVQEHNFKWAAPIMSTPVKNMTVAIIGTGRIGAATGKIYAGFGAKVVGYDAYPN
NSLDFIEYKDTVEEAIADADIISLHVPANKESFHLFDADMFSKVKKGAVLVNAARGAVID
TPELIKAVNDGTLYGAAIDTYENEAPYFTYDWTGKEIEDETLLELIKHENILVTPHIAFF
SDEAVRNLVEGGLNAALSVINTGKCETQLN
>SEQF2892_02125 5-amino-6-(5-phospho-D-ribitylamino)uracil phosphatase YbjI
MVKAIAVDMDGTFLDSKKNYDKDRFEKIFKALKERNIEFIAASGNQFAKLQSIFGERDMF
FISENGAVIYRGKDLYNYRSFNQVEYKEVVDYLNIDRNIKEFIVCGLKSAYILKDTSEAF
KKDAHFYYHQLEEIDSFQPLPEDEYVKIALNINRDTHSTLDTDLEEKFSNIIKLVSSGHD
SIDIIMPNMTKGQALQRLLEEWHMATSDLMAFGDANNDKDMLELAEHSYVMANSHDKSLF
EVAKAVAPSNDEQGVLQIIEQEVLK
>SEQF2892_02126 hypothetical protein
MKNWINRLMTILGVILILVAVYLFAKPHIDNYLHEKDNDNKIEQYDKQDKSSNKQTPTIP
KDKTKMAGYISVPDAEIKEPVYPGPATPEQLNRGVSFAEKDESLSDQNISIAGHTFTDRP
HYQFTNLKAAKKGSKVYFKIGNETREYKMTSIRDVNPDEVEVLDEHKGEKNQLTLITCDD
YNEQTGVWEKRKIFVAKQVN
>SEQF2892_02127 L-methionine sulfoximine/L-methionine sulfone acetyltransferase
MIREAKIEDLPAILSIYNDAILHTTAVYTYDVQTLDERKAWFDMKNKANEPIFVFEQAGK
AVGFATYGQFRNWPAYLYSIEHSIYVDKSNRGKGIASQLLQHLIEDARSRNYRTIVAGID
ASNDSSIKLHEKFNFKHAGTIQNVGYKFDRWLDLAFYQYNLHDK
>SEQF2892_02128 hypothetical protein
MLRLCIIFFIFVTNTTITQLWTVEGTWENLLLQSMSLSMIIVFLFYYVGFVIAEKKRKQI
ETLFKKEFFHEKEDFFEKDDKRKVSE
>SEQF2892_02129 L-serine dehydratase, alpha chain
MFDSIRETIDYAVENKMSFADIMIQEEMELSGKTRDEVRETMKQNLDVMRDAVIKGSTGE
GVKSVTGYTGQDAIKLAKYNENNHALSGHEMVEAVKGAVATNEVNAAMGIICATPTAGSS
GTIPGVLFKLEKTHDLTEEQMIDFLFVSSLFGRVVANNASVAGATGGCQAEVGSASAMAA
AAAVSIFGGEPEASGHAMALAISNLLGLVCDPVAGLVEIPCVMRNAIGSGNALISADLAL
AGVESRIPVDEVIEAMDKVGRGLPAELRETGLGGLAGTPTGEAIKRKIFGEAEVNSFS
>SEQF2892_02130 L-serine dehydratase, beta chain
MATKKSYDYQSAFDIIGPVMMGPSSSHTAGAVKIGNAAYAVLGGMQPDKLTIHYYESFAQ
THQGHGTDLAIVGGAMGYSTFDSRIKSSLAIAKDQNIEVNIIEEEGDSIGEHPNCAYLVA
EGNGRHIEVIGNSIGGGTIKLKRISVEGLDIDFNYGLPILEMDGAANKSEVNHFINDVNE
LGADIKEEMTQTGDNFSLAVLPLNKALSESTLDQIKEKYSHLNISYIK
>SEQF2892_02131 hypothetical protein
MNIILGVGTLVLVLIVMTLFLNFAPYGKQGLQALSGAACATFLPQAFLSYAIGGVFHIEF
LQTIGDLAGSLAGVAVGILTGLKMGISPVFAVIIGLVLHDFKLLPAFIAAYIISFGIKFI
EKKVPEGLDLIAVILIAPALVFGLATVISPGVMAVLTQIGGAVTSVGDSNPYALAIILGL
VIPVTGMTPLSSMVLTSLLGLTGIPMAIGALTCTGSSFVNYVLFSRLNIGGSKSKAFAVF
VEPLTQIDLIAKYPLQLYGTNAIIGVVNACIVTFSGLVIGVKGMATPIAGAIVLFGFNDA
TKSIITIIVVAVVSVVLAFIFSTLIKKFNLMNMSIKLPSKQKQPKESV
>SEQF2892_02132 Xylulose kinase
MMDKGGMVMEDVVLGIDLGTSAVKIIAVNRQGEVIASTSEPLTLIQDRAGYSEQDPEEWF
EAVKKGIKYINEVPEMANYTVKGISFSGQMHGLVPLNSEHKPIRHAILWNDTRNSEQCAQ
IKEVYGERLNGNPILEGFTLPKMLWMKQNEPSLWEQVSVFVLPKDYVRYCLTGHIHMEYS
DAASTLLLSPKTHDWTRDVGERLGIGDIYPPLVRSTEEVGVVRSELEQELGFKAPVKVYA
GGGDNACGAIGAGIINGNDTLCSIGTSGVVLNVESEGYHEYKNNIHFFDHSVPQTFYAMG
VTLAAGYSLNWLKQTFFEHESFEDIVQQASTSTIGSNHLLFAPYLAGERTPHGDAFIRGS
FIGISGSHNKADFARAVLEGITFSLYDSIQLMREAGKEITHITSIGGGAKSSFWLQMQAD
IFNATIRKLKHEEGPSMGAAMIAAYGLKWFESFDECVDKFIDIAQTFEPDAKRHTQYEAY
YKVYKDIYRQTHQLTEALLKIED
>SEQF2892_02133 Capsule biosynthesis protein CapD
MNIYNKVTLSVILVITILISFVFYYFNKEDRPDKDTLFENKIADHKSSGSNKKYGVASNN
AIATRVGNKIIEDGGNAVDAAMGVSYALAVTEPHSSGLGGGGATLTYNGNEGEEPKVYEY
KTLSSYNYKKGDEIGTPGFVQGIHDMHQREGKMDEKKIFSYIVPLAEDGFEVDSELERSL
KIYGSDIDRNSPFFKGKRTVREGDVVKQPALAKTLKGIRDKGPKYFYKDIAKSVSKQVDS
ELIEKDFSTFKTEEKKPVSTKYLNNTIYSASNPLGGVLMLQGLKIDESANSNNDRTDYIN
GIIKSRDVMYRNRDIVNGQEANNDSHLSENYLLDNLNNVNSGGNEMNSDFDTSLDTTSTT
HFVVIDKNGKLASTTNTLSSFFGSGKFVKQGFYMNNSLTNFSSDPNSPNYGGKHKAPRSY
TSPSIVVGPDFYMGIGTPGGNKIPTILNEVLIDYLRGDGTLQESIDKPRFYNDGGTVYYE
NATSDEDINTFKSMGYGVKEKRNDANFGSVQGAIYNKNDQTVEIGQDVGNR
>SEQF2892_02134 hypothetical protein
MNIKKHWLGIVTTLIIIAILLMVTFAKANEGLDNYEKNELKDATEQYLSKGAS
>SEQF2892_02135 Capsule biosynthesis protein CapA
MKKKKRLSASEWLLKQSKRHKRFNFSYTLIVLIVALVLLVFAIRAVKVEPVEAMPSSGND
YIRSTYLGNITLNKHFRQMDLNDVFKGLKQPLQQSDFSTASLLVSHFSNDPKTNIKKNIE
NIMFLKKENVKSVNLINNTIDNVQAQDLSKQVEAQTDYNFMTGNGSNPINSKTVQQTVKG
KKIANVSFTDVGSNYEDPLKNTTSISLDPKIFVPLIKNLKENNDLVVVNVDWGITNERSV
TDRQKEYAHALVKSGADVIIGHNSVVQKVEKYKNASIFYSLGILTSDSFLSKNQKGMVVQ
HDWNGQHNKFSITPVRGADGKITKDNMNKMEAQRYYNNINDKSIHLKEENGGYTFEY
>SEQF2892_02136 Capsule biosynthesis protein CapC
MIGSELYFSLFVGIVLSLIFAEKFGINPAGLVVPGYLALIFDQPIMLLSVLVISCLTFFI
VTYGISRWVILYGRRKFAAMILTGMVLKFLFDLIYPLTPFEMVEVSGIGVVIPGIIANTI
QKQGVVITLSTTMLLTCITYVILFLYSFIN
>SEQF2892_02137 Capsule biosynthesis protein CapB
MILIIICIALILWLGIKEKNRHTNRLNKIPIRININGIRGKSTITRMIYSVLREDHYHVI
GKTTGTDARMLYWFTDKEYPVIRKPQGANIGEQRDIVRKVVKQKADSLVNECMAVNPDYQ
ITFQKDLVKANIGVIVNVMEDHMDVLGPTLQDVAQAFTATIPYKGTLVVMKDDYTKFFAK
EAKKRKTKLIVVDKDEVPESYLRKFPYLVFPDNVAIALGVAEAVGVDKETALRGMVNAPP
DPGAVEIKYFNANRTRNVFVNAFAANEPQSTKAILNKVESYNYPYTKKVVILNCRSDRVD
RTRQFVENFIDDVDFDTLICTGKSTQMVTDLMQHLPDKKYLNFENREFPEIEKAILQESQ
NALIFCVGNIHGPGGRIAEFIEGIE
>SEQF2892_02138 hypothetical protein
MGKPLTKPVKIAISIYLAMVLLVCSSYLVLILVGSLQGNDMSSSVLDTDHQHINSVTKDS
NEGINDTKLNKASATSDDVAKEETISNTNDTISNTDTEKVGASSSD
>SEQF2892_02139 HTH-type transcriptional regulator CdhR
MVHMSEAETIKLFKRFAGDTPFNFLQNYRLEQSAKQLMYHHKNVTEVAMDCGFSTTSYFI
QNFKQKYSLTPKQFQIKYAKYLK
>SEQF2892_02140 hypothetical protein
MYVTNGVIKVKLAENTLEIHEGEGLFINSNVVHEIRDANEGARLYCWNIGLPNVTEYINF
TYVSRIVDQAQSIPFIKLIPKGEENVSLLRRIERVGHIYLSQKDYYQLQILSEFYQCLNH
LLNIFD
>SEQF2892_02141 hypothetical protein
MVSEIIINEDLEEKINYPDRRWPHVILHTSLSETLLGYIPLH
>SEQF2892_02142 hypothetical protein
MNHTQHRLKGVLFAIIGATLWGLGGTAFAFYLFIDSLKYLSPKETTLLGTIEPVIAVVTS
ALWLGVTFQSVQVIGIVLILILILMLSLKKQPEEM
>SEQF2892_02143 Monoterpene epsilon-lactone hydrolase
MKKSMITVATSAILGTLAFIKVKEKRSYKSFITEKYIRMSGMKKTFENEADAKKALEETK
EITAGKYGGTSYEFKHDVRTKSWNGCVTYIVNDQRNHQQKVVLYIHGGAWFQDPLDNHFN
FIDELAGQLDAKVIMPIYPKVPHRDYRTTFELLKLIYDKQAAKVESSEQLIVMGDSAGGQ
IALSFAEYLKAETTLPQPGHIVMLSPVLDGTLSNPDAKTYERIDPMLGIEGSKYFIKLWA
SQLPIEDYRISPINGDLEGLGRLSIFIGTKETLYPDALKLSQMLNDKGIEHDFMPGYNLF
HIYPIFPLPERQKFFTQLKSIIL
>SEQF2892_02144 L-lactate dehydrogenase 1
MARHKIVLIGSGYVGSAFAHAIVAKGLVDEMAIIDIDEDKAKADVWDLNHATPFGDNFVN
VHVGQYEDFKDADIVVICASAKLAKGETRLKLLEDNVDIFVPMIQRIVDSGFDGYFVLPS
NPVDIMSYVVKRVSNFPKNKIIGSGTSLDTARFQFFLSREFDVAPNQVYAPIIGEHGDSQ
VAVWSHAQIAGEPVLDLLPSNTNLEAFKTSISNRTTQIGYDIYVRKGTTNFGISLSLVRI
VEAILFNKNIIMNVSSYVEGEYGLSDVYIGVPTVINRNGADRIIELALSKEELSQLHHSA
DIILDYQRQADAIIDQMC
>SEQF2892_02145 hypothetical protein
MAKHLSNMEAFHQIINNNQLVVVHVMRDHCSVCHAVLPQIEDIVASYPNVKLAVINQSDV
EVIAGELSIFTVPVDLIFMNGKEMHRQARFIDMQRFEHQLKLMYDSCFET
>SEQF2892_02146 hypothetical protein
MEHEGLLVAEREIEVNNYDIDAMGIVSNIVYIRWFEDLRTIFINEYMTFSEMMKEHISPI
LMKTEIEYKVPITIHDKPVGRCWFVKAGRMKWVFKFEITSGDKVHCIGQQTGGFLDLERQ
RITKMPEVFQNLLK
>SEQF2892_02147 Alcohol dehydrogenase
MKAYVYEKPGVAKLIDKEKPVITESTDAIIRMVKTTICGTDLHIIKGDTPEVPSNTTLGH
EGIGIVESVGSSVNNFKVGDKVIVSCISPCGKCYYCKKGIYAHCEKDGGWILGHLIDGTQ
AEYVKVPFADNSLYHAPESLPDEALVMLSDILPTGYEIGVLKGKVKPGSTVSIVGAGPVG
LAALLTAQFYSPSKIIMLDLDDNRLATAKELGATHTINSTNVEDAVAQVKSLNHRGVDVA
IEAVGIPKTFDLCQKLIGVDGTIANVGVHGLPVQFDIDKLWIKNINVTTGLVSANTTEEL
LEALKSKIIQPEQLVTHYSKLSDIEHAYDLFRNATDHKAIKLLIENDITE
>SEQF2892_02148 PTS system glucose-specific EIICBA component
MFKKLFGQLQRIGKALMLPVAILPAAGLLLAIGTAFQGEALQQYLPFIKNGVIQNIANMM
TGAGGIIFDNLPIIFALGVAIGLAGGDGVAAIAAFVGFIIMNKTMGAFLNVTPAQLEDPS
KGFANVLGIPTLQTGVFGGIIIGALAAWCYNKFYNISLPSYLGFFAGKRFVPIMMATTSF
ILAFPMAWIWPFIQNGLNAFSTGLLDSNTGLAVFLFGFIKRLLIPFGLHHIFHAPFWFEF
GSWKNAAGEIIRGDQRIFIEQIREGVHLTSGKFMQGEFPVMMFGLPAAALAIYQTAKPEN
KKVVGGLMLSAALTSFLTGITEPLEFSFLFVAPLLFFIHAVLDGLSFLTLYLLNLHLGYT
FSGGFIDFVLLGILPNKTPWWLVIPVGLVYAVIYYVVFRFLIVKFNFKTPGREDKQASVA
NTSASKLPFDVLDAMGGKENIKHLDACITRLRVEVNDKSKVDVEGLKALGASGVLEVGNN
MQAIFGPKSDQIKHDMARIMNGDITKPSETTVTEDTSDEPVQLEEVKETDIYAPGTGHII
PLSEVPDKVFSEKMMGDGIGFVPEKGGIVAPFDGTVKTIFPTKHAIGLESDTGIEVLIHI
GIDTVKLNGEGFESLVDVNEPVTQGQPLMKINLAYLKEHAPSVVTPVIITNQGDKTLTFD
DVDSVDPGKRIMTIK
>SEQF2892_02149 hypothetical protein
MCKSILNTLRIKDKNLNFSDEVTEKKHKGRMSLFYYAELTYQPTHCENCSTKNENFSIVK
NGKKTSTITLLKIMEMPAYLELQKQRFYCKSCDSHFTAKSNIVDAHCFISNKTKLAVLDK
VQEYRSQKSIAKSCLVSSMTVSRVINQAASDVGQSSFEALPEHLMMDEFKSVKNVIGKMS
FIYADAVSNRIVDVVADRKLKSLKDHFYRYSLKLRQKVKIVTIDMYESYMSLIKQIFPNA
KIIIDRFHIVQSLNRALNMSRVHVMNCYRTSNRPLYNKYKSYWKLFLKPFETLEAFNYHK
VHLFKEWKSEKVIINYLLGVDIELFNTYHYVHELRRLLKENQIEKFNHKLFSIHLSDVCP
KLRPVIRTLRRLAAFIENTMTYSNLTNGPLEGINNKIKLIKRLSFGYRNYDNLRNRIIIT
SRLFASTTKKEIKQPKVA
>SEQF2892_02150 Putative thiamine pyrophosphate-containing protein YdaP
MAKIKANEALVKALEAWDIDHLYGIPGDSIDAVVDSLRTVRDSFKFYHVRHEEVASLAAA
SYTKMTGKIGVALSIGGPGIVHLLNGMYDAKMDRVPQLILAGQTNSTLLGTKAFQETNIT
DMVSDVSVYNHQIQKGDNVFEIVNEAIRTAYEKRGVAVVVCPNDLLTQKIKDTTHRAIDT
TKPKAPTPTLRSIKKAAKLIDKSKKPVMIIGVGAQNAKDELREFVEAAKIPVIHTLPAKT
IIPDDHPYSIGNLGKIGTKTSYQTIQDADLLIMAGTNYPYVDYLPKKNIKAIQIDTNPDV
IGHRFSVNVGIVGDAKLAFHQLTDAIKHVPQRPFLEKTLERKAVWDKWMEQDMNQESTPI
RPERLMKSISKYSDDDAVFSIDVGTSTVWSTRYLNLSVNNKFIISSWLGTMGCGLPGAIA
SKIAFPKRQAISISGDGAFQMVMQDFATAVQYDLPMTIFVMNNKQLSFIKYEQQAAGELE
YAIDFSDMDHAKFAEAAGGKGYVLKDPSRIDEVVEAALNENVPTIVDVHVDPNAAPLPGK
IVNEEAINYGKWAYRSITEDKKLDFDEIPPISVAAKRFL
>SEQF2892_02151 Holin-like protein CidB
MTLIQAILMILLTVVMYFAAKKLQQKYDNPFLNPALVGSVGVIIVLLLTHQNYHDYMTGG
KWINHLLNATVVCLAYPLYKNRHKIIENLSIIFSSVMVGVILNFVLVFTSLNLLGYDEET
IVTILPRSITAAVGIEVSQELGGTDTITVLFIITTGLIGSMMGSMLLKVGNFKTSIARGL
TYGNASHAFGTAKALEHDNESGAFSSIGMILTAVISSILIPIMIILFY
>SEQF2892_02152 Holin-like protein CidA
MKKVLYISKVIIQIAIIIVISYLGSLLQTLLHIPLAGSIVGMILLYLLLELKVIRMNWIS
DGAEFLLATMVFFFIPSVVGIMDIVSDITKSYIIFFLLIIVGTSCVALASGYIAEKMVKQ
PNVKRGHQ
>SEQF2892_02153 hypothetical protein
MYKNYNMTQLTLPMETSVLISTNDISRHVNDIVETIPDNEFDEFRHHRGATSYHPKMMLK
VILYAYTQSVFSGRKIEKMLNDSIRMMWLSQNQKPSYKTINRFRVNPKIDALLESLFIQF
YSQCVKQNLIDDKAIFIDGTKIEANANRYTFVWKKSIQNHESKMNEDSKALYHELVTNKI
IPEIKEDHDNELTKEEIDLIGSHLDKEIEDLNQHINNEKCTKTRKQIRLKRTKIKKYKKQ
INDYFERKYRYEFQKSILKDRNSYSKTDHDATFMRMKEDHTKNGQLKPGYNLQIATNSQF
VLSYNVYQNPTDTRTMIPFLNSIQETYGHLPEYIVADAGYGSESNYKAIIDDFNRTSLIT
YGMFIKDKTKKYKSDIFNTQNWNYDEINDEFICPNNKRLGFKRYAYRHDKYGYKRDFKLY
ECDDCSECPLKNQCMNFNSKTNKKIMKNYNWEYFKSQINKKLSEPETKNIYSQRKIDVEP
VFGFMKAILGFTRMSVRGLNKVKRELGFVLMALNIRKVVAQRAENNQKIYKKDNFYIISI
EIVFFSLIQELYVPDSFFIVKSLWTQYYCHQHLTTSTTIDIKAIT
>SEQF2892_02155 HTH-type transcriptional regulator CynR
MKYFMEVVNQGGMTNASKSLYIAQPTISKAIKDIENELKMTLFDRQKRYLVLTDAGKIFY
KKCEEIIALYDNIPFEINGLLGLETGHINIGMSAVMDMQQFIYILGEFHKLYPNVTYNLN
ESGGKSIETRLINDQIDIGITTIPIDENVFDYLPLYSEDLRLVVSKEHDLASRDSVTMAE
LKNEDFILFNEDFYLNDKIIAAAKNAGFLPNTVSNVSQWNFIEYLLLARLGVSILPEHIA
NMLKDNIRSIKIEDTGMSWELGAIWKKDKLLSHATSKWIEFMSKRLKYD
>SEQF2892_02156 hypothetical protein
MSFYEFMQNFVGDDTPLGELVNWINQDSNFPRDVKSQVEVLSYFRNNPCPENIPVTIVKR
ALAVFNQFTNV
>SEQF2892_02157 Staphylococcal secretory antigen ssaA2
MKFKKLFSRLLLATGIMFAGTFTYQNIEHTHVSKAASYNYYTKGQCTWWAYQRRAQLGKP
VSNRWGNAKNWYYNAKRSGYRTGHTPKRYAVMQSTAGYYGHVAVVERVYSNGSIKVSEYN
YNRPSAYGTRYLSKWSARNYNYIY
>SEQF2892_02158 3-hydroxy-3-methylglutaryl-coenzyme A reductase
MKSLDKTFRHLSREDKLKQLVDYGWLTDESYDVLLKNPLINEEVANSLIENVIGQGTLPV
GLLPKIIVDDKEYVVPMMVEEPSVVAAASYGAKLVNNTGGFKTVKSERLMIGQIVFDDVS
DTDALAQAIYDLEPQIKQIAAEAYPSIIERGGGYRRIEIDTFPENQLLSLKVFVDTKDAM
GANMLNTILEAITAHMKNEFPNRDVLMSILSNHATASVVRVQGEIDIKDLNKGDRSGEEV
AQRMERASVLAQVDIHRAATHNKGVMNGIHAVVLATGNDTRGAEASAHAYASRDGQYRGI
ATWKFDKERGRLVGTIEVPMTLAIVGGGTKVLPIAKASLELLNVQSAQELGQVVAAVGLA
QNFSACRALVSEGIQKGHMSLQYKSLAIVVGAQGDEIARVAEALKAAPKANTATAQQILK
DLRQQ
>SEQF2892_02159 Acetyl-CoA acetyltransferase
MKKIAIVSAKRTPIGRYKGKLRNYSAVELGTTALKGAIDSANIDPNIIQQVIFGNVLQSG
VGQNPARQIAIKAGVPDTTPAMTINEVCGSGLKAIILGKQLIQLGEADVVAVGGVESMTN
APQLILKEGQEPVESFMHDGLTDAFHYVPMGVTAENIAEKYDITREMQDEFANHSQAKAA
KATQDGKFNNEIIGMTDAEGEQMTSDEGVRPNSSVEKLATLKTIFKEDGTVTGGNASSIN
DGSSALILMEESYAKAHGYDILGIVGDYAEVGCDPQYMGYAPFYAVEKLLDKTDSKIDDV
DIVEMTEAFAAQSIPVKDNLHIPDEKLNIYGGAIALGHPIGASGARLVTTLVNALEQENK
RTGIATACIGGGLGIALMIDKGE
>SEQF2892_02160 Hydroxymethylglutaryl-CoA synthase
MSIGIDKINFYVPKYYVDMAKLAEARQVDPNKFLIGIGQTQMAVSPVSQDIVSMGANAAK
DIITDDDKKHIGMVIVATESAIDNAKAAAVQIHNLLGIQPFARCFEMKEACYAATPAIQL
AKDYIEKRPNEKVLVIASDTARYGIQSGGEPTQGAGAVAMLISNNPSILELNDDAVAYTE
DVYDFWRPTGHKYPLVAGALSKDAYIKSFQESWNEYARREDKTLSDFESLCFHVPFTKMG
KKALDSIINDADETTQERLTSGYEDAVYYNRYVGNIYTGSLYLSLISLLENRSLKGGQTI
GLFSYGSGSVGEFFSATLVEGYEKQLDIEGHKALLNERQEVSVEDYESFFKRFDDLEFDH
ATEQTDDDKSIYYLENIQDDIRQYHIPK
>SEQF2892_02161 Methylated-DNA--protein-cysteine methyltransferase
MSYSMLYKSPVQNLELISDGESLTHVLYKYNDTTVTHPTNPDLDIFKKVVEWLNEYFSGN
RPQIDFSLKPEGTDFQKSVWRKLQEIEYGQLKTYGDLANLVGEERNKPNMSAQAIGGAVG
SNPISIIIPCHRVVGKDGSLTGYGGTINHKIKLLELEQVDMNNLYRPKNSTKP
>SEQF2892_02162 hypothetical protein
MAGLNKDDVDLHFNTNQFNEDDHAKQISFFYKALYQINDIVLGIIFLIGSFLFFSDQTMI
AGTILFVIGSIQMTARPVISFVHDMKLSKYYKRKYKQLLDEKKQH
>SEQF2892_02163 Cobalt/magnesium transport protein CorA
MEVLSDIITSFNKSPKAITTIELTTIMVDKITHQYFKYVDHVEDIVFSFEYQNVDKVNNR
KLMDDVYNIRSEIIKLKRVLIPMEQLLNEIIDESPLDVSHEYQLLIKHIHSRLLRQTDTL
MACEHITDDIKDNNESYRSNRINGVMNVLTIISSIFFPLSFLTGWYGMNFSYMPELDWHY
SYFVFIAISLVVVVSLITLFKKKNWF
>SEQF2892_02164 hypothetical protein
MAIRVHFQDQSNHFHTACTFSAIPEDAKLVWIDFENPTKNDQALLTQ
>SEQF2892_02165 hypothetical protein
MKGTKQLDQIKEDNKKQLKKLFKYDKDNALTFSKEDREKVQDKFGVYVIFDKKTPIFVGQ
TGGYSTGYQLITKDLFNKLGQYNLKSGVGTTKFKKGLAQKKGVNEEDIKSITAEDYNLKF
QYVNVKDEPAFINVLEILAIEYAKDKGYELYNFNQN
>SEQF2892_02166 hypothetical protein
MNDKDLRVIKTKKALTDSLYSLLEQEMFTPLTVNKICKHASVHRTTFYKHFYDKYELLKY
LLKLTHDDYFATDIKERLNNPFQTLANSFNKEEVSRIELKQYNDKEFEDVRNKYLIEIMQ
KDFKTNMHRITVDNVVPKSLVFYVFGSVLNAFIDWKKNENVEIKPKQMDQIFHKLINIKA
HD
>SEQF2892_02167 hypothetical protein
MTELFPYLAFEKAKDAIAYYEEVFGATNVKRLEVSEEQAEQFGMTKEQAAEATMHAEFEV
LGVKILCSDSFGRVENINNGISLLIDFDVNNQDDSDRVQQFYDEIKDHDSLDIEMPLKEQ
FWGGKMGAFTDKYGVRWMLHGQDYTKLN
>SEQF2892_02168 1-pyrroline-5-carboxylate dehydrogenase
MVVPFKNEPGIDFSVQENVERFQKTLEQVKNELGQTLPIVIDGEHITKDDTFDSINPANT
SELIAKVSKATKEDVDKAFESSNKAYKAWRQWSHKDRAELLLRVAAIIRRRKEEISAVMV
YEAGKPWDEAVGDAAEGIDFIEYYARSMMELADGKPVLDREGEHNKYFYKSIGTGVTIPP
WNFPFAIMAGTTLAPVVAGNTVLLKPAEDTVLTAYKLIEILEEAGLPKGVVNFVPGDPKE
IGDYLVDSVHTHFVTFTGSRATGTRIYERSAVVQEGQTFLKRVIAEMGGKDAIVVDENID
TDLAAESIITSAFGFSGQKCSACSRAIVHSSVYDEVLEKAVTLTKELTVGNTVDNTFMGP
VINKKQFDKIKKYIEIGGKEGKIEIGGEADDSTGYFIKPTIISGLKSSDQVMQEEIFGPV
VGFTKFDNFEEAIEIANDTDYGLTGAVITNNRENWIKAVNEFDVGNLYLNRGCTAAVVGY
HPFGGFKMSGTDAKTGSPDYLLNFLEQKVVSEMF
>SEQF2892_02169 Putative acetyltransferase
MTEKEKMLAHQWYDANFDKDLETERVRAKDLCFDFNQTRPSDDSRRQAILTELFGYTLEN
VAINSPFDTDYGWNVKLGKNVFVNSNCYFMDGGGITIGNDVFIGPSCGFYTAHHPLTPKE
RNAGLELAQPITIGNNIWFGGNVVVTPGVTIGDGSVIAAGSVVTKDVPPNSLVAGVPAKV
IREINENDAPKN
>SEQF2892_02170 General stress protein 39
MNLLEFHKQIKGYTQNRQPGTERDMDPRPISELNEYKAAGKLQGKVALITGGDSGIGRSV
AILFAKEGANVAIGYYDEHEDAEETVNRLKEIGVKAKAYAHDLKDAQQSKDLVQQVVQEF
GGLNILVNNGAVQYPQDSFMDITPEQFKDTFETNIFGMFFLSQAAVPYLSDNDTIINTTS
VTAYRGSGHLIDYASTKGAIVSFTRSLATTLMEKNIRVNGVAPGPIYTPLIPATFDEDKV
ENQGGNTPMGRRGQPAELAPAYVFLATNADSSYITGQIIHVNGGDYITT
>SEQF2892_02171 hypothetical protein
MRGLLKGIIALLIILGVIKTFQDHDVMNEANYYYNQAKNGELVQNISNFDFNNYKDLNLE
NFKPSDFF
>SEQF2892_02172 Copper-exporting P-type ATPase A
MSNKQNATLNITGMTCAACSNRIEKRLNKMDNVKAQVNLTTEKATIEYDTNDYAINDFVT
TVQKLGYDVVIDKAELDITGMTCAACSNRIEKVLNKAPGVKDATVNLTTEQAMVTYYPGQ
TDLDTLIGRIRNLGYDAQPKQSEEDQATRKQQELKHKRNKLMISTILSLPLLMTMLVHLF
NMHLPDILMNPWFQFILATPIQFIIGWQFYVGAYKNLRNGGFNMDVLVALGTSAAYFYSI
YEMIKWFSGATNMPHLYFETSAVLITLILFGKYLEARAKSQTTNALSELLNLQAKEARLI
DDNGMEKMVPLNQVNVDDILLIKPGEKIPVDGQIIKGETAIDESMLTGESMPVDKHVDDV
VIGSTMNTNGVITIMATKVGKDTALSNIIKVVEEAQSSKAPIQRLADIISGYFVPIVIAI
ALLTFLIWITLVHPGQFEDALVAAISVLVIACPCALGLATPTSIMVGTGRAAENGILFKG
GEYVERTNQVDTVVFDKTGTLTHGKPEVTYFEGDKDTLTLVASAENNSEHPLATAIVNYA
KQHKVNLVNVTNYQTLPGHGIQAIIDDSMLFVGNQKLMLDHQINIQSIKQKMKQMEAEGH
TVMLIAYDGELRGMIAVADTVKASAKEAIQQLSSMNIRTVMLTGDNERTAKAIAKEVGID
QVIAGVLPEDKAHHITQLQEQKHNVAMVGDGINDAPALVKADIGIAMGTGTEVAIEAADI
TILGGDIQLVPKAIHASHKTIRNIKQNLFWAFGYNIAGIPIAAMGLLAPWIAGAAMALSS
VSVVSNALRLKRMKL
>SEQF2892_02173 Copper chaperone CopZ
MINKVINVEGMSCDHCRNAVESALAKLNGVTSAEVDLDKNQVRVDYDENRVSVEQMKEAI
EDQGYDVK
>SEQF2892_02174 D-lactate dehydrogenase
MTKIKIMSVRDEDIPYIEEWAEQNNVEVELNKEILTEDNVDDVQGFDGLSLSQQHPISED
VFAKLQQFGIKHIAQRSAGFDTYDLNLATQYGIIISNVPSYSPSSIAEFAVTQAINIVRN
QNDIQRKLKDYDFRWEPSILSRSISDLTVAVIGTGRIGSIAVSIFAKGYRSHVVAYDPFP
NEKVAQYVEYKDTLEEALRDADIVTVHIPATKYNPHLFNRDLFSKFKKGAVFVNAARGSI
VDTRALLDAIDSGHIKGAALDTYEHERGLFPGDYRNKAINDDLLDELIAREDIWLTPHIA
FYTDAAVKNLIVDALDAVIDVMNTGTTKLRVN
>SEQF2892_02175 Transaminase BacF
MTISNKLANIPDSYFGKTMGRKVEHGPLPLINMAVGIPDGETPKGIVDHFADAVRIPENQ
KYGAFHGKESFKEVIVNFYQRQYGVELHKDDEVCILYGTKNGLVALPTCIVNPGENVLLP
DPGYTDYLAGVMLAGANPVPLNLEPPHYLPDWSKVDAQTLARTSLVYLTYPNNPTGSTAT
KAVFDEAIQRFKGTHTKIVHDFAYSAFGFDAKNPSILASKDAKEVAIEIFSLSKGYNMSG
FRVGFAVGNKDMIQALKKYQTHTNAGMFGALQDAATYALNHYDDFLDQQNETFKRRRDTF
EKQLKDANLPFVHSKGGIYSWLQTPPGYDSESFEQYLLKEQSILVAPGIPFGENGRHYVR
ISLALDDQLLTEAAKRLASLSYLYNE
>SEQF2892_02177 Dehydrosqualene desaturase
MSQFKKDGFTFDMGPTIVMVPDVYKAVFEESGKRFEDYVDMKPLTHIFDIYFSDKDKVSV
STDLAQLSQTLEATEPGSTQGFMQFLTDVYKRYEVARKYFLERTFRKPSEFYNPLTLYRG
LKLKTFNNANQLIDNYVSNEKIRKLLAFQTLYIGIDPKQGPSIYSIIPMIEMVHGVHYIK
GGMYGLAQGLLQLGQDHGVKVELNADVQEIIIDPKFKRADGLRVNGDIRRFDKVLCTADF
PYVAQNLMPVHSPLKNYSPEKVDNMDYSCSAFLIYAGINRQLRDKLHVHNVVFARDFRGN
IDDIFSGKMPDDPSLYLYFPSVEDEALAPKDQTGMYVLMPVPELKTGEIDWKDPNMVEKA
KDVIYNKLETIEALKDIRQDVVSETVFTPLDFESRYNAKFGSAFGLMPTLTQSNYYRPPN
VSRDYKDLYFAGASTHPGAGVPIVLTSAKITAEAMLEDIEHGK
>SEQF2892_02178 Dehydrosqualene synthase
MSTLEENYQYCHQIMKDYSKSFSYAFDMLPEQQRRAIWAIYAVCRIVDDSIDVHQDVEYL
HKINRDVKAIEHQTTTTFESDDRIMTAFADAATHFQMNFQALYDLIDTVEADQHFEMFET
DRGLLDYCYGVAGTVGVLLIPILATPPSDEAYEYGKQLGEALQLTNILRDVGEDYRNGRI
YFSKARLNEFNVSIADEIERDQLSDNYIKIWEFYATLADNNYDMVLNHLDVYNEESRMII
ELAAQVYRGILTEVRKADYSLKDRAYVSKWKKHKIYRNLKKKYKD
>SEQF2892_02179 4,4'-diaponeurosporenoate glycosyltransferase
MDADVELNNEHALEAIIQSYARQQYRGLMSIQPYHVVYKPYEHLSAMFNLMTVVGTNSFS
TLSKSKGESLAFGPVTVMNKSDYILTQGHKNAASHIIEGFSLGKAFQRCQLPVTRFEGQG
FVSFRMYEAGFKTMIEGWTKHLAVGASSTQPHIMMLIILWMVGCITSFSGLALSLFMKTL
SFKRMALSYSLYTLQFIRLHRRVGRFSILFLAINPILFLVFILVYINSYRHIHYTKQVKW
KGRQFSIK
>SEQF2892_02180 4,4'-diaponeurosporenoate glycosyltransferase
MTKLESLLHASTGLSLISGYLMYNRRYLLSFDKKREGETTQSISVIIPARNEEKRLPKLL
KSLSQQSMRVECIVMDDDSNDRTAEIAREMGAKVYNVTYDNNGNTWIGKSYAC
>SEQF2892_02181 Diapolycopene oxygenase
MSQKKIIIIGGGLGGISAAIRLAQSGFDVSLYDKNNHIGGKVNRLETEGFGFDLGPSILT
MPYIFENLFNYSDKQMKDYVTIERLPLQWRSFFTNGEVIDLYEDLSQMLNANTYLNNDDI
QQLHQFLNYAEKIHRFTEKGYFALGLDKVSEIIKYQGLLRSLKGVDYFSTMQQAINRYIE
KQKLRDMLGYFIKYVGSSSYDAPAVLTLLIHMQYEQGLWYVKGGIHKLAQALEQLAIEEG
VAIHTGMDVCSIDTYFNHITGVRLDDGSHVSADYIVSNREVIPTYRDLLHFSNKKIAQLE
KVYEPAASGYVMHLGVDKEYAQLAHHNFLFSNDSKRNYREVFHDKVLPQDPTIYLVNSNK
SDPTQAPEGHENLKVLPHIPYIQNQPFTEEQYSDFRERVLDKLEKMGLTDLRQHIIYEDI
WTPHDIERTYGSNKGAIYGVVADKKKNKGFKFPKQSEYFDNLFFVGGSVNPGGGMPMVTL
SGQQVADKINALECKVTTDSRE
>SEQF2892_02182 putative transglycosylase IsaA
MKKTVIASSLAVALGVTGYALTTDNSAHASESTTNYAQLANLAQNNPSELNAHPVQAGAY
NITFVKDGFKYNFTSDGQSWSWNYTYVGGADTVATTQAAPAAQSTDYSASYSNEASTQSV
SSNQQSSNTNVEAVSAPKTTSYSASTSSSSSASTGGSVKAQFLANGGTEAAWNAIVMPES
GGNPNAVNPAGYRGLGQTMESWGTGSVASQTKGMINYANNRYGSLDAAIAFRANHGWW
>SEQF2892_02183 Thymidylate kinase
MANKIEKLALKTAELTRQTHELGIPVMILFEGVPASGKTRLSNELLLNFDAKYTHFIATQ
SPQKDDLRYQFLQKYWNTLPKKGDINVYFRSWYSHYLDYRENEIKHERYKNYEVLKEQIA
SFEDMLIEDDYEIIKFFIEINEDKRQEHIKQTKENPLMRWKVQEYGSVLSTETYLEDMHQ
FIKQDKQWKIIDYTERQIAIEKMYEHIIERLEQAIAKHHAKDKAYDGKFSESFSTEMFDK
DVEKVSKEEYKTLITELQKRMREIQFALYDRKIPLILVFEGMDAAGKGGNIKRIREKLDP
TGYEVNGISAPTDVELKHHYLWRFAKDMPRSGHIELFDRSWYGRVLVERIEGFATVNEWQ
RAYDEINAFEKMWTDEGAIILKFFLTLDKDEQLKRFKDRQNNVDKQWKITDEDWRNRDKW
DLYVEASHDMVKKTNTTHAPWLVVPADHKKTSRIEIMKYIIRKCEKVLWGVKDY
>SEQF2892_02184 hypothetical protein
MTSTLREIGVKDFTFRVLSGVAIGIVVGLVPNAILGEIFKAFMHHHPFFGTLLHVVQAMQ
FTVPALIGALIALKFDMTPLAIAVVACASYVGSGAAQFKNGAWVIAGIGDLINTMITATI
AVLFILLIEKRVGSMALIVYPTIVGGLSATIGVLILPYVHMITTGIGNMVNSFTELQPVL
MCMLISMVFSFIIISPLSTVAIAIAIGITGLAAGSASIGISATEAVLLIGTSKVNRVAVP
ISIFFGGVKMMMPNMVKYPIIMLPILITAGISGIAGSLIGIAGTKESAGFGFIGMIGPIS
AFKFLHVDSAILSILLIILGFFVVPLVTAFILDIIFRKVLRLYTNDIYKFMG
>SEQF2892_02185 Glycyl-glycine endopeptidase LytM
MKQFIKIVMTILICVGIGVSVTYLIREIDIQPSQMTLNDDNQFGDWKRDGRLTHGYGTYN
HGLEFEGNDKHYGNDYDLPENTEVLAATDGVVTRLFEDELGGKVIQISESNGQYHQWYMH
LNDFKVTQGQKVKAGDVIALSGNTGEQTTGSHLHFQRMKGGIGNDYAEDPQPFINQLPEK
EKSLFNI
>SEQF2892_02186 hypothetical protein
MTTTKVDPRIIRTKKLLVEAFQEVSREKKMSQITVKDITERATVNRATFYAHFTDKYDIL
DYTLSETILKDLNDTLAISDMINEAVITNLFISIANYMVEVQDSCKMNSETFCNQAHQRI
NNELEDIFTIMLRNSYPEQDIDVLVNSASFLASGLCGLARHWLDTSSLTAEAFIDKNLPF
LIHHITHL
>SEQF2892_02187 Phthiodiolone/phenolphthiodiolone dimycocerosates ketoreductase
MSDIDEHEGFKRTFKNNKLTLGLSIPFDNKQQNNIDFDEQVRLAQKAESLGFASLSVRDN
PLYSPHLGNVTTNYDPFVFLTYLSAFTSKIALGTGSTVATLRHPIHLAKSAASLDLISNQ
RLLLGMATGDRSFEFPAFKVDENELTERYQTTIHSIRELWQSHSPKISNSIFELYEDSGL
QVLPKHHTIPMFGTGYSKQSMAWLQENMDGWLFYAQPFQEQKKLVEAWHSGTDRFKPFMN
ILMIDLSRNPNETVKPIKGGFRTGRKNLLQILKAYESINTNHIILRFTNDDRDIEELIEE
VGTYIVPHFPAHTN
>SEQF2892_02188 hypothetical protein
MRELLDRINQLANKEKVESLSVEEKQEQHQLRQEYLGMIRGQVLHTFSTMKVLDPLGQDV
TPDKVYDLREEYGNIQEN
>SEQF2892_02189 hypothetical protein
MIQSMWFNLHVEDLERSEQFYRYLGFEINKNPDMLDKMVGIKIGQTIVILIENNHFEKVT
HESVSKQPNEVIISLGVKTNDEVDELMRKVESSGGKVIDEPGTYQGYYGATFADPDGHKY
NFLVC
>SEQF2892_02190 NAD(P)H azoreductase
MGKSILVIGATGKQGNAVVKRLLLDGWKVRAFTRNKSNEKLASIDNDNLEIFEGDLSDQD
SLTNAMKEQYGVYSVQPIIVDDIEEELRQGKMIIKTAEEQNIDYVVYSTAGGVNRDRTGP
HFEALADIENELKDSSLNYTIIKPSFFMDNFLRITKVENGEIMIPEFINQDVKFAMISSI
DIARIASNVFGNPEKYNHQAIEIASDELTLKKVVKTFAMVTGKLTEIKGSFSSGTAERGW
LEEKGYIIDFNQMDEINPGRLTLEQWISEVNF
>SEQF2892_02191 hypothetical protein
MDAPNGFFGNKLQTFIHLVWDVRDLINDNIRQNGDQPKDYTYLKGEKEDYWFLQ
>SEQF2892_02192 hypothetical protein
MLTVQYAKGLPHIQINAADPGSTNTDLVGDFSNNSKPASEGIIPIIKLATIDKNGPTGTF
IDGNGTMPW
>SEQF2892_02193 hypothetical protein
MKSINFEEHYVVEEIQKETMKYMSSDPNGVPMKTMLEGLEQKSGFTDADEISYHDKRIDF
MDKHDVEMQVLSYGNGAPSNLEGQRAIDLCKKANDTLAEYVEKYPDRFVGFATLPINEPE
AAVEEFKRCINDLKFKGALIMGHPKNGFLDQEEYEPLFAAAEELNAPIYLHPSPIQSDVY
QAYYKGNYPDVTAATFACFGYGWHVDVGIHAIHLVLSGVFDRHPNLNIIIGH
>SEQF2892_02194 hypothetical protein
MDSILFADHLQHPISHYFKNNFYITPSGMLTKPQFDLVKAEVGVDRILYSADYPYVEPEQ
LGTFLSNLGLTEEEQEKISYTNGAKLLGLDK
>SEQF2892_02195 putative hydrolase
MKTLELQGAKLRYHKVGNGPVIIFIPGANGTGDIFMPLAQQLKDKFTVVAVDRRGYGQSE
LTEPLPEEAINPDSRYRVKRDAQDIAELAKSLSDEPVYVLGSSSGSIVAMHVLKEHPEVV
KKIAFHEPPINTFLPDAKYWQDKNAEIIDIAINEGMPQAMKLFGETLQISKLDQQYMSKP
AEAENDADSKKRFDEMLGWFKYEIRQYTESDISIDGFKKHKDIITLLNGTASKGSFPQEV
NFFISEETGTKIIDIPGGHLGYVQDSEGFAKVLLEMWA
>SEQF2892_02196 hypothetical protein
MLFTRNKPYTNKTLLAKEDILELIQFERFCRDNALWESTETCFADNSYINISWFKGNGSE
FVASSMILGHK
>SEQF2892_02197 hypothetical protein
MQATIQTRLPIQNVEMELQSDAKLVYCLEQDDQGVWYITRLECIYEKDSLTPVKPTTINL
PKDDFTDYRSSYACLSYALNAIGYDVNSELQGIDRPNEVNAYYDEIDDWLTFKEEEKEAY
>SEQF2892_02198 hypothetical protein
MKKIDLHAHYISPGFSKFLDDYFDGKGDGVATPKFSPEGYLELMARMEIEYGVLSISSPH
ISVAPDEEMIYLAKEVNAYATEFTHKYPEQLGFFATLPLPLVKESIETIDTALDQQGALG
FTLPTNARGIYVGDDRLDKVLAKLDERHAVVALHPNEPKPNIEAMSDVVPAPLMEFIFDT
TRTVIYMSQNNVFSKYPNIKWIIPHCGALLPVIAQRVAMGNKMFESERKPDDLEQVMKEL
YFDLAGKVLPYQLPNIAQCVDMDKIVYGSDAPYTTDQVVTMLADELESTELISRHELEKM
LYDNGKQLLKSINEK
>SEQF2892_02199 hypothetical protein
MKKDWQEQLPLNHIRDIKTVSGGDVNEAFKVTTEDDVYFLLVQRNRDKSFYAAEIAGLNA
FEEAGVTAPHVIDSGEINGDAFLILSYLDEGTTGSQRELGQLVAKMHSQQQSDGKFGFDL
PHEGGDISFDNTWSDSWIEIFVERRMDHLRDELMRKGLWNDEDNKVYEQVRTVMVNELEN
HNSNPSLLHGDLWGGNYMFLTDGSPALFDPAPFYGDREFDLGITTVFGGFTREFYDEYEK
HYPLGKGSRKRLEFYRLYLFMVHLLKFGGMYASSVNRSMDEILA
>SEQF2892_02200 Dihydroorotate dehydrogenase (quinone)
MYKLIKPLLFKFDPEKAHDMTIDALKLGQKRPFLLPIMHKIFNYEDPSLTQTIKGITFNN
PIGLAAGFDKSCEVPKALENVGFGALELGGITPKPQDGNPKPRMYRLVEDNALINRMGFN
NIGMNRALWNLRRHSYNIPVGLNVGVNKTTPYNERYQDYIKVIDTFKADVSFFTVNISSP
NTENLQSFHDKDEFSMLCKALKDFKANTEVNVPIFLKLTSDLELDGFKNILPAITETFDG
MILANTTRKRDGLTSSNKVEDGGLSGQPLFKRNLELVKWAYQQTNGEFLIIGTGGIFSAK
DAIQMMRNGASLVQIYSSLVIEGPGLTKKINKDIAAYLKQHNYNNVSDIIGLDAK
>SEQF2892_02201 hypothetical protein
MTAEDKNTKQNADQPSKSKEQPSNQNDKLTKDDDNSIGYNGEKKTALDLEIERELLEMME
NEDPEPEKQKKGLKIAGILSAFVIAILAIIRFINRTI
>SEQF2892_02202 hypothetical protein
MLKADPIIAKMKNQKINYDRVLKKLINQWEREGLRPKILLHSCCAPCSTYTLEYLTEYAD
VAIYFANPNIHPKNEYLRRAKVQEQFVNDFNERTGKNVKYIEAEYKPHEFMKMAKSRGLT
EEPEGGLRCTACFEMRLELVAEAAVKYGYDYFGSALTLSPKKNAQLINELGMEVQHLYDV
SYLPSDFKKNKGYERSIEMCNDYHIFRQCYCGCVFAAMAQGIDFKQINQEAKDFLQQF
>SEQF2892_02203 hypothetical protein
MDKFSQILFNWFTQNPTGRDEREQGVLEHKFAVMFLLTYITIVILGTISLVIDMKRETVN
FGTICLLALSVILTFVSLWINRRNRLDELKAHSAEEYKQWVKKHAIKCSFFVVYFATVMF
IITGVIFPYIFNDGFDFKEQLIKCAFSGVLFGGIMFIYYMIMLKKEY
>SEQF2892_02204 hypothetical protein
MLVFSYRGASEKNNLDENRVYSKEAYQRLLKKHKLGSIFGGIMFGVIMSLLNLTRLYFSD
QKIELGFFITFNFISALIFGVVSYFVGKGKIVKEYGEGD
>SEQF2892_02205 hypothetical protein
MTNFRDKMINRIIGTTTELDEREKEELYGHVTTTFIITYLGLLILAFISLINDYVVQRVN
VPTIGIFVLFFIASIFLSRGIRKK
>SEQF2892_02206 hypothetical protein
MTQDRRIRKSQQAIKTAFIDLLHKYDFNDVTVQQITDLADINRGTFYTHYLDKYDLLDKM
EDEHVDIVRNFIKESKKSSGGKFSTEDLRHIMEFLIAHIEENITFYQLMFKIGTESRLHE
KLYGLLTNYLNSFTNLDGDISGIPFSYFMSYVSGAGLSFLRHWVEDGNRIPKEDLIQYFY
DIVNNGPATIIQREINK
>SEQF2892_02207 hypothetical protein
MPVEIELLPSGTLFKKDESLAVVVKGNEIIKGNSTPLPNMKTRYEHEDTVNRGNHLVYTG
SGYDSHLIIPVIE
>SEQF2892_02208 hypothetical protein
MQCPNCGQTYQQGDQYCGSCGNKLNGSLSQSTQSTTESFNSEIQSTSHSTAIKQEQINGE
QNHSEYDRGEFAHRYMSYEHRYAEGPFTIKVKSTFNESKQFLKQAFTSHDVVMKGNKSFS
ITLLSSLVIIGLLILGMLLHLLSASLFDGYFVDTATIILKFVLTTMLALAFLFIVTFAVI
RLMIVESISFKKILSDYILVNTLSVSILFLGFIVFFFEMYIFSGILIAFSVILLLTSSVY
LISKYSVNHTLRFASFYSVMIFFVIIGFALHLFGSTIIHRYDDLGILHQLFWRWL
>SEQF2892_02209 Alpha-acetolactate decarboxylase
MSHVLYQHGTLGTLMAGLLEGTASIDELLEHGDSGLATLTGSNGEVIFLDGEAFHANEHK
EFKKLNGDEMTPYATITRFEADQTYQTSNKDSETVLNEVKEHMLSDNLFSAVKISGTFKK
MHVRMMPKQEPPYTRLIDSARRQPEETREDIKGTVIGFFTPELFHGIGSAGFHIHFANDD
RNFGGHVLDFEVDDVTVEIQNFETFEQHFPVNNKTFTETEIDYADVDAEIREAE
>SEQF2892_02210 Acetolactate synthase
MTKENYSAANMVIDTLKNNNVDYVFGIPGAKIDYLFNALEDDGPELIVTRHEQNAAMMAQ
GIGRLTGKPGVALVTSGPGVSNLTTGLLTATSEGDPVLAIGGQVKRNDLLRMTHQAVDNA
SLLRSSTKYSAEVQDPESLSEVMTNAIRTATSGKNGASFISIPQDVIESPVTSNAIDLCE
QPQLGVPNSEDIQDVIKAIKHAKFPVLLVGMRSSSEKETEAIRQLVAKSNLPVVETFQGA
GVLNRELENHFFGRVGLFRNQVGDELLRKADLVVAIGYDPIEYEASNWNKELDTEIIVID
EVQAEITNFLRPKKELIGNIAGTIQLLSENVHEPIINQNRLDDLERLRAEVIEATGIKYT
HEDGVMHPLEIIETMQKTLTDDTTVTVDVGSHYIWMARKFRSYNPRHLLFSNGMQTLGVA
LPWAIAAALVRPNTQVVSVAGDGGFLFSGQDLETAVRKNLNIIQLIWNDGKYNMVEFQEE
MKYKRSAGVEFGPVDYVKYAESFGAKGLRVTNQEELEAALKEGYATEGPVLIDIPVNYKD
NIKLSTNVLPDSLN
>SEQF2892_02211 putative amino acid permease YhdG
MASFFKNLTRKEDPTIYQNKDGHLKRTLRVRDFLALGVGTIVSTAIFTLPGVVAAEHAGP
AVALSFLLAAIVAGLVAFSYAEMASTMPFAGSAYSWINVLFGEFSGWVAGWALLAEYFIA
VAFVASGFSANLRGLVSPLGIVLPKALSNPFGADGGVIDIIAAVVIIITAIILSRGMTEA
ARVENVLVILKVFAIVLFIIVGLTAIQASNYVPFIPEHKVTENGDFGGWQGIYAGVSMIF
LAYIGFDSIAANSAEAINPQRTMPRGILGSLAVALVLFVGVALVLVGMFHYSKYAGNAEP
VGWALRQSGHGIIAAVIQAISVIGMFTALIGMMLAGSRLLYSFGRDGLLPPWLSKLNHKH
LPNRALLILTIIGVLIGSMFPFAFLAQLISAGTLVAFMFVSLAMYRLRKREGKDLPEPSF
KVPFFPVLPIITFILVLLVFWGLSFDAKLYTLIWFVVGIIIYLSYGVRHSKKNEEEDYVV
PKD
>SEQF2892_02212 Isoleucine 2-epimerase
MSKAEELINEDGKYFAASGRIKYYPLAIDHGYGATLVDVDGKEYIDLLSSASSQNVGHAP
KPVTEAIKKQAEKFIHYTPAYMYHEPAVKLSKKLCEIAPGDYEKRVTFGLSGSDANDGII
KFARAYTGRPYIISFTNAYHGSTFGSLSMSAISLNMRKHYGPLLNGFYHIPFPDKYRGMY
EQPNANTVEEYLAPLKEMFAKYVPAEEVACIVVETIQGDGGLLEPVDGYFEALEALCREH
GILIAVDDIQQGLGRTGTWSSIDHFNFTPDLITFGKSLAGGLPMSAIVGRKEIIETLEAP
AHLFTTGANPVSCEAALATLGMIEDEDLLTASSEKGAYVRKRMDQWVNDYDFVGDVRGKG
LSIGIDIVSNKQAKTRASEEALKICNYCFDHGLVLIAVAGNVLRFQPPLVITYEQLDYAL
NTIENALQALQDGQLNNYNIDGQGW
>SEQF2892_02213 hypothetical protein
MYKNYNMTQLTLPMETSVLIPTNDISRHVNDIVETIPDNEFDEFRHHRGATSYHPKMMLK
VILYAYTQSVFSGRKIEKMLNDSIRMMWLSQNQKPSYKTINRFRVNPKIDALLESLFIQF
YSQCVKQNLIDDKAIFIDGTKIEANANRYTFVWKKSIQNHESKMNEDSKALYHELVTNKI
IPEIKEDHDNELTKEEIDLIGSHLDKEIEDLNQHINNEKCTKTRKQIRLKRTKIKKYKKQ
INDYFERKYRYEFQKSILKDRNSYSKTDHDATFMRMKEDHMKNGQLKPGYNLQIATNSQF
VLSYNVYQNPTDTRTMIPFLNSIQETYGHLPEYIVADAGYGSESNYKAIIDDFNRTPLIT
YGMFIKDKTKKYKSDIFNTQNWNYDEINDEFICPNNKRLGFKRYAYRHDKYGYKRDFKLY
ECDDCSECPLKNQCMNFNSKTNKKIMKNYNWEYFKSQINKKLSEPETKNIYSQRKIDVEP
VFGFMKAILGFTRMSVRGLNKVKRELGFVLMALNIRKVVAQGAENNQKIYKKDNFYIISI
EIVFFSLIQELYVPDSLFKKKIINTKNYKL
>SEQF2892_02215 Methionine-binding lipoprotein MetQ
MKKWLSVISILVLVIVLAGCGKDKEGNKKITVAASPAPHGDVLKKAKEQLKKKGYDLEIK
EVNDYKVPNKLLDKGDIDANFFQHVPYLKAEKKSHGYKIEELGKVFTTPMGVYSKKYKNL
KDIPEDSTIYVSNNPAEEGRFLSFFVDEGLIKLKKGVKIEDAKFEDIAENKKNLKFNHQQ
GAEFLPKTYKNGEGAAVIMNSNYAIDNGLKPSKDAIVMEGKSSPFANIIAVQEGHKKDKK
FQELLKVMQSKEIKDYIKKEYGDDVIPYESK
>SEQF2892_02217 hypothetical protein
MIRYGYHFLSALLISILLLLIMFTMDVVTHTTHLTLLLINIDFIADPNQTPLILELLIHI
VIGFLIYITFLIIYKFFKPFYKISYLLLIIIFLILYPLLILLAQRSFFQFSWTEYGLWMI
AHLIFTVCMAWSIPYFSKKKW
>SEQF2892_02218 hypothetical protein
MKVSLFASTLISSTVLLTAFSGHQAFAADIVTKNNAQEVASEALSNSGGNPDLQNFGKVI
DKGDYFEIKSHNKANAGLGVYKVHKNGQVEYKNDKYSNFNQLQSGETYVEHGIANAAELD
DLKEEASKINSVDCARELNSYYVGNVKSNEVPSSQSVKKQGNHNSTNAQSSLPETGHSDS
EQSIQLLGSIFLLLGGALVAKQSHKKIS
>SEQF2892_02219 hypothetical protein
MKKNKIFAVLTTSALLLAACSNGDNSSSSGQKGDSQKNEQTNSQSEKLKKNNDKNKNENK
VDYPKDGVKGIYVTSNSTEGDKIDELIKFIKDSKLNTMVIDVKDDEGNITMKLNTGNKQV
DKNTLDIVDGKKLLKKLHNNNIYPIARIVTFKDTKLAEEHPEWSFKESDGSVWTNGKGDS
FVNPFMKEVWDYDITVAKAAAKAGFQDIQFDYVRFPEGFENEADSLTYSKGDYKNSKLSS
GDQRVDTITKFLEHANKELKPMGVNVSADVFGYSALVKNAPGIGQSFPKMSENVDAISSM
IYPSHWSNGDFGLDAPDTEPYKTVNRYIQKENSLLDSLGKKKPISRPWIQDFTASYLGDG
NYIDYDAKAVSEQVQALKDNGVNEFLLWNAGNEYTEGANYNPKKGSAKERDPEGVEQDTK
QQDNKDDNKKDSTEENGNSNQ
>SEQF2892_02220 Pyrimidine 5'-nucleotidase YjjG
MIKKVKLVIFDLDNTLFSFNKLWIKANKDTFETYTLFKDIDYSDFMKLFEKYDLYFWKQH
DEGVITLDELRELRLIKTLQHFDINISREEANEYFESFFTKLLSSITVNRKMNDLLMTLK
ENVNIAILTNGKIKEQNTKIDNLDIRTIFEKNIFISENIGCEKPDPKAFLNVTSRLNVNS
EECLFIGDSYRNDIMGALNVNMAAIWLTNSDKDTELNVKDGLYCCEDNIEVLLKKLLDDE
YKDLTIYN
>SEQF2892_02221 hypothetical protein
MEKRILIIGSPGSGKSTLAHHLHKMYGIPLYHMDIINWIDNKTTISQEELIEQLNQIIAK
NTWIIDGNYSDTLPLRLKRATDVIWLKEPRWKCIYRVIKRVIIHNLKRHRIGGNPNTISF
EFIKYVWQFPENNNEFIKLQQLKTQDHIKWVISNSSLKNL
>SEQF2892_02222 Fructose-bisphosphate aldolase class 1
MNKEQLEKMTNGKGFIAALDQSGGSTPKALKEYGVNEDEYSNDDEMFQLVHDMRTRVVTS
PSFSPDKILGAILFEQTMDREVEGKYTGDYLADKGVVPFLKVDKGLAEQQNGVQLMKPID
DLDDTLDRAVERHIFGTKMRSNILELNEQGIKDVVEQQFEFAKKIIAKGLVPIIEPEVNI
NAKDKAEIEEVLKAELKKGLDALNDDQLVMLKLTIPTKANLYKELADHPNVVRVVVLSGG
YSRDEANKLLKDNDELIASFSRALASDLRASQSQEEFDKALGDAVDSIYDASVNKN
>SEQF2892_02223 Transcriptional regulator YqjI
MMFRRHMQDIRQRMDHFEQFGRSKGPQGFERFGGFGRRGGGRDRFFKKGNLQFIILQMLE
EESRHGYQIIKDLEERFKGFYSPSPCSIYPILQMLEDRDFVSISKEGNKKIYTITDEGKT
FLKENVDQDEFTKRLEQFKNVDFEQMKASREQLQGLFHGFMKASQSALQDEEKQKELNVF
IEETKQKLERFYK
>SEQF2892_02224 hypothetical protein
MKKLIKQGHLIVSGPTVNARKDIKEAYLIFKVKNRDELMTLLEKDPFWYKGLVSNYTIEE
WKPLFGNLEQLTNEEFNDEE
>SEQF2892_02225 Aryl-phospho-beta-D-glucosidase BglA
MSKLPNDFLWGGALAANQFEGGYDQGGKGLSVIDVMTAGAHGKAREITQDVEPDKYYPNH
VGIDFYNRYKEDVKMFSDMGLKCLRTSIAWTRIFPKGDEVEPNEEGLQFYDDLFDELLKY
NIQPVITGGKFGKVLIHV
>SEQF2892_02226 putative HTH-type transcriptional regulator YydK
MLKYERIAQDITSAIANDEYNVGDKLPSVEQLKARYEVSKSTIIKALAILQRDGMIFQTR
GSGIYVRNKNKSGYINLLKTKGFSDNLQGHQITSKVLTFETIKPNDEVRAHLRLTEQDEE
VYYVERIRYLDHNPLCIETSYFNKTLVTHLDHDSAEHSIFDYLQAQLKINIGFSDIYFYI
DFLTEREAPQLDLNPNDPCMRHDLTFYTNKGLPFDYSKIVYHYKYANFFIPIES
>SEQF2892_02227 putative malate:quinone oxidoreductase 2
MAESKDVILIGAGVLSTTFGSMLNELEPNWNIKLYERMDRPGLESSNERHNAGTGHAALC
ELNYTVQQPDGSIDIDKAKEINEEFEISKQFWSHLVKAGHIENPREFINPLPHISFVRGV
NNKEFLKKRYEAMKQSPMFDNIEYTEDIEVMRKWIPLMMKGRVDDGKMAASKIDEGTDVN
FGELTRKMSRHLELDEHVEVKYSHQVLDFERLSNGKWRVKIKDLKTGNVFEEVTDYVFIG
AGGAAIPLLQKTGIPESKHLGGFPITGQFLTCTNPQVIEAHDAKVYGKEPPGTPPMTVPH
LDARYIEGKRTLLFGPFANVGPKFLKNGSNLDLFKSIKPYNITTMLAAAVKNLPLIKYSF
DQIIMTKEGCMNHLRTFYPEARDEDWELYTAGKRVQVIKDTEKEGKGFIQFGTEVVNSED
HSVIALLGESPGASTSVSVALEVLEKNFPEQIGQWNAKIKEMIPSYGQSLIEDVELMRKI
RRQTSKDLELGYYEDAK
>SEQF2892_02228 Putative pyruvate, phosphate dikinase regulatory protein
MNETQSNEQILKLFIVSDSIGETAQRMIHATLTQFPDLHNVEIKKFPYIKDEEEFLNILN
LAREQHAIVATTLVSESFNALGHQFAHEHDIPYVDYMSDLISIIKKVTHSQPLMESGALR
KLNDEYFKRIEAIEYSVKYDDGKHFTDIGEADALIVGVSRTSKTPLSMYLANKGYKIANI
PLVPEIEIPDNVYKQKGLKVFGLTASPQYIANIRKNRAETLGLSSESRYNNLDRIKKELV
YAEEVFKKLNATVINTEYKSIEESAFYIEKFLQPKL
>SEQF2892_02229 Pyruvate, phosphate dikinase
MTKYIYAFDEGQKSMKDLLGGKGANLSEMKRLGLPVPDGFTITTAACIEYLRQGKSLSTD
VKTQLIDHLADFSERTGKAFSSDANLLLVSVRSGAKISMPGMMDTILNLGLNDDNVKKLA
DKTGDARFAYDCYRRLLQMFGEVVYNVPMQAFDTYFEDYKQRHNFENDAAITAEGLQEIC
ERFKDIYMEEVYKPFPQEPLKQLEEAIEAVFKSWDNDRARIYRDLNDIPHDIGTAVNIQE
MVFGNSGNNSGTGVAFTRNPVSGENKLFGEYLLNAQGEDVVAGIRTPKDISTLHDQMPDV
HQEFVEVTKQLEQHYKDMQDIEFTIENGKLYLLQTRNGKRTARAAIKIAVDLVDEGVIKK
EEAMSNVDVKSIDQLLHPNFDEKALKQATEISKIGLPASPGAATGQIVFSAEDAKAQADA
GKKVILMRPETSPEDIEGMIASEAIVTTHGGMTSHAAVVARGMGKCCVTGCSDLEINTMA
KTVYYDGGELHEGDTISVDGSKGDIYIGEIETVSAEHSEEFTQFMEWSEDIARLNVRMNA
ETPQDIKAGYDFGSKGIGLVRTEHMFFGAERLVEMRRFILSSSYEQRVEALNNIRNYQVE
DFEAIFRLSGERPTIVRLLDPPLHEFLPNSDEDVENVARQLNIPKEVLNKRIVDLHEVNP
MLGHRGCRLAITYPELYEMQVEAIMGSVLKLKKEGITCKPEIMIPLVSTVEEFTTLKEKL
VKTIEQLEDEQGDSVPYLIGTMIETPRACLVADELAKHCDFFSFGTNDLTQLTFGFSRDD
AGKFINVYTESNILKLDPFQTLDRDGVGKLIEIAVEQAKKVNPKIKIGVCGELGGDAKSI
RRFNQLAIDYVSCSPFRVPGAILATAQSQAEESEQ
>SEQF2892_02230 HTH-type transcriptional regulator CynR
MEITKLKYFKVVANMNNISEAAKRLNISQPALSKAIASIEDELGVALFDRKGRHIYLNRY
GELMLNYIDSAFRELNEGERIIKELTGIESGQVTFAVTFPHVMPLLIQNYVSRHPNIKIK
QYQAISERATHLILNNEVDFAISSSKIEHRDISWEPIIQDDIYLTVSKEHPLSQCTSLEL
TQIKDERLIGQIEGYGFRDTIDYILKQEGIVPNYQVEVEDSSAILKLVAMNIGISFTPKQ
ALRNLDKQIVAIPINNEHCYREIGLAYKKSHYFTEVASSFKTFVTDYFQNHIN
>SEQF2892_02231 Dihydroanticapsin 7-dehydrogenase
MRLENKVALITGSGGGMGFETAKRFVEEGATVIISDLKEDVVNQAVDTLSKETNQKVYGY
VLDVSKEASVEDTFSNIKHDIGKLDILINCAGITGADKTTDQLTEEEWDQVFAVDVKGVF
FCTKHAVPLLRENGGGSIVNFSSILGLVGTDELTPYAAAKGAVTNMTRQDAISFGKDHIR
VNSVHPGTILTPLVKKLGAETEGGLEAYTAKMSERHPIGYLGEPVDVANAVLFLASDEAR
FITGAALTVDGGYTAR
>SEQF2892_02232 Acetyl-coenzyme A synthetase
MDNSSLLAPETYNIVSEIEKHASNTSKKALIYENGVDEPITVTYSELIKNANKVGHVLLN
HGLKKGDKVLIMMPRAIMTYELYLAALKLGIAIIPSSEMLRTKDLQYRITHGEIKAVIAK
SDFIEEFKGVKEYDALTKFIIDGHETDWINIEDEKASQSDALDIEKTSRDDLAILSYTSG
TTGNPKAVTHSHGWGFAHMKMAPEHWLCIKEDDLVWATAAPGWQKWVWSPFLSIMGSGAT
AFVYNGKFNPSRYLELLQGFEINVLCCTPTEYRMMAKLDNLQEYNLEHLHSAVSAGEPLN
REVVEQFRNNFNLTVRDGYGQTESTLLIGFLKDTKSRPGSMGKEIPGSRVTIVDDEGQPV
ETNVKGNIALPLDFPGLFKGYYKDEERTKAAQAGDYYITGDLAHIDEDGYFWFEGRRDDI
IISSGYTIGPFEVEDALTNHPAVKECAVVASPHEIRGNIVKAFVILQDNYQGNDDLVKEL
QTFAKNEVAPYKYPRAIEFVDSLPKTNSGKIRRVELRDAEREKYNKENGFK
>SEQF2892_02233 Heme-degrading monooxygenase HmoB
MILKDSYKTYVVEEKGDNTISIKKNNDEHQYDVLEVIDDLSNDSFCVLNHLFVNEGMEDA
FEKKFLERPKYLQNVPGFKALRFLRPQVAGRHYIILTLWEERQAFYDWQNSNEYSQTHKH
RGTEGGVDRNIVNRDLSYNVRIELSGLESKLDLSHIF
>SEQF2892_02234 hypothetical protein
MQGFIGDQTPLGELAHWISQDQHFPKYERISDNILSYFTKITTLDHEFLEVVKRSISLYE
QSQL
>SEQF2892_02235 putative hydrolase YxeP
MMKDLVKRLQEKEEKMIEIRRHLHEHPELSFQESETPKYITDFYKDKDCEVKTNVGENGV
KVTIDSGNPGKTIAIRADFDALPIQEDTGLSFASKNDGVMHACGHDAHTAYMLILAETLI
EMKDQFNGKVIVIHQPAEEMPPGGAKGMIEDGVLDGVDHVLGTHVMTNMEPGKVFYRPEN
VQTGRSYFKLTIQGEGGHGSSPHTANDAIVAGANFVTTAQTIVSRRLNPFETGVVTIGSF
DGKGQFNVIKDKIELEGDVRALTDATRDKIADELQQIVKGLEATFGVKCDFEFSKDYPAL
YNDPDFTNYVAETIKKADLDDVKGVEECEAQPPSEDFAFFAKTLPSTFIYSGAAPQDGKA
YPHHHPKFKIDEKSMLVAAEAVGAVVLDYLNSK
>SEQF2892_02236 Quinolone resistance protein NorB
MEMKQQQFTGNNKLLLGIVLGVITFWLFAQSLLNLVPTIQHSFSSSIGTTSIAISITALF
SGMFVVGAGSFADKLGRVKMTYIGLILSIIGSLLIIVTPFTPMLILGRIIQGLSAAAIMP
STLAIIKTYYQGSDRQRALSFWSIGSWGGSGFASLFGGMIDTAIGWRWIYIISIIVAILA
ILLIKGTPETKANQTTNTKFDFVGLTLFVIMMLSINVVITQSAKLGLFSPTILALIAVFI
ISTIIFIRVEMKMHYPLIDFKLFNNKAYTSATVSNFMLNGVAGTLIVANTFVQQGLGFST
FQTGLLSITYLITVLLMIRVGEKVLQKVGARKPMLLGTALNMVGILLISFTFLSSQMYVV
VCVIGYLLYGLGLGFYATPSTDTAISNSPEDKVGVASGIYKMASSLGGAFGIALSGTLYG
IGAAMVNINFGAMLGLWLNILMAIISFTVILIGVPKQQSK
>SEQF2892_02237 putative hydrolase YxeP
MNKQLINTLQEKEERMIEIRRYLHQHPELSFKEQETPKYIADFYKDKDCEVETNVGPNGV
KVTIDSGKPGKTIAIRADFDALSIQEATGLPFASKNEGVMHACGHDAHTAYMLILGETLI
EIKDQFKGKVIIIHQPAEEMPPGGAQGMIKDGVLDGVDHVLGAHVMSTMEAGKVFYREGF
VQTGRAYFKLKVQGSGGHGSSPHMANDAIVAGAQFVTEVQTIVSRRLSPFETGVITIGSF
DGKGQFNVIKDAVELEGDVRALTDDTRDTIEKELKRLVEGLESTFGVTCEFVFKKDYPAL
YNDPEFTQYVAQTIKEADADDIQGIEVCEPQPPSEDFAFYAATLPSTFIYSGAAPKDGKI
YPHHHPKFTIDESSMLVAAEAVGTVVLDYLS
>SEQF2892_02238 hypothetical protein
MVQDLVNDTSWREHVVASDEIIPHSHQYMTLDECLLFLMNHQIHLSIRLRPPHSATAFQA
YCDTWVQILKHFINMTTHSSRMQLSVIIDAIDLKQYIQLYEVFNRYISNVKFIVNYQDFS
NQKNNLKLLFKDHSEKVNMLAFEANQNDVVNLEVSEDIQYQYAKNHINETVEALVEWLPK
KQKDMPLMLLNWNTLTGNSNLTNGEYFRAGIIFKQLLDINEKVCTVGYWLNYELHQKYGV
MNEHQLMGIDLYHQFDGKRPAFFTSNFFRMLQNNVRFRNEECMVVGDDTHLQIVVWDADH
YNPYYTISEQPNVMEKRNFKIEINQLQSGLYKIKHYTLDKENGALYRVWQQHNTTYGMDQ
ETIDYVNRISYPKLDIAEVEVEETLTYHLKVMTNSIHIIEVNKYV
>SEQF2892_02239 HTH-type transcriptional activator RhaS
MNTNYEITFDTKKEDIASDYLSLNLILKGNVTCQSENQNKHYHVGDLILINSYQNFLILE
DSDVSYMSLRLSNNYFSHYIEDKNIYFHFEEVSKKIHDDIKTLLAKIGITYLRKGKFHQL
HMDQMMIQLIEMLVKFIPYQSRQELIHEHNKDDVFASLASEFINQHFMERIGLDDLSDYI
NLSSSYTSRLFTKKLGTSFNSYLNKVRTRNAEHDLKYSDISITDIAMKNGFSNSTSLAKH
FKLWYHMTPGDYRKEFQVKDLNQLKMKPLNKQSIKRYIQYLSSYVNNQMDVVIHSAEPQK
EIDIQLEDRLGYLNKYNHIVQIGSIVNMRVHRYREQILEVKDRVV
>SEQF2892_02240 Oxygen-dependent choline dehydrogenase
MSKKNSYDYVIIGGGSAGSVLGNRLTEDKDKEVLVLEAGRSDYPWDLFIQMPAALMFPSG
NRFYDWIYQTEEEPHMGRKVDHARGKVLGGSSSINGMIYQRGNPMDYEGWAEPEGMESWD
FAHCLPYFKRLEKTYGATPFDQFRGHHGPIKLKRGPATNPLFKSFFDAGVEAGYHKTKDV
NGYRQEGFGPFDSQVHNGRRVSASRAYLHPAMKRKNLTVKTRAFVTKIHFDGNKATGVTF
KRNGRYHTVDAGEVILSGGAFNTPQLLQLSGIGDAEFLKSKGIEPRMHLPGVGENFEDHL
EVYIQHECKEPVSLQPSLDVKRMPWIGLQWIFARKGAAASNHFEGGAFVRSNNQVAYPNL
MFHFLPIAVRYDGQKAPVAHGYQVHVGPMYSNSRGSLKIKSKDPFEKPSIVFNYLSTKED
EQEWVEAIRVARNILAQKAMDPFNGGEISPGPSVQTDEEILDWVRRDGETALHPSCSAKM
GPASDPMSVVDPLTMKVHGMENLRVVDASAMPRTTNGNIHAPVLMLAEKAADIIRGKKPL
EPQYVDYYKHGVSDENAGAMEFDPYYQH
>SEQF2892_02241 Betaine aldehyde dehydrogenase
MELVEKLSNRQYIDGEWVESSNKNTRDIINPYNQEVIFTVAEGTAEDAERAILAARRAFE
DAEWSLETSEVRGKKVRAIADKITENRDELAKLETLDTGKTLEESYADMDDIANVFTYFA
GLADKDGGEMINSPIPNTESKVVKEPVGVVTQITPWNYPLLQASWKIAPALATGCSLVMK
PSEITPLTTIRVFELMEEVGFPKGVINLVLSSGEEIGDTLSGHEEVDLVSFTGGIETGKH
IMKNAANHVTNIALELGGKNPNIIFDDADFEVAVDQALNGGYFHAGQVCSAGSRILVHND
IKADFEKALIDRVGKIKLGNGFDDDTEMGPVISTEHRNKIEGYMEIAKEEGATIAIGGKR
PEREDLQAGLFFEPTVITDCDTSMRIVQEEVFGPVVTIEGFDSEEEAIKLANDSIYGLAG
AVFTKDIGKAQRVANKLKLGTVWINDFHPYFAQAPWGGYKQSGIGRELGKEGLEEYLTSK
HILTNTNPEPVNFFSK
>SEQF2892_02242 HTH-type transcriptional repressor OpcR
MARSTNYDQKIEEAKDLVINSIGETMDLYGTNRSVGNLYGTMVFEGSMTLDEMREHLQMS
KPSMSAGVKKLQEFDIVKQQFTRGSRKQHFIAEKNFFHFFRNFFTQKWEREVDTNLEAVE
KAQLLLDETLKNADLDDHAKAEVDKIQAQLDHTKQYCKWLENLSNAIESGQIFEHYPIPE
KEDI
>SEQF2892_02243 Glycine betaine transporter BetL
MKREKIMDWPTFIGTVIVLLVAVTPMMVFPKASEKVITDINSAISNSIGSVYLFMGLIIL
FFVLYIAFGRYGNVTLGKATDRPEFNNFSWASMLFCAGIGSDILYWGVIEWAFYYQVPPN
GAKGMSDEALTYATQYGMFHWGPIAWAIYVLPALPIGYLVFVKKQPIYKISQACRPVLKG
QTDKFLGKLVDILFIFGLLGGAATSLALGVPMISAGIEKLTGIDGENMVVRSIILLTITV
VFAVSSYSGLKKGIQKLSDVNVWLSFLLLGFVFIVGPTVFIMETTITSFGNMLRDFFHMA
TWMEPFGGIKGRKETNFPQDWTIFYWSWWLVYAPFIGLFIARISKGRRLKEVILGTIIYG
TLGCLLFFGIFGNYAVYLQITGEFNVINFLNSHGTEATIIQVMHQLPFSSLIVVLFLISA
FLFLATTFDSGSYILAAASQKKVIGEPLKANRLFWAFALCLLPFSLMLVGGERALEVLKT
ASILASVPLIVIFIFMMISFIITLNRDRIKLETRADKHKEIERRSLRIVQVKEKSDDDDN
L
>SEQF2892_02244 Anaerobic C4-dicarboxylate transporter DcuA
MLLFVVEIIIMILAIILGLRTAGALGCGIFAIVAQLIMIFGFQLPPGSAPVTAVLIILSI
GIAGGTLQATGGIDYLVFLASKIIERFPKSIIFIAPMIVFLFVFGVGTANIALSLEPIIA
KTAVRANIQPKRPLTASVLTANLALLCSPAASATAYIISVMAGYHISMGQYLSIVLPTAI
ITMLMLSVFCTFVGRKTTVTASEIAHTPEVPVKQSFTTKTKLGVVGFLLCVAGILTFGIF
PNLMPSFNVDGEQVKVTMTEIVQFFMYLSVAINLLMMKINTSDILSSNIAQSAIGALFAV
LGPGWLGATVFNAPQNLKIIQDDIGQTIQSIPWLVIVLVAIVAMIVISQTATASIMVPIV
MSMGIPPMYFIAMVQTLNVNFVIPAQPTLLFAVNLDETGRTRATSFIIPGFFAIGVSIVV
GFLIKFLLGL
>SEQF2892_02245 hypothetical protein
MTFDVIKWIILALIAIVTIAIICGLIWGSLLEERAYDKRSKKEKRKETEKNLEMAKGHTD
DKGVDGDYEEAPTKEGTLKDEHINHREK
>SEQF2892_02246 Staphylococcal secretory antigen SsaA
MKKIATATIATAGIATFGLAHQDADAAEINNGYNPNDPYSYSYTYTIDQQGNYHYEWQGN
WSPSQAQQGGQQNTGNQAVNNTQSNNNYSYNYNNNQSNQSTQSYTANNNAGGGLGASYST
SDRNVKVTTQNAPTTQSTSSSSSSEALAGKSSGGSNLYTAGQCTYYVYDKVGGKIGSTWG
NANNWATAAAADGYTVNNTPKAGAVMQTSQGAYGHVAYVESVNDDGSVKVSEMNYNGGPG
VVSSRTISASQAGSYNYIS
>SEQF2892_02247 Citrate transporter
MQGDSMWLTIMGIIIIGSIVGLLIAKKISPVVGMILIPSIGALLLGYGIKDLVKFFNSGL
ESVMSVVIMFIFAIIFFGIMTDSGLFKPIVKRLILMTRGNVVIVCIVTALIGMFAQLDGA
GAVTFLLSIPALLPLYKALNMNKYLLILLLAISAAIMNMVPWGGPMARVASVLKVKSVNE
LWYGIIPVQLIGFVLVLIFATYLGFREKKRIKKAIDNGEVEPTLNIDIHRLVKNYERDQD
IKFPVRGRALKHGWVIWANVLLTIIVLVMMLANVAPPEFAFMIGVAIALVINFPNVDEQM
NRLKAHAPNALMMAAVIIAAGMFLGVLEETGMLKSIALNFIKIIPDAVGPYLHIIVGFFG
VPLDLLTSTDAYYFALLPIVEQTASQFGINPVSTAYSMVIGNIVGTFVSPFSPALWLAIG
LAEANMGTYIKYAFFWIWGFAIVLLGIAVLIGTVTI
>SEQF2892_02248 putative adenylyl-sulfate kinase
MSQSSNITWHDSEVTKSDRQQQNGHKSVVIWFTGLSGSGKSTVSVELEKALFQLGKHSYR
LDGDNVRHGLNKNLGFSPEDRKENIRRIGEVSKLLVDAGTIAITAFISPYRADRDEVREI
LEDGEFIEVYTECSVEACEQRDPKGLYKKARSGEIKEFTGISAPYEAPHQPEITINTEHQ
SVEESVNTIIEYLKNKQYI
>SEQF2892_02249 Sulfate adenylyltransferase
MTTHEQIINYTIKPHGGTLINRVVEGEERDYLLEAAQSYKVITLNPWSISDLELIGIGGF
SPLTGFMGEADYTKVVEDTHLENGLVWSIPITLPVSEEEADKLEIGDDIALYGEDGELYG
TLKLEEKYTYDKKKEAQNVYGTTDEAHPGVKKVYDKGNVYLAGPIQLINRPKHDEFSDFH
LDPAETRQLFHDLGWKTVVGFQTRNPVHRAHEYIQKSALEIVDGLLLNPLVGETKSDDIP
ADVRMESYQAILKNYFPKDRARLVIYPAAMRYAGPREAILHATVRKNYGCTHFIVGRDHA
GVGDYYGTYEAQELISQFEDELDIQILKFEHAFYCEKCGNMATAKTCPHDASEHVHLSGT
KVREKLRNGESLPTKFSRPEVAEVLIKGLKQN
>SEQF2892_02250 hypothetical protein
MRKLFIFALAGFLAQLVDGSLGMGFGASSSSILLTYGIAPAIVSATVHFSEIATTAASGT
SHWKFENVHKPTMLKLAIPGAISGFIGAGLLTQIHGDYIKPYIALFLLSMGIYILYQFLF
KRNREIHTHVGKLSGFKLVPQGAIAGFLDAIGGGGWGPVNTPLLLASHKIQPRYAIGTVS
ASEFFVTLSTSLSFIIFLGITQINWWFVIALSVGGMIAAPISAYLTKILPINILAICVGG
LIIFTNSNALMTYFVHDDTISNIVRFAIICAIVILVIITVIRNKKLSFS
>SEQF2892_02251 Precorrin-2 dehydrogenase
MSNMPLMIDLQNKKIVIVGGGKVATRRAKSLVEYCSHVHIVSPSITKELHTLFQQQRLTW
AEKMFEPQDISHAFLVIIATNQPEVNQHVKDSLPEGTLLNHAADASAGNVTFPSMLRRGK
LTISVSTDGASPKLGRQIISTLQDTYDERYESYIDFLYESRQLIKASTIEPSRKQALLQH
VLSEDYLDEEKQKEFKRWLQSQV
>SEQF2892_02252 Uroporphyrinogen-III C-methyltransferase
MGKVYLVGAGPGDPDLLTIKGMKAIQMSDVILYDRLVNKDILDLAKPGTKFFYCGKDPNR
HSLPQEETNRMLVNLAKKGHVITRLKGGDPFVFGRGGEEAEILAQHQIAFEIVPGITSGI
AAPAYAGIPVTHRDYSSSVAFVTAVNKPGMSKDDYWAHLAHGPETLCVYMGVKRLPEICD
LLIEHGKSIDTPVALVHLGTTTSQKTIDGTLGNIVEKASEIKNPAMIIIGDVVQMRQKIS
WFKEQTTDLEMTLP
>SEQF2892_02253 Sulfite reductase [NADPH] hemoprotein beta-component
MAKTNKQMSEELDKKLDALEYLKDESNYLRGTIEQGLADPLTGAISDDDTKLLKFHGSYQ
QDDRDLRDERRKQKLEPAYSFMIRVRLPGGTATPEQWIAMDDISNNYANQTLKLTTRQTF
QFHGILKRNLKTSMKKINESVLDTIAACGDVNRNTMCNPNPYQSHIHKEINDYATKISDH
LLPKTNAYHEIWLDGEKVLDSSEEIEPMYGKKYLPRKFKIGIALPPSNDIDVYSQDIGLI
GIVEDETLVGFNVTVGGGMGMTHGNTDTYPQVGRLAGFVPKEQVVDVCEKILTIQRDYGN
RENRKNARFKYTVDRLGVDKVVEELNTRLGWEIEEARDFEFEHNGDRLGWIEGDEGVWNY
TLFIQNGRVKDTEDYQLKTALRKIAETHTGDFRLSPNQNLIIANVTPEKKEEIQNLIDQY
GLTDGKNYTGLRRNSMACVAFPTCGLAMAESERYLPSLISKIEDLLDEAGVNDEEITIRM
TGCPNGCARPALAEIAFIGKAPGKYNMYLGGGFKGERLNKLYKENIGEQEILESLRPILM
DYGKERLEGEHFGDFVIRSGVVAKVHGGQDFHS
>SEQF2892_02254 Sulfite reductase [NADPH] flavoprotein alpha-component
MNLSVTNSPFTEGQAAQINELIQTLTPEQKVWLSGYLVANQQLTSNGTVPSQTGSSSTNA
NGLTEGTEAMLQQNEPVITPEKRAITLLYGSETGNAQGLAEIFEERLSNIGHNVTLKAMD
DFKPKNLKNVEDLFIITSTQGEGDPPDNAAELHEFIHGRKAPKLEGVRFSVLALGDQTYE
YFCQTGRDFDRKLDELGAERIYDRVDCDVDYEEDAEKWMANVINAIDTAPEGTQNEQIVS
ESIKSAKEKKFSKANPYQAEVLENINLNGQGSNKETRHIEFLLDNFGEDYEVGDCLVVLP
QNDPALVDLLISTLGWDPNDQVQISDEGDTLGLEEALTTHFEITKLTKPLLINAASFFEN
EELNEKVEDNEWVQSYIEGRDLIDLLNDFATTELQPENLYQLLRKLPPREYSISSSYEAL
PDEVHITVGAVRYNSHGRDRSGVCSVQFAERIQPGDTVPIYLKRNPNFKFPKEGDTPVIM
IGPGTGVAPFRAYMQEREEHGFKGNTWLFFGDQHFTTDFLYQTEWQEWLKDGVLGKMDVA
FSRDTDEKVYVQHRIAEHSKEFNEWLQKGASIYICGDEKHMAKDVHQAIRNVLVKEQNLS
EEDAEAYLKQMKKDKRYQRDVY
>SEQF2892_02255 Phosphoadenosine phosphosulfate reductase
MSVPTITYENFEGDPFIDSISTDDATKGAYEILEWAYRTYGDSIVYSCSFGAESMVLIDL
IYQIKPDAQIVFLDTDLHFQETYDLIDRVKEHFPKLRIEMKKPDLTLEEQADKYNPALWK
NNPNQCCYIRKIKPLEEVLGGAVAWVSGLRRDQSPTRANTNFINKDERFKSVKVCPLIYW
TEDEVWDYIKKHDLPYNALHDQHYPSIGCIPCTAPVFDSEDSRAGRWSNFDKTECGLHVA
DKP
>SEQF2892_02256 hypothetical protein
MNFCPRCGNKITKEQRFCSKCGNDLRIFEGDSIESQYEVAERKTSIWPFKLVGLVVIGII
VSCCFAYYHFFLKEEEQPKQTATTTTHVKKDKDTTEEGKVSNDPIKAEKQKSKQSEDEKD
KDATHSQAPKIDVMSEDFHKSFMQKDTRDSYMGIKPGMTRAEVEKRYGSSNRVFHKTGMD
YLYTIYGNLAVAYELKGNKEVVREIGVAPLNVDEQTFIDKYSDYDKNNDAGSYTYNTVKN
NGFEILVTTKNGKIALIQCIPENHY
>SEQF2892_02257 hypothetical protein
MNEAKTIGLVVAPGVTEKLAESLIDDIPNILSHQNNNQHDWEVDLVVDPLTGYAESVGKI
FKKIQDYHDKRQWDYVVAITDLPMFHNERVLALDINKKNGAAVFSYPAFGWRPVKKRFKN
AIVAIINEVHHSEAEKNDYDDNDNVTYAVNKQFPLSKIEKTEVYLDETGNDHLRYLSNTR
SMGMVRLVSGMTFANNPLNMMASLSNIVAIAFTTGAFGLIFTTMWQMSMEFSMWRLFGIS
IIAVLGMLLWIMMSHDLWESVKQSRNKRITWLYNLTTVMTLFVAIIIYYIILYTLFLIAE
LVLLPSDFLGQQVGLKGPAGIDLYLSIPWFAASISTVAGAIGAGLLNDQLIKESTYGYRQ
QMRYDDRDKGEE
>SEQF2892_02258 hypothetical protein
MTYTIGLVPSPGVAHKLVDNAIPKIQQHLHERISDVDKWHFESKVDLLIGSAEDVHESID
KAAELKEEYDWDFVICITDLPSISGNKVVISDFNSEKQVSMLSLPALGWINLERKLVKSM
TALVEQLYHNNTKERPKVHPLIKPKAVDPREDESSKRRYINRYFILGWLQLILGLTRANE
PWKNLFNFKKIISVAFATGTYVSIFSMPWELSVQYSTLRFIVLMIISILGMAGWLLYAHQ
LFEEKTAKSQRVYRYVYNATTLLTLVIITLMNYVVLYLLLSISISLFVPVSLFNSWTSAN
PDFTFINYLKLLWFVSSLGLLAGAMGSTVENEEKIRRITYSYRQYHRYKEAQQEEKEKKE
QQSQDVSQHDVEQSSSNKESNDEQYEGKKQDHREEDES
>SEQF2892_02260 hypothetical protein
MANQTNDYTSHHTQNNKIKRTVERILTWLGVVLQALAAIMFLVLKPLMGNSNFKDQMISE
SQKQGNSVSTSELNQGIDVLGSFFSFLTWGAVISLILAIIGGILISKKPKIAGILLIIAG
LIALMSNWISVILWIVAGIMLLVRKGKKKDSYANGYYDNNNHNNSRNHDHDNNRHDDQND
DRRDHDRDNRHDDRYNDRHNNEFNDNRHNHNAHREHDRDNDYNNRRDNHHDDKDVNAQNN
AFILDEEDKAKEQRDIKEHYSNDDVHNGSHDLSNHNDNNRYDNKRDRSNLERNDYQESNR
RDDLHRSDEDFNRRNDVDWSSDDRKDNNFNQNQVHNHNHDNEERSQFGSRSDRYQDEANK
DLNDFDKDRHDHKDNDFVRDEADKLKDKKDNDPYKY
>SEQF2892_02261 Bacitracin export permease protein BceB
MTIHMLWKMIAQNFKMQRHVIMPFILALSIMFATEFVLLSLNMNDYVQKRSQLLPIFIDA
GNFFMSVLGFIFILYANRFMMKRRQQELAMNMILGMEKKHFRMIMLIEMVYQYVLIALIS
ITGGYLFGVLIFMLMNKLMHQTGMSLLDYPFNVKAMCITLIILAAVMLFLFLINNLKILF
QSPIKLIHQRQRAERKLPKFVLYALLVIGIVTLFSSYHIALSNQMVLRSLYDLFGAIGLV
MIGTYCLYLSLGVLLLDWLKRIPKMYYNPKYFFTISGLQSRMNSNAIGLASITMLCTFLI
VTVGMTISTYRGISDQVDSIMSDQYRVSIDGNLHNNKKTQEKVRRLERDIKDHAKVDFFK
KNAVSLIAVDYKQPGLFKHRNNKDYNMTINSAYLVIMTQHDYNELNTKKVKLKHEELGFE
SLNQPFKKLSKATMMGNQFNIKQLNGHNYSYPVPGALTVVTPDDKTFQQLTNYYVNADKN
DRHGTQKVQNTFMHFNIMTKHTTDFDKVKNQLIQRYKVNIDDKKEVAGTLYEINGGLIFI
GTVVSIILFIGTFLMMYYKNVAEGYEDRKNYQIMQHVGIDNDRIKDTINKQIIWIFALPI
IVATIHVIFASKIIFNVLGILNVNHVGVFVTSYVGVIISVVVIYALMYWVTSRIYYMIVN
RYH
>SEQF2892_02262 ABC transporter ATP-binding protein YxdL
MLLDVKNVKKTFGRGLNATIALNGISFTVDKGEFVAIMGESGSGKSTLLNLIATFDKVSE
GNITINNQDIRKLRNKQIAHFRRDNLGFVFQDFNVLPTMTNQDNILMPLVLANRSHKVME
QRMNTLSSKLGIEKLLSKYPYQVSGGEQQRIAIGRALINEPDLLLADEPTGALDSKTSKQ
IMTLFREINDNTQTILMVTHSSIDASYAKRVLFIKDGRLYHEIYRGEESQHDFQKRIADS
LAILNESGD
>SEQF2892_02263 Sensor histidine kinase GraS
MLKAFIKSILNEIIIIITFILLFLLIFFLFNLPLSAFLLGAGIMLFIMIIYWLVQLSGFK
EQVQMADTIHELEHELQQVKSDQTEYQANVENYFLTWVHQMKTPITASKLLLERNEDNVV
NRVRQEIIQIDNYTSLALSYLKLMNQETDMSFSKVKINDLVRPLIMKYSIQFIDQKTKIH
YERCEDEVLTDAQWCSIMIEQILNNALKYARGKDIWITFDQQQHVLTIRDNGVGISQADL
PKIFDKGYSGYNGRLNANSSGIGLFIVKYISQHLHHLVDVQSELNKGTAFSIYFPKNN
>SEQF2892_02264 Response regulator protein GraR
MKVFIVEDDFVIAESLEQELSKWNYEVIVAKQFDNIIDVFNANQPQLVLLDINLPTFNGY
HWCQEIRKTSNVPIMFISSRTDNMDQIMAIQMGGDDFIEKPFNLSLTVTKIQALLRRTYD
LAVSNNEITVKDCKLVVDEATLYHQDESVQLSFTELQILNMLFRNEGKYVSRTALIEKCW
ESENFIDDNTLAVNMTRLRKKLQSIGVVDLIETKKNVGYKVS
>SEQF2892_02265 hypothetical protein
MIFVMLSPLLIIGFIALSIMEERKRKKKTEQKEAEFEKEKNKVSNPEYDDDHKA
>SEQF2892_02266 hypothetical protein
METLKELFEQLDYWEQYSPKSYGGSMLRVAKIGDVKTQIYDSISIEDIRTYILNKK
>SEQF2892_02268 Alkaline phosphatase 3
MSFINKFGKTTVASSILAASVLGTTHVSFASGSGEGNQGQQGQNEDYMAIGNTKNPKNVI
FMVGDGMGPAYNSAYRYYTDNPNTKELDQTAFDKYLKGTNRTNPNDPKENVTDSAAGGTA
FATGHKTYNGAISVDNNKKPLKSVLEKAKELGKSTGIVTTAEVTDATPAVYAAHVDDRDK
KDEIAQQFYNDKINGQHKADVILGGGSKYFGKENGNLTDKFQKDGYDYVTNKDELANSQS
DQVLGLFSEKDMPLQIDAPQSNPLLVDMENSALSKLEKNDKGFFLMVEGASIDKSGHPND
ITGVMSEMGGFEKAFQNAIDYSNKHKDTLVVATADHSTGGLSIAKGKDYVWNPEAIHKMK
HSGSYMTKQIADGKDPEKVINDGYGFEFPSKQMDKVKDAAKELKEAQDKAKIEDDEKVAA
ATTKLQDAIQKPINDESHTGWTTYGHTGEDVNTYAHGPGENKFAGNNDNTDSAKNIFDFF
NNDVTSNQNQQ
>SEQF2892_02270 Transcriptional regulator LytR
MKKKKSTIFKVLLTIIIIVVILAIIAGVYLFSKIHSLSDSITNPLDRDKSELRDKPAKEG
DPMTVVLYGIDDDAQREQQGMGQRSDSIVLMSINPKDKKTVMVSVPRDTRAKIVGKGTTE
KINHAYAYGGPKMAVNSLEKLMDVPVDHYISIDMDGVKTVVDELGGVTITSNGSFITKDS
TNTYQFTKGEQYKMDGKEALAYMRSRKEDGAGGDEGRQLRQQQVITAVAREAFSVNSVTK
LNGIFKAAQDNLKTDLSFIQLNRFKSDYDKAQDNVERLTINGQNALGDDNLYYFYPDKNS
LKEVKEKLKENLNLN
>SEQF2892_02271 UDP-N-acetylglucosamine 2-epimerase
MKKIMTIFGTRPEAIKMAPLVKELEKNENLKPVVVITAQHREMLDSVLKIFDVKPDHDLN
IMKANQTLAELTSRITTKLDEVIKEENPDMVLVHGDTTSTFVGGLTAFYNQTPIGHVEAG
LRTWNKYSPFPEEMNRVMVGNMADLNFAPTDKAAENLKNENKDEESIVVTGNTAIDAMKT
TIKSDYQSEILEKHGDKKIILLTAHRRENIGQPMHNIFKAVKQLVDEYEDVVVVYPMHKN
PKVREIASQYLKNNPRIELIEPLDVIDFHNFANESHLILTDSGGVQEEAPSLGKPVLVLR
DTTERPEGVEAGTLKVVGTTNESVYKEAKALIDDENEYLKMSKASNPYGDGEASRRICEN
IEYYFGIRSDKPESFKYDQ
>SEQF2892_02272 UDP-N-acetyl-D-mannosamine dehydrogenase
MKLTVVGLGYIGLPTSIMFAKHGVDVLGVDINQKTIDSLQSGKVNIEEPGLQEVFEEVLE
AGKLKVSTQPAEADAFIISVPTPNNDDEYESCDISIVLSAVNSVLPHLKKGDTIIVESTI
APRTMDDHVKPLIEEKGFTIGEDVYLVHCPERVLPGKILEELVYNNRIIGGVTPNCVEAG
KRVYSTFVQGEMIETNARTAEMSKLMENTYRDLNIALANEITKISNNLDVNVLDVIEMAN
KHPRVNIHSPGPGVGGHCLAVDPYFIIAKDPEHSPLIQTGRKVNRSMPEYVVENVKRILS
DVEDAKVSVFGLTYKGDVDDIRESPAFDIYKLLQEESLEVTAYDPHVELDFVEKDIKNAT
ENASLVLILSDHSEFKSFKDSDFVNMKNKIIFDTKNVVKSSFDEVSYFNYGNLYETRNIK
LNK
>SEQF2892_02273 N-acetyl-alpha-D-glucosaminyl-diphospho-ditrans,octacis-undecaprenol 4-epimerase
MNKKILITGTSGYVGSHLAESLERSGNIVQRLSVRNSLWKNQSFSNIDTLIHTAALVHNN
DPSAKLEDYFKINTHLPIELAKKAKKDGVHQFIFMSTMAVYGKDGDLGQVEKITNPSEIH
PVTNYGISKVKAEEQLFEMNDERFKVVIVRPPMIYGKDSPGNFSKLKKVAEILPVIPKIN
NMRSALYIEHLDGYINLLIDKESNGIYHPKDSFNFDTTEVITEIRNAQNKKTILIPIPKF
TYPLLNRVKVISKLYGNLIYGNDLYLHEEKIENEEQNFKTIINDIMNQN
>SEQF2892_02274 putative sugar transferase EpsL
MKRAFDIFCAIYGLIVAGPFLLIVSLLIRLESPGPAIFKQKRPTLNNKLFNIYKFRSMKI
DSPNVATDLMDPADFITKTGKFIRKTSIDELPQLVNVLKGDMSIVGPRPALYNQYELIEK
RTKANVHTIRPGVTGLAQVMGRDNNTDDQKVMYDKYYLENQSFKLDMYIIYKTVINTISS
EGVSH
>SEQF2892_02275 hypothetical protein
MKKKKLLILCQYFYPEYVSSATLPTQMAEDLVNKGMKVDVISGWPNEYSKERKVQKQVNY
KGINIRRLKYSKFNNKSKIGRIFNFFSLFVMFILQMPKMLKYDHILVYSNPPILPLIPDV
LHRVFKKDYSFVVYDIAPDNALKTGATNPGSLIDRLMKFINKRVYRSAKNVIVLGTEMKN
YLLQNKISGNPGNIHVIPNWYTESADDQVHNPEFRKLREQYDKILLYSGNMGQLQDMETI
IDFLKLNKENNNTLTILCGHGKKYQHVKQTIEGNNIPNVKIYEFLTGTDYTDVLKIADAC
FASLVEEGVGLGVPSKNYGYLANKKPLVLIMDKQSDIVKHVEEYNAGIQINNGAAIDIQN
FIDHHSKEDLQNMGQNAYQLFKDKYTREHNTKKYYELLNGGH
>SEQF2892_02276 hypothetical protein
MSKKLFVIDTIKTIFSSLIIALGLQFIAYPFIHRGMGDNNFGEILTVYTILTITSVVLGN
TLNNIRLINVDHYSSNNYFSRFYRTLIVSIAIETIALFILLFVYFNLSILDIFVLLFVNI
LMCLRIYLNVFFRMKLEYNKILYVAIVQFIGMMLGLMMFSVTHYWIIVFLISELFAVVYT
LYELRNLNRAEANSKAKPIVKDFVMLLGTNGLNNINLYLDRLILLPLIGGRAVTLAFLST
FVGKMLATFMYPVNNVLLSYISVNSSWNKLKQYISVNVYSILALIAVMIVSYPLTIFIVS
WLYQTDPKDFKNLILIGNLGVLINAVSIMIQTLNTKHISISKQANYITIHTIIYILISML
VTKYYGLVGFFWATLLANLLKYVVLNLLGICMIKKQKN
>SEQF2892_02277 hypothetical protein
MKYFMLCAIISMNLFIVVSTLFKETFKLPIDSLYYPIMVLIAALTILYAIFNVFKTKKMP
IGFALLVFLVLLIFVAYFISPHNNEKLSENNLKFFLLWSVSAAICGVYIKYLSKQTVEKF
FKWIFIVFSITFLLVILLPYLFGSLPGYINFGLMNYQNASYLSAFTSGLGIYIILRVKVK
YRFFYIVMTFLTLPSVFIPGGRGGAILLILYFMLALVILTFKREIPAIIKILVYFVAFVA
AVSLIIYVFKSGGDSRTFSYIKGGSFDVGGTSGRGPIYEMSMYFISRQPIFGYGPFNYYY
LIHNIPHNIILEMLLSFGFVGLIIILFALVLMAINFIKNYDSKSIDLLVIFIAIYPITLL
MFSSNYLVTSEFWFVLFYFLTKGRKNYV
>SEQF2892_02278 Alpha-D-kanosaminyltransferase
MKILNIVSSNIVQDPRILKQMETIKNITNTHLMLGMNNKNVTKERLEKLDFQYKLLGERN
ENRSILSKLLKRINFARGVIRQIKRYKPDVIHANDFDALLMVYLSGYKKANIIFDAHEIY
AKNAFINKYSIISKIVEIMEKHIIDKRVNSFITVSHAAKSYYLEKGYKKTPYVITNAPIL
DESIKLSNDKLANEVVYQGQIVADRGYEEFVKASKIQDDKKVSYIVRGFGPLENDLKDLI
KSIDANVRIDEPVEVTELVKKLSESDIGVVLTKPVSINFEYTVSNKIFECIHAGLPVILS
PVKEHHFLNDKYNFGIVIDEVTSKNIADAVNKLADNKKLYDELRENAIKASKILNWQNES
QKLVELYKQTV
>SEQF2892_02279 Streptogramin A acetyltransferase
MIKQLTGLLKSSSSKEKNVRVNKLAYIKNSTFKGNNYVDRFCKIRNSTIGEYSYIGFSSD
FNNVEIGNYCSISSDVKIGLGKHPVDHFSSSPVFYSNNNPFGIREAYSSFDENPKKTLIG
HDVWVGANVIIMDGVEIGTGAIIAAGAVVTKNVSPYEIVGGVPAKTIKKRFDETTISQLL
SSKWWEMSPKALKSKNFSLNNLKASKE
>SEQF2892_02280 UDP-2,3-diacetamido-2,3-dideoxy-D-glucuronate 2-epimerase
MEKLKLMTIVGTRPEIIRLSATIKACDKYFNQVLVHTGQNYDYTLNQVFFEDLELREPDH
YLEAVGNHLGETMGNILAKSYEVLAEEQPDALLILGDTNSCLAAVSAKRLKIPVFHMEAG
NRCFDQNVPEEINRKIVDHVSDVNLPYTEHSRRYLLDEGFQKQNIFVTGSPMKEVLDEYA
YKIDESNILEKLELKPQNYILVSAHREENIDNEKNFLSLMNAINDIAEKYQIPVIYSTHP
RSWKKIEERNFKFHPLVKQLKPFGFFDYNALQKNAFVVLSDSGTLSEESSILKFPGVLIR
TSTERPEVLDKGTVIVGGISYDNLVQSVELAKSMQENDEPMIDAIDYKDTNVSTKVVKII
QSYKDIINRNTWRKS
>SEQF2892_02281 UDP-2-acetamido-2,6-beta-L-arabino-hexul-4-ose reductase
MKIVITGSNGFVGKNLKEDLKATTDNEILEVNRQTTTEDMKKYLLEADSVVHLAGINRPK
NEEEFKEGNVEFLSEVLNILKDNTKKPTIILSSSIQAENDNPYGNSKREGEAVLEQFAKD
NGNQVLIYRLPNLFGKWCKPNYNSVIATFCHKIARNEEIQVNDENVVLHLNYIDDVIKEF
KNAIDGHPNIEEGEPKVPNVYEKKLGTIAKLLYQFNEIPNDKSLPNIEDPFEHALHSTYL
SYLPEESFSYPLKMNIDNRGSFTEIFKTKDRGQVSVNISKPGIVKGNHWHHTKNEKFLVV
SGTGVIRFRKVGQDEVIEYHVSGEKLEVVDIPVGYTHNIENLGDTDMVTIMWVNEIFDSN
NPDTYFLEV
>SEQF2892_02282 UDP-glucose 4-epimerase
MFKDKVLLITGGTGSFGNAVMERFLDTDIKEIRVFSRDEKKQDDMRKKYNNPKLKFYIGD
VRDSHSVETAMREVDYVFHAAALKQVPSCEFFPMEAVKTNVIGTENVLQNAIRNNVKKVI
CLSTDKAAYPINAMGISKSMMEKVFVAKSRNVDSDQTLICGTRYGNVMASRGSVIPLFID
KIKAGEPLTVTDPNMTRFLMSLEEAVELVVHAFKHAQTGDIMVQKAPSSKVGDLAEALLQ
LFEADNEIKIIGTRHGEKQAETLLTREEYAQCEDMGDYFRVPADSRDLNYSNYYDDGNEK
ITEAYEYNSDNTNILTVDEIKEKLLTLEYVRTELSNFKQG
>SEQF2892_02283 UDP-N-acetyl-alpha-D-glucosamine C6 dehydratase
MDNLSARKRLLILILIDSLIVAFSVFICYTILEPFFEGYSHKLLILNSVVLLISHHVFAY
IFNLYHRAWEYASVNELLLIVESVTCSIIATMILVPIFTAHPPFFRLYLITWMMHLILIG
GSRISWRVGRGFVVGKKKKKKPTLIVGAGRGGSLLIRQMLRSPEMGLEPVLAVDDDIQKR
KLTIAEGVKVQGTIDDIPNLVNKYRIKRIIIAIPTLKPDRLKEINNICNSTGIELFKMPS
IEQVLAGELEVNQLKRVEVEDLLGRDPVELDMAMISKELTHKTIMVTGAGGSIGSEICRQ
VCKFEPERIILLGHGENSIYLIHQELNAIYKDKIEIIPIIADVQNGERIQEIMDEYKPYA
VYHAAAHKHVPLMEYNPIEAFRNNVLGTRNVATAAKNAEVRKFVMVSTDKAVNPPNVMGA
SKRVAEMVVQSLNDENSQTDFVAVRFGNVLGSRGSVIPLFKKQIEAGGPVTVTHPDMTRY
FMTIPEASRLVLQAGALAQGGEVFVLDMGEPVKIVDLARNLIRLSGKTEDEIQIKFSGIR
PGEKMYEELLNENEIHPEQVYEKIYRGKVKDFSKEEVDAIIEDLGKEFNKEKILKIANE
>SEQF2892_02284 Tyrosine-protein phosphatase YwqE
MIDIHNHILIGVDDGPKSKQDMLNLLRQGKDEGVKEVIVTPHHLSPQFDNEYIKVREKLQ
QLLDLDEVKELGIKLYPGQEIRISDQIIPQLEKGEAIGLNHSKYLLIELPSGGVPHYTNR
LFFELQSKGYVPIIAHPERNKEISQNLDVLFKLINEGALSQLTSASLLGKHGKKIQKISL
QMIENNLVHFIASDAHHETQRPFIMESLYKDRKLKKYEKSIKILVNNANYIVKNEDISKK
QPTQYYNDKKLFGLF
>SEQF2892_02285 Putative tyrosine-protein kinase YveL
MAKNKKEERKKLNHPLYVHDKPKSVASERFRGIRSNIMFSGVEETRSIIVTSEKPAAGKS
IISANIAITYAQAGYKTLIIDGDMRKPTQQYVFETSNYDGLSNLIIGKSDLDKAIRSTRV
ENLSLLTSGPVPPNPSELISSDRFLKLLDSLFELFDFILIDTPPVNTVTDAQVFLQYVPD
CVMVIDSENNNKDEIKKAKSLIEKAEGHILGAVLNKTAKDKSSSYYYYGDDE
>SEQF2892_02286 Capsular polysaccharide type 8 biosynthesis protein cap8A
MENSLDLSKISKLLKKNWWLLVLLPLIFLLITLVITFFLMKPQYQANTQVLVNQKEKNPE
MMAQEVQGNIQLVNTYSEIIKSPRILDEVSKKDKKFSVEEIEDMMTVTNKDQSQILDIDV
KSGNKKDAERVANEVADVFKERMPKIMKVDNVSILSRANGTSTQVSPKIFLNIAVAILLG
LFLAIIILILKALFDKRMKTEEDVERELDIPVLGSIPKLK
>SEQF2892_02287 hypothetical protein
MKGLLITVVLGVAAYVGFKKYQNKVNEMPNIEY
>SEQF2892_02288 FMN-dependent NADH-azoreductase
MAKLLYITAHPLDELASNSMAAGKAFIVSYKENHASDEVKHIDLFKEDIPVIDKDVLTGW
GKLRNGDDLTKEEQQKVDRFSEILEEFLSADKYVFVSPMWNLSFPPVLKAYIDAISIAGK
TFKYTAEGPQGLLTDKKVLHIQSRGGFYSEGPAADVESGDRYLRTIMTFLGVPSYENVII
EGHNAEPERTEEIKAASITEAQEMGKNF
>SEQF2892_02289 Transcriptional regulator SlyA
MDSNKNDYEHMLFYFAYKTFIKTADEIIEKYDMSRQHHRFLFFINKLPGITIKQLLKTLE
ISKQGSHATLRKLKEEGLIVEQTSEEDRRVKQLFPTPKGSKLVDKLNKAQDELMQSTFQK
VGHDWYDIMEELSNYREGFQDIQHLKDEK
>SEQF2892_02290 Indole-3-pyruvate decarboxylase
MKQRVGQYLMDAVHHAGVDKIFGVPGDFNLAFLDDIVRHEGVEWVGTTNELNGSYAADGY
ARINGLGVLVTTFGVGELSAVNGIAGSYAERVPVIAITGAPTQAVEQAGKYVHHSLGEGR
FDSYQKMFEHITTAQAYITAENATTEIPRVINAAIHERRPVHIHLPIDVAMTEIEVDSEY
DVAPIPDVNVDRYINMVADKLRSASQPVIITGHEINSFHLHKALEQFVNQTHIPVAQLSL
GKGAFNEENPYYIGIYDGKIAEDQIKDYVDNSDAILNIGAKLTDSATAGFSYEFDIDDVV
MLNHHNFKLNETVAEDVTLPSLIDGLNTIDYRYEGSFPTFEKGSSKEVALSNDILTQSTY
FDMMQQFIKEDDVLLAEQGTSFFGAYDLALPKDMTFIGQPLWGSIGYTLPATLGTQMADP
NRRNILLIGDGSLQLTVQELSTMIRQDIKPIIFVINNDGYTVERLIHGMEETYNDIRMWD
YKALPKVFGGDNVVVHDVKTSNDLQNVFDAINAAPEQLHFTEVTMKWDDAPAKLRDISKA
FAAQNK
>SEQF2892_02291 Capsule biosynthesis protein CapA
MIKYYVSCLVLFFTFAILCGMALAEDVTDEASVVAVGDNLIHPVVYNDALQQDGSFNFKP
MYLHIKNDIQSPDLAFINQESPLGGDDRPFSGFKNFNTPSQIAQDVVETGFDMVNGANNH
SLDQGDEGVLNHLKTWNKFDKQVLFTGIFNSEKDAQTIPVMTVNGIKVSLLSYTYGTNEM
TSQYPYTIKTFDEATIKQDIQKAKQQSDVVIVSAHWGNENHHTPNKTQKKYAQLFADEGV
DVVIGTHPHVIQPVKWVKSKRDNHQTLVAYSLGNFLNGQNTGDEHNQLLGRLNFDIVKAP
KGAHIENVKWTSMVNHYQQWDPTNKDTRHDFEVYNLDDYNEDLAQDHGLRNDKKSQWDIK
HLQDITKDVIDSEYLDEKSI
>SEQF2892_02292 hypothetical protein
MILLPLSIIMGCVGYIFKCHPPTERNGWYGYRTKKSMANDRNWIKAQKQYGIYSLKYLWV
LLLFGIIGLVIEIVGIMRSTDAIIMTGLGIEFVVMVWYMLIVYLKVEKTL
>SEQF2892_02293 Putative alcohol dehydrogenase D
MKTRAAVLYEMEASQPYKESKPLKIESLELEDPHEHEVLLKIHAAGLCHSDLSVINGSRP
RPLPMALGHEATGEVLKVGSSVTRVKEGDHVVCTFIPSCGKCIPCKEGRPALCENGAKAN
EKGEMLEGGIRLSNEDGQVYHHLGVSGFAEHAVVSENSIVKISNEIPFERAAVFGCAVIT
GIGAVMNTAQIRPGSNVAVVGLGGIGLNAIIGAKLAGANEIIALDINEDKFDLAKQFGAT
ATFNSSDDDIDEQIKEYVPGGVEYAFETAGVVPAMQVAYRITKRGGTTVTTGLPHPKDEF
SFPQVTLAAEERTVKGSYVGSCVPDRDIPRFVSLYKQGRLNIDPLISEVITLDDINEGFD
KLASGDVGRIIVKMH
>SEQF2892_02294 N-acyl homoserine lactonase AiiB
MVNVKKQRMKIYVLDNGRMKMDKNLMIANSNQATMDNPNQPNEMHEFPIYTVFIDHPEAK
ILFDTACNPNAMGDNGRWITATQKAFPYFADEACHLTKRLEQIGIDLKDVDIVVASHLHL
DHAGCLEYFTNATVIVHNDELNGTMQSYARNQKEGAYIWADIDAWIKNDLTWKTMKRDED
YLKLVDGVKVLNFGSGHAWGMIGLEIETEELGTIILASDAIYTKESMEPTLKPPGILYDS
VGWTNSVEKIKKLAAEKNAQIWFGHDGEQFAKFRKSTDGYYE
>SEQF2892_02295 Catabolite control protein A
MATIKDVAQRAGLSISTVSRYLNHHPYISENKKIKIQQAMDELDYVPNSVAMQLRSNKSY
TIGIIVPRITNPYFAYLIDAIDKEIKGTPYHTLIMQTYNDKEEELRLLNMFKQRHIAGVI
MDALENDIEVLETYTKYGPIILSADQSMQSDKVKIIHTNQRQTTYDAIQYLINKGYRNIA
YCTDNNYYDHCFNKPRNVGFRVAMKDNGLDIRNEWIFNNVHTIEDGEQIGKILLRQEQLP
DAIFTGSDEVALGLMDFMTAHQIDIPNQIAIMGYDNQPISSFLKIPLSTVNQPVNDIGKQ
LINYLLALLEETEFKIKDDVLKLNIVERQST
>SEQF2892_02296 hypothetical protein
MALMTINYLSPSLGMQQSFVAIIPEDGSFFDETQSPKSYKSLMLLHGLSSDATSYTRFTS
VERYADEHQLAIIMPNADHSGYANMTYGHSYYDHILEVYHYAHKLLPLSPKREDNFIAGH
SMGGYGTMKFALTQGRLFSKASPLSAVFQAQGLMQLDYPDFAPKAITGEDTNIKDTELDT
YYLVDEAVEKGLTIPKLLIQCGTEDFLYEDNQQFMTYLDDKGIDYQYEEGPGEHDYAFWD
KAIKRTIEWLVEE
>SEQF2892_02297 HTH-type transcriptional regulator ArcR
MAGKTYINNRDNDLSEGLKQLASYLNIPTGVIQAFKSECFVRRYNKGQIIYYSSDQPTYV
YLLLDGIVLRETINEDGDAYRKLNKEQLLFPLNHLFRKIELNEMCTAITPCNVIGIPKDM
LEYLCKNHDDIFVTLFEKLNNELELLMEYNMALTTKLARERIEKVLYYLCHAIAYDHDEF
YEIKHIMTIQLLSDLAGISRETTGHIVHELKEEKKLIKNGKNWMIIK
>SEQF2892_02298 Arginine/ornithine antiporter
MNESDTNKLGKTSLIGLVIGSMIGGGAFNIISDMGGQAGGLAIMIGWIITAIGMISLAFV
FQNLTNVRPDLEGGIYSYAQAGFGDFIGFSSAWGYWFAAFLGNVAYATLLMSAVGNFFPI
FKGGNTLPSIIVASFLLWGVHFLILRGVETAAFINSIVTVAKLIPIFLVIICMIVVFNFD
TFKAGFYGMTSGGTGIFSWGDTMSQVKSTMLVTVWVFTGIEGAVVFSGRAKSKKDVGTAT
VIGLVSVLVIYFLMTVLAQGVIQQNQIADLASPSMAQVLEHIVGHWGSVLVNIGLIISVL
GAWLGWTLLAGELPFIVAKDGLFPKWFAKENKNKAPINALLITNILVQIFLVSMLFTDSA
YQFAFSLASSAILIPYMFSAFYQLKYTIEHKGHATVKQWAIGIIASIYAIWLVYAAGIDY
LLLTMLLYIPGLFVYRFVQRNNHKPLTKGDYILFAVIIILAIIGITRLAMGSVSVF
>SEQF2892_02299 Arginine deiminase
MTQGPIQVNSEIGRLKTVLLKRPGKELENLVPDHLSGLLFDDIPYLKVAQEEHDKFAQTL
RDEGVEVVYLEKLAAEAIADKDVREQFIDDILAESQKTVLGHEAEIKTFFATLSDQELID
KIMAGVRKEEIELKTTHLVEYMDDRYPFYLDPMPNLYFTRDPQASVGRGMTINRMYWRAR
RRESLFMTYILKYHPRFKDADVPVWLDRNSPFNIEGGDELILSKEALAIGISERTSAQAI
ERLARNIFKDESTTFKKVIAIEIPNSRTFMHLDTVFTMIDYDKFTVHSAIFKEENNMNLF
TIEYDEAKDDIKITHSNKLRETLADVLGVEKIEFIPTGNGDVIDGAREQWNDGSNTLCIR
PGVVVTYDRNYVSNQLLRDKGIKVLEITGSELVRGRGGPRCMSQPLFREEI
>SEQF2892_02300 Arginine repressor
MKKNKRLDLIATVVKNNRFNKKEEIADYIDTHFGVRYSVTTISRDLKELKIFKVPAVSNQ
SYYKKLDNTQQMDAKTKLLHYYDSEIKSIIIKDSYILIKTSPGFAQCINYFIDRMNINEI
LGTVGGNDTLMVLTNSEEMAKYVHYKLFNHKYSN
>SEQF2892_02301 Immunodominant staphylococcal antigen B
MRKTTKTLVTTTLAISTLFGVGVTSALTETSIAHAESKATTNTTHSKANATSAYYNYKGY
AGQDVSFVLDKHFKNAVKAENVTFNGIKLKATTSSKNVKKYDQYFRNVSKYGKTASLLDL
NVTGKMTLDQLNKNYGKDLQKVNNHKHNTTGIYFYQPNSKGMTVWFDVDNGKVDRVVMGY
STVKQAMKETK
>SEQF2892_02302 hypothetical protein
MIPNPNAPDEYKYETDYRKIPRQYLDANIPQGRGMVKWAPFATMPEQYQRLNDFIEEQNK
IAMPSLSDDQFENINRQLTYKFTQHQLAMISYWRNGYIQSIAAYIRRIDSLNRCITISNE
NGSQTMKLDFEVICNVE
>SEQF2892_02303 Immunodominant staphylococcal antigen B
MNKVVKTIASTTLAFGTLLGVSSAVLPVQDTAHAATQTKGYYYSYNGYVDKDAKFLTDKN
FINAIKHDNIKFNGIKLAKTNSTTVKEKYNQKFTGVTSNGKKANKLQFIVKGDLTYSQLK
KAYGKDLKKVKGNNNVKGSGIYVYKPNKDGLATSFVLNNNKVVEVDISYVGFTTSK
>SEQF2892_02304 hypothetical protein
MKKVLAGIVILLLVVALGFSIFFAATGTKHSNSSDDHKTEKHDKKEKKDKTKEEQTDEQS
TTSDNGENAQSESASNNTVNTQQSYSTQQNNSTTQTQQSKTKENSSRQNSSESATSEKNT
KETQTQQPSTQQPSTKKPSTTQPSTQNKTTTNSSSTQSSSSSGSSSDSKDKN
>SEQF2892_02305 ESX secretion system protein YueB
MKNALKLFITDLKRVAKTPAVWVILAGLAILPSFYAWFNLWAMWDPYSHTGHIKVAVVNE
DKGDKVRGKKINVGNTLEDNLKKNDKFDWQFVSREKADHEIKMGKYYAGIYIPKEFSHQI
TGTLRKKPQKADIEYKVNQKINAVAPKMTDTGSTVIVDEANKQFNETVTKALLQEANKVG
IQLEDEVPTINKIKNAVYAAHDSLPQINKIADRIEYLNDHQDDLDKYANQFRALGNYKGD
ILDAQQKLNDVNAAIPSLNEKAKLILALNEYMPNIEKLLDVASNDIPAQFPKINRGVDIA
SEGLDLANTRLNDAQGYLTSAQQRVGDYQEAAGRAQEVNNQANSALRQQSTSGLPQYQIQ
KLSTDNSQDTVNDNQIVSNNDVKSMNSALAEALLTLSSNSDNQAKATQSDIKALKDISYG
VIGSNRPTEFNDMLRNLKTRLENSSKSNQQLIDVLKELEKREHVDLSSQIKQVESANNRI
SDSLRSTNQLIDALKNGSSGKAEAVNVLRSLPDLNKALGNYRDFIKNDLNNRLLVVSNQI
TQELNKGQNTLSDVQSKLNTINRVIIAGQDIVTDGQNRIANIQSELPALEQTYINAMQTA
QKYFPTVKKDVANAADFVRNDLPDLEQQLANATATVNTNLPTLFNKYDNAVDLLNQNQPR
AKEALANVANFSENRLPDIEKDLNKANKIFKKLDEDDAVDKVIDALKNDLKKQADVVANP
IHKKQVDVFPVKDYGSGMTPFYTSLSIWVGALLLVSLLSVDNKHEALEDELTKRQIYLGK
GAFFIMMGIIQALIVTIGDLVILKAQVESPTLFILVALCGAIVFNTIVYTCVSLLGNPGK
AIAIILLVLQIAGGGGTFPVVTAPKFFQTISPYLPFTYVIDSLRETVGGIVPEILITKMI
ILILFGLGFFILGILVKPVLDPIMRKISKRVDESKVTE
>SEQF2892_02306 N-acetylmuramoyl-L-alanine amidase domain-containing protein
MSKHKFMIYFLTTTLVLPTFTISIAHAEDTNEDAKVKSSSTQEEQTEHNKDANDNNTNEA
SQPDDTQSDNTSSEAPTKEDSKNKIKREKSKSSDTSSEEKDDDNTSVSRSHQKRYKDTNS
TYRTPLSPIFDATHSSGLPASNFLNPDLYQNGFSLTHLIASLFNFDSDISDYEQPTSASE
TDDDTHSTNEQDSDAQDQDQTEHSASSSDTTDRDKNDIKQSSEQANQSDKTSQQDETDTN
QQSTANQDKDDASVSKALDAIDDFVSDETDDDKDNQGSNNTDDTDHQSNNDDTSTDSNND
SSKTSSSNSNSLSESALDTVLDKYSEDAKKTHQDFESSKKDNASDTSKDEKSKESTNKAS
NPQLPTKKELEHKTTPAQSFEDDFKQNNTRSTSLFQTLPQLNGSDVTDGDITVVENKGTR
DFIKSIAKDAHKIGQDKDLYASVMIAQAILESSSGNSTLAQAPNYNLFGIKGNYKGQSVY
FNTLEAGSDNSMFSINAGFRKYPSTKASLEDYADLIKNGIDGNPTIYKPTWKHEAIDYRD
ATRHLSRTYATDPNYATKLNSLIKHYHLTDFDKKKMPDLDRYAKQTSSGEDASGSEFKSF
EITDSSSPYPQGQCTWYVYERVQQFGKKVGSDWGDAHNWDNRAERDNYDVSQTPSTHSAV
VFEAGQAGAHDVYGHVAFVEKVNKDGSIVISESNVKGLGIVSYRTIDASTAEDLHYIEPK
>SEQF2892_02307 PTS system glucose-specific EIICBA component
MNKLFEKAQQFGKSFMLPIAILPAVGLLLGIGGTLSNPNTVKAYPFLDITLLQNIFTLMS
SAGNIVFQNLPVIFAIGVAIGLARSDKGTAGLAALIGFLIMNATMNGMLQITDDLAKTTE
LAQKGQSMVLGIQTIETGVFGGIVTGILTAYLHNKFNKIELPAYLGFFSGSRFVPIITAV
SSIFLGVIMFFVWPTVQSWIFNAGGLVEKTGAIGTFFFGFILRLLGPFGLHHIFYLPFWQ
TGLGGSLEVNGHMVRGTQNIFLAQLGDPSVTHYFSGISRYMSGRFITMMFGLCGAALAIY
HTAKPEHKKVVGGLMLSAALTSFLTGITEPLEFSFLFVAPVLYLIHAFLDGLAFMMADIF
NITVGQTFSGGFIDYILFGVLQGNSKTNYLWVIPIGIVWFCLYYIIFRFLIIKFNFKTPG
REDKEQIESVEATERADTIIKGLGGATNIEEVDCCATRLRVTLKDGSLLSKDTLMTTDAK
GVIIRGNGAQIVYGPHVTTIKNEVEEVLEQKS
>SEQF2892_02308 hypothetical protein
MTHTNEVTNSTSKGRKKRFSLKMPGAFTILFILTVIAVMATWMIPAGAYSKLSYDGGAHE
FKIVDAHNKSKTVPGTQEQLDKLGVKIDVDQFKSGAINKPISIPGTYERLEQKPAGPDQI
TSSMVNGTIEAVDVMVFILVLGGLIGVVQKSGSFESGLLALTKKTKGHEFLLVFMVSVLM
VLGGTLCGIEEEAVAFYPILVPIFIAMGYDSIICVGAIFLASSVGSTFSTVNPFSVVIAS
NAAGTTFVDGLYWRIVGLIVATIFTVSYLYWYAKKIKKDPKASYTYEDKTKFENQWSVIN
DDGGEKPFTLRKKIILILFILPFPIMVWGVMTQGWWFPIMASMFLAFTIVIMLMVALGKD
GLGEKVVVDAFVEGASSLVGVSLIIGLARGINMIMNDGLISDTILNFSSSLVQGVSGPIF
IVILLIIFFFLGFIIPSSSGLAVLAMPIFAPLADTVGIPRFVIVTAYQFGQYAMLFLAPT
GLIMATLQMLDMKYSHWLKFVWPVVAFVFIFGGGMLITQVLIYS
>SEQF2892_02309 hypothetical protein
MKKLRQHSKFNSYLKVSCSVLLMSGTLVGYGFTKDGFAQSNDRIDNVSSEMTSVQNKLDK
AIDKAKAKIDRLKYLQATDIKSYKEDIEDARNQSEIDQILRDAQEEDRISNEESTKETGE
KASTSNESSLSTAKQSSTNEENKLDELDKVIADLDSLSEKVDTHQQNGDMKSEQDSTNNN
ENSQISSGQSASSQNNKNQINDKNDDTSILDEMDNVKNDIESTKESAHSSVEDIRDQTDS
SIQDDNSTESQSKNNTNTASDKSILSGIKQIDKDEDSHKSNKIDSKEGHVDALTDELSAN
QKIDQAITKVENQQDNTSKRYSDHKLKQLRQLEQQVKQNSSLTNEQKKNVEKNIRNVRQN
VKANRDEISGRLEQSSNKQATVEQILGSVFSKNEAQKIAKQIKTNGQSDKQITDQMMKHI
DNLKTTTSDDILASMFDQAPDKEALIKTLLSTRLGNNEASQIAKQLAKENLSSSELVNQV
KQKINANQKITADDILKDVLDKSSDPKQTIETLLATKLNQTQAKALADLIARAQTDKADA
LDLVKNALNGTAGDLLQLQNKLDTAKNNLSYILDPITNRPSLFDRINGNASSSTPLNQGS
HLLDGLTGSSLLDGLNSGGSLLDNIEDIPNPVKGLSLGQLGDDDGFLSGLFDDEGNLSLP
NTGEVVKKSWLPVTVLLVIAGGTLIGLGRRKQQNTKH
>SEQF2892_02310 Serine/threonine-protein phosphatase 1
MKERILVVSDIHGHRKALVTLLKAVNFNVRKDQLVLMGDYVNNGPDSFGTLKLVKRLKRR
GALALAGNHEMRWLESKDKKIKRWHKFLRELSTIEVIDNYIFAHAGIDTSKPLNKQIKEY
TTGHYNHNLNRNIPKNKYLIHGHIPNYRYGLKNDELYKKKNILDIDTGAGHNKFLSLIDL
TNAYQYSVKVTDTKKINTKRIKL
>SEQF2892_02311 HTH-type transcriptional activator CmpR
MNTKQLLIFKHFVEAQNENAVAEKLGITQPTVTFHLKNLSKECGLPLYFKKGKHFNLTEA
GELLYRNANKMLNLIEETTDMMEDFKQSKRGTLRIGASHAPIYSILPSTFKNYMHEHPNI
DINLTVDTAPIIIEKVKNRKIDIAVIAEKGFNEGELQVKRLHENPLVLAMDKRHPLAQKD
HLTLEDISSYRFIIHNSGATRDSIDEWRNKNFINLDVHMETNSISSILTTIKDSNYLSLV
SENAISHHSSIISKTLPNAPTTSYISLIYRNDRHLTSIIQDFITLIYNTK
>SEQF2892_02312 hypothetical protein
MLVLSIILLLLGLILIGISRFVAYQRNIDLREKIYIPGVIFVLIGALLLLFYLMN
>SEQF2892_02313 Membrane protein YdfJ
MAKLLYKLGKFIAKNKWLSVIGWLVILGVIITPLMINSPKFDSDITMNGLKSLDTNDKIS
KEFHQDSEKASMKIVFHSNKNDGLNNKDTKKDIEDALDNIRQNDDYIQNISNPYDSGQVN
DEGDTAIANVSYVVPQTGLKDSSKHIIDKELKDITDNHNVQIEKTQGGAMNAEPGGTSEI
VGIVVAFVILLITFGSLIAAGMPIISAIIGLGSSVGIIALLTYIFDIPNFTLTLAVMIGL
AVGIDYSLFILFRFKELKKKGVDTVEAIATAVGTAGSAVIFAGLTVMIAVCGLSLVGIDF
LAVMGFASAISVLFAVLAALTLLPALISIFHKSIKIKDKPSKSKDPKDHPWAKFIVGKPV
IAVIVSLIILILAAIPVSGMRLGIPDDSLKPTNSSEYKAYKLISDNFGEGYNGQIVMLVN
TKDGGSKSTIERDLNNMRSDLEDIDNVDTVSKAQLTDNNNYALFTIIPEKGPNSQSTENL
VYDLRDYHSQAQEKYDYGTEISGQSVINIDMSEKLNNAIPVFAGVIVVLAFFLLMIVFRS
ILVPLKAVLGFILSLMATLGFTTLVIQHGFMGSLFGIENTGPLLAFLPVITIGLLFGLAI
DYELFLMTRVHEEYSKTGDNDHSIRVGIKESGPVIVAAALIMFSVFIAFVFQDDSAIKSM
GIALGFGVLFDAFVVRMTLIPALTKLFGKASWYLPKWLGAVLPNVDVEGKALEEDNHHDT
SSENGHANDRNNDYTRQDKDNHSYQNDNRKHNRNYNDEDYNRSVHLDNHHDQHHRQHHYD
NQRDDIDYESLYTQNGDHTHYDERNYNDRHYQDNYDRNNDYRHSNHVQHNDNHDDYHDSN
FDKTTNLYKELTDSNIDQDVLFKALMLYARENNKGVYDRYNRSSQHRHDDELRD
>SEQF2892_02314 Glycine betaine/carnitine transport binding protein GbuC
MLKRRSSKFLGLLATLALAIMLSACGNSGSGSGSSDDSQTSLGNKEIEIPYIASDNSTPR
SLVIAEVLKKAGYDVTTTPVTASGPLYAAVSENSDSFHASGIFPTTDKSYYDKFKSKLTI
YDDKHLIDNAKVGLAVPKYVQDVDSISDLKNSAFGKSVDWTIQGTDARNGVMQETKDELD
SDNLDKYSLKESSDQDQFKKIQSAFKQQEPIVFTAMEPSWFSKELDVKMLKDPDNIYGNN
NQHIDLVFNKDFKEAHPAAYTIATRMADDWSKSDEDKLAKKIFVDNKNPEQVAKDYVDDN
DNKVDEWLEGIETN
>SEQF2892_02315 hypothetical protein
MPSANQKRMIKHIHETVFILLHDYHFDEITVQKICDNAEINRSTFYRYFQDKYELLYTLP
DFITQQIIAKGDTSADITTPESFEDFIYYIGNNKKIFKHLLVSSRQADVFRSLTNVSREM
MLNNSTRKRDPLAQKIRESKHPEIVADFYSSGIIEVLRRWVENDYNYTVEEVFETLNNVL
ETSLYCYDK
>SEQF2892_02316 hypothetical protein
MISNALNLILMIVLIIFNMVNIGVWPLVILALLIVANSIFMVYKTVDAKKRK
>SEQF2892_02317 Multidrug resistance protein D
MSIQKTMNYNKITTIFFIAGIIVMSSLYTAIPLTAEFAKDFKIPQSIATLNGVAFSVTYS
VSCLFYGTISEKYGRIRTILFGICGLVMICMVMGFVHSFAILVVLRAIQGIFAAAFSPVS
ITYVTETYSPVKRMTAISFISTSFMLSGIIGQNLSEIIVGFSNWHMVYFTLTVLYIILAF
VIHRQIPESPVKNPDIQLLKFFNNFSDFKTNKAVLLCYGVSLTLLTMFISMYTVFNHYVT
SDTIGGDETTAINAKLFGIIGMLLSLIAGRISDLIGVKNLILSALVVSTVALILMSVTTN
IVLLIIWSVLFVSGIAFAIPSTISKVGLTVRGNQGFFLSVNTFVLFLGTAIAPILSIVLN
TISSFTVQFNIIAVIGIIAIMIALCMPRRKYELR
>SEQF2892_02318 Alkanal monooxygenase alpha chain
MLKIELGLTSFADNGDMVMPDGTQAAVSNAQRIRDIVEEIELADQLGLDIYGLGEHHRPD
YAVSDPVTVLAAAASRTEHIKLASAVTVLSSDDPVRVYQRYATLDAVSNGRAEIMIGRGS
FIESFSLFGYNLNDYEDLFNEKLQLLLKINEYEVVSWDGKLRPSFDPTGIYPRVEHGKLP
ISIATGGTSESSLRAGAFGLPITYAIIGGNPRRFTRNIEIYKSVAESYGHNPDELSVSVH
SWGYIAETDEDAKKEFFPSLKAHHDILGRERGWPSFDENMFEREVGSQGAIYLGSPETVA
QKIIETVETLGLNRFMIHTPVGSMPHEYVMKSIRLFGERVKPIVDKYFENK
>SEQF2892_02319 hypothetical protein
MILRYAANLKLAKELYSSAKPKLKGDQGMIDTFQNVFGLPESSVKLAGTVEAAAAAFYAA
SFLNKNLSRLGSIATFGVLGVAAYKHFEAGHGKEGAQHALDLLGLAALSFADTFDCDNK
>SEQF2892_02320 Quinone oxidoreductase 2
MTVLLTGATGHLGSHITEHAIKEQVPDFNIGIRNPDKMPSHWKDKVGVRELDYFNEESMV
RAFKGIDTVIFIPSIIHPSFKRLPEVENLVSAAHKAHVSHIMFIGYYADQHNNPFHMSPY
FGYAERLLASSGLKYTYVRMAMYMDPLKPYLPELADMQKLIYPAGEGRINYISRDDIARG
IVALLQQPDKFGHRYLLSGYSYSMTELAAILSEAAGSKIEYSPVSLEKFSEMYDEPKGFG
ALLASMYEAGARGLLDQHSNDFEQLVHDKPQTFPEFLKK
>SEQF2892_02321 Peptide methionine sulfoxide reductase msrA/msrB
METVYIAGGCLWGVQAFIKTLPGVLSTEAGRANGISETLSDKYDGYAECVKTSFDPMQTS
ITDLMNYLFEIIDPYSINKQGVDEGPKYRTGIYSDEQKHLEEARDFISKRPDKERIAVEV
LPLNNYVASAEEHQDRLDKHPEDISYCHVTPDMLKKYL
>SEQF2892_02322 hypothetical protein
MEHNYMNEPKLTNRIIEMILGITGSIFGIIGGLIALILTNYDKSYGSELVGLMTIVATSS
IILSAITLTLSCLINKRRVLIGIILIVAAIIHIYLLGFFGYLSGILILVAGIIALVRK
>SEQF2892_02323 hypothetical protein
MKRLFFISIIFLVFLGGCSFSDNKDKAEGEEANNKAKATDKMKKFKIGQVVDADGVDIKV
VKAEFVDNYDEYSAPVNGKALRVYIKFRNNNDDQVLMDNTDFSMKVNNENYEEWYGSEDM
HEGFSHQLNQHNTASGYITYDVPESDQYTLELDTVPNFNKVRAQWIINKSEIKNSNGTKD
TSASSTTDVEDESDTTSSSKKENDDSDQADVGVTYPAYMYNALVDEYNSLTDGEKMNHVS
KGVLEIEYDQLEARVEALYEKENAKAEKEYEKAMQDHEDQLAQEEYEQQQAEQAENEASE
SDDNSNGPGSDDPSLDSGTEDTEDTEDTSSEDDAA
>SEQF2892_02324 hypothetical protein
MTGIISSVLLLISMGSLAIAFLTGIYEILSWLRDKDYSPTFKIPVLFFGLYVLFYIPTFI
LIN
>SEQF2892_02325 Response regulator MprA
MEGFHILLVEDDETIAKNLKQILQQKGAQVTLDRTGDSVFNVLNDVHIIIMDIMLPNNDG
LSITDEIRSISTIPIIYLSARVDIDSKVKGLNNGDDYLTKPFNPRELISRINNLLTIHYA
DKEAQFYEFKVNAKDKIIKSNDGNQLSLTKTERRLFFYMYENRDLILTKDQIIDYVWQFE
SASENTLNAYVKKLRTKLLDSGTIIETIYGIGYRLNGG
>SEQF2892_02326 hypothetical protein
MRLLKKYYMFMGLGLLSIPLVFLAINSMILLCILFIEKVLGYPIGLNFKSSGLTIIFYIF
FFLILITLVIIASRYVYKIVNRLRLLNDKLLDIANSDKLPNKLDIPTHINDEIDEVGQSI
NILIDRLRFRELEIIENKKQEQNYINQLAHDINTPLTALNLELYQLGFQYQINDNDIELS
YEKINYISNLIKALPNKDDISKFYTFNHQVDIQACINTTIDKWHYLLDSKNILTILNVEG
NCIYWHGDQLWYERLFDNIISNVYKHSNSSRITIYLNENYITIQDNGIGFNDMSTKSKGL
TIIKDICERFSLKLNIKSDSNGTIITIENNRE
>SEQF2892_02327 Glycosyltransferase-stabilizing protein Gtf2
MINLFEIFDEASQKLQQSLQFAGFKHETIVMDDDGFLPDNVMTPYQFFANYKRNDDDKPA
FFNEVQVPPLWEIKGNHNHAEIIDNGNVRGRIFYREHFKNRIVSFVEWFDTKDRLRSVDF
YNKDGFKFAETVYDLNKKPILKTYVDRQGKEVLYENFVTKDIILDWQGQSHFFASKQDFI
SFYLDQIDVDTSTVFINSLATPFFVLYQTNHVSNAVLFWQEQSHGNVPGNMKLLLDKETL
NSKVIIPDSAEFESITSNVEAQYRPLISQLGYLYDYQKSNNYNKQVFNLTNSDDLPNLEE
IIRQCEDYELHIGAITEMSATLMGLGKYDNVKLYPTITQAKINQLFQTCDIYLDINKGGE
IVNAVERAMLHNQLILSYDETAHRRSFIAKKNITKQDEPQQLIDILNEIAKEPRVFKERV
IAQQEQNNCIDESTFRNVIMTALNH
>SEQF2892_02328 Glycosyltransferase Gtf1
MTIYNINFGIGWASSGVEYAQAYRAKLLREVNQPAKFIFLDFISAENIQTLTDNIGFKDD
EVIWLYQYFSDIPIAPTTYTVDDLKKDLGNPVTAQVVTGKTMRLYIGNDKSYVSCYLKNE
DDIIVDRAEFVVNGMLVRKDYYSYVRTFSEYYAPYENRAKLYKRQFYNEDGSIAYKEYID
GESSVYVFEDARLYSKQEFVAYFMKKLHLTEQDIVIIDRSTEVGQSILEHKGSSKVGIVV
HAEHYSENATNDSYILWNNYYEYVFAQAPYIDFYITATDLQNQVLSEQFQKYTSHQPSVR
TIPVGSLHQLSYPIGERKRYSMLTASRLASEKHVDWIAKAVIKAKKKVPQLTFDIYGHGN
ERSRIEEIIKENEAQDYIQLKGHKKLDEIYANYDLFVSASTSEGFGLTLMEAVGSGLGMI
GFDVNYGNPTFISHGENGYLIPIDKDNQDVEVITNLMAEKIVQYFNNGPKHSHEKSYKIA
ESFKTEHITQKWQNLIDEVLYD
>SEQF2892_02329 Protein translocase subunit SecA
MANQVSNVINSMRLKRLQKQLTAVNRLSDQMRDYSDEALQAKTAEFKQRLEKRETTLDKL
LPEAYATIREASKRVLGMYPKDVQVMGAIVMHQGNIAEMQTGEGKTLTATMPLYLNALTG
KSAFLITTNDYLANRDFQEMRPLYEWLGLTASLGFVDIPDYEYADNEKQMLYNHDIIYTT
NGRLGFDYLFDNLADHINAKYLPELNFAIIDEVDSIILDAAQTPLVISGAPRVQSNLFHI
IKMFVETLVEDEHFKLNVNKKEVWLTDKGIDVANHYFKVNNIYLPQYFDLVRVINLSLRA
KYLFKDNLDYFIYNGEVVLIDRITGRMLPGTKLQSGLHQAIEAKEGVELSQDLSVMATIT
FQNLFKLFNGFSGMTGTGKLGEKEFFDLYSKLVVEIPTNHPIIRNDKEDRVYAKSDEKNK
AILEKVKEIHATKQPVLLITRTAEAAEYFSTQLFKDNIPNNLLIAQNVAKEAQMIAEAGQ
LGAVTVSTSMAGRGTDIKLGSGVYELGGLAVIINEHMENSRVDRQLRGRSGRQGDPGVSQ
IYVSLDDYIVKRWSNSKLAENEKLKDVDPDKLQDSPFFRRRVRGIVSKAQRVSEETAMMA
REMANEFEKSIGIQRDRVYEERNRILETSDFSAFDFDSLARDVFDYDLRTKHIHNKDDII
KYIYEQLSFSFKDDAISQQIQTREQTIDYLVQQFNKQLKENMKIANNDYFKLRFLQKAIL
KAIDVEWINQVDQLQQLKASVNNRQNGQRNAIFEYHKVALETYEMMLINIKRATIRNLCL
SILTFDKDQDLVVHFP
>SEQF2892_02330 Accessory Sec system protein Asp3
MSALNSYTLTWRHINTTTFMYGTKLRIEDDGTYFNNPLMPSGTVIHDWRMLTTFSEHKYA
PSLPILKKKQHYKVALNYNVKPLGSVYIKITFYRKNDTEHSNLIIQNSDAEFEFPEEAYA
YKIELINAGLSELFFKNIIIQELDTDESETQSIVESKVNLDVLNRVIFGESVNARGDQNG
>SEQF2892_02331 Accessory Sec system protein Asp2
MARKFRILQVGGKDLEPLFDSKKGVEWDYLDDALFTFDSGYIEAVKSIIKAFGNFDLVFV
QSAYSPELMDLLRVVATPHNTVIDAQMWSPNYDAEPLIQHKFVKKLNYQTEEDLHHQLLA
VTFPGQYGDRVSPIKTTVNPHFQGTYKYEGNKSLVLEGDFGTSFKPIVTWTQSLVSDEDK
VNELWPEYSLEGDVEIEYTFRLSPFGSTEYPDTTLRFEHKDLNQPIQLPLRTTQMNVSVS
LKAKGKGKLRIGAIHKRWSRLEMGQFIMGGQRFTDEKRDEFIHYFNPSDMKPPLNVYFSG
YRPAEGFEGYFMMNKMNAPFILIGDPRLEGGSFYLGSETFEQGIINVIQNALDFLGFKHD
ELILSGLSMGSFGALYYAAQLEPAAVVVGKPLLNIGTIADNMKLLRPNEFGTANDVLLAN
TGGISTSDVQHLDSRFWEKLKNSNLTNTIFAIAYMYNDDYDATAFQNLSPVLSQQGSHVM
SRGVPGRHNDDSPTITSWFVNFYNIILKDQFGRDSDVSIK
>SEQF2892_02332 hypothetical protein
MKQFIPAWYDSNNWWDSAVVPFYIKRKTTEFDDMVSLMLMHHKNNEPFNTIILNYNPLLR
LFLHRHELYEMNYWSLFDEIQGATHGTPVAIDYRELSWPEDTEFIYTPFQVLAIKSDNQF
SKMIFSQEGYLICIEDYEHKTLSRKLIFDDRGFVSSIEIYHDGQSPMKRYYLAVKGQIIM
TQDFMTEKITIQPEFYDLFQKKSYGNMDELIFEKIQQYNTSTLADDDKVIIAADKRHNYV
LTDTFKPENMCFSLFSQRNAYIDATLLETIGKANQCIVDTQANATKLNQFITQNPEYQPF
KIMRVTPFDAQMLPNISSQLYETNIGVWIDSLSEEDLKTVIDQLSQYVSQHEQTIIHLLT
RLNENDIQQWLRDEIDQLNALLNVEEEEFSPEVQDILQTELEEDEIEKVKLIYVPFEEDL
MKELSQLRVIVDLNQEPDLYLQISSISAGVPQINRRETDYVDDKLNGLIIDNIQQLRVAL
NYFINNLKNWNYSFAHSIKLSDEFSSEKIIQRLNSVIEGEIHGT
>SEQF2892_02333 Accessory Sec system protein translocase subunit SecY2
MIKKHEYKILYKRILFTCFILIVYIFGSNISIVGSEGIYDNKDTFFKLAVSNVGGDLHTL
NVFSLGLGPWLTSLVIIMLLNYRNLDQATKQTRSEKHYKERIITIVFAIFQSYFVISTYI
HNNFIKDSNIILLMLILVAGTMLLVWLADQNITYGICGPMPIVLTSLIKSLFNNQHFFKL
SVSVLLLILVIVTLVIALLILLFIELSEYRLNYKDIMNNSTNKTPTYLAWKLNPAGSISI
MISLSVYVLLNNMINLIATLLGSNANFEFLSFANPIGIMFYIVLQIVLSYLLSRFLINTK
KKADEFLKNGNYFDSIRPGRETERYLNSKARRVCWTGGILVALILAVPLYSTLLVPNLST
EIYFSMQLIILVYISINIGETIRTYLYFDRYKQILNKYW
>SEQF2892_02334 Serine-rich adhesin for platelets
MSRKERNLKRSFGQEKARVKLYKSGKQWVKAGIREVQLLKVLGLPFLNKDVEQINNLDTN
KDKNFKNQAMKATGLAGGAFTFAMLNDHHAYAASETPMTSEIASNSETVANQNSTTVTKS
ETSTTEYISSQTSTSQDATSSTNSTEKKYFIIYNR
>SEQF2892_02335 hypothetical protein
MLLRRVTEEDLFSLIKLENEGFTPDEAATPEALKQRINKIPDTFIIAEKEGRIIGYINGP
VINQRYITDDLFEEIQSNPNSGGYLSVLGLVVNKDYQRQGIAGKLLEQFEKLAKQQVRCG
VTLTCREALVSLYERYGYNNEGESTSQHAGIKWYNMVKEV
>SEQF2892_02336 hypothetical protein
MIKRRFKYAFGTTLVTSSLLLMSHGHAFAVTNNIDQAFNHDNNGQPITSQDSNNNVDPGF
NHDVDDNNDTDPGFNHDVIHNNDPAKHQAEDNDMGFNGYAEQNGLVKQTSKSNSQQDPAK
HQAEDNDMGFNGYAEQNGLVKQTSKSNSQQDPAKHQAEDNDMGFNGYAEQNGLVKQTSKS
NSQQDPAKHQAEDNDMGFNGYVEQNGLVKQTSKSNSQQDPTKHQAEDNDMGFNGYAEQNG
LVKQTSKSNSQQDPTKHQAEDNDMGFNGYAEQNGLVKQTSKSNSQQDPTKHQAEDNDMGF
NGYVEQNGLVKQTSKSNSQQDPTKHQAEDNDMGFNGYAEQNGLVKQQDQSPKSQMNSTLS
KQATRSQETSQTSLHHELPMTGERASTTTFVYSFIAFILGVGVISLRRKFSK
>SEQF2892_02337 hypothetical protein
MENVNSNKYRNDEFYGSRNENIASSISYLSVFFAPVLLPIVMWIIADKPVSIHARKALFN
HILTWVCFTLAPLALMLSASVMGNASTNTESWIVFGSWTIAVVLVVVGVYLFIKNIIRGI
KLLLV
>SEQF2892_02338 Phosphate-import permease protein PhnE
MTQNKDNLEQKFPIKSKKHKQKIIKNWIIAIVVLAIIAWGFVGMPALELKSKSIEILKSI
FHGLFHPDWGYVYIPAGEDLLRGLLETFAIAVIGTFIAAIICIPFAFLGAQNLIKIRPVT
GITKFLLSVIRVFPEIVMALIFIKAVGPGSFSGVLALGIHSVGMLGKLFVEDIERLDFTS
VEALKASGANKTKTLIFAVIPQILPSFLSLVLYRFELNLRSASILGLIGAGGIGTPLIFA
LQTRSWDRVGIILIGLVIMVAIVDLISGAIRKRIV
>SEQF2892_02339 Phosphate-import permease protein PhnE
MTTPTTSKYDEYLNKKFSLKTSFTIFLVLALIIWSFLYTGFSFADLMVGLPQIGSFFGQM
VPPDWAYIHTILKPMLDTIRMAIVGTFLGAIVSIPIALICASNIVKTKWISIPARFILNI
VRTIPDLLLAAIFVAVFGIGQIPGVLALFILTICVIAKLLYEALETIDPGPMEAMTAVGA
NKTKWIVFGVVPQILSTFFSYVLFAFEINIRASAVLGLVGAGGIGLFYDSTLGLFQYPKT
AMIILFTLVIVVIIDYVSSKVREQLA
>SEQF2892_02340 Glutamine transport ATP-binding protein GlnQ
MSQIEFKDVNKVYPNGHVGLKDINLNIEKGDFAVIVGLSGAGKSTLLRSVNRLHDITSGD
ILIEGKSITKAKGNDLLMMRRNIGMIFQHFNLVKRSSVLRNVLSGRVGYHPTWKMVLGLF
PKEDKVKAMDALERVNILDKYDQRSDELSGGQQQRISIARALAQEPAIILADEPVASLDP
LTTKQVMDDLKKINEELGITILINLHFVDLALEYGTRIIGLRAGELVFDGPASEATEEVF
NDIYGRKLKDDEKLGVE
>SEQF2892_02341 Phosphate-import protein PhnD
MKQMKYLLVLALTVIIFAAACGNNSSLDSNNKSSDSGSDSGKDGYKPKELTVQFVPSQNA
DTLEAKAKPLEKLLSKKLDIPVKVSVSTNYNTIVEAMKSKKVDVGFLPPTAYTLAHDQKA
ADLLLKAQRYGVNEDGSNSKKLVDDYKSEILVKKDSGINSLKDLKGKKIALQDVTSTAGY
TFPISTLKEEAGIDATKDMKIVNVKGHDQAVISLLNGDVDAAAVFQDARTIVKKDQPNVF
KDTKIIKLTEPIPNDTISVRPDMDKAFQDKLKKAFKDIAKTKEGHKIISEVYSHEGYTDA
KDSDFDIVRKYEKQVQDMK
>SEQF2892_02342 2',3'-cyclic-nucleotide 2'-phosphodiesterase/3'-nucleotidase
MTQLSFYIVSDVHGYIFPTDFSKTNQQLPMGLLYANLLIEQSSKNDDIYFKIDNGDFLQG
APLCNYLVSELRSSKPLTTIYNRLNFDLGTIGNHEFNYGLPYLIDTLQNLNHPVLCANIL
DSKQQPFTGEGVHYFEKEGLTIGVIGLTTQNIPNWEQPHHIEGLIFKSAIETLTQLLPNV
REKADIVVVSYHGGFERDIDTEEPTEDLTGENEASEILHRFHESIDVLITGHQHRDIATV
KYETAVIQPGTRATQIGKVTLTIGDNNQIIDTQSELLPVVGDSEYSLLPEDSKLLTHLED
WLDTEITTLPEPMLVEDQFEARMKPHPLINLINVMLLEKSGADIASTALFDSAAGFNKRI
TMRDIINNYPFPNTFQVLKLTGAGIKDALEKSASYFTLNDKNEITINDAFLYPKPQHFNY
DMYGGITYTIHVREPIGQRVTDIKVGNEPLISDKTYTICVNNYRAVGGGNYDMFAEAPVV
KDIQEEGAQLLIDFITNNDISNIPQVLNFKVEL
>SEQF2892_02343 hypothetical protein
MSEFLAAIVGGIFALIGTFWGIKYQITKEKEEKREDYKNDILSMIDLTAYKASKISKIHL
SETNALINKPQTLEKCDDVEGLFVKLDDQIQELLGTMSHHEEESNKPIRDLLNCYESLEN
YISKFSIAARIYNDKYETNSDDKRVIIVKTKEKLDRNIDTFINDLRQFSKHHFNHDMYEP
TLKFESE
>SEQF2892_02344 Inner membrane transport protein YdhP
MKGNRMMFFIFMLGTFTVGMAEYVVTGLLTQIASDMKVSISSAGLLISVYAVSVALIGPF
MRIFTMNVRAKRLLPILVAIFIGSNVVGMLAPNFQVLLLSRLLSASMHAPFFGVCMSVAA
AVAPRGKQPQAIALVQAGLTIAVMIGVPFGSFLGGFANWRAVFGVMIGLAIITMLGMLKF
VPDVSLSTESNVKNELKVFKNPHILIVMSIIVFGYSGVFTTYTFMEPMIHDFAPFKIVGL
TICLFMFGLGGVLGNLITGNVPEPKLTKYLFYTFLLLFLTIVLFVTFVHNAILAIIICFL
FGFGTFGTTPLLNSKIILSAKEAPLLASTLAASIFNVANFLGAIIGSILLSIGLPYLMIT
FVSGGIIILGILINAVNYFYEKKHFQFEK
>SEQF2892_02345 putative cystine transporter YijE
MNLHQRSYLYFYICIILTTICMGSSFPTGKYLISIEHVPPMLLGGWRFTIAGFIILLVLF
LKRGVKYVLPSIDHNSYKGFIFVATIGLLQTAGTMGLLNIAMSLGVSSSMSAVLLFTNPL
WLAVLAHFILKERLTMIKVVALVIGVIGVTICLGLDRSLLGWGACVALLGSLCWSCNTVV
TKQFKFDKGAWVLTGWQLLFGGIIMFLISQLLGERYHIGQLNGWGWVWFWWLVFPASIGS
FGLWFSSLNLRGATISSSFLFLVPLFSTIFSIIGLGEPFTLHIMIGGLCVVVALIAINYS
PHHLSN
>SEQF2892_02346 HTH-type transcriptional regulator IscR
MKLSIGWEQAVYVLLMLNLLSEHSVMTSTALSDRLNVSDSYLKKIIKALVKEGLVNSSTG
KNGGFSLNKPLNQITFYDVFLAIEGRDAIFSSQQLLKPFLGENEGQKAEMCVVSHALNTI
QHTLISTLSSITLDEVNQNIVTKYRLNDLNQWVLTNSKTL
>SEQF2892_02347 HTH-type transcriptional regulator SutR
MRNRLKELRARDGFNQTQLAKQAGISRQTVSLIERNDFMPSILTAVKIARIFNEPVENVF
IFEEGDL
>SEQF2892_02348 hypothetical protein
MKVKRYLILLVLGGIIGGFVGSSMGSISNFLSNVNFAHTHFGLIICIIASLIIIGLTFYL
WKVQKDALKFKNQSLNSIEDDDADLFEMKSNLNFNKSSIIIYIQLIISFVALLLIVFGHG
SNSDVLYAIIPYMLTIIPSIMLGFFNRRFDSRYPKIGEKIILKKP
>SEQF2892_02349 ABC transporter ATP-binding protein YtrB
MEHLLQVQDLNKSYKKSNFHLKDISLTLQPGEIIGLIGKNGSGKSTLINTLVGNRFKDSG
EISFFDQVISDKDHAYKEHIGVVFDDLRVPDKLEIKDMDKVFADIFKTWNSDRFFEVIQR
FELPTNVQIKTFSRGMRMKAALAMALAHDTKLLILDEATAGMDVSGREEVIEMLEDYISE
GNGILISSHISEDIEHLATKLIFMRDGEIVLQESKEELLNQYGIVEVDEHDDLDIPQDII
IASRVRQGQRQTLVKDWSSVTNANPLNTIDDATKLIMRGDK
>SEQF2892_02350 hypothetical protein
MKGLILSSFYASKKSLITYLIVAIVASFLFAFINPAMACFLPMIFLLSPVTDNLKREKDS
KWMYYISTLPTHRSAYIKSYFAFYGILIFIGLIIGLIAVLAIHQNLMLTLISGLVGIGAA
GTYAIMFPLTFKFGPENSNVIMISTSVIVLILFFITYFGVIMSAIVRSGSFSDLGTNPTD
IFFISLYAILGLICLVASYFISIAIFNKQEL
>SEQF2892_02351 Arylamine N-acetyltransferase
MDIQTIEHYLNIDSSKYHEPSLEALNYYIKRYMLAVPFENINVQNGMPVSVEINDLYDKL
INQHRGGFCYEMNHFFGTYLEEKGFTVYRMSATVEQPNGNRSPEGSHMSLVVPINDVYYV
ADVGFGDLPLQALPITNIDPTHPVTDITGEFRAISEHEGTYSIQKLEDDSWITRYEARFQ
PKQIEDFEDMIQYNSQHPDSIFVQQLIVTQPQSFGRATMSSHHLTLSKQDGKDKYDVTSD
NYRNILKEYFNLDVKIKPLEA
>SEQF2892_02352 UvrABC system protein A
MTNIDIIGAKQNNLKNINVSIPKHQLTVFTGRSGSGKSSLVFNTVAAESERLLNETYSSY
VQHQLTQYEKPDVDQIKHLPVAMIINQKRLGGNSRSTVGTISDIYASVRLLWSRIGKPFV
GYSDIFSFNNPKGMCETCSGLGYVEDIDLNELLDYDKSLNEDAIKFPSFRPDSWRGKRYL
YTGLFDNDKKLKDYTKEEMDTLLYTEPTKLKNPPSNWPRTAKFEGLIHRFRRSFLLNDNF
EKKRFKEDIDRVVSKHDCPDCHGQRLNDTVLSCEINGLNIAEFTNLQIDEALAFLKKIKS
GKARVIIEPLKKQLEALSYIGLNYLTLARETTSLSGGESQRIKLIRHLNSPLSDLIYIID
EPSVGLHPEDIQRINDIIQSLKDKGNTVLVVEHDPDVIKTADHIIDLGPLAGKNGGEITF
TGSYNELLSSDTSTGQALNRQHQLKKTPRKSKDMLQIANISRNNLQNVSTKLPKHAMTVV
TGVAGSGKSSLITAGFEREQEAIFIDQKPVHASNRSNLLTYLDIFDDVRSFFSQHTGLKK
SMFSYNSEGACPECHGKGVLKTELAFMPDFSQVCELCGGTRYRPEVLEAKVEGYSIADIL
ALTVDEAIEKFSDSPGIIRPLQALADTGLNYMTLGQSLDTLSGGEIQRVKLSRYLTQDVT
DKIFIFDEPTTGLHEDDLPILIDCFNHLIEEGNTVILIEHNLTMMTQADWLIDIGPYAGD
KGGQLLYAGEPEGIFDIDNSITAKHLKRYIGQ
>SEQF2892_02353 Oleate hydratase
MYYSNGNYEAFARPEKPENVEVKSAYLIGSGLASLAAACFLIRDGQMDGSKIHVLEELSK
PGGSLDGDELPLKGYVVRGGREMENHFECLWDLFRSIPSLEMDNASVLDEFYWLNKEDPN
YSRCRVIEKRGHQLSTDGDFTLTPQAIKEIIHLCLMKEETLNDVKITDVFSNDFLHSNFW
IYWKTMFAFEPWHSAMEMRRYLMRFVHHIGGLADFSALKFTKYNQYESLVLPMIAYLESH
GVQFQYDVQVLNIKVDITTKEKVAREIQLKRSGKDDIIPLTPDDLVFVTNGSITESSTYG
DNNTPAPPTKEIGGSWTLWRNLAKQSPEFGCPEKFYHRLPDKSWFVSATATTNNMTIINT
IEQICKRDPLAGKTVTGGIVTVNDSKWQMSFTVNRQQQFKSQPEDEVSVWIYALYSNING
DYIHKPITECSGNEICQEWLYHMGVPINQIEDLAKTQCNTIPVYMPYICSYFMPRSIGDR
PLVVPENARNIAFIGNFAETERDTVFTTEYSVRTAMEAVYQLLDIDRGVPEVVATEFDLR
ILMDALYELNDGKNLSELSEHNKIQKLALNAFLKKIKGTYIEELLHQHKLL
>SEQF2892_02354 hypothetical protein
MNKQDLRVQKTHQALITSFSDLLQTKSFEQITVQDLCAKANVRRSTFYRHFNDKYDLLNH
VVGTLIDHFRELYLPDINPDNPRHFFEKLMRDALTFIHDNKGIVRSVITLNFYGEVYTIF
YEQIYKAVQKQIEFDRQSGQFYVDVTIYGEFLTGGILSVITNWIQHGQQQSIDKVTKEIV
NMICGAREVHLKKLS
>SEQF2892_02355 D-alanyl-D-alanine carboxypeptidase DacF
MFGKFVKGIGIITTISLLHTSISDASESPVTIANKEKNSSISTKYQPSGVMLTTDQGQIL
YNYRGNNQVDPASMSKMMTLYLTYEAIENGKLKLNDKVKITNKYATMSNLPNLSSVSLKQ
GQTYTIEELIKQTTLASSNAAAMILGEKVSGDNNTFTNKMNQQAKSFNMTNTNFVNPAGT
QNSLLDQYAPSKFKKQDFPKSTAKDMNLLMQALIKKYPQILQISKLPRDTQRGNTFKSTN
LSLKGQPLYLPGTDGLKTGTSNKGYNIALTNKQDQLRLNETIMNVKPFGDVNAKYNRNRI
GNQIIKQYRQKYEYKKVLTEGDHEIDGKKYHVKKDLYDVVPKDKSQWHLAINSKGKVYVH
YYRDFLPGSQYPRVAADKKWKWF
>SEQF2892_02356 hypothetical protein
MIKKYLLSVFTVLIAIVLCACQSTSQTHEKKAKEETHNKEENIYAKKRSSGQNDWVEYKG
DVAHIFFHPLITDPKVAFTGEANQAKGNNDWMITVEEFKRSLDELYKHHYILIDPHDAYD
FNSKPIKKKSLKLPKGKKPLILSIDDMNYYEYMRENGYADRLVLDKYNHVVSQTKGKDGK
FTQSESNDIVPILNRFVKEHPDFSLNGQKGVVGLTGYNGVLGYRTNELDSKDYSKRKEQA
IKVANAMKRDGWTFASHSWGHIDFANSSYDRIVKDTERWKKEVTPIIGKTDLFIFPHGAQ
DRGSAGYQYLENKAGFKFLAGVGPNNFTDIGEDSVYQDRVAIDGLNLYDFKYKLKPFVDS
DKVYSKEDRSYFKGEKGYK
>SEQF2892_02357 Phosphoglucomutase
MKDNWMKYKDDSLVASFYDSQITTFQEQGFETELAFGTAGIRGQFGLGPGRLNRYTIQRL
ALGIANYLKDKEDNPSIVIHYDIRHLSSEFAHIITQILTSNGIKVYLADVYKTTPQLSFA
VRYLQTSAGIMITASHNPKDYNGIKVYGADGAQLDEGTSLEVAQYINNLGNPLKLNINLN
QELIEKNTFDLPEAVYDSYINELTNLTGDIPQSDLKVVYTSLHGTGVPIIPDVLKHLNFQ
NVSLVKSQCELDPNFSSVKSANPEEREAFDLAIQQAHDLEANLVIATDPDVDRMGFVERN
ADGQTYYFGGSEIGALLIKYLLEYTNVPNHSFVIQSIVSGELGKRLAQQHGVTVKEVLIG
FKHIAKAIRELDDTESFLFAYEESYGYLADDFVRDKDAIQIVPLIIKYASILKNEGKTLH
DALKEIHREVGLYRDKPMSKVFEGIEGQQQINALMDKLRRNIPDVIAGLKVIAVEDYETL
KRIYKEDNTEEAISLPQANVIRIIFKEGFIALRPSGTEPKLKFYLSLNVDNFEQVSQDIY
NYIFGDTE
>SEQF2892_02358 Lactonase drp35
MTNQSLPKLTYTGASKSAVPIISESELQTVTAEPWLKISDEGLQLEGLIFDRDHNLFLCE
VFGGKIFKVDIDTKEVSTAFQSTKQNPAAVKIHKDGRLFTCYLGDFESTGGIFATNEHGE
QFEEIISELNTEYCIDDMVFDSKGGFYFTDFRGYSTNPKGGVYYVSPDFKTVTPVIQNIS
VANGVALSTDEKVLWVTETTTNRLHRIQLEDDGVTIAPFGATIPYYFTGHEGPDSVCIDS
DDNLYVAMYGQGRVLVFNKRGYPIGQILMPGRDEGKMLRSTHPQFIPGTNQLLICTNDIE
NGSEGGSMIYTVEAFAKGHESYQFQ
>SEQF2892_02359 Thiosulfate sulfurtransferase GlpE
MDYRVLLYYKYTTIDDPETFAAEHLEFCKSNNLKGRILVSTEGINGTLSGTKEDTDKYIE
HMHSDERFADMTFKIDEAEGHAFKKMHVRPRNEIVALGLEDDVDPRVTTGKYYSPSEFKE
ALEDEDTVILDARNDYEFDLGHFRGAIRPDITRFRDLPDWIRENKDQLDGKNIVTYCTGG
IRCEKFSGWLVKEGFENVGQLHGGIATYGKDPETKGQYWDGKMYVFDERISVDVNQVEKT
VIGKEHFDGTPCERYINCSNPECNKQILVSEENEDKYLGACSYDCAKHERNRYVAKNNIS
DEEWNRRLENFKDVPEHAHA
>SEQF2892_02360 hypothetical protein
MRKHSKDYFHLFYSQLFANTGDILTIVGLIAIVFNITSKTTAASMIPIIFTSGIFMSSFI
SNYIYQYFTQKQVLSIFQGLKLVSLASIAGLLIFGISPIFIFVLLFLNAIFDGFTNPIKN
SMIPFIENKDAITSANALMNMMSSVVQLSTWALGGILMSLIGAKYLFLFALVLEMISYFF
ILRLSERQIYKNEKANIFSSFKAVIRDNYRDKLSLYLNISIIFESFATTIWIAAIILTYT
RTYLHVPDYWFGLINALFFSGTIIAGLWINHKDRFFTQINYPIIIYVPLLLAFINLSFIL
HHSIMIALLFSLFMGIFEDMRYISLNSMIQRNTPKEILTSTYILNNLFNSIFFALGTFII
SIIVDYYGITWAYIICFSMYIVTFILGLFFRKTLKIEMHN
>SEQF2892_02361 Penicillin acylase
MCTGFTFQAKNGDVILGRTMDYDYPLTGHPAVQPRHYYWESRVDYKGTTTYGFTGAGSDM
EGFIFGDGVNEHGLAISNQYDRGYASYANKIHDGYINISQTEVLTWVLGYNKTIEELIEQ
ADQVNVVAHTLNDINEAPPLHYHVSDATGRTAEITFVEGRIVLHDNPVGVLTNSPDLNWH
YENLKNYANVTPYKPQYKRYKNLYIGNESGTSGLPGGYTSAERYVRAAYLVSNMLPDDGD
DAVLDAFRILDSVSIPKGAVRPSEDEFHYTLYQSVFNLTSRTLYVKYYNSNRIAELQLTE
ELLNSDDLVIFDPITQGLSTDKVN
>SEQF2892_02362 Quinolone resistance protein NorB
MSSHQSRFDGKLIIAASFAVLTYWLFAQSFINIGSSLQKTFGAADSTLNLSISLVSFVTG
IFMVGAGDIADKVGNLKMTIIGLVFSIIGCLSLIIVPVTPFLVIGRIFQGLSAAVLLPST
IGLVSDNFKGQSLRKAYSFMMIATVGGIGFSSYVGGLISSFLSWQFIFVISIALSIIAIF
ILSRRKEVPRQERDHQPFDYVGMVIFGVIIACLMLLMTQGFTYGLTSRFTLTVAIVGLIA
LVVFYIFEKGRPTPFIDFSIVKNRAFLGSTINNFVLNTGVGTTVVFNGYAQKQFGMSEAQ
TGLVTVPYVFMAIAMIRLGEKAIQKYGGKSMLIAGPLFPAIGIILISFTFLSPSWYVGIV
TFAFVVCAIGNGLVATPGLTIAVFNMPEEKVSFATGLYKMGATLGGAFGIALNTTVFTVC
QQFYSVEMSAMISFLVGAIIMILGLISAFILIPKNVKA
>SEQF2892_02363 hypothetical protein
MEWIKLIGILIIIIGFILKFDTIAIILIAAVVTGLVAGMDIVEVLSTLGKAFVDQRLVTL
FMLTLPMVGLIERFGLKQQASKLISNVKKITTGRLLTLYLIIREIAGVASIRIGGHPQFV
RPLINPMVQGALRTRYNLTDKDIDEKDIEKLKAEASAMENYGNFFGQNLFVGAAGVLLMV
GTFQSLDIKVNAMSLVLASIPVAIITLILVWIKNILLDRYFNKKYGNNEVKNHE
>SEQF2892_02364 hypothetical protein
MSEATLNHILEIFYILIGLQFLYTAYRALRSQDKSKSLGTAAFWTILAILFIGGPYIPDA
INGLLVLAMGALTLFRQVKIKNIIDVNDKEVEKGSAKYGNKLFIPAIVLAVVAVVVSNWT
PLGGAIGLGISSIVGLIAALLIIKPKLSYTLYDSDRLTQQVGTTGILPQFLAALGVLFTA
SGVGQVISKGISSFLPEGNHLIGAIAYILGMVLFTMLMGNAFAAFTVITASIGIPFVIAQ
GGDPIVAGALAMTGGFCGTLLTPMAANFNTLPVALLEMKQEFGVIKAQAPIALALIVIHI
ALMYFWAF
>SEQF2892_02365 Pyrrolidone-carboxylate peptidase
MKILVTAFDPFGGEKINPALEAVKQLENTIGEHTISKLEIPTVFHESKDVIDKELANGNY
DVVLSIGQAGGRYDLTPERVGINIDDARIPDNKGNQPIDVAIQEDGAPAYFSNLPVKTMT
EAIKAAGVPASLSNTAGTFVCNHVLYQLGYLADKSYPGLLFGFIHVPFIPEQVTDKPEKP
SMSIETIAKGLTAAIKAISKEDDAKVALGETH
>SEQF2892_02366 Nickel-binding periplasmic protein
MKKRIFYSLSMCAMLMLSGCAQHHNDNKEVKVSLPREFNTNQLDAQGFDAPMPVYNAIYQ
PLVTYGKNGKIEPGLVTSWEASEDGKHYLFHLKKNVKFNDGSDFDASAVKFSIERAKATD
TTDPMETLDKLKSITIKDKHTVEIELKSPSNQVLNELSQVRPLRIMSPHAVKGGNTTGKF
EKAIGTGPFKVADSTNETVSFQPNTYYRNGHPLNYNLTFQSIEDSDSRHLAIESHSIDIT
GGSLGQMTPQQVKESHRNKALSVHTSPSTETQFMGFNPQHKILQDKTMREAISKAINTDD
LSSDKKLKGLFQQNVQYVNAHNQPDHVYSPSTSKSLIRSLGYKMNNDGYFEKDDHILSLK
LALQTDEFPEWKTKAEIMQQDLKKVGIKLDINILDSQTYYETLTVRKDFDLIYYRTYTNA
LMPYNFLNARFKQDGSRPGVFANDTTLTSMIKQFPTMINMHDRQRAFNKLSSYIDQQYLI
VPISYPNETFVTSPKIRQFEFSGQTDAPINYDKLKVSNND
>SEQF2892_02367 Nickel transport system permease protein NikB
MTNIVKHFIRLLIYLIIISFVLFLLLENTTGNPAVQYLQEHGVAQITPERIKMAQEKLGL
SQAMPVRYVQWLGNVFTGDLGTSFSNGEPVTERISQAIVPTIKLIFGSAIILFPISYVIG
YLCGNHSRKKWSVVITRIAQVVTSLPEYWLAIIFIYYFGVKWHLFPFVGSNSWQYFVLPI
VILVLVEGSHMLLLSSHLFESTLQGQPFQLAQLRQFKLKDRIYVQVKEILAPLMTITINN
FIHLFSRVIILEVIFSISGLGKLLINSINLRDYPVILGILMMIITFIMVLNFFGDVLLEK
SDPRLRMSKKSGGRIAYED
>SEQF2892_02368 Nickel transport system permease protein NikC
MIHQSEALLPPSLHHLLGTDHLGRDFFTRLFVGSMVTLGLTTLIIVGSVILGLILGLAAA
LIGRWLDALLMAFADMLIALPSIIIALVVLGFINNSIVGLCLALMIGWLGRYLRYFRNLA
RDVQTQPFVKFASLSGLTRTQTTVRHIIPHLMRNVTALITADFGKLMLSISGLAFIGLGV
KPPLPELGAILYDGKSYFYSAPWLFFFPGILLGGFALICQILNRRFTQ
>SEQF2892_02369 Oligopeptide transport ATP-binding protein OppD
MSNTQSSIHSINALLHLKNVSVYDGNHALLNQVDLTVTEGSFHCLVGESGSGKSLLARTV
LNMRHPHLKYQGQIAIDLNNTDAMFQDTNSNFFQNVRIRKHFDALFDALNTQLSRQQQHE
FVLRQFRHLGLENPEDLFNDYPFQLSGGMAQRIALVMSIVKEAKLLIVDEPTSALDFDNR
NQLMKLLNHVVQEHNMTLLFITHDLSLAMDYATHISVMRNGQMIESGEANDILVRPEHAY
SQQLIELAHRRYRYVAD
>SEQF2892_02370 Nickel import ATP-binding protein NikE
MLQIKSLNKSFSEKQIFKNFNLELKDTDNLIISGTSGSGKSTLAQIIAGLDDNYEGMVNY
KDMTLGHVSQQDWLKHIQYVPQYNANTLDTKKTVSWILKQPLKHFNIPKNQHDDKMLSVI
EQCKLDKSLLPKKVSTLSGGQFQRLWIAKALLVEPEVLILDEATTNLDVINEEIILQMLR
NMDKLQLIIITHDPYLLDSLPGKHLKIEHI
>SEQF2892_02371 hypothetical protein
MSKDEMSHDHITGDFQISQKPYWKLLLQSLFLICILFVAESMVIFLVEKPKYFWIAIVGV
IIAFLILKLSKLKLFQFSRITKKQWLIIIIGFILANGADYIYFEFMPTTGNEKELEESYR
NVPLYLQLIAIGILGPIIEEIIFRGLLIKGIFRGAPIVGGILSVILFAGAHGPSNIGEWF
IYGFSGFIFVIAYLTTKRLEIPIIIHMLGNILATFQNYFW
>SEQF2892_02372 hypothetical protein
MMNHQNMDTISNTTSSSNEDNSTKDHIHTEKRRPTGNKFVRALIFIGWMLLIQIPIVSSM
FIYSFSIYMDTLTCTLVTIIYFILAAVIIWLVRGYYKRHTYEKPKKFTGKDIAVNVGWAV
LLRLIVIGMSYLMLFATGSMQTQNDKMLLGDMNAAKPTPDQLGQVFPLIVFVLTITFVAP
YLEELVYRGIFKEILFKRTRFWLPFILSSLIFASQHGISNWVAILMYTMMGMIFYLAYHR
RKNVRDSMMVHMIHNGVSGIMVLVSYFMVFFS
>SEQF2892_02373 hypothetical protein
MKKYLLVIPVIILTFTLVGCSSSSEEKNSKDTSNDNKQSQNSSKHNHKIPKHIFDKTTKN
QKISESTIKKDIKTYLDTDRKLTDAREPYEDKLDSDEKLSKKKEQKFNHIVDLQERNLKN
FANYINNNQMPNKEYEQYTKKISNYMIAIYQTNQRALNLDEDASLKDILDVNKDKNIANG
REQAKIEKFLKEKNIQTIAFDK
>SEQF2892_02374 hypothetical protein
MKILKIAGMFLLALLIMVVTQGIASIFSDLIPFLGMGAILQGILYIIFAFLVVRLFIKHV
LKDRLNAYRITKPKFSVIYVVLGIGLPVAVYAVYVIFVPGDFIVHHFSTLNDILHTFFWA
IFVTAIGGAVVEEMVCRGLLMGYIEKKTNINIAIISTAIFFGAIHLLNGGLNVTSFFLLL
ISGSLVGIMFGLATYKFNTIWASITLHFCWNLSQLLLITEKESQYSIWQYVVHTNNIAIT
GNQFGYEASIISIAGYIGVILILLMIKHRDIQ
>SEQF2892_02375 Sodium/glucose cotransporter
MHQVGFGAWNWVAVIGYLVIMLLIGAYFTKRAGKDTDSFFTASGRLPSWAIGFSIYATTL
SAITFMSTPEKAFLTDWAYIAGNIAIIAIIPILIAFYVPFFKKLRVTSAYEYLEARFGPS
IRVIGSLLFVIFHLGRIAIVIYLPTLAITAVSDMNPFIVASLVGILCILYTFLGGFEGVV
WSDFIQGVILLGGALMIIVIGAFEIKGGFGTIVSDAIANKKIISADNWKLNGAAAAIPII
FLGNIFNNLHQYTASQDVVQRYQASDSMDETKKSLWTNGVLALISAPIFYGMGTMMYSFY
QHEQVLPKGFNTSSIVPYFILTEMPPFVGGLLIAAIFAAAQSTISSSLNSISACISEDIK
HRFFGKGADKSEVNFARLVIVVAGLLSYGISIYLIAADSNNLWDLFLLITGLFGVPLAGI
FAVGIFTKRANTFGVLVGLVAGVIIAYVLNDVGGGNAPFYVSIISFVVAFIFGYLVSLVV
PSKNAKDITGLTIFDKDKPSTYISKVVEKK
>SEQF2892_02376 N-acetylneuraminate lyase
MEDKLKGLYAALLVPFDEHGQVKEEGLKQIAKNAIETEKLDGLYVNGSSGENFLISKEQK
KQIFRVVKETVGDDVNLIAQIGSLDLNEAIELGKYATELGYDALSAVTPFYYPFSFEEIK
QYYFDIIEATQNNMIIYAIPDLTGVNISIEQFGELFNHEKVVGVKYTAPNFFLLERIRKA
FPNKLILSGFDEMLVQATISGVDGAIGSTYNVNGRRARQIFDLAREGKIAEAYQIQHDTN
DIIETVLSMGIYPTLKEILKSRGIDGGLPKRPFRPFDESHRDALDTLIKKYDL
>SEQF2892_02377 Beta-glucoside kinase
MYKIAVDIGGTNIKVAVINDDLEMIDYKKIKTPDNFHIRIVDETYKLVEGFVNQYQLKNP
FIGISSAGVVDSDLGQIIYTGPTIPNYDGTQFFDVFKDLSDDIAVYNDVDAALLGELKLH
RYEEDHIFCLTLGTGIGGAFYSEASGIYQGSRHRANEIGYLLYREEDGKTYEQRASTSAL
KNLMTKYQFEYGTDVPKIFDLAEEGNEEALNILNEWSNYVAEGIAQIQIIYDPGLILIGG
GISSQGETLLKYIEPKIHHYLPSDYGIAKIQTTQTKNHAALFGAITKQ
>SEQF2892_02378 putative HTH-type transcriptional regulator YbbH
MKFENRIQRSRHVLTKMDKKIIEYIQTHELDENFSTINSLAYAIGTSPATITRFSGKLNY
ANFQDMKFNLQHEKSEKVVENAPLVQLIHRYHQNIIQQTGEFISEEKIKRLAHNLKTCRQ
VNFAGLGSSGLTASEFYYRTMRMGIKGSVSTDAHQMKISASLLSSRDMFVAISNSGETLE
LIEAAKIARNQGAYVVVITNFEGSALTKNADLVLITTAQSSNNDSKFINSQIATLFLLDI
VSYLLLNDTHMHHVYQQTRDVILGNEKE
>SEQF2892_02379 Putative N-acetylmannosamine-6-phosphate 2-epimerase
MLPNGLIVSCQALPDEPLHSSFIMSKMALAAYQGGAVGIRANTKEDILAIREEVSLPVIG
IVKRDYEGSNVFITATSKEVDELIESGCEVIALDATTQTRPKESLEELVHYIREKAPHVE
IMADISTVEEAINADHLNFDYIGTTLRGYTSYTKGHILFENDFEFLKEVLEKVNAKVIAE
GNVITPEMYKKVSDLGVHCTVVGGAITRPKQITERFIEAVQQK
>SEQF2892_02380 Glucosamine-6-phosphate deaminase
MKITNLVDKKLASDYVAIELLKLIKDKPDAILGLATGGTMTDVYPRFSELLSANHVDLAN
VQTFNLDEYVGLEPEHAQSYHTYMHQLLFDHNASWNADNIHIPQGHVDDLEREARRYENQ
LKQIGQPDIQLLGIGENGHIGFNEPGTSFESETRVVDLTESTINANSVHFDHIDDVPKQA
VSMGLNSIMRAKRIILLAFGERKRDAIHQLLNGETNESLPASILHQHPNVEIIVDDTIFN
RL
>SEQF2892_02381 hypothetical protein
MNNDFRFPNAKHFFSWLAWLSIIALIALIILNLIVYSTFKSFNNFTLAFEFHQTELIFLI
TFSVIAVISIIMYLILKLFKHS
>SEQF2892_02382 N-acetylglucosamine-6-phosphate deacetylase
MSTNYVITNGKIYTEKQVIENGYLVVEDGKISDIQQGTYTGELEQIDVKGQNVLPGFIDI
HIHGGYGEDAMDASYDGLKHLAEQLLSEGTTTFLATTMTQSDANIEKALKNIVAYQADQQ
RGEAAEVGGVHLEGPFISEHKVGAQNPKYVQRPSASKIQHFQEVANQQIKIITFAPEVEG
AHDTLNQLHEDIIFSMGHTVATFDEANEAVDHGAKHVTHLYNAATPFEHRDPGVFGAAWT
NEQLNTEIIVDGIHSHPASVHIAYKQKGNEHMYLITDAMRAKGMEDGEYDLGGQNVIVKG
KEARLASGALAGSILKMNDGLYNLIEYTHDSLENLWRVTSLNQAIALKIDDHKGSLAIGK
DADIVVVDDTIRVDKTIKSGVVHQY
>SEQF2892_02383 Ectoine/hydroxyectoine transporter
MNDKRKKNNYLVYGISVAIIILITAMAGIFPKAFGANAQHIYNFISNSFGWLFLLIIFIL
DIFLISLAISRYGRFKLGSDDEEPEFSFLS
>SEQF2892_02384 Ectoine/hydroxyectoine transporter
MLFSAGLGVGIVFWGVAEPLTHYLHSPFPKDVPNQSAESARVAMGYTFFHWGISQWSIFA
MAGLIVAYFQFRKKRDGLISTAMEPVFGQAYKRPFRNVIDILAIIATVMGIATSIGLGIM
QISGGLNHVFHVPNNNVTKIAITVLMVCIFLGSAITGLNRGVKWLSNINIILGAVLLLFM
LIFGDLKFIFESYTLAIGDYIRHFVEYSLRINPYSGNNAWIQQWTVFYWAWVISWSPFIG
GFVARVSRGRTIREFIMCVLIVPPLISFVWIAGFGGMAVKVAMGGDNIAKLVDKDYTVAL
FELLSKFPLADITSILAVVLIFLLIVTSADSTTHIVAGMATGGSENPKVKHKVIWGLLIG
AISVAMTIAGGLTSLQTASVVTGLPFSIILLLMTLSIMRALRREHTKHFQMSYIDDDKNY
SIPLEQREDHNKSNEKEKDKEQNNEEE
>SEQF2892_02385 hypothetical protein
MKKNNNMNLYFNLLPLIKLIISIFLFILYFVIYHVDDNWVIVSLYCLLPIFVNSSITLAY
KLFNK
>SEQF2892_02386 hypothetical protein
MNYKQSSPEVLRQLIRDGELVGHTSGMAEGYIQANVVILPSKYAYDFLKFCFRNPKTCPL
LDVSEVGAHSFPYYGPYADIRTDVPKYRIYEHGQLIKEVDDITDLYTEDMVSFLIGCSFT
FEHALLEAGLPVRHIEEGHNVPMYRTNIPAESSGYFKGNITVSMRPMTMTQAIKATEITS
HFKNVHGTPIHIGTPEELGITDIDKPDYGEAVTIKPNEVPVFWGCGVTPQSVALDAKPEL
MITHSPGHMFITDIKDSELND
>SEQF2892_02387 hypothetical protein
MFTIGTLIAKDDTWILWAIIIVWATVSIFLEQKYQWASTISGAIIALVGAMLLSNFKIIP
TESPVYDTVWDYAVPISIPLLLFSSNILKIWKESRRLLYIFLIASVGTLMGTTVGFILLH
QWIPYLAKIGAMMTGSYIGGGVNFAALSTKFKTPSDMISSTVVADNSVMALYFMLLIVIP
SLPIIKRWFKTDYQTESTPEMQQSYWQPKQIQLLDIALSIAIAVALVAISFKLSEVIQHV
IPQSNVLLTILVSFFGDQYLLLTTLTLLAVAIWGDFFDKLAGSSEIGTFIIYIFFVVIGT
PASFMTIIKTAPLLFVYVMIILIFNLGLSLILGKLFNFKIEEILLASNATAGGPTTAAAL
AISKGWQGLVGPILIIGTLGYVIGNYAGTLIYQLLIHIG
>SEQF2892_02388 Putative malate transporter YflS
MNNSVKYKKFILPLVIGILIAVLAPFRPESLSLDAWLMFAIFVGTIIGCITQPMPIGAVS
IIGFTLTVLVGVIDTKTAVQGFGNPSIWLIAMAFFISRGFVKTGLGRRIALQFVRLFGKK
TLGLAYSLVGVDLILAPATPSNTARAGGIMFPIIQSLSKSFDSDPKQGTERKVGSFLIFT
EFHGNLITAAMFLTAMAGNPLAQNLAEKTAHVHVTWMNWFLAAIVPGIVSLIVIPFIIYK
MYPPTVKETPDAKDWAENELADMGSIAKAEKFMIGVFIIALLLWVVGSFIGVDATLTAFI
ALSLLLITGVLDWKDILNETGAWNTLVWFSVLVMMADQLNQLGFIPWLSHTIANSLGGLS
WPVVLVILIIFYFYSHYLFASSTAHVSAMYAALLGVAVAAGAPPLFSALMLGFFGNLMAS
TTHYSSGPAPILYAAGYVTQKRWWLMNLALGVVYFVIWLGLGSLWMKLIGLM
>SEQF2892_02389 hypothetical protein
MIPEERNSYTLTEEEAIIFATAKFKPFHNRLEEDTPQPNPFKKLVENEKDKPSTL
>SEQF2892_02390 hypothetical protein
MKKINHQLCNIFELTNYEMEDEFLLKLIRRNISKFKTSSNPSIASYLQDKALSLNKQNSI
RTYLLIDSDTSELIGYFCLKIVIIKFEINVSKNIKKKISSDAMKNNEFPSLLITKLARDD
QYKGLVSGKTILEYAFSIAYDIYKKTALKHVCVDWYDHFKLEKFYCEDCGFKIFQYRNTD
KGKIVSAFYKF
>SEQF2892_02391 Biotin synthase
MRLNLAERILNQDVLSKDEALALFEDETIDTFELLNEAYIIRKHFFGKKVKLNMILNAKS
GICSEDCGYCGQSVKMKEKQRYALVEPDKIKAGAQVATENHIGTYCIVMSGRGPTNREVD
HICETVHDIKVLHPQLKICACLGLTNEEQAEKLKEAGVDRYNHNLNTSERYHNEVVTTHT
YEDRVRTVEIMKANHISPCSGVICGMGETNEDIIDMAFALREIDADSIPINFLHPIKGTK
FGGLDLLSPMKCLRIIAMFRLINPSKEIRIAGGREVNLRSLQAIALKAANSIFVGDYLIT
GGQPNELDYQMIEDLGFEIDG
>SEQF2892_02392 putative oxidoreductase
MSKFAPLLEPITLSNGITLANRFVLSPMTTNSSTKEGHITEEDIRYAKRRANSAGLQVTG
AAYIEPYGQLFEYGFNISDDACIPGLRKVAQAMKQEGNKAIIQLAHAGRFSNTAIMNYGE
VYGPSPMTLHSPIKHDVLEMSVEKIHDVIQQYADATSRAIQAGFDGVEISVAQRLLIQTF
FSTFSNQRHDQYGVDSLENRARFGLEVMQAVQKVIDEEAPSDFIFGYRATPEETRGSDLG
YTVDEFNQHLDWVMEVANIHYVAIASWGRNIYQNKTRTPGDNYGRRVNQVVYEYLNGHVP
LIASGGINTPETALDALNNADMVGMSSPFVTEPDFVHKLAEGREDDIDLHVHPDELDELA
IPHAAFKDIVQMMDYGEGLQKKTRDELRKLEKNYDEE
>SEQF2892_02393 Limonene 1,2-monooxygenase
MDFNILDYAMIDEGKDATQALQDTTRLAKLADDLGYKRFWLTEHHDVPAFASGSPELLMM
HLLGETKRIKLGSGGVMLPHYSPFKVAENFKMLEALHPGRVDLGIGNNPGTAVVKRAMDE
DKRDYLDYAQSIEDIRHYLTQAPEEQRVGQVISQPHLSRHPEMWLLSASQRSAKLAATQG
MGYTLGTFLLPSQDKIDAAKASVETYREHFQQTALNMSPTVMLTTFAIVTDTEEEAQDLL
HALDVWLLGKRQFAEFDRFPSIETAQQYNLSDRDKRVIAQHRARILAGTIEQVKPRLDAM
IQEFKADEVLVVPLLPGIDQRCRTIERIAQAYL
>SEQF2892_02394 Glycine cleavage system H-like protein
MAKLANYLYVEKVGNQYIYRMTPELQDDVGTVGYVEFMGPDDVNVNDEIVSIEASKTVLD
VQSPLAGKIVERNTKAEDEPAILNSEKPEENWLVKLENVDEAAYDALPDPDED
>SEQF2892_02395 Protein-ADP-ribose hydrolase
MSVNQQERLAYLIETMWKEQYGDKPLDLPHTDTEQWELYRGLANVRPPEPVSSEYLDIQD
AYLSTLNNQQDITHIDDLTPVSDEPLYLWLGDITTLDIDGIVNAANSRFLGCMQANHECI
DNIIHTKAGVQLRLDCAHIIEQQGRKEGVGKAKVTSAYNLPAKYVIHTVGPQIRKQPVSQ
MNRDLLARCYRSCLALADEKGLRHLAFCCISTGVFGFPQDEASRIAIETTRQYLHETGSE
LKVLFNVFTDRDLELYKEAFNDNNR
>SEQF2892_02396 hypothetical protein
MTTTDNPTHNENWIALDKAQQQDATQTDILAQAIDEADAIVVGIGAGMSASDGFTYIGER
FTQNFPDFIEKYNFFDMLQASLHPFDSWQEYWAFESRFVKLNYLDQPVGPSYVALKKMLE
HKDYHIITTNADNAFLVADYDLNKVFHIQGEYILWQCSQHCHAQTYRDDDAIREMVAKQE
DMKIPYELIPHCPKCDAPMEINKRKAQVGMVEDADFHAQLDRYNHFLDTHKNGKVLYLEI
GIGYTTPQFVKHPFQRMTRHNPNAVFMTLNKKAYRIPKSIQDRTIHLTEDIASLIINAQR
QLTT
>SEQF2892_02397 Lipoate--protein ligase 2
MYLIEPIRNGKYIDDGAVNLAMQVYINNNIFLDEDILLPYYCQPKVEIGRFQNTAVEINQ
DYVDENNIKVVRRDTGGGAVYVDDGAVNVCCILEQDTSIYGDFQRFYRPAIQALHNLGAT
DVIQSGRNDLALNEKKISGAAMTLLNNRIYGGYSLLLDVDYDAMVNVLKPNRKKIESKGI
KSVRARVGQIRDALDPKYQDITIHEFKDLMIKQIMGIDDIKDAKRYELTDEDWAGIDQLV
AEKYDNWEWNYGRSPRYEYNRNERFSCGTIDISLSIEHNRIAACRIYGDFFGQGNIHDVE
EHLIGTRMVKADLIERLNDIDLTFYFGNLSVEEFVSFILS
>SEQF2892_02398 hypothetical protein
MFYILLFISVLIFGIIWTIITNKYLPSETLDTKNTDRTGYDERQRTMFLEIFSKTFVGLV
YTFFIGMILKIFALYQGHHTVYPFNQFPELAYILIVALLLVMNYFIVKKKYTP
>SEQF2892_02399 hypothetical protein
MGMSQDTLSKNVNVSRQTVNAIENNKYDPTLQLAFKLAKQFNTTVDDLFNP
>SEQF2892_02400 hypothetical protein
MLKRQDEMEKQHFSIASKWTTVYFFIVLAVYNFYIKFTEGDFNIVWLILLIGLVIYWGIA
TYLKYKTRIKD
>SEQF2892_02401 Carbamate kinase 1
MSKIVVALGGNALGQSPEEQLELVKGTAKSLVSLIQKGYEVVISHGNGPQVGSINLGLNY
AAENGQGPAFPFPECGAMSQAYIGYQLQESLLNELHALNIDKQVVTLVTQVEVAGDDQAF
NNPTKPIGLFYTKEQAEQTMEEKGYKFVEDSGRGYRRVVPSPMPINIVELDSIETLIKHG
TLVIAAGGGGIPVVKEEGNYKGVDAVIDKDKTSALLAAHLKSDQLIILTAVDYVYINYGK
DNQEALGEVTVDEMNQHIADGQFAKGSMLPKVEAALQFIEKNPEGSVLITSLEDLGDALD
GKIGTLIKK
>SEQF2892_02402 Ornithine carbamoyltransferase
MQNLRNRSFLTLLDFSQKEVEFLLNLSEDLKRAKYAGIEQQKLKGKNIALIFEKDSTRTR
CAFETAAYDQGAHVTYLGPTGSQMGKKESAKDTARVLGGMYDGIEYRGFSQRTVEELAKY
SGVPVWNGLTDEDHPTQVLADFLTAKEVLKKPYHEINFTYVGDGRNNVANALMQGAAIMG
MTFHLVCPKELNPTDELLNRCKEIAAKNGGEILVTDDIDEGVKGSDVIYTDVWVSMGEPD
EVWEKRIKLLEPYRVTKEMMEKTGNPRAIFEHCLPSFHDTETKIGKEIQEKYGLTEMEVA
DEVFESEQSVVFQEAENRAHTIKAVMVATLGE
>SEQF2892_02403 hypothetical protein
MDLLIGTLFLILVLIIFTLFTYKAPNGMRAMGALANAAIATFLVEAFNKYVGGEVFGIKF
LEELGDAAGGLGGVAAAGLTALAIGVSPVYALVIGAACGGMDLLPGFFAGYLIGYVMKYT
EKYVPDGVDLIGSVVLLAPLARLIAAGLTPVVNNTLLKIGDIIQSSTDTNPIFMGIVLGG
IITVVGTAPLSSMALTALLGLTGIPMAIGAMAAFSSAFMNGTLFHRLKLGDRKSTISVSI
EPLSQADIVSANPIPIYITNFFGGAAAGLIIALSGMINDATGTATPIAGFLVMFGFNNPM
TVVIYGVVMAIVGGLAGWIGSLVFKKYPIVTKQDMIDRGAKDA
>SEQF2892_02404 HTH-type transcriptional regulator ImmR
MKTKSVGERIRNLRKSKKMSQERLAEKLNVSRHSISNWERDVSSPDIHALLEMTELFGVS
LNHLVKGDELIVNKYVYAALAFFLGSLGAHRFYRKQYGKALLYILFCWTGIPGVIGMIEG
VIAFIKTADAQGNI
>SEQF2892_02405 hypothetical protein
MRRSLLTYIILVFVLTYSIEGLVYLIGGLQAFSIIASLTMLFPAITAIIVWAIYYRDKKF
WKFFGLRLGKIKYWFIHPLMMLLALIIIYLVSYMLNPNQFLNSTEQQDRMKEIFIFLPDV
PLFINLLIPIILNLSIGILFSMIAYLGEELGWRAFMYPKLTNIGITKGLILGGFIWGLWH
LPLILMGHNYPNHPILGNIMMILMCIPFGIILFYSYIKSGNIFVPAIMHGILNQFSSTVT
TFSIKESQFNPLLYGSTGLVGIVIFSLVALFLIKTIKKSNHIYNF
>SEQF2892_02406 hypothetical protein
MALPFLITFIVLVIGISTGLMQNVSVSTDIHIWAMFLFNCLFAVLYEAFPEEVLIRGLIL
NELRK
>SEQF2892_02407 hypothetical protein
MKVRQFSIYKILTYMILTIAILEVAGELGGLAMNHGLA
>SEQF2892_02408 FMN-dependent NADH-azoreductase
MISIIYAGNQSGTCYGIFKLLTQKLENKEKYIFNLQLIKEDILILEKGYKHELTDKQNKF
INIINQSDTLIFIYPLYWLNMPMLLKGFIDMTFWPNEAFSFKNKQYYKNGLWKDKKAIVI
YTIGGSEWFNLLNLNLGYRVLKYPLNLVGISNIKKFYIDQLNRSNKQSVNKKVNSLVEKV
MKSI
>SEQF2892_02409 HTH-type transcriptional regulator CueR
MQIDEVSKKLNISKSMIRYYEEKGLINISRNQNNYREFNQTVYTTLKLIKDLKRLNLSLE
EIKYIVNLFNKPTSKECNIQSTKYLDRIIKDYKRSINEQINILNRLEQVKELSQDMKFEE
NKTEILNMLAGVKEYD
>SEQF2892_02410 hypothetical protein
MSLIIKYLKMIGVIILTFVLTVIAQNIALLWHLLDLKSFETILHGITYVGLTFLFIKLLI
NKGFKEKLSDYRINTLKFSLSYLSVGLLIPIINIIIYCVFIPGHFEITKADTVIEYLEML
FEIIVLGGVCAPIAEELTVRGLLMGYIEKKENITFAIIVTSVLFALVHLFNGGMSGVSLI
LLVVSGTVAGILYGMTAYKFNSIWPSVFMHMCWNLSDFVHIATHNDDYGVIQYIIKVKNI
LLTGGAYGNTSSLIAIVLFVIAIILVAMKSVQRINLRD
>SEQF2892_02411 hypothetical protein
MKLAEQIRKHRKENDLTQDQLATELYTTRQTVSKWEQGTIEPNAQMIVQLAQRFDISTDE
LLTGQTSHPYKREESQSYPEHLNFWDFLSQKWWFVLILVVIVCGTITQIFTS
>SEQF2892_02413 Putative thiamine biosynthesis protein
MEKLIVGLEWFLNPDHLPLILGIEKGWFKEEALEIEMIEPEKHFDALEEIENNSMDIAIT
EPIHLVEDKATNQNVVGFARYLHTNGGVMYNKDKGIKTPKDLVGKRLQYPGAPDLGGIAI
AKTMIEANGVTYKEGDITPVNNNFYHTDALLNDKADAATLIFENFEILEAKSKGLNVDYF
ALKDYNVPDFCQLIFITTPNKLKEDKGKIKKFLKVIKKAIQFINTHLEEAVDVYAKYTQT
DVSNQLNKDTIIATTKCFTNDLSMSPEFYDDLQLWLKENGKIETTIDAKEYFNNHLLFNR
TSK
>SEQF2892_02414 Lipase
MDNKQLGNKRESFSIRKYSIGTASILVGSLLFLGGGEALAAESNESNTSEKVPMEQTQSA
QEQPSHEASTERVEQPQNKAIATQETKTNEDASSEETQSNEADTKSNEVIHNDTQSNETS
EQSTEEPKTQQNKASDDVTTQEVTSTEQPTQEKTQSTSKQEVTTQETSTTEVQPKNEQSQ
TEEQPQHETKETSSQSNTQEAPTKETKKPTQPITENKQSEKSNTTQQTNQKANSEVSQSN
VTSTEEVTNTNETRTRTQPFSKEEMNKVTATEESDVAVSDVPQTQMKYMSTKQKQVLFNT
LQRDANTQDQQPKAILSTIPEWTSAQRTKNASRTGQDQLNITHKGRYTSGADFGNGGTEI
VKYNPKNGYAYSVNGDKEALDIIDVKHPGKDGAINLVKRIYLQDNGIEAGDLTSVTVHPS
GDYVAVSAPAVDKTKPGHVVFYGSNGDYINNVTVGSLPDMVTFSKDSKYLLVANEGEPSD
DYTVNPPGSVSVIDVTGGPANVTANNVRTAMFTKEHQEGIRALGPNAEDAYLNIEPEYIA
VDSQSKYAYVTLQEVSAIAKVDIVKGQIVQVKGLPYKDHSLAQNAMDVSDEDGKSELRRV
PVLGLLQPDGIDTYDYNGETYLLIANEGDSQDYEGYSEEKRVKKLKDDIQLDARYYQGYT
QAELDDMVDNGLFDDEQLGRLKVTTSHAFKDADGKYNALVSYGGRSFSILRASDLEMIYD
SGSDIEQRVLDLLPERFNANYESADDIKVDDRSDDKGPEAENVVVGKVGSHSYAFVGLER
VGGIMIYDITNPNEPYFVKYLYDLDNKDISPEGITFESAEESPNGKPMLIASFELSGTTS
AWELEDLTGDQESDDGEDSDNPGNTNGESNDDDTTPNPPSENEGSNTDHDVDNGEQPDNG
DDTSSNDEDNHSSDDTNGNDEGLEPPYEVDGDIFEDDSDEVISDKEDNNDTSAQSHEEVE
SKGASHNINHSAHANHQEESRDKLTVNSNTHNLSVVSTKSSSHHAVTTNHGSVVSDKSNH
ANTSSDNVKKELPKSGQTETNTTLWSVLLGGLGLAFIRKRKTSKSEK
>SEQF2892_02415 hypothetical protein
MKIINLIMIIIMLITYGLVSYQLYNINHEKQLELYGYFITIDVTILGFLMTLISIIAAIR
SNKIVNDYLNTHGDMFKSIFALTFIAGSVSIFICLFLITLSTGMVNNIFLIIFIAFQLIF
ITSCVLNTYNMFEMIFKKNFKVNKNENIYK
>SEQF2892_02416 hypothetical protein
MVNIKRKFMKIEAYRLIVFDVEDVERGNGELLDFDSFDKEFQKKKINNHTKLEHGLSMHT
LNSINKIEQTKYELIFSKLDSTDYPIVVNNSGEISDMKDNISNDSRIGHITCGLYDDTYK
VLLLQINFNAMTVSNIENYINKVFIKEDKVIKLIPLIDSGVFTKAKNGYKTKIDVSMHVE
KEKTTDKKSSLLFKKYSEAQEMNAVNASFSFSMGHVRKDSLEEKQANQLLKDIEENMNII
GKAKVSYKEQLEDKITVADLLLQKLHAFIYFDIPERATLREETILREIKKKYDESFVNQL
RDFFATQTFK
>SEQF2892_02417 Type-1 restriction enzyme R protein
MSYQGEFALENEVIKQLESQGYERVILRDHDQLVNNFRQILNERNMDKLNNKPLTDTEFA
RLMTDISDKSVFESAMQLRDSYTLERDDKSKVYLYFLDTEHWCQNKFQVTNQVSVDDKYK
GRYDVTILINGLPLVQIELKRSGIAITQAFNQIERYRKHNYRGLFRFIQLFVVSNKKETR
YYANSDKEIFKSFMFYWSDKDNRRINNLKEFIQDFLDRCRVAKMISRYMITNETDKLLMA
LRPYQVYAVEALINRATETNNNGYIWHTTGSGKTLTSFKTSQILSRDPGFKKVIFLVDRK
DLDSQTLAEFNKFQMDSVDLTVNTHKLLKQLDDPYQKLIVTTIQKMSNAVKTGAKVMDKY
KEDKVVFIIDECHRTQFGEMHRLIRQHFLNAQYFGFTGTPRFEENSSQDGRATADIFEKC
LHTYLIKDAIRDGNVLGFSVEYISTFAKDLHEMDDTYVANIDENELWMADDRLKLVAQHM
IDNHHKKTRNQMYTSIFTVQSIPMAIKYYKIFKQLKEEGKHDLNVSTIFTYGANEDSKQQ
TDNKHTKDELAEIMKDYNATFDKNYSLDSFDGFFNDISKRVKQGIPDERLDILIVVDMFL
TGFDSKKLNTLYVDRNLKYHGLIQAYSRTNRVEKETKPYGNIVCYRNLKDNTDRAIELFS
QTNDTDTVLSPSFEVILAQFKSELEALFKLAPTPDSVDDLEREEDKYQFVMIYRALASIM
QRLKTFDEFYFTTDVVGIDEQTYEDYKSKYLNIYDQVKTTNNTEKTSVLEDIDFKIEVLR
NDLINVQYILDLLNNIDLTDKKQTERVRNQIKQLLDKADDDKLRLKAELIREFLDKVIPQ
LDEDAVVEDAYFNFEEKVKEKEIQDFADSKEYPVELLKEVINEYEFSGQLDNTVVEQGIK
GGLLVRTQKIENVKSFVQETSEKYGAAN
>SEQF2892_02418 putative type I restriction enzymeP M protein
MSTTEKQRQQQADLQRKLWSIANDLRGNMDANEFKNYILGLIFYRFLSEKNEEIASDLLK
EDGISYEEAMNNDTYKPIVEKELIARIGFVIEPQYLFSNLINEIEKQTFQIEDLSNAVKN
VENSTRGHESEDDFIHLFDDMDLTSSRLGNTNAKRTQLISKVMVQISTLPFVHSDLEIDM
LGDAYEYLIGQFAASAGKKAGEFYTPQQVSTILAKIVTTGKQDLKSVYDPTCGSGSLLLR
VGAEAKVRQYFGQEYNSTTYNLARMNMLLHDVNYKRFQIENDDTLESPAVHEERFDAVVA
NPPYSANWSADPSFLDDERFSNYGKLAPKSKADFAFIQHMIYHLDDNGTMAVVLPHGVLF
RGAAEGTIRKYLIEEKNYLDAVIGLPANLFFGTSIPTSILVFKKCREANDNVVFIDASQS
FEKGKNQNHLTDEDVNKIVETYRNRETIDKYSYIATLEEIKENDYNLNIPRYVDTFEEEE
PIDLDHVQQQLADIDKEIADVESEINEYLNELGVLKND
>SEQF2892_02419 Putative type-1 restriction enzyme specificity protein MG438
MTEQQNTPELRFPEFNGEWQLNKLENIASFSKGKSLSKKDLNHEGEPCILYGELYTRYGS
ILKSAYSKTSIDNSSLVYSKKNQVLIPSSGETDIDIATATCIDTNENIIIGGDLNILTPT
NTDGRFISLYINGKGKYNLARYAQGKTVVHLYNSDIKKLKLMLPFDIKEQNKIGDFFSKL
DRQIELEEDKLELLEQQKKGYMQKIFSQELRFKDENGEVHPGWKLKKLNDIANVYQPQNL
SQNKFQEKGYPVYGANGVIGYYKDFNHNDTEIAIACRGNTCGRVNLTEPKSWITSNAMVV
NILDKKETEFYFLYQYLRIINYDNVISGSGQPQITRKNMNSIELLMPNYVEQQKIGNFLV
KIDELILRQDKKIELLKQRKQGLLQKMFI
>SEQF2892_02420 hypothetical protein
MQKILGFKLDNYYYFLKDYRNFYMQHIDPRFITNLFSDLNIIGTYTSWHNIDSIAYNSVS
YFDFNVPLSSFKKEDLIQFINNFYINFNNSSNLIGENLDTEYNRIILPPLILSISDEIKY
VGVSVKFFRRSEFIIEVFQNIDKSVPSKDYTYFTYSNLKIYKPIKNGEKSIQYEKSEFNS
IEETLYEYLSIIEHNIFGVLKTNFFNKHFSILYFDNKMFNLKMDSDLISHFVSAPYIEVL
GNAFHNKITKIPHYHFEIFPNKKIQAITIDKNKYNILESEYKDNRLKYTAINISYFLSSL
FPIHNKIFINELKLLRSDKWNFRSLKDINLFVQFLNNINYNHTSLYTNNNHSITELYIKL
KTSLIEETIQTEIDDIFENMKANTINEKTNYSYLYINLISVLTFIITCFSIIQVLDIFNI
GNSTMIISPFIIIALIWIAWRFYKYSNFMKIVDNLNKFGVEKPSFLIKLYNFIFF
>SEQF2892_02421 hypothetical protein
MLKSFDLDIIKHAVKIFVVATICLVITTIFCYFVHPSFNELKNMGNASEEIGNTKGLEKV
WKYIVNNGFRVPLQMFILALLPIPYLYLINLVVTIIMPGILLGFLLSFDLHKGLIGSIAF
IPHYTFEIMGFCILASALYMLNKAITRRFTNLFRKSKKENYVIKDNLINVIKFYVLIALP
LIIIAAFLETYVANFIFELMS
>SEQF2892_02422 Teichoic acid poly(glycerol phosphate) polymerase
MQIIKQDGSILHIYFENPINKIEKLYIKNEFNSLTLEKTNGDLHFKIDLVEVAKQFIQYE
NKKIYIIVEESTPILTTQSNLKVTNSQSEVSGLTEVLIDDSENIKIQPYITRNGYLHLSL
DDVDLNKTYFSRRHIDTLKINNSEAIIEGQFATLNSTLKDVQLLIKTRLTDREKFVNINL
EEIGKTKNASTYNFSVDIYKDLIEFMKYEYKNEDIIDIYLSIKVLESSENLRIKIGNPRI
MAEKLLKGEIITEFNGNIVSLTPYFTMKGRNLSFRINTYDIDSYLTYVDELKRPKRPNFL
KKENQKIWVIGEKSYKAQDNGYHFFKYMRTYHPDKPVYYIIEKDSKEAENVLPFGNVIFY
NSAEHFKIMIKADYICTTHHPELIYPTTSDIYTRKIKAVKVFLQHGVLGTKNLSNINGNQ
LKDFNVDLFITSSSREKEIVVRDLNFFSNQVAVTGLARFDELFNPNVEVKNQILIIPTWR
DCLTSIDRLQTSEYLKRMNDLLHSQKLKEIANKGTDIIFCLHPNMQPFIDYFDVPSYVTS
IKQGDIDVQKLIKESKLMITDYSSVAFDFSFLNKPVIYYQFDRNEFLGKEASHIDIEKEL
PGIIVNAQDKLERELDNIQKKQFKIDEALEKRIDRFIAYKDRNNCERIFDAITNFRETSK
VKSKIKYNILSQHAVNRFRKDKKYFKVMEKFNTGLTRLLPVKKDLIVFESNVGKLVGDSP
KFIYDELKKYNKKYQIVWATNTLYPFNDPNVKTVKRLSPEYFYYLSRAKYWINNQNFPHY
LRKHKDTIYIQTWHGTPLKKMLNDVETFQGRDANYKNRVNQAIKNWDYLISPSPYASACF
KTAFDFQKEILEVGYPRNDVFYNVENTDMTEKKKLIKQKLGIEGNKKIILYAPTFRDDEI
NKAKKHIINLKLDLPRLKESIGDEYILILRPHIIISNALNLSESLKDFVVDGTKYPEISD
LYLISDICITDYSSVMFDFANTKKPLLFFTYDLEFYKNKLRGFYFDFEKEAPGPLIKTND
GLIEAIKNITNVQEEYDDKYQVFYNRFCTFEKGIASKTIVDKFFKQDC
>SEQF2892_02423 hypothetical protein
MKKLILVFNSVLCLMFFFKYRQLKKDHHFYLTNIESEDDKLNEMGMYKDKDGNIYPIEEA
IE
>SEQF2892_02424 hypothetical protein
MNSNTEFKKGILYALGAYVLWGILPIYWKLIGGVSAFEILAYRIVLSMIFMILMIVVLKK
SQTFKRDLKHLFSHPIELIVIIIAGYVITINWGTFIWAVSNGHVLQSSLGYYINPLVSIL
LAFIFLKERFNKFETLAIIFATIGVLYMTIRVGEFPVISLMLAFSFGIYGLLKKIVKIEA
ISSIAIECIVTAPAGLIYMIYLWNTGTSSVGLNMDTFWLMFSGAVTAIPLILFSAGAKRI
PLSLTGFIQYVGPTIMFFLGIFAFKEHFDAQQLVTFALIWFGIVLYSISQYVKMKRNPRP
E
>SEQF2892_02425 hypothetical protein
MTGNTGNGCVKCGHTEVEEGTLSATGSGLSKMFDVQHNNFKTITCKNCGYTEFYKTNNNR
TSDIVDLFFGG
>SEQF2892_02426 PTS system mannitol-specific EIICB component
MAQTETQEKKGLGRKVQAFGSFLSSMIMPNIGAFIAWGFIAAIFIDNGWYPNKELSQLAG
PMITYLIPLLIAFSGGRLIHDLRGGIVASTATMGVIVALPDTPMLLGAMIMGPLVGWLMK
KVDQFLQPRTPQGFEMLFNNFSAGILAFIMTILGFKLLAPIMQFIMHILSVAVEFLVHLH
LLPIVSIIVEPAKILFLNNAINHGVFTPLGTDQAASAGQSILFAIESNPGPGIGILLAYM
IFGKGTAKATSYGAGIIHFFGGIHEIYFPYVLMRPLLFIAVILGGMTGVATYQATGFGFK
SPASPGSFIVYCLNAPKGEFLHMVLGVFLAALVSFVVATLIMKLTKEPKQDLEAATAKME
STKGKKSSVSSKLTGATTGTGAAGVAANKADDEDKKEASSEDEEEDLLDNYNTEDVDAHD
YSNVDHVIFACDAGMGSSAMGASMLRNKFKKAGISDVNVTNTAINQLPNNAQLVITQKTL
TDRAIKQVPNAIHISVDNFLNSPRYEELLNNLKKDQDKA
>SEQF2892_02427 Transcriptional regulator MtlR
MLMSTREKEIIELLIKYYGQYVTIYEIAQQLGVSSRTIHRELKGIETYLQGFNMTLERAN
KKGIKLSCDDDQIQLLKQEMAQHDTIDLSVEEQKAIILYALIQSKHAVKQYSLAQEIGVS
VQSLTKLLDDLENDLASYQLNLYRKRGEGVYLDGPESKKREFLSQLMVNNLNSTSVYSVI
ENHFVYQSINQSQQALVDLDSIFKIERILMDYLGQLPYTLTESSYLTLTVHIVLSIARIQ
NVEYVSINEDIHNSVKDTFEHQIATEIAKRIETLYDIDFNQAEVTFITIHLRGANRRTTS
KMFENNEFDDRKIQAFVNRVERLSGQSFEDYATLVHGLSLHINPAINRLEANIETYNPLT
EMIKYKYPRLFDIVHKAIDQTWRELVFPDSEIAFIVLHFGGSLKSQSTQLLHILVVCSSG
IGTSRLLATRLQQSFNEIEKITQASVSDLKMLNLEDYDGIISTVKLDITTPFITVNPLLP
ESDVTYVASFLKTTEHKAKQHEEREMKHSIQDPDQVVMNIEYGLTLLNSMQFEYKDVTIW
NHYLADYLEEHGVIAPNSQTSFAELLQDKLNQNPGWILQPYPVAIPHMKDDLILRPLILI
TILNESLGMQSTQNDLFKIKYMVSLFIPNNDEMAQLVGELSAELGHHLEQIDDYMQDPDA
MKHILRDSFLKRIQNQLT
>SEQF2892_02428 Mannitol-specific phosphotransferase enzyme IIA component
MTELFSNDNIFLNVSVGSQDEAIEKAGRALVDNGSVNEAYIQAMKEREQLVSTFMGNGLA
IPHGTDEAKGDVLASGLTLLQIPEGVDWNGETVKVVVGIAGKDGEHLDLLSKIAITFSEE
ENVDRIVNAKSAEEIKQVFEEADA
>SEQF2892_02429 Mannitol-1-phosphate 5-dehydrogenase
MKAVHFGAGNIGRGFIGYILSDNNIDVTFADVNEEIINALDNEGAYNVILANEEKTTTRV
TGVSAINSGQPSDELKQAILEADIITTAVGVNILPIIAKSFAPVLKEKENHVNIVACENA
IMATDTLKEAILDITGPLGDNIHFANSAVDRIVPLQKNNNILDVMVEPFFEWVVEKDAWY
GEELEHIKYVDDLTPYIERKLLTVNTGHALLAYAGRFYGRDTVLDAVKDEAIVADLRQVL
GETSEYIVDNFSFTKEEQAAYVEKIIGRFENPYLSDEVTRVGRGTIRKIGPKDRIIKPLS
YLYENNLRRKGLLKAAALLLKYDDMNDKETVEMREYIDAHGVKAFLQEYAKINDRLADEI
VAVYDEL
>SEQF2892_02430 Cyclopentanol dehydrogenase
MGKLDGKVAFITGAGSGMGKAQAILYASEGAKVIIADINEETVNQTASDIKAHGGEALPV
TIDVSNKESVDHAVKQGVEAFGTINILSNTAGILDDYKPTLETSEELWDRIININLKGTY
LVTNAVLPHMIDNGKGTVINIASIGAFVAGGGGAAYTSAKHGIAGYTKQLSFDYGLKGIK
ANAIAPGAVDTGMTHAMFEEGSADVIKKTNSVPAGRYGQPEEIAQLSLFLASDDSDFIHG
SIIPIDGGWLVD
>SEQF2892_02431 hypothetical protein
MMTKEQEDYIFKLKAELMFRGKDEDEVHAIGDELQDHFEMAEANGDDVSNILNTPVKDYA
DNFSKEMSFTKGLPKYLTYFVLFMFAIFTIPDFFENDFTLTLGYILNTIFIFVLSVVVPL
FLIKKAIMKYGDAKRVYVYAFIGGIILFSLMVLSTFIAKRYPIYTLVTLNQTQSIITGHI
LLAIVMVLCFIVKQKLFALVIFIVCLPNIIGQIFKAHSHSNEQFLTISLVLYIVLIIGMN
IAFFGHAYYTNRKEKKRNS
>SEQF2892_02432 hypothetical protein
MSVSNQMMKGLLDGAILGLIAKGETYGYEILEKLNENQFPEVSDGSIYPVLLRLSKKGYV
HTTTRKSDNGGPKRKYYTISESGQEELERFKEKWSYLNSGMNNLFGSDEYDD
>SEQF2892_02433 Dihydrolipoyl dehydrogenase
MMSKSYDLIVIGAGPGGYVAAIRAAQLGKNVAIVEKQHVGGVCLNVGCIPSKIFLEYGAK
MRDINSANNWGIKTNHIDIDVTSLVKRKDQVVKTVTDDVRDALRQHNVDFIEGEAEVLEG
LKVQVDQAIYTAKDIILATGTKPFVPPIEGLDKAHFEIADTFFDMEQLPKQLVIIGGGVI
ASEIASSMADLDVDVTILEKGDSILSSEIKEIRDHLSTYLKQQGVNIITNSETKKVNAKT
LEIGGKDGPKEIPYETLLFATGRQPNVHVAKALNLEQNGKCLQVNEHYETSYAHVYAIGD
LVPGYQLAHTASAHGKYVAEYIAGKQLETINQEDIPRCIYTRLESASVGLSELQAQEAGY
EVEVTTAPFQKNPKAILKGETQGMVKIVANKQDGKILGGFVVGPHATDLISEILGIKVSG
GTLNDISRIIQPHPSLSEVIGESTDASFGKAIYQ
>SEQF2892_02434 Dihydrolipoyllysine-residue acetyltransferase component of pyruvate dehydrogenase complex
MSENIIMPKLGMTMKEGTVEEWFKAEGDVVEQGESICTISSEKLTQDVEAPASGTLLEIK
VQAGEETEVKSVLGIIGDEGESTESSSTTESENEEQNNSHSENEEQQTSDTTSVNEDDSK
HNEDANKSNNVEPKNDKRIFISPLARKMAEDKSFDISRIQGTGGNNRITKLDIQRVEEQG
YDIEATNEDMQSKEDKNTKFNSANVGEGLNSMRKRIAQNMRQSLAETAQLTLHRKVDADR
LLDFKDKLSAELENANQDTKLTVTALLAKAIVLALKDYGAMNARYENGQLTEYDDVHLGV
ATSLDEGLMVPVINNADTKSIGALAKEIKSSAEAVRDGNTNDVKLSGATFTITNMGTSGI
EYFTPILNLSETGILGVGALSKEVVLEGDSVKQVSRIPLSLTFDHQILDGASAADFLKVL
AKYIENPYLLIL
>SEQF2892_02435 Acetoin:2,6-dichlorophenolindophenol oxidoreductase subunit beta
MSEERKLTFMGAINEAIDQSMEQDDNVILIGTDVSGGAGVEHIKDDDTFGGVFGVTKGLA
KKYSRDRVIDTPIAEHITLSSAVGAAATGMRPIAELMFNDFIGFGLDPILNQGAKMRYMF
GGKAKIPLVVRTVHGAGAGAAAQHSQSLYNMFAAIPGVKVVVPSNPYDAKGLLMAAVQDD
NLVVFSEDKTLLGQKGDVPEEPYTIEIGKAKVTREGDDLTIVAIGKMVAVAEETADKLEE
DNVSVEVIDLRSVSPWDEETVLESVKKTGRLIVIDESNPQCNVAGDVASVIGDIGFDYLD
GPIKKVTAPDTPVPFAANLEQAYIPNVDKVLDVASGLIEDLKQVNS
>SEQF2892_02436 Acetoin:2,6-dichlorophenolindophenol oxidoreductase subunit alpha
MEKEQARWIYKTMNEIRYFEEKVHKIFSDGKIPGFVHLYVGEEAVATGVMSQLEDDDYIT
STHRGHGHAIAKGCDLNGMMAEIMGKRDGLGHGKGGSMHVAEIDKGMLGANGIVSGGFGL
ATGAGISIRNQGKKNVAVCFFGDGAANEGNFHEGLNFASILNLPVIFVCENNQFGEGTTH
DYASASETIAERASAYNMPGVRVDGMDVVEVYKAAQEAVERAKNGEGPTLIECDTYRKYG
HFEGDEQKVKSPNDRNADKNATEDFKRQALEEGWLTEEEVDEIEKAAEQAVEDAVKYADE
SELPDVDSLHEDVFA
>SEQF2892_02437 Dihydrolipoyl dehydrogenase
MILRKWVIMMTDSYDLIVVGAGPGGYVAAIRAAQLGQKVAIVEKTNAGGTCLNVGCIPSK
TLLEHGTKAHDIRKANDWGIETQGMKVNFPKLVQRKQHIVSTLTGGVKQLLKKNKVTFIK
GEATVTKDLEVKVNNQTYQAKDIILATGSKPFIPPIEGLNDIKYETTDTFFDIETLPKQL
AIIGGGVIATELASSMADLGVEVTMIEVNEDILLTEIEEVRELLKDHLKNQSIRILTGAK
ISKVTTSKVILDNHEDVSFDTLLVATGRQPNIKVAEDLDIDMDGKFVQVDEHYQTTINHV
YAIGDLVKGYQLAHSASSHGLHVVETLAGLKPMPVSPNNITRCIYTRLEAASVGLSESQA
KEAGYDVSVTQSSFQGNAKALVKGEAQGFIKIVTDKAYGEVLGAFIVGPHATDLISEVLG
VKASEGTMNELSNIIQPHPSLSEAIGESTDAYFGKAIHM
>SEQF2892_02438 hypothetical protein
MSIIESSNNGNTPFQKLLGHQEELMQSWTQLSDVLENDGALSKELKEELRRMLAQKNGCQ
YCKAKGQPTGSLKDEKSSVCIGFTEVFIKMGDQIPDNIINVLKDSLTTEEIVELIAFIKF
TNAQQNFGAIMKLQL
>SEQF2892_02439 Cystathionine beta-lyase PatB
MTYNFDEIIDRRSTNAMNVEGYKGYLFGDADTSDLEEHDELIRMWVADMDFATPEVVLDA
IRERLDKKILGYTNIFGTDYYEAFMSWTERRFGYTFPQEHLVFSHGIVAGLIELVSYICD
DDDKALIFTPSYGPFKMACDKNNIKTVYSPMINHNGYYEVDFEDVRQKVETENIKLCIFA
NPHNPTGRVWSEDELKQLGQIMVDNDVWIISDEIHCDIKRDGQTHVPFAKAVPDYDKIVT
AMSQSKAFNIAGLMFSNIIIPNRRLLKTWKLHHFSSENPLSIVATQAAYEKGEDWLAAMN
DYLDDNFKYLAQFLEQELPHAEFKIPEATYLAWVDLSYYIKAKHIDEPIAKYFIKHAGVI
IEGQEQFVHNAEGHIRINIAVPREIMIKGLQKIKDALV
>SEQF2892_02440 hypothetical protein
MAQDSGKLKWSSLIMGTLLLIVAVIIFSYPVKNFYTLTWLIGLFILINGVIQLLFRRAAR
ALAGSGSGLIVVIGIIDIIFGLLVIFNVGASSTFFIFMFAAWFIVSSVIGLMTISKQSRL
KGLSIIVNVLGLLLGIILLFNPMMGMILVSTMIAITFAILGVTYVIDGLA
>SEQF2892_02441 Molecular chaperone Hsp31 and glyoxalase 3
MNTKRALVVVTSVTKYPDMNRPTGLWFGEVVHFADVLYKNGYKVHYISPEGGYTAIDPQS
LQEDMMTDLDWEYYQNKDFMTRLGHTVTPDAVKAENYDVIYFAGGHGTIWDFKDNEDLQK
LTQEIYENNDVVASVCHGAIGLLNVKDAEGKHIIDGKTVTGFSNSEEQAVGLADVVPYLT
EDELKNRGANYEQGDNWTEFAVADGRIITGQNPQSGKAVAEKFLESQK
>SEQF2892_02442 Dihydrolipoyl dehydrogenase
MKQYDVAFIGSGHEAWHAALTLKHAGKDVAIIEKDTIAGTCTNYGCNAKILLEGPYEVLE
KSAQYNGIIQSQDLHVNWENLMDYKKQVINPMNGMLKGMFEQQGIDVYMGAGVIKDAHTV
TVNDEALQTENIVIATGQHSNKLDIEGKELTHDSRDFLSMDELPKRMTFIGVGIISVEFA
SIMIKSGVEVTMIHHSDKPLKGFNQTHVTQLIKKLEDEGVHFYFDEETQKVEKIGEAYKV
STASGLTIDTDYVLDATGRNPNVEGIGLDQVGIEYSKKGISVDGHLRTNVSNIYASGDVL
DKDIPKLTPTATFESNYIAAHILGMTQDEIQYPAIPSVLYSLPRLSQIGVSVQEAEQSER
YTVKHIPFGKQMVFEYKNETDAEMYAVLDEEKRLVGADIYGVDAADLINLLVFIINQRMT
EQDLNQLIFAFPGASSGVIDMLKVNML
>SEQF2892_02443 Organic hydroperoxide resistance transcriptional regulator
MNNEDMKLANQLCFSAYNVSRLFAKFYEQQLKPFGLTYSQYLVLLALWEHDNQPLHEVGK
QLDLSSNTLTPLLKRLEQSGWVKRQRSEADKRQLVVSLTQKGHEQQKAVFEAVAQCLPPE
FDETQYNETKAVLSKLEQSLKALTNK
>SEQF2892_02444 Sorbitol dehydrogenase
MSETIPEKMNVALMHEPYDIEIVKRDMPKVGPKDVLIKMMAVGVCGSDVHYYAHGRVGEF
VVEKPIVLGHECAGMVAQVGDEVTDFKVGDRVAIEPGEPCRECEYCKSGQYNLCPHMEFM
ATPPYDGAFCEYVSHPADFLYHLPDSVTYEQATLVEPFSVGLQACKRADIKPGSTVVIMG
MGPVGLMAVVAAKAYGATNIIVSDLEDNRLEAAKRLGATTAINIKNEDVVERIKELTDGQ
GVNYAIETAGNPIALRSALNSLKDGGTLAIVGLPQEDMNEINVPFIANHEINIVGVFRYA
NTYPQGIQILSTTDADIDSLFTHQFELNDTKEAMELTRTSKGDALKVMVYPNGFLDK
>SEQF2892_02445 Succinate-semialdehyde dehydrogenase [NADP(+)]
MASLEVLNPATNEVIETLEYTSETTAKQQIEKAHKAFKSWREVDAHERADKLYKWFSLIN
EHKDELAELITKEGGKPLKEAQGEVDYANSYVSWYAEEAKRIYGRTIPANTPNKNIIVKK
FPVGVVGAITPWNFPAAMITRKIAPALAAGCTIVCKPATQTPLTTIRLIELAHEAGIPED
AVQYVIMPGKDAGELFTKHPVMQKVTFTGSTNVGKKLIAQAAESVENVTMELGGLAPLIV
HEDADIEYAVDQTIASKFRNAGQTCICANRVYVHEAVEAEFVQQLTQKVHELKVGNGMDE
DVTIGPLINEDGVKKVVNQLKDAESKGAKLSRSLDEAQEMGGNFLKPVVVSNANQDMLAM
QEETFGPIVPIATYSDLEDAIQMANDTQFGLAAYFFTNDYRTGFHLYNSLDYGVIGWNDG
GPSAAHAPFGGMKESGYGREGGTEGIEPYLETKYLSIGNM
>SEQF2892_02446 KsdD-like steroid dehydrogenase
MNKKIFVIGSGLSGLVASTELLKKGYHVTMLDQEPRQAIGGQAYWSFGGLFLVNSKIQQR
LGVKDSYELALNDWLGSAQFDRPDDEDYWAKQWAEAYVRFATFEKKNYLKEMGVRLTPIL
GWAERGGASASGHGNSVPRFHITWGTGPGLAEPFSRFVLEKEQEGQFKFLPRHQVTDIGI
EHNQVTHISGIILEPSDVERGEKSSRTVIDTFHYEVDELLITSGGIGANMPLIRKYWPKR
LGNPPKTMIQGVPDSTDGHLIQVTEDAGANIVNKDRM
>SEQF2892_02447 KsdD-like steroid dehydrogenase
MWFDATGKRMAAPDYPGFDTLHTLETIMKTGYDYSWFILTEDIIKKEFVLSGSEQNPDLT
DKDIKLLLQERLGSKATSPVEAFMDKGPDFILADDLGTLVRKMNDLAGNDLLNYETIKHE
IKARDLQIDNPFTKDPQVAFINNARQFLGDKLVRTAKPHKILSGRNGRLIAVKLNIISRK
TLGGIQTNLDGQALNPSMQPIQGLYAVGEASGFGGGGVHGYRALEGTFLGGCIFSDIRAA
EGIHHHIQ
>SEQF2892_02448 hypothetical protein
MPRDSLKSLKNKTVTVIGRIEHITITPKVKIPNKPIFSKILLIDVNIGGQYFDHVWVYAS
KRYFHNQEPFLQQVVKFKSKVTPYVKHGQRGYVEDYGIDYVKSLSILPNTSMEEYDERYY
DDDITVDFFLTN
>SEQF2892_02449 hypothetical protein
MKRSIDLEKTLKSLDGQKYGAYKRTKDIYAFDQFHLAIDHVQVDPFAPPSKMRLIIQRDV
AKIPSDLLDEKDKRIAVSDFLTRAFGHQATAFNRTVKGSGKNGKIFIDHCGQEMLERTSV
VINDKEIEVRIEVGMPAAGRKILGKAAAHTLINGLPKIVDQAIMYQNIDQQALQHQVTLK
LDQTYIRNQLEQQHLVAFVANNAILPRKSGVSDEPMKGAIQFTSPQAFETTFNLPSGRAV
TGMSIPEGITLIVGGGYHGKSTLLEALERSVYDHIPNDGREFVITRHDAMKIRAEDGRGI
QNVNISPFIDNLPGKKDTTHFSTDNASGSTSQAANVMEALEAQTSTLLIDEDTSATNFMI
RDGRMQKLIAPDKEPITPFSNKVRPLFEAHQVSTILIVGGSGDYFDVADQVMMMDEYHLK
DVTAEAKDIAQSDGYQRDLQANTQFGAIPSRVPLNASFSKKGKDDRMKAKGLHTVMYGKD
AIDISGLEQLVDDSQTNALTVMMNYFRHHLIDNHKSLIEATNQMYDLIDEEGIEAISNFD
GHPGNLALPRKQEFIGTLNRYRGLKVK
>SEQF2892_02450 2-dehydro-3-deoxy-D-gluconate 5-dehydrogenase
MTNIIDQFKVNGRVAIVTGGAMGLGKAMAEALAQAGADIVIADIKLDLAQETAKAIADNE
GVKTTALKVDVTNPENVSKMVDDVVNEYGKVDILVNNAGMTINEKAEDVSYENWLKVINL
NLNGVFLVAQAVGRQMIKQGYGSIINTSSMSGLIANKPQEQASYNASKAGVIMLTKSLAM
EWSKYGIKVNTIAPGYMKTALTEPMFNTGGEMIDYWMGATPMGRPGEPEELGGIVVYLAS
DASSFAQGSVFTIDGGYTAL
>SEQF2892_02451 Alpha-ketoglutarate permease
MNKTKVESGIKMANEIEKRERQFLGLPMVLIWGYIAVAIFMTGDGMEQAFLSKYIMSLGF
DNSEAGNVLTVYGLVVAIASWLSGVMAEIFSPRRVMTFAFIIWMIFHVGFLVFGLEQQNY
AMMMIMYGIRGLAYPMFIYSFVVWITYSSPSYKLASAMGWFWAMYSIGIGVLGSYLPSFS
IPIIGEMGTLWSSLIFILIGGLIAMFLVKDKKGGDVEAQRMTKKEMLREFGRGITILKNK
NVAVAFVVRIINQLSLFGLVVFLPHVYTADFGFTTSEWLRVWGLMYIITIFTNLFWGIMG
DKIGWVRQVRWFGCIGMAVSTLAFYYFPAWSGPNIFVTTLIALMFGFAVAAFVPMSAIFP
TLVPEHKGAAVSVHNLAAGLSNFLGYGLASVMLIFASAEVTIWAYAVIYVLGFVLTFFMK
VQQPGRQVKTTVNTQSN
>SEQF2892_02452 Ribulokinase
MDNTEIKQFIEDGHLTVGIEFGSTRIKAIAIDDQCQTLATGSFEWENSYRNGYWTYSMND
AWVGIQKAYGAMTQELKEKYDATVKQLASLGISGMMHGYLPFDDNDDLLVPFRTWRNNNA
NKAAEILREDFQVNIPERWSIAQLYQSALDQEAHVEKVSYMTTLSGYIHWYLTDEKVLGI
GDASGMFPIDSETQDYRDDIIERFNKKFSEKGYTQDVRDILPKVVVAGEYAGCLTETGAK
LVDPNGELQAGCPLCAPEADAATGMVATNSVAPRTGNISAGTSIFSMIVLEKPIKDVYPE
VDIVTTPDGYEVAMIHANNCTSDINAWVDLFGEVFETMGVKYDKGELFTKLFERALKGDE
DLGKLLSYGYISGEFITDVQHGYPMLVRSVDSNFNLANLMKTHIYSAFSTLKIGIDLLKE
REDIHIDSMFGHGGIFKTEKVAQSFLAAALDSPVRVMQTASEGGAWGIAVLARYMIETKT
SNLATYLNDFAFKGTESMTIEPTKDEVASFEQYTERFKQGIPLERLAHEQFNSEQK
>SEQF2892_02453 hypothetical protein
MRAAEKTNVKRVIMTANFGAVGFSNKDKSSVTAEEHWTNPNEKGLSVYEKSKLIAERGAW
DFVNATENHIEFATINPVAILGPSLNQHMSLSFQFVENIARGKMKRIPNIPMNIVDVRDV
AQLHVLAMKTPEANGKRFIATADGQISMPEIAQLIKKERLN
>SEQF2892_02454 hypothetical protein
MKEQALVTGGTGFLGLRIVAELLKQDYGVRATIRSLSKKDTILETLKAQNIDT
>SEQF2892_02455 Putative metal-dependent hydrolase YfiT
MDVRFPIGEFEAPTNSTLVDVKQWMSEIEAYSDQLKETVHQLSDEQLERCYREGSWTVRQ
LVHHIADSQINLYERLKMALTEDDVTTFMFNQERWAELPDSKLPMQVSITILEGLNQRVV
EMGNHVTEGELNRSIKLSDGSNVPVSELLAKLSWHERHHLEHIKIALSDQGVSKE
>SEQF2892_02456 hypothetical protein
MNLNSINLVSGILCLLSFLLVVSIMFTSMFWFLPGLFVMLLAIIANVLGILKGNKAINIT
MLILNIVFLVIFSSPLLLA
>SEQF2892_02457 hypothetical protein
MEEKKHKKFKFKTPHTYALLMFVIFLAWLLTYIIPAGEYAREKKGDQTLVVSGTYHTVES
ANVNFLEIFRSIPEGLISGGEIVFYIFLVGGAFGIIHKTGAFENGVNKAMRMLGKANFLM
IPLTMTIFSILGFTIGLAEETIIFVPIGIIIARTLGYDALTGAAMVILGAASGFSGGMLN
PFTVGVAQTVAELPMFSGWGLRTIIYLFILTAAISTVMLYARKVKKDKSKSIVYELEKEE
GHITQEITYQHFSKRQAASLLIIVATILFNVFGIFVFDWTFNEMSANFLLAGIVAGLVSG
LGLNGTFDALIEGMQNILFGAMIVGFAKGIVVILENGKIIDTIVHGMTTLLSDIPASFVI
IAMFILQFLLNFFIPSGSGQALTTMPLMVPISDLLHINRQLTVLAFQYGDSISNILFPTS
AILMGALAVGRITYTQWIKFVWKLILLWVIICAVAMSIALIIGY
>SEQF2892_02458 Arsenical pump membrane protein
MMTFLAILIFVITLIFVIWQPKGLDIGITAIVGAALALITGVVGWSDIVEVTDIVWNATL
TFVAVILISLILDEIGFFEWAALHMVRASKGDGFRMFVYIMLLGAIVAAFFANDGAALIL
TPIVLAMVRHLGFSKKVIFPFIIASGFIADATSLPFTVSNLVNIVSADYFNIGFVEYLSH
MLIPNIFSLLASIIVLWIYFRTTIPKTIDIRKVQSPGAAIKDQKLFRISWLVLAILLIGY
LVSEFIHVPVSLIAGIVAIIFLLLARQSDVVSTGKVIKGAPWNIVIFSLGMYLVVFGLKN
VDITTILGHIFASISAHGLFTSIMGVGFISAILSSIMNNLPTVLIDAIAIHQSQVTGILR
EGMIYANVIGSDLGPKITPIGSLATLLWLHVLAQKDVKISWGVYFKTGIVITIPVLFFTL
LGLFLTLLIF
>SEQF2892_02459 hypothetical protein
MELSIFHDGQFFIGLVEYREEDRVKLVKFTFGTEPNSAEIFNFIYGHLDELINQTKVSIE
KKKPKKVNPKRLQRQVAKEQKQPKTSTYAQKAIKKEQEMKKVQSKKSKKLKKEQTKARKR
QLKVQKNKQKKKGH
>SEQF2892_02461 DNA mismatch repair protein MutS
MNIYQTYALLVIGIIILGLIVNVVVTIIDKRKLINHIHTLWRNKKPIENFIRPNSRFDHQ
FKLKRDQHNNLIDDKTWSDLNMEEIFHRSNFNFTAIGEMRWFATLRNMFKVNNKQLLDQF
NNDETFRVNVSYHLASIGKVVYPIFPDQLKAIKRNNLFMICPFLPFIGLIICFISPSTGV
LITLFSILLNIVLSGTLKRTYDQDLKSLFYTAKVLKEGYHLDQIKGTPEINTNFSHFKGA
RLFSGLLGKVGDQDIGGAFIMLLKMAFMVDYFLFHIIQHTYYRYQDEVMACYDYVSTLDN
HYSLAMYRRTLDTYCEPTAFSNEQTLTFTNLIHPLLENAVPNDLDINHNILLTGSNASGK
STFMKAVAINLILAQTIETATADAFSYRPGLVYTLMANADDVLSGDSYFMAELKSIRRLF
DIETHMPVYCFIDEIFKGTNTTERIAASESVLSYLNHQPEYRIVAATHDIELSELLKDNY
QNYHFNETIENDEIHFDYKIKKGKANTRNAIELLRITNFPNKIYKRAKNQVKDLD
>SEQF2892_02462 hypothetical protein
MKRITIADSLRGFSLLGIFLANLLIFQFSLSGKDYIEHFHLNPVNQGIFNFIIILVEESF
LPIFAILFGFSMDKLYQSMKLKGLPRPRLKLLRRAIFLLILGFIHASYIWEGDILLAYSL
AMLCVIPFISLSTKAFKWFNIVIISLMLVMGIWSMFDDSQASTSSDKYDSASYIHKVQKI
YTEGSYNDIHHVDDIATSPKFAELEDQLGDNKGAIFLIAILFEIPLFTLGIFLSRCGWFE
KDARHFWSSKLFIYLIPVSIIAKSTLLWLGNDKISGTLVAIFGPVLSLGYMSLFKYLYQH
YEKHPIFKGLENAGKISLTVYITQSIIGTLIFYSYGLGLFGKDILIYTSILFVFIYIVLV
LLATLHQRHFRYGPLEYLLRMFTYWKWHVGKRK
>SEQF2892_02463 Inner membrane protein YhaI
MNPKVSFGEAFKLFWKNYFNFKGRSRRSEYWFMQLWHLIFYGPALILYIMSLIMIMLSAG
FQSEALSIVSVVMLVITIIYIVLYAIITFIPNLAMTVRRFHDTNRTMFIPIFSVVLGVIS
FIVQLIWNISDPNGENGWALLFILLFALVQFAISIYQLVITCLNSKFNKNKYGESPKFKG
HYE
>SEQF2892_02464 hypothetical protein
MKKLLFMCGVFLLLLAACGSNDGSKEDSAKTKSNAEQTKSKKSKKDQKLEKEVAKLSEKQ
KLALAFCVEDVDRYTLTKNEILTGIYEYKLATGNKNFKLVDFKLVKYDDSIKNAPKGMNF
YNVSPNKGNFEALIGVSNDKIFIGRMQSGSLDYKDLLGKGKEVKLIDVYKANKDNKALPE
LTDKINIVDNLSKKDKENNNPLSAEYLEKSGTVNTHFRNQVYQMISDFEGIAVGKTNYLW
DDVKMVGHSGDWIVNYRNKDGEILGTYKTKNNKIIKLDANGKVIKQEN
>SEQF2892_02465 N-acetylmuramic acid/N-acetylglucosamine kinase
MNINKKYYIGIDGGGTKTAGVIGNNYGEIVGYTIAESTNIQVKGLDSAKTTLMNMISILR
TQAKIELNDINTIYLSLSGAGRELEKNLIIKSLEEYKLHRIKVIVENDAICALASGTYGE
SGIVLIAGTGSISYCYNKKTNELNRVGGWGYVLGDEGSGYDIGRQALVAIMKSYDGRGKS
TQLTETIKKHLSLRHETDIIPYVYQNLEMRSNIASLAKVVFEVARSGDDVAIEIINNSID
SLIELVKGAFLSIDKKQYKPPIVLCGGLFSNLEFKDNVIIKLKKTYPSNEIIIPKFPPVI
GAYVLSLIENNQNKFTRTIQQAVENSWNDINKLY
>SEQF2892_02466 hypothetical protein
MHRLGISIYPTQSDLEMMKGYIDNSVRYGFKRIFTNLLSVKQEEREIFEKFKEIVKYANK
NGMEVIADINREVFKDLQIDNLDLTFFDQLGVSGIRIDSGFSAQEVAKMTHNKQNMYIEL
NISTSATFINDVLNYKPNKDNLIGCHNFYPQQYTGLSFNHFQETSESYKQHQLTTAAFVT
SQHGNIGPWKVMEGLPTLEDHRDLPIEVQAKHLLMTGLIDDIIISNAYATNEELYALSKI
NLSMPTLNIELNPDISNLEKKIILEEEHFNRGDVSDYVIRSTMSRVHFKDREFPPHNTSK
IEKGDILICNETYGHYKGEMQIALHNMENSGVKNVIGKITEDEHFLLDLIEPWQSFVLNV
KE
>SEQF2892_02467 hypothetical protein
MRLLYILSLLILLIFCLKLSQLIIKKVAINRWLLLVIMPFIIGIPILIFDEINKFGWIII
YFLITFNSILFFEKSRQLLENKKVKGVIYKSEEGK
>SEQF2892_02468 Lichenan-specific phosphotransferase enzyme IIA component
MENKNEVEIFEIIAHGGNAKSLAYEALNSATEGNFEEAKKFLDESEQEMAEAHKTQTRLI
QDEINGEKVDTSLLMIHAQDHLMTALSEKSLIEKMIELYKKLEEK
>SEQF2892_02469 Lichenan permease IIC component
MQKILQWLEKVLMTPMAKASEQRHLVAIRDGIIATLPLIIVGSFFTLFASPPIPYLADLV
QPHAEKIMIANRMTLGLMALYAAFCMGYNLSKSYKMDGLSGGLLSLATFLMMNIPLNLDD
KLAKKDAVGYVLPMADLGGSGLFVAIISMIFAVEISRLVIKSGFTIKMPEQVPSSVARSF
ESLIPATLVIIISWFIRVILNIDLNKIVNMLFEPLGKFAGDSLLGALIPVFFIVLLWAAG
IHGVAVMGAVFQPIWFSLLDQNIDAKAAGEQLPNIVVEPFFQWFVWIGGAGATLSLCILM
VFSKSEYLKKVGRFSIIPSIFNINEPLIFGTPLVMNPILALPFIFIPLVLTTITYFVFKL
GLIAKITILAPWTLPGPIGALFATNGDWKALILVLINLLIAIVLYYPFFKKYEREMLAQE
QSLNEDSAEKE
>SEQF2892_02470 Lichenan-specific phosphotransferase enzyme IIB component
MKVIMVCSGGMSSAMVVDSIKKQADKENYDLEIKAVGSEEFENQIENYDLGLVAPQVKHR
LDKFKKMGDEVGKPVDVVDPMGYTPIGAPKILKQIKGYDK
>SEQF2892_02471 putative HTH-type transcriptional regulator YbbH
MHGSLIIIESSLSDLNPSERRVAEYILEHPDEIINYSVQKLADLTNVSVATVVRLSKKLK
CKGFQDLKLKIAYDLNEPGNYQRGYAEIDKGYSIEEVTQTVFHNNTKTLRDTERILSTEN
IKHAFELIVNSRKTCIYGIGASALIAQDFKQKLTRIDYWCDVGNSFDEQVTLSANLSSED
VVIAISSSGQTKDIVNSTQLAKEKGAKVISITKYGNNPISNLSDVQLFVSSSEKAKRSGA
MSSRIAMLSIIDILYICIASNDYLSNRQKLENTRKAIKNNKFK
>SEQF2892_02472 Putative carboxypeptidase YodJ
MKKFLSILILSTLILCACSFERDVENKNDRNASTKTTGNEQKKKEVINGRTYYDGILIVN
KTTKLPSDYNPGEEPKAQRALQQMFTDAERDGVSLYKISGFRSYETQVNLYNQYVARDGE
ENADRYSARPGTSEHQSGLSYDVGAIGSDANLREQFGETKEGQWIARHAHRYGFIVRYPK
GKEQITGYQYEPWHLRYLGKNNATKVQQSGQSLEEYVKYKDRSEN
>SEQF2892_02473 hypothetical protein
MTLAFCVDHVDQYTLTKNEILTGFYLAIAPAGEEHYKLVDFTLVKYDKPIANAPKDMYFY
TVYPDKRSFAAIIGVNNEKIFLGGTQAAISDYNELMQHGREVNLKDVYLKNKNNKALPEL
VSKMHIDNKYPEISYDENGMSNKEIERSGVVGLHL
>SEQF2892_02474 hypothetical protein
MKKFLSISITFMLVLTSCSTHEPSKENKTESHTKQTDTKTTKDNKK
>SEQF2892_02475 Aspartate 1-decarboxylase
MIRTMMNGKIHRARVTESNLNYVGSITIDADILDAVDILPNEKVAIVNNNNGARFETYVI
AGERGSGKICLNGAASRLVEVDDVVIIMTYVQLDERELVDHAPKVAVMNEKNEIIQMIHE
KEGTTIK
>SEQF2892_02476 Pantothenate synthetase
MTKVIQTVSEMQQITQELKRTGKTIGFVPTMGALHEGHLSMMRRSVEENDITVISVFVNP
LQFGPNEDFDAYPRQIDQDVALVEAINVDYVFHPAVEEMYPNKLSVTLKVGRLAEVLEGA
QRPGHFDGVVTIVNKLFNIVSPNKAYFGKKDAQQLAIVEKMVEDFNHPIEIVGIDIVREA
DGLARSSRNVYLTDDERQEAVHLSKSLEIAQTLYKQGERRSHIIVGEIKTYLSEHTSGHI
DEVAIYSYPDLEVATEIQGQIFISLAVKFSKARLIDNIILGSE
>SEQF2892_02477 3-methyl-2-oxobutanoate hydroxymethyltransferase
MKNLAKLVEMKQDKTKISMITAYDFPSAKQAQDANIDMILVGDSLGMTVLGYETTTQVTL
EDMIHHGKAVRRGADDTFVVVDLPIGAVGVSDEHDLKNAITLYQETNANALKVEGAHLVN
FIKKSTQIGIPIVAHLGLMPQSVGVMGYRLQGSTKDAAKQLIQEAHAVQEAGAVALVLEA
IPSDLAGLISEQLDIPVIGIGAGKDTDGQVLVYHDMLNYGVDRYAKFVKQFGDFSVGIDA
IKHYDEEVKAGTFPAEAHTYKKKILNEVNNND
>SEQF2892_02478 Putative 2-dehydropantoate 2-reductase
MKIAVIGPGAVGTTIAYELQQSLPNVTLIGRANKIITLQPVNETIKVHSIDDINTQFDVI
IIAVKTHQLNSLIPKLHHFSHNETCFILAQNGYGLLPQLPFKHKYQAVVYISGQKSGNEV
VHFRDYRLHLQKNDTTTHLKALFDTTKIEIVLEDNIEEKIWYKLLVNLGINSITALGHNT
AQILKINEVKHLCRQLLKEGHQVAEASGIQFPNTIVDDIMQIYAGYPDHMGTSMYYDIIN
HQPLEVEAIQGFIFKQAKSHNVNTPHLDTVYALLRSHQSLIN
>SEQF2892_02479 Ribose import binding protein RbsB
MKKLLAMTLALVLFLAACSLESPLKNDKNGKTNKKKSEITIGVSISTLNNPFFVKIKNGI
EKDAKAQGMKVKVVDARDDSAKQTNDIEDLIQQQVDYLIVNPTDSSAISSAVESANNEGI
PVITLDRSVDKGEVASFIASDNVEGGKMAGNYLVDKVGKNAKVGELEGVPGASATRERGK
GFHEIADKQLKVIAKQSAKFDRAEGLNVTQNMLEAHPDIKAIFAQNDEMALGAIEAIGDK
DIQVIGFDGNEDAMKSIKNGKLDATIAQQPELMGKEAIKVVNGLMKGDSVNKQIKVPLKL
KQSKN
>SEQF2892_02480 Ribose import permease protein RbsC
MAPFIATLATMTIFRGLTLVITDGNPITNLGDSYLFQLFGKGYFIGIPVPAVTMIIVFVI
LLIILQKTTFGRHTYAIGGNEVAAKISGIKVNKIKILIYGISGLMSALAGGILTSRLNSA
QPTAGTSYELDAIAAVVLGGTSLTGGKGRIVGTLIGVLIIGVLNNGLNLLGVSSFYQQVV
KGVVILIAVLIDRKK
>SEQF2892_02481 Ribose import permease protein RbsC
MKQFTAKTSFMEKIIPFIGLILLIIVVSILNPSFLDLSNLLNLLRQISINGLIAFGMTFI
ILTGGIDLSVGSILALSSAFIALMITSGVDPIIALIIGVLIGFVLGAVMVY
>SEQF2892_02482 Ribose import ATP-binding protein RbsA
MIQMTNIHKAFGDNEVLKGVDFTLKLGTVHALMGENGAGKSTLMKILVGIHKKDQGVITN
SDIEIDYNNPKEAEEKGLTFIHQELNLYPELTVLDNLFVGKEIRNKIGILNKKEMKQQAE
QVFKELDFYIPLNKVVKDCSIGEQQMIEIAKAMMTKAQIIIMDEPTATLTDKEIRRLFDM
IHNLKAKGVAFVYISHRMAEIFEISDEITVMRDGVSVMYDETANLTYNQIVKAMVGRELD
EQFPHRTYEPQDVVLNVKRLNNPLHHIENQSFYLKEGEILGVSGLMGAGRTEMMRSLFGV
DKADNEIEIKGQTVSITSPIEAMKHGLAFITENRKEEGLILDFSIKDNMVLPSLFSFSKH
GIVDDKSSEQFVDTMRKRLNIKSPGRLPAGSLSGGNQQKVVLAKWIGTGAQIIILDEPTR
GIDVGAKREIYHLMNELTDRGVSIIMVSSELPEVIGMSDRVMVVHEGNIKGDLTGNEITE
ENIMTLATGGTLNETVYS
>SEQF2892_02483 D-ribose pyranase
MYKTGILNSNISKVLSDLGHTDQIVIADCGLPVPKDVKKIDLALTLGQPSFLEVYEVLKQ
HMEIEHVTIAEEMEVDNAPIFEQVTKDFSEIEQVNHETFKALTKNAKTIIRTGEATPYAN
IILQSGVIF
>SEQF2892_02484 Ribokinase
MTSIYVVGSLSIDLVVSTNKVPSKGETVLGESFFTTPGGKGANQAVAAARLGDDVYMVGR
IGDDDFGNQIFTNLEDNHVLTTFLKPVTHSASGTAHITLSDNDNSIIVVPSANNYVTSDY
ALEALSQAQAGDIVLIQQEIPAETVRDVVLYCDEHDMISILNPAPFREVEADVIDKATYI
TPNETESSAMFQTDIDKALERYPNKLIITLGDKGAMYHNGTEKIQIDGFKREVKDTTGAG
DTFNGAFAVGLQKRYSIAQALKLANLAASHSVTGMGAQGGMPTFSEIAGELDV
>SEQF2892_02485 Ribose operon repressor
MFYLILHLKEKSDKFLCKRLHKRGGKVRTIKEVAQQANVSVATVSRVINKSGYVKEATRK
RIEQVIEELDYYPNETARTLFTKKSKTIGLLLPDMSNPFFTIVAKGVEDTAIQKGYHIMI
GNGEMQEHKELNYLTTFKVNNCSGVIASQLSTQFAFDQFNSYQLPYVLIDRVTDNQQCIE
ADHYKGGKLQAETIIKGNAQRVLLLHQDLNYRSFEERFNGARTTLKNHDIQLWIENEHDI
TIDKLKAYVNQNHIDSVVCSNDVSALKIMKWLHDLHFHIPDDVQVIGYDDIPLAKLFYPS
LTTIEQPAYEIGKQAALGLINQLEHNDVTTKVVLDVDVIHRESTRRKKK
>SEQF2892_02486 hypothetical protein
MDKSTRILNILTLLLKGHVVTQHDLNQFTDVSKKSIQRDINTINTFFYENEFWSHSNTRV
VYNHQLAGYELKQKTQSKHSLGILSLLIKLQSLTPILHHDIHKFLLSSISSMKVSDKHVL
MSTLNQFKIRQELLPGKNLMILQKAIVNKGIVRIELKDKKIVIKPLSILYMHYDYWFTYE
EDHEIETILLRDILSVKVLNLKFKKDGTCNPVLFQIHTHFWNQFQQQFSIKEVVERSEDY
ITVWVNCTRFDAYYIAYQLAPHAKILKPQSYIDSFVERLNEIKGIYK
>SEQF2892_02487 hypothetical protein
MKRNYLMIGALTGTMLLAGCSLSDFGLGNEASEDNNKSSQTDKSNKDSNSKSDNSTNDNK
KNNDVNSVNSVKDLNQAEKVALALSDDSVSNVAITANDLKRHSYIENSNTGKKQQSIDKY
ELQATGEAVEDAPEGMTFYSASPSKGSFATLIGVSDDKVAVIGTQSTGKYRQFIQSDLGH
ELDVKDLYHKYGKDSDYKKVAKQISISGGSNSNNKNTKEYFAKIWLTARNDADDIFNGED
HTYEPVDMSGEPINPYNEDASEVYPEGTVVLSPSVTVLGHITFKDNNDGTVTFYDVPSHF
QDHRWTEDGYSKQETARILKNGQTKKIKNASDSDIEKVASYITSDTPRQPEHYDSSNSDD
SSSEDSDSSSSDKTVTRDNVIDKVEEYEGHTLDTDTYTYKEPEKNSDGDWGFSFTDKNGE
LAGSYIVTSDGSVTKYDENGEEE
>SEQF2892_02488 Serine protease SplF
MWKSKFGKTFIASVVMGTTMFGYAGHHDDAQAVGNYYYDGLHAGEYSGYLKAKKISNSSI
SNKYYPKASQSNLKSIGRVSNLNGWKVGIPEYKGQDSMGTGTVIGAHTFVTNGHVIDDKY
GKAAAPKYIKFQLNRNGKSIPYTFHANEVIKVPQYDIAIVHTKENMSKYAKPMRIATDSE
IKKLKFNTPLYSLGYSKINGDNTKPYLSKFRVTQFSPNGSEIQTKDIFRSGASGSPMLNS
KYTTMYGMRTYGHNLGGTATDMYAKQEASGGESFKGYAGKFVRQHIK
>SEQF2892_02489 Lipase
MKTRENRFSIRKLSVGASSVVVATLLFMGGGSAQAAEKQQEVGTPETASAQSIGDKDTHA
TQKGQVQSTEQDKSQASQTENNTNNSQTSLHNEHNQTDDASTTNETTTTSNETHQSTTVK
SEKPASNNDNQQTEAKQTSKQSLSTDTQTSKPTTNDGITKQQSESSKQEEPSTQSTDTAS
KEDDTIKKTTAHTQSQTNETSDNKKEALNQLHSNVVKSEDANTSSNETNPNTIKLTEQQQ
SIESNMSDKPKVDNQQGQSQPKDNDDNQGDALKTATQPQQQTLTKKEATTSEVTNRLNTQ
NSDNNNISIDGQTNSTLDSDKSSKQNKDAQSGLNTLKNNAVATTNTQSKSQAATGTKDQT
NKVAKQAQYKNQDPIILVHGFNGFTDDINPSVLAHYWGGGKLNIRQDLEENGYESYEASI
SAFGSNYDRAVELYYYIKGGTVDYGAAHAAKYGHERYGKTYEGVYKDWQPGQKVHLVGHS
MGGQTIRQLESLLRNGNPEEQEYQRVHGGDISPLYQGQNDNMISSITTLGTPHNGTHASD
LLGNEALIRQVVFDAGKVLGNKDSRVDFGLSQWGLKQQPNESYVDYVKRVKDSKLWQTKD
NGFYDLTREGATNLNRQTSLNPNIVYKTYTGESTHASLFGRQKSDLNLFFPFTLTANVIG
KAAEKEWRENDGLVSVISSQHPFNQAYIQATDTNQKGIWQVTPTKHDWDHVDFVGQDSTD
TKRTRAELQQFWHGLADDLVQSENLTRNA
>SEQF2892_02490 2-epi-5-epi-valiolone epimerase
MNINRGINHIGLTVPDIEAATAFFKEGLNGKIAYDSQRKTDEPRGGEIVEHILGLEEGTS
IIHKRMMVFGNGPNIEMFEFKDAHQGQAQTLQDIGFTHISFYIEAEHFDEAVKQLTQAGG
QPISEPHANTKYEDTEGNQTVYVKSPWGSLIELQTVPNGFYYPDDSEAEVFVPKKVDN
>SEQF2892_02491 hypothetical protein
MDNKQLETLIRIQKRLYESTKAVLSFDKRYRIKSFVLERPEGNIVIYHSPGLNEAVTDIQ
LLGGASCVLMNHEHESLGGTPRIDIPFWIHRDDVADDVAAINRTVPIDGQFEQRETIADD
LEVIPTPGHTSGMTMFLWDNDEHRFLFTGAFLCVDDGEWRIVILNSSDRQTSIKSLELIQ
DLDFDAIVPWVAIEGEGAVFFVENEEDKRNRLQKSIDRVRHGEHT
>SEQF2892_02492 Putative NAD(P)H nitroreductase YodC
MLNDFNEILEGRKSVKGFDPDYKIPHEEMNEMIAKATKAPSSVNMQPWRFVVVESDEAKA
KLRPLIQFNTNQNDTSSAMIVIFGDLQCYEEGEYIYEQAVVNGHMPQEVKEQMLPIVLEN
YKNRTRQSMNDIVKVDSSLAAMQLMLVAKQHGYDTNPIGGFKHEEIGKAFGYDLERYVPV
MIVAIGKKAKEAHTSFRMPVDRVIDYK
>SEQF2892_02493 D-serine/D-alanine/glycine transporter
MADKLQRELSNRHIQLIAIGGAIGTGLFLGAGESIHLAGPSILLTYIIVGLVLFMFMRAM
GEILLSNLGFKSFGDIAHHHIGPMAGFMVGWTYWLTWIISGMAEVTAVAKYVEFWYPAIP
NWLTVAFTILVLVGMNLFSAKLFGELEFWLSLIKVITIIALIVVGIVMVIFAMKTDYGTA
SVANIWSHGGFFPNGISGFLMAFQMAIFSFIGIELIGITAGETKNPYKTIPQAINNVPFR
ILIFYIGSLAVIMSVVPWNQLDPAESPYVKLFGLVGIPFAAGIINFVVLTAAASSCNSGI
FANSRTLFGLAGRKQGPPFLHKTNKHGVPYYAILLTCGLLSIAIILNAVFKDATKVFVQI
TTFSTVLNIMIWTCIMIAYLGFVKRNPELHKDSKFKMPGGKYTAYAILVFFAFIFIVLLI
NSTTRFAVLFAPVWAIVLVIMYQKYRKESEKATIAMEDEKDLEKELKDK
>SEQF2892_02494 Lipoprotein-releasing system ATP-binding protein LolD
MLKFDEVTKEFQDGNHIIEAVKPTSLSFEKGELIAIVGPSGSGKSTFLTMAGALQTPTSG
EIYINDKKISKMSQKQLAKMRMKEIGFILQATNLVPFLTIKQQFHLLKSYKKDVLITEEY
EKLLNDLGLKEIENKLPSEVSGGQKQRVAIAKAIYTQPSIILADEPTASLDTENAMAVME
ILKEQSKQRHKTCIIVTHDERLTKFCDKVFHMEDGRLKEK
>SEQF2892_02495 putative ABC transporter permease
MFLAWNEIKRNKLKFGLIIGILVLISYLLFLLSGLASGLINMNTEGIKKWKADAIVLNKD
ANQTVQQSVFKSSDVEGKFKEEAPLKQIGVIASNGDSEENALLFGVTSNSFLIPMIEEGK
KFNKDNDVVIDQSLKDKGFKVGDTITLSQSDEKLHIVGVSESAKYNASPVIFANDKTIEK
INPALSSDKTNAVVVKDSNWKDKNVDKDLEVIGIDDFVENLPGYKPQNLTMNFMITFLFV
ISATVIGVFLYVITLQKKNLFGVLKAQGFTNGFLMKMVLAQTFILALIGTLIGLILTLLT
SLLLPEAVPVQFNIGTLIIFGIVLILTSLVGSLFSVLSIRKIDPLKAIG
>SEQF2892_02496 HTH-type transcriptional regulator CynR
MTLINRDSNPLELTYSAERFLDYLHEIEDIDTQMRDELQTISNLKKGRIRIGVNPILATH
TLYSILPKFIEHYPGVEIELVEEVTHRIEQIVSDQKVDIGVTILPLYTEDLSYDILYTEN
VYLALPPGHQLIEQVKAHADDGEFPFHLLDIEKFILLKPEMTLRQLSNQILNDYNVVPEV
MMGTVSVENALRLVNEGIAITFVPKSVKDMTSHRFNGAFVQLNPHHYYNRVVLAYKENDK
KPLSRAAKTFIQMAKSGMKQDMN
>SEQF2892_02497 hypothetical protein
MRIGIIGATGKVGNKVLTEAQAHGHEVTAIVRNASKLNDQDVKVIEKDIFSLTVDDIKDL
DVIVNAFGAPLGEEEAHVEAGRALIKLLKEVDTRVIVVGGAGSLFVDEAHTTRVLETPDF
PDMFKPTAKGQGRNLQDLQDSEGITWTFVSPSAEFDAEGKRTGSYTLGKDELLVNSQGNS
YISYADYAIAIVDEAENAAHINERFTVVGEQV
>SEQF2892_02498 Putative HTH-type transcriptional regulator YwnA
MKISSRFTVAVHILALVKVEQSQPLTSSWIASSVNTNAVVIRRLVGKLKQANLIETQQGS
GGIQLRKPLTDITLLDVYQAVEVVDEGELFQMHEDTNINCVVGANIQSVLEIILLRAQDA
MEGVLANVTMDDIVTGILQRNG
>SEQF2892_02499 Hemolysin C
MGTTLSLITFILLLVLTAFFVATEFAIVKVRETRIAQLSNAGEKKAIAAKKVVDHLDEYL
AACQLGITITALGIGMVGESTFEFILHPLFSSIGIPEAWIHPFTIGGAFVIATFLHVVVG
EMAPKTIAIQKAEYITLLFAKPIIFFYKIMYPFIWILNGAARLILKMFNMKPAKESEVFH
SEEELKQLIHDSHEGGEINDSELHHINQAFKFDNLVAKDIMIDEKHVKTLNLNTSFDDAI
QQIKIDAFTRYPAVKDDQIVGFIHSKSLFNVEQPSKLETFVNPIINVKMNTPLKHILEMM
KKRKVHIAAVYNDADFKGIITLENILEEIVGDIEDEYN
>SEQF2892_02500 hypothetical protein
MHNHFEHIQPPNQFKYREGRTVLKQQYDFKCDNRIYFGEDIFRDLHNHSYRLYVGVLSPI
GDYGLGLDFNEVDAIYNKVIEPKLNNQLINETLPDMNTTAENIAMWIWDEFEQHLPGEHC
MYALQLFETDRHGVSLNRSIMKP
>SEQF2892_02501 hypothetical protein
MIGTSGGAQAATGLTSDKSFDVIYDEQIAPKSNETPPVKDMSGIFERYAQIQEHSNSPKE
WIENYSVYALEDHKFNESVHITRLEHRIKGTEWPSNLMITAINARKAERVALTSDSQVNL
HKAMASSGSLPGVWPATTIDGDKHFDGGCHSMENVDLAIGSKKVLILATNLPISTPYKLE
DAIKELEESGTKVKLITPSKAVFDKLNELGGNTVDPSIRPDIFKAGEAQALEDVEIIRNF
WNE
>SEQF2892_02503 hypothetical protein
MNIYKLRYQHYKDIVDDNILTVFVLAKNEEEVEQFAKKVSYAVESITQISQEEYEKEKAK
DEHFGLEHAENYLD
>SEQF2892_02504 hypothetical protein
MIPKQAYKQLVLSMLALMIAMSISRFAYTPILPFMQQDTSMNNQNAGLLATFNYLGYLIG
AIIPMFITIKSKVFDLKLYVMINVISVILMGFSEHFLIWSVLRIIAGITSGTIFVLASNV
ALEALRMANKQSISGILYSAVGIGIFSSSIFIFLYTQAQTWKATWIILGVVALMAGIIIL
TSMKNNPSISIHTTSLNQNPGKALNRAFIIPFSIAYFFEGAGYIVTGTFLVALIKTIPAY
ADYAALSWMFVGLGAMPATLIWSLFAEKFGYKKAIYSALILQIISVGLPIFSHHMLGLII
ASMLFGATFLGLTTLFMSKSQELMYYTNQKLNLVSLLTVIYSVGQMIAPMIAGLLIGDSN
NYQLALTFAMILLILGFIFSVISYRFNAYK
>SEQF2892_02505 Nickel import ATP-binding protein NikE
MLKIERLTKYIDGKLIFKDISCAINDQHLLISGESGCGKSTLAKIIAGLDMNYQGDLYFN
GQLRKSYTTKEWMKHIQYVPQYQRDTLNQRKTVLSTLLEPLKNYKFDKQSYTSRIEAVLR
QCKLPQSILNQSISTLSGGQFQRVWIAKALILEPEILILDEATTNLDVINEEEILQMLIT
LKQTQLIIITHDAYVLSRFKGVQLQLKQLNN
>SEQF2892_02506 Oligopeptide transport ATP-binding protein OppD
MSNDQQKNNAMNTVVKVNQLSILDHNRSLLNDVNLTITKGAFHCIIGESGSGKSLLTRTI
LGMKPSQLSYQGDIKIDLNKADAVFQDVQSNMFQNVTLAKHFQYIYEANHSQLSKQDIKE
DVLDKMQLLGLNQGEQLLKRYPFELSGGMAQRVAFIMSLIRCPDYLFLDEPTSALEQENV
KKFMHYLIKAQEHYQMTIVFITHDINLVKDYATHISIMQQGHLIESGEASSILANPTHSY
TKNLIAIAHRRQAYA
>SEQF2892_02507 Glutathione transport system permease protein GsiD
MKKYQTYIAISTILSVMFVLIVYCFMQDTQNLDPLQSPNSQHWLGTDQLGRDFFVRLIVG
SLVTLSLTSVVVLLSVCIGLVFGLIAGIERKWLDQIIMFIADMLLAIPSFIIALVILSLV
SNSMLGLILALTIGWIGRYLRYFRNLTRDIQKRPFVSYARLSGNSTFRTTVTHVIPHLLS
NIFALVTADFGKMMLSISGLAFLGLGIKPPTPELGTILFDGKSYFNGAPWLFFFPGVLLG
GFALLCQMINKKITQ
>SEQF2892_02508 Nickel transport system permease protein NikB
MLKRTIKLIFYLIVSSFIIFVLVEKTSGNPAILYLQRHGYTSITQENIEAAQHKLGLGQH
FLLRYIDWVGHALTGNLGYSFSTNEPVTTMIMEAVIPTLILIVVSSCIMLPLGYMVGYFI
GTRPHTRYANGIRGFAQVMTSMPEYWLAILFIYYLGVRWQLLPFVGSDSWQHFVLPIFTI
VVIEGCHILLMTSHLIAQTLDNDAYQLAQLRHYSLKVRIIVQIKEIFAPLMTISINSVIH
LIGKVVILEVIFSMSGIGKLLINAINQRDYPLIQGIVVFIIVSIMFINYLGDIIILNNEP
RLRRHTKRQAHEKRGVS
>SEQF2892_02509 Nickel-binding periplasmic protein
MKKRVLITMAASATLLLAGCGNDQKEDKNITVSLPTEAKADKLDAQGYDAAMPVYSAVYD
ALVKYDKDKGVKAGLAEKWHVDDSGKVYEFHLKKNVKFSDGSALDAKAVKFSIERAKAMN
KGTTVETLKKLDKVVVKNDHVVQIRLKSPSNQVLNELTQVRPLRIMSPHSVENGKVNGKF
EKAIGTGAFVVDKTGKEKTTMKPNKYFNHSHPVTYNLAFQTIEDGDSRNSAVQSGSVDIS
GGALGMLSDQQIKQDKKNKNLTVEDKPSTVSHFMAFNPDNDVLKQRTIREAISKSIDTKD
IAGKSVNGLFQKNVEFVNKDNQQAHDYDVKDAEKLLKEAGYHKNSDSIFEKDGKSLTFNL
VIQTAEFPSWKDKAEKVQRQLKKAGIKLNVKTLDSQSYYDTLWTKKDYDLIFYRTYSDAL
MPYNFMSSVFKNNDDKSGVLANDKTLTQQLDDFPTTVSKKEQQRSFDEIFKQFNQQYYGV
PIAYPNETFVVSDKVKQFKFSGLTDAPIDYKALKVNE
>SEQF2892_02510 tRNA (mo5U34)-methyltransferase
MTKSYDVWWQKGQESDDDMARDHQEAWERTIEMLDTSDIKGKTILDVGCNQGGFLRKLYD
TMPFKEGVGIDLARLSLEKAETLKGERPLTYYLTDKPQETNRTFDTAVSTSVLYLIEDIP
QHAQDLKEVLKPGGVYYASFADLTNNPSRQFMDDTINQYGATPSQNHSLKHIVDSFVDSG
FEVAVMKEPAPDVIDLTHYSDFYLSPNDYLQTLYEESFLIKASVKEGIGK
>SEQF2892_02511 Branched-chain amino acid transport system 2 carrier protein
MMKQKLSIKENIFIGSMLFGLFFGAGNLIFPIHLGQTAGENVWLANLGFLITAIGLPFLG
IVAIGISKTNGVFDISSRVSKGYAYAFTIALYLVIGPFFALPRLATISYEIAFSPFISAG
TGKIVLPIFSILFFLIAWFFSRKPSKILDYIGKFLNPVFLVLLGIVVVLAFIKPMGGISH
APVSANYSDSVLLKGFIDGYNTLDALASLAFGIIIVTTIKKLGITNPNGIAKETFKSGFI
SIVGMGIIYTLLALMGTMSLGHFKVSENGGIALAQIAQHYLGDYGIIILSLIIIVACLKT
AIGLITAFSETFTELFPKMNYLWLATGVALLACIFANVGLTKIIMYSTPVLMFIYPLAIT
LILLTLVSPLFNHSTIVYKFTTFFTMFAAFFDGVNASPDFFAKTSFAQALISFAERYLPF
FTIGMGWIVPAIIGFVVGLIVNLIRSRRQTQTK
>SEQF2892_02512 Putative metal chaperone YciC
MSEVNIDKDLVADGGGLSRTDEKLVELSNGCICCTLRDDLLQEVERLVEKGNIDYIVIES
TGISEPVPVAQTFSYVDEALGIDLTSICKLDTMVTVVDANRFINDINSEDLLVDRDQGAD
QTDERSIADLLIDQVEFCDVLVLNKTDLVTEAELTKLENILRKLQPDAHLIKTTNAEVDI
NEVLDTGRFDFEQASNSAGWIKELTEGGHAEHTPETEEYGIGSFVYSRRLPFHAKRFNDW
LEQMPNNIVRAKGIVWLAQYNQVACLLSQAGSSCNISPVTYWVAAMSKEQREQILNQRPD
VAQSWDIEYGDRNTQFVIIGTELDQEKIVKELDQCLVNGDEIDSDWNQLEDPYHWQIRKA
>SEQF2892_02513 hypothetical protein
MCKSILNTLRIKDKNLNFSDEVIEKKHKGRMSLFYYAELTYQPTHCENCSTKNENFSIVK
NGKKTSTITLLKIMEMPAYLELQKQRFYCKSCDSHFTAKSNIVDAHCFISNKTKLAVLDK
AQEYRSQKSIAKSCLVSSMTVSRVINQAASDVGQSSFDALPEHLMMDEFKSVKNVIGKMS
FIYADAVSHRIVDVVADRKLKSLKDHFYRYSLKLRQKVKTVTIDMYEPYMSLIKQLFPNA
KIIIDRFHIVQSLNRALNMSRVHVMNCYRTSNRPLYNKYKSYWKLFLKPFETLEAFNYHK
VHLFKEWKTEKGIINYLLGVDVELFNTYHYVHELRRLLKENQIEKFNHKLFSIHLSDVCP
KLRPVIRTLRRLAAFIENTMTYSNLTNGPLEGINNKIKLIKRVSFGYRNYDNLRNRIIIT
SRLFASTTKKEIKQPKVA
>SEQF2892_02514 High-affinity zinc uptake system ATP-binding protein ZnuC
MIDISNMNLHLNHKHVLKDITLKIPISGEIIGIMGPNGAGKSSLLKSLIGSFNASGEMNL
YGKSIHKQLQYITYIPQKAQLDLDFPINVEKVILSGCYQTIGWFRRVDHASKMKFHKLLR
DLDLESLQYKQISELSGGQLQRVLVARALMSDSTIYLLDEPFVGIDFNSEQLIMEKLQHL
KNQGKLILIVHHDLSKAEQYFDRILLLNCTVRFFGPSYQAMQPQYLNKTFLFNVTSTLKE
GSDISND
>SEQF2892_02515 Manganese transport system membrane protein MntB
MTDFIQHLLDYQFLNRALITSIVVGIVCGTVGSLIILRGLSLMGDAMSHAVLPGVALSFL
FNIPMFIGALVTGMIASLLIGYISNNSKTKPDAAIGISFTAFLATGVIIISLINSTTDLH
HILFGNLLAITRQTFWTTIIIGVIVILLIVILYRPLMISTFDATFSRVSGLNTTMIHYFV
MLLLALVTVASIQTVGIILVVALLVTPASTAFLITKNLYSMMIVASLIGIVSSIIGLYFS
FIYNLPSGATIVIATFSIYILSLLFSKIKTKYRGVQTT
>SEQF2892_02516 Manganese-binding lipoprotein MntA
MKKFIPLLIALILVLAACGSNSSEQHSKGHDKLKVVTTNSIIYDMVKQVGGDKVDVHSIV
PVGQDPHEYEVKPKDIKQLTDADVIFYNGFNLESGNGWFEKALEQADKSTNDKSVFAVSK
GVKPIYLNGENGNKDKVDPHAWLSLDNGIQYVKNIQEQLVKADSSHKADYHKQGNAYLAQ
LEKLNKDSKDKFNDIPKQERAMITSEGAFKYFSKAFDIKPGYIWEINTEKQGTPSQMKQA
IQFVKDNHIKHLLVETSVDKKSMNSLSEETGKSIYGEVFTDSIGEKGSKGDSYYKMMKHN
IKTIHGSME
>SEQF2892_02517 Putative glycosyltransferase EpsH
MTKLVSIIVSVYNKGQFLEKCIESLIDLKMDKNNIEAIFVDDCSTDESVNIIKHYEKDYD
FIKLIQLSENTGSPSEPRNIGMREAQGKYITLLDADDWLDKEGFPQVIEKVNADDADLGY
GQSYKHKFKNVKYHAKFTSYKEASHLKPQDISKIFRAVGPPGKVFKRSLVMDNHIEFEHM
KYGEDKLFFFQLFGKVDDITMSTIPMYHVNRYDENKSLVQQTSMLDKANLNLEVLDRTCH
MDMSSELKHMALARIIEVDFISRFLRTKTFIKSADKEKFYAVIEKVEQKIKEQGIDINTL
ITNPVFKQIYTLYHHADESVFVNFTKDVVNDQWRYIIQDGIVFRDFVHQYDMIKPTVVDC
YPVYEGTQMMEENKYEVIRVMKPDDISIQSVSLIEINNAANEYEVTYKYSDDKIYVPHEE
FEKLNKDININFNVNYGESGRSLVYASYPSFNDVFKMKRQNFKVEFVHKKNENKTQQVTN
RKSEYFTRIMNPMMTLKKIKIYKDVSFKEEVGSLEAGTRVEASDIQYTTKGTPRLVLDDG
SIITANKDFITLINTSGLNKYITEVPKKVKVIKACKLYDSRDFKDNTVRKLKKGDVLPIR
DIIYTTNSTPRLVTQEGLFLTANKDFIKVIK
>SEQF2892_02518 putative poly-beta-1,6-N-acetyl-D-glucosamine export protein
MRVYTSIIFWMRTIACLSVVMIHTITTTFYKFDMPNEGYLLRIFQLLLLYATPMFVFISE
FLLAKQYKTKVKDGFFKQKLLTLGIPYIIINLGLAYVYGHPKNFEDYMDSVVFMMFHGGT
LTYFIVIIFQFYLLHIVFAKHLVKLNPIKLVIYSLIITTLFWAMRNFVPAPESIYLNWLW
QREGWMIFIGWLSYFLLGFYMGYHYEKLMNHIQKYTIHILSGMVIVTIFVVCNYLFGILT
LVDSKRFDTPIYVTLVILLFFLIASYFKYVPRFIIFISNYSFSIYLIHYFFVHRLGALHD
HPLLNILFTLTVTFSICIAYVMNLSKFGKYIVGGIGKMKYETYYQSYKQNLVD
>SEQF2892_02519 hypothetical protein
MKSIETMQSYHLLELLFSNSNVSYVLEEWNQQYEAVEIKTRNGLFKSRFAQRTPNKKGYF
FVMWKKDENNTNVPFTEDDLENQLIVNIVDDNRRGQFIFPKDILIKKGILKSDDSKGKMA
LRVYPPWETGLNNTAAKTQVWQCAYFNEIVHE
>SEQF2892_02520 hypothetical protein
MALIKYQFKNYIRTYKLIAPFVTFFTLLIIMYFYSGQPIMSSFASTSMILLFVTGWITVT
IIDAESLQEKQLLFTQLKSKSTYLTNKLIFSILLILPLGIVAIIYPIITFRFEHIPNVIE
IVIGIYSHIITIIVGVLITTLLKTIPKLSYKFVWLIMMLIFLFSILRVVIIEAFSISSYV
LWIFPPISDFMMMLNEDIMLILNKDFLIINIWMVVYLVILTTVLYINFNKSEYI
>SEQF2892_02521 putative ABC transporter ATP-binding protein YxlF
MQAFSIEGKNISKEINHQAIIKNMSMNFPNNSIILIEGKNGSGKSVTLKMLANIMKPSSG
LLSVKGNISYAPDHLPMTINLTVKEYLDFIDSISIKKQSDIKISQLTHLFNLESFLPKRI
HECSKGTQQKVNLIQCLIKKADIYIMDEPFSGLDKNAIAELKSLLIQFKQFATIVLTSHE
QIVDYTFVTHRYNIEQNHLIDNSSTNADMKMLIKIRQVSEKDLSIILKEHDFQMSKDGSI
IVNSSQSNQVIALLIHNGYFIEEVRRHTKNGVN
>SEQF2892_02522 Threonine--tRNA ligase 2
MNKIPYTLVLGDDEQQHHTVSVRKYAHDENETMDIQAFIEKLKHEIESKALLV
>SEQF2892_02523 Threonine--tRNA ligase 2
MHIKDALNRSHQCATVQLDFQMPEKFELTYINEQNEKERPVVLHRAMFGSLDRFFGILIE
HFKGAFPLWMAPVQVNLIGVSDNNNGYVRTVEEALRD
>SEQF2892_02524 Threonine--tRNA ligase 2
MRHSAAHVLAQALTRLYPDVKSTIGPVIEHGFYYDIDLDESISEADLNKIEKEMKKIHNE
NLKFVRQDLSYAEAKNIFKENPYKLELIEEHRDDQLSLYQQGEFIDLCVSPHVPSTKFVN
HFKLTKVSGAYWRGNSDNKMLQRIYGVAFSSKDQFDDYFEFLREAEERNHRRLGKQLKLF
MFSEEAPGMPFYLSNGQFIRNQMESFLREVQLKHDYDEVRTPLMMNKRIWEESGHWDHYH
ENMYFTKVDENDYALKPMNCPGHMLIFKNELRSYKDLPLRIAEFGQVHRHEFSGALNGLL
RVRTFCQDDAHIFIMKSQIKSEVQEILKLIDYIYSVFGFEYSIELSTRPDDYLGELDLWN
EAEQSLAHVLDDL
>SEQF2892_02525 Threonine--tRNA ligase
MSNQQINIQFPDGSNKAYQAGVLASDVAKSISQSLYKEAVVCRVNDRLVDLTHPLQEDCE
LTFYTLSD
>SEQF2892_02527 hypothetical protein
MGEREMITPRTFIFNVLNGVALAIVVGMIPNAILGELSKYLSQYNDIFTKVAFVTQGIQY
SIPILTGVLIAGQFKLTQLQTAVTGAAAFVGSGASTFTDNKWVIVGIGDLINTMITASIA
VGIILLISHKLGSLNMIVLPIVGGAVAGLLGLLILPYTKLITLGLGDVINGLTNTQPIIM
TILIAMIFSILIVSPISSIGIGLAIGISGLAAGSAAVGVAASAIMLTVGSWRVNKPGVPI
TVLLGAVKLMMPTLIRHPMMMLPIVCTAGVSGFVGGLLNIKGTPDSAGFGLIGLVGPIKS
LNLLDMGTTSGLLIIAIAYIIVPLISALFFHYLFVKVLKIYDPNIFKYQV
>SEQF2892_02528 putative succinyl-diaminopimelate desuccinylase
MFINYTLGIDNTNIIFKVGIHMRTFQEEDKIKLLADIIEIQSENENEIEVCHYIQNLLAQ
YDIPSKILKVSETRANLVAEIGSGSPILAMSGHMDVVDAGRHDKWTYPPFKLTEHDGKLY
GRGTTDMKGALMGMVIALIELKMSGDLPKGTIRLLATTGEEKEQEGAKRFVKDGFLDDID
GLIIGEPTDNGVFYAHKGSMACKVTATGVAAHSSMPFLGKNAVDTLVQFINQLNSKYDNI
KQHDLQHELDVSPMVNKFMKGTLSEEEENFASGFTLMGSIIKGGKQFNSVPEEASIEYNV
RPVPEYNNDFVKSLFQQTVDEVNPEALSFEVVSDHRPVTSDKDSTLIQVITEVAPHYVNE
>SEQF2892_02529 hypothetical protein
MATDKSFHEIFLSKINSSKIKTRSMMGEYLVYYDGKMIGGLYDNRLLVKASNSSLEKLEG
YELVSPYPNAKEMIFIPNISDIEDIETLFSDIKNDLR
>SEQF2892_02530 FMN-dependent NADH-azoreductase 1
MKTLIINAHPDFNNESTYTAKVKNLFLDKYKTTFPNGEIEEMNLYDIDVPRIEGDQLLNV
>SEQF2892_02531 FMN-dependent NADH-azoreductase 1
MSAFLLNQFKANHLIVILIPLHNFNITSRLKDYIDNIMIARETFKYTEDGFVGLMTDDYK
ALLLQASSGVYTNDDRYTPLEFSYYYLKEMFKEIMGFDEFYNARAQGTSVLPEDEILDAA
NKDLNNVFDAFYTQK
>SEQF2892_02532 Serine protease SplE
MNKGVTLKRYSLILVVFLITMCLSYLFQFNEAHASTKSDHLGVQQTSQQQVIRQQNNSIN
VSKDKVIATQPKVQTPSKVTNRNQASLQKTMAPSKRAHVTSTHVTSKSTKVQSKVQPSSQ
NFSKQKQRQKQPTKVNKKVVSTNKKPQKVSKVTRAQSAKPQLLAQTTKVKSKSTPPKTST
RKPTTKMAVITKTKTAKPSAQTTVKASTKASSTTKKNYYNKAPKRWPSNVPGGDNVRDFG
QTTKESGIDDALKIMKKSGNKGVTIEHAKGKDANIATVYNWNPKAKQLTYGTGTAIGKHT
ILTANHVVNDQNAHKPLTPSQPQNMRINILQEGSKIVRTLEVFGVQMLQYGDVSLVYTYE
DISKYMKIRKIASESSIKAMKANTPIHMYHYGKPTGKYKNDPAGTMYHSKGKYTMPARNV
NPIGYYQMMAEPGSSGGAVLNSKNEVIGVHAFRLNSGDYKKYNLNTMAEIRGKLRKEIID
NIV
>SEQF2892_02533 hypothetical protein
MSLGTLVHVMFYTLFFIIVGMAIVFGVYLQKRKQKNSKSK
>SEQF2892_02534 High-affinity zinc uptake system binding-protein ZnuA
MFKRSIILLFVAVLTLSLAACGKGDSDKSSDHKGKLEVKTTVYPLKSFAQQIGGKYVDVE
SVYPNGVDPHTYDPSQKQMVDIGKSDLFVYTGDNLDPVAKKIAKAINDKDKTLSLESTLD
KNSDLLKGEEDEHEHEHGEEHEHGEEHEHHHHGKYDPHIWLDPVISQKFAKEIKDELVKK
DSKHKDYYEDNYNKLVKDLKGIDKDMKEAVKGNEGKTVYISHDSIGYLADRYNFKQEGIE
NMNAEEPSQKDLTNIVKQIKEDKVKYILAEENVSNKVADTVRRETDAKTIKFYNMGSHTK
QQDDDKNTYQSFMKENVKAIEKALKNE
>SEQF2892_02535 Zinc-binding GTPase YeiR
MEIIIVGGFLGSGKTTTLNHLITDALDHNLKTALIINEFGKMSVDSQLIHPTIPISEIVE
GCICCAMKSNVSQQLHEIYLEHRPDLVFIECSGIAEPLAVVDACITPVLAPITTIRSMLG
IIDAKLYEKIETYPRDIQALFYEQLSHCSTLFVNKIDIADFNQVARLLRHLEVINGDANI
QVGQWGELALNTLLNVKHLDAKQRGTLHHAINHQLIDTPRSQTKADFIERLTQLPQQVYR
VKGFVRFTDSKLIHLVQYAEGEIELTPIQFKSDVPLYLVAIGKHLDDIELDL
>SEQF2892_02536 hypothetical protein
MEEINLLEDKKLANKLAIYSYISFVVFGIIFYFIMKFSDTPKFFDSLLVNALFVIILIVL
MFVVHECIHGIFFKLFSPKNKVYFGAASGMIYCAIPGGTFTPFTFLISSIAPFVIITMLF
IVTLFLGWFPRGLFFFFATFHAGCCAGDFYWVWKMIKAPKNATIETTDKGIIIH
>SEQF2892_02537 putative MscS family protein YkuT
MSQFKDTLYKLFEPMMKIEFYQNLLVNLLIILAYILMGMIVIAISRKLVTKFFNVNEKKK
NRHKIKRSETLSTLIQNLISYVVWFIVLTSILSRFGISVSAILAGAGVVGVAVGFGAQTI
VKDIITGFFIIFEGQFDVSDYVQINASGVTIAEGTVKTIGLRSTRIQSDTGEIYTLPNGM
ISEIVNYSATDVSPIVMIPISPNENYKVIEEKLLRFLPTLKNKYDIFVSAPELLGLDSVD
GNEMVIKLLAHVKPGMHFPGQRLLRKEVIQYFSEEGIHIPKPTLVKLDKELNKKE
>SEQF2892_02538 hypothetical protein
MSQTDYQIKPDNIKGNSEETSSISKISYEIENANNKSLKKWQRLFDGWFYDYTWK
>SEQF2892_02539 putative lipoprotein
MTIEPKGKYMESRGMFLYINRNTRTTKGYYYVRKTTDDSKGRLKDDEKRYPVKMEHNQII
PTKPIPNDKLKKEIENFKFFVQYANFKDINDYKNGDISYNPNIPSYSAKYQLNNNDYNVK
QLRKRYDIPTNQAPKLMLKGDGDLKGSSVGSKNLEFTFVENKEEDIFFTDAVQFTPSEDD
ES
>SEQF2892_02540 Transcriptional repressor SdpR
MSYKELSTILKILSDPSRLEILDLLSCGELCACDLLEHFQFSQPTLSHHMKSLVDNELVI
VQKDGNKHMYQLNHSILDDVNKNLTIINTSDQHCICKNVKSGEC
>SEQF2892_02541 Arsenical pump membrane protein
MMTTLAIVIFLLTLLFVIWQPKGLDIGITALIGAVIAIITGVVSFSDVLEVTGIVWNATL
TFVAVILISLILDEIGFFEWSAIHMVKASKGNGLKMFIFIMLLGAIVAAFFANDGAALIL
TPIVLAMVRNLGFNKKMIFPFIIASGFIADTTSLPLIVSNLVNIVSADYFDIGFVEYFSR
MIIPNIFSLIASILVLWLYFRKSIPKRFDTENLSDPKSAIKDPKLFKISWIVLSVLLIGY
LVSEFIQIPVSIIAGIIAIIFVLLARKSKAVHTKQVIKGAPWNIVLFSIGMYLVVFGLKN
VGITTILADVLSNISSHGLFSSIMGMGFISAFLSSIMNNMPTVLIDAIAISQSSATGILK
EGMIYANVIGSDLGPKITPIGSLATLLWLHVLTQKGVKISWGTYFKTGIIITIPVLFVTL
LGLYLTLIIF
>SEQF2892_02542 Glutaredoxin arsenate reductase
MDKKTIYFICTGNSCRSQMAEGWGKKILGEDWNVYSAGIETHGVNPKAIEAMKEVDIDIS
NHTSDLIDNDILKQSDLVVTLCSDADDNCPILPPNVKKEHWGFDDPAGKE
>SEQF2892_02543 Chromate transport protein
MVFSALFINNDSSLTWIQGLKLVAVAIVAQAIIGMGKKLTNTKSTITLALFVLILSLTID
NLYIQVIALSITGIYGLIFLKETSTDINNLRVKTFKLPKMLGFISISLFFLLLIVLPIVS
SMTNNLWLRMFDSFYRSGSLVFGGGHVVLPLLENEFVPQGLISPDSFITGYAAAQAVPGP
LFTFSSYIGMSIEGIGGGVLATIAIFLPAFLLLFGVLPFWDDIKSNTYAEGFLKGISAGV
VGILIAAFYNPIWASTIKSELDFVLAISLFVFLVYYKLPSWSIVLIGIIIGIMFY
>SEQF2892_02544 Lactococcin-G-processing and transport ATP-binding protein LagD
MNIKYIKQYDEKDCGPTCLAMISQSFGKRVSIPRLRDYAKTDKLGTNLYGLIKAGEHIGI
KLTGVKVDSVNELKKVELPIIAHIVNKQGYNHFVIIESLKKDKIHIVDPAKGKYKLTKQQ
FNEIWTNIAVLVKKTESFNSRDESPSYMNIFTDIFKKNYKTLITIVIISVLINIIGIIGA
LYFKILTDNVIPSNVLSNLHTISIGVLILYIINALVTYLRYQMILKLSLEIDIGLMKDYF
KHVLHLPMNFFDTRKSGEILQRFMDTSKIREALSSSTVTLLVDTFMIIVGCVLLYLQSPT
LLLITVIFIPFFILCSLMMKQPFEHYNQKVAENDAELSSYLIESFDGSSTIKSYQSEPDR
FEQGSQKFNQLINNLIRLGQLSNIQLTINNFLKITVSLVILWIGSYFVMNDQMTLGSLLA
FNALTIFYLGPIERLINIQPTLQSSFVAARRIAEITDLDTEDKLHDNNYPFIFNNVINMD
NVKFQYGYRDVILDGINLKINKGQKIAIVGESGSGKSTIGKLLNHYYDVAEGEISIDQRP
INKIQLDELRHHIGYVSQETFLFADTILNNLLHGMNKGKSKEDIINACQLAEAVDFIQKQ
PDQFNTMLEKEGSNLSGGQAQRISLARTFLKDPDIYIFDEATSALDSRTEFKIMRHIDNL
IQSGKTAIVISHKLSTIQNADVIYTLKNGKIVEKGTHKNLLKNRNEYYKLWQLQTKNKEV
>SEQF2892_02545 hypothetical protein
MKHLTEKDLKSINAGDFWGDLGTITGNVINRVPKFGKSKSKNDK
>SEQF2892_02546 hypothetical protein
MKELTYDELIKNNGGNNETDPDGFAEHVGYGIGKVSDGVKSFVGNVADELK
>SEQF2892_02547 hypothetical protein
MQNLTNAETKNVNGGNKFTDAVNATKDWFGRVGKGADKAHEDNGWP
>SEQF2892_02548 hypothetical protein
MNYFRYKQFNKDVITVAVGYYLRYALSYRDISETLRERGVNVHHSTVYRWVQEYAPILYQ
IWKKKHKKVYYKWRIDETYIKIKGKWSYLYRAIDAEMQRDID
>SEQF2892_02549 hypothetical protein
MGVKYVLKKLKPQEQSCCSVEIEEKKEKNEKEQQDNNCCCNN
>SEQF2892_02550 Putative two-component membrane permease complex subunit SMU_747c
MLDSIMEFIKTFVMLFFELLILFIIVSFIVSLIQQVVSEEKIKRFLSKPNQAISYILGMV
FGAMTPFCSCSTIPILAGLLNSKVPFGPAMSFLISSPLMNPLMIFMLWALLGWKVAIVYF
IVLAIFSILTGFVFSKMNLAETYKGVNVKGDGFFANKNGSRFKQALNDAWAFLYPMIPYL
FIGVFIGAFIYGFVPETFITKYASGGGIISVFIASIIGIPMYIRPETMLPIAEALASKGM
SLGTVVALIIGGAGASIPEVVLLSKLFKKKFVISFVIAILVVAISTGLIVNIVI
>SEQF2892_02551 Arsenical resistance operon repressor
MEVIKAKTDMSEDQQFDFYENMFNALADKIRLKILNQISQSFNKSLCVCDLEELLDIKQS
KLSYHLKKLVDANVLIAEKHGTWNYYKINEQQIQVVLNEDTCCKIL
>SEQF2892_02552 hypothetical protein
MRVNHASTLTVGYFVSYLNLVMLSREINLKEATIYMEKEFFKGNINQYGESTKNNYKQAI
QELK
>SEQF2892_02553 Arsenical resistance operon trans-acting repressor ArsD
MLNIEIYEEAMCCSTGVCGPEPDETLIKANQINEYLKQNQIEVQRYNMNNNPNEFIKNQE
VIRLIQEKGDEVLPITFIEGNITKTGAYITQEEADEIITVNQMRNGGCCGGDGCC
>SEQF2892_02554 Arsenical pump-driving ATPase
MEMDAVKYLNKLNLDNIELTKYLFFTGKGGVGKTTISSFIALNLAENGKKVALVSTDPAS
NLQDVFQMELSNKLTKYQPIPNLSIANFDPIAAADDYKAQSIEPYEGILPEDVLSEMKEQ
LSGSCTVEVAAFNEFTNFLSDKTLEQEFDFIIFDTAPTGHTLRMLELPSAWTDYLNTTSN
DASCLGQLSGLDENRDKYNLALEKLRNPKDTTMMLIARPTHSSIYEIQRAQQELQQLSIS
KFKVIINNYIEESHGLISSQMKSEQDKNINHFTEWLNNNHAYYVPYKKQKEEGIESLTNL
LNDDNLIENDDFIVEDHPQFNKLIDEIESSKVQYLFTMGKGGVGKTTVATQLATALSNKG
YRVLLATTDPTKEINVETTSNLNTAYIDEEQALEKYKKEVLATVNDDTPQDDIDYIMEDL
KSPCTEEIAFFKAFSDIMENQDDMDYVIVDTAPTGHTLLLLDSSENHHRELKKKSTQTTS
NVETLLPKIQNKNLTQMIIVTLAEKTPYLESKRLVEDLNRANIGHNWWVVNQSLVTLNQR
DDLFSNKKEDESFWINKIKNESLDNYFVIPYGGVS
>SEQF2892_02555 Coenzyme A disulfide reductase
MKKIVIIGSVAAGTSVAAKARRNSEDVEIIVFDKDSDISYSVCGIPYYIGGNVSDIDELT
PRNAKWFKERFNIDIYTKYEVNQINDTDQTITVTNLVNDEKMIQEYDELVLATGSSPKEL
PQLNSEEYNNVFKVKNINDAKAIYNYIESNDVQNITIIGGGFIGLEMLEQLSNYNTSIIQ
RSTFMPHLDYDISFMIQEYIEDKANVYTYNEIDIIDYDENHTINRVSLKTGELIDTDLII
IGIGVTPNTKLAKEIGINIGKSGAIQTNKYFETNIPHIYAIGDVAESYNLITGDPIYRPL
GSTANKMGRILGDRLTGGNLEHKGILGTGIVRIFDMTIAQTGLTEKEAIDLDIDIDVLHN
VKPNRPEYMQGQEMVIKAIFDKNNSKLLGAQIIGYEGVDKRIDVLATAITFGAHAEDLFH
LDLAYAPPFSITKDPVIYTGMIGHNITRGRKIITPEEVIKQNNDLLILDVRSPKQFEVNH
VDGAINIPLKILRSYAKTLDKNQKIVTYCNKGTTGNAAQNVLINLGFKQVFNLSGGNKNY
QRYKRFQVERKKKN
>SEQF2892_02556 Transcriptional repressor SdpR
MNYKKISQYLKVIADSSRLEILDLLSCGELCACDLLEHFSFSQPTLSHHMKVLKDNNLIT
SRKDGNKILYKLNHDVLDDVTSRLTLLSSSAGPCICETVEKGEC
>SEQF2892_02557 Arsenical pump membrane protein
MMTILAITIFVLTLIFVIWQPKGLDIGITALIGAVVAIITGVVSFSDVLEVTGIVWNATL
TFVAVILISLILDEIGFFEWSAIHMVRASKGNGLKMFIFIMLLGSVVAAFFANDGAALIL
TPIVLAMVRSLGFDKKAIFPFIIASGFIADTTSLPLIVSNLVNIVSADYFDIGFVEYFSK
MIIPNIFSLIASILVLWLYFRKSIPRKFDAVNIREPKEAIKDKKLFNISWIVLTVLLVGY
LISEFINIPVSIIAGIIALIFVLLARKSKAVHTKQVIKGAPWNIVLFSIGMYLVVFGLKN
VGITTLLGDVLTNISNYGLFSSIMGMGFIAAFLSSIMNNMPTVLIDAIAIGQSQTTSILK
EGMIYANVIGSDLGPKITPIGSLATLLWLHVLTQKGVKISWGQYFKIGIIMTIPVLFITL
LGLYLTLIIF
>SEQF2892_02558 Glutaredoxin arsenate reductase
MDKKTIYFICTGNSCRSQMAEGWGKKILGDEWQVYSGGIEAHGVNPKAIEAMKEVGIDIS
NHASNLIDKNILNQSDLVVTLCSDADQNCPVLPPNVKKEHWGFDDPAGKPWSEFQRVRDE
IKAAIDSFKAR
>SEQF2892_02559 hypothetical protein
MMKKDKDTNDQKSESHMKHNDESKVPEDMTSTNEGEFKVGDKVTITAGHMPGMKGAEATV
KGAYKTYAYVVSYKPTNGNEKVNNHKWVVNEEIKDAPKDGFSKGDTVKLEASHMSGMKGA
TANIDNVKKTTVYVVDYKSKDNGKIIKNHKWMTGNELKAR
>SEQF2892_02560 Multicopper oxidase mco
MYNKVFTILIIIFSIIIIASNDTFAESKNDMMNMKEDKKNTMDMTNMKHHDERKKLNSSQ
GKNEIIFPEVAESKKDNNGYKNYTLKAQKGKTEFYKNNFSNTLGYNGNLLGPTLKLKKGD
KVKIKLINNLDENTTFHWHGLEVNGKVDGGPSQIIKPGKEKTIKFEVNQDSATLWYHPHP
SPNTAKQVYNGLSGLLYIEDSKKNNYPSNYGKNDLPIIIQDKTFVSKKLNYSKTKDEDGT
QGDTVLVNGIVNPKLTTKEEKIRLRLLNGSNARDLNLKLSNNQSFEYIASDGGQLKNAKK
LKEINLAPSERKEIVIDLSKMKGEKISLVDNDKTVILPISNKEKSSNKGNTPKVSKKIKL
EGMNDHVTINGNKFDPNRIDFTQKLNQKEVWEIENVKDKMGGMKHPFHIHGTQFKVLSVD
GEKPPKDMRGKKDVISLEPGQKAKIEVVFKNTGTYMFHCHILEHEDNGMMGQVKVTN
>SEQF2892_02561 Copper-exporting P-type ATPase B
MNNNGEEHNHQNHMNHSNHMHHDNHASHHHSGHAHHHGNFKVKFFVSLIFAIPIILLSPM
MGVNLPFQFTFPGSEWVVLILSTILFFYGGKPFLSGGKDEIATKKPGMMTLVALGISVAY
IYSLYAFYMNNFSSATGHTMDFFWELATLILIMLLGHWIEMNAVGNAGDALKKMAELLPN
SAIKVMDNGQREEVKISDIMTDDIVEVKAGESIPTDGIIVQGQTSIDESLVTGESKKVQK
NQNDNVIGGSINGSGTIQVKVTAVGEDGYLSQVMGLVNQAQNDKSSAELLSDKVAGYLFY
FAVIVGVISFIVWMLIQNDVDFALERLVTVLVIACPHALGLAIPLVTARSTSIGAHNGLI
IKNRESVEIAQHIDYVMMDKTGTLTEGNFSVNHYESFKNDLSNDTILSLFASLESQSNHP
LAISIVDFAKSKNVSFTNPQDVNNIPGVGLEGLIDNKTYKITNVSYLDKHKLNYDDDLFT
KLAQQGNSISYLIEDQQVIGMIAQGDQIKESSKQMVADLLSRHITPVMLTGDNNEVAHAV
AKELGISDVHAQLMPEDKESIIKDYQSDGNKVMMVGDGINDAPSLIRADIGIAIGAGTDV
AVDSGDIILVKSNPSDIIHFLTLSNNTMRKMVQNLWWGAGYNIVAVPLAAGALAFIGLIL
SPAVGAILMSLSTVIVAINAFTLKLK
>SEQF2892_02562 Transcriptional repressor SdpR
MSYKELSLQLKILSDPSRLEILDLLSCGELCACDLLAYFQFSQPTLSHHMKILVDNELVS
TRKDGTKRMYRLNHKSLDSINNELTYISSPTQQCMCKKIKTGECT
>SEQF2892_02563 Arsenical pump membrane protein
MTILAIIIFLLTLMFVIWQPKGLDIGITALFGAIIAIITGVVSLSDVIEVTGIVWNATLT
FVAVILISLILDEIGFFEWAAIHMVRASNGHGFKMFVYIMLLGAIVAAFFANDGAALILT
PIVLAMVRNLGFNQKVIFPFIIASGFIADTTSLPLIVSNLVNIVSADYFHIGFIEYVSRM
MIPNLFSLLASIVVLWLYFRKSIPKTFDTENLSDPKSVIKDSKLFKLSWIVLAVLLVGYL
VSEFIQIPVSIIAGIIAFIFVILAHKSKAVHTKQVIKGAPWNIVLFSIGMYLVVFGLKNV
EITTILADVLSNISSHGLFSSIMGMGFISAFLSSIMNNMPTVLIDAIAIGQSSATGILKE
GMIYANVIGSDLGPKITPIGSLATLLWLHVLTQKGVKISWGTYFKTGIIITIPVLFVTLL
GLYLTLIIF
>SEQF2892_02564 Glutaredoxin arsenate reductase
MDKKTIYFICSGNSCRSQMAEGWGKEILGEDWNVYSAGIETHGVNPKAIEAMKEVDIDIS
NHTSDLIDSDILEQSDLVVTLCSDADDNCPILPPNVKKEHWGFDDPAGKEWPEFQRVRDE
IGKRIQEFKETLV
>SEQF2892_02565 Cadmium resistance transcriptional regulatory protein CadC
MSNNKICDVICVHEEKVNYALRFLKEEKTQRLINTLLKISDENKLKIILALIKEKELCVC
DLSITLGLSIASTSHHLRALYKRDVLDFYKDGKMAYYYIKDIEMKSLLIKCMT
>SEQF2892_02566 hypothetical protein
MVQTIVTAAILYIATAVDLLVILLIFFARAKTRKEYRDIYIGQYLGSIILILVSLFLAFV
LNYVPEKWILGLLGLIPIYLGIKVAIYDDCEGEKRAKKELNEKGLSKLVRTVSLVTIASC
GADNIGLFVPYFVTLDIVELLTTLIVFLVLIFFLVFTAQKLARIPGVGEIVEKFSRWIMA
VIYIALGLFIIIENETIQTILGFIL
>SEQF2892_02567 hypothetical protein
MKNIIVRFIFSLLFYKSGVSHFKNKDMFLKIVPSYLPFKHAIVKCSGILEFIIVFYVLGA
KNRSRVRKVVQGFLWLVFLANIYAARKNISYKDERDRTDSVKQHVIRLPLQFVMVALAKL
L
>SEQF2892_02568 Putative NADP-dependent oxidoreductase YfmJ
MNNQQVVLAKRPQSIPQDDVFRFETIDTREPHAGEVQVESIYVSVDPYMRGRMNDTKSYV
QPFQVNEPLQGHIVGKVTQSNDERLSVGDYVTGILPWKKINTVNGDDVTPVPSKDVPLHL
YLSVLGMPGMTAYTGLLQIGQPQSGETVVVSAASGAVGSVVGQIAKIKGAKVVGIAGGKQ
KTTYLTDELGFDAAIDYKQDDFAQQLEAAVPDGIDVYFENVGGAISDEVFKYLNRFARVP
VCGAISAYNNEKDDIGPRIQGTLIKNQALMQGFVVAQFADHFKEASEQLAQWVSEGKIKF
EVTIDEGFDNLPSAFRKLFTGENFGKQVVKVAEE
>SEQF2892_02569 putative sugar epimerase YhfK
MKSLIIGANGGVGQHLVRKLKARDVDFTAGVRKEEQVEALKADGIDATYIDVAKQSIDEL
IELFKSYDQILFSVGSGGSTGDDQTIIVDLDGAVKAIKASEQIDHQHFIMVSTYDSRREA
FDASGDLKPYTIAKHYADDYLRHANLKYTIVHPGALTNEHETQQFNMSAQFENVQNPSIT
REDVAEVLVSVLTDEVLQGHEFQIINGDLSLLDATTKYLEE
>SEQF2892_02570 Molecular chaperone Hsp31 and glyoxalase 3
MKKALIAVTNIAKYDNLERPTGAWFSEVTHFAKDFYDAGYDVDFVSPNGGYVPLDPISLS
PEMMGAEDWEYYTDHDYMNKFGQTLSPKEVNPSDYQAIYFAGGHGAIWDLRNNKELNDIA
LSIYNNQGVLSSVCHGAAGLLDIKENGDYLVRHKDVTGFTNSEEQANGTTEYMPYLLEDE
FISNGAHFKKEADWSNFAVVDGRIVTGQNPQSGHAVAENALKILANQ
>SEQF2892_02571 putative HTH-type transcriptional regulator
MKQYYIEYVSDYCNIPKSKLRYYEKKSILKHIDRDSNNKRLYTDDDIEMIKFIQCLSNLN
MPLKEIRKNTDMLYQNQIDVPSVLRAHLEFLNEQRNLISTHIDLIEQKLQTAMTE
>SEQF2892_02572 hypothetical protein
MERLKSDYNVLNLHVNEKNEGAIRFYTKHQFEIRSKEFEVETQEYEYFMKWDSN
>SEQF2892_02573 hypothetical protein
MYSNWGRELQSIIENIDTKDVKEVMSQASKSYEELNSKRYTRNKEKYPMILNDIVKYELY
LLDGCNNVDEENKPKKWEDHDLFVPTKTNFSANFKKFCLALGIDSENFKIGKFYAFKYDS
KLIIHDILSNNSDYIHFLKNGVNKKDLESTNKINDNIYYFIKNEITNPIDYKTAMTNYYL
YFLIDSNIEVGIKSKVIDIITAPNVSSAQKIDIINYYMDELDELKDEVNARLAATQSYSY
SDYLEQECRVQIDVNLAKYLTKKETQASAPKSLVTRLLSQSELVDPPEYTKENRNKLISE
LKKALNYHLKNNNDKNNLDDSEYFYITSK
>SEQF2892_02574 hypothetical protein
MKYEGEYFVKHTPSVPFIIISKNSKWNSVYLKTGPNPKRQKRNWKGGNN
>SEQF2892_02575 hypothetical protein
MTNNIFKQYPYWLDSTAWYELIRAKNKNDEDKIIRLSSPIIIKNKFLDPTTGVEKLTITD
GKNIERIETSDILTTQKLPRLVMFGFSINEKYIKSLGNALQLMRQSLPISTLYTGVGVLR
TDEGTVISLDEPYLSKDIEQSQADEIICETKYDLQPKGTFEGWWQMYLDEVKGNLLLELS
VIFGVSSLVTAFLKTKHEVEYFGTIFSFMGNSSTGKSTAAALAVSIAGNPSKGDQTLFRG
WNGTRNAIEGYLSNNFGVPIVLDELSAATFKDTNGLLYSLAEGQGRLRANREGNVKKPHH
FGSSVISTAEHTIFKDASANDGLRARCIEISDVFTTSADNADAIKKGTSKNYGHVMPLVA
EYLLNRESEVIKWFYKEHDWFKVQLNNETNNVGIRMFKRYATIMTSARILERVIATPIDL
DAVREYLVSYHVDSVSERSLGAKAIDSVVQFVARNRSKFAENEKLSIMTENYGLIKLKDD
HIQVKMLKDVFKHMLEENQYQDVKNVIDSLRAEGYIQMDSDRIAIKRNVKDTHGKTKTIL
FYHLVLPSEFAPVLGLSSNSEPFTPPQFDNNTTNKELLNKFVKDGRKWEEKGDLEL
>SEQF2892_02576 hypothetical protein
MKTKVNLLNYTIDSVEVDDHQKPIVVNYIDRYYHMQQYVLTETEQKLLKFYHLYPEFINE
KEITEYIVPSTRSERITMQHVINSI
>SEQF2892_02577 Transposon gamma-delta resolvase
MKQAIGYLRQSTTKQQSLAAQKQTIKVLAEKHNIQHITFYSDKQSGRTNKRNGYQQITEQ
IQQGQCDVLCCYRLNRLHRNLKNALKLMKLCQTYHVHILSVHDGYFDMDKAFDRLKLNIF
ISLAELESDNIGEQVKNGIKEKARQGKLITTHAPFGYHYHNGTFTIDTVKSPTVKAVFNY
YLQGYGYKKIAQYLEADDKFINRKPYQVRNIILNPNYCGRVINQYGQYENMFPAIVSTTI
YEEAQVTRTQKQVKRKPSENQLKQKIKCPYCHSTLTNMTVRKPNHSLRYYVCPKNMNNAR
FVCEFKGINAQELETSVLATCQDFFQNQQLYSKINHTIQQRLKRQRDIETKTTLNHEQLI
EKLAQDKIDAETFREQTQSLRQQSKPISSISTYQIRKAFQNIIQQRFTLNMLYPYIDEIH
ITKNKTLTGIYFKNEPLNIVNQTAQSSIA
>SEQF2892_02578 DNA-invertase hin
MQQLKQKRVGIYVRVSTEIQNTEGYSINGQINQIRDYCQFHHFEVTDIYADRGISGKSMN
RPELQRMLKDANEGHIDCVMVYKTNRLSRNTSDLLKIVEDLHKQNVEFFSLSERMEVNTS
SGKLMLQILASFSEFERNNIVENVFMGQTRRAQEGYYQGNLPLGYDKIPDSKHELMINQH
EANIVKYIFESYAKGHGYRKIANTLNHKGYVTKKGKPFSISSITYILSNPFYMGKIQFAK
YKDWNEKRRKGLNDKPIIAEGKHAPIISQALWDKVQARKKQVSQKPQVHGKGTNLLTGIV
HCPQCGAPMAASNTTNTLKDGTKKRIRYYSCSNFRNKGSKVCSANSVRADVIEKYVMDQI
LEIVKSDKVLKQVVERVNQDNQVDVAALNHDIAYKQQQFDEINTKLKNLVQTIEDNPDLT
SALKPTIHQYETQLNDITNQMNQLKHQQNQEKPSYDTKQIAALLQRIFQNIEFMDKSQLK
ALYLTVIDRIDIRKDENHKKQFYVTLKLNNEIIKQLFNNNNLDEVLLSTSSLFLPQTLYF
QI
>SEQF2892_02579 hypothetical protein
MKTTTQELKQYITRLFQLSNNETWECEALEEAAENILPTRFVDHTPLAHLTLDTYTYYND
ELHELSIYPFLMYTNNQLISIGYLDHFDMDFLYLTDTKNTIIDERHLLKEGGTRHE
>SEQF2892_02580 hypothetical protein
MNNWIKVAQISVTVINEVIDIMKEKQNGGK
>SEQF2892_02581 hypothetical protein
MNINRYITRGISEHLSLDLQILLWNMVKERDNQPDTDYLHIFRLKEDENILSIIHEQEQP
TYKLEYHYTNYIKNQNALPKKVYVIREDDVDVFYYVMLLPEEY
>SEQF2892_02582 hypothetical protein
MNTIKSTINTEAIFSDDEQHRYLLKKTWDEKKPACTVITMYPHLDGVLSLDLTTVLILNQ
LANTEQYGAVYLVNLFSNIRTPENLKHIKNPYDEHTDIHLMKAISESDTVILAYGAYAKR
PVVIDRVEQVMEMLKPHKKKVKKLINPVTNEIMHPLNPKARQKWILKS
>SEQF2892_02583 hypothetical protein
MMLKVILYAYTQSVFSGRKIEKMLNDSIRMMWLSQNQKPSYKTINQFRVNPKVDALLESL
FIQFYSQCVKQNLIDDKAIFIDGTKIEANANRYTFVWKKSIQNHESKMNEDSKALYHELV
TNKIIPEIKEDHDNELTKEEIDLIGSHLDKEIEDLNQHINNEKCTKTRKQIRLKRTKIKK
YKKQINDYFERKYRYEFQKSILKDRNSYSKTDYDATFMRMKEDHMKNGQLKPGYNLQIAT
NSQFVLSYNVYQNPTDTRTMIPFLNSIQETYGHLPEYIVADAGYGSESNYKAIIDDFNRT
PLITYGMFIKDKTKKYKSDIFNTQNWNYDEINDEFICPNNKRLGFKRYAYRHDKYGYKRD
FKLYECDDCSECPLKNQCMNFNSKTNKKIMKNYNWEYFKSQINKKLSEPETKNIYSQRKI
DVEPVFGFMKAILGFTRMSVRGLNKVKRELGFVLMALNIRKVVAQRAENNQKIYKKDNFY
IISIEIVFFHLSKNFMSRTHYDLFFYC
>SEQF2892_02584 hypothetical protein
MYVVYRASHETAKEALGDKELRAIAHELTKTVKDNMSVDWSKRDSAKAKMRVQVRRLLKK
YGYPPDLQKMAVEQVVEQAELMASQQ
>SEQF2892_02585 Methicillin resistance mecR1 protein
MLSSFLMLSIISSLLTICVIFLVRMLYIKYTQNIMSHKIWLLVLVSTLIPLIPFYKISNF
TFSKDMMNRNVSDTTSSVSHMLDGQQSSVTKDLAINVNQFETSNITYMILLIWVFGSLLC
LFYMIKAFRQIDVIKSSSLESSYLNERLKVCQSKMQFYKKHITISYSSNIDNPMVFGLVK
SQIVLPTVVVETMNDKEIEYIILHELSHVKSHDLIFNQLYVVFKMIFWFNPALYISKTMM
DNDCEKVCDRNVLKILNRHEHIRYGESILKCSILKSQHINNVAAQYLLGFNSNIKERVKY
IALYDSMPKPNRNKRIVAYIVCSISSFT
>SEQF2892_02586 Beta-lactam-inducible penicillin-binding protein
MKKIKIVPLILIVVVVGFGIYFYASKDKEINNTIDAIEDKNFKQVYKDSSYISKSDNGEV
EMTERPIKIYNSLGVKDINIQDRKIKKVSKNKKRVDAQYKIKTNYGNIDRNVQFNFVKED
GMWKLDWDHSVIIPGMQKDQSIHIENLKSERGKILDRNNVELANTGTAYEIGIVPKNVSK
KDYKAIAKELSISEDYIKQQMDQNWVQDDTFVPLKTVKKMDEYLSDFAKKFHLTTNETES
RNYPLGKATSHLLGYVGPINSEELKQKEYKGYKDDAVIGKKGLEKLYDKKLQHEDGYRVT
IVDDNSNTIAHTLIEKKKKDGKDIQLTIDAKVQKSIYNNMKNDYGSGTAIHPQTGELLAL
VSTPSYDVYPFMYGMSNEEYNKLTEDKKEPLLNKFQITTSPGSTQKILTAMIGLNNKTLD
DKTSYKIDGKGWQKDKSWGGYNVTRYEVVNGNIDLKQAIESSDNIFFARVALELGSKKFE
KGMKKLGVGEDIPSDYPFYNAQISNKNLDNEILLADSGYGQGEILINPVQILSIYSALEN
NGNINAPHLLKDTKNKVWKKNIISKENINLLTDGMQQVVNKTHKEDIYRSYANLIGKSGT
AELKMKQGETGRQIGWFISYDKDNPNMMMAINVKDVQDKGMASYNAKISGKVYDELYENG
NKKYDIDE
>SEQF2892_02587 Bifunctional protein PaaZ
MKYDDFIVGETFKTKSLHITEEEIIQFATTFDPQYMHIDKEKAEQSRFKGIIASGMHTLS
ISFKLWVEEGKYGEEVVAGTQMNNVKFIKPVYPGNTLYVIAEITNKKSIKKENGLVTVSL
STYNENEEIVFKGEVTALINNS
>SEQF2892_02588 Glycerophosphodiester phosphodiesterase, cytoplasmic
MLTVYGHRGLPSKAPENTIASFKAASEVEGINWLELDVAITKDEQLIIIHDDYLERTTNM
SGEITELNYDEIKDASAGSWFGEKFKDEHLPTFDDVVKIANEYNMNLNVELKGITGPNGL
ALSKSMVKQVEEQLTNLNQNQEVLISSFNVVLVKLAEEIMPQYNRAVIFHTTSFREDWRT
LLDYCNAKIVNTEDAKLTKAKVKMVKEAGYELNVWTVNKPARANQLANWGVDGIFTDNAD
KMVHLSQ
>SEQF2892_02589 hypothetical protein
MLESREQLSVEEYETFFNRFDNQEFDFERELTQDPYSKVYLYSIEDHIRTYKIEK
>SEQF2892_02590 hypothetical protein
MNYFRYKQFNKDVITVAVGYYLRYALSYRDISEILRERGVNVHHSTVYRWVQEYAPILYQ
IWKKKHKKAYYKWRIDETYIKIKGKWSYLYRAIDAEGHTLDIWLRKQRDNHSAYAFIKRL
IKQFGKPQKVITDQAPSTKVAMAKVIKAFKLKPDCHCTSKYLNNLIEQDHRHIKVRKTRY
QSINTAKNTLKGIECIYALYKKNRRSLQIYGFSPCHEISIMLAS
>SEQF2892_02591 hypothetical protein
MSDNLSLFIDYINDNIIYGSEIKREKLENLFNQFAIKNVEKNIVYDELKSLDITIIESQD
SYKNKLKRLFSVLLQSKKI
>SEQF2892_02592 hypothetical protein
MIDNFMQVLKLIKEKRTNNVVKKSDWDKGDLYKTLVHDKLPKQLKVHIKEDKYSVVGKVA
TGNYSKVPWISIYDENITKETKDGYYLVYLFHPEGEGIYLSLNQGWSKISDMFPRDKNAA
KQRALTLSSELNKYITSNEFNTGRFYYAENKDSSYDLKNDYPSGYSHGSIRFKYYDLNEG
FTEEDMLEDLKKFLELFNELASKVTKTSYDSLVNSIDEIQEDSEIEEIRTAQKDKTLKEV
EAPKGIIPKYKKGVSKTTKNDSEIEKSNKENKLTGKVGEKLALNYFNELIDNKIDEDKKE
QFRNILNDNPGSQHGHGYDLVAFDPTNTDKAVEKFIEIKTSTSSSIEEPFFMSLNEMFAM
KEYKQKYLILRIFNVSGKEPQFYFIDPYANYSEFKDVDDLIDKVFNVEAIQYKVFGEK
>SEQF2892_02593 Ribosomal RNA large subunit methyltransferase H
MKITILAVGKLKEKYWKQAISEYEKRLGAYSKIEIIEVPDEKAPENMSDKEIEQVKEKEG
QRILAKIKPQATVITLEIQGKMLSSEGLAEEMQRRMTQGQSDFVFVIGGSNGLHEDVLKR
SNYALSFSKMTFPHQMMRVVLIEQVYRAFKIMRGEAYHK
>SEQF2892_02594 Putative metallo-hydrolase YycJ
MSRLIQMSVLASGSTGNATYVESDKGSLLVDVGLTGKKMEDLFSQIDRNIKDLNGILVTH
EHSDHIKGLGVLARKYGLPIYANENTWKAIEKKDSKIPMDQKFIFNPYETKSIAGFDIES
FNVSHDAIDPQFYIFHNNYKKFTMITDTGYVSDRMKGMIQGSDAFMFESNHDVDMLRMCR
YPWKTKQRILSDMGHVSNEDAGLAMTDVITGNTKRIYLSHLSQDNNMKDLARMSVSQVLN
EHDIDTEKEVLLCDTDKAQATPIYTL
>SEQF2892_02595 Two-component system WalR/WalK regulatory protein YycI
MNWKRTKTLFIFVFILVNILLVLIYVNKVTKSQINESESDNEVKFQQEEIKISKDILNKD
VSGTKMQMITAKSKDFESYAKGKSSLEAEDSGNTLTGEIDSTVNVSDSNLSDLKDYIMSN
VYNGKMYQLGDVTSDTVTYEQAYEGYPLVNNNKARLRFNINDGKATSYEQSVMNNIEPAK
SDNNPKKQVITPRKAVETLYFNRYLKSGDEVMDARLGYYSVVRETNVQLLQANWEIKVKH
KGKEDVKTYYVEATSSNPKVIDN
>SEQF2892_02596 Two-component system WalR/WalK regulatory protein YycH
MKSKEHIKSIILFLLVMMSVVLTFMVWNFSPDLNNIDSTDSKKSNAKTIGKPMSANIENV
ISPYQIVEVKGDKVKGLAPSRAQLSQVTGTLKNHEVSKVEHIHRDYNLNIPMLNDHFTVL
DFTYDMPLTTYLGQVLNSSAKVPKNFKFNRIIVSQNPKENIELYAISEDRHEVMKVTLTT
KANHFIKVMDHLNKEMQKYSEVITNKDTIDKSTHIFAPNRPKDMRSYRMVYDTIPVETMN
AILFEDSVIIRSGKSGSTTYNNNTGVANYNDESKKYHYKNLSEDESSSSDMDSTIPSTFE
YINGHGGFFNDDFRLFNTDNSSGELTYQLFLNGHPTFNDQQLNDIEVTWGDKGIYDYKRA
LLRSSVPLEGKTKSLDSVESVRSSLANNHTIDFEKVTNMVIGYKEDDQPDKDDIEVQRNS
EFVPTWYVQYDGDWYTYEDGRLE
>SEQF2892_02597 Sensor protein kinase WalK
MKWLKQLQSLHTKLVIVYVLLIIIGMQIIGLYFTNSLEKELTNNFMKNIKQYATQLEVNI
ERIYRDDPSNAQKEVQSLLNEYANRQEIEEIRFIDKDQIIMATAKISSHNMINQKVNDNS
VQKALSLGESNSHNVLKDYGSGKERIWIYNLPVKNGNETIGNIYIESNINDVYNQLNNIN
QIFIIGTAISLFITVILGFFIARTITRPITDMRNQTVEMSKGNYTQRVKIYGNDEIGELA
LAFNNLSKRVQEAQANTESEKRRLDSVITHMSDGIIATDRHGRVRIVNDMAIKMLGMSKE
DLIGYYMLSVLNLEDEFSLDEIQENNDSFLLDMNEDEGIIARVNFSTIVQETGFVTGYIA
VLHDVTEQQQVERERREFVANVSHELRTPLTSMNSYIEALEEGAWKDDNLAPSFLSVTRE
ETERMIRLVNDLLQLSKMDNESEQITKEIVDFNMFINKIINRHEMAAKDTTFVREIPSET
IFTEIDPDKMTQVFDNVITNAMKYSRGEKRVEFHVKQNALYNRMTIRIKDNGIGIPINKV
DKIFDRFYRVDKARTRKMGGTGLGLAISKEIVEAHNGRIWANSVEGQGTSIFITLPCEVI
DDGDWDEE
>SEQF2892_02598 Transcriptional regulatory protein WalR
MARKVVVVDDEKPIADILEFNLKKEGYDVYCAYDGNDAVDLIYEEEPDIVLLDIMLPGRD
GMEVCREVRKKFEMPIIMLTAKDSEIDKVLGLELGADDYVTKPFSTRELIARVKANLRRH
YSQPAQEVSDTTNEITIKDIVIYPDAYSIKKRGEDIELTHREFELFHYLSKHMGQVMTRE
HLLQTVWGYDYFGDVRTVDVTIRRLREKIEDDPSHPEYIVTRRGVGYFLQQHD
>SEQF2892_02601 Adenylosuccinate synthetase
MSSIVVVGTQWGDEGKGKITDFLAEQADVIARFSGGNNAGHTIQFGGETYKLHLVPSGIF
YKDKLAVIGNGVVVDPVALLKELDGLNERGVSTSNLRISNRAQVILPYHLAQDEYEERRR
GDNKIGTTKKGIGPAYVDKAQRIGIRMADLLEKETFERRLKENIEVKNAYFKGMFNETCP
RFDEIFDEYYAAGQRLKEFVTDTSKILDDAFVAEEKVLFEGAQGVMLDIDHGTYPFVTSS
NPVAGNVTVGTGVGPTFVSKVIGVCKAYTSRVGDGPFPTELFDEDGHHIREVGREYGTTT
GRPRRVGWFDSVVLRHSRRVSGITDLSINSIDVLTGLDTVKICTAYELDGEEITEYPANL
DQLRRCKPIFEELPGWEEDITGCRTLEELPDNARKYLERISELCNVRISIFSVGPDRDQT
NLLEQLW
>SEQF2892_02602 Replicative DNA helicase
MDNMYEQKQMPHNNEAEQSVLGAIILDPQLINSTQEVLLPESFYRGAHQHIFRAMMNLNE
DGDEIDVVTLMDQLTKEGTLSEAGGPQYLAELSNNVPTTRNIQYYTNIVANHALKRRLIQ
TADSIANDGYDNELELDAILSDAERRILELSSNRQSDGFKDIRDVLGQVYETAEELDQNS
GQTPGIPTGYRDLDQMTAGFNRNDLIILAARPSVGKTAFALNIAQKVATHEGNYTVGIFS
LEMGADQLATRMICSSGNVDSNRLRTGTMTEEDWNRFTIAVGKLSRTKIFIDDTPGIRIT
DLRSKCRRLKQEHGLDMIVIDYLQLIQGSGSRASDNRQQEVSEISRTLKAIARELECPVI
ALSQLSRGVEQRQDKRPMMSDIRESGSIEQDADIVAFLYRDDYYNRGEGEDDDDGGNFEP
QSNDENGEIEIIIAKQRNGPTGTVKLHFMKQYNKFTDIDYAHAEMS
>SEQF2892_02603 50S ribosomal protein L9
MKVIFTQDVKGKGKKGEIKDVPVGYANNFLIKNNYAVEATPGNLKQLEQQNKRAEADRQK
EIDDAKALKSKLEEIEVEVSAKTGEGGKLFGSVSTKQIAEALKTQHDIKIDKRKMDLPQG
IHALGYTNVPVKLDKEVEGTIRVHTVEK
>SEQF2892_02604 Cyclic-di-AMP phosphodiesterase GdpP
MNRQSTKKALLIPFILMVLTSIALVVVWFIFKPLVATIAAAILVVLIIISIVLVRQALLK
MDNYVDNLSGHISAGSNRAIKRLPIGMVVLDADDHIEWINQYMSEHLETNVISEPVNEVF
PNILKQLEKVQEVEIEHGQYHYHVRHSEEESCLYFFDITDEVQTNELYEESKPIIATLFL
DNYDEITQNMNDTQRSEINSMVTRVISRWASEYNIYFKRYNSDQFVAYLNQKILAEIEES
NFEILSQLREKSVGYRAQLTLSIGVGEGTENLIDLGELSQSGLDLALGRGGDQVAIKNMN
GNVRFYGGKTDPMEKRTRVRARVISHALKDILTEGDKVIIMGHKRPDLDAIGAAIGVSRF
ALMNNLEAYVVLNEEDIDPTLRRVMDEIDKKPELKERFVTSDEAWDMMTSKSTIVVVDTH
KPEMVLDENILNKANRKVVIDHHRRGESFISNPLLVYMEPYASSTAELVTELLEYQPTEQ
RLTRLESTVMYAGIIVDTRNFTLRTGSRTFDAASYLRAHGADTILTQHFLKDDVDTYINR
SELIRTVEVQDNGIAIAHGSNEKIYHPVTVAQAADELLSLEGIEASYVVAKREDNLIGIS
ARSLGSINVQLTMEALGGGGHLTNAATQLKGLSIEEAIEQLQQAITEQMSRSEDA
>SEQF2892_02605 hypothetical protein
MFSKVHPKATIIGTIALVMVALVTYVLPVLGLILCLFATIPGIILWNKSIPSFGIGALIT
VILTTLLGNTFVLSAMILVLILSFIIGQLLKERASKERILFIATTYLSIFTLVAFMLLQT
FKKIPSATTLIKPFKDTMHNAVVTSGVEADYKTILEEGFRQMAVQLPSFIIIMVFILVLI
NLIITFPILRKFKVATPIFKPLFAWQLNRSLLWVYMVVLLCVMFATEPSTFQSIVLNFEV
VLSLLMYIQGLSVIHFFGKAKRIPNAVTILLMVVGTIITPATHIIALLGVLDLGINLKRM
IKK
>SEQF2892_02606 Homoserine O-acetyltransferase
MTNYTVETLNLGPFTTESGEMIDNLQLRYEHVGYAGQPLVVVCHALTGNHLTYGTDDEPG
WWREIIDGGYMPIYDYQFLTFNVIGSPFGSSSPLTNPNFPKHLTLRDIVKAIELGIRALG
FNKINILIGGSLGGMQVMELLYNQQFEVDKAVILAATDKTSSYSRAFNEIAREAIHLGGK
EGLSIARQLGFLTYRSSKSYDQRFSPDEVVSYQRHQGNKFKETYDLSCYLTMLNVLDSHN
VDRGRTNVDDVYQSLDTKVLTMGFTDDLLYPDDQVRAVGERFKYHRHFFVPDNVGHDGFL
LNFNDWAPNLYHFLKVTKFKRK
>SEQF2892_02608 hypothetical protein
MTTSWHMFILIVLCGLVTLIIRVVPFLMISRIQLSETVIKWLSFIPITLFTALILDGIIE
QQEGVAGYTLNIPFVLVTIPTVFVALFTRSLTTTILVGIVLIAGLRFFF
>SEQF2892_02609 Inner membrane protein YgaZ
MPSHVTFKQGVKECIPTLLGYVGIGLSFGIVATSQHFSIIEILLLCLLVYAGAAQFIICA
LVATGTPISAIVLTTLIVNSRFFLLSMTLAPNYKDYGIWNRLGLSSILTDETFGVAITPH
LKGEKINDRWLHGLNLTAYSFWALASIVGALLGKYISNPDMLGLDFAITAMFIFLTMAQF
ESITSSKLKIYIVLIVFVIVMMLSLSWFMPSYVAILIASMLAATLGVVMDK
>SEQF2892_02610 Serine--tRNA ligase
MLDIRLFREQADTVKSKIELRGDDPKVVDEVLELDNERRQLIGKTEEMKARRNKVSEEIA
EKKRNKENADDVIKEMRELGDEIKENDAKLNEVDNKVRDILIRIPNLIAEDVPQGDSDEE
NVEVKKWGTPREFDFEPKAHWDLVEELKMADFERAAKISGARFVYLTKDGALLERALMNY
MLTKHTTQHGYTEMMTPQLVNADTMFGTGQLPKFEEDLFKVEKEGLYTIPTAEVPLTNFY
RDEIIQPGVLPEKFTAQTACFRSEAGSAGRDTRGLIRLHQFDKVEMVRIEKPEDSWDALE
DMTQNAEAILEELGLPYRRVILCTGDIGFSASKTYDLEVWLPSYDNYKEISSCSNCTDFQ
ARRANIRFKRDAASKPELAHTLNGSGLAVGRTFAAIVENYQNADGSITIPEALVPFMGGK
TEIRPVND
>SEQF2892_02612 ADP-dependent (S)-NAD(P)H-hydrate dehydratase
METLTTVNIPKRKEETHKGDYGKILLIGGSANLGGAIMLAARACVYSGSGLITVATHPTN
HAALHSRCPEAMVIDINDTKMLTKMIENTDSILIGPGLGVDFKGNNAITFLLQNIQPHQN
LIVDGDAITIFSKLKPDIPTCRIIFTPHQKEWERLSGIPIEEQTYERNREAVDKLGAAVV
LKKHGTEIFFKDKEYRLAIGTPAMATGGMGDTLAGMITSFVGQFDDFRDAITSATYTHSY
IGEKLSESMYVVPPSRLISEIPYVMKELEN
>SEQF2892_02613 DNA gyrase subunit A
MADLPQSRINERNITSEMRESFLDYAMSVIVSRALPDVRDGLKPVHRRILYGLNEQGMTP
DKPYKKSARIVGDVMGKYHPHGDSSIYDAMVRMAQTFSYRYPLVDGQGNFGSMDGDGAAA
MRYTEAKMTKITLELLRDINKDTIDFLDNYDGTEREPEVLPSRFPNLLVNGASGIAVGMA
TNIPPHNLTEVINGVLHLSKNPDVTIAELMEDIQGPDFPTAGLILGKSGIRRAYETGRGS
IQMRARAEIEERGGGRQRIVVTQIPYQVNKARMIEKIAELVREKKIEGITDLRDETSLRT
GVRVVIDVRKDANANVILNNLYKQTPLQTSFGVNMIALVNGRPKLINLKQALVEYLEHQK
TVVRRRTEYNLKKAKDRAHILEGLRIALDHIDEIITTIRESETDKVAMETLQERFKLSER
QAQAILDMRLRRLTGLERDKIENEYNELLGYISELEEILADDEVLLQLVRDELTDIKERF
GDERRTEIQLGGLDDLEDEDLILEEQIVITLSHNNYIKRLPVSTYRSQHRGGRGVQGMNT
LEEDFVSQLVTLSTHDHVLFFTNKGRVYKLKGYEVPELSRQSKGIPVINAIELDNDETIS
TMIAVRNLEDEDSYLVFATKNGIVKRSALSNFSHINKNGKIAIGFKEDDELIAVRLTDGN
QDILIGTSHASLIRFAETSLRPLGRTAAGVRGISLREDDVVVGLDVAHADSEDEVLVVTE
NGYGKRTPVSEYRLSNRGGKGIKTAKITERNGNIVCITTVNGEEDLMIVTNSGVIIRLEV
EDISQNGRATQGVRLMKLGDDQFVSTVAKVIDKTEDEDATEAAQTENGESNAESTESPSE
EVIDDDTPGNALHTEADEETTVSSDEEATDERIEVRQDFMDRVNEDIENASNNDEDDEN
>SEQF2892_02614 DNA gyrase subunit B
MVNTLSDVNNTDNYGAGQIQVLEGLEAVRKRPGMYIGSTSERGLHHLVWEIVDNSIDEAL
AGYANQIEVIIEKDNWIKVTDNGRGIPVDIQEKMGRPAVEVILTVLHAGGKFGGGGYKVS
GGLHGVGSSVVNALSEDLEVYVHRNDTIYHQAYKKGVPQFDLKEVGSTGKTGTVIRFKAD
SEIFTETTVYNYETLQKRIRELAFLNKGISITLRDEREDVEQREDTYHYEGGIKSYVELL
NENKEPIHEEPIYIHQTKDDVEIEIAMQYNSGYATNLLSYANNIHTYEGGTHEDGFKRAL
TRILNSYGTQSKIIKDDKERLSGEDTREGLTAVVSIKHGDPQFEGQTKTKLGNSEVRQIV
DRLFAEHFERFLYEHPNVARIVVEKGIMASRARVAAKKAREVTRRKSALEISSLPGKLAD
CSSKKPEESEIFLVEGDSAGGSTKEGRDSKTQAILPLRGKILNVEKARLDRILNNNEIRQ
MITAFGTGIGGEFDISKARYHKIVIMTDADVDGAHIRTLLLTFFYRFMRPLIEAGYVYIA
QPPLYKLAQGKQKYYVFNDRELDKLKSELSPTPKWQISRYKGLGEMNADQLWETTMNPEN
RMMLQVKLEDAIEADQTFEMLMGDVVENRRQFIEDNAVYANLDF
>SEQF2892_02615 DNA replication and repair protein RecF
MKLKTLQLENYRNYEEVTLECHPDVNILIGENAQGKTNLLESIYTLALAKSHRTSNDKEL
IRFNSEYAKIEGVLNYRHGTMPLTMFITKKGKQVKVNHLEQSRLTQYVGHLNVVLFAPED
LNIVKGSPQIRRRFIDMELGQISAVYLNDLAQYQRILKQKNNYLKQLQLGQKQDTTMLEV
LNQQFAQYALNVTLRREHFIKELESLAKPIHAGITNERETLSLTYLPSIKLSDMSKGEQT
LLDEVITLLNDNIKREMDRGVCLFGPHRDDLGFNVNDMDAQTYGSQGQQRTTALSIKLAE
IELMNIEVGEYPVLLLDDVLSELDDSRQTHLLSTIQHKVQTFVTTTSVDGIDHEIMNNAK
LYRINQGEIIK
>SEQF2892_02616 hypothetical protein
MVQEVVVEGDITLGQFLKTEGIIESGGQAKWFLQDVEVLINGERETRRGKKLANQDRIDF
PDIPEIDSVIIIHQGEQ
>SEQF2892_02617 DNA polymerase III subunit beta
MMEFTIRRDYFINQLNDTLKAISPRTTLPILTGIKIDAKDNEVILTGSDSEISIEITIPK
QVDGEDIVTISETGSVVLPGRFFVDIIKKLPGKDVKLSTNEQFQTLITSGHSEFNLSGLD
PDQYPLLPQISRDDAIQLSVKVLKNIIAQTNFAVSTSETRPVLTGVNWLIQDDELICTAT
DSHRLAVRKLKLEDDSENKNVIIPGKALSELNKIMSDSDEEIDIFFASNQVLFKVGNVNF
ISRLLEGHYPDTTRLFPENYEIKLGLDNGEFYHAIDRASLLAREGGNNVIKLSTGNDVVE
LSSTSPEIGTVKEEVTATDVEGGNLKISFNSRYMMDALKAIDNDEVEVEFFGTMKPFILK
PKEDDSVTQLILPIRTY
>SEQF2892_02618 Chromosomal replication initiator protein DnaA
MSEQEIWKKVLEVAESEISKSTFNTFLKDTELKEIRDNVAIIFVIHEFYAEWLNSNYKEV
IQTIMKDVIGYEVEPKFFTAEQLAELDETSRKSNTPSEPQRQIIEDGHEGIDQFNTHNTF
DTFVIGPGNRFPHAASLAVAEAPAQAYNPLFIYGGVGLGKTHLMHAIGHHVLSNQPNAKV
LYTSSEKFTNDFIKSIRNNEPEAFREKYRNIDVLLIDDIQFIQNKEQTQEEFFHTFNELH
QNKKQIVISSDRPPKEIAKLEDRLRSRFEWGLIVDITPPDYETRMAILQKKIEEENLEIP
AEALNYIANQIQSNIRELEGALTRLLAYSKLQGRPITTELAAEALKDIIQVPKSKKITIQ
DIQKVVGHYYNVRIEDFSAKKRTKSIAYPRQIAMYLSRELTDFSLPKIGEEFGGRDHTTV
IHAHEKIAKDIKADTIFKQEVEDLEKEIRNQ
>SEQF2892_02619 hypothetical protein
MTQVHFTLKSEEIQSIIEYSVKDDVSKNILTTVFNQLMENQRTEYIQAKEYERTENRQSQ
RNGYYERSFTTRVGTLELKVPRTRDGHFSPTVFERYQRNEKALMASMLEMYVSGVSTRKV
SKIVEELCGKSVSKSFVSSLTEQLEPMVNEWQNRLLSEKNYPYLMTDVLYIKVREENRVL
SKSCHIAIGITKDGDREIIGFMIQSGESEETWTTFFEYLKERGLQGTELVISDAHKGLVS
AIRKSFTNVSWQRCQVHFLRNIFTTIPKKNSKSFREAVKGIFKFTDINLAREAKNRLIHD
YIDQPKYSKACASLDDGFEDAFQYTVQGNSHNRLKSTNLIERLNQEVRRREKIIRIFPNQ
TSANRLIGAVLMDLHDEWIYSSRKYINFDK
>SEQF2892_02621 hypothetical protein
MISVISYSIEIFKYLYSEFSFPLLIMVIIIIFYKQIKNILDDLTKLHISWNDRSIGIERE
KKETVELMQMLLKDKVGSEGKSVIYEGQRGAGGEELDTHDPMYFSNLITSKIFLINQVEK
YNKFFIAEKLFEGYESKCMEKYGTNYHGAIIETRDENIILTDETIRKFYFLTKDIEKENE
YLSLDDLNKFRLLIFAFTH
>SEQF2892_02622 Beta-lactamase
MKKLIFLIVIALVLSACNSNSSHAKELNDLEKKYNAHIGVYALDTKSGKEVKFNSDKRFA
YASTSKAINSAILLEQVPYNKLNKKVHINKDDIVAYSPILEKYVGKDITLKALIEASMTY
SDNTANNKIIKEIGGIKKVKQRLKELGDKVTNPVRYEIELNYYSPKSKKDTSTPAAFGKT
LNKLIANGKLSKENKKFLLDLMLNNKSGDTLIKDGVPKDYKVADKSGQAITYASRNDVAF
VYPKGQSEPIVLVIFTNKDNKSDKPNDKLISETAKSVMKEF
>SEQF2892_02623 Regulatory protein BlaR1
MAKLLIMSIVSFCFIFLLLLFFRYILKRYFNYMLNYKVWYLTLLAGLIPFIPIKFSLFKF
NNVNNQAPTVESKSHDLNHNINTTKPIQEFATDIHKFNWDSIDNICTVIWIVLVIILSFK
FLKALLYLKYLKKQSLYLNENEKNKIDTILFNHQYKKNIVIRKAETIQSPITFWYGKYII
LIPSSYFKSVIDKRLKYIILHEYAHAKNRDTLHLIIFNIFSIIMSYNPLVHIVKRKIIHD
NEVEADRFVLNNINKNEFKTYAESIMDSVLNVPFFNKNILSHSFNGKKSLLKRRLINIKE
ANLKKQSKLILIFICIFTFLLMVIQSQFLMGQSITDYNYKKPLHNDYQILDKSKIFGSNS
GSFVMYSMKKDKYYIYNEKESRKRYSPNSTYKIYLAMFGLDRHIINDENSRMSWNHKHYP
FDAWNKEQDLNTAMQNSVNWYFERISDQIPKNYTATQLKQLNYGNKNLGSYKSYWMEDSL
KISNLEQVIVFKNMMEQNNHFSKKAKNQLSSSLLIKKNEKYELYGKTGTGIVNGKYNNGW
FVGYVITNHDKYYFATHLSDGKPSGKNAELISEKILKEMGVLNGQ
>SEQF2892_02624 Penicillinase repressor
MANKQVEISMAEWDVMNIIWGKKSVSANEIVVEIQKYKEVSDKTIRTLITRLYKKEIIKR
YKSENIYFYSSNIKEDDIKMKTAKTFLNKLYGGDMKSLVLNFAKNEELNNKEIEELRDIL
NDISKK
>SEQF2892_02625 DNA-invertase hin
MKIGYARVSTGLQNLNLQEDQLNQYGCEKIFSDHISGSKSKRPGLDKAIEFARAGDTIVV
WRLDRLGRNMEDLITLVNELNNRGVSFHSLEENITMDKSSSTGQLLFHLFAAFAEFERNL
ILERSSAGRIAARARGRYGGRPEKLNKQDLKLLKTLYDNGTPIKTIAEQWKVSRTTIYRY
LNRLNNQENKDK
>SEQF2892_02626 Putative transposon Tn552 DNA-invertase bin3
MIVGYARVSSVDQNLERQLENLKTFGAEKIFTEKQSGQSIENRPVFQEALNFVRMGDRFV
VESIDRLGRNYDEVINTVNYLKEKEVQLMITSLPMMNEVIGNPLLDKFMKDLIIQILAMV
SEQERNESKRRQAQGIQVAKEKGVYKGRPLLYSPNAKDPQKRVIYHRVVEMLEEGKAISK
IAKEVNITRQTVYRIKHDNDDLF
>SEQF2892_02627 hypothetical protein
MTKKMVIISFGRILLIIIGALITAYGLESILIPNNVSDGGVTGISIVGSTLFGLPLGILI
GIINLPFIWLGYKQIGRKFAIFSIIGILSLSIFTSIMHHVPTIIEGDSLLITVVGGVVIG
LGMGLALRNGGALDGIDMLAVLLSRKLPFGTSDLILFLNTFVFILVSTVFGFKGAILSAL
AYFIASKVIHIIEEGLSGSKTFKIITKDYDIMNKEIKERLGRYCTFTKVTIDEENNSFVE
ISCVINKLEEQKLKEIINDVDPDAFIAIYDTAEVKAGNMKKSDIY
>SEQF2892_02628 Capsule biosynthesis protein CapD
MLQGLKLDEMLNNGQSDEQYLNSVLSGRDLMYSNRDIVNAKTNFSQEYLSNMYISNKYNN
QNTSDSISDNSVKKTSTLHFVVVNKQGQMTSTTNTLSGYFGSGKYMDEGFYMNNSMTNFS
DNKDSNNYHAKNTVPRSYISPTIIVGPDYYMGIGSPGGNKIPTILNEVIIDYLRGNGSLQ
DSIYKPRFYNDGNTVHFEKGMNKKYLDILQNQGYNIKEEKDNPNFGSVQAGIYHIKNKKT
EIANDVGTR
>SEQF2892_02629 hypothetical protein
MPFNVLVSCGCFTISPFLTVLPSPLKKGDDLSIPLLYFFTLQQNPYFLITNNAEKLRIRL
EELFNANTVYIQRIKDRPLEARKDVDERDLEKIDQCVILFGDVKLMIADDTEGLPITKGN
NVSLCVTFENVEDTKRIYDKFVELGSEILLPFAPKFYTEGYGYVKDEFGIAYHLFTKRKN
